data_2jz7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jz7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.2 t80 . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.8 mt -134.1 131.69 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.341 -0.849 . . . . 0.0 110.205 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.5 tt -129.37 125.22 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.08 -1.012 . . . . 0.0 108.762 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.8 t -122.88 139.04 54.46 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.332 -0.855 . . . . 0.0 110.302 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.648 ' OG1' ' OG1' ' B' ' 69' ' ' THR . 3.1 m -91.12 98.6 11.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.012 -1.055 . . . . 0.0 108.928 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.56 91.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.23 -0.919 . . . . 0.0 110.319 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -162.93 -128.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -173.68 -17.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.271 -0.893 . . . . 0.0 109.6 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.443 HG22 HD13 ' A' ' 15' ' ' ILE . 24.1 mt 49.69 69.0 2.93 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.581 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.76 156.85 50.93 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.975 1.783 . . . . 0.0 110.035 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.18 -9.42 74.88 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.824 -1.179 . . . . 0.0 110.495 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.5 mt -122.54 139.31 54.04 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.137 -1.214 . . . . 0.0 110.071 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -87.56 116.46 25.69 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.7 mt -107.12 134.62 49.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.348 -0.845 . . . . 0.0 109.339 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.532 ' CE1' ' O ' ' A' ' 22' ' ' SER . 2.1 t80 -121.11 129.71 53.42 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.532 ' O ' ' CE1' ' A' ' 21' ' ' TYR . 20.8 t -84.24 129.07 34.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.407 -0.808 . . . . 0.0 110.522 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.644 ' CD2' ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -119.29 15.44 13.07 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.03 170.8 11.94 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.352 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -109.13 144.5 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.78 144.75 42.99 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.552 -0.718 . . . . 0.0 109.4 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -152.39 139.92 19.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.91 -1.119 . . . . 0.0 108.258 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 t -150.26 136.55 18.78 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.902 -1.124 . . . . 0.0 109.548 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.0 mt -101.38 126.91 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.144 -0.973 . . . . 0.0 109.171 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.7 p -175.36 175.98 2.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.338 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 16.0 p-10 -115.75 161.16 19.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.542 -0.723 . . . . 0.0 109.117 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 11.2 m-20 77.14 120.26 0.05 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.6 t -66.26 -33.13 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.444 -0.785 . . . . 0.0 109.697 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -56.97 -39.65 75.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.911 . . . . 0.0 110.145 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -76.57 -36.51 57.54 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.179 -0.95 . . . . 0.0 109.372 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.7 mt -64.36 -51.9 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.932 -1.105 . . . . 0.0 109.399 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.74 -50.18 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.048 -1.033 . . . . 0.0 109.257 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -60.16 -41.38 92.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.295 -0.878 . . . . 0.0 109.758 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -62.93 -46.16 89.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.136 -0.977 . . . . 0.0 110.009 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.5 mt -69.38 -46.47 66.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.001 -1.062 . . . . 0.0 108.767 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -48.03 -55.05 11.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.789 -1.194 . . . . 0.0 108.87 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.45 -35.23 67.65 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.939 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -75.13 -35.88 61.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.37 -0.831 . . . . 0.0 109.81 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.8 t -73.82 -50.91 26.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.146 -0.971 . . . . 0.0 109.439 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -68.71 -31.7 70.97 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.566 -1.334 . . . . 0.0 109.174 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.84 -31.63 72.68 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -90.38 5.63 46.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -0.877 . . . . 0.0 109.023 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.72 27.04 73.03 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.664 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.92 -167.58 23.8 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 34.7 ttp -110.73 -41.3 4.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.616 -0.932 . . . . 0.0 109.478 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.91 -153.01 11.35 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 tp -133.2 135.46 45.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.357 -1.084 . . . . 0.0 109.788 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.418 ' O ' ' CB ' ' A' ' 54' ' ' ALA . 1.1 pt -111.0 146.38 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.497 -0.752 . . . . 0.0 110.276 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 53' ' ' ILE . . . 75.01 87.79 0.09 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.357 -0.839 . . . . 0.0 109.14 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -115.05 50.51 0.97 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.591 ' O ' ' O ' ' A' ' 57' ' ' ILE . 30.4 ttm180 -65.87 -56.81 9.89 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.536 -0.727 . . . . 0.0 109.602 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.591 ' O ' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.065 0 CA-C-O 122.202 1.001 . . . . 0.0 109.436 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.7 p90 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.665 0.745 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.98 159.57 29.72 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.546 ' HG1' ' HG1' ' E' ' 11' ' ' THR . 60.4 m -107.03 140.13 40.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.149 -1.207 . . . . 0.0 109.37 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.4 mt -87.34 135.74 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 m -138.96 162.14 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 109.673 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -154.46 143.11 20.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.887 . . . . 0.0 109.042 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.84 150.37 35.62 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.915 -1.116 . . . . 0.0 108.015 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.9 t70 . . . . . 0 C--N 1.3 -1.547 0 O-C-N 120.919 -1.113 . . . . 0.0 109.097 179.645 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 82.1 t80 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 11.9 mt -136.09 138.27 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.284 -0.885 . . . . 0.0 109.962 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.443 ' O ' ' CG2' ' B' ' 9' ' ' ILE . 3.8 tt -118.99 121.84 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.267 -0.895 . . . . 0.0 108.588 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 7.3 t -123.76 135.56 53.89 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.395 -0.815 . . . . 0.0 110.296 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 21.6 m -113.68 112.42 23.45 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 52.52 55.55 8.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.394 -0.816 . . . . 0.0 110.205 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -160.4 111.73 1.91 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.538 -0.727 . . . . 0.0 109.082 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -64.38 169.91 4.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 109.62 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.405 HG21 HD13 ' B' ' 15' ' ' ILE . 22.5 mt -135.48 71.69 65.61 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.519 -0.738 . . . . 0.0 109.064 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.8 157.6 37.18 Favored 'Trans proline' 0 C--N 1.319 -0.979 0 C-N-CA 121.873 1.715 . . . . 0.0 110.054 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.73 -8.4 73.99 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.367 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 20.4 mt -123.38 139.55 53.92 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.221 -1.164 . . . . 0.0 110.097 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -88.48 109.01 19.69 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt -97.85 141.34 30.95 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.266 -0.896 . . . . 0.0 110.773 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' B' ' 71' ' ' VAL . 4.2 t80 -121.35 129.27 52.97 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 28.9 t -72.94 130.61 40.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.674 -1.266 . . . . 0.0 111.317 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.44 ' O ' ' NZ ' ' B' ' 47' ' ' LYS . 18.5 mt -118.68 9.35 12.13 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.3 -161.81 19.71 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.22 144.99 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 122.234 -0.568 . . . . 0.0 109.484 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.69 158.12 20.44 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 86.0 p -150.25 140.82 22.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 108.917 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 20.6 p -140.24 135.34 32.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.326 -0.859 . . . . 0.0 109.409 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.459 ' O ' ' CB ' ' B' ' 30' ' ' SER . 96.5 mt -126.79 125.48 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' B' ' 29' ' ' ILE . 1.9 p 163.3 -164.11 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 16.0 p-10 -122.19 173.13 7.78 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 18.3 m-80 76.91 112.46 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.3 -35.36 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.435 -0.791 . . . . 0.0 109.642 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -56.99 -37.27 71.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 110.057 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -76.46 -36.61 57.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.219 -0.926 . . . . 0.0 109.324 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 82.0 mt -66.22 -53.62 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.898 -1.126 . . . . 0.0 109.425 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 40.2 t -59.35 -51.87 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.004 -1.06 . . . . 0.0 109.513 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -56.13 -36.22 68.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 109.622 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -66.68 -40.33 88.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.043 -1.036 . . . . 0.0 109.852 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 70.4 mt -74.5 -50.84 16.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.95 -1.094 . . . . 0.0 108.988 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -48.85 -53.01 21.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.808 -1.182 . . . . 0.0 108.861 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -59.0 -36.79 75.49 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.438 -0.788 . . . . 0.0 110.026 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -75.25 -35.85 61.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.232 -0.918 . . . . 0.0 109.945 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 4.9 t -74.2 -51.42 23.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 109.448 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 33.7 tptt -70.75 -29.75 66.07 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.234 -1.386 . . . . 0.0 109.548 -175.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.12 -31.25 71.7 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.44 ' NZ ' ' O ' ' B' ' 23' ' ' LEU . 12.5 mtpt -92.75 2.19 56.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 109.226 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.22 29.3 64.62 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.336 -1.411 . . . . 0.0 110.016 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.77 -170.54 25.73 Favored Glycine 0 N--CA 1.492 2.383 0 O-C-N 121.209 -1.171 . . . . 0.0 110.585 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -107.95 -48.8 3.32 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.725 -0.868 . . . . 0.0 109.291 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -167.7 -160.94 16.14 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.4 tp -136.82 138.51 40.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.299 -1.118 . . . . 0.0 109.99 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.552 ' O ' ' CB ' ' B' ' 54' ' ' ALA . 0.4 OUTLIER -107.0 147.62 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.411 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.64 ' O ' ' CB ' ' B' ' 55' ' ' PHE . . . 90.38 -146.59 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.64 ' CB ' ' O ' ' B' ' 54' ' ' ALA . 67.4 t80 120.71 -101.52 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 120.529 1.513 . . . . 0.0 107.077 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' B' ' 55' ' ' PHE . 25.8 mtm180 55.52 161.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.38 -0.825 . . . . 0.0 109.79 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 79.3 mt . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.249 -0.907 . . . . 0.0 108.941 -179.594 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 tp . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.53 115.43 4.72 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' B' ' 67' ' ' TYR . 7.3 p90 -137.24 -175.96 4.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -1.115 . . . . 0.0 110.319 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.48 167.63 29.4 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' THR . . . . . 0.648 ' OG1' ' OG1' ' A' ' 11' ' ' THR . 87.5 m -95.01 138.48 32.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.029 -1.277 . . . . 0.0 109.076 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 70.6 mt -87.5 125.36 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 3.0 m -122.78 162.51 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.306 -0.871 . . . . 0.0 110.558 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . 0.427 ' NZ ' ' CG ' ' B' ' 74' ' ' ASP . 11.6 tttp -154.92 135.15 13.17 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.02 114.82 29.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.556 -1.34 . . . . 0.0 111.598 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . 0.427 ' CG ' ' NZ ' ' B' ' 72' ' ' LYS . 6.8 p-10 . . . . . 0 N--CA 1.491 1.603 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.241 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . 0.6 ' HZ1' ' NZ ' ' C' ' 45' ' ' LYS . 53.6 tttp . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 7' ' ' PHE . . . . . 0.481 ' N ' ' HG2' ' C' ' 6' ' ' LYS . 70.1 t80 -101.42 119.88 39.43 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.042 -1.036 . . . . 0.0 109.268 -178.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 8' ' ' ILE . . . . . 0.411 ' O ' ' HA3' ' C' ' 51' ' ' GLY . 60.8 mt -115.46 143.21 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.543 -0.723 . . . . 0.0 110.067 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' ILE . . . . . . . . . . . . . 12.9 tt -138.54 114.56 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.742 -1.224 . . . . 0.0 108.853 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -123.95 161.78 24.73 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.395 -0.816 . . . . 0.0 108.958 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 1.2 p -114.6 79.0 1.21 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . 0.463 ' O ' ' CG ' ' C' ' 13' ' ' ASP . . . -179.04 -10.21 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.486 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . 0.463 ' CG ' ' O ' ' C' ' 12' ' ' ALA . 3.2 p30 43.73 83.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.348 0.594 . . . . 0.0 110.272 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -154.72 -87.86 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.402 -0.811 . . . . 0.0 109.545 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 7.3 mt 48.99 66.23 6.01 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.226 -0.921 . . . . 0.0 109.247 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.53 157.71 49.55 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 C-N-CA 122.085 1.856 . . . . 0.0 109.885 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.99 -7.0 73.22 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.676 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 58.2 mt -124.46 140.55 52.84 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.997 -1.296 . . . . 0.0 110.246 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . 0.419 ' N ' ' CD ' ' C' ' 19' ' ' GLN . 2.9 mp0 -85.64 108.38 17.98 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -92.2 134.25 35.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.077 -1.014 . . . . 0.0 110.092 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -117.35 130.31 56.43 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.82 131.64 43.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.68 -1.262 . . . . 0.0 111.134 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 25.0 mt -114.64 10.54 16.75 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.14 -154.57 16.41 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -134.69 143.56 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.82 -0.812 . . . . 0.0 109.492 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.98 149.24 40.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.832 -0.542 . . . . 0.0 109.714 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 60.7 p -151.56 138.18 18.75 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -149.34 147.77 28.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.98 -1.075 . . . . 0.0 108.973 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 tt -127.59 133.37 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.2 -0.937 . . . . 0.0 109.049 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 5.3 t -169.54 170.56 8.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.291 -0.88 . . . . 0.0 109.474 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -104.31 37.56 2.07 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.835 0.826 . . . . 0.0 110.296 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -152.5 125.08 8.3 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . 0.43 ' CG2' ' N ' ' C' ' 34' ' ' ASP . 0.7 OUTLIER -72.69 -45.51 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.106 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . 0.43 ' N ' ' CG2' ' C' ' 33' ' ' VAL . 5.7 p-10 -62.08 -34.77 76.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.426 -0.796 . . . . 0.0 109.99 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -74.01 -38.51 64.07 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.584 -0.846 . . . . 0.0 108.808 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 68.1 mt -63.02 -51.33 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.96 . . . . 0.0 108.646 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.55 -49.8 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.991 . . . . 0.0 108.691 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -61.68 -45.5 93.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.348 -0.845 . . . . 0.0 109.955 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -59.39 -46.63 88.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.329 -0.857 . . . . 0.0 109.557 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 41.1 mt -66.93 -44.24 81.19 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.123 -0.986 . . . . 0.0 108.384 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' ARG . . . . . 0.407 HH21 ' HZ3' ' C' ' 45' ' ' LYS . 55.5 ttt180 -46.76 -56.21 6.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.818 -1.176 . . . . 0.0 108.636 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -53.46 -32.16 48.78 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.34 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -74.42 -40.77 61.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.444 -0.785 . . . . 0.0 109.259 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 10.1 t -77.85 -53.53 14.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 120.774 -1.204 . . . . 0.0 108.921 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' LYS . . . . . 0.6 ' NZ ' ' HZ1' ' C' ' 6' ' ' LYS . 16.8 tttt -50.58 -31.66 16.46 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.769 1.271 . . . . 0.0 109.795 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.38 -25.81 46.38 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.482 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -98.15 -0.92 43.38 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.9 26.46 73.91 Favored Glycine 0 N--CA 1.487 2.087 0 C-N-CA 118.335 -1.888 . . . . 0.0 109.637 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.79 -167.87 15.55 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 5.0 ttp -110.18 -43.79 3.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.586 -0.949 . . . . 0.0 110.462 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' C' ' 8' ' ' ILE . . . 177.55 -172.22 44.95 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.556 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.52 132.07 53.64 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.374 -1.074 . . . . 0.0 110.62 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 pt -109.61 139.14 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.44 61.96 2.65 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.888 -1.133 . . . . 0.0 108.665 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -96.57 109.32 21.94 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' ARG . . . . . 0.674 ' HG3' HH11 ' C' ' 56' ' ' ARG . 9.7 mmm-85 -125.02 154.62 40.98 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.419 -0.8 . . . . 0.0 109.306 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' ILE . . . . . 0.476 ' CG2' ' HH ' ' D' ' 67' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 44.6 p90 . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 121.694 0.759 . . . . 0.0 109.711 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.48 166.42 34.17 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.406 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 34.4 m -101.92 140.21 36.5 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.307 -1.113 . . . . 0.0 108.424 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 56.2 mt -85.53 148.5 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 6.8 m -142.96 156.18 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.158 -0.964 . . . . 0.0 109.765 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -146.04 156.17 43.29 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.216 -0.927 . . . . 0.0 108.731 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' C' ' 74' ' ' ASP . . . -119.88 153.38 35.92 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' C' ' 73' ' ' ALA . 16.2 m-20 . . . . . 0 N--CA 1.505 2.288 0 CA-C-O 121.37 0.605 . . . . 0.0 109.736 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -101.44 123.8 46.08 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.274 -0.891 . . . . 0.0 109.515 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 87.4 mt -119.12 146.29 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.636 -0.665 . . . . 0.0 109.489 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 9' ' ' ILE . . . . . 0.474 ' O ' ' CG2' ' D' ' 9' ' ' ILE . 13.2 tt -138.35 116.38 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.419 -0.8 . . . . 0.0 109.001 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t -121.95 160.75 24.18 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 11' ' ' THR . . . . . 0.512 ' OG1' ' OG1' ' E' ' 69' ' ' THR . 1.3 m -130.45 123.79 30.57 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . 59.85 49.81 7.56 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 122.117 0.96 . . . . 0.0 109.307 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -138.6 -171.02 2.96 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 55.0 mp0 -147.09 -18.03 0.4 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.035 -1.041 . . . . 0.0 109.622 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 27.8 mt 49.36 66.74 5.26 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.237 -0.914 . . . . 0.0 109.148 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.04 157.59 38.39 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 121.962 1.774 . . . . 0.0 110.076 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.97 -8.09 73.27 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.508 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 25.5 mt -122.52 138.44 54.56 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.147 -1.207 . . . . 0.0 110.187 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -90.31 116.74 28.51 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 11.9 mt -100.61 140.43 34.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.576 -0.702 . . . . 0.0 110.725 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -118.63 129.79 55.5 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 6.2 t -68.46 130.2 42.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.712 -1.243 . . . . 0.0 112.022 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . 0.503 ' O ' ' NZ ' ' D' ' 47' ' ' LYS . 40.4 mt -116.54 13.64 15.37 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.68 -170.13 13.21 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.51 142.3 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.843 -0.798 . . . . 0.0 109.419 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.81 144.17 44.37 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.57 -0.706 . . . . 0.0 109.46 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 51.8 m -152.09 138.19 18.25 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.955 -1.091 . . . . 0.0 108.479 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 11.6 t -150.07 132.16 15.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.914 -1.116 . . . . 0.0 109.327 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 tt -100.01 130.04 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.108 -0.995 . . . . 0.0 109.379 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 6.3 p -178.21 179.47 0.81 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.439 -0.788 . . . . 0.0 109.238 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' D' ' 32' ' ' ASN . 3.3 p30 -112.18 157.17 21.18 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.515 -0.741 . . . . 0.0 109.166 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.599 HD21 ' H ' ' D' ' 34' ' ' ASP . 0.1 OUTLIER 79.23 117.1 0.06 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.556 -0.715 . . . . 0.0 109.129 -178.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 91.6 t -62.75 -31.03 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.542 -0.724 . . . . 0.0 109.534 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' ASP . . . . . 0.599 ' H ' HD21 ' D' ' 32' ' ' ASN . 62.5 m-20 -59.4 -41.01 88.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.933 . . . . 0.0 110.029 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -74.09 -39.65 63.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.261 -0.899 . . . . 0.0 109.087 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 71.4 mt -65.36 -53.97 33.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.953 -1.092 . . . . 0.0 108.908 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 25.3 t -61.43 -50.23 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.124 -0.985 . . . . 0.0 109.224 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -56.42 -36.43 68.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.2 -0.937 . . . . 0.0 109.828 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' ASN . . . . . 0.471 ' N ' HD21 ' D' ' 39' ' ' ASN . 0.9 OUTLIER -71.73 -38.01 70.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.032 -1.042 . . . . 0.0 109.406 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' D' ' 41' ' ' ARG . 26.7 mt -69.56 -48.92 58.7 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.962 -1.086 . . . . 0.0 108.152 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' D' ' 40' ' ' LEU . 99.2 mtt180 -46.24 -57.76 4.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.308 -1.495 . . . . 0.0 108.993 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -50.17 -28.93 8.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.037 -1.039 . . . . 0.0 110.448 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -68.61 -56.66 7.5 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.732 -1.23 . . . . 0.0 110.011 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' D' ' 48' ' ' GLY . 1.8 m -64.91 -48.82 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.672 0 O-C-N 120.275 -1.515 . . . . 0.0 107.825 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -49.94 -46.15 51.92 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.72 1.248 . . . . 0.0 110.809 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.89 -30.15 56.06 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.642 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . 0.503 ' NZ ' ' O ' ' D' ' 23' ' ' LEU . 5.8 ttmt -92.47 -3.87 54.52 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.239 -0.913 . . . . 0.0 108.794 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' D' ' 44' ' ' VAL . . . 81.1 20.24 65.39 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.313 -1.422 . . . . 0.0 109.598 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.8 -166.57 13.27 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.68 -25.49 5.48 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.581 -0.952 . . . . 0.0 111.822 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.34 -163.21 33.31 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 5.6 mp -123.93 139.43 53.96 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.443 -1.033 . . . . 0.0 109.833 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 53' ' ' ILE . . . . . . . . . . . . . 1.3 pt -106.75 143.42 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.593 -0.692 . . . . 0.0 109.412 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 57.03 60.01 3.19 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.824 -1.172 . . . . 0.0 108.554 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . 0.401 ' CE2' ' OH ' ' E' ' 67' ' ' TYR . 46.9 t80 -84.35 71.34 10.68 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.493 -0.754 . . . . 0.0 109.846 -179.213 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 67' ' ' TYR . . . . . 0.476 ' HH ' ' CG2' ' C' ' 57' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 121.762 0.791 . . . . 0.0 110.365 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.31 152.52 23.68 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 76.7 m -107.3 137.71 44.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.034 -1.274 . . . . 0.0 108.298 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 mt -87.78 137.0 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 108.272 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.1 m -126.65 162.58 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 CA-C-O 121.617 0.722 . . . . 0.0 109.92 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -147.19 145.14 29.4 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.05 151.84 23.48 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.1 -1.0 . . . . 0.0 108.322 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 O-C-N 120.81 -1.181 . . . . 0.0 109.683 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 tptp . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 120.992 0.425 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -107.29 119.74 40.21 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.368 -0.833 . . . . 0.0 109.492 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 54.2 mt -107.59 130.89 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.533 -0.73 . . . . 0.0 109.203 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 9' ' ' ILE . . . . . 0.422 ' O ' HG21 ' E' ' 9' ' ' ILE . 8.3 tt -120.92 115.09 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.13 155.6 39.65 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.833 -1.167 . . . . 0.0 108.659 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 11' ' ' THR . . . . . 0.546 ' HG1' ' HG1' ' A' ' 69' ' ' THR . 2.3 p -118.9 95.96 5.05 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -165.88 -113.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.141 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -135.64 -42.32 0.68 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.833 . . . . 0.0 109.576 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -173.29 174.16 3.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.225 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 72.9 mt -112.57 95.68 33.3 Favored Pre-proline 0 N--CA 1.498 1.953 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.47 155.9 59.7 Favored 'Trans proline' 0 C--N 1.325 -0.671 0 C-N-CA 121.726 1.618 . . . . 0.0 110.83 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.48 -7.86 77.46 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 18' ' ' LEU . . . . . . . . . . . . . 56.3 mt -129.3 141.55 51.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -1.118 . . . . 0.0 109.836 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 19' ' ' GLN . . . . . 0.46 ' N ' ' CD ' ' E' ' 19' ' ' GLN . 3.5 mp0 -85.37 108.59 17.91 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 13.9 mt -96.78 135.0 39.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.247 -0.908 . . . . 0.0 110.036 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 21' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -123.46 129.48 51.3 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -86.53 132.53 33.89 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.205 -0.935 . . . . 0.0 111.292 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . 0.65 ' CD2' ' N ' ' E' ' 23' ' ' LEU . 0.4 OUTLIER -121.7 21.23 10.87 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.42 172.79 13.41 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.406 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 43.8 mm -108.69 143.52 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.39 145.03 41.79 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.315 -0.866 . . . . 0.0 108.886 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 84.8 p -152.08 136.66 16.93 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 13.5 t -150.06 149.65 30.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.936 -1.103 . . . . 0.0 109.192 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 2.2 tp -125.41 132.47 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 1.3 p 175.71 -173.82 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.008 -1.058 . . . . 0.0 109.251 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 31' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' E' ' 32' ' ' ASN . 29.1 m-20 -123.81 168.4 12.79 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.61 -0.681 . . . . 0.0 109.369 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 32' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 9.1 t-20 75.64 123.89 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.02 -34.36 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.341 -0.85 . . . . 0.0 109.467 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -59.16 -46.26 88.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 110.172 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -75.55 -39.4 58.26 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.086 -1.009 . . . . 0.0 109.564 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.62 -48.97 85.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.843 -1.16 . . . . 0.0 109.104 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 48.7 t -63.17 -48.91 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.014 -1.054 . . . . 0.0 109.478 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -59.42 -40.22 86.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.938 . . . . 0.0 109.618 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -58.48 -45.13 89.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.529 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 49.1 mt -72.37 -48.03 44.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.114 -0.992 . . . . 0.0 109.164 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -50.74 -42.96 58.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.716 -1.24 . . . . 0.0 109.354 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -69.25 -38.89 78.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.557 -0.715 . . . . 0.0 109.694 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.08 -34.69 59.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.918 . . . . 0.0 109.742 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 t -69.25 -52.6 31.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.197 -0.94 . . . . 0.0 109.668 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -72.3 -34.4 68.1 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.323 -1.351 . . . . 0.0 109.14 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.96 -32.27 61.36 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.14 -5.27 55.28 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.236 -0.915 . . . . 0.0 110.11 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.95 6.17 37.51 Favored Glycine 0 N--CA 1.504 3.21 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.36 159.58 48.73 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -124.37 -9.48 7.49 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.289 -1.124 . . . . 0.0 110.786 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.3 163.17 35.91 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.05 -1.548 . . . . 0.0 109.898 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 4.9 tp -120.79 143.09 49.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.653 -0.91 . . . . 0.0 110.093 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 53' ' ' ILE . . . . . . . . . . . . . 14.0 mt -113.12 138.87 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.568 -0.708 . . . . 0.0 110.411 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . 64.73 78.69 0.28 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.436 -0.79 . . . . 0.0 110.593 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -90.49 98.94 12.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.514 -0.742 . . . . 0.0 109.931 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 56' ' ' ARG . . . . . 0.494 ' NH1' ' NH1' ' A' ' 56' ' ' ARG . 7.6 tpp180 -97.66 166.77 11.34 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.288 -0.883 . . . . 0.0 109.068 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 47.8 mt . . . . . 0 N--CA 1.497 1.915 0 O-C-N 121.361 -0.837 . . . . 0.0 109.172 179.947 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 67' ' ' TYR . . . . . 0.401 ' OH ' ' CE2' ' D' ' 55' ' ' PHE . 4.0 t80 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 121.717 0.77 . . . . 0.0 110.407 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.58 140.18 6.38 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 69' ' ' THR . . . . . 0.512 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 20.4 m -93.11 138.7 31.3 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.93 -1.335 . . . . 0.0 108.623 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 72.4 mt -85.48 139.19 17.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.44 161.46 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.175 -0.953 . . . . 0.0 110.189 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -155.92 147.25 22.59 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -110.95 150.65 28.94 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.123 -0.986 . . . . 0.0 108.595 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.056 -1.027 . . . . 0.0 109.563 179.879 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.7 t80 . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 121.009 0.433 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.4 mt -112.07 139.11 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.513 -0.742 . . . . 0.0 109.823 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.464 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 6.3 tt -130.56 118.51 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -124.02 148.97 46.6 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.7 m -123.92 73.27 1.2 Allowed 'General case' 0 N--CA 1.511 2.622 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.727 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.2 -86.67 0.03 OUTLIER 'General case' 0 C--O 1.214 -0.791 0 O-C-N 119.585 -1.947 . . . . 0.0 107.576 -176.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.45 -78.56 0.6 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.274 -0.891 . . . . 0.0 109.68 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -162.4 -159.29 0.57 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.134 -0.979 . . . . 0.0 109.317 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.4 mt -120.78 91.76 47.62 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.495 -0.753 . . . . 0.0 109.235 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.51 155.73 51.17 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.784 1.656 . . . . 0.0 110.23 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.63 -14.08 64.97 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.1 mt -121.86 139.48 53.57 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.427 -1.043 . . . . 0.0 109.503 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.27 108.43 15.72 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.1 mt -99.33 133.55 43.47 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.304 -0.873 . . . . 0.0 110.038 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.527 ' CE1' ' O ' ' A' ' 22' ' ' SER . 0.4 OUTLIER -120.86 129.97 53.74 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.527 ' O ' ' CE1' ' A' ' 21' ' ' TYR . 47.0 t -51.85 127.87 22.27 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.127 -0.983 . . . . 0.0 111.067 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.8 mt -114.44 5.9 15.77 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.17 -177.24 16.36 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.88 144.81 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 122.002 -0.705 . . . . 0.0 109.485 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.48 155.93 23.43 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.6 p -151.62 144.5 24.45 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.826 -1.171 . . . . 0.0 108.469 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.2 p -148.47 132.4 17.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.246 -0.909 . . . . 0.0 109.305 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.62 126.99 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.3 p 173.11 -125.87 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.301 0.572 . . . . 0.0 109.609 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -162.59 168.53 21.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.159 -0.963 . . . . 0.0 108.589 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.2 m120 72.06 115.1 0.05 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.443 -0.786 . . . . 0.0 109.279 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.7 -31.99 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.607 -0.683 . . . . 0.0 109.314 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -58.99 -42.26 89.61 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.259 -0.9 . . . . 0.0 109.568 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -75.38 -41.02 57.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.988 -1.07 . . . . 0.0 109.869 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.33 -53.01 51.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 120.896 -1.127 . . . . 0.0 109.535 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.9 t -57.17 -48.81 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.134 -0.978 . . . . 0.0 109.028 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -59.31 -38.94 81.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.958 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -68.13 -39.98 82.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.058 -1.026 . . . . 0.0 109.768 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.93 -44.07 90.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.972 -1.08 . . . . 0.0 109.002 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -48.63 -54.48 14.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.801 -1.187 . . . . 0.0 109.471 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -57.82 -35.86 71.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.378 -0.826 . . . . 0.0 110.105 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -75.06 -36.18 61.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.219 -0.925 . . . . 0.0 109.806 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 t -71.16 -51.15 36.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.247 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -72.65 -33.28 66.49 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 117.81 -1.556 . . . . 0.0 109.598 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.69 76.18 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.869 . . . . 0.0 109.826 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -85.28 -4.11 59.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.539 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.75 0.49 55.26 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.66 155.55 53.4 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.34 -10.54 8.9 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.235 -1.156 . . . . 0.0 110.057 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.84 143.39 8.27 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.17 -1.491 . . . . 0.0 109.51 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.7 tp -101.32 142.64 32.44 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.743 -0.857 . . . . 0.0 110.12 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.461 ' CD1' ' C ' ' A' ' 53' ' ' ILE . 1.3 pp -120.27 150.29 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.476 -0.765 . . . . 0.0 110.559 -176.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.65 61.89 2.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.262 -1.524 . . . . 0.0 109.429 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.418 ' O ' ' CG ' ' A' ' 55' ' ' PHE . 39.8 t80 -100.22 73.96 1.73 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.646 HH11 ' HG2' ' A' ' 56' ' ' ARG . 7.0 mtt-85 -72.37 143.76 48.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.587 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.0 mm . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 109.213 179.846 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 26.0 p90 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.874 0.845 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.01 165.66 26.78 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.47 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.9 m -97.93 134.73 40.65 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.6 mt -88.02 146.53 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.64 160.51 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.177 -0.952 . . . . 0.0 110.462 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.496 ' NZ ' ' CB ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -144.64 160.42 41.21 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.158 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 74' ' ' ASP . . . -118.34 152.14 36.39 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 73' ' ' ALA . 20.8 t0 . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 121.293 0.568 . . . . 0.0 109.608 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 39.2 t80 . . . . . 0 N--CA 1.503 2.185 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 39.6 mt -103.9 134.78 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.322 -0.861 . . . . 0.0 110.123 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 39.0 mt -125.56 117.38 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 7.7 t -126.18 151.96 46.63 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.909 0.861 . . . . 0.0 108.749 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' THR . . . . . 0.522 ' OG1' ' OG1' ' C' ' 69' ' ' THR . 4.4 p -119.66 96.56 5.24 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -178.45 -87.74 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.528 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -155.55 -160.72 1.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.399 -0.813 . . . . 0.0 109.597 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -65.36 121.94 15.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.313 -0.867 . . . . 0.0 109.601 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 77.5 mt -52.58 110.27 1.86 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.56 -0.713 . . . . 0.0 109.386 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.46 153.75 72.76 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.293 1.329 . . . . 0.0 110.396 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.65 -16.09 58.86 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 71.8 mt -121.88 140.16 52.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.403 -1.057 . . . . 0.0 109.34 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -85.1 108.42 17.66 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 12.7 mt -96.89 138.35 34.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.211 -0.931 . . . . 0.0 110.233 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . 0.504 ' CE1' ' O ' ' B' ' 22' ' ' SER . 2.1 t80 -121.01 130.09 53.66 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.504 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 41.0 t -72.01 131.84 43.46 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 120.892 -1.13 . . . . 0.0 110.532 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mp -118.92 12.79 12.95 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.67 -174.39 16.29 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -116.66 145.2 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.83 143.9 43.9 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 46.2 m -152.52 141.79 21.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.581 -1.325 . . . . 0.0 108.305 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 12.9 t -149.48 151.84 34.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.036 -1.04 . . . . 0.0 108.646 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' B' ' 30' ' ' SER . 49.1 mt -112.4 158.02 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.117 -0.989 . . . . 0.0 108.674 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.672 ' O ' ' CG ' ' B' ' 31' ' ' ASP . 16.9 m 51.34 108.35 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.741 0 O-C-N 121.039 -1.038 . . . . 0.0 110.683 177.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.672 ' CG ' ' O ' ' B' ' 30' ' ' SER . 37.3 m-20 171.15 129.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . 0.441 ' O ' HG12 ' B' ' 36' ' ' ILE . 23.0 t-20 -84.27 173.04 11.31 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 120.917 -1.114 . . . . 0.0 108.384 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' B' ' 32' ' ' ASN . 15.5 t -44.8 -42.77 2.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 O-C-N 120.943 -1.098 . . . . 0.0 110.297 -174.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -64.19 -44.23 92.66 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.63 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -74.73 -45.83 41.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.327 -1.483 . . . . 0.0 111.546 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.441 HG12 ' O ' ' B' ' 32' ' ' ASN . 0.6 OUTLIER -58.75 -48.98 84.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 O-C-N 120.017 -1.677 . . . . 0.0 109.413 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.79 -45.19 99.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 118.846 -1.142 . . . . 0.0 108.711 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -67.55 -50.34 59.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.347 -0.845 . . . . 0.0 109.424 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.55 HD21 ' N ' ' B' ' 39' ' ' ASN . 0.8 OUTLIER -54.9 -47.39 74.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.108 -0.995 . . . . 0.0 108.966 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.75 -43.46 79.81 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.411 -0.806 . . . . 0.0 108.943 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -50.85 -45.33 59.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.626 -1.296 . . . . 0.0 109.419 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -66.41 -39.37 88.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.461 -0.774 . . . . 0.0 110.055 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -76.82 -34.99 57.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.689 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 15.3 t -71.86 -51.9 28.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.209 -0.932 . . . . 0.0 109.025 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -70.22 -30.18 67.2 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.14 -1.424 . . . . 0.0 109.558 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.55 -30.01 70.38 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -93.62 -5.31 49.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.381 -0.824 . . . . 0.0 109.821 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.87 15.49 28.62 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.02 159.84 29.24 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.1 -1.02 4.63 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.173 -1.193 . . . . 0.0 110.816 -176.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.82 173.62 43.4 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.422 -1.37 . . . . 0.0 109.773 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 5.5 tp -130.53 133.81 46.53 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.67 -0.9 . . . . 0.0 109.43 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.57 139.66 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.672 -0.643 . . . . 0.0 110.243 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 50.83 61.12 3.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.949 -1.094 . . . . 0.0 110.633 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -100.39 114.3 27.74 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.323 0.583 . . . . 0.0 110.654 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -102.46 119.12 38.28 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 pt . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.128 -0.982 . . . . 0.0 109.858 -179.547 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.26 149.66 20.39 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' B' ' 67' ' ' TYR . 4.8 p90 -150.03 152.97 35.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.158 -1.201 . . . . 0.0 110.202 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.73 156.53 28.07 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 52.6 m -101.21 136.12 41.56 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.061 -1.258 . . . . 0.0 107.92 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 53.5 mt -86.04 146.62 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.9 m -138.51 156.71 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.308 -0.87 . . . . 0.0 110.21 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -150.55 132.44 15.11 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.54 129.34 50.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.856 -1.152 . . . . 0.0 108.3 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 t70 . . . . . 0 N--CA 1.488 1.445 0 O-C-N 120.844 -1.16 . . . . 0.0 108.681 177.785 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.375 0.607 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -95.23 122.59 38.09 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.518 -0.738 . . . . 0.0 110.026 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 86.2 mt -111.06 128.89 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.485 -0.76 . . . . 0.0 109.866 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' ILE . . . . . . . . . . . . . 7.7 tt -124.19 116.92 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 7.9 t -113.36 135.99 53.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.661 -1.274 . . . . 0.0 109.039 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' C' ' 12' ' ' ALA . 0.3 OUTLIER -56.99 -85.75 0.01 OUTLIER 'General case' 0 C--N 1.279 -2.471 0 O-C-N 121.873 -0.517 . . . . 0.0 111.178 178.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . 0.492 ' N ' ' OG1' ' C' ' 11' ' ' THR . . . -133.43 92.68 3.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.639 -1.288 . . . . 0.0 108.131 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -147.57 -134.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.294 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -165.86 -9.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.07 -1.019 . . . . 0.0 109.474 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 27.8 mt 55.64 68.74 2.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.39 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.89 156.22 50.18 Favored 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 121.931 1.754 . . . . 0.0 109.984 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.12 -14.96 63.15 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 19.1 mt -119.34 137.47 53.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.434 -1.039 . . . . 0.0 109.153 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.77 107.92 19.22 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 11.6 mt -97.88 140.66 31.9 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.199 -0.938 . . . . 0.0 110.246 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' TYR . . . . . 0.62 ' CE1' ' O ' ' C' ' 22' ' ' SER . 0.6 OUTLIER -123.17 129.94 52.1 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' SER . . . . . 0.62 ' O ' ' CE1' ' C' ' 21' ' ' TYR . 24.9 t -66.37 135.71 54.73 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.273 1.035 . . . . 0.0 112.45 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 mt -123.86 13.86 9.23 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.512 -0.742 . . . . 0.0 109.357 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.29 179.74 15.99 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.5 145.8 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 122.21 -0.583 . . . . 0.0 109.56 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.89 159.71 18.78 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.93 147.09 26.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.752 -1.217 . . . . 0.0 108.474 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 51.7 p -146.0 142.1 28.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.509 -0.744 . . . . 0.0 109.872 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' C' ' 30' ' ' SER . 55.8 mt -127.18 124.86 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 29' ' ' ILE . 3.6 p 157.77 -159.59 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -132.62 -174.7 3.53 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 1.8 m120 73.97 114.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 22.2 t -68.39 -34.34 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.445 -0.784 . . . . 0.0 109.482 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.4 -38.87 78.25 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.236 -0.915 . . . . 0.0 109.269 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -75.14 -39.81 60.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.932 -1.105 . . . . 0.0 109.586 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.45 -52.38 56.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.602 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 5.7 t -58.24 -48.31 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.009 -1.057 . . . . 0.0 108.782 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.77 -44.97 91.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 109.955 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -57.21 -49.9 74.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.104 -0.997 . . . . 0.0 109.496 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 82.7 mt -64.44 -43.71 93.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.076 -1.015 . . . . 0.0 108.673 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' ARG . . . . . 0.722 HH11 ' HG2' ' C' ' 41' ' ' ARG . 2.7 ttt-85 -49.78 -47.28 51.18 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.774 -1.204 . . . . 0.0 109.579 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -67.04 -38.41 85.82 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.488 -0.758 . . . . 0.0 110.253 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -76.65 -35.5 57.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.897 . . . . 0.0 109.795 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 t -67.58 -50.88 57.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.176 -0.953 . . . . 0.0 108.949 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -71.76 -35.47 70.1 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.155 -1.418 . . . . 0.0 109.208 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.26 -33.34 67.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.486 -0.759 . . . . 0.0 108.97 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.61 -4.97 59.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.509 -0.744 . . . . 0.0 109.521 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.47 5.18 59.16 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.3 161.65 48.89 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -128.46 -0.2 5.61 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.293 -1.122 . . . . 0.0 110.014 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.42 151.09 17.48 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 16.0 tp -112.96 140.47 47.74 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.565 -0.962 . . . . 0.0 109.949 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' ILE . . . . . 0.55 ' O ' ' CB ' ' C' ' 54' ' ' ALA . 27.9 mt -112.34 140.66 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.59 -0.694 . . . . 0.0 109.488 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' C' ' 53' ' ' ILE . . . 92.01 -41.36 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 118.342 0.519 . . . . 0.0 110.093 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . 0.511 ' C ' ' O ' ' C' ' 54' ' ' ALA . 18.0 t80 27.97 89.77 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 120.804 0.335 . . . . 0.0 110.177 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' ARG . . . . . 0.638 ' CG ' HH11 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -93.82 143.79 26.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.013 -1.054 . . . . 0.0 109.65 -178.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 26.2 p90 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 122.252 1.025 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.44 161.76 31.76 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' THR . . . . . 0.522 ' OG1' ' OG1' ' B' ' 11' ' ' THR . 69.1 m -93.83 137.02 33.5 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.276 -1.132 . . . . 0.0 108.406 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 60.9 mt -86.11 141.32 14.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' C' ' 21' ' ' TYR . 6.9 m -144.92 163.21 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.788 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -152.06 162.32 41.27 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' C' ' 74' ' ' ASP . . . -104.03 151.43 23.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 108.985 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' C' ' 73' ' ' ALA . 2.9 t0 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 109.85 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 121.587 0.708 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -94.12 124.29 38.04 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.668 -0.645 . . . . 0.0 109.849 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 71.8 mt -116.94 143.17 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.618 -0.676 . . . . 0.0 109.91 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 9' ' ' ILE . . . . . 0.472 ' O ' ' CG2' ' D' ' 9' ' ' ILE . 7.7 tt -136.03 114.65 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.5 ' HG1' ' N ' ' D' ' 11' ' ' THR . 9.8 t -122.18 161.72 22.68 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.333 -0.855 . . . . 0.0 108.826 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 11' ' ' THR . . . . . 0.5 ' N ' ' HG1' ' D' ' 10' ' ' THR . 0.1 OUTLIER -125.16 73.27 1.29 Allowed 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.17 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.69 -116.64 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.766 0 O-C-N 119.43 -2.044 . . . . 0.0 107.363 -176.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 24.7 p30 -93.68 -137.97 0.2 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.971 -1.08 . . . . 0.0 109.428 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -109.86 -159.75 0.69 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.379 -0.826 . . . . 0.0 109.151 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 56.6 mt -125.48 85.27 58.88 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.579 -0.701 . . . . 0.0 109.203 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -60.11 157.26 35.38 Favored 'Trans proline' 0 N--CA 1.48 0.725 0 C-N-CA 121.91 1.74 . . . . 0.0 110.093 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.95 -4.46 75.0 Favored Glycine 0 N--CA 1.498 2.779 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.056 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 59.6 mt -130.64 141.38 50.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.191 . . . . 0.0 109.706 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -85.42 108.5 17.89 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 14.1 mt -94.95 133.11 39.07 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.117 -0.989 . . . . 0.0 109.635 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' D' ' 22' ' ' SER . 1.6 t80 -114.02 129.67 56.59 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' SER . . . . . 0.433 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 0.0 OUTLIER -70.63 131.69 44.31 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 120.618 -1.301 . . . . 0.0 110.942 -179.415 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 mt -117.29 11.34 14.0 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.91 -179.68 18.4 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.87 141.87 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.853 -0.792 . . . . 0.0 108.933 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.59 142.94 44.58 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 43.8 p -152.2 130.82 12.29 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 10.6 t -143.35 130.23 20.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.758 -1.213 . . . . 0.0 108.716 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.438 ' O ' ' OG ' ' D' ' 30' ' ' SER . 19.4 tt -97.72 130.29 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.879 -1.138 . . . . 0.0 108.961 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.531 ' O ' ' O ' ' D' ' 31' ' ' ASP . 72.1 m -168.73 2.36 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.739 -1.226 . . . . 0.0 109.968 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' ASP . . . . . 0.531 ' O ' ' O ' ' D' ' 30' ' ' SER . 26.5 t70 51.27 161.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.48 -0.763 . . . . 0.0 110.447 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 0.1 OUTLIER 71.86 128.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.63 -1.293 . . . . 0.0 108.67 -178.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 20.2 t -69.94 -36.73 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 121.224 -0.923 . . . . 0.0 110.15 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' D' ' 34' ' ' ASP . 25.4 p-10 -58.51 -47.03 85.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.161 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -76.26 -38.64 55.96 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.957 -1.089 . . . . 0.0 109.86 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 60.9 mt -63.79 -53.69 41.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 120.882 -1.136 . . . . 0.0 109.493 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 43.4 t -63.5 -49.65 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.167 -0.958 . . . . 0.0 109.658 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -58.13 -39.44 78.75 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.159 -0.963 . . . . 0.0 109.637 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -65.98 -42.31 90.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 29.1 mt -67.77 -46.29 72.44 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.956 -1.09 . . . . 0.0 108.749 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -46.77 -53.4 11.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.884 -1.135 . . . . 0.0 109.056 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -55.65 -31.0 61.96 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.32 -0.862 . . . . 0.0 109.154 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -73.11 -36.27 66.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.16 -0.963 . . . . 0.0 109.609 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.66 -50.71 25.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 120.886 -1.134 . . . . 0.0 109.281 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -49.92 -33.81 18.61 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 122.988 1.375 . . . . 0.0 109.873 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.97 -29.06 49.57 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.824 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -97.75 6.27 48.12 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.36 29.14 59.99 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 117.952 -2.071 . . . . 0.0 109.687 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.75 -170.27 5.07 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 11.3 ttp -109.51 -41.57 4.55 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.494 -1.004 . . . . 0.0 110.063 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 171.25 175.69 39.87 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.24 139.42 42.96 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.479 -1.012 . . . . 0.0 109.993 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 pt -112.28 142.47 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.748 -0.595 . . . . 0.0 110.238 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' D' ' 55' ' ' PHE . . . 68.93 -61.54 0.42 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.42 -0.8 . . . . 0.0 110.516 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . 0.422 ' O ' ' CG ' ' D' ' 55' ' ' PHE . 13.1 t80 42.7 83.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.05 -1.031 . . . . 0.0 109.493 -179.776 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 121.48 0.657 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.0 137.43 3.18 Favored Glycine 0 C--N 1.288 -2.101 0 C-N-CA 119.015 -1.564 . . . . 0.0 110.856 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 6.9 m -101.08 144.29 30.17 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.74 -0.859 . . . . 0.0 108.951 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 26.7 mt -89.07 142.19 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 m -135.13 166.65 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.371 0.605 . . . . 0.0 109.48 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 72' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' D' ' 21' ' ' TYR . 7.7 tttt -146.47 145.39 30.18 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' D' ' 74' ' ' ASP . . . -125.42 153.98 42.63 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' D' ' 73' ' ' ALA . 25.2 t0 . . . . . 0 N--CA 1.492 1.642 0 CA-C-N 119.018 0.826 . . . . 0.0 110.15 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 6' ' ' LYS . . . . . 0.409 ' HZ2' HD11 ' E' ' 8' ' ' ILE . 6.8 ptmm? . . . . . 0 N--CA 1.498 1.954 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -94.93 119.08 32.88 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.388 -0.82 . . . . 0.0 109.788 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . 0.409 HD11 ' HZ2' ' E' ' 6' ' ' LYS . 33.8 mt -113.35 134.21 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.568 -0.708 . . . . 0.0 109.407 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 9' ' ' ILE . . . . . 0.451 ' CG2' ' O ' ' E' ' 9' ' ' ILE . 15.7 tt -130.67 114.42 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 6.5 t -122.46 157.9 30.95 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.891 0.853 . . . . 0.0 109.103 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 11' ' ' THR . . . . . 0.45 ' O ' ' CB ' ' E' ' 12' ' ' ALA . 4.1 p -100.25 77.69 1.99 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 177.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' E' ' 11' ' ' THR . . . 157.55 -90.97 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.778 0.799 . . . . 0.0 109.714 177.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -165.16 -71.32 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 51.14 -153.26 0.18 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 110.245 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 15' ' ' ILE . . . . . 0.635 ' N ' ' HD3' ' E' ' 16' ' ' PRO . 2.8 mt 60.54 48.16 1.6 Allowed Pre-proline 0 N--CA 1.483 1.223 0 O-C-N 121.849 -0.532 . . . . 0.0 109.632 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . 0.635 ' HD3' ' N ' ' E' ' 15' ' ' ILE . 1.6 Cg_endo -66.77 154.48 74.36 Favored 'Trans proline' 0 C--N 1.326 -0.629 0 C-N-CA 121.532 1.488 . . . . 0.0 109.81 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.99 -9.96 74.71 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.927 -1.606 . . . . 0.0 110.943 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 18' ' ' LEU . . . . . . . . . . . . . 75.5 mt -118.73 137.72 53.15 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.138 1.469 . . . . 0.0 109.387 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -86.12 112.88 21.71 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 12.5 mt -89.16 135.22 33.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -0.912 . . . . 0.0 110.62 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 21' ' ' TYR . . . . . 0.554 ' CE1' ' O ' ' E' ' 22' ' ' SER . 1.2 t80 -119.66 130.79 55.23 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 22' ' ' SER . . . . . 0.554 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 0.0 OUTLIER -71.68 131.46 43.2 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.977 -1.077 . . . . 0.0 111.071 -179.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mp -118.41 12.92 13.46 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.03 179.49 15.97 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 tp -114.47 144.81 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.977 -0.719 . . . . 0.0 109.303 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.6 144.98 41.18 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 90.3 p -152.43 139.95 19.68 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.705 -1.247 . . . . 0.0 107.93 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 8.7 t -150.49 144.14 25.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.889 -1.132 . . . . 0.0 109.025 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 4.7 mm -106.42 128.46 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.251 -0.906 . . . . 0.0 108.879 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.627 ' HG ' ' H ' ' E' ' 31' ' ' ASP . 29.0 t -175.06 177.9 1.86 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -0.802 . . . . 0.0 109.007 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 31' ' ' ASP . . . . . 0.627 ' H ' ' HG ' ' E' ' 30' ' ' SER . 46.6 t0 -116.43 161.14 19.54 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.486 -0.759 . . . . 0.0 109.235 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 32' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 2.4 m120 75.96 123.56 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 52.6 t -67.5 -33.33 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.396 -0.815 . . . . 0.0 109.415 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -58.55 -43.05 89.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 110.153 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -75.6 -37.93 59.45 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.112 -0.993 . . . . 0.0 109.466 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.71 -49.42 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 109.451 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 44.7 t -63.83 -49.64 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.031 -1.043 . . . . 0.0 109.653 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.79 -37.37 73.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.832 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -65.56 -41.49 92.89 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -0.958 . . . . 0.0 109.792 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 30.9 mt -68.2 -45.96 71.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.085 -1.01 . . . . 0.0 109.106 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -48.62 -50.71 31.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.786 -1.196 . . . . 0.0 109.363 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -61.04 -36.47 79.64 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.464 -0.773 . . . . 0.0 110.209 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -76.57 -35.08 58.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.952 . . . . 0.0 109.77 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 9.1 t -70.44 -51.82 34.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.07 -1.019 . . . . 0.0 108.846 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 -30.72 67.33 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.046 -1.462 . . . . 0.0 109.275 -175.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.48 -34.9 76.26 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.449 -0.782 . . . . 0.0 109.713 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.42 -5.45 58.84 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.064 -1.023 . . . . 0.0 109.889 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 106.49 -1.19 36.99 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.04 156.95 52.69 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 6.4 ptm -120.53 -2.46 9.97 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.392 -1.063 . . . . 0.0 110.29 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.65 156.01 19.88 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.06 -1.543 . . . . 0.0 109.686 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 5.3 tp -106.26 136.28 46.25 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.722 -0.869 . . . . 0.0 109.28 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 pt -108.83 144.38 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.45 -0.781 . . . . 0.0 110.012 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.474 ' HA ' HH12 ' E' ' 56' ' ' ARG . . . 64.12 82.55 0.18 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.114 -0.991 . . . . 0.0 110.794 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 55' ' ' PHE . . . . . 0.486 ' O ' ' CG ' ' E' ' 55' ' ' PHE . 72.6 t80 -113.75 19.04 17.03 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.192 0.52 . . . . 0.0 109.683 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 56' ' ' ARG . . . . . 0.704 HH11 ' HG3' ' E' ' 56' ' ' ARG . 15.8 mtm-85 -59.68 111.86 1.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.16 -0.962 . . . . 0.0 109.645 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 64.6 mt . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.284 179.874 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 38.1 p90 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.567 0.699 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.3 172.33 25.3 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.327 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 69' ' ' THR . . . . . 0.467 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 54.8 m -99.17 134.62 41.75 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.348 -1.089 . . . . 0.0 108.196 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 66.9 mt -78.31 146.07 8.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.8 m -130.34 152.11 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.96 -1.088 . . . . 0.0 109.905 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -144.9 141.16 28.83 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.76 138.86 36.25 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--N 1.312 -1.063 0 O-C-N 120.451 -1.406 . . . . 0.0 108.969 178.087 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.2 t80 . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.0 mt -132.9 124.76 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.284 -0.885 . . . . 0.0 109.723 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.465 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 7.4 tt -119.3 118.99 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 t -117.35 133.39 56.04 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.388 -0.82 . . . . 0.0 108.868 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.543 ' OG1' ' OG1' ' B' ' 69' ' ' THR . 3.2 m -107.96 70.03 0.75 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.426 -0.796 . . . . 0.0 111.863 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.98 -9.92 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 O-C-N 120.197 -1.564 . . . . 0.0 108.328 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.6 OUTLIER 64.25 57.54 1.21 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.711 -0.618 . . . . 0.0 110.331 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -178.85 137.81 0.15 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.576 -0.703 . . . . 0.0 109.889 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.509 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 9.5 tt -163.78 58.65 0.71 Allowed Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.217 -0.927 . . . . 0.0 108.857 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 15' ' ' ILE . 3.2 Cg_exo -59.21 158.24 26.96 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 121.971 1.781 . . . . 0.0 110.562 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.33 -3.91 66.67 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.671 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 25.2 mt -128.33 136.95 51.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.817 -1.402 . . . . 0.0 109.344 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -87.84 108.62 19.24 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.589 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 1.9 mt -120.8 129.98 53.8 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.105 0.478 . . . . 0.0 110.544 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -104.88 141.9 35.71 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.634 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.467 ' C ' ' H ' ' A' ' 24' ' ' GLY . 28.8 t -78.74 88.06 4.62 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.03 11.01 0.61 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.591 -0.693 . . . . 0.0 110.499 -177.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 22' ' ' SER . . . 125.17 -175.89 17.24 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.0 mm -110.05 141.67 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.364 0.602 . . . . 0.0 109.381 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -109.88 151.89 26.48 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 122.025 0.917 . . . . 0.0 109.628 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.3 m -139.97 143.65 36.63 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.69 147.49 43.76 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.999 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.455 ' O ' ' OG ' ' A' ' 30' ' ' SER . 4.2 tp -127.5 132.98 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 120.935 1.698 . . . . 0.0 106.66 176.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 29' ' ' ILE . 2.0 m 173.29 -161.5 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.907 -1.121 . . . . 0.0 108.991 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -117.67 -75.31 0.58 Allowed 'General case' 0 N--CA 1.512 2.641 0 O-C-N 121.301 -0.874 . . . . 0.0 112.449 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -65.57 149.18 50.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.772 -1.205 . . . . 0.0 108.128 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -40.3 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -52.39 -28.49 19.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.349 -0.845 . . . . 0.0 109.791 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -79.51 -33.13 42.35 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.187 -0.945 . . . . 0.0 109.368 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.6 mt -60.66 -53.01 54.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.311 -0.868 . . . . 0.0 109.234 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.5 t -54.9 -50.37 62.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.084 -1.01 . . . . 0.0 109.105 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -60.18 -40.07 88.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 110.149 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -65.4 -41.91 93.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.073 -1.017 . . . . 0.0 109.514 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.3 mt -62.43 -41.38 98.66 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.054 -1.029 . . . . 0.0 109.146 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.528 ' CG ' HH11 ' A' ' 41' ' ' ARG . 0.0 OUTLIER -49.91 -51.3 41.83 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.504 -1.373 . . . . 0.0 109.296 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -61.67 -37.48 84.23 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.774 -1.204 . . . . 0.0 110.68 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -77.1 -36.02 55.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.306 -0.871 . . . . 0.0 110.089 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 t -70.81 -50.56 42.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.425 -0.797 . . . . 0.0 108.965 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -67.74 -29.04 68.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.393 -1.442 . . . . 0.0 109.271 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.71 -31.21 71.0 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.524 0.678 . . . . 0.0 109.385 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -89.27 -5.62 57.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.443 -0.785 . . . . 0.0 109.466 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.09 7.67 63.85 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.77 157.62 41.93 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.35 -1.58 5.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.243 -1.151 . . . . 0.0 110.349 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.61 153.02 23.04 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.318 -1.42 . . . . 0.0 109.72 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.7 tp -116.99 139.75 50.29 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.656 -0.908 . . . . 0.0 109.793 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.4 mt -113.13 139.23 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.742 -0.599 . . . . 0.0 110.053 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 67.75 84.38 0.15 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.292 -0.88 . . . . 0.0 110.884 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -122.11 69.94 0.96 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.249 0.547 . . . . 0.0 110.431 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.406 HH22 ' NE ' ' E' ' 56' ' ' ARG . 14.6 ptt180 -98.13 122.68 41.57 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.269 -0.894 . . . . 0.0 109.178 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.5 mt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.341 -0.849 . . . . 0.0 109.449 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.5 p90 . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.982 0.896 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.18 -178.02 48.02 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.4 m -118.89 137.69 53.27 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.5 mt -89.31 130.59 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 20' ' ' LEU . 14.0 m -144.27 151.62 15.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 119.352 -0.939 . . . . 0.0 109.189 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.7 pttt -145.48 151.13 37.7 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.1 -1.0 . . . . 0.0 109.167 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.02 150.58 39.71 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.493 ' N ' ' OH ' ' A' ' 21' ' ' TYR . 14.2 p-10 . . . . . 0 N--CA 1.498 1.946 0 O-C-N 121.094 -1.004 . . . . 0.0 108.622 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 86.3 t80 . . . . . 0 N--CA 1.499 2.003 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 64.5 mt -112.5 128.02 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.591 -0.693 . . . . 0.0 110.079 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.422 ' O ' ' CG2' ' B' ' 9' ' ' ILE . 5.7 tt -124.74 113.34 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.402 ' HG1' ' N ' ' B' ' 11' ' ' THR . 4.3 t -123.52 161.13 25.51 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.907 0.861 . . . . 0.0 109.181 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' THR . . . . . 0.572 ' O ' ' C ' ' B' ' 12' ' ' ALA . 12.3 p -99.89 -109.88 0.2 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.173 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.572 ' C ' ' O ' ' B' ' 11' ' ' THR . . . 16.6 -115.03 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 118.486 0.584 . . . . 0.0 111.715 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -111.38 -140.1 0.38 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.623 -0.673 . . . . 0.0 109.312 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -93.93 -157.3 0.54 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.279 -0.888 . . . . 0.0 109.973 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 mt -113.54 98.47 46.98 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.486 -0.759 . . . . 0.0 109.356 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.74 156.83 40.69 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 C-N-CA 121.694 1.596 . . . . 0.0 110.144 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.84 -4.5 75.44 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 34.3 mt -131.45 141.35 49.79 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.175 -1.191 . . . . 0.0 109.996 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -85.05 107.65 17.26 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 12.9 mt -103.16 137.27 41.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.612 -0.68 . . . . 0.0 109.831 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . 0.53 ' CE1' ' O ' ' B' ' 22' ' ' SER . 1.3 t80 -118.62 130.31 55.8 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.53 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 32.6 t -66.27 134.07 51.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 0.0 111.341 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 8.0 mt -121.07 10.31 10.72 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.6 175.0 15.78 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . 0.429 HD12 ' OG1' ' A' ' 11' ' ' THR . 0.1 OUTLIER -113.32 146.6 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.47 159.72 21.64 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 48.8 m -153.04 147.43 25.88 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' THR . . . . . 0.464 ' OG1' HG22 ' B' ' 36' ' ' ILE . 5.2 p -149.64 148.27 29.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 109.533 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.465 ' O ' ' OG ' ' B' ' 30' ' ' SER . 1.3 tp -126.5 127.51 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' B' ' 29' ' ' ILE . 2.8 m -168.27 171.29 9.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.168 -0.958 . . . . 0.0 109.751 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -80.41 -61.05 2.09 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.422 -0.799 . . . . 0.0 112.124 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -74.57 128.26 35.12 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.555 -1.341 . . . . 0.0 108.501 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 m -69.33 -33.65 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.613 -0.68 . . . . 0.0 109.182 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -59.57 -29.71 68.14 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.475 -0.765 . . . . 0.0 110.103 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -70.88 -35.93 72.57 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.507 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.464 HG22 ' OG1' ' B' ' 28' ' ' THR . 77.3 mt -61.45 -47.28 94.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.114 -0.991 . . . . 0.0 109.397 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 68.9 t -54.98 -50.6 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.919 -1.113 . . . . 0.0 109.285 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -59.91 -40.63 89.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.393 -0.817 . . . . 0.0 109.585 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -64.65 -41.9 95.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.164 -0.96 . . . . 0.0 109.369 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 73.0 mt -65.75 -44.07 87.02 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 109.027 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -48.79 -46.66 41.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.49 -1.381 . . . . 0.0 109.383 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -65.27 -37.38 87.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.627 -0.671 . . . . 0.0 110.207 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -77.04 -35.03 57.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 109.912 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.64 -51.57 44.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.286 -0.884 . . . . 0.0 108.834 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.07 -30.54 66.71 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 118.108 -1.437 . . . . 0.0 109.216 -175.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.0 -32.14 72.58 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -91.61 -5.49 53.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.728 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.61 3.63 46.58 Favored Glycine 0 N--CA 1.502 3.094 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.78 159.41 47.78 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -126.71 -2.06 6.68 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.352 -1.087 . . . . 0.0 110.471 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -165.42 158.09 30.81 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.324 -1.417 . . . . 0.0 109.612 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 6.1 tp -114.99 137.24 52.23 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.668 -0.901 . . . . 0.0 109.744 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 68.1 mt -114.35 145.63 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.674 -0.641 . . . . 0.0 110.239 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 69.61 88.9 0.11 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.045 -1.034 . . . . 0.0 111.199 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -142.56 69.48 1.31 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.23 0.538 . . . . 0.0 110.171 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -108.35 146.16 33.41 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mm . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.585 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.541 ' N ' ' CD2' ' B' ' 65' ' ' LEU . 2.0 mm? . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.12 71.12 0.54 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' TYR . . . . . 0.45 ' O ' ' CD2' ' B' ' 67' ' ' TYR . 49.6 p90 -73.38 126.12 29.42 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.267 -1.137 . . . . 0.0 109.494 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.95 156.44 26.68 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' THR . . . . . 0.543 ' OG1' ' OG1' ' A' ' 11' ' ' THR . 48.4 m -103.04 134.89 45.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.861 -1.376 . . . . 0.0 108.523 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 66.1 mt -89.98 134.59 28.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.8 m -141.66 163.12 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 110.48 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -153.78 148.98 26.96 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.36 150.75 30.64 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.129 -0.982 . . . . 0.0 108.494 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' B' ' 74' ' ' ASP . 26.7 p-10 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 120.93 -1.106 . . . . 0.0 108.914 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . 0.547 ' O ' ' O ' ' C' ' 50' ' ' MET . 44.8 mtmt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -104.85 121.53 43.87 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 76.1 mt -134.57 126.66 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.284 -0.885 . . . . 0.0 109.607 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' C' ' 9' ' ' ILE . 14.8 tt -122.06 115.5 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.76 156.88 42.84 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 122.139 0.971 . . . . 0.0 108.849 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' THR . . . . . 0.668 ' HG1' ' HG1' ' D' ' 69' ' ' THR . 1.3 p -116.24 94.04 4.48 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.53 -108.73 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.799 177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -148.26 -50.93 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 109.592 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' C' ' 15' ' ' ILE . 3.3 tp10 -154.78 176.8 12.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.168 -0.958 . . . . 0.0 109.294 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . 0.423 ' H ' ' HG3' ' C' ' 14' ' ' GLU . 29.3 mt -124.04 87.74 53.04 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -60.63 156.0 44.89 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.876 1.717 . . . . 0.0 110.238 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.28 -8.81 77.19 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 31.7 mt -132.23 142.79 49.54 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.373 -1.075 . . . . 0.0 109.496 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -86.19 108.66 18.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 14.8 mt -96.71 137.33 35.96 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 109.964 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' TYR . . . . . 0.404 ' N ' ' O ' ' C' ' 72' ' ' LYS . 18.1 t80 -123.5 129.04 50.64 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.1 t -87.56 131.79 34.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.342 -0.849 . . . . 0.0 109.608 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . 0.649 ' CD2' ' N ' ' C' ' 23' ' ' LEU . 0.2 OUTLIER -123.28 11.53 9.39 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.61 168.49 11.85 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.266 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -106.7 146.18 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.99 144.83 42.45 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 75.2 m -152.68 138.66 18.14 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 12.1 t -149.77 141.06 23.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.843 -1.161 . . . . 0.0 108.644 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.488 ' O ' ' OG ' ' C' ' 30' ' ' SER . 15.3 tt -115.31 129.82 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' C' ' 29' ' ' ILE . 6.4 m -169.72 -141.36 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.043 -1.036 . . . . 0.0 109.796 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -157.55 161.73 38.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.248 -0.908 . . . . 0.0 108.972 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 73.81 127.34 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -67.57 -33.68 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.51 -0.744 . . . . 0.0 109.363 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -59.01 -46.69 87.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.358 -0.839 . . . . 0.0 110.176 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -76.03 -40.27 53.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.203 -0.936 . . . . 0.0 109.78 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 71.5 mt -60.29 -39.42 80.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.881 -1.137 . . . . 0.0 109.297 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -69.3 -47.03 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.776 -1.202 . . . . 0.0 109.534 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -60.24 -41.42 93.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.935 . . . . 0.0 109.843 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -58.81 -48.32 81.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 109.941 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 28.4 mt -70.32 -47.59 60.41 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.047 -1.033 . . . . 0.0 109.111 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' ARG . . . . . 0.468 HH21 ' HZ1' ' C' ' 45' ' ' LYS . 39.9 mtp180 -49.44 -48.0 47.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.535 -1.353 . . . . 0.0 109.016 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' LYS . . . . . 0.421 ' O ' ' CB ' ' C' ' 46' ' ' ALA . 46.1 mtpt -63.8 -37.65 88.17 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 109.831 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' GLN . . . . . 0.539 HE22 ' HZ1' ' C' ' 47' ' ' LYS . 0.0 OUTLIER -75.98 -35.66 59.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 109.912 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 20.2 t -76.63 -51.75 18.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 109.067 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' LYS . . . . . 0.468 ' HZ1' HH21 ' C' ' 41' ' ' ARG . 18.2 mtmt -69.43 -29.94 67.76 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.858 -1.537 . . . . 0.0 109.461 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' C' ' 42' ' ' LYS . . . -64.07 -33.38 75.63 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . 0.539 ' HZ1' HE22 ' C' ' 43' ' ' GLN . 0.0 OUTLIER -90.63 2.69 55.64 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.245 -0.91 . . . . 0.0 108.699 179.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.42 29.65 65.75 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.053 -1.546 . . . . 0.0 109.962 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.37 -168.74 24.33 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.057 -1.261 . . . . 0.0 110.053 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' MET . . . . . 0.547 ' O ' ' O ' ' C' ' 6' ' ' LYS . 14.6 ttt -108.42 -41.75 4.76 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.567 -0.961 . . . . 0.0 109.692 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 173.96 -153.9 18.19 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 tp -136.01 137.45 41.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.413 -1.051 . . . . 0.0 109.985 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 49.0 mt -110.52 141.12 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.571 -0.706 . . . . 0.0 109.741 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 64.65 75.18 0.38 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.204 -0.935 . . . . 0.0 108.66 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -93.99 140.31 29.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 109.075 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' ARG . . . . . 0.662 HH11 ' HG2' ' C' ' 56' ' ' ARG . 0.0 OUTLIER -134.57 174.66 10.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.584 -0.698 . . . . 0.0 109.284 179.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 39.8 mt . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 3.7 t80 . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.879 0.847 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 174.35 157.6 16.3 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 21.1 m -98.37 144.26 27.94 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.357 -1.084 . . . . 0.0 109.59 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 56.1 mt -91.19 132.06 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.09 163.14 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.44 0.638 . . . . 0.0 109.854 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' C' ' 21' ' ' TYR . 16.2 ttmm -153.65 141.05 19.7 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.0 150.0 36.52 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.737 -1.227 . . . . 0.0 108.152 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--N 1.301 -1.501 0 O-C-N 120.982 -1.074 . . . . 0.0 109.029 179.754 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 72.1 tttt . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.614 0.721 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -94.59 124.52 38.67 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.717 -0.615 . . . . 0.0 109.462 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 20.0 mt -115.94 137.71 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.556 -0.715 . . . . 0.0 109.963 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 9' ' ' ILE . . . . . 0.431 ' O ' ' CG2' ' D' ' 9' ' ' ILE . 9.4 tt -119.49 124.28 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.99 130.81 56.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.511 -0.743 . . . . 0.0 109.556 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 3.1 m -129.79 120.86 25.72 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.05 12.04 2.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.248 -0.907 . . . . 0.0 109.697 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -126.23 108.38 11.24 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.482 0.658 . . . . 0.0 109.36 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . 0.463 ' HG3' ' H ' ' D' ' 15' ' ' ILE . 8.2 tp10 -62.33 169.42 2.88 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.269 -0.895 . . . . 0.0 108.655 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' ILE . . . . . 0.499 ' O ' ' CG2' ' D' ' 15' ' ' ILE . 13.1 tt -134.55 60.91 45.73 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.271 -0.893 . . . . 0.0 109.509 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' D' ' 15' ' ' ILE . 2.0 Cg_endo -61.14 157.58 38.93 Favored 'Trans proline' 0 C--N 1.323 -0.787 0 C-N-CA 122.242 1.961 . . . . 0.0 110.171 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.68 -2.77 67.44 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.671 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 19.1 mt -128.43 138.47 52.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.813 -1.404 . . . . 0.0 109.803 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -85.12 108.69 17.8 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt -97.95 139.36 33.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.356 -0.84 . . . . 0.0 110.516 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -119.85 129.13 54.26 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 10.3 t -71.62 131.25 42.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.48 -1.388 . . . . 0.0 111.105 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 32.1 mt -115.94 5.86 14.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.38 -176.18 16.01 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.54 143.05 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.9 -0.765 . . . . 0.0 109.158 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.19 162.6 16.83 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.861 0.838 . . . . 0.0 110.34 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -152.21 149.57 28.88 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -151.41 153.24 34.31 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.143 0.973 . . . . 0.0 109.475 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.467 ' O ' ' OG ' ' D' ' 30' ' ' SER . 6.0 tt -123.08 145.83 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.029 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' D' ' 29' ' ' ILE . 2.1 m 169.92 155.07 0.05 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.392 -0.817 . . . . 0.0 109.547 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' ASP . . . . . 0.496 ' O ' ' ND2' ' D' ' 32' ' ' ASN . 1.8 p30 -100.09 63.78 1.18 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.303 -0.873 . . . . 0.0 109.627 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' D' ' 31' ' ' ASP . 0.2 OUTLIER 176.84 132.76 0.05 Allowed 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 2.0 m -69.81 -40.89 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -63.31 -32.67 74.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.488 -0.757 . . . . 0.0 109.915 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -74.1 -39.34 63.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.246 -0.909 . . . . 0.0 109.109 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 mt -60.34 -48.99 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.35 -0.844 . . . . 0.0 108.963 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 63.0 t -57.48 -45.41 85.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.717 0 O-C-N 121.13 -0.981 . . . . 0.0 108.518 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -63.84 -43.1 97.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.186 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' ASN . . . . . 0.423 ' N ' HD21 ' D' ' 39' ' ' ASN . 1.5 m120 -57.95 -47.74 82.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.132 -0.98 . . . . 0.0 109.548 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 26.6 mt -63.95 -41.58 97.56 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 109.259 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -51.51 -39.84 58.44 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.443 -1.41 . . . . 0.0 109.815 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -72.95 -40.62 65.21 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.388 -0.82 . . . . 0.0 110.238 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -76.32 -36.15 58.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.389 -0.82 . . . . 0.0 109.704 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.97 -49.82 64.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.453 -0.78 . . . . 0.0 108.927 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -70.47 -31.22 68.27 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.087 -1.445 . . . . 0.0 108.989 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.06 -33.71 76.37 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -87.17 0.62 55.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.472 -0.768 . . . . 0.0 109.393 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.0 2.49 74.68 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.3 158.58 49.4 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.95 -1.3 5.92 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.261 -1.141 . . . . 0.0 110.196 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.04 168.29 40.69 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 2.7 tp -131.7 137.98 48.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.601 -0.941 . . . . 0.0 109.291 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 pt -106.72 144.24 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.515 -0.74 . . . . 0.0 109.538 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 65.77 76.36 0.32 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 0.0 109.815 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . 0.539 ' CG ' ' O ' ' D' ' 55' ' ' PHE . 62.6 t80 -106.36 34.44 3.38 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' ARG . . . . . 0.561 ' NH1' HH22 ' E' ' 56' ' ' ARG . 25.5 mtm180 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 120.989 -1.069 . . . . 0.0 109.42 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 67' ' ' TYR . . . . . 0.488 ' O ' ' CD2' ' D' ' 67' ' ' TYR . 16.4 p90 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.348 0.594 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -127.35 166.51 20.06 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 69' ' ' THR . . . . . 0.668 ' HG1' ' HG1' ' C' ' 11' ' ' THR . 54.7 m -110.71 138.08 47.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.109 -1.23 . . . . 0.0 108.482 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 41.0 mt -84.32 150.3 4.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.24 158.96 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.138 -0.976 . . . . 0.0 109.993 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -144.44 154.32 42.83 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.68 151.86 42.66 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.019 -1.051 . . . . 0.0 108.527 179.388 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -93.99 118.71 31.88 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.056 -1.027 . . . . 0.0 109.328 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 71.7 mt -111.65 129.18 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.588 -0.695 . . . . 0.0 110.113 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 9' ' ' ILE . . . . . 0.462 ' CG2' ' O ' ' E' ' 9' ' ' ILE . 17.4 tt -130.08 113.36 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 3.7 t -122.88 161.68 23.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.264 -0.897 . . . . 0.0 108.784 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 11' ' ' THR . . . . . . . . . . . . . 3.1 p -113.07 85.71 2.23 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.68 -124.12 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.351 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 13' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' E' ' 14' ' ' GLU . 1.0 OUTLIER -162.34 92.68 0.83 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.431 -0.793 . . . . 0.0 109.031 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . 0.453 ' CB ' ' O ' ' E' ' 13' ' ' ASP . 12.1 tt0 75.46 150.35 0.11 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.875 -0.515 . . . . 0.0 110.069 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.38 97.13 50.43 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -60.09 154.9 48.22 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.608 1.539 . . . . 0.0 110.507 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.33 -5.78 77.97 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 18' ' ' LEU . . . . . . . . . . . . . 17.1 mt -130.99 140.88 50.19 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.267 -1.137 . . . . 0.0 110.058 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 19' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' E' ' 73' ' ' ALA . 3.2 mp0 -83.64 109.48 17.48 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 18.0 mt -97.92 135.84 39.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.077 -1.014 . . . . 0.0 110.464 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 21' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' E' ' 72' ' ' LYS . 1.2 t80 -119.85 129.41 54.39 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 22' ' ' SER . . . . . 0.425 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 16.4 t -61.65 127.41 31.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.628 -1.295 . . . . 0.0 111.587 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mt -114.61 9.36 16.54 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.74 -177.62 16.86 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . 0.478 HD11 ' HG1' ' E' ' 69' ' ' THR . 50.3 mm -113.13 140.93 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.659 -0.907 . . . . 0.0 109.325 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.92 146.02 43.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.663 -0.648 . . . . 0.0 109.395 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 68.1 m -152.2 140.19 20.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.9 -1.125 . . . . 0.0 108.137 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.23 150.96 33.44 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.079 -1.013 . . . . 0.0 108.747 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 mm -120.03 135.05 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.4 -0.813 . . . . 0.0 109.487 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.87 159.93 18.85 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.517 -0.739 . . . . 0.0 109.896 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 31' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -83.18 -60.63 2.09 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.521 -0.737 . . . . 0.0 112.707 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -79.7 147.87 31.78 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.662 -1.274 . . . . 0.0 108.306 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 94.7 t -68.31 -34.59 66.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.696 -0.627 . . . . 0.0 109.626 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.11 -35.21 59.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.306 -0.871 . . . . 0.0 110.073 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -78.57 -33.63 47.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.057 -1.027 . . . . 0.0 109.188 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.08 -52.9 53.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 120.866 -1.146 . . . . 0.0 109.603 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.88 -50.52 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.084 -1.01 . . . . 0.0 110.145 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -57.21 -37.52 72.35 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.24 -0.913 . . . . 0.0 109.102 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -69.16 -40.48 78.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.937 -1.102 . . . . 0.0 110.137 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 39.3 mt -72.05 -49.62 35.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.882 -1.137 . . . . 0.0 109.196 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -48.1 -48.88 33.48 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.664 -1.272 . . . . 0.0 109.169 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -57.93 -32.9 68.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.317 -0.864 . . . . 0.0 109.32 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -73.38 -35.25 65.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.166 -0.959 . . . . 0.0 109.435 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.11 -51.34 20.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 120.56 -1.337 . . . . 0.0 109.083 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.35 -30.96 8.43 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.48 1.133 . . . . 0.0 109.699 -176.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.6 -25.11 49.62 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.59 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -95.65 13.53 26.01 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.07 29.87 29.43 Favored Glycine 0 N--CA 1.486 1.971 0 C-N-CA 118.032 -2.032 . . . . 0.0 109.877 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.37 -164.42 6.13 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -114.59 -35.68 4.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.59 -0.947 . . . . 0.0 110.011 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 172.33 -169.97 43.05 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 tp -118.54 140.86 49.22 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.404 -1.057 . . . . 0.0 110.173 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 53' ' ' ILE . . . . . 0.419 HG21 ' H ' ' E' ' 14' ' ' GLU . 64.5 mt -113.13 143.02 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.587 -0.696 . . . . 0.0 110.803 -178.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . 62.39 75.7 0.39 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 110.176 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -97.53 85.62 3.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.497 -0.752 . . . . 0.0 109.287 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 56' ' ' ARG . . . . . 0.561 HH22 ' NH1' ' D' ' 56' ' ' ARG . 28.6 ttm180 -84.44 160.44 20.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.405 -0.809 . . . . 0.0 109.621 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 76.6 mt . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.415 -0.803 . . . . 0.0 108.905 179.645 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 33.2 p90 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.66 0.743 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . 162.04 170.18 26.44 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 69' ' ' THR . . . . . 0.478 ' HG1' HD11 ' E' ' 25' ' ' ILE . 1.9 m -98.34 136.26 38.75 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 49.9 mt -81.69 143.31 12.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 2.7 m -129.33 158.45 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.361 -0.837 . . . . 0.0 109.654 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 72' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' E' ' 21' ' ' TYR . 16.1 tttm -139.47 156.66 46.8 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' E' ' 19' ' ' GLN . . . -117.31 113.88 22.78 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.016 0.912 . . . . 0.0 111.765 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 . . . . . 0 C--N 1.299 -1.609 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.132 -178.498 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.1 t80 . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.6 mt -114.64 138.15 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.548 -0.72 . . . . 0.0 109.62 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.479 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 12.8 tt -134.97 115.16 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.518 -0.738 . . . . 0.0 109.326 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.491 ' HG1' ' N ' ' A' ' 11' ' ' THR . 5.8 t -122.16 157.96 30.4 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.491 ' N ' ' HG1' ' A' ' 10' ' ' THR . 0.2 OUTLIER -116.28 113.33 22.83 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.264 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.47 80.3 0.19 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 122.119 0.961 . . . . 0.0 109.819 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 14' ' ' GLU . 19.2 t0 -152.98 -140.95 0.1 Allowed 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.718 -0.614 . . . . 0.0 109.413 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 4.0 tm-20 -167.7 -22.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.496 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.427 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 11.6 mt 52.88 64.51 7.12 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.338 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HD3' ' N ' ' A' ' 15' ' ' ILE . 2.4 Cg_endo -62.14 154.81 60.15 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 122.018 1.812 . . . . 0.0 110.12 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.56 -10.07 75.6 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.5 mt -123.13 136.14 54.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.299 -1.118 . . . . 0.0 109.214 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -97.99 112.92 24.68 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.08 137.05 54.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.615 -0.678 . . . . 0.0 109.244 -178.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -108.22 153.22 23.51 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.1 t -74.33 132.77 42.35 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.753 0.787 . . . . 0.0 110.769 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 mt -119.85 17.62 12.61 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.654 0.74 . . . . 0.0 109.119 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.8 176.84 16.6 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.62 144.48 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.78 144.71 45.08 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.88 141.55 21.81 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.87 -1.144 . . . . 0.0 107.926 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -150.21 151.66 33.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.963 -1.085 . . . . 0.0 109.072 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.7 mt -114.02 128.08 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.45 -0.781 . . . . 0.0 109.101 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.7 p -177.74 178.67 0.97 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.85 . . . . 0.0 108.93 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -118.46 168.1 10.97 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.519 -0.738 . . . . 0.0 109.03 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 75.09 119.46 0.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.6 t -68.06 -34.59 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.439 -0.788 . . . . 0.0 109.159 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -59.26 -40.41 85.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.883 . . . . 0.0 110.231 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -75.89 -38.59 57.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.226 -0.921 . . . . 0.0 109.628 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.2 mt -62.2 -46.66 95.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.036 -1.04 . . . . 0.0 109.365 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.2 t -56.95 -48.73 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.947 -1.096 . . . . 0.0 108.913 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.22 -42.58 99.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.364 -0.835 . . . . 0.0 110.366 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -57.09 -49.02 77.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 109.497 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.0 mt -68.64 -45.07 72.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.098 -1.001 . . . . 0.0 108.714 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -51.45 -48.31 62.8 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.888 -1.133 . . . . 0.0 109.88 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -63.69 -37.29 86.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.44 -0.787 . . . . 0.0 110.23 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -76.56 -35.54 58.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.388 -0.82 . . . . 0.0 109.835 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.3 t -68.09 -51.04 52.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.996 -1.065 . . . . 0.0 108.857 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -65.99 -32.75 74.41 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.15 -1.42 . . . . 0.0 109.555 -175.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.45 -28.47 69.7 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.9 -4.71 57.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.522 -0.736 . . . . 0.0 109.864 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.09 10.45 59.71 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.5 156.53 39.09 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.435 ' SD ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -123.08 -11.54 8.03 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.389 -1.066 . . . . 0.0 109.327 -178.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.435 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -154.55 162.29 30.63 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.3 tp -128.91 139.99 51.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.677 -0.896 . . . . 0.0 109.489 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.9 mt -113.3 144.41 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.568 -0.707 . . . . 0.0 109.684 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 67.48 72.85 0.33 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.263 -0.898 . . . . 0.0 110.081 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.508 ' CG ' ' O ' ' A' ' 55' ' ' PHE . 65.8 t80 -95.31 45.59 1.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 108.965 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.2 tpp180 -44.2 128.99 6.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.418 -0.801 . . . . 0.0 109.94 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mm . . . . . 0 C--N 1.303 -1.448 0 O-C-N 121.367 -0.833 . . . . 0.0 109.318 -179.89 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 122.239 1.019 . . . . 0.0 109.695 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 178.57 171.32 41.72 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.631 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.709 ' OG1' ' OG1' ' E' ' 11' ' ' THR . 86.8 m -103.15 135.9 43.94 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.206 -1.173 . . . . 0.0 108.776 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.6 mt -85.06 121.67 37.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.7 m -139.23 157.44 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 O-C-N 121.302 -0.874 . . . . 0.0 109.817 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -149.51 153.61 37.47 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.096 -1.002 . . . . 0.0 109.449 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.57 150.99 30.58 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.174 -0.954 . . . . 0.0 108.931 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.585 ' N ' ' OH ' ' A' ' 21' ' ' TYR . 1.9 p-10 . . . . . 0 C--N 1.302 -1.489 0 O-C-N 121.151 -0.968 . . . . 0.0 109.291 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 t80 . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 90.8 mt -122.3 129.7 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.24 -0.913 . . . . 0.0 109.833 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 16.6 tt -134.27 118.66 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t -125.54 152.91 44.41 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.097 -1.002 . . . . 0.0 108.557 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' THR . . . . . 0.519 ' O ' ' CB ' ' B' ' 12' ' ' ALA . 1.0 OUTLIER -96.89 79.99 2.97 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.451 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' B' ' 11' ' ' THR . . . 148.76 -98.41 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 35.8 t70 178.1 56.02 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -96.27 81.84 3.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.075 -1.016 . . . . 0.0 109.994 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.614 ' N ' ' HD3' ' B' ' 16' ' ' PRO . 5.7 mt -144.08 52.78 2.01 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.455 -0.778 . . . . 0.0 109.213 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.614 ' HD3' ' N ' ' B' ' 15' ' ' ILE . 2.1 Cg_endo -62.73 151.98 80.82 Favored 'Trans proline' 0 C--N 1.322 -0.865 0 C-N-CA 121.883 1.722 . . . . 0.0 109.945 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.43 -9.08 78.17 Favored Glycine 0 N--CA 1.484 1.874 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.23 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 71.2 mt -126.63 139.59 53.06 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 119.038 1.419 . . . . 0.0 108.879 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' B' ' 73' ' ' ALA . 23.0 mp0 -84.33 115.45 22.5 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.5 mt -89.67 138.69 31.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.802 -1.186 . . . . 0.0 110.174 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -120.02 128.91 53.97 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.54 -0.725 . . . . 0.0 109.644 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 30.2 t -77.69 132.97 38.43 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 120.59 -1.319 . . . . 0.0 109.858 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 37.5 mt -116.99 9.54 13.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.576 -0.703 . . . . 0.0 109.112 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.49 -170.67 17.39 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 33.9 mm -112.4 141.58 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.984 -0.715 . . . . 0.0 109.263 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.43 144.02 42.59 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.52 -0.738 . . . . 0.0 109.591 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 70.0 m -152.24 138.99 18.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 108.786 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 11.9 t -149.65 141.21 23.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.993 -1.067 . . . . 0.0 109.333 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 4.4 mp -111.74 125.57 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.164 -0.96 . . . . 0.0 109.244 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 45.5 p -173.74 -145.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.685 -0.634 . . . . 0.0 109.723 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 11.3 m-20 -157.68 164.89 36.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.289 -0.882 . . . . 0.0 109.137 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 21.4 t30 75.75 132.0 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 108.823 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 44.8 t -65.06 -32.1 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.66 -0.65 . . . . 0.0 109.493 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -58.72 -46.61 86.97 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.281 -0.887 . . . . 0.0 110.126 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.46 -41.11 61.35 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.352 -0.842 . . . . 0.0 109.756 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.64 -44.76 99.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 120.887 -1.133 . . . . 0.0 109.333 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 33.1 t -68.8 -47.11 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.856 -1.152 . . . . 0.0 109.574 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.99 -43.17 99.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.132 -0.98 . . . . 0.0 110.009 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -58.33 -48.71 79.68 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.32 -0.862 . . . . 0.0 109.67 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 52.4 mt -70.13 -47.88 59.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.083 -1.011 . . . . 0.0 108.662 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -49.79 -52.62 30.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.882 -1.136 . . . . 0.0 109.523 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -59.35 -35.69 74.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.315 -0.866 . . . . 0.0 110.084 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -75.53 -35.85 60.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.743 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 24.2 t -71.39 -50.93 37.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.11 -0.994 . . . . 0.0 109.104 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -70.35 -36.79 74.42 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.104 -1.438 . . . . 0.0 109.401 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.7 -34.19 69.19 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -85.09 3.72 37.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.25 -0.906 . . . . 0.0 109.053 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.95 7.94 84.84 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.86 -158.48 1.09 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' MET . . . . . 0.442 ' SD ' ' C ' ' B' ' 50' ' ' MET . 0.0 OUTLIER -170.47 -26.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.177 -1.19 . . . . 0.0 110.164 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -136.77 159.14 24.45 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 5.4 tp -138.39 143.08 39.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.414 -1.05 . . . . 0.0 109.39 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.79 150.24 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.493 -0.754 . . . . 0.0 108.979 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 75.82 177.5 0.2 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.62 ' CG ' ' O ' ' B' ' 55' ' ' PHE . 36.5 t80 170.98 11.79 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 121.646 2.021 . . . . 0.0 106.143 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . 0.672 ' CG ' HH11 ' B' ' 56' ' ' ARG . 0.0 OUTLIER -44.08 122.46 2.91 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.392 -1.442 . . . . 0.0 109.854 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 pt . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.561 -0.712 . . . . 0.0 109.421 -179.869 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.445 ' N ' ' CD2' ' B' ' 65' ' ' LEU . 1.5 pt? . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 122.543 1.164 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.98 158.82 18.3 Favored Glycine 0 N--CA 1.505 3.294 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -161.14 174.87 13.04 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.16 -1.2 . . . . 0.0 109.691 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.72 -165.25 32.44 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 55.1 m -126.47 137.77 53.43 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 61.2 mt -85.27 133.31 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.42 154.98 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.52 -0.737 . . . . 0.0 109.21 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -146.46 137.99 24.58 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' B' ' 19' ' ' GLN . . . -109.41 151.46 26.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.156 -0.965 . . . . 0.0 109.228 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' B' ' 74' ' ' ASP . 35.6 p-10 . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 60.7 mttm . . . . . 0 N--CA 1.5 2.036 0 CA-C-O 121.303 0.573 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -93.29 124.98 37.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.309 -0.869 . . . . 0.0 109.214 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 13.2 mt -121.13 147.9 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.461 -0.775 . . . . 0.0 110.655 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' ILE . . . . . 0.454 ' CG2' ' O ' ' C' ' 9' ' ' ILE . 11.1 tt -137.08 114.42 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.093 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 9.9 t -122.24 158.71 28.88 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.004 0.907 . . . . 0.0 108.848 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -85.21 -115.44 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.11 101.36 10.92 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.099 -1.0 . . . . 0.0 109.019 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -167.06 -18.55 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.524 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 59.5 163.2 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.599 -0.688 . . . . 0.0 109.22 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 66.5 mt -125.73 85.09 59.59 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.525 -0.735 . . . . 0.0 109.223 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.44 156.83 39.17 Favored 'Trans proline' 0 C--N 1.324 -0.736 0 C-N-CA 122.024 1.816 . . . . 0.0 110.168 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.05 -6.69 76.36 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 61.6 mt -128.7 137.82 51.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -1.209 . . . . 0.0 108.786 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -87.37 108.35 18.95 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 10.5 mt -93.91 138.45 32.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.4 -0.812 . . . . 0.0 109.652 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' TYR . . . . . 0.416 ' CZ ' ' O ' ' C' ' 22' ' ' SER . 3.0 t80 -123.2 131.82 53.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.502 -0.749 . . . . 0.0 109.252 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' SER . . . . . 0.416 ' O ' ' CZ ' ' C' ' 21' ' ' TYR . 0.0 OUTLIER -53.85 128.74 31.15 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.114 -0.991 . . . . 0.0 111.169 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mt -120.14 11.73 11.7 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.899 0.856 . . . . 0.0 109.308 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.5 -169.05 13.23 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 40.5 mm -122.73 139.09 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.683 0.754 . . . . 0.0 109.777 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -110.26 149.96 29.4 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 29.6 m -143.47 138.83 29.53 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.566 -0.709 . . . . 0.0 109.827 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 15.1 t -150.01 153.69 36.94 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.186 -0.946 . . . . 0.0 109.154 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' C' ' 30' ' ' SER . 5.5 tp -88.43 144.23 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.491 -1.381 . . . . 0.0 109.958 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.456 ' O ' ' O ' ' C' ' 29' ' ' ILE . 48.0 t -51.59 -106.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.567 -0.708 . . . . 0.0 110.276 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' C' ' 32' ' ' ASN . 34.9 t0 59.78 63.05 1.56 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' C' ' 31' ' ' ASP . 0.5 OUTLIER 89.16 115.67 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -176.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.4 -38.92 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.121 -0.987 . . . . 0.0 109.754 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . 0.424 ' H ' HD21 ' C' ' 32' ' ' ASN . 0.8 OUTLIER -54.14 -30.27 48.44 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.31 -0.869 . . . . 0.0 108.709 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.69 -35.57 70.29 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 70.3 mt -65.23 -52.31 54.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 C-N-CA 118.429 -1.308 . . . . 0.0 110.43 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 85.4 t -71.04 -46.02 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.881 -1.137 . . . . 0.0 109.752 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.06 -43.85 97.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 0.0 109.397 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -64.13 -39.88 94.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.988 -1.07 . . . . 0.0 109.58 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 65.7 mt -68.97 -44.59 72.6 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 108.809 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' ARG . . . . . 0.738 HH11 ' HG3' ' C' ' 41' ' ' ARG . 0.1 OUTLIER -51.25 -53.68 33.09 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.752 -1.217 . . . . 0.0 109.913 -179.109 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' LYS . . . . . 0.445 ' O ' ' CB ' ' C' ' 46' ' ' ALA . 54.4 mttt -59.48 -37.66 78.8 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.777 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -75.9 -35.02 59.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.133 -0.979 . . . . 0.0 110.091 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 5.2 t -73.97 -51.88 22.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.12 -0.988 . . . . 0.0 108.934 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -72.61 -29.9 63.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 119.972 -1.705 . . . . 0.0 109.488 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' C' ' 42' ' ' LYS . . . -61.11 -29.73 69.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.522 -0.736 . . . . 0.0 109.491 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.66 -4.84 23.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.45 -0.782 . . . . 0.0 109.773 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.38 31.58 6.41 Favored Glycine 0 N--CA 1.498 2.825 0 C-N-CA 119.509 -1.329 . . . . 0.0 111.892 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.69 -178.73 52.49 Favored Glycine 0 N--CA 1.487 2.069 0 O-C-N 120.075 -1.838 . . . . 0.0 111.2 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 21.2 ttt -108.31 -40.86 5.04 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.459 -1.024 . . . . 0.0 110.712 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 175.07 -175.81 47.13 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 6.1 tp -110.62 132.07 54.5 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.511 -0.993 . . . . 0.0 109.694 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 pt -107.84 143.95 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.573 -0.704 . . . . 0.0 109.562 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 64.55 81.72 0.2 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.973 . . . . 0.0 110.113 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.54 -59.15 5.09 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.764 -0.775 . . . . 0.0 108.931 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' ARG . . . . . 0.527 ' HE ' ' HA ' ' C' ' 56' ' ' ARG . 0.0 OUTLIER 60.07 82.99 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.426 -0.796 . . . . 0.0 109.5 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' C' ' 67' ' ' TYR . 11.1 p90 . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -131.82 155.69 21.55 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 81.2 m -104.86 136.36 44.5 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.879 -1.365 . . . . 0.0 107.811 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 33.9 mt -90.45 139.0 18.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 108.746 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -145.08 164.13 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.356 -0.84 . . . . 0.0 110.216 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -150.6 147.74 27.79 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' C' ' 74' ' ' ASP . . . -124.09 150.73 44.68 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.19 -0.944 . . . . 0.0 108.939 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' C' ' 73' ' ' ALA . 3.9 m-20 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.388 -0.82 . . . . 0.0 111.262 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -116.32 120.06 37.68 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.388 -0.82 . . . . 0.0 109.419 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 76.5 mt -99.75 133.78 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.287 -0.883 . . . . 0.0 109.286 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 9' ' ' ILE . . . . . . . . . . . . . 20.3 tt -125.1 124.63 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.492 -0.755 . . . . 0.0 109.555 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.512 ' OG1' ' CG ' ' D' ' 13' ' ' ASP . 11.3 t -119.17 131.9 55.91 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 11' ' ' THR . . . . . 0.49 ' HG1' ' HG1' ' E' ' 69' ' ' THR . 5.9 m -112.59 114.84 27.68 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.3 -0.875 . . . . 0.0 110.896 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . 51.67 77.39 0.14 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.231 -0.918 . . . . 0.0 109.816 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' D' ' 13' ' ' ASP . 4.5 p-10 178.07 -138.6 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -173.28 171.55 4.01 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.848 -1.157 . . . . 0.0 108.759 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 11.5 mt -129.62 78.45 75.42 Favored Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.76 156.13 44.83 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 122.054 1.836 . . . . 0.0 110.035 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.86 -9.79 74.93 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 59.1 mt -127.4 136.04 51.3 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 119.032 1.416 . . . . 0.0 108.501 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -86.56 108.05 18.4 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 6.0 mt -102.81 128.29 49.63 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.506 -0.746 . . . . 0.0 109.853 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' D' ' 21' ' ' TYR . 0.5 OUTLIER -119.17 145.98 45.55 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.338 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.3 t -86.87 131.63 34.05 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.455 0.645 . . . . 0.0 110.426 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . 0.664 ' N ' ' CD2' ' D' ' 23' ' ' LEU . 0.3 OUTLIER -119.56 5.94 11.07 Favored 'General case' 0 N--CA 1.512 2.637 0 CA-C-O 122.948 1.356 . . . . 0.0 108.381 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.46 174.0 21.16 Favored Glycine 0 N--CA 1.497 2.73 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.685 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.12 144.81 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.86 144.19 42.83 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 74.0 m -151.48 139.73 20.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 15.1 t -149.62 147.83 28.59 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.964 -1.085 . . . . 0.0 109.036 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 80.3 mt -117.08 128.17 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.306 -0.871 . . . . 0.0 108.847 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.643 ' HG ' ' H ' ' D' ' 31' ' ' ASP . 12.8 t -177.67 179.62 0.89 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.445 -0.785 . . . . 0.0 108.962 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' ASP . . . . . 0.643 ' H ' ' HG ' ' D' ' 30' ' ' SER . 19.4 p-10 -116.06 163.7 15.55 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.558 -0.714 . . . . 0.0 109.555 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 5.8 t-20 75.68 126.3 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.142 -0.974 . . . . 0.0 108.68 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 89.1 t -68.98 -33.73 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.595 -0.691 . . . . 0.0 109.738 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' D' ' 35' ' ' GLU . 1.3 p30 -59.57 -41.52 90.39 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.125 -0.984 . . . . 0.0 109.58 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' GLU . . . . . 0.527 ' N ' ' OD1' ' D' ' 34' ' ' ASP . 16.8 tp10 -75.3 -41.22 57.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.124 -0.985 . . . . 0.0 109.284 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 90.9 mt -64.26 -42.57 95.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 O-C-N 120.962 -1.086 . . . . 0.0 109.232 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 t -64.14 -49.79 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.769 -1.207 . . . . 0.0 109.223 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.09 -38.66 83.59 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.861 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -60.55 -44.06 96.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 109.602 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 35.1 mt -70.37 -46.23 64.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.206 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -51.37 -45.37 62.39 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.767 -1.208 . . . . 0.0 109.601 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -67.3 -39.29 85.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.432 -0.793 . . . . 0.0 110.062 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -75.91 -36.09 59.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.411 -0.806 . . . . 0.0 109.727 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 15.4 t -69.7 -50.77 47.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 108.787 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -64.6 -34.07 77.41 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 118.243 -1.383 . . . . 0.0 109.322 -175.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.93 -30.94 71.94 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.736 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -85.02 -3.97 58.98 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.16 5.09 68.05 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.15 159.97 52.17 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.36 -7.67 7.56 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.424 -1.045 . . . . 0.0 109.379 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.69 166.37 37.95 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 8.0 tp -129.73 142.79 50.64 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.661 -0.905 . . . . 0.0 109.794 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -107.41 140.65 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.734 -0.604 . . . . 0.0 110.577 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 67.64 86.47 0.13 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.515 -0.741 . . . . 0.0 110.47 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -100.63 37.67 1.66 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.694 0.759 . . . . 0.0 109.743 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' ARG . . . . . 0.743 ' HG3' HH11 ' D' ' 56' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.769 0 O-C-N 120.481 -1.387 . . . . 0.0 109.135 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 18.6 p90 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 122.557 1.17 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.66 -176.79 43.44 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 70.9 m -111.64 137.61 49.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.275 -1.132 . . . . 0.0 108.864 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 70' ' ' ILE . . . . . 0.457 ' O ' HD23 ' D' ' 23' ' ' LEU . 62.5 mt -84.54 136.71 22.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 13.5 m -146.75 151.56 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.543 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 72' ' ' LYS . . . . . 0.496 ' HZ1' ' HB2' ' D' ' 72' ' ' LYS . 0.9 OUTLIER -139.07 164.59 29.38 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.973 -1.08 . . . . 0.0 109.029 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.7 150.83 36.17 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 16.9 t0 . . . . . 0 N--CA 1.487 1.381 0 O-C-N 120.979 -1.076 . . . . 0.0 108.569 179.179 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 pttp . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.786 0.803 . . . . 0.0 108.923 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -105.36 123.73 48.36 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.655 -0.653 . . . . 0.0 109.762 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 89.7 mt -98.0 123.64 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.072 -1.017 . . . . 0.0 110.672 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 9' ' ' ILE . . . . . 0.438 ' CG2' ' O ' ' E' ' 9' ' ' ILE . 19.5 tt -137.21 116.66 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 10' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' E' ' 13' ' ' ASP . 15.2 t -124.66 157.29 35.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.0 -1.063 . . . . 0.0 108.934 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 11' ' ' THR . . . . . 0.709 ' OG1' ' OG1' ' A' ' 69' ' ' THR . 0.0 OUTLIER -135.26 128.24 31.49 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.346 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.4 35.37 24.87 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.898 0.856 . . . . 0.0 109.612 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 13' ' ' ASP . . . . . 0.459 ' HB3' ' OG1' ' E' ' 10' ' ' THR . 23.5 t0 -152.48 86.26 1.27 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.617 -0.677 . . . . 0.0 109.355 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -57.81 170.01 0.66 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 108.957 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 40.0 mt -122.32 80.19 45.22 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.358 -0.839 . . . . 0.0 109.116 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.53 156.99 38.75 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.109 1.873 . . . . 0.0 110.083 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.52 -5.48 73.99 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 18' ' ' LEU . . . . . . . . . . . . . 50.0 mt -128.21 136.62 51.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.938 -1.331 . . . . 0.0 108.776 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -86.04 108.61 18.33 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 10.7 mt -95.42 136.58 35.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.329 -0.857 . . . . 0.0 109.703 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 21' ' ' TYR . . . . . 0.427 ' CZ ' ' O ' ' E' ' 22' ' ' SER . 2.4 t80 -121.04 132.3 54.8 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.575 -0.703 . . . . 0.0 109.174 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 22' ' ' SER . . . . . 0.427 ' O ' ' CZ ' ' E' ' 21' ' ' TYR . 0.0 OUTLIER -58.72 130.77 48.49 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.04 -1.037 . . . . 0.0 111.162 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 mt -116.87 12.53 14.76 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.14 -174.08 15.07 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 31.0 mm -112.44 140.87 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.609 -0.936 . . . . 0.0 109.416 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.32 143.98 45.38 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.706 -0.621 . . . . 0.0 109.657 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 4.0 p -152.38 141.61 21.43 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.817 -1.177 . . . . 0.0 108.512 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 14.2 t -149.64 134.01 17.41 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.107 -0.996 . . . . 0.0 109.152 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 59.9 mt -108.41 127.5 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.333 -0.855 . . . . 0.0 108.909 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 94.5 p -172.55 -140.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.42 -0.8 . . . . 0.0 109.535 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 31' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' E' ' 32' ' ' ASN . 24.7 t70 -155.97 158.67 38.29 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.207 -0.933 . . . . 0.0 109.578 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 32' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 15.1 t30 73.83 126.72 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.19 -0.943 . . . . 0.0 108.867 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.27 -32.16 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.479 -0.763 . . . . 0.0 109.527 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -57.45 -45.59 84.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.876 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -76.05 -38.91 56.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.164 -0.96 . . . . 0.0 109.756 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 79.6 mt -61.78 -49.57 83.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.891 -1.131 . . . . 0.0 109.3 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -62.48 -48.6 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.973 -1.079 . . . . 0.0 109.287 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.67 -39.84 81.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.221 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 39' ' ' ASN . . . . . 0.435 HD21 ' N ' ' E' ' 39' ' ' ASN . 2.0 m120 -64.51 -44.89 89.5 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.24 -0.913 . . . . 0.0 109.688 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 40' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' E' ' 41' ' ' ARG . 27.8 mt -68.63 -45.7 71.17 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.014 -1.054 . . . . 0.0 108.543 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 41' ' ' ARG . . . . . 0.826 HH11 ' HG2' ' E' ' 41' ' ' ARG . 5.3 ttt-85 -47.84 -53.67 14.87 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.79 -1.193 . . . . 0.0 109.054 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -60.01 -35.87 75.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.408 -0.808 . . . . 0.0 110.012 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -77.16 -35.03 56.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.503 -0.748 . . . . 0.0 109.93 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 t -70.45 -51.92 33.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 121.053 -1.029 . . . . 0.0 108.677 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -68.42 -31.8 71.38 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.326 -1.35 . . . . 0.0 109.275 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.75 -29.44 69.95 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.22 -5.62 58.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.589 -0.694 . . . . 0.0 109.686 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.49 3.94 58.38 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.74 163.2 45.75 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -125.15 -10.45 7.06 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.394 -1.062 . . . . 0.0 109.771 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.68 157.92 30.0 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.106 -1.521 . . . . 0.0 109.648 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.43 139.93 46.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.709 -0.877 . . . . 0.0 109.32 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 pt -106.66 140.06 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.418 -0.801 . . . . 0.0 109.597 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.79 82.2 0.16 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 122.259 1.028 . . . . 0.0 111.73 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -60.11 -102.84 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.142 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 56' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' E' ' 57' ' ' ILE . 6.4 ttm180 -173.84 -125.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.962 -1.086 . . . . 0.0 108.989 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 57' ' ' ILE . . . . . 0.468 ' O ' ' O ' ' E' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.246 0 O-C-N 121.726 -0.609 . . . . 0.0 109.771 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 33.6 t80 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.615 0.721 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.16 165.93 28.11 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 69' ' ' THR . . . . . 0.49 ' HG1' ' HG1' ' D' ' 11' ' ' THR . 61.3 m -107.79 137.77 45.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.407 -1.054 . . . . 0.0 108.183 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 28.9 mt -85.37 144.33 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 m -144.77 163.33 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.287 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -153.79 155.43 35.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 0.0 108.749 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.48 150.94 35.69 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.123 -0.986 . . . . 0.0 108.739 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.4 t0 . . . . . 0 N--CA 1.486 1.336 0 O-C-N 120.964 -1.085 . . . . 0.0 108.666 179.31 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 56.7 t80 . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.6 mt -115.21 143.51 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.63 -0.669 . . . . 0.0 109.477 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.45 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 11.4 tt -124.69 119.71 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.425 ' OG1' ' OD2' ' A' ' 13' ' ' ASP . 5.5 t -112.32 132.48 54.96 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.372 -0.83 . . . . 0.0 109.351 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.526 ' OG1' ' HB ' ' B' ' 69' ' ' THR . 0.2 OUTLIER -64.05 -135.77 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.387 -0.821 . . . . 0.0 109.919 -179.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.19 80.27 6.29 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.714 0.768 . . . . 0.0 109.843 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.425 ' OD2' ' OG1' ' A' ' 10' ' ' THR . 8.1 p-10 -154.99 -126.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -171.49 171.58 5.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.987 -1.07 . . . . 0.0 109.3 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.1 mt -130.65 75.12 79.35 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.389 -0.82 . . . . 0.0 108.884 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.77 157.65 36.83 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 122.09 1.86 . . . . 0.0 110.177 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.01 -7.49 73.16 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 73.3 mt -125.41 137.81 54.01 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.077 -1.249 . . . . 0.0 109.482 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -86.55 108.4 18.56 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 3.7 mt -110.56 128.81 55.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.495 -0.753 . . . . 0.0 109.999 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.596 ' OH ' ' N ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -107.75 149.81 27.73 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.038 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.25 126.01 30.21 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.68 14.28 21.19 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.6 178.37 18.48 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.03 143.96 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.958 -0.731 . . . . 0.0 109.174 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.52 154.87 25.25 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.668 -0.645 . . . . 0.0 109.779 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.2 m -128.7 156.46 43.45 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.48 145.98 49.22 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.246 -0.909 . . . . 0.0 109.324 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.435 ' O ' ' OG ' ' A' ' 30' ' ' SER . 2.2 mm -129.13 128.48 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 120.953 1.706 . . . . 0.0 106.797 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 29' ' ' ILE . 1.2 m 171.86 -165.54 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.919 -1.113 . . . . 0.0 109.303 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -120.84 -70.86 0.76 Allowed 'General case' 0 N--CA 1.513 2.704 0 O-C-N 121.619 -0.675 . . . . 0.0 112.453 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -62.61 149.76 42.48 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.526 -1.359 . . . . 0.0 108.453 176.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.17 -39.98 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.83 -29.44 40.99 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.421 -0.799 . . . . 0.0 109.762 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.402 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 12.8 mm-40 -78.46 -33.91 48.08 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.38 -0.825 . . . . 0.0 109.371 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.6 mt -62.56 -47.64 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.911 . . . . 0.0 109.258 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.25 -53.17 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.738 -1.226 . . . . 0.0 110.267 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -57.2 -36.9 71.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.203 -0.936 . . . . 0.0 109.95 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 35' ' ' GLU . 76.8 m-20 -64.71 -43.44 93.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.201 -0.937 . . . . 0.0 110.132 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.1 mt -69.89 -45.86 66.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.935 -1.103 . . . . 0.0 109.53 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -48.97 -45.88 42.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.8 -1.188 . . . . 0.0 109.223 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -64.52 -36.62 84.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.479 -0.763 . . . . 0.0 110.182 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -75.53 -36.16 60.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.365 -0.835 . . . . 0.0 109.824 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.8 t -69.24 -50.13 55.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.126 -0.984 . . . . 0.0 109.487 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -64.76 -29.7 70.68 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.013 -175.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.2 -32.09 69.85 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.498 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.88 3.29 34.5 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.479 -0.763 . . . . 0.0 109.099 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.84 4.33 88.21 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.88 -157.22 0.4 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -166.11 -23.46 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.203 -1.174 . . . . 0.0 110.023 178.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.548 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -151.18 143.9 11.09 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.6 tp -106.84 138.98 41.98 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.962 . . . . 0.0 109.357 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -109.48 139.67 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.604 -0.685 . . . . 0.0 110.628 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 73.09 85.24 0.11 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.679 -0.638 . . . . 0.0 110.586 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -111.47 121.2 44.57 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -140.39 105.87 5.08 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -0.853 . . . . 0.0 109.422 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.7 mt . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.363 -0.836 . . . . 0.0 109.248 179.829 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.8 p90 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.602 0.715 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.27 148.04 17.47 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 79.5 m -105.12 143.0 33.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.015 -1.286 . . . . 0.0 109.384 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.8 mt -91.66 143.72 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.41 -0.806 . . . . 0.0 109.102 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 20' ' ' LEU . 10.6 m -142.27 151.97 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 109.101 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -141.09 143.82 34.55 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.16 -0.962 . . . . 0.0 108.933 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.591 ' O ' ' CB ' ' A' ' 74' ' ' ASP . . . -124.44 152.58 43.12 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.596 ' N ' ' OH ' ' A' ' 21' ' ' TYR . 25.6 t0 . . . . . 0 N--CA 1.507 2.389 0 CA-C-O 121.221 0.534 . . . . 0.0 110.213 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 71.7 t80 . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 121.274 0.559 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.5 mt -112.08 132.73 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.436 ' O ' ' CG2' ' B' ' 9' ' ' ILE . 10.1 tt -125.78 114.39 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.78 158.93 32.13 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.412 -0.805 . . . . 0.0 108.945 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 12.6 p -110.64 86.52 2.33 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.38 -110.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.685 -0.635 . . . . 0.0 109.914 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -147.02 -161.35 1.31 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.227 -0.92 . . . . 0.0 109.576 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . 0.416 ' O ' ' HD3' ' B' ' 16' ' ' PRO . 0.7 OUTLIER -58.84 131.45 51.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.421 -0.799 . . . . 0.0 109.583 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.03 110.2 3.01 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' B' ' 14' ' ' GLU . 1.9 Cg_endo -63.68 154.11 71.17 Favored 'Trans proline' 0 N--CA 1.481 0.746 0 C-N-CA 121.286 1.324 . . . . 0.0 110.26 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.44 -6.68 82.23 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.32 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 73.2 mt -129.94 142.43 50.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -1.139 . . . . 0.0 109.976 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -87.7 108.25 19.02 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -93.29 140.52 29.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.156 -0.965 . . . . 0.0 110.484 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . 0.405 ' CD1' ' N ' ' B' ' 22' ' ' SER . 1.3 t80 -123.2 131.3 53.63 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.405 ' N ' ' CD1' ' B' ' 21' ' ' TYR . 11.8 t -59.5 129.75 43.5 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.085 -1.009 . . . . 0.0 110.607 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mt -117.07 9.24 13.56 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.78 173.77 16.38 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 49.3 mm -111.19 143.5 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.868 -0.783 . . . . 0.0 109.101 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.28 144.65 43.42 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.377 -0.827 . . . . 0.0 109.199 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 9.4 p -152.53 143.74 23.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.986 -1.071 . . . . 0.0 108.71 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 7.7 t -150.35 152.82 35.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.137 -0.977 . . . . 0.0 109.426 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 1.8 mm -122.92 128.1 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 53.8 p -173.49 -153.17 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.519 -0.738 . . . . 0.0 109.709 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 3.7 p-10 -135.31 157.14 47.67 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.461 -0.774 . . . . 0.0 109.495 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 4.1 t-20 82.57 115.16 0.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.1 -39.94 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.26 -35.44 77.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.374 -0.829 . . . . 0.0 110.129 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -73.33 -37.17 66.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.317 -0.865 . . . . 0.0 108.929 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 14.3 mt -62.23 -42.88 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 108.928 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 63.6 t -55.44 -48.82 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.988 -1.07 . . . . 0.0 108.627 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.74 -40.45 92.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.4 -0.812 . . . . 0.0 110.008 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -59.16 -46.57 88.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.13 -0.981 . . . . 0.0 109.72 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.97 -46.39 65.32 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.799 -1.188 . . . . 0.0 108.678 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . 0.757 HH11 ' HG2' ' B' ' 41' ' ' ARG . 6.4 ttt-85 -49.63 -49.61 46.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.822 -1.174 . . . . 0.0 108.878 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 6.3 pttm -61.42 -35.24 76.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 0.0 108.909 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -71.67 -36.5 70.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.517 -0.74 . . . . 0.0 109.225 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 52.2 t -75.35 -49.75 26.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.981 -1.074 . . . . 0.0 109.21 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.638 ' HZ2' ' NH1' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -48.96 -31.99 8.35 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.531 1.158 . . . . 0.0 110.276 -178.287 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.53 -27.04 51.56 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.71 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -93.84 13.12 23.53 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.14 31.11 32.94 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 118.656 -1.735 . . . . 0.0 109.814 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.3 153.75 28.03 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 68.1 mmm -63.1 -45.35 92.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.349 -1.089 . . . . 0.0 110.673 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.27 -169.49 39.82 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.1 tp -102.43 141.82 34.64 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.507 -0.996 . . . . 0.0 110.034 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' B' ' 53' ' ' ILE . 1.1 pp -119.64 147.77 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.794 0.807 . . . . 0.0 112.075 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 52.94 52.73 13.29 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 119.692 -1.88 . . . . 0.0 109.403 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -83.76 96.35 8.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.018 -1.051 . . . . 0.0 109.327 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . 0.821 HH21 HH22 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -97.56 138.04 35.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.351 -0.843 . . . . 0.0 109.189 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 97.7 mt . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.344 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.601 0.715 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' B' ' 67' ' ' TYR . . . -81.71 60.64 4.73 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' B' ' 66' ' ' GLY . 3.0 p90 -44.02 121.57 2.51 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.512 -0.993 . . . . 0.0 109.334 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.22 135.28 5.58 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' THR . . . . . 0.526 ' HB ' ' OG1' ' A' ' 11' ' ' THR . 23.6 m -95.79 138.22 33.75 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.104 -1.233 . . . . 0.0 108.348 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 47.6 mt -84.94 141.78 14.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.52 163.97 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.774 0.797 . . . . 0.0 109.811 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -151.01 151.32 31.9 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.97 149.88 45.46 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 7.7 t70 . . . . . 0 C--N 1.302 -1.478 0 O-C-N 121.026 -1.046 . . . . 0.0 109.366 179.693 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 56.7 mttm . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.058 0.456 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -92.03 120.76 32.97 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 80.5 mt -116.82 145.75 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.535 -0.728 . . . . 0.0 109.817 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' ILE . . . . . 0.448 ' CG2' ' O ' ' C' ' 9' ' ' ILE . 11.5 tt -130.5 114.63 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.424 ' OG1' ' OD1' ' C' ' 13' ' ' ASP . 11.7 t -123.09 159.36 28.66 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.962 0.887 . . . . 0.0 108.823 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' THR . . . . . 0.456 ' OG1' ' OG1' ' D' ' 69' ' ' THR . 1.7 p -88.5 -113.5 0.06 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.49 99.0 8.62 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.258 -0.902 . . . . 0.0 109.239 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . 0.424 ' OD1' ' OG1' ' C' ' 10' ' ' THR . 0.9 OUTLIER -169.01 -13.44 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.72 -179.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 57.24 173.02 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.312 -0.867 . . . . 0.0 109.57 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 66.4 mt -134.37 83.35 44.07 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.47 -0.769 . . . . 0.0 109.142 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.64 157.14 43.59 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 121.936 1.758 . . . . 0.0 110.139 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.38 -7.85 75.15 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 37.0 mt -127.86 140.37 52.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.142 -1.211 . . . . 0.0 109.716 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -86.44 110.39 19.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -95.67 136.29 36.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.112 -0.993 . . . . 0.0 110.182 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -118.51 130.16 55.77 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 4.9 t -65.26 128.38 35.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.935 -1.103 . . . . 0.0 110.746 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 12.4 mt -115.04 8.5 15.76 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.74 178.72 18.86 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.08 144.22 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.801 -0.823 . . . . 0.0 109.066 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.62 144.21 44.23 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.645 -0.66 . . . . 0.0 109.609 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 86.9 p -152.41 136.08 16.16 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 10.7 t -149.88 153.34 36.53 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.942 -1.099 . . . . 0.0 109.339 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 4.9 mp -125.28 132.03 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.18 -0.95 . . . . 0.0 108.726 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.425 ' O ' ' O ' ' C' ' 31' ' ' ASP . 0.2 OUTLIER -169.98 7.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.568 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' C' ' 32' ' ' ASN . 21.5 t0 58.88 153.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.314 -0.866 . . . . 0.0 109.808 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . 0.469 ' N ' ' OD1' ' C' ' 31' ' ' ASP . 3.6 m120 81.26 115.17 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.11 -40.81 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -58.81 -33.71 70.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.364 -0.835 . . . . 0.0 109.914 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -76.44 -36.36 58.0 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.289 -0.882 . . . . 0.0 109.188 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 55.5 mt -62.95 -52.7 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 0.0 109.086 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -51.71 -49.45 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 108.574 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -61.42 -41.84 97.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.394 -0.816 . . . . 0.0 109.631 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -64.63 -46.15 83.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 0.0 109.871 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.32 -46.86 72.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.025 -1.047 . . . . 0.0 108.547 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' ARG . . . . . 0.615 ' CG ' HH11 ' C' ' 41' ' ' ARG . 0.0 OUTLIER -47.75 -53.71 14.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.0 -1.062 . . . . 0.0 109.087 178.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -57.56 -35.11 69.93 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.306 -0.871 . . . . 0.0 110.214 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -75.9 -35.69 59.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.508 -0.745 . . . . 0.0 109.706 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 4.7 t -73.55 -51.64 24.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.139 -0.975 . . . . 0.0 108.99 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' LYS . . . . . 0.418 ' HZ1' ' NH2' ' C' ' 41' ' ' ARG . 22.8 ttpt -63.45 -29.13 70.46 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.205 -175.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.77 -29.57 69.56 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -91.39 6.47 45.27 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.411 -0.805 . . . . 0.0 109.146 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.11 28.97 74.09 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.0 -1.571 . . . . 0.0 109.479 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.57 -164.11 14.18 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 5.6 tmm? -117.39 -37.55 3.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.947 . . . . 0.0 110.573 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 176.75 169.27 37.87 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 7.5 tp -95.64 132.78 40.44 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.348 -1.089 . . . . 0.0 109.836 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 pt -109.85 144.86 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.507 -0.746 . . . . 0.0 109.936 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 69.37 82.81 0.16 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -114.73 85.55 2.27 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' ARG . . . . . 0.821 HH22 HH21 ' B' ' 56' ' ' ARG . 89.3 mtt180 -112.1 161.54 16.39 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.543 -0.723 . . . . 0.0 109.262 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 67.8 mt . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.443 -0.786 . . . . 0.0 108.934 -179.922 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 36.7 p90 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.631 0.729 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.35 149.09 20.82 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 49.8 m -96.8 136.8 36.84 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.975 -1.309 . . . . 0.0 108.271 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 37.4 mt -83.83 139.72 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.8 m -126.31 165.04 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.306 -0.871 . . . . 0.0 109.913 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -155.28 140.02 17.1 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.448 ' O ' ' CG ' ' C' ' 74' ' ' ASP . . . -116.58 115.06 25.03 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.895 -1.128 . . . . 0.0 110.674 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' C' ' 73' ' ' ALA . 3.0 m-20 . . . . . 0 N--CA 1.494 1.742 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.597 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 94.9 mttt . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -94.3 124.95 38.63 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.362 -0.836 . . . . 0.0 109.807 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 75.5 mt -114.54 127.41 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.554 -0.716 . . . . 0.0 109.219 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 9' ' ' ILE . . . . . 0.431 ' O ' ' CG2' ' D' ' 9' ' ' ILE . 17.0 tt -121.26 114.94 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.7 t -122.52 151.88 40.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.39 72.45 0.95 Allowed 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.555 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.31 -101.59 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.159 -1.588 . . . . 0.0 108.417 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -119.87 -154.6 0.58 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.414 -0.804 . . . . 0.0 109.614 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -78.68 -172.0 2.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.237 -0.914 . . . . 0.0 109.564 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 84.5 mt -120.35 93.68 48.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -61.58 155.62 52.17 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.716 1.611 . . . . 0.0 110.607 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.44 -9.63 75.64 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 71.7 mt -129.37 141.41 51.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.266 -1.137 . . . . 0.0 109.487 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -84.96 108.86 17.79 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 13.8 mt -91.4 133.82 35.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.896 -1.128 . . . . 0.0 110.145 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' TYR . . . . . 0.541 ' CE1' ' O ' ' D' ' 22' ' ' SER . 0.9 OUTLIER -120.82 130.67 54.06 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' SER . . . . . 0.541 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 0.0 OUTLIER -66.37 130.64 43.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.156 -0.965 . . . . 0.0 111.494 -179.018 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 14.0 mt -119.94 14.16 12.35 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.04 -174.46 15.21 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 46.7 mm -112.75 138.87 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 122.014 -0.698 . . . . 0.0 109.187 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.28 144.39 43.81 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.336 -0.853 . . . . 0.0 110.212 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 22.4 p -153.17 135.33 14.85 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 7.3 t -150.17 141.21 22.98 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.821 -1.175 . . . . 0.0 109.85 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 tp -126.47 131.84 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.491 ' O ' ' O ' ' D' ' 31' ' ' ASP . 56.8 p -168.51 8.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.625 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' D' ' 30' ' ' SER . 36.9 t0 54.2 156.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.528 -0.733 . . . . 0.0 110.177 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 2.3 t-20 74.37 129.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.959 -1.088 . . . . 0.0 108.504 -178.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 t -67.61 -35.55 73.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.424 -0.797 . . . . 0.0 109.587 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -59.06 -44.31 91.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.355 -0.841 . . . . 0.0 110.559 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -75.5 -37.47 60.14 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.958 -1.089 . . . . 0.0 109.517 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 83.5 mt -66.48 -42.09 89.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.914 -1.116 . . . . 0.0 109.513 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -65.46 -53.73 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.639 -1.288 . . . . 0.0 110.135 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -55.42 -35.52 65.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.293 -0.88 . . . . 0.0 109.433 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' ASN . . . . . 0.468 ' N ' HD21 ' D' ' 39' ' ' ASN . 1.0 OUTLIER -66.55 -41.14 89.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.843 . . . . 0.0 109.813 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 17.4 mt -75.42 -51.07 13.94 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.883 -1.136 . . . . 0.0 108.815 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' ARG . . . . . 0.495 ' HE ' ' HZ3' ' D' ' 45' ' ' LYS . 60.8 ttt180 -48.85 -52.6 23.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.835 -1.165 . . . . 0.0 108.974 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' D' ' 46' ' ' ALA . 27.7 ttmt -59.81 -36.75 77.4 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.472 -0.768 . . . . 0.0 110.225 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -75.27 -35.77 61.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.122 -0.987 . . . . 0.0 110.003 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -74.38 -51.7 22.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.135 -0.978 . . . . 0.0 109.487 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' LYS . . . . . 0.495 ' HZ3' ' HE ' ' D' ' 41' ' ' ARG . 21.5 mtmt -71.74 -34.57 69.64 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.451 -1.406 . . . . 0.0 109.812 -176.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' D' ' 42' ' ' LYS . . . -56.69 -30.81 63.82 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -92.63 -5.06 52.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.34 -0.85 . . . . 0.0 109.748 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.35 8.23 56.49 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.63 -173.6 4.52 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 50' ' ' MET . . . . . 0.435 ' SD ' ' C ' ' D' ' 50' ' ' MET . 0.0 OUTLIER -161.19 -23.37 0.05 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.091 -1.241 . . . . 0.0 110.885 176.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -137.32 146.8 18.75 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 34.9 tp -137.12 146.17 44.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.678 -0.895 . . . . 0.0 109.289 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 53' ' ' ILE . . . . . 0.454 ' CD1' ' H ' ' D' ' 53' ' ' ILE . 0.1 OUTLIER -109.69 162.63 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.47 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.622 ' O ' ' CB ' ' D' ' 55' ' ' PHE . . . 65.81 -163.45 0.25 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . 0.622 ' CB ' ' O ' ' D' ' 54' ' ' ALA . 67.2 t80 134.19 -5.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' ARG . . . . . 0.683 ' NH1' HH22 ' E' ' 56' ' ' ARG . 16.6 ptm180 . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.3 -0.875 . . . . 0.0 109.805 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 3.5 p90 . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 121.502 0.668 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.21 166.03 35.61 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 69' ' ' THR . . . . . 0.456 ' OG1' ' OG1' ' C' ' 11' ' ' THR . 98.7 m -115.14 137.95 51.45 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.568 -0.96 . . . . 0.0 108.417 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 46.0 mt -87.16 126.42 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.94 -1.1 . . . . 0.0 108.326 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 71' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' D' ' 21' ' ' TYR . 3.5 m -137.97 162.97 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.337 -0.852 . . . . 0.0 110.22 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -153.52 154.11 33.69 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.468 ' O ' ' CB ' ' D' ' 74' ' ' ASP . . . -121.15 115.41 23.02 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.548 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' D' ' 73' ' ' ALA . 2.0 m-20 . . . . . 0 N--CA 1.503 2.212 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 60.1 mttp . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -112.17 119.71 39.31 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.363 -0.836 . . . . 0.0 109.595 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 69.8 mt -100.85 128.18 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.396 -0.815 . . . . 0.0 109.77 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 9' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' E' ' 9' ' ' ILE . 11.3 tt -128.42 115.03 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 1.7 t -125.41 157.47 36.76 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.902 0.858 . . . . 0.0 109.11 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.97 92.58 3.79 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.99 -150.87 0.06 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.194 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 13' ' ' ASP . . . . . 0.493 ' CG ' ' H ' ' E' ' 14' ' ' GLU . 1.7 p-10 -76.63 -72.52 0.33 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.214 -0.929 . . . . 0.0 109.551 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . 0.493 ' H ' ' CG ' ' E' ' 13' ' ' ASP . 13.8 pt-20 -153.44 -166.95 2.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.168 -0.958 . . . . 0.0 109.291 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 52.9 mt -121.45 88.34 46.1 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.14 156.18 51.78 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 121.791 1.66 . . . . 0.0 110.641 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.97 -5.92 76.2 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 18' ' ' LEU . . . . . . . . . . . . . 37.9 mt -129.34 139.86 51.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.286 -1.126 . . . . 0.0 109.971 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -84.23 108.53 17.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 14.2 mt -101.91 136.54 41.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.344 -0.848 . . . . 0.0 110.304 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 21' ' ' TYR . . . . . 0.55 ' CE1' ' O ' ' E' ' 22' ' ' SER . 0.4 OUTLIER -120.57 129.91 53.98 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 22' ' ' SER . . . . . 0.55 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 13.4 t -56.74 130.16 44.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 111.668 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 11.9 mt -119.22 5.62 11.23 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.39 -179.19 16.68 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.09 145.33 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 122.033 -0.687 . . . . 0.0 109.263 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.25 159.68 22.28 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.645 -0.659 . . . . 0.0 109.348 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 89.3 p -153.11 143.6 22.59 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 11.2 p -142.93 134.47 26.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.183 -0.948 . . . . 0.0 111.02 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.547 ' O ' ' OG ' ' E' ' 30' ' ' SER . 2.1 mm -125.63 126.39 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.547 ' OG ' ' O ' ' E' ' 29' ' ' ILE . 3.3 m 157.09 16.12 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 31' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' E' ' 32' ' ' ASN . 1.0 OUTLIER 51.5 -174.08 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.006 -1.059 . . . . 0.0 108.892 -179.082 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 32' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 9.2 t-20 73.48 94.3 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 33' ' ' VAL . . . . . 0.408 ' CG2' ' N ' ' E' ' 34' ' ' ASP . 0.7 OUTLIER -70.78 -42.98 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.309 -0.869 . . . . 0.0 108.993 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 34' ' ' ASP . . . . . 0.408 ' N ' ' CG2' ' E' ' 33' ' ' VAL . 43.1 t0 -58.39 -44.19 88.83 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.388 -0.82 . . . . 0.0 110.771 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 35' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' E' ' 39' ' ' ASN . 62.1 mm-40 -70.03 -37.05 75.48 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.95 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 37.8 mt -61.64 -41.36 90.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.149 -0.97 . . . . 0.0 108.886 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 48.4 t -55.16 -51.58 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.941 -1.099 . . . . 0.0 108.778 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -59.1 -39.2 81.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.347 -0.846 . . . . 0.0 109.541 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 39' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' E' ' 35' ' ' GLU . 34.0 m120 -63.42 -42.11 98.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 109.508 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 74.5 mt -73.36 -50.03 24.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.132 -0.98 . . . . 0.0 108.962 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -48.93 -48.31 42.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.756 -1.215 . . . . 0.0 108.993 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -63.36 -37.4 87.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.582 -0.699 . . . . 0.0 109.935 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -75.6 -35.55 60.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.267 -0.896 . . . . 0.0 109.66 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 13.2 t -70.74 -51.44 36.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.308 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -71.21 -35.34 71.49 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.294 -176.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.63 -30.61 67.42 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -92.14 -5.44 52.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.364 -0.835 . . . . 0.0 109.871 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.63 11.82 46.18 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.61 159.28 33.16 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.26 -6.19 5.4 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.27 -1.135 . . . . 0.0 110.521 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -152.24 164.21 30.45 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 6.9 tp -136.95 143.45 42.87 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.405 -1.056 . . . . 0.0 109.516 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 53' ' ' ILE . . . . . 0.542 ' O ' ' CB ' ' E' ' 54' ' ' ALA . 4.8 mt -113.6 151.66 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.604 ' O ' ' CB ' ' E' ' 55' ' ' PHE . . . 88.7 -144.58 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 55' ' ' PHE . . . . . 0.604 ' CB ' ' O ' ' E' ' 54' ' ' ALA . 62.9 t80 104.87 11.96 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 120.726 1.603 . . . . 0.0 107.607 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 56' ' ' ARG . . . . . 0.683 HH22 ' NH1' ' D' ' 56' ' ' ARG . 73.8 mtm180 -69.16 124.73 24.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.354 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 88.3 mt . . . . . 0 N--CA 1.498 1.967 0 O-C-N 121.516 -0.74 . . . . 0.0 109.292 -179.784 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 67' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' E' ' 67' ' ' TYR . 18.4 p90 . . . . . 0 N--CA 1.5 2.055 0 CA-C-O 122.286 1.041 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.66 157.97 14.71 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 93.6 m -90.52 134.6 34.25 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.038 -1.272 . . . . 0.0 107.691 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 58.6 mt -90.23 137.91 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 71' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' E' ' 21' ' ' TYR . 3.2 m -144.17 163.92 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.26 -0.9 . . . . 0.0 110.766 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -148.01 152.61 37.74 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.18 152.55 33.5 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.327 -0.858 . . . . 0.0 108.727 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 110.094 179.422 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 57.5 t80 . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 70.0 mt -112.17 140.02 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.518 -0.739 . . . . 0.0 110.009 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.455 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 5.8 tt -137.61 115.88 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.446 -0.784 . . . . 0.0 108.923 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -123.49 158.38 31.4 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.27 121.02 32.84 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.75 47.34 20.62 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.994 0.902 . . . . 0.0 109.624 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -167.4 94.77 0.45 Allowed 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.404 0.621 . . . . 0.0 109.445 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -61.24 -178.2 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.263 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.7 mt -123.67 87.9 52.22 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.51 -0.744 . . . . 0.0 109.085 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -61.1 156.02 47.29 Favored 'Trans proline' 0 C--N 1.321 -0.888 0 C-N-CA 121.905 1.736 . . . . 0.0 110.222 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.64 -11.76 71.37 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.2 mt -126.79 137.64 53.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.143 -1.21 . . . . 0.0 108.734 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.6 ' NE2' ' H ' ' A' ' 74' ' ' ASP . 1.2 pp0? -87.62 118.47 27.12 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.4 mt -101.46 128.35 47.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.131 -0.98 . . . . 0.0 109.587 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' A' ' 22' ' ' SER . 2.3 t80 -115.21 129.95 56.78 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.531 ' O ' ' CE1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -85.57 130.26 34.62 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.408 -0.808 . . . . 0.0 110.353 -179.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.659 ' CD2' ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -118.94 19.44 13.03 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 137.33 172.42 12.53 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.98 145.14 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.11 147.45 37.29 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.623 -0.673 . . . . 0.0 109.315 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.5 p -151.48 135.55 16.63 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.63 150.56 34.64 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.044 -1.035 . . . . 0.0 108.766 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.21 129.45 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 83.8 p -169.37 175.95 5.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 109.126 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.429 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 3.2 m-20 -101.94 146.91 27.2 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.297 -0.877 . . . . 0.0 110.152 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 13.2 m-20 77.63 128.95 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.566 -0.708 . . . . 0.0 109.259 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.98 -31.09 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.593 -0.692 . . . . 0.0 109.36 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -56.22 -40.24 73.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.299 -0.876 . . . . 0.0 109.712 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.402 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 1.1 mp0 -76.23 -40.28 52.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.324 -0.86 . . . . 0.0 109.277 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.3 mt -62.22 -50.53 79.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.896 -1.127 . . . . 0.0 108.847 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.0 t -66.63 -49.45 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.11 -0.994 . . . . 0.0 109.473 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.53 -40.71 88.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.0 109.601 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 35' ' ' GLU . 15.9 m120 -64.13 -41.33 97.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 109.321 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.4 mt -68.23 -44.24 76.18 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.15 -0.969 . . . . 0.0 109.128 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -48.92 -42.77 38.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.572 -1.33 . . . . 0.0 109.436 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -69.94 -38.02 76.05 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.493 0.663 . . . . 0.0 110.102 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -77.32 -35.04 55.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.492 -0.755 . . . . 0.0 110.057 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.83 -52.07 31.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.027 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -66.59 -29.53 69.6 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.215 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.49 -28.6 68.69 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.626 0.727 . . . . 0.0 109.048 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -90.22 -5.65 56.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.564 -0.71 . . . . 0.0 109.558 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.5 4.37 58.24 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.84 161.93 48.24 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -129.58 -2.35 4.85 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.303 -1.116 . . . . 0.0 110.303 -177.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.8 166.48 39.68 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.308 -1.425 . . . . 0.0 109.685 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 tp -125.16 143.63 50.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.665 -0.903 . . . . 0.0 109.655 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.403 ' O ' ' CD1' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -117.73 148.71 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.625 -0.672 . . . . 0.0 110.072 -178.228 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.22 68.78 0.74 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.897 -1.127 . . . . 0.0 110.125 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -107.29 54.56 0.67 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.656 ' NH1' HH22 ' E' ' 56' ' ' ARG . 1.7 ttt-85 -80.18 152.96 28.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.302 -0.874 . . . . 0.0 109.634 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.4 mt . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.947 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.1 p90 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.815 0.816 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.58 153.23 17.07 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.478 ' OG1' ' OG1' ' E' ' 11' ' ' THR . 96.8 m -105.71 138.26 42.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.304 -1.115 . . . . 0.0 108.964 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 50.4 mt -83.01 137.32 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.4 m -140.66 159.05 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.247 -0.908 . . . . 0.0 109.701 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -153.69 159.09 41.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.296 -0.878 . . . . 0.0 109.052 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.519 ' O ' ' CG ' ' A' ' 74' ' ' ASP . . . -114.83 114.17 25.18 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.227 -0.921 . . . . 0.0 110.756 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.6 ' H ' ' NE2' ' A' ' 19' ' ' GLN . 20.5 m-20 . . . . . 0 N--CA 1.496 1.856 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 68.6 t80 . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 93.8 mt -132.87 129.96 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.386 -0.821 . . . . 0.0 109.754 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.466 ' O ' ' CG2' ' B' ' 9' ' ' ILE . 10.9 tt -133.01 116.36 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.2 t -123.9 152.78 42.01 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' THR . . . . . 0.437 ' H ' ' HG1' ' B' ' 11' ' ' THR . 0.8 OUTLIER -103.01 74.76 1.33 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 176.97 -116.18 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 176.98 54.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -129.38 104.44 7.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.39 -0.819 . . . . 0.0 109.605 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.646 ' N ' ' HD3' ' B' ' 16' ' ' PRO . 6.2 mm -140.61 53.04 3.62 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.346 -0.847 . . . . 0.0 108.915 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.646 ' HD3' ' N ' ' B' ' 15' ' ' ILE . 1.8 Cg_endo -64.07 155.49 64.41 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.531 1.487 . . . . 0.0 110.196 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.12 -11.71 71.43 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 79.8 mt -128.24 139.5 52.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.01 -1.288 . . . . 0.0 109.035 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -85.51 108.86 18.12 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.4 mt -89.84 132.63 35.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 110.348 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . 0.54 ' CE1' ' O ' ' B' ' 22' ' ' SER . 0.4 OUTLIER -112.38 129.29 56.36 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.54 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 36.2 t -71.73 118.25 14.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.793 -1.192 . . . . 0.0 109.336 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.499 HD12 ' HB2' ' B' ' 72' ' ' LYS . 5.8 mt -94.69 -4.57 47.29 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.42 -163.4 24.03 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -122.39 141.76 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.54 144.81 42.23 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.567 -0.708 . . . . 0.0 109.275 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 3.0 t -151.77 137.88 18.28 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -148.92 141.76 24.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.013 -1.054 . . . . 0.0 109.247 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 tp -104.8 127.93 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.287 -0.883 . . . . 0.0 109.213 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 15.5 t -171.19 169.79 6.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.918 . . . . 0.0 109.053 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 2.7 p-10 -110.16 158.78 17.98 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.507 -0.746 . . . . 0.0 109.215 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 2.2 m120 75.97 129.55 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.97 -32.86 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.488 -0.757 . . . . 0.0 109.306 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.96 -42.15 89.2 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.282 -0.886 . . . . 0.0 109.773 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -75.73 -41.4 53.54 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.225 -0.922 . . . . 0.0 109.516 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.79 -43.05 98.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 120.858 -1.151 . . . . 0.0 108.923 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.21 -50.78 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.768 -1.208 . . . . 0.0 109.497 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -59.01 -39.51 82.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.339 -0.851 . . . . 0.0 109.513 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -61.65 -46.12 91.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.639 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 28.6 mt -70.74 -46.83 62.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.105 -0.997 . . . . 0.0 108.986 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -48.57 -44.54 36.84 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.695 -1.253 . . . . 0.0 109.405 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -67.97 -38.4 82.69 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.559 0.695 . . . . 0.0 110.242 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -77.54 -34.11 54.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.395 -0.816 . . . . 0.0 110.183 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.796 ' O ' ' N ' ' B' ' 48' ' ' GLY . 2.3 t -70.03 -51.67 37.54 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.946 0 O-C-N 121.148 -0.97 . . . . 0.0 109.812 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -60.11 -31.39 69.99 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 119.666 -1.896 . . . . 0.0 110.328 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.7 -37.22 56.49 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.009 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.4 -12.92 11.01 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.549 -0.719 . . . . 0.0 109.923 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . 0.796 ' N ' ' O ' ' B' ' 44' ' ' VAL . . . -105.8 -45.75 1.26 Allowed Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.96 -35.23 0.29 Allowed Glycine 0 C--N 1.289 -2.066 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.156 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' MET . . . . . 0.496 ' H ' ' C ' ' B' ' 48' ' ' GLY . 0.0 OUTLIER -96.44 -75.08 0.54 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 119.253 1.527 . . . . 0.0 109.886 -179.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.37 -153.58 10.77 Favored Glycine 0 C--N 1.288 -2.104 0 C-N-CA 118.288 -1.91 . . . . 0.0 109.425 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.2 tp -133.11 139.13 46.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.696 -0.885 . . . . 0.0 109.682 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 pt -111.82 145.53 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.658 -0.651 . . . . 0.0 109.913 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 63.92 72.45 0.46 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.121 -0.987 . . . . 0.0 109.337 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.558 ' CG ' ' O ' ' B' ' 55' ' ' PHE . 60.4 t80 -101.51 33.65 2.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.37 -0.831 . . . . 0.0 108.917 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . 0.755 ' HG3' HH11 ' B' ' 56' ' ' ARG . 0.0 OUTLIER -59.51 122.98 15.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.982 -1.074 . . . . 0.0 109.34 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.432 ' N ' ' HH ' ' C' ' 67' ' ' TYR . 91.2 mt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 20.7 tp . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.192 0.52 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.78 165.05 33.12 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' TYR . . . . . 0.51 ' HH ' ' NE ' ' A' ' 56' ' ' ARG . 35.5 p90 -167.13 179.83 4.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.04 -1.271 . . . . 0.0 110.209 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.09 169.63 35.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 50.4 m -100.66 132.94 45.79 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.123 -1.222 . . . . 0.0 108.037 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 3.0 mt -87.82 145.44 7.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 5.9 m -146.29 166.06 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.886 -1.134 . . . . 0.0 111.01 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . 0.499 ' HB2' HD12 ' B' ' 23' ' ' LEU . 0.4 OUTLIER -146.55 156.25 43.1 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.45 ' O ' ' OD1' ' B' ' 74' ' ' ASP . . . -116.57 116.02 26.83 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.72 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' B' ' 73' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -105.78 120.66 42.26 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.099 -1.001 . . . . 0.0 109.126 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 17.7 mt -116.39 143.01 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' C' ' 9' ' ' ILE . 7.2 tt -112.96 124.62 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.93 131.28 55.16 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.44 -0.787 . . . . 0.0 109.369 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 1.6 m -121.3 114.37 21.25 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.42 34.56 24.45 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.301 -0.875 . . . . 0.0 109.653 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -153.36 95.49 1.93 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.708 -0.62 . . . . 0.0 109.505 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -67.31 176.82 2.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.086 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 51.4 mt -127.04 81.68 69.47 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.485 -0.759 . . . . 0.0 109.095 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.31 156.78 38.78 Favored 'Trans proline' 0 C--N 1.322 -0.83 0 C-N-CA 121.964 1.776 . . . . 0.0 110.119 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.17 -4.54 74.37 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.307 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 25.7 mt -126.78 137.48 53.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.105 -1.232 . . . . 0.0 109.17 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -86.77 108.28 18.64 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 12.8 mt -92.36 132.97 36.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 109.462 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' C' ' 71' ' ' VAL . 1.2 t80 -114.73 129.37 56.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.363 -0.835 . . . . 0.0 108.755 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' SER . . . . . 0.436 ' O ' ' CE1' ' C' ' 21' ' ' TYR . 8.2 t -61.97 127.68 32.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.899 -1.126 . . . . 0.0 111.624 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 14.2 mt -113.47 9.13 18.03 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.71 -174.52 15.34 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 177.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.57 139.76 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.651 -0.911 . . . . 0.0 109.584 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.47 146.84 44.19 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.693 -0.63 . . . . 0.0 109.92 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 4.7 t -151.91 139.23 19.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.154 -0.966 . . . . 0.0 108.688 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.77 140.28 22.46 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.962 -1.086 . . . . 0.0 109.641 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 7.1 tp -95.66 147.9 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.999 -1.063 . . . . 0.0 108.602 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.501 ' OG ' ' N ' ' C' ' 31' ' ' ASP . 27.1 t -169.3 -168.24 0.8 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.112 -0.992 . . . . 0.0 109.12 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' ASP . . . . . 0.501 ' N ' ' OG ' ' C' ' 30' ' ' SER . 19.4 t0 -109.72 -80.64 0.58 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.352 -0.843 . . . . 0.0 111.667 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -75.98 159.66 30.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.909 -1.12 . . . . 0.0 109.434 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.33 -31.44 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 CA-C-O 121.241 0.543 . . . . 0.0 109.591 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.5 -37.85 65.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.65 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -76.38 -36.22 58.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.35 -0.844 . . . . 0.0 109.019 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 82.9 mt -61.78 -51.98 66.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 120.984 -1.073 . . . . 0.0 109.539 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 51.4 t -57.65 -48.11 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.086 -1.009 . . . . 0.0 108.985 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -63.49 -43.89 95.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.652 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -58.27 -48.63 79.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.13 -0.981 . . . . 0.0 109.47 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 55.5 mt -68.98 -44.22 73.33 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.736 -1.227 . . . . 0.0 108.76 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -50.97 -46.18 61.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.773 -1.205 . . . . 0.0 109.445 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -61.87 -34.66 76.4 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.516 -0.874 . . . . 0.0 108.967 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -70.76 -36.09 72.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.447 -0.783 . . . . 0.0 108.971 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 51.5 t -72.89 -49.29 40.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.89 -1.131 . . . . 0.0 109.155 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -49.36 -34.23 15.53 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.448 1.118 . . . . 0.0 110.505 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.84 -28.55 50.2 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.573 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -94.62 9.53 38.36 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.89 30.73 30.21 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 118.355 -1.879 . . . . 0.0 109.534 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.35 -162.44 8.81 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -115.07 -35.66 4.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.44 -1.036 . . . . 0.0 110.424 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.19 179.73 40.32 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 tp -101.36 138.33 38.52 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.427 -1.043 . . . . 0.0 109.786 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 1.3 pt -113.97 144.38 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.528 -0.732 . . . . 0.0 110.149 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 62.72 62.45 1.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -0.88 . . . . 0.0 109.236 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -92.99 66.0 4.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.958 -1.089 . . . . 0.0 108.448 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -72.68 149.66 43.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.5 -0.75 . . . . 0.0 110.032 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 59.0 mt . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.08 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' TYR . . . . . 0.432 ' HH ' ' N ' ' B' ' 57' ' ' ILE . 37.1 p90 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.871 0.843 . . . . 0.0 109.885 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.92 -173.25 44.03 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 29.3 m -119.46 134.05 55.4 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 45.2 mt -82.56 146.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' C' ' 21' ' ' TYR . 4.6 m -139.83 164.06 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.392 -0.817 . . . . 0.0 110.225 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -142.34 154.61 44.81 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.36 116.21 29.32 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.843 0.83 . . . . 0.0 111.239 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 25.9 t70 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.391 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 63.4 mttp . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -96.43 128.85 43.73 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.212 -0.93 . . . . 0.0 109.611 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 62.8 mt -128.14 141.99 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.543 -0.723 . . . . 0.0 109.095 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 9' ' ' ILE . . . . . 0.409 ' O ' HG21 ' D' ' 9' ' ' ILE . 10.1 tt -114.97 117.36 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.16 131.83 54.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.934 -1.104 . . . . 0.0 108.971 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 11' ' ' THR . . . . . 0.446 ' OG1' ' OG1' ' E' ' 69' ' ' THR . 3.4 m -104.02 98.0 7.89 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.89 65.12 0.94 Allowed 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.948 0.88 . . . . 0.0 110.068 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -132.97 -141.44 0.2 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -169.44 -31.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 109.389 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 28.7 mt 50.21 67.14 4.67 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.185 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.85 156.41 48.88 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 C-N-CA 122.122 1.881 . . . . 0.0 110.126 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.5 -4.01 72.54 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.612 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 29.0 mt -125.16 135.83 53.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.872 -1.369 . . . . 0.0 108.967 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -86.38 112.49 21.5 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 11.9 mt -95.59 133.68 39.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.044 -1.035 . . . . 0.0 109.807 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' D' ' 22' ' ' SER . 4.4 t80 -122.45 129.97 52.59 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' SER . . . . . 0.433 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 48.2 t -85.84 129.63 34.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.573 -0.704 . . . . 0.0 110.97 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . 0.629 ' N ' ' CD2' ' D' ' 23' ' ' LEU . 0.3 OUTLIER -119.4 13.31 12.66 Favored 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 122.235 1.017 . . . . 0.0 108.483 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 143.26 170.29 12.98 Favored Glycine 0 N--CA 1.49 2.298 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.026 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -109.39 142.69 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' D' ' 67' ' ' TYR . . . -114.22 148.21 37.73 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 89.4 p -152.09 141.55 21.63 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 14.9 t -149.67 140.84 23.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.157 -0.965 . . . . 0.0 109.044 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 tt -115.7 129.81 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 90.1 p -177.26 -131.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.545 -0.722 . . . . 0.0 109.257 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' D' ' 32' ' ' ASN . 15.1 p-10 -166.51 169.69 13.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.211 -0.931 . . . . 0.0 109.471 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 6.8 t-20 73.65 127.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 0.0 108.666 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 22.9 t -68.88 -35.09 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.379 -0.826 . . . . 0.0 109.656 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' D' ' 35' ' ' GLU . 0.9 OUTLIER -59.21 -45.11 91.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.85 -179.509 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' GLU . . . . . 0.463 ' N ' ' OD1' ' D' ' 34' ' ' ASP . 55.2 mm-40 -75.25 -40.11 59.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.185 -0.947 . . . . 0.0 109.413 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.79 -53.17 50.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.962 -1.087 . . . . 0.0 109.482 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 44.3 t -61.49 -47.81 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.056 -1.027 . . . . 0.0 109.211 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -61.45 -41.98 98.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.691 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -58.54 -46.66 86.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 109.474 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 47.7 mt -71.4 -46.89 59.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.175 -0.953 . . . . 0.0 109.007 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -49.9 -44.99 50.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.816 -1.177 . . . . 0.0 109.172 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -63.31 -34.61 78.07 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.057 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -73.92 -36.9 64.75 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.324 -0.86 . . . . 0.0 109.328 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 t -73.4 -51.21 26.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.792 -1.193 . . . . 0.0 108.887 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.92 -33.42 37.08 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.73 1.253 . . . . 0.0 110.098 -177.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.82 -30.33 51.08 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.837 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -92.2 4.2 53.73 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.77 26.44 62.74 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 118.492 -1.813 . . . . 0.0 109.359 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.38 -167.67 13.37 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 9.9 ttp -107.38 -43.47 4.55 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.499 -1.0 . . . . 0.0 109.706 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 173.55 -152.79 16.13 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 tp -131.81 142.34 49.7 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.446 -1.032 . . . . 0.0 109.716 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 53' ' ' ILE . . . . . 0.613 ' CD1' ' H ' ' D' ' 53' ' ' ILE . 0.0 OUTLIER -113.98 147.4 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.598 -0.689 . . . . 0.0 110.181 -178.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.601 ' O ' ' O ' ' D' ' 55' ' ' PHE . . . 84.08 -54.63 0.13 Allowed 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 118.683 0.674 . . . . 0.0 111.607 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . 0.601 ' O ' ' O ' ' D' ' 54' ' ' ALA . 50.4 t80 43.03 -179.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' ARG . . . . . 0.451 ' N ' ' CD2' ' D' ' 55' ' ' PHE . 1.6 mmm180 . . . . . 0 N--CA 1.499 2.007 0 O-C-N 120.461 -1.4 . . . . 0.0 109.139 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 67' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' D' ' 26' ' ' ALA . 4.3 p90 . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 121.968 0.89 . . . . 0.0 110.125 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.18 175.15 40.09 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 4.9 m -97.9 134.91 40.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.99 -1.3 . . . . 0.0 108.176 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 50.3 mt -79.45 134.71 27.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.9 163.04 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.466 -0.771 . . . . 0.0 109.737 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -154.19 140.35 18.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.446 -0.784 . . . . 0.0 108.998 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.74 150.78 25.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.829 -1.169 . . . . 0.0 108.868 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 7.6 t70 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.087 -1.008 . . . . 0.0 109.317 179.494 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 6' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' E' ' 50' ' ' MET . 54.8 tttt . . . . . 0 N--CA 1.499 1.99 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -105.08 122.51 46.03 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 14.3 mt -134.3 131.56 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.362 -0.836 . . . . 0.0 109.736 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 9' ' ' ILE . . . . . 0.406 ' O ' ' CG2' ' E' ' 9' ' ' ILE . 19.2 tt -121.82 117.25 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.53 133.63 55.79 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.459 -0.776 . . . . 0.0 108.988 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 11' ' ' THR . . . . . 0.478 ' OG1' ' OG1' ' A' ' 69' ' ' THR . 25.3 m -86.88 61.63 6.92 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.048 -1.032 . . . . 0.0 111.085 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . 174.99 -110.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 167.88 113.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . 0.457 ' CG ' ' H ' ' E' ' 15' ' ' ILE . 0.8 OUTLIER -173.73 -96.79 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.057 -1.027 . . . . 0.0 109.635 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 15' ' ' ILE . . . . . 0.493 ' N ' ' HD3' ' E' ' 16' ' ' PRO . 8.6 mt 59.0 60.1 5.12 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 109.61 -179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . 0.493 ' HD3' ' N ' ' E' ' 15' ' ' ILE . 1.6 Cg_endo -64.9 153.15 79.51 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 122.018 1.812 . . . . 0.0 109.734 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.52 -8.77 78.48 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.356 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 18' ' ' LEU . . . . . . . . . . . . . 61.3 mt -124.55 137.56 54.39 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.077 -1.249 . . . . 0.0 109.188 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -86.99 108.73 18.97 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 12.8 mt -89.4 136.32 33.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 110.001 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 21' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -117.81 129.69 55.82 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.0 127.38 30.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.811 -1.181 . . . . 0.0 110.941 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 23.4 mt -113.58 8.49 17.7 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.55 -163.15 13.13 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -128.18 143.67 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.867 -0.784 . . . . 0.0 109.216 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.24 147.81 39.9 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.4 0.619 . . . . 0.0 109.439 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 60.0 p -151.71 135.01 15.98 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.84 148.79 30.31 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.98 -1.075 . . . . 0.0 108.835 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 tp -127.1 133.51 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 4.5 m -151.21 -152.7 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 109.067 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 31' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' E' ' 32' ' ' ASN . 0.9 OUTLIER -106.22 -82.72 0.53 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.36 -0.837 . . . . 0.0 111.114 -178.51 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 32' ' ' ASN . . . . . 0.44 ' H ' ' CG ' ' E' ' 31' ' ' ASP . 87.7 m-20 -81.01 165.11 22.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.03 . . . . 0.0 109.428 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 64.6 t -68.15 -31.9 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.789 -0.569 . . . . 0.0 109.731 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.37 -40.91 68.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 109.859 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -76.66 -35.48 57.92 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.19 -0.944 . . . . 0.0 109.082 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 69.2 mt -63.97 -52.89 50.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 120.929 -1.107 . . . . 0.0 109.425 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.54 -49.1 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.067 -1.021 . . . . 0.0 109.396 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -58.61 -39.11 79.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.892 . . . . 0.0 109.381 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -69.47 -39.94 77.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 0.0 109.782 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 21.7 mt -68.2 -45.59 72.95 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.917 -1.115 . . . . 0.0 108.711 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -47.43 -56.61 6.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.859 -1.151 . . . . 0.0 108.944 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -55.06 -32.94 62.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.861 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -75.53 -40.82 56.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.9 . . . . 0.0 110.087 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 38.4 t -76.88 -52.51 16.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.935 -1.103 . . . . 0.0 108.879 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -56.57 -28.6 60.56 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.381 1.086 . . . . 0.0 110.21 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.73 -28.46 58.54 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.507 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -87.22 10.91 15.49 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.64 29.17 53.6 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.081 -1.533 . . . . 0.0 109.417 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.97 -168.81 30.04 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 50' ' ' MET . . . . . 0.473 ' O ' ' O ' ' E' ' 6' ' ' LYS . 65.5 mtp -103.96 -37.42 7.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.514 -0.992 . . . . 0.0 109.288 177.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 174.5 -153.27 15.91 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 12.0 tp -126.94 135.72 51.28 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.525 -0.985 . . . . 0.0 109.744 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 pt -110.36 146.19 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.528 -0.732 . . . . 0.0 109.958 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . 67.66 87.41 0.12 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 109.711 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -138.4 82.16 1.89 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 56' ' ' ARG . . . . . 0.656 HH22 ' NH1' ' A' ' 56' ' ' ARG . 12.8 ptm180 -120.48 8.74 10.78 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.636 -0.665 . . . . 0.0 109.338 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 72.4 mt . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.539 -0.726 . . . . 0.0 109.693 -179.948 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 19.0 p90 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 122.048 0.928 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.01 162.07 32.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 69' ' ' THR . . . . . 0.446 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 52.8 m -102.96 134.34 46.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.103 -1.233 . . . . 0.0 108.09 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 37.2 mt -86.07 136.45 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 6.5 m -132.22 165.86 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.4 -0.813 . . . . 0.0 110.2 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -153.95 140.74 19.09 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.97 151.1 22.86 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.791 -1.193 . . . . 0.0 108.85 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.063 -1.023 . . . . 0.0 109.576 179.49 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.4 t80 . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 76.6 mt -109.91 130.86 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.376 -0.828 . . . . 0.0 109.936 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.439 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 6.7 tt -135.05 114.61 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.6 t -123.16 160.05 27.32 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.958 0.885 . . . . 0.0 109.223 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 12' ' ' ALA . 11.0 p -96.34 -110.1 0.15 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.746 -0.596 . . . . 0.0 109.733 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 11' ' ' THR . . . 37.7 -104.44 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.1 -1.0 . . . . 0.0 111.073 177.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 15.0 p-10 -142.85 -64.68 0.4 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.446 -0.784 . . . . 0.0 109.793 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.5 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 11.5 pt-20 -152.16 -166.75 2.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.108 -0.995 . . . . 0.0 109.56 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.8 mt -116.59 97.72 50.59 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.603 -0.686 . . . . 0.0 109.303 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.18 156.31 46.02 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.82 1.68 . . . . 0.0 110.273 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.11 -7.59 78.46 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 62.4 mt -129.88 141.37 50.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.31 -1.112 . . . . 0.0 109.467 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.6 117.05 25.12 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.6 mt -101.34 136.66 40.82 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.132 -0.98 . . . . 0.0 109.154 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -113.62 129.26 56.6 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.385 -0.822 . . . . 0.0 109.083 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.1 t -73.37 124.57 26.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.488 -1.383 . . . . 0.0 109.377 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.7 mt -111.07 8.45 21.82 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.37 -167.04 21.47 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.3 mm -122.26 142.23 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.8 153.44 29.09 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.5 m -152.2 145.08 24.4 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.07 -1.019 . . . . 0.0 109.084 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.7 p -143.84 131.07 20.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.469 -0.769 . . . . 0.0 108.983 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.628 ' O ' ' CB ' ' A' ' 30' ' ' SER . 91.8 mt -105.87 153.34 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.628 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 88.9 p 120.89 -147.53 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 32' ' ' ASN . 22.0 t70 -145.64 -160.73 1.18 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.472 ' H ' ' CG ' ' A' ' 31' ' ' ASP . 14.0 m-20 70.66 101.61 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.4 t -62.56 -35.97 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.123 -0.986 . . . . 0.0 109.325 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.69 -41.7 86.87 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.248 -0.908 . . . . 0.0 109.692 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -75.81 -41.17 53.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.316 -0.865 . . . . 0.0 109.486 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.5 mt -63.41 -53.79 40.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.945 -1.097 . . . . 0.0 108.959 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.9 t -55.96 -49.87 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 108.999 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.91 -40.12 87.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 109.94 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.423 ' N ' HD21 ' A' ' 39' ' ' ASN . 1.5 m120 -62.11 -44.02 97.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.176 -0.953 . . . . 0.0 109.499 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.3 mt -71.12 -49.08 48.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.105 -0.997 . . . . 0.0 108.7 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -48.8 -49.35 39.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.805 -1.184 . . . . 0.0 109.277 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -63.21 -36.39 83.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.513 -0.742 . . . . 0.0 110.217 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.67 -35.53 57.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.833 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 t -68.3 -51.2 50.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 109.196 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -67.13 -37.94 84.7 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.773 -1.205 . . . . 0.0 109.161 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.1 -32.64 66.5 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -85.45 -4.53 59.19 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.46 -0.775 . . . . 0.0 109.341 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.66 9.13 61.63 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.84 -157.22 3.76 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.4 ptm -165.1 -20.15 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.09 -1.241 . . . . 0.0 110.385 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -152.56 160.11 28.8 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 tp -118.06 138.87 51.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.652 -0.91 . . . . 0.0 109.115 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.51 147.08 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.483 -0.761 . . . . 0.0 109.969 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 70.75 85.08 0.13 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.456 -0.778 . . . . 0.0 110.932 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -123.62 102.59 7.93 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -123.13 138.09 54.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.517 -0.739 . . . . 0.0 109.813 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.405 ' O ' ' CG1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.7 p90 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.414 0.626 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.7 149.21 18.75 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.2 m -106.56 140.65 39.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -1.131 . . . . 0.0 108.821 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.2 mt -84.5 134.04 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.68 155.47 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.235 -0.916 . . . . 0.0 109.104 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -148.26 134.24 19.17 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.16 148.41 28.88 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.139 -0.976 . . . . 0.0 108.542 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 25.2 p-10 . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.129 -0.982 . . . . 0.0 109.031 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 74.5 t80 . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 71.1 mt -124.44 141.47 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.476 -0.765 . . . . 0.0 109.433 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.462 ' O ' ' CG2' ' B' ' 9' ' ' ILE . 6.8 tt -136.87 119.76 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 7.6 t -124.6 156.58 37.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.196 -0.94 . . . . 0.0 108.622 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' THR . . . . . 0.468 ' HB ' ' H ' ' B' ' 12' ' ' ALA . 0.0 OUTLIER -68.33 -132.34 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.468 ' H ' ' HB ' ' B' ' 11' ' ' THR . . . -94.09 110.21 21.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.138 -0.976 . . . . 0.0 110.014 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -162.75 -134.22 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . 0.634 ' O ' ' C ' ' B' ' 15' ' ' ILE . 6.4 pt-20 -172.99 46.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.064 -1.022 . . . . 0.0 109.49 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.634 ' C ' ' O ' ' B' ' 14' ' ' GLU . 11.3 mt -1.81 77.58 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.505 0 O-C-N 122.357 -0.214 . . . . 0.0 110.586 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.498 ' N ' ' O ' ' B' ' 14' ' ' GLU . 2.3 Cg_endo -62.12 155.49 55.8 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.831 1.687 . . . . 0.0 110.183 -177.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.44 -11.59 71.74 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 34.7 mt -124.37 137.52 54.46 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.08 -1.247 . . . . 0.0 109.228 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.17 116.1 24.15 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.45 138.73 35.24 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.242 -0.911 . . . . 0.0 109.687 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -118.29 129.79 55.66 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.41 ' H ' ' HG ' ' B' ' 22' ' ' SER . 0.0 OUTLIER -68.82 129.18 39.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.732 -1.23 . . . . 0.0 110.673 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 74.2 mt -115.62 7.1 14.71 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.96 -156.06 16.18 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.63 142.94 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.885 -0.773 . . . . 0.0 109.389 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.2 144.6 44.6 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.774 -0.579 . . . . 0.0 109.954 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 30.7 p -152.45 141.83 21.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.191 -0.943 . . . . 0.0 108.743 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.59 152.76 36.02 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.077 -1.015 . . . . 0.0 109.72 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.52 152.27 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.245 -0.909 . . . . 0.0 108.949 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 173.05 143.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.445 -0.784 . . . . 0.0 109.242 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.411 ' O ' ' CG ' ' B' ' 32' ' ' ASN . 15.2 p-10 -93.08 30.1 1.71 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.235 -0.916 . . . . 0.0 110.325 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . 0.411 ' CG ' ' O ' ' B' ' 31' ' ' ASP . 27.1 m120 -162.23 141.17 9.28 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.548 0.689 . . . . 0.0 109.902 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.23 -37.27 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.396 -0.815 . . . . 0.0 109.57 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.71 -38.77 72.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 0.0 109.536 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -75.28 -36.93 61.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.235 -0.916 . . . . 0.0 108.696 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 82.4 mt -65.29 -53.5 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.917 -1.114 . . . . 0.0 109.25 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -54.54 -51.34 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.109 -0.994 . . . . 0.0 109.134 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.83 -43.02 98.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.35 -0.844 . . . . 0.0 109.758 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -60.65 -45.24 94.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.29 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 61.1 mt -67.09 -46.08 75.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.155 -0.966 . . . . 0.0 108.911 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -50.1 -43.7 51.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.764 -1.21 . . . . 0.0 109.459 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -67.87 -38.6 83.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.614 -0.679 . . . . 0.0 110.272 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -76.48 -35.62 58.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.453 -0.779 . . . . 0.0 109.858 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 t -66.12 -50.12 71.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 109.21 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -62.96 -31.03 72.04 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.238 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.68 -31.74 71.05 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.763 0.792 . . . . 0.0 109.394 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -84.91 -5.38 59.34 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.75 8.96 75.64 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.69 164.61 45.18 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.98 1.85 2.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.03 -1.277 . . . . 0.0 110.325 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.7 165.75 38.61 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.921 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 tp -136.52 137.9 40.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.585 -0.95 . . . . 0.0 109.163 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' B' ' 54' ' ' ALA . 0.0 OUTLIER -109.4 151.68 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.47 -0.769 . . . . 0.0 109.872 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' B' ' 55' ' ' PHE . . . 78.83 -64.02 0.27 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.327 -0.858 . . . . 0.0 112.678 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.495 ' CG ' ' O ' ' B' ' 55' ' ' PHE . 61.2 t80 34.74 36.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.394 0.616 . . . . 0.0 109.788 177.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . 0.745 ' HG3' HH11 ' B' ' 56' ' ' ARG . 14.3 mtm-85 -64.39 154.71 34.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.868 -1.145 . . . . 0.0 109.73 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.406 HD12 HG22 ' B' ' 57' ' ' ILE . 84.6 mt . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -127.79 -114.89 1.86 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' TYR . . . . . 0.436 ' CD1' ' O ' ' B' ' 67' ' ' TYR . 32.4 p90 -172.87 130.97 0.51 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -1.172 . . . . 0.0 109.142 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.54 148.11 19.75 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 79.0 m -102.18 136.29 42.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.907 -1.349 . . . . 0.0 108.761 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 49.1 mt -83.03 142.88 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 m -135.45 157.71 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.151 -0.968 . . . . 0.0 109.767 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.17 151.35 36.63 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.4 150.22 34.99 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.028 -1.045 . . . . 0.0 109.242 179.435 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -102.46 144.31 31.07 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 14.1 mt -132.98 135.97 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.464 -0.772 . . . . 0.0 109.577 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' ILE . . . . . 0.418 ' O ' ' CG2' ' C' ' 9' ' ' ILE . 16.4 tt -137.77 115.0 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -123.05 158.68 30.06 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' THR . . . . . 0.493 ' OG1' ' OG1' ' D' ' 69' ' ' THR . 7.6 p -114.82 85.09 2.18 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.35 -133.08 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.72 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -107.6 -55.98 2.28 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.55 -0.719 . . . . 0.0 109.39 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . 0.495 ' HG2' ' H ' ' C' ' 15' ' ' ILE . 22.7 tt0 -164.89 -179.32 5.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.933 . . . . 0.0 108.886 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . 0.495 ' H ' ' HG2' ' C' ' 14' ' ' GLU . 63.6 mt -112.12 92.04 17.44 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.95 156.7 42.53 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 122.0 1.8 . . . . 0.0 110.456 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.74 -6.08 76.92 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 77.6 mt -130.63 140.44 50.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -1.179 . . . . 0.0 109.494 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -86.01 107.56 17.83 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . 0.482 ' HB3' ' HB ' ' C' ' 71' ' ' VAL . 6.7 mt -111.0 128.17 55.76 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.485 -0.759 . . . . 0.0 110.451 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' TYR . . . . . 0.641 ' CD1' ' N ' ' C' ' 21' ' ' TYR . 0.0 OUTLIER -112.42 142.75 44.58 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.7 136.42 45.58 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.627 0.727 . . . . 0.0 110.106 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 mt -120.43 12.93 11.74 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.5 -175.46 16.72 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 49.4 mm -114.58 139.23 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.13 143.95 42.32 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.35 -0.843 . . . . 0.0 109.217 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 19.2 m -152.83 146.87 25.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.094 -1.004 . . . . 0.0 109.211 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 9.6 t -149.9 137.18 19.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.351 -0.843 . . . . 0.0 109.171 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 89.2 mt -108.23 157.97 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.698 ' O ' ' CG ' ' C' ' 31' ' ' ASP . 15.4 m 62.74 85.09 0.13 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.526 -0.734 . . . . 0.0 109.774 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' ASP . . . . . 0.698 ' CG ' ' O ' ' C' ' 30' ' ' SER . 27.2 m-20 173.04 132.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -83.73 175.17 9.87 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 1.9 m -46.16 -42.62 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.636 0 O-C-N 120.56 -1.337 . . . . 0.0 107.673 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -63.0 -48.7 77.66 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.297 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -73.14 -36.73 66.74 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.955 -1.091 . . . . 0.0 108.896 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 89.5 mt -61.96 -52.53 59.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.824 -1.172 . . . . 0.0 109.396 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.97 -48.58 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -0.965 . . . . 0.0 109.399 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -56.0 -36.23 67.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 109.007 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' ASN . . . . . 0.48 ' ND2' ' OD2' ' C' ' 31' ' ' ASP . 79.8 m-20 -76.07 -37.79 57.82 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.728 -1.232 . . . . 0.0 110.565 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . 0.428 ' O ' HG12 ' C' ' 44' ' ' VAL . 78.7 mt -74.27 -53.28 10.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.741 -1.225 . . . . 0.0 110.024 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' ARG . . . . . 0.455 ' HG3' ' H ' ' C' ' 42' ' ' LYS . 2.2 ppt_? -47.19 -45.23 22.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.075 -1.016 . . . . 0.0 109.279 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' LYS . . . . . 0.455 ' H ' ' HG3' ' C' ' 41' ' ' ARG . 2.1 tmmm? -60.12 -32.46 71.02 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.051 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' GLN . . . . . 0.511 ' O ' ' HB2' ' C' ' 47' ' ' LYS . 69.8 mm-40 -75.31 -36.61 61.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -0.971 . . . . 0.0 110.756 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' VAL . . . . . 0.617 ' O ' ' N ' ' C' ' 49' ' ' GLY . 0.8 OUTLIER -76.8 -52.1 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.712 -1.243 . . . . 0.0 109.83 -179.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' LYS . . . . . 0.475 ' N ' ' CG2' ' C' ' 44' ' ' VAL . 0.3 OUTLIER -61.53 -33.0 73.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.28 -1.512 . . . . 0.0 109.38 -175.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.7 -32.89 62.31 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.85 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' C' ' 43' ' ' GLN . 3.9 mtpp -93.31 -7.61 44.41 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' C' ' 44' ' ' VAL . . . 105.39 -1.25 40.05 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' C' ' 44' ' ' VAL . . . -65.18 -173.68 4.08 Favored Glycine 0 N--CA 1.483 1.798 0 O-C-N 119.913 -1.934 . . . . 0.0 109.597 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.08 9.87 0.44 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.094 -1.239 . . . . 0.0 110.003 176.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.07 164.73 18.81 Favored Glycine 0 N--CA 1.483 1.8 0 C-N-CA 118.974 -1.584 . . . . 0.0 109.813 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.76 149.6 38.23 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.87 -0.783 . . . . 0.0 109.88 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' ILE . . . . . 0.46 ' CD1' ' HG1' ' B' ' 11' ' ' THR . 1.1 pt -113.15 143.67 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.678 -0.639 . . . . 0.0 110.104 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' C' ' 53' ' ' ILE . . . 77.78 -50.66 0.51 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.68 -0.637 . . . . 0.0 110.679 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' C' ' 54' ' ' ALA . 50.0 t80 42.24 68.98 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' ARG . . . . . 0.65 ' CG ' HH11 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -77.02 137.98 39.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.129 -178.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 42.7 p90 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.578 0.704 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 166.49 -162.0 35.68 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 21.8 m -123.92 136.65 54.47 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.13 142.85 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' C' ' 20' ' ' LEU . 5.2 m -137.18 150.19 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.661 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -119.17 146.01 45.53 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.45 149.43 26.17 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' C' ' 74' ' ' ASP . 25.9 p-10 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 120.772 -1.205 . . . . 0.0 109.376 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 N--CA 1.494 1.742 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -92.49 120.01 32.54 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.102 -0.999 . . . . 0.0 108.743 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 50.7 mt -126.14 129.87 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.461 -0.774 . . . . 0.0 110.093 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 9' ' ' ILE . . . . . 0.44 ' O ' ' CG2' ' D' ' 9' ' ' ILE . 17.1 tt -113.64 114.43 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t -123.55 160.68 26.49 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.147 -0.971 . . . . 0.0 109.082 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.5 p -91.84 -113.2 0.09 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.5 -120.15 0.87 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.106 . . . . 0.0 110.426 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -152.7 -27.16 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.728 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -168.56 177.1 5.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 0.0 109.53 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' ILE . . . . . 0.405 HG21 HD13 ' D' ' 15' ' ' ILE . 96.1 mt -116.55 97.61 50.37 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.13 155.96 47.82 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.772 1.648 . . . . 0.0 110.415 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.18 -7.54 78.34 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 64.8 mt -129.28 140.46 51.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -1.103 . . . . 0.0 109.513 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -84.52 108.49 17.32 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 15.1 mt -97.26 135.26 39.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.825 . . . . 0.0 110.025 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' TYR . . . . . 0.5 ' CE1' ' O ' ' D' ' 22' ' ' SER . 1.5 t80 -117.74 130.04 56.07 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' SER . . . . . 0.5 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 28.3 t -75.0 129.68 38.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.911 -1.118 . . . . 0.0 110.917 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mt -117.3 12.17 14.24 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.79 177.84 15.2 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.65 145.02 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.892 -0.769 . . . . 0.0 108.943 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.69 144.12 42.74 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.6 -0.688 . . . . 0.0 109.348 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 92.4 p -152.2 138.42 18.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.083 -1.011 . . . . 0.0 108.611 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 13.5 t -149.51 146.33 27.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.052 -1.03 . . . . 0.0 109.134 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . 0.405 HG21 HD12 ' D' ' 29' ' ' ILE . 47.5 mm -116.94 131.54 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.274 -0.891 . . . . 0.0 109.199 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 11.9 m -153.46 -158.04 0.84 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.207 -0.933 . . . . 0.0 109.408 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -106.88 -80.03 0.57 Allowed 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.406 -0.809 . . . . 0.0 111.153 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -65.39 144.78 56.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.896 -1.127 . . . . 0.0 109.153 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 1.9 m -69.42 -36.15 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -58.25 -29.47 65.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.522 -0.736 . . . . 0.0 109.606 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -75.03 -36.02 61.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.364 -0.835 . . . . 0.0 108.888 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 54.8 mt -60.97 -49.62 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.308 -0.87 . . . . 0.0 108.96 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 54.1 t -55.45 -49.44 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.998 . . . . 0.0 109.019 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.82 -41.07 90.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 109.593 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -62.48 -42.76 99.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 0.0 109.337 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 60.5 mt -67.55 -45.38 75.85 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.086 -1.009 . . . . 0.0 108.59 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -50.14 -55.3 15.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.858 -1.152 . . . . 0.0 109.198 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -58.76 -37.63 76.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.252 -0.905 . . . . 0.0 110.453 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -75.68 -35.61 60.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 109.764 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 9.6 t -69.0 -50.49 53.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.25 -0.907 . . . . 0.0 109.234 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -64.21 -29.92 71.01 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.483 -1.287 . . . . 0.0 109.002 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.71 -29.03 67.37 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.33 -5.29 56.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.503 -0.748 . . . . 0.0 109.921 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.0 9.42 58.32 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.2 158.74 40.46 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 3.0 ptm -126.9 -5.04 6.3 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.295 -1.121 . . . . 0.0 110.07 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.27 164.18 36.5 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 8.2 tp -125.42 134.05 52.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.7 -0.882 . . . . 0.0 109.186 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 53' ' ' ILE . . . . . 0.423 ' CD1' ' O ' ' D' ' 53' ' ' ILE . 0.0 OUTLIER -107.68 147.3 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.525 -0.735 . . . . 0.0 110.58 -178.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 51.73 63.44 2.24 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.369 -1.457 . . . . 0.0 109.668 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . 0.572 ' O ' ' O ' ' D' ' 56' ' ' ARG . 2.7 t80 -46.27 -60.15 2.49 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.282 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' ARG . . . . . 0.572 ' O ' ' O ' ' D' ' 55' ' ' PHE . 26.2 mmt180 . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 121.649 0.737 . . . . 0.0 110.201 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 34.7 p90 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.573 0.702 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -149.13 169.46 29.51 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 69' ' ' THR . . . . . 0.493 ' OG1' ' OG1' ' C' ' 11' ' ' THR . 88.9 m -113.03 138.04 50.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.254 -1.145 . . . . 0.0 108.67 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 27.5 mt -87.36 135.65 24.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.6 155.72 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.799 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -151.55 158.0 42.98 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -120.19 150.16 41.1 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.123 -0.985 . . . . 0.0 109.306 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 121.562 0.696 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -94.21 118.82 32.12 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 76.2 mt -107.03 125.5 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.375 -0.828 . . . . 0.0 110.242 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 9' ' ' ILE . . . . . 0.44 ' CG2' ' O ' ' E' ' 9' ' ' ILE . 20.8 tt -133.42 113.79 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -123.78 161.57 24.95 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.294 -0.879 . . . . 0.0 109.528 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 11' ' ' THR . . . . . 0.439 ' O ' ' C ' ' E' ' 12' ' ' ALA . 0.8 OUTLIER -87.87 -113.75 0.05 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' E' ' 11' ' ' THR . . . 41.64 -122.92 0.56 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 109.486 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 p30 175.53 26.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.549 -0.72 . . . . 0.0 109.647 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -173.44 151.69 2.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.206 -0.934 . . . . 0.0 109.638 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 15' ' ' ILE . . . . . 0.455 ' O ' ' CG2' ' E' ' 15' ' ' ILE . 18.0 tt -138.4 77.53 34.8 Favored Pre-proline 0 N--CA 1.498 1.971 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.86 156.85 36.06 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 122.116 1.878 . . . . 0.0 110.935 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.4 -6.73 71.63 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 18' ' ' LEU . . . . . . . . . . . . . 28.9 mt -128.69 137.43 51.61 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.896 -1.356 . . . . 0.0 109.544 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -84.22 108.79 17.31 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 20' ' ' LEU . . . . . 0.433 HD12 HG21 ' E' ' 15' ' ' ILE . 10.9 mt -104.95 146.05 29.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 111.009 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 21' ' ' TYR . . . . . 0.423 ' CZ ' ' O ' ' E' ' 22' ' ' SER . 1.6 t80 -129.76 130.66 45.68 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 22' ' ' SER . . . . . 0.423 ' O ' ' CZ ' ' E' ' 21' ' ' TYR . 13.7 t -53.02 130.61 34.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 111.104 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 mt -120.41 9.22 10.9 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.75 177.77 18.42 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . 0.417 ' CD1' ' HG1' ' E' ' 69' ' ' THR . 47.2 mm -112.42 143.23 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.784 -0.833 . . . . 0.0 109.358 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.06 154.53 28.7 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 5.2 p -149.67 147.32 27.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.054 -1.029 . . . . 0.0 109.043 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 17.2 p -148.71 132.09 16.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.44 -0.788 . . . . 0.0 109.354 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.453 ' O ' ' CB ' ' E' ' 30' ' ' SER . 86.3 mt -126.66 127.5 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' E' ' 29' ' ' ILE . 2.6 t 164.37 14.07 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 31' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' E' ' 32' ' ' ASN . 30.8 t0 51.91 -179.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.171 -0.956 . . . . 0.0 109.32 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 32' ' ' ASN . . . . . 0.454 ' H ' ' CG ' ' E' ' 31' ' ' ASP . 5.6 m-20 68.59 105.8 0.05 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.582 -0.698 . . . . 0.0 109.246 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 50.3 t -67.0 -34.52 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.259 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -58.73 -46.88 86.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 110.127 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -75.46 -37.44 60.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.107 -0.995 . . . . 0.0 109.187 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 70.2 mt -64.84 -50.82 73.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.945 -1.097 . . . . 0.0 109.579 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 19.2 t -58.91 -51.12 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.05 -1.032 . . . . 0.0 109.195 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -38.44 73.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 109.116 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -65.05 -39.02 92.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.163 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 54.4 mt -71.13 -48.13 53.92 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.147 -0.971 . . . . 0.0 109.084 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 41' ' ' ARG . . . . . 0.806 HH11 ' HG3' ' E' ' 41' ' ' ARG . 0.2 OUTLIER -50.67 -46.17 58.5 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.929 -1.107 . . . . 0.0 109.638 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -62.67 -34.53 77.29 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.176 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -70.63 -36.59 73.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.195 -0.941 . . . . 0.0 108.767 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 20.9 t -77.2 -51.36 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.754 -1.217 . . . . 0.0 109.222 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -49.03 -33.01 10.4 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.444 1.116 . . . . 0.0 110.254 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.31 -26.99 52.74 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.437 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -94.26 10.91 32.18 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.99 31.17 55.6 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 118.342 -1.885 . . . . 0.0 109.797 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -86.14 159.57 32.69 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 34.9 mmm -67.41 -41.69 84.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.144 -1.209 . . . . 0.0 110.5 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.74 -142.64 7.74 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 6.7 tp -130.71 132.55 45.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.531 -0.982 . . . . 0.0 109.284 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 53' ' ' ILE . . . . . . . . . . . . . 1.3 pt -107.53 145.52 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.568 -0.708 . . . . 0.0 110.192 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' E' ' 56' ' ' ARG . . . 71.37 -50.52 0.69 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.264 -0.897 . . . . 0.0 109.821 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 5.9 t80 50.93 -79.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 56' ' ' ARG . . . . . 0.687 HH11 ' HG2' ' E' ' 56' ' ' ARG . 0.0 OUTLIER 64.04 145.48 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.429 -0.794 . . . . 0.0 109.774 178.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 75.9 mt . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.777 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 13.4 p90 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.372 0.606 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.42 154.15 25.31 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 69' ' ' THR . . . . . 0.417 ' HG1' ' CD1' ' E' ' 25' ' ' ILE . 70.6 m -99.97 134.9 42.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.144 -1.21 . . . . 0.0 108.082 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 12.6 mt -89.2 141.21 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 m -144.72 163.41 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.387 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -149.04 154.62 39.56 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.94 151.57 37.91 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 t70 . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.67 -0.644 . . . . 0.0 109.634 179.817 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.4 t80 . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.0 mt -114.66 140.88 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.541 -0.724 . . . . 0.0 109.218 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 14.4 tt -125.02 125.02 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.85 130.25 56.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.481 -0.762 . . . . 0.0 109.004 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.527 ' OG1' ' OG1' ' B' ' 69' ' ' THR . 45.7 m -105.21 105.15 15.06 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 52.88 58.11 5.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.311 -0.868 . . . . 0.0 109.892 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 39.9 t0 -143.59 -140.03 0.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.568 -0.708 . . . . 0.0 109.376 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.494 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 5.9 pt-20 -173.66 166.44 4.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.194 -0.942 . . . . 0.0 109.187 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.5 mt -136.13 71.21 62.03 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.378 -0.826 . . . . 0.0 109.158 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.26 156.55 45.02 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 C-N-CA 122.211 1.941 . . . . 0.0 110.225 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.27 -1.08 69.36 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.284 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.1 mt -130.77 138.86 50.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.961 -1.317 . . . . 0.0 109.433 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.409 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 22.3 mm100 -84.6 108.77 17.52 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.6 mt -93.84 136.42 34.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.145 -0.972 . . . . 0.0 110.241 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 72' ' ' LYS . 47.4 t80 -116.02 129.13 56.23 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.23 124.52 24.32 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 120.305 -1.497 . . . . 0.0 110.316 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 35.7 mt -110.1 3.86 20.64 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.04 -178.37 16.46 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.28 144.74 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.802 -0.822 . . . . 0.0 109.187 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.49 143.95 44.95 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.246 0.546 . . . . 0.0 110.078 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.3 m -152.29 134.69 15.21 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.0 t -150.1 153.65 36.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.822 -1.174 . . . . 0.0 109.328 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.2 mp -105.33 154.38 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 173.81 158.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 109.231 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -100.65 139.29 36.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.337 -0.852 . . . . 0.0 110.053 -178.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 3.9 t-20 81.04 141.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.81 -32.76 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.847 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.403 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 1.2 p30 -57.92 -43.5 86.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.927 . . . . 0.0 110.16 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.403 ' N ' ' CG ' ' A' ' 34' ' ' ASP . 63.9 mt-10 -75.18 -38.65 60.74 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.408 -0.808 . . . . 0.0 109.377 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.7 mt -63.52 -44.86 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.992 . . . . 0.0 109.478 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.77 -49.8 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.966 -1.084 . . . . 0.0 109.799 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -58.43 -38.94 78.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 109.678 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.495 ' N ' HD21 ' A' ' 39' ' ' ASN . 1.0 OUTLIER -63.12 -44.74 94.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.713 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.44 -46.51 66.59 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.091 -1.006 . . . . 0.0 109.102 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.741 ' HG3' HH11 ' A' ' 41' ' ' ARG . 0.1 OUTLIER -49.43 -49.87 43.24 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 120.797 -1.19 . . . . 0.0 109.892 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -61.39 -36.97 81.74 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.521 -0.737 . . . . 0.0 110.29 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -77.07 -35.49 56.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.511 -0.743 . . . . 0.0 109.899 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.8 t -66.71 -50.88 62.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.035 -1.041 . . . . 0.0 109.103 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.72 -35.65 80.63 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.392 -1.323 . . . . 0.0 109.015 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.26 -28.86 69.47 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -5.63 56.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.517 -0.74 . . . . 0.0 109.881 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.81 11.82 57.42 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.08 161.55 36.12 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -125.27 -3.4 7.46 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.27 -1.135 . . . . 0.0 109.918 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.31 154.99 24.22 Favored Glycine 0 N--CA 1.487 2.087 0 C-N-CA 119.35 -1.405 . . . . 0.0 109.699 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.06 146.46 36.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.663 -0.904 . . . . 0.0 109.815 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.38 145.6 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.5 -0.75 . . . . 0.0 110.071 -177.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 70.2 79.24 0.19 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.581 -0.699 . . . . 0.0 110.451 176.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -103.07 136.61 42.56 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.488 ' NH1' ' NH2' ' E' ' 56' ' ' ARG . 58.0 ttt180 -151.84 156.47 40.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.73 -1.231 . . . . 0.0 109.764 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.409 HD12 HG23 ' A' ' 57' ' ' ILE . 98.1 mt . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.8 t80 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.804 0.811 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.23 153.23 22.62 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.324 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.2 m -105.22 137.47 42.95 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.225 -1.162 . . . . 0.0 108.703 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 52.4 mt -80.66 141.86 14.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -131.59 153.7 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.379 -0.826 . . . . 0.0 109.466 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.574 ' NZ ' ' O ' ' A' ' 74' ' ' ASP . 15.9 ttpp -142.03 133.53 26.7 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 19' ' ' GLN . . . -123.45 151.82 42.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.001 -1.062 . . . . 0.0 108.568 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.574 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 13.4 m-20 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 120.882 -1.136 . . . . 0.0 110.234 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 86.7 t80 . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 68.4 mt -115.94 146.28 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.612 -0.68 . . . . 0.0 109.6 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.467 ' O ' ' CG2' ' B' ' 9' ' ' ILE . 9.5 tt -131.82 115.22 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -123.49 158.36 31.46 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' THR . . . . . 0.466 ' OG1' ' OG1' ' C' ' 69' ' ' THR . 1.5 m -112.67 103.18 11.21 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.33 88.45 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.468 -0.77 . . . . 0.0 109.853 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -162.08 -20.78 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.428 -0.795 . . . . 0.0 109.514 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 60.37 160.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.627 -0.671 . . . . 0.0 109.417 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 mt -130.4 82.94 64.03 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.561 -0.712 . . . . 0.0 109.084 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.58 156.37 42.52 Favored 'Trans proline' 0 C--N 1.323 -0.815 0 C-N-CA 122.068 1.845 . . . . 0.0 110.252 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.71 -6.34 77.12 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 66.9 mt -130.96 139.64 50.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.049 -1.265 . . . . 0.0 109.06 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.18 116.43 23.53 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.79 140.42 33.01 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.18 -0.95 . . . . 0.0 110.032 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -123.31 129.51 51.43 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 42.0 t -67.44 130.61 43.59 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.826 -1.171 . . . . 0.0 111.138 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 72.3 mt -116.71 8.24 13.69 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.42 -171.13 14.9 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 40.6 mm -119.05 141.9 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.908 -0.76 . . . . 0.0 109.367 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.15 144.82 42.01 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.616 -0.678 . . . . 0.0 109.425 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 85.3 p -152.22 137.8 17.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.097 -1.002 . . . . 0.0 108.599 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 8.8 t -149.74 149.6 30.81 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.937 -1.102 . . . . 0.0 109.265 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 66.1 mt -116.13 126.33 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.307 -0.87 . . . . 0.0 109.047 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 32.5 t -174.87 -146.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.148 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -158.91 172.01 18.99 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.211 -0.931 . . . . 0.0 108.814 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 2.1 m120 73.46 130.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 t -68.88 -35.12 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.551 -0.718 . . . . 0.0 109.49 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -58.96 -45.22 91.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.268 -0.895 . . . . 0.0 109.944 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -75.58 -42.1 52.93 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 0.0 109.872 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 77.8 mt -63.46 -53.77 41.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.917 -1.115 . . . . 0.0 109.322 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 t -56.9 -48.54 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.012 -1.055 . . . . 0.0 108.765 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -61.65 -41.18 97.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 110.064 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -58.68 -48.01 82.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.551 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 57.6 mt -74.26 -50.49 18.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 108.934 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -48.81 -47.85 41.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.776 -1.202 . . . . 0.0 108.892 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -61.32 -34.91 76.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 109.449 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -74.42 -36.03 63.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.524 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.29 -51.66 20.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.926 -1.109 . . . . 0.0 108.898 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -51.32 -29.25 14.45 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 122.613 1.196 . . . . 0.0 109.788 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.3 -26.76 52.59 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.439 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -94.26 8.41 41.88 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.07 31.13 68.14 Favored Glycine 0 N--CA 1.476 1.353 0 C-N-CA 118.157 -1.973 . . . . 0.0 109.911 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.48 -169.34 32.44 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 25.0 mmm -106.86 -37.2 6.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.397 -1.061 . . . . 0.0 109.554 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 176.16 -149.49 9.91 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 tp -137.65 143.72 41.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.357 -1.084 . . . . 0.0 109.823 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.495 ' O ' ' CB ' ' B' ' 54' ' ' ALA . 1.2 pt -114.36 146.63 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.5 -0.75 . . . . 0.0 109.376 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.524 ' O ' ' C ' ' B' ' 55' ' ' PHE . . . 82.88 -48.42 0.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 118.769 0.713 . . . . 0.0 109.893 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.524 ' C ' ' O ' ' B' ' 54' ' ' ALA . 78.5 t80 25.1 92.54 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 120.965 0.412 . . . . 0.0 110.593 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . 0.787 ' HG3' HH11 ' B' ' 56' ' ' ARG . 11.2 ttm-85 -98.77 153.46 18.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.214 -0.929 . . . . 0.0 109.821 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mp . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.755 0.788 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.14 53.49 0.94 Allowed Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' TYR . . . . . 0.442 ' HH ' ' HE ' ' B' ' 56' ' ' ARG . 20.3 p90 -59.3 178.44 0.14 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.685 1.231 . . . . 0.0 110.228 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.63 160.41 26.25 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' THR . . . . . 0.527 ' OG1' ' OG1' ' A' ' 11' ' ' THR . 21.7 m -95.87 135.04 38.13 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 120.494 -1.591 . . . . 0.0 107.786 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 58.9 mt -83.64 146.39 6.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 m -136.31 162.33 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.551 -0.718 . . . . 0.0 109.989 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -152.28 141.76 21.67 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.37 151.36 29.87 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.953 -1.092 . . . . 0.0 108.694 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 56.4 t0 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 120.957 -1.089 . . . . 0.0 108.689 179.264 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 120.963 0.411 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -97.8 121.82 40.16 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.479 -0.763 . . . . 0.0 109.053 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.94 135.98 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.479 -0.763 . . . . 0.0 110.591 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' ILE . . . . . 0.462 ' CG2' ' O ' ' C' ' 9' ' ' ILE . 13.9 tt -132.12 113.33 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 4.9 t -124.45 160.65 27.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.346 -0.846 . . . . 0.0 109.284 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 4.3 p -110.26 83.45 1.76 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.75 -28.45 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.647 -0.658 . . . . 0.0 110.14 177.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . 0.604 ' N ' ' OD1' ' C' ' 13' ' ' ASP . 0.0 OUTLIER 68.51 43.33 1.41 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.479 -0.763 . . . . 0.0 109.49 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -178.67 129.3 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.105 -0.997 . . . . 0.0 109.521 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 16.6 mt -134.28 79.14 56.21 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.98 155.14 51.83 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 122.02 1.814 . . . . 0.0 110.503 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.15 -6.17 78.61 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 53.9 mt -131.6 139.58 49.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -1.198 . . . . 0.0 109.518 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . 0.564 ' O ' ' HA ' ' C' ' 73' ' ' ALA . 25.9 mt-30 -84.91 114.24 21.98 Favored 'General case' 0 C--O 1.192 -1.929 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 16.1 mt -94.64 138.56 32.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.783 -1.198 . . . . 0.0 110.752 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' TYR . . . . . 0.519 ' H ' ' H ' ' C' ' 72' ' ' LYS . 29.3 t80 -116.99 128.29 55.04 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.606 -0.684 . . . . 0.0 109.733 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.04 123.34 21.87 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 120.022 -1.674 . . . . 0.0 110.308 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 78.6 mt -114.69 7.68 16.0 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.96 -174.74 15.89 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.17 144.17 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 122.037 -0.684 . . . . 0.0 109.244 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.3 144.6 45.71 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.95 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 42.1 m -152.61 142.39 22.0 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.96 -1.087 . . . . 0.0 108.421 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 9.2 t -149.52 146.69 27.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.101 -0.999 . . . . 0.0 109.359 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 71.7 mt -113.52 137.37 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.399 -0.813 . . . . 0.0 110.253 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.561 ' HG ' ' H ' ' C' ' 31' ' ' ASP . 0.1 OUTLIER -158.97 -172.81 3.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.48 -0.763 . . . . 0.0 109.78 -179.1 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' ASP . . . . . 0.561 ' H ' ' HG ' ' C' ' 30' ' ' SER . 4.8 m-20 -97.14 -76.14 0.52 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.322 -0.861 . . . . 0.0 111.91 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -76.88 156.07 32.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.927 -1.108 . . . . 0.0 109.104 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.52 -32.89 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.315 0.579 . . . . 0.0 109.803 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' C' ' 34' ' ' ASP . 0.0 OUTLIER -53.54 -38.0 63.38 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.329 -0.857 . . . . 0.0 109.474 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -76.86 -35.36 57.53 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.017 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 81.5 mt -63.56 -53.28 47.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.047 -1.033 . . . . 0.0 108.991 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.11 -50.59 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.05 -1.031 . . . . 0.0 109.152 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -57.92 -38.94 76.81 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.304 -0.873 . . . . 0.0 108.964 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -65.79 -42.12 91.14 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.93 . . . . 0.0 109.522 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 24.8 mt -69.41 -47.65 63.46 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.012 -1.055 . . . . 0.0 108.753 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -49.41 -54.15 18.98 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.885 -1.134 . . . . 0.0 109.261 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -56.66 -34.16 67.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.899 . . . . 0.0 109.208 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -74.8 -43.74 53.14 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.33 -0.856 . . . . 0.0 109.321 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 10.5 t -71.64 -52.29 26.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 O-C-N 120.846 -1.159 . . . . 0.0 108.647 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -51.73 -31.5 26.66 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.823 1.296 . . . . 0.0 110.075 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.3 -28.09 47.43 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.705 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.13 4.32 53.4 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.72 26.49 69.95 Favored Glycine 0 N--CA 1.48 1.605 0 C-N-CA 118.631 -1.747 . . . . 0.0 109.804 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.85 162.98 50.76 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 16.2 ttp -79.91 -42.04 24.9 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.836 -1.39 . . . . 0.0 109.946 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 172.5 -170.3 43.37 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 tp -113.2 141.97 46.34 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.561 -0.964 . . . . 0.0 110.403 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' ILE . . . . . 0.403 ' O ' ' CB ' ' C' ' 54' ' ' ALA . 2.2 pt -119.82 145.71 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.44 -0.787 . . . . 0.0 110.406 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . 0.452 ' HA ' ' OD1' ' C' ' 13' ' ' ASP . . . 70.99 -56.01 0.63 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.209 -0.932 . . . . 0.0 110.823 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 1.1 t80 61.37 -123.4 0.84 Allowed 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' ARG . . . . . 0.768 HH11 ' HG2' ' C' ' 56' ' ' ARG . 0.0 OUTLIER -170.36 -138.65 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.239 -0.913 . . . . 0.0 109.928 -179.432 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' ILE . . . . . 0.526 ' H ' ' CG ' ' C' ' 56' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.185 -0.947 . . . . 0.0 109.637 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' TYR . . . . . 0.438 ' OH ' ' CZ ' ' C' ' 56' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.39 173.41 15.37 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' THR . . . . . 0.466 ' OG1' ' OG1' ' B' ' 11' ' ' THR . 53.0 m -122.75 132.82 54.4 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 119.036 1.418 . . . . 0.0 107.582 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 57.7 mt -79.13 129.73 37.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.17 161.88 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.445 -0.784 . . . . 0.0 109.87 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' LYS . . . . . 0.519 ' H ' ' H ' ' C' ' 21' ' ' TYR . 6.5 tttt -154.21 142.62 20.61 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' C' ' 19' ' ' GLN . . . -102.64 128.8 49.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.08 -1.013 . . . . 0.0 109.374 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.0 109.065 178.853 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt . . . . . 0 N--CA 1.498 1.933 0 CA-C-O 121.997 0.903 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -102.15 121.57 42.48 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 58.3 mt -133.65 128.42 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.434 -0.791 . . . . 0.0 109.351 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 9' ' ' ILE . . . . . 0.459 ' O ' ' CG2' ' D' ' 9' ' ' ILE . 9.1 tt -128.23 115.12 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.7 t -125.64 157.36 37.45 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 11' ' ' THR . . . . . 0.484 ' OG1' ' OG1' ' E' ' 69' ' ' THR . 3.5 m -102.55 81.9 2.09 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.3 -112.15 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.452 -0.78 . . . . 0.0 110.203 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -152.49 -135.67 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.552 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -63.22 158.96 18.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -0.876 . . . . 0.0 109.371 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 38.9 mt -112.23 98.95 44.91 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.18 155.84 43.37 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.896 1.731 . . . . 0.0 110.392 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.68 -8.11 78.89 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 80.6 mt -131.44 142.27 49.98 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.42 -1.047 . . . . 0.0 109.309 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -87.77 108.45 19.13 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mt -114.9 131.6 56.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.687 -0.633 . . . . 0.0 109.599 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' TYR . . . . . 0.595 ' OH ' ' N ' ' D' ' 74' ' ' ASP . 0.0 OUTLIER -113.73 143.42 44.64 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 16.6 t -75.06 128.33 35.29 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.93 12.38 20.77 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.5 -179.09 16.35 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.9 144.01 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 122.174 -0.604 . . . . 0.0 109.606 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.25 144.28 40.67 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.405 0.621 . . . . 0.0 109.377 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.47 138.4 18.1 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.265 -0.897 . . . . 0.0 109.356 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 12.7 t -149.73 144.5 26.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.044 -1.035 . . . . 0.0 109.189 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 12.9 tt -117.95 127.91 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.271 -0.893 . . . . 0.0 108.93 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 30.1 t -173.65 174.28 3.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 109.056 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' D' ' 32' ' ' ASN . 29.5 t70 -107.49 157.29 18.14 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.332 -0.855 . . . . 0.0 109.565 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 8.6 t30 85.97 123.81 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 -177.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -69.86 -38.95 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -63.12 -31.0 72.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.539 -0.726 . . . . 0.0 109.878 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -75.0 -41.08 60.19 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.223 -0.923 . . . . 0.0 109.717 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 92.6 mt -62.2 -46.31 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.999 -1.063 . . . . 0.0 108.7 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 17.0 t -55.75 -48.07 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.909 -1.119 . . . . 0.0 108.288 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -62.76 -42.23 99.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.024 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -59.67 -45.56 91.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.333 -0.855 . . . . 0.0 109.415 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 49.4 mt -71.36 -48.0 52.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 108.899 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -49.07 -50.92 34.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.79 -1.194 . . . . 0.0 109.113 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -59.96 -36.21 76.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.398 -0.814 . . . . 0.0 109.952 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -75.8 -35.85 59.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.465 -0.772 . . . . 0.0 109.598 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 13.1 t -71.07 -50.79 39.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.066 -1.022 . . . . 0.0 108.799 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -64.74 -30.13 71.13 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 118.29 -1.364 . . . . 0.0 109.255 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.66 -30.41 69.95 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . 0.494 ' NZ ' ' HB3' ' D' ' 47' ' ' LYS . 0.1 OUTLIER -90.36 2.07 55.93 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.79 23.83 74.13 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.08 -165.65 7.92 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 7.8 ttt -110.2 -41.26 4.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.418 -1.048 . . . . 0.0 109.702 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 173.58 -158.66 28.06 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 3.4 tp -125.07 139.86 53.42 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.595 -0.944 . . . . 0.0 110.36 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 53' ' ' ILE . . . . . 0.482 ' O ' ' CB ' ' D' ' 54' ' ' ALA . 1.0 OUTLIER -118.06 148.53 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.672 -0.643 . . . . 0.0 110.501 -177.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' D' ' 53' ' ' ILE . . . 82.73 -38.22 0.09 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 118.832 0.742 . . . . 0.0 109.131 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . 0.498 ' O ' ' O ' ' D' ' 56' ' ' ARG . 31.3 t80 49.18 -110.41 0.4 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.624 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' ARG . . . . . 0.682 ' HG2' HH11 ' D' ' 56' ' ' ARG . 6.4 mtt-85 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.418 0.628 . . . . 0.0 109.868 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 t80 . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 122.277 1.037 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.1 139.68 5.81 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 46.9 m -109.55 148.32 31.45 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.065 -1.256 . . . . 0.0 109.536 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 24.1 mt -97.78 148.04 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.54 0.686 . . . . 0.0 109.577 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 m -143.34 154.18 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.491 -0.755 . . . . 0.0 109.357 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 72' ' ' LYS . . . . . 0.481 ' NZ ' ' OD2' ' D' ' 74' ' ' ASP . 26.3 ttpp -139.98 142.5 36.33 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.049 -1.032 . . . . 0.0 108.667 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' D' ' 74' ' ' ASP . . . -124.11 141.36 52.12 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . 0.595 ' N ' ' OH ' ' D' ' 21' ' ' TYR . 3.5 p30 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 6' ' ' LYS . . . . . 0.557 ' CG ' ' H ' ' E' ' 7' ' ' PHE . 14.7 tttt . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 121.215 0.531 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 7' ' ' PHE . . . . . 0.557 ' H ' ' CG ' ' E' ' 6' ' ' LYS . 18.8 t80 -109.85 120.73 43.39 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.562 -0.711 . . . . 0.0 109.672 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 83.7 mt -96.86 128.57 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.323 -0.86 . . . . 0.0 110.988 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 9' ' ' ILE . . . . . 0.438 ' O ' ' CG2' ' E' ' 9' ' ' ILE . 17.1 tt -134.48 121.01 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 1.3 t -113.34 133.25 55.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.322 -0.861 . . . . 0.0 109.336 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.63 -90.74 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.397 -0.814 . . . . 0.0 110.984 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.09 72.72 1.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.123 -0.986 . . . . 0.0 108.366 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -160.26 141.53 12.32 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.415 0.626 . . . . 0.0 109.512 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -79.56 178.68 7.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.398 -0.814 . . . . 0.0 109.127 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 57.5 mt -123.6 88.17 51.96 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.474 -0.766 . . . . 0.0 109.184 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.55 155.49 52.76 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 121.962 1.775 . . . . 0.0 110.158 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.02 -12.34 69.78 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 18' ' ' LEU . . . . . . . . . . . . . 15.9 mt -125.2 136.83 53.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -1.185 . . . . 0.0 108.982 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.14 112.84 21.68 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt -99.08 142.62 30.34 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.187 -0.946 . . . . 0.0 109.83 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 21' ' ' TYR . . . . . 0.403 ' CE1' ' O ' ' E' ' 22' ' ' SER . 1.5 t80 -123.29 130.07 52.23 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 22' ' ' SER . . . . . 0.403 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 4.3 t -61.39 129.97 43.8 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.83 -1.169 . . . . 0.0 110.953 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 mt -117.65 9.26 13.03 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.67 -173.6 14.86 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.77 143.92 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 122.033 -0.687 . . . . 0.0 109.433 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.61 144.04 47.34 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.943 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 19.4 m -152.18 136.34 16.57 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 10.9 t -149.92 151.49 33.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.972 -1.08 . . . . 0.0 109.222 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 56.6 mt -127.0 133.44 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.111 -0.993 . . . . 0.0 108.702 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.574 ' O ' ' N ' ' E' ' 32' ' ' ASN . 78.1 p -156.29 31.77 0.33 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.134 -0.979 . . . . 0.0 110.769 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 31' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' E' ' 31' ' ' ASP . 0.7 OUTLIER 54.28 -70.59 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 32' ' ' ASN . . . . . 0.574 ' N ' ' O ' ' E' ' 30' ' ' SER . 7.3 m120 -66.1 135.41 54.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.732 -1.23 . . . . 0.0 107.93 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 33' ' ' VAL . . . . . 0.421 ' CG2' ' N ' ' E' ' 34' ' ' ASP . 1.0 OUTLIER -70.88 -42.21 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 34' ' ' ASP . . . . . 0.421 ' N ' ' CG2' ' E' ' 33' ' ' VAL . 29.8 t70 -52.53 -28.02 18.98 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.512 -0.742 . . . . 0.0 109.825 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -78.11 -33.39 50.6 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.422 -0.799 . . . . 0.0 109.202 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.16 -52.77 57.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.031 -1.043 . . . . 0.0 108.776 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.89 -49.24 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.085 -1.01 . . . . 0.0 108.967 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -60.71 -41.86 96.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.414 -0.804 . . . . 0.0 108.978 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -64.46 -45.2 88.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.471 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 70.4 mt -64.57 -44.03 92.01 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.098 -1.001 . . . . 0.0 108.329 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 41' ' ' ARG . . . . . 0.715 HH11 ' HG2' ' E' ' 41' ' ' ARG . 0.0 OUTLIER -48.84 -55.5 11.48 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.845 -1.159 . . . . 0.0 109.352 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -55.96 -33.56 64.89 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.088 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -74.44 -40.07 62.17 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.462 -0.773 . . . . 0.0 109.494 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 12.8 t -73.87 -52.01 22.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 120.879 -1.138 . . . . 0.0 108.82 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -50.59 -29.6 11.22 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.692 1.234 . . . . 0.0 109.741 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.63 -25.84 50.04 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.383 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -95.71 4.38 53.04 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.67 30.73 78.73 Favored Glycine 0 N--CA 1.479 1.555 0 C-N-CA 118.009 -2.043 . . . . 0.0 110.181 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.32 153.92 23.84 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 10.8 mtm -66.46 -29.61 69.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -1.111 . . . . 0.0 110.474 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.74 -137.51 4.61 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 tp -133.64 137.93 45.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.421 -1.046 . . . . 0.0 110.086 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.12 144.9 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.609 -0.682 . . . . 0.0 110.163 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . 64.91 74.84 0.38 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.166 -0.959 . . . . 0.0 110.216 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -98.56 107.47 19.93 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 56' ' ' ARG . . . . . 0.66 ' CG ' HH11 ' E' ' 56' ' ' ARG . 0.4 OUTLIER -97.3 135.63 38.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.582 -0.699 . . . . 0.0 110.529 -178.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 tt . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.719 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 . . . . . 0 N--CA 1.498 1.929 0 CA-C-O 121.358 0.599 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.61 149.72 21.11 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 69' ' ' THR . . . . . 0.484 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 8.6 m -112.81 137.5 51.05 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 32.0 mt -82.78 148.68 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 m -130.44 164.8 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.662 -0.649 . . . . 0.0 109.907 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -147.95 145.43 28.57 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.89 137.96 49.15 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t70 . . . . . 0 N--CA 1.488 1.47 0 O-C-N 120.728 -1.233 . . . . 0.0 108.13 178.118 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.7 t80 . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.5 mt -134.49 138.15 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.29 -0.881 . . . . 0.0 109.978 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.478 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 6.9 tt -127.8 118.21 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.788 -1.195 . . . . 0.0 108.088 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.4 t -127.24 154.93 44.24 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.059 -1.026 . . . . 0.0 109.563 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 m -135.54 115.95 13.63 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.52 66.23 1.23 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.344 -0.848 . . . . 0.0 109.655 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -164.13 -24.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.54 -0.725 . . . . 0.0 109.504 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 57.15 171.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.519 -0.738 . . . . 0.0 109.438 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mt -139.01 74.7 36.53 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.371 -0.831 . . . . 0.0 109.099 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.44 156.47 41.22 Favored 'Trans proline' 0 C--N 1.32 -0.952 0 C-N-CA 122.132 1.888 . . . . 0.0 110.197 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.08 -3.71 73.55 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.261 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 42.6 mt -129.9 137.87 50.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.279 . . . . 0.0 108.871 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 12.0 pt20 -85.91 113.82 22.33 Favored 'General case' 0 C--O 1.2 -1.518 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -95.0 138.81 32.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.892 -1.13 . . . . 0.0 109.603 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.557 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 42.4 t80 -109.97 155.07 22.26 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.45 126.56 38.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 119.857 -1.777 . . . . 0.0 108.07 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.7 mt -117.08 5.91 12.83 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.69 -164.36 13.51 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.35 145.24 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 122.027 -0.69 . . . . 0.0 109.653 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.99 154.37 25.41 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 87.0 p -147.11 150.18 34.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.126 -0.984 . . . . 0.0 109.087 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.7 p -148.86 134.71 18.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.539 -0.726 . . . . 0.0 109.468 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.673 ' O ' ' OG ' ' A' ' 30' ' ' SER . 10.6 mm -127.12 126.0 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.673 ' OG ' ' O ' ' A' ' 29' ' ' ILE . 23.4 m 171.81 -129.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.175 0.512 . . . . 0.0 109.679 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.464 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 3.1 p30 -153.38 165.15 36.68 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.045 -1.034 . . . . 0.0 109.227 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 7.8 t-20 77.55 109.52 0.07 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -177.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.36 -38.06 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.359 -0.838 . . . . 0.0 108.868 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 35' ' ' GLU . 1.9 p30 -61.17 -32.4 72.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.845 . . . . 0.0 110.095 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.46 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 31.1 tt0 -75.69 -37.45 59.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 0.0 109.139 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.1 mt -62.51 -42.61 96.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.12 -0.988 . . . . 0.0 108.836 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.28 -50.19 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.007 -1.058 . . . . 0.0 108.81 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -59.37 -38.94 81.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 109.663 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -61.76 -43.34 99.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.387 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 76.8 mt -68.07 -46.05 72.15 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.169 -0.957 . . . . 0.0 108.527 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -50.65 -53.3 32.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.899 -1.126 . . . . 0.0 109.199 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -57.81 -33.53 68.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.426 -0.796 . . . . 0.0 109.093 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -72.98 -41.88 63.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.331 -0.855 . . . . 0.0 109.34 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.1 t -77.01 -50.93 19.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 120.682 -1.261 . . . . 0.0 109.359 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -49.73 -32.97 14.79 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 122.681 1.229 . . . . 0.0 109.954 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.25 -29.26 48.0 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.824 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -93.54 5.8 50.39 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.25 29.43 68.71 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 118.265 -1.922 . . . . 0.0 109.629 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.2 -168.53 11.06 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -104.85 -53.9 2.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -1.059 . . . . 0.0 109.955 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.74 178.21 48.02 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.485 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 3.9 mm? -98.88 135.05 40.87 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.377 -1.073 . . . . 0.0 110.261 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 54' ' ' ALA . 1.4 pt -112.11 139.01 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.664 -0.647 . . . . 0.0 109.392 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 53' ' ' ILE . . . 43.52 45.79 5.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.157 -0.964 . . . . 0.0 109.501 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.12 -27.17 28.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 0.0 109.209 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.62 HH22 ' CB ' ' B' ' 27' ' ' SER . 8.4 mmt180 -42.33 160.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.665 0.745 . . . . 0.0 109.891 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.599 ' H ' ' CD1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.769 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.6 p90 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.984 0.897 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.31 156.98 13.09 Favored Glycine 0 N--CA 1.487 2.091 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.284 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.471 ' OG1' ' OG1' ' E' ' 11' ' ' THR . 52.8 m -98.29 135.39 39.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.193 -1.18 . . . . 0.0 108.617 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.4 mt -89.63 131.28 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 5.4 m -138.5 167.7 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.664 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -150.94 150.86 31.33 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 19' ' ' GLN . . . -105.98 115.65 30.59 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.181 -0.949 . . . . 0.0 110.938 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.384 0.612 . . . . 0.0 109.596 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 88.9 t80 . . . . . 0 N--CA 1.501 2.092 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 14.9 mt -115.57 135.68 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.454 -0.779 . . . . 0.0 110.383 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.449 ' O ' ' CG2' ' B' ' 9' ' ' ILE . 19.0 tt -134.46 114.09 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.9 t -123.01 159.59 28.06 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.377 -0.827 . . . . 0.0 108.926 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.0 p -101.68 72.72 1.39 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -177.01 -137.3 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.156 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 179.68 90.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.473 -0.767 . . . . 0.0 109.577 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -156.85 -81.56 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.349 -0.844 . . . . 0.0 109.447 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.482 ' N ' ' HD3' ' B' ' 16' ' ' PRO . 8.2 mt 47.18 62.35 12.02 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.118 -0.989 . . . . 0.0 108.952 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' B' ' 15' ' ' ILE . 1.4 Cg_endo -65.97 155.63 68.53 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.997 1.798 . . . . 0.0 109.909 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.07 -10.65 74.42 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.308 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 76.1 mt -124.89 137.28 54.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.08 -1.247 . . . . 0.0 108.638 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -101.45 116.41 32.72 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' B' ' 72' ' ' LYS . 0.2 OUTLIER -111.99 134.57 53.46 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.556 -0.715 . . . . 0.0 110.688 -177.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . 0.658 ' CD1' ' N ' ' B' ' 21' ' ' TYR . 0.0 OUTLIER -105.17 152.75 22.44 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.02 128.83 34.8 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.504 -0.747 . . . . 0.0 109.6 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 mt -113.17 7.06 17.77 Favored 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.03 -157.08 22.49 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 176.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -135.02 143.68 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.963 -0.728 . . . . 0.0 109.359 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.94 145.59 45.65 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.128 0.49 . . . . 0.0 109.738 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.62 ' CB ' HH22 ' A' ' 56' ' ' ARG . 0.0 OUTLIER -152.05 141.36 21.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.005 -1.059 . . . . 0.0 108.459 179.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 14.1 t -149.63 152.85 36.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.199 -0.938 . . . . 0.0 109.083 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 68.6 mt -126.8 133.1 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.2 -0.937 . . . . 0.0 109.375 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 34.2 t -165.59 166.06 18.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.438 -0.789 . . . . 0.0 109.338 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -96.63 70.95 2.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.238 -0.914 . . . . 0.0 109.645 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 169.31 129.04 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.44 ' CG2' ' N ' ' B' ' 34' ' ' ASP . 1.3 m -71.16 -43.62 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.44 ' N ' ' CG2' ' B' ' 33' ' ' VAL . 33.9 m-20 -63.76 -45.16 91.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.348 -0.845 . . . . 0.0 109.681 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -60.37 -39.18 86.31 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.678 -0.809 . . . . 0.0 108.872 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 48.5 mt -64.07 -51.89 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.92 . . . . 0.0 108.877 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -53.64 -48.31 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.977 . . . . 0.0 108.508 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -60.8 -40.26 91.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.335 -0.853 . . . . 0.0 110.102 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -64.36 -44.38 91.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 109.478 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 40.9 mt -68.45 -48.76 63.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.131 -0.981 . . . . 0.0 108.527 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -49.0 -48.58 43.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.846 -1.159 . . . . 0.0 108.945 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.424 ' CB ' ' HZ2' ' B' ' 42' ' ' LYS . 6.9 ttpm? -62.19 -36.31 81.5 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.51 -0.744 . . . . 0.0 109.965 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -75.5 -35.96 60.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.385 -0.822 . . . . 0.0 109.668 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.75 -51.6 26.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.062 -1.024 . . . . 0.0 108.902 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -56.0 -28.73 58.47 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.669 1.223 . . . . 0.0 109.147 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.26 -28.33 59.78 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.385 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -96.42 -5.22 40.25 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.11 24.72 70.7 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 118.466 -1.825 . . . . 0.0 109.175 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.25 -171.11 9.25 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -112.36 -40.12 4.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.502 -0.999 . . . . 0.0 109.896 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 171.52 175.53 39.94 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.495 ' CD2' ' N ' ' B' ' 52' ' ' LEU . 2.3 mm? -96.99 133.85 41.13 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.378 -1.072 . . . . 0.0 109.942 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 49.7 mt -110.25 137.05 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.727 -0.608 . . . . 0.0 109.973 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 57.95 71.42 0.58 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.816 . . . . 0.0 109.815 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' B' ' 56' ' ' ARG . 2.0 t80 -58.38 -73.25 0.08 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.36 -0.837 . . . . 0.0 108.923 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' B' ' 55' ' ' PHE . 7.1 tpt180 58.01 113.61 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.411 -0.806 . . . . 0.0 110.157 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 46.7 tp . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -123.12 152.4 16.93 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -167.81 -175.48 2.76 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.473 -1.016 . . . . 0.0 109.399 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.0 -162.4 35.29 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 97.6 m -123.84 137.79 54.6 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 31.1 mt -83.81 125.49 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 6.5 m -136.94 164.18 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.824 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' B' ' 20' ' ' LEU . 3.0 mttt -136.1 146.67 47.26 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.33 -0.856 . . . . 0.0 108.879 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' B' ' 74' ' ' ASP . . . -114.88 116.75 29.05 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.81 -0.556 . . . . 0.0 110.235 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . 0.567 ' O ' ' OH ' ' B' ' 21' ' ' TYR . 5.5 t70 . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 121.774 0.797 . . . . 0.0 109.655 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 53.8 mttm . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -92.77 120.31 33.02 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.135 -0.978 . . . . 0.0 108.728 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 44.8 mt -119.45 128.57 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.513 -0.742 . . . . 0.0 109.788 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' ILE . . . . . 0.45 ' CG2' ' O ' ' C' ' 9' ' ' ILE . 13.4 tt -119.96 114.14 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -122.94 159.97 27.17 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 7.7 p -125.55 77.57 1.66 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.642 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.35 -117.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.398 -1.439 . . . . 0.0 108.371 -176.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -84.41 -134.27 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.136 -0.977 . . . . 0.0 109.796 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.75 28.93 5.54 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.529 -0.732 . . . . 0.0 109.862 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 33.2 mt 57.06 81.63 0.25 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.393 -0.817 . . . . 0.0 109.58 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.93 156.84 41.61 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 122.21 1.94 . . . . 0.0 110.37 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.18 -0.95 69.44 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.378 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 60.8 mt -131.52 138.99 49.17 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.111 -1.229 . . . . 0.0 109.155 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -97.54 109.55 22.29 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.2 143.97 47.97 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' TYR . . . . . 0.666 ' CD1' ' N ' ' C' ' 21' ' ' TYR . 0.0 OUTLIER -113.65 146.85 39.14 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.509 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -72.85 136.91 45.41 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.642 0.734 . . . . 0.0 109.999 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 5.8 mt -118.47 15.37 13.8 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.02 179.76 16.18 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 47.1 mm -112.3 142.26 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.795 -0.827 . . . . 0.0 108.826 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.38 144.17 43.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.528 -0.733 . . . . 0.0 109.899 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 35.4 t -152.31 137.66 17.57 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 15.2 t -149.62 152.3 35.22 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.055 -1.028 . . . . 0.0 109.369 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -102.15 155.02 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' C' ' 31' ' ' ASP . 12.1 t -176.19 -178.06 0.95 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.975 . . . . 0.0 109.225 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' ASP . . . . . 0.448 ' N ' ' OG ' ' C' ' 30' ' ' SER . 20.0 t70 -102.2 -80.78 0.5 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.411 -0.806 . . . . 0.0 110.971 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -65.08 144.12 57.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.996 -1.065 . . . . 0.0 108.731 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.47 -38.44 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -54.59 -28.16 44.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.459 -0.776 . . . . 0.0 109.848 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -76.23 -34.74 59.22 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.309 -0.869 . . . . 0.0 109.479 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 84.2 mt -58.76 -46.9 90.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.171 -0.955 . . . . 0.0 108.913 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 55.6 t -56.86 -49.57 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.952 -1.092 . . . . 0.0 108.637 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -61.8 -42.78 99.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.437 -0.789 . . . . 0.0 109.402 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -60.26 -48.67 80.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.535 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 67.2 mt -64.68 -42.9 95.03 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' ARG . . . . . 0.717 HH11 ' HG2' ' C' ' 41' ' ' ARG . 0.8 OUTLIER -48.2 -47.7 35.28 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.861 -1.15 . . . . 0.0 109.275 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -63.13 -31.83 73.06 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -73.8 -41.74 61.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.832 . . . . 0.0 109.518 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 38.1 t -68.29 -51.24 49.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.705 -1.247 . . . . 0.0 109.292 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -51.0 -33.44 24.84 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.642 1.211 . . . . 0.0 110.223 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.76 -28.83 50.72 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.678 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.55 7.31 43.8 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.48 29.77 64.11 Favored Glycine 0 N--CA 1.487 2.08 0 C-N-CA 118.672 -1.727 . . . . 0.0 109.759 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.26 148.9 27.14 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -65.23 -33.63 76.45 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.174 -1.192 . . . . 0.0 110.826 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 171.56 -159.04 30.47 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 11.4 tp -121.18 135.57 55.12 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.588 -0.948 . . . . 0.0 109.622 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' ILE . . . . . 0.41 HG23 HD12 ' C' ' 53' ' ' ILE . 60.7 mt -110.87 144.03 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.492 -0.755 . . . . 0.0 110.022 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.12 82.64 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.232 -0.918 . . . . 0.0 110.713 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . 0.439 ' O ' ' CD2' ' C' ' 55' ' ' PHE . 82.5 t80 -126.9 65.79 1.28 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.332 0.587 . . . . 0.0 110.143 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' ARG . . . . . 0.686 HH11 ' HG2' ' C' ' 56' ' ' ARG . 7.7 mtt-85 -80.02 148.43 31.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 109.495 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 44.5 mm . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.828 . . . . 0.0 109.292 179.905 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' C' ' 67' ' ' TYR . 21.7 p90 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.571 0.701 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.38 165.34 32.85 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 95.1 m -117.05 141.46 48.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.294 -1.121 . . . . 0.0 108.925 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 41.9 mt -95.09 133.48 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.443 -0.785 . . . . 0.0 109.019 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 10.6 m -144.26 156.15 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.41 -0.806 . . . . 0.0 109.608 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' LYS . . . . . 0.431 ' HG3' ' CE2' ' C' ' 21' ' ' TYR . 18.4 ptpt -142.33 140.06 32.0 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.26 -0.9 . . . . 0.0 108.691 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.466 ' O ' ' CB ' ' C' ' 74' ' ' ASP . . . -126.67 152.96 46.03 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.761 -1.212 . . . . 0.0 108.503 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' C' ' 73' ' ' ALA . 27.1 t70 . . . . . 0 N--CA 1.499 1.989 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 mtpt . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -114.77 121.96 44.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.493 -0.754 . . . . 0.0 109.555 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 51.6 mt -101.65 131.39 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.445 -0.784 . . . . 0.0 109.477 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 9' ' ' ILE . . . . . 0.422 ' O ' ' CG2' ' D' ' 9' ' ' ILE . 18.7 tt -124.42 119.89 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 6.0 t -116.35 132.19 56.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.341 -0.85 . . . . 0.0 109.228 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 11' ' ' THR . . . . . 0.729 ' OG1' ' OG1' ' E' ' 69' ' ' THR . 8.6 m -67.74 -117.83 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 12' ' ' ALA . . . . . 0.659 ' C ' ' O ' ' D' ' 11' ' ' THR . . . -2.39 -98.83 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.504 0 CA-C-N 118.318 0.508 . . . . 0.0 110.357 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' D' ' 12' ' ' ALA . 3.5 p30 161.91 91.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? 176.65 128.99 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.503 -0.748 . . . . 0.0 109.864 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' ILE . . . . . 0.441 HD12 HG23 ' D' ' 15' ' ' ILE . 35.5 mt -143.46 69.34 17.44 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.26 155.49 56.53 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.928 1.752 . . . . 0.0 110.284 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.63 -4.73 76.41 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 15.7 mt -129.88 138.64 51.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -1.193 . . . . 0.0 109.967 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -83.74 108.39 16.76 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 mt -103.3 138.88 39.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.463 -0.773 . . . . 0.0 110.425 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' TYR . . . . . 0.473 ' CE1' ' O ' ' D' ' 22' ' ' SER . 1.4 t80 -121.39 129.94 53.32 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' SER . . . . . 0.473 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 21.5 t -67.37 133.1 48.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.987 -1.07 . . . . 0.0 111.478 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 mt -123.74 12.42 9.18 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.34 176.03 19.33 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -109.78 144.33 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.905 -0.762 . . . . 0.0 109.567 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.56 154.1 30.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.663 -0.648 . . . . 0.0 109.556 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 6.6 p -152.51 137.29 17.04 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 12.5 t -149.44 151.36 33.87 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.077 -1.014 . . . . 0.0 109.63 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 6.4 mt -102.99 155.26 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 120.924 -1.11 . . . . 0.0 108.658 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.516 ' O ' ' N ' ' D' ' 32' ' ' ASN . 0.6 OUTLIER 176.13 -20.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.04 -1.037 . . . . 0.0 110.403 179.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 62.8 -41.39 0.18 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.777 -0.577 . . . . 0.0 111.465 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.541 ' O ' HG13 ' D' ' 36' ' ' ILE . 7.8 t-20 -85.86 141.22 29.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.972 -1.08 . . . . 0.0 109.28 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 3.0 t -68.41 -41.6 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.874 -1.141 . . . . 0.0 110.612 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -54.53 -43.97 72.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.39 -0.819 . . . . 0.0 110.238 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -76.8 -36.64 56.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.426 -0.797 . . . . 0.0 109.678 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . 0.541 HG13 ' O ' ' D' ' 32' ' ' ASN . 96.8 mt -61.69 -41.52 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.961 -1.087 . . . . 0.0 108.623 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 13.6 t -69.39 -46.37 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.665 -1.272 . . . . 0.0 108.954 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -66.98 -44.34 80.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.397 -0.814 . . . . 0.0 110.793 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -55.04 -48.5 73.36 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.041 -1.037 . . . . 0.0 109.659 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 38.8 mt -64.85 -37.79 88.81 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.297 -0.877 . . . . 0.0 109.287 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -54.53 -43.8 72.25 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.614 -1.304 . . . . 0.0 109.73 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm -67.62 -40.07 84.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.3 -0.875 . . . . 0.0 110.373 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -75.79 -36.14 59.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.86 . . . . 0.0 109.755 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.83 -50.07 73.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.049 -1.032 . . . . 0.0 109.333 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -65.25 -30.71 71.61 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 118.411 -1.316 . . . . 0.0 108.743 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.33 -28.46 66.26 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.554 0.692 . . . . 0.0 109.267 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -93.09 -6.55 47.82 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.469 -0.769 . . . . 0.0 109.514 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.16 30.06 15.45 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.145 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.77 155.55 18.29 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.39 -9.1 9.53 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.466 -1.02 . . . . 0.0 109.282 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.94 162.74 30.62 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 4.1 tp -130.47 140.32 50.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.632 -0.923 . . . . 0.0 109.769 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 53' ' ' ILE . . . . . . . . . . . . . 13.9 mt -108.48 138.39 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 65.63 76.71 0.32 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.314 -0.867 . . . . 0.0 109.779 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . 0.661 ' CE2' ' O ' ' D' ' 56' ' ' ARG . 84.1 t80 -99.06 138.89 35.52 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.49 -0.756 . . . . 0.0 110.313 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' ARG . . . . . 0.661 ' O ' ' CE2' ' D' ' 55' ' ' PHE . 26.7 ttp180 . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 30.4 p90 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.625 0.726 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.24 152.32 11.01 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.544 -1.312 . . . . 0.0 110.327 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 48.9 m -94.04 134.5 36.38 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.009 -1.289 . . . . 0.0 108.458 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 44.5 mt -84.81 127.58 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 71' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' D' ' 21' ' ' TYR . 4.3 m -135.38 159.31 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 110.218 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 10.6 pttp -152.25 148.6 27.76 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.76 150.72 26.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.23 -0.919 . . . . 0.0 108.852 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 p30 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.023 -1.048 . . . . 0.0 109.393 179.41 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -97.92 123.08 41.74 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.355 -0.841 . . . . 0.0 109.416 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 34.0 mt -111.67 135.33 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.459 -0.776 . . . . 0.0 109.591 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 9' ' ' ILE . . . . . 0.461 ' CG2' ' O ' ' E' ' 9' ' ' ILE . 10.5 tt -132.43 115.76 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 10' ' ' THR . . . . . 0.489 ' HG1' ' N ' ' E' ' 11' ' ' THR . 4.1 t -124.0 155.87 37.46 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 11' ' ' THR . . . . . 0.489 ' N ' ' HG1' ' E' ' 10' ' ' THR . 2.0 p -115.95 89.45 3.11 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.74 -95.57 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.987 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -160.14 -35.9 0.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.4 -0.813 . . . . 0.0 109.426 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . 0.411 ' CG ' ' N ' ' E' ' 15' ' ' ILE . 29.7 tt0 -166.71 167.32 15.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 109.302 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 15' ' ' ILE . . . . . 0.411 ' N ' ' CG ' ' E' ' 14' ' ' GLU . 87.0 mt -115.73 92.75 35.03 Favored Pre-proline 0 N--CA 1.496 1.843 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.12 155.28 51.75 Favored 'Trans proline' 0 C--N 1.322 -0.85 0 C-N-CA 121.912 1.741 . . . . 0.0 110.318 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.9 -10.19 75.05 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 18' ' ' LEU . . . . . . . . . . . . . 20.4 mt -127.59 138.95 53.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -1.1 . . . . 0.0 109.52 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -84.45 108.68 17.38 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 14.1 mt -96.99 142.97 28.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.389 -0.82 . . . . 0.0 110.752 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 21' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -126.36 130.15 50.21 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.77 129.37 39.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.733 -1.23 . . . . 0.0 110.793 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 97.6 mt -114.41 3.9 15.14 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.3 -172.9 19.68 Favored Glycine 0 N--CA 1.499 2.9 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 39.6 mm -110.39 140.87 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.798 -0.825 . . . . 0.0 109.32 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.3 146.93 44.86 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.646 -0.659 . . . . 0.0 109.313 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 40.5 m -152.59 148.41 27.31 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.907 -1.121 . . . . 0.0 108.916 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 25.2 p -148.88 134.15 18.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.45 -0.781 . . . . 0.0 109.337 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' E' ' 30' ' ' SER . 87.5 mt -126.53 127.83 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 30' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' E' ' 29' ' ' ILE . 3.6 t 162.51 14.43 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 31' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' E' ' 31' ' ' ASP . 1.4 m-20 51.55 -174.23 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.125 -0.984 . . . . 0.0 109.02 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 32' ' ' ASN . . . . . . . . . . . . . 8.0 m120 68.1 100.18 0.05 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 45.0 t -69.16 -37.27 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.211 -0.931 . . . . 0.0 109.5 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -57.52 -42.14 82.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 110.029 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.79 -38.18 58.48 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.287 -0.883 . . . . 0.0 109.42 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 55.9 mt -63.51 -51.71 67.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.03 -1.044 . . . . 0.0 109.534 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 57.6 t -51.8 -51.14 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.082 -1.011 . . . . 0.0 109.125 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.07 -38.06 78.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -0.869 . . . . 0.0 109.409 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -63.66 -40.81 97.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.122 -0.986 . . . . 0.0 109.511 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 41.6 mt -68.49 -44.45 74.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.148 -0.97 . . . . 0.0 109.338 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -51.43 -37.71 49.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.653 -1.28 . . . . 0.0 109.596 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -73.71 -39.46 64.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.59 -0.694 . . . . 0.0 109.831 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -75.98 -35.79 59.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.371 -0.831 . . . . 0.0 109.67 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 11.5 t -67.32 -50.92 58.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 109.055 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -70.4 -36.88 74.33 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.315 -1.354 . . . . 0.0 109.035 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.45 -31.26 69.14 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -87.89 -5.25 58.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.412 -0.805 . . . . 0.0 109.809 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.21 5.54 58.11 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.03 161.23 48.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.99 -3.2 5.15 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.086 -1.243 . . . . 0.0 109.893 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.82 149.45 12.54 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 4.6 tp -108.64 139.96 42.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.675 -0.897 . . . . 0.0 109.595 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.67 142.85 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.567 -0.708 . . . . 0.0 110.255 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . 62.24 75.87 0.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 110.131 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 55' ' ' PHE . . . . . 0.482 ' O ' ' CG ' ' E' ' 55' ' ' PHE . 58.7 t80 -104.65 23.95 12.54 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 56' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -54.82 149.16 11.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.84 . . . . 0.0 109.242 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 65.0 mt . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.932 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 37.2 p90 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.394 0.616 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.46 165.12 35.4 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 69' ' ' THR . . . . . 0.729 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 30.5 m -113.7 139.67 48.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.639 -0.918 . . . . 0.0 108.757 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 43.3 mt -84.93 146.44 6.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 m -139.42 154.4 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.206 -0.934 . . . . 0.0 109.942 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -143.47 151.81 40.76 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.13 150.53 35.86 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.419 -0.801 . . . . 0.0 108.957 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.102 -0.999 . . . . 0.0 109.132 179.254 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.9 t80 . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 57.0 mt -136.82 139.18 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.383 -0.823 . . . . 0.0 109.461 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.476 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 13.9 tt -121.38 115.6 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.2 t -127.01 147.02 50.15 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.109 -0.994 . . . . 0.0 108.509 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.574 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -66.84 -110.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 177.111 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.519 ' N ' ' OG1' ' A' ' 11' ' ' THR . . . -33.0 -88.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.724 -0.61 . . . . 0.0 110.186 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.504 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 1.3 p-10 -170.33 -92.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.951 -1.093 . . . . 0.0 109.086 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.504 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 30.0 mt-10 74.71 -135.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.661 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 2.6 mt 65.01 46.41 0.54 Allowed Pre-proline 0 N--CA 1.486 1.351 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -176.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.661 ' HD3' ' N ' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -66.08 151.77 82.96 Favored 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 121.431 1.421 . . . . 0.0 110.003 179.184 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.16 -5.38 78.34 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.118 -1.515 . . . . 0.0 111.122 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.7 mt -124.77 137.07 54.34 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.792 -1.416 . . . . 0.0 108.503 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.624 ' NE2' ' H ' ' A' ' 19' ' ' GLN . 0.7 OUTLIER -90.14 113.41 25.16 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mt -107.22 128.18 54.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.701 -0.624 . . . . 0.0 110.106 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.581 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -109.86 157.88 18.75 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.3 t -81.56 126.45 31.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.478 -0.764 . . . . 0.0 109.618 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.4 mt -108.95 2.5 21.41 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.94 177.65 14.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.46 141.5 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.82 144.77 42.99 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.1 t -152.57 138.07 17.69 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.9 t -149.8 150.4 31.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.028 -1.045 . . . . 0.0 108.997 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.93 131.88 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 31' ' ' ASP . 14.3 p -172.5 13.47 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.324 -0.86 . . . . 0.0 109.576 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 30' ' ' SER . 37.1 t70 57.35 154.44 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.63 -0.669 . . . . 0.0 110.196 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER 73.84 111.2 0.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.082 -1.011 . . . . 0.0 108.567 -178.298 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.88 -33.54 62.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.358 -0.839 . . . . 0.0 109.354 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -52.52 -35.98 54.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 85.4 mt-10 -78.44 -33.88 48.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 108.809 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.0 mt -65.07 -53.82 36.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 120.961 -1.087 . . . . 0.0 108.937 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 t -58.06 -50.32 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.085 -1.009 . . . . 0.0 108.348 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -61.26 -41.27 96.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.565 -0.709 . . . . 0.0 109.761 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 35' ' ' GLU . 17.9 m120 -66.64 -42.52 86.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 0.0 109.329 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.49 -42.67 99.65 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.107 -0.995 . . . . 0.0 108.448 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -48.06 -56.4 7.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.625 -1.297 . . . . 0.0 109.389 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -57.34 -35.41 69.87 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.288 -0.882 . . . . 0.0 110.249 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.27 -35.53 58.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.791 . . . . 0.0 109.903 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.5 t -72.19 -51.29 30.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.187 -0.946 . . . . 0.0 108.834 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -69.6 -31.47 69.62 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 117.942 -1.503 . . . . 0.0 108.962 -175.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.12 71.62 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.7 mtpt -95.64 -3.83 45.51 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.36 27.6 47.61 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 118.864 -1.636 . . . . 0.0 109.751 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.18 -166.67 34.41 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -109.78 -46.65 3.46 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.53 -0.982 . . . . 0.0 109.851 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 174.98 -152.08 13.2 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -129.07 140.27 51.66 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.677 -0.896 . . . . 0.0 109.886 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.81 150.15 25.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.941 -0.474 . . . . 0.0 109.854 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 11' ' ' THR . . . 73.5 108.5 0.07 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.996 -1.065 . . . . 0.0 111.301 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -127.07 148.38 50.14 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.504 0.669 . . . . 0.0 109.86 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.679 ' HE ' ' NH1' ' B' ' 56' ' ' ARG . 19.3 ttt180 -131.72 -31.57 1.54 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.457 0.646 . . . . 0.0 109.446 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.297 -1.689 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 33.7 p90 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.559 0.695 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.58 161.23 32.07 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 80.8 m -107.8 140.0 41.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.265 -1.138 . . . . 0.0 108.862 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 54.8 mt -88.55 129.77 39.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.75 155.04 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.498 -0.751 . . . . 0.0 109.602 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -142.61 147.91 36.6 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.176 -0.953 . . . . 0.0 109.245 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.87 151.04 39.49 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.339 -0.851 . . . . 0.0 108.807 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.102 -0.999 . . . . 0.0 108.702 179.269 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 66.7 t80 . . . . . 0 N--CA 1.505 2.323 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 68.0 mt -112.89 128.37 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.507 -0.746 . . . . 0.0 109.985 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' B' ' 52' ' ' LEU . 2.9 tt -131.67 114.67 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.408 ' HG1' ' N ' ' B' ' 11' ' ' THR . 4.5 t -122.46 158.59 29.42 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.308 1.051 . . . . 0.0 109.272 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' THR . . . . . 0.408 ' N ' ' HG1' ' B' ' 10' ' ' THR . 9.3 p -90.64 -105.84 0.1 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 42.72 -112.72 0.21 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.121 -0.987 . . . . 0.0 110.901 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -165.82 -20.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.271 -0.893 . . . . 0.0 109.909 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . 0.465 ' CG ' ' N ' ' B' ' 15' ' ' ILE . 67.3 tt0 -167.33 166.63 14.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.117 -0.99 . . . . 0.0 109.25 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.465 ' N ' ' CG ' ' B' ' 14' ' ' GLU . 61.5 mt -114.58 93.0 30.96 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -61.61 155.01 55.92 Favored 'Trans proline' 0 C--N 1.323 -0.803 0 C-N-CA 121.787 1.658 . . . . 0.0 110.485 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.88 -6.38 79.38 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 43.1 mt -132.17 141.43 49.1 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.474 -1.015 . . . . 0.0 109.699 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . 0.448 ' CG ' ' O ' ' B' ' 19' ' ' GLN . 2.5 pt20 -84.91 109.62 18.27 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 mt -102.57 136.71 41.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.953 -1.092 . . . . 0.0 109.437 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' B' ' 22' ' ' SER . 0.8 OUTLIER -121.39 130.46 53.61 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.559 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.56 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 40.2 t -60.2 129.3 41.01 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.035 0.921 . . . . 0.0 111.691 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 11.2 mt -114.08 12.09 17.82 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.33 -166.2 13.22 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 mm -120.13 134.74 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.06 149.41 38.95 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.487 -0.758 . . . . 0.0 109.917 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 7.7 t -152.6 140.85 20.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.2 -0.937 . . . . 0.0 109.384 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 4.3 t -149.62 146.46 27.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.296 -0.877 . . . . 0.0 109.167 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 31.3 mt -127.7 131.75 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 53.8 m -155.91 14.77 0.34 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.993 -1.067 . . . . 0.0 110.306 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 72.36 -70.03 0.17 Allowed 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -76.81 140.42 40.68 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.993 -1.067 . . . . 0.0 108.153 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 96.7 t -69.05 -37.46 77.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.523 -0.736 . . . . 0.0 109.806 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.22 -36.27 51.7 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.356 -0.84 . . . . 0.0 110.516 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.08 -32.85 39.21 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.278 -0.889 . . . . 0.0 109.618 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 35.0 mt -62.27 -53.58 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.275 -0.89 . . . . 0.0 109.045 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 23.4 t -56.99 -49.8 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.229 -0.919 . . . . 0.0 108.59 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -60.95 -39.71 90.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.407 -0.808 . . . . 0.0 110.108 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -64.05 -43.43 95.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.164 -0.96 . . . . 0.0 109.594 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 18.8 mt -64.81 -43.05 94.42 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.115 -0.99 . . . . 0.0 109.185 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -49.94 -40.99 45.37 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.584 -1.323 . . . . 0.0 109.923 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -70.31 -37.11 74.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.605 -0.685 . . . . 0.0 110.051 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -76.5 -35.35 58.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.46 -0.775 . . . . 0.0 109.677 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 3.0 t -66.5 -50.3 68.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.134 -0.979 . . . . 0.0 108.913 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -65.45 -30.1 70.85 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.044 -1.462 . . . . 0.0 109.142 -175.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.93 -29.83 68.17 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.488 0.661 . . . . 0.0 109.312 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 mmmt -86.56 -5.47 59.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.627 -0.67 . . . . 0.0 109.517 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.01 5.38 62.54 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.66 164.32 50.5 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -128.65 -3.62 5.33 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.093 -1.24 . . . . 0.0 110.075 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.31 143.57 8.67 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' B' ' 9' ' ' ILE . 8.8 tp -108.23 141.87 39.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.582 -0.952 . . . . 0.0 109.659 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 11.6 pt -142.66 172.07 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.789 -1.194 . . . . 0.0 108.876 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.35 33.01 22.75 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.518 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.6 120.41 30.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.788 -1.195 . . . . 0.0 108.612 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' ARG . . . . . 0.679 ' NH1' ' HE ' ' A' ' 56' ' ' ARG . 39.4 ttp180 -105.13 166.8 10.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.419 -0.801 . . . . 0.0 109.626 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.43 ' CD1' ' CE1' ' C' ' 67' ' ' TYR . 16.5 mm . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.396 -0.815 . . . . 0.0 109.407 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.49 ' N ' ' CD2' ' B' ' 65' ' ' LEU . 1.5 pt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.62 126.18 8.15 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' TYR . . . . . 0.482 ' CG ' ' O ' ' B' ' 67' ' ' TYR . 7.7 p90 -122.75 129.03 51.28 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.579 -0.954 . . . . 0.0 109.053 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.87 151.55 23.26 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m -104.48 143.76 32.59 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.303 -1.116 . . . . 0.0 108.79 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 49.2 mt -90.01 143.26 11.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.61 164.91 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.931 . . . . 0.0 110.02 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -154.08 157.31 38.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.538 -0.726 . . . . 0.0 109.236 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.33 150.7 38.38 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.165 -0.96 . . . . 0.0 108.605 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 8.5 t70 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.95 -1.094 . . . . 0.0 109.453 179.658 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . 0.523 ' CG ' ' H ' ' C' ' 7' ' ' PHE . 42.1 tttm . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.475 0.655 . . . . 0.0 109.658 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' PHE . . . . . 0.523 ' H ' ' CG ' ' C' ' 6' ' ' LYS . 67.6 t80 -92.75 124.33 36.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.423 -0.798 . . . . 0.0 109.778 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 64.3 mt -115.24 143.26 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.481 -0.762 . . . . 0.0 110.045 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' ILE . . . . . 0.467 ' O ' ' CG2' ' C' ' 9' ' ' ILE . 11.2 tt -137.49 117.62 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.511 -0.743 . . . . 0.0 109.483 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.91 147.04 45.97 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.643 1.211 . . . . 0.0 107.938 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' THR . . . . . 0.417 ' H ' HG23 ' C' ' 11' ' ' THR . 4.4 t -86.87 55.58 3.63 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.169 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -177.83 -124.77 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 119.955 -1.716 . . . . 0.0 108.321 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.82 108.4 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.229 -0.92 . . . . 0.0 109.002 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . 0.403 ' CG ' ' H ' ' C' ' 15' ' ' ILE . 3.2 pt-20 -163.49 -100.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.155 -0.965 . . . . 0.0 109.751 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' ILE . . . . . 0.488 ' N ' ' HD3' ' C' ' 16' ' ' PRO . 5.3 mt 57.23 61.23 6.53 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.825 . . . . 0.0 109.285 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' C' ' 15' ' ' ILE . 2.2 Cg_endo -63.67 155.37 63.64 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 122.195 1.93 . . . . 0.0 109.618 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.29 -17.11 57.11 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 51.5 mt -117.04 135.74 53.49 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.098 -1.236 . . . . 0.0 108.807 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -86.41 108.6 18.56 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 11.3 mt -93.2 136.66 33.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.305 -0.872 . . . . 0.0 109.724 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -118.52 130.27 55.83 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 9.3 t -58.06 131.41 50.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.779 -1.2 . . . . 0.0 111.102 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 mt -120.36 11.59 11.5 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.74 -179.95 19.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.43 141.06 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 122.007 -0.701 . . . . 0.0 109.465 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.48 146.46 38.4 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 6.5 p -151.9 139.77 19.97 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.991 -1.068 . . . . 0.0 108.53 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 15.0 t -149.92 138.63 20.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.012 -1.055 . . . . 0.0 108.813 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 11.6 tt -105.18 130.44 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.925 . . . . 0.0 109.068 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 91.8 p -168.97 -145.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.039 -1.038 . . . . 0.0 109.668 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' ASP . . . . . 0.465 ' O ' ' CB ' ' C' ' 32' ' ' ASN . 21.3 t0 -150.73 153.96 36.5 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.204 -0.935 . . . . 0.0 109.523 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' C' ' 31' ' ' ASP . 3.7 t-20 77.15 129.26 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 108.748 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 45.2 t -66.58 -31.94 55.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.56 -0.712 . . . . 0.0 109.466 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -56.75 -42.6 79.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.821 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -75.97 -38.37 57.57 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.206 -0.933 . . . . 0.0 109.301 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 79.2 mt -59.81 -42.1 87.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 120.819 -1.175 . . . . 0.0 109.336 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.1 -43.91 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.718 -1.238 . . . . 0.0 109.092 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -66.33 -46.88 75.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.381 -0.824 . . . . 0.0 110.189 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -56.08 -49.67 73.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.071 -1.018 . . . . 0.0 109.682 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 84.2 mt -67.85 -44.71 76.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.128 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -50.73 -43.09 57.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.714 -1.241 . . . . 0.0 109.797 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -65.97 -36.26 82.83 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.797 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -76.39 -35.36 58.67 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.798 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 t -68.52 -50.85 52.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.952 -1.093 . . . . 0.0 109.079 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -59.55 -29.73 68.12 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.567 -1.253 . . . . 0.0 109.882 -175.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.3 -29.24 61.54 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.791 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -85.5 8.53 18.84 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.37 3.04 81.66 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.33 162.32 54.53 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' MET . . . . . 0.419 ' C ' ' SD ' ' C' ' 50' ' ' MET . 0.0 OUTLIER -131.17 -3.09 3.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.128 -1.219 . . . . 0.0 110.222 -177.189 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.5 127.85 1.81 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.245 -1.455 . . . . 0.0 110.01 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 53.5 tp -96.45 139.19 32.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.553 -0.969 . . . . 0.0 108.844 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 26.7 pt -144.01 173.26 5.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.788 -1.195 . . . . 0.0 108.313 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 70.99 77.22 0.18 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.936 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . 0.463 ' CD2' ' OH ' ' D' ' 67' ' ' TYR . 0.2 OUTLIER -80.08 154.4 28.13 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.122 -0.986 . . . . 0.0 109.333 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -136.78 46.36 2.22 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.56 -0.712 . . . . 0.0 109.957 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.299 -1.619 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' TYR . . . . . 0.43 ' CE1' ' CD1' ' B' ' 57' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 122.082 0.944 . . . . 0.0 109.866 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.02 140.99 6.61 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 3.4 m -90.12 135.53 33.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.868 -1.372 . . . . 0.0 107.775 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 47.3 mt -86.1 145.15 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 m -144.73 162.9 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.966 . . . . 0.0 110.229 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -152.37 147.03 25.82 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.96 140.58 39.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.923 -1.111 . . . . 0.0 108.012 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 42.2 t0 . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.245 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.676 0.75 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -108.54 121.93 46.02 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 28.2 mt -133.82 129.73 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.365 -0.834 . . . . 0.0 109.928 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 9' ' ' ILE . . . . . 0.441 ' O ' ' CG2' ' D' ' 9' ' ' ILE . 13.4 tt -137.15 114.19 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.56 160.75 27.67 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 11' ' ' THR . . . . . 0.549 ' OG1' ' OG1' ' E' ' 69' ' ' THR . 1.2 p -121.43 83.53 2.1 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.34 -134.26 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.331 -0.855 . . . . 0.0 109.099 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -99.79 -56.27 2.43 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.374 -0.829 . . . . 0.0 109.774 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -161.85 -171.05 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.124 -0.985 . . . . 0.0 109.444 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 68.4 mt -123.53 87.81 51.97 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.542 -0.724 . . . . 0.0 109.113 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.67 155.19 55.2 Favored 'Trans proline' 0 C--N 1.323 -0.781 0 C-N-CA 121.927 1.751 . . . . 0.0 110.305 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.14 -9.76 75.74 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 43.9 mt -128.0 139.01 52.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.118 -1.225 . . . . 0.0 109.27 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -85.2 108.05 17.54 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 12.2 mt -99.45 134.92 41.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.448 -0.783 . . . . 0.0 109.502 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' TYR . . . . . 0.497 ' CE1' ' O ' ' D' ' 22' ' ' SER . 0.8 OUTLIER -116.68 129.99 56.46 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' SER . . . . . 0.497 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 0.0 OUTLIER -61.87 128.34 35.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.771 -1.206 . . . . 0.0 110.517 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 8.3 mt -114.6 7.6 16.1 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.2 -179.54 17.06 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 49.6 mm -111.95 142.33 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.733 -0.863 . . . . 0.0 108.927 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.12 143.99 44.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.69 -0.631 . . . . 0.0 109.679 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 98.8 p -152.71 136.04 15.84 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 14.6 t -149.81 150.88 32.65 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.916 -1.115 . . . . 0.0 109.327 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 47.3 mm -113.39 139.86 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.322 -0.861 . . . . 0.0 109.555 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' SER . . . . . 0.557 ' OG ' ' N ' ' D' ' 31' ' ' ASP . 1.4 t -175.72 -171.66 0.48 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.384 -0.822 . . . . 0.0 108.938 -178.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' ASP . . . . . 0.557 ' N ' ' OG ' ' D' ' 30' ' ' SER . 1.3 p30 -124.86 145.08 49.97 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.495 -0.753 . . . . 0.0 109.415 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' D' ' 31' ' ' ASP . 1.5 m-20 78.21 133.18 0.06 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.604 0.716 . . . . 0.0 109.333 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.29 -31.27 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.547 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -56.95 -42.5 80.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 110.112 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -76.2 -38.89 55.91 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.338 -0.851 . . . . 0.0 109.486 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.04 -46.88 92.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.847 -1.158 . . . . 0.0 109.416 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.37 -51.53 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.97 -1.081 . . . . 0.0 110.01 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -55.99 -36.18 67.59 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 109.643 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -67.25 -42.4 84.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.105 -0.997 . . . . 0.0 110.091 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 44.8 mt -69.05 -46.51 67.69 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.981 -1.074 . . . . 0.0 108.724 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -47.16 -55.91 7.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.72 -1.237 . . . . 0.0 109.456 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -54.98 -33.44 62.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.215 -0.928 . . . . 0.0 110.408 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -77.35 -35.02 54.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.365 -0.834 . . . . 0.0 109.975 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 t -68.6 -51.4 46.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.038 -1.038 . . . . 0.0 108.904 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -67.78 -33.85 75.63 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 117.988 -1.485 . . . . 0.0 109.415 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.38 -32.83 72.76 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 mmtm -87.76 -4.94 58.86 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.41 -0.806 . . . . 0.0 109.125 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.56 9.39 64.72 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.16 175.92 54.35 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.14 2.45 0.77 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.897 -1.355 . . . . 0.0 110.143 -175.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.18 160.12 33.05 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.575 -1.297 . . . . 0.0 109.958 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 7.0 tp -130.06 139.12 51.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.724 -0.868 . . . . 0.0 109.339 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 53' ' ' ILE . . . . . . . . . . . . . 23.9 mt -114.04 141.15 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.644 -0.66 . . . . 0.0 110.242 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 63.1 79.55 0.26 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.341 -0.85 . . . . 0.0 111.904 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . 0.536 ' CG ' ' O ' ' D' ' 55' ' ' PHE . 56.0 t80 -107.22 35.91 2.88 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.51 0.671 . . . . 0.0 110.279 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' ARG . . . . . 0.829 ' HG3' HH11 ' D' ' 56' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.301 -1.54 0 O-C-N 120.961 -1.087 . . . . 0.0 109.911 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 67' ' ' TYR . . . . . 0.463 ' OH ' ' CD2' ' C' ' 55' ' ' PHE . 62.8 t80 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.827 0.823 . . . . 0.0 110.008 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.58 155.67 21.54 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 54.3 m -106.52 140.12 39.91 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.443 -1.034 . . . . 0.0 108.806 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 33.3 mt -90.25 137.68 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 m -144.39 166.28 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.82 . . . . 0.0 109.501 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.78 150.36 27.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.95 151.65 37.02 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.174 -0.954 . . . . 0.0 108.6 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 120.907 -1.121 . . . . 0.0 109.59 179.654 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 121.421 0.629 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -115.17 150.55 35.88 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 42.5 mt -129.25 137.61 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.506 -0.746 . . . . 0.0 109.147 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 9' ' ' ILE . . . . . 0.46 ' CG2' ' O ' ' E' ' 9' ' ' ILE . 17.5 tt -123.91 117.12 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 13.2 t -126.05 148.94 49.2 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 11' ' ' THR . . . . . 0.423 ' H ' ' HG1' ' E' ' 11' ' ' THR . 0.6 OUTLIER -76.19 -119.21 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 12' ' ' ALA . . . . . 0.417 ' H ' ' HB ' ' E' ' 11' ' ' THR . . . -111.35 98.5 7.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.312 -0.868 . . . . 0.0 109.68 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 13' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' E' ' 13' ' ' ASP . 20.3 p-10 -163.22 -7.09 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.694 -0.629 . . . . 0.0 109.475 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 59.8 163.59 0.05 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.599 -0.688 . . . . 0.0 109.468 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 18.4 mt -124.98 84.01 59.47 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.85 156.25 44.63 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 122.002 1.801 . . . . 0.0 110.095 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.63 -9.92 74.94 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 18' ' ' LEU . . . . . . . . . . . . . 65.7 mt -126.96 137.86 53.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.075 -1.25 . . . . 0.0 108.821 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -86.86 110.61 20.09 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 11.7 mt -92.1 135.2 34.16 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.969 -1.082 . . . . 0.0 109.592 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 21' ' ' TYR . . . . . 0.467 ' CE1' ' O ' ' E' ' 22' ' ' SER . 1.0 OUTLIER -117.83 129.82 55.89 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 22' ' ' SER . . . . . 0.467 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 0.0 OUTLIER -63.97 129.95 42.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.779 -1.201 . . . . 0.0 111.259 -179.252 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 13.1 mt -120.09 12.52 11.92 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.68 -155.41 16.22 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -135.34 144.12 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.979 -0.718 . . . . 0.0 109.596 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.03 144.11 44.13 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 38.5 t -152.14 138.95 18.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.053 -1.029 . . . . 0.0 108.455 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.54 153.43 37.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.082 -1.011 . . . . 0.0 109.033 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 71.0 mt -124.9 130.98 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.193 -0.942 . . . . 0.0 109.276 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 31.2 t -163.09 167.85 21.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.393 -0.817 . . . . 0.0 109.664 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 31' ' ' ASP . . . . . 0.553 ' N ' ' OD1' ' E' ' 31' ' ' ASP . 16.4 p-10 -81.38 -65.55 1.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.404 -0.81 . . . . 0.0 112.628 -177.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 32' ' ' ASN . . . . . 0.426 ' H ' ' CG ' ' E' ' 31' ' ' ASP . 6.3 t-20 -78.28 147.62 34.24 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.711 -1.243 . . . . 0.0 109.05 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 73.3 t -68.88 -31.18 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.564 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -54.09 -34.09 59.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 109.734 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 35' ' ' GLU . . . . . 0.419 ' O ' ' ND2' ' E' ' 39' ' ' ASN . 41.5 mm-40 -77.23 -35.02 55.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.312 -0.867 . . . . 0.0 108.803 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 66.3 mt -64.74 -53.6 40.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.042 -1.036 . . . . 0.0 109.154 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 60.9 t -55.79 -52.87 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.105 -0.997 . . . . 0.0 109.564 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.01 -36.49 70.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.419 -0.8 . . . . 0.0 109.633 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 39' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' E' ' 35' ' ' GLU . 74.1 m-20 -66.74 -41.11 88.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.043 -1.036 . . . . 0.0 109.831 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 40.2 mt -72.4 -50.34 27.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.99 -1.068 . . . . 0.0 109.041 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -49.04 -52.16 26.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.697 -1.252 . . . . 0.0 109.371 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -59.36 -37.3 77.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.261 -0.9 . . . . 0.0 110.824 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -77.91 -34.84 51.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 110.032 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 12.8 t -74.05 -52.8 19.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.148 -0.97 . . . . 0.0 108.864 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 9.9 mtpp -59.26 -27.88 66.21 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.704 -1.248 . . . . 0.0 110.058 -176.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.03 -28.19 62.2 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.819 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -87.84 0.1 56.25 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.82 6.89 84.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.19 -174.88 5.88 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 3.3 ptm -155.71 -1.21 0.14 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.211 -1.17 . . . . 0.0 110.83 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.82 150.55 18.72 Favored Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.296 -1.43 . . . . 0.0 109.738 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 15.2 tp -122.37 134.22 54.63 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 53' ' ' ILE . . . . . 0.461 ' CD1' ' O ' ' E' ' 53' ' ' ILE . 0.0 OUTLIER -106.93 147.4 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.521 -0.737 . . . . 0.0 109.659 -178.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 54' ' ' ALA . . . . . 0.523 ' O ' ' C ' ' E' ' 55' ' ' PHE . . . 78.56 -63.43 0.3 Allowed 'General case' 0 N--CA 1.508 2.443 0 O-C-N 121.156 -0.965 . . . . 0.0 112.794 177.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 55' ' ' PHE . . . . . 0.552 ' O ' ' CG ' ' E' ' 55' ' ' PHE . 52.5 t80 31.64 39.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.595 0.712 . . . . 0.0 109.866 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 56' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' E' ' 54' ' ' ALA . 97.5 mtt180 -62.65 127.53 31.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.879 -1.138 . . . . 0.0 109.612 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 78.3 mt . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.255 -0.903 . . . . 0.0 109.161 179.912 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 121.465 0.65 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.11 156.73 28.4 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 69' ' ' THR . . . . . 0.549 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 98.1 m -104.39 137.1 42.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.415 -1.05 . . . . 0.0 108.194 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 28.3 mt -85.41 135.88 23.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 m -142.98 162.96 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.733 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -151.68 147.81 27.17 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.03 151.48 35.43 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.2 -0.937 . . . . 0.0 108.675 178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 6.1 t70 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 120.878 -1.139 . . . . 0.0 109.226 179.411 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.528 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.9 mm 53.02 92.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.253 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.464 ' O ' ' CG ' ' A' ' 3' ' ' PHE . 24.3 p90 -151.25 115.94 5.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.204 -0.935 . . . . 0.0 109.455 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -118.44 -48.67 2.5 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.548 -0.72 . . . . 0.0 109.221 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 7' ' ' PHE . 1.3 p-10 -106.11 -88.9 0.44 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.427 -0.796 . . . . 0.0 109.536 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.474 ' H ' ' CG ' ' A' ' 5' ' ' ASP . 29.7 mtpt 59.52 -67.93 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.225 0.535 . . . . 0.0 110.271 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.585 ' N ' ' O ' ' A' ' 5' ' ' ASP . 73.2 t80 -90.19 120.73 31.6 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.512 -0.743 . . . . 0.0 109.162 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.8 mt -134.1 131.69 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.341 -0.849 . . . . 0.0 110.205 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.5 tt -129.37 125.22 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.08 -1.012 . . . . 0.0 108.762 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.8 t -122.88 139.04 54.46 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.332 -0.855 . . . . 0.0 110.302 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.648 ' OG1' ' OG1' ' B' ' 69' ' ' THR . 3.1 m -91.12 98.6 11.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.012 -1.055 . . . . 0.0 108.928 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.56 91.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.23 -0.919 . . . . 0.0 110.319 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -162.93 -128.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -173.68 -17.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.271 -0.893 . . . . 0.0 109.6 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.443 HG22 HD13 ' A' ' 15' ' ' ILE . 24.1 mt 49.69 69.0 2.93 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.581 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.76 156.85 50.93 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.975 1.783 . . . . 0.0 110.035 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.18 -9.42 74.88 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.824 -1.179 . . . . 0.0 110.495 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.5 mt -122.54 139.31 54.04 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.137 -1.214 . . . . 0.0 110.071 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -87.56 116.46 25.69 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.7 mt -107.12 134.62 49.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.348 -0.845 . . . . 0.0 109.339 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.532 ' CE1' ' O ' ' A' ' 22' ' ' SER . 2.1 t80 -121.11 129.71 53.42 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.532 ' O ' ' CE1' ' A' ' 21' ' ' TYR . 20.8 t -84.24 129.07 34.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.407 -0.808 . . . . 0.0 110.522 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.644 ' CD2' ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -119.29 15.44 13.07 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.03 170.8 11.94 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.352 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -109.13 144.5 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.78 144.75 42.99 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.552 -0.718 . . . . 0.0 109.4 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -152.39 139.92 19.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.91 -1.119 . . . . 0.0 108.258 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 t -150.26 136.55 18.78 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.902 -1.124 . . . . 0.0 109.548 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.0 mt -101.38 126.91 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.144 -0.973 . . . . 0.0 109.171 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.7 p -175.36 175.98 2.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.338 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 16.0 p-10 -115.75 161.16 19.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.542 -0.723 . . . . 0.0 109.117 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 11.2 m-20 77.14 120.26 0.05 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.6 t -66.26 -33.13 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.444 -0.785 . . . . 0.0 109.697 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -56.97 -39.65 75.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.911 . . . . 0.0 110.145 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -76.57 -36.51 57.54 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.179 -0.95 . . . . 0.0 109.372 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.7 mt -64.36 -51.9 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.932 -1.105 . . . . 0.0 109.399 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.74 -50.18 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.048 -1.033 . . . . 0.0 109.257 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -60.16 -41.38 92.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.295 -0.878 . . . . 0.0 109.758 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -62.93 -46.16 89.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.136 -0.977 . . . . 0.0 110.009 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.5 mt -69.38 -46.47 66.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.001 -1.062 . . . . 0.0 108.767 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -48.03 -55.05 11.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.789 -1.194 . . . . 0.0 108.87 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.45 -35.23 67.65 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.939 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -75.13 -35.88 61.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.37 -0.831 . . . . 0.0 109.81 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.8 t -73.82 -50.91 26.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.146 -0.971 . . . . 0.0 109.439 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -68.71 -31.7 70.97 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.566 -1.334 . . . . 0.0 109.174 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.84 -31.63 72.68 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -90.38 5.63 46.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -0.877 . . . . 0.0 109.023 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.72 27.04 73.03 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.664 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.92 -167.58 23.8 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.457 ' O ' ' O ' ' A' ' 6' ' ' LYS . 34.7 ttp -110.73 -41.3 4.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.616 -0.932 . . . . 0.0 109.478 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.91 -153.01 11.35 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 tp -133.2 135.46 45.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.357 -1.084 . . . . 0.0 109.788 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.418 ' O ' ' CB ' ' A' ' 54' ' ' ALA . 1.1 pt -111.0 146.38 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.497 -0.752 . . . . 0.0 110.276 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 53' ' ' ILE . . . 75.01 87.79 0.09 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.357 -0.839 . . . . 0.0 109.14 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -115.05 50.51 0.97 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.591 ' O ' ' O ' ' A' ' 57' ' ' ILE . 30.4 ttm180 -65.87 -56.81 9.89 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.536 -0.727 . . . . 0.0 109.602 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.591 ' O ' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER 42.22 108.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-O 122.202 1.001 . . . . 0.0 109.436 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.1 t -72.38 171.79 11.58 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 120.052 -1.655 . . . . 0.0 109.426 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 24.7 p -68.58 168.19 13.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.181 -0.95 . . . . 0.0 109.331 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.14 158.93 24.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.1 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -160.83 -31.5 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.924 . . . . 0.0 109.395 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.99 -29.93 0.12 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -167.25 70.17 0.1 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.151 -1.205 . . . . 0.0 109.569 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -94.55 -167.03 1.58 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.209 -0.932 . . . . 0.0 109.67 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.406 HD11 ' H ' ' A' ' 66' ' ' GLY . 41.2 tp -167.33 139.06 3.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.185 -0.947 . . . . 0.0 109.985 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.406 ' H ' HD11 ' A' ' 65' ' ' LEU . . . -105.08 83.36 0.37 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -77.87 152.01 33.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -1.162 . . . . 0.0 109.904 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.98 159.57 29.72 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.546 ' HG1' ' HG1' ' E' ' 11' ' ' THR . 60.4 m -107.03 140.13 40.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.149 -1.207 . . . . 0.0 109.37 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.4 mt -87.34 135.74 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 m -138.96 162.14 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 109.673 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -154.46 143.11 20.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.887 . . . . 0.0 109.042 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.84 150.37 35.62 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.915 -1.116 . . . . 0.0 108.015 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -165.2 163.07 20.31 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.919 -1.113 . . . . 0.0 109.097 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.62 137.34 55.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.397 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.78 174.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.335 -0.853 . . . . 0.0 109.769 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -91.2 -153.51 0.32 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.259 -0.901 . . . . 0.0 109.455 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.44 ' O ' ' CD2' ' A' ' 78' ' ' PHE . 18.2 p90 -79.91 117.08 20.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.892 . . . . 0.0 109.61 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 80' ' ' MET . 0.1 OUTLIER -85.6 -81.62 0.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.242 -0.911 . . . . 0.0 109.319 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.417 ' H ' HG23 ' A' ' 79' ' ' THR . 55.8 mtt 51.96 21.51 1.52 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 109.602 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.495 179.91 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.7 mmt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.5 4.05 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.407 -0.808 . . . . 0.0 109.097 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.585 ' O ' ' N ' ' B' ' 5' ' ' ASP . 63.5 m-85 -61.14 -37.35 82.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.459 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 53.6 -80.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.681 -0.637 . . . . 0.0 109.607 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' B' ' 3' ' ' PHE . 1.6 m-20 -54.64 136.45 45.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 109.813 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' B' ' 50' ' ' MET . 46.1 mtmt -134.95 -63.91 0.68 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.42 -0.8 . . . . 0.0 109.333 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -89.91 120.91 31.54 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.266 -0.897 . . . . 0.0 109.172 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 11.9 mt -136.09 138.27 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.284 -0.885 . . . . 0.0 109.962 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.443 ' O ' ' CG2' ' B' ' 9' ' ' ILE . 3.8 tt -118.99 121.84 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.267 -0.895 . . . . 0.0 108.588 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 7.3 t -123.76 135.56 53.89 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.395 -0.815 . . . . 0.0 110.296 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 21.6 m -113.68 112.42 23.45 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 52.52 55.55 8.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.394 -0.816 . . . . 0.0 110.205 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -160.4 111.73 1.91 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.538 -0.727 . . . . 0.0 109.082 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -64.38 169.91 4.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 109.62 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.405 HG21 HD13 ' B' ' 15' ' ' ILE . 22.5 mt -135.48 71.69 65.61 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.519 -0.738 . . . . 0.0 109.064 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.8 157.6 37.18 Favored 'Trans proline' 0 C--N 1.319 -0.979 0 C-N-CA 121.873 1.715 . . . . 0.0 110.054 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.73 -8.4 73.99 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.367 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 20.4 mt -123.38 139.55 53.92 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.221 -1.164 . . . . 0.0 110.097 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -88.48 109.01 19.69 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt -97.85 141.34 30.95 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.266 -0.896 . . . . 0.0 110.773 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' B' ' 71' ' ' VAL . 4.2 t80 -121.35 129.27 52.97 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 28.9 t -72.94 130.61 40.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.674 -1.266 . . . . 0.0 111.317 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.44 ' O ' ' NZ ' ' B' ' 47' ' ' LYS . 18.5 mt -118.68 9.35 12.13 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.3 -161.81 19.71 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.22 144.99 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 122.234 -0.568 . . . . 0.0 109.484 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.69 158.12 20.44 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 86.0 p -150.25 140.82 22.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 108.917 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 20.6 p -140.24 135.34 32.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.326 -0.859 . . . . 0.0 109.409 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.459 ' O ' ' CB ' ' B' ' 30' ' ' SER . 96.5 mt -126.79 125.48 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' B' ' 29' ' ' ILE . 1.9 p 163.3 -164.11 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 16.0 p-10 -122.19 173.13 7.78 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 18.3 m-80 76.91 112.46 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.3 -35.36 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.435 -0.791 . . . . 0.0 109.642 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -56.99 -37.27 71.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 110.057 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -76.46 -36.61 57.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.219 -0.926 . . . . 0.0 109.324 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 82.0 mt -66.22 -53.62 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.898 -1.126 . . . . 0.0 109.425 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 40.2 t -59.35 -51.87 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.004 -1.06 . . . . 0.0 109.513 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -56.13 -36.22 68.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 109.622 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -66.68 -40.33 88.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.043 -1.036 . . . . 0.0 109.852 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 70.4 mt -74.5 -50.84 16.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.95 -1.094 . . . . 0.0 108.988 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -48.85 -53.01 21.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.808 -1.182 . . . . 0.0 108.861 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -59.0 -36.79 75.49 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.438 -0.788 . . . . 0.0 110.026 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -75.25 -35.85 61.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.232 -0.918 . . . . 0.0 109.945 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 4.9 t -74.2 -51.42 23.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 109.448 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 33.7 tptt -70.75 -29.75 66.07 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.234 -1.386 . . . . 0.0 109.548 -175.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.12 -31.25 71.7 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.44 ' NZ ' ' O ' ' B' ' 23' ' ' LEU . 12.5 mtpt -92.75 2.19 56.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 109.226 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.22 29.3 64.62 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.336 -1.411 . . . . 0.0 110.016 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.77 -170.54 25.73 Favored Glycine 0 N--CA 1.492 2.383 0 O-C-N 121.209 -1.171 . . . . 0.0 110.585 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' MET . . . . . 0.501 ' O ' ' O ' ' B' ' 6' ' ' LYS . 0.3 OUTLIER -107.95 -48.8 3.32 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.725 -0.868 . . . . 0.0 109.291 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -167.7 -160.94 16.14 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.4 tp -136.82 138.51 40.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.299 -1.118 . . . . 0.0 109.99 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.552 ' O ' ' CB ' ' B' ' 54' ' ' ALA . 0.4 OUTLIER -107.0 147.62 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.411 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.64 ' O ' ' CB ' ' B' ' 55' ' ' PHE . . . 90.38 -146.59 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.64 ' CB ' ' O ' ' B' ' 54' ' ' ALA . 67.4 t80 120.71 -101.52 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 120.529 1.513 . . . . 0.0 107.077 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' B' ' 55' ' ' PHE . 25.8 mtm180 55.52 161.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.38 -0.825 . . . . 0.0 109.79 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 79.3 mt -138.93 160.08 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.249 -0.907 . . . . 0.0 108.941 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 2.7 m -167.61 157.64 10.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.256 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 42.8 t 50.5 75.8 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.46 -0.775 . . . . 0.0 109.824 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.51 176.08 9.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 109.354 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t70 53.22 14.58 0.53 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 109.649 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -154.99 -171.89 22.15 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.66 152.82 18.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.238 -1.154 . . . . 0.0 110.368 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.469 ' CD2' ' N ' ' B' ' 65' ' ' LEU . 61.8 t80 -146.01 -111.02 0.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.466 -0.771 . . . . 0.0 108.943 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.469 ' N ' ' CD2' ' B' ' 64' ' ' PHE . 6.4 tp -175.57 108.44 0.09 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.53 115.43 4.72 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' B' ' 67' ' ' TYR . 7.3 p90 -137.24 -175.96 4.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -1.115 . . . . 0.0 110.319 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.48 167.63 29.4 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' THR . . . . . 0.648 ' OG1' ' OG1' ' A' ' 11' ' ' THR . 87.5 m -95.01 138.48 32.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.029 -1.277 . . . . 0.0 109.076 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 70.6 mt -87.5 125.36 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 3.0 m -122.78 162.51 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.306 -0.871 . . . . 0.0 110.558 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . 0.427 ' NZ ' ' CG ' ' B' ' 74' ' ' ASP . 11.6 tttp -154.92 135.15 13.17 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.02 114.82 29.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.556 -1.34 . . . . 0.0 111.598 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . 0.427 ' CG ' ' NZ ' ' B' ' 72' ' ' LYS . 6.8 p-10 -168.95 4.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.241 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' B' ' 75' ' ' GLU . 1.8 pm0 -71.25 -5.69 34.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.93 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.17 -175.57 0.05 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.911 . . . . 0.0 109.506 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' B' ' 77' ' ' GLN . 20.3 mp0 -95.36 -139.12 0.24 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.263 -0.898 . . . . 0.0 109.547 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -155.83 151.55 27.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.255 -0.903 . . . . 0.0 109.395 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 44.8 p -70.22 138.78 51.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 109.574 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -71.85 85.95 0.96 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.923 . . . . 0.0 109.52 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.509 179.949 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 14.4 mmt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 77.1 mt -78.31 119.75 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.0 109.432 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -86.79 -172.3 3.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.3 -0.875 . . . . 0.0 109.406 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.82 153.8 41.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 109.344 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' C' ' 6' ' ' LYS . 2.0 p-10 -102.63 -96.42 0.29 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.385 -0.822 . . . . 0.0 109.287 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . 0.6 ' HZ1' ' NZ ' ' C' ' 45' ' ' LYS . 53.6 tttp -133.35 -95.63 0.31 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' PHE . . . . . 0.481 ' N ' ' HG2' ' C' ' 6' ' ' LYS . 70.1 t80 -101.42 119.88 39.43 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.042 -1.036 . . . . 0.0 109.268 -178.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' ILE . . . . . 0.411 ' O ' ' HA3' ' C' ' 51' ' ' GLY . 60.8 mt -115.46 143.21 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.543 -0.723 . . . . 0.0 110.067 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' ILE . . . . . . . . . . . . . 12.9 tt -138.54 114.56 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.742 -1.224 . . . . 0.0 108.853 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -123.95 161.78 24.73 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.395 -0.816 . . . . 0.0 108.958 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 1.2 p -114.6 79.0 1.21 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . 0.463 ' O ' ' CG ' ' C' ' 13' ' ' ASP . . . -179.04 -10.21 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.486 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . 0.463 ' CG ' ' O ' ' C' ' 12' ' ' ALA . 3.2 p30 43.73 83.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.348 0.594 . . . . 0.0 110.272 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -154.72 -87.86 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.402 -0.811 . . . . 0.0 109.545 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 7.3 mt 48.99 66.23 6.01 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.226 -0.921 . . . . 0.0 109.247 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.53 157.71 49.55 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 C-N-CA 122.085 1.856 . . . . 0.0 109.885 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.99 -7.0 73.22 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.676 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 58.2 mt -124.46 140.55 52.84 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.997 -1.296 . . . . 0.0 110.246 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . 0.419 ' N ' ' CD ' ' C' ' 19' ' ' GLN . 2.9 mp0 -85.64 108.38 17.98 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -92.2 134.25 35.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.077 -1.014 . . . . 0.0 110.092 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -117.35 130.31 56.43 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.82 131.64 43.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.68 -1.262 . . . . 0.0 111.134 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 25.0 mt -114.64 10.54 16.75 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.14 -154.57 16.41 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -134.69 143.56 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.82 -0.812 . . . . 0.0 109.492 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.98 149.24 40.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.832 -0.542 . . . . 0.0 109.714 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 60.7 p -151.56 138.18 18.75 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -149.34 147.77 28.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.98 -1.075 . . . . 0.0 108.973 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 tt -127.59 133.37 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.2 -0.937 . . . . 0.0 109.049 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 5.3 t -169.54 170.56 8.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.291 -0.88 . . . . 0.0 109.474 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -104.31 37.56 2.07 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.835 0.826 . . . . 0.0 110.296 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -152.5 125.08 8.3 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . 0.43 ' CG2' ' N ' ' C' ' 34' ' ' ASP . 0.7 OUTLIER -72.69 -45.51 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.106 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . 0.43 ' N ' ' CG2' ' C' ' 33' ' ' VAL . 5.7 p-10 -62.08 -34.77 76.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.426 -0.796 . . . . 0.0 109.99 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -74.01 -38.51 64.07 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.584 -0.846 . . . . 0.0 108.808 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 68.1 mt -63.02 -51.33 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.96 . . . . 0.0 108.646 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.55 -49.8 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.991 . . . . 0.0 108.691 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -61.68 -45.5 93.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.348 -0.845 . . . . 0.0 109.955 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -59.39 -46.63 88.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.329 -0.857 . . . . 0.0 109.557 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 41.1 mt -66.93 -44.24 81.19 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.123 -0.986 . . . . 0.0 108.384 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' ARG . . . . . 0.407 HH21 ' HZ3' ' C' ' 45' ' ' LYS . 55.5 ttt180 -46.76 -56.21 6.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.818 -1.176 . . . . 0.0 108.636 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -53.46 -32.16 48.78 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.34 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -74.42 -40.77 61.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.444 -0.785 . . . . 0.0 109.259 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 10.1 t -77.85 -53.53 14.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 120.774 -1.204 . . . . 0.0 108.921 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' LYS . . . . . 0.6 ' NZ ' ' HZ1' ' C' ' 6' ' ' LYS . 16.8 tttt -50.58 -31.66 16.46 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.769 1.271 . . . . 0.0 109.795 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.38 -25.81 46.38 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.482 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -98.15 -0.92 43.38 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.9 26.46 73.91 Favored Glycine 0 N--CA 1.487 2.087 0 C-N-CA 118.335 -1.888 . . . . 0.0 109.637 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.79 -167.87 15.55 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 5.0 ttp -110.18 -43.79 3.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.586 -0.949 . . . . 0.0 110.462 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' C' ' 8' ' ' ILE . . . 177.55 -172.22 44.95 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.556 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.52 132.07 53.64 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.374 -1.074 . . . . 0.0 110.62 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 pt -109.61 139.14 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.44 61.96 2.65 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.888 -1.133 . . . . 0.0 108.665 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -96.57 109.32 21.94 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' ARG . . . . . 0.674 ' HG3' HH11 ' C' ' 56' ' ' ARG . 9.7 mmm-85 -125.02 154.62 40.98 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.419 -0.8 . . . . 0.0 109.306 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' ILE . . . . . 0.476 ' CG2' ' HH ' ' D' ' 67' ' ' TYR . 0.3 OUTLIER -141.18 147.45 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.014 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 175.57 90.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.455 -0.778 . . . . 0.0 109.198 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' CYS . . . . . 0.491 ' SG ' ' N ' ' C' ' 63' ' ' LYS . 4.3 t -164.97 149.53 9.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.072 -1.017 . . . . 0.0 109.499 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.4 -73.79 0.65 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.606 -0.684 . . . . 0.0 109.161 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.08 -71.46 0.36 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.92 . . . . 0.0 108.925 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.91 41.43 0.35 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . 0.491 ' N ' ' SG ' ' C' ' 59' ' ' CYS . 7.8 mtmp? -80.46 -115.15 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.109 -1.23 . . . . 0.0 110.031 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' C' ' 64' ' ' PHE . 4.9 m-85 -61.92 -174.82 0.06 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.543 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -163.66 -174.0 3.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.098 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.5 147.84 19.69 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -159.04 161.16 36.52 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.188 -1.183 . . . . 0.0 109.711 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.48 166.42 34.17 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.406 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 34.4 m -101.92 140.21 36.5 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.307 -1.113 . . . . 0.0 108.424 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 56.2 mt -85.53 148.5 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 6.8 m -142.96 156.18 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.158 -0.964 . . . . 0.0 109.765 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -146.04 156.17 43.29 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.216 -0.927 . . . . 0.0 108.731 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' C' ' 74' ' ' ASP . . . -119.88 153.38 35.92 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' C' ' 73' ' ' ALA . 16.2 m-20 92.66 -171.91 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.37 0.605 . . . . 0.0 109.736 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -67.98 150.46 48.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.828 . . . . 0.0 109.553 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.01 14.25 12.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.306 -0.871 . . . . 0.0 109.537 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 53.52 17.8 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.232 -0.918 . . . . 0.0 109.512 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -144.54 119.62 10.07 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.271 -0.893 . . . . 0.0 108.824 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 23.1 m -131.32 -55.45 1.03 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.541 -0.724 . . . . 0.0 109.364 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 9.4 mmt -137.66 -61.07 0.64 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.377 -0.827 . . . . 0.0 109.144 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.541 -179.909 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.525 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.7 mpt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 tp -164.74 -33.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.327 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -87.81 143.29 27.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.283 -0.886 . . . . 0.0 109.642 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 56.46 54.78 7.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 109.61 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -154.69 -0.01 0.18 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.235 -0.916 . . . . 0.0 109.509 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -92.81 96.47 10.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.202 -0.936 . . . . 0.0 109.429 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -101.44 123.8 46.08 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.274 -0.891 . . . . 0.0 109.515 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 87.4 mt -119.12 146.29 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.636 -0.665 . . . . 0.0 109.489 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' ILE . . . . . 0.474 ' O ' ' CG2' ' D' ' 9' ' ' ILE . 13.2 tt -138.35 116.38 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.419 -0.8 . . . . 0.0 109.001 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t -121.95 160.75 24.18 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' THR . . . . . 0.512 ' OG1' ' OG1' ' E' ' 69' ' ' THR . 1.3 m -130.45 123.79 30.57 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . 59.85 49.81 7.56 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 122.117 0.96 . . . . 0.0 109.307 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -138.6 -171.02 2.96 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 55.0 mp0 -147.09 -18.03 0.4 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.035 -1.041 . . . . 0.0 109.622 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 27.8 mt 49.36 66.74 5.26 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.237 -0.914 . . . . 0.0 109.148 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.04 157.59 38.39 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 121.962 1.774 . . . . 0.0 110.076 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.97 -8.09 73.27 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.508 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 25.5 mt -122.52 138.44 54.56 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.147 -1.207 . . . . 0.0 110.187 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -90.31 116.74 28.51 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 11.9 mt -100.61 140.43 34.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.576 -0.702 . . . . 0.0 110.725 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -118.63 129.79 55.5 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 6.2 t -68.46 130.2 42.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.712 -1.243 . . . . 0.0 112.022 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . 0.503 ' O ' ' NZ ' ' D' ' 47' ' ' LYS . 40.4 mt -116.54 13.64 15.37 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.68 -170.13 13.21 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.51 142.3 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.843 -0.798 . . . . 0.0 109.419 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.81 144.17 44.37 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.57 -0.706 . . . . 0.0 109.46 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 51.8 m -152.09 138.19 18.25 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.955 -1.091 . . . . 0.0 108.479 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 11.6 t -150.07 132.16 15.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.914 -1.116 . . . . 0.0 109.327 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 tt -100.01 130.04 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.108 -0.995 . . . . 0.0 109.379 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 6.3 p -178.21 179.47 0.81 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.439 -0.788 . . . . 0.0 109.238 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' D' ' 32' ' ' ASN . 3.3 p30 -112.18 157.17 21.18 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.515 -0.741 . . . . 0.0 109.166 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.599 HD21 ' H ' ' D' ' 34' ' ' ASP . 0.1 OUTLIER 79.23 117.1 0.06 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.556 -0.715 . . . . 0.0 109.129 -178.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 91.6 t -62.75 -31.03 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.542 -0.724 . . . . 0.0 109.534 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' ASP . . . . . 0.599 ' H ' HD21 ' D' ' 32' ' ' ASN . 62.5 m-20 -59.4 -41.01 88.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.933 . . . . 0.0 110.029 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -74.09 -39.65 63.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.261 -0.899 . . . . 0.0 109.087 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 71.4 mt -65.36 -53.97 33.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.953 -1.092 . . . . 0.0 108.908 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 25.3 t -61.43 -50.23 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.124 -0.985 . . . . 0.0 109.224 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -56.42 -36.43 68.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.2 -0.937 . . . . 0.0 109.828 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' ASN . . . . . 0.471 ' N ' HD21 ' D' ' 39' ' ' ASN . 0.9 OUTLIER -71.73 -38.01 70.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.032 -1.042 . . . . 0.0 109.406 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' D' ' 41' ' ' ARG . 26.7 mt -69.56 -48.92 58.7 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.962 -1.086 . . . . 0.0 108.152 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' D' ' 40' ' ' LEU . 99.2 mtt180 -46.24 -57.76 4.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.308 -1.495 . . . . 0.0 108.993 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -50.17 -28.93 8.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.037 -1.039 . . . . 0.0 110.448 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -68.61 -56.66 7.5 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.732 -1.23 . . . . 0.0 110.011 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' D' ' 48' ' ' GLY . 1.8 m -64.91 -48.82 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.672 0 O-C-N 120.275 -1.515 . . . . 0.0 107.825 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -49.94 -46.15 51.92 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.72 1.248 . . . . 0.0 110.809 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.89 -30.15 56.06 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.642 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . 0.503 ' NZ ' ' O ' ' D' ' 23' ' ' LEU . 5.8 ttmt -92.47 -3.87 54.52 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.239 -0.913 . . . . 0.0 108.794 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' D' ' 44' ' ' VAL . . . 81.1 20.24 65.39 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.313 -1.422 . . . . 0.0 109.598 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.8 -166.57 13.27 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.68 -25.49 5.48 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.581 -0.952 . . . . 0.0 111.822 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.34 -163.21 33.31 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 5.6 mp -123.93 139.43 53.96 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.443 -1.033 . . . . 0.0 109.833 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' ILE . . . . . . . . . . . . . 1.3 pt -106.75 143.42 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.593 -0.692 . . . . 0.0 109.412 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 57.03 60.01 3.19 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.824 -1.172 . . . . 0.0 108.554 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . 0.401 ' CE2' ' OH ' ' E' ' 67' ' ' TYR . 46.9 t80 -84.35 71.34 10.68 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -91.8 120.54 32.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.493 -0.754 . . . . 0.0 109.846 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' ILE . . . . . 0.51 ' O ' ' C ' ' D' ' 58' ' ' THR . 39.6 mt -89.8 -51.89 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 108.737 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' THR . . . . . 0.51 ' C ' ' O ' ' D' ' 57' ' ' ILE . 0.0 OUTLIER 28.57 87.77 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.159 0.504 . . . . 0.0 110.728 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' D' ' 60' ' ' ALA . 42.7 t -80.74 167.05 20.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 109.509 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' ALA . . . . . 0.434 ' N ' ' SG ' ' D' ' 59' ' ' CYS . . . -131.45 -48.8 0.98 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.541 -0.725 . . . . 0.0 109.246 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -165.61 78.36 0.28 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.39 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.91 -11.93 51.47 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -85.35 101.87 12.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.206 -1.173 . . . . 0.0 109.256 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -114.61 48.22 1.15 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.588 -0.695 . . . . 0.0 109.221 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' D' ' 67' ' ' TYR . 2.4 mp -84.15 92.47 7.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.175 -0.953 . . . . 0.0 109.753 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.89 76.11 0.02 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' D' ' 65' ' ' LEU . 0.4 OUTLIER -57.73 130.71 47.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.282 -1.128 . . . . 0.0 110.365 -179.106 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.31 152.52 23.68 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 76.7 m -107.3 137.71 44.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.034 -1.274 . . . . 0.0 108.298 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 mt -87.78 137.0 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 108.272 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.1 m -126.65 162.58 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 CA-C-O 121.617 0.722 . . . . 0.0 109.92 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -147.19 145.14 29.4 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.05 151.84 23.48 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.1 -1.0 . . . . 0.0 108.322 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.59 -174.81 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.81 -1.181 . . . . 0.0 109.683 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 54.37 65.89 1.38 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.403 -0.811 . . . . 0.0 108.944 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' D' ' 78' ' ' PHE . . . -81.35 -28.6 34.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.623 -0.673 . . . . 0.0 109.579 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 59.09 3.08 0.31 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.274 -0.891 . . . . 0.0 109.247 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 78' ' ' PHE . . . . . 0.507 ' H ' ' C ' ' D' ' 76' ' ' ALA . 88.3 t80 -95.43 -37.1 11.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.118 -0.989 . . . . 0.0 109.574 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 92.6 m -158.17 119.44 3.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.214 -0.929 . . . . 0.0 109.378 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 19.3 mmt -57.88 -34.11 69.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.549 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.625 179.998 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ptp . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 24.2 mt -80.63 99.45 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 0.0 109.429 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 3' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -68.07 -162.08 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.916 . . . . 0.0 109.412 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -161.75 128.07 3.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.862 . . . . 0.0 108.703 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 5' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' E' ' 7' ' ' PHE . 0.5 OUTLIER 168.12 -55.92 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 6' ' ' LYS . . . . . 0.406 ' N ' ' OD1' ' E' ' 5' ' ' ASP . 25.5 tptp 51.84 -87.77 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.589 -1.319 . . . . 0.0 109.867 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 7' ' ' PHE . . . . . 0.563 ' N ' ' O ' ' E' ' 5' ' ' ASP . 73.2 t80 -107.29 119.74 40.21 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.368 -0.833 . . . . 0.0 109.492 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 54.2 mt -107.59 130.89 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.533 -0.73 . . . . 0.0 109.203 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 9' ' ' ILE . . . . . 0.422 ' O ' HG21 ' E' ' 9' ' ' ILE . 8.3 tt -120.92 115.09 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.13 155.6 39.65 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.833 -1.167 . . . . 0.0 108.659 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 11' ' ' THR . . . . . 0.546 ' HG1' ' HG1' ' A' ' 69' ' ' THR . 2.3 p -118.9 95.96 5.05 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -165.88 -113.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.141 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -135.64 -42.32 0.68 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.833 . . . . 0.0 109.576 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -173.29 174.16 3.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.225 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 72.9 mt -112.57 95.68 33.3 Favored Pre-proline 0 N--CA 1.498 1.953 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.47 155.9 59.7 Favored 'Trans proline' 0 C--N 1.325 -0.671 0 C-N-CA 121.726 1.618 . . . . 0.0 110.83 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.48 -7.86 77.46 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 18' ' ' LEU . . . . . . . . . . . . . 56.3 mt -129.3 141.55 51.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -1.118 . . . . 0.0 109.836 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 19' ' ' GLN . . . . . 0.46 ' N ' ' CD ' ' E' ' 19' ' ' GLN . 3.5 mp0 -85.37 108.59 17.91 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 13.9 mt -96.78 135.0 39.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.247 -0.908 . . . . 0.0 110.036 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 21' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -123.46 129.48 51.3 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -86.53 132.53 33.89 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.205 -0.935 . . . . 0.0 111.292 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . 0.65 ' CD2' ' N ' ' E' ' 23' ' ' LEU . 0.4 OUTLIER -121.7 21.23 10.87 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.42 172.79 13.41 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.406 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 43.8 mm -108.69 143.52 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.39 145.03 41.79 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.315 -0.866 . . . . 0.0 108.886 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 84.8 p -152.08 136.66 16.93 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 13.5 t -150.06 149.65 30.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.936 -1.103 . . . . 0.0 109.192 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 2.2 tp -125.41 132.47 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 1.3 p 175.71 -173.82 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.008 -1.058 . . . . 0.0 109.251 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 31' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' E' ' 32' ' ' ASN . 29.1 m-20 -123.81 168.4 12.79 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.61 -0.681 . . . . 0.0 109.369 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 32' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 9.1 t-20 75.64 123.89 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.02 -34.36 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.341 -0.85 . . . . 0.0 109.467 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -59.16 -46.26 88.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 110.172 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -75.55 -39.4 58.26 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.086 -1.009 . . . . 0.0 109.564 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.62 -48.97 85.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.843 -1.16 . . . . 0.0 109.104 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 48.7 t -63.17 -48.91 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.014 -1.054 . . . . 0.0 109.478 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -59.42 -40.22 86.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.938 . . . . 0.0 109.618 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -58.48 -45.13 89.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.529 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 49.1 mt -72.37 -48.03 44.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.114 -0.992 . . . . 0.0 109.164 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -50.74 -42.96 58.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.716 -1.24 . . . . 0.0 109.354 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -69.25 -38.89 78.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.557 -0.715 . . . . 0.0 109.694 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.08 -34.69 59.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.918 . . . . 0.0 109.742 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 t -69.25 -52.6 31.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.197 -0.94 . . . . 0.0 109.668 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -72.3 -34.4 68.1 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.323 -1.351 . . . . 0.0 109.14 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.96 -32.27 61.36 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.14 -5.27 55.28 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.236 -0.915 . . . . 0.0 110.11 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.95 6.17 37.51 Favored Glycine 0 N--CA 1.504 3.21 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.36 159.58 48.73 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -124.37 -9.48 7.49 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.289 -1.124 . . . . 0.0 110.786 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.3 163.17 35.91 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.05 -1.548 . . . . 0.0 109.898 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 4.9 tp -120.79 143.09 49.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.653 -0.91 . . . . 0.0 110.093 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 53' ' ' ILE . . . . . . . . . . . . . 14.0 mt -113.12 138.87 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.568 -0.708 . . . . 0.0 110.411 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . 64.73 78.69 0.28 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.436 -0.79 . . . . 0.0 110.593 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -90.49 98.94 12.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.514 -0.742 . . . . 0.0 109.931 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 56' ' ' ARG . . . . . 0.494 ' NH1' ' NH1' ' A' ' 56' ' ' ARG . 7.6 tpp180 -97.66 166.77 11.34 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.288 -0.883 . . . . 0.0 109.068 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 47.8 mt -133.88 -64.69 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.361 -0.837 . . . . 0.0 109.172 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 58' ' ' THR . . . . . . . . . . . . . 2.5 p -143.12 145.59 32.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.339 -0.851 . . . . 0.0 109.352 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 59' ' ' CYS . . . . . 0.425 ' C ' ' H ' ' E' ' 61' ' ' ASP . 34.2 m -141.41 -50.1 0.41 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.473 -0.767 . . . . 0.0 109.142 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.98 11.61 1.39 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -0.857 . . . . 0.0 109.427 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 61' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' E' ' 59' ' ' CYS . 2.3 m-20 55.01 46.62 23.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.72 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.77 -123.25 0.87 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -69.32 124.27 23.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -1.162 . . . . 0.0 109.417 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 64' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -167.81 121.54 0.94 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.278 -0.889 . . . . 0.0 109.252 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.496 ' CD1' ' N ' ' E' ' 65' ' ' LEU . 4.3 mp -89.8 143.47 26.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 108.67 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 66' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' E' ' 67' ' ' TYR . . . -55.85 -41.88 84.7 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 67' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' E' ' 66' ' ' GLY . 4.0 t80 59.74 127.81 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.543 -0.974 . . . . 0.0 110.407 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.58 140.18 6.38 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 69' ' ' THR . . . . . 0.512 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 20.4 m -93.11 138.7 31.3 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.93 -1.335 . . . . 0.0 108.623 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 72.4 mt -85.48 139.19 17.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.44 161.46 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.175 -0.953 . . . . 0.0 110.189 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -155.92 147.25 22.59 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -110.95 150.65 28.94 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.123 -0.986 . . . . 0.0 108.595 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -69.65 151.6 45.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.056 -1.027 . . . . 0.0 109.563 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -84.91 -57.75 2.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.424 -0.798 . . . . 0.0 109.645 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.69 -14.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.928 . . . . 0.0 109.501 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 77' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -68.72 129.24 39.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.435 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -76.39 143.75 40.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 109.485 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 26.6 p -75.38 -8.79 57.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.863 . . . . 0.0 109.37 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 20.8 mmt -64.52 -41.75 96.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 109.47 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.397 -179.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 tpt . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.3 mm -70.79 96.36 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 109.463 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.42 ' C ' ' H ' ' A' ' 5' ' ' ASP . 7.7 p90 -96.49 8.32 44.36 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.241 -0.912 . . . . 0.0 109.456 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -79.7 25.2 0.35 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 109.514 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 3' ' ' PHE . 8.6 p30 -172.54 96.9 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.382 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -166.1 70.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 109.322 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -102.62 123.14 45.79 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.422 -0.799 . . . . 0.0 110.141 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.4 mt -112.07 139.11 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.513 -0.742 . . . . 0.0 109.823 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.464 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 6.3 tt -130.56 118.51 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -124.02 148.97 46.6 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.7 m -123.92 73.27 1.2 Allowed 'General case' 0 N--CA 1.511 2.622 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.727 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.2 -86.67 0.03 OUTLIER 'General case' 0 C--O 1.214 -0.791 0 O-C-N 119.585 -1.947 . . . . 0.0 107.576 -176.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.45 -78.56 0.6 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.274 -0.891 . . . . 0.0 109.68 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -162.4 -159.29 0.57 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.134 -0.979 . . . . 0.0 109.317 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.4 mt -120.78 91.76 47.62 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.495 -0.753 . . . . 0.0 109.235 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.51 155.73 51.17 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.784 1.656 . . . . 0.0 110.23 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.63 -14.08 64.97 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.1 mt -121.86 139.48 53.57 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.427 -1.043 . . . . 0.0 109.503 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.27 108.43 15.72 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.1 mt -99.33 133.55 43.47 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.304 -0.873 . . . . 0.0 110.038 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.527 ' CE1' ' O ' ' A' ' 22' ' ' SER . 0.4 OUTLIER -120.86 129.97 53.74 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.527 ' O ' ' CE1' ' A' ' 21' ' ' TYR . 47.0 t -51.85 127.87 22.27 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.127 -0.983 . . . . 0.0 111.067 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.8 mt -114.44 5.9 15.77 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.17 -177.24 16.36 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.88 144.81 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 122.002 -0.705 . . . . 0.0 109.485 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.48 155.93 23.43 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.6 p -151.62 144.5 24.45 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.826 -1.171 . . . . 0.0 108.469 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.2 p -148.47 132.4 17.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.246 -0.909 . . . . 0.0 109.305 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.62 126.99 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.3 p 173.11 -125.87 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.301 0.572 . . . . 0.0 109.609 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -162.59 168.53 21.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.159 -0.963 . . . . 0.0 108.589 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.2 m120 72.06 115.1 0.05 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.443 -0.786 . . . . 0.0 109.279 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.7 -31.99 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.607 -0.683 . . . . 0.0 109.314 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -58.99 -42.26 89.61 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.259 -0.9 . . . . 0.0 109.568 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -75.38 -41.02 57.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.988 -1.07 . . . . 0.0 109.869 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.33 -53.01 51.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 120.896 -1.127 . . . . 0.0 109.535 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.9 t -57.17 -48.81 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.134 -0.978 . . . . 0.0 109.028 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -59.31 -38.94 81.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.958 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -68.13 -39.98 82.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.058 -1.026 . . . . 0.0 109.768 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.93 -44.07 90.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.972 -1.08 . . . . 0.0 109.002 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -48.63 -54.48 14.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.801 -1.187 . . . . 0.0 109.471 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -57.82 -35.86 71.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.378 -0.826 . . . . 0.0 110.105 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -75.06 -36.18 61.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.219 -0.925 . . . . 0.0 109.806 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 t -71.16 -51.15 36.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.247 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -72.65 -33.28 66.49 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 117.81 -1.556 . . . . 0.0 109.598 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.69 76.18 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.869 . . . . 0.0 109.826 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -85.28 -4.11 59.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.539 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.75 0.49 55.26 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.66 155.55 53.4 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.34 -10.54 8.9 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.235 -1.156 . . . . 0.0 110.057 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.84 143.39 8.27 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.17 -1.491 . . . . 0.0 109.51 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.7 tp -101.32 142.64 32.44 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.743 -0.857 . . . . 0.0 110.12 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.461 ' CD1' ' C ' ' A' ' 53' ' ' ILE . 1.3 pp -120.27 150.29 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.476 -0.765 . . . . 0.0 110.559 -176.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.65 61.89 2.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.262 -1.524 . . . . 0.0 109.429 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.418 ' O ' ' CG ' ' A' ' 55' ' ' PHE . 39.8 t80 -100.22 73.96 1.73 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.646 HH11 ' HG2' ' A' ' 56' ' ' ARG . 7.0 mtt-85 -72.37 143.76 48.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.587 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.0 mm -84.9 -81.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 109.213 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.8 p -123.03 85.98 2.51 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.463 -0.773 . . . . 0.0 109.622 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 16.0 p -82.66 -127.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.368 -0.832 . . . . 0.0 109.179 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.67 -83.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.97 . . . . 0.0 109.497 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 3.1 m-20 -74.73 7.31 3.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.386 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.83 48.1 2.61 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 64' ' ' PHE . 0.7 OUTLIER -53.6 -53.59 49.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.916 -1.344 . . . . 0.0 109.146 -179.66 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.449 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 54.2 m-85 -158.0 60.53 0.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.392 -0.818 . . . . 0.0 109.085 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 tp -149.25 123.17 9.35 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.15 132.21 11.02 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 26.0 p90 -141.98 -176.04 4.64 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.255 -1.144 . . . . 0.0 109.549 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.01 165.66 26.78 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.47 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.9 m -97.93 134.73 40.65 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.6 mt -88.02 146.53 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.64 160.51 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.177 -0.952 . . . . 0.0 110.462 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.496 ' NZ ' ' CB ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -144.64 160.42 41.21 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.158 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 74' ' ' ASP . . . -118.34 152.14 36.39 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 75' ' ' GLU . 20.8 t0 79.07 -158.47 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.293 0.568 . . . . 0.0 109.608 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.468 ' H ' ' CG ' ' A' ' 74' ' ' ASP . 11.2 pt-20 -95.24 -173.06 2.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.221 -0.925 . . . . 0.0 109.416 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.0 -111.78 0.16 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.427 -0.796 . . . . 0.0 108.971 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -132.31 -4.3 3.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.45 -0.781 . . . . 0.0 109.266 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -63.88 -73.39 0.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 0.0 109.407 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 84.7 m -65.79 144.18 57.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 109.432 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.533 ' N ' ' SD ' ' A' ' 80' ' ' MET . 3.9 mpp? -67.93 118.05 10.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 109.399 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.48 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ptp . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 83.2 mt -129.71 -66.99 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.425 -0.797 . . . . 0.0 109.308 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.432 ' O ' ' CG ' ' B' ' 3' ' ' PHE . 6.6 p90 -146.19 34.53 0.99 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.102 -0.999 . . . . 0.0 109.56 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -150.69 -41.38 0.13 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.962 -1.086 . . . . 0.0 108.917 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.48 36.67 2.09 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.566 -0.709 . . . . 0.0 109.721 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -99.17 112.22 24.42 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.296 -0.877 . . . . 0.0 108.859 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -105.23 118.33 36.27 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 39.6 mt -103.9 134.78 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.322 -0.861 . . . . 0.0 110.123 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 39.0 mt -125.56 117.38 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 7.7 t -126.18 151.96 46.63 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.909 0.861 . . . . 0.0 108.749 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' THR . . . . . 0.522 ' OG1' ' OG1' ' C' ' 69' ' ' THR . 4.4 p -119.66 96.56 5.24 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -178.45 -87.74 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.528 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -155.55 -160.72 1.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.399 -0.813 . . . . 0.0 109.597 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -65.36 121.94 15.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.313 -0.867 . . . . 0.0 109.601 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 77.5 mt -52.58 110.27 1.86 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.56 -0.713 . . . . 0.0 109.386 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.46 153.75 72.76 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.293 1.329 . . . . 0.0 110.396 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.65 -16.09 58.86 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 71.8 mt -121.88 140.16 52.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.403 -1.057 . . . . 0.0 109.34 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -85.1 108.42 17.66 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 12.7 mt -96.89 138.35 34.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.211 -0.931 . . . . 0.0 110.233 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . 0.504 ' CE1' ' O ' ' B' ' 22' ' ' SER . 2.1 t80 -121.01 130.09 53.66 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.504 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 41.0 t -72.01 131.84 43.46 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 120.892 -1.13 . . . . 0.0 110.532 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mp -118.92 12.79 12.95 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.67 -174.39 16.29 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -116.66 145.2 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.83 143.9 43.9 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 46.2 m -152.52 141.79 21.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.581 -1.325 . . . . 0.0 108.305 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 12.9 t -149.48 151.84 34.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.036 -1.04 . . . . 0.0 108.646 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' B' ' 30' ' ' SER . 49.1 mt -112.4 158.02 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.117 -0.989 . . . . 0.0 108.674 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.672 ' O ' ' CG ' ' B' ' 31' ' ' ASP . 16.9 m 51.34 108.35 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.741 0 O-C-N 121.039 -1.038 . . . . 0.0 110.683 177.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.672 ' CG ' ' O ' ' B' ' 30' ' ' SER . 37.3 m-20 171.15 129.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . 0.441 ' O ' HG12 ' B' ' 36' ' ' ILE . 23.0 t-20 -84.27 173.04 11.31 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 120.917 -1.114 . . . . 0.0 108.384 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' B' ' 32' ' ' ASN . 15.5 t -44.8 -42.77 2.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 O-C-N 120.943 -1.098 . . . . 0.0 110.297 -174.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -64.19 -44.23 92.66 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.63 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -74.73 -45.83 41.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.327 -1.483 . . . . 0.0 111.546 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.441 HG12 ' O ' ' B' ' 32' ' ' ASN . 0.6 OUTLIER -58.75 -48.98 84.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 O-C-N 120.017 -1.677 . . . . 0.0 109.413 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.79 -45.19 99.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 118.846 -1.142 . . . . 0.0 108.711 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -67.55 -50.34 59.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.347 -0.845 . . . . 0.0 109.424 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.55 HD21 ' N ' ' B' ' 39' ' ' ASN . 0.8 OUTLIER -54.9 -47.39 74.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.108 -0.995 . . . . 0.0 108.966 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.75 -43.46 79.81 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.411 -0.806 . . . . 0.0 108.943 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -50.85 -45.33 59.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.626 -1.296 . . . . 0.0 109.419 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -66.41 -39.37 88.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.461 -0.774 . . . . 0.0 110.055 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -76.82 -34.99 57.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.689 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 15.3 t -71.86 -51.9 28.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.209 -0.932 . . . . 0.0 109.025 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -70.22 -30.18 67.2 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.14 -1.424 . . . . 0.0 109.558 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.55 -30.01 70.38 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -93.62 -5.31 49.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.381 -0.824 . . . . 0.0 109.821 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.87 15.49 28.62 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.02 159.84 29.24 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.1 -1.02 4.63 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.173 -1.193 . . . . 0.0 110.816 -176.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.82 173.62 43.4 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.422 -1.37 . . . . 0.0 109.773 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 5.5 tp -130.53 133.81 46.53 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.67 -0.9 . . . . 0.0 109.43 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.57 139.66 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.672 -0.643 . . . . 0.0 110.243 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 50.83 61.12 3.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.949 -1.094 . . . . 0.0 110.633 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -100.39 114.3 27.74 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.323 0.583 . . . . 0.0 110.654 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -102.46 119.12 38.28 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 pt -75.01 175.42 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.128 -0.982 . . . . 0.0 109.858 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 76.6 p -78.21 -151.67 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.811 . . . . 0.0 109.897 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 8.7 p -168.3 177.5 5.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.755 -1.215 . . . . 0.0 109.2 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.48 83.94 6.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 109.428 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -156.81 46.87 0.43 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.262 -0.898 . . . . 0.0 109.303 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.3 -160.01 45.52 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -75.43 82.94 2.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -1.129 . . . . 0.0 109.831 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -69.72 -148.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.157 -0.965 . . . . 0.0 108.917 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.1 mt -159.59 114.98 2.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.427 -0.796 . . . . 0.0 109.671 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.26 149.66 20.39 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' B' ' 67' ' ' TYR . 4.8 p90 -150.03 152.97 35.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.158 -1.201 . . . . 0.0 110.202 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.73 156.53 28.07 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 52.6 m -101.21 136.12 41.56 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.061 -1.258 . . . . 0.0 107.92 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 53.5 mt -86.04 146.62 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.9 m -138.51 156.71 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.308 -0.87 . . . . 0.0 110.21 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -150.55 132.44 15.11 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.54 129.34 50.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.856 -1.152 . . . . 0.0 108.3 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -172.62 -142.03 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.844 -1.16 . . . . 0.0 108.681 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -166.19 -47.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.152 -0.968 . . . . 0.0 109.171 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.515 ' O ' ' O ' ' B' ' 77' ' ' GLN . . . -79.38 1.67 24.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.262 -0.899 . . . . 0.0 109.67 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . 0.515 ' O ' ' O ' ' B' ' 76' ' ' ALA . 25.4 mm100 54.92 160.21 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 118.701 -1.2 . . . . 0.0 108.883 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -168.38 20.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.355 -0.841 . . . . 0.0 109.58 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 44.6 p -130.01 67.39 1.47 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.412 -0.805 . . . . 0.0 109.419 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' MET . . . . . . . . . . . . . 11.7 mmt 49.58 83.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.382 -0.823 . . . . 0.0 109.563 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.511 179.939 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.0 mtt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . 0.499 ' CD1' ' N ' ' C' ' 2' ' ' ILE . 3.5 mp -88.04 86.13 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.232 -0.918 . . . . 0.0 109.35 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -75.17 135.71 41.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 109.274 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . 0.45 ' N ' ' OE1' ' C' ' 4' ' ' GLU . 56.9 mp0 -103.4 -21.58 13.79 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.404 -0.81 . . . . 0.0 109.178 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' C' ' 4' ' ' GLU . 5.1 m-20 52.18 99.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.061 -1.025 . . . . 0.0 109.745 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -155.12 53.09 0.62 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.569 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -95.23 122.59 38.09 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.518 -0.738 . . . . 0.0 110.026 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 86.2 mt -111.06 128.89 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.485 -0.76 . . . . 0.0 109.866 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' ILE . . . . . . . . . . . . . 7.7 tt -124.19 116.92 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 7.9 t -113.36 135.99 53.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.661 -1.274 . . . . 0.0 109.039 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' C' ' 12' ' ' ALA . 0.3 OUTLIER -56.99 -85.75 0.01 OUTLIER 'General case' 0 C--N 1.279 -2.471 0 O-C-N 121.873 -0.517 . . . . 0.0 111.178 178.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . 0.492 ' N ' ' OG1' ' C' ' 11' ' ' THR . . . -133.43 92.68 3.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.639 -1.288 . . . . 0.0 108.131 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -147.57 -134.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.294 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -165.86 -9.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.07 -1.019 . . . . 0.0 109.474 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 27.8 mt 55.64 68.74 2.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.39 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.89 156.22 50.18 Favored 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 121.931 1.754 . . . . 0.0 109.984 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.12 -14.96 63.15 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 19.1 mt -119.34 137.47 53.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.434 -1.039 . . . . 0.0 109.153 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.77 107.92 19.22 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 11.6 mt -97.88 140.66 31.9 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.199 -0.938 . . . . 0.0 110.246 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' TYR . . . . . 0.62 ' CE1' ' O ' ' C' ' 22' ' ' SER . 0.6 OUTLIER -123.17 129.94 52.1 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' SER . . . . . 0.62 ' O ' ' CE1' ' C' ' 21' ' ' TYR . 24.9 t -66.37 135.71 54.73 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.273 1.035 . . . . 0.0 112.45 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 mt -123.86 13.86 9.23 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.512 -0.742 . . . . 0.0 109.357 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.29 179.74 15.99 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.5 145.8 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 122.21 -0.583 . . . . 0.0 109.56 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.89 159.71 18.78 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.93 147.09 26.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.752 -1.217 . . . . 0.0 108.474 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 51.7 p -146.0 142.1 28.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.509 -0.744 . . . . 0.0 109.872 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' C' ' 30' ' ' SER . 55.8 mt -127.18 124.86 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 29' ' ' ILE . 3.6 p 157.77 -159.59 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -132.62 -174.7 3.53 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 1.8 m120 73.97 114.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 22.2 t -68.39 -34.34 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.445 -0.784 . . . . 0.0 109.482 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.4 -38.87 78.25 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.236 -0.915 . . . . 0.0 109.269 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -75.14 -39.81 60.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.932 -1.105 . . . . 0.0 109.586 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.45 -52.38 56.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.602 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 5.7 t -58.24 -48.31 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.009 -1.057 . . . . 0.0 108.782 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.77 -44.97 91.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 109.955 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -57.21 -49.9 74.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.104 -0.997 . . . . 0.0 109.496 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 82.7 mt -64.44 -43.71 93.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.076 -1.015 . . . . 0.0 108.673 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' ARG . . . . . 0.722 HH11 ' HG2' ' C' ' 41' ' ' ARG . 2.7 ttt-85 -49.78 -47.28 51.18 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.774 -1.204 . . . . 0.0 109.579 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -67.04 -38.41 85.82 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.488 -0.758 . . . . 0.0 110.253 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -76.65 -35.5 57.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.897 . . . . 0.0 109.795 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 t -67.58 -50.88 57.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.176 -0.953 . . . . 0.0 108.949 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -71.76 -35.47 70.1 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.155 -1.418 . . . . 0.0 109.208 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.26 -33.34 67.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.486 -0.759 . . . . 0.0 108.97 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.61 -4.97 59.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.509 -0.744 . . . . 0.0 109.521 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.47 5.18 59.16 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.3 161.65 48.89 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -128.46 -0.2 5.61 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.293 -1.122 . . . . 0.0 110.014 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.42 151.09 17.48 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 16.0 tp -112.96 140.47 47.74 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.565 -0.962 . . . . 0.0 109.949 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . 0.55 ' O ' ' CB ' ' C' ' 54' ' ' ALA . 27.9 mt -112.34 140.66 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.59 -0.694 . . . . 0.0 109.488 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' C' ' 53' ' ' ILE . . . 92.01 -41.36 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 118.342 0.519 . . . . 0.0 110.093 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . 0.511 ' C ' ' O ' ' C' ' 54' ' ' ALA . 18.0 t80 27.97 89.77 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 120.804 0.335 . . . . 0.0 110.177 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' ARG . . . . . 0.638 ' CG ' HH11 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -93.82 143.79 26.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.013 -1.054 . . . . 0.0 109.65 -178.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' ILE . . . . . 0.513 ' O ' ' C ' ' C' ' 58' ' ' THR . 0.1 OUTLIER -150.97 -11.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' THR . . . . . 0.513 ' C ' ' O ' ' C' ' 57' ' ' ILE . 3.1 m -33.76 140.69 0.05 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.545 -0.722 . . . . 0.0 110.171 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' CYS . . . . . . . . . . . . . 52.7 t -140.95 150.79 43.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.309 -0.87 . . . . 0.0 109.445 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.19 117.9 1.43 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 58.06 19.9 6.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.512 -0.742 . . . . 0.0 109.6 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.36 121.41 2.65 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . 0.526 ' HZ1' ' N ' ' C' ' 66' ' ' GLY . 22.8 tptp -47.67 145.3 2.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.427 -1.043 . . . . 0.0 109.553 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -102.24 -66.75 0.91 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.514 -0.741 . . . . 0.0 109.432 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -174.32 122.77 0.29 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.204 -0.935 . . . . 0.0 109.722 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . 0.526 ' N ' ' HZ1' ' C' ' 63' ' ' LYS . . . -95.38 147.6 18.68 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.611 -1.795 . . . . 0.0 108.611 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -149.42 173.6 13.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.103 -1.233 . . . . 0.0 109.987 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.44 161.76 31.76 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' THR . . . . . 0.522 ' OG1' ' OG1' ' B' ' 11' ' ' THR . 69.1 m -93.83 137.02 33.5 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.276 -1.132 . . . . 0.0 108.406 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 60.9 mt -86.11 141.32 14.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' C' ' 21' ' ' TYR . 6.9 m -144.92 163.21 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.788 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -152.06 162.32 41.27 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' C' ' 74' ' ' ASP . . . -104.03 151.43 23.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 108.985 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' C' ' 73' ' ' ALA . 2.9 t0 -55.59 -165.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 109.85 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 54.53 52.14 12.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.147 -0.971 . . . . 0.0 109.096 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.8 -136.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 54.7 -179.41 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.31 -0.869 . . . . 0.0 109.647 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -157.67 -18.49 0.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.926 . . . . 0.0 109.437 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 56.0 p -67.36 -157.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 109.379 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 51.2 ttp -161.77 103.14 1.18 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.372 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.524 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.447 ' O ' ' O ' ' D' ' 2' ' ' ILE . 16.4 mmt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' D' ' 1' ' ' MET . 4.9 mp 55.27 165.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.479 -0.763 . . . . 0.0 109.473 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 51.7 21.04 1.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.353 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -74.43 62.42 0.99 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.205 -0.934 . . . . 0.0 109.306 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -160.22 117.43 2.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.407 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.61 166.37 13.22 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.44 -0.787 . . . . 0.0 109.332 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -94.12 124.29 38.04 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.668 -0.645 . . . . 0.0 109.849 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 71.8 mt -116.94 143.17 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.618 -0.676 . . . . 0.0 109.91 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' ILE . . . . . 0.472 ' O ' ' CG2' ' D' ' 9' ' ' ILE . 7.7 tt -136.03 114.65 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.5 ' HG1' ' N ' ' D' ' 11' ' ' THR . 9.8 t -122.18 161.72 22.68 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.333 -0.855 . . . . 0.0 108.826 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' THR . . . . . 0.5 ' N ' ' HG1' ' D' ' 10' ' ' THR . 0.1 OUTLIER -125.16 73.27 1.29 Allowed 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.17 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.69 -116.64 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.766 0 O-C-N 119.43 -2.044 . . . . 0.0 107.363 -176.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 24.7 p30 -93.68 -137.97 0.2 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.971 -1.08 . . . . 0.0 109.428 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -109.86 -159.75 0.69 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.379 -0.826 . . . . 0.0 109.151 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 56.6 mt -125.48 85.27 58.88 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.579 -0.701 . . . . 0.0 109.203 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -60.11 157.26 35.38 Favored 'Trans proline' 0 N--CA 1.48 0.725 0 C-N-CA 121.91 1.74 . . . . 0.0 110.093 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.95 -4.46 75.0 Favored Glycine 0 N--CA 1.498 2.779 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.056 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 59.6 mt -130.64 141.38 50.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.191 . . . . 0.0 109.706 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -85.42 108.5 17.89 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 14.1 mt -94.95 133.11 39.07 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.117 -0.989 . . . . 0.0 109.635 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' D' ' 22' ' ' SER . 1.6 t80 -114.02 129.67 56.59 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' SER . . . . . 0.433 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 0.0 OUTLIER -70.63 131.69 44.31 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 120.618 -1.301 . . . . 0.0 110.942 -179.415 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 mt -117.29 11.34 14.0 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.91 -179.68 18.4 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.87 141.87 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.853 -0.792 . . . . 0.0 108.933 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.59 142.94 44.58 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 43.8 p -152.2 130.82 12.29 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' THR . . . . . 0.57 ' H ' ' HA3' ' D' ' 66' ' ' GLY . 10.6 t -143.35 130.23 20.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.758 -1.213 . . . . 0.0 108.716 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.438 ' O ' ' OG ' ' D' ' 30' ' ' SER . 19.4 tt -97.72 130.29 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.879 -1.138 . . . . 0.0 108.961 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.531 ' O ' ' O ' ' D' ' 31' ' ' ASP . 72.1 m -168.73 2.36 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.739 -1.226 . . . . 0.0 109.968 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' ASP . . . . . 0.531 ' O ' ' O ' ' D' ' 30' ' ' SER . 26.5 t70 51.27 161.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.48 -0.763 . . . . 0.0 110.447 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 0.1 OUTLIER 71.86 128.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.63 -1.293 . . . . 0.0 108.67 -178.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 20.2 t -69.94 -36.73 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 121.224 -0.923 . . . . 0.0 110.15 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' D' ' 34' ' ' ASP . 25.4 p-10 -58.51 -47.03 85.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.161 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -76.26 -38.64 55.96 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.957 -1.089 . . . . 0.0 109.86 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 60.9 mt -63.79 -53.69 41.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 120.882 -1.136 . . . . 0.0 109.493 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 43.4 t -63.5 -49.65 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.167 -0.958 . . . . 0.0 109.658 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -58.13 -39.44 78.75 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.159 -0.963 . . . . 0.0 109.637 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -65.98 -42.31 90.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 29.1 mt -67.77 -46.29 72.44 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.956 -1.09 . . . . 0.0 108.749 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -46.77 -53.4 11.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.884 -1.135 . . . . 0.0 109.056 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -55.65 -31.0 61.96 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.32 -0.862 . . . . 0.0 109.154 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -73.11 -36.27 66.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.16 -0.963 . . . . 0.0 109.609 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.66 -50.71 25.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 120.886 -1.134 . . . . 0.0 109.281 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -49.92 -33.81 18.61 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 122.988 1.375 . . . . 0.0 109.873 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.97 -29.06 49.57 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.824 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -97.75 6.27 48.12 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.36 29.14 59.99 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 117.952 -2.071 . . . . 0.0 109.687 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.75 -170.27 5.07 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 11.3 ttp -109.51 -41.57 4.55 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.494 -1.004 . . . . 0.0 110.063 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 171.25 175.69 39.87 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.24 139.42 42.96 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.479 -1.012 . . . . 0.0 109.993 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 pt -112.28 142.47 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.748 -0.595 . . . . 0.0 110.238 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' D' ' 55' ' ' PHE . . . 68.93 -61.54 0.42 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.42 -0.8 . . . . 0.0 110.516 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . 0.422 ' O ' ' CG ' ' D' ' 55' ' ' PHE . 13.1 t80 42.7 83.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -84.28 140.37 31.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.05 -1.031 . . . . 0.0 109.493 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' ILE . . . . . . . . . . . . . 60.2 mt -99.19 157.44 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.391 -0.818 . . . . 0.0 108.968 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' THR . . . . . 0.493 ' OG1' ' N ' ' D' ' 59' ' ' CYS . 0.2 OUTLIER -160.01 179.02 9.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.365 -0.835 . . . . 0.0 109.113 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' CYS . . . . . 0.493 ' N ' ' OG1' ' D' ' 58' ' ' THR . 49.2 t -63.67 -119.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.65 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' ALA . . . . . 0.437 ' N ' ' SG ' ' D' ' 59' ' ' CYS . . . -176.48 119.1 0.13 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.187 -0.945 . . . . 0.0 109.32 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -163.75 118.92 1.6 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 109.377 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.2 135.43 4.48 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' D' ' 64' ' ' PHE . 68.7 mttm -50.12 150.72 2.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.761 -0.846 . . . . 0.0 109.743 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . 0.449 ' O ' ' O ' ' D' ' 63' ' ' LYS . 34.2 m-85 57.95 113.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.565 -0.709 . . . . 0.0 109.576 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 1.008 ' O ' ' O ' ' D' ' 66' ' ' GLY . 1.4 tm? -156.57 -33.41 0.08 Allowed 'General case' 0 C--O 1.185 -2.329 0 O-C-N 121.149 -0.969 . . . . 0.0 109.321 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 66' ' ' GLY . . . . . 1.008 ' O ' ' O ' ' D' ' 65' ' ' LEU . . . -23.84 -147.94 0.0 OUTLIER Glycine 1 N--CA 1.516 4.033 0 CA-C-O 122.271 0.928 . . . . 0.0 112.134 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -177.38 99.23 0.05 OUTLIER 'General case' 0 C--N 1.287 -2.15 0 O-C-N 118.88 -2.541 . . . . 0.0 110.112 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.0 137.43 3.18 Favored Glycine 0 C--N 1.288 -2.101 0 C-N-CA 119.015 -1.564 . . . . 0.0 110.856 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 6.9 m -101.08 144.29 30.17 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.74 -0.859 . . . . 0.0 108.951 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 26.7 mt -89.07 142.19 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 m -135.13 166.65 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.371 0.605 . . . . 0.0 109.48 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 72' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' D' ' 21' ' ' TYR . 7.7 tttt -146.47 145.39 30.18 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' D' ' 74' ' ' ASP . . . -125.42 153.98 42.63 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' D' ' 73' ' ' ALA . 25.2 t0 71.81 77.93 0.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 119.018 0.826 . . . . 0.0 110.15 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -117.25 45.46 1.89 Allowed 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.21 -141.78 0.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.293 -0.879 . . . . 0.0 108.956 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -123.3 174.24 7.44 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.309 -0.869 . . . . 0.0 109.379 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 78' ' ' PHE . . . . . 0.512 ' CD2' ' N ' ' D' ' 79' ' ' THR . 9.4 p90 -79.9 -55.79 4.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 109.511 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 79' ' ' THR . . . . . 0.512 ' N ' ' CD2' ' D' ' 78' ' ' PHE . 50.4 p 46.29 83.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.333 -0.854 . . . . 0.0 109.733 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 56.4 mtp -73.09 -18.01 61.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.504 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.461 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ptt? . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 13.6 pt -75.94 53.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.902 . . . . 0.0 109.364 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 3' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -62.55 -50.3 71.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.541 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -161.62 90.49 0.79 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 0.0 109.611 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 5' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -159.03 157.04 30.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.9 . . . . 0.0 108.909 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 6' ' ' LYS . . . . . 0.409 ' HZ2' HD11 ' E' ' 8' ' ' ILE . 6.8 ptmm? -130.83 121.55 25.51 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.415 -0.803 . . . . 0.0 109.435 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -94.93 119.08 32.88 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.388 -0.82 . . . . 0.0 109.788 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . 0.409 HD11 ' HZ2' ' E' ' 6' ' ' LYS . 33.8 mt -113.35 134.21 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.568 -0.708 . . . . 0.0 109.407 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 9' ' ' ILE . . . . . 0.451 ' CG2' ' O ' ' E' ' 9' ' ' ILE . 15.7 tt -130.67 114.42 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 6.5 t -122.46 157.9 30.95 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.891 0.853 . . . . 0.0 109.103 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 11' ' ' THR . . . . . 0.45 ' O ' ' CB ' ' E' ' 12' ' ' ALA . 4.1 p -100.25 77.69 1.99 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 177.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' E' ' 11' ' ' THR . . . 157.55 -90.97 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.778 0.799 . . . . 0.0 109.714 177.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -165.16 -71.32 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 51.14 -153.26 0.18 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 110.245 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 15' ' ' ILE . . . . . 0.635 ' N ' ' HD3' ' E' ' 16' ' ' PRO . 2.8 mt 60.54 48.16 1.6 Allowed Pre-proline 0 N--CA 1.483 1.223 0 O-C-N 121.849 -0.532 . . . . 0.0 109.632 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . 0.635 ' HD3' ' N ' ' E' ' 15' ' ' ILE . 1.6 Cg_endo -66.77 154.48 74.36 Favored 'Trans proline' 0 C--N 1.326 -0.629 0 C-N-CA 121.532 1.488 . . . . 0.0 109.81 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.99 -9.96 74.71 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.927 -1.606 . . . . 0.0 110.943 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 18' ' ' LEU . . . . . . . . . . . . . 75.5 mt -118.73 137.72 53.15 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.138 1.469 . . . . 0.0 109.387 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -86.12 112.88 21.71 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 12.5 mt -89.16 135.22 33.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -0.912 . . . . 0.0 110.62 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 21' ' ' TYR . . . . . 0.554 ' CE1' ' O ' ' E' ' 22' ' ' SER . 1.2 t80 -119.66 130.79 55.23 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 22' ' ' SER . . . . . 0.554 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 0.0 OUTLIER -71.68 131.46 43.2 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.977 -1.077 . . . . 0.0 111.071 -179.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mp -118.41 12.92 13.46 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.03 179.49 15.97 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 tp -114.47 144.81 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.977 -0.719 . . . . 0.0 109.303 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.6 144.98 41.18 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 90.3 p -152.43 139.95 19.68 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.705 -1.247 . . . . 0.0 107.93 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 8.7 t -150.49 144.14 25.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.889 -1.132 . . . . 0.0 109.025 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 4.7 mm -106.42 128.46 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.251 -0.906 . . . . 0.0 108.879 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.627 ' HG ' ' H ' ' E' ' 31' ' ' ASP . 29.0 t -175.06 177.9 1.86 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -0.802 . . . . 0.0 109.007 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 31' ' ' ASP . . . . . 0.627 ' H ' ' HG ' ' E' ' 30' ' ' SER . 46.6 t0 -116.43 161.14 19.54 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.486 -0.759 . . . . 0.0 109.235 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 32' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 2.4 m120 75.96 123.56 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 52.6 t -67.5 -33.33 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.396 -0.815 . . . . 0.0 109.415 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -58.55 -43.05 89.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 110.153 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -75.6 -37.93 59.45 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.112 -0.993 . . . . 0.0 109.466 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.71 -49.42 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 109.451 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 44.7 t -63.83 -49.64 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.031 -1.043 . . . . 0.0 109.653 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.79 -37.37 73.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.832 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -65.56 -41.49 92.89 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -0.958 . . . . 0.0 109.792 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 30.9 mt -68.2 -45.96 71.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.085 -1.01 . . . . 0.0 109.106 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -48.62 -50.71 31.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.786 -1.196 . . . . 0.0 109.363 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -61.04 -36.47 79.64 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.464 -0.773 . . . . 0.0 110.209 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -76.57 -35.08 58.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.952 . . . . 0.0 109.77 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 9.1 t -70.44 -51.82 34.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.07 -1.019 . . . . 0.0 108.846 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 -30.72 67.33 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.046 -1.462 . . . . 0.0 109.275 -175.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.48 -34.9 76.26 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.449 -0.782 . . . . 0.0 109.713 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.42 -5.45 58.84 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.064 -1.023 . . . . 0.0 109.889 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 106.49 -1.19 36.99 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.04 156.95 52.69 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 6.4 ptm -120.53 -2.46 9.97 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.392 -1.063 . . . . 0.0 110.29 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.65 156.01 19.88 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.06 -1.543 . . . . 0.0 109.686 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 5.3 tp -106.26 136.28 46.25 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.722 -0.869 . . . . 0.0 109.28 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 pt -108.83 144.38 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.45 -0.781 . . . . 0.0 110.012 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.474 ' HA ' HH12 ' E' ' 56' ' ' ARG . . . 64.12 82.55 0.18 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.114 -0.991 . . . . 0.0 110.794 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 55' ' ' PHE . . . . . 0.486 ' O ' ' CG ' ' E' ' 55' ' ' PHE . 72.6 t80 -113.75 19.04 17.03 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.192 0.52 . . . . 0.0 109.683 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 56' ' ' ARG . . . . . 0.704 HH11 ' HG3' ' E' ' 56' ' ' ARG . 15.8 mtm-85 -59.68 111.86 1.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.16 -0.962 . . . . 0.0 109.645 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 64.6 mt -78.16 94.84 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.284 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 58' ' ' THR . . . . . 0.405 ' O ' ' SG ' ' E' ' 59' ' ' CYS . 0.1 OUTLIER -171.08 91.51 0.15 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.288 -0.882 . . . . 0.0 109.493 -179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 59' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' E' ' 58' ' ' THR . 67.9 m -152.49 -95.34 0.05 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.012 -1.055 . . . . 0.0 109.491 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.14 121.0 17.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.647 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -64.35 155.17 33.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 109.283 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.4 132.05 0.05 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp 55.54 98.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.327 -1.102 . . . . 0.0 109.418 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 64' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -57.35 178.35 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 109.69 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.55 168.8 23.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.284 -0.885 . . . . 0.0 109.15 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 66' ' ' GLY . . . . . . . . . . . . . . . -146.21 110.54 0.54 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -142.9 -176.66 4.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.426 -1.044 . . . . 0.0 109.395 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.3 172.33 25.3 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.327 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 69' ' ' THR . . . . . 0.467 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 54.8 m -99.17 134.62 41.75 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.348 -1.089 . . . . 0.0 108.196 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 66.9 mt -78.31 146.07 8.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.8 m -130.34 152.11 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.96 -1.088 . . . . 0.0 109.905 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -144.9 141.16 28.83 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.76 138.86 36.25 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -76.06 137.66 40.33 Favored 'General case' 0 C--N 1.312 -1.063 0 O-C-N 120.451 -1.406 . . . . 0.0 108.969 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -57.09 153.09 12.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.617 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.83 -34.24 72.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.374 -0.829 . . . . 0.0 109.685 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -108.79 98.16 7.7 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.48 -0.763 . . . . 0.0 109.292 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -164.78 148.13 8.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.326 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 40.2 p -82.11 -144.44 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.933 . . . . 0.0 109.392 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -140.95 -162.95 1.44 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.34 -0.85 . . . . 0.0 109.351 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.408 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.4 ttt . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.9 mm -83.2 151.08 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.187 -0.946 . . . . 0.0 109.329 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -158.95 6.72 0.11 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 109.278 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -87.56 52.93 2.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.92 . . . . 0.0 109.441 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -168.91 14.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.092 -1.005 . . . . 0.0 109.44 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 50' ' ' MET . 0.2 OUTLIER -86.47 147.85 25.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.271 -0.893 . . . . 0.0 109.267 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -115.26 122.18 45.19 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.0 mt -132.9 124.76 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.284 -0.885 . . . . 0.0 109.723 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.465 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 7.4 tt -119.3 118.99 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 t -117.35 133.39 56.04 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.388 -0.82 . . . . 0.0 108.868 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.543 ' OG1' ' OG1' ' B' ' 69' ' ' THR . 3.2 m -107.96 70.03 0.75 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.426 -0.796 . . . . 0.0 111.863 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.98 -9.92 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 O-C-N 120.197 -1.564 . . . . 0.0 108.328 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.6 OUTLIER 64.25 57.54 1.21 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.711 -0.618 . . . . 0.0 110.331 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -178.85 137.81 0.15 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.576 -0.703 . . . . 0.0 109.889 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.509 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 9.5 tt -163.78 58.65 0.71 Allowed Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.217 -0.927 . . . . 0.0 108.857 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 15' ' ' ILE . 3.2 Cg_exo -59.21 158.24 26.96 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 121.971 1.781 . . . . 0.0 110.562 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.33 -3.91 66.67 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.671 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 25.2 mt -128.33 136.95 51.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.817 -1.402 . . . . 0.0 109.344 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -87.84 108.62 19.24 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.589 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 1.9 mt -120.8 129.98 53.8 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.105 0.478 . . . . 0.0 110.544 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -104.88 141.9 35.71 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.634 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.467 ' C ' ' H ' ' A' ' 24' ' ' GLY . 28.8 t -78.74 88.06 4.62 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.03 11.01 0.61 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.591 -0.693 . . . . 0.0 110.499 -177.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 22' ' ' SER . . . 125.17 -175.89 17.24 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.0 mm -110.05 141.67 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.364 0.602 . . . . 0.0 109.381 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -109.88 151.89 26.48 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 122.025 0.917 . . . . 0.0 109.628 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.3 m -139.97 143.65 36.63 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.69 147.49 43.76 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.999 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.455 ' O ' ' OG ' ' A' ' 30' ' ' SER . 4.2 tp -127.5 132.98 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 120.935 1.698 . . . . 0.0 106.66 176.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 29' ' ' ILE . 2.0 m 173.29 -161.5 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.907 -1.121 . . . . 0.0 108.991 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -117.67 -75.31 0.58 Allowed 'General case' 0 N--CA 1.512 2.641 0 O-C-N 121.301 -0.874 . . . . 0.0 112.449 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -65.57 149.18 50.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.772 -1.205 . . . . 0.0 108.128 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.45 -40.3 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -52.39 -28.49 19.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.349 -0.845 . . . . 0.0 109.791 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -79.51 -33.13 42.35 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.187 -0.945 . . . . 0.0 109.368 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.6 mt -60.66 -53.01 54.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.311 -0.868 . . . . 0.0 109.234 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.5 t -54.9 -50.37 62.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.084 -1.01 . . . . 0.0 109.105 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -60.18 -40.07 88.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 110.149 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -65.4 -41.91 93.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.073 -1.017 . . . . 0.0 109.514 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.3 mt -62.43 -41.38 98.66 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.054 -1.029 . . . . 0.0 109.146 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.528 ' CG ' HH11 ' A' ' 41' ' ' ARG . 0.0 OUTLIER -49.91 -51.3 41.83 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.504 -1.373 . . . . 0.0 109.296 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -61.67 -37.48 84.23 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.774 -1.204 . . . . 0.0 110.68 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -77.1 -36.02 55.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.306 -0.871 . . . . 0.0 110.089 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 t -70.81 -50.56 42.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.425 -0.797 . . . . 0.0 108.965 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -67.74 -29.04 68.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.393 -1.442 . . . . 0.0 109.271 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.71 -31.21 71.0 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.524 0.678 . . . . 0.0 109.385 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -89.27 -5.62 57.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.443 -0.785 . . . . 0.0 109.466 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.09 7.67 63.85 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.77 157.62 41.93 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -129.35 -1.58 5.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.243 -1.151 . . . . 0.0 110.349 -177.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.61 153.02 23.04 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.318 -1.42 . . . . 0.0 109.72 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.7 tp -116.99 139.75 50.29 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.656 -0.908 . . . . 0.0 109.793 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.4 mt -113.13 139.23 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.742 -0.599 . . . . 0.0 110.053 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 67.75 84.38 0.15 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.292 -0.88 . . . . 0.0 110.884 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -122.11 69.94 0.96 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.249 0.547 . . . . 0.0 110.431 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.406 HH22 ' NE ' ' E' ' 56' ' ' ARG . 14.6 ptt180 -98.13 122.68 41.57 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.269 -0.894 . . . . 0.0 109.178 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.5 mt -79.82 129.16 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.341 -0.849 . . . . 0.0 109.449 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.6 p -95.12 156.16 16.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.265 -0.897 . . . . 0.0 109.156 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.1 t -59.02 -52.26 66.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 109.383 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 44.09 79.7 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.541 -0.725 . . . . 0.0 109.576 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.6 67.93 1.15 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.27 -0.894 . . . . 0.0 109.894 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.417 ' O ' ' CD2' ' A' ' 64' ' ' PHE . . . 147.3 -101.13 0.23 Allowed Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -64.84 101.97 0.54 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.336 -1.096 . . . . 0.0 110.184 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.417 ' CD2' ' O ' ' A' ' 62' ' ' GLY . 98.0 m-85 -88.09 140.27 29.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.276 -0.89 . . . . 0.0 109.15 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 tp -165.36 92.9 0.57 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.094 -1.004 . . . . 0.0 111.453 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.53 170.03 10.34 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -158.45 160.19 36.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.99 -1.3 . . . . 0.0 110.045 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.18 -178.02 48.02 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.4 m -118.89 137.69 53.27 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.5 mt -89.31 130.59 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 20' ' ' LEU . 14.0 m -144.27 151.62 15.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 119.352 -0.939 . . . . 0.0 109.189 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.7 pttt -145.48 151.13 37.7 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.1 -1.0 . . . . 0.0 109.167 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.02 150.58 39.71 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.493 ' N ' ' OH ' ' A' ' 21' ' ' TYR . 14.2 p-10 -136.84 -158.17 0.84 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.094 -1.004 . . . . 0.0 108.622 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -99.88 -84.85 0.41 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.312 -0.868 . . . . 0.0 109.47 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.9 157.04 18.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.346 -0.847 . . . . 0.0 109.21 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.419 ' O ' ' O ' ' A' ' 78' ' ' PHE . 13.5 mm100 -135.26 -80.53 0.43 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.38 -0.825 . . . . 0.0 108.927 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.419 ' O ' ' O ' ' A' ' 77' ' ' GLN . 5.3 t80 62.23 125.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.517 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.7 m -163.12 -26.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.907 . . . . 0.0 109.394 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 19.8 mmt -67.4 -101.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.494 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.441 -179.953 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ttt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.546 ' C ' ' H ' ' B' ' 4' ' ' GLU . 0.5 OUTLIER -69.98 129.64 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 20.9 t80 70.23 -33.85 0.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.728 -0.608 . . . . 0.0 109.857 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.546 ' H ' ' C ' ' B' ' 2' ' ' ILE . 24.3 tt0 50.62 -131.15 2.04 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.321 -0.862 . . . . 0.0 110.09 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.407 ' H ' ' CG ' ' B' ' 4' ' ' GLU . 8.1 m-20 50.25 40.95 23.47 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.027 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -114.2 121.91 45.17 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.325 -0.859 . . . . 0.0 109.281 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -94.09 117.83 30.66 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.227 -0.921 . . . . 0.0 108.868 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 64.5 mt -112.5 128.02 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.591 -0.693 . . . . 0.0 110.079 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.422 ' O ' ' CG2' ' B' ' 9' ' ' ILE . 5.7 tt -124.74 113.34 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.402 ' HG1' ' N ' ' B' ' 11' ' ' THR . 4.3 t -123.52 161.13 25.51 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.907 0.861 . . . . 0.0 109.181 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' THR . . . . . 0.572 ' O ' ' C ' ' B' ' 12' ' ' ALA . 12.3 p -99.89 -109.88 0.2 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.173 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.572 ' C ' ' O ' ' B' ' 11' ' ' THR . . . 16.6 -115.03 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 118.486 0.584 . . . . 0.0 111.715 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -111.38 -140.1 0.38 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.623 -0.673 . . . . 0.0 109.312 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -93.93 -157.3 0.54 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.279 -0.888 . . . . 0.0 109.973 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 mt -113.54 98.47 46.98 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.486 -0.759 . . . . 0.0 109.356 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.74 156.83 40.69 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 C-N-CA 121.694 1.596 . . . . 0.0 110.144 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.84 -4.5 75.44 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 34.3 mt -131.45 141.35 49.79 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.175 -1.191 . . . . 0.0 109.996 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -85.05 107.65 17.26 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 12.9 mt -103.16 137.27 41.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.612 -0.68 . . . . 0.0 109.831 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . 0.53 ' CE1' ' O ' ' B' ' 22' ' ' SER . 1.3 t80 -118.62 130.31 55.8 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.53 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 32.6 t -66.27 134.07 51.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 0.0 111.341 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 8.0 mt -121.07 10.31 10.72 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.6 175.0 15.78 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . 0.429 HD12 ' OG1' ' A' ' 11' ' ' THR . 0.1 OUTLIER -113.32 146.6 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.47 159.72 21.64 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 48.8 m -153.04 147.43 25.88 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' THR . . . . . 0.464 ' OG1' HG22 ' B' ' 36' ' ' ILE . 5.2 p -149.64 148.27 29.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 109.533 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.465 ' O ' ' OG ' ' B' ' 30' ' ' SER . 1.3 tp -126.5 127.51 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' B' ' 29' ' ' ILE . 2.8 m -168.27 171.29 9.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.168 -0.958 . . . . 0.0 109.751 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -80.41 -61.05 2.09 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.422 -0.799 . . . . 0.0 112.124 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -74.57 128.26 35.12 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.555 -1.341 . . . . 0.0 108.501 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 m -69.33 -33.65 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.613 -0.68 . . . . 0.0 109.182 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -59.57 -29.71 68.14 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.475 -0.765 . . . . 0.0 110.103 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -70.88 -35.93 72.57 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.507 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.464 HG22 ' OG1' ' B' ' 28' ' ' THR . 77.3 mt -61.45 -47.28 94.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.114 -0.991 . . . . 0.0 109.397 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 68.9 t -54.98 -50.6 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.919 -1.113 . . . . 0.0 109.285 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -59.91 -40.63 89.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.393 -0.817 . . . . 0.0 109.585 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -64.65 -41.9 95.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.164 -0.96 . . . . 0.0 109.369 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 73.0 mt -65.75 -44.07 87.02 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 109.027 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -48.79 -46.66 41.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.49 -1.381 . . . . 0.0 109.383 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -65.27 -37.38 87.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.627 -0.671 . . . . 0.0 110.207 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -77.04 -35.03 57.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 109.912 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.64 -51.57 44.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.286 -0.884 . . . . 0.0 108.834 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.07 -30.54 66.71 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 118.108 -1.437 . . . . 0.0 109.216 -175.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.0 -32.14 72.58 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -91.61 -5.49 53.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.728 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.61 3.63 46.58 Favored Glycine 0 N--CA 1.502 3.094 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.78 159.41 47.78 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -126.71 -2.06 6.68 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.352 -1.087 . . . . 0.0 110.471 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -165.42 158.09 30.81 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.324 -1.417 . . . . 0.0 109.612 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 6.1 tp -114.99 137.24 52.23 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.668 -0.901 . . . . 0.0 109.744 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 68.1 mt -114.35 145.63 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.674 -0.641 . . . . 0.0 110.239 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 69.61 88.9 0.11 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.045 -1.034 . . . . 0.0 111.199 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -142.56 69.48 1.31 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.23 0.538 . . . . 0.0 110.171 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -108.35 146.16 33.41 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mm -109.62 37.26 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -71.03 -131.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 109.48 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . 0.457 ' SG ' ' CE1' ' B' ' 64' ' ' PHE . 84.4 m 56.55 -174.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.513 -0.742 . . . . 0.0 109.569 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -151.87 110.57 3.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.276 -0.89 . . . . 0.0 109.628 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -172.94 177.92 2.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.458 -0.776 . . . . 0.0 109.254 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -51.79 -51.42 39.38 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -137.44 -165.6 1.79 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.393 -1.063 . . . . 0.0 109.258 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.457 ' CE1' ' SG ' ' B' ' 59' ' ' CYS . 16.7 t80 -157.0 146.05 20.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 109.761 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.541 ' N ' ' CD2' ' B' ' 65' ' ' LEU . 2.0 mm? -89.38 148.45 23.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.446 -0.784 . . . . 0.0 109.165 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.12 71.12 0.54 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' TYR . . . . . 0.45 ' O ' ' CD2' ' B' ' 67' ' ' TYR . 49.6 p90 -73.38 126.12 29.42 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.267 -1.137 . . . . 0.0 109.494 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.95 156.44 26.68 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' THR . . . . . 0.543 ' OG1' ' OG1' ' A' ' 11' ' ' THR . 48.4 m -103.04 134.89 45.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.861 -1.376 . . . . 0.0 108.523 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 66.1 mt -89.98 134.59 28.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.8 m -141.66 163.12 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 110.48 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -153.78 148.98 26.96 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.36 150.75 30.64 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.129 -0.982 . . . . 0.0 108.494 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' B' ' 74' ' ' ASP . 26.7 p-10 -163.43 58.0 0.18 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.93 -1.106 . . . . 0.0 108.914 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -145.35 102.31 3.7 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.321 -0.862 . . . . 0.0 109.27 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.51 -46.96 2.75 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.57 -0.706 . . . . 0.0 109.371 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -61.79 140.55 58.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 109.415 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -163.08 102.93 0.98 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 109.354 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.36 170.49 8.19 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.524 -0.735 . . . . 0.0 109.363 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' MET . . . . . 0.556 ' N ' ' SD ' ' B' ' 80' ' ' MET . 0.0 OUTLIER -73.81 -80.39 0.07 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.857 . . . . 0.0 109.53 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.529 -179.942 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 41.5 mtt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 tt -161.3 -48.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.335 -0.853 . . . . 0.0 108.934 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -168.93 -78.91 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.306 -0.871 . . . . 0.0 109.149 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 47.76 -133.4 1.26 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 109.495 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' ASP . . . . . 0.518 ' CG ' ' H ' ' C' ' 6' ' ' LYS . 24.0 t0 -67.08 -147.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.152 -0.968 . . . . 0.0 109.119 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . 0.547 ' O ' ' O ' ' C' ' 50' ' ' MET . 44.8 mtmt -150.61 84.38 1.36 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 109.214 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -104.85 121.53 43.87 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 76.1 mt -134.57 126.66 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.284 -0.885 . . . . 0.0 109.607 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' C' ' 9' ' ' ILE . 14.8 tt -122.06 115.5 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.76 156.88 42.84 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 122.139 0.971 . . . . 0.0 108.849 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' THR . . . . . 0.668 ' HG1' ' HG1' ' D' ' 69' ' ' THR . 1.3 p -116.24 94.04 4.48 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.53 -108.73 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.799 177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -148.26 -50.93 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 109.592 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' C' ' 15' ' ' ILE . 3.3 tp10 -154.78 176.8 12.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.168 -0.958 . . . . 0.0 109.294 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . 0.423 ' H ' ' HG3' ' C' ' 14' ' ' GLU . 29.3 mt -124.04 87.74 53.04 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -60.63 156.0 44.89 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.876 1.717 . . . . 0.0 110.238 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.28 -8.81 77.19 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 31.7 mt -132.23 142.79 49.54 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.373 -1.075 . . . . 0.0 109.496 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -86.19 108.66 18.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 14.8 mt -96.71 137.33 35.96 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 109.964 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' TYR . . . . . 0.404 ' N ' ' O ' ' C' ' 72' ' ' LYS . 18.1 t80 -123.5 129.04 50.64 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.1 t -87.56 131.79 34.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.342 -0.849 . . . . 0.0 109.608 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . 0.649 ' CD2' ' N ' ' C' ' 23' ' ' LEU . 0.2 OUTLIER -123.28 11.53 9.39 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.61 168.49 11.85 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.266 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -106.7 146.18 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.99 144.83 42.45 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 75.2 m -152.68 138.66 18.14 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 12.1 t -149.77 141.06 23.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.843 -1.161 . . . . 0.0 108.644 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.488 ' O ' ' OG ' ' C' ' 30' ' ' SER . 15.3 tt -115.31 129.82 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' C' ' 29' ' ' ILE . 6.4 m -169.72 -141.36 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.043 -1.036 . . . . 0.0 109.796 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -157.55 161.73 38.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.248 -0.908 . . . . 0.0 108.972 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 73.81 127.34 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -67.57 -33.68 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.51 -0.744 . . . . 0.0 109.363 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -59.01 -46.69 87.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.358 -0.839 . . . . 0.0 110.176 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -76.03 -40.27 53.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.203 -0.936 . . . . 0.0 109.78 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 71.5 mt -60.29 -39.42 80.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.881 -1.137 . . . . 0.0 109.297 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -69.3 -47.03 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.776 -1.202 . . . . 0.0 109.534 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -60.24 -41.42 93.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.935 . . . . 0.0 109.843 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -58.81 -48.32 81.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 109.941 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 28.4 mt -70.32 -47.59 60.41 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.047 -1.033 . . . . 0.0 109.111 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' ARG . . . . . 0.468 HH21 ' HZ1' ' C' ' 45' ' ' LYS . 39.9 mtp180 -49.44 -48.0 47.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.535 -1.353 . . . . 0.0 109.016 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' LYS . . . . . 0.421 ' O ' ' CB ' ' C' ' 46' ' ' ALA . 46.1 mtpt -63.8 -37.65 88.17 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 109.831 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' GLN . . . . . 0.539 HE22 ' HZ1' ' C' ' 47' ' ' LYS . 0.0 OUTLIER -75.98 -35.66 59.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 109.912 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 20.2 t -76.63 -51.75 18.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 109.067 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' LYS . . . . . 0.468 ' HZ1' HH21 ' C' ' 41' ' ' ARG . 18.2 mtmt -69.43 -29.94 67.76 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.858 -1.537 . . . . 0.0 109.461 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' C' ' 42' ' ' LYS . . . -64.07 -33.38 75.63 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . 0.539 ' HZ1' HE22 ' C' ' 43' ' ' GLN . 0.0 OUTLIER -90.63 2.69 55.64 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.245 -0.91 . . . . 0.0 108.699 179.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.42 29.65 65.75 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.053 -1.546 . . . . 0.0 109.962 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.37 -168.74 24.33 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.057 -1.261 . . . . 0.0 110.053 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' MET . . . . . 0.547 ' O ' ' O ' ' C' ' 6' ' ' LYS . 14.6 ttt -108.42 -41.75 4.76 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.567 -0.961 . . . . 0.0 109.692 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 173.96 -153.9 18.19 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 tp -136.01 137.45 41.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.413 -1.051 . . . . 0.0 109.985 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 49.0 mt -110.52 141.12 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.571 -0.706 . . . . 0.0 109.741 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 64.65 75.18 0.38 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.204 -0.935 . . . . 0.0 108.66 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -93.99 140.31 29.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 109.075 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' ARG . . . . . 0.662 HH11 ' HG2' ' C' ' 56' ' ' ARG . 0.0 OUTLIER -134.57 174.66 10.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.584 -0.698 . . . . 0.0 109.284 179.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 39.8 mt -136.92 154.12 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' THR . . . . . . . . . . . . . 4.7 m -78.85 138.01 37.95 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' CYS . . . . . 0.55 ' SG ' ' N ' ' C' ' 60' ' ' ALA . 15.1 p -65.22 -145.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.145 -0.972 . . . . 0.0 109.514 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . 0.55 ' N ' ' SG ' ' C' ' 59' ' ' CYS . . . -73.15 52.12 0.33 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.362 -0.837 . . . . 0.0 109.409 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' C' ' 60' ' ' ALA . 21.5 t70 60.15 116.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.468 -0.77 . . . . 0.0 109.634 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.03 -10.54 4.8 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . 0.415 ' O ' ' CD2' ' C' ' 64' ' ' PHE . 88.2 tttt -83.78 -93.9 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -1.152 . . . . 0.0 109.507 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' C' ' 63' ' ' LYS . 4.1 m-85 -156.69 -99.28 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 109.043 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' C' ' 65' ' ' LEU . 1.4 pt? -167.31 -177.79 3.79 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.248 -0.907 . . . . 0.0 110.109 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' C' ' 67' ' ' TYR . . . -64.42 -75.46 0.37 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' TYR . . . . . 0.456 ' CB ' ' O ' ' C' ' 66' ' ' GLY . 3.7 t80 76.55 144.21 0.08 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.428 -1.043 . . . . 0.0 109.958 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 174.35 157.6 16.3 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 21.1 m -98.37 144.26 27.94 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.357 -1.084 . . . . 0.0 109.59 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 56.1 mt -91.19 132.06 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.09 163.14 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.44 0.638 . . . . 0.0 109.854 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' C' ' 21' ' ' TYR . 16.2 ttmm -153.65 141.05 19.7 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.0 150.0 36.52 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.737 -1.227 . . . . 0.0 108.152 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.83 -177.23 4.8 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.982 -1.074 . . . . 0.0 109.029 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -141.25 53.77 1.55 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.346 -0.846 . . . . 0.0 109.342 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.51 -13.42 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.358 -0.839 . . . . 0.0 109.4 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 57.68 -130.3 1.5 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.892 . . . . 0.0 109.517 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -59.07 119.49 7.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.954 . . . . 0.0 109.568 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.69 124.37 24.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.283 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 9.8 tpt -60.54 -47.85 84.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.922 . . . . 0.0 109.433 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.474 -179.994 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' ILE . . . . . . . . . . . . . 11.0 pt -62.62 129.62 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.275 -0.891 . . . . 0.0 109.259 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -88.97 106.38 18.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.008 -1.057 . . . . 0.0 109.368 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' D' ' 6' ' ' LYS . 27.2 tt0 -160.86 5.82 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 109.677 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' D' ' 6' ' ' LYS . 4.7 m-20 63.61 -65.21 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' D' ' 4' ' ' GLU . 72.1 tttt 73.15 104.41 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.614 0.721 . . . . 0.0 109.543 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -94.59 124.52 38.67 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.717 -0.615 . . . . 0.0 109.462 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 20.0 mt -115.94 137.71 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.556 -0.715 . . . . 0.0 109.963 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' ILE . . . . . 0.431 ' O ' ' CG2' ' D' ' 9' ' ' ILE . 9.4 tt -119.49 124.28 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.99 130.81 56.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.511 -0.743 . . . . 0.0 109.556 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 3.1 m -129.79 120.86 25.72 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.05 12.04 2.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.248 -0.907 . . . . 0.0 109.697 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -126.23 108.38 11.24 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.482 0.658 . . . . 0.0 109.36 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . 0.463 ' HG3' ' H ' ' D' ' 15' ' ' ILE . 8.2 tp10 -62.33 169.42 2.88 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.269 -0.895 . . . . 0.0 108.655 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' ILE . . . . . 0.499 ' O ' ' CG2' ' D' ' 15' ' ' ILE . 13.1 tt -134.55 60.91 45.73 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.271 -0.893 . . . . 0.0 109.509 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' D' ' 15' ' ' ILE . 2.0 Cg_endo -61.14 157.58 38.93 Favored 'Trans proline' 0 C--N 1.323 -0.787 0 C-N-CA 122.242 1.961 . . . . 0.0 110.171 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.68 -2.77 67.44 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.671 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 19.1 mt -128.43 138.47 52.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.813 -1.404 . . . . 0.0 109.803 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -85.12 108.69 17.8 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt -97.95 139.36 33.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.356 -0.84 . . . . 0.0 110.516 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -119.85 129.13 54.26 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 10.3 t -71.62 131.25 42.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.48 -1.388 . . . . 0.0 111.105 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 32.1 mt -115.94 5.86 14.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.38 -176.18 16.01 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.54 143.05 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.9 -0.765 . . . . 0.0 109.158 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.19 162.6 16.83 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.861 0.838 . . . . 0.0 110.34 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -152.21 149.57 28.88 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -151.41 153.24 34.31 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.143 0.973 . . . . 0.0 109.475 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.467 ' O ' ' OG ' ' D' ' 30' ' ' SER . 6.0 tt -123.08 145.83 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.029 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' D' ' 29' ' ' ILE . 2.1 m 169.92 155.07 0.05 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.392 -0.817 . . . . 0.0 109.547 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' ASP . . . . . 0.496 ' O ' ' ND2' ' D' ' 32' ' ' ASN . 1.8 p30 -100.09 63.78 1.18 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.303 -0.873 . . . . 0.0 109.627 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' D' ' 31' ' ' ASP . 0.2 OUTLIER 176.84 132.76 0.05 Allowed 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 2.0 m -69.81 -40.89 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -63.31 -32.67 74.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.488 -0.757 . . . . 0.0 109.915 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -74.1 -39.34 63.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.246 -0.909 . . . . 0.0 109.109 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 mt -60.34 -48.99 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.35 -0.844 . . . . 0.0 108.963 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 63.0 t -57.48 -45.41 85.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.717 0 O-C-N 121.13 -0.981 . . . . 0.0 108.518 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -63.84 -43.1 97.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.186 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' ASN . . . . . 0.423 ' N ' HD21 ' D' ' 39' ' ' ASN . 1.5 m120 -57.95 -47.74 82.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.132 -0.98 . . . . 0.0 109.548 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 26.6 mt -63.95 -41.58 97.56 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 109.259 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -51.51 -39.84 58.44 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.443 -1.41 . . . . 0.0 109.815 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -72.95 -40.62 65.21 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.388 -0.82 . . . . 0.0 110.238 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -76.32 -36.15 58.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.389 -0.82 . . . . 0.0 109.704 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.97 -49.82 64.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.453 -0.78 . . . . 0.0 108.927 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -70.47 -31.22 68.27 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.087 -1.445 . . . . 0.0 108.989 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.06 -33.71 76.37 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -87.17 0.62 55.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.472 -0.768 . . . . 0.0 109.393 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.0 2.49 74.68 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.3 158.58 49.4 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.95 -1.3 5.92 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.261 -1.141 . . . . 0.0 110.196 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.04 168.29 40.69 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 2.7 tp -131.7 137.98 48.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.601 -0.941 . . . . 0.0 109.291 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 pt -106.72 144.24 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.515 -0.74 . . . . 0.0 109.538 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 65.77 76.36 0.32 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 0.0 109.815 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . 0.539 ' CG ' ' O ' ' D' ' 55' ' ' PHE . 62.6 t80 -106.36 34.44 3.38 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' ARG . . . . . 0.561 ' NH1' HH22 ' E' ' 56' ' ' ARG . 25.5 mtm180 -54.89 126.39 24.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.989 -1.069 . . . . 0.0 109.42 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' ILE . . . . . . . . . . . . . 48.1 mm -62.66 153.97 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.295 -0.878 . . . . 0.0 109.38 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' THR . . . . . 0.418 ' OG1' ' N ' ' D' ' 59' ' ' CYS . 0.1 OUTLIER -79.3 -87.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.418 -0.802 . . . . 0.0 109.443 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' CYS . . . . . 0.418 ' N ' ' OG1' ' D' ' 58' ' ' THR . 49.4 t -165.42 161.82 19.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.943 . . . . 0.0 109.482 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . 49.57 78.25 0.1 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 109.648 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 45.1 t0 48.56 -99.29 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 109.614 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 62' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' D' ' 64' ' ' PHE . . . -162.76 26.35 0.23 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -77.47 18.97 0.38 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -1.148 . . . . 0.0 109.781 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . 0.43 ' H ' ' C ' ' D' ' 62' ' ' GLY . 12.9 m-85 -112.6 -89.92 0.51 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.451 -0.781 . . . . 0.0 109.091 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . . . . . . . . . 10.2 tp -161.84 -114.29 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.551 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . 152.79 143.59 3.72 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 67' ' ' TYR . . . . . 0.488 ' O ' ' CD2' ' D' ' 67' ' ' TYR . 16.4 p90 -134.16 106.91 7.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.781 -0.835 . . . . 0.0 109.47 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -127.35 166.51 20.06 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 69' ' ' THR . . . . . 0.668 ' HG1' ' HG1' ' C' ' 11' ' ' THR . 54.7 m -110.71 138.08 47.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.109 -1.23 . . . . 0.0 108.482 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 41.0 mt -84.32 150.3 4.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.24 158.96 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.138 -0.976 . . . . 0.0 109.993 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -144.44 154.32 42.83 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.68 151.86 42.66 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -137.97 178.87 6.79 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.019 -1.051 . . . . 0.0 108.527 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -158.44 146.33 18.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 109.174 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.23 62.77 1.11 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.352 -0.842 . . . . 0.0 109.502 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -141.92 -140.97 0.13 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.314 -0.866 . . . . 0.0 109.293 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 78' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -78.17 101.3 6.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.545 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 5.7 m -63.98 -42.95 97.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.197 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 11.8 tpp -150.07 -137.11 0.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.282 -0.886 . . . . 0.0 109.465 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.494 -179.911 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 8.1 ptp . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.234 0.54 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . 0.484 ' O ' ' C ' ' E' ' 3' ' ' PHE . 14.4 mt 48.37 48.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.349 -0.844 . . . . 0.0 109.549 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 3' ' ' PHE . . . . . 0.484 ' C ' ' O ' ' E' ' 2' ' ' ILE . 9.3 p90 34.08 47.25 0.18 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.553 -0.717 . . . . 0.0 110.268 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.75 107.0 1.89 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.327 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 5' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -69.33 -143.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.464 -0.772 . . . . 0.0 108.958 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -94.27 77.67 3.96 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.081 -1.012 . . . . 0.0 109.838 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -93.99 118.71 31.88 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.056 -1.027 . . . . 0.0 109.328 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 71.7 mt -111.65 129.18 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.588 -0.695 . . . . 0.0 110.113 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 9' ' ' ILE . . . . . 0.462 ' CG2' ' O ' ' E' ' 9' ' ' ILE . 17.4 tt -130.08 113.36 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 3.7 t -122.88 161.68 23.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.264 -0.897 . . . . 0.0 108.784 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 11' ' ' THR . . . . . . . . . . . . . 3.1 p -113.07 85.71 2.23 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.68 -124.12 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.351 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 13' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' E' ' 14' ' ' GLU . 1.0 OUTLIER -162.34 92.68 0.83 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.431 -0.793 . . . . 0.0 109.031 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . 0.453 ' CB ' ' O ' ' E' ' 13' ' ' ASP . 12.1 tt0 75.46 150.35 0.11 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.875 -0.515 . . . . 0.0 110.069 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.38 97.13 50.43 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -60.09 154.9 48.22 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.608 1.539 . . . . 0.0 110.507 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.33 -5.78 77.97 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 18' ' ' LEU . . . . . . . . . . . . . 17.1 mt -130.99 140.88 50.19 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.267 -1.137 . . . . 0.0 110.058 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 19' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' E' ' 73' ' ' ALA . 3.2 mp0 -83.64 109.48 17.48 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 18.0 mt -97.92 135.84 39.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.077 -1.014 . . . . 0.0 110.464 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 21' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' E' ' 72' ' ' LYS . 1.2 t80 -119.85 129.41 54.39 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 22' ' ' SER . . . . . 0.425 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 16.4 t -61.65 127.41 31.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.628 -1.295 . . . . 0.0 111.587 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mt -114.61 9.36 16.54 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.74 -177.62 16.86 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . 0.478 HD11 ' HG1' ' E' ' 69' ' ' THR . 50.3 mm -113.13 140.93 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.659 -0.907 . . . . 0.0 109.325 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.92 146.02 43.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.663 -0.648 . . . . 0.0 109.395 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 68.1 m -152.2 140.19 20.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.9 -1.125 . . . . 0.0 108.137 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.23 150.96 33.44 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.079 -1.013 . . . . 0.0 108.747 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 mm -120.03 135.05 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.4 -0.813 . . . . 0.0 109.487 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.87 159.93 18.85 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.517 -0.739 . . . . 0.0 109.896 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 31' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -83.18 -60.63 2.09 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.521 -0.737 . . . . 0.0 112.707 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -79.7 147.87 31.78 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.662 -1.274 . . . . 0.0 108.306 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 94.7 t -68.31 -34.59 66.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.696 -0.627 . . . . 0.0 109.626 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.11 -35.21 59.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.306 -0.871 . . . . 0.0 110.073 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -78.57 -33.63 47.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.057 -1.027 . . . . 0.0 109.188 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.08 -52.9 53.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 120.866 -1.146 . . . . 0.0 109.603 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.88 -50.52 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.084 -1.01 . . . . 0.0 110.145 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -57.21 -37.52 72.35 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.24 -0.913 . . . . 0.0 109.102 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -69.16 -40.48 78.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.937 -1.102 . . . . 0.0 110.137 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 39.3 mt -72.05 -49.62 35.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.882 -1.137 . . . . 0.0 109.196 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -48.1 -48.88 33.48 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.664 -1.272 . . . . 0.0 109.169 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -57.93 -32.9 68.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.317 -0.864 . . . . 0.0 109.32 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -73.38 -35.25 65.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.166 -0.959 . . . . 0.0 109.435 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.11 -51.34 20.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 120.56 -1.337 . . . . 0.0 109.083 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.35 -30.96 8.43 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.48 1.133 . . . . 0.0 109.699 -176.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.6 -25.11 49.62 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.59 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -95.65 13.53 26.01 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.07 29.87 29.43 Favored Glycine 0 N--CA 1.486 1.971 0 C-N-CA 118.032 -2.032 . . . . 0.0 109.877 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.37 -164.42 6.13 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -114.59 -35.68 4.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.59 -0.947 . . . . 0.0 110.011 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 172.33 -169.97 43.05 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 tp -118.54 140.86 49.22 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.404 -1.057 . . . . 0.0 110.173 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 53' ' ' ILE . . . . . 0.419 HG21 ' H ' ' E' ' 14' ' ' GLU . 64.5 mt -113.13 143.02 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.587 -0.696 . . . . 0.0 110.803 -178.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . 62.39 75.7 0.39 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 110.176 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -97.53 85.62 3.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.497 -0.752 . . . . 0.0 109.287 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 56' ' ' ARG . . . . . 0.561 HH22 ' NH1' ' D' ' 56' ' ' ARG . 28.6 ttm180 -84.44 160.44 20.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.405 -0.809 . . . . 0.0 109.621 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 76.6 mt -137.19 97.6 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.415 -0.803 . . . . 0.0 108.905 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 58' ' ' THR . . . . . . . . . . . . . 23.3 p -67.29 152.32 45.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.141 -0.974 . . . . 0.0 109.254 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 59' ' ' CYS . . . . . . . . . . . . . 69.3 m -149.08 125.33 10.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.206 -0.934 . . . . 0.0 109.479 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -175.97 -74.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.859 . . . . 0.0 109.353 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 61' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' E' ' 63' ' ' LYS . 26.0 t0 -164.45 87.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.889 . . . . 0.0 109.459 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.27 -11.4 6.64 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . 0.439 ' H ' ' C ' ' E' ' 61' ' ' ASP . 89.1 mttt -71.94 0.89 8.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -1.155 . . . . 0.0 109.616 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 64' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -50.96 124.11 10.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.266 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 27.0 tp -152.54 125.76 8.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.306 -0.871 . . . . 0.0 108.886 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 66' ' ' GLY . . . . . . . . . . . . . . . -122.59 127.07 6.59 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -148.36 -170.16 3.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -1.138 . . . . 0.0 109.663 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . 162.04 170.18 26.44 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 69' ' ' THR . . . . . 0.478 ' HG1' HD11 ' E' ' 25' ' ' ILE . 1.9 m -98.34 136.26 38.75 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 49.9 mt -81.69 143.31 12.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 2.7 m -129.33 158.45 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.361 -0.837 . . . . 0.0 109.654 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 72' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' E' ' 21' ' ' TYR . 16.1 tttm -139.47 156.66 46.8 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' E' ' 19' ' ' GLN . . . -117.31 113.88 22.78 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.016 0.912 . . . . 0.0 111.765 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -169.99 101.81 0.3 Allowed 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.132 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -154.09 -33.58 0.11 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.926 -1.109 . . . . 0.0 109.381 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.86 -171.55 3.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.94 . . . . 0.0 109.512 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 77' ' ' GLN . . . . . 0.519 ' N ' ' CD ' ' E' ' 77' ' ' GLN . 2.1 pm0 -163.81 26.36 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 109.495 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -159.68 109.38 1.86 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 0.0 109.457 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 1.6 t -172.74 43.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.384 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 80' ' ' MET . . . . . 0.529 ' SD ' ' N ' ' E' ' 80' ' ' MET . 1.9 mpt? 47.42 -118.09 0.88 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 109.545 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.377 179.851 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 mmt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 74.6 mt -80.54 -33.95 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.336 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 24.5 t80 58.04 97.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 109.397 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -54.9 158.62 2.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.246 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -103.44 99.54 9.38 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.284 -0.885 . . . . 0.0 109.252 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -87.67 156.19 19.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.243 -0.911 . . . . 0.0 109.16 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -94.49 124.28 38.42 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.168 -0.957 . . . . 0.0 109.86 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.6 mt -114.64 138.15 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.548 -0.72 . . . . 0.0 109.62 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.479 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 12.8 tt -134.97 115.16 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.518 -0.738 . . . . 0.0 109.326 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.491 ' HG1' ' N ' ' A' ' 11' ' ' THR . 5.8 t -122.16 157.96 30.4 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.491 ' N ' ' HG1' ' A' ' 10' ' ' THR . 0.2 OUTLIER -116.28 113.33 22.83 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.264 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.47 80.3 0.19 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 122.119 0.961 . . . . 0.0 109.819 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 14' ' ' GLU . 19.2 t0 -152.98 -140.95 0.1 Allowed 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.718 -0.614 . . . . 0.0 109.413 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 4.0 tm-20 -167.7 -22.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.496 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.427 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 11.6 mt 52.88 64.51 7.12 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.338 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HD3' ' N ' ' A' ' 15' ' ' ILE . 2.4 Cg_endo -62.14 154.81 60.15 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 122.018 1.812 . . . . 0.0 110.12 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.56 -10.07 75.6 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.5 mt -123.13 136.14 54.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.299 -1.118 . . . . 0.0 109.214 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -97.99 112.92 24.68 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.08 137.05 54.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.615 -0.678 . . . . 0.0 109.244 -178.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -108.22 153.22 23.51 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.1 t -74.33 132.77 42.35 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.753 0.787 . . . . 0.0 110.769 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 mt -119.85 17.62 12.61 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.654 0.74 . . . . 0.0 109.119 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.8 176.84 16.6 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.62 144.48 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.78 144.71 45.08 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.88 141.55 21.81 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.87 -1.144 . . . . 0.0 107.926 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -150.21 151.66 33.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.963 -1.085 . . . . 0.0 109.072 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.7 mt -114.02 128.08 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.45 -0.781 . . . . 0.0 109.101 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.7 p -177.74 178.67 0.97 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.85 . . . . 0.0 108.93 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -118.46 168.1 10.97 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.519 -0.738 . . . . 0.0 109.03 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 75.09 119.46 0.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.6 t -68.06 -34.59 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.439 -0.788 . . . . 0.0 109.159 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -59.26 -40.41 85.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.883 . . . . 0.0 110.231 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -75.89 -38.59 57.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.226 -0.921 . . . . 0.0 109.628 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.2 mt -62.2 -46.66 95.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.036 -1.04 . . . . 0.0 109.365 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.2 t -56.95 -48.73 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.947 -1.096 . . . . 0.0 108.913 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.22 -42.58 99.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.364 -0.835 . . . . 0.0 110.366 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -57.09 -49.02 77.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 109.497 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.0 mt -68.64 -45.07 72.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.098 -1.001 . . . . 0.0 108.714 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -51.45 -48.31 62.8 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.888 -1.133 . . . . 0.0 109.88 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -63.69 -37.29 86.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.44 -0.787 . . . . 0.0 110.23 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -76.56 -35.54 58.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.388 -0.82 . . . . 0.0 109.835 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.3 t -68.09 -51.04 52.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.996 -1.065 . . . . 0.0 108.857 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -65.99 -32.75 74.41 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.15 -1.42 . . . . 0.0 109.555 -175.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.45 -28.47 69.7 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.9 -4.71 57.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.522 -0.736 . . . . 0.0 109.864 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.09 10.45 59.71 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.5 156.53 39.09 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.435 ' SD ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -123.08 -11.54 8.03 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.389 -1.066 . . . . 0.0 109.327 -178.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.435 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -154.55 162.29 30.63 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.3 tp -128.91 139.99 51.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.677 -0.896 . . . . 0.0 109.489 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.9 mt -113.3 144.41 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.568 -0.707 . . . . 0.0 109.684 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 67.48 72.85 0.33 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.263 -0.898 . . . . 0.0 110.081 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.508 ' CG ' ' O ' ' A' ' 55' ' ' PHE . 65.8 t80 -95.31 45.59 1.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 108.965 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.2 tpp180 -44.2 128.99 6.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.418 -0.801 . . . . 0.0 109.94 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.455 ' CG2' ' N ' ' A' ' 58' ' ' THR . 5.6 mm -69.63 161.81 4.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.367 -0.833 . . . . 0.0 109.318 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.455 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 0.9 OUTLIER -144.55 65.22 1.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.453 -0.78 . . . . 0.0 109.281 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.1 p -49.01 -37.23 19.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.55 -174.71 0.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 109.344 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -156.87 -5.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.216 -0.927 . . . . 0.0 109.497 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.62 -128.8 0.02 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -71.87 -0.88 12.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.193 -1.181 . . . . 0.0 109.722 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -97.16 156.57 16.34 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.411 -0.805 . . . . 0.0 108.956 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.493 ' CD2' ' N ' ' A' ' 65' ' ' LEU . 1.4 pt? -169.16 179.02 4.15 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.468 -0.77 . . . . 0.0 109.852 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.56 164.63 20.0 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -166.09 -177.87 4.37 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.358 -1.084 . . . . 0.0 109.695 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 178.57 171.32 41.72 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.631 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.709 ' OG1' ' OG1' ' E' ' 11' ' ' THR . 86.8 m -103.15 135.9 43.94 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.206 -1.173 . . . . 0.0 108.776 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.6 mt -85.06 121.67 37.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.7 m -139.23 157.44 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 O-C-N 121.302 -0.874 . . . . 0.0 109.817 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -149.51 153.61 37.47 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.096 -1.002 . . . . 0.0 109.449 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.57 150.99 30.58 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.174 -0.954 . . . . 0.0 108.931 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.585 ' N ' ' OH ' ' A' ' 21' ' ' TYR . 1.9 p-10 -78.22 -2.38 37.47 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.151 -0.968 . . . . 0.0 109.291 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 61.62 40.74 13.06 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.788 -0.57 . . . . 0.0 109.788 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 48.43 -166.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.227 -0.921 . . . . 0.0 109.446 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 44.04 71.41 0.25 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.411 -0.806 . . . . 0.0 109.627 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -157.5 -62.89 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.931 . . . . 0.0 109.518 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.7 p -68.79 86.78 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 19.5 mtt 48.1 78.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.915 . . . . 0.0 109.608 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.434 -179.96 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 53.2 mtp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 15.9 pt -88.61 16.75 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.225 -0.922 . . . . 0.0 109.475 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -59.36 148.61 31.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.446 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -165.96 -4.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 0.0 109.495 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' B' ' 5' ' ' ASP . 37.2 p-10 -155.63 156.67 35.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.404 -0.81 . . . . 0.0 109.218 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -109.73 -69.64 0.85 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.589 -0.695 . . . . 0.0 109.915 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -114.4 151.31 33.32 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 90.8 mt -122.3 129.7 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.24 -0.913 . . . . 0.0 109.833 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 16.6 tt -134.27 118.66 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t -125.54 152.91 44.41 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.097 -1.002 . . . . 0.0 108.557 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' THR . . . . . 0.519 ' O ' ' CB ' ' B' ' 12' ' ' ALA . 1.0 OUTLIER -96.89 79.99 2.97 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.451 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' B' ' 11' ' ' THR . . . 148.76 -98.41 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 35.8 t70 178.1 56.02 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -96.27 81.84 3.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.075 -1.016 . . . . 0.0 109.994 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.614 ' N ' ' HD3' ' B' ' 16' ' ' PRO . 5.7 mt -144.08 52.78 2.01 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.455 -0.778 . . . . 0.0 109.213 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.614 ' HD3' ' N ' ' B' ' 15' ' ' ILE . 2.1 Cg_endo -62.73 151.98 80.82 Favored 'Trans proline' 0 C--N 1.322 -0.865 0 C-N-CA 121.883 1.722 . . . . 0.0 109.945 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.43 -9.08 78.17 Favored Glycine 0 N--CA 1.484 1.874 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.23 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 71.2 mt -126.63 139.59 53.06 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 119.038 1.419 . . . . 0.0 108.879 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' B' ' 73' ' ' ALA . 23.0 mp0 -84.33 115.45 22.5 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.5 mt -89.67 138.69 31.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.802 -1.186 . . . . 0.0 110.174 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -120.02 128.91 53.97 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.54 -0.725 . . . . 0.0 109.644 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 30.2 t -77.69 132.97 38.43 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 120.59 -1.319 . . . . 0.0 109.858 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 37.5 mt -116.99 9.54 13.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.576 -0.703 . . . . 0.0 109.112 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.49 -170.67 17.39 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 33.9 mm -112.4 141.58 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.984 -0.715 . . . . 0.0 109.263 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.43 144.02 42.59 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.52 -0.738 . . . . 0.0 109.591 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 70.0 m -152.24 138.99 18.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 108.786 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 11.9 t -149.65 141.21 23.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.993 -1.067 . . . . 0.0 109.333 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 4.4 mp -111.74 125.57 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.164 -0.96 . . . . 0.0 109.244 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 45.5 p -173.74 -145.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.685 -0.634 . . . . 0.0 109.723 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 11.3 m-20 -157.68 164.89 36.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.289 -0.882 . . . . 0.0 109.137 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 21.4 t30 75.75 132.0 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 108.823 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 44.8 t -65.06 -32.1 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.66 -0.65 . . . . 0.0 109.493 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -58.72 -46.61 86.97 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.281 -0.887 . . . . 0.0 110.126 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.46 -41.11 61.35 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.352 -0.842 . . . . 0.0 109.756 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.64 -44.76 99.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 120.887 -1.133 . . . . 0.0 109.333 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 33.1 t -68.8 -47.11 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.856 -1.152 . . . . 0.0 109.574 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.99 -43.17 99.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.132 -0.98 . . . . 0.0 110.009 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -58.33 -48.71 79.68 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.32 -0.862 . . . . 0.0 109.67 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 52.4 mt -70.13 -47.88 59.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.083 -1.011 . . . . 0.0 108.662 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -49.79 -52.62 30.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.882 -1.136 . . . . 0.0 109.523 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -59.35 -35.69 74.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.315 -0.866 . . . . 0.0 110.084 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -75.53 -35.85 60.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.743 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 24.2 t -71.39 -50.93 37.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.11 -0.994 . . . . 0.0 109.104 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -70.35 -36.79 74.42 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.104 -1.438 . . . . 0.0 109.401 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.7 -34.19 69.19 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -85.09 3.72 37.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.25 -0.906 . . . . 0.0 109.053 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.95 7.94 84.84 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.86 -158.48 1.09 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' MET . . . . . 0.442 ' SD ' ' C ' ' B' ' 50' ' ' MET . 0.0 OUTLIER -170.47 -26.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.177 -1.19 . . . . 0.0 110.164 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -136.77 159.14 24.45 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 5.4 tp -138.39 143.08 39.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.414 -1.05 . . . . 0.0 109.39 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.79 150.24 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.493 -0.754 . . . . 0.0 108.979 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 75.82 177.5 0.2 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.62 ' CG ' ' O ' ' B' ' 55' ' ' PHE . 36.5 t80 170.98 11.79 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 121.646 2.021 . . . . 0.0 106.143 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.672 ' CG ' HH11 ' B' ' 56' ' ' ARG . 0.0 OUTLIER -44.08 122.46 2.91 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.392 -1.442 . . . . 0.0 109.854 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 pt -104.4 172.75 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.561 -0.712 . . . . 0.0 109.421 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 47.3 p -150.99 129.72 12.34 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.354 -0.841 . . . . 0.0 109.301 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 83.0 m -70.19 -174.71 0.85 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.39 133.95 48.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.214 -0.929 . . . . 0.0 109.371 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -149.0 -66.92 0.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.227 -0.92 . . . . 0.0 109.366 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -171.4 -48.69 0.04 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -144.48 -14.14 0.58 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.073 -1.251 . . . . 0.0 109.321 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -49.82 152.89 1.4 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.174 -0.954 . . . . 0.0 109.211 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.445 ' N ' ' CD2' ' B' ' 65' ' ' LEU . 1.5 pt? -161.15 176.59 11.13 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 122.543 1.164 . . . . 0.0 110.053 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.98 158.82 18.3 Favored Glycine 0 N--CA 1.505 3.294 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -161.14 174.87 13.04 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.16 -1.2 . . . . 0.0 109.691 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.72 -165.25 32.44 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 55.1 m -126.47 137.77 53.43 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 61.2 mt -85.27 133.31 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.42 154.98 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.52 -0.737 . . . . 0.0 109.21 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -146.46 137.99 24.58 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' B' ' 19' ' ' GLN . . . -109.41 151.46 26.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.156 -0.965 . . . . 0.0 109.228 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' B' ' 74' ' ' ASP . 35.6 p-10 -130.67 -167.53 1.85 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -167.0 168.79 13.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 109.263 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.64 57.09 0.75 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.533 -0.73 . . . . 0.0 109.345 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 55.75 -147.34 0.53 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.578 -0.701 . . . . 0.0 109.549 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -64.78 160.12 20.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.192 -0.943 . . . . 0.0 109.48 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.438 ' OG1' ' N ' ' B' ' 80' ' ' MET . 2.0 t -73.48 -176.35 2.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.641 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' MET . . . . . 0.438 ' N ' ' OG1' ' B' ' 79' ' ' THR . 13.5 mmt -72.0 114.57 10.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.869 . . . . 0.0 109.41 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.507 -179.982 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 33.4 tpp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 20.5 tt -164.57 142.97 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.887 . . . . 0.0 109.435 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -80.71 -47.49 13.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 109.461 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -163.81 156.41 17.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 109.526 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -68.99 -158.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -120.79 95.66 4.8 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.454 -0.779 . . . . 0.0 110.052 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -93.29 124.98 37.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.309 -0.869 . . . . 0.0 109.214 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 13.2 mt -121.13 147.9 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.461 -0.775 . . . . 0.0 110.655 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' ILE . . . . . 0.454 ' CG2' ' O ' ' C' ' 9' ' ' ILE . 11.1 tt -137.08 114.42 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.093 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 9.9 t -122.24 158.71 28.88 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.004 0.907 . . . . 0.0 108.848 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -85.21 -115.44 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.11 101.36 10.92 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.099 -1.0 . . . . 0.0 109.019 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -167.06 -18.55 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.524 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 59.5 163.2 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.599 -0.688 . . . . 0.0 109.22 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 66.5 mt -125.73 85.09 59.59 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.525 -0.735 . . . . 0.0 109.223 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.44 156.83 39.17 Favored 'Trans proline' 0 C--N 1.324 -0.736 0 C-N-CA 122.024 1.816 . . . . 0.0 110.168 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.05 -6.69 76.36 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 61.6 mt -128.7 137.82 51.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -1.209 . . . . 0.0 108.786 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -87.37 108.35 18.95 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 10.5 mt -93.91 138.45 32.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.4 -0.812 . . . . 0.0 109.652 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' TYR . . . . . 0.416 ' CZ ' ' O ' ' C' ' 22' ' ' SER . 3.0 t80 -123.2 131.82 53.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.502 -0.749 . . . . 0.0 109.252 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' SER . . . . . 0.416 ' O ' ' CZ ' ' C' ' 21' ' ' TYR . 0.0 OUTLIER -53.85 128.74 31.15 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.114 -0.991 . . . . 0.0 111.169 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mt -120.14 11.73 11.7 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.899 0.856 . . . . 0.0 109.308 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.5 -169.05 13.23 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 40.5 mm -122.73 139.09 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.683 0.754 . . . . 0.0 109.777 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -110.26 149.96 29.4 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 29.6 m -143.47 138.83 29.53 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.566 -0.709 . . . . 0.0 109.827 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' THR . . . . . 0.428 ' O ' ' CD1' ' C' ' 65' ' ' LEU . 15.1 t -150.01 153.69 36.94 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.186 -0.946 . . . . 0.0 109.154 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' C' ' 30' ' ' SER . 5.5 tp -88.43 144.23 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.491 -1.381 . . . . 0.0 109.958 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.456 ' O ' ' O ' ' C' ' 29' ' ' ILE . 48.0 t -51.59 -106.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.567 -0.708 . . . . 0.0 110.276 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' C' ' 32' ' ' ASN . 34.9 t0 59.78 63.05 1.56 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' C' ' 31' ' ' ASP . 0.5 OUTLIER 89.16 115.67 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -176.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.4 -38.92 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.121 -0.987 . . . . 0.0 109.754 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . 0.424 ' H ' HD21 ' C' ' 32' ' ' ASN . 0.8 OUTLIER -54.14 -30.27 48.44 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.31 -0.869 . . . . 0.0 108.709 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.69 -35.57 70.29 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 70.3 mt -65.23 -52.31 54.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 C-N-CA 118.429 -1.308 . . . . 0.0 110.43 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 85.4 t -71.04 -46.02 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.881 -1.137 . . . . 0.0 109.752 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.06 -43.85 97.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 0.0 109.397 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -64.13 -39.88 94.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.988 -1.07 . . . . 0.0 109.58 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 65.7 mt -68.97 -44.59 72.6 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 108.809 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' ARG . . . . . 0.738 HH11 ' HG3' ' C' ' 41' ' ' ARG . 0.1 OUTLIER -51.25 -53.68 33.09 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.752 -1.217 . . . . 0.0 109.913 -179.109 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' LYS . . . . . 0.445 ' O ' ' CB ' ' C' ' 46' ' ' ALA . 54.4 mttt -59.48 -37.66 78.8 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.777 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -75.9 -35.02 59.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.133 -0.979 . . . . 0.0 110.091 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 5.2 t -73.97 -51.88 22.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.12 -0.988 . . . . 0.0 108.934 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -72.61 -29.9 63.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 119.972 -1.705 . . . . 0.0 109.488 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' C' ' 42' ' ' LYS . . . -61.11 -29.73 69.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.522 -0.736 . . . . 0.0 109.491 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.66 -4.84 23.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.45 -0.782 . . . . 0.0 109.773 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.38 31.58 6.41 Favored Glycine 0 N--CA 1.498 2.825 0 C-N-CA 119.509 -1.329 . . . . 0.0 111.892 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.69 -178.73 52.49 Favored Glycine 0 N--CA 1.487 2.069 0 O-C-N 120.075 -1.838 . . . . 0.0 111.2 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 21.2 ttt -108.31 -40.86 5.04 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.459 -1.024 . . . . 0.0 110.712 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 175.07 -175.81 47.13 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 6.1 tp -110.62 132.07 54.5 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.511 -0.993 . . . . 0.0 109.694 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 pt -107.84 143.95 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.573 -0.704 . . . . 0.0 109.562 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 64.55 81.72 0.2 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.973 . . . . 0.0 110.113 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.54 -59.15 5.09 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.764 -0.775 . . . . 0.0 108.931 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' ARG . . . . . 0.527 ' HE ' ' HA ' ' C' ' 56' ' ' ARG . 0.0 OUTLIER 60.07 82.99 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.426 -0.796 . . . . 0.0 109.5 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.0 136.53 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' THR . . . . . . . . . . . . . 14.9 m -162.09 133.58 5.32 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.377 -0.827 . . . . 0.0 109.407 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' CYS . . . . . . . . . . . . . 41.1 t -98.58 135.74 39.67 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.312 -0.868 . . . . 0.0 109.13 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.66 65.65 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 0.0 109.518 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 t70 46.91 44.27 14.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.612 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . 174.41 64.4 0.05 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -55.5 101.32 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -1.164 . . . . 0.0 109.465 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -82.76 -177.09 6.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 109.379 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.43 HD12 ' N ' ' C' ' 66' ' ' GLY . 14.8 tp -88.17 127.74 35.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -0.944 . . . . 0.0 109.466 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . 0.43 ' N ' HD12 ' C' ' 65' ' ' LEU . . . -64.68 166.64 30.89 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' C' ' 67' ' ' TYR . 11.1 p90 -151.66 119.99 6.38 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.913 -1.345 . . . . 0.0 108.923 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -131.82 155.69 21.55 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 81.2 m -104.86 136.36 44.5 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.879 -1.365 . . . . 0.0 107.811 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 33.9 mt -90.45 139.0 18.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 108.746 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -145.08 164.13 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.356 -0.84 . . . . 0.0 110.216 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -150.6 147.74 27.79 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' C' ' 74' ' ' ASP . . . -124.09 150.73 44.68 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.19 -0.944 . . . . 0.0 108.939 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' C' ' 73' ' ' ALA . 3.9 m-20 40.27 100.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.388 -0.82 . . . . 0.0 111.262 178.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' C' ' 76' ' ' ALA . 25.0 tt0 -115.5 -30.27 6.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.306 -0.871 . . . . 0.0 109.348 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' C' ' 75' ' ' GLU . . . 42.66 -145.85 0.06 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -132.29 -135.73 0.19 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.408 -0.807 . . . . 0.0 109.176 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 47.54 29.35 1.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.489 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.433 ' C ' ' H ' ' C' ' 81' ' ' ALA . 70.0 p -53.66 -22.03 8.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.4 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -78.17 37.86 0.27 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.385 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' C' ' 79' ' ' THR . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.44 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.431 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.3 0.572 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' ILE . . . . . . . . . . . . . 2.9 tp -165.66 -28.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.909 . . . . 0.0 108.974 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -148.54 -150.26 0.34 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.096 -1.002 . . . . 0.0 109.313 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 54.5 179.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.657 -0.652 . . . . 0.0 109.396 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -148.25 -39.82 0.17 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.145 -0.972 . . . . 0.0 109.414 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -168.88 -111.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.654 -0.654 . . . . 0.0 109.744 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -116.32 120.06 37.68 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.388 -0.82 . . . . 0.0 109.419 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 76.5 mt -99.75 133.78 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.287 -0.883 . . . . 0.0 109.286 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' ILE . . . . . . . . . . . . . 20.3 tt -125.1 124.63 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.492 -0.755 . . . . 0.0 109.555 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.512 ' OG1' ' CG ' ' D' ' 13' ' ' ASP . 11.3 t -119.17 131.9 55.91 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' THR . . . . . 0.49 ' HG1' ' HG1' ' E' ' 69' ' ' THR . 5.9 m -112.59 114.84 27.68 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.3 -0.875 . . . . 0.0 110.896 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . 51.67 77.39 0.14 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.231 -0.918 . . . . 0.0 109.816 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' D' ' 13' ' ' ASP . 4.5 p-10 178.07 -138.6 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -173.28 171.55 4.01 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.848 -1.157 . . . . 0.0 108.759 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 11.5 mt -129.62 78.45 75.42 Favored Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.76 156.13 44.83 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 122.054 1.836 . . . . 0.0 110.035 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.86 -9.79 74.93 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 59.1 mt -127.4 136.04 51.3 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 119.032 1.416 . . . . 0.0 108.501 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -86.56 108.05 18.4 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 6.0 mt -102.81 128.29 49.63 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.506 -0.746 . . . . 0.0 109.853 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' D' ' 21' ' ' TYR . 0.5 OUTLIER -119.17 145.98 45.55 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.338 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.3 t -86.87 131.63 34.05 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.455 0.645 . . . . 0.0 110.426 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . 0.664 ' N ' ' CD2' ' D' ' 23' ' ' LEU . 0.3 OUTLIER -119.56 5.94 11.07 Favored 'General case' 0 N--CA 1.512 2.637 0 CA-C-O 122.948 1.356 . . . . 0.0 108.381 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.46 174.0 21.16 Favored Glycine 0 N--CA 1.497 2.73 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.685 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.12 144.81 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.86 144.19 42.83 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 74.0 m -151.48 139.73 20.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 15.1 t -149.62 147.83 28.59 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.964 -1.085 . . . . 0.0 109.036 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 80.3 mt -117.08 128.17 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.306 -0.871 . . . . 0.0 108.847 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.643 ' HG ' ' H ' ' D' ' 31' ' ' ASP . 12.8 t -177.67 179.62 0.89 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.445 -0.785 . . . . 0.0 108.962 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' ASP . . . . . 0.643 ' H ' ' HG ' ' D' ' 30' ' ' SER . 19.4 p-10 -116.06 163.7 15.55 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.558 -0.714 . . . . 0.0 109.555 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 5.8 t-20 75.68 126.3 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.142 -0.974 . . . . 0.0 108.68 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 89.1 t -68.98 -33.73 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.595 -0.691 . . . . 0.0 109.738 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' D' ' 35' ' ' GLU . 1.3 p30 -59.57 -41.52 90.39 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.125 -0.984 . . . . 0.0 109.58 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' GLU . . . . . 0.527 ' N ' ' OD1' ' D' ' 34' ' ' ASP . 16.8 tp10 -75.3 -41.22 57.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.124 -0.985 . . . . 0.0 109.284 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 90.9 mt -64.26 -42.57 95.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 O-C-N 120.962 -1.086 . . . . 0.0 109.232 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 t -64.14 -49.79 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.769 -1.207 . . . . 0.0 109.223 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.09 -38.66 83.59 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.861 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -60.55 -44.06 96.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 109.602 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 35.1 mt -70.37 -46.23 64.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.206 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -51.37 -45.37 62.39 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.767 -1.208 . . . . 0.0 109.601 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -67.3 -39.29 85.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.432 -0.793 . . . . 0.0 110.062 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -75.91 -36.09 59.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.411 -0.806 . . . . 0.0 109.727 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 15.4 t -69.7 -50.77 47.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 108.787 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -64.6 -34.07 77.41 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 118.243 -1.383 . . . . 0.0 109.322 -175.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.93 -30.94 71.94 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.736 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -85.02 -3.97 58.98 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.16 5.09 68.05 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.15 159.97 52.17 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.36 -7.67 7.56 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.424 -1.045 . . . . 0.0 109.379 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.69 166.37 37.95 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 8.0 tp -129.73 142.79 50.64 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.661 -0.905 . . . . 0.0 109.794 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -107.41 140.65 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.734 -0.604 . . . . 0.0 110.577 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 67.64 86.47 0.13 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.515 -0.741 . . . . 0.0 110.47 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -100.63 37.67 1.66 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.694 0.759 . . . . 0.0 109.743 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' ARG . . . . . 0.743 ' HG3' HH11 ' D' ' 56' ' ' ARG . 0.1 OUTLIER -66.18 130.56 43.64 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.481 -1.387 . . . . 0.0 109.135 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.2 -177.29 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.386 -0.821 . . . . 0.0 109.162 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' THR . . . . . 0.61 ' O ' ' CG ' ' D' ' 64' ' ' PHE . 53.6 m -160.45 76.31 0.59 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' CYS . . . . . . . . . . . . . 43.4 t -146.37 140.32 26.28 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.044 -1.035 . . . . 0.0 109.723 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -179.83 11.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.411 -0.806 . . . . 0.0 109.462 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -162.65 3.57 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.132 -0.98 . . . . 0.0 109.584 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.88 -154.28 16.87 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -98.26 147.44 24.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.344 -1.092 . . . . 0.0 109.394 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . 0.61 ' CG ' ' O ' ' D' ' 58' ' ' THR . 56.6 m-85 -140.83 -105.57 0.15 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.316 -0.865 . . . . 0.0 109.413 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . . . . . . . . . 14.1 tp -176.78 122.49 0.14 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.25 -0.906 . . . . 0.0 110.403 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.75 123.98 5.88 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -137.47 -167.03 2.04 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.557 1.17 . . . . 0.0 110.359 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.66 -176.79 43.44 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 70.9 m -111.64 137.61 49.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.275 -1.132 . . . . 0.0 108.864 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 70' ' ' ILE . . . . . 0.457 ' O ' HD23 ' D' ' 23' ' ' LEU . 62.5 mt -84.54 136.71 22.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 13.5 m -146.75 151.56 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.543 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 72' ' ' LYS . . . . . 0.496 ' HZ1' ' HB2' ' D' ' 72' ' ' LYS . 0.9 OUTLIER -139.07 164.59 29.38 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.973 -1.08 . . . . 0.0 109.029 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.7 150.83 36.17 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -165.24 95.73 0.67 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.979 -1.076 . . . . 0.0 108.569 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -164.51 -70.18 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.3 -0.875 . . . . 0.0 109.014 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.23 64.34 1.73 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.45 -0.781 . . . . 0.0 109.552 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -166.15 93.86 0.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.448 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 78' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -155.7 147.05 22.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.87 . . . . 0.0 109.355 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 74.0 m 51.43 86.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.881 . . . . 0.0 109.409 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 3.6 mmt -57.53 131.58 50.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.527 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.45 -179.952 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ptt? . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.454 0.645 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 19.9 pt -62.01 -179.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.039 -1.038 . . . . 0.0 109.486 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 3' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' E' ' 3' ' ' PHE . 6.3 p90 -151.52 -34.51 0.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 109.453 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . 0.496 ' CD ' HH21 ' E' ' 41' ' ' ARG . 15.7 tp10 177.34 103.79 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 175.52 72.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.606 -0.684 . . . . 0.0 109.214 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -168.14 59.32 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -0.859 . . . . 0.0 108.923 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -105.36 123.73 48.36 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.655 -0.653 . . . . 0.0 109.762 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 89.7 mt -98.0 123.64 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.072 -1.017 . . . . 0.0 110.672 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 9' ' ' ILE . . . . . 0.438 ' CG2' ' O ' ' E' ' 9' ' ' ILE . 19.5 tt -137.21 116.66 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 10' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' E' ' 13' ' ' ASP . 15.2 t -124.66 157.29 35.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.0 -1.063 . . . . 0.0 108.934 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 11' ' ' THR . . . . . 0.709 ' OG1' ' OG1' ' A' ' 69' ' ' THR . 0.0 OUTLIER -135.26 128.24 31.49 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.346 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.4 35.37 24.87 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.898 0.856 . . . . 0.0 109.612 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 13' ' ' ASP . . . . . 0.459 ' HB3' ' OG1' ' E' ' 10' ' ' THR . 23.5 t0 -152.48 86.26 1.27 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.617 -0.677 . . . . 0.0 109.355 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -57.81 170.01 0.66 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 108.957 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 40.0 mt -122.32 80.19 45.22 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.358 -0.839 . . . . 0.0 109.116 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.53 156.99 38.75 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.109 1.873 . . . . 0.0 110.083 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.52 -5.48 73.99 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 18' ' ' LEU . . . . . . . . . . . . . 50.0 mt -128.21 136.62 51.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.938 -1.331 . . . . 0.0 108.776 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -86.04 108.61 18.33 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 10.7 mt -95.42 136.58 35.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.329 -0.857 . . . . 0.0 109.703 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 21' ' ' TYR . . . . . 0.427 ' CZ ' ' O ' ' E' ' 22' ' ' SER . 2.4 t80 -121.04 132.3 54.8 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.575 -0.703 . . . . 0.0 109.174 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 22' ' ' SER . . . . . 0.427 ' O ' ' CZ ' ' E' ' 21' ' ' TYR . 0.0 OUTLIER -58.72 130.77 48.49 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.04 -1.037 . . . . 0.0 111.162 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 mt -116.87 12.53 14.76 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.14 -174.08 15.07 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 31.0 mm -112.44 140.87 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.609 -0.936 . . . . 0.0 109.416 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.32 143.98 45.38 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.706 -0.621 . . . . 0.0 109.657 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 4.0 p -152.38 141.61 21.43 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.817 -1.177 . . . . 0.0 108.512 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 14.2 t -149.64 134.01 17.41 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.107 -0.996 . . . . 0.0 109.152 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 59.9 mt -108.41 127.5 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.333 -0.855 . . . . 0.0 108.909 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 94.5 p -172.55 -140.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.42 -0.8 . . . . 0.0 109.535 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 31' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' E' ' 32' ' ' ASN . 24.7 t70 -155.97 158.67 38.29 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.207 -0.933 . . . . 0.0 109.578 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 32' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 15.1 t30 73.83 126.72 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.19 -0.943 . . . . 0.0 108.867 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.27 -32.16 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.479 -0.763 . . . . 0.0 109.527 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -57.45 -45.59 84.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.876 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -76.05 -38.91 56.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.164 -0.96 . . . . 0.0 109.756 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 79.6 mt -61.78 -49.57 83.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.891 -1.131 . . . . 0.0 109.3 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -62.48 -48.6 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.973 -1.079 . . . . 0.0 109.287 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.67 -39.84 81.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.221 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 39' ' ' ASN . . . . . 0.435 HD21 ' N ' ' E' ' 39' ' ' ASN . 2.0 m120 -64.51 -44.89 89.5 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.24 -0.913 . . . . 0.0 109.688 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 40' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' E' ' 41' ' ' ARG . 27.8 mt -68.63 -45.7 71.17 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.014 -1.054 . . . . 0.0 108.543 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 41' ' ' ARG . . . . . 0.826 HH11 ' HG2' ' E' ' 41' ' ' ARG . 5.3 ttt-85 -47.84 -53.67 14.87 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.79 -1.193 . . . . 0.0 109.054 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -60.01 -35.87 75.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.408 -0.808 . . . . 0.0 110.012 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -77.16 -35.03 56.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.503 -0.748 . . . . 0.0 109.93 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 t -70.45 -51.92 33.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 121.053 -1.029 . . . . 0.0 108.677 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -68.42 -31.8 71.38 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.326 -1.35 . . . . 0.0 109.275 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.75 -29.44 69.95 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.22 -5.62 58.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.589 -0.694 . . . . 0.0 109.686 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.49 3.94 58.38 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.74 163.2 45.75 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -125.15 -10.45 7.06 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.394 -1.062 . . . . 0.0 109.771 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.68 157.92 30.0 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.106 -1.521 . . . . 0.0 109.648 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.43 139.93 46.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.709 -0.877 . . . . 0.0 109.32 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 pt -106.66 140.06 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.418 -0.801 . . . . 0.0 109.597 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.79 82.2 0.16 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 122.259 1.028 . . . . 0.0 111.73 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -60.11 -102.84 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.142 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 56' ' ' ARG . . . . . 0.502 ' HE ' ' HA2' ' E' ' 66' ' ' GLY . 6.4 ttm180 -173.84 -125.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.962 -1.086 . . . . 0.0 108.989 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 57' ' ' ILE . . . . . 0.468 ' O ' ' O ' ' E' ' 56' ' ' ARG . 0.0 OUTLIER 39.34 96.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 121.726 -0.609 . . . . 0.0 109.771 179.03 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 58' ' ' THR . . . . . . . . . . . . . 2.0 m -122.7 -134.92 0.29 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 59' ' ' CYS . . . . . . . . . . . . . 27.1 t -171.5 157.79 4.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.879 . . . . 0.0 109.531 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . 51.53 57.11 6.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 109.877 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -173.85 -12.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.362 -0.836 . . . . 0.0 109.546 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.65 132.79 0.09 OUTLIER Glycine 0 N--CA 1.495 2.58 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 pptp? -163.31 153.15 15.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -1.128 . . . . 0.0 109.619 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 64' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -168.19 35.02 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -0.925 . . . . 0.0 109.471 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.401 ' O ' ' NE ' ' E' ' 56' ' ' ARG . 0.0 OUTLIER -163.57 150.57 12.31 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.3 -0.875 . . . . 0.0 109.213 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 66' ' ' GLY . . . . . 0.502 ' HA2' ' HE ' ' E' ' 56' ' ' ARG . . . -85.69 146.46 21.5 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 176.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -153.9 110.05 3.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.269 -1.136 . . . . 0.0 109.493 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.16 165.93 28.11 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 69' ' ' THR . . . . . 0.49 ' HG1' ' HG1' ' D' ' 11' ' ' THR . 61.3 m -107.79 137.77 45.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.407 -1.054 . . . . 0.0 108.183 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 28.9 mt -85.37 144.33 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 m -144.77 163.33 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.287 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -153.79 155.43 35.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 0.0 108.749 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.48 150.94 35.69 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.123 -0.986 . . . . 0.0 108.739 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -168.66 53.84 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.964 -1.085 . . . . 0.0 108.666 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -124.44 105.4 9.38 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.496 -0.753 . . . . 0.0 109.341 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . -167.01 -60.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.291 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 77' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -87.16 -177.64 6.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.285 -0.884 . . . . 0.0 109.333 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 78' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' E' ' 78' ' ' PHE . 19.0 p90 -88.5 120.29 29.74 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.259 -0.9 . . . . 0.0 109.423 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 25.6 m -160.26 -77.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.42 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 36.6 mtp -81.05 155.06 26.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.294 -0.879 . . . . 0.0 109.563 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.492 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.7 ttp . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.0 pt -144.77 -174.02 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.344 -0.848 . . . . 0.0 109.195 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 3' ' ' PHE . 9.2 p90 -145.34 49.77 1.24 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.194 -0.942 . . . . 0.0 109.338 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 60.08 8.29 1.44 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -0.834 . . . . 0.0 109.554 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 50.71 -151.92 0.2 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.889 . . . . 0.0 109.446 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.479 ' CG ' ' H ' ' A' ' 7' ' ' PHE . 29.0 ttmt -152.18 173.51 14.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.387 -0.821 . . . . 0.0 109.786 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.479 ' H ' ' CG ' ' A' ' 6' ' ' LYS . 56.7 t80 -91.68 120.01 32.05 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.33 -0.856 . . . . 0.0 109.437 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.6 mt -115.21 143.51 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.63 -0.669 . . . . 0.0 109.477 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.45 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 11.4 tt -124.69 119.71 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.425 ' OG1' ' OD2' ' A' ' 13' ' ' ASP . 5.5 t -112.32 132.48 54.96 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.372 -0.83 . . . . 0.0 109.351 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.526 ' OG1' ' HB ' ' B' ' 69' ' ' THR . 0.2 OUTLIER -64.05 -135.77 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.387 -0.821 . . . . 0.0 109.919 -179.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.19 80.27 6.29 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.714 0.768 . . . . 0.0 109.843 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.425 ' OD2' ' OG1' ' A' ' 10' ' ' THR . 8.1 p-10 -154.99 -126.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -171.49 171.58 5.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.987 -1.07 . . . . 0.0 109.3 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.1 mt -130.65 75.12 79.35 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.389 -0.82 . . . . 0.0 108.884 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.77 157.65 36.83 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 122.09 1.86 . . . . 0.0 110.177 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.01 -7.49 73.16 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 73.3 mt -125.41 137.81 54.01 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.077 -1.249 . . . . 0.0 109.482 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -86.55 108.4 18.56 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 3.7 mt -110.56 128.81 55.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.495 -0.753 . . . . 0.0 109.999 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.596 ' OH ' ' N ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -107.75 149.81 27.73 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.038 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.25 126.01 30.21 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.68 14.28 21.19 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.6 178.37 18.48 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.03 143.96 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.958 -0.731 . . . . 0.0 109.174 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.52 154.87 25.25 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.668 -0.645 . . . . 0.0 109.779 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.2 m -128.7 156.46 43.45 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.48 145.98 49.22 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.246 -0.909 . . . . 0.0 109.324 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.435 ' O ' ' OG ' ' A' ' 30' ' ' SER . 2.2 mm -129.13 128.48 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 120.953 1.706 . . . . 0.0 106.797 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 29' ' ' ILE . 1.2 m 171.86 -165.54 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.919 -1.113 . . . . 0.0 109.303 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -120.84 -70.86 0.76 Allowed 'General case' 0 N--CA 1.513 2.704 0 O-C-N 121.619 -0.675 . . . . 0.0 112.453 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -62.61 149.76 42.48 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.526 -1.359 . . . . 0.0 108.453 176.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.17 -39.98 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.83 -29.44 40.99 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.421 -0.799 . . . . 0.0 109.762 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.402 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 12.8 mm-40 -78.46 -33.91 48.08 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.38 -0.825 . . . . 0.0 109.371 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.6 mt -62.56 -47.64 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.911 . . . . 0.0 109.258 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.25 -53.17 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.738 -1.226 . . . . 0.0 110.267 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -57.2 -36.9 71.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.203 -0.936 . . . . 0.0 109.95 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 35' ' ' GLU . 76.8 m-20 -64.71 -43.44 93.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.201 -0.937 . . . . 0.0 110.132 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.1 mt -69.89 -45.86 66.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.935 -1.103 . . . . 0.0 109.53 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -48.97 -45.88 42.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.8 -1.188 . . . . 0.0 109.223 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -64.52 -36.62 84.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.479 -0.763 . . . . 0.0 110.182 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -75.53 -36.16 60.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.365 -0.835 . . . . 0.0 109.824 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.8 t -69.24 -50.13 55.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.126 -0.984 . . . . 0.0 109.487 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -64.76 -29.7 70.68 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.013 -175.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.2 -32.09 69.85 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.498 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.88 3.29 34.5 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.479 -0.763 . . . . 0.0 109.099 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.84 4.33 88.21 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.88 -157.22 0.4 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -166.11 -23.46 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.203 -1.174 . . . . 0.0 110.023 178.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.548 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -151.18 143.9 11.09 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.6 tp -106.84 138.98 41.98 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.962 . . . . 0.0 109.357 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -109.48 139.67 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.604 -0.685 . . . . 0.0 110.628 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 73.09 85.24 0.11 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.679 -0.638 . . . . 0.0 110.586 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -111.47 121.2 44.57 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -140.39 105.87 5.08 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -0.853 . . . . 0.0 109.422 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.7 mt -63.95 139.5 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.363 -0.836 . . . . 0.0 109.248 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.7 m -77.27 -94.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 109.448 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.9 p -156.79 174.13 15.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.07 -1.018 . . . . 0.0 109.405 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.37 136.65 32.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.268 -0.895 . . . . 0.0 109.544 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 50.03 85.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 109.768 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 64' ' ' PHE . . . 150.79 136.32 2.5 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? 65.44 -45.28 0.37 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.468 ' H ' ' C ' ' A' ' 62' ' ' GLY . 46.7 m-85 47.44 47.96 16.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.24 -0.913 . . . . 0.0 109.706 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 177.96 141.41 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.32 -0.863 . . . . 0.0 109.25 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -122.61 -125.86 3.12 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -172.2 137.35 0.89 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.793 -1.416 . . . . 0.0 110.185 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.27 148.04 17.47 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 79.5 m -105.12 143.0 33.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.015 -1.286 . . . . 0.0 109.384 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.8 mt -91.66 143.72 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.41 -0.806 . . . . 0.0 109.102 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 20' ' ' LEU . 10.6 m -142.27 151.97 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 109.101 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -141.09 143.82 34.55 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.16 -0.962 . . . . 0.0 108.933 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.591 ' O ' ' CB ' ' A' ' 74' ' ' ASP . . . -124.44 152.58 43.12 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.596 ' N ' ' OH ' ' A' ' 21' ' ' TYR . 25.6 t0 97.57 85.5 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 CA-C-O 121.221 0.534 . . . . 0.0 110.213 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -139.8 -48.73 0.47 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.32 -0.862 . . . . 0.0 109.168 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.502 ' O ' ' C ' ' A' ' 77' ' ' GLN . . . -168.31 44.08 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 109.182 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 79' ' ' THR . 1.1 tm0? -30.58 -52.69 0.17 Allowed 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.345 0.593 . . . . 0.0 110.453 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.414 ' O ' ' OG1' ' A' ' 79' ' ' THR . 74.6 m-85 -64.27 72.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.395 -0.816 . . . . 0.0 109.476 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.4 m -166.48 144.14 5.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.897 . . . . 0.0 109.215 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.51 18.07 4.14 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.282 -0.886 . . . . 0.0 109.217 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.519 179.846 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.531 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 9.8 mm -75.52 -27.02 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.204 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -71.73 -159.93 0.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.248 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.432 ' N ' ' CD ' ' B' ' 4' ' ' GLU . 15.5 mp0 -122.97 77.48 1.46 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.517 -0.739 . . . . 0.0 109.293 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.549 ' CG ' ' H ' ' B' ' 6' ' ' LYS . 22.5 t70 -136.08 -148.87 0.31 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.537 -0.727 . . . . 0.0 109.15 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.549 ' H ' ' CG ' ' B' ' 5' ' ' ASP . 32.3 tttm 63.91 121.61 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.867 . . . . 0.0 109.536 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -106.46 118.89 37.83 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.368 -0.833 . . . . 0.0 109.526 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.5 mt -112.08 132.73 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.436 ' O ' ' CG2' ' B' ' 9' ' ' ILE . 10.1 tt -125.78 114.39 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.78 158.93 32.13 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.412 -0.805 . . . . 0.0 108.945 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 12.6 p -110.64 86.52 2.33 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.38 -110.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.685 -0.635 . . . . 0.0 109.914 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -147.02 -161.35 1.31 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.227 -0.92 . . . . 0.0 109.576 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . 0.416 ' O ' ' HD3' ' B' ' 16' ' ' PRO . 0.7 OUTLIER -58.84 131.45 51.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.421 -0.799 . . . . 0.0 109.583 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.03 110.2 3.01 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' B' ' 14' ' ' GLU . 1.9 Cg_endo -63.68 154.11 71.17 Favored 'Trans proline' 0 N--CA 1.481 0.746 0 C-N-CA 121.286 1.324 . . . . 0.0 110.26 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.44 -6.68 82.23 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.32 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 73.2 mt -129.94 142.43 50.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -1.139 . . . . 0.0 109.976 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -87.7 108.25 19.02 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -93.29 140.52 29.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.156 -0.965 . . . . 0.0 110.484 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . 0.405 ' CD1' ' N ' ' B' ' 22' ' ' SER . 1.3 t80 -123.2 131.3 53.63 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.405 ' N ' ' CD1' ' B' ' 21' ' ' TYR . 11.8 t -59.5 129.75 43.5 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.085 -1.009 . . . . 0.0 110.607 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mt -117.07 9.24 13.56 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.78 173.77 16.38 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 49.3 mm -111.19 143.5 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.868 -0.783 . . . . 0.0 109.101 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.28 144.65 43.42 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.377 -0.827 . . . . 0.0 109.199 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 9.4 p -152.53 143.74 23.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.986 -1.071 . . . . 0.0 108.71 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 7.7 t -150.35 152.82 35.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.137 -0.977 . . . . 0.0 109.426 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 1.8 mm -122.92 128.1 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 53.8 p -173.49 -153.17 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.519 -0.738 . . . . 0.0 109.709 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 3.7 p-10 -135.31 157.14 47.67 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.461 -0.774 . . . . 0.0 109.495 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 4.1 t-20 82.57 115.16 0.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.1 -39.94 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.26 -35.44 77.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.374 -0.829 . . . . 0.0 110.129 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -73.33 -37.17 66.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.317 -0.865 . . . . 0.0 108.929 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 14.3 mt -62.23 -42.88 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 108.928 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 63.6 t -55.44 -48.82 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.988 -1.07 . . . . 0.0 108.627 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.74 -40.45 92.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.4 -0.812 . . . . 0.0 110.008 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -59.16 -46.57 88.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.13 -0.981 . . . . 0.0 109.72 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.97 -46.39 65.32 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.799 -1.188 . . . . 0.0 108.678 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . 0.757 HH11 ' HG2' ' B' ' 41' ' ' ARG . 6.4 ttt-85 -49.63 -49.61 46.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.822 -1.174 . . . . 0.0 108.878 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 6.3 pttm -61.42 -35.24 76.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 0.0 108.909 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -71.67 -36.5 70.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.517 -0.74 . . . . 0.0 109.225 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 52.2 t -75.35 -49.75 26.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.981 -1.074 . . . . 0.0 109.21 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.638 ' HZ2' ' NH1' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -48.96 -31.99 8.35 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.531 1.158 . . . . 0.0 110.276 -178.287 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.53 -27.04 51.56 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.71 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -93.84 13.12 23.53 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.14 31.11 32.94 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 118.656 -1.735 . . . . 0.0 109.814 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.3 153.75 28.03 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 68.1 mmm -63.1 -45.35 92.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.349 -1.089 . . . . 0.0 110.673 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.27 -169.49 39.82 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.1 tp -102.43 141.82 34.64 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.507 -0.996 . . . . 0.0 110.034 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' B' ' 53' ' ' ILE . 1.1 pp -119.64 147.77 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.794 0.807 . . . . 0.0 112.075 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 52.94 52.73 13.29 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 119.692 -1.88 . . . . 0.0 109.403 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -83.76 96.35 8.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.018 -1.051 . . . . 0.0 109.327 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.821 HH21 HH22 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -97.56 138.04 35.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.351 -0.843 . . . . 0.0 109.189 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 97.7 mt -109.07 118.14 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 35.7 p -128.43 26.53 5.66 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 45.7 t -69.24 112.17 5.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.313 -0.867 . . . . 0.0 109.25 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.89 -117.52 0.08 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.267 -0.896 . . . . 0.0 109.206 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.58 -8.62 14.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.097 -1.002 . . . . 0.0 109.392 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.66 139.16 6.32 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.431 ' HD3' ' H ' ' B' ' 63' ' ' LYS . 0.8 OUTLIER -81.95 120.14 24.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.428 -1.042 . . . . 0.0 109.772 -179.453 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.443 ' O ' ' O ' ' B' ' 65' ' ' LEU . 92.0 m-85 -98.51 13.5 31.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.373 -0.83 . . . . 0.0 109.416 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' B' ' 64' ' ' PHE . 5.3 mp 58.89 144.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.601 0.715 . . . . 0.0 110.255 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' B' ' 67' ' ' TYR . . . -81.71 60.64 4.73 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' B' ' 66' ' ' GLY . 3.0 p90 -44.02 121.57 2.51 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.512 -0.993 . . . . 0.0 109.334 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.22 135.28 5.58 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' THR . . . . . 0.526 ' HB ' ' OG1' ' A' ' 11' ' ' THR . 23.6 m -95.79 138.22 33.75 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.104 -1.233 . . . . 0.0 108.348 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 47.6 mt -84.94 141.78 14.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.52 163.97 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.774 0.797 . . . . 0.0 109.811 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -151.01 151.32 31.9 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.97 149.88 45.46 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -73.39 150.78 41.51 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.026 -1.046 . . . . 0.0 109.366 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -82.57 25.81 0.61 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.932 . . . . 0.0 109.514 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -162.32 168.5 22.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . 0.495 ' CD ' ' N ' ' B' ' 77' ' ' GLN . 3.8 pm0 -151.77 -8.19 0.22 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.226 -0.921 . . . . 0.0 109.445 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -81.71 61.23 5.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.351 -0.843 . . . . 0.0 109.467 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 60.9 p -142.24 130.32 22.0 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.326 -0.859 . . . . 0.0 109.287 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' MET . . . . . 0.511 ' N ' ' SD ' ' B' ' 80' ' ' MET . 1.1 mpt? -67.38 -101.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.361 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.536 -179.94 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 10.1 ptt? . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 1.1 tp -93.63 105.2 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.293 -0.88 . . . . 0.0 109.133 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' PHE . . . . . 0.476 ' O ' ' N ' ' C' ' 5' ' ' ASP . 18.4 m-85 -91.79 64.44 4.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.783 -1.198 . . . . 0.0 108.86 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . 0.482 ' O ' ' C ' ' C' ' 5' ' ' ASP . 12.3 pt-20 34.56 33.99 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.826 -0.546 . . . . 0.0 110.684 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' ASP . . . . . 0.482 ' C ' ' O ' ' C' ' 4' ' ' GLU . 3.4 p-10 33.95 79.85 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.246 0.546 . . . . 0.0 109.909 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -72.96 126.53 30.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.885 . . . . 0.0 109.858 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -92.03 120.76 32.97 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 80.5 mt -116.82 145.75 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.535 -0.728 . . . . 0.0 109.817 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' ILE . . . . . 0.448 ' CG2' ' O ' ' C' ' 9' ' ' ILE . 11.5 tt -130.5 114.63 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.424 ' OG1' ' OD1' ' C' ' 13' ' ' ASP . 11.7 t -123.09 159.36 28.66 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.962 0.887 . . . . 0.0 108.823 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' THR . . . . . 0.456 ' OG1' ' OG1' ' D' ' 69' ' ' THR . 1.7 p -88.5 -113.5 0.06 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.49 99.0 8.62 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.258 -0.902 . . . . 0.0 109.239 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . 0.424 ' OD1' ' OG1' ' C' ' 10' ' ' THR . 0.9 OUTLIER -169.01 -13.44 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.72 -179.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 57.24 173.02 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.312 -0.867 . . . . 0.0 109.57 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 66.4 mt -134.37 83.35 44.07 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.47 -0.769 . . . . 0.0 109.142 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.64 157.14 43.59 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 121.936 1.758 . . . . 0.0 110.139 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.38 -7.85 75.15 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 37.0 mt -127.86 140.37 52.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.142 -1.211 . . . . 0.0 109.716 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -86.44 110.39 19.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -95.67 136.29 36.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.112 -0.993 . . . . 0.0 110.182 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -118.51 130.16 55.77 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 4.9 t -65.26 128.38 35.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.935 -1.103 . . . . 0.0 110.746 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 12.4 mt -115.04 8.5 15.76 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.74 178.72 18.86 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.08 144.22 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.801 -0.823 . . . . 0.0 109.066 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.62 144.21 44.23 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.645 -0.66 . . . . 0.0 109.609 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 86.9 p -152.41 136.08 16.16 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 10.7 t -149.88 153.34 36.53 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.942 -1.099 . . . . 0.0 109.339 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 4.9 mp -125.28 132.03 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.18 -0.95 . . . . 0.0 108.726 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.425 ' O ' ' O ' ' C' ' 31' ' ' ASP . 0.2 OUTLIER -169.98 7.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.568 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' C' ' 32' ' ' ASN . 21.5 t0 58.88 153.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.314 -0.866 . . . . 0.0 109.808 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . 0.469 ' N ' ' OD1' ' C' ' 31' ' ' ASP . 3.6 m120 81.26 115.17 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.11 -40.81 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -58.81 -33.71 70.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.364 -0.835 . . . . 0.0 109.914 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -76.44 -36.36 58.0 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.289 -0.882 . . . . 0.0 109.188 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 55.5 mt -62.95 -52.7 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 0.0 109.086 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -51.71 -49.45 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 108.574 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -61.42 -41.84 97.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.394 -0.816 . . . . 0.0 109.631 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -64.63 -46.15 83.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 0.0 109.871 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.32 -46.86 72.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.025 -1.047 . . . . 0.0 108.547 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' ARG . . . . . 0.615 ' CG ' HH11 ' C' ' 41' ' ' ARG . 0.0 OUTLIER -47.75 -53.71 14.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.0 -1.062 . . . . 0.0 109.087 178.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -57.56 -35.11 69.93 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.306 -0.871 . . . . 0.0 110.214 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -75.9 -35.69 59.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.508 -0.745 . . . . 0.0 109.706 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 4.7 t -73.55 -51.64 24.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.139 -0.975 . . . . 0.0 108.99 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' LYS . . . . . 0.418 ' HZ1' ' NH2' ' C' ' 41' ' ' ARG . 22.8 ttpt -63.45 -29.13 70.46 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.205 -175.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.77 -29.57 69.56 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -91.39 6.47 45.27 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.411 -0.805 . . . . 0.0 109.146 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.11 28.97 74.09 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.0 -1.571 . . . . 0.0 109.479 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.57 -164.11 14.18 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 5.6 tmm? -117.39 -37.55 3.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.947 . . . . 0.0 110.573 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 176.75 169.27 37.87 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 7.5 tp -95.64 132.78 40.44 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.348 -1.089 . . . . 0.0 109.836 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 pt -109.85 144.86 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.507 -0.746 . . . . 0.0 109.936 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 69.37 82.81 0.16 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -114.73 85.55 2.27 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' ARG . . . . . 0.821 HH22 HH21 ' B' ' 56' ' ' ARG . 89.3 mtt180 -112.1 161.54 16.39 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.543 -0.723 . . . . 0.0 109.262 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 67.8 mt -139.21 80.37 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.443 -0.786 . . . . 0.0 108.934 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' THR . . . . . . . . . . . . . 70.9 p -74.46 -55.54 5.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 109.136 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' CYS . . . . . . . . . . . . . 73.3 m 49.7 -97.03 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.345 -0.847 . . . . 0.0 109.827 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . 57.13 34.03 24.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -160.22 -73.95 0.07 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.121 -0.987 . . . . 0.0 110.013 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . 0.465 ' O ' ' CE1' ' C' ' 64' ' ' PHE . . . -168.36 -77.53 0.04 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -55.13 143.53 26.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.846 -0.797 . . . . 0.0 109.997 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . 0.465 ' CE1' ' O ' ' C' ' 62' ' ' GLY . 32.7 m-85 -110.09 117.06 32.71 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 11.1 mt -118.59 109.22 15.9 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.87 0.843 . . . . 0.0 110.986 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.32 57.2 2.76 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -49.46 133.16 20.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.15 -1.206 . . . . 0.0 110.103 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.35 149.09 20.82 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 49.8 m -96.8 136.8 36.84 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.975 -1.309 . . . . 0.0 108.271 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 37.4 mt -83.83 139.72 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.8 m -126.31 165.04 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.306 -0.871 . . . . 0.0 109.913 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -155.28 140.02 17.1 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.448 ' O ' ' CG ' ' C' ' 74' ' ' ASP . . . -116.58 115.06 25.03 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.895 -1.128 . . . . 0.0 110.674 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' C' ' 73' ' ' ALA . 3.0 m-20 -178.49 12.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.597 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -80.99 38.1 0.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 109.639 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.93 3.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.537 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' GLN . . . . . 0.409 ' O ' ' CG ' ' C' ' 78' ' ' PHE . 7.9 tp-100 -82.03 39.95 0.59 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.0 109.432 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . 0.409 ' CG ' ' O ' ' C' ' 77' ' ' GLN . 75.2 m-85 -155.49 53.63 0.61 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 109.304 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 28.7 p 47.87 83.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.27 -0.894 . . . . 0.0 109.526 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 23.8 mtt 55.2 -123.7 2.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.402 -0.811 . . . . 0.0 109.499 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.409 -179.937 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ptp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' ILE . . . . . . . . . . . . . 33.1 pt -83.59 -151.1 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.33 -0.856 . . . . 0.0 109.331 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -161.14 25.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.286 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' D' ' 6' ' ' LYS . 48.3 mm-40 50.82 -146.13 0.46 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.317 -0.865 . . . . 0.0 109.553 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' D' ' 5' ' ' ASP . 3.7 m-20 60.33 3.9 0.61 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.445 -0.784 . . . . 0.0 109.97 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' D' ' 4' ' ' GLU . 94.9 mttt -88.7 72.74 8.63 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.074 -1.016 . . . . 0.0 109.192 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -94.3 124.95 38.63 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.362 -0.836 . . . . 0.0 109.807 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 75.5 mt -114.54 127.41 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.554 -0.716 . . . . 0.0 109.219 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' ILE . . . . . 0.431 ' O ' ' CG2' ' D' ' 9' ' ' ILE . 17.0 tt -121.26 114.94 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.7 t -122.52 151.88 40.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.39 72.45 0.95 Allowed 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.555 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.31 -101.59 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.159 -1.588 . . . . 0.0 108.417 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -119.87 -154.6 0.58 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.414 -0.804 . . . . 0.0 109.614 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -78.68 -172.0 2.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.237 -0.914 . . . . 0.0 109.564 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 84.5 mt -120.35 93.68 48.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -61.58 155.62 52.17 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.716 1.611 . . . . 0.0 110.607 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.44 -9.63 75.64 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 71.7 mt -129.37 141.41 51.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.266 -1.137 . . . . 0.0 109.487 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -84.96 108.86 17.79 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 13.8 mt -91.4 133.82 35.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.896 -1.128 . . . . 0.0 110.145 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' TYR . . . . . 0.541 ' CE1' ' O ' ' D' ' 22' ' ' SER . 0.9 OUTLIER -120.82 130.67 54.06 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' SER . . . . . 0.541 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 0.0 OUTLIER -66.37 130.64 43.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.156 -0.965 . . . . 0.0 111.494 -179.018 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 14.0 mt -119.94 14.16 12.35 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.04 -174.46 15.21 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 46.7 mm -112.75 138.87 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 122.014 -0.698 . . . . 0.0 109.187 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.28 144.39 43.81 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.336 -0.853 . . . . 0.0 110.212 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 22.4 p -153.17 135.33 14.85 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 7.3 t -150.17 141.21 22.98 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.821 -1.175 . . . . 0.0 109.85 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 tp -126.47 131.84 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.491 ' O ' ' O ' ' D' ' 31' ' ' ASP . 56.8 p -168.51 8.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.625 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' D' ' 30' ' ' SER . 36.9 t0 54.2 156.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.528 -0.733 . . . . 0.0 110.177 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 2.3 t-20 74.37 129.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.959 -1.088 . . . . 0.0 108.504 -178.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 t -67.61 -35.55 73.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.424 -0.797 . . . . 0.0 109.587 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -59.06 -44.31 91.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.355 -0.841 . . . . 0.0 110.559 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -75.5 -37.47 60.14 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.958 -1.089 . . . . 0.0 109.517 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 83.5 mt -66.48 -42.09 89.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.914 -1.116 . . . . 0.0 109.513 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -65.46 -53.73 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.639 -1.288 . . . . 0.0 110.135 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -55.42 -35.52 65.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.293 -0.88 . . . . 0.0 109.433 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' ASN . . . . . 0.468 ' N ' HD21 ' D' ' 39' ' ' ASN . 1.0 OUTLIER -66.55 -41.14 89.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.843 . . . . 0.0 109.813 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 17.4 mt -75.42 -51.07 13.94 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.883 -1.136 . . . . 0.0 108.815 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' ARG . . . . . 0.495 ' HE ' ' HZ3' ' D' ' 45' ' ' LYS . 60.8 ttt180 -48.85 -52.6 23.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.835 -1.165 . . . . 0.0 108.974 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' D' ' 46' ' ' ALA . 27.7 ttmt -59.81 -36.75 77.4 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.472 -0.768 . . . . 0.0 110.225 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -75.27 -35.77 61.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.122 -0.987 . . . . 0.0 110.003 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -74.38 -51.7 22.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.135 -0.978 . . . . 0.0 109.487 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' LYS . . . . . 0.495 ' HZ3' ' HE ' ' D' ' 41' ' ' ARG . 21.5 mtmt -71.74 -34.57 69.64 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.451 -1.406 . . . . 0.0 109.812 -176.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' D' ' 42' ' ' LYS . . . -56.69 -30.81 63.82 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -92.63 -5.06 52.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.34 -0.85 . . . . 0.0 109.748 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.35 8.23 56.49 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.63 -173.6 4.52 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' MET . . . . . 0.435 ' SD ' ' C ' ' D' ' 50' ' ' MET . 0.0 OUTLIER -161.19 -23.37 0.05 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.091 -1.241 . . . . 0.0 110.885 176.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -137.32 146.8 18.75 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 34.9 tp -137.12 146.17 44.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.678 -0.895 . . . . 0.0 109.289 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' ILE . . . . . 0.454 ' CD1' ' H ' ' D' ' 53' ' ' ILE . 0.1 OUTLIER -109.69 162.63 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.47 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.622 ' O ' ' CB ' ' D' ' 55' ' ' PHE . . . 65.81 -163.45 0.25 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . 0.622 ' CB ' ' O ' ' D' ' 54' ' ' ALA . 67.2 t80 134.19 -5.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' ARG . . . . . 0.683 ' NH1' HH22 ' E' ' 56' ' ' ARG . 16.6 ptm180 -51.21 145.81 7.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.3 -0.875 . . . . 0.0 109.805 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.52 140.11 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.59 95.86 1.95 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.905 . . . . 0.0 109.398 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' CYS . . . . . . . . . . . . . 25.7 p -102.01 135.57 43.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.406 -0.809 . . . . 0.0 108.974 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -146.72 125.27 12.44 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.203 -0.936 . . . . 0.0 109.701 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 49.65 -97.5 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.379 -0.826 . . . . 0.0 109.721 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.16 -172.7 0.73 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -77.98 -159.5 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.411 -1.052 . . . . 0.0 110.172 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . 0.667 ' CG ' ' N ' ' D' ' 65' ' ' LEU . 61.9 t80 -165.61 -179.2 5.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.352 -0.842 . . . . 0.0 109.328 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 0.667 ' N ' ' CG ' ' D' ' 64' ' ' PHE . 12.2 tp -164.0 105.24 0.9 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.069 -1.02 . . . . 0.0 111.006 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.09 179.73 1.09 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -154.11 138.89 17.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.05 -1.264 . . . . 0.0 109.401 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.21 166.03 35.61 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 69' ' ' THR . . . . . 0.456 ' OG1' ' OG1' ' C' ' 11' ' ' THR . 98.7 m -115.14 137.95 51.45 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.568 -0.96 . . . . 0.0 108.417 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 46.0 mt -87.16 126.42 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.94 -1.1 . . . . 0.0 108.326 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 71' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' D' ' 21' ' ' TYR . 3.5 m -137.97 162.97 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.337 -0.852 . . . . 0.0 110.22 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -153.52 154.11 33.69 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.468 ' O ' ' CB ' ' D' ' 74' ' ' ASP . . . -121.15 115.41 23.02 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.548 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' D' ' 73' ' ' ALA . 2.0 m-20 159.79 -102.02 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -173.03 138.23 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.68 157.74 34.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.105 -0.997 . . . . 0.0 108.663 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -64.83 -2.86 2.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.521 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 78' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -76.61 88.24 3.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.94 . . . . 0.0 109.323 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 9.5 t -163.44 -39.59 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.902 . . . . 0.0 109.516 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 21.7 ttt -162.77 -30.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 117.887 -1.054 . . . . 0.0 109.71 -179.968 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 2.2 tpt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . 0.439 ' O ' ' CG ' ' E' ' 3' ' ' PHE . 3.2 tt -166.47 117.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.297 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 3' ' ' PHE . . . . . 0.439 ' CG ' ' O ' ' E' ' 2' ' ' ILE . 85.1 m-85 -154.46 17.73 0.47 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.011 -1.055 . . . . 0.0 109.182 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' E' ' 4' ' ' GLU . 10.9 mp0 -67.72 -13.38 62.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.873 . . . . 0.0 109.27 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 5' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -72.25 111.62 7.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.304 -0.873 . . . . 0.0 109.37 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -103.03 -79.1 0.54 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.351 -0.843 . . . . 0.0 109.286 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -112.17 119.71 39.31 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.363 -0.836 . . . . 0.0 109.595 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 69.8 mt -100.85 128.18 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.396 -0.815 . . . . 0.0 109.77 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 9' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' E' ' 9' ' ' ILE . 11.3 tt -128.42 115.03 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 1.7 t -125.41 157.47 36.76 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.902 0.858 . . . . 0.0 109.11 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.97 92.58 3.79 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.99 -150.87 0.06 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.194 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 13' ' ' ASP . . . . . 0.493 ' CG ' ' H ' ' E' ' 14' ' ' GLU . 1.7 p-10 -76.63 -72.52 0.33 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.214 -0.929 . . . . 0.0 109.551 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . 0.493 ' H ' ' CG ' ' E' ' 13' ' ' ASP . 13.8 pt-20 -153.44 -166.95 2.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.168 -0.958 . . . . 0.0 109.291 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 52.9 mt -121.45 88.34 46.1 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.14 156.18 51.78 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 121.791 1.66 . . . . 0.0 110.641 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.97 -5.92 76.2 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 18' ' ' LEU . . . . . . . . . . . . . 37.9 mt -129.34 139.86 51.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.286 -1.126 . . . . 0.0 109.971 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -84.23 108.53 17.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 14.2 mt -101.91 136.54 41.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.344 -0.848 . . . . 0.0 110.304 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 21' ' ' TYR . . . . . 0.55 ' CE1' ' O ' ' E' ' 22' ' ' SER . 0.4 OUTLIER -120.57 129.91 53.98 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 22' ' ' SER . . . . . 0.55 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 13.4 t -56.74 130.16 44.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 111.668 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 11.9 mt -119.22 5.62 11.23 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.39 -179.19 16.68 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.09 145.33 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 122.033 -0.687 . . . . 0.0 109.263 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.25 159.68 22.28 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.645 -0.659 . . . . 0.0 109.348 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 89.3 p -153.11 143.6 22.59 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 28' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' E' ' 65' ' ' LEU . 11.2 p -142.93 134.47 26.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.183 -0.948 . . . . 0.0 111.02 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.547 ' O ' ' OG ' ' E' ' 30' ' ' SER . 2.1 mm -125.63 126.39 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.547 ' OG ' ' O ' ' E' ' 29' ' ' ILE . 3.3 m 157.09 16.12 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 31' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' E' ' 32' ' ' ASN . 1.0 OUTLIER 51.5 -174.08 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.006 -1.059 . . . . 0.0 108.892 -179.082 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 32' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 9.2 t-20 73.48 94.3 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 33' ' ' VAL . . . . . 0.408 ' CG2' ' N ' ' E' ' 34' ' ' ASP . 0.7 OUTLIER -70.78 -42.98 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.309 -0.869 . . . . 0.0 108.993 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 34' ' ' ASP . . . . . 0.408 ' N ' ' CG2' ' E' ' 33' ' ' VAL . 43.1 t0 -58.39 -44.19 88.83 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.388 -0.82 . . . . 0.0 110.771 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 35' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' E' ' 39' ' ' ASN . 62.1 mm-40 -70.03 -37.05 75.48 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.95 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 37.8 mt -61.64 -41.36 90.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.149 -0.97 . . . . 0.0 108.886 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 48.4 t -55.16 -51.58 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.941 -1.099 . . . . 0.0 108.778 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -59.1 -39.2 81.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.347 -0.846 . . . . 0.0 109.541 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 39' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' E' ' 35' ' ' GLU . 34.0 m120 -63.42 -42.11 98.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 109.508 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 74.5 mt -73.36 -50.03 24.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.132 -0.98 . . . . 0.0 108.962 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -48.93 -48.31 42.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.756 -1.215 . . . . 0.0 108.993 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -63.36 -37.4 87.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.582 -0.699 . . . . 0.0 109.935 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -75.6 -35.55 60.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.267 -0.896 . . . . 0.0 109.66 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 13.2 t -70.74 -51.44 36.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.308 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -71.21 -35.34 71.49 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.294 -176.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.63 -30.61 67.42 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -92.14 -5.44 52.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.364 -0.835 . . . . 0.0 109.871 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.63 11.82 46.18 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.61 159.28 33.16 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.26 -6.19 5.4 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.27 -1.135 . . . . 0.0 110.521 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -152.24 164.21 30.45 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 6.9 tp -136.95 143.45 42.87 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.405 -1.056 . . . . 0.0 109.516 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 53' ' ' ILE . . . . . 0.542 ' O ' ' CB ' ' E' ' 54' ' ' ALA . 4.8 mt -113.6 151.66 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.604 ' O ' ' CB ' ' E' ' 55' ' ' PHE . . . 88.7 -144.58 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 55' ' ' PHE . . . . . 0.604 ' CB ' ' O ' ' E' ' 54' ' ' ALA . 62.9 t80 104.87 11.96 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 120.726 1.603 . . . . 0.0 107.607 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 56' ' ' ARG . . . . . 0.683 HH22 ' NH1' ' D' ' 56' ' ' ARG . 73.8 mtm180 -69.16 124.73 24.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.354 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 57' ' ' ILE . . . . . 0.435 ' CG2' ' N ' ' E' ' 58' ' ' THR . 88.3 mt -124.92 166.03 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.516 -0.74 . . . . 0.0 109.292 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 58' ' ' THR . . . . . 0.435 ' N ' ' CG2' ' E' ' 57' ' ' ILE . 3.2 m -144.79 3.38 1.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.282 -0.886 . . . . 0.0 109.063 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 59' ' ' CYS . . . . . . . . . . . . . 92.2 m 51.87 25.88 3.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.575 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.46 -121.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.337 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -170.16 29.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.228 -0.92 . . . . 0.0 109.395 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.36 -20.64 0.09 OUTLIER Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.012 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -76.62 -110.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.072 -1.252 . . . . 0.0 108.536 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 64' ' ' PHE . . . . . 0.429 ' CD1' ' OG1' ' E' ' 58' ' ' THR . 73.3 m-85 -56.23 174.54 0.13 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.972 . . . . 0.0 108.929 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.562 ' N ' HD23 ' E' ' 65' ' ' LEU . 1.6 pt? -161.65 -35.3 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.129 -0.982 . . . . 0.0 110.257 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 66' ' ' GLY . . . . . . . . . . . . . . . 130.19 65.87 0.1 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 107.692 -2.163 . . . . 0.0 107.692 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 67' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' E' ' 67' ' ' TYR . 18.4 p90 -118.08 176.98 4.96 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.141 -1.211 . . . . 0.0 110.292 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.66 157.97 14.71 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 93.6 m -90.52 134.6 34.25 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.038 -1.272 . . . . 0.0 107.691 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 58.6 mt -90.23 137.91 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 71' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' E' ' 21' ' ' TYR . 3.2 m -144.17 163.92 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.26 -0.9 . . . . 0.0 110.766 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -148.01 152.61 37.74 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.18 152.55 33.5 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.327 -0.858 . . . . 0.0 108.727 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 57.37 -99.43 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 110.094 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -138.12 161.44 36.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.351 -0.843 . . . . 0.0 109.48 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 76' ' ' ALA . . . . . 0.486 ' C ' ' H ' ' E' ' 78' ' ' PHE . . . -57.09 -164.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.511 -0.743 . . . . 0.0 109.202 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 77' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -74.94 36.5 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.285 -0.884 . . . . 0.0 109.174 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 78' ' ' PHE . . . . . 0.486 ' H ' ' C ' ' E' ' 76' ' ' ALA . 94.7 m-85 51.69 16.14 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.335 -0.853 . . . . 0.0 109.813 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 66.9 p 44.29 -119.78 0.7 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.465 -0.772 . . . . 0.0 109.733 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 45.8 mtt -81.96 147.98 28.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 0.0 109.207 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.462 -179.941 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.552 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.354 0.597 . . . . 0.0 109.399 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.9 tt -71.63 -31.75 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.243 -0.911 . . . . 0.0 109.409 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.403 ' H ' ' H ' ' A' ' 4' ' ' GLU . 18.6 t80 -160.52 0.17 0.07 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.176 -0.953 . . . . 0.0 109.474 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.403 ' H ' ' H ' ' A' ' 3' ' ' PHE . 0.3 OUTLIER 64.48 55.0 1.41 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -127.15 -153.82 0.59 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.301 -0.874 . . . . 0.0 109.113 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -161.24 76.99 0.55 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.329 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -99.37 122.26 42.25 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.478 -0.764 . . . . 0.0 109.358 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 70.0 mt -112.17 140.02 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.518 -0.739 . . . . 0.0 110.009 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.455 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 5.8 tt -137.61 115.88 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.446 -0.784 . . . . 0.0 108.923 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -123.49 158.38 31.4 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.27 121.02 32.84 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.75 47.34 20.62 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.994 0.902 . . . . 0.0 109.624 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -167.4 94.77 0.45 Allowed 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.404 0.621 . . . . 0.0 109.445 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -61.24 -178.2 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.263 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.7 mt -123.67 87.9 52.22 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.51 -0.744 . . . . 0.0 109.085 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -61.1 156.02 47.29 Favored 'Trans proline' 0 C--N 1.321 -0.888 0 C-N-CA 121.905 1.736 . . . . 0.0 110.222 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.64 -11.76 71.37 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.2 mt -126.79 137.64 53.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.143 -1.21 . . . . 0.0 108.734 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.6 ' NE2' ' H ' ' A' ' 74' ' ' ASP . 1.2 pp0? -87.62 118.47 27.12 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.4 mt -101.46 128.35 47.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.131 -0.98 . . . . 0.0 109.587 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' A' ' 22' ' ' SER . 2.3 t80 -115.21 129.95 56.78 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.531 ' O ' ' CE1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -85.57 130.26 34.62 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.408 -0.808 . . . . 0.0 110.353 -179.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.659 ' CD2' ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -118.94 19.44 13.03 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 137.33 172.42 12.53 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.98 145.14 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.11 147.45 37.29 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.623 -0.673 . . . . 0.0 109.315 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.5 p -151.48 135.55 16.63 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.63 150.56 34.64 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.044 -1.035 . . . . 0.0 108.766 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.21 129.45 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 83.8 p -169.37 175.95 5.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 109.126 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.429 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 3.2 m-20 -101.94 146.91 27.2 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.297 -0.877 . . . . 0.0 110.152 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 13.2 m-20 77.63 128.95 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.566 -0.708 . . . . 0.0 109.259 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.98 -31.09 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.593 -0.692 . . . . 0.0 109.36 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -56.22 -40.24 73.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.299 -0.876 . . . . 0.0 109.712 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.402 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 1.1 mp0 -76.23 -40.28 52.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.324 -0.86 . . . . 0.0 109.277 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.3 mt -62.22 -50.53 79.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.896 -1.127 . . . . 0.0 108.847 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.0 t -66.63 -49.45 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.11 -0.994 . . . . 0.0 109.473 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.53 -40.71 88.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.0 109.601 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 35' ' ' GLU . 15.9 m120 -64.13 -41.33 97.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 109.321 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.4 mt -68.23 -44.24 76.18 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.15 -0.969 . . . . 0.0 109.128 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -48.92 -42.77 38.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.572 -1.33 . . . . 0.0 109.436 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -69.94 -38.02 76.05 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.493 0.663 . . . . 0.0 110.102 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -77.32 -35.04 55.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.492 -0.755 . . . . 0.0 110.057 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.83 -52.07 31.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.027 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -66.59 -29.53 69.6 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.215 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.49 -28.6 68.69 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.626 0.727 . . . . 0.0 109.048 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -90.22 -5.65 56.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.564 -0.71 . . . . 0.0 109.558 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.5 4.37 58.24 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.84 161.93 48.24 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -129.58 -2.35 4.85 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.303 -1.116 . . . . 0.0 110.303 -177.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.8 166.48 39.68 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.308 -1.425 . . . . 0.0 109.685 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 tp -125.16 143.63 50.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.665 -0.903 . . . . 0.0 109.655 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.403 ' O ' ' CD1' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -117.73 148.71 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.625 -0.672 . . . . 0.0 110.072 -178.228 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.22 68.78 0.74 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.897 -1.127 . . . . 0.0 110.125 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -107.29 54.56 0.67 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.656 ' NH1' HH22 ' E' ' 56' ' ' ARG . 1.7 ttt-85 -80.18 152.96 28.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.302 -0.874 . . . . 0.0 109.634 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.4 mt -131.21 152.93 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 m -138.45 66.05 1.44 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.375 -0.828 . . . . 0.0 109.155 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.8 p -169.64 -172.5 1.43 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 0.0 109.468 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.54 -131.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.306 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.13 -44.55 83.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.937 . . . . 0.0 109.452 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.64 -129.74 1.4 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm 54.09 51.17 15.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 109.254 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -143.18 -82.09 0.18 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.279 -0.888 . . . . 0.0 109.354 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.5 tp -176.11 120.61 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 109.524 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.9 74.61 0.21 Allowed Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -74.08 153.9 39.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.176 -1.191 . . . . 0.0 110.083 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.58 153.23 17.07 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.478 ' OG1' ' OG1' ' E' ' 11' ' ' THR . 96.8 m -105.71 138.26 42.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.304 -1.115 . . . . 0.0 108.964 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 50.4 mt -83.01 137.32 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.4 m -140.66 159.05 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.247 -0.908 . . . . 0.0 109.701 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -153.69 159.09 41.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.296 -0.878 . . . . 0.0 109.052 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.519 ' O ' ' CG ' ' A' ' 74' ' ' ASP . . . -114.83 114.17 25.18 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.227 -0.921 . . . . 0.0 110.756 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.6 ' H ' ' NE2' ' A' ' 19' ' ' GLN . 20.5 m-20 -170.69 -129.3 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 67.42 -49.21 0.5 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.203 -0.936 . . . . 0.0 109.855 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.39 173.28 0.08 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.229 -0.919 . . . . 0.0 109.572 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -148.53 -159.29 1.01 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.363 -0.836 . . . . 0.0 109.374 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -159.71 130.25 5.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 109.373 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.8 m -162.27 87.55 0.63 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.911 . . . . 0.0 109.441 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 10.0 ttt -95.21 25.52 4.26 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.244 -0.91 . . . . 0.0 109.226 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.382 180.0 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 pp -118.66 -178.04 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -147.01 -83.16 0.12 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.306 -0.871 . . . . 0.0 108.931 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -58.59 134.33 56.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.93 . . . . 0.0 109.517 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.56 -51.53 3.18 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.557 -0.715 . . . . 0.0 109.435 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' B' ' 50' ' ' MET . 25.2 ttmt -158.42 87.67 0.91 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 109.416 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -109.91 122.34 47.31 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 93.8 mt -132.87 129.96 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.386 -0.821 . . . . 0.0 109.754 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.466 ' O ' ' CG2' ' B' ' 9' ' ' ILE . 10.9 tt -133.01 116.36 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.2 t -123.9 152.78 42.01 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' THR . . . . . 0.437 ' H ' ' HG1' ' B' ' 11' ' ' THR . 0.8 OUTLIER -103.01 74.76 1.33 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 176.97 -116.18 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 176.98 54.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -129.38 104.44 7.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.39 -0.819 . . . . 0.0 109.605 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.646 ' N ' ' HD3' ' B' ' 16' ' ' PRO . 6.2 mm -140.61 53.04 3.62 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.346 -0.847 . . . . 0.0 108.915 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.646 ' HD3' ' N ' ' B' ' 15' ' ' ILE . 1.8 Cg_endo -64.07 155.49 64.41 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.531 1.487 . . . . 0.0 110.196 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.12 -11.71 71.43 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 79.8 mt -128.24 139.5 52.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.01 -1.288 . . . . 0.0 109.035 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -85.51 108.86 18.12 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.4 mt -89.84 132.63 35.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 110.348 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . 0.54 ' CE1' ' O ' ' B' ' 22' ' ' SER . 0.4 OUTLIER -112.38 129.29 56.36 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.54 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 36.2 t -71.73 118.25 14.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.793 -1.192 . . . . 0.0 109.336 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.499 HD12 ' HB2' ' B' ' 72' ' ' LYS . 5.8 mt -94.69 -4.57 47.29 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.42 -163.4 24.03 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -122.39 141.76 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.54 144.81 42.23 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.567 -0.708 . . . . 0.0 109.275 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 3.0 t -151.77 137.88 18.28 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -148.92 141.76 24.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.013 -1.054 . . . . 0.0 109.247 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 tp -104.8 127.93 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.287 -0.883 . . . . 0.0 109.213 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 15.5 t -171.19 169.79 6.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.918 . . . . 0.0 109.053 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 2.7 p-10 -110.16 158.78 17.98 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.507 -0.746 . . . . 0.0 109.215 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 2.2 m120 75.97 129.55 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.97 -32.86 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.488 -0.757 . . . . 0.0 109.306 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.96 -42.15 89.2 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.282 -0.886 . . . . 0.0 109.773 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -75.73 -41.4 53.54 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.225 -0.922 . . . . 0.0 109.516 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.79 -43.05 98.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 120.858 -1.151 . . . . 0.0 108.923 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.21 -50.78 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.768 -1.208 . . . . 0.0 109.497 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -59.01 -39.51 82.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.339 -0.851 . . . . 0.0 109.513 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -61.65 -46.12 91.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.639 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 28.6 mt -70.74 -46.83 62.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.105 -0.997 . . . . 0.0 108.986 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -48.57 -44.54 36.84 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.695 -1.253 . . . . 0.0 109.405 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -67.97 -38.4 82.69 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.559 0.695 . . . . 0.0 110.242 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -77.54 -34.11 54.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.395 -0.816 . . . . 0.0 110.183 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.796 ' O ' ' N ' ' B' ' 48' ' ' GLY . 2.3 t -70.03 -51.67 37.54 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.946 0 O-C-N 121.148 -0.97 . . . . 0.0 109.812 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -60.11 -31.39 69.99 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 119.666 -1.896 . . . . 0.0 110.328 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.7 -37.22 56.49 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.009 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.4 -12.92 11.01 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.549 -0.719 . . . . 0.0 109.923 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . 0.796 ' N ' ' O ' ' B' ' 44' ' ' VAL . . . -105.8 -45.75 1.26 Allowed Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.96 -35.23 0.29 Allowed Glycine 0 C--N 1.289 -2.066 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.156 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' MET . . . . . 0.496 ' H ' ' C ' ' B' ' 48' ' ' GLY . 0.0 OUTLIER -96.44 -75.08 0.54 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 119.253 1.527 . . . . 0.0 109.886 -179.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.37 -153.58 10.77 Favored Glycine 0 C--N 1.288 -2.104 0 C-N-CA 118.288 -1.91 . . . . 0.0 109.425 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.2 tp -133.11 139.13 46.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.696 -0.885 . . . . 0.0 109.682 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 pt -111.82 145.53 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.658 -0.651 . . . . 0.0 109.913 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 63.92 72.45 0.46 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.121 -0.987 . . . . 0.0 109.337 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.558 ' CG ' ' O ' ' B' ' 55' ' ' PHE . 60.4 t80 -101.51 33.65 2.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.37 -0.831 . . . . 0.0 108.917 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.755 ' HG3' HH11 ' B' ' 56' ' ' ARG . 0.0 OUTLIER -59.51 122.98 15.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.982 -1.074 . . . . 0.0 109.34 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.432 ' N ' ' HH ' ' C' ' 67' ' ' TYR . 91.2 mt -75.59 150.12 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' THR . . . . . 0.457 ' HG1' ' H ' ' B' ' 59' ' ' CYS . 80.8 p -73.97 -119.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.318 -0.863 . . . . 0.0 109.413 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . 0.457 ' H ' ' HG1' ' B' ' 58' ' ' THR . 47.0 t -67.26 -116.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.925 . . . . 0.0 109.638 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.424 ' N ' ' SG ' ' B' ' 59' ' ' CYS . . . -64.81 -156.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.164 -0.96 . . . . 0.0 109.608 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -51.98 -18.05 1.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.216 -0.928 . . . . 0.0 109.244 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' B' ' 64' ' ' PHE . . . 171.34 -96.97 0.11 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 mttm 50.1 12.88 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.477 -1.013 . . . . 0.0 109.692 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' B' ' 62' ' ' GLY . 7.2 m-85 -139.33 -76.07 0.35 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.357 -0.839 . . . . 0.0 108.872 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' B' ' 64' ' ' PHE . 20.7 tp 172.78 120.3 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.694 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.78 165.05 33.12 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' TYR . . . . . 0.51 ' HH ' ' NE ' ' A' ' 56' ' ' ARG . 35.5 p90 -167.13 179.83 4.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.04 -1.271 . . . . 0.0 110.209 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.09 169.63 35.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 50.4 m -100.66 132.94 45.79 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.123 -1.222 . . . . 0.0 108.037 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 3.0 mt -87.82 145.44 7.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 5.9 m -146.29 166.06 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.886 -1.134 . . . . 0.0 111.01 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . 0.499 ' HB2' HD12 ' B' ' 23' ' ' LEU . 0.4 OUTLIER -146.55 156.25 43.1 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.45 ' O ' ' OD1' ' B' ' 74' ' ' ASP . . . -116.57 116.02 26.83 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.72 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' B' ' 73' ' ' ALA . 0.1 OUTLIER 175.41 168.79 0.34 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -178.286 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -60.26 92.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.413 -0.804 . . . . 0.0 109.17 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' B' ' 78' ' ' PHE . . . -81.76 -167.82 1.66 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.278 -0.889 . . . . 0.0 108.905 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 53.96 -82.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.592 -0.692 . . . . 0.0 109.692 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . 0.558 ' N ' ' O ' ' B' ' 76' ' ' ALA . 19.5 m-85 -72.98 55.16 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 0.0 109.479 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 29.1 m -73.66 128.62 36.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 109.506 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' MET . . . . . . . . . . . . . 21.0 mmt 49.58 80.98 0.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 109.606 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.568 -179.952 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.463 ' N ' ' SD ' ' C' ' 1' ' ' MET . 2.3 mpt? . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 18.1 tt -161.65 6.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.909 . . . . 0.0 109.227 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 59.49 176.81 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.103 -0.998 . . . . 0.0 109.262 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -142.55 8.04 1.74 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.283 -0.885 . . . . 0.0 109.283 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -99.79 9.27 43.32 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.312 -0.867 . . . . 0.0 109.42 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? -73.93 84.56 1.73 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.304 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -105.78 120.66 42.26 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.099 -1.001 . . . . 0.0 109.126 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 17.7 mt -116.39 143.01 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' C' ' 9' ' ' ILE . 7.2 tt -112.96 124.62 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.93 131.28 55.16 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.44 -0.787 . . . . 0.0 109.369 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 1.6 m -121.3 114.37 21.25 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.42 34.56 24.45 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.301 -0.875 . . . . 0.0 109.653 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -153.36 95.49 1.93 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.708 -0.62 . . . . 0.0 109.505 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -67.31 176.82 2.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.086 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 51.4 mt -127.04 81.68 69.47 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.485 -0.759 . . . . 0.0 109.095 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.31 156.78 38.78 Favored 'Trans proline' 0 C--N 1.322 -0.83 0 C-N-CA 121.964 1.776 . . . . 0.0 110.119 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.17 -4.54 74.37 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.307 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 25.7 mt -126.78 137.48 53.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.105 -1.232 . . . . 0.0 109.17 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -86.77 108.28 18.64 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 12.8 mt -92.36 132.97 36.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 109.462 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' C' ' 71' ' ' VAL . 1.2 t80 -114.73 129.37 56.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.363 -0.835 . . . . 0.0 108.755 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' SER . . . . . 0.436 ' O ' ' CE1' ' C' ' 21' ' ' TYR . 8.2 t -61.97 127.68 32.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.899 -1.126 . . . . 0.0 111.624 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 14.2 mt -113.47 9.13 18.03 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.71 -174.52 15.34 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 177.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.57 139.76 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.651 -0.911 . . . . 0.0 109.584 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.47 146.84 44.19 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.693 -0.63 . . . . 0.0 109.92 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 4.7 t -151.91 139.23 19.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.154 -0.966 . . . . 0.0 108.688 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.77 140.28 22.46 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.962 -1.086 . . . . 0.0 109.641 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 7.1 tp -95.66 147.9 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.999 -1.063 . . . . 0.0 108.602 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.501 ' OG ' ' N ' ' C' ' 31' ' ' ASP . 27.1 t -169.3 -168.24 0.8 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.112 -0.992 . . . . 0.0 109.12 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' ASP . . . . . 0.501 ' N ' ' OG ' ' C' ' 30' ' ' SER . 19.4 t0 -109.72 -80.64 0.58 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.352 -0.843 . . . . 0.0 111.667 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -75.98 159.66 30.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.909 -1.12 . . . . 0.0 109.434 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.33 -31.44 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 CA-C-O 121.241 0.543 . . . . 0.0 109.591 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.5 -37.85 65.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.65 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -76.38 -36.22 58.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.35 -0.844 . . . . 0.0 109.019 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 82.9 mt -61.78 -51.98 66.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 120.984 -1.073 . . . . 0.0 109.539 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 51.4 t -57.65 -48.11 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.086 -1.009 . . . . 0.0 108.985 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -63.49 -43.89 95.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.652 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -58.27 -48.63 79.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.13 -0.981 . . . . 0.0 109.47 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 55.5 mt -68.98 -44.22 73.33 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.736 -1.227 . . . . 0.0 108.76 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -50.97 -46.18 61.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.773 -1.205 . . . . 0.0 109.445 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -61.87 -34.66 76.4 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.516 -0.874 . . . . 0.0 108.967 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -70.76 -36.09 72.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.447 -0.783 . . . . 0.0 108.971 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 51.5 t -72.89 -49.29 40.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.89 -1.131 . . . . 0.0 109.155 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -49.36 -34.23 15.53 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.448 1.118 . . . . 0.0 110.505 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.84 -28.55 50.2 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.573 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -94.62 9.53 38.36 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.89 30.73 30.21 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 118.355 -1.879 . . . . 0.0 109.534 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.35 -162.44 8.81 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -115.07 -35.66 4.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.44 -1.036 . . . . 0.0 110.424 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.19 179.73 40.32 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 tp -101.36 138.33 38.52 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.427 -1.043 . . . . 0.0 109.786 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 1.3 pt -113.97 144.38 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.528 -0.732 . . . . 0.0 110.149 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 62.72 62.45 1.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -0.88 . . . . 0.0 109.236 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -92.99 66.0 4.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.958 -1.089 . . . . 0.0 108.448 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -72.68 149.66 43.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.5 -0.75 . . . . 0.0 110.032 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 59.0 mt -125.52 -43.84 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' THR . . . . . 0.609 ' O ' ' N ' ' C' ' 60' ' ' ALA . 88.8 m -73.99 176.51 6.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.878 . . . . 0.0 109.047 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' CYS . . . . . 0.512 ' H ' ' CG2' ' C' ' 58' ' ' THR . 41.6 t 49.61 -85.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.421 -0.799 . . . . 0.0 109.0 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . 0.609 ' N ' ' O ' ' C' ' 58' ' ' THR . . . -78.62 146.31 34.2 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' ASP . . . . . 0.477 ' CG ' ' O ' ' C' ' 61' ' ' ASP . 6.7 t0 53.36 51.86 14.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.16 -0.963 . . . . 0.0 109.252 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.27 75.16 0.19 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' C' ' 61' ' ' ASP . 34.2 ttpt 53.59 69.38 0.71 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.64 -0.918 . . . . 0.0 109.473 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -160.93 -26.84 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.391 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 17.3 tp -178.4 117.09 0.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.449 -0.782 . . . . 0.0 109.326 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.69 152.59 24.17 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' TYR . . . . . 0.432 ' HH ' ' N ' ' B' ' 57' ' ' ILE . 37.1 p90 -158.15 -175.07 5.14 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.214 -1.168 . . . . 0.0 109.885 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.92 -173.25 44.03 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 29.3 m -119.46 134.05 55.4 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 45.2 mt -82.56 146.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' C' ' 21' ' ' TYR . 4.6 m -139.83 164.06 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.392 -0.817 . . . . 0.0 110.225 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -142.34 154.61 44.81 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.36 116.21 29.32 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.843 0.83 . . . . 0.0 111.239 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -167.58 -114.46 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 52.56 87.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.235 -0.916 . . . . 0.0 109.323 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -165.44 168.11 16.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 0.0 109.13 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -124.23 156.84 36.13 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.497 -0.752 . . . . 0.0 109.351 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -58.94 147.97 32.19 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.341 -0.85 . . . . 0.0 109.562 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 76.4 p -71.08 166.42 21.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 109.421 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -17.44 64.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.496 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.518 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' D' ' 3' ' ' PHE . 1.1 pt -145.56 -87.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.264 -0.898 . . . . 0.0 109.025 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' D' ' 2' ' ' ILE . 0.2 OUTLIER 62.37 148.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' D' ' 3' ' ' PHE . 61.0 mt-10 40.85 -147.29 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.133 -0.98 . . . . 0.0 110.184 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -125.99 159.85 31.6 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.536 -0.728 . . . . 0.0 109.107 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -71.03 85.35 0.71 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 109.55 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -96.43 128.85 43.73 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.212 -0.93 . . . . 0.0 109.611 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 62.8 mt -128.14 141.99 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.543 -0.723 . . . . 0.0 109.095 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' ILE . . . . . 0.409 ' O ' HG21 ' D' ' 9' ' ' ILE . 10.1 tt -114.97 117.36 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.16 131.83 54.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.934 -1.104 . . . . 0.0 108.971 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' THR . . . . . 0.446 ' OG1' ' OG1' ' E' ' 69' ' ' THR . 3.4 m -104.02 98.0 7.89 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.89 65.12 0.94 Allowed 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.948 0.88 . . . . 0.0 110.068 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -132.97 -141.44 0.2 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -169.44 -31.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 109.389 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 28.7 mt 50.21 67.14 4.67 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.185 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.85 156.41 48.88 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 C-N-CA 122.122 1.881 . . . . 0.0 110.126 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.5 -4.01 72.54 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.612 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 29.0 mt -125.16 135.83 53.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.872 -1.369 . . . . 0.0 108.967 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -86.38 112.49 21.5 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 11.9 mt -95.59 133.68 39.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.044 -1.035 . . . . 0.0 109.807 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' D' ' 22' ' ' SER . 4.4 t80 -122.45 129.97 52.59 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' SER . . . . . 0.433 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 48.2 t -85.84 129.63 34.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.573 -0.704 . . . . 0.0 110.97 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . 0.629 ' N ' ' CD2' ' D' ' 23' ' ' LEU . 0.3 OUTLIER -119.4 13.31 12.66 Favored 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 122.235 1.017 . . . . 0.0 108.483 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 143.26 170.29 12.98 Favored Glycine 0 N--CA 1.49 2.298 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.026 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -109.39 142.69 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' D' ' 67' ' ' TYR . . . -114.22 148.21 37.73 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 89.4 p -152.09 141.55 21.63 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 14.9 t -149.67 140.84 23.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.157 -0.965 . . . . 0.0 109.044 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 tt -115.7 129.81 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 90.1 p -177.26 -131.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.545 -0.722 . . . . 0.0 109.257 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' D' ' 32' ' ' ASN . 15.1 p-10 -166.51 169.69 13.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.211 -0.931 . . . . 0.0 109.471 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 6.8 t-20 73.65 127.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 0.0 108.666 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 22.9 t -68.88 -35.09 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.379 -0.826 . . . . 0.0 109.656 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' D' ' 35' ' ' GLU . 0.9 OUTLIER -59.21 -45.11 91.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.85 -179.509 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' GLU . . . . . 0.463 ' N ' ' OD1' ' D' ' 34' ' ' ASP . 55.2 mm-40 -75.25 -40.11 59.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.185 -0.947 . . . . 0.0 109.413 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.79 -53.17 50.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.962 -1.087 . . . . 0.0 109.482 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 44.3 t -61.49 -47.81 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.056 -1.027 . . . . 0.0 109.211 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -61.45 -41.98 98.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.691 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -58.54 -46.66 86.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 109.474 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 47.7 mt -71.4 -46.89 59.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.175 -0.953 . . . . 0.0 109.007 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -49.9 -44.99 50.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.816 -1.177 . . . . 0.0 109.172 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -63.31 -34.61 78.07 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.057 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -73.92 -36.9 64.75 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.324 -0.86 . . . . 0.0 109.328 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 t -73.4 -51.21 26.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.792 -1.193 . . . . 0.0 108.887 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.92 -33.42 37.08 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.73 1.253 . . . . 0.0 110.098 -177.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.82 -30.33 51.08 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.837 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -92.2 4.2 53.73 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.77 26.44 62.74 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 118.492 -1.813 . . . . 0.0 109.359 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.38 -167.67 13.37 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 9.9 ttp -107.38 -43.47 4.55 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.499 -1.0 . . . . 0.0 109.706 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 173.55 -152.79 16.13 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 tp -131.81 142.34 49.7 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.446 -1.032 . . . . 0.0 109.716 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' ILE . . . . . 0.613 ' CD1' ' H ' ' D' ' 53' ' ' ILE . 0.0 OUTLIER -113.98 147.4 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.598 -0.689 . . . . 0.0 110.181 -178.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.601 ' O ' ' O ' ' D' ' 55' ' ' PHE . . . 84.08 -54.63 0.13 Allowed 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 118.683 0.674 . . . . 0.0 111.607 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . 0.601 ' O ' ' O ' ' D' ' 54' ' ' ALA . 50.4 t80 43.03 -179.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' ARG . . . . . 0.493 ' HE ' ' CG2' ' C' ' 58' ' ' THR . 1.6 mmm180 174.22 144.57 0.05 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.461 -1.4 . . . . 0.0 109.139 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' ILE . . . . . . . . . . . . . 15.4 mm -83.24 145.82 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 109.045 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' THR . . . . . 0.486 ' HG1' ' N ' ' D' ' 59' ' ' CYS . 82.6 p -79.57 -124.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.406 -0.809 . . . . 0.0 109.257 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' CYS . . . . . 0.486 ' N ' ' HG1' ' D' ' 58' ' ' THR . 26.0 p -165.94 -163.63 0.64 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 109.392 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.66 -65.61 0.66 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -80.13 -117.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.556 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . -150.56 54.07 0.49 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.94 -34.01 21.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.334 -1.098 . . . . 0.0 109.616 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -115.29 138.86 50.5 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.555 -0.716 . . . . 0.0 109.357 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . . . . . . . . . 6.2 mp -106.69 162.32 13.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.504 -0.747 . . . . 0.0 109.054 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.58 41.14 2.3 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 67' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' D' ' 26' ' ' ALA . 4.3 p90 -64.76 -167.86 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.441 -1.035 . . . . 0.0 110.125 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.18 175.15 40.09 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 4.9 m -97.9 134.91 40.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.99 -1.3 . . . . 0.0 108.176 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 50.3 mt -79.45 134.71 27.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.9 163.04 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.466 -0.771 . . . . 0.0 109.737 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -154.19 140.35 18.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.446 -0.784 . . . . 0.0 108.998 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.74 150.78 25.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.829 -1.169 . . . . 0.0 108.868 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . 0.449 ' CG ' ' H ' ' D' ' 75' ' ' GLU . 7.6 t70 -73.58 -151.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.087 -1.008 . . . . 0.0 109.317 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 75' ' ' GLU . . . . . 0.449 ' H ' ' CG ' ' D' ' 74' ' ' ASP . 2.5 tm-20 -164.13 81.4 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 109.489 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' D' ' 78' ' ' PHE . . . 176.63 -13.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.358 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 62.96 -70.46 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.511 -0.743 . . . . 0.0 109.161 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 78' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' D' ' 76' ' ' ALA . 68.7 m-85 -83.45 104.28 13.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.921 . . . . 0.0 109.231 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 23.6 m -55.8 95.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.649 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 24.2 mmt 49.71 -114.66 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.898 . . . . 0.0 109.529 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.385 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . 0.503 ' N ' ' CD1' ' E' ' 2' ' ' ILE . 0.1 OUTLIER -136.26 -5.84 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.5 -0.75 . . . . 0.0 109.519 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 3' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -78.25 37.89 0.27 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.904 . . . . 0.0 109.4 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' E' ' 2' ' ' ILE . 6.9 mm-40 -69.28 -51.76 34.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.884 . . . . 0.0 109.551 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.44 117.19 9.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 6' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' E' ' 50' ' ' MET . 54.8 tttt -138.33 -68.65 0.45 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.187 -0.945 . . . . 0.0 109.082 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -105.08 122.51 46.03 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 14.3 mt -134.3 131.56 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.362 -0.836 . . . . 0.0 109.736 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 9' ' ' ILE . . . . . 0.406 ' O ' ' CG2' ' E' ' 9' ' ' ILE . 19.2 tt -121.82 117.25 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.53 133.63 55.79 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.459 -0.776 . . . . 0.0 108.988 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 11' ' ' THR . . . . . 0.478 ' OG1' ' OG1' ' A' ' 69' ' ' THR . 25.3 m -86.88 61.63 6.92 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.048 -1.032 . . . . 0.0 111.085 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . 174.99 -110.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 167.88 113.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . 0.457 ' CG ' ' H ' ' E' ' 15' ' ' ILE . 0.8 OUTLIER -173.73 -96.79 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.057 -1.027 . . . . 0.0 109.635 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 15' ' ' ILE . . . . . 0.493 ' N ' ' HD3' ' E' ' 16' ' ' PRO . 8.6 mt 59.0 60.1 5.12 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 109.61 -179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . 0.493 ' HD3' ' N ' ' E' ' 15' ' ' ILE . 1.6 Cg_endo -64.9 153.15 79.51 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 122.018 1.812 . . . . 0.0 109.734 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.52 -8.77 78.48 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.356 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 18' ' ' LEU . . . . . . . . . . . . . 61.3 mt -124.55 137.56 54.39 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.077 -1.249 . . . . 0.0 109.188 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -86.99 108.73 18.97 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 12.8 mt -89.4 136.32 33.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 110.001 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 21' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -117.81 129.69 55.82 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.0 127.38 30.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.811 -1.181 . . . . 0.0 110.941 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 23.4 mt -113.58 8.49 17.7 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.55 -163.15 13.13 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -128.18 143.67 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.867 -0.784 . . . . 0.0 109.216 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.24 147.81 39.9 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.4 0.619 . . . . 0.0 109.439 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 60.0 p -151.71 135.01 15.98 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.84 148.79 30.31 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.98 -1.075 . . . . 0.0 108.835 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 tp -127.1 133.51 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 4.5 m -151.21 -152.7 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 109.067 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 31' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' E' ' 32' ' ' ASN . 0.9 OUTLIER -106.22 -82.72 0.53 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.36 -0.837 . . . . 0.0 111.114 -178.51 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 32' ' ' ASN . . . . . 0.44 ' H ' ' CG ' ' E' ' 31' ' ' ASP . 87.7 m-20 -81.01 165.11 22.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.03 . . . . 0.0 109.428 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 64.6 t -68.15 -31.9 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.789 -0.569 . . . . 0.0 109.731 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.37 -40.91 68.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 109.859 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -76.66 -35.48 57.92 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.19 -0.944 . . . . 0.0 109.082 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 69.2 mt -63.97 -52.89 50.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 120.929 -1.107 . . . . 0.0 109.425 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.54 -49.1 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.067 -1.021 . . . . 0.0 109.396 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -58.61 -39.11 79.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.892 . . . . 0.0 109.381 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -69.47 -39.94 77.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 0.0 109.782 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 21.7 mt -68.2 -45.59 72.95 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.917 -1.115 . . . . 0.0 108.711 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -47.43 -56.61 6.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.859 -1.151 . . . . 0.0 108.944 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -55.06 -32.94 62.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.861 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -75.53 -40.82 56.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.9 . . . . 0.0 110.087 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 38.4 t -76.88 -52.51 16.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.935 -1.103 . . . . 0.0 108.879 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -56.57 -28.6 60.56 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.381 1.086 . . . . 0.0 110.21 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.73 -28.46 58.54 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.507 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -87.22 10.91 15.49 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.64 29.17 53.6 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.081 -1.533 . . . . 0.0 109.417 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.97 -168.81 30.04 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 50' ' ' MET . . . . . 0.473 ' O ' ' O ' ' E' ' 6' ' ' LYS . 65.5 mtp -103.96 -37.42 7.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.514 -0.992 . . . . 0.0 109.288 177.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 174.5 -153.27 15.91 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 12.0 tp -126.94 135.72 51.28 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.525 -0.985 . . . . 0.0 109.744 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 pt -110.36 146.19 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.528 -0.732 . . . . 0.0 109.958 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . 67.66 87.41 0.12 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 109.711 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -138.4 82.16 1.89 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 56' ' ' ARG . . . . . 0.656 HH22 ' NH1' ' A' ' 56' ' ' ARG . 12.8 ptm180 -120.48 8.74 10.78 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.636 -0.665 . . . . 0.0 109.338 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 57' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' E' ' 59' ' ' CYS . 72.4 mt 57.63 -0.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.539 -0.726 . . . . 0.0 109.693 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 58' ' ' THR . . . . . 0.575 ' H ' ' C ' ' E' ' 56' ' ' ARG . 63.0 m 54.59 -87.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.69 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 59' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' E' ' 57' ' ' ILE . 73.1 m -76.09 -120.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 109.609 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.6 79.57 1.33 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.113 -0.992 . . . . 0.0 109.513 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 43.9 t0 51.06 19.6 0.71 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.342 -0.849 . . . . 0.0 109.656 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.88 -141.4 1.26 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -91.0 61.62 4.67 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.226 -1.161 . . . . 0.0 109.433 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 64' ' ' PHE . . . . . 0.473 ' CZ ' ' SG ' ' E' ' 59' ' ' CYS . 55.0 m-85 -137.38 -173.35 3.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.39 -0.819 . . . . 0.0 109.201 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 mp -137.2 146.11 44.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.404 -0.81 . . . . 0.0 109.877 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.4 60.71 4.52 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -55.82 169.28 0.36 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.327 -1.102 . . . . 0.0 110.039 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.01 162.07 32.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 69' ' ' THR . . . . . 0.446 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 52.8 m -102.96 134.34 46.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.103 -1.233 . . . . 0.0 108.09 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 37.2 mt -86.07 136.45 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 6.5 m -132.22 165.86 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.4 -0.813 . . . . 0.0 110.2 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -153.95 140.74 19.09 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.97 151.1 22.86 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.791 -1.193 . . . . 0.0 108.85 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -72.54 -1.93 17.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.063 -1.023 . . . . 0.0 109.576 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 75' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' E' ' 77' ' ' GLN . 13.2 tt0 65.97 18.06 10.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.376 -0.828 . . . . 0.0 109.634 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . 62.03 1.21 0.63 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.325 -0.859 . . . . 0.0 109.717 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 77' ' ' GLN . . . . . 0.476 ' H ' ' C ' ' E' ' 75' ' ' GLU . 21.5 mm-40 51.39 -153.91 0.17 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.211 -0.93 . . . . 0.0 109.578 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -59.04 159.6 7.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.616 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 88.4 m -79.49 165.88 22.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 109.177 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 4.7 ptt? -138.25 86.75 2.19 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.382 -0.823 . . . . 0.0 109.278 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.415 179.857 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mtm . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.9 tp -93.52 151.12 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.266 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 3' ' ' PHE . 0.6 OUTLIER -90.03 67.43 7.04 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.164 -0.96 . . . . 0.0 109.089 179.604 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 56.19 -89.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.439 -0.788 . . . . 0.0 110.194 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 3' ' ' PHE . 57.5 t0 56.9 100.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.401 -0.812 . . . . 0.0 109.47 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -82.44 105.44 13.5 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.26 -0.9 . . . . 0.0 109.296 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -103.44 122.98 46.0 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.607 -0.683 . . . . 0.0 109.328 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 76.6 mt -109.91 130.86 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.376 -0.828 . . . . 0.0 109.936 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.439 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 6.7 tt -135.05 114.61 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.6 t -123.16 160.05 27.32 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.958 0.885 . . . . 0.0 109.223 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 12' ' ' ALA . 11.0 p -96.34 -110.1 0.15 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.746 -0.596 . . . . 0.0 109.733 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 11' ' ' THR . . . 37.7 -104.44 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.1 -1.0 . . . . 0.0 111.073 177.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 15.0 p-10 -142.85 -64.68 0.4 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.446 -0.784 . . . . 0.0 109.793 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.5 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 11.5 pt-20 -152.16 -166.75 2.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.108 -0.995 . . . . 0.0 109.56 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.8 mt -116.59 97.72 50.59 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.603 -0.686 . . . . 0.0 109.303 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.18 156.31 46.02 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.82 1.68 . . . . 0.0 110.273 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.11 -7.59 78.46 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 62.4 mt -129.88 141.37 50.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.31 -1.112 . . . . 0.0 109.467 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.6 117.05 25.12 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.6 mt -101.34 136.66 40.82 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.132 -0.98 . . . . 0.0 109.154 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -113.62 129.26 56.6 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.385 -0.822 . . . . 0.0 109.083 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.1 t -73.37 124.57 26.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.488 -1.383 . . . . 0.0 109.377 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.7 mt -111.07 8.45 21.82 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.37 -167.04 21.47 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.3 mm -122.26 142.23 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.8 153.44 29.09 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.5 m -152.2 145.08 24.4 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.07 -1.019 . . . . 0.0 109.084 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.7 p -143.84 131.07 20.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.469 -0.769 . . . . 0.0 108.983 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.628 ' O ' ' CB ' ' A' ' 30' ' ' SER . 91.8 mt -105.87 153.34 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.628 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 88.9 p 120.89 -147.53 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 32' ' ' ASN . 22.0 t70 -145.64 -160.73 1.18 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.472 ' H ' ' CG ' ' A' ' 31' ' ' ASP . 14.0 m-20 70.66 101.61 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.4 t -62.56 -35.97 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.123 -0.986 . . . . 0.0 109.325 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.69 -41.7 86.87 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.248 -0.908 . . . . 0.0 109.692 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -75.81 -41.17 53.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.316 -0.865 . . . . 0.0 109.486 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.5 mt -63.41 -53.79 40.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.945 -1.097 . . . . 0.0 108.959 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.9 t -55.96 -49.87 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 108.999 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.91 -40.12 87.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 109.94 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.423 ' N ' HD21 ' A' ' 39' ' ' ASN . 1.5 m120 -62.11 -44.02 97.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.176 -0.953 . . . . 0.0 109.499 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.3 mt -71.12 -49.08 48.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.105 -0.997 . . . . 0.0 108.7 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -48.8 -49.35 39.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.805 -1.184 . . . . 0.0 109.277 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -63.21 -36.39 83.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.513 -0.742 . . . . 0.0 110.217 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.67 -35.53 57.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.833 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 t -68.3 -51.2 50.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 109.196 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -67.13 -37.94 84.7 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.773 -1.205 . . . . 0.0 109.161 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.1 -32.64 66.5 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -85.45 -4.53 59.19 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.46 -0.775 . . . . 0.0 109.341 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.66 9.13 61.63 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.84 -157.22 3.76 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.4 ptm -165.1 -20.15 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.09 -1.241 . . . . 0.0 110.385 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -152.56 160.11 28.8 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 tp -118.06 138.87 51.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.652 -0.91 . . . . 0.0 109.115 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.51 147.08 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.483 -0.761 . . . . 0.0 109.969 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 70.75 85.08 0.13 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.456 -0.778 . . . . 0.0 110.932 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -123.62 102.59 7.93 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -123.13 138.09 54.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.517 -0.739 . . . . 0.0 109.813 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.405 ' O ' ' CG1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -142.64 110.99 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.661 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 59' ' ' CYS . 37.3 p -81.09 114.18 19.77 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.829 -1.169 . . . . 0.0 109.288 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' B' ' 64' ' ' PHE . 12.5 m 38.18 -137.58 0.06 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.628 -0.67 . . . . 0.0 110.16 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -153.03 45.12 0.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -0.91 . . . . 0.0 109.199 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.2 p30 -136.9 -16.81 1.45 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.483 -0.76 . . . . 0.0 109.408 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 64' ' ' PHE . . . -134.14 -179.21 16.2 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.4 tttt 65.25 -70.97 0.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -1.111 . . . . 0.0 109.507 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 62' ' ' GLY . 1.8 m-85 49.57 53.19 13.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.242 -0.911 . . . . 0.0 109.13 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.8 tp -164.75 103.11 0.8 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.828 -1.17 . . . . 0.0 109.922 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.54 61.21 4.19 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -46.62 144.18 2.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.317 -1.108 . . . . 0.0 110.02 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.7 149.21 18.75 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.2 m -106.56 140.65 39.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -1.131 . . . . 0.0 108.821 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.2 mt -84.5 134.04 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.68 155.47 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.235 -0.916 . . . . 0.0 109.104 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -148.26 134.24 19.17 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.16 148.41 28.88 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.139 -0.976 . . . . 0.0 108.542 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 25.2 p-10 -176.35 55.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.129 -0.982 . . . . 0.0 109.031 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -101.72 -115.54 0.19 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.297 -0.877 . . . . 0.0 109.471 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.39 -178.86 0.55 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 109.258 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -126.35 -120.44 0.26 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.495 -0.753 . . . . 0.0 109.041 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.442 ' O ' ' OG1' ' A' ' 79' ' ' THR . 99.5 m-85 47.58 76.76 0.1 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.208 -0.932 . . . . 0.0 109.497 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 78' ' ' PHE . 55.4 p 50.07 -163.59 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.381 -0.824 . . . . 0.0 109.584 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 15.9 mmt -64.65 134.77 54.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 109.434 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.387 -179.916 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.281 0.562 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 2.8 pp -69.33 178.1 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.345 -0.847 . . . . 0.0 109.417 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -150.63 120.44 7.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.327 -0.858 . . . . 0.0 109.204 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -75.8 108.41 8.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.989 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 t0 68.94 112.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.555 -178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -167.86 99.65 0.47 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -0.968 . . . . 0.0 109.074 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -98.18 132.54 43.61 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.504 -0.747 . . . . 0.0 109.137 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 71.1 mt -124.44 141.47 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.476 -0.765 . . . . 0.0 109.433 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.462 ' O ' ' CG2' ' B' ' 9' ' ' ILE . 6.8 tt -136.87 119.76 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 7.6 t -124.6 156.58 37.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.196 -0.94 . . . . 0.0 108.622 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' THR . . . . . 0.468 ' HB ' ' H ' ' B' ' 12' ' ' ALA . 0.0 OUTLIER -68.33 -132.34 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.468 ' H ' ' HB ' ' B' ' 11' ' ' THR . . . -94.09 110.21 21.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.138 -0.976 . . . . 0.0 110.014 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -162.75 -134.22 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . 0.634 ' O ' ' C ' ' B' ' 15' ' ' ILE . 6.4 pt-20 -172.99 46.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.064 -1.022 . . . . 0.0 109.49 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.634 ' C ' ' O ' ' B' ' 14' ' ' GLU . 11.3 mt -1.81 77.58 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.505 0 O-C-N 122.357 -0.214 . . . . 0.0 110.586 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.498 ' N ' ' O ' ' B' ' 14' ' ' GLU . 2.3 Cg_endo -62.12 155.49 55.8 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.831 1.687 . . . . 0.0 110.183 -177.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.44 -11.59 71.74 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 34.7 mt -124.37 137.52 54.46 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.08 -1.247 . . . . 0.0 109.228 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.17 116.1 24.15 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.45 138.73 35.24 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.242 -0.911 . . . . 0.0 109.687 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -118.29 129.79 55.66 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.41 ' H ' ' HG ' ' B' ' 22' ' ' SER . 0.0 OUTLIER -68.82 129.18 39.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.732 -1.23 . . . . 0.0 110.673 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 74.2 mt -115.62 7.1 14.71 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.96 -156.06 16.18 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.63 142.94 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.885 -0.773 . . . . 0.0 109.389 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.2 144.6 44.6 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.774 -0.579 . . . . 0.0 109.954 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 30.7 p -152.45 141.83 21.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.191 -0.943 . . . . 0.0 108.743 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.59 152.76 36.02 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.077 -1.015 . . . . 0.0 109.72 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.52 152.27 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.245 -0.909 . . . . 0.0 108.949 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 173.05 143.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.445 -0.784 . . . . 0.0 109.242 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.411 ' O ' ' CG ' ' B' ' 32' ' ' ASN . 15.2 p-10 -93.08 30.1 1.71 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.235 -0.916 . . . . 0.0 110.325 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . 0.411 ' CG ' ' O ' ' B' ' 31' ' ' ASP . 27.1 m120 -162.23 141.17 9.28 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.548 0.689 . . . . 0.0 109.902 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.23 -37.27 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.396 -0.815 . . . . 0.0 109.57 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.71 -38.77 72.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 0.0 109.536 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -75.28 -36.93 61.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.235 -0.916 . . . . 0.0 108.696 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 82.4 mt -65.29 -53.5 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.917 -1.114 . . . . 0.0 109.25 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -54.54 -51.34 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.109 -0.994 . . . . 0.0 109.134 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.83 -43.02 98.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.35 -0.844 . . . . 0.0 109.758 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -60.65 -45.24 94.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.29 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 61.1 mt -67.09 -46.08 75.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.155 -0.966 . . . . 0.0 108.911 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -50.1 -43.7 51.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.764 -1.21 . . . . 0.0 109.459 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -67.87 -38.6 83.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.614 -0.679 . . . . 0.0 110.272 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -76.48 -35.62 58.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.453 -0.779 . . . . 0.0 109.858 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 t -66.12 -50.12 71.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 109.21 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -62.96 -31.03 72.04 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.238 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.68 -31.74 71.05 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.763 0.792 . . . . 0.0 109.394 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -84.91 -5.38 59.34 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.75 8.96 75.64 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.69 164.61 45.18 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.98 1.85 2.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.03 -1.277 . . . . 0.0 110.325 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.7 165.75 38.61 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.921 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 tp -136.52 137.9 40.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.585 -0.95 . . . . 0.0 109.163 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' B' ' 54' ' ' ALA . 0.0 OUTLIER -109.4 151.68 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.47 -0.769 . . . . 0.0 109.872 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' B' ' 55' ' ' PHE . . . 78.83 -64.02 0.27 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.327 -0.858 . . . . 0.0 112.678 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.495 ' CG ' ' O ' ' B' ' 55' ' ' PHE . 61.2 t80 34.74 36.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.394 0.616 . . . . 0.0 109.788 177.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.745 ' HG3' HH11 ' B' ' 56' ' ' ARG . 14.3 mtm-85 -64.39 154.71 34.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.868 -1.145 . . . . 0.0 109.73 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.406 HD12 HG22 ' B' ' 57' ' ' ILE . 84.6 mt -132.43 157.61 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 2.3 m -124.36 -131.27 0.26 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 43.6 t -160.02 151.95 20.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 109.369 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -168.72 -178.23 3.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 109.486 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -72.47 -64.42 0.96 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.319 -0.863 . . . . 0.0 109.376 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.02 -32.35 0.27 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -49.59 -54.3 19.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.479 -1.013 . . . . 0.0 110.1 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.476 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 1.5 t80 58.66 -127.68 1.39 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.219 -0.926 . . . . 0.0 109.173 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' B' ' 64' ' ' PHE . 4.4 tt 61.45 137.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.612 -0.68 . . . . 0.0 109.605 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -127.79 -114.89 1.86 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' TYR . . . . . 0.436 ' CD1' ' O ' ' B' ' 67' ' ' TYR . 32.4 p90 -172.87 130.97 0.51 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -1.172 . . . . 0.0 109.142 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.54 148.11 19.75 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 79.0 m -102.18 136.29 42.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.907 -1.349 . . . . 0.0 108.761 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 49.1 mt -83.03 142.88 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 m -135.45 157.71 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.151 -0.968 . . . . 0.0 109.767 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.17 151.35 36.63 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.4 150.22 34.99 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -84.77 169.73 13.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.028 -1.045 . . . . 0.0 109.242 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -90.28 123.99 34.51 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.292 -0.88 . . . . 0.0 109.345 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.16 11.16 17.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.173 -0.954 . . . . 0.0 109.538 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -84.82 124.27 31.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.213 -0.929 . . . . 0.0 109.398 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -78.6 14.36 1.32 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 109.496 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 6.7 t -163.84 26.02 0.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 109.485 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' MET . . . . . . . . . . . . . 6.8 mmt 50.89 -157.13 0.11 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -0.936 . . . . 0.0 109.5 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.448 179.992 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 70.0 mt -71.94 -23.91 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.449 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' PHE . . . . . 0.405 ' C ' ' H ' ' C' ' 5' ' ' ASP . 37.6 t80 -160.49 -30.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 109.416 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . 0.423 ' N ' ' CD ' ' C' ' 4' ' ' GLU . 13.8 mp0 -69.7 2.06 3.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.326 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' C' ' 6' ' ' LYS . 19.2 t70 -77.44 -146.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 109.291 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . 0.468 ' H ' ' CG ' ' C' ' 5' ' ' ASP . 41.6 mtpt -138.69 74.99 1.5 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.274 -0.891 . . . . 0.0 109.269 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -102.46 144.31 31.07 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 14.1 mt -132.98 135.97 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.464 -0.772 . . . . 0.0 109.577 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' ILE . . . . . 0.418 ' O ' ' CG2' ' C' ' 9' ' ' ILE . 16.4 tt -137.77 115.0 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -123.05 158.68 30.06 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' THR . . . . . 0.493 ' OG1' ' OG1' ' D' ' 69' ' ' THR . 7.6 p -114.82 85.09 2.18 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.35 -133.08 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.72 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -107.6 -55.98 2.28 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.55 -0.719 . . . . 0.0 109.39 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . 0.495 ' HG2' ' H ' ' C' ' 15' ' ' ILE . 22.7 tt0 -164.89 -179.32 5.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.933 . . . . 0.0 108.886 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . 0.495 ' H ' ' HG2' ' C' ' 14' ' ' GLU . 63.6 mt -112.12 92.04 17.44 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.95 156.7 42.53 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 122.0 1.8 . . . . 0.0 110.456 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.74 -6.08 76.92 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 77.6 mt -130.63 140.44 50.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -1.179 . . . . 0.0 109.494 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -86.01 107.56 17.83 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . 0.482 ' HB3' ' HB ' ' C' ' 71' ' ' VAL . 6.7 mt -111.0 128.17 55.76 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.485 -0.759 . . . . 0.0 110.451 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' TYR . . . . . 0.641 ' CD1' ' N ' ' C' ' 21' ' ' TYR . 0.0 OUTLIER -112.42 142.75 44.58 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.7 136.42 45.58 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.627 0.727 . . . . 0.0 110.106 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 mt -120.43 12.93 11.74 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.5 -175.46 16.72 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 49.4 mm -114.58 139.23 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.13 143.95 42.32 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.35 -0.843 . . . . 0.0 109.217 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 19.2 m -152.83 146.87 25.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.094 -1.004 . . . . 0.0 109.211 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 9.6 t -149.9 137.18 19.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.351 -0.843 . . . . 0.0 109.171 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 89.2 mt -108.23 157.97 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.698 ' O ' ' CG ' ' C' ' 31' ' ' ASP . 15.4 m 62.74 85.09 0.13 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.526 -0.734 . . . . 0.0 109.774 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' ASP . . . . . 0.698 ' CG ' ' O ' ' C' ' 30' ' ' SER . 27.2 m-20 173.04 132.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -83.73 175.17 9.87 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 1.9 m -46.16 -42.62 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.636 0 O-C-N 120.56 -1.337 . . . . 0.0 107.673 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -63.0 -48.7 77.66 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.297 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -73.14 -36.73 66.74 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.955 -1.091 . . . . 0.0 108.896 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 89.5 mt -61.96 -52.53 59.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.824 -1.172 . . . . 0.0 109.396 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.97 -48.58 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -0.965 . . . . 0.0 109.399 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -56.0 -36.23 67.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 109.007 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' ASN . . . . . 0.48 ' ND2' ' OD2' ' C' ' 31' ' ' ASP . 79.8 m-20 -76.07 -37.79 57.82 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.728 -1.232 . . . . 0.0 110.565 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . 0.428 ' O ' HG12 ' C' ' 44' ' ' VAL . 78.7 mt -74.27 -53.28 10.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.741 -1.225 . . . . 0.0 110.024 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' ARG . . . . . 0.455 ' HG3' ' H ' ' C' ' 42' ' ' LYS . 2.2 ppt_? -47.19 -45.23 22.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.075 -1.016 . . . . 0.0 109.279 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' LYS . . . . . 0.455 ' H ' ' HG3' ' C' ' 41' ' ' ARG . 2.1 tmmm? -60.12 -32.46 71.02 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.051 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' GLN . . . . . 0.511 ' O ' ' HB2' ' C' ' 47' ' ' LYS . 69.8 mm-40 -75.31 -36.61 61.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -0.971 . . . . 0.0 110.756 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' VAL . . . . . 0.617 ' O ' ' N ' ' C' ' 49' ' ' GLY . 0.8 OUTLIER -76.8 -52.1 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.712 -1.243 . . . . 0.0 109.83 -179.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' LYS . . . . . 0.475 ' N ' ' CG2' ' C' ' 44' ' ' VAL . 0.3 OUTLIER -61.53 -33.0 73.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.28 -1.512 . . . . 0.0 109.38 -175.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.7 -32.89 62.31 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.85 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' C' ' 43' ' ' GLN . 3.9 mtpp -93.31 -7.61 44.41 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' C' ' 44' ' ' VAL . . . 105.39 -1.25 40.05 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' C' ' 44' ' ' VAL . . . -65.18 -173.68 4.08 Favored Glycine 0 N--CA 1.483 1.798 0 O-C-N 119.913 -1.934 . . . . 0.0 109.597 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.08 9.87 0.44 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.094 -1.239 . . . . 0.0 110.003 176.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.07 164.73 18.81 Favored Glycine 0 N--CA 1.483 1.8 0 C-N-CA 118.974 -1.584 . . . . 0.0 109.813 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.76 149.6 38.23 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.87 -0.783 . . . . 0.0 109.88 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . 0.46 ' CD1' ' HG1' ' B' ' 11' ' ' THR . 1.1 pt -113.15 143.67 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.678 -0.639 . . . . 0.0 110.104 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' C' ' 53' ' ' ILE . . . 77.78 -50.66 0.51 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.68 -0.637 . . . . 0.0 110.679 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' C' ' 54' ' ' ALA . 50.0 t80 42.24 68.98 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' ARG . . . . . 0.65 ' CG ' HH11 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -77.02 137.98 39.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.129 -178.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.59 132.63 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' THR . . . . . 0.489 ' OG1' ' N ' ' C' ' 59' ' ' CYS . 2.1 t -135.81 -167.47 2.04 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' CYS . . . . . 0.489 ' N ' ' OG1' ' C' ' 58' ' ' THR . 48.7 t -138.8 143.14 38.78 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.313 -0.867 . . . . 0.0 109.274 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . 0.54 ' C ' ' H ' ' C' ' 62' ' ' GLY . . . -165.02 133.37 3.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.175 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 5.6 t70 70.15 -33.09 0.25 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.59 -0.694 . . . . 0.0 109.805 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' C' ' 60' ' ' ALA . . . 152.34 -66.28 0.34 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -66.13 -164.45 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.629 -0.924 . . . . 0.0 109.656 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' C' ' 64' ' ' PHE . 0.6 OUTLIER -141.65 179.06 7.05 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.337 -0.852 . . . . 0.0 109.247 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 23.7 tp -145.48 106.42 4.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.358 -0.839 . . . . 0.0 108.945 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.88 147.09 18.09 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -162.21 -176.49 5.16 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.323 -1.104 . . . . 0.0 109.51 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 166.49 -162.0 35.68 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 21.8 m -123.92 136.65 54.47 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.13 142.85 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' C' ' 20' ' ' LEU . 5.2 m -137.18 150.19 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.661 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -119.17 146.01 45.53 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.45 149.43 26.17 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' C' ' 74' ' ' ASP . 25.9 p-10 -83.64 142.33 30.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.772 -1.205 . . . . 0.0 109.376 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' C' ' 76' ' ' ALA . 68.8 tt0 -91.12 -39.14 12.32 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.19 -0.944 . . . . 0.0 109.673 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' C' ' 75' ' ' GLU . . . 73.16 -48.01 0.68 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.695 -0.628 . . . . 0.0 109.879 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -77.79 78.47 4.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.219 -0.926 . . . . 0.0 109.709 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 45.93 -153.78 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.361 -0.837 . . . . 0.0 109.697 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.526 ' HG1' ' N ' ' C' ' 80' ' ' MET . 66.8 p -144.32 -123.8 0.08 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.2 -0.938 . . . . 0.0 109.059 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' MET . . . . . 0.526 ' N ' ' HG1' ' C' ' 79' ' ' THR . 36.3 mtm -93.77 -56.36 2.92 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.164 -0.96 . . . . 0.0 109.53 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.558 -179.989 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ptt? . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' ILE . . . . . . . . . . . . . 4.6 pt -75.71 -40.01 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 109.427 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -114.03 44.93 1.57 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.416 -0.802 . . . . 0.0 109.083 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.65 154.06 22.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.216 -0.927 . . . . 0.0 109.38 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' ASP . . . . . . . . . . . . . 42.3 p-10 -75.17 -172.9 1.83 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 109.317 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -80.26 108.73 14.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.219 -0.926 . . . . 0.0 109.69 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -92.49 120.01 32.54 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.102 -0.999 . . . . 0.0 108.743 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 50.7 mt -126.14 129.87 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.461 -0.774 . . . . 0.0 110.093 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' ILE . . . . . 0.44 ' O ' ' CG2' ' D' ' 9' ' ' ILE . 17.1 tt -113.64 114.43 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t -123.55 160.68 26.49 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.147 -0.971 . . . . 0.0 109.082 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.5 p -91.84 -113.2 0.09 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.5 -120.15 0.87 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.106 . . . . 0.0 110.426 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -152.7 -27.16 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.728 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -168.56 177.1 5.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 0.0 109.53 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' ILE . . . . . 0.405 HG21 HD13 ' D' ' 15' ' ' ILE . 96.1 mt -116.55 97.61 50.37 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.13 155.96 47.82 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.772 1.648 . . . . 0.0 110.415 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.18 -7.54 78.34 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 64.8 mt -129.28 140.46 51.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -1.103 . . . . 0.0 109.513 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -84.52 108.49 17.32 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 15.1 mt -97.26 135.26 39.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.825 . . . . 0.0 110.025 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' TYR . . . . . 0.5 ' CE1' ' O ' ' D' ' 22' ' ' SER . 1.5 t80 -117.74 130.04 56.07 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' SER . . . . . 0.5 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 28.3 t -75.0 129.68 38.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.911 -1.118 . . . . 0.0 110.917 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mt -117.3 12.17 14.24 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.79 177.84 15.2 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.65 145.02 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.892 -0.769 . . . . 0.0 108.943 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.69 144.12 42.74 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.6 -0.688 . . . . 0.0 109.348 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 92.4 p -152.2 138.42 18.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.083 -1.011 . . . . 0.0 108.611 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 13.5 t -149.51 146.33 27.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.052 -1.03 . . . . 0.0 109.134 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . 0.405 HG21 HD12 ' D' ' 29' ' ' ILE . 47.5 mm -116.94 131.54 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.274 -0.891 . . . . 0.0 109.199 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 11.9 m -153.46 -158.04 0.84 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.207 -0.933 . . . . 0.0 109.408 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -106.88 -80.03 0.57 Allowed 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.406 -0.809 . . . . 0.0 111.153 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -65.39 144.78 56.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.896 -1.127 . . . . 0.0 109.153 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 1.9 m -69.42 -36.15 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -58.25 -29.47 65.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.522 -0.736 . . . . 0.0 109.606 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -75.03 -36.02 61.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.364 -0.835 . . . . 0.0 108.888 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 54.8 mt -60.97 -49.62 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.308 -0.87 . . . . 0.0 108.96 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 54.1 t -55.45 -49.44 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.998 . . . . 0.0 109.019 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.82 -41.07 90.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 109.593 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -62.48 -42.76 99.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 0.0 109.337 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 60.5 mt -67.55 -45.38 75.85 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.086 -1.009 . . . . 0.0 108.59 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -50.14 -55.3 15.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.858 -1.152 . . . . 0.0 109.198 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -58.76 -37.63 76.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.252 -0.905 . . . . 0.0 110.453 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -75.68 -35.61 60.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 109.764 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 9.6 t -69.0 -50.49 53.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.25 -0.907 . . . . 0.0 109.234 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -64.21 -29.92 71.01 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.483 -1.287 . . . . 0.0 109.002 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.71 -29.03 67.37 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.33 -5.29 56.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.503 -0.748 . . . . 0.0 109.921 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.0 9.42 58.32 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.2 158.74 40.46 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 3.0 ptm -126.9 -5.04 6.3 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.295 -1.121 . . . . 0.0 110.07 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.27 164.18 36.5 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 8.2 tp -125.42 134.05 52.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.7 -0.882 . . . . 0.0 109.186 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' ILE . . . . . 0.423 ' CD1' ' O ' ' D' ' 53' ' ' ILE . 0.0 OUTLIER -107.68 147.3 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.525 -0.735 . . . . 0.0 110.58 -178.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 51.73 63.44 2.24 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.369 -1.457 . . . . 0.0 109.668 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . 0.572 ' O ' ' O ' ' D' ' 56' ' ' ARG . 2.7 t80 -46.27 -60.15 2.49 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.282 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' ARG . . . . . 0.572 ' O ' ' O ' ' D' ' 55' ' ' PHE . 26.2 mmt180 53.44 125.17 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.649 0.737 . . . . 0.0 110.201 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' ILE . . . . . . . . . . . . . 1.6 pt -136.87 -34.8 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.85 -1.156 . . . . 0.0 108.39 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 46.36 -163.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.597 0.713 . . . . 0.0 109.753 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' CYS . . . . . . . . . . . . . 19.0 p -167.4 -41.94 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.006 -1.059 . . . . 0.0 109.074 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . 47.46 -149.97 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.827 . . . . 0.0 109.606 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -58.17 104.98 0.23 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.218 -0.926 . . . . 0.0 109.18 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.32 -146.71 18.13 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -168.72 91.6 0.27 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.346 -1.091 . . . . 0.0 109.34 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.63 72.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 109.514 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . . . . . . . . . 31.0 tp -152.64 128.43 10.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.743 -1.223 . . . . 0.0 110.228 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.95 121.17 1.59 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -137.71 132.68 33.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.519 -0.989 . . . . 0.0 109.576 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -149.13 169.46 29.51 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 69' ' ' THR . . . . . 0.493 ' OG1' ' OG1' ' C' ' 11' ' ' THR . 88.9 m -113.03 138.04 50.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.254 -1.145 . . . . 0.0 108.67 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 27.5 mt -87.36 135.65 24.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.6 155.72 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.799 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -151.55 158.0 42.98 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -120.19 150.16 41.1 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.27 154.53 38.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.123 -0.985 . . . . 0.0 109.306 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -89.55 135.86 33.36 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.309 -0.869 . . . . 0.0 109.503 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.1 -155.73 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.364 -0.835 . . . . 0.0 109.701 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -156.73 -145.01 0.14 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.203 -0.935 . . . . 0.0 109.308 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 78' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -78.72 -105.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.872 . . . . 0.0 109.361 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 74.4 p -92.64 -67.29 0.87 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.287 -0.883 . . . . 0.0 109.557 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 43.9 mtm -57.73 104.78 0.2 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.425 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.388 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ptt? . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.313 0.578 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 75.3 mt -64.76 143.81 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 109.299 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 3' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -81.04 -64.68 1.14 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 0.0 109.496 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -157.55 -8.63 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.925 . . . . 0.0 109.606 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 5' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -45.94 112.72 0.51 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.305 -0.872 . . . . 0.0 109.246 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -95.7 106.23 18.32 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.442 -0.786 . . . . 0.0 110.095 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -94.21 118.82 32.12 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 76.2 mt -107.03 125.5 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.375 -0.828 . . . . 0.0 110.242 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 9' ' ' ILE . . . . . 0.44 ' CG2' ' O ' ' E' ' 9' ' ' ILE . 20.8 tt -133.42 113.79 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -123.78 161.57 24.95 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.294 -0.879 . . . . 0.0 109.528 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 11' ' ' THR . . . . . 0.439 ' O ' ' C ' ' E' ' 12' ' ' ALA . 0.8 OUTLIER -87.87 -113.75 0.05 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' E' ' 11' ' ' THR . . . 41.64 -122.92 0.56 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 109.486 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 p30 175.53 26.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.549 -0.72 . . . . 0.0 109.647 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -173.44 151.69 2.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.206 -0.934 . . . . 0.0 109.638 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 15' ' ' ILE . . . . . 0.455 ' O ' ' CG2' ' E' ' 15' ' ' ILE . 18.0 tt -138.4 77.53 34.8 Favored Pre-proline 0 N--CA 1.498 1.971 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.86 156.85 36.06 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 122.116 1.878 . . . . 0.0 110.935 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.4 -6.73 71.63 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 18' ' ' LEU . . . . . . . . . . . . . 28.9 mt -128.69 137.43 51.61 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.896 -1.356 . . . . 0.0 109.544 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -84.22 108.79 17.31 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 20' ' ' LEU . . . . . 0.433 HD12 HG21 ' E' ' 15' ' ' ILE . 10.9 mt -104.95 146.05 29.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 111.009 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 21' ' ' TYR . . . . . 0.423 ' CZ ' ' O ' ' E' ' 22' ' ' SER . 1.6 t80 -129.76 130.66 45.68 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 22' ' ' SER . . . . . 0.423 ' O ' ' CZ ' ' E' ' 21' ' ' TYR . 13.7 t -53.02 130.61 34.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 111.104 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 mt -120.41 9.22 10.9 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.75 177.77 18.42 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . 0.417 ' CD1' ' HG1' ' E' ' 69' ' ' THR . 47.2 mm -112.42 143.23 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.784 -0.833 . . . . 0.0 109.358 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.06 154.53 28.7 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 5.2 p -149.67 147.32 27.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.054 -1.029 . . . . 0.0 109.043 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 17.2 p -148.71 132.09 16.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.44 -0.788 . . . . 0.0 109.354 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.453 ' O ' ' CB ' ' E' ' 30' ' ' SER . 86.3 mt -126.66 127.5 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' E' ' 29' ' ' ILE . 2.6 t 164.37 14.07 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 31' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' E' ' 32' ' ' ASN . 30.8 t0 51.91 -179.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.171 -0.956 . . . . 0.0 109.32 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 32' ' ' ASN . . . . . 0.454 ' H ' ' CG ' ' E' ' 31' ' ' ASP . 5.6 m-20 68.59 105.8 0.05 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.582 -0.698 . . . . 0.0 109.246 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 50.3 t -67.0 -34.52 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.259 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -58.73 -46.88 86.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 110.127 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -75.46 -37.44 60.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.107 -0.995 . . . . 0.0 109.187 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 70.2 mt -64.84 -50.82 73.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.945 -1.097 . . . . 0.0 109.579 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 19.2 t -58.91 -51.12 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.05 -1.032 . . . . 0.0 109.195 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -38.44 73.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 109.116 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -65.05 -39.02 92.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.163 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 54.4 mt -71.13 -48.13 53.92 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.147 -0.971 . . . . 0.0 109.084 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 41' ' ' ARG . . . . . 0.806 HH11 ' HG3' ' E' ' 41' ' ' ARG . 0.2 OUTLIER -50.67 -46.17 58.5 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.929 -1.107 . . . . 0.0 109.638 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -62.67 -34.53 77.29 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.176 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -70.63 -36.59 73.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.195 -0.941 . . . . 0.0 108.767 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 20.9 t -77.2 -51.36 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.754 -1.217 . . . . 0.0 109.222 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -49.03 -33.01 10.4 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.444 1.116 . . . . 0.0 110.254 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.31 -26.99 52.74 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.437 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -94.26 10.91 32.18 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.99 31.17 55.6 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 118.342 -1.885 . . . . 0.0 109.797 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -86.14 159.57 32.69 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 34.9 mmm -67.41 -41.69 84.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.144 -1.209 . . . . 0.0 110.5 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.74 -142.64 7.74 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 6.7 tp -130.71 132.55 45.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.531 -0.982 . . . . 0.0 109.284 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 53' ' ' ILE . . . . . . . . . . . . . 1.3 pt -107.53 145.52 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.568 -0.708 . . . . 0.0 110.192 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' E' ' 56' ' ' ARG . . . 71.37 -50.52 0.69 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.264 -0.897 . . . . 0.0 109.821 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 5.9 t80 50.93 -79.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 56' ' ' ARG . . . . . 0.687 HH11 ' HG2' ' E' ' 56' ' ' ARG . 0.0 OUTLIER 64.04 145.48 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.429 -0.794 . . . . 0.0 109.774 178.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 75.9 mt -128.1 112.08 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 58' ' ' THR . . . . . . . . . . . . . 11.3 m -84.9 70.28 10.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 109.442 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 59' ' ' CYS . . . . . . . . . . . . . 7.9 p -95.26 41.12 1.1 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.198 -0.939 . . . . 0.0 109.218 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -46.96 -78.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.27 -0.894 . . . . 0.0 109.882 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -152.0 100.67 2.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.195 -0.94 . . . . 0.0 109.44 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.14 164.64 17.63 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt 49.66 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.346 -1.09 . . . . 0.0 110.567 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 64' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -91.13 159.42 16.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.452 -0.78 . . . . 0.0 109.206 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 28.0 tp -169.66 109.81 0.43 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.013 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.44 74.2 0.66 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -65.5 138.59 58.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.116 -1.226 . . . . 0.0 109.721 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.42 154.15 25.31 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 69' ' ' THR . . . . . 0.417 ' HG1' ' CD1' ' E' ' 25' ' ' ILE . 70.6 m -99.97 134.9 42.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.144 -1.21 . . . . 0.0 108.082 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 12.6 mt -89.2 141.21 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 m -144.72 163.41 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.387 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -149.04 154.62 39.56 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.94 151.57 37.91 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 t70 66.91 -123.65 0.24 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.67 -0.644 . . . . 0.0 109.634 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -119.39 177.85 4.76 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.349 -0.844 . . . . 0.0 109.473 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.74 -179.34 4.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.416 -0.803 . . . . 0.0 109.143 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 77' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -82.05 73.71 9.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 109.316 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -158.29 125.63 5.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 109.434 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 46.9 p -76.1 152.27 36.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 45.0 ttm -150.48 77.95 1.31 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.212 -0.93 . . . . 0.0 109.283 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.39 -179.947 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 mtp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.8 mp -100.58 150.25 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.335 -0.853 . . . . 0.0 109.35 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.0 t80 60.97 29.74 19.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 109.467 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.24 -35.23 63.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 109.489 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -70.06 121.42 17.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.527 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -62.93 95.95 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.3 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -104.01 123.02 46.44 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.653 -0.654 . . . . 0.0 109.77 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.0 mt -114.66 140.88 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.541 -0.724 . . . . 0.0 109.218 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 14.4 tt -125.02 125.02 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.85 130.25 56.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.481 -0.762 . . . . 0.0 109.004 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.527 ' OG1' ' OG1' ' B' ' 69' ' ' THR . 45.7 m -105.21 105.15 15.06 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 52.88 58.11 5.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.311 -0.868 . . . . 0.0 109.892 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 39.9 t0 -143.59 -140.03 0.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.568 -0.708 . . . . 0.0 109.376 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.494 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 5.9 pt-20 -173.66 166.44 4.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.194 -0.942 . . . . 0.0 109.187 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.5 mt -136.13 71.21 62.03 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.378 -0.826 . . . . 0.0 109.158 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.26 156.55 45.02 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 C-N-CA 122.211 1.941 . . . . 0.0 110.225 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.27 -1.08 69.36 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.284 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.1 mt -130.77 138.86 50.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.961 -1.317 . . . . 0.0 109.433 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.409 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 22.3 mm100 -84.6 108.77 17.52 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.6 mt -93.84 136.42 34.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.145 -0.972 . . . . 0.0 110.241 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 72' ' ' LYS . 47.4 t80 -116.02 129.13 56.23 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.23 124.52 24.32 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 120.305 -1.497 . . . . 0.0 110.316 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 35.7 mt -110.1 3.86 20.64 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.04 -178.37 16.46 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.28 144.74 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.802 -0.822 . . . . 0.0 109.187 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.49 143.95 44.95 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.246 0.546 . . . . 0.0 110.078 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.3 m -152.29 134.69 15.21 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.0 t -150.1 153.65 36.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.822 -1.174 . . . . 0.0 109.328 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.2 mp -105.33 154.38 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 173.81 158.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 109.231 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -100.65 139.29 36.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.337 -0.852 . . . . 0.0 110.053 -178.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 3.9 t-20 81.04 141.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.81 -32.76 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.847 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.403 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 1.2 p30 -57.92 -43.5 86.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.927 . . . . 0.0 110.16 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.403 ' N ' ' CG ' ' A' ' 34' ' ' ASP . 63.9 mt-10 -75.18 -38.65 60.74 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.408 -0.808 . . . . 0.0 109.377 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.7 mt -63.52 -44.86 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.992 . . . . 0.0 109.478 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.77 -49.8 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.966 -1.084 . . . . 0.0 109.799 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -58.43 -38.94 78.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 109.678 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.495 ' N ' HD21 ' A' ' 39' ' ' ASN . 1.0 OUTLIER -63.12 -44.74 94.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.713 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.44 -46.51 66.59 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.091 -1.006 . . . . 0.0 109.102 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.741 ' HG3' HH11 ' A' ' 41' ' ' ARG . 0.1 OUTLIER -49.43 -49.87 43.24 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 120.797 -1.19 . . . . 0.0 109.892 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -61.39 -36.97 81.74 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.521 -0.737 . . . . 0.0 110.29 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -77.07 -35.49 56.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.511 -0.743 . . . . 0.0 109.899 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.8 t -66.71 -50.88 62.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.035 -1.041 . . . . 0.0 109.103 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.72 -35.65 80.63 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.392 -1.323 . . . . 0.0 109.015 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.26 -28.86 69.47 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -5.63 56.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.517 -0.74 . . . . 0.0 109.881 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.81 11.82 57.42 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.08 161.55 36.12 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -125.27 -3.4 7.46 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.27 -1.135 . . . . 0.0 109.918 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.31 154.99 24.22 Favored Glycine 0 N--CA 1.487 2.087 0 C-N-CA 119.35 -1.405 . . . . 0.0 109.699 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.06 146.46 36.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.663 -0.904 . . . . 0.0 109.815 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.38 145.6 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.5 -0.75 . . . . 0.0 110.071 -177.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 70.2 79.24 0.19 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.581 -0.699 . . . . 0.0 110.451 176.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -103.07 136.61 42.56 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.488 ' NH1' ' NH2' ' E' ' 56' ' ' ARG . 58.0 ttt180 -151.84 156.47 40.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.73 -1.231 . . . . 0.0 109.764 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.417 ' O ' ' OG1' ' A' ' 58' ' ' THR . 98.1 mt -140.62 -63.84 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 57' ' ' ILE . 66.6 p 47.26 -167.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.378 -0.827 . . . . 0.0 109.717 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.416 ' O ' ' O ' ' A' ' 58' ' ' THR . 13.2 m 54.89 170.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.506 -0.746 . . . . 0.0 109.684 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.14 -60.14 1.64 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.344 -0.847 . . . . 0.0 109.539 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -54.87 124.09 15.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.429 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -93.91 41.92 2.57 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.34 30.53 3.55 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.287 -1.125 . . . . 0.0 109.672 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -83.55 -98.31 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.134 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -173.04 100.34 0.13 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.475 -0.766 . . . . 0.0 110.282 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.42 -175.88 0.61 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -161.47 141.6 10.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.143 -1.21 . . . . 0.0 110.073 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.23 153.23 22.62 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.324 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.2 m -105.22 137.47 42.95 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.225 -1.162 . . . . 0.0 108.703 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 52.4 mt -80.66 141.86 14.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -131.59 153.7 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.379 -0.826 . . . . 0.0 109.466 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.574 ' NZ ' ' O ' ' A' ' 74' ' ' ASP . 15.9 ttpp -142.03 133.53 26.7 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 19' ' ' GLN . . . -123.45 151.82 42.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.001 -1.062 . . . . 0.0 108.568 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.574 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 13.4 m-20 55.45 -143.8 0.71 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.882 -1.136 . . . . 0.0 110.234 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.413 ' N ' ' CD ' ' A' ' 75' ' ' GLU . 18.2 mp0 -62.79 -85.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 109.305 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -169.94 -46.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 109.464 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -93.4 -67.37 0.86 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.227 -0.92 . . . . 0.0 109.444 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 79' ' ' THR . 88.7 t80 -164.87 127.55 2.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.405 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.435 ' O ' ' CD2' ' A' ' 78' ' ' PHE . 0.9 OUTLIER -55.47 160.49 2.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 109.557 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.525 ' N ' ' SD ' ' A' ' 80' ' ' MET . 0.3 OUTLIER -61.91 -56.25 21.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 109.483 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.451 -179.913 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 55.2 mtt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 4.8 tt -167.06 148.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.88 . . . . 0.0 109.155 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' B' ' 3' ' ' PHE . 15.6 p90 -142.59 54.23 1.41 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.343 -0.848 . . . . 0.0 109.387 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -60.49 -25.56 66.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.278 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.81 132.61 35.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 109.521 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -138.54 -108.3 0.17 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -0.923 . . . . 0.0 108.671 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -92.81 120.44 33.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.139 -0.975 . . . . 0.0 109.22 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 68.4 mt -115.94 146.28 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.612 -0.68 . . . . 0.0 109.6 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.467 ' O ' ' CG2' ' B' ' 9' ' ' ILE . 9.5 tt -131.82 115.22 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -123.49 158.36 31.46 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' THR . . . . . 0.466 ' OG1' ' OG1' ' C' ' 69' ' ' THR . 1.5 m -112.67 103.18 11.21 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.33 88.45 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.468 -0.77 . . . . 0.0 109.853 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -162.08 -20.78 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.428 -0.795 . . . . 0.0 109.514 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 60.37 160.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.627 -0.671 . . . . 0.0 109.417 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 mt -130.4 82.94 64.03 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.561 -0.712 . . . . 0.0 109.084 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.58 156.37 42.52 Favored 'Trans proline' 0 C--N 1.323 -0.815 0 C-N-CA 122.068 1.845 . . . . 0.0 110.252 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.71 -6.34 77.12 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 66.9 mt -130.96 139.64 50.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.049 -1.265 . . . . 0.0 109.06 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.18 116.43 23.53 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.79 140.42 33.01 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.18 -0.95 . . . . 0.0 110.032 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -123.31 129.51 51.43 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 42.0 t -67.44 130.61 43.59 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.826 -1.171 . . . . 0.0 111.138 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 72.3 mt -116.71 8.24 13.69 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.42 -171.13 14.9 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 40.6 mm -119.05 141.9 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.908 -0.76 . . . . 0.0 109.367 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.15 144.82 42.01 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.616 -0.678 . . . . 0.0 109.425 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 85.3 p -152.22 137.8 17.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.097 -1.002 . . . . 0.0 108.599 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 8.8 t -149.74 149.6 30.81 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.937 -1.102 . . . . 0.0 109.265 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 66.1 mt -116.13 126.33 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.307 -0.87 . . . . 0.0 109.047 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 32.5 t -174.87 -146.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.148 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -158.91 172.01 18.99 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.211 -0.931 . . . . 0.0 108.814 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 2.1 m120 73.46 130.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 t -68.88 -35.12 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.551 -0.718 . . . . 0.0 109.49 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -58.96 -45.22 91.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.268 -0.895 . . . . 0.0 109.944 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -75.58 -42.1 52.93 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 0.0 109.872 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 77.8 mt -63.46 -53.77 41.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.917 -1.115 . . . . 0.0 109.322 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 t -56.9 -48.54 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.012 -1.055 . . . . 0.0 108.765 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -61.65 -41.18 97.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 110.064 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -58.68 -48.01 82.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.551 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 57.6 mt -74.26 -50.49 18.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 108.934 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -48.81 -47.85 41.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.776 -1.202 . . . . 0.0 108.892 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -61.32 -34.91 76.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 109.449 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -74.42 -36.03 63.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.524 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.29 -51.66 20.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.926 -1.109 . . . . 0.0 108.898 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -51.32 -29.25 14.45 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 122.613 1.196 . . . . 0.0 109.788 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.3 -26.76 52.59 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.439 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -94.26 8.41 41.88 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.07 31.13 68.14 Favored Glycine 0 N--CA 1.476 1.353 0 C-N-CA 118.157 -1.973 . . . . 0.0 109.911 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.48 -169.34 32.44 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 25.0 mmm -106.86 -37.2 6.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.397 -1.061 . . . . 0.0 109.554 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 176.16 -149.49 9.91 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 tp -137.65 143.72 41.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.357 -1.084 . . . . 0.0 109.823 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.495 ' O ' ' CB ' ' B' ' 54' ' ' ALA . 1.2 pt -114.36 146.63 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.5 -0.75 . . . . 0.0 109.376 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.524 ' O ' ' C ' ' B' ' 55' ' ' PHE . . . 82.88 -48.42 0.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 118.769 0.713 . . . . 0.0 109.893 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.524 ' C ' ' O ' ' B' ' 54' ' ' ALA . 78.5 t80 25.1 92.54 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 120.965 0.412 . . . . 0.0 110.593 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.787 ' HG3' HH11 ' B' ' 56' ' ' ARG . 11.2 ttm-85 -98.77 153.46 18.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.214 -0.929 . . . . 0.0 109.821 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -162.73 151.16 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' THR . . . . . 0.407 ' OG1' ' CD2' ' B' ' 64' ' ' PHE . 63.5 p -137.46 -136.05 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 179.83 -173.29 0.21 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -0.963 . . . . 0.0 109.02 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . 64.67 -176.9 0.17 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.651 -0.656 . . . . 0.0 109.644 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -72.31 148.4 45.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.334 -0.854 . . . . 0.0 109.214 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' B' ' 64' ' ' PHE . . . 136.76 2.57 2.47 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' B' ' 64' ' ' PHE . 52.7 mttp 60.06 -71.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.999 -0.706 . . . . 0.0 110.192 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.544 ' N ' ' O ' ' B' ' 62' ' ' GLY . 59.5 m-85 58.68 157.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mp -140.73 136.45 32.57 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.755 0.788 . . . . 0.0 110.763 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.14 53.49 0.94 Allowed Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' TYR . . . . . 0.442 ' HH ' ' HE ' ' B' ' 56' ' ' ARG . 20.3 p90 -59.3 178.44 0.14 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.685 1.231 . . . . 0.0 110.228 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.63 160.41 26.25 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' THR . . . . . 0.527 ' OG1' ' OG1' ' A' ' 11' ' ' THR . 21.7 m -95.87 135.04 38.13 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 120.494 -1.591 . . . . 0.0 107.786 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 58.9 mt -83.64 146.39 6.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 m -136.31 162.33 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.551 -0.718 . . . . 0.0 109.989 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -152.28 141.76 21.67 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.37 151.36 29.87 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.953 -1.092 . . . . 0.0 108.694 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -154.35 64.6 0.69 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.957 -1.089 . . . . 0.0 108.689 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -75.47 -56.59 4.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 109.562 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . 63.34 47.64 3.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.56 -0.713 . . . . 0.0 109.65 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -129.46 107.49 9.53 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.484 -0.76 . . . . 0.0 109.409 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -164.4 109.91 1.0 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.83 . . . . 0.0 109.343 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.586 ' HG1' ' H ' ' B' ' 80' ' ' MET . 1.4 t -160.21 -177.56 6.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.451 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' MET . . . . . 0.586 ' H ' ' HG1' ' B' ' 79' ' ' THR . 26.5 mmt -61.85 -32.99 73.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 109.53 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.418 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.54 ' O ' ' N ' ' C' ' 3' ' ' PHE . 1.8 mpt? . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 59.5 mt 58.51 -79.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.679 -0.638 . . . . 0.0 109.522 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' C' ' 1' ' ' MET . 0.1 OUTLIER 54.67 -156.59 0.22 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 109.068 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -125.55 -31.11 3.02 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.573 -0.704 . . . . 0.0 109.396 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -51.99 -47.17 65.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.076 -1.015 . . . . 0.0 109.104 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? 70.33 104.95 0.06 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.505 -0.747 . . . . 0.0 109.987 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -97.8 121.82 40.16 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.479 -0.763 . . . . 0.0 109.053 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.94 135.98 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.479 -0.763 . . . . 0.0 110.591 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' ILE . . . . . 0.462 ' CG2' ' O ' ' C' ' 9' ' ' ILE . 13.9 tt -132.12 113.33 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 4.9 t -124.45 160.65 27.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.346 -0.846 . . . . 0.0 109.284 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 4.3 p -110.26 83.45 1.76 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.75 -28.45 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.647 -0.658 . . . . 0.0 110.14 177.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . 0.604 ' N ' ' OD1' ' C' ' 13' ' ' ASP . 0.0 OUTLIER 68.51 43.33 1.41 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.479 -0.763 . . . . 0.0 109.49 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -178.67 129.3 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.105 -0.997 . . . . 0.0 109.521 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 16.6 mt -134.28 79.14 56.21 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.98 155.14 51.83 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 122.02 1.814 . . . . 0.0 110.503 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.15 -6.17 78.61 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 53.9 mt -131.6 139.58 49.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -1.198 . . . . 0.0 109.518 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . 0.564 ' O ' ' HA ' ' C' ' 73' ' ' ALA . 25.9 mt-30 -84.91 114.24 21.98 Favored 'General case' 0 C--O 1.192 -1.929 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 16.1 mt -94.64 138.56 32.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.783 -1.198 . . . . 0.0 110.752 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' TYR . . . . . 0.519 ' H ' ' H ' ' C' ' 72' ' ' LYS . 29.3 t80 -116.99 128.29 55.04 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.606 -0.684 . . . . 0.0 109.733 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.04 123.34 21.87 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 120.022 -1.674 . . . . 0.0 110.308 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 78.6 mt -114.69 7.68 16.0 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.96 -174.74 15.89 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.17 144.17 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 122.037 -0.684 . . . . 0.0 109.244 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.3 144.6 45.71 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.95 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 42.1 m -152.61 142.39 22.0 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.96 -1.087 . . . . 0.0 108.421 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 9.2 t -149.52 146.69 27.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.101 -0.999 . . . . 0.0 109.359 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 71.7 mt -113.52 137.37 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.399 -0.813 . . . . 0.0 110.253 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.561 ' HG ' ' H ' ' C' ' 31' ' ' ASP . 0.1 OUTLIER -158.97 -172.81 3.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.48 -0.763 . . . . 0.0 109.78 -179.1 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' ASP . . . . . 0.561 ' H ' ' HG ' ' C' ' 30' ' ' SER . 4.8 m-20 -97.14 -76.14 0.52 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.322 -0.861 . . . . 0.0 111.91 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -76.88 156.07 32.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.927 -1.108 . . . . 0.0 109.104 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.52 -32.89 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.315 0.579 . . . . 0.0 109.803 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' C' ' 34' ' ' ASP . 0.0 OUTLIER -53.54 -38.0 63.38 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.329 -0.857 . . . . 0.0 109.474 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -76.86 -35.36 57.53 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.017 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 81.5 mt -63.56 -53.28 47.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.047 -1.033 . . . . 0.0 108.991 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.11 -50.59 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.05 -1.031 . . . . 0.0 109.152 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -57.92 -38.94 76.81 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.304 -0.873 . . . . 0.0 108.964 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -65.79 -42.12 91.14 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.93 . . . . 0.0 109.522 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 24.8 mt -69.41 -47.65 63.46 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.012 -1.055 . . . . 0.0 108.753 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -49.41 -54.15 18.98 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.885 -1.134 . . . . 0.0 109.261 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -56.66 -34.16 67.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.899 . . . . 0.0 109.208 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -74.8 -43.74 53.14 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.33 -0.856 . . . . 0.0 109.321 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 10.5 t -71.64 -52.29 26.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 O-C-N 120.846 -1.159 . . . . 0.0 108.647 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -51.73 -31.5 26.66 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.823 1.296 . . . . 0.0 110.075 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.3 -28.09 47.43 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.705 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.13 4.32 53.4 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.72 26.49 69.95 Favored Glycine 0 N--CA 1.48 1.605 0 C-N-CA 118.631 -1.747 . . . . 0.0 109.804 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.85 162.98 50.76 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 16.2 ttp -79.91 -42.04 24.9 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.836 -1.39 . . . . 0.0 109.946 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 172.5 -170.3 43.37 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 tp -113.2 141.97 46.34 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.561 -0.964 . . . . 0.0 110.403 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . 0.403 ' O ' ' CB ' ' C' ' 54' ' ' ALA . 2.2 pt -119.82 145.71 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.44 -0.787 . . . . 0.0 110.406 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . 0.452 ' HA ' ' OD1' ' C' ' 13' ' ' ASP . . . 70.99 -56.01 0.63 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.209 -0.932 . . . . 0.0 110.823 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 1.1 t80 61.37 -123.4 0.84 Allowed 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' ARG . . . . . 0.768 HH11 ' HG2' ' C' ' 56' ' ' ARG . 0.0 OUTLIER -170.36 -138.65 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.239 -0.913 . . . . 0.0 109.928 -179.432 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' ILE . . . . . 0.526 ' H ' ' CG ' ' C' ' 56' ' ' ARG . 0.6 OUTLIER 49.95 84.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.185 -0.947 . . . . 0.0 109.637 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' C' ' 59' ' ' CYS . 2.2 t -167.55 -172.82 2.02 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.114 -0.991 . . . . 0.0 109.5 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' CYS . . . . . 0.45 ' N ' ' OG1' ' C' ' 58' ' ' THR . 40.9 t 52.5 -96.09 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.361 -0.837 . . . . 0.0 109.607 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.94 41.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.226 -0.922 . . . . 0.0 109.411 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -162.33 108.13 1.24 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.336 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.79 72.78 0.2 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -119.22 -52.29 2.29 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.504 -0.998 . . . . 0.0 109.315 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -74.12 -145.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 109.715 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.443 ' CD1' ' C ' ' C' ' 65' ' ' LEU . 0.4 OUTLIER -82.48 -176.39 6.21 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.123 -0.985 . . . . 0.0 109.416 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . 0.51 ' C ' ' CD2' ' C' ' 67' ' ' TYR . . . -126.05 -140.26 5.27 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 106.144 -2.782 . . . . 0.0 106.144 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' TYR . . . . . 0.51 ' CD2' ' C ' ' C' ' 66' ' ' GLY . 0.1 OUTLIER -165.67 102.23 0.69 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.869 -1.371 . . . . 0.0 108.127 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.39 173.41 15.37 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' THR . . . . . 0.466 ' OG1' ' OG1' ' B' ' 11' ' ' THR . 53.0 m -122.75 132.82 54.4 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 119.036 1.418 . . . . 0.0 107.582 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 57.7 mt -79.13 129.73 37.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.17 161.88 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.445 -0.784 . . . . 0.0 109.87 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' LYS . . . . . 0.519 ' H ' ' H ' ' C' ' 21' ' ' TYR . 6.5 tttt -154.21 142.62 20.61 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' C' ' 19' ' ' GLN . . . -102.64 128.8 49.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.08 -1.013 . . . . 0.0 109.374 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.1 165.53 18.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.0 109.065 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -99.18 147.5 25.05 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.443 -0.786 . . . . 0.0 109.473 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -163.42 -22.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 0.0 109.306 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -74.51 140.34 44.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.388 -0.82 . . . . 0.0 109.471 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' C' ' 78' ' ' PHE . 4.4 p90 -82.75 -29.1 29.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.286 -0.884 . . . . 0.0 109.58 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 1.8 p -139.55 152.65 47.06 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.295 -0.878 . . . . 0.0 109.277 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 15.3 tpt -164.18 149.68 10.58 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.399 -0.813 . . . . 0.0 109.385 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.314 -179.896 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' D' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' ILE . . . . . . . . . . . . . 5.3 tt -69.25 156.82 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.069 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -122.85 94.31 4.23 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -81.35 -74.4 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.865 . . . . 0.0 109.343 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.34 137.57 18.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.261 -0.899 . . . . 0.0 109.425 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -144.28 -65.21 0.36 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.997 0.903 . . . . 0.0 109.828 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -102.15 121.57 42.48 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 58.3 mt -133.65 128.42 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.434 -0.791 . . . . 0.0 109.351 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' ILE . . . . . 0.459 ' O ' ' CG2' ' D' ' 9' ' ' ILE . 9.1 tt -128.23 115.12 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.7 t -125.64 157.36 37.45 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' THR . . . . . 0.484 ' OG1' ' OG1' ' E' ' 69' ' ' THR . 3.5 m -102.55 81.9 2.09 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.3 -112.15 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.452 -0.78 . . . . 0.0 110.203 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -152.49 -135.67 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.552 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -63.22 158.96 18.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -0.876 . . . . 0.0 109.371 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 38.9 mt -112.23 98.95 44.91 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.18 155.84 43.37 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.896 1.731 . . . . 0.0 110.392 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.68 -8.11 78.89 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 80.6 mt -131.44 142.27 49.98 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.42 -1.047 . . . . 0.0 109.309 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -87.77 108.45 19.13 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mt -114.9 131.6 56.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.687 -0.633 . . . . 0.0 109.599 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' TYR . . . . . 0.595 ' OH ' ' N ' ' D' ' 74' ' ' ASP . 0.0 OUTLIER -113.73 143.42 44.64 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 16.6 t -75.06 128.33 35.29 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.93 12.38 20.77 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.5 -179.09 16.35 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.9 144.01 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 122.174 -0.604 . . . . 0.0 109.606 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.25 144.28 40.67 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.405 0.621 . . . . 0.0 109.377 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.47 138.4 18.1 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.265 -0.897 . . . . 0.0 109.356 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 12.7 t -149.73 144.5 26.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.044 -1.035 . . . . 0.0 109.189 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 12.9 tt -117.95 127.91 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.271 -0.893 . . . . 0.0 108.93 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 30.1 t -173.65 174.28 3.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 109.056 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' D' ' 32' ' ' ASN . 29.5 t70 -107.49 157.29 18.14 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.332 -0.855 . . . . 0.0 109.565 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 8.6 t30 85.97 123.81 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 -177.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -69.86 -38.95 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -63.12 -31.0 72.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.539 -0.726 . . . . 0.0 109.878 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -75.0 -41.08 60.19 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.223 -0.923 . . . . 0.0 109.717 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 92.6 mt -62.2 -46.31 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.999 -1.063 . . . . 0.0 108.7 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 17.0 t -55.75 -48.07 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.909 -1.119 . . . . 0.0 108.288 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -62.76 -42.23 99.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.024 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -59.67 -45.56 91.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.333 -0.855 . . . . 0.0 109.415 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 49.4 mt -71.36 -48.0 52.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 108.899 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -49.07 -50.92 34.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.79 -1.194 . . . . 0.0 109.113 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -59.96 -36.21 76.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.398 -0.814 . . . . 0.0 109.952 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -75.8 -35.85 59.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.465 -0.772 . . . . 0.0 109.598 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 13.1 t -71.07 -50.79 39.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.066 -1.022 . . . . 0.0 108.799 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -64.74 -30.13 71.13 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 118.29 -1.364 . . . . 0.0 109.255 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.66 -30.41 69.95 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . 0.494 ' NZ ' ' HB3' ' D' ' 47' ' ' LYS . 0.1 OUTLIER -90.36 2.07 55.93 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.79 23.83 74.13 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.08 -165.65 7.92 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 7.8 ttt -110.2 -41.26 4.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.418 -1.048 . . . . 0.0 109.702 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 173.58 -158.66 28.06 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 3.4 tp -125.07 139.86 53.42 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.595 -0.944 . . . . 0.0 110.36 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' ILE . . . . . 0.482 ' O ' ' CB ' ' D' ' 54' ' ' ALA . 1.0 OUTLIER -118.06 148.53 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.672 -0.643 . . . . 0.0 110.501 -177.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' D' ' 53' ' ' ILE . . . 82.73 -38.22 0.09 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 118.832 0.742 . . . . 0.0 109.131 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . 0.498 ' O ' ' O ' ' D' ' 56' ' ' ARG . 31.3 t80 49.18 -110.41 0.4 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.624 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' ARG . . . . . 0.682 ' HG2' HH11 ' D' ' 56' ' ' ARG . 6.4 mtt-85 57.59 123.54 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.418 0.628 . . . . 0.0 109.868 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' ILE . . . . . . . . . . . . . 1.9 pt -136.21 -168.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.246 -0.909 . . . . 0.0 109.198 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' THR . . . . . . . . . . . . . 39.7 p -144.93 118.68 9.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.534 -0.729 . . . . 0.0 109.107 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' CYS . . . . . . . . . . . . . 15.3 p -163.87 68.42 0.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.413 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.28 -8.84 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.359 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -162.04 -17.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.33 -0.856 . . . . 0.0 109.31 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . 174.38 106.95 0.2 Allowed Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.632 -1.27 . . . . 0.0 109.959 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . 0.621 ' HD3' ' H ' ' D' ' 63' ' ' LYS . 0.0 OUTLIER -61.68 -93.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.895 -1.356 . . . . 0.0 109.293 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . 0.47 ' HB3' ' O ' ' D' ' 63' ' ' LYS . 63.9 t80 74.38 60.42 0.08 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.183 0.516 . . . . 0.0 110.518 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 0.4 ' CB ' ' O ' ' D' ' 64' ' ' PHE . 3.2 tp 68.05 159.7 0.16 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.341 -0.849 . . . . 0.0 109.182 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 66' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' D' ' 67' ' ' TYR . . . -118.0 -30.44 1.78 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 178.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 67' ' ' TYR . . . . . 0.502 ' CB ' ' O ' ' D' ' 66' ' ' GLY . 1.7 t80 81.03 123.79 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.277 1.037 . . . . 0.0 111.665 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.1 139.68 5.81 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 46.9 m -109.55 148.32 31.45 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.065 -1.256 . . . . 0.0 109.536 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 24.1 mt -97.78 148.04 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.54 0.686 . . . . 0.0 109.577 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 m -143.34 154.18 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.491 -0.755 . . . . 0.0 109.357 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 72' ' ' LYS . . . . . 0.481 ' NZ ' ' OD2' ' D' ' 74' ' ' ASP . 26.3 ttpp -139.98 142.5 36.33 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.049 -1.032 . . . . 0.0 108.667 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' D' ' 74' ' ' ASP . . . -124.11 141.36 52.12 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . 0.595 ' N ' ' OH ' ' D' ' 21' ' ' TYR . 3.5 p30 172.37 30.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -78.17 122.38 25.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.039 -1.038 . . . . 0.0 109.696 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -175.93 -101.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.983 . . . . 0.0 111.011 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 171.95 146.15 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 78' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -123.5 -44.79 2.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.442 -0.786 . . . . 0.0 109.437 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 3.8 t -166.76 31.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 17.6 mmt 49.73 -159.33 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.281 -0.887 . . . . 0.0 109.477 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.449 -179.938 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 33.1 mtt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 6.2 pt -88.17 166.45 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.249 -0.907 . . . . 0.0 109.179 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 3' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -137.64 1.35 2.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.425 -0.797 . . . . 0.0 109.222 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -76.25 63.75 1.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 109.635 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 5' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -54.1 173.12 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.297 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 6' ' ' LYS . . . . . 0.557 ' CG ' ' H ' ' E' ' 7' ' ' PHE . 14.7 tttt -154.57 -154.51 0.51 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.912 -1.118 . . . . 0.0 109.793 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 7' ' ' PHE . . . . . 0.557 ' H ' ' CG ' ' E' ' 6' ' ' LYS . 18.8 t80 -109.85 120.73 43.39 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.562 -0.711 . . . . 0.0 109.672 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 83.7 mt -96.86 128.57 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.323 -0.86 . . . . 0.0 110.988 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 9' ' ' ILE . . . . . 0.438 ' O ' ' CG2' ' E' ' 9' ' ' ILE . 17.1 tt -134.48 121.01 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 1.3 t -113.34 133.25 55.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.322 -0.861 . . . . 0.0 109.336 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.63 -90.74 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.397 -0.814 . . . . 0.0 110.984 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.09 72.72 1.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.123 -0.986 . . . . 0.0 108.366 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -160.26 141.53 12.32 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.415 0.626 . . . . 0.0 109.512 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -79.56 178.68 7.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.398 -0.814 . . . . 0.0 109.127 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 57.5 mt -123.6 88.17 51.96 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.474 -0.766 . . . . 0.0 109.184 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.55 155.49 52.76 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 121.962 1.775 . . . . 0.0 110.158 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.02 -12.34 69.78 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 18' ' ' LEU . . . . . . . . . . . . . 15.9 mt -125.2 136.83 53.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -1.185 . . . . 0.0 108.982 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.14 112.84 21.68 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt -99.08 142.62 30.34 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.187 -0.946 . . . . 0.0 109.83 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 21' ' ' TYR . . . . . 0.403 ' CE1' ' O ' ' E' ' 22' ' ' SER . 1.5 t80 -123.29 130.07 52.23 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 22' ' ' SER . . . . . 0.403 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 4.3 t -61.39 129.97 43.8 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.83 -1.169 . . . . 0.0 110.953 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 mt -117.65 9.26 13.03 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.67 -173.6 14.86 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.77 143.92 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 122.033 -0.687 . . . . 0.0 109.433 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.61 144.04 47.34 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.943 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 19.4 m -152.18 136.34 16.57 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 10.9 t -149.92 151.49 33.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.972 -1.08 . . . . 0.0 109.222 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 56.6 mt -127.0 133.44 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.111 -0.993 . . . . 0.0 108.702 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.574 ' O ' ' N ' ' E' ' 32' ' ' ASN . 78.1 p -156.29 31.77 0.33 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.134 -0.979 . . . . 0.0 110.769 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 31' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' E' ' 31' ' ' ASP . 0.7 OUTLIER 54.28 -70.59 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 32' ' ' ASN . . . . . 0.574 ' N ' ' O ' ' E' ' 30' ' ' SER . 7.3 m120 -66.1 135.41 54.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.732 -1.23 . . . . 0.0 107.93 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 33' ' ' VAL . . . . . 0.421 ' CG2' ' N ' ' E' ' 34' ' ' ASP . 1.0 OUTLIER -70.88 -42.21 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 34' ' ' ASP . . . . . 0.421 ' N ' ' CG2' ' E' ' 33' ' ' VAL . 29.8 t70 -52.53 -28.02 18.98 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.512 -0.742 . . . . 0.0 109.825 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -78.11 -33.39 50.6 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.422 -0.799 . . . . 0.0 109.202 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.16 -52.77 57.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.031 -1.043 . . . . 0.0 108.776 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.89 -49.24 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.085 -1.01 . . . . 0.0 108.967 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -60.71 -41.86 96.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.414 -0.804 . . . . 0.0 108.978 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -64.46 -45.2 88.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.471 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 70.4 mt -64.57 -44.03 92.01 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.098 -1.001 . . . . 0.0 108.329 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 41' ' ' ARG . . . . . 0.715 HH11 ' HG2' ' E' ' 41' ' ' ARG . 0.0 OUTLIER -48.84 -55.5 11.48 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.845 -1.159 . . . . 0.0 109.352 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -55.96 -33.56 64.89 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.088 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -74.44 -40.07 62.17 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.462 -0.773 . . . . 0.0 109.494 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 12.8 t -73.87 -52.01 22.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 120.879 -1.138 . . . . 0.0 108.82 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -50.59 -29.6 11.22 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.692 1.234 . . . . 0.0 109.741 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.63 -25.84 50.04 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.383 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -95.71 4.38 53.04 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.67 30.73 78.73 Favored Glycine 0 N--CA 1.479 1.555 0 C-N-CA 118.009 -2.043 . . . . 0.0 110.181 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.32 153.92 23.84 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 10.8 mtm -66.46 -29.61 69.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -1.111 . . . . 0.0 110.474 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.74 -137.51 4.61 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 tp -133.64 137.93 45.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.421 -1.046 . . . . 0.0 110.086 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.12 144.9 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.609 -0.682 . . . . 0.0 110.163 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . 64.91 74.84 0.38 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.166 -0.959 . . . . 0.0 110.216 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -98.56 107.47 19.93 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 56' ' ' ARG . . . . . 0.66 ' CG ' HH11 ' E' ' 56' ' ' ARG . 0.4 OUTLIER -97.3 135.63 38.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.582 -0.699 . . . . 0.0 110.529 -178.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 tt 179.04 104.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 58' ' ' THR . . . . . . . . . . . . . 63.0 m -149.51 -95.48 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.04 -1.038 . . . . 0.0 109.408 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 59' ' ' CYS . . . . . . . . . . . . . 78.4 m -67.24 104.93 1.59 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.195 -0.941 . . . . 0.0 109.768 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.02 48.18 0.7 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.255 -0.903 . . . . 0.0 109.258 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -54.22 -22.03 10.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.865 . . . . 0.0 109.502 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 163.14 -6.05 0.08 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -92.08 150.21 21.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.16 -1.2 . . . . 0.0 109.523 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 64' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -153.55 31.44 0.46 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.253 -0.904 . . . . 0.0 109.286 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.506 ' H ' HD12 ' E' ' 65' ' ' LEU . 3.3 mp -99.53 118.15 35.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.399 -0.813 . . . . 0.0 110.306 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 66' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' E' ' 67' ' ' TYR . . . -71.11 59.56 1.05 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 67' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' E' ' 66' ' ' GLY . 78.3 m-85 -39.55 114.2 0.4 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.63 -0.924 . . . . 0.0 110.032 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.61 149.72 21.11 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 69' ' ' THR . . . . . 0.484 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 8.6 m -112.81 137.5 51.05 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 32.0 mt -82.78 148.68 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 m -130.44 164.8 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.662 -0.649 . . . . 0.0 109.907 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -147.95 145.43 28.57 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.89 137.96 49.15 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -145.3 120.53 10.18 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.728 -1.233 . . . . 0.0 108.13 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -160.95 54.6 0.3 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -0.936 . . . . 0.0 109.326 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.19 -46.18 11.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.908 . . . . 0.0 109.491 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 77' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -165.31 -143.55 0.06 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.301 -0.874 . . . . 0.0 109.412 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -95.25 115.5 27.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.094 -1.004 . . . . 0.0 109.363 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 36.7 p -69.08 102.58 1.67 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.341 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 11.1 mmt -57.31 154.75 10.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.497 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.44 -179.967 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.289 0.566 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 2' ' ' ILE . 10.3 mm -78.05 -64.16 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 109.357 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -85.98 116.98 24.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -0.912 . . . . 0.0 109.443 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.03 164.56 23.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 109.529 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -84.79 134.71 34.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 109.46 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -89.93 132.75 35.16 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.327 -0.858 . . . . 0.0 108.884 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -101.7 121.98 43.06 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.5 mt -134.49 138.15 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.29 -0.881 . . . . 0.0 109.978 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.478 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 6.9 tt -127.8 118.21 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.788 -1.195 . . . . 0.0 108.088 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.4 t -127.24 154.93 44.24 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.059 -1.026 . . . . 0.0 109.563 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 m -135.54 115.95 13.63 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.52 66.23 1.23 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.344 -0.848 . . . . 0.0 109.655 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -164.13 -24.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.54 -0.725 . . . . 0.0 109.504 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 57.15 171.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.519 -0.738 . . . . 0.0 109.438 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mt -139.01 74.7 36.53 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.371 -0.831 . . . . 0.0 109.099 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.44 156.47 41.22 Favored 'Trans proline' 0 C--N 1.32 -0.952 0 C-N-CA 122.132 1.888 . . . . 0.0 110.197 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.08 -3.71 73.55 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.261 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 42.6 mt -129.9 137.87 50.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.279 . . . . 0.0 108.871 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 12.0 pt20 -85.91 113.82 22.33 Favored 'General case' 0 C--O 1.2 -1.518 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -95.0 138.81 32.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.892 -1.13 . . . . 0.0 109.603 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.557 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 42.4 t80 -109.97 155.07 22.26 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.45 126.56 38.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 119.857 -1.777 . . . . 0.0 108.07 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.7 mt -117.08 5.91 12.83 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.69 -164.36 13.51 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.35 145.24 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 122.027 -0.69 . . . . 0.0 109.653 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.99 154.37 25.41 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 87.0 p -147.11 150.18 34.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.126 -0.984 . . . . 0.0 109.087 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.7 p -148.86 134.71 18.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.539 -0.726 . . . . 0.0 109.468 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.673 ' O ' ' OG ' ' A' ' 30' ' ' SER . 10.6 mm -127.12 126.0 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.673 ' OG ' ' O ' ' A' ' 29' ' ' ILE . 23.4 m 171.81 -129.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.175 0.512 . . . . 0.0 109.679 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.464 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 3.1 p30 -153.38 165.15 36.68 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.045 -1.034 . . . . 0.0 109.227 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 7.8 t-20 77.55 109.52 0.07 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -177.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.36 -38.06 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.359 -0.838 . . . . 0.0 108.868 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 35' ' ' GLU . 1.9 p30 -61.17 -32.4 72.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.845 . . . . 0.0 110.095 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.46 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 31.1 tt0 -75.69 -37.45 59.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 0.0 109.139 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.1 mt -62.51 -42.61 96.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.12 -0.988 . . . . 0.0 108.836 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.28 -50.19 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.007 -1.058 . . . . 0.0 108.81 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -59.37 -38.94 81.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 109.663 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -61.76 -43.34 99.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.387 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 76.8 mt -68.07 -46.05 72.15 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.169 -0.957 . . . . 0.0 108.527 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -50.65 -53.3 32.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.899 -1.126 . . . . 0.0 109.199 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -57.81 -33.53 68.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.426 -0.796 . . . . 0.0 109.093 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -72.98 -41.88 63.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.331 -0.855 . . . . 0.0 109.34 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.1 t -77.01 -50.93 19.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 120.682 -1.261 . . . . 0.0 109.359 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -49.73 -32.97 14.79 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 122.681 1.229 . . . . 0.0 109.954 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.25 -29.26 48.0 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.824 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -93.54 5.8 50.39 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.25 29.43 68.71 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 118.265 -1.922 . . . . 0.0 109.629 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.2 -168.53 11.06 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -104.85 -53.9 2.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -1.059 . . . . 0.0 109.955 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.74 178.21 48.02 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.485 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 3.9 mm? -98.88 135.05 40.87 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.377 -1.073 . . . . 0.0 110.261 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 54' ' ' ALA . 1.4 pt -112.11 139.01 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.664 -0.647 . . . . 0.0 109.392 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 53' ' ' ILE . . . 43.52 45.79 5.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.157 -0.964 . . . . 0.0 109.501 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.12 -27.17 28.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 0.0 109.209 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.62 HH22 ' CB ' ' B' ' 27' ' ' SER . 8.4 mmt180 -42.33 160.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.665 0.745 . . . . 0.0 109.891 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.599 ' H ' ' CD1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -51.12 -21.76 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.472 HG23 ' H ' ' A' ' 59' ' ' CYS . 0.2 OUTLIER 69.61 -176.99 0.21 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 0.0 109.48 -179.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.472 ' H ' HG23 ' A' ' 58' ' ' THR . 41.9 t -65.71 80.98 0.07 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.215 -0.928 . . . . 0.0 109.565 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -151.5 -38.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.911 . . . . 0.0 109.265 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.5 t70 53.75 18.73 1.62 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.366 -0.833 . . . . 0.0 109.341 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.58 -25.12 73.97 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.9 tttt 54.44 39.09 30.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.365 -1.08 . . . . 0.0 109.28 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.467 ' CE1' ' O ' ' A' ' 30' ' ' SER . 1.4 t80 -168.56 42.38 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.23 -0.919 . . . . 0.0 109.37 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.5 tp -165.89 129.9 2.22 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.252 -0.905 . . . . 0.0 109.804 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.07 133.13 6.3 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -150.17 174.54 12.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.389 -1.065 . . . . 0.0 109.83 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.31 156.98 13.09 Favored Glycine 0 N--CA 1.487 2.091 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.284 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.471 ' OG1' ' OG1' ' E' ' 11' ' ' THR . 52.8 m -98.29 135.39 39.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.193 -1.18 . . . . 0.0 108.617 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.4 mt -89.63 131.28 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 5.4 m -138.5 167.7 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.664 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -150.94 150.86 31.33 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 19' ' ' GLN . . . -105.98 115.65 30.59 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.181 -0.949 . . . . 0.0 110.938 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 173.63 165.73 0.18 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.384 0.612 . . . . 0.0 109.596 -178.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -58.89 -29.13 66.79 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.457 -0.777 . . . . 0.0 109.251 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.55 -172.14 0.06 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.337 -0.852 . . . . 0.0 109.086 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 61.04 158.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.475 -0.765 . . . . 0.0 109.604 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -61.45 145.31 52.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.31 -0.868 . . . . 0.0 109.41 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.76 171.14 14.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.887 . . . . 0.0 109.309 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 50.6 mtm -57.89 -58.74 7.05 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.436 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 16.2 pt -58.07 -20.43 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.918 . . . . 0.0 109.457 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 23.4 t80 54.18 -126.84 2.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.306 -0.872 . . . . 0.0 109.483 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -64.63 123.66 19.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 0.0 109.41 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -75.18 -71.63 0.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.28 -0.888 . . . . 0.0 109.362 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -168.0 98.13 0.45 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.098 -1.001 . . . . 0.0 109.71 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -92.95 120.08 32.9 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.172 -0.955 . . . . 0.0 108.728 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 14.9 mt -115.57 135.68 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.454 -0.779 . . . . 0.0 110.383 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.449 ' O ' ' CG2' ' B' ' 9' ' ' ILE . 19.0 tt -134.46 114.09 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.9 t -123.01 159.59 28.06 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.377 -0.827 . . . . 0.0 108.926 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.0 p -101.68 72.72 1.39 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -177.01 -137.3 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.156 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 179.68 90.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.473 -0.767 . . . . 0.0 109.577 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -156.85 -81.56 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.349 -0.844 . . . . 0.0 109.447 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.482 ' N ' ' HD3' ' B' ' 16' ' ' PRO . 8.2 mt 47.18 62.35 12.02 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.118 -0.989 . . . . 0.0 108.952 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' B' ' 15' ' ' ILE . 1.4 Cg_endo -65.97 155.63 68.53 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.997 1.798 . . . . 0.0 109.909 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.07 -10.65 74.42 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.308 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 76.1 mt -124.89 137.28 54.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.08 -1.247 . . . . 0.0 108.638 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -101.45 116.41 32.72 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' B' ' 72' ' ' LYS . 0.2 OUTLIER -111.99 134.57 53.46 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.556 -0.715 . . . . 0.0 110.688 -177.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . 0.658 ' CD1' ' N ' ' B' ' 21' ' ' TYR . 0.0 OUTLIER -105.17 152.75 22.44 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.02 128.83 34.8 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.504 -0.747 . . . . 0.0 109.6 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 mt -113.17 7.06 17.77 Favored 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.03 -157.08 22.49 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 176.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -135.02 143.68 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.963 -0.728 . . . . 0.0 109.359 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.94 145.59 45.65 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.128 0.49 . . . . 0.0 109.738 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.62 ' CB ' HH22 ' A' ' 56' ' ' ARG . 0.0 OUTLIER -152.05 141.36 21.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.005 -1.059 . . . . 0.0 108.459 179.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 14.1 t -149.63 152.85 36.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.199 -0.938 . . . . 0.0 109.083 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 68.6 mt -126.8 133.1 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.2 -0.937 . . . . 0.0 109.375 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 34.2 t -165.59 166.06 18.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.438 -0.789 . . . . 0.0 109.338 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -96.63 70.95 2.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.238 -0.914 . . . . 0.0 109.645 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 169.31 129.04 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.44 ' CG2' ' N ' ' B' ' 34' ' ' ASP . 1.3 m -71.16 -43.62 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.44 ' N ' ' CG2' ' B' ' 33' ' ' VAL . 33.9 m-20 -63.76 -45.16 91.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.348 -0.845 . . . . 0.0 109.681 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -60.37 -39.18 86.31 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.678 -0.809 . . . . 0.0 108.872 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 48.5 mt -64.07 -51.89 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.92 . . . . 0.0 108.877 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -53.64 -48.31 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.977 . . . . 0.0 108.508 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -60.8 -40.26 91.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.335 -0.853 . . . . 0.0 110.102 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -64.36 -44.38 91.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 109.478 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 40.9 mt -68.45 -48.76 63.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.131 -0.981 . . . . 0.0 108.527 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -49.0 -48.58 43.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.846 -1.159 . . . . 0.0 108.945 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.424 ' CB ' ' HZ2' ' B' ' 42' ' ' LYS . 6.9 ttpm? -62.19 -36.31 81.5 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.51 -0.744 . . . . 0.0 109.965 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -75.5 -35.96 60.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.385 -0.822 . . . . 0.0 109.668 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.75 -51.6 26.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.062 -1.024 . . . . 0.0 108.902 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -56.0 -28.73 58.47 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.669 1.223 . . . . 0.0 109.147 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.26 -28.33 59.78 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.385 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -96.42 -5.22 40.25 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.11 24.72 70.7 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 118.466 -1.825 . . . . 0.0 109.175 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.25 -171.11 9.25 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -112.36 -40.12 4.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.502 -0.999 . . . . 0.0 109.896 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 171.52 175.53 39.94 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.495 ' CD2' ' N ' ' B' ' 52' ' ' LEU . 2.3 mm? -96.99 133.85 41.13 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.378 -1.072 . . . . 0.0 109.942 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 49.7 mt -110.25 137.05 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.727 -0.608 . . . . 0.0 109.973 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 57.95 71.42 0.58 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.816 . . . . 0.0 109.815 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' B' ' 56' ' ' ARG . 2.0 t80 -58.38 -73.25 0.08 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.36 -0.837 . . . . 0.0 108.923 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' B' ' 55' ' ' PHE . 7.1 tpt180 58.01 113.61 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.411 -0.806 . . . . 0.0 110.157 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.78 133.49 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 17.0 p -143.9 142.2 30.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.31 -0.869 . . . . 0.0 109.367 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 7.6 t -179.82 151.11 0.42 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -165.76 43.4 0.07 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.893 . . . . 0.0 109.328 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -164.38 -9.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 109.519 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.02 -138.45 2.43 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -77.65 165.0 24.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -1.141 . . . . 0.0 109.605 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -79.22 -165.0 0.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 0.0 109.565 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 46.7 tp -157.49 113.43 2.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.393 -0.817 . . . . 0.0 109.078 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -123.12 152.4 16.93 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -167.81 -175.48 2.76 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.473 -1.016 . . . . 0.0 109.399 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.0 -162.4 35.29 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 97.6 m -123.84 137.79 54.6 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 31.1 mt -83.81 125.49 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 6.5 m -136.94 164.18 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.824 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' B' ' 20' ' ' LEU . 3.0 mttt -136.1 146.67 47.26 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.33 -0.856 . . . . 0.0 108.879 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' B' ' 74' ' ' ASP . . . -114.88 116.75 29.05 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.81 -0.556 . . . . 0.0 110.235 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . 0.567 ' O ' ' OH ' ' B' ' 21' ' ' TYR . 5.5 t70 156.25 131.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.774 0.797 . . . . 0.0 109.655 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -173.41 158.24 3.46 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.724 -1.235 . . . . 0.0 109.462 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.31 167.67 20.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.866 . . . . 0.0 109.197 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -99.55 -60.14 1.59 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.34 -0.85 . . . . 0.0 109.489 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -67.45 143.63 56.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.209 -0.932 . . . . 0.0 110.002 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 10.0 m -50.16 159.66 0.43 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.475 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' MET . . . . . . . . . . . . . 7.3 tpt -112.61 61.15 0.63 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.546 -0.721 . . . . 0.0 109.297 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.379 179.902 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 11.2 mm -62.65 -84.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -83.35 170.85 14.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.893 . . . . 0.0 109.161 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -139.03 172.86 12.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.362 -0.836 . . . . 0.0 109.215 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' ASP . . . . . 0.439 ' OD1' ' NH2' ' C' ' 41' ' ' ARG . 26.3 t70 -162.44 48.69 0.17 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.234 -0.916 . . . . 0.0 110.362 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -73.23 45.87 0.17 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.722 -1.236 . . . . 0.0 110.147 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -92.77 120.31 33.02 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.135 -0.978 . . . . 0.0 108.728 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 44.8 mt -119.45 128.57 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.513 -0.742 . . . . 0.0 109.788 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' ILE . . . . . 0.45 ' CG2' ' O ' ' C' ' 9' ' ' ILE . 13.4 tt -119.96 114.14 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -122.94 159.97 27.17 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 7.7 p -125.55 77.57 1.66 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.642 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.35 -117.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.398 -1.439 . . . . 0.0 108.371 -176.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -84.41 -134.27 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.136 -0.977 . . . . 0.0 109.796 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.75 28.93 5.54 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.529 -0.732 . . . . 0.0 109.862 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 33.2 mt 57.06 81.63 0.25 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.393 -0.817 . . . . 0.0 109.58 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.93 156.84 41.61 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 122.21 1.94 . . . . 0.0 110.37 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.18 -0.95 69.44 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.378 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 60.8 mt -131.52 138.99 49.17 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.111 -1.229 . . . . 0.0 109.155 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -97.54 109.55 22.29 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.2 143.97 47.97 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' TYR . . . . . 0.666 ' CD1' ' N ' ' C' ' 21' ' ' TYR . 0.0 OUTLIER -113.65 146.85 39.14 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.509 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -72.85 136.91 45.41 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.642 0.734 . . . . 0.0 109.999 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 5.8 mt -118.47 15.37 13.8 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.02 179.76 16.18 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 47.1 mm -112.3 142.26 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.795 -0.827 . . . . 0.0 108.826 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.38 144.17 43.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.528 -0.733 . . . . 0.0 109.899 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 35.4 t -152.31 137.66 17.57 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 15.2 t -149.62 152.3 35.22 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.055 -1.028 . . . . 0.0 109.369 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -102.15 155.02 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' C' ' 31' ' ' ASP . 12.1 t -176.19 -178.06 0.95 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.975 . . . . 0.0 109.225 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' ASP . . . . . 0.448 ' N ' ' OG ' ' C' ' 30' ' ' SER . 20.0 t70 -102.2 -80.78 0.5 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.411 -0.806 . . . . 0.0 110.971 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -65.08 144.12 57.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.996 -1.065 . . . . 0.0 108.731 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.47 -38.44 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -54.59 -28.16 44.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.459 -0.776 . . . . 0.0 109.848 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -76.23 -34.74 59.22 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.309 -0.869 . . . . 0.0 109.479 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 84.2 mt -58.76 -46.9 90.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.171 -0.955 . . . . 0.0 108.913 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 55.6 t -56.86 -49.57 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.952 -1.092 . . . . 0.0 108.637 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -61.8 -42.78 99.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.437 -0.789 . . . . 0.0 109.402 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -60.26 -48.67 80.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.535 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 67.2 mt -64.68 -42.9 95.03 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' ARG . . . . . 0.717 HH11 ' HG2' ' C' ' 41' ' ' ARG . 0.8 OUTLIER -48.2 -47.7 35.28 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.861 -1.15 . . . . 0.0 109.275 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -63.13 -31.83 73.06 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -73.8 -41.74 61.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.832 . . . . 0.0 109.518 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 38.1 t -68.29 -51.24 49.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.705 -1.247 . . . . 0.0 109.292 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -51.0 -33.44 24.84 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.642 1.211 . . . . 0.0 110.223 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.76 -28.83 50.72 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.678 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.55 7.31 43.8 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.48 29.77 64.11 Favored Glycine 0 N--CA 1.487 2.08 0 C-N-CA 118.672 -1.727 . . . . 0.0 109.759 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.26 148.9 27.14 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -65.23 -33.63 76.45 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.174 -1.192 . . . . 0.0 110.826 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 171.56 -159.04 30.47 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 11.4 tp -121.18 135.57 55.12 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.588 -0.948 . . . . 0.0 109.622 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . 0.41 HG23 HD12 ' C' ' 53' ' ' ILE . 60.7 mt -110.87 144.03 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.492 -0.755 . . . . 0.0 110.022 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.12 82.64 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.232 -0.918 . . . . 0.0 110.713 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . 0.439 ' O ' ' CD2' ' C' ' 55' ' ' PHE . 82.5 t80 -126.9 65.79 1.28 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.332 0.587 . . . . 0.0 110.143 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' ARG . . . . . 0.686 HH11 ' HG2' ' C' ' 56' ' ' ARG . 7.7 mtt-85 -80.02 148.43 31.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 109.495 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 44.5 mm -77.81 154.13 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.828 . . . . 0.0 109.292 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' C' ' 59' ' ' CYS . 1.1 t -59.99 -179.04 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.33 -0.856 . . . . 0.0 109.517 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' CYS . . . . . 0.447 ' N ' ' OG1' ' C' ' 58' ' ' THR . 12.4 p -161.39 -10.42 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 109.445 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -165.36 -127.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 109.467 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -69.96 71.58 0.39 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.191 -0.943 . . . . 0.0 108.854 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -168.57 9.01 0.05 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.84 174.87 10.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.473 -1.016 . . . . 0.0 109.739 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 49.35 49.76 19.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.354 -0.841 . . . . 0.0 109.194 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 8.1 tp -176.43 89.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.536 -0.727 . . . . 0.0 109.895 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.91 155.09 50.57 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' C' ' 67' ' ' TYR . 21.7 p90 -147.53 120.83 8.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.105 -1.232 . . . . 0.0 109.767 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.38 165.34 32.85 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 95.1 m -117.05 141.46 48.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.294 -1.121 . . . . 0.0 108.925 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 41.9 mt -95.09 133.48 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.443 -0.785 . . . . 0.0 109.019 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 10.6 m -144.26 156.15 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.41 -0.806 . . . . 0.0 109.608 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' LYS . . . . . 0.431 ' HG3' ' CE2' ' C' ' 21' ' ' TYR . 18.4 ptpt -142.33 140.06 32.0 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.26 -0.9 . . . . 0.0 108.691 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.466 ' O ' ' CB ' ' C' ' 74' ' ' ASP . . . -126.67 152.96 46.03 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.761 -1.212 . . . . 0.0 108.503 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.576 ' O ' ' CB ' ' C' ' 75' ' ' GLU . 27.1 t70 82.47 -130.99 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' GLU . . . . . 0.576 ' CB ' ' O ' ' C' ' 74' ' ' ASP . 35.6 tt0 93.78 -54.93 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' ALA . . . . . 0.523 ' C ' ' O ' ' C' ' 75' ' ' GLU . . . 27.51 51.52 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.66 0 O-C-N 122.012 -0.43 . . . . 0.0 110.028 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' C' ' 76' ' ' ALA . 16.7 tp60 35.84 -120.65 0.13 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.986 -0.446 . . . . 0.0 109.854 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -130.36 -79.23 0.54 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.312 -0.868 . . . . 0.0 109.085 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 7.3 m -160.82 -116.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 109.35 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 37.3 mtt -64.97 -60.81 2.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.082 -1.011 . . . . 0.0 109.452 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.49 -179.878 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.497 ' SD ' ' N ' ' D' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' ILE . . . . . . . . . . . . . 11.6 pt -147.33 56.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.278 -0.888 . . . . 0.0 109.254 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -62.94 -44.77 95.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.433 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.8 152.09 46.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.336 -0.852 . . . . 0.0 108.837 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -121.28 103.99 9.38 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.631 -0.668 . . . . 0.0 109.45 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 mtpt -151.73 80.95 1.28 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 109.412 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -114.77 121.96 44.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.493 -0.754 . . . . 0.0 109.555 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 51.6 mt -101.65 131.39 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.445 -0.784 . . . . 0.0 109.477 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' ILE . . . . . 0.422 ' O ' ' CG2' ' D' ' 9' ' ' ILE . 18.7 tt -124.42 119.89 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 6.0 t -116.35 132.19 56.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.341 -0.85 . . . . 0.0 109.228 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' THR . . . . . 0.729 ' OG1' ' OG1' ' E' ' 69' ' ' THR . 8.6 m -67.74 -117.83 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' ALA . . . . . 0.659 ' C ' ' O ' ' D' ' 11' ' ' THR . . . -2.39 -98.83 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.504 0 CA-C-N 118.318 0.508 . . . . 0.0 110.357 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' D' ' 12' ' ' ALA . 3.5 p30 161.91 91.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? 176.65 128.99 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.503 -0.748 . . . . 0.0 109.864 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' ILE . . . . . 0.441 HD12 HG23 ' D' ' 15' ' ' ILE . 35.5 mt -143.46 69.34 17.44 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.26 155.49 56.53 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.928 1.752 . . . . 0.0 110.284 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.63 -4.73 76.41 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 15.7 mt -129.88 138.64 51.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -1.193 . . . . 0.0 109.967 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -83.74 108.39 16.76 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 mt -103.3 138.88 39.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.463 -0.773 . . . . 0.0 110.425 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' TYR . . . . . 0.473 ' CE1' ' O ' ' D' ' 22' ' ' SER . 1.4 t80 -121.39 129.94 53.32 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' SER . . . . . 0.473 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 21.5 t -67.37 133.1 48.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.987 -1.07 . . . . 0.0 111.478 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 mt -123.74 12.42 9.18 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.34 176.03 19.33 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -109.78 144.33 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.905 -0.762 . . . . 0.0 109.567 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.56 154.1 30.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.663 -0.648 . . . . 0.0 109.556 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 6.6 p -152.51 137.29 17.04 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 12.5 t -149.44 151.36 33.87 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.077 -1.014 . . . . 0.0 109.63 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 6.4 mt -102.99 155.26 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 120.924 -1.11 . . . . 0.0 108.658 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.516 ' O ' ' N ' ' D' ' 32' ' ' ASN . 0.6 OUTLIER 176.13 -20.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.04 -1.037 . . . . 0.0 110.403 179.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 62.8 -41.39 0.18 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.777 -0.577 . . . . 0.0 111.465 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.541 ' O ' HG13 ' D' ' 36' ' ' ILE . 7.8 t-20 -85.86 141.22 29.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.972 -1.08 . . . . 0.0 109.28 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 3.0 t -68.41 -41.6 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.874 -1.141 . . . . 0.0 110.612 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -54.53 -43.97 72.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.39 -0.819 . . . . 0.0 110.238 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -76.8 -36.64 56.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.426 -0.797 . . . . 0.0 109.678 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . 0.541 HG13 ' O ' ' D' ' 32' ' ' ASN . 96.8 mt -61.69 -41.52 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.961 -1.087 . . . . 0.0 108.623 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 13.6 t -69.39 -46.37 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.665 -1.272 . . . . 0.0 108.954 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -66.98 -44.34 80.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.397 -0.814 . . . . 0.0 110.793 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -55.04 -48.5 73.36 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.041 -1.037 . . . . 0.0 109.659 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 38.8 mt -64.85 -37.79 88.81 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.297 -0.877 . . . . 0.0 109.287 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -54.53 -43.8 72.25 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.614 -1.304 . . . . 0.0 109.73 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm -67.62 -40.07 84.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.3 -0.875 . . . . 0.0 110.373 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -75.79 -36.14 59.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.86 . . . . 0.0 109.755 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.83 -50.07 73.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.049 -1.032 . . . . 0.0 109.333 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -65.25 -30.71 71.61 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 118.411 -1.316 . . . . 0.0 108.743 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.33 -28.46 66.26 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.554 0.692 . . . . 0.0 109.267 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -93.09 -6.55 47.82 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.469 -0.769 . . . . 0.0 109.514 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.16 30.06 15.45 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.145 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.77 155.55 18.29 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.39 -9.1 9.53 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.466 -1.02 . . . . 0.0 109.282 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.94 162.74 30.62 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 4.1 tp -130.47 140.32 50.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.632 -0.923 . . . . 0.0 109.769 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' ILE . . . . . . . . . . . . . 13.9 mt -108.48 138.39 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 65.63 76.71 0.32 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.314 -0.867 . . . . 0.0 109.779 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . 0.661 ' CE2' ' O ' ' D' ' 56' ' ' ARG . 84.1 t80 -99.06 138.89 35.52 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.49 -0.756 . . . . 0.0 110.313 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' ARG . . . . . 0.661 ' O ' ' CE2' ' D' ' 55' ' ' PHE . 26.7 ttp180 -95.72 163.17 13.3 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' ILE . . . . . 0.715 ' CD1' ' N ' ' D' ' 57' ' ' ILE . 0.1 OUTLIER -134.15 -129.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.321 -0.862 . . . . 0.0 109.676 -177.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' THR . . . . . . . . . . . . . 75.1 p -55.54 -77.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.077 -1.015 . . . . 0.0 110.094 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' CYS . . . . . . . . . . . . . 5.9 t 68.49 105.57 0.05 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' D' ' 62' ' ' GLY . . . -46.39 145.92 1.59 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.283 -0.886 . . . . 0.0 109.708 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 50.88 -90.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.3 -0.875 . . . . 0.0 109.412 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 62' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' D' ' 60' ' ' ALA . . . 80.56 48.58 6.2 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -52.24 -23.87 6.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -1.117 . . . . 0.0 109.271 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -85.1 -125.89 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.392 -0.818 . . . . 0.0 109.381 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . 0.56 ' CD2' ' N ' ' D' ' 65' ' ' LEU . 1.2 pt? -168.66 170.29 9.56 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.361 -0.837 . . . . 0.0 109.978 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.01 171.89 11.52 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -160.89 153.61 20.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.953 -1.321 . . . . 0.0 109.535 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.24 152.32 11.01 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.544 -1.312 . . . . 0.0 110.327 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 48.9 m -94.04 134.5 36.38 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.009 -1.289 . . . . 0.0 108.458 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 44.5 mt -84.81 127.58 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 71' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' D' ' 21' ' ' TYR . 4.3 m -135.38 159.31 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 110.218 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 10.6 pttp -152.25 148.6 27.76 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.76 150.72 26.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.23 -0.919 . . . . 0.0 108.852 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -73.88 154.25 39.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.023 -1.048 . . . . 0.0 109.393 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -88.88 -127.28 0.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.237 -0.914 . . . . 0.0 109.477 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -163.33 -171.71 2.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.924 . . . . 0.0 109.188 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -141.35 135.07 30.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.308 -0.87 . . . . 0.0 109.454 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 78' ' ' PHE . . . . . . . . . . . . . 76.2 t80 48.67 84.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.37 -0.831 . . . . 0.0 109.554 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 79' ' ' THR . . . . . 0.489 ' HG1' ' N ' ' D' ' 80' ' ' MET . 6.3 t -125.0 166.74 15.8 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.453 -0.779 . . . . 0.0 109.478 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 80' ' ' MET . . . . . 0.489 ' N ' ' HG1' ' D' ' 79' ' ' THR . 34.8 ttm 53.19 86.65 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.368 -0.833 . . . . 0.0 109.52 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.468 -179.967 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mmt . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.43 0.633 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -70.55 161.23 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.418 -0.801 . . . . 0.0 109.196 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 3' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -70.54 -50.97 32.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.453 -0.779 . . . . 0.0 109.564 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -136.3 -179.78 5.88 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.377 -0.827 . . . . 0.0 109.419 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 5' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' E' ' 6' ' ' LYS . 1.7 p-10 -59.66 -78.03 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.867 . . . . 0.0 109.347 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 6' ' ' LYS . . . . . 0.522 ' H ' ' CG ' ' E' ' 5' ' ' ASP . 0.0 OUTLIER -175.36 85.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.333 -0.854 . . . . 0.0 108.961 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -97.92 123.08 41.74 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.355 -0.841 . . . . 0.0 109.416 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 34.0 mt -111.67 135.33 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.459 -0.776 . . . . 0.0 109.591 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 9' ' ' ILE . . . . . 0.461 ' CG2' ' O ' ' E' ' 9' ' ' ILE . 10.5 tt -132.43 115.76 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 10' ' ' THR . . . . . 0.489 ' HG1' ' N ' ' E' ' 11' ' ' THR . 4.1 t -124.0 155.87 37.46 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 11' ' ' THR . . . . . 0.489 ' N ' ' HG1' ' E' ' 10' ' ' THR . 2.0 p -115.95 89.45 3.11 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.74 -95.57 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.987 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -160.14 -35.9 0.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.4 -0.813 . . . . 0.0 109.426 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . 0.411 ' CG ' ' N ' ' E' ' 15' ' ' ILE . 29.7 tt0 -166.71 167.32 15.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 109.302 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 15' ' ' ILE . . . . . 0.411 ' N ' ' CG ' ' E' ' 14' ' ' GLU . 87.0 mt -115.73 92.75 35.03 Favored Pre-proline 0 N--CA 1.496 1.843 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.12 155.28 51.75 Favored 'Trans proline' 0 C--N 1.322 -0.85 0 C-N-CA 121.912 1.741 . . . . 0.0 110.318 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.9 -10.19 75.05 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 18' ' ' LEU . . . . . . . . . . . . . 20.4 mt -127.59 138.95 53.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -1.1 . . . . 0.0 109.52 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -84.45 108.68 17.38 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 14.1 mt -96.99 142.97 28.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.389 -0.82 . . . . 0.0 110.752 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 21' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -126.36 130.15 50.21 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.77 129.37 39.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.733 -1.23 . . . . 0.0 110.793 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 97.6 mt -114.41 3.9 15.14 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.3 -172.9 19.68 Favored Glycine 0 N--CA 1.499 2.9 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 39.6 mm -110.39 140.87 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.798 -0.825 . . . . 0.0 109.32 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.3 146.93 44.86 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.646 -0.659 . . . . 0.0 109.313 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 40.5 m -152.59 148.41 27.31 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.907 -1.121 . . . . 0.0 108.916 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 25.2 p -148.88 134.15 18.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.45 -0.781 . . . . 0.0 109.337 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' E' ' 30' ' ' SER . 87.5 mt -126.53 127.83 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 30' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' E' ' 29' ' ' ILE . 3.6 t 162.51 14.43 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 31' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' E' ' 31' ' ' ASP . 1.4 m-20 51.55 -174.23 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.125 -0.984 . . . . 0.0 109.02 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 32' ' ' ASN . . . . . . . . . . . . . 8.0 m120 68.1 100.18 0.05 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 45.0 t -69.16 -37.27 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.211 -0.931 . . . . 0.0 109.5 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -57.52 -42.14 82.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 110.029 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.79 -38.18 58.48 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.287 -0.883 . . . . 0.0 109.42 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 55.9 mt -63.51 -51.71 67.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.03 -1.044 . . . . 0.0 109.534 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 57.6 t -51.8 -51.14 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.082 -1.011 . . . . 0.0 109.125 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.07 -38.06 78.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -0.869 . . . . 0.0 109.409 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -63.66 -40.81 97.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.122 -0.986 . . . . 0.0 109.511 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 41.6 mt -68.49 -44.45 74.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.148 -0.97 . . . . 0.0 109.338 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -51.43 -37.71 49.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.653 -1.28 . . . . 0.0 109.596 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -73.71 -39.46 64.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.59 -0.694 . . . . 0.0 109.831 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -75.98 -35.79 59.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.371 -0.831 . . . . 0.0 109.67 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 11.5 t -67.32 -50.92 58.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 109.055 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -70.4 -36.88 74.33 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.315 -1.354 . . . . 0.0 109.035 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.45 -31.26 69.14 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -87.89 -5.25 58.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.412 -0.805 . . . . 0.0 109.809 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.21 5.54 58.11 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.03 161.23 48.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.99 -3.2 5.15 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.086 -1.243 . . . . 0.0 109.893 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.82 149.45 12.54 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 4.6 tp -108.64 139.96 42.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.675 -0.897 . . . . 0.0 109.595 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.67 142.85 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.567 -0.708 . . . . 0.0 110.255 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . 62.24 75.87 0.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 110.131 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 55' ' ' PHE . . . . . 0.482 ' O ' ' CG ' ' E' ' 55' ' ' PHE . 58.7 t80 -104.65 23.95 12.54 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 56' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -54.82 149.16 11.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.84 . . . . 0.0 109.242 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 65.0 mt -119.96 97.87 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 58' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' E' ' 59' ' ' CYS . 1.0 OUTLIER -140.74 -168.49 2.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.442 -0.786 . . . . 0.0 109.212 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 59' ' ' CYS . . . . . 0.539 ' N ' ' OG1' ' E' ' 58' ' ' THR . 4.8 t 63.08 51.4 2.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.881 . . . . 0.0 109.498 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.71 78.72 0.11 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 109.402 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -77.59 -28.53 51.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -0.87 . . . . 0.0 109.494 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 62' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' E' ' 64' ' ' PHE . . . -176.8 -101.68 0.15 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -76.83 34.9 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.397 -1.06 . . . . 0.0 109.561 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 64' ' ' PHE . . . . . 0.472 ' H ' ' C ' ' E' ' 62' ' ' GLY . 75.4 m-85 51.46 -174.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.571 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 tp -174.86 127.83 0.3 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.87 79.21 0.62 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -80.01 134.14 36.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -1.173 . . . . 0.0 109.45 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.46 165.12 35.4 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 69' ' ' THR . . . . . 0.729 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 30.5 m -113.7 139.67 48.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.639 -0.918 . . . . 0.0 108.757 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 43.3 mt -84.93 146.44 6.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 m -139.42 154.4 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.206 -0.934 . . . . 0.0 109.942 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -143.47 151.81 40.76 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.13 150.53 35.86 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.419 -0.801 . . . . 0.0 108.957 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -79.02 -168.17 1.38 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.102 -0.999 . . . . 0.0 109.132 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.84 -86.65 0.61 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.513 -0.742 . . . . 0.0 109.546 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . -169.12 174.92 5.97 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.033 -1.042 . . . . 0.0 109.041 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 77' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -90.84 -64.46 1.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.199 -0.938 . . . . 0.0 109.33 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -75.26 144.85 42.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -0.959 . . . . 0.0 109.43 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -167.95 -23.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.865 . . . . 0.0 109.453 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 16.6 tpp -163.68 32.24 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.226 -0.921 . . . . 0.0 109.42 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.666 -179.959 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.337 0.589 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.449 ' CD1' ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -62.49 174.99 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.348 -0.845 . . . . 0.0 109.541 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -160.46 -162.44 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.063 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -131.48 45.86 2.74 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.343 -0.848 . . . . 0.0 109.344 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -63.81 131.34 47.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 109.228 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -138.07 -65.23 0.52 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.39 -0.819 . . . . 0.0 110.541 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -89.69 121.07 31.52 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.147 -0.971 . . . . 0.0 109.247 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 57.0 mt -136.82 139.18 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.383 -0.823 . . . . 0.0 109.461 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.476 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 13.9 tt -121.38 115.6 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.2 t -127.01 147.02 50.15 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.109 -0.994 . . . . 0.0 108.509 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.574 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -66.84 -110.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 177.111 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.519 ' N ' ' OG1' ' A' ' 11' ' ' THR . . . -33.0 -88.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.724 -0.61 . . . . 0.0 110.186 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.504 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 1.3 p-10 -170.33 -92.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.951 -1.093 . . . . 0.0 109.086 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.504 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 30.0 mt-10 74.71 -135.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.661 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 2.6 mt 65.01 46.41 0.54 Allowed Pre-proline 0 N--CA 1.486 1.351 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -176.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.661 ' HD3' ' N ' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -66.08 151.77 82.96 Favored 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 121.431 1.421 . . . . 0.0 110.003 179.184 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.16 -5.38 78.34 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.118 -1.515 . . . . 0.0 111.122 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.7 mt -124.77 137.07 54.34 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.792 -1.416 . . . . 0.0 108.503 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.624 ' NE2' ' H ' ' A' ' 19' ' ' GLN . 0.7 OUTLIER -90.14 113.41 25.16 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mt -107.22 128.18 54.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.701 -0.624 . . . . 0.0 110.106 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.581 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -109.86 157.88 18.75 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.3 t -81.56 126.45 31.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.478 -0.764 . . . . 0.0 109.618 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.4 mt -108.95 2.5 21.41 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.94 177.65 14.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.46 141.5 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.82 144.77 42.99 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.1 t -152.57 138.07 17.69 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.9 t -149.8 150.4 31.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.028 -1.045 . . . . 0.0 108.997 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.93 131.88 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 31' ' ' ASP . 14.3 p -172.5 13.47 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.324 -0.86 . . . . 0.0 109.576 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 30' ' ' SER . 37.1 t70 57.35 154.44 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.63 -0.669 . . . . 0.0 110.196 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER 73.84 111.2 0.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.082 -1.011 . . . . 0.0 108.567 -178.298 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.88 -33.54 62.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.358 -0.839 . . . . 0.0 109.354 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -52.52 -35.98 54.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 85.4 mt-10 -78.44 -33.88 48.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 108.809 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.0 mt -65.07 -53.82 36.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 120.961 -1.087 . . . . 0.0 108.937 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 t -58.06 -50.32 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.085 -1.009 . . . . 0.0 108.348 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -61.26 -41.27 96.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.565 -0.709 . . . . 0.0 109.761 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 35' ' ' GLU . 17.9 m120 -66.64 -42.52 86.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 0.0 109.329 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.49 -42.67 99.65 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.107 -0.995 . . . . 0.0 108.448 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -48.06 -56.4 7.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.625 -1.297 . . . . 0.0 109.389 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -57.34 -35.41 69.87 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.288 -0.882 . . . . 0.0 110.249 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.27 -35.53 58.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.791 . . . . 0.0 109.903 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.5 t -72.19 -51.29 30.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.187 -0.946 . . . . 0.0 108.834 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -69.6 -31.47 69.62 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 117.942 -1.503 . . . . 0.0 108.962 -175.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.12 71.62 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.7 mtpt -95.64 -3.83 45.51 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.36 27.6 47.61 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 118.864 -1.636 . . . . 0.0 109.751 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.18 -166.67 34.41 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -109.78 -46.65 3.46 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.53 -0.982 . . . . 0.0 109.851 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 174.98 -152.08 13.2 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -129.07 140.27 51.66 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.677 -0.896 . . . . 0.0 109.886 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.81 150.15 25.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.941 -0.474 . . . . 0.0 109.854 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 11' ' ' THR . . . 73.5 108.5 0.07 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.996 -1.065 . . . . 0.0 111.301 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -127.07 148.38 50.14 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.504 0.669 . . . . 0.0 109.86 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.679 ' HE ' ' NH1' ' B' ' 56' ' ' ARG . 19.3 ttt180 -131.72 -31.57 1.54 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.457 0.646 . . . . 0.0 109.446 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -103.29 -173.46 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.458 ' HB ' ' OG ' ' B' ' 27' ' ' SER . 0.0 OUTLIER -168.96 -13.53 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.161 -0.962 . . . . 0.0 109.898 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 49.7 t -166.67 -79.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.133 -0.979 . . . . 0.0 109.281 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.31 149.18 34.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.172 -0.955 . . . . 0.0 109.325 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -145.33 -66.98 0.31 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.364 -0.835 . . . . 0.0 109.41 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.56 84.51 0.03 OUTLIER Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 mttp 53.31 75.46 0.25 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.334 -1.097 . . . . 0.0 109.326 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -134.94 -33.39 0.93 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.434 -0.791 . . . . 0.0 109.683 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.1 tp 54.14 96.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.788 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.97 170.63 5.16 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -156.46 137.79 13.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.209 -1.171 . . . . 0.0 109.735 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.58 161.23 32.07 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 80.8 m -107.8 140.0 41.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.265 -1.138 . . . . 0.0 108.862 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 54.8 mt -88.55 129.77 39.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.75 155.04 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.498 -0.751 . . . . 0.0 109.602 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -142.61 147.91 36.6 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.176 -0.953 . . . . 0.0 109.245 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.87 151.04 39.49 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.339 -0.851 . . . . 0.0 108.807 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -146.3 86.21 1.68 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.102 -0.999 . . . . 0.0 108.702 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -68.24 -153.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.297 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.86 9.76 0.33 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.277 -0.889 . . . . 0.0 109.356 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -72.31 -149.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.337 -0.852 . . . . 0.0 109.394 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.7 t80 51.73 55.39 9.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 109.488 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t -59.51 161.48 5.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.505 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 26.4 ttt -153.95 110.68 3.36 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.314 -0.866 . . . . 0.0 109.361 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.369 -179.922 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 40.2 mtt . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 4.1 tt -152.14 127.61 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.384 -0.823 . . . . 0.0 109.139 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -151.77 -130.93 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 109.29 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -171.22 33.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.14 -0.975 . . . . 0.0 109.174 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -82.55 81.89 8.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.873 . . . . 0.0 108.955 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -107.85 -89.33 0.46 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -103.63 121.22 42.49 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.211 -0.93 . . . . 0.0 109.549 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 68.0 mt -112.89 128.37 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.507 -0.746 . . . . 0.0 109.985 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' B' ' 52' ' ' LEU . 2.9 tt -131.67 114.67 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.408 ' HG1' ' N ' ' B' ' 11' ' ' THR . 4.5 t -122.46 158.59 29.42 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.308 1.051 . . . . 0.0 109.272 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' THR . . . . . 0.408 ' N ' ' HG1' ' B' ' 10' ' ' THR . 9.3 p -90.64 -105.84 0.1 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 42.72 -112.72 0.21 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.121 -0.987 . . . . 0.0 110.901 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -165.82 -20.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.271 -0.893 . . . . 0.0 109.909 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . 0.465 ' CG ' ' N ' ' B' ' 15' ' ' ILE . 67.3 tt0 -167.33 166.63 14.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.117 -0.99 . . . . 0.0 109.25 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.465 ' N ' ' CG ' ' B' ' 14' ' ' GLU . 61.5 mt -114.58 93.0 30.96 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -61.61 155.01 55.92 Favored 'Trans proline' 0 C--N 1.323 -0.803 0 C-N-CA 121.787 1.658 . . . . 0.0 110.485 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.88 -6.38 79.38 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 43.1 mt -132.17 141.43 49.1 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.474 -1.015 . . . . 0.0 109.699 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . 0.448 ' CG ' ' O ' ' B' ' 19' ' ' GLN . 2.5 pt20 -84.91 109.62 18.27 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 mt -102.57 136.71 41.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.953 -1.092 . . . . 0.0 109.437 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' B' ' 22' ' ' SER . 0.8 OUTLIER -121.39 130.46 53.61 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.559 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.56 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 40.2 t -60.2 129.3 41.01 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.035 0.921 . . . . 0.0 111.691 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 11.2 mt -114.08 12.09 17.82 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.33 -166.2 13.22 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 mm -120.13 134.74 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.06 149.41 38.95 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.487 -0.758 . . . . 0.0 109.917 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.458 ' OG ' ' HB ' ' A' ' 58' ' ' THR . 7.7 t -152.6 140.85 20.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.2 -0.937 . . . . 0.0 109.384 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 4.3 t -149.62 146.46 27.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.296 -0.877 . . . . 0.0 109.167 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 31.3 mt -127.7 131.75 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 53.8 m -155.91 14.77 0.34 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.993 -1.067 . . . . 0.0 110.306 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 72.36 -70.03 0.17 Allowed 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -76.81 140.42 40.68 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.993 -1.067 . . . . 0.0 108.153 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 96.7 t -69.05 -37.46 77.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.523 -0.736 . . . . 0.0 109.806 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.22 -36.27 51.7 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.356 -0.84 . . . . 0.0 110.516 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.08 -32.85 39.21 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.278 -0.889 . . . . 0.0 109.618 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 35.0 mt -62.27 -53.58 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.275 -0.89 . . . . 0.0 109.045 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 23.4 t -56.99 -49.8 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.229 -0.919 . . . . 0.0 108.59 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -60.95 -39.71 90.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.407 -0.808 . . . . 0.0 110.108 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -64.05 -43.43 95.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.164 -0.96 . . . . 0.0 109.594 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 18.8 mt -64.81 -43.05 94.42 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.115 -0.99 . . . . 0.0 109.185 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -49.94 -40.99 45.37 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.584 -1.323 . . . . 0.0 109.923 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -70.31 -37.11 74.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.605 -0.685 . . . . 0.0 110.051 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -76.5 -35.35 58.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.46 -0.775 . . . . 0.0 109.677 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 3.0 t -66.5 -50.3 68.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.134 -0.979 . . . . 0.0 108.913 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -65.45 -30.1 70.85 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.044 -1.462 . . . . 0.0 109.142 -175.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.93 -29.83 68.17 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.488 0.661 . . . . 0.0 109.312 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 mmmt -86.56 -5.47 59.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.627 -0.67 . . . . 0.0 109.517 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.01 5.38 62.54 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.66 164.32 50.5 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -128.65 -3.62 5.33 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.093 -1.24 . . . . 0.0 110.075 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.31 143.57 8.67 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' B' ' 9' ' ' ILE . 8.8 tp -108.23 141.87 39.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.582 -0.952 . . . . 0.0 109.659 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 11.6 pt -142.66 172.07 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.789 -1.194 . . . . 0.0 108.876 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.35 33.01 22.75 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.518 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.6 120.41 30.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.788 -1.195 . . . . 0.0 108.612 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.679 ' NH1' ' HE ' ' A' ' 56' ' ' ARG . 39.4 ttp180 -105.13 166.8 10.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.419 -0.801 . . . . 0.0 109.626 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.544 ' CG2' ' N ' ' B' ' 58' ' ' THR . 16.5 mm -86.22 175.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.396 -0.815 . . . . 0.0 109.407 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' THR . . . . . 0.544 ' N ' ' CG2' ' B' ' 57' ' ' ILE . 0.5 OUTLIER -145.54 168.01 21.64 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.435 -0.79 . . . . 0.0 109.274 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 10.7 t -71.55 -178.73 2.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.347 -0.846 . . . . 0.0 109.458 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.67 -52.97 11.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.471 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.46 ' CG ' ' H ' ' B' ' 62' ' ' GLY . 29.2 t70 -69.4 -175.13 0.76 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.453 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' B' ' 64' ' ' PHE . . . -63.23 -111.45 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 54.6 mttp 52.06 -92.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -1.116 . . . . 0.0 109.43 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.477 ' N ' ' O ' ' B' ' 62' ' ' GLY . 26.8 m-85 -79.52 169.19 18.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.216 -0.927 . . . . 0.0 109.146 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.49 ' N ' ' CD2' ' B' ' 65' ' ' LEU . 1.5 pt? -163.79 179.24 7.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.391 -0.818 . . . . 0.0 109.179 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.62 126.18 8.15 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' TYR . . . . . 0.482 ' CG ' ' O ' ' B' ' 67' ' ' TYR . 7.7 p90 -122.75 129.03 51.28 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.579 -0.954 . . . . 0.0 109.053 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.87 151.55 23.26 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m -104.48 143.76 32.59 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.303 -1.116 . . . . 0.0 108.79 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 49.2 mt -90.01 143.26 11.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.61 164.91 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.931 . . . . 0.0 110.02 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -154.08 157.31 38.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.538 -0.726 . . . . 0.0 109.236 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.33 150.7 38.38 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.165 -0.96 . . . . 0.0 108.605 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -69.24 139.56 54.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.95 -1.094 . . . . 0.0 109.453 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' GLU . . . . . 0.525 ' CD ' ' H ' ' B' ' 75' ' ' GLU . 1.4 pm0 -69.55 -169.54 0.23 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.273 -0.892 . . . . 0.0 109.402 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -157.21 156.52 32.73 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.311 -0.868 . . . . 0.0 109.126 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -80.66 156.54 26.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.093 -1.004 . . . . 0.0 109.259 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 35.1 t80 57.24 58.6 3.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.386 -0.821 . . . . 0.0 109.545 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.405 ' C ' ' H ' ' B' ' 81' ' ' ALA . 0.0 OUTLIER -76.3 115.77 16.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.433 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' MET . . . . . . . . . . . . . 9.2 ptt? -79.14 38.37 0.35 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.307 -0.87 . . . . 0.0 109.433 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.405 ' H ' ' C ' ' B' ' 79' ' ' THR . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.52 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 51.5 mtp . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 59.0 mt -68.13 131.1 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.299 -0.876 . . . . 0.0 109.271 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 17.3 t80 55.46 92.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.389 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -59.6 157.06 12.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.275 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -136.65 -20.56 1.33 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.399 -0.813 . . . . 0.0 109.602 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . 0.523 ' CG ' ' H ' ' C' ' 7' ' ' PHE . 42.1 tttm 56.69 176.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.475 0.655 . . . . 0.0 109.658 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' PHE . . . . . 0.523 ' H ' ' CG ' ' C' ' 6' ' ' LYS . 67.6 t80 -92.75 124.33 36.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.423 -0.798 . . . . 0.0 109.778 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 64.3 mt -115.24 143.26 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.481 -0.762 . . . . 0.0 110.045 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' ILE . . . . . 0.467 ' O ' ' CG2' ' C' ' 9' ' ' ILE . 11.2 tt -137.49 117.62 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.511 -0.743 . . . . 0.0 109.483 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.91 147.04 45.97 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.643 1.211 . . . . 0.0 107.938 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' THR . . . . . 0.417 ' H ' HG23 ' C' ' 11' ' ' THR . 4.4 t -86.87 55.58 3.63 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.169 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -177.83 -124.77 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 119.955 -1.716 . . . . 0.0 108.321 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.82 108.4 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.229 -0.92 . . . . 0.0 109.002 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . 0.403 ' CG ' ' H ' ' C' ' 15' ' ' ILE . 3.2 pt-20 -163.49 -100.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.155 -0.965 . . . . 0.0 109.751 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' ILE . . . . . 0.488 ' N ' ' HD3' ' C' ' 16' ' ' PRO . 5.3 mt 57.23 61.23 6.53 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.825 . . . . 0.0 109.285 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' C' ' 15' ' ' ILE . 2.2 Cg_endo -63.67 155.37 63.64 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 122.195 1.93 . . . . 0.0 109.618 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.29 -17.11 57.11 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 51.5 mt -117.04 135.74 53.49 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.098 -1.236 . . . . 0.0 108.807 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -86.41 108.6 18.56 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 11.3 mt -93.2 136.66 33.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.305 -0.872 . . . . 0.0 109.724 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -118.52 130.27 55.83 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 9.3 t -58.06 131.41 50.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.779 -1.2 . . . . 0.0 111.102 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 mt -120.36 11.59 11.5 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.74 -179.95 19.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.43 141.06 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 122.007 -0.701 . . . . 0.0 109.465 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.48 146.46 38.4 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 6.5 p -151.9 139.77 19.97 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.991 -1.068 . . . . 0.0 108.53 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 15.0 t -149.92 138.63 20.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.012 -1.055 . . . . 0.0 108.813 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 11.6 tt -105.18 130.44 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.925 . . . . 0.0 109.068 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 91.8 p -168.97 -145.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.039 -1.038 . . . . 0.0 109.668 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' ASP . . . . . 0.465 ' O ' ' CB ' ' C' ' 32' ' ' ASN . 21.3 t0 -150.73 153.96 36.5 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.204 -0.935 . . . . 0.0 109.523 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' ASN . . . . . 0.544 ' H ' ' HZ3' ' C' ' 63' ' ' LYS . 3.7 t-20 77.15 129.26 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 108.748 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 45.2 t -66.58 -31.94 55.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.56 -0.712 . . . . 0.0 109.466 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -56.75 -42.6 79.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.821 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -75.97 -38.37 57.57 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.206 -0.933 . . . . 0.0 109.301 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 79.2 mt -59.81 -42.1 87.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 120.819 -1.175 . . . . 0.0 109.336 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.1 -43.91 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.718 -1.238 . . . . 0.0 109.092 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -66.33 -46.88 75.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.381 -0.824 . . . . 0.0 110.189 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -56.08 -49.67 73.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.071 -1.018 . . . . 0.0 109.682 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 84.2 mt -67.85 -44.71 76.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.128 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -50.73 -43.09 57.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.714 -1.241 . . . . 0.0 109.797 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -65.97 -36.26 82.83 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.797 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -76.39 -35.36 58.67 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.798 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 t -68.52 -50.85 52.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.952 -1.093 . . . . 0.0 109.079 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -59.55 -29.73 68.12 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.567 -1.253 . . . . 0.0 109.882 -175.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.3 -29.24 61.54 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.791 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -85.5 8.53 18.84 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.37 3.04 81.66 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.33 162.32 54.53 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' MET . . . . . 0.419 ' C ' ' SD ' ' C' ' 50' ' ' MET . 0.0 OUTLIER -131.17 -3.09 3.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.128 -1.219 . . . . 0.0 110.222 -177.189 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.5 127.85 1.81 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.245 -1.455 . . . . 0.0 110.01 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 53.5 tp -96.45 139.19 32.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.553 -0.969 . . . . 0.0 108.844 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 26.7 pt -144.01 173.26 5.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.788 -1.195 . . . . 0.0 108.313 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 70.99 77.22 0.18 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.936 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . 0.463 ' CD2' ' OH ' ' D' ' 67' ' ' TYR . 0.2 OUTLIER -80.08 154.4 28.13 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.122 -0.986 . . . . 0.0 109.333 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -136.78 46.36 2.22 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.56 -0.712 . . . . 0.0 109.957 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.62 -18.36 6.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' THR . . . . . . . . . . . . . 37.5 p -67.74 -61.27 1.96 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.045 -1.034 . . . . 0.0 109.722 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' CYS . . . . . . . . . . . . . 24.0 p -68.35 -178.51 1.1 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.29 -0.881 . . . . 0.0 109.448 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . 63.3 150.97 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.496 -0.753 . . . . 0.0 109.702 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -56.73 119.11 5.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.282 -0.887 . . . . 0.0 109.213 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.25 -98.95 0.12 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . 0.544 ' HZ3' ' H ' ' C' ' 32' ' ' ASN . 17.4 pttt -135.94 -48.66 0.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 2.9 t80 65.38 -69.25 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.947 . . . . 0.0 109.816 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' C' ' 63' ' ' LYS . 1.0 OUTLIER -143.58 128.21 18.13 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.286 -0.884 . . . . 0.0 109.192 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.35 141.33 20.48 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.136 -1.986 . . . . 0.0 108.136 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' TYR . . . . . 0.43 ' CE1' ' CD1' ' B' ' 57' ' ' ILE . 0.3 OUTLIER -134.2 150.78 51.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.507 -0.996 . . . . 0.0 109.866 -179.404 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.02 140.99 6.61 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 3.4 m -90.12 135.53 33.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.868 -1.372 . . . . 0.0 107.775 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 47.3 mt -86.1 145.15 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 m -144.73 162.9 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.966 . . . . 0.0 110.229 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -152.37 147.03 25.82 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.96 140.58 39.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.923 -1.111 . . . . 0.0 108.012 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' C' ' 75' ' ' GLU . 42.2 t0 -131.3 39.67 3.51 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' C' ' 74' ' ' ASP . 30.4 tt0 -39.48 129.62 1.84 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.587 -0.696 . . . . 0.0 109.942 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -157.98 -32.56 0.07 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.312 -0.868 . . . . 0.0 109.249 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -103.94 141.56 35.95 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.541 -0.725 . . . . 0.0 109.132 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -67.81 148.24 51.48 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.256 -0.902 . . . . 0.0 109.469 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 52.5 m -161.13 139.53 9.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.87 . . . . 0.0 109.309 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 3.9 ptp -80.11 87.09 5.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.856 . . . . 0.0 109.26 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.423 179.867 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 29.9 mtm . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' ILE . . . . . 0.544 ' CD1' ' N ' ' D' ' 2' ' ' ILE . 0.2 OUTLIER -140.67 -22.71 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.458 -0.776 . . . . 0.0 109.426 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 55.7 -165.14 0.12 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.489 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -158.22 62.83 0.45 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.356 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' D' ' 7' ' ' PHE . 22.0 p-10 -169.54 45.89 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.214 -0.929 . . . . 0.0 110.048 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -63.9 81.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.045 -1.034 . . . . 0.0 110.23 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' D' ' 5' ' ' ASP . 67.0 t80 -108.54 121.93 46.02 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 28.2 mt -133.82 129.73 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.365 -0.834 . . . . 0.0 109.928 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' ILE . . . . . 0.441 ' O ' ' CG2' ' D' ' 9' ' ' ILE . 13.4 tt -137.15 114.19 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.56 160.75 27.67 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' THR . . . . . 0.549 ' OG1' ' OG1' ' E' ' 69' ' ' THR . 1.2 p -121.43 83.53 2.1 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.34 -134.26 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.331 -0.855 . . . . 0.0 109.099 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -99.79 -56.27 2.43 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.374 -0.829 . . . . 0.0 109.774 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -161.85 -171.05 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.124 -0.985 . . . . 0.0 109.444 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 68.4 mt -123.53 87.81 51.97 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.542 -0.724 . . . . 0.0 109.113 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.67 155.19 55.2 Favored 'Trans proline' 0 C--N 1.323 -0.781 0 C-N-CA 121.927 1.751 . . . . 0.0 110.305 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.14 -9.76 75.74 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 43.9 mt -128.0 139.01 52.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.118 -1.225 . . . . 0.0 109.27 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -85.2 108.05 17.54 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 12.2 mt -99.45 134.92 41.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.448 -0.783 . . . . 0.0 109.502 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' TYR . . . . . 0.497 ' CE1' ' O ' ' D' ' 22' ' ' SER . 0.8 OUTLIER -116.68 129.99 56.46 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' SER . . . . . 0.497 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 0.0 OUTLIER -61.87 128.34 35.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.771 -1.206 . . . . 0.0 110.517 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 8.3 mt -114.6 7.6 16.1 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.2 -179.54 17.06 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 49.6 mm -111.95 142.33 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.733 -0.863 . . . . 0.0 108.927 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.12 143.99 44.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.69 -0.631 . . . . 0.0 109.679 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 98.8 p -152.71 136.04 15.84 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 14.6 t -149.81 150.88 32.65 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.916 -1.115 . . . . 0.0 109.327 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 47.3 mm -113.39 139.86 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.322 -0.861 . . . . 0.0 109.555 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' SER . . . . . 0.557 ' OG ' ' N ' ' D' ' 31' ' ' ASP . 1.4 t -175.72 -171.66 0.48 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.384 -0.822 . . . . 0.0 108.938 -178.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' ASP . . . . . 0.557 ' N ' ' OG ' ' D' ' 30' ' ' SER . 1.3 p30 -124.86 145.08 49.97 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.495 -0.753 . . . . 0.0 109.415 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' D' ' 31' ' ' ASP . 1.5 m-20 78.21 133.18 0.06 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.604 0.716 . . . . 0.0 109.333 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.29 -31.27 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.547 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -56.95 -42.5 80.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 110.112 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -76.2 -38.89 55.91 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.338 -0.851 . . . . 0.0 109.486 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.04 -46.88 92.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.847 -1.158 . . . . 0.0 109.416 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.37 -51.53 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.97 -1.081 . . . . 0.0 110.01 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -55.99 -36.18 67.59 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 109.643 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -67.25 -42.4 84.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.105 -0.997 . . . . 0.0 110.091 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 44.8 mt -69.05 -46.51 67.69 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.981 -1.074 . . . . 0.0 108.724 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -47.16 -55.91 7.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.72 -1.237 . . . . 0.0 109.456 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -54.98 -33.44 62.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.215 -0.928 . . . . 0.0 110.408 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -77.35 -35.02 54.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.365 -0.834 . . . . 0.0 109.975 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 t -68.6 -51.4 46.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.038 -1.038 . . . . 0.0 108.904 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -67.78 -33.85 75.63 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 117.988 -1.485 . . . . 0.0 109.415 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.38 -32.83 72.76 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 mmtm -87.76 -4.94 58.86 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.41 -0.806 . . . . 0.0 109.125 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.56 9.39 64.72 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.16 175.92 54.35 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.14 2.45 0.77 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.897 -1.355 . . . . 0.0 110.143 -175.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.18 160.12 33.05 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.575 -1.297 . . . . 0.0 109.958 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 7.0 tp -130.06 139.12 51.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.724 -0.868 . . . . 0.0 109.339 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' ILE . . . . . . . . . . . . . 23.9 mt -114.04 141.15 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.644 -0.66 . . . . 0.0 110.242 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 63.1 79.55 0.26 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.341 -0.85 . . . . 0.0 111.904 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . 0.536 ' CG ' ' O ' ' D' ' 55' ' ' PHE . 56.0 t80 -107.22 35.91 2.88 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.51 0.671 . . . . 0.0 110.279 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' ARG . . . . . 0.829 ' HG3' HH11 ' D' ' 56' ' ' ARG . 0.6 OUTLIER -67.47 158.4 31.93 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.961 -1.087 . . . . 0.0 109.911 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' ILE . . . . . . . . . . . . . 97.3 mt -135.99 148.51 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' THR . . . . . . . . . . . . . 68.9 p -66.3 -155.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.445 -0.784 . . . . 0.0 109.243 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' CYS . . . . . . . . . . . . . 18.7 p -65.22 -128.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.921 . . . . 0.0 109.322 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.66 177.67 2.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.971 . . . . 0.0 109.161 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 59.04 103.52 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.526 -0.734 . . . . 0.0 109.926 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.89 9.02 85.19 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -162.48 118.17 1.9 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.113 -1.228 . . . . 0.0 109.477 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -139.58 145.93 39.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.467 -0.771 . . . . 0.0 109.138 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 65' ' ' LEU . . . . . . . . . . . . . 58.4 tp -165.75 118.16 1.11 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.838 . . . . 0.0 109.315 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.44 128.46 9.32 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 67' ' ' TYR . . . . . 0.463 ' OH ' ' CD2' ' C' ' 55' ' ' PHE . 62.8 t80 -133.23 144.27 49.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.441 -1.035 . . . . 0.0 110.008 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.58 155.67 21.54 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 54.3 m -106.52 140.12 39.91 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.443 -1.034 . . . . 0.0 108.806 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 33.3 mt -90.25 137.68 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 m -144.39 166.28 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.82 . . . . 0.0 109.501 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.78 150.36 27.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.95 151.65 37.02 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.174 -0.954 . . . . 0.0 108.6 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -71.9 -3.54 23.09 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.907 -1.121 . . . . 0.0 109.59 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 57.68 174.02 0.05 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.458 -0.776 . . . . 0.0 109.692 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -172.45 -22.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -62.61 -22.86 66.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.574 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -64.44 -47.31 79.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 109.498 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 3.9 m -160.46 153.59 21.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.341 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 23.3 ttt -158.67 -60.49 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.421 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.489 179.985 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 12.2 ttt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 82.3 mt -122.52 149.89 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.499 -0.751 . . . . 0.0 109.326 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 3' ' ' PHE . . . . . 0.43 ' CZ ' ' CD2' ' A' ' 21' ' ' TYR . 37.2 m-85 -88.57 -134.33 0.09 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -52.27 168.14 0.11 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.799 -1.188 . . . . 0.0 109.639 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 5' ' ' ASP . . . . . 0.551 ' CG ' ' H ' ' E' ' 6' ' ' LYS . 37.5 t0 -147.87 -157.17 0.79 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.345 -0.847 . . . . 0.0 109.545 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 6' ' ' LYS . . . . . 0.551 ' H ' ' CG ' ' E' ' 5' ' ' ASP . 43.0 mtmt 61.17 -82.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.421 0.629 . . . . 0.0 110.646 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -115.17 150.55 35.88 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 42.5 mt -129.25 137.61 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.506 -0.746 . . . . 0.0 109.147 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 9' ' ' ILE . . . . . 0.46 ' CG2' ' O ' ' E' ' 9' ' ' ILE . 17.5 tt -123.91 117.12 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 13.2 t -126.05 148.94 49.2 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 11' ' ' THR . . . . . 0.423 ' H ' ' HG1' ' E' ' 11' ' ' THR . 0.6 OUTLIER -76.19 -119.21 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . 0.417 ' H ' ' HB ' ' E' ' 11' ' ' THR . . . -111.35 98.5 7.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.312 -0.868 . . . . 0.0 109.68 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 13' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' E' ' 13' ' ' ASP . 20.3 p-10 -163.22 -7.09 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.694 -0.629 . . . . 0.0 109.475 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 59.8 163.59 0.05 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.599 -0.688 . . . . 0.0 109.468 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 18.4 mt -124.98 84.01 59.47 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.85 156.25 44.63 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 122.002 1.801 . . . . 0.0 110.095 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.63 -9.92 74.94 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 18' ' ' LEU . . . . . . . . . . . . . 65.7 mt -126.96 137.86 53.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.075 -1.25 . . . . 0.0 108.821 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -86.86 110.61 20.09 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 11.7 mt -92.1 135.2 34.16 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.969 -1.082 . . . . 0.0 109.592 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 21' ' ' TYR . . . . . 0.467 ' CE1' ' O ' ' E' ' 22' ' ' SER . 1.0 OUTLIER -117.83 129.82 55.89 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 22' ' ' SER . . . . . 0.467 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 0.0 OUTLIER -63.97 129.95 42.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.779 -1.201 . . . . 0.0 111.259 -179.252 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 13.1 mt -120.09 12.52 11.92 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.68 -155.41 16.22 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -135.34 144.12 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.979 -0.718 . . . . 0.0 109.596 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.03 144.11 44.13 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 38.5 t -152.14 138.95 18.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.053 -1.029 . . . . 0.0 108.455 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.54 153.43 37.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.082 -1.011 . . . . 0.0 109.033 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 71.0 mt -124.9 130.98 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.193 -0.942 . . . . 0.0 109.276 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 31.2 t -163.09 167.85 21.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.393 -0.817 . . . . 0.0 109.664 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 31' ' ' ASP . . . . . 0.553 ' N ' ' OD1' ' E' ' 31' ' ' ASP . 16.4 p-10 -81.38 -65.55 1.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.404 -0.81 . . . . 0.0 112.628 -177.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 32' ' ' ASN . . . . . 0.426 ' H ' ' CG ' ' E' ' 31' ' ' ASP . 6.3 t-20 -78.28 147.62 34.24 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.711 -1.243 . . . . 0.0 109.05 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 73.3 t -68.88 -31.18 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.564 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -54.09 -34.09 59.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 109.734 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 35' ' ' GLU . . . . . 0.419 ' O ' ' ND2' ' E' ' 39' ' ' ASN . 41.5 mm-40 -77.23 -35.02 55.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.312 -0.867 . . . . 0.0 108.803 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 66.3 mt -64.74 -53.6 40.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.042 -1.036 . . . . 0.0 109.154 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 60.9 t -55.79 -52.87 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.105 -0.997 . . . . 0.0 109.564 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.01 -36.49 70.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.419 -0.8 . . . . 0.0 109.633 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 39' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' E' ' 35' ' ' GLU . 74.1 m-20 -66.74 -41.11 88.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.043 -1.036 . . . . 0.0 109.831 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 40.2 mt -72.4 -50.34 27.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.99 -1.068 . . . . 0.0 109.041 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -49.04 -52.16 26.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.697 -1.252 . . . . 0.0 109.371 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -59.36 -37.3 77.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.261 -0.9 . . . . 0.0 110.824 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -77.91 -34.84 51.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 110.032 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 12.8 t -74.05 -52.8 19.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.148 -0.97 . . . . 0.0 108.864 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 9.9 mtpp -59.26 -27.88 66.21 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.704 -1.248 . . . . 0.0 110.058 -176.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.03 -28.19 62.2 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.819 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -87.84 0.1 56.25 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.82 6.89 84.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.19 -174.88 5.88 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 3.3 ptm -155.71 -1.21 0.14 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.211 -1.17 . . . . 0.0 110.83 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.82 150.55 18.72 Favored Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.296 -1.43 . . . . 0.0 109.738 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 15.2 tp -122.37 134.22 54.63 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 53' ' ' ILE . . . . . 0.461 ' CD1' ' O ' ' E' ' 53' ' ' ILE . 0.0 OUTLIER -106.93 147.4 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.521 -0.737 . . . . 0.0 109.659 -178.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . 0.523 ' O ' ' C ' ' E' ' 55' ' ' PHE . . . 78.56 -63.43 0.3 Allowed 'General case' 0 N--CA 1.508 2.443 0 O-C-N 121.156 -0.965 . . . . 0.0 112.794 177.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 55' ' ' PHE . . . . . 0.552 ' O ' ' CG ' ' E' ' 55' ' ' PHE . 52.5 t80 31.64 39.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.595 0.712 . . . . 0.0 109.866 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 56' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' E' ' 54' ' ' ALA . 97.5 mtt180 -62.65 127.53 31.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.879 -1.138 . . . . 0.0 109.612 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 78.3 mt -92.16 -34.78 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.255 -0.903 . . . . 0.0 109.161 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 58' ' ' THR . . . . . . . . . . . . . 69.7 p -76.63 146.49 38.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.67 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 59' ' ' CYS . . . . . . . . . . . . . 6.3 p -173.87 141.13 0.78 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.0 109.349 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . 51.03 -131.38 2.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.89 . . . . 0.0 109.55 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -165.39 115.87 1.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 0.0 109.263 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.32 -60.74 0.54 Allowed Glycine 0 N--CA 1.501 2.978 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -95.89 -176.43 3.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.286 -1.126 . . . . 0.0 109.36 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -135.57 159.47 41.52 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.49 -0.757 . . . . 0.0 109.185 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 53.1 tp -165.23 126.93 2.05 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.476 -0.765 . . . . 0.0 109.401 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.36 -67.15 1.77 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 66.12 121.65 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.221 -1.164 . . . . 0.0 109.656 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.11 156.73 28.4 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 69' ' ' THR . . . . . 0.549 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 98.1 m -104.39 137.1 42.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.415 -1.05 . . . . 0.0 108.194 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 28.3 mt -85.41 135.88 23.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 m -142.98 162.96 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.733 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -151.68 147.81 27.17 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.03 151.48 35.43 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.2 -0.937 . . . . 0.0 108.675 178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -76.75 -5.88 49.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.878 -1.139 . . . . 0.0 109.226 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 54.58 -100.99 0.11 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.293 -0.88 . . . . 0.0 109.605 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . -166.64 70.22 0.11 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.908 -1.12 . . . . 0.0 109.735 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 77' ' ' GLN . . . . . 0.575 ' O ' ' N ' ' E' ' 79' ' ' THR . 98.0 mt-30 -46.11 -87.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.255 -0.903 . . . . 0.0 109.883 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 41.8 t80 56.09 -79.09 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.491 -0.755 . . . . 0.0 109.696 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 79' ' ' THR . . . . . 0.575 ' N ' ' O ' ' E' ' 77' ' ' GLN . 0.1 OUTLIER -56.71 -28.63 61.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.422 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 21.0 ttt 50.76 85.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 109.555 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.453 -179.94 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.2 t80 . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.8 mt -134.1 131.69 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.341 -0.849 . . . . 0.0 110.205 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 9' ' ' ILE . 19.5 tt -129.37 125.22 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.08 -1.012 . . . . 0.0 108.762 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.8 t -122.88 139.04 54.46 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.332 -0.855 . . . . 0.0 110.302 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.526 ' OG1' ' OG1' ' B' ' 69' ' ' THR . 3.1 m -91.12 98.6 11.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.012 -1.055 . . . . 0.0 108.928 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.56 91.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.23 -0.919 . . . . 0.0 110.319 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -162.93 -128.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -173.68 -17.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.271 -0.893 . . . . 0.0 109.6 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.1 mt 49.69 69.0 2.93 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.581 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.76 156.85 50.93 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.975 1.783 . . . . 0.0 110.035 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.18 -9.42 74.88 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.824 -1.179 . . . . 0.0 110.495 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 18' ' ' LEU . 32.5 mt -122.54 139.31 54.04 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.137 -1.214 . . . . 0.0 110.071 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -87.56 116.46 25.69 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.7 mt -107.12 134.62 49.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.348 -0.845 . . . . 0.0 109.339 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.532 ' CE1' ' O ' ' A' ' 22' ' ' SER . 2.1 t80 -121.11 129.71 53.42 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.532 ' O ' ' CE1' ' A' ' 21' ' ' TYR . 20.8 t -84.24 129.07 34.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.407 -0.808 . . . . 0.0 110.522 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.923 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -119.29 15.44 13.07 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.03 170.8 11.94 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.352 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -109.13 144.5 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.78 144.75 42.99 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.552 -0.718 . . . . 0.0 109.4 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -152.39 139.92 19.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.91 -1.119 . . . . 0.0 108.258 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 t -150.26 136.55 18.78 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.902 -1.124 . . . . 0.0 109.548 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.0 mt -101.38 126.91 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.144 -0.973 . . . . 0.0 109.171 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.7 p -175.36 175.98 2.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.338 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 16.0 p-10 -115.75 161.16 19.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.542 -0.723 . . . . 0.0 109.117 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 11.2 m-20 77.14 120.26 0.05 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.6 t -66.26 -33.13 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.444 -0.785 . . . . 0.0 109.697 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -56.97 -39.65 75.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.911 . . . . 0.0 110.145 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -76.57 -36.51 57.54 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.179 -0.95 . . . . 0.0 109.372 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.7 mt -64.36 -51.9 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.932 -1.105 . . . . 0.0 109.399 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.74 -50.18 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.048 -1.033 . . . . 0.0 109.257 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -60.16 -41.38 92.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.295 -0.878 . . . . 0.0 109.758 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -62.93 -46.16 89.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.136 -0.977 . . . . 0.0 110.009 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.5 mt -69.38 -46.47 66.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.001 -1.062 . . . . 0.0 108.767 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -48.03 -55.05 11.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.789 -1.194 . . . . 0.0 108.87 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.45 -35.23 67.65 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.939 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -75.13 -35.88 61.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.37 -0.831 . . . . 0.0 109.81 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.8 t -73.82 -50.91 26.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.146 -0.971 . . . . 0.0 109.439 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -68.71 -31.7 70.97 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.566 -1.334 . . . . 0.0 109.174 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.84 -31.63 72.68 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -90.38 5.63 46.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -0.877 . . . . 0.0 109.023 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.72 27.04 73.03 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.664 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.92 -167.58 23.8 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 34.7 ttp -110.73 -41.3 4.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.616 -0.932 . . . . 0.0 109.478 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.91 -153.01 11.35 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 tp -133.2 135.46 45.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.357 -1.084 . . . . 0.0 109.788 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.575 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 1.1 pt -111.0 146.38 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.497 -0.752 . . . . 0.0 110.276 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 75.01 87.79 0.09 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.357 -0.839 . . . . 0.0 109.14 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -115.05 50.51 0.97 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.591 ' O ' ' O ' ' A' ' 57' ' ' ILE . 30.4 ttm180 -65.87 -56.81 9.89 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.536 -0.727 . . . . 0.0 109.602 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.591 ' O ' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.065 0 CA-C-O 122.202 1.001 . . . . 0.0 109.436 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.7 p90 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.665 0.745 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.98 159.57 29.72 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.4 m -107.03 140.13 40.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.149 -1.207 . . . . 0.0 109.37 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.4 mt -87.34 135.74 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 m -138.96 162.14 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 109.673 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -154.46 143.11 20.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.887 . . . . 0.0 109.042 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.84 150.37 35.62 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.915 -1.116 . . . . 0.0 108.015 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.9 t70 . . . . . 0 C--N 1.3 -1.547 0 O-C-N 120.919 -1.113 . . . . 0.0 109.097 179.645 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 82.1 t80 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 11.9 mt -136.09 138.27 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.284 -0.885 . . . . 0.0 109.962 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.443 ' O ' ' CG2' ' B' ' 9' ' ' ILE . 3.8 tt -118.99 121.84 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.267 -0.895 . . . . 0.0 108.588 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 7.3 t -123.76 135.56 53.89 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.395 -0.815 . . . . 0.0 110.296 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.401 ' OG1' HD11 ' C' ' 25' ' ' ILE . 21.6 m -113.68 112.42 23.45 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 52.52 55.55 8.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.394 -0.816 . . . . 0.0 110.205 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -160.4 111.73 1.91 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.538 -0.727 . . . . 0.0 109.082 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -64.38 169.91 4.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 109.62 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 22.5 mt -135.48 71.69 65.61 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.519 -0.738 . . . . 0.0 109.064 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.8 157.6 37.18 Favored 'Trans proline' 0 C--N 1.319 -0.979 0 C-N-CA 121.873 1.715 . . . . 0.0 110.054 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.73 -8.4 73.99 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.367 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' B' ' 18' ' ' LEU . 20.4 mt -123.38 139.55 53.92 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.221 -1.164 . . . . 0.0 110.097 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -88.48 109.01 19.69 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt -97.85 141.34 30.95 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.266 -0.896 . . . . 0.0 110.773 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' TYR . . . . . 0.463 ' H ' ' H ' ' B' ' 72' ' ' LYS . 4.2 t80 -121.35 129.27 52.97 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 28.9 t -72.94 130.61 40.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.674 -1.266 . . . . 0.0 111.317 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.572 HD11 ' CB ' ' B' ' 72' ' ' LYS . 18.5 mt -118.68 9.35 12.13 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.3 -161.81 19.71 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.22 144.99 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 122.234 -0.568 . . . . 0.0 109.484 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.69 158.12 20.44 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 86.0 p -150.25 140.82 22.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 108.917 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 20.6 p -140.24 135.34 32.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.326 -0.859 . . . . 0.0 109.409 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.459 ' O ' ' CB ' ' B' ' 30' ' ' SER . 96.5 mt -126.79 125.48 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' B' ' 29' ' ' ILE . 1.9 p 163.3 -164.11 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 16.0 p-10 -122.19 173.13 7.78 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 18.3 m-80 76.91 112.46 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.3 -35.36 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.435 -0.791 . . . . 0.0 109.642 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -56.99 -37.27 71.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 110.057 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -76.46 -36.61 57.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.219 -0.926 . . . . 0.0 109.324 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 82.0 mt -66.22 -53.62 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.898 -1.126 . . . . 0.0 109.425 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 40.2 t -59.35 -51.87 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.004 -1.06 . . . . 0.0 109.513 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -56.13 -36.22 68.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 109.622 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -66.68 -40.33 88.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.043 -1.036 . . . . 0.0 109.852 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 70.4 mt -74.5 -50.84 16.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.95 -1.094 . . . . 0.0 108.988 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -48.85 -53.01 21.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.808 -1.182 . . . . 0.0 108.861 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' B' ' 46' ' ' ALA . 31.6 ttpt -59.0 -36.79 75.49 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.438 -0.788 . . . . 0.0 110.026 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -75.25 -35.85 61.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.232 -0.918 . . . . 0.0 109.945 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 4.9 t -74.2 -51.42 23.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 109.448 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 33.7 tptt -70.75 -29.75 66.07 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.234 -1.386 . . . . 0.0 109.548 -175.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' B' ' 42' ' ' LYS . . . -62.12 -31.25 71.7 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -92.75 2.19 56.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 109.226 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.22 29.3 64.62 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.336 -1.411 . . . . 0.0 110.016 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.77 -170.54 25.73 Favored Glycine 0 N--CA 1.492 2.383 0 O-C-N 121.209 -1.171 . . . . 0.0 110.585 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -107.95 -48.8 3.32 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.725 -0.868 . . . . 0.0 109.291 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -167.7 -160.94 16.14 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.4 tp -136.82 138.51 40.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.299 -1.118 . . . . 0.0 109.99 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.655 ' O ' ' HB3' ' B' ' 54' ' ' ALA . 0.4 OUTLIER -107.0 147.62 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.411 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 90.38 -146.59 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.64 ' CB ' ' O ' ' B' ' 54' ' ' ALA . 67.4 t80 120.71 -101.52 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 120.529 1.513 . . . . 0.0 107.077 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' B' ' 55' ' ' PHE . 25.8 mtm180 55.52 161.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.38 -0.825 . . . . 0.0 109.79 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 79.3 mt . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.249 -0.907 . . . . 0.0 108.941 -179.594 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 tp . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.53 115.43 4.72 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' B' ' 67' ' ' TYR . 7.3 p90 -137.24 -175.96 4.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -1.115 . . . . 0.0 110.319 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.48 167.63 29.4 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' THR . . . . . 0.526 ' OG1' ' OG1' ' A' ' 11' ' ' THR . 87.5 m -95.01 138.48 32.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.029 -1.277 . . . . 0.0 109.076 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.418 HG22 HD12 ' B' ' 23' ' ' LEU . 70.6 mt -87.5 125.36 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 3.0 m -122.78 162.51 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.306 -0.871 . . . . 0.0 110.558 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.572 ' CB ' HD11 ' B' ' 23' ' ' LEU . 11.6 tttp -154.92 135.15 13.17 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.02 114.82 29.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.556 -1.34 . . . . 0.0 111.598 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' ASP . . . . . 0.427 ' CG ' ' NZ ' ' B' ' 72' ' ' LYS . 6.8 p-10 . . . . . 0 N--CA 1.491 1.603 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.241 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 6' ' ' LYS . . . . . 0.501 ' HG2' ' N ' ' C' ' 7' ' ' PHE . 53.6 tttp . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 7' ' ' PHE . . . . . 0.501 ' N ' ' HG2' ' C' ' 6' ' ' LYS . 70.1 t80 -101.42 119.88 39.43 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.042 -1.036 . . . . 0.0 109.268 -178.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 8' ' ' ILE . . . . . 0.444 ' O ' ' HA3' ' C' ' 51' ' ' GLY . 60.8 mt -115.46 143.21 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.543 -0.723 . . . . 0.0 110.067 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 9' ' ' ILE . . . . . 0.551 ' O ' HG23 ' C' ' 9' ' ' ILE . 12.9 tt -138.54 114.56 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.742 -1.224 . . . . 0.0 108.853 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -123.95 161.78 24.73 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.395 -0.816 . . . . 0.0 108.958 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 1.2 p -114.6 79.0 1.21 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 12' ' ' ALA . . . . . 0.463 ' O ' ' CG ' ' C' ' 13' ' ' ASP . . . -179.04 -10.21 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.486 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 13' ' ' ASP . . . . . 0.463 ' CG ' ' O ' ' C' ' 12' ' ' ALA . 3.2 p30 43.73 83.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.348 0.594 . . . . 0.0 110.272 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -154.72 -87.86 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.402 -0.811 . . . . 0.0 109.545 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 7.3 mt 48.99 66.23 6.01 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.226 -0.921 . . . . 0.0 109.247 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.53 157.71 49.55 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 C-N-CA 122.085 1.856 . . . . 0.0 109.885 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.99 -7.0 73.22 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.676 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 18' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' C' ' 18' ' ' LEU . 58.2 mt -124.46 140.55 52.84 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.997 -1.296 . . . . 0.0 110.246 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 19' ' ' GLN . . . . . 0.419 ' N ' ' CD ' ' C' ' 19' ' ' GLN . 2.9 mp0 -85.64 108.38 17.98 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -92.2 134.25 35.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.077 -1.014 . . . . 0.0 110.092 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 21' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -117.35 130.31 56.43 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.82 131.64 43.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.68 -1.262 . . . . 0.0 111.134 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.803 HD11 ' HB2' ' C' ' 72' ' ' LYS . 25.0 mt -114.64 10.54 16.75 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.14 -154.57 16.41 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 25' ' ' ILE . . . . . 0.401 HD11 ' OG1' ' B' ' 11' ' ' THR . 0.3 OUTLIER -134.69 143.56 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.82 -0.812 . . . . 0.0 109.492 -179.411 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.98 149.24 40.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.832 -0.542 . . . . 0.0 109.714 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 60.7 p -151.56 138.18 18.75 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -149.34 147.77 28.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.98 -1.075 . . . . 0.0 108.973 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 tt -127.59 133.37 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.2 -0.937 . . . . 0.0 109.049 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 5.3 t -169.54 170.56 8.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.291 -0.88 . . . . 0.0 109.474 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -104.31 37.56 2.07 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.835 0.826 . . . . 0.0 110.296 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -152.5 125.08 8.3 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.457 ' H ' HG13 ' C' ' 33' ' ' VAL . 0.7 OUTLIER -72.69 -45.51 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.106 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 34' ' ' ASP . . . . . 0.43 ' N ' ' CG2' ' C' ' 33' ' ' VAL . 5.7 p-10 -62.08 -34.77 76.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.426 -0.796 . . . . 0.0 109.99 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -74.01 -38.51 64.07 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.584 -0.846 . . . . 0.0 108.808 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 68.1 mt -63.02 -51.33 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.96 . . . . 0.0 108.646 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.55 -49.8 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.991 . . . . 0.0 108.691 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -61.68 -45.5 93.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.348 -0.845 . . . . 0.0 109.955 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -59.39 -46.63 88.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.329 -0.857 . . . . 0.0 109.557 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' C' ' 40' ' ' LEU . 41.1 mt -66.93 -44.24 81.19 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.123 -0.986 . . . . 0.0 108.384 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -46.76 -56.21 6.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.818 -1.176 . . . . 0.0 108.636 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -53.46 -32.16 48.78 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.34 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -74.42 -40.77 61.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.444 -0.785 . . . . 0.0 109.259 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 10.1 t -77.85 -53.53 14.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 120.774 -1.204 . . . . 0.0 108.921 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -50.58 -31.66 16.46 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.769 1.271 . . . . 0.0 109.795 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.38 -25.81 46.38 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.482 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -98.15 -0.92 43.38 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.9 26.46 73.91 Favored Glycine 0 N--CA 1.487 2.087 0 C-N-CA 118.335 -1.888 . . . . 0.0 109.637 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.79 -167.87 15.55 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 5.0 ttp -110.18 -43.79 3.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.586 -0.949 . . . . 0.0 110.462 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 51' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' C' ' 8' ' ' ILE . . . 177.55 -172.22 44.95 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.556 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.52 132.07 53.64 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.374 -1.074 . . . . 0.0 110.62 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 pt -109.61 139.14 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.44 61.96 2.65 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.888 -1.133 . . . . 0.0 108.665 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -96.57 109.32 21.94 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' ARG . . . . . 0.713 ' HG3' HH11 ' C' ' 56' ' ' ARG . 9.7 mmm-85 -125.02 154.62 40.98 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.419 -0.8 . . . . 0.0 109.306 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 44.6 p90 . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 121.694 0.759 . . . . 0.0 109.711 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.48 166.42 34.17 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.406 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 34.4 m -101.92 140.21 36.5 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.307 -1.113 . . . . 0.0 108.424 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 70' ' ' ILE . . . . . 0.539 HG22 HD12 ' C' ' 23' ' ' LEU . 56.2 mt -85.53 148.5 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 6.8 m -142.96 156.18 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.158 -0.964 . . . . 0.0 109.765 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 72' ' ' LYS . . . . . 0.803 ' HB2' HD11 ' C' ' 23' ' ' LEU . 21.6 ttpt -146.04 156.17 43.29 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.216 -0.927 . . . . 0.0 108.731 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' C' ' 74' ' ' ASP . . . -119.88 153.38 35.92 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' C' ' 73' ' ' ALA . 16.2 m-20 . . . . . 0 N--CA 1.505 2.288 0 CA-C-O 121.37 0.605 . . . . 0.0 109.736 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -101.44 123.8 46.08 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.274 -0.891 . . . . 0.0 109.515 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 87.4 mt -119.12 146.29 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.636 -0.665 . . . . 0.0 109.489 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 9' ' ' ILE . . . . . 0.59 HG23 ' O ' ' D' ' 9' ' ' ILE . 13.2 tt -138.35 116.38 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.419 -0.8 . . . . 0.0 109.001 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t -121.95 160.75 24.18 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 11' ' ' THR . . . . . 0.512 ' OG1' ' OG1' ' E' ' 69' ' ' THR . 1.3 m -130.45 123.79 30.57 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 12' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' D' ' 11' ' ' THR . . . 59.85 49.81 7.56 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 122.117 0.96 . . . . 0.0 109.307 178.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -138.6 -171.02 2.96 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 55.0 mp0 -147.09 -18.03 0.4 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.035 -1.041 . . . . 0.0 109.622 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 27.8 mt 49.36 66.74 5.26 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.237 -0.914 . . . . 0.0 109.148 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.04 157.59 38.39 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 121.962 1.774 . . . . 0.0 110.076 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.97 -8.09 73.27 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.508 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 25.5 mt -122.52 138.44 54.56 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.147 -1.207 . . . . 0.0 110.187 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -90.31 116.74 28.51 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 11.9 mt -100.61 140.43 34.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.576 -0.702 . . . . 0.0 110.725 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 21' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -118.63 129.79 55.5 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 6.2 t -68.46 130.2 42.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.712 -1.243 . . . . 0.0 112.022 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.587 HD11 ' CB ' ' D' ' 72' ' ' LYS . 40.4 mt -116.54 13.64 15.37 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.68 -170.13 13.21 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.51 142.3 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.843 -0.798 . . . . 0.0 109.419 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.81 144.17 44.37 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.57 -0.706 . . . . 0.0 109.46 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 51.8 m -152.09 138.19 18.25 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.955 -1.091 . . . . 0.0 108.479 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 28' ' ' THR . . . . . 0.433 ' O ' HG23 ' D' ' 28' ' ' THR . 11.6 t -150.07 132.16 15.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.914 -1.116 . . . . 0.0 109.327 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 tt -100.01 130.04 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.108 -0.995 . . . . 0.0 109.379 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 6.3 p -178.21 179.47 0.81 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.439 -0.788 . . . . 0.0 109.238 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 31' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' D' ' 32' ' ' ASN . 3.3 p30 -112.18 157.17 21.18 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.515 -0.741 . . . . 0.0 109.166 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 5.7 t-20 79.23 117.1 0.06 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.556 -0.715 . . . . 0.0 109.129 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 91.6 t -62.75 -31.03 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.542 -0.724 . . . . 0.0 109.534 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -59.4 -41.01 88.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.933 . . . . 0.0 110.029 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -74.09 -39.65 63.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.261 -0.899 . . . . 0.0 109.087 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 71.4 mt -65.36 -53.97 33.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.953 -1.092 . . . . 0.0 108.908 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 25.3 t -61.43 -50.23 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.124 -0.985 . . . . 0.0 109.224 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -56.42 -36.43 68.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.2 -0.937 . . . . 0.0 109.828 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -71.73 -38.01 70.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.032 -1.042 . . . . 0.0 109.406 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 40' ' ' LEU . . . . . 0.702 HD13 ' CD2' ' D' ' 52' ' ' LEU . 26.7 mt -69.56 -48.92 58.7 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.962 -1.086 . . . . 0.0 108.152 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 41' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' D' ' 40' ' ' LEU . 99.2 mtt180 -46.24 -57.76 4.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.308 -1.495 . . . . 0.0 108.993 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -50.17 -28.93 8.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.037 -1.039 . . . . 0.0 110.448 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -68.61 -56.66 7.5 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.732 -1.23 . . . . 0.0 110.011 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 44' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' D' ' 48' ' ' GLY . 1.8 m -64.91 -48.82 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.672 0 O-C-N 120.275 -1.515 . . . . 0.0 107.825 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -49.94 -46.15 51.92 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.72 1.248 . . . . 0.0 110.809 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.89 -30.15 56.06 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.642 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 47' ' ' LYS . . . . . 0.464 ' NZ ' ' O ' ' D' ' 23' ' ' LEU . 5.8 ttmt -92.47 -3.87 54.52 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.239 -0.913 . . . . 0.0 108.794 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 48' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' D' ' 44' ' ' VAL . . . 81.1 20.24 65.39 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.313 -1.422 . . . . 0.0 109.598 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.8 -166.57 13.27 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.68 -25.49 5.48 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.581 -0.952 . . . . 0.0 111.822 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 51' ' ' GLY . . . . . 0.501 ' O ' HD12 ' D' ' 52' ' ' LEU . . . 159.34 -163.21 33.31 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 52' ' ' LEU . . . . . 0.702 ' CD2' HD13 ' D' ' 40' ' ' LEU . 5.6 mp -123.93 139.43 53.96 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.443 -1.033 . . . . 0.0 109.833 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 53' ' ' ILE . . . . . . . . . . . . . 1.3 pt -106.75 143.42 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.593 -0.692 . . . . 0.0 109.412 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 57.03 60.01 3.19 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.824 -1.172 . . . . 0.0 108.554 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 55' ' ' PHE . . . . . 0.412 ' CD2' HD11 ' D' ' 9' ' ' ILE . 46.9 t80 -84.35 71.34 10.68 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 56' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.493 -0.754 . . . . 0.0 109.846 -179.213 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 121.762 0.791 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.31 152.52 23.68 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 76.7 m -107.3 137.71 44.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.034 -1.274 . . . . 0.0 108.298 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 mt -87.78 137.0 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 108.272 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.1 m -126.65 162.58 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 CA-C-O 121.617 0.722 . . . . 0.0 109.92 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 72' ' ' LYS . . . . . 0.587 ' CB ' HD11 ' D' ' 23' ' ' LEU . 2.0 ttmt -147.19 145.14 29.4 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.05 151.84 23.48 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.1 -1.0 . . . . 0.0 108.322 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 O-C-N 120.81 -1.181 . . . . 0.0 109.683 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 tptp . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 120.992 0.425 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -107.29 119.74 40.21 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.368 -0.833 . . . . 0.0 109.492 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 54.2 mt -107.59 130.89 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.533 -0.73 . . . . 0.0 109.203 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 9' ' ' ILE . . . . . 0.471 HD11 ' CG ' ' E' ' 55' ' ' PHE . 8.3 tt -120.92 115.09 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.13 155.6 39.65 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.833 -1.167 . . . . 0.0 108.659 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 11' ' ' THR . . . . . . . . . . . . . 2.3 p -118.9 95.96 5.05 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -165.88 -113.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.141 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -135.64 -42.32 0.68 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.833 . . . . 0.0 109.576 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -173.29 174.16 3.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.225 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 72.9 mt -112.57 95.68 33.3 Favored Pre-proline 0 N--CA 1.498 1.953 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.47 155.9 59.7 Favored 'Trans proline' 0 C--N 1.325 -0.671 0 C-N-CA 121.726 1.618 . . . . 0.0 110.83 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.48 -7.86 77.46 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 18' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' E' ' 18' ' ' LEU . 56.3 mt -129.3 141.55 51.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -1.118 . . . . 0.0 109.836 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 19' ' ' GLN . . . . . 0.46 ' N ' ' CD ' ' E' ' 19' ' ' GLN . 3.5 mp0 -85.37 108.59 17.91 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 13.9 mt -96.78 135.0 39.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.247 -0.908 . . . . 0.0 110.036 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 21' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -123.46 129.48 51.3 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -86.53 132.53 33.89 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.205 -0.935 . . . . 0.0 111.292 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.948 ' N ' HD23 ' E' ' 23' ' ' LEU . 0.4 OUTLIER -121.7 21.23 10.87 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.42 172.79 13.41 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.406 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 43.8 mm -108.69 143.52 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.39 145.03 41.79 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.315 -0.866 . . . . 0.0 108.886 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 84.8 p -152.08 136.66 16.93 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 13.5 t -150.06 149.65 30.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.936 -1.103 . . . . 0.0 109.192 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 2.2 tp -125.41 132.47 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 1.3 p 175.71 -173.82 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.008 -1.058 . . . . 0.0 109.251 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 31' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' E' ' 32' ' ' ASN . 29.1 m-20 -123.81 168.4 12.79 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.61 -0.681 . . . . 0.0 109.369 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 32' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 9.1 t-20 75.64 123.89 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.02 -34.36 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.341 -0.85 . . . . 0.0 109.467 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -59.16 -46.26 88.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 110.172 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -75.55 -39.4 58.26 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.086 -1.009 . . . . 0.0 109.564 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.62 -48.97 85.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.843 -1.16 . . . . 0.0 109.104 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 48.7 t -63.17 -48.91 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.014 -1.054 . . . . 0.0 109.478 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -59.42 -40.22 86.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.938 . . . . 0.0 109.618 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -58.48 -45.13 89.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.529 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 49.1 mt -72.37 -48.03 44.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.114 -0.992 . . . . 0.0 109.164 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -50.74 -42.96 58.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.716 -1.24 . . . . 0.0 109.354 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -69.25 -38.89 78.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.557 -0.715 . . . . 0.0 109.694 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -76.08 -34.69 59.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.918 . . . . 0.0 109.742 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 t -69.25 -52.6 31.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.197 -0.94 . . . . 0.0 109.668 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -72.3 -34.4 68.1 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.323 -1.351 . . . . 0.0 109.14 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.96 -32.27 61.36 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.14 -5.27 55.28 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.236 -0.915 . . . . 0.0 110.11 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.95 6.17 37.51 Favored Glycine 0 N--CA 1.504 3.21 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.36 159.58 48.73 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -124.37 -9.48 7.49 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.289 -1.124 . . . . 0.0 110.786 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.3 163.17 35.91 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.05 -1.548 . . . . 0.0 109.898 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 4.9 tp -120.79 143.09 49.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.653 -0.91 . . . . 0.0 110.093 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 53' ' ' ILE . . . . . 0.416 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 14.0 mt -113.12 138.87 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.568 -0.708 . . . . 0.0 110.411 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 64.73 78.69 0.28 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.436 -0.79 . . . . 0.0 110.593 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 55' ' ' PHE . . . . . 0.471 ' CG ' HD11 ' E' ' 9' ' ' ILE . 84.0 t80 -90.49 98.94 12.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.514 -0.742 . . . . 0.0 109.931 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 56' ' ' ARG . . . . . 0.494 ' NH1' ' NH1' ' A' ' 56' ' ' ARG . 7.6 tpp180 -97.66 166.77 11.34 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.288 -0.883 . . . . 0.0 109.068 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 47.8 mt . . . . . 0 N--CA 1.497 1.915 0 O-C-N 121.361 -0.837 . . . . 0.0 109.172 179.947 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 67' ' ' TYR . . . . . 0.401 ' OH ' ' CE2' ' D' ' 55' ' ' PHE . 4.0 t80 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 121.717 0.77 . . . . 0.0 110.407 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.58 140.18 6.38 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 69' ' ' THR . . . . . 0.512 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 20.4 m -93.11 138.7 31.3 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.93 -1.335 . . . . 0.0 108.623 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 70' ' ' ILE . . . . . 0.45 HG22 HD21 ' E' ' 23' ' ' LEU . 72.4 mt -85.48 139.19 17.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.44 161.46 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.175 -0.953 . . . . 0.0 110.189 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -155.92 147.25 22.59 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -110.95 150.65 28.94 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.123 -0.986 . . . . 0.0 108.595 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.056 -1.027 . . . . 0.0 109.563 179.879 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.7 t80 . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 121.009 0.433 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.4 mt -112.07 139.11 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.513 -0.742 . . . . 0.0 109.823 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 9' ' ' ILE . 6.3 tt -130.56 118.51 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -124.02 148.97 46.6 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.604 ' OG1' HD11 ' B' ' 25' ' ' ILE . 1.7 m -123.92 73.27 1.2 Allowed 'General case' 0 N--CA 1.511 2.622 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.727 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.2 -86.67 0.03 OUTLIER 'General case' 0 C--O 1.214 -0.791 0 O-C-N 119.585 -1.947 . . . . 0.0 107.576 -176.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.45 -78.56 0.6 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.274 -0.891 . . . . 0.0 109.68 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -162.4 -159.29 0.57 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.134 -0.979 . . . . 0.0 109.317 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.4 mt -120.78 91.76 47.62 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.495 -0.753 . . . . 0.0 109.235 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.51 155.73 51.17 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.784 1.656 . . . . 0.0 110.23 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.63 -14.08 64.97 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 18' ' ' LEU . 50.1 mt -121.86 139.48 53.57 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.427 -1.043 . . . . 0.0 109.503 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.27 108.43 15.72 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.1 mt -99.33 133.55 43.47 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.304 -0.873 . . . . 0.0 110.038 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.527 ' CE1' ' O ' ' A' ' 22' ' ' SER . 0.4 OUTLIER -120.86 129.97 53.74 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.527 ' O ' ' CE1' ' A' ' 21' ' ' TYR . 47.0 t -51.85 127.87 22.27 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.127 -0.983 . . . . 0.0 111.067 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' A' ' 23' ' ' LEU . 5.8 mt -114.44 5.9 15.77 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.17 -177.24 16.36 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.88 144.81 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 122.002 -0.705 . . . . 0.0 109.485 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.48 155.93 23.43 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.6 p -151.62 144.5 24.45 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.826 -1.171 . . . . 0.0 108.469 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.2 p -148.47 132.4 17.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.246 -0.909 . . . . 0.0 109.305 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.62 126.99 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.3 p 173.11 -125.87 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.301 0.572 . . . . 0.0 109.609 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -162.59 168.53 21.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.159 -0.963 . . . . 0.0 108.589 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.2 m120 72.06 115.1 0.05 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.443 -0.786 . . . . 0.0 109.279 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.7 -31.99 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.607 -0.683 . . . . 0.0 109.314 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -58.99 -42.26 89.61 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.259 -0.9 . . . . 0.0 109.568 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.433 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 96.3 mt-10 -75.38 -41.02 57.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.988 -1.07 . . . . 0.0 109.869 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.33 -53.01 51.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 120.896 -1.127 . . . . 0.0 109.535 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.9 t -57.17 -48.81 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.134 -0.978 . . . . 0.0 109.028 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -59.31 -38.94 81.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.958 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 35' ' ' GLU . 4.5 m-80 -68.13 -39.98 82.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.058 -1.026 . . . . 0.0 109.768 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 40' ' ' LEU . 67.9 mt -64.93 -44.07 90.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.972 -1.08 . . . . 0.0 109.002 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -48.63 -54.48 14.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.801 -1.187 . . . . 0.0 109.471 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -57.82 -35.86 71.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.378 -0.826 . . . . 0.0 110.105 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -75.06 -36.18 61.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.219 -0.925 . . . . 0.0 109.806 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 t -71.16 -51.15 36.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.247 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -72.65 -33.28 66.49 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 117.81 -1.556 . . . . 0.0 109.598 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.69 76.18 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.869 . . . . 0.0 109.826 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -85.28 -4.11 59.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.539 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.75 0.49 55.26 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.66 155.55 53.4 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.34 -10.54 8.9 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.235 -1.156 . . . . 0.0 110.057 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.84 143.39 8.27 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.17 -1.491 . . . . 0.0 109.51 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.7 tp -101.32 142.64 32.44 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.743 -0.857 . . . . 0.0 110.12 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.831 ' O ' HD12 ' A' ' 53' ' ' ILE . 1.3 pp -120.27 150.29 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.476 -0.765 . . . . 0.0 110.559 -176.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.65 61.89 2.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.262 -1.524 . . . . 0.0 109.429 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.493 ' CD2' HD11 ' A' ' 9' ' ' ILE . 39.8 t80 -100.22 73.96 1.73 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.712 HH11 ' HG2' ' A' ' 56' ' ' ARG . 7.0 mtt-85 -72.37 143.76 48.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.587 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.0 mm . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 109.213 179.846 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 26.0 p90 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.874 0.845 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.01 165.66 26.78 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.47 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.9 m -97.93 134.73 40.65 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.6 mt -88.02 146.53 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.64 160.51 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.177 -0.952 . . . . 0.0 110.462 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.503 ' HZ2' ' CB ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -144.64 160.42 41.21 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.158 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 74' ' ' ASP . . . -118.34 152.14 36.39 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 73' ' ' ALA . 20.8 t0 . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 121.293 0.568 . . . . 0.0 109.608 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 39.2 t80 . . . . . 0 N--CA 1.503 2.185 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 39.6 mt -103.9 134.78 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.322 -0.861 . . . . 0.0 110.123 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 39.0 mt -125.56 117.38 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 7.7 t -126.18 151.96 46.63 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.909 0.861 . . . . 0.0 108.749 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.456 ' CB ' ' HG1' ' C' ' 69' ' ' THR . 4.4 p -119.66 96.56 5.24 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -178.45 -87.74 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.528 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -155.55 -160.72 1.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.399 -0.813 . . . . 0.0 109.597 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -65.36 121.94 15.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.313 -0.867 . . . . 0.0 109.601 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 77.5 mt -52.58 110.27 1.86 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.56 -0.713 . . . . 0.0 109.386 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.46 153.75 72.76 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.293 1.329 . . . . 0.0 110.396 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.65 -16.09 58.86 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' B' ' 18' ' ' LEU . 71.8 mt -121.88 140.16 52.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.403 -1.057 . . . . 0.0 109.34 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -85.1 108.42 17.66 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 12.7 mt -96.89 138.35 34.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.211 -0.931 . . . . 0.0 110.233 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' TYR . . . . . 0.504 ' CE1' ' O ' ' B' ' 22' ' ' SER . 2.1 t80 -121.01 130.09 53.66 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.504 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 41.0 t -72.01 131.84 43.46 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 120.892 -1.13 . . . . 0.0 110.532 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.48 HD11 ' CB ' ' B' ' 72' ' ' LYS . 1.2 mp -118.92 12.79 12.95 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.67 -174.39 16.29 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ILE . . . . . 0.604 HD11 ' OG1' ' A' ' 11' ' ' THR . 0.3 OUTLIER -116.66 145.2 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.252 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.83 143.9 43.9 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 46.2 m -152.52 141.79 21.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.581 -1.325 . . . . 0.0 108.305 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 12.9 t -149.48 151.84 34.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.036 -1.04 . . . . 0.0 108.646 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' B' ' 30' ' ' SER . 49.1 mt -112.4 158.02 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.117 -0.989 . . . . 0.0 108.674 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.672 ' O ' ' CG ' ' B' ' 31' ' ' ASP . 16.9 m 51.34 108.35 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.741 0 O-C-N 121.039 -1.038 . . . . 0.0 110.683 177.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.672 ' CG ' ' O ' ' B' ' 30' ' ' SER . 37.3 m-20 171.15 129.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ASN . . . . . 0.488 ' O ' HG12 ' B' ' 36' ' ' ILE . 23.0 t-20 -84.27 173.04 11.31 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 120.917 -1.114 . . . . 0.0 108.384 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.532 ' HA ' HD11 ' B' ' 36' ' ' ILE . 15.5 t -44.8 -42.77 2.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 O-C-N 120.943 -1.098 . . . . 0.0 110.297 -174.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -64.19 -44.23 92.66 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.63 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -74.73 -45.83 41.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.327 -1.483 . . . . 0.0 111.546 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.532 HD11 ' HA ' ' B' ' 33' ' ' VAL . 0.6 OUTLIER -58.75 -48.98 84.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 O-C-N 120.017 -1.677 . . . . 0.0 109.413 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.79 -45.19 99.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 118.846 -1.142 . . . . 0.0 108.711 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -67.55 -50.34 59.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.347 -0.845 . . . . 0.0 109.424 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.451 ' ND2' ' OD2' ' B' ' 31' ' ' ASP . 4.5 m-20 -54.9 -47.39 74.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.108 -0.995 . . . . 0.0 108.966 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.75 -43.46 79.81 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.411 -0.806 . . . . 0.0 108.943 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -50.85 -45.33 59.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.626 -1.296 . . . . 0.0 109.419 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' B' ' 46' ' ' ALA . 64.0 mttm -66.41 -39.37 88.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.461 -0.774 . . . . 0.0 110.055 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -76.82 -34.99 57.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.689 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.473 HG21 HD13 ' B' ' 52' ' ' LEU . 15.3 t -71.86 -51.9 28.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.209 -0.932 . . . . 0.0 109.025 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -70.22 -30.18 67.2 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.14 -1.424 . . . . 0.0 109.558 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' B' ' 42' ' ' LYS . . . -61.55 -30.01 70.38 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -93.62 -5.31 49.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.381 -0.824 . . . . 0.0 109.821 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.87 15.49 28.62 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.02 159.84 29.24 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.1 -1.02 4.63 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.173 -1.193 . . . . 0.0 110.816 -176.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.82 173.62 43.4 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.422 -1.37 . . . . 0.0 109.773 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.473 HD13 HG21 ' B' ' 44' ' ' VAL . 5.5 tp -130.53 133.81 46.53 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.67 -0.9 . . . . 0.0 109.43 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.57 139.66 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.672 -0.643 . . . . 0.0 110.243 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 50.83 61.12 3.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.949 -1.094 . . . . 0.0 110.633 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -100.39 114.3 27.74 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.323 0.583 . . . . 0.0 110.654 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -102.46 119.12 38.28 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 pt . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.128 -0.982 . . . . 0.0 109.858 -179.547 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.26 149.66 20.39 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' B' ' 67' ' ' TYR . 4.8 p90 -150.03 152.97 35.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.158 -1.201 . . . . 0.0 110.202 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.73 156.53 28.07 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 52.6 m -101.21 136.12 41.56 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.061 -1.258 . . . . 0.0 107.92 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 53.5 mt -86.04 146.62 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.9 m -138.51 156.71 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.308 -0.87 . . . . 0.0 110.21 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.48 ' CB ' HD11 ' B' ' 23' ' ' LEU . 23.4 ttpp -150.55 132.44 15.11 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.54 129.34 50.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.856 -1.152 . . . . 0.0 108.3 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 t70 . . . . . 0 N--CA 1.488 1.445 0 O-C-N 120.844 -1.16 . . . . 0.0 108.681 177.785 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.375 0.607 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -95.23 122.59 38.09 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.518 -0.738 . . . . 0.0 110.026 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 86.2 mt -111.06 128.89 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.485 -0.76 . . . . 0.0 109.866 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 9' ' ' ILE . . . . . 0.615 HG23 HD13 ' D' ' 25' ' ' ILE . 7.7 tt -124.19 116.92 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 7.9 t -113.36 135.99 53.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.661 -1.274 . . . . 0.0 109.039 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 11' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' C' ' 12' ' ' ALA . 0.3 OUTLIER -56.99 -85.75 0.01 OUTLIER 'General case' 0 C--N 1.279 -2.471 0 O-C-N 121.873 -0.517 . . . . 0.0 111.178 178.673 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 12' ' ' ALA . . . . . 0.492 ' N ' ' OG1' ' C' ' 11' ' ' THR . . . -133.43 92.68 3.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.639 -1.288 . . . . 0.0 108.131 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -147.57 -134.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.294 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -165.86 -9.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.07 -1.019 . . . . 0.0 109.474 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 27.8 mt 55.64 68.74 2.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.39 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.89 156.22 50.18 Favored 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 121.931 1.754 . . . . 0.0 109.984 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.12 -14.96 63.15 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 18' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' C' ' 18' ' ' LEU . 19.1 mt -119.34 137.47 53.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.434 -1.039 . . . . 0.0 109.153 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.77 107.92 19.22 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.474 HD13 HD11 ' C' ' 53' ' ' ILE . 11.6 mt -97.88 140.66 31.9 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.199 -0.938 . . . . 0.0 110.246 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 21' ' ' TYR . . . . . 0.62 ' CE1' ' O ' ' C' ' 22' ' ' SER . 0.6 OUTLIER -123.17 129.94 52.1 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.63 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 22' ' ' SER . . . . . 0.62 ' O ' ' CE1' ' C' ' 21' ' ' TYR . 24.9 t -66.37 135.71 54.73 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.273 1.035 . . . . 0.0 112.45 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 mt -123.86 13.86 9.23 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.512 -0.742 . . . . 0.0 109.357 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.29 179.74 15.99 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.5 145.8 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 122.21 -0.583 . . . . 0.0 109.56 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.89 159.71 18.78 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.93 147.09 26.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.752 -1.217 . . . . 0.0 108.474 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 28' ' ' THR . . . . . 0.427 HG23 HD21 ' C' ' 40' ' ' LEU . 51.7 p -146.0 142.1 28.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.509 -0.744 . . . . 0.0 109.872 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' C' ' 30' ' ' SER . 55.8 mt -127.18 124.86 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 29' ' ' ILE . 3.6 p 157.77 -159.59 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -132.62 -174.7 3.53 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 73.97 114.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.481 HG22 HD12 ' C' ' 57' ' ' ILE . 22.2 t -68.39 -34.34 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.445 -0.784 . . . . 0.0 109.482 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.4 -38.87 78.25 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.236 -0.915 . . . . 0.0 109.269 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -75.14 -39.81 60.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.932 -1.105 . . . . 0.0 109.586 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.45 -52.38 56.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.602 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 5.7 t -58.24 -48.31 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.009 -1.057 . . . . 0.0 108.782 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.77 -44.97 91.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 109.955 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -57.21 -49.9 74.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.104 -0.997 . . . . 0.0 109.496 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' LEU . . . . . 0.427 HD21 HG23 ' C' ' 28' ' ' THR . 82.7 mt -64.44 -43.71 93.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.076 -1.015 . . . . 0.0 108.673 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 41' ' ' ARG . . . . . 0.789 HH11 ' HG2' ' C' ' 41' ' ' ARG . 2.7 ttt-85 -49.78 -47.28 51.18 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.774 -1.204 . . . . 0.0 109.579 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -67.04 -38.41 85.82 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.488 -0.758 . . . . 0.0 110.253 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -76.65 -35.5 57.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.897 . . . . 0.0 109.795 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 t -67.58 -50.88 57.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.176 -0.953 . . . . 0.0 108.949 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -71.76 -35.47 70.1 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.155 -1.418 . . . . 0.0 109.208 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.26 -33.34 67.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.486 -0.759 . . . . 0.0 108.97 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.61 -4.97 59.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.509 -0.744 . . . . 0.0 109.521 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.47 5.18 59.16 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.3 161.65 48.89 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -128.46 -0.2 5.61 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.293 -1.122 . . . . 0.0 110.014 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.42 151.09 17.48 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 16.0 tp -112.96 140.47 47.74 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.565 -0.962 . . . . 0.0 109.949 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 53' ' ' ILE . . . . . 0.654 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 27.9 mt -112.34 140.66 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.59 -0.694 . . . . 0.0 109.488 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 92.01 -41.36 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 118.342 0.519 . . . . 0.0 110.093 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 55' ' ' PHE . . . . . 0.511 ' C ' ' O ' ' C' ' 54' ' ' ALA . 18.0 t80 27.97 89.77 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 120.804 0.335 . . . . 0.0 110.177 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 56' ' ' ARG . . . . . 0.652 ' CG ' HH11 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -93.82 143.79 26.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.013 -1.054 . . . . 0.0 109.65 -178.745 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 57' ' ' ILE . . . . . 0.481 HD12 HG22 ' C' ' 33' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 26.2 p90 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 122.252 1.025 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.44 161.76 31.76 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 69' ' ' THR . . . . . 0.456 ' HG1' ' CB ' ' B' ' 11' ' ' THR . 69.1 m -93.83 137.02 33.5 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.276 -1.132 . . . . 0.0 108.406 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 60.9 mt -86.11 141.32 14.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 71' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' C' ' 21' ' ' TYR . 6.9 m -144.92 163.21 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.788 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -152.06 162.32 41.27 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' C' ' 74' ' ' ASP . . . -104.03 151.43 23.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 108.985 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' C' ' 73' ' ' ALA . 2.9 t0 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 109.85 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 121.587 0.708 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -94.12 124.29 38.04 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.668 -0.645 . . . . 0.0 109.849 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 71.8 mt -116.94 143.17 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.618 -0.676 . . . . 0.0 109.91 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 9' ' ' ILE . . . . . 0.607 HG23 ' O ' ' D' ' 9' ' ' ILE . 7.7 tt -136.03 114.65 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.8 t -122.18 161.72 22.68 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.333 -0.855 . . . . 0.0 108.826 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.16 73.27 1.29 Allowed 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.17 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.69 -116.64 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.766 0 O-C-N 119.43 -2.044 . . . . 0.0 107.363 -176.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 24.7 p30 -93.68 -137.97 0.2 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.971 -1.08 . . . . 0.0 109.428 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -109.86 -159.75 0.69 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.379 -0.826 . . . . 0.0 109.151 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 56.6 mt -125.48 85.27 58.88 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.579 -0.701 . . . . 0.0 109.203 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -60.11 157.26 35.38 Favored 'Trans proline' 0 N--CA 1.48 0.725 0 C-N-CA 121.91 1.74 . . . . 0.0 110.093 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.95 -4.46 75.0 Favored Glycine 0 N--CA 1.498 2.779 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.056 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 59.6 mt -130.64 141.38 50.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.191 . . . . 0.0 109.706 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -85.42 108.5 17.89 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 14.1 mt -94.95 133.11 39.07 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.117 -0.989 . . . . 0.0 109.635 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 21' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' D' ' 22' ' ' SER . 1.6 t80 -114.02 129.67 56.59 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 22' ' ' SER . . . . . 0.433 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 0.0 OUTLIER -70.63 131.69 44.31 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 120.618 -1.301 . . . . 0.0 110.942 -179.415 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 mt -117.29 11.34 14.0 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.91 -179.68 18.4 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 25' ' ' ILE . . . . . 0.615 HD13 HG23 ' C' ' 9' ' ' ILE . 1.5 mp -108.87 141.87 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.853 -0.792 . . . . 0.0 108.933 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.59 142.94 44.58 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 43.8 p -152.2 130.82 12.29 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 28' ' ' THR . . . . . 0.427 ' O ' HG23 ' D' ' 28' ' ' THR . 10.6 t -143.35 130.23 20.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.758 -1.213 . . . . 0.0 108.716 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 29' ' ' ILE . . . . . 0.484 ' O ' HG23 ' D' ' 29' ' ' ILE . 19.4 tt -97.72 130.29 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.879 -1.138 . . . . 0.0 108.961 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.531 ' O ' ' O ' ' D' ' 31' ' ' ASP . 72.1 m -168.73 2.36 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.739 -1.226 . . . . 0.0 109.968 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 31' ' ' ASP . . . . . 0.531 ' O ' ' O ' ' D' ' 30' ' ' SER . 26.5 t70 51.27 161.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.48 -0.763 . . . . 0.0 110.447 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 4.6 t-20 71.86 128.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.63 -1.293 . . . . 0.0 108.67 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 20.2 t -69.94 -36.73 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 121.224 -0.923 . . . . 0.0 110.15 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 34' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' D' ' 35' ' ' GLU . 25.4 p-10 -58.51 -47.03 85.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.161 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 35' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' D' ' 34' ' ' ASP . 49.9 mt-10 -76.26 -38.64 55.96 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.957 -1.089 . . . . 0.0 109.86 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 60.9 mt -63.79 -53.69 41.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 120.882 -1.136 . . . . 0.0 109.493 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 43.4 t -63.5 -49.65 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.167 -0.958 . . . . 0.0 109.658 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -58.13 -39.44 78.75 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.159 -0.963 . . . . 0.0 109.637 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -65.98 -42.31 90.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 40' ' ' LEU . . . . . 0.649 HD13 HD21 ' D' ' 52' ' ' LEU . 29.1 mt -67.77 -46.29 72.44 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.956 -1.09 . . . . 0.0 108.749 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -46.77 -53.4 11.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.884 -1.135 . . . . 0.0 109.056 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -55.65 -31.0 61.96 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.32 -0.862 . . . . 0.0 109.154 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -73.11 -36.27 66.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.16 -0.963 . . . . 0.0 109.609 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.66 -50.71 25.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 120.886 -1.134 . . . . 0.0 109.281 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -49.92 -33.81 18.61 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 122.988 1.375 . . . . 0.0 109.873 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.97 -29.06 49.57 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.824 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -97.75 6.27 48.12 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.36 29.14 59.99 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 117.952 -2.071 . . . . 0.0 109.687 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.75 -170.27 5.07 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 11.3 ttp -109.51 -41.57 4.55 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.494 -1.004 . . . . 0.0 110.063 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 171.25 175.69 39.87 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 52' ' ' LEU . . . . . 0.649 HD21 HD13 ' D' ' 40' ' ' LEU . 1.0 OUTLIER -108.24 139.42 42.96 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.479 -1.012 . . . . 0.0 109.993 -179.509 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 53' ' ' ILE . . . . . 0.5 ' O ' ' HB3' ' D' ' 54' ' ' ALA . 1.2 pt -112.28 142.47 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.748 -0.595 . . . . 0.0 110.238 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 68.93 -61.54 0.42 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.42 -0.8 . . . . 0.0 110.516 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 55' ' ' PHE . . . . . 0.437 ' N ' ' O ' ' D' ' 53' ' ' ILE . 13.1 t80 42.7 83.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 56' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.05 -1.031 . . . . 0.0 109.493 -179.776 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 121.48 0.657 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.0 137.43 3.18 Favored Glycine 0 C--N 1.288 -2.101 0 C-N-CA 119.015 -1.564 . . . . 0.0 110.856 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 6.9 m -101.08 144.29 30.17 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.74 -0.859 . . . . 0.0 108.951 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 26.7 mt -89.07 142.19 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 m -135.13 166.65 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.371 0.605 . . . . 0.0 109.48 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 72' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' D' ' 21' ' ' TYR . 7.7 tttt -146.47 145.39 30.18 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' D' ' 74' ' ' ASP . . . -125.42 153.98 42.63 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 74' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' D' ' 73' ' ' ALA . 25.2 t0 . . . . . 0 N--CA 1.492 1.642 0 CA-C-N 119.018 0.826 . . . . 0.0 110.15 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 6' ' ' LYS . . . . . 0.442 ' HZ2' ' HG3' ' E' ' 6' ' ' LYS . 6.8 ptmm? . . . . . 0 N--CA 1.498 1.954 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -94.93 119.08 32.88 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.388 -0.82 . . . . 0.0 109.788 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 33.8 mt -113.35 134.21 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.568 -0.708 . . . . 0.0 109.407 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 9' ' ' ILE . . . . . 0.624 ' O ' HG23 ' E' ' 9' ' ' ILE . 15.7 tt -130.67 114.42 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 6.5 t -122.46 157.9 30.95 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.891 0.853 . . . . 0.0 109.103 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 11' ' ' THR . . . . . 0.601 ' O ' ' HB2' ' E' ' 12' ' ' ALA . 4.1 p -100.25 77.69 1.99 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 177.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 12' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' E' ' 11' ' ' THR . . . 157.55 -90.97 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.778 0.799 . . . . 0.0 109.714 177.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -165.16 -71.32 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 51.14 -153.26 0.18 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 110.245 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 15' ' ' ILE . . . . . 0.667 ' N ' ' HD3' ' E' ' 16' ' ' PRO . 2.8 mt 60.54 48.16 1.6 Allowed Pre-proline 0 N--CA 1.483 1.223 0 O-C-N 121.849 -0.532 . . . . 0.0 109.632 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 16' ' ' PRO . . . . . 0.667 ' HD3' ' N ' ' E' ' 15' ' ' ILE . 1.6 Cg_endo -66.77 154.48 74.36 Favored 'Trans proline' 0 C--N 1.326 -0.629 0 C-N-CA 121.532 1.488 . . . . 0.0 109.81 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.99 -9.96 74.71 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.927 -1.606 . . . . 0.0 110.943 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 18' ' ' LEU . . . . . 0.487 HD12 ' CG2' ' E' ' 15' ' ' ILE . 75.5 mt -118.73 137.72 53.15 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.138 1.469 . . . . 0.0 109.387 -178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -86.12 112.88 21.71 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 12.5 mt -89.16 135.22 33.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -0.912 . . . . 0.0 110.62 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 21' ' ' TYR . . . . . 0.554 ' CE1' ' O ' ' E' ' 22' ' ' SER . 1.2 t80 -119.66 130.79 55.23 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 22' ' ' SER . . . . . 0.554 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 0.0 OUTLIER -71.68 131.46 43.2 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.977 -1.077 . . . . 0.0 111.071 -179.403 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.502 HD11 ' CB ' ' E' ' 72' ' ' LYS . 1.1 mp -118.41 12.92 13.46 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.03 179.49 15.97 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 tp -114.47 144.81 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.977 -0.719 . . . . 0.0 109.303 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.6 144.98 41.18 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 90.3 p -152.43 139.95 19.68 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.705 -1.247 . . . . 0.0 107.93 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 8.7 t -150.49 144.14 25.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.889 -1.132 . . . . 0.0 109.025 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 4.7 mm -106.42 128.46 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.251 -0.906 . . . . 0.0 108.879 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 29.0 t -175.06 177.9 1.86 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -0.802 . . . . 0.0 109.007 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 31' ' ' ASP . . . . . 0.403 ' O ' ' CB ' ' E' ' 32' ' ' ASN . 46.6 t0 -116.43 161.14 19.54 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.486 -0.759 . . . . 0.0 109.235 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 32' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 7.0 m-20 75.96 123.56 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 52.6 t -67.5 -33.33 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.396 -0.815 . . . . 0.0 109.415 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -58.55 -43.05 89.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 110.153 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -75.6 -37.93 59.45 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.112 -0.993 . . . . 0.0 109.466 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.71 -49.42 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 109.451 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 44.7 t -63.83 -49.64 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.031 -1.043 . . . . 0.0 109.653 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.79 -37.37 73.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.832 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -65.56 -41.49 92.89 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -0.958 . . . . 0.0 109.792 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 40' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' E' ' 40' ' ' LEU . 30.9 mt -68.2 -45.96 71.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.085 -1.01 . . . . 0.0 109.106 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -48.62 -50.71 31.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.786 -1.196 . . . . 0.0 109.363 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 42' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' E' ' 46' ' ' ALA . 31.7 ttpt -61.04 -36.47 79.64 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.464 -0.773 . . . . 0.0 110.209 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -76.57 -35.08 58.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.952 . . . . 0.0 109.77 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 9.1 t -70.44 -51.82 34.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.07 -1.019 . . . . 0.0 108.846 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 -30.72 67.33 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.046 -1.462 . . . . 0.0 109.275 -175.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' E' ' 42' ' ' LYS . . . -61.48 -34.9 76.26 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.449 -0.782 . . . . 0.0 109.713 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.42 -5.45 58.84 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.064 -1.023 . . . . 0.0 109.889 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 106.49 -1.19 36.99 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.04 156.95 52.69 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 6.4 ptm -120.53 -2.46 9.97 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.392 -1.063 . . . . 0.0 110.29 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.65 156.01 19.88 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.06 -1.543 . . . . 0.0 109.686 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 5.3 tp -106.26 136.28 46.25 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.722 -0.869 . . . . 0.0 109.28 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 53' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 1.2 pt -108.83 144.38 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.45 -0.781 . . . . 0.0 110.012 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.493 ' HA ' HH12 ' E' ' 56' ' ' ARG . . . 64.12 82.55 0.18 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.114 -0.991 . . . . 0.0 110.794 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 55' ' ' PHE . . . . . 0.486 ' O ' ' CG ' ' E' ' 55' ' ' PHE . 72.6 t80 -113.75 19.04 17.03 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.192 0.52 . . . . 0.0 109.683 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 56' ' ' ARG . . . . . 0.755 HH11 ' HG3' ' E' ' 56' ' ' ARG . 15.8 mtm-85 -59.68 111.86 1.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.16 -0.962 . . . . 0.0 109.645 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 64.6 mt . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.284 179.874 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 38.1 p90 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.567 0.699 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.3 172.33 25.3 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.327 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 54.8 m -99.17 134.62 41.75 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.348 -1.089 . . . . 0.0 108.196 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 66.9 mt -78.31 146.07 8.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.8 m -130.34 152.11 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.96 -1.088 . . . . 0.0 109.905 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 72' ' ' LYS . . . . . 0.502 ' CB ' HD11 ' E' ' 23' ' ' LEU . 24.4 ttpp -144.9 141.16 28.83 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.76 138.86 36.25 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--N 1.312 -1.063 0 O-C-N 120.451 -1.406 . . . . 0.0 108.969 178.087 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.2 t80 . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.0 mt -132.9 124.76 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.284 -0.885 . . . . 0.0 109.723 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.465 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 7.4 tt -119.3 118.99 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 t -117.35 133.39 56.04 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.388 -0.82 . . . . 0.0 108.868 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.456 ' OG1' ' OG1' ' B' ' 69' ' ' THR . 3.2 m -107.96 70.03 0.75 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.426 -0.796 . . . . 0.0 111.863 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.414 ' H ' ' H ' ' A' ' 13' ' ' ASP . . . -162.98 -9.92 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 O-C-N 120.197 -1.564 . . . . 0.0 108.328 -175.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.6 OUTLIER 64.25 57.54 1.21 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.711 -0.618 . . . . 0.0 110.331 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -178.85 137.81 0.15 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.576 -0.703 . . . . 0.0 109.889 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.768 HG23 ' O ' ' A' ' 15' ' ' ILE . 9.5 tt -163.78 58.65 0.71 Allowed Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.217 -0.927 . . . . 0.0 108.857 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HD3' ' N ' ' A' ' 15' ' ' ILE . 3.2 Cg_exo -59.21 158.24 26.96 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 121.971 1.781 . . . . 0.0 110.562 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.33 -3.91 66.67 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.671 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.737 ' HB3' HD21 ' A' ' 20' ' ' LEU . 25.2 mt -128.33 136.95 51.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.817 -1.402 . . . . 0.0 109.344 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -87.84 108.62 19.24 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.737 HD21 ' HB3' ' A' ' 18' ' ' LEU . 1.9 mt -120.8 129.98 53.8 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.105 0.478 . . . . 0.0 110.544 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -104.88 141.9 35.71 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.634 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 24' ' ' GLY . 28.8 t -78.74 88.06 4.62 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.03 11.01 0.61 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.591 -0.693 . . . . 0.0 110.499 -177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 22' ' ' SER . . . 125.17 -175.89 17.24 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.421 HD11 HG23 ' E' ' 9' ' ' ILE . 47.0 mm -110.05 141.67 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.364 0.602 . . . . 0.0 109.381 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -109.88 151.89 26.48 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 122.025 0.917 . . . . 0.0 109.628 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.3 m -139.97 143.65 36.63 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.69 147.49 43.76 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.999 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.437 ' O ' ' OG ' ' A' ' 30' ' ' SER . 4.2 tp -127.5 132.98 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 120.935 1.698 . . . . 0.0 106.66 176.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 29' ' ' ILE . 2.0 m 173.29 -161.5 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.907 -1.121 . . . . 0.0 108.991 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -117.67 -75.31 0.58 Allowed 'General case' 0 N--CA 1.512 2.641 0 O-C-N 121.301 -0.874 . . . . 0.0 112.449 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -65.57 149.18 50.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.772 -1.205 . . . . 0.0 108.128 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.46 ' H ' HG13 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -70.45 -40.3 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -52.39 -28.49 19.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.349 -0.845 . . . . 0.0 109.791 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -79.51 -33.13 42.35 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.187 -0.945 . . . . 0.0 109.368 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 33' ' ' VAL . 41.6 mt -60.66 -53.01 54.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.311 -0.868 . . . . 0.0 109.234 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.5 t -54.9 -50.37 62.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.084 -1.01 . . . . 0.0 109.105 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -60.18 -40.07 88.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 110.149 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -65.4 -41.91 93.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.073 -1.017 . . . . 0.0 109.514 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 40' ' ' LEU . 13.3 mt -62.43 -41.38 98.66 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.054 -1.029 . . . . 0.0 109.146 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.542 ' CG ' HH11 ' A' ' 41' ' ' ARG . 0.0 OUTLIER -49.91 -51.3 41.83 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.504 -1.373 . . . . 0.0 109.296 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -61.67 -37.48 84.23 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.774 -1.204 . . . . 0.0 110.68 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -77.1 -36.02 55.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.306 -0.871 . . . . 0.0 110.089 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 t -70.81 -50.56 42.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.425 -0.797 . . . . 0.0 108.965 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -67.74 -29.04 68.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.393 -1.442 . . . . 0.0 109.271 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.71 -31.21 71.0 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.524 0.678 . . . . 0.0 109.385 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -89.27 -5.62 57.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.443 -0.785 . . . . 0.0 109.466 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.09 7.67 63.85 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.77 157.62 41.93 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.35 -1.58 5.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.243 -1.151 . . . . 0.0 110.349 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.61 153.02 23.04 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.318 -1.42 . . . . 0.0 109.72 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.7 tp -116.99 139.75 50.29 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.656 -0.908 . . . . 0.0 109.793 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.482 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 22.4 mt -113.13 139.23 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.742 -0.599 . . . . 0.0 110.053 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 67.75 84.38 0.15 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.292 -0.88 . . . . 0.0 110.884 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -122.11 69.94 0.96 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.249 0.547 . . . . 0.0 110.431 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.425 HH22 ' NE ' ' E' ' 56' ' ' ARG . 14.6 ptt180 -98.13 122.68 41.57 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.269 -0.894 . . . . 0.0 109.178 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.5 mt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.341 -0.849 . . . . 0.0 109.449 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.5 p90 . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.982 0.896 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.18 -178.02 48.02 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.4 m -118.89 137.69 53.27 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.5 mt -89.31 130.59 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.676 ' HB ' ' HB3' ' A' ' 20' ' ' LEU . 14.0 m -144.27 151.62 15.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 119.352 -0.939 . . . . 0.0 109.189 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.7 pttt -145.48 151.13 37.7 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.1 -1.0 . . . . 0.0 109.167 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.02 150.58 39.71 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.493 ' N ' ' OH ' ' A' ' 21' ' ' TYR . 14.2 p-10 . . . . . 0 N--CA 1.498 1.946 0 O-C-N 121.094 -1.004 . . . . 0.0 108.622 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 86.3 t80 . . . . . 0 N--CA 1.499 2.003 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 64.5 mt -112.5 128.02 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.591 -0.693 . . . . 0.0 110.079 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.624 ' O ' HG23 ' B' ' 9' ' ' ILE . 5.7 tt -124.74 113.34 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.3 t -123.52 161.13 25.51 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.907 0.861 . . . . 0.0 109.181 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.572 ' O ' ' C ' ' B' ' 12' ' ' ALA . 12.3 p -99.89 -109.88 0.2 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.173 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.572 ' C ' ' O ' ' B' ' 11' ' ' THR . . . 16.6 -115.03 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 118.486 0.584 . . . . 0.0 111.715 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -111.38 -140.1 0.38 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.623 -0.673 . . . . 0.0 109.312 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -93.93 -157.3 0.54 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.279 -0.888 . . . . 0.0 109.973 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 mt -113.54 98.47 46.98 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.486 -0.759 . . . . 0.0 109.356 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.74 156.83 40.69 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 C-N-CA 121.694 1.596 . . . . 0.0 110.144 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.84 -4.5 75.44 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' B' ' 18' ' ' LEU . 34.3 mt -131.45 141.35 49.79 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.175 -1.191 . . . . 0.0 109.996 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -85.05 107.65 17.26 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 12.9 mt -103.16 137.27 41.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.612 -0.68 . . . . 0.0 109.831 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' TYR . . . . . 0.53 ' CE1' ' O ' ' B' ' 22' ' ' SER . 1.3 t80 -118.62 130.31 55.8 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.53 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 32.6 t -66.27 134.07 51.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 0.0 111.341 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 8.0 mt -121.07 10.31 10.72 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.6 175.0 15.78 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ILE . . . . . 0.451 HD11 ' OG1' ' A' ' 11' ' ' THR . 0.1 OUTLIER -113.32 146.6 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.47 159.72 21.64 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 48.8 m -153.04 147.43 25.88 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.712 ' OG1' HG23 ' B' ' 36' ' ' ILE . 5.2 p -149.64 148.27 29.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 109.533 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.465 ' O ' ' OG ' ' B' ' 30' ' ' SER . 1.3 tp -126.5 127.51 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' B' ' 29' ' ' ILE . 2.8 m -168.27 171.29 9.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.168 -0.958 . . . . 0.0 109.751 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -80.41 -61.05 2.09 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.422 -0.799 . . . . 0.0 112.124 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -74.57 128.26 35.12 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.555 -1.341 . . . . 0.0 108.501 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.404 ' H ' HG13 ' B' ' 33' ' ' VAL . 2.1 m -69.33 -33.65 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.613 -0.68 . . . . 0.0 109.182 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -59.57 -29.71 68.14 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.475 -0.765 . . . . 0.0 110.103 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -70.88 -35.93 72.57 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.507 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.712 HG23 ' OG1' ' B' ' 28' ' ' THR . 77.3 mt -61.45 -47.28 94.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.114 -0.991 . . . . 0.0 109.397 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 68.9 t -54.98 -50.6 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.919 -1.113 . . . . 0.0 109.285 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -59.91 -40.63 89.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.393 -0.817 . . . . 0.0 109.585 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -64.65 -41.9 95.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.164 -0.96 . . . . 0.0 109.369 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 73.0 mt -65.75 -44.07 87.02 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 109.027 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -48.79 -46.66 41.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.49 -1.381 . . . . 0.0 109.383 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -65.27 -37.38 87.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.627 -0.671 . . . . 0.0 110.207 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -77.04 -35.03 57.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 109.912 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.64 -51.57 44.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.286 -0.884 . . . . 0.0 108.834 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.07 -30.54 66.71 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 118.108 -1.437 . . . . 0.0 109.216 -175.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.0 -32.14 72.58 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -91.61 -5.49 53.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.728 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.61 3.63 46.58 Favored Glycine 0 N--CA 1.502 3.094 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.78 159.41 47.78 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -126.71 -2.06 6.68 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.352 -1.087 . . . . 0.0 110.471 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -165.42 158.09 30.81 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.324 -1.417 . . . . 0.0 109.612 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 6.1 tp -114.99 137.24 52.23 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.668 -0.901 . . . . 0.0 109.744 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.514 ' O ' ' HB3' ' B' ' 54' ' ' ALA . 68.1 mt -114.35 145.63 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.674 -0.641 . . . . 0.0 110.239 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 69.61 88.9 0.11 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.045 -1.034 . . . . 0.0 111.199 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -142.56 69.48 1.31 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.23 0.538 . . . . 0.0 110.171 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -108.35 146.16 33.41 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mm . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.585 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.798 HD22 ' N ' ' B' ' 65' ' ' LEU . 2.0 mm? . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.12 71.12 0.54 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' TYR . . . . . 0.45 ' O ' ' CD2' ' B' ' 67' ' ' TYR . 49.6 p90 -73.38 126.12 29.42 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.267 -1.137 . . . . 0.0 109.494 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.95 156.44 26.68 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' THR . . . . . 0.456 ' OG1' ' OG1' ' A' ' 11' ' ' THR . 48.4 m -103.04 134.89 45.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.861 -1.376 . . . . 0.0 108.523 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 66.1 mt -89.98 134.59 28.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.8 m -141.66 163.12 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 110.48 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -153.78 148.98 26.96 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.36 150.75 30.64 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.129 -0.982 . . . . 0.0 108.494 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' B' ' 74' ' ' ASP . 26.7 p-10 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 120.93 -1.106 . . . . 0.0 108.914 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 6' ' ' LYS . . . . . 0.547 ' O ' ' O ' ' C' ' 50' ' ' MET . 44.8 mtmt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -104.85 121.53 43.87 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 76.1 mt -134.57 126.66 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.284 -0.885 . . . . 0.0 109.607 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 9' ' ' ILE . . . . . 0.58 ' O ' HG23 ' C' ' 9' ' ' ILE . 14.8 tt -122.06 115.5 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.76 156.88 42.84 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 122.139 0.971 . . . . 0.0 108.849 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -116.24 94.04 4.48 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.53 -108.73 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.799 177.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -148.26 -50.93 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 109.592 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 14' ' ' GLU . . . . . 0.411 ' HG3' ' H ' ' C' ' 15' ' ' ILE . 3.3 tp10 -154.78 176.8 12.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.168 -0.958 . . . . 0.0 109.294 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 15' ' ' ILE . . . . . 0.411 ' H ' ' HG3' ' C' ' 14' ' ' GLU . 29.3 mt -124.04 87.74 53.04 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -60.63 156.0 44.89 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.876 1.717 . . . . 0.0 110.238 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.28 -8.81 77.19 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 31.7 mt -132.23 142.79 49.54 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.373 -1.075 . . . . 0.0 109.496 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -86.19 108.66 18.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 14.8 mt -96.71 137.33 35.96 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 109.964 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 21' ' ' TYR . . . . . 0.404 ' N ' ' O ' ' C' ' 72' ' ' LYS . 18.1 t80 -123.5 129.04 50.64 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.1 t -87.56 131.79 34.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.342 -0.849 . . . . 0.0 109.608 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.942 ' N ' HD23 ' C' ' 23' ' ' LEU . 0.2 OUTLIER -123.28 11.53 9.39 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.61 168.49 11.85 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.266 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -106.7 146.18 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.99 144.83 42.45 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 75.2 m -152.68 138.66 18.14 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 12.1 t -149.77 141.06 23.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.843 -1.161 . . . . 0.0 108.644 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.491 HG23 ' O ' ' C' ' 29' ' ' ILE . 15.3 tt -115.31 129.82 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' C' ' 29' ' ' ILE . 6.4 m -169.72 -141.36 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.043 -1.036 . . . . 0.0 109.796 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -157.55 161.73 38.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.248 -0.908 . . . . 0.0 108.972 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 73.81 127.34 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -67.57 -33.68 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.51 -0.744 . . . . 0.0 109.363 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -59.01 -46.69 87.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.358 -0.839 . . . . 0.0 110.176 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -76.03 -40.27 53.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.203 -0.936 . . . . 0.0 109.78 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 71.5 mt -60.29 -39.42 80.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.881 -1.137 . . . . 0.0 109.297 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -69.3 -47.03 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.776 -1.202 . . . . 0.0 109.534 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -60.24 -41.42 93.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.935 . . . . 0.0 109.843 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -58.81 -48.32 81.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 109.941 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 28.4 mt -70.32 -47.59 60.41 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.047 -1.033 . . . . 0.0 109.111 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 41' ' ' ARG . . . . . 0.425 HH21 ' NZ ' ' C' ' 45' ' ' LYS . 39.9 mtp180 -49.44 -48.0 47.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.535 -1.353 . . . . 0.0 109.016 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 42' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' C' ' 46' ' ' ALA . 46.1 mtpt -63.8 -37.65 88.17 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 109.831 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 43' ' ' GLN . . . . . 0.426 ' O ' ' NE2' ' C' ' 43' ' ' GLN . 0.0 OUTLIER -75.98 -35.66 59.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 109.912 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 20.2 t -76.63 -51.75 18.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 109.067 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' LYS . . . . . 0.425 ' NZ ' HH21 ' C' ' 41' ' ' ARG . 18.2 mtmt -69.43 -29.94 67.76 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.858 -1.537 . . . . 0.0 109.461 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' C' ' 42' ' ' LYS . . . -64.07 -33.38 75.63 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 47' ' ' LYS . . . . . 0.543 ' HD2' HD12 ' C' ' 23' ' ' LEU . 0.0 OUTLIER -90.63 2.69 55.64 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.245 -0.91 . . . . 0.0 108.699 179.325 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.42 29.65 65.75 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.053 -1.546 . . . . 0.0 109.962 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.37 -168.74 24.33 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.057 -1.261 . . . . 0.0 110.053 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 50' ' ' MET . . . . . 0.547 ' O ' ' O ' ' C' ' 6' ' ' LYS . 14.6 ttt -108.42 -41.75 4.76 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.567 -0.961 . . . . 0.0 109.692 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 173.96 -153.9 18.19 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 tp -136.01 137.45 41.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.413 -1.051 . . . . 0.0 109.985 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 53' ' ' ILE . . . . . 0.446 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 49.0 mt -110.52 141.12 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.571 -0.706 . . . . 0.0 109.741 -178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 64.65 75.18 0.38 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.204 -0.935 . . . . 0.0 108.66 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -93.99 140.31 29.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 109.075 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 56' ' ' ARG . . . . . 0.73 HH11 ' HG2' ' C' ' 56' ' ' ARG . 0.0 OUTLIER -134.57 174.66 10.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.584 -0.698 . . . . 0.0 109.284 179.688 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 39.8 mt . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 3.7 t80 . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.879 0.847 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 174.35 157.6 16.3 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 21.1 m -98.37 144.26 27.94 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.357 -1.084 . . . . 0.0 109.59 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 56.1 mt -91.19 132.06 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.09 163.14 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.44 0.638 . . . . 0.0 109.854 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 72' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' C' ' 21' ' ' TYR . 16.2 ttmm -153.65 141.05 19.7 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.0 150.0 36.52 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.737 -1.227 . . . . 0.0 108.152 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--N 1.301 -1.501 0 O-C-N 120.982 -1.074 . . . . 0.0 109.029 179.754 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 72.1 tttt . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.614 0.721 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -94.59 124.52 38.67 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.717 -0.615 . . . . 0.0 109.462 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 20.0 mt -115.94 137.71 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.556 -0.715 . . . . 0.0 109.963 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 9' ' ' ILE . . . . . 0.431 ' O ' ' CG2' ' D' ' 9' ' ' ILE . 9.4 tt -119.49 124.28 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.99 130.81 56.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.511 -0.743 . . . . 0.0 109.556 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 11' ' ' THR . . . . . 0.403 ' O ' ' HB3' ' D' ' 12' ' ' ALA . 3.1 m -129.79 120.86 25.72 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 12' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' D' ' 11' ' ' THR . . . 60.05 12.04 2.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.248 -0.907 . . . . 0.0 109.697 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -126.23 108.38 11.24 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.482 0.658 . . . . 0.0 109.36 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 14' ' ' GLU . . . . . 0.446 ' HG3' ' H ' ' D' ' 15' ' ' ILE . 8.2 tp10 -62.33 169.42 2.88 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.269 -0.895 . . . . 0.0 108.655 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 15' ' ' ILE . . . . . 0.746 ' O ' HG23 ' D' ' 15' ' ' ILE . 13.1 tt -134.55 60.91 45.73 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.271 -0.893 . . . . 0.0 109.509 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' D' ' 15' ' ' ILE . 2.0 Cg_endo -61.14 157.58 38.93 Favored 'Trans proline' 0 C--N 1.323 -0.787 0 C-N-CA 122.242 1.961 . . . . 0.0 110.171 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.68 -2.77 67.44 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.671 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 18' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' D' ' 18' ' ' LEU . 19.1 mt -128.43 138.47 52.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.813 -1.404 . . . . 0.0 109.803 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -85.12 108.69 17.8 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt -97.95 139.36 33.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.356 -0.84 . . . . 0.0 110.516 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 21' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -119.85 129.13 54.26 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 10.3 t -71.62 131.25 42.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.48 -1.388 . . . . 0.0 111.105 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' D' ' 72' ' ' LYS . 32.1 mt -115.94 5.86 14.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.38 -176.18 16.01 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.54 143.05 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.9 -0.765 . . . . 0.0 109.158 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.19 162.6 16.83 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.861 0.838 . . . . 0.0 110.34 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -152.21 149.57 28.88 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -151.41 153.24 34.31 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.143 0.973 . . . . 0.0 109.475 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 tt -123.08 145.83 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.029 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 2.1 m 169.92 155.07 0.05 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.392 -0.817 . . . . 0.0 109.547 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 31' ' ' ASP . . . . . 0.496 ' O ' ' ND2' ' D' ' 32' ' ' ASN . 1.8 p30 -100.09 63.78 1.18 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.303 -0.873 . . . . 0.0 109.627 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' D' ' 31' ' ' ASP . 0.2 OUTLIER 176.84 132.76 0.05 Allowed 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.86 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 33' ' ' VAL . . . . . 0.429 ' H ' HG13 ' D' ' 33' ' ' VAL . 2.0 m -69.81 -40.89 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -63.31 -32.67 74.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.488 -0.757 . . . . 0.0 109.915 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -74.1 -39.34 63.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.246 -0.909 . . . . 0.0 109.109 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 mt -60.34 -48.99 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.35 -0.844 . . . . 0.0 108.963 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 63.0 t -57.48 -45.41 85.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.717 0 O-C-N 121.13 -0.981 . . . . 0.0 108.518 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -63.84 -43.1 97.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.186 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -57.95 -47.74 82.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.132 -0.98 . . . . 0.0 109.548 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 26.6 mt -63.95 -41.58 97.56 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 109.259 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -51.51 -39.84 58.44 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.443 -1.41 . . . . 0.0 109.815 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -72.95 -40.62 65.21 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.388 -0.82 . . . . 0.0 110.238 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -76.32 -36.15 58.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.389 -0.82 . . . . 0.0 109.704 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.97 -49.82 64.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.453 -0.78 . . . . 0.0 108.927 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -70.47 -31.22 68.27 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.087 -1.445 . . . . 0.0 108.989 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.06 -33.71 76.37 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -87.17 0.62 55.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.472 -0.768 . . . . 0.0 109.393 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.0 2.49 74.68 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.3 158.58 49.4 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.95 -1.3 5.92 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.261 -1.141 . . . . 0.0 110.196 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.04 168.29 40.69 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 52' ' ' LEU . . . . . 0.413 HD21 ' HA3' ' D' ' 68' ' ' GLY . 2.7 tp -131.7 137.98 48.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.601 -0.941 . . . . 0.0 109.291 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 53' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' D' ' 54' ' ' ALA . 1.9 pt -106.72 144.24 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.515 -0.74 . . . . 0.0 109.538 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 65.77 76.36 0.32 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 0.0 109.815 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 55' ' ' PHE . . . . . 0.539 ' CG ' ' O ' ' D' ' 55' ' ' PHE . 62.6 t80 -106.36 34.44 3.38 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 56' ' ' ARG . . . . . 0.573 ' NH1' HH22 ' E' ' 56' ' ' ARG . 25.5 mtm180 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 120.989 -1.069 . . . . 0.0 109.42 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 67' ' ' TYR . . . . . 0.488 ' O ' ' CD2' ' D' ' 67' ' ' TYR . 16.4 p90 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.348 0.594 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 68' ' ' GLY . . . . . 0.413 ' HA3' HD21 ' D' ' 52' ' ' LEU . . . -127.35 166.51 20.06 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 54.7 m -110.71 138.08 47.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.109 -1.23 . . . . 0.0 108.482 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 70' ' ' ILE . . . . . 0.491 HG22 HD12 ' D' ' 23' ' ' LEU . 41.0 mt -84.32 150.3 4.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.24 158.96 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.138 -0.976 . . . . 0.0 109.993 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 72' ' ' LYS . . . . . 0.674 ' HB2' HD11 ' D' ' 23' ' ' LEU . 5.2 ttpt -144.44 154.32 42.83 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.68 151.86 42.66 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.019 -1.051 . . . . 0.0 108.527 179.388 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -93.99 118.71 31.88 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.056 -1.027 . . . . 0.0 109.328 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 71.7 mt -111.65 129.18 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.588 -0.695 . . . . 0.0 110.113 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 9' ' ' ILE . . . . . 0.623 ' O ' HG23 ' E' ' 9' ' ' ILE . 17.4 tt -130.08 113.36 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 3.7 t -122.88 161.68 23.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.264 -0.897 . . . . 0.0 108.784 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 11' ' ' THR . . . . . . . . . . . . . 3.1 p -113.07 85.71 2.23 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.68 -124.12 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.351 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 13' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' E' ' 14' ' ' GLU . 1.0 OUTLIER -162.34 92.68 0.83 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.431 -0.793 . . . . 0.0 109.031 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 14' ' ' GLU . . . . . 0.541 ' H ' HG21 ' E' ' 53' ' ' ILE . 12.1 tt0 75.46 150.35 0.11 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.875 -0.515 . . . . 0.0 110.069 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.38 97.13 50.43 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -60.09 154.9 48.22 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.608 1.539 . . . . 0.0 110.507 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.33 -5.78 77.97 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 18' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' E' ' 18' ' ' LEU . 17.1 mt -130.99 140.88 50.19 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.267 -1.137 . . . . 0.0 110.058 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 19' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' E' ' 73' ' ' ALA . 3.2 mp0 -83.64 109.48 17.48 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 18.0 mt -97.92 135.84 39.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.077 -1.014 . . . . 0.0 110.464 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 21' ' ' TYR . . . . . 0.434 ' H ' ' H ' ' E' ' 72' ' ' LYS . 1.2 t80 -119.85 129.41 54.39 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 22' ' ' SER . . . . . 0.425 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 16.4 t -61.65 127.41 31.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.628 -1.295 . . . . 0.0 111.587 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' E' ' 23' ' ' LEU . 7.5 mt -114.61 9.36 16.54 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.74 -177.62 16.86 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 50.3 mm -113.13 140.93 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.659 -0.907 . . . . 0.0 109.325 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.92 146.02 43.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.663 -0.648 . . . . 0.0 109.395 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 68.1 m -152.2 140.19 20.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.9 -1.125 . . . . 0.0 108.137 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.23 150.96 33.44 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.079 -1.013 . . . . 0.0 108.747 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 mm -120.03 135.05 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.4 -0.813 . . . . 0.0 109.487 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.87 159.93 18.85 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.517 -0.739 . . . . 0.0 109.896 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 31' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -83.18 -60.63 2.09 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.521 -0.737 . . . . 0.0 112.707 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -79.7 147.87 31.78 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.662 -1.274 . . . . 0.0 108.306 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 94.7 t -68.31 -34.59 66.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.696 -0.627 . . . . 0.0 109.626 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.11 -35.21 59.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.306 -0.871 . . . . 0.0 110.073 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -78.57 -33.63 47.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.057 -1.027 . . . . 0.0 109.188 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.08 -52.9 53.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 120.866 -1.146 . . . . 0.0 109.603 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.88 -50.52 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.084 -1.01 . . . . 0.0 110.145 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -57.21 -37.52 72.35 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.24 -0.913 . . . . 0.0 109.102 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -69.16 -40.48 78.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.937 -1.102 . . . . 0.0 110.137 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 39.3 mt -72.05 -49.62 35.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.882 -1.137 . . . . 0.0 109.196 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -48.1 -48.88 33.48 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.664 -1.272 . . . . 0.0 109.169 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -57.93 -32.9 68.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.317 -0.864 . . . . 0.0 109.32 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -73.38 -35.25 65.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.166 -0.959 . . . . 0.0 109.435 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.11 -51.34 20.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 120.56 -1.337 . . . . 0.0 109.083 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.35 -30.96 8.43 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.48 1.133 . . . . 0.0 109.699 -176.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.6 -25.11 49.62 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.59 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -95.65 13.53 26.01 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.07 29.87 29.43 Favored Glycine 0 N--CA 1.486 1.971 0 C-N-CA 118.032 -2.032 . . . . 0.0 109.877 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.37 -164.42 6.13 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -114.59 -35.68 4.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.59 -0.947 . . . . 0.0 110.011 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 172.33 -169.97 43.05 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 tp -118.54 140.86 49.22 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.404 -1.057 . . . . 0.0 110.173 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 53' ' ' ILE . . . . . 0.541 HG21 ' H ' ' E' ' 14' ' ' GLU . 64.5 mt -113.13 143.02 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.587 -0.696 . . . . 0.0 110.803 -178.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . 62.39 75.7 0.39 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 110.176 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -97.53 85.62 3.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.497 -0.752 . . . . 0.0 109.287 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 56' ' ' ARG . . . . . 0.573 HH22 ' NH1' ' D' ' 56' ' ' ARG . 28.6 ttm180 -84.44 160.44 20.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.405 -0.809 . . . . 0.0 109.621 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 76.6 mt . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.415 -0.803 . . . . 0.0 108.905 179.645 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 33.2 p90 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.66 0.743 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . 162.04 170.18 26.44 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 1.9 m -98.34 136.26 38.75 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 49.9 mt -81.69 143.31 12.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 71' ' ' VAL . . . . . 0.461 HG21 HD11 ' E' ' 53' ' ' ILE . 2.7 m -129.33 158.45 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.361 -0.837 . . . . 0.0 109.654 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 72' ' ' LYS . . . . . 0.434 ' H ' ' H ' ' E' ' 21' ' ' TYR . 16.1 tttm -139.47 156.66 46.8 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 73' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' E' ' 19' ' ' GLN . . . -117.31 113.88 22.78 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.016 0.912 . . . . 0.0 111.765 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 . . . . . 0 C--N 1.299 -1.609 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.132 -178.498 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.1 t80 . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.6 mt -114.64 138.15 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.548 -0.72 . . . . 0.0 109.62 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.611 ' O ' HG23 ' A' ' 9' ' ' ILE . 12.8 tt -134.97 115.16 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.518 -0.738 . . . . 0.0 109.326 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.8 t -122.16 157.96 30.4 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.28 113.33 22.83 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.47 80.3 0.19 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 122.119 0.961 . . . . 0.0 109.819 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 14' ' ' GLU . 19.2 t0 -152.98 -140.95 0.1 Allowed 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.718 -0.614 . . . . 0.0 109.413 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 4.0 tm-20 -167.7 -22.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.496 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.419 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 11.6 mt 52.88 64.51 7.12 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.338 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 15' ' ' ILE . 2.4 Cg_endo -62.14 154.81 60.15 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 122.018 1.812 . . . . 0.0 110.12 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.56 -10.07 75.6 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.454 ' HA ' HD23 ' A' ' 18' ' ' LEU . 35.5 mt -123.13 136.14 54.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.299 -1.118 . . . . 0.0 109.214 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -97.99 112.92 24.68 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.08 137.05 54.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.615 -0.678 . . . . 0.0 109.244 -178.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -108.22 153.22 23.51 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.433 ' HA ' HG12 ' A' ' 71' ' ' VAL . 32.1 t -74.33 132.77 42.35 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.753 0.787 . . . . 0.0 110.769 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 mt -119.85 17.62 12.61 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.654 0.74 . . . . 0.0 109.119 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.8 176.84 16.6 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.408 HD13 HG23 ' E' ' 9' ' ' ILE . 1.0 OUTLIER -114.62 144.48 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.397 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.78 144.71 45.08 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.88 141.55 21.81 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.87 -1.144 . . . . 0.0 107.926 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -150.21 151.66 33.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.963 -1.085 . . . . 0.0 109.072 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.7 mt -114.02 128.08 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.45 -0.781 . . . . 0.0 109.101 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.7 p -177.74 178.67 0.97 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.85 . . . . 0.0 108.93 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -118.46 168.1 10.97 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.519 -0.738 . . . . 0.0 109.03 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.1 m120 75.09 119.46 0.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.6 t -68.06 -34.59 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.439 -0.788 . . . . 0.0 109.159 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -59.26 -40.41 85.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.883 . . . . 0.0 110.231 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -75.89 -38.59 57.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.226 -0.921 . . . . 0.0 109.628 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.2 mt -62.2 -46.66 95.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.036 -1.04 . . . . 0.0 109.365 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.2 t -56.95 -48.73 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.947 -1.096 . . . . 0.0 108.913 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.22 -42.58 99.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.364 -0.835 . . . . 0.0 110.366 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -57.09 -49.02 77.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 109.497 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 40' ' ' LEU . 43.0 mt -68.64 -45.07 72.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.098 -1.001 . . . . 0.0 108.714 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -51.45 -48.31 62.8 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.888 -1.133 . . . . 0.0 109.88 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -63.69 -37.29 86.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.44 -0.787 . . . . 0.0 110.23 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -76.56 -35.54 58.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.388 -0.82 . . . . 0.0 109.835 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.3 t -68.09 -51.04 52.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.996 -1.065 . . . . 0.0 108.857 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -65.99 -32.75 74.41 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.15 -1.42 . . . . 0.0 109.555 -175.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.45 -28.47 69.7 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.9 -4.71 57.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.522 -0.736 . . . . 0.0 109.864 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.09 10.45 59.71 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.5 156.53 39.09 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.435 ' SD ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -123.08 -11.54 8.03 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.389 -1.066 . . . . 0.0 109.327 -178.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.435 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -154.55 162.29 30.63 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.3 tp -128.91 139.99 51.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.677 -0.896 . . . . 0.0 109.489 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.498 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 59.9 mt -113.3 144.41 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.568 -0.707 . . . . 0.0 109.684 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 67.48 72.85 0.33 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.263 -0.898 . . . . 0.0 110.081 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.508 ' CG ' ' O ' ' A' ' 55' ' ' PHE . 65.8 t80 -95.31 45.59 1.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 108.965 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.2 tpp180 -44.2 128.99 6.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.418 -0.801 . . . . 0.0 109.94 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mm . . . . . 0 C--N 1.303 -1.448 0 O-C-N 121.367 -0.833 . . . . 0.0 109.318 -179.89 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.415 ' CD2' HD12 ' E' ' 57' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 122.239 1.019 . . . . 0.0 109.695 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 178.57 171.32 41.72 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.631 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.704 ' OG1' ' OG1' ' E' ' 11' ' ' THR . 86.8 m -103.15 135.9 43.94 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.206 -1.173 . . . . 0.0 108.776 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.6 mt -85.06 121.67 37.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 22' ' ' SER . 16.7 m -139.23 157.44 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 O-C-N 121.302 -0.874 . . . . 0.0 109.817 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -149.51 153.61 37.47 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.096 -1.002 . . . . 0.0 109.449 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.57 150.99 30.58 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.174 -0.954 . . . . 0.0 108.931 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.585 ' N ' ' OH ' ' A' ' 21' ' ' TYR . 1.9 p-10 . . . . . 0 C--N 1.302 -1.489 0 O-C-N 121.151 -0.968 . . . . 0.0 109.291 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 t80 . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 90.8 mt -122.3 129.7 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.24 -0.913 . . . . 0.0 109.833 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.536 ' O ' HG23 ' B' ' 9' ' ' ILE . 16.6 tt -134.27 118.66 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t -125.54 152.91 44.41 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.097 -1.002 . . . . 0.0 108.557 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.624 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 1.0 OUTLIER -96.89 79.99 2.97 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.451 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' B' ' 11' ' ' THR . . . 148.76 -98.41 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 35.8 t70 178.1 56.02 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -96.27 81.84 3.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.075 -1.016 . . . . 0.0 109.994 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.621 ' N ' ' HD3' ' B' ' 16' ' ' PRO . 5.7 mt -144.08 52.78 2.01 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.455 -0.778 . . . . 0.0 109.213 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.621 ' HD3' ' N ' ' B' ' 15' ' ' ILE . 2.1 Cg_endo -62.73 151.98 80.82 Favored 'Trans proline' 0 C--N 1.322 -0.865 0 C-N-CA 121.883 1.722 . . . . 0.0 109.945 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.43 -9.08 78.17 Favored Glycine 0 N--CA 1.484 1.874 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.23 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' LEU . . . . . 0.426 HD12 ' CG2' ' B' ' 15' ' ' ILE . 71.2 mt -126.63 139.59 53.06 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 119.038 1.419 . . . . 0.0 108.879 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' B' ' 73' ' ' ALA . 23.0 mp0 -84.33 115.45 22.5 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.5 mt -89.67 138.69 31.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.802 -1.186 . . . . 0.0 110.174 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' TYR . . . . . 0.461 ' H ' ' H ' ' B' ' 72' ' ' LYS . 31.1 t80 -120.02 128.91 53.97 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.54 -0.725 . . . . 0.0 109.644 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 30.2 t -77.69 132.97 38.43 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 120.59 -1.319 . . . . 0.0 109.858 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.444 HD11 ' CB ' ' B' ' 72' ' ' LYS . 37.5 mt -116.99 9.54 13.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.576 -0.703 . . . . 0.0 109.112 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.49 -170.67 17.39 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 33.9 mm -112.4 141.58 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.984 -0.715 . . . . 0.0 109.263 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.43 144.02 42.59 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.52 -0.738 . . . . 0.0 109.591 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 70.0 m -152.24 138.99 18.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 108.786 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 11.9 t -149.65 141.21 23.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.993 -1.067 . . . . 0.0 109.333 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.63 HD12 ' N ' ' B' ' 29' ' ' ILE . 4.4 mp -111.74 125.57 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.164 -0.96 . . . . 0.0 109.244 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 45.5 p -173.74 -145.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.685 -0.634 . . . . 0.0 109.723 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 11.3 m-20 -157.68 164.89 36.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.289 -0.882 . . . . 0.0 109.137 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 21.4 t30 75.75 132.0 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 108.823 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 44.8 t -65.06 -32.1 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.66 -0.65 . . . . 0.0 109.493 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -58.72 -46.61 86.97 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.281 -0.887 . . . . 0.0 110.126 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.46 -41.11 61.35 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.352 -0.842 . . . . 0.0 109.756 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.64 -44.76 99.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 120.887 -1.133 . . . . 0.0 109.333 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 33.1 t -68.8 -47.11 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.856 -1.152 . . . . 0.0 109.574 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.99 -43.17 99.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.132 -0.98 . . . . 0.0 110.009 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -58.33 -48.71 79.68 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.32 -0.862 . . . . 0.0 109.67 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 52.4 mt -70.13 -47.88 59.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.083 -1.011 . . . . 0.0 108.662 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -49.79 -52.62 30.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.882 -1.136 . . . . 0.0 109.523 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -59.35 -35.69 74.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.315 -0.866 . . . . 0.0 110.084 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -75.53 -35.85 60.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.743 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 24.2 t -71.39 -50.93 37.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.11 -0.994 . . . . 0.0 109.104 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -70.35 -36.79 74.42 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.104 -1.438 . . . . 0.0 109.401 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.7 -34.19 69.19 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -85.09 3.72 37.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.25 -0.906 . . . . 0.0 109.053 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.95 7.94 84.84 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.86 -158.48 1.09 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' MET . . . . . 0.442 ' SD ' ' C ' ' B' ' 50' ' ' MET . 0.0 OUTLIER -170.47 -26.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.177 -1.19 . . . . 0.0 110.164 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -136.77 159.14 24.45 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 5.4 tp -138.39 143.08 39.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.414 -1.05 . . . . 0.0 109.39 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.561 ' O ' ' HB3' ' B' ' 54' ' ' ALA . 0.6 OUTLIER -106.79 150.24 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.493 -0.754 . . . . 0.0 108.979 -179.175 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 75.82 177.5 0.2 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.62 ' CG ' ' O ' ' B' ' 55' ' ' PHE . 36.5 t80 170.98 11.79 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 121.646 2.021 . . . . 0.0 106.143 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' ARG . . . . . 0.696 ' CG ' HH11 ' B' ' 56' ' ' ARG . 0.0 OUTLIER -44.08 122.46 2.91 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.392 -1.442 . . . . 0.0 109.854 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 pt . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.561 -0.712 . . . . 0.0 109.421 -179.869 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.557 HD23 ' N ' ' B' ' 65' ' ' LEU . 1.5 pt? . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 122.543 1.164 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.98 158.82 18.3 Favored Glycine 0 N--CA 1.505 3.294 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -161.14 174.87 13.04 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.16 -1.2 . . . . 0.0 109.691 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.72 -165.25 32.44 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 55.1 m -126.47 137.77 53.43 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 61.2 mt -85.27 133.31 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 4.4 m -126.42 154.98 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.52 -0.737 . . . . 0.0 109.21 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.461 ' H ' ' H ' ' B' ' 21' ' ' TYR . 5.5 tttt -146.46 137.99 24.58 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' B' ' 19' ' ' GLN . . . -109.41 151.46 26.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.156 -0.965 . . . . 0.0 109.228 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' B' ' 74' ' ' ASP . 35.6 p-10 . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 60.7 mttm . . . . . 0 N--CA 1.5 2.036 0 CA-C-O 121.303 0.573 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -93.29 124.98 37.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.309 -0.869 . . . . 0.0 109.214 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 13.2 mt -121.13 147.9 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.461 -0.775 . . . . 0.0 110.655 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 9' ' ' ILE . . . . . 0.633 ' O ' HG23 ' C' ' 9' ' ' ILE . 11.1 tt -137.08 114.42 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.093 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 9.9 t -122.24 158.71 28.88 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.004 0.907 . . . . 0.0 108.848 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 11' ' ' THR . . . . . 0.429 HG23 ' OG1' ' D' ' 69' ' ' THR . 1.4 p -85.21 -115.44 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.11 101.36 10.92 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.099 -1.0 . . . . 0.0 109.019 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -167.06 -18.55 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.524 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 59.5 163.2 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.599 -0.688 . . . . 0.0 109.22 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 66.5 mt -125.73 85.09 59.59 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.525 -0.735 . . . . 0.0 109.223 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.44 156.83 39.17 Favored 'Trans proline' 0 C--N 1.324 -0.736 0 C-N-CA 122.024 1.816 . . . . 0.0 110.168 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.05 -6.69 76.36 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 61.6 mt -128.7 137.82 51.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -1.209 . . . . 0.0 108.786 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -87.37 108.35 18.95 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 10.5 mt -93.91 138.45 32.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.4 -0.812 . . . . 0.0 109.652 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 21' ' ' TYR . . . . . 0.416 ' CZ ' ' O ' ' C' ' 22' ' ' SER . 3.0 t80 -123.2 131.82 53.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.502 -0.749 . . . . 0.0 109.252 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 22' ' ' SER . . . . . 0.416 ' O ' ' CZ ' ' C' ' 21' ' ' TYR . 0.0 OUTLIER -53.85 128.74 31.15 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.114 -0.991 . . . . 0.0 111.169 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mt -120.14 11.73 11.7 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.899 0.856 . . . . 0.0 109.308 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.5 -169.05 13.23 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 25' ' ' ILE . . . . . 0.427 HD11 HG23 ' B' ' 9' ' ' ILE . 40.5 mm -122.73 139.09 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.683 0.754 . . . . 0.0 109.777 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -110.26 149.96 29.4 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 29.6 m -143.47 138.83 29.53 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.566 -0.709 . . . . 0.0 109.827 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 15.1 t -150.01 153.69 36.94 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.186 -0.946 . . . . 0.0 109.154 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' C' ' 30' ' ' SER . 5.5 tp -88.43 144.23 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.491 -1.381 . . . . 0.0 109.958 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.456 ' O ' ' O ' ' C' ' 29' ' ' ILE . 48.0 t -51.59 -106.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.567 -0.708 . . . . 0.0 110.276 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 31' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' C' ' 32' ' ' ASN . 34.9 t0 59.78 63.05 1.56 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 32' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' C' ' 31' ' ' ASP . 5.4 t-20 89.16 115.67 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.4 -38.92 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.121 -0.987 . . . . 0.0 109.754 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.14 -30.27 48.44 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.31 -0.869 . . . . 0.0 108.709 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.69 -35.57 70.29 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 70.3 mt -65.23 -52.31 54.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 C-N-CA 118.429 -1.308 . . . . 0.0 110.43 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 85.4 t -71.04 -46.02 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.881 -1.137 . . . . 0.0 109.752 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.06 -43.85 97.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 0.0 109.397 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -64.13 -39.88 94.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.988 -1.07 . . . . 0.0 109.58 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 65.7 mt -68.97 -44.59 72.6 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 108.809 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 41' ' ' ARG . . . . . 0.788 HH11 ' HG3' ' C' ' 41' ' ' ARG . 0.1 OUTLIER -51.25 -53.68 33.09 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.752 -1.217 . . . . 0.0 109.913 -179.109 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 42' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' C' ' 46' ' ' ALA . 54.4 mttt -59.48 -37.66 78.8 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.777 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -75.9 -35.02 59.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.133 -0.979 . . . . 0.0 110.091 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 44' ' ' VAL . . . . . 0.421 ' O ' ' HG3' ' C' ' 47' ' ' LYS . 5.2 t -73.97 -51.88 22.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.12 -0.988 . . . . 0.0 108.934 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -72.61 -29.9 63.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 119.972 -1.705 . . . . 0.0 109.488 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' C' ' 42' ' ' LYS . . . -61.11 -29.73 69.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.522 -0.736 . . . . 0.0 109.491 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 47' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' C' ' 44' ' ' VAL . 0.0 OUTLIER -103.66 -4.84 23.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.45 -0.782 . . . . 0.0 109.773 -179.157 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.38 31.58 6.41 Favored Glycine 0 N--CA 1.498 2.825 0 C-N-CA 119.509 -1.329 . . . . 0.0 111.892 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.69 -178.73 52.49 Favored Glycine 0 N--CA 1.487 2.069 0 O-C-N 120.075 -1.838 . . . . 0.0 111.2 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 21.2 ttt -108.31 -40.86 5.04 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.459 -1.024 . . . . 0.0 110.712 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 175.07 -175.81 47.13 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 6.1 tp -110.62 132.07 54.5 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.511 -0.993 . . . . 0.0 109.694 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 53' ' ' ILE . . . . . 0.434 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 1.2 pt -107.84 143.95 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.573 -0.704 . . . . 0.0 109.562 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 64.55 81.72 0.2 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.973 . . . . 0.0 110.113 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.54 -59.15 5.09 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.764 -0.775 . . . . 0.0 108.931 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 56' ' ' ARG . . . . . 0.589 ' HE ' ' HA ' ' C' ' 56' ' ' ARG . 0.0 OUTLIER 60.07 82.99 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.426 -0.796 . . . . 0.0 109.5 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 67' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' C' ' 67' ' ' TYR . 11.1 p90 . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -131.82 155.69 21.55 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 81.2 m -104.86 136.36 44.5 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.879 -1.365 . . . . 0.0 107.811 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 33.9 mt -90.45 139.0 18.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 108.746 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -145.08 164.13 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.356 -0.84 . . . . 0.0 110.216 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -150.6 147.74 27.79 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' C' ' 74' ' ' ASP . . . -124.09 150.73 44.68 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.19 -0.944 . . . . 0.0 108.939 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' C' ' 73' ' ' ALA . 3.9 m-20 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.388 -0.82 . . . . 0.0 111.262 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -116.32 120.06 37.68 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.388 -0.82 . . . . 0.0 109.419 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 76.5 mt -99.75 133.78 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.287 -0.883 . . . . 0.0 109.286 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 9' ' ' ILE . . . . . 0.517 HG23 ' O ' ' D' ' 9' ' ' ILE . 20.3 tt -125.1 124.63 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.492 -0.755 . . . . 0.0 109.555 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.512 ' OG1' ' CG ' ' D' ' 13' ' ' ASP . 11.3 t -119.17 131.9 55.91 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m -112.59 114.84 27.68 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.3 -0.875 . . . . 0.0 110.896 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . 51.67 77.39 0.14 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.231 -0.918 . . . . 0.0 109.816 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 13' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' D' ' 13' ' ' ASP . 4.5 p-10 178.07 -138.6 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -173.28 171.55 4.01 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.848 -1.157 . . . . 0.0 108.759 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 11.5 mt -129.62 78.45 75.42 Favored Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.76 156.13 44.83 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 122.054 1.836 . . . . 0.0 110.035 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.86 -9.79 74.93 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 18' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' D' ' 18' ' ' LEU . 59.1 mt -127.4 136.04 51.3 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 119.032 1.416 . . . . 0.0 108.501 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -86.56 108.05 18.4 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' D' ' 71' ' ' VAL . 6.0 mt -102.81 128.29 49.63 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.506 -0.746 . . . . 0.0 109.853 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 21' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' D' ' 71' ' ' VAL . 0.5 OUTLIER -119.17 145.98 45.55 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.338 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.3 t -86.87 131.63 34.05 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.455 0.645 . . . . 0.0 110.426 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.943 HD23 ' N ' ' D' ' 23' ' ' LEU . 0.3 OUTLIER -119.56 5.94 11.07 Favored 'General case' 0 N--CA 1.512 2.637 0 CA-C-O 122.948 1.356 . . . . 0.0 108.381 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.46 174.0 21.16 Favored Glycine 0 N--CA 1.497 2.73 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.685 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.12 144.81 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.86 144.19 42.83 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 74.0 m -151.48 139.73 20.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 15.1 t -149.62 147.83 28.59 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.964 -1.085 . . . . 0.0 109.036 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 80.3 mt -117.08 128.17 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.306 -0.871 . . . . 0.0 108.847 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' D' ' 31' ' ' ASP . 12.8 t -177.67 179.62 0.89 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.445 -0.785 . . . . 0.0 108.962 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 31' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' D' ' 32' ' ' ASN . 19.4 p-10 -116.06 163.7 15.55 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.558 -0.714 . . . . 0.0 109.555 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 5.8 t-20 75.68 126.3 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.142 -0.974 . . . . 0.0 108.68 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 89.1 t -68.98 -33.73 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.595 -0.691 . . . . 0.0 109.738 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 34' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' D' ' 35' ' ' GLU . 1.3 p30 -59.57 -41.52 90.39 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.125 -0.984 . . . . 0.0 109.58 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 35' ' ' GLU . . . . . 0.527 ' N ' ' OD1' ' D' ' 34' ' ' ASP . 16.8 tp10 -75.3 -41.22 57.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.124 -0.985 . . . . 0.0 109.284 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 90.9 mt -64.26 -42.57 95.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 O-C-N 120.962 -1.086 . . . . 0.0 109.232 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 t -64.14 -49.79 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.769 -1.207 . . . . 0.0 109.223 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.09 -38.66 83.59 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.861 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -60.55 -44.06 96.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 109.602 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 35.1 mt -70.37 -46.23 64.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.206 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -51.37 -45.37 62.39 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.767 -1.208 . . . . 0.0 109.601 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -67.3 -39.29 85.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.432 -0.793 . . . . 0.0 110.062 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -75.91 -36.09 59.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.411 -0.806 . . . . 0.0 109.727 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 15.4 t -69.7 -50.77 47.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 108.787 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -64.6 -34.07 77.41 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 118.243 -1.383 . . . . 0.0 109.322 -175.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.93 -30.94 71.94 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.736 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -85.02 -3.97 58.98 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.16 5.09 68.05 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.15 159.97 52.17 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.36 -7.67 7.56 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.424 -1.045 . . . . 0.0 109.379 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.69 166.37 37.95 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 52' ' ' LEU . . . . . 0.452 HD21 ' HA3' ' D' ' 68' ' ' GLY . 8.0 tp -129.73 142.79 50.64 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.661 -0.905 . . . . 0.0 109.794 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 53' ' ' ILE . . . . . 0.477 ' O ' ' HB3' ' D' ' 54' ' ' ALA . 0.7 OUTLIER -107.41 140.65 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.734 -0.604 . . . . 0.0 110.577 -179.017 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 67.64 86.47 0.13 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.515 -0.741 . . . . 0.0 110.47 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 55' ' ' PHE . . . . . 0.472 ' CD2' HD11 ' D' ' 9' ' ' ILE . 4.9 t80 -100.63 37.67 1.66 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.694 0.759 . . . . 0.0 109.743 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 56' ' ' ARG . . . . . 0.791 ' HG3' HH11 ' D' ' 56' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.769 0 O-C-N 120.481 -1.387 . . . . 0.0 109.135 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 18.6 p90 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 122.557 1.17 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 68' ' ' GLY . . . . . 0.452 ' HA3' HD21 ' D' ' 52' ' ' LEU . . . 169.66 -176.79 43.44 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 69' ' ' THR . . . . . 0.429 ' OG1' HG23 ' C' ' 11' ' ' THR . 70.9 m -111.64 137.61 49.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.275 -1.132 . . . . 0.0 108.864 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 62.5 mt -84.54 136.71 22.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 71' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' D' ' 20' ' ' LEU . 13.5 m -146.75 151.56 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.543 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.07 164.59 29.38 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.973 -1.08 . . . . 0.0 109.029 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.7 150.83 36.17 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 16.9 t0 . . . . . 0 N--CA 1.487 1.381 0 O-C-N 120.979 -1.076 . . . . 0.0 108.569 179.179 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 pttp . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.786 0.803 . . . . 0.0 108.923 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -105.36 123.73 48.36 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.655 -0.653 . . . . 0.0 109.762 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 89.7 mt -98.0 123.64 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.072 -1.017 . . . . 0.0 110.672 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 9' ' ' ILE . . . . . 0.572 ' O ' HG23 ' E' ' 9' ' ' ILE . 19.5 tt -137.21 116.66 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 10' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' E' ' 13' ' ' ASP . 15.2 t -124.66 157.29 35.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.0 -1.063 . . . . 0.0 108.934 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 11' ' ' THR . . . . . 0.704 ' OG1' ' OG1' ' A' ' 69' ' ' THR . 0.0 OUTLIER -135.26 128.24 31.49 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.346 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.4 35.37 24.87 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.898 0.856 . . . . 0.0 109.612 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 13' ' ' ASP . . . . . 0.484 ' HB3' ' OG1' ' E' ' 10' ' ' THR . 23.5 t0 -152.48 86.26 1.27 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.617 -0.677 . . . . 0.0 109.355 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -57.81 170.01 0.66 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 108.957 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 40.0 mt -122.32 80.19 45.22 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.358 -0.839 . . . . 0.0 109.116 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.53 156.99 38.75 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.109 1.873 . . . . 0.0 110.083 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.52 -5.48 73.99 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 18' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' E' ' 18' ' ' LEU . 50.0 mt -128.21 136.62 51.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.938 -1.331 . . . . 0.0 108.776 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -86.04 108.61 18.33 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 10.7 mt -95.42 136.58 35.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.329 -0.857 . . . . 0.0 109.703 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 21' ' ' TYR . . . . . 0.427 ' CZ ' ' O ' ' E' ' 22' ' ' SER . 2.4 t80 -121.04 132.3 54.8 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.575 -0.703 . . . . 0.0 109.174 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 22' ' ' SER . . . . . 0.427 ' O ' ' CZ ' ' E' ' 21' ' ' TYR . 0.0 OUTLIER -58.72 130.77 48.49 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.04 -1.037 . . . . 0.0 111.162 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 mt -116.87 12.53 14.76 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.14 -174.08 15.07 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 25' ' ' ILE . . . . . 0.442 HD11 ' CG2' ' D' ' 9' ' ' ILE . 31.0 mm -112.44 140.87 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.609 -0.936 . . . . 0.0 109.416 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.32 143.98 45.38 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.706 -0.621 . . . . 0.0 109.657 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 4.0 p -152.38 141.61 21.43 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.817 -1.177 . . . . 0.0 108.512 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 28' ' ' THR . . . . . 0.416 ' O ' HG23 ' E' ' 28' ' ' THR . 14.2 t -149.64 134.01 17.41 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.107 -0.996 . . . . 0.0 109.152 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 59.9 mt -108.41 127.5 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.333 -0.855 . . . . 0.0 108.909 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 94.5 p -172.55 -140.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.42 -0.8 . . . . 0.0 109.535 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 31' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' E' ' 32' ' ' ASN . 24.7 t70 -155.97 158.67 38.29 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.207 -0.933 . . . . 0.0 109.578 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 32' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 15.1 t30 73.83 126.72 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.19 -0.943 . . . . 0.0 108.867 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.27 -32.16 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.479 -0.763 . . . . 0.0 109.527 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -57.45 -45.59 84.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.876 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -76.05 -38.91 56.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.164 -0.96 . . . . 0.0 109.756 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 79.6 mt -61.78 -49.57 83.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.891 -1.131 . . . . 0.0 109.3 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -62.48 -48.6 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.973 -1.079 . . . . 0.0 109.287 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.67 -39.84 81.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.221 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 -64.51 -44.89 89.5 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.24 -0.913 . . . . 0.0 109.688 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 40' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' E' ' 40' ' ' LEU . 27.8 mt -68.63 -45.7 71.17 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.014 -1.054 . . . . 0.0 108.543 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 41' ' ' ARG . . . . . 0.878 HH11 ' HG2' ' E' ' 41' ' ' ARG . 5.3 ttt-85 -47.84 -53.67 14.87 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.79 -1.193 . . . . 0.0 109.054 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -60.01 -35.87 75.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.408 -0.808 . . . . 0.0 110.012 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -77.16 -35.03 56.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.503 -0.748 . . . . 0.0 109.93 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 t -70.45 -51.92 33.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 121.053 -1.029 . . . . 0.0 108.677 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -68.42 -31.8 71.38 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.326 -1.35 . . . . 0.0 109.275 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.75 -29.44 69.95 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.22 -5.62 58.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.589 -0.694 . . . . 0.0 109.686 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.49 3.94 58.38 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.74 163.2 45.75 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -125.15 -10.45 7.06 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.394 -1.062 . . . . 0.0 109.771 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.68 157.92 30.0 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.106 -1.521 . . . . 0.0 109.648 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.43 139.93 46.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.709 -0.877 . . . . 0.0 109.32 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 53' ' ' ILE . . . . . 0.417 HG21 HD13 ' E' ' 53' ' ' ILE . 1.2 pt -106.66 140.06 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.418 -0.801 . . . . 0.0 109.597 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.79 82.2 0.16 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 122.259 1.028 . . . . 0.0 111.73 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 55' ' ' PHE . . . . . 0.48 ' CD1' HD11 ' E' ' 9' ' ' ILE . 45.9 t80 -60.11 -102.84 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.142 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 56' ' ' ARG . . . . . 0.491 ' HD2' ' H ' ' E' ' 57' ' ' ILE . 6.4 ttm180 -173.84 -125.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.962 -1.086 . . . . 0.0 108.989 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 57' ' ' ILE . . . . . 0.491 ' H ' ' HD2' ' E' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.246 0 O-C-N 121.726 -0.609 . . . . 0.0 109.771 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 33.6 t80 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.615 0.721 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.16 165.93 28.11 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 61.3 m -107.79 137.77 45.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.407 -1.054 . . . . 0.0 108.183 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 28.9 mt -85.37 144.33 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 m -144.77 163.33 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.287 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -153.79 155.43 35.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 0.0 108.749 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.48 150.94 35.69 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.123 -0.986 . . . . 0.0 108.739 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.4 t0 . . . . . 0 N--CA 1.486 1.336 0 O-C-N 120.964 -1.085 . . . . 0.0 108.666 179.31 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 56.7 t80 . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.6 mt -115.21 143.51 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.63 -0.669 . . . . 0.0 109.477 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.45 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 11.4 tt -124.69 119.71 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.425 ' OG1' ' OD2' ' A' ' 13' ' ' ASP . 5.5 t -112.32 132.48 54.96 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.372 -0.83 . . . . 0.0 109.351 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.533 ' OG1' ' HB ' ' B' ' 69' ' ' THR . 0.2 OUTLIER -64.05 -135.77 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.387 -0.821 . . . . 0.0 109.919 -179.671 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.19 80.27 6.29 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.714 0.768 . . . . 0.0 109.843 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.425 ' OD2' ' OG1' ' A' ' 10' ' ' THR . 8.1 p-10 -154.99 -126.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -171.49 171.58 5.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.987 -1.07 . . . . 0.0 109.3 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.1 mt -130.65 75.12 79.35 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.389 -0.82 . . . . 0.0 108.884 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.77 157.65 36.83 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 122.09 1.86 . . . . 0.0 110.177 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.01 -7.49 73.16 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 18' ' ' LEU . 73.3 mt -125.41 137.81 54.01 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.077 -1.249 . . . . 0.0 109.482 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -86.55 108.4 18.56 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 3.7 mt -110.56 128.81 55.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.495 -0.753 . . . . 0.0 109.999 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.596 ' OH ' ' N ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -107.75 149.81 27.73 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.038 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.25 126.01 30.21 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.68 14.28 21.19 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.6 178.37 18.48 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.03 143.96 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.958 -0.731 . . . . 0.0 109.174 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.52 154.87 25.25 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.668 -0.645 . . . . 0.0 109.779 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.2 m -128.7 156.46 43.45 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.48 145.98 49.22 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.246 -0.909 . . . . 0.0 109.324 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.418 ' O ' ' CB ' ' A' ' 30' ' ' SER . 2.2 mm -129.13 128.48 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 120.953 1.706 . . . . 0.0 106.797 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 1.2 m 171.86 -165.54 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.919 -1.113 . . . . 0.0 109.303 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -120.84 -70.86 0.76 Allowed 'General case' 0 N--CA 1.513 2.704 0 O-C-N 121.619 -0.675 . . . . 0.0 112.453 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -62.61 149.76 42.48 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.526 -1.359 . . . . 0.0 108.453 176.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.474 ' H ' HG13 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -70.17 -39.98 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.83 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.83 -29.44 40.99 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.421 -0.799 . . . . 0.0 109.762 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.402 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 12.8 mm-40 -78.46 -33.91 48.08 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.38 -0.825 . . . . 0.0 109.371 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.6 mt -62.56 -47.64 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.911 . . . . 0.0 109.258 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.25 -53.17 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.738 -1.226 . . . . 0.0 110.267 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -57.2 -36.9 71.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.203 -0.936 . . . . 0.0 109.95 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 35' ' ' GLU . 76.8 m-20 -64.71 -43.44 93.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.201 -0.937 . . . . 0.0 110.132 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 40' ' ' LEU . 21.1 mt -69.89 -45.86 66.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.935 -1.103 . . . . 0.0 109.53 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -48.97 -45.88 42.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.8 -1.188 . . . . 0.0 109.223 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -64.52 -36.62 84.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.479 -0.763 . . . . 0.0 110.182 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -75.53 -36.16 60.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.365 -0.835 . . . . 0.0 109.824 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.8 t -69.24 -50.13 55.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.126 -0.984 . . . . 0.0 109.487 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -64.76 -29.7 70.68 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.013 -175.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.2 -32.09 69.85 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.498 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.88 3.29 34.5 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.479 -0.763 . . . . 0.0 109.099 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.84 4.33 88.21 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.88 -157.22 0.4 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -166.11 -23.46 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.203 -1.174 . . . . 0.0 110.023 178.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.548 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -151.18 143.9 11.09 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.6 tp -106.84 138.98 41.98 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.962 . . . . 0.0 109.357 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.8 OUTLIER -109.48 139.67 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.604 -0.685 . . . . 0.0 110.628 -178.812 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 73.09 85.24 0.11 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.679 -0.638 . . . . 0.0 110.586 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -111.47 121.2 44.57 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -140.39 105.87 5.08 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -0.853 . . . . 0.0 109.422 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.7 mt . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.363 -0.836 . . . . 0.0 109.248 179.829 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.8 p90 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.602 0.715 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.27 148.04 17.47 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 79.5 m -105.12 143.0 33.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.015 -1.286 . . . . 0.0 109.384 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.8 mt -91.66 143.72 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.41 -0.806 . . . . 0.0 109.102 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 20' ' ' LEU . 10.6 m -142.27 151.97 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 109.101 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -141.09 143.82 34.55 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.16 -0.962 . . . . 0.0 108.933 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.591 ' O ' ' CB ' ' A' ' 74' ' ' ASP . . . -124.44 152.58 43.12 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.596 ' N ' ' OH ' ' A' ' 21' ' ' TYR . 25.6 t0 . . . . . 0 N--CA 1.507 2.389 0 CA-C-O 121.221 0.534 . . . . 0.0 110.213 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 71.7 t80 . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 121.274 0.559 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.5 mt -112.08 132.73 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.625 ' O ' HG23 ' B' ' 9' ' ' ILE . 10.1 tt -125.78 114.39 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.78 158.93 32.13 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.412 -0.805 . . . . 0.0 108.945 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 12.6 p -110.64 86.52 2.33 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.38 -110.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.685 -0.635 . . . . 0.0 109.914 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -147.02 -161.35 1.31 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.227 -0.92 . . . . 0.0 109.576 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLU . . . . . 0.418 ' O ' ' HD3' ' B' ' 16' ' ' PRO . 0.7 OUTLIER -58.84 131.45 51.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.421 -0.799 . . . . 0.0 109.583 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.03 110.2 3.01 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' B' ' 14' ' ' GLU . 1.9 Cg_endo -63.68 154.11 71.17 Favored 'Trans proline' 0 N--CA 1.481 0.746 0 C-N-CA 121.286 1.324 . . . . 0.0 110.26 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.44 -6.68 82.23 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.32 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 73.2 mt -129.94 142.43 50.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -1.139 . . . . 0.0 109.976 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -87.7 108.25 19.02 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -93.29 140.52 29.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.156 -0.965 . . . . 0.0 110.484 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' TYR . . . . . 0.454 ' H ' ' H ' ' B' ' 72' ' ' LYS . 1.3 t80 -123.2 131.3 53.63 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.405 ' N ' ' CD1' ' B' ' 21' ' ' TYR . 11.8 t -59.5 129.75 43.5 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.085 -1.009 . . . . 0.0 110.607 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' B' ' 23' ' ' LEU . 7.1 mt -117.07 9.24 13.56 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.78 173.77 16.38 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 49.3 mm -111.19 143.5 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.868 -0.783 . . . . 0.0 109.101 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.28 144.65 43.42 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.377 -0.827 . . . . 0.0 109.199 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 9.4 p -152.53 143.74 23.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.986 -1.071 . . . . 0.0 108.71 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 7.7 t -150.35 152.82 35.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.137 -0.977 . . . . 0.0 109.426 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 1.8 mm -122.92 128.1 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 53.8 p -173.49 -153.17 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.519 -0.738 . . . . 0.0 109.709 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 3.7 p-10 -135.31 157.14 47.67 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.461 -0.774 . . . . 0.0 109.495 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 4.1 t-20 82.57 115.16 0.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.485 ' H ' HG13 ' B' ' 33' ' ' VAL . 0.8 OUTLIER -70.1 -39.94 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.26 -35.44 77.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.374 -0.829 . . . . 0.0 110.129 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -73.33 -37.17 66.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.317 -0.865 . . . . 0.0 108.929 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 14.3 mt -62.23 -42.88 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 108.928 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 63.6 t -55.44 -48.82 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.988 -1.07 . . . . 0.0 108.627 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.74 -40.45 92.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.4 -0.812 . . . . 0.0 110.008 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -59.16 -46.57 88.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.13 -0.981 . . . . 0.0 109.72 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.97 -46.39 65.32 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.799 -1.188 . . . . 0.0 108.678 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ARG . . . . . 0.804 HH11 ' HG2' ' B' ' 41' ' ' ARG . 6.4 ttt-85 -49.63 -49.61 46.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.822 -1.174 . . . . 0.0 108.878 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 6.3 pttm -61.42 -35.24 76.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 0.0 108.909 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -71.67 -36.5 70.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.517 -0.74 . . . . 0.0 109.225 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 52.2 t -75.35 -49.75 26.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.981 -1.074 . . . . 0.0 109.21 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.519 ' HZ2' ' NH1' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -48.96 -31.99 8.35 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.531 1.158 . . . . 0.0 110.276 -178.287 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.53 -27.04 51.56 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.71 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -93.84 13.12 23.53 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.14 31.11 32.94 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 118.656 -1.735 . . . . 0.0 109.814 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.3 153.75 28.03 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 68.1 mmm -63.1 -45.35 92.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.349 -1.089 . . . . 0.0 110.673 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.27 -169.49 39.82 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.1 tp -102.43 141.82 34.64 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.507 -0.996 . . . . 0.0 110.034 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.789 HD12 ' O ' ' B' ' 53' ' ' ILE . 1.1 pp -119.64 147.77 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.794 0.807 . . . . 0.0 112.075 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 52.94 52.73 13.29 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 119.692 -1.88 . . . . 0.0 109.403 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.525 ' CD2' HD11 ' B' ' 9' ' ' ILE . 46.2 t80 -83.76 96.35 8.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.018 -1.051 . . . . 0.0 109.327 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' ARG . . . . . 0.851 HH21 HH22 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -97.56 138.04 35.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.351 -0.843 . . . . 0.0 109.189 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 97.7 mt . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.344 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.442 HD12 ' N ' ' B' ' 65' ' ' LEU . 5.3 mp . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.601 0.715 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' B' ' 67' ' ' TYR . . . -81.71 60.64 4.73 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' B' ' 66' ' ' GLY . 3.0 p90 -44.02 121.57 2.51 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.512 -0.993 . . . . 0.0 109.334 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.22 135.28 5.58 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' THR . . . . . 0.533 ' HB ' ' OG1' ' A' ' 11' ' ' THR . 23.6 m -95.79 138.22 33.75 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.104 -1.233 . . . . 0.0 108.348 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 47.6 mt -84.94 141.78 14.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.52 163.97 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.774 0.797 . . . . 0.0 109.811 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.454 ' H ' ' H ' ' B' ' 21' ' ' TYR . 15.6 tttt -151.01 151.32 31.9 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.97 149.88 45.46 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 7.7 t70 . . . . . 0 C--N 1.302 -1.478 0 O-C-N 121.026 -1.046 . . . . 0.0 109.366 179.693 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 56.7 mttm . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.058 0.456 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -92.03 120.76 32.97 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 80.5 mt -116.82 145.75 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.535 -0.728 . . . . 0.0 109.817 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 9' ' ' ILE . . . . . 0.647 ' O ' HG23 ' C' ' 9' ' ' ILE . 11.5 tt -130.5 114.63 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 11.7 t -123.09 159.36 28.66 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.962 0.887 . . . . 0.0 108.823 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 11' ' ' THR . . . . . 0.568 ' HG1' ' CB ' ' D' ' 69' ' ' THR . 1.7 p -88.5 -113.5 0.06 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.49 99.0 8.62 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.258 -0.902 . . . . 0.0 109.239 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -169.01 -13.44 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.72 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 57.24 173.02 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.312 -0.867 . . . . 0.0 109.57 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 66.4 mt -134.37 83.35 44.07 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.47 -0.769 . . . . 0.0 109.142 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.64 157.14 43.59 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 121.936 1.758 . . . . 0.0 110.139 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.38 -7.85 75.15 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 37.0 mt -127.86 140.37 52.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.142 -1.211 . . . . 0.0 109.716 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -86.44 110.39 19.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -95.67 136.29 36.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.112 -0.993 . . . . 0.0 110.182 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 21' ' ' TYR . . . . . 0.449 ' H ' ' H ' ' C' ' 72' ' ' LYS . 1.9 t80 -118.51 130.16 55.77 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 4.9 t -65.26 128.38 35.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.935 -1.103 . . . . 0.0 110.746 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' C' ' 23' ' ' LEU . 12.4 mt -115.04 8.5 15.76 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.74 178.72 18.86 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.08 144.22 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.801 -0.823 . . . . 0.0 109.066 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.62 144.21 44.23 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.645 -0.66 . . . . 0.0 109.609 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 86.9 p -152.41 136.08 16.16 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 10.7 t -149.88 153.34 36.53 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.942 -1.099 . . . . 0.0 109.339 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.578 ' N ' HD12 ' C' ' 29' ' ' ILE . 4.9 mp -125.28 132.03 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.18 -0.95 . . . . 0.0 108.726 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.425 ' O ' ' O ' ' C' ' 31' ' ' ASP . 0.2 OUTLIER -169.98 7.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.568 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 31' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' C' ' 32' ' ' ASN . 21.5 t0 58.88 153.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.314 -0.866 . . . . 0.0 109.808 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 32' ' ' ASN . . . . . 0.469 ' N ' ' OD1' ' C' ' 31' ' ' ASP . 10.7 m-20 81.26 115.17 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.48 ' H ' HG13 ' C' ' 33' ' ' VAL . 0.9 OUTLIER -70.11 -40.81 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -58.81 -33.71 70.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.364 -0.835 . . . . 0.0 109.914 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -76.44 -36.36 58.0 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.289 -0.882 . . . . 0.0 109.188 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 55.5 mt -62.95 -52.7 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 0.0 109.086 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -51.71 -49.45 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 108.574 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -61.42 -41.84 97.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.394 -0.816 . . . . 0.0 109.631 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -64.63 -46.15 83.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 0.0 109.871 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.32 -46.86 72.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.025 -1.047 . . . . 0.0 108.547 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 41' ' ' ARG . . . . . 0.632 ' CG ' HH11 ' C' ' 41' ' ' ARG . 0.0 OUTLIER -47.75 -53.71 14.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.0 -1.062 . . . . 0.0 109.087 178.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -57.56 -35.11 69.93 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.306 -0.871 . . . . 0.0 110.214 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -75.9 -35.69 59.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.508 -0.745 . . . . 0.0 109.706 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 4.7 t -73.55 -51.64 24.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.139 -0.975 . . . . 0.0 108.99 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -63.45 -29.13 70.46 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.205 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.77 -29.57 69.56 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -91.39 6.47 45.27 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.411 -0.805 . . . . 0.0 109.146 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.11 28.97 74.09 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.0 -1.571 . . . . 0.0 109.479 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.57 -164.11 14.18 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 5.6 tmm? -117.39 -37.55 3.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.947 . . . . 0.0 110.573 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 176.75 169.27 37.87 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 7.5 tp -95.64 132.78 40.44 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.348 -1.089 . . . . 0.0 109.836 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 53' ' ' ILE . . . . . 0.531 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 1.1 pt -109.85 144.86 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.507 -0.746 . . . . 0.0 109.936 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 69.37 82.81 0.16 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 55' ' ' PHE . . . . . 0.43 ' H ' ' HA ' ' C' ' 11' ' ' THR . 90.1 t80 -114.73 85.55 2.27 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 56' ' ' ARG . . . . . 0.851 HH22 HH21 ' B' ' 56' ' ' ARG . 89.3 mtt180 -112.1 161.54 16.39 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.543 -0.723 . . . . 0.0 109.262 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 67.8 mt . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.443 -0.786 . . . . 0.0 108.934 -179.922 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 36.7 p90 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.631 0.729 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.35 149.09 20.82 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 49.8 m -96.8 136.8 36.84 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.975 -1.309 . . . . 0.0 108.271 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 37.4 mt -83.83 139.72 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.8 m -126.31 165.04 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.306 -0.871 . . . . 0.0 109.913 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 72' ' ' LYS . . . . . 0.449 ' H ' ' H ' ' C' ' 21' ' ' TYR . 9.5 tttm -155.28 140.02 17.1 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.448 ' O ' ' CG ' ' C' ' 74' ' ' ASP . . . -116.58 115.06 25.03 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.895 -1.128 . . . . 0.0 110.674 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' C' ' 73' ' ' ALA . 3.0 m-20 . . . . . 0 N--CA 1.494 1.742 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.597 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 94.9 mttt . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -94.3 124.95 38.63 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.362 -0.836 . . . . 0.0 109.807 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 75.5 mt -114.54 127.41 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.554 -0.716 . . . . 0.0 109.219 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 9' ' ' ILE . . . . . 0.709 HD11 ' CG ' ' D' ' 55' ' ' PHE . 17.0 tt -121.26 114.94 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.7 t -122.52 151.88 40.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.39 72.45 0.95 Allowed 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.555 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.31 -101.59 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.159 -1.588 . . . . 0.0 108.417 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -119.87 -154.6 0.58 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.414 -0.804 . . . . 0.0 109.614 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -78.68 -172.0 2.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.237 -0.914 . . . . 0.0 109.564 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 84.5 mt -120.35 93.68 48.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -61.58 155.62 52.17 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.716 1.611 . . . . 0.0 110.607 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.44 -9.63 75.64 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 71.7 mt -129.37 141.41 51.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.266 -1.137 . . . . 0.0 109.487 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -84.96 108.86 17.79 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 13.8 mt -91.4 133.82 35.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.896 -1.128 . . . . 0.0 110.145 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 21' ' ' TYR . . . . . 0.541 ' CE1' ' O ' ' D' ' 22' ' ' SER . 0.9 OUTLIER -120.82 130.67 54.06 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 22' ' ' SER . . . . . 0.541 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 0.0 OUTLIER -66.37 130.64 43.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.156 -0.965 . . . . 0.0 111.494 -179.018 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 14.0 mt -119.94 14.16 12.35 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.04 -174.46 15.21 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 46.7 mm -112.75 138.87 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 122.014 -0.698 . . . . 0.0 109.187 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.28 144.39 43.81 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.336 -0.853 . . . . 0.0 110.212 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 22.4 p -153.17 135.33 14.85 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 7.3 t -150.17 141.21 22.98 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.821 -1.175 . . . . 0.0 109.85 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 tp -126.47 131.84 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.491 ' O ' ' O ' ' D' ' 31' ' ' ASP . 56.8 p -168.51 8.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.625 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 31' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' D' ' 30' ' ' SER . 36.9 t0 54.2 156.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.528 -0.733 . . . . 0.0 110.177 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 2.3 t-20 74.37 129.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.959 -1.088 . . . . 0.0 108.504 -178.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 t -67.61 -35.55 73.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.424 -0.797 . . . . 0.0 109.587 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -59.06 -44.31 91.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.355 -0.841 . . . . 0.0 110.559 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -75.5 -37.47 60.14 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.958 -1.089 . . . . 0.0 109.517 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 83.5 mt -66.48 -42.09 89.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.914 -1.116 . . . . 0.0 109.513 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -65.46 -53.73 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.639 -1.288 . . . . 0.0 110.135 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -55.42 -35.52 65.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.293 -0.88 . . . . 0.0 109.433 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -66.55 -41.14 89.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.843 . . . . 0.0 109.813 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 17.4 mt -75.42 -51.07 13.94 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.883 -1.136 . . . . 0.0 108.815 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -48.85 -52.6 23.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.835 -1.165 . . . . 0.0 108.974 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 42' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' D' ' 46' ' ' ALA . 27.7 ttmt -59.81 -36.75 77.4 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.472 -0.768 . . . . 0.0 110.225 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -75.27 -35.77 61.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.122 -0.987 . . . . 0.0 110.003 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -74.38 -51.7 22.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.135 -0.978 . . . . 0.0 109.487 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -71.74 -34.57 69.64 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.451 -1.406 . . . . 0.0 109.812 -176.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' D' ' 42' ' ' LYS . . . -56.69 -30.81 63.82 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -92.63 -5.06 52.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.34 -0.85 . . . . 0.0 109.748 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.35 8.23 56.49 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.63 -173.6 4.52 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 50' ' ' MET . . . . . 0.435 ' SD ' ' C ' ' D' ' 50' ' ' MET . 0.0 OUTLIER -161.19 -23.37 0.05 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.091 -1.241 . . . . 0.0 110.885 176.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -137.32 146.8 18.75 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 52' ' ' LEU . . . . . 0.522 HD12 ' O ' ' D' ' 69' ' ' THR . 34.9 tp -137.12 146.17 44.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.678 -0.895 . . . . 0.0 109.289 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 53' ' ' ILE . . . . . 0.838 HD12 ' H ' ' D' ' 53' ' ' ILE . 0.1 OUTLIER -109.69 162.63 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.47 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.622 ' O ' ' CB ' ' D' ' 55' ' ' PHE . . . 65.81 -163.45 0.25 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 55' ' ' PHE . . . . . 0.709 ' CG ' HD11 ' D' ' 9' ' ' ILE . 67.2 t80 134.19 -5.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 56' ' ' ARG . . . . . 0.704 ' NH1' HH22 ' E' ' 56' ' ' ARG . 16.6 ptm180 . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.3 -0.875 . . . . 0.0 109.805 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 3.5 p90 . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 121.502 0.668 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.21 166.03 35.61 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 69' ' ' THR . . . . . 0.568 ' CB ' ' HG1' ' C' ' 11' ' ' THR . 98.7 m -115.14 137.95 51.45 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.568 -0.96 . . . . 0.0 108.417 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 46.0 mt -87.16 126.42 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.94 -1.1 . . . . 0.0 108.326 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 71' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' D' ' 21' ' ' TYR . 3.5 m -137.97 162.97 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.337 -0.852 . . . . 0.0 110.22 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -153.52 154.11 33.69 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.468 ' O ' ' CB ' ' D' ' 74' ' ' ASP . . . -121.15 115.41 23.02 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.548 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 74' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' D' ' 73' ' ' ALA . 2.0 m-20 . . . . . 0 N--CA 1.503 2.212 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 60.1 mttp . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -112.17 119.71 39.31 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.363 -0.836 . . . . 0.0 109.595 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 69.8 mt -100.85 128.18 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.396 -0.815 . . . . 0.0 109.77 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 9' ' ' ILE . . . . . 0.676 HD11 ' CG ' ' E' ' 55' ' ' PHE . 11.3 tt -128.42 115.03 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 1.7 t -125.41 157.47 36.76 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.902 0.858 . . . . 0.0 109.11 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.97 92.58 3.79 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.99 -150.87 0.06 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.194 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 13' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' E' ' 14' ' ' GLU . 1.7 p-10 -76.63 -72.52 0.33 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.214 -0.929 . . . . 0.0 109.551 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 14' ' ' GLU . . . . . 0.454 ' H ' ' CG ' ' E' ' 13' ' ' ASP . 13.8 pt-20 -153.44 -166.95 2.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.168 -0.958 . . . . 0.0 109.291 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 52.9 mt -121.45 88.34 46.1 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.14 156.18 51.78 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 121.791 1.66 . . . . 0.0 110.641 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.97 -5.92 76.2 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 18' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' E' ' 18' ' ' LEU . 37.9 mt -129.34 139.86 51.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.286 -1.126 . . . . 0.0 109.971 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -84.23 108.53 17.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 14.2 mt -101.91 136.54 41.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.344 -0.848 . . . . 0.0 110.304 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 21' ' ' TYR . . . . . 0.55 ' CE1' ' O ' ' E' ' 22' ' ' SER . 0.4 OUTLIER -120.57 129.91 53.98 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 22' ' ' SER . . . . . 0.55 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 13.4 t -56.74 130.16 44.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 111.668 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 11.9 mt -119.22 5.62 11.23 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.39 -179.19 16.68 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.09 145.33 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 122.033 -0.687 . . . . 0.0 109.263 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.25 159.68 22.28 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.645 -0.659 . . . . 0.0 109.348 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 89.3 p -153.11 143.6 22.59 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 28' ' ' THR . . . . . 0.404 HG23 HD21 ' E' ' 40' ' ' LEU . 11.2 p -142.93 134.47 26.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.183 -0.948 . . . . 0.0 111.02 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.513 ' O ' ' CB ' ' E' ' 30' ' ' SER . 2.1 mm -125.63 126.39 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' E' ' 29' ' ' ILE . 3.3 m 157.09 16.12 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 31' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' E' ' 32' ' ' ASN . 1.0 OUTLIER 51.5 -174.08 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.006 -1.059 . . . . 0.0 108.892 -179.082 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 32' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 9.2 t-20 73.48 94.3 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 33' ' ' VAL . . . . . 0.49 ' H ' HG13 ' E' ' 33' ' ' VAL . 0.7 OUTLIER -70.78 -42.98 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.309 -0.869 . . . . 0.0 108.993 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 34' ' ' ASP . . . . . 0.408 ' N ' ' CG2' ' E' ' 33' ' ' VAL . 43.1 t0 -58.39 -44.19 88.83 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.388 -0.82 . . . . 0.0 110.771 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 35' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' E' ' 39' ' ' ASN . 62.1 mm-40 -70.03 -37.05 75.48 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.95 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 37.8 mt -61.64 -41.36 90.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.149 -0.97 . . . . 0.0 108.886 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 48.4 t -55.16 -51.58 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.941 -1.099 . . . . 0.0 108.778 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -59.1 -39.2 81.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.347 -0.846 . . . . 0.0 109.541 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 39' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' E' ' 35' ' ' GLU . 34.0 m120 -63.42 -42.11 98.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 109.508 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 40' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' E' ' 40' ' ' LEU . 74.5 mt -73.36 -50.03 24.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.132 -0.98 . . . . 0.0 108.962 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -48.93 -48.31 42.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.756 -1.215 . . . . 0.0 108.993 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -63.36 -37.4 87.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.582 -0.699 . . . . 0.0 109.935 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -75.6 -35.55 60.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.267 -0.896 . . . . 0.0 109.66 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 13.2 t -70.74 -51.44 36.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.308 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -71.21 -35.34 71.49 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.294 -176.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.63 -30.61 67.42 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -92.14 -5.44 52.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.364 -0.835 . . . . 0.0 109.871 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.63 11.82 46.18 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.61 159.28 33.16 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.26 -6.19 5.4 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.27 -1.135 . . . . 0.0 110.521 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -152.24 164.21 30.45 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 6.9 tp -136.95 143.45 42.87 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.405 -1.056 . . . . 0.0 109.516 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 53' ' ' ILE . . . . . 0.655 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 4.8 mt -113.6 151.66 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 88.7 -144.58 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 55' ' ' PHE . . . . . 0.676 ' CG ' HD11 ' E' ' 9' ' ' ILE . 62.9 t80 104.87 11.96 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 120.726 1.603 . . . . 0.0 107.607 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 56' ' ' ARG . . . . . 0.704 HH22 ' NH1' ' D' ' 56' ' ' ARG . 73.8 mtm180 -69.16 124.73 24.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.354 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 88.3 mt . . . . . 0 N--CA 1.498 1.967 0 O-C-N 121.516 -0.74 . . . . 0.0 109.292 -179.784 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 67' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' E' ' 67' ' ' TYR . 18.4 p90 . . . . . 0 N--CA 1.5 2.055 0 CA-C-O 122.286 1.041 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.66 157.97 14.71 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 93.6 m -90.52 134.6 34.25 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.038 -1.272 . . . . 0.0 107.691 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 58.6 mt -90.23 137.91 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 71' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' E' ' 21' ' ' TYR . 3.2 m -144.17 163.92 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.26 -0.9 . . . . 0.0 110.766 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -148.01 152.61 37.74 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.18 152.55 33.5 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.327 -0.858 . . . . 0.0 108.727 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 110.094 179.422 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 57.5 t80 . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 70.0 mt -112.17 140.02 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.518 -0.739 . . . . 0.0 110.009 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 9' ' ' ILE . 5.8 tt -137.61 115.88 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.446 -0.784 . . . . 0.0 108.923 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -123.49 158.38 31.4 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.27 121.02 32.84 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.75 47.34 20.62 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.994 0.902 . . . . 0.0 109.624 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -167.4 94.77 0.45 Allowed 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.404 0.621 . . . . 0.0 109.445 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -61.24 -178.2 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.263 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.7 mt -123.67 87.9 52.22 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.51 -0.744 . . . . 0.0 109.085 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -61.1 156.02 47.29 Favored 'Trans proline' 0 C--N 1.321 -0.888 0 C-N-CA 121.905 1.736 . . . . 0.0 110.222 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.64 -11.76 71.37 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.2 mt -126.79 137.64 53.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.143 -1.21 . . . . 0.0 108.734 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.728 ' NE2' ' H ' ' A' ' 74' ' ' ASP . 1.2 pp0? -87.62 118.47 27.12 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.4 mt -101.46 128.35 47.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.131 -0.98 . . . . 0.0 109.587 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' A' ' 22' ' ' SER . 2.3 t80 -115.21 129.95 56.78 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.531 ' O ' ' CE1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -85.57 130.26 34.62 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.408 -0.808 . . . . 0.0 110.353 -179.719 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.942 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -118.94 19.44 13.03 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 137.33 172.42 12.53 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.98 145.14 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.11 147.45 37.29 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.623 -0.673 . . . . 0.0 109.315 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.5 p -151.48 135.55 16.63 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.63 150.56 34.64 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.044 -1.035 . . . . 0.0 108.766 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.21 129.45 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 83.8 p -169.37 175.95 5.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 109.126 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.429 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 3.2 m-20 -101.94 146.91 27.2 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.297 -0.877 . . . . 0.0 110.152 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 13.2 m-20 77.63 128.95 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.566 -0.708 . . . . 0.0 109.259 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.98 -31.09 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.593 -0.692 . . . . 0.0 109.36 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -56.22 -40.24 73.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.299 -0.876 . . . . 0.0 109.712 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.402 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 1.1 mp0 -76.23 -40.28 52.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.324 -0.86 . . . . 0.0 109.277 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.3 mt -62.22 -50.53 79.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.896 -1.127 . . . . 0.0 108.847 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.0 t -66.63 -49.45 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.11 -0.994 . . . . 0.0 109.473 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.53 -40.71 88.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.0 109.601 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 35' ' ' GLU . 15.9 m120 -64.13 -41.33 97.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 109.321 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 40' ' ' LEU . 29.4 mt -68.23 -44.24 76.18 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.15 -0.969 . . . . 0.0 109.128 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -48.92 -42.77 38.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.572 -1.33 . . . . 0.0 109.436 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -69.94 -38.02 76.05 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.493 0.663 . . . . 0.0 110.102 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -77.32 -35.04 55.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.492 -0.755 . . . . 0.0 110.057 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.83 -52.07 31.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.027 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -66.59 -29.53 69.6 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.215 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.49 -28.6 68.69 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.626 0.727 . . . . 0.0 109.048 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -90.22 -5.65 56.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.564 -0.71 . . . . 0.0 109.558 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.5 4.37 58.24 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.84 161.93 48.24 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -129.58 -2.35 4.85 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.303 -1.116 . . . . 0.0 110.303 -177.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.8 166.48 39.68 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.308 -1.425 . . . . 0.0 109.685 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 tp -125.16 143.63 50.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.665 -0.903 . . . . 0.0 109.655 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.801 HD13 ' O ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -117.73 148.71 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.625 -0.672 . . . . 0.0 110.072 -178.228 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.22 68.78 0.74 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.897 -1.127 . . . . 0.0 110.125 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -107.29 54.56 0.67 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.671 ' NH1' HH22 ' E' ' 56' ' ' ARG . 1.7 ttt-85 -80.18 152.96 28.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.302 -0.874 . . . . 0.0 109.634 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.4 mt . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.947 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.1 p90 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.815 0.816 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.58 153.23 17.07 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.427 ' OG1' ' OG1' ' E' ' 11' ' ' THR . 96.8 m -105.71 138.26 42.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.304 -1.115 . . . . 0.0 108.964 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 50.4 mt -83.01 137.32 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.4 m -140.66 159.05 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.247 -0.908 . . . . 0.0 109.701 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -153.69 159.09 41.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.296 -0.878 . . . . 0.0 109.052 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.519 ' O ' ' CG ' ' A' ' 74' ' ' ASP . . . -114.83 114.17 25.18 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.227 -0.921 . . . . 0.0 110.756 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.728 ' H ' ' NE2' ' A' ' 19' ' ' GLN . 20.5 m-20 . . . . . 0 N--CA 1.496 1.856 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 68.6 t80 . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 93.8 mt -132.87 129.96 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.386 -0.821 . . . . 0.0 109.754 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.602 ' O ' HG23 ' B' ' 9' ' ' ILE . 10.9 tt -133.01 116.36 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.2 t -123.9 152.78 42.01 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 0.8 OUTLIER -103.01 74.76 1.33 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' B' ' 11' ' ' THR . . . 176.97 -116.18 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 176.98 54.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -129.38 104.44 7.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.39 -0.819 . . . . 0.0 109.605 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.752 HG22 ' O ' ' B' ' 15' ' ' ILE . 6.2 mm -140.61 53.04 3.62 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.346 -0.847 . . . . 0.0 108.915 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.628 ' HD3' ' N ' ' B' ' 15' ' ' ILE . 1.8 Cg_endo -64.07 155.49 64.41 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.531 1.487 . . . . 0.0 110.196 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.12 -11.71 71.43 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 79.8 mt -128.24 139.5 52.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.01 -1.288 . . . . 0.0 109.035 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -85.51 108.86 18.12 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.427 HD11 ' HB ' ' B' ' 15' ' ' ILE . 13.4 mt -89.84 132.63 35.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 110.348 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' TYR . . . . . 0.54 ' CE1' ' O ' ' B' ' 22' ' ' SER . 0.4 OUTLIER -112.38 129.29 56.36 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.54 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 36.2 t -71.73 118.25 14.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.793 -1.192 . . . . 0.0 109.336 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' B' ' 72' ' ' LYS . 5.8 mt -94.69 -4.57 47.29 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.42 -163.4 24.03 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -122.39 141.76 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.407 ' HB2' HD11 ' B' ' 70' ' ' ILE . . . -113.54 144.81 42.23 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.567 -0.708 . . . . 0.0 109.275 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 3.0 t -151.77 137.88 18.28 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -148.92 141.76 24.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.013 -1.054 . . . . 0.0 109.247 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 tp -104.8 127.93 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.287 -0.883 . . . . 0.0 109.213 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 15.5 t -171.19 169.79 6.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.918 . . . . 0.0 109.053 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 2.7 p-10 -110.16 158.78 17.98 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.507 -0.746 . . . . 0.0 109.215 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 2.2 m120 75.97 129.55 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.97 -32.86 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.488 -0.757 . . . . 0.0 109.306 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.96 -42.15 89.2 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.282 -0.886 . . . . 0.0 109.773 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -75.73 -41.4 53.54 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.225 -0.922 . . . . 0.0 109.516 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.79 -43.05 98.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 120.858 -1.151 . . . . 0.0 108.923 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.21 -50.78 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.768 -1.208 . . . . 0.0 109.497 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -59.01 -39.51 82.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.339 -0.851 . . . . 0.0 109.513 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -61.65 -46.12 91.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.639 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' B' ' 40' ' ' LEU . 28.6 mt -70.74 -46.83 62.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.105 -0.997 . . . . 0.0 108.986 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -48.57 -44.54 36.84 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.695 -1.253 . . . . 0.0 109.405 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -67.97 -38.4 82.69 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.559 0.695 . . . . 0.0 110.242 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -77.54 -34.11 54.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.395 -0.816 . . . . 0.0 110.183 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.796 ' O ' ' N ' ' B' ' 48' ' ' GLY . 2.3 t -70.03 -51.67 37.54 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.946 0 O-C-N 121.148 -0.97 . . . . 0.0 109.812 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -60.11 -31.39 69.99 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 119.666 -1.896 . . . . 0.0 110.328 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.7 -37.22 56.49 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.009 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.4 -12.92 11.01 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.549 -0.719 . . . . 0.0 109.923 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' GLY . . . . . 0.796 ' N ' ' O ' ' B' ' 44' ' ' VAL . . . -105.8 -45.75 1.26 Allowed Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.96 -35.23 0.29 Allowed Glycine 0 C--N 1.289 -2.066 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.156 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' MET . . . . . 0.456 ' H ' ' C ' ' B' ' 48' ' ' GLY . 0.0 OUTLIER -96.44 -75.08 0.54 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 119.253 1.527 . . . . 0.0 109.886 -179.313 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.37 -153.58 10.77 Favored Glycine 0 C--N 1.288 -2.104 0 C-N-CA 118.288 -1.91 . . . . 0.0 109.425 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.2 tp -133.11 139.13 46.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.696 -0.885 . . . . 0.0 109.682 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.466 ' O ' ' HB3' ' B' ' 54' ' ' ALA . 1.7 pt -111.82 145.53 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.658 -0.651 . . . . 0.0 109.913 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 63.92 72.45 0.46 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.121 -0.987 . . . . 0.0 109.337 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.558 ' CG ' ' O ' ' B' ' 55' ' ' PHE . 60.4 t80 -101.51 33.65 2.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.37 -0.831 . . . . 0.0 108.917 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' ARG . . . . . 0.795 ' HG3' HH11 ' B' ' 56' ' ' ARG . 0.0 OUTLIER -59.51 122.98 15.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.982 -1.074 . . . . 0.0 109.34 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 91.2 mt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 179.999 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 20.7 tp . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.192 0.52 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.78 165.05 33.12 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -167.13 179.83 4.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.04 -1.271 . . . . 0.0 110.209 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.09 169.63 35.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 50.4 m -100.66 132.94 45.79 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.123 -1.222 . . . . 0.0 108.037 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.498 HG22 ' HA2' ' B' ' 48' ' ' GLY . 3.0 mt -87.82 145.44 7.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 5.9 m -146.29 166.06 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.886 -1.134 . . . . 0.0 111.01 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.537 ' HB2' HD11 ' B' ' 23' ' ' LEU . 0.4 OUTLIER -146.55 156.25 43.1 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.728 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.45 ' O ' ' OD1' ' B' ' 74' ' ' ASP . . . -116.57 116.02 26.83 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.72 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' B' ' 73' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -105.78 120.66 42.26 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.099 -1.001 . . . . 0.0 109.126 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 17.7 mt -116.39 143.01 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 9' ' ' ILE . . . . . 0.456 ' O ' HG23 ' C' ' 9' ' ' ILE . 7.2 tt -112.96 124.62 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.93 131.28 55.16 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.44 -0.787 . . . . 0.0 109.369 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 11' ' ' THR . . . . . 0.487 ' HG1' HD11 ' D' ' 25' ' ' ILE . 1.6 m -121.3 114.37 21.25 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.42 34.56 24.45 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.301 -0.875 . . . . 0.0 109.653 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -153.36 95.49 1.93 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.708 -0.62 . . . . 0.0 109.505 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -67.31 176.82 2.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.086 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 51.4 mt -127.04 81.68 69.47 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.485 -0.759 . . . . 0.0 109.095 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.31 156.78 38.78 Favored 'Trans proline' 0 C--N 1.322 -0.83 0 C-N-CA 121.964 1.776 . . . . 0.0 110.119 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.17 -4.54 74.37 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.307 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 18' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' C' ' 18' ' ' LEU . 25.7 mt -126.78 137.48 53.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.105 -1.232 . . . . 0.0 109.17 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -86.77 108.28 18.64 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 12.8 mt -92.36 132.97 36.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 109.462 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 21' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' C' ' 71' ' ' VAL . 1.2 t80 -114.73 129.37 56.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.363 -0.835 . . . . 0.0 108.755 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 22' ' ' SER . . . . . 0.436 ' O ' ' CE1' ' C' ' 21' ' ' TYR . 8.2 t -61.97 127.68 32.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.899 -1.126 . . . . 0.0 111.624 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' C' ' 23' ' ' LEU . 14.2 mt -113.47 9.13 18.03 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.71 -174.52 15.34 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 177.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.57 139.76 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.651 -0.911 . . . . 0.0 109.584 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.47 146.84 44.19 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.693 -0.63 . . . . 0.0 109.92 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 4.7 t -151.91 139.23 19.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.154 -0.966 . . . . 0.0 108.688 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.77 140.28 22.46 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.962 -1.086 . . . . 0.0 109.641 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 7.1 tp -95.66 147.9 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.999 -1.063 . . . . 0.0 108.602 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.501 ' OG ' ' N ' ' C' ' 31' ' ' ASP . 27.1 t -169.3 -168.24 0.8 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.112 -0.992 . . . . 0.0 109.12 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 31' ' ' ASP . . . . . 0.501 ' N ' ' OG ' ' C' ' 30' ' ' SER . 19.4 t0 -109.72 -80.64 0.58 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.352 -0.843 . . . . 0.0 111.667 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -75.98 159.66 30.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.909 -1.12 . . . . 0.0 109.434 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.33 -31.44 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 CA-C-O 121.241 0.543 . . . . 0.0 109.591 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.5 -37.85 65.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.65 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 35' ' ' GLU . . . . . 0.492 ' O ' ' ND2' ' C' ' 39' ' ' ASN . 12.2 mm-40 -76.38 -36.22 58.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.35 -0.844 . . . . 0.0 109.019 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 82.9 mt -61.78 -51.98 66.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 120.984 -1.073 . . . . 0.0 109.539 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 51.4 t -57.65 -48.11 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.086 -1.009 . . . . 0.0 108.985 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -63.49 -43.89 95.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.652 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' C' ' 35' ' ' GLU . 2.5 m-80 -58.27 -48.63 79.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.13 -0.981 . . . . 0.0 109.47 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 55.5 mt -68.98 -44.22 73.33 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.736 -1.227 . . . . 0.0 108.76 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -50.97 -46.18 61.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.773 -1.205 . . . . 0.0 109.445 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -61.87 -34.66 76.4 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.516 -0.874 . . . . 0.0 108.967 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -70.76 -36.09 72.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.447 -0.783 . . . . 0.0 108.971 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 51.5 t -72.89 -49.29 40.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.89 -1.131 . . . . 0.0 109.155 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -49.36 -34.23 15.53 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.448 1.118 . . . . 0.0 110.505 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.84 -28.55 50.2 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.573 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -94.62 9.53 38.36 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.89 30.73 30.21 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 118.355 -1.879 . . . . 0.0 109.534 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.35 -162.44 8.81 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -115.07 -35.66 4.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.44 -1.036 . . . . 0.0 110.424 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.19 179.73 40.32 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 tp -101.36 138.33 38.52 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.427 -1.043 . . . . 0.0 109.786 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 53' ' ' ILE . . . . . 0.45 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 1.3 pt -113.97 144.38 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.528 -0.732 . . . . 0.0 110.149 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 62.72 62.45 1.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -0.88 . . . . 0.0 109.236 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -92.99 66.0 4.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.958 -1.089 . . . . 0.0 108.448 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 56' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -72.68 149.66 43.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.5 -0.75 . . . . 0.0 110.032 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 59.0 mt . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.08 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 37.1 p90 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.871 0.843 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.92 -173.25 44.03 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 29.3 m -119.46 134.05 55.4 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 45.2 mt -82.56 146.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 71' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' C' ' 21' ' ' TYR . 4.6 m -139.83 164.06 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.392 -0.817 . . . . 0.0 110.225 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -142.34 154.61 44.81 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.36 116.21 29.32 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.843 0.83 . . . . 0.0 111.239 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 25.9 t70 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.391 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 63.4 mttp . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -96.43 128.85 43.73 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.212 -0.93 . . . . 0.0 109.611 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 62.8 mt -128.14 141.99 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.543 -0.723 . . . . 0.0 109.095 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 9' ' ' ILE . . . . . 0.405 ' O ' HG23 ' D' ' 9' ' ' ILE . 10.1 tt -114.97 117.36 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.16 131.83 54.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.934 -1.104 . . . . 0.0 108.971 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 11' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' D' ' 12' ' ' ALA . 3.4 m -104.02 98.0 7.89 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 12' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' D' ' 11' ' ' THR . . . 61.89 65.12 0.94 Allowed 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.948 0.88 . . . . 0.0 110.068 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -132.97 -141.44 0.2 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -169.44 -31.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 109.389 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 28.7 mt 50.21 67.14 4.67 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.185 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.85 156.41 48.88 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 C-N-CA 122.122 1.881 . . . . 0.0 110.126 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.5 -4.01 72.54 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.612 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 29.0 mt -125.16 135.83 53.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.872 -1.369 . . . . 0.0 108.967 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -86.38 112.49 21.5 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 11.9 mt -95.59 133.68 39.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.044 -1.035 . . . . 0.0 109.807 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 21' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' D' ' 22' ' ' SER . 4.4 t80 -122.45 129.97 52.59 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 22' ' ' SER . . . . . 0.433 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 48.2 t -85.84 129.63 34.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.573 -0.704 . . . . 0.0 110.97 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.919 HD23 ' N ' ' D' ' 23' ' ' LEU . 0.3 OUTLIER -119.4 13.31 12.66 Favored 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 122.235 1.017 . . . . 0.0 108.483 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 143.26 170.29 12.98 Favored Glycine 0 N--CA 1.49 2.298 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.026 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 25' ' ' ILE . . . . . 0.487 HD11 ' HG1' ' C' ' 11' ' ' THR . 0.7 OUTLIER -109.39 142.69 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.389 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 26' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' D' ' 67' ' ' TYR . . . -114.22 148.21 37.73 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 89.4 p -152.09 141.55 21.63 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 14.9 t -149.67 140.84 23.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.157 -0.965 . . . . 0.0 109.044 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 tt -115.7 129.81 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 90.1 p -177.26 -131.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.545 -0.722 . . . . 0.0 109.257 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 31' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' D' ' 32' ' ' ASN . 15.1 p-10 -166.51 169.69 13.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.211 -0.931 . . . . 0.0 109.471 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 6.8 t-20 73.65 127.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 0.0 108.666 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 22.9 t -68.88 -35.09 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.379 -0.826 . . . . 0.0 109.656 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 34' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' D' ' 35' ' ' GLU . 0.9 OUTLIER -59.21 -45.11 91.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.85 -179.509 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 35' ' ' GLU . . . . . 0.463 ' N ' ' OD1' ' D' ' 34' ' ' ASP . 55.2 mm-40 -75.25 -40.11 59.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.185 -0.947 . . . . 0.0 109.413 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.79 -53.17 50.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.962 -1.087 . . . . 0.0 109.482 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 44.3 t -61.49 -47.81 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.056 -1.027 . . . . 0.0 109.211 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -61.45 -41.98 98.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.691 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -58.54 -46.66 86.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 109.474 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 40' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' D' ' 40' ' ' LEU . 47.7 mt -71.4 -46.89 59.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.175 -0.953 . . . . 0.0 109.007 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -49.9 -44.99 50.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.816 -1.177 . . . . 0.0 109.172 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -63.31 -34.61 78.07 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.057 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -73.92 -36.9 64.75 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.324 -0.86 . . . . 0.0 109.328 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 t -73.4 -51.21 26.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.792 -1.193 . . . . 0.0 108.887 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.92 -33.42 37.08 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.73 1.253 . . . . 0.0 110.098 -177.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.82 -30.33 51.08 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.837 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -92.2 4.2 53.73 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.77 26.44 62.74 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 118.492 -1.813 . . . . 0.0 109.359 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.38 -167.67 13.37 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 9.9 ttp -107.38 -43.47 4.55 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.499 -1.0 . . . . 0.0 109.706 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 173.55 -152.79 16.13 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 tp -131.81 142.34 49.7 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.446 -1.032 . . . . 0.0 109.716 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 53' ' ' ILE . . . . . 1.035 HD12 ' H ' ' D' ' 53' ' ' ILE . 0.0 OUTLIER -113.98 147.4 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.598 -0.689 . . . . 0.0 110.181 -178.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 84.08 -54.63 0.13 Allowed 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 118.683 0.674 . . . . 0.0 111.607 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 55' ' ' PHE . . . . . 0.601 ' O ' ' O ' ' D' ' 54' ' ' ALA . 50.4 t80 43.03 -179.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 56' ' ' ARG . . . . . 0.451 ' N ' ' CD2' ' D' ' 55' ' ' PHE . 1.6 mmm180 . . . . . 0 N--CA 1.499 2.007 0 O-C-N 120.461 -1.4 . . . . 0.0 109.139 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 67' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' D' ' 26' ' ' ALA . 4.3 p90 . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 121.968 0.89 . . . . 0.0 110.125 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.18 175.15 40.09 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 69' ' ' THR . . . . . 0.468 ' OG1' HD11 ' D' ' 25' ' ' ILE . 4.9 m -97.9 134.91 40.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.99 -1.3 . . . . 0.0 108.176 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 70' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' D' ' 22' ' ' SER . 50.3 mt -79.45 134.71 27.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.9 163.04 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.466 -0.771 . . . . 0.0 109.737 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 72' ' ' LYS . . . . . 0.428 ' H ' ' H ' ' D' ' 21' ' ' TYR . 14.9 ttpp -154.19 140.35 18.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.446 -0.784 . . . . 0.0 108.998 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.74 150.78 25.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.829 -1.169 . . . . 0.0 108.868 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 7.6 t70 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.087 -1.008 . . . . 0.0 109.317 179.494 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 6' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' E' ' 50' ' ' MET . 54.8 tttt . . . . . 0 N--CA 1.499 1.99 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -105.08 122.51 46.03 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 14.3 mt -134.3 131.56 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.362 -0.836 . . . . 0.0 109.736 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 9' ' ' ILE . . . . . 0.585 ' O ' HG23 ' E' ' 9' ' ' ILE . 19.2 tt -121.82 117.25 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.53 133.63 55.79 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.459 -0.776 . . . . 0.0 108.988 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 11' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' E' ' 12' ' ' ALA . 25.3 m -86.88 61.63 6.92 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.048 -1.032 . . . . 0.0 111.085 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 12' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' E' ' 11' ' ' THR . . . 174.99 -110.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -176.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 167.88 113.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 14' ' ' GLU . . . . . 0.425 ' CG ' ' H ' ' E' ' 15' ' ' ILE . 0.8 OUTLIER -173.73 -96.79 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.057 -1.027 . . . . 0.0 109.635 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 15' ' ' ILE . . . . . 0.51 ' N ' ' HD3' ' E' ' 16' ' ' PRO . 8.6 mt 59.0 60.1 5.12 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 109.61 -179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 16' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' E' ' 15' ' ' ILE . 1.6 Cg_endo -64.9 153.15 79.51 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 122.018 1.812 . . . . 0.0 109.734 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.52 -8.77 78.48 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.356 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 18' ' ' LEU . . . . . 0.482 HD12 ' CG2' ' E' ' 15' ' ' ILE . 61.3 mt -124.55 137.56 54.39 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.077 -1.249 . . . . 0.0 109.188 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -86.99 108.73 18.97 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 12.8 mt -89.4 136.32 33.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 110.001 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 21' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' E' ' 71' ' ' VAL . 4.3 t80 -117.81 129.69 55.82 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.0 127.38 30.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.811 -1.181 . . . . 0.0 110.941 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' E' ' 23' ' ' LEU . 23.4 mt -113.58 8.49 17.7 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.55 -163.15 13.13 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -128.18 143.67 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.867 -0.784 . . . . 0.0 109.216 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.24 147.81 39.9 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.4 0.619 . . . . 0.0 109.439 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 60.0 p -151.71 135.01 15.98 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.84 148.79 30.31 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.98 -1.075 . . . . 0.0 108.835 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 tp -127.1 133.51 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 4.5 m -151.21 -152.7 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 109.067 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 31' ' ' ASP . . . . . 0.423 ' CG ' ' H ' ' E' ' 32' ' ' ASN . 0.9 OUTLIER -106.22 -82.72 0.53 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.36 -0.837 . . . . 0.0 111.114 -178.51 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 32' ' ' ASN . . . . . 0.423 ' H ' ' CG ' ' E' ' 31' ' ' ASP . 87.7 m-20 -81.01 165.11 22.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.03 . . . . 0.0 109.428 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 64.6 t -68.15 -31.9 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.789 -0.569 . . . . 0.0 109.731 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.37 -40.91 68.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 109.859 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -76.66 -35.48 57.92 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.19 -0.944 . . . . 0.0 109.082 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 69.2 mt -63.97 -52.89 50.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 120.929 -1.107 . . . . 0.0 109.425 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.54 -49.1 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.067 -1.021 . . . . 0.0 109.396 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -58.61 -39.11 79.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.892 . . . . 0.0 109.381 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -69.47 -39.94 77.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 0.0 109.782 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 40' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' E' ' 40' ' ' LEU . 21.7 mt -68.2 -45.59 72.95 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.917 -1.115 . . . . 0.0 108.711 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -47.43 -56.61 6.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.859 -1.151 . . . . 0.0 108.944 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -55.06 -32.94 62.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.861 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -75.53 -40.82 56.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.9 . . . . 0.0 110.087 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 38.4 t -76.88 -52.51 16.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.935 -1.103 . . . . 0.0 108.879 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -56.57 -28.6 60.56 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.381 1.086 . . . . 0.0 110.21 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.73 -28.46 58.54 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.507 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -87.22 10.91 15.49 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.64 29.17 53.6 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.081 -1.533 . . . . 0.0 109.417 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.97 -168.81 30.04 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 50' ' ' MET . . . . . 0.473 ' O ' ' O ' ' E' ' 6' ' ' LYS . 65.5 mtp -103.96 -37.42 7.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.514 -0.992 . . . . 0.0 109.288 177.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 174.5 -153.27 15.91 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 12.0 tp -126.94 135.72 51.28 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.525 -0.985 . . . . 0.0 109.744 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 53' ' ' ILE . . . . . 0.476 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 1.2 pt -110.36 146.19 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.528 -0.732 . . . . 0.0 109.958 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 67.66 87.41 0.12 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 109.711 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -138.4 82.16 1.89 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 56' ' ' ARG . . . . . 0.671 HH22 ' NH1' ' A' ' 56' ' ' ARG . 12.8 ptm180 -120.48 8.74 10.78 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.636 -0.665 . . . . 0.0 109.338 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 57' ' ' ILE . . . . . 0.541 HG22 ' O ' ' E' ' 57' ' ' ILE . 72.4 mt . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.539 -0.726 . . . . 0.0 109.693 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 19.0 p90 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 122.048 0.928 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.01 162.07 32.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 52.8 m -102.96 134.34 46.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.103 -1.233 . . . . 0.0 108.09 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 37.2 mt -86.07 136.45 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 71' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' E' ' 21' ' ' TYR . 6.5 m -132.22 165.86 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.4 -0.813 . . . . 0.0 110.2 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 72' ' ' LYS . . . . . 0.449 ' CB ' HD11 ' E' ' 23' ' ' LEU . 1.5 ttpp -153.95 140.74 19.09 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.97 151.1 22.86 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.791 -1.193 . . . . 0.0 108.85 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.063 -1.023 . . . . 0.0 109.576 179.49 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.4 t80 . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 76.6 mt -109.91 130.86 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.376 -0.828 . . . . 0.0 109.936 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.61 ' O ' HG23 ' A' ' 9' ' ' ILE . 6.7 tt -135.05 114.61 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.6 t -123.16 160.05 27.32 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.958 0.885 . . . . 0.0 109.223 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 12' ' ' ALA . 11.0 p -96.34 -110.1 0.15 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.746 -0.596 . . . . 0.0 109.733 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 11' ' ' THR . . . 37.7 -104.44 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.1 -1.0 . . . . 0.0 111.073 177.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 15.0 p-10 -142.85 -64.68 0.4 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.446 -0.784 . . . . 0.0 109.793 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.467 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 11.5 pt-20 -152.16 -166.75 2.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.108 -0.995 . . . . 0.0 109.56 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.8 mt -116.59 97.72 50.59 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.603 -0.686 . . . . 0.0 109.303 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.18 156.31 46.02 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.82 1.68 . . . . 0.0 110.273 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.11 -7.59 78.46 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 18' ' ' LEU . 62.4 mt -129.88 141.37 50.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.31 -1.112 . . . . 0.0 109.467 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.6 117.05 25.12 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.6 mt -101.34 136.66 40.82 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.132 -0.98 . . . . 0.0 109.154 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.424 ' H ' ' H ' ' A' ' 72' ' ' LYS . 12.3 t80 -113.62 129.26 56.6 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.385 -0.822 . . . . 0.0 109.083 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.1 t -73.37 124.57 26.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.488 -1.383 . . . . 0.0 109.377 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.7 mt -111.07 8.45 21.82 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.37 -167.04 21.47 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.3 mm -122.26 142.23 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.8 153.44 29.09 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.5 m -152.2 145.08 24.4 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.07 -1.019 . . . . 0.0 109.084 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.7 p -143.84 131.07 20.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.469 -0.769 . . . . 0.0 108.983 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.628 ' O ' ' CB ' ' A' ' 30' ' ' SER . 91.8 mt -105.87 153.34 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.628 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 88.9 p 120.89 -147.53 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 32' ' ' ASN . 22.0 t70 -145.64 -160.73 1.18 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.457 ' H ' ' CG ' ' A' ' 31' ' ' ASP . 14.0 m-20 70.66 101.61 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.4 t -62.56 -35.97 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.123 -0.986 . . . . 0.0 109.325 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.69 -41.7 86.87 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.248 -0.908 . . . . 0.0 109.692 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -75.81 -41.17 53.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.316 -0.865 . . . . 0.0 109.486 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.5 mt -63.41 -53.79 40.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.945 -1.097 . . . . 0.0 108.959 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.9 t -55.96 -49.87 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 108.999 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.91 -40.12 87.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 109.94 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -62.11 -44.02 97.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.176 -0.953 . . . . 0.0 109.499 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.3 mt -71.12 -49.08 48.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.105 -0.997 . . . . 0.0 108.7 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -48.8 -49.35 39.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.805 -1.184 . . . . 0.0 109.277 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -63.21 -36.39 83.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.513 -0.742 . . . . 0.0 110.217 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.67 -35.53 57.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.833 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 t -68.3 -51.2 50.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 109.196 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -67.13 -37.94 84.7 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.773 -1.205 . . . . 0.0 109.161 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.1 -32.64 66.5 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -85.45 -4.53 59.19 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.46 -0.775 . . . . 0.0 109.341 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.66 9.13 61.63 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.84 -157.22 3.76 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.4 ptm -165.1 -20.15 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.09 -1.241 . . . . 0.0 110.385 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -152.56 160.11 28.8 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 tp -118.06 138.87 51.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.652 -0.91 . . . . 0.0 109.115 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.551 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 1.1 pt -114.51 147.08 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.483 -0.761 . . . . 0.0 109.969 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 70.75 85.08 0.13 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.456 -0.778 . . . . 0.0 110.932 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.4 ' CG ' HD11 ' A' ' 9' ' ' ILE . 52.8 t80 -123.62 102.59 7.93 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -123.13 138.09 54.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.517 -0.739 . . . . 0.0 109.813 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.405 ' O ' ' CG1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.7 p90 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.414 0.626 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.7 149.21 18.75 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.492 ' OG1' HG23 ' E' ' 11' ' ' THR . 21.2 m -106.56 140.65 39.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -1.131 . . . . 0.0 108.821 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.2 mt -84.5 134.04 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.68 155.47 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.235 -0.916 . . . . 0.0 109.104 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.424 ' H ' ' H ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -148.26 134.24 19.17 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.16 148.41 28.88 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.139 -0.976 . . . . 0.0 108.542 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 25.2 p-10 . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.129 -0.982 . . . . 0.0 109.031 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 74.5 t80 . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 71.1 mt -124.44 141.47 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.476 -0.765 . . . . 0.0 109.433 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.462 ' O ' ' CG2' ' B' ' 9' ' ' ILE . 6.8 tt -136.87 119.76 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 7.6 t -124.6 156.58 37.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.196 -0.94 . . . . 0.0 108.622 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.477 ' HB ' ' H ' ' B' ' 12' ' ' ALA . 0.0 OUTLIER -68.33 -132.34 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.477 ' H ' ' HB ' ' B' ' 11' ' ' THR . . . -94.09 110.21 21.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.138 -0.976 . . . . 0.0 110.014 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -162.75 -134.22 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLU . . . . . 0.634 ' O ' ' C ' ' B' ' 15' ' ' ILE . 6.4 pt-20 -172.99 46.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.064 -1.022 . . . . 0.0 109.49 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.634 ' C ' ' O ' ' B' ' 14' ' ' GLU . 11.3 mt -1.81 77.58 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.505 0 O-C-N 122.357 -0.214 . . . . 0.0 110.586 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.498 ' N ' ' O ' ' B' ' 14' ' ' GLU . 2.3 Cg_endo -62.12 155.49 55.8 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.831 1.687 . . . . 0.0 110.183 -177.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.44 -11.59 71.74 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 34.7 mt -124.37 137.52 54.46 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.08 -1.247 . . . . 0.0 109.228 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.17 116.1 24.15 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.45 138.73 35.24 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.242 -0.911 . . . . 0.0 109.687 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -118.29 129.79 55.66 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.82 129.18 39.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.732 -1.23 . . . . 0.0 110.673 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.404 HD11 ' CB ' ' B' ' 72' ' ' LYS . 74.2 mt -115.62 7.1 14.71 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.96 -156.06 16.18 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.63 142.94 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.885 -0.773 . . . . 0.0 109.389 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.2 144.6 44.6 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.774 -0.579 . . . . 0.0 109.954 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 30.7 p -152.45 141.83 21.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.191 -0.943 . . . . 0.0 108.743 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.59 152.76 36.02 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.077 -1.015 . . . . 0.0 109.72 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.428 HD12 ' N ' ' B' ' 29' ' ' ILE . 3.4 mp -98.52 152.27 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.245 -0.909 . . . . 0.0 108.949 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 173.05 143.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.445 -0.784 . . . . 0.0 109.242 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.411 ' O ' ' CG ' ' B' ' 32' ' ' ASN . 15.2 p-10 -93.08 30.1 1.71 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.235 -0.916 . . . . 0.0 110.325 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ASN . . . . . 0.411 ' CG ' ' O ' ' B' ' 31' ' ' ASP . 27.1 m120 -162.23 141.17 9.28 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.548 0.689 . . . . 0.0 109.902 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.23 -37.27 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.396 -0.815 . . . . 0.0 109.57 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.71 -38.77 72.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 0.0 109.536 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -75.28 -36.93 61.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.235 -0.916 . . . . 0.0 108.696 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 82.4 mt -65.29 -53.5 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.917 -1.114 . . . . 0.0 109.25 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -54.54 -51.34 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.109 -0.994 . . . . 0.0 109.134 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.83 -43.02 98.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.35 -0.844 . . . . 0.0 109.758 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -60.65 -45.24 94.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.29 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' B' ' 40' ' ' LEU . 61.1 mt -67.09 -46.08 75.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.155 -0.966 . . . . 0.0 108.911 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -50.1 -43.7 51.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.764 -1.21 . . . . 0.0 109.459 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -67.87 -38.6 83.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.614 -0.679 . . . . 0.0 110.272 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -76.48 -35.62 58.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.453 -0.779 . . . . 0.0 109.858 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 t -66.12 -50.12 71.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 109.21 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -62.96 -31.03 72.04 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.238 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.68 -31.74 71.05 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.763 0.792 . . . . 0.0 109.394 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -84.91 -5.38 59.34 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.75 8.96 75.64 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.69 164.61 45.18 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.98 1.85 2.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.03 -1.277 . . . . 0.0 110.325 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.7 165.75 38.61 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.921 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 tp -136.52 137.9 40.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.585 -0.95 . . . . 0.0 109.163 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.906 HD13 ' O ' ' B' ' 53' ' ' ILE . 0.0 OUTLIER -109.4 151.68 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.47 -0.769 . . . . 0.0 109.872 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 78.83 -64.02 0.27 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.327 -0.858 . . . . 0.0 112.678 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.495 ' CG ' ' O ' ' B' ' 55' ' ' PHE . 61.2 t80 34.74 36.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.394 0.616 . . . . 0.0 109.788 177.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' ARG . . . . . 0.793 ' HG3' HH11 ' B' ' 56' ' ' ARG . 14.3 mtm-85 -64.39 154.71 34.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.868 -1.145 . . . . 0.0 109.73 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 84.6 mt . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.788 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -127.79 -114.89 1.86 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' TYR . . . . . 0.436 ' CD1' ' O ' ' B' ' 67' ' ' TYR . 32.4 p90 -172.87 130.97 0.51 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -1.172 . . . . 0.0 109.142 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.54 148.11 19.75 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 79.0 m -102.18 136.29 42.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.907 -1.349 . . . . 0.0 108.761 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 49.1 mt -83.03 142.88 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 m -135.45 157.71 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.151 -0.968 . . . . 0.0 109.767 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.404 ' CB ' HD11 ' B' ' 23' ' ' LEU . 0.0 OUTLIER -147.17 151.35 36.63 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.31 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.4 150.22 34.99 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.028 -1.045 . . . . 0.0 109.242 179.435 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -102.46 144.31 31.07 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 14.1 mt -132.98 135.97 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.464 -0.772 . . . . 0.0 109.577 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 9' ' ' ILE . . . . . 0.61 ' O ' HG23 ' C' ' 9' ' ' ILE . 16.4 tt -137.77 115.0 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -123.05 158.68 30.06 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 7.6 p -114.82 85.09 2.18 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.35 -133.08 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.72 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -107.6 -55.98 2.28 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.55 -0.719 . . . . 0.0 109.39 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 14' ' ' GLU . . . . . 0.522 ' HG2' ' H ' ' C' ' 15' ' ' ILE . 22.7 tt0 -164.89 -179.32 5.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.933 . . . . 0.0 108.886 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 15' ' ' ILE . . . . . 0.522 ' H ' ' HG2' ' C' ' 14' ' ' GLU . 63.6 mt -112.12 92.04 17.44 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.95 156.7 42.53 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 122.0 1.8 . . . . 0.0 110.456 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.74 -6.08 76.92 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 77.6 mt -130.63 140.44 50.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -1.179 . . . . 0.0 109.494 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -86.01 107.56 17.83 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.545 ' HB3' ' HB ' ' C' ' 71' ' ' VAL . 6.7 mt -111.0 128.17 55.76 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.485 -0.759 . . . . 0.0 110.451 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 21' ' ' TYR . . . . . 0.641 ' CD1' ' N ' ' C' ' 21' ' ' TYR . 0.0 OUTLIER -112.42 142.75 44.58 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.639 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.7 136.42 45.58 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.627 0.727 . . . . 0.0 110.106 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.451 HD21 ' HD3' ' C' ' 72' ' ' LYS . 2.1 mt -120.43 12.93 11.74 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.5 -175.46 16.72 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 25' ' ' ILE . . . . . 0.438 HD11 HG23 ' B' ' 9' ' ' ILE . 49.4 mm -114.58 139.23 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.13 143.95 42.32 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.35 -0.843 . . . . 0.0 109.217 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 19.2 m -152.83 146.87 25.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.094 -1.004 . . . . 0.0 109.211 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 9.6 t -149.9 137.18 19.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.351 -0.843 . . . . 0.0 109.171 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.404 HG22 ' N ' ' C' ' 30' ' ' SER . 89.2 mt -108.23 157.97 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.698 ' O ' ' CG ' ' C' ' 31' ' ' ASP . 15.4 m 62.74 85.09 0.13 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.526 -0.734 . . . . 0.0 109.774 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 31' ' ' ASP . . . . . 0.698 ' CG ' ' O ' ' C' ' 30' ' ' SER . 27.2 m-20 173.04 132.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -83.73 175.17 9.87 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 1.9 m -46.16 -42.62 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.636 0 O-C-N 120.56 -1.337 . . . . 0.0 107.673 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -63.0 -48.7 77.66 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.297 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -73.14 -36.73 66.74 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.955 -1.091 . . . . 0.0 108.896 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 89.5 mt -61.96 -52.53 59.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.824 -1.172 . . . . 0.0 109.396 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.97 -48.58 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -0.965 . . . . 0.0 109.399 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 38' ' ' GLU . . . . . 0.442 ' HA ' ' HE ' ' C' ' 41' ' ' ARG . 24.3 mm-40 -56.0 -36.23 67.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 109.007 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 39' ' ' ASN . . . . . 0.48 ' ND2' ' OD2' ' C' ' 31' ' ' ASP . 79.8 m-20 -76.07 -37.79 57.82 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.728 -1.232 . . . . 0.0 110.565 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 40' ' ' LEU . . . . . 0.58 ' O ' HG13 ' C' ' 44' ' ' VAL . 78.7 mt -74.27 -53.28 10.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.741 -1.225 . . . . 0.0 110.024 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 41' ' ' ARG . . . . . 0.453 ' NH1' ' HE2' ' C' ' 45' ' ' LYS . 2.2 ppt_? -47.19 -45.23 22.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.075 -1.016 . . . . 0.0 109.279 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -60.12 -32.46 71.02 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.051 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 43' ' ' GLN . . . . . 0.524 ' O ' ' HB2' ' C' ' 47' ' ' LYS . 69.8 mm-40 -75.31 -36.61 61.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -0.971 . . . . 0.0 110.756 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 44' ' ' VAL . . . . . 0.617 ' O ' ' N ' ' C' ' 49' ' ' GLY . 0.8 OUTLIER -76.8 -52.1 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.712 -1.243 . . . . 0.0 109.83 -179.189 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 45' ' ' LYS . . . . . 0.475 ' N ' ' CG2' ' C' ' 44' ' ' VAL . 0.3 OUTLIER -61.53 -33.0 73.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.28 -1.512 . . . . 0.0 109.38 -175.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.7 -32.89 62.31 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.85 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 47' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' C' ' 43' ' ' GLN . 3.9 mtpp -93.31 -7.61 44.41 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 48' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' C' ' 44' ' ' VAL . . . 105.39 -1.25 40.05 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 49' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' C' ' 44' ' ' VAL . . . -65.18 -173.68 4.08 Favored Glycine 0 N--CA 1.483 1.798 0 O-C-N 119.913 -1.934 . . . . 0.0 109.597 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.08 9.87 0.44 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.094 -1.239 . . . . 0.0 110.003 176.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.07 164.73 18.81 Favored Glycine 0 N--CA 1.483 1.8 0 C-N-CA 118.974 -1.584 . . . . 0.0 109.813 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 52' ' ' LEU . . . . . 0.427 HD22 HD13 ' C' ' 40' ' ' LEU . 0.4 OUTLIER -115.76 149.6 38.23 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.87 -0.783 . . . . 0.0 109.88 179.033 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 53' ' ' ILE . . . . . 0.63 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 1.1 pt -113.15 143.67 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.678 -0.639 . . . . 0.0 110.104 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 77.78 -50.66 0.51 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.68 -0.637 . . . . 0.0 110.679 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 55' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' C' ' 54' ' ' ALA . 50.0 t80 42.24 68.98 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 56' ' ' ARG . . . . . 0.67 ' CG ' HH11 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -77.02 137.98 39.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.129 -178.799 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 42.7 p90 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.578 0.704 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 166.49 -162.0 35.68 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 21.8 m -123.92 136.65 54.47 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.13 142.85 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 71' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' C' ' 20' ' ' LEU . 5.2 m -137.18 150.19 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.661 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 72' ' ' LYS . . . . . 0.451 ' HD3' HD21 ' C' ' 23' ' ' LEU . 12.9 mtpp -119.17 146.01 45.53 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.45 149.43 26.17 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' C' ' 74' ' ' ASP . 25.9 p-10 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 120.772 -1.205 . . . . 0.0 109.376 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 N--CA 1.494 1.742 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -92.49 120.01 32.54 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.102 -0.999 . . . . 0.0 108.743 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 50.7 mt -126.14 129.87 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.461 -0.774 . . . . 0.0 110.093 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 9' ' ' ILE . . . . . 0.601 HG23 ' O ' ' D' ' 9' ' ' ILE . 17.1 tt -113.64 114.43 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t -123.55 160.68 26.49 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.147 -0.971 . . . . 0.0 109.082 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.5 p -91.84 -113.2 0.09 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.5 -120.15 0.87 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.106 . . . . 0.0 110.426 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -152.7 -27.16 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.728 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -168.56 177.1 5.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 0.0 109.53 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 96.1 mt -116.55 97.61 50.37 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.13 155.96 47.82 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.772 1.648 . . . . 0.0 110.415 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.18 -7.54 78.34 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 64.8 mt -129.28 140.46 51.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -1.103 . . . . 0.0 109.513 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -84.52 108.49 17.32 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 15.1 mt -97.26 135.26 39.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.825 . . . . 0.0 110.025 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 21' ' ' TYR . . . . . 0.5 ' CE1' ' O ' ' D' ' 22' ' ' SER . 1.5 t80 -117.74 130.04 56.07 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 22' ' ' SER . . . . . 0.5 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 28.3 t -75.0 129.68 38.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.911 -1.118 . . . . 0.0 110.917 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mt -117.3 12.17 14.24 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.79 177.84 15.2 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.65 145.02 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.892 -0.769 . . . . 0.0 108.943 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.69 144.12 42.74 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.6 -0.688 . . . . 0.0 109.348 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 92.4 p -152.2 138.42 18.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.083 -1.011 . . . . 0.0 108.611 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 13.5 t -149.51 146.33 27.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.052 -1.03 . . . . 0.0 109.134 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 47.5 mm -116.94 131.54 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.274 -0.891 . . . . 0.0 109.199 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 11.9 m -153.46 -158.04 0.84 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.207 -0.933 . . . . 0.0 109.408 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 31' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -106.88 -80.03 0.57 Allowed 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.406 -0.809 . . . . 0.0 111.153 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -65.39 144.78 56.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.896 -1.127 . . . . 0.0 109.153 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 33' ' ' VAL . . . . . 0.413 ' H ' HG13 ' D' ' 33' ' ' VAL . 1.9 m -69.42 -36.15 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -58.25 -29.47 65.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.522 -0.736 . . . . 0.0 109.606 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -75.03 -36.02 61.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.364 -0.835 . . . . 0.0 108.888 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 54.8 mt -60.97 -49.62 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.308 -0.87 . . . . 0.0 108.96 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 54.1 t -55.45 -49.44 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.998 . . . . 0.0 109.019 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.82 -41.07 90.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 109.593 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -62.48 -42.76 99.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 0.0 109.337 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 60.5 mt -67.55 -45.38 75.85 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.086 -1.009 . . . . 0.0 108.59 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -50.14 -55.3 15.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.858 -1.152 . . . . 0.0 109.198 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -58.76 -37.63 76.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.252 -0.905 . . . . 0.0 110.453 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -75.68 -35.61 60.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 109.764 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 9.6 t -69.0 -50.49 53.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.25 -0.907 . . . . 0.0 109.234 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -64.21 -29.92 71.01 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.483 -1.287 . . . . 0.0 109.002 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.71 -29.03 67.37 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.33 -5.29 56.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.503 -0.748 . . . . 0.0 109.921 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.0 9.42 58.32 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.2 158.74 40.46 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 3.0 ptm -126.9 -5.04 6.3 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.295 -1.121 . . . . 0.0 110.07 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.27 164.18 36.5 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 8.2 tp -125.42 134.05 52.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.7 -0.882 . . . . 0.0 109.186 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 53' ' ' ILE . . . . . 0.808 HD13 ' O ' ' D' ' 53' ' ' ILE . 0.0 OUTLIER -107.68 147.3 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.525 -0.735 . . . . 0.0 110.58 -178.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 51.73 63.44 2.24 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.369 -1.457 . . . . 0.0 109.668 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 55' ' ' PHE . . . . . 0.572 ' O ' ' O ' ' D' ' 56' ' ' ARG . 2.7 t80 -46.27 -60.15 2.49 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.282 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 56' ' ' ARG . . . . . 0.572 ' O ' ' O ' ' D' ' 55' ' ' PHE . 26.2 mmt180 . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 121.649 0.737 . . . . 0.0 110.201 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 34.7 p90 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.573 0.702 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -149.13 169.46 29.51 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 88.9 m -113.03 138.04 50.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.254 -1.145 . . . . 0.0 108.67 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 27.5 mt -87.36 135.65 24.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.6 155.72 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.799 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -151.55 158.0 42.98 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -120.19 150.16 41.1 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.123 -0.985 . . . . 0.0 109.306 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 121.562 0.696 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -94.21 118.82 32.12 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 76.2 mt -107.03 125.5 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.375 -0.828 . . . . 0.0 110.242 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 9' ' ' ILE . . . . . 0.617 ' O ' HG23 ' E' ' 9' ' ' ILE . 20.8 tt -133.42 113.79 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -123.78 161.57 24.95 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.294 -0.879 . . . . 0.0 109.528 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 11' ' ' THR . . . . . 0.492 HG23 ' OG1' ' A' ' 69' ' ' THR . 0.8 OUTLIER -87.87 -113.75 0.05 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 12' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' E' ' 11' ' ' THR . . . 41.64 -122.92 0.56 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 109.486 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 p30 175.53 26.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.549 -0.72 . . . . 0.0 109.647 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -173.44 151.69 2.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.206 -0.934 . . . . 0.0 109.638 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 15' ' ' ILE . . . . . 0.722 ' O ' HG23 ' E' ' 15' ' ' ILE . 18.0 tt -138.4 77.53 34.8 Favored Pre-proline 0 N--CA 1.498 1.971 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.86 156.85 36.06 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 122.116 1.878 . . . . 0.0 110.935 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.4 -6.73 71.63 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 18' ' ' LEU . . . . . 0.463 ' HA ' HD23 ' E' ' 18' ' ' LEU . 28.9 mt -128.69 137.43 51.61 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.896 -1.356 . . . . 0.0 109.544 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -84.22 108.79 17.31 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 20' ' ' LEU . . . . . 0.613 HD11 ' CG2' ' E' ' 15' ' ' ILE . 10.9 mt -104.95 146.05 29.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 111.009 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 21' ' ' TYR . . . . . 0.423 ' CZ ' ' O ' ' E' ' 22' ' ' SER . 1.6 t80 -129.76 130.66 45.68 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 22' ' ' SER . . . . . 0.423 ' O ' ' CZ ' ' E' ' 21' ' ' TYR . 13.7 t -53.02 130.61 34.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 111.104 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' E' ' 23' ' ' LEU . 5.3 mt -120.41 9.22 10.9 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.75 177.77 18.42 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 47.2 mm -112.42 143.23 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.784 -0.833 . . . . 0.0 109.358 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.06 154.53 28.7 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 5.2 p -149.67 147.32 27.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.054 -1.029 . . . . 0.0 109.043 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 28' ' ' THR . . . . . 0.556 ' OG1' HG23 ' E' ' 36' ' ' ILE . 17.2 p -148.71 132.09 16.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.44 -0.788 . . . . 0.0 109.354 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.453 ' O ' ' CB ' ' E' ' 30' ' ' SER . 86.3 mt -126.66 127.5 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' E' ' 29' ' ' ILE . 2.6 t 164.37 14.07 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 31' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' E' ' 32' ' ' ASN . 30.8 t0 51.91 -179.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.171 -0.956 . . . . 0.0 109.32 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 32' ' ' ASN . . . . . 0.462 ' H ' ' CG ' ' E' ' 31' ' ' ASP . 5.6 m-20 68.59 105.8 0.05 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.582 -0.698 . . . . 0.0 109.246 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 50.3 t -67.0 -34.52 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.259 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -58.73 -46.88 86.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 110.127 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 35' ' ' GLU . . . . . 0.481 ' O ' ' ND2' ' E' ' 39' ' ' ASN . 30.9 tt0 -75.46 -37.44 60.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.107 -0.995 . . . . 0.0 109.187 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 36' ' ' ILE . . . . . 0.556 HG23 ' OG1' ' E' ' 28' ' ' THR . 70.2 mt -64.84 -50.82 73.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.945 -1.097 . . . . 0.0 109.579 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 19.2 t -58.91 -51.12 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.05 -1.032 . . . . 0.0 109.195 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -38.44 73.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 109.116 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 39' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' E' ' 35' ' ' GLU . 2.3 m-80 -65.05 -39.02 92.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.163 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 54.4 mt -71.13 -48.13 53.92 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.147 -0.971 . . . . 0.0 109.084 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 41' ' ' ARG . . . . . 0.845 HH11 ' HG3' ' E' ' 41' ' ' ARG . 0.2 OUTLIER -50.67 -46.17 58.5 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.929 -1.107 . . . . 0.0 109.638 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -62.67 -34.53 77.29 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.176 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -70.63 -36.59 73.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.195 -0.941 . . . . 0.0 108.767 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 20.9 t -77.2 -51.36 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.754 -1.217 . . . . 0.0 109.222 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -49.03 -33.01 10.4 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.444 1.116 . . . . 0.0 110.254 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.31 -26.99 52.74 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.437 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -94.26 10.91 32.18 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.99 31.17 55.6 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 118.342 -1.885 . . . . 0.0 109.797 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -86.14 159.57 32.69 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 34.9 mmm -67.41 -41.69 84.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.144 -1.209 . . . . 0.0 110.5 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.74 -142.64 7.74 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 6.7 tp -130.71 132.55 45.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.531 -0.982 . . . . 0.0 109.284 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 53' ' ' ILE . . . . . 0.574 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 1.3 pt -107.53 145.52 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.568 -0.708 . . . . 0.0 110.192 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' E' ' 56' ' ' ARG . . . 71.37 -50.52 0.69 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.264 -0.897 . . . . 0.0 109.821 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 5.9 t80 50.93 -79.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 56' ' ' ARG . . . . . 0.748 HH11 ' HG2' ' E' ' 56' ' ' ARG . 0.0 OUTLIER 64.04 145.48 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.429 -0.794 . . . . 0.0 109.774 178.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 75.9 mt . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.777 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 13.4 p90 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.372 0.606 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.42 154.15 25.31 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 70.6 m -99.97 134.9 42.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.144 -1.21 . . . . 0.0 108.082 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 12.6 mt -89.2 141.21 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 m -144.72 163.41 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.387 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -149.04 154.62 39.56 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.94 151.57 37.91 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 t70 . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.67 -0.644 . . . . 0.0 109.634 179.817 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.4 t80 . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.0 mt -114.66 140.88 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.541 -0.724 . . . . 0.0 109.218 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 9' ' ' ILE . 14.4 tt -125.02 125.02 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.85 130.25 56.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.481 -0.762 . . . . 0.0 109.004 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.445 ' OG1' ' OG1' ' B' ' 69' ' ' THR . 45.7 m -105.21 105.15 15.06 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 52.88 58.11 5.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.311 -0.868 . . . . 0.0 109.892 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 39.9 t0 -143.59 -140.03 0.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.568 -0.708 . . . . 0.0 109.376 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.455 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 5.9 pt-20 -173.66 166.44 4.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.194 -0.942 . . . . 0.0 109.187 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.5 mt -136.13 71.21 62.03 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.378 -0.826 . . . . 0.0 109.158 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.26 156.55 45.02 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 C-N-CA 122.211 1.941 . . . . 0.0 110.225 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.27 -1.08 69.36 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.284 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 18' ' ' LEU . 37.1 mt -130.77 138.86 50.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.961 -1.317 . . . . 0.0 109.433 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.409 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 22.3 mm100 -84.6 108.77 17.52 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.6 mt -93.84 136.42 34.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.145 -0.972 . . . . 0.0 110.241 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 72' ' ' LYS . 47.4 t80 -116.02 129.13 56.23 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.23 124.52 24.32 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 120.305 -1.497 . . . . 0.0 110.316 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 72' ' ' LYS . 35.7 mt -110.1 3.86 20.64 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.04 -178.37 16.46 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.28 144.74 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.802 -0.822 . . . . 0.0 109.187 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.49 143.95 44.95 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.246 0.546 . . . . 0.0 110.078 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.3 m -152.29 134.69 15.21 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.0 t -150.1 153.65 36.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.822 -1.174 . . . . 0.0 109.328 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.2 mp -105.33 154.38 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 173.81 158.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 109.231 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -100.65 139.29 36.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.337 -0.852 . . . . 0.0 110.053 -178.805 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 3.9 t-20 81.04 141.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.81 -32.76 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.847 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.403 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 1.2 p30 -57.92 -43.5 86.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.927 . . . . 0.0 110.16 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.403 ' N ' ' CG ' ' A' ' 34' ' ' ASP . 63.9 mt-10 -75.18 -38.65 60.74 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.408 -0.808 . . . . 0.0 109.377 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.7 mt -63.52 -44.86 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.992 . . . . 0.0 109.478 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.77 -49.8 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.966 -1.084 . . . . 0.0 109.799 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -58.43 -38.94 78.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 109.678 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -63.12 -44.74 94.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.713 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.493 ' HA ' HD23 ' A' ' 40' ' ' LEU . 15.1 mt -69.44 -46.51 66.59 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.091 -1.006 . . . . 0.0 109.102 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.8 ' HG3' HH11 ' A' ' 41' ' ' ARG . 0.1 OUTLIER -49.43 -49.87 43.24 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 120.797 -1.19 . . . . 0.0 109.892 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -61.39 -36.97 81.74 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.521 -0.737 . . . . 0.0 110.29 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -77.07 -35.49 56.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.511 -0.743 . . . . 0.0 109.899 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.8 t -66.71 -50.88 62.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.035 -1.041 . . . . 0.0 109.103 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.72 -35.65 80.63 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.392 -1.323 . . . . 0.0 109.015 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.26 -28.86 69.47 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -5.63 56.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.517 -0.74 . . . . 0.0 109.881 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.81 11.82 57.42 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.08 161.55 36.12 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -125.27 -3.4 7.46 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.27 -1.135 . . . . 0.0 109.918 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.31 154.99 24.22 Favored Glycine 0 N--CA 1.487 2.087 0 C-N-CA 119.35 -1.405 . . . . 0.0 109.699 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.06 146.46 36.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.663 -0.904 . . . . 0.0 109.815 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.513 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -119.38 145.6 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.5 -0.75 . . . . 0.0 110.071 -177.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 70.2 79.24 0.19 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.581 -0.699 . . . . 0.0 110.451 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -103.07 136.61 42.56 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.488 ' NH1' ' NH2' ' E' ' 56' ' ' ARG . 58.0 ttt180 -151.84 156.47 40.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.73 -1.231 . . . . 0.0 109.764 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.1 mt . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.8 t80 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.804 0.811 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.23 153.23 22.62 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.324 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.433 ' OG1' HG23 ' E' ' 11' ' ' THR . 19.2 m -105.22 137.47 42.95 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.225 -1.162 . . . . 0.0 108.703 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 52.4 mt -80.66 141.86 14.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -131.59 153.7 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.379 -0.826 . . . . 0.0 109.466 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.574 ' NZ ' ' O ' ' A' ' 74' ' ' ASP . 15.9 ttpp -142.03 133.53 26.7 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 19' ' ' GLN . . . -123.45 151.82 42.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.001 -1.062 . . . . 0.0 108.568 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.574 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 13.4 m-20 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 120.882 -1.136 . . . . 0.0 110.234 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 86.7 t80 . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 68.4 mt -115.94 146.28 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.612 -0.68 . . . . 0.0 109.6 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.617 ' O ' HG23 ' B' ' 9' ' ' ILE . 9.5 tt -131.82 115.22 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -123.49 158.36 31.46 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.463 ' OG1' ' OG1' ' C' ' 69' ' ' THR . 1.5 m -112.67 103.18 11.21 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.33 88.45 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.468 -0.77 . . . . 0.0 109.853 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -162.08 -20.78 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.428 -0.795 . . . . 0.0 109.514 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 60.37 160.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.627 -0.671 . . . . 0.0 109.417 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 mt -130.4 82.94 64.03 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.561 -0.712 . . . . 0.0 109.084 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.58 156.37 42.52 Favored 'Trans proline' 0 C--N 1.323 -0.815 0 C-N-CA 122.068 1.845 . . . . 0.0 110.252 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.71 -6.34 77.12 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' B' ' 18' ' ' LEU . 66.9 mt -130.96 139.64 50.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.049 -1.265 . . . . 0.0 109.06 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.18 116.43 23.53 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.79 140.42 33.01 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.18 -0.95 . . . . 0.0 110.032 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' B' ' 71' ' ' VAL . 2.1 t80 -123.31 129.51 51.43 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 42.0 t -67.44 130.61 43.59 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.826 -1.171 . . . . 0.0 111.138 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.521 HD11 ' CB ' ' B' ' 72' ' ' LYS . 72.3 mt -116.71 8.24 13.69 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.42 -171.13 14.9 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 40.6 mm -119.05 141.9 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.908 -0.76 . . . . 0.0 109.367 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.15 144.82 42.01 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.616 -0.678 . . . . 0.0 109.425 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 85.3 p -152.22 137.8 17.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.097 -1.002 . . . . 0.0 108.599 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 8.8 t -149.74 149.6 30.81 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.937 -1.102 . . . . 0.0 109.265 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 66.1 mt -116.13 126.33 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.307 -0.87 . . . . 0.0 109.047 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 32.5 t -174.87 -146.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.148 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -158.91 172.01 18.99 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.211 -0.931 . . . . 0.0 108.814 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 2.1 m120 73.46 130.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 t -68.88 -35.12 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.551 -0.718 . . . . 0.0 109.49 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -58.96 -45.22 91.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.268 -0.895 . . . . 0.0 109.944 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -75.58 -42.1 52.93 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 0.0 109.872 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 77.8 mt -63.46 -53.77 41.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.917 -1.115 . . . . 0.0 109.322 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 t -56.9 -48.54 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.012 -1.055 . . . . 0.0 108.765 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -61.65 -41.18 97.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 110.064 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -58.68 -48.01 82.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.551 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 57.6 mt -74.26 -50.49 18.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 108.934 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -48.81 -47.85 41.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.776 -1.202 . . . . 0.0 108.892 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -61.32 -34.91 76.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 109.449 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -74.42 -36.03 63.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.524 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.29 -51.66 20.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.926 -1.109 . . . . 0.0 108.898 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -51.32 -29.25 14.45 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 122.613 1.196 . . . . 0.0 109.788 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.3 -26.76 52.59 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.439 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -94.26 8.41 41.88 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.07 31.13 68.14 Favored Glycine 0 N--CA 1.476 1.353 0 C-N-CA 118.157 -1.973 . . . . 0.0 109.911 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.48 -169.34 32.44 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 25.0 mmm -106.86 -37.2 6.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.397 -1.061 . . . . 0.0 109.554 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 176.16 -149.49 9.91 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 tp -137.65 143.72 41.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.357 -1.084 . . . . 0.0 109.823 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.65 ' O ' ' HB3' ' B' ' 54' ' ' ALA . 1.2 pt -114.36 146.63 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.5 -0.75 . . . . 0.0 109.376 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 82.88 -48.42 0.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 118.769 0.713 . . . . 0.0 109.893 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.524 ' C ' ' O ' ' B' ' 54' ' ' ALA . 78.5 t80 25.1 92.54 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 120.965 0.412 . . . . 0.0 110.593 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' ARG . . . . . 0.833 ' HG3' HH11 ' B' ' 56' ' ' ARG . 11.2 ttm-85 -98.77 153.46 18.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.214 -0.929 . . . . 0.0 109.821 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mp . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.755 0.788 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.14 53.49 0.94 Allowed Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -59.3 178.44 0.14 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.685 1.231 . . . . 0.0 110.228 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.63 160.41 26.25 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' THR . . . . . 0.445 ' OG1' ' OG1' ' A' ' 11' ' ' THR . 21.7 m -95.87 135.04 38.13 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 120.494 -1.591 . . . . 0.0 107.786 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 58.9 mt -83.64 146.39 6.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 4.3 m -136.31 162.33 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.551 -0.718 . . . . 0.0 109.989 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.521 ' CB ' HD11 ' B' ' 23' ' ' LEU . 5.9 tttt -152.28 141.76 21.67 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.37 151.36 29.87 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.953 -1.092 . . . . 0.0 108.694 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 56.4 t0 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 120.957 -1.089 . . . . 0.0 108.689 179.264 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 120.963 0.411 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -97.8 121.82 40.16 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.479 -0.763 . . . . 0.0 109.053 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.94 135.98 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.479 -0.763 . . . . 0.0 110.591 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 9' ' ' ILE . . . . . 0.633 ' O ' HG23 ' C' ' 9' ' ' ILE . 13.9 tt -132.12 113.33 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 4.9 t -124.45 160.65 27.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.346 -0.846 . . . . 0.0 109.284 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 4.3 p -110.26 83.45 1.76 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.75 -28.45 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.647 -0.658 . . . . 0.0 110.14 177.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 13' ' ' ASP . . . . . 0.604 ' N ' ' OD1' ' C' ' 13' ' ' ASP . 0.0 OUTLIER 68.51 43.33 1.41 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.479 -0.763 . . . . 0.0 109.49 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -178.67 129.3 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.105 -0.997 . . . . 0.0 109.521 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 16.6 mt -134.28 79.14 56.21 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.98 155.14 51.83 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 122.02 1.814 . . . . 0.0 110.503 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.15 -6.17 78.61 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 18' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' C' ' 18' ' ' LEU . 53.9 mt -131.6 139.58 49.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -1.198 . . . . 0.0 109.518 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 19' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' C' ' 73' ' ' ALA . 85.6 mt-30 -84.91 114.24 21.98 Favored 'General case' 0 C--O 1.192 -1.929 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 16.1 mt -94.64 138.56 32.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.783 -1.198 . . . . 0.0 110.752 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 21' ' ' TYR . . . . . 0.688 ' H ' ' H ' ' C' ' 72' ' ' LYS . 29.3 t80 -116.99 128.29 55.04 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.606 -0.684 . . . . 0.0 109.733 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.04 123.34 21.87 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 120.022 -1.674 . . . . 0.0 110.308 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.474 HD11 ' CB ' ' C' ' 72' ' ' LYS . 78.6 mt -114.69 7.68 16.0 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.96 -174.74 15.89 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.17 144.17 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 122.037 -0.684 . . . . 0.0 109.244 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.3 144.6 45.71 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.95 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 42.1 m -152.61 142.39 22.0 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.96 -1.087 . . . . 0.0 108.421 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 9.2 t -149.52 146.69 27.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.101 -0.999 . . . . 0.0 109.359 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 71.7 mt -113.52 137.37 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.399 -0.813 . . . . 0.0 110.253 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.554 ' OG ' ' N ' ' C' ' 31' ' ' ASP . 0.1 OUTLIER -158.97 -172.81 3.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.48 -0.763 . . . . 0.0 109.78 -179.1 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 31' ' ' ASP . . . . . 0.554 ' N ' ' OG ' ' C' ' 30' ' ' SER . 4.8 m-20 -97.14 -76.14 0.52 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.322 -0.861 . . . . 0.0 111.91 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -76.88 156.07 32.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.927 -1.108 . . . . 0.0 109.104 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.52 -32.89 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.315 0.579 . . . . 0.0 109.803 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.54 -38.0 63.38 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.329 -0.857 . . . . 0.0 109.474 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -76.86 -35.36 57.53 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.017 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 81.5 mt -63.56 -53.28 47.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.047 -1.033 . . . . 0.0 108.991 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.11 -50.59 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.05 -1.031 . . . . 0.0 109.152 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -57.92 -38.94 76.81 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.304 -0.873 . . . . 0.0 108.964 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -65.79 -42.12 91.14 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.93 . . . . 0.0 109.522 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 40' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' C' ' 40' ' ' LEU . 24.8 mt -69.41 -47.65 63.46 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.012 -1.055 . . . . 0.0 108.753 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -49.41 -54.15 18.98 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.885 -1.134 . . . . 0.0 109.261 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -56.66 -34.16 67.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.899 . . . . 0.0 109.208 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -74.8 -43.74 53.14 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.33 -0.856 . . . . 0.0 109.321 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 10.5 t -71.64 -52.29 26.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 O-C-N 120.846 -1.159 . . . . 0.0 108.647 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -51.73 -31.5 26.66 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.823 1.296 . . . . 0.0 110.075 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.3 -28.09 47.43 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.705 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.13 4.32 53.4 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.72 26.49 69.95 Favored Glycine 0 N--CA 1.48 1.605 0 C-N-CA 118.631 -1.747 . . . . 0.0 109.804 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.85 162.98 50.76 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 16.2 ttp -79.91 -42.04 24.9 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.836 -1.39 . . . . 0.0 109.946 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 172.5 -170.3 43.37 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 tp -113.2 141.97 46.34 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.561 -0.964 . . . . 0.0 110.403 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 53' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 2.2 pt -119.82 145.71 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.44 -0.787 . . . . 0.0 110.406 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 70.99 -56.01 0.63 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.209 -0.932 . . . . 0.0 110.823 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 1.1 t80 61.37 -123.4 0.84 Allowed 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' ARG . . . . . 0.838 HH11 ' HG2' ' C' ' 56' ' ' ARG . 0.0 OUTLIER -170.36 -138.65 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.239 -0.913 . . . . 0.0 109.928 -179.432 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 57' ' ' ILE . . . . . 0.484 ' H ' ' CG ' ' C' ' 56' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.185 -0.947 . . . . 0.0 109.637 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 67' ' ' TYR . . . . . 0.438 ' OH ' ' CZ ' ' C' ' 56' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.39 173.41 15.37 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 69' ' ' THR . . . . . 0.463 ' OG1' ' OG1' ' B' ' 11' ' ' THR . 53.0 m -122.75 132.82 54.4 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 119.036 1.418 . . . . 0.0 107.582 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 57.7 mt -79.13 129.73 37.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.17 161.88 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.445 -0.784 . . . . 0.0 109.87 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 72' ' ' LYS . . . . . 0.688 ' H ' ' H ' ' C' ' 21' ' ' TYR . 6.5 tttt -154.21 142.62 20.61 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' C' ' 19' ' ' GLN . . . -102.64 128.8 49.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.08 -1.013 . . . . 0.0 109.374 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.0 109.065 178.853 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt . . . . . 0 N--CA 1.498 1.933 0 CA-C-O 121.997 0.903 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -102.15 121.57 42.48 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 58.3 mt -133.65 128.42 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.434 -0.791 . . . . 0.0 109.351 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 9' ' ' ILE . . . . . 0.625 HG23 ' O ' ' D' ' 9' ' ' ILE . 9.1 tt -128.23 115.12 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.7 t -125.64 157.36 37.45 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 3.5 m -102.55 81.9 2.09 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.3 -112.15 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.452 -0.78 . . . . 0.0 110.203 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -152.49 -135.67 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.552 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -63.22 158.96 18.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -0.876 . . . . 0.0 109.371 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 38.9 mt -112.23 98.95 44.91 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.18 155.84 43.37 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.896 1.731 . . . . 0.0 110.392 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.68 -8.11 78.89 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 80.6 mt -131.44 142.27 49.98 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.42 -1.047 . . . . 0.0 109.309 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -87.77 108.45 19.13 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 20' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' D' ' 71' ' ' VAL . 4.3 mt -114.9 131.6 56.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.687 -0.633 . . . . 0.0 109.599 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 21' ' ' TYR . . . . . 0.595 ' OH ' ' N ' ' D' ' 74' ' ' ASP . 0.0 OUTLIER -113.73 143.42 44.64 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.576 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 16.6 t -75.06 128.33 35.29 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' D' ' 72' ' ' LYS . 0.7 OUTLIER -111.93 12.38 20.77 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.575 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.5 -179.09 16.35 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.9 144.01 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 122.174 -0.604 . . . . 0.0 109.606 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.25 144.28 40.67 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.405 0.621 . . . . 0.0 109.377 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.47 138.4 18.1 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.265 -0.897 . . . . 0.0 109.356 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 12.7 t -149.73 144.5 26.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.044 -1.035 . . . . 0.0 109.189 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 29' ' ' ILE . . . . . 0.43 ' O ' HG23 ' D' ' 29' ' ' ILE . 12.9 tt -117.95 127.91 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.271 -0.893 . . . . 0.0 108.93 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 30.1 t -173.65 174.28 3.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 109.056 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 31' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' D' ' 32' ' ' ASN . 29.5 t70 -107.49 157.29 18.14 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.332 -0.855 . . . . 0.0 109.565 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 3.7 t-20 85.97 123.81 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 -177.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 33' ' ' VAL . . . . . 0.454 ' H ' HG13 ' D' ' 33' ' ' VAL . 1.0 OUTLIER -69.86 -38.95 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -63.12 -31.0 72.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.539 -0.726 . . . . 0.0 109.878 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -75.0 -41.08 60.19 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.223 -0.923 . . . . 0.0 109.717 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 92.6 mt -62.2 -46.31 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.999 -1.063 . . . . 0.0 108.7 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 17.0 t -55.75 -48.07 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.909 -1.119 . . . . 0.0 108.288 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -62.76 -42.23 99.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.024 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -59.67 -45.56 91.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.333 -0.855 . . . . 0.0 109.415 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 40' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' D' ' 40' ' ' LEU . 49.4 mt -71.36 -48.0 52.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 108.899 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -49.07 -50.92 34.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.79 -1.194 . . . . 0.0 109.113 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -59.96 -36.21 76.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.398 -0.814 . . . . 0.0 109.952 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -75.8 -35.85 59.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.465 -0.772 . . . . 0.0 109.598 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 13.1 t -71.07 -50.79 39.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.066 -1.022 . . . . 0.0 108.799 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -64.74 -30.13 71.13 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 118.29 -1.364 . . . . 0.0 109.255 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.66 -30.41 69.95 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 47' ' ' LYS . . . . . 0.514 ' NZ ' ' HB3' ' D' ' 47' ' ' LYS . 0.1 OUTLIER -90.36 2.07 55.93 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.79 23.83 74.13 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.08 -165.65 7.92 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 7.8 ttt -110.2 -41.26 4.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.418 -1.048 . . . . 0.0 109.702 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 173.58 -158.66 28.06 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 3.4 tp -125.07 139.86 53.42 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.595 -0.944 . . . . 0.0 110.36 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 53' ' ' ILE . . . . . 0.656 ' O ' ' HB3' ' D' ' 54' ' ' ALA . 1.0 OUTLIER -118.06 148.53 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.672 -0.643 . . . . 0.0 110.501 -177.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 82.73 -38.22 0.09 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 118.832 0.742 . . . . 0.0 109.131 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 55' ' ' PHE . . . . . 0.498 ' O ' ' O ' ' D' ' 56' ' ' ARG . 31.3 t80 49.18 -110.41 0.4 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.624 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 56' ' ' ARG . . . . . 0.753 ' HG2' HH11 ' D' ' 56' ' ' ARG . 6.4 mtt-85 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.418 0.628 . . . . 0.0 109.868 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 t80 . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 122.277 1.037 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.1 139.68 5.81 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 46.9 m -109.55 148.32 31.45 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.065 -1.256 . . . . 0.0 109.536 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 24.1 mt -97.78 148.04 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.54 0.686 . . . . 0.0 109.577 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 71' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' D' ' 20' ' ' LEU . 12.2 m -143.34 154.18 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.491 -0.755 . . . . 0.0 109.357 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 72' ' ' LYS . . . . . 0.431 ' HB2' HD11 ' D' ' 23' ' ' LEU . 26.3 ttpp -139.98 142.5 36.33 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.049 -1.032 . . . . 0.0 108.667 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' D' ' 74' ' ' ASP . . . -124.11 141.36 52.12 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 74' ' ' ASP . . . . . 0.595 ' N ' ' OH ' ' D' ' 21' ' ' TYR . 3.5 p30 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 6' ' ' LYS . . . . . 0.512 ' CG ' ' H ' ' E' ' 7' ' ' PHE . 14.7 tttt . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 121.215 0.531 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 7' ' ' PHE . . . . . 0.512 ' H ' ' CG ' ' E' ' 6' ' ' LYS . 18.8 t80 -109.85 120.73 43.39 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.562 -0.711 . . . . 0.0 109.672 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 83.7 mt -96.86 128.57 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.323 -0.86 . . . . 0.0 110.988 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 9' ' ' ILE . . . . . 0.554 ' O ' HG23 ' E' ' 9' ' ' ILE . 17.1 tt -134.48 121.01 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 1.3 t -113.34 133.25 55.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.322 -0.861 . . . . 0.0 109.336 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 11' ' ' THR . . . . . 0.433 HG23 ' OG1' ' A' ' 69' ' ' THR . 0.0 OUTLIER -53.63 -90.74 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.397 -0.814 . . . . 0.0 110.984 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.09 72.72 1.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.123 -0.986 . . . . 0.0 108.366 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -160.26 141.53 12.32 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.415 0.626 . . . . 0.0 109.512 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -79.56 178.68 7.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.398 -0.814 . . . . 0.0 109.127 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 57.5 mt -123.6 88.17 51.96 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.474 -0.766 . . . . 0.0 109.184 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.55 155.49 52.76 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 121.962 1.775 . . . . 0.0 110.158 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.02 -12.34 69.78 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 18' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' E' ' 18' ' ' LEU . 15.9 mt -125.2 136.83 53.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -1.185 . . . . 0.0 108.982 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.14 112.84 21.68 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt -99.08 142.62 30.34 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.187 -0.946 . . . . 0.0 109.83 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 21' ' ' TYR . . . . . 0.479 ' H ' ' H ' ' E' ' 72' ' ' LYS . 1.5 t80 -123.29 130.07 52.23 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 22' ' ' SER . . . . . 0.403 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 4.3 t -61.39 129.97 43.8 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.83 -1.169 . . . . 0.0 110.953 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' E' ' 23' ' ' LEU . 6.8 mt -117.65 9.26 13.03 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.67 -173.6 14.86 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.77 143.92 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 122.033 -0.687 . . . . 0.0 109.433 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.61 144.04 47.34 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.943 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 19.4 m -152.18 136.34 16.57 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 10.9 t -149.92 151.49 33.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.972 -1.08 . . . . 0.0 109.222 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 56.6 mt -127.0 133.44 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.111 -0.993 . . . . 0.0 108.702 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.574 ' O ' ' N ' ' E' ' 32' ' ' ASN . 78.1 p -156.29 31.77 0.33 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.134 -0.979 . . . . 0.0 110.769 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 31' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' E' ' 31' ' ' ASP . 0.7 OUTLIER 54.28 -70.59 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 32' ' ' ASN . . . . . 0.574 ' N ' ' O ' ' E' ' 30' ' ' SER . 7.3 m120 -66.1 135.41 54.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.732 -1.23 . . . . 0.0 107.93 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 33' ' ' VAL . . . . . 0.482 ' H ' HG13 ' E' ' 33' ' ' VAL . 1.0 OUTLIER -70.88 -42.21 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 34' ' ' ASP . . . . . 0.421 ' N ' ' CG2' ' E' ' 33' ' ' VAL . 29.8 t70 -52.53 -28.02 18.98 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.512 -0.742 . . . . 0.0 109.825 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -78.11 -33.39 50.6 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.422 -0.799 . . . . 0.0 109.202 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.16 -52.77 57.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.031 -1.043 . . . . 0.0 108.776 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.89 -49.24 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.085 -1.01 . . . . 0.0 108.967 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -60.71 -41.86 96.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.414 -0.804 . . . . 0.0 108.978 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -64.46 -45.2 88.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.471 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 40' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' E' ' 40' ' ' LEU . 70.4 mt -64.57 -44.03 92.01 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.098 -1.001 . . . . 0.0 108.329 178.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 41' ' ' ARG . . . . . 0.796 HH11 ' HG2' ' E' ' 41' ' ' ARG . 0.0 OUTLIER -48.84 -55.5 11.48 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.845 -1.159 . . . . 0.0 109.352 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -55.96 -33.56 64.89 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.088 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -74.44 -40.07 62.17 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.462 -0.773 . . . . 0.0 109.494 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 12.8 t -73.87 -52.01 22.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 120.879 -1.138 . . . . 0.0 108.82 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -50.59 -29.6 11.22 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.692 1.234 . . . . 0.0 109.741 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.63 -25.84 50.04 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.383 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -95.71 4.38 53.04 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.67 30.73 78.73 Favored Glycine 0 N--CA 1.479 1.555 0 C-N-CA 118.009 -2.043 . . . . 0.0 110.181 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.32 153.92 23.84 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 10.8 mtm -66.46 -29.61 69.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -1.111 . . . . 0.0 110.474 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.74 -137.51 4.61 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 tp -133.64 137.93 45.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.421 -1.046 . . . . 0.0 110.086 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 53' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 1.1 pt -115.12 144.9 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.609 -0.682 . . . . 0.0 110.163 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 64.91 74.84 0.38 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.166 -0.959 . . . . 0.0 110.216 178.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 55' ' ' PHE . . . . . 0.4 ' CE2' HG21 ' E' ' 57' ' ' ILE . 17.9 t80 -98.56 107.47 19.93 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 56' ' ' ARG . . . . . 0.685 ' CG ' HH11 ' E' ' 56' ' ' ARG . 0.4 OUTLIER -97.3 135.63 38.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.582 -0.699 . . . . 0.0 110.529 -178.903 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 57' ' ' ILE . . . . . 0.4 HG21 ' CE2' ' E' ' 55' ' ' PHE . 1.2 tt . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 . . . . . 0 N--CA 1.498 1.929 0 CA-C-O 121.358 0.599 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.61 149.72 21.11 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 8.6 m -112.81 137.5 51.05 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 32.0 mt -82.78 148.68 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 m -130.44 164.8 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.662 -0.649 . . . . 0.0 109.907 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 72' ' ' LYS . . . . . 0.479 ' H ' ' H ' ' E' ' 21' ' ' TYR . 14.6 tttm -147.95 145.43 28.57 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.89 137.96 49.15 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t70 . . . . . 0 N--CA 1.488 1.47 0 O-C-N 120.728 -1.233 . . . . 0.0 108.13 178.118 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.7 t80 . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.5 mt -134.49 138.15 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.29 -0.881 . . . . 0.0 109.978 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.478 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 6.9 tt -127.8 118.21 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.788 -1.195 . . . . 0.0 108.088 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.4 t -127.24 154.93 44.24 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.059 -1.026 . . . . 0.0 109.563 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.424 HG21 ' HG3' ' A' ' 56' ' ' ARG . 1.4 m -135.54 115.95 13.63 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.52 66.23 1.23 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.344 -0.848 . . . . 0.0 109.655 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -164.13 -24.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.54 -0.725 . . . . 0.0 109.504 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 57.15 171.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.519 -0.738 . . . . 0.0 109.438 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mt -139.01 74.7 36.53 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.371 -0.831 . . . . 0.0 109.099 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.44 156.47 41.22 Favored 'Trans proline' 0 C--N 1.32 -0.952 0 C-N-CA 122.132 1.888 . . . . 0.0 110.197 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.08 -3.71 73.55 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.261 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 18' ' ' LEU . 42.6 mt -129.9 137.87 50.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.279 . . . . 0.0 108.871 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.454 ' H ' ' HG2' ' A' ' 19' ' ' GLN . 12.0 pt20 -85.91 113.82 22.33 Favored 'General case' 0 C--O 1.2 -1.518 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -95.0 138.81 32.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.892 -1.13 . . . . 0.0 109.603 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.712 ' O ' HG12 ' A' ' 71' ' ' VAL . 42.4 t80 -109.97 155.07 22.26 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.45 126.56 38.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 119.857 -1.777 . . . . 0.0 108.07 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.7 mt -117.08 5.91 12.83 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.69 -164.36 13.51 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.35 145.24 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 122.027 -0.69 . . . . 0.0 109.653 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.99 154.37 25.41 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 87.0 p -147.11 150.18 34.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.126 -0.984 . . . . 0.0 109.087 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.7 p -148.86 134.71 18.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.539 -0.726 . . . . 0.0 109.468 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.653 ' O ' ' OG ' ' A' ' 30' ' ' SER . 10.6 mm -127.12 126.0 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.653 ' OG ' ' O ' ' A' ' 29' ' ' ILE . 23.4 m 171.81 -129.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.175 0.512 . . . . 0.0 109.679 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.464 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 3.1 p30 -153.38 165.15 36.68 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.045 -1.034 . . . . 0.0 109.227 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 7.8 t-20 77.55 109.52 0.07 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -177.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.494 ' H ' HG13 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -69.36 -38.06 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.359 -0.838 . . . . 0.0 108.868 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 35' ' ' GLU . 1.9 p30 -61.17 -32.4 72.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.845 . . . . 0.0 110.095 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.46 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 31.1 tt0 -75.69 -37.45 59.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 0.0 109.139 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.1 mt -62.51 -42.61 96.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.12 -0.988 . . . . 0.0 108.836 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.28 -50.19 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.007 -1.058 . . . . 0.0 108.81 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -59.37 -38.94 81.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 109.663 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -61.76 -43.34 99.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.387 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 76.8 mt -68.07 -46.05 72.15 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.169 -0.957 . . . . 0.0 108.527 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -50.65 -53.3 32.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.899 -1.126 . . . . 0.0 109.199 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -57.81 -33.53 68.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.426 -0.796 . . . . 0.0 109.093 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -72.98 -41.88 63.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.331 -0.855 . . . . 0.0 109.34 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.568 HG21 HD21 ' A' ' 52' ' ' LEU . 21.1 t -77.01 -50.93 19.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 120.682 -1.261 . . . . 0.0 109.359 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -49.73 -32.97 14.79 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 122.681 1.229 . . . . 0.0 109.954 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.25 -29.26 48.0 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.824 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -93.54 5.8 50.39 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.25 29.43 68.71 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 118.265 -1.922 . . . . 0.0 109.629 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.2 -168.53 11.06 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -104.85 -53.9 2.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -1.059 . . . . 0.0 109.955 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.415 ' C ' HD22 ' A' ' 52' ' ' LEU . . . -176.74 178.21 48.02 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.568 HD21 HG21 ' A' ' 44' ' ' VAL . 3.9 mm? -98.88 135.05 40.87 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.377 -1.073 . . . . 0.0 110.261 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 54' ' ' ALA . 1.4 pt -112.11 139.01 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.664 -0.647 . . . . 0.0 109.392 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 53' ' ' ILE . . . 43.52 45.79 5.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.157 -0.964 . . . . 0.0 109.501 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.12 -27.17 28.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 0.0 109.209 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.643 HH22 ' CB ' ' B' ' 27' ' ' SER . 8.4 mmt180 -42.33 160.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.665 0.745 . . . . 0.0 109.891 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.669 ' H ' ' CD1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.769 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.6 p90 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.984 0.897 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.31 156.98 13.09 Favored Glycine 0 N--CA 1.487 2.091 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.284 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.8 m -98.29 135.39 39.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.193 -1.18 . . . . 0.0 108.617 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.4 mt -89.63 131.28 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 21' ' ' TYR . 5.4 m -138.5 167.7 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.664 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -150.94 150.86 31.33 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 19' ' ' GLN . . . -105.98 115.65 30.59 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.181 -0.949 . . . . 0.0 110.938 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.384 0.612 . . . . 0.0 109.596 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 88.9 t80 . . . . . 0 N--CA 1.501 2.092 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 14.9 mt -115.57 135.68 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.454 -0.779 . . . . 0.0 110.383 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.677 HD11 ' CD1' ' B' ' 55' ' ' PHE . 19.0 tt -134.46 114.09 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.9 t -123.01 159.59 28.06 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.377 -0.827 . . . . 0.0 108.926 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.0 p -101.68 72.72 1.39 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -177.01 -137.3 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.156 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 179.68 90.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.473 -0.767 . . . . 0.0 109.577 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLU . . . . . 0.401 ' HB3' ' HD3' ' B' ' 16' ' ' PRO . 32.5 mt-10 -156.85 -81.56 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.349 -0.844 . . . . 0.0 109.447 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.506 ' N ' ' HD3' ' B' ' 16' ' ' PRO . 8.2 mt 47.18 62.35 12.02 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.118 -0.989 . . . . 0.0 108.952 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' B' ' 15' ' ' ILE . 1.4 Cg_endo -65.97 155.63 68.53 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.997 1.798 . . . . 0.0 109.909 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.07 -10.65 74.42 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.308 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' LEU . . . . . 0.408 HD12 ' CG2' ' B' ' 15' ' ' ILE . 76.1 mt -124.89 137.28 54.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.08 -1.247 . . . . 0.0 108.638 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -101.45 116.41 32.72 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' B' ' 72' ' ' LYS . 0.2 OUTLIER -111.99 134.57 53.46 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.556 -0.715 . . . . 0.0 110.688 -177.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 21' ' ' TYR . . . . . 0.658 ' CD1' ' N ' ' B' ' 21' ' ' TYR . 0.0 OUTLIER -105.17 152.75 22.44 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.02 128.83 34.8 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.504 -0.747 . . . . 0.0 109.6 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 mt -113.17 7.06 17.77 Favored 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.03 -157.08 22.49 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 176.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -135.02 143.68 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.963 -0.728 . . . . 0.0 109.359 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.94 145.59 45.65 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.128 0.49 . . . . 0.0 109.738 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.643 ' CB ' HH22 ' A' ' 56' ' ' ARG . 0.0 OUTLIER -152.05 141.36 21.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.005 -1.059 . . . . 0.0 108.459 179.783 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 14.1 t -149.63 152.85 36.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.199 -0.938 . . . . 0.0 109.083 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 68.6 mt -126.8 133.1 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.2 -0.937 . . . . 0.0 109.375 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 34.2 t -165.59 166.06 18.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.438 -0.789 . . . . 0.0 109.338 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -96.63 70.95 2.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.238 -0.914 . . . . 0.0 109.645 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 169.31 129.04 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.44 ' CG2' ' N ' ' B' ' 34' ' ' ASP . 1.3 m -71.16 -43.62 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.44 ' N ' ' CG2' ' B' ' 33' ' ' VAL . 33.9 m-20 -63.76 -45.16 91.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.348 -0.845 . . . . 0.0 109.681 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -60.37 -39.18 86.31 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.678 -0.809 . . . . 0.0 108.872 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 48.5 mt -64.07 -51.89 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.92 . . . . 0.0 108.877 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -53.64 -48.31 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.977 . . . . 0.0 108.508 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -60.8 -40.26 91.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.335 -0.853 . . . . 0.0 110.102 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -64.36 -44.38 91.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 109.478 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' B' ' 40' ' ' LEU . 40.9 mt -68.45 -48.76 63.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.131 -0.981 . . . . 0.0 108.527 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -49.0 -48.58 43.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.846 -1.159 . . . . 0.0 108.945 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -62.19 -36.31 81.5 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.51 -0.744 . . . . 0.0 109.965 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -75.5 -35.96 60.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.385 -0.822 . . . . 0.0 109.668 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.75 -51.6 26.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.062 -1.024 . . . . 0.0 108.902 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -56.0 -28.73 58.47 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.669 1.223 . . . . 0.0 109.147 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.26 -28.33 59.78 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.385 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -96.42 -5.22 40.25 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.11 24.72 70.7 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 118.466 -1.825 . . . . 0.0 109.175 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.25 -171.11 9.25 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -112.36 -40.12 4.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.502 -0.999 . . . . 0.0 109.896 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 171.52 175.53 39.94 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.495 ' CD2' ' N ' ' B' ' 52' ' ' LEU . 2.3 mm? -96.99 133.85 41.13 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.378 -1.072 . . . . 0.0 109.942 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 49.7 mt -110.25 137.05 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.727 -0.608 . . . . 0.0 109.973 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 57.95 71.42 0.58 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.816 . . . . 0.0 109.815 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.677 ' CD1' HD11 ' B' ' 9' ' ' ILE . 2.0 t80 -58.38 -73.25 0.08 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.36 -0.837 . . . . 0.0 108.923 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' B' ' 55' ' ' PHE . 7.1 tpt180 58.01 113.61 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.411 -0.806 . . . . 0.0 110.157 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 46.7 tp . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -123.12 152.4 16.93 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -167.81 -175.48 2.76 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.473 -1.016 . . . . 0.0 109.399 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.0 -162.4 35.29 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 97.6 m -123.84 137.79 54.6 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 31.1 mt -83.81 125.49 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 6.5 m -136.94 164.18 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.824 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 72' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' B' ' 20' ' ' LEU . 3.0 mttt -136.1 146.67 47.26 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.33 -0.856 . . . . 0.0 108.879 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' B' ' 74' ' ' ASP . . . -114.88 116.75 29.05 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.81 -0.556 . . . . 0.0 110.235 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' ASP . . . . . 0.566 ' O ' ' OH ' ' B' ' 21' ' ' TYR . 5.5 t70 . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 121.774 0.797 . . . . 0.0 109.655 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 53.8 mttm . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -92.77 120.31 33.02 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.135 -0.978 . . . . 0.0 108.728 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 44.8 mt -119.45 128.57 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.513 -0.742 . . . . 0.0 109.788 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 9' ' ' ILE . . . . . 0.61 ' O ' HG23 ' C' ' 9' ' ' ILE . 13.4 tt -119.96 114.14 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -122.94 159.97 27.17 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 11' ' ' THR . . . . . 0.432 HG22 ' H ' ' C' ' 55' ' ' PHE . 7.7 p -125.55 77.57 1.66 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.642 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.35 -117.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.398 -1.439 . . . . 0.0 108.371 -176.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -84.41 -134.27 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.136 -0.977 . . . . 0.0 109.796 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.75 28.93 5.54 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.529 -0.732 . . . . 0.0 109.862 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 33.2 mt 57.06 81.63 0.25 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.393 -0.817 . . . . 0.0 109.58 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.93 156.84 41.61 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 122.21 1.94 . . . . 0.0 110.37 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.18 -0.95 69.44 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.378 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 60.8 mt -131.52 138.99 49.17 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.111 -1.229 . . . . 0.0 109.155 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -97.54 109.55 22.29 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 20' ' ' LEU . . . . . 0.604 HD23 ' HB2' ' C' ' 73' ' ' ALA . 0.0 OUTLIER -120.2 143.97 47.97 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.748 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 21' ' ' TYR . . . . . 0.666 ' CD1' ' N ' ' C' ' 21' ' ' TYR . 0.0 OUTLIER -113.65 146.85 39.14 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.509 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -72.85 136.91 45.41 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.642 0.734 . . . . 0.0 109.999 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.437 HD12 HG22 ' C' ' 70' ' ' ILE . 5.8 mt -118.47 15.37 13.8 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.02 179.76 16.18 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 47.1 mm -112.3 142.26 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.795 -0.827 . . . . 0.0 108.826 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.38 144.17 43.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.528 -0.733 . . . . 0.0 109.899 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 35.4 t -152.31 137.66 17.57 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 15.2 t -149.62 152.3 35.22 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.055 -1.028 . . . . 0.0 109.369 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -102.15 155.02 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 30' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' C' ' 31' ' ' ASP . 12.1 t -176.19 -178.06 0.95 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.975 . . . . 0.0 109.225 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 31' ' ' ASP . . . . . 0.448 ' N ' ' OG ' ' C' ' 30' ' ' SER . 20.0 t70 -102.2 -80.78 0.5 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.411 -0.806 . . . . 0.0 110.971 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -65.08 144.12 57.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.996 -1.065 . . . . 0.0 108.731 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 33' ' ' VAL . . . . . 0.417 ' H ' HG13 ' C' ' 33' ' ' VAL . 1.4 m -69.47 -38.44 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -54.59 -28.16 44.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.459 -0.776 . . . . 0.0 109.848 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -76.23 -34.74 59.22 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.309 -0.869 . . . . 0.0 109.479 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 84.2 mt -58.76 -46.9 90.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.171 -0.955 . . . . 0.0 108.913 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 55.6 t -56.86 -49.57 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.952 -1.092 . . . . 0.0 108.637 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -61.8 -42.78 99.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.437 -0.789 . . . . 0.0 109.402 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -60.26 -48.67 80.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.535 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 67.2 mt -64.68 -42.9 95.03 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 41' ' ' ARG . . . . . 0.778 HH11 ' HG2' ' C' ' 41' ' ' ARG . 0.8 OUTLIER -48.2 -47.7 35.28 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.861 -1.15 . . . . 0.0 109.275 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -63.13 -31.83 73.06 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -73.8 -41.74 61.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.832 . . . . 0.0 109.518 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 38.1 t -68.29 -51.24 49.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.705 -1.247 . . . . 0.0 109.292 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -51.0 -33.44 24.84 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.642 1.211 . . . . 0.0 110.223 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.76 -28.83 50.72 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.678 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.55 7.31 43.8 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.48 29.77 64.11 Favored Glycine 0 N--CA 1.487 2.08 0 C-N-CA 118.672 -1.727 . . . . 0.0 109.759 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.26 148.9 27.14 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -65.23 -33.63 76.45 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.174 -1.192 . . . . 0.0 110.826 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 171.56 -159.04 30.47 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 11.4 tp -121.18 135.57 55.12 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.588 -0.948 . . . . 0.0 109.622 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 60.7 mt -110.87 144.03 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.492 -0.755 . . . . 0.0 110.022 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.12 82.64 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.232 -0.918 . . . . 0.0 110.713 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 55' ' ' PHE . . . . . 0.439 ' O ' ' CD2' ' C' ' 55' ' ' PHE . 82.5 t80 -126.9 65.79 1.28 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.332 0.587 . . . . 0.0 110.143 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 56' ' ' ARG . . . . . 0.744 HH11 ' HG2' ' C' ' 56' ' ' ARG . 7.7 mtt-85 -80.02 148.43 31.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 109.495 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 44.5 mm . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.828 . . . . 0.0 109.292 179.905 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 67' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' C' ' 67' ' ' TYR . 21.7 p90 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.571 0.701 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.38 165.34 32.85 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 95.1 m -117.05 141.46 48.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.294 -1.121 . . . . 0.0 108.925 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 70' ' ' ILE . . . . . 0.437 HG22 HD12 ' C' ' 23' ' ' LEU . 41.9 mt -95.09 133.48 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.443 -0.785 . . . . 0.0 109.019 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 10.6 m -144.26 156.15 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.41 -0.806 . . . . 0.0 109.608 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 72' ' ' LYS . . . . . 0.463 ' HG3' ' CE2' ' C' ' 21' ' ' TYR . 18.4 ptpt -142.33 140.06 32.0 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.26 -0.9 . . . . 0.0 108.691 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.604 ' HB2' HD23 ' C' ' 20' ' ' LEU . . . -126.67 152.96 46.03 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.761 -1.212 . . . . 0.0 108.503 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' C' ' 73' ' ' ALA . 27.1 t70 . . . . . 0 N--CA 1.499 1.989 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 mtpt . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -114.77 121.96 44.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.493 -0.754 . . . . 0.0 109.555 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 51.6 mt -101.65 131.39 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.445 -0.784 . . . . 0.0 109.477 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 9' ' ' ILE . . . . . 0.664 HD11 ' CD2' ' D' ' 55' ' ' PHE . 18.7 tt -124.42 119.89 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 6.0 t -116.35 132.19 56.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.341 -0.85 . . . . 0.0 109.228 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 11' ' ' THR . . . . . 0.729 ' OG1' ' OG1' ' E' ' 69' ' ' THR . 8.6 m -67.74 -117.83 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 12' ' ' ALA . . . . . 0.659 ' C ' ' O ' ' D' ' 11' ' ' THR . . . -2.39 -98.83 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.504 0 CA-C-N 118.318 0.508 . . . . 0.0 110.357 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 13' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' D' ' 12' ' ' ALA . 3.5 p30 161.91 91.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? 176.65 128.99 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.503 -0.748 . . . . 0.0 109.864 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 35.5 mt -143.46 69.34 17.44 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.26 155.49 56.53 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.928 1.752 . . . . 0.0 110.284 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.63 -4.73 76.41 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 18' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' D' ' 18' ' ' LEU . 15.7 mt -129.88 138.64 51.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -1.193 . . . . 0.0 109.967 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -83.74 108.39 16.76 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 mt -103.3 138.88 39.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.463 -0.773 . . . . 0.0 110.425 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 21' ' ' TYR . . . . . 0.473 ' CE1' ' O ' ' D' ' 22' ' ' SER . 1.4 t80 -121.39 129.94 53.32 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 22' ' ' SER . . . . . 0.473 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 21.5 t -67.37 133.1 48.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.987 -1.07 . . . . 0.0 111.478 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 mt -123.74 12.42 9.18 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.34 176.03 19.33 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -109.78 144.33 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.905 -0.762 . . . . 0.0 109.567 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.56 154.1 30.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.663 -0.648 . . . . 0.0 109.556 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 6.6 p -152.51 137.29 17.04 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 12.5 t -149.44 151.36 33.87 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.077 -1.014 . . . . 0.0 109.63 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 6.4 mt -102.99 155.26 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 120.924 -1.11 . . . . 0.0 108.658 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.516 ' O ' ' N ' ' D' ' 32' ' ' ASN . 0.6 OUTLIER 176.13 -20.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.04 -1.037 . . . . 0.0 110.403 179.622 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 62.8 -41.39 0.18 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.777 -0.577 . . . . 0.0 111.465 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.541 ' O ' HG13 ' D' ' 36' ' ' ILE . 7.8 t-20 -85.86 141.22 29.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.972 -1.08 . . . . 0.0 109.28 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 33' ' ' VAL . . . . . 0.4 ' H ' HG23 ' D' ' 33' ' ' VAL . 3.0 t -68.41 -41.6 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.874 -1.141 . . . . 0.0 110.612 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -54.53 -43.97 72.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.39 -0.819 . . . . 0.0 110.238 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -76.8 -36.64 56.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.426 -0.797 . . . . 0.0 109.678 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 36' ' ' ILE . . . . . 0.645 HG22 ' CE1' ' D' ' 55' ' ' PHE . 96.8 mt -61.69 -41.52 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.961 -1.087 . . . . 0.0 108.623 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.416 HG23 ' CZ ' ' D' ' 55' ' ' PHE . 13.6 t -69.39 -46.37 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.665 -1.272 . . . . 0.0 108.954 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -66.98 -44.34 80.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.397 -0.814 . . . . 0.0 110.793 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -55.04 -48.5 73.36 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.041 -1.037 . . . . 0.0 109.659 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 38.8 mt -64.85 -37.79 88.81 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.297 -0.877 . . . . 0.0 109.287 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -54.53 -43.8 72.25 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.614 -1.304 . . . . 0.0 109.73 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm -67.62 -40.07 84.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.3 -0.875 . . . . 0.0 110.373 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -75.79 -36.14 59.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.86 . . . . 0.0 109.755 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.83 -50.07 73.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.049 -1.032 . . . . 0.0 109.333 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -65.25 -30.71 71.61 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 118.411 -1.316 . . . . 0.0 108.743 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.33 -28.46 66.26 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.554 0.692 . . . . 0.0 109.267 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -93.09 -6.55 47.82 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.469 -0.769 . . . . 0.0 109.514 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.16 30.06 15.45 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.145 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.77 155.55 18.29 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.39 -9.1 9.53 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.466 -1.02 . . . . 0.0 109.282 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.94 162.74 30.62 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 4.1 tp -130.47 140.32 50.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.632 -0.923 . . . . 0.0 109.769 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 53' ' ' ILE . . . . . 0.458 ' O ' ' HB3' ' D' ' 54' ' ' ALA . 13.9 mt -108.48 138.39 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 54' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 65.63 76.71 0.32 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.314 -0.867 . . . . 0.0 109.779 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 55' ' ' PHE . . . . . 0.664 ' CD2' HD11 ' D' ' 9' ' ' ILE . 84.1 t80 -99.06 138.89 35.52 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.49 -0.756 . . . . 0.0 110.313 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 56' ' ' ARG . . . . . 0.661 ' O ' ' CE2' ' D' ' 55' ' ' PHE . 26.7 ttp180 . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 30.4 p90 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.625 0.726 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.24 152.32 11.01 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.544 -1.312 . . . . 0.0 110.327 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 48.9 m -94.04 134.5 36.38 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.009 -1.289 . . . . 0.0 108.458 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 44.5 mt -84.81 127.58 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 71' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' D' ' 21' ' ' TYR . 4.3 m -135.38 159.31 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 110.218 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 10.6 pttp -152.25 148.6 27.76 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.76 150.72 26.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.23 -0.919 . . . . 0.0 108.852 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 p30 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.023 -1.048 . . . . 0.0 109.393 179.41 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -97.92 123.08 41.74 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.355 -0.841 . . . . 0.0 109.416 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 34.0 mt -111.67 135.33 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.459 -0.776 . . . . 0.0 109.591 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 9' ' ' ILE . . . . . 0.6 ' O ' HG23 ' E' ' 9' ' ' ILE . 10.5 tt -132.43 115.76 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 4.1 t -124.0 155.87 37.46 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 11' ' ' THR . . . . . . . . . . . . . 2.0 p -115.95 89.45 3.11 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.74 -95.57 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.987 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -160.14 -35.9 0.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.4 -0.813 . . . . 0.0 109.426 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 14' ' ' GLU . . . . . 0.411 ' CG ' ' N ' ' E' ' 15' ' ' ILE . 29.7 tt0 -166.71 167.32 15.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 109.302 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 15' ' ' ILE . . . . . 0.411 ' N ' ' CG ' ' E' ' 14' ' ' GLU . 87.0 mt -115.73 92.75 35.03 Favored Pre-proline 0 N--CA 1.496 1.843 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.12 155.28 51.75 Favored 'Trans proline' 0 C--N 1.322 -0.85 0 C-N-CA 121.912 1.741 . . . . 0.0 110.318 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.9 -10.19 75.05 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 18' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' E' ' 18' ' ' LEU . 20.4 mt -127.59 138.95 53.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -1.1 . . . . 0.0 109.52 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -84.45 108.68 17.38 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 14.1 mt -96.99 142.97 28.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.389 -0.82 . . . . 0.0 110.752 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 21' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -126.36 130.15 50.21 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.77 129.37 39.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.733 -1.23 . . . . 0.0 110.793 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.899 HD11 ' HB2' ' E' ' 72' ' ' LYS . 97.6 mt -114.41 3.9 15.14 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.3 -172.9 19.68 Favored Glycine 0 N--CA 1.499 2.9 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 25' ' ' ILE . . . . . 0.471 HD11 HG23 ' D' ' 9' ' ' ILE . 39.6 mm -110.39 140.87 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.798 -0.825 . . . . 0.0 109.32 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.3 146.93 44.86 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.646 -0.659 . . . . 0.0 109.313 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 40.5 m -152.59 148.41 27.31 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.907 -1.121 . . . . 0.0 108.916 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 28' ' ' THR . . . . . 0.459 ' OG1' HG23 ' E' ' 36' ' ' ILE . 25.2 p -148.88 134.15 18.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.45 -0.781 . . . . 0.0 109.337 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 29' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' E' ' 30' ' ' SER . 87.5 mt -126.53 127.83 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' E' ' 29' ' ' ILE . 3.6 t 162.51 14.43 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 31' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' E' ' 31' ' ' ASP . 1.4 m-20 51.55 -174.23 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.125 -0.984 . . . . 0.0 109.02 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 32' ' ' ASN . . . . . . . . . . . . . 8.0 m120 68.1 100.18 0.05 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 45.0 t -69.16 -37.27 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.211 -0.931 . . . . 0.0 109.5 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -57.52 -42.14 82.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 110.029 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.79 -38.18 58.48 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.287 -0.883 . . . . 0.0 109.42 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 36' ' ' ILE . . . . . 0.459 HG23 ' OG1' ' E' ' 28' ' ' THR . 55.9 mt -63.51 -51.71 67.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.03 -1.044 . . . . 0.0 109.534 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 57.6 t -51.8 -51.14 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.082 -1.011 . . . . 0.0 109.125 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.07 -38.06 78.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -0.869 . . . . 0.0 109.409 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -63.66 -40.81 97.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.122 -0.986 . . . . 0.0 109.511 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 40' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' E' ' 40' ' ' LEU . 41.6 mt -68.49 -44.45 74.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.148 -0.97 . . . . 0.0 109.338 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -51.43 -37.71 49.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.653 -1.28 . . . . 0.0 109.596 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -73.71 -39.46 64.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.59 -0.694 . . . . 0.0 109.831 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -75.98 -35.79 59.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.371 -0.831 . . . . 0.0 109.67 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 11.5 t -67.32 -50.92 58.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 109.055 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -70.4 -36.88 74.33 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.315 -1.354 . . . . 0.0 109.035 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.45 -31.26 69.14 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -87.89 -5.25 58.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.412 -0.805 . . . . 0.0 109.809 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.21 5.54 58.11 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.03 161.23 48.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.99 -3.2 5.15 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.086 -1.243 . . . . 0.0 109.893 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.82 149.45 12.54 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 4.6 tp -108.64 139.96 42.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.675 -0.897 . . . . 0.0 109.595 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 53' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 1.0 OUTLIER -111.67 142.85 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.567 -0.708 . . . . 0.0 110.255 -178.67 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 62.24 75.87 0.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 110.131 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 55' ' ' PHE . . . . . 0.482 ' O ' ' CG ' ' E' ' 55' ' ' PHE . 58.7 t80 -104.65 23.95 12.54 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 56' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -54.82 149.16 11.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.84 . . . . 0.0 109.242 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 65.0 mt . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.932 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 37.2 p90 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.394 0.616 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.46 165.12 35.4 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 69' ' ' THR . . . . . 0.729 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 30.5 m -113.7 139.67 48.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.639 -0.918 . . . . 0.0 108.757 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 70' ' ' ILE . . . . . 0.546 HG22 HD12 ' E' ' 23' ' ' LEU . 43.3 mt -84.93 146.44 6.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 m -139.42 154.4 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.206 -0.934 . . . . 0.0 109.942 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 72' ' ' LYS . . . . . 0.899 ' HB2' HD11 ' E' ' 23' ' ' LEU . 33.0 ttpt -143.47 151.81 40.76 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.13 150.53 35.86 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.419 -0.801 . . . . 0.0 108.957 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.102 -0.999 . . . . 0.0 109.132 179.254 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.9 t80 . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 57.0 mt -136.82 139.18 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.383 -0.823 . . . . 0.0 109.461 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.537 ' O ' HG23 ' A' ' 9' ' ' ILE . 13.9 tt -121.38 115.6 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.2 t -127.01 147.02 50.15 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.109 -0.994 . . . . 0.0 108.509 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.574 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -66.84 -110.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 177.111 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.519 ' N ' ' OG1' ' A' ' 11' ' ' THR . . . -33.0 -88.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.724 -0.61 . . . . 0.0 110.186 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 1.3 p-10 -170.33 -92.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.951 -1.093 . . . . 0.0 109.086 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.463 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 30.0 mt-10 74.71 -135.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.699 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 2.6 mt 65.01 46.41 0.54 Allowed Pre-proline 0 N--CA 1.486 1.351 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -176.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.699 ' HD3' ' N ' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -66.08 151.77 82.96 Favored 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 121.431 1.421 . . . . 0.0 110.003 179.184 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.16 -5.38 78.34 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.118 -1.515 . . . . 0.0 111.122 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 18' ' ' LEU . 59.7 mt -124.77 137.07 54.34 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.792 -1.416 . . . . 0.0 108.503 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -90.14 113.41 25.16 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.46 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 3.3 mt -107.22 128.18 54.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.701 -0.624 . . . . 0.0 110.106 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.581 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -109.86 157.88 18.75 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.3 t -81.56 126.45 31.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.478 -0.764 . . . . 0.0 109.618 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.712 HD11 ' CB ' ' A' ' 72' ' ' LYS . 16.4 mt -108.95 2.5 21.41 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.94 177.65 14.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.46 141.5 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.82 144.77 42.99 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.1 t -152.57 138.07 17.69 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.9 t -149.8 150.4 31.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.028 -1.045 . . . . 0.0 108.997 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.93 131.88 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 31' ' ' ASP . 14.3 p -172.5 13.47 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.324 -0.86 . . . . 0.0 109.576 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 30' ' ' SER . 37.1 t70 57.35 154.44 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.63 -0.669 . . . . 0.0 110.196 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 3.5 t-20 73.84 111.2 0.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.082 -1.011 . . . . 0.0 108.567 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.88 -33.54 62.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.358 -0.839 . . . . 0.0 109.354 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -52.52 -35.98 54.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 85.4 mt-10 -78.44 -33.88 48.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 108.809 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.0 mt -65.07 -53.82 36.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 120.961 -1.087 . . . . 0.0 108.937 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 t -58.06 -50.32 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.085 -1.009 . . . . 0.0 108.348 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -61.26 -41.27 96.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.565 -0.709 . . . . 0.0 109.761 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 35' ' ' GLU . 17.9 m120 -66.64 -42.52 86.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 0.0 109.329 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 40' ' ' LEU . 70.2 mt -62.49 -42.67 99.65 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.107 -0.995 . . . . 0.0 108.448 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -48.06 -56.4 7.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.625 -1.297 . . . . 0.0 109.389 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 93.8 mttt -57.34 -35.41 69.87 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.288 -0.882 . . . . 0.0 110.249 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -76.27 -35.53 58.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.791 . . . . 0.0 109.903 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.5 t -72.19 -51.29 30.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.187 -0.946 . . . . 0.0 108.834 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -69.6 -31.47 69.62 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 117.942 -1.503 . . . . 0.0 108.962 -175.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 42' ' ' LYS . . . -62.22 -31.12 71.62 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.7 mtpt -95.64 -3.83 45.51 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.36 27.6 47.61 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 118.864 -1.636 . . . . 0.0 109.751 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.18 -166.67 34.41 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -109.78 -46.65 3.46 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.53 -0.982 . . . . 0.0 109.851 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 174.98 -152.08 13.2 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -129.07 140.27 51.66 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.677 -0.896 . . . . 0.0 109.886 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.781 HD13 ' O ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -121.81 150.15 25.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.941 -0.474 . . . . 0.0 109.854 -178.167 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 11' ' ' THR . . . 73.5 108.5 0.07 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.996 -1.065 . . . . 0.0 111.301 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -127.07 148.38 50.14 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.504 0.669 . . . . 0.0 109.86 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.708 ' HE ' ' NH1' ' B' ' 56' ' ' ARG . 19.3 ttt180 -131.72 -31.57 1.54 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.457 0.646 . . . . 0.0 109.446 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.297 -1.689 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 33.7 p90 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.559 0.695 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.58 161.23 32.07 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.602 ' CB ' ' HG1' ' E' ' 11' ' ' THR . 80.8 m -107.8 140.0 41.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.265 -1.138 . . . . 0.0 108.862 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.515 HG22 HD12 ' A' ' 23' ' ' LEU . 54.8 mt -88.55 129.77 39.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 20' ' ' LEU . 15.7 m -132.75 155.04 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.498 -0.751 . . . . 0.0 109.602 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.712 ' CB ' HD11 ' A' ' 23' ' ' LEU . 10.4 tttp -142.61 147.91 36.6 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.176 -0.953 . . . . 0.0 109.245 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.87 151.04 39.49 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.339 -0.851 . . . . 0.0 108.807 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.102 -0.999 . . . . 0.0 108.702 179.269 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 66.7 t80 . . . . . 0 N--CA 1.505 2.323 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 68.0 mt -112.89 128.37 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.507 -0.746 . . . . 0.0 109.985 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' B' ' 52' ' ' LEU . 2.9 tt -131.67 114.67 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.478 HG22 HG22 ' B' ' 53' ' ' ILE . 4.5 t -122.46 158.59 29.42 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.308 1.051 . . . . 0.0 109.272 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.475 HG23 ' OG1' ' C' ' 69' ' ' THR . 9.3 p -90.64 -105.84 0.1 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 42.72 -112.72 0.21 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.121 -0.987 . . . . 0.0 110.901 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -165.82 -20.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.271 -0.893 . . . . 0.0 109.909 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLU . . . . . 0.465 ' CG ' ' N ' ' B' ' 15' ' ' ILE . 67.3 tt0 -167.33 166.63 14.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.117 -0.99 . . . . 0.0 109.25 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.465 ' N ' ' CG ' ' B' ' 14' ' ' GLU . 61.5 mt -114.58 93.0 30.96 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -61.61 155.01 55.92 Favored 'Trans proline' 0 C--N 1.323 -0.803 0 C-N-CA 121.787 1.658 . . . . 0.0 110.485 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.88 -6.38 79.38 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 43.1 mt -132.17 141.43 49.1 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.474 -1.015 . . . . 0.0 109.699 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' GLN . . . . . 0.448 ' CG ' ' O ' ' B' ' 19' ' ' GLN . 19.5 pt20 -84.91 109.62 18.27 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 mt -102.57 136.71 41.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.953 -1.092 . . . . 0.0 109.437 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' B' ' 22' ' ' SER . 0.8 OUTLIER -121.39 130.46 53.61 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.559 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.56 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 40.2 t -60.2 129.3 41.01 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.035 0.921 . . . . 0.0 111.691 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 11.2 mt -114.08 12.09 17.82 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.33 -166.2 13.22 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 mm -120.13 134.74 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.06 149.41 38.95 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.487 -0.758 . . . . 0.0 109.917 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 7.7 t -152.6 140.85 20.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.2 -0.937 . . . . 0.0 109.384 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 4.3 t -149.62 146.46 27.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.296 -0.877 . . . . 0.0 109.167 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 31.3 mt -127.7 131.75 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 53.8 m -155.91 14.77 0.34 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.993 -1.067 . . . . 0.0 110.306 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 72.36 -70.03 0.17 Allowed 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -76.81 140.42 40.68 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.993 -1.067 . . . . 0.0 108.153 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.471 HG11 ' OH ' ' C' ' 67' ' ' TYR . 96.7 t -69.05 -37.46 77.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.523 -0.736 . . . . 0.0 109.806 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.22 -36.27 51.7 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.356 -0.84 . . . . 0.0 110.516 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.08 -32.85 39.21 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.278 -0.889 . . . . 0.0 109.618 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 35.0 mt -62.27 -53.58 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.275 -0.89 . . . . 0.0 109.045 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 23.4 t -56.99 -49.8 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.229 -0.919 . . . . 0.0 108.59 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -60.95 -39.71 90.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.407 -0.808 . . . . 0.0 110.108 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -64.05 -43.43 95.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.164 -0.96 . . . . 0.0 109.594 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' B' ' 40' ' ' LEU . 18.8 mt -64.81 -43.05 94.42 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.115 -0.99 . . . . 0.0 109.185 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -49.94 -40.99 45.37 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.584 -1.323 . . . . 0.0 109.923 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -70.31 -37.11 74.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.605 -0.685 . . . . 0.0 110.051 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -76.5 -35.35 58.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.46 -0.775 . . . . 0.0 109.677 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 3.0 t -66.5 -50.3 68.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.134 -0.979 . . . . 0.0 108.913 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -65.45 -30.1 70.85 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.044 -1.462 . . . . 0.0 109.142 -175.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.93 -29.83 68.17 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.488 0.661 . . . . 0.0 109.312 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 mmmt -86.56 -5.47 59.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.627 -0.67 . . . . 0.0 109.517 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.01 5.38 62.54 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.66 164.32 50.5 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -128.65 -3.62 5.33 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.093 -1.24 . . . . 0.0 110.075 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.31 143.57 8.67 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' B' ' 9' ' ' ILE . 8.8 tp -108.23 141.87 39.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.582 -0.952 . . . . 0.0 109.659 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.478 HG22 HG22 ' B' ' 10' ' ' THR . 11.6 pt -142.66 172.07 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.789 -1.194 . . . . 0.0 108.876 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.35 33.01 22.75 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.518 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.6 120.41 30.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.788 -1.195 . . . . 0.0 108.612 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' ARG . . . . . 0.708 ' NH1' ' HE ' ' A' ' 56' ' ' ARG . 39.4 ttp180 -105.13 166.8 10.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.419 -0.801 . . . . 0.0 109.626 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.805 HD11 ' CE1' ' C' ' 67' ' ' TYR . 16.5 mm . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.396 -0.815 . . . . 0.0 109.407 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.628 HD23 ' N ' ' B' ' 65' ' ' LEU . 1.5 pt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.62 126.18 8.15 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' TYR . . . . . 0.482 ' CG ' ' O ' ' B' ' 67' ' ' TYR . 7.7 p90 -122.75 129.03 51.28 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.579 -0.954 . . . . 0.0 109.053 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.87 151.55 23.26 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m -104.48 143.76 32.59 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.303 -1.116 . . . . 0.0 108.79 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 49.2 mt -90.01 143.26 11.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.61 164.91 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.931 . . . . 0.0 110.02 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -154.08 157.31 38.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.538 -0.726 . . . . 0.0 109.236 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.33 150.7 38.38 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.165 -0.96 . . . . 0.0 108.605 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 8.5 t70 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.95 -1.094 . . . . 0.0 109.453 179.658 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 6' ' ' LYS . . . . . 0.458 ' CG ' ' H ' ' C' ' 7' ' ' PHE . 42.1 tttm . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.475 0.655 . . . . 0.0 109.658 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 7' ' ' PHE . . . . . 0.458 ' H ' ' CG ' ' C' ' 6' ' ' LYS . 67.6 t80 -92.75 124.33 36.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.423 -0.798 . . . . 0.0 109.778 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 64.3 mt -115.24 143.26 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.481 -0.762 . . . . 0.0 110.045 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 9' ' ' ILE . . . . . 0.59 ' O ' HG23 ' C' ' 9' ' ' ILE . 11.2 tt -137.49 117.62 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.511 -0.743 . . . . 0.0 109.483 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.528 HG22 HG22 ' C' ' 53' ' ' ILE . 1.0 OUTLIER -120.91 147.04 45.97 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.643 1.211 . . . . 0.0 107.938 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 11' ' ' THR . . . . . 0.433 ' O ' HG23 ' C' ' 11' ' ' THR . 4.4 t -86.87 55.58 3.63 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.169 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -177.83 -124.77 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 119.955 -1.716 . . . . 0.0 108.321 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.82 108.4 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.229 -0.92 . . . . 0.0 109.002 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -163.49 -100.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.155 -0.965 . . . . 0.0 109.751 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 15' ' ' ILE . . . . . 0.491 ' N ' ' HD3' ' C' ' 16' ' ' PRO . 5.3 mt 57.23 61.23 6.53 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.825 . . . . 0.0 109.285 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 16' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' C' ' 15' ' ' ILE . 2.2 Cg_endo -63.67 155.37 63.64 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 122.195 1.93 . . . . 0.0 109.618 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.29 -17.11 57.11 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 18' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' C' ' 18' ' ' LEU . 51.5 mt -117.04 135.74 53.49 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.098 -1.236 . . . . 0.0 108.807 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -86.41 108.6 18.56 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 11.3 mt -93.2 136.66 33.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.305 -0.872 . . . . 0.0 109.724 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 21' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -118.52 130.27 55.83 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 9.3 t -58.06 131.41 50.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.779 -1.2 . . . . 0.0 111.102 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 mt -120.36 11.59 11.5 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.74 -179.95 19.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' ILE . . . . . 0.481 ' N ' HD13 ' C' ' 25' ' ' ILE . 0.0 OUTLIER -113.43 141.06 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 122.007 -0.701 . . . . 0.0 109.465 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.48 146.46 38.4 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 6.5 p -151.9 139.77 19.97 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.991 -1.068 . . . . 0.0 108.53 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 15.0 t -149.92 138.63 20.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.012 -1.055 . . . . 0.0 108.813 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.413 HG23 ' O ' ' C' ' 29' ' ' ILE . 11.6 tt -105.18 130.44 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.925 . . . . 0.0 109.068 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 91.8 p -168.97 -145.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.039 -1.038 . . . . 0.0 109.668 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 31' ' ' ASP . . . . . 0.465 ' O ' ' CB ' ' C' ' 32' ' ' ASN . 21.3 t0 -150.73 153.96 36.5 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.204 -0.935 . . . . 0.0 109.523 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 32' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' C' ' 31' ' ' ASP . 3.7 t-20 77.15 129.26 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 108.748 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 45.2 t -66.58 -31.94 55.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.56 -0.712 . . . . 0.0 109.466 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -56.75 -42.6 79.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.821 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -75.97 -38.37 57.57 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.206 -0.933 . . . . 0.0 109.301 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 79.2 mt -59.81 -42.1 87.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 120.819 -1.175 . . . . 0.0 109.336 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.1 -43.91 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.718 -1.238 . . . . 0.0 109.092 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -66.33 -46.88 75.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.381 -0.824 . . . . 0.0 110.189 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -56.08 -49.67 73.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.071 -1.018 . . . . 0.0 109.682 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 84.2 mt -67.85 -44.71 76.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.128 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -50.73 -43.09 57.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.714 -1.241 . . . . 0.0 109.797 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -65.97 -36.26 82.83 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.797 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -76.39 -35.36 58.67 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.798 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 t -68.52 -50.85 52.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.952 -1.093 . . . . 0.0 109.079 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -59.55 -29.73 68.12 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.567 -1.253 . . . . 0.0 109.882 -175.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.3 -29.24 61.54 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.791 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -85.5 8.53 18.84 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.37 3.04 81.66 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.33 162.32 54.53 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 50' ' ' MET . . . . . 0.419 ' C ' ' SD ' ' C' ' 50' ' ' MET . 0.0 OUTLIER -131.17 -3.09 3.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.128 -1.219 . . . . 0.0 110.222 -177.189 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.5 127.85 1.81 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.245 -1.455 . . . . 0.0 110.01 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 53.5 tp -96.45 139.19 32.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.553 -0.969 . . . . 0.0 108.844 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 53' ' ' ILE . . . . . 0.543 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 26.7 pt -144.01 173.26 5.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.788 -1.195 . . . . 0.0 108.313 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 54' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 70.99 77.22 0.18 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.936 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 55' ' ' PHE . . . . . 0.439 ' CE2' ' OH ' ' D' ' 67' ' ' TYR . 0.2 OUTLIER -80.08 154.4 28.13 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.122 -0.986 . . . . 0.0 109.333 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 56' ' ' ARG . . . . . 0.622 ' CG ' HH11 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -136.78 46.36 2.22 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.56 -0.712 . . . . 0.0 109.957 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.299 -1.619 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 67' ' ' TYR . . . . . 0.805 ' CE1' HD11 ' B' ' 57' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 122.082 0.944 . . . . 0.0 109.866 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.02 140.99 6.61 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 69' ' ' THR . . . . . 0.475 ' OG1' HG23 ' B' ' 11' ' ' THR . 3.4 m -90.12 135.53 33.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.868 -1.372 . . . . 0.0 107.775 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 47.3 mt -86.1 145.15 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 m -144.73 162.9 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.966 . . . . 0.0 110.229 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -152.37 147.03 25.82 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.96 140.58 39.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.923 -1.111 . . . . 0.0 108.012 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 42.2 t0 . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.245 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.676 0.75 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -108.54 121.93 46.02 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 28.2 mt -133.82 129.73 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.365 -0.834 . . . . 0.0 109.928 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 9' ' ' ILE . . . . . 0.633 HG23 ' O ' ' D' ' 9' ' ' ILE . 13.4 tt -137.15 114.19 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.56 160.75 27.67 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 11' ' ' THR . . . . . 0.547 ' OG1' ' OG1' ' E' ' 69' ' ' THR . 1.2 p -121.43 83.53 2.1 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.34 -134.26 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.331 -0.855 . . . . 0.0 109.099 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -99.79 -56.27 2.43 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.374 -0.829 . . . . 0.0 109.774 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -161.85 -171.05 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.124 -0.985 . . . . 0.0 109.444 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 68.4 mt -123.53 87.81 51.97 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.542 -0.724 . . . . 0.0 109.113 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.67 155.19 55.2 Favored 'Trans proline' 0 C--N 1.323 -0.781 0 C-N-CA 121.927 1.751 . . . . 0.0 110.305 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.14 -9.76 75.74 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 18' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' D' ' 18' ' ' LEU . 43.9 mt -128.0 139.01 52.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.118 -1.225 . . . . 0.0 109.27 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -85.2 108.05 17.54 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 12.2 mt -99.45 134.92 41.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.448 -0.783 . . . . 0.0 109.502 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 21' ' ' TYR . . . . . 0.497 ' CE1' ' O ' ' D' ' 22' ' ' SER . 0.8 OUTLIER -116.68 129.99 56.46 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 22' ' ' SER . . . . . 0.497 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 0.0 OUTLIER -61.87 128.34 35.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.771 -1.206 . . . . 0.0 110.517 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' D' ' 23' ' ' LEU . 8.3 mt -114.6 7.6 16.1 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.2 -179.54 17.06 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 49.6 mm -111.95 142.33 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.733 -0.863 . . . . 0.0 108.927 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.12 143.99 44.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.69 -0.631 . . . . 0.0 109.679 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 98.8 p -152.71 136.04 15.84 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 14.6 t -149.81 150.88 32.65 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.916 -1.115 . . . . 0.0 109.327 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 47.3 mm -113.39 139.86 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.322 -0.861 . . . . 0.0 109.555 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 30' ' ' SER . . . . . 0.557 ' OG ' ' N ' ' D' ' 31' ' ' ASP . 1.4 t -175.72 -171.66 0.48 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.384 -0.822 . . . . 0.0 108.938 -178.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 31' ' ' ASP . . . . . 0.557 ' N ' ' OG ' ' D' ' 30' ' ' SER . 1.3 p30 -124.86 145.08 49.97 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.495 -0.753 . . . . 0.0 109.415 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 32' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' D' ' 31' ' ' ASP . 1.5 m-20 78.21 133.18 0.06 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.604 0.716 . . . . 0.0 109.333 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.29 -31.27 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.547 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -56.95 -42.5 80.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 110.112 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -76.2 -38.89 55.91 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.338 -0.851 . . . . 0.0 109.486 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.04 -46.88 92.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.847 -1.158 . . . . 0.0 109.416 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.37 -51.53 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.97 -1.081 . . . . 0.0 110.01 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -55.99 -36.18 67.59 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 109.643 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -67.25 -42.4 84.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.105 -0.997 . . . . 0.0 110.091 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 40' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' D' ' 40' ' ' LEU . 44.8 mt -69.05 -46.51 67.69 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.981 -1.074 . . . . 0.0 108.724 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -47.16 -55.91 7.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.72 -1.237 . . . . 0.0 109.456 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -54.98 -33.44 62.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.215 -0.928 . . . . 0.0 110.408 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -77.35 -35.02 54.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.365 -0.834 . . . . 0.0 109.975 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 t -68.6 -51.4 46.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.038 -1.038 . . . . 0.0 108.904 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -67.78 -33.85 75.63 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 117.988 -1.485 . . . . 0.0 109.415 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.38 -32.83 72.76 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 mmtm -87.76 -4.94 58.86 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.41 -0.806 . . . . 0.0 109.125 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.56 9.39 64.72 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.16 175.92 54.35 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.14 2.45 0.77 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.897 -1.355 . . . . 0.0 110.143 -175.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.18 160.12 33.05 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.575 -1.297 . . . . 0.0 109.958 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 7.0 tp -130.06 139.12 51.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.724 -0.868 . . . . 0.0 109.339 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 53' ' ' ILE . . . . . . . . . . . . . 23.9 mt -114.04 141.15 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.644 -0.66 . . . . 0.0 110.242 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 63.1 79.55 0.26 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.341 -0.85 . . . . 0.0 111.904 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 55' ' ' PHE . . . . . 0.536 ' CG ' ' O ' ' D' ' 55' ' ' PHE . 56.0 t80 -107.22 35.91 2.88 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.51 0.671 . . . . 0.0 110.279 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 56' ' ' ARG . . . . . 0.877 ' HG3' HH11 ' D' ' 56' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.301 -1.54 0 O-C-N 120.961 -1.087 . . . . 0.0 109.911 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 67' ' ' TYR . . . . . 0.439 ' OH ' ' CE2' ' C' ' 55' ' ' PHE . 62.8 t80 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.827 0.823 . . . . 0.0 110.008 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.58 155.67 21.54 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 54.3 m -106.52 140.12 39.91 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.443 -1.034 . . . . 0.0 108.806 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 70' ' ' ILE . . . . . 0.404 HD13 HG21 ' D' ' 70' ' ' ILE . 33.3 mt -90.25 137.68 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 m -144.39 166.28 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.82 . . . . 0.0 109.501 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.78 150.36 27.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.95 151.65 37.02 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.174 -0.954 . . . . 0.0 108.6 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 120.907 -1.121 . . . . 0.0 109.59 179.654 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 121.421 0.629 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -115.17 150.55 35.88 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 42.5 mt -129.25 137.61 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.506 -0.746 . . . . 0.0 109.147 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 9' ' ' ILE . . . . . 0.594 ' O ' HG23 ' E' ' 9' ' ' ILE . 17.5 tt -123.91 117.12 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 13.2 t -126.05 148.94 49.2 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 11' ' ' THR . . . . . 0.602 ' HG1' ' CB ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -76.19 -119.21 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.639 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 12' ' ' ALA . . . . . 0.406 ' H ' ' HB ' ' E' ' 11' ' ' THR . . . -111.35 98.5 7.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.312 -0.868 . . . . 0.0 109.68 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 13' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' E' ' 13' ' ' ASP . 20.3 p-10 -163.22 -7.09 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.694 -0.629 . . . . 0.0 109.475 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 59.8 163.59 0.05 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.599 -0.688 . . . . 0.0 109.468 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 18.4 mt -124.98 84.01 59.47 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.85 156.25 44.63 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 122.002 1.801 . . . . 0.0 110.095 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.63 -9.92 74.94 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 18' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' E' ' 18' ' ' LEU . 65.7 mt -126.96 137.86 53.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.075 -1.25 . . . . 0.0 108.821 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 19' ' ' GLN . . . . . 0.443 ' H ' ' HG2' ' E' ' 19' ' ' GLN . 7.8 pt20 -86.86 110.61 20.09 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 11.7 mt -92.1 135.2 34.16 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.969 -1.082 . . . . 0.0 109.592 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 21' ' ' TYR . . . . . 0.467 ' CE1' ' O ' ' E' ' 22' ' ' SER . 1.0 OUTLIER -117.83 129.82 55.89 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 22' ' ' SER . . . . . 0.467 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 0.0 OUTLIER -63.97 129.95 42.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.779 -1.201 . . . . 0.0 111.259 -179.252 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' E' ' 23' ' ' LEU . 13.1 mt -120.09 12.52 11.92 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.68 -155.41 16.22 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 25' ' ' ILE . . . . . 0.418 HG21 HD13 ' E' ' 25' ' ' ILE . 0.7 OUTLIER -135.34 144.12 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.979 -0.718 . . . . 0.0 109.596 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.03 144.11 44.13 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 38.5 t -152.14 138.95 18.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.053 -1.029 . . . . 0.0 108.455 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.54 153.43 37.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.082 -1.011 . . . . 0.0 109.033 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 71.0 mt -124.9 130.98 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.193 -0.942 . . . . 0.0 109.276 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 31.2 t -163.09 167.85 21.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.393 -0.817 . . . . 0.0 109.664 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 31' ' ' ASP . . . . . 0.553 ' N ' ' OD1' ' E' ' 31' ' ' ASP . 16.4 p-10 -81.38 -65.55 1.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.404 -0.81 . . . . 0.0 112.628 -177.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 32' ' ' ASN . . . . . 0.459 ' H ' ' CG ' ' E' ' 31' ' ' ASP . 6.3 t-20 -78.28 147.62 34.24 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.711 -1.243 . . . . 0.0 109.05 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 73.3 t -68.88 -31.18 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.564 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -54.09 -34.09 59.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 109.734 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 35' ' ' GLU . . . . . 0.419 ' O ' ' ND2' ' E' ' 39' ' ' ASN . 41.5 mm-40 -77.23 -35.02 55.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.312 -0.867 . . . . 0.0 108.803 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 66.3 mt -64.74 -53.6 40.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.042 -1.036 . . . . 0.0 109.154 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 60.9 t -55.79 -52.87 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.105 -0.997 . . . . 0.0 109.564 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.01 -36.49 70.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.419 -0.8 . . . . 0.0 109.633 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 39' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' E' ' 35' ' ' GLU . 74.1 m-20 -66.74 -41.11 88.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.043 -1.036 . . . . 0.0 109.831 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 40.2 mt -72.4 -50.34 27.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.99 -1.068 . . . . 0.0 109.041 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -49.04 -52.16 26.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.697 -1.252 . . . . 0.0 109.371 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -59.36 -37.3 77.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.261 -0.9 . . . . 0.0 110.824 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -77.91 -34.84 51.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 110.032 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 12.8 t -74.05 -52.8 19.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.148 -0.97 . . . . 0.0 108.864 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 9.9 mtpp -59.26 -27.88 66.21 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.704 -1.248 . . . . 0.0 110.058 -176.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.03 -28.19 62.2 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.819 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -87.84 0.1 56.25 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.82 6.89 84.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.19 -174.88 5.88 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 3.3 ptm -155.71 -1.21 0.14 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.211 -1.17 . . . . 0.0 110.83 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.82 150.55 18.72 Favored Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.296 -1.43 . . . . 0.0 109.738 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 15.2 tp -122.37 134.22 54.63 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 53' ' ' ILE . . . . . 0.882 HD13 ' O ' ' E' ' 53' ' ' ILE . 0.0 OUTLIER -106.93 147.4 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.521 -0.737 . . . . 0.0 109.659 -178.908 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 54' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 78.56 -63.43 0.3 Allowed 'General case' 0 N--CA 1.508 2.443 0 O-C-N 121.156 -0.965 . . . . 0.0 112.794 177.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 55' ' ' PHE . . . . . 0.552 ' O ' ' CG ' ' E' ' 55' ' ' PHE . 52.5 t80 31.64 39.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.595 0.712 . . . . 0.0 109.866 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 56' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' E' ' 54' ' ' ALA . 97.5 mtt180 -62.65 127.53 31.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.879 -1.138 . . . . 0.0 109.612 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 78.3 mt . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.255 -0.903 . . . . 0.0 109.161 179.912 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 121.465 0.65 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.11 156.73 28.4 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 69' ' ' THR . . . . . 0.547 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 98.1 m -104.39 137.1 42.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.415 -1.05 . . . . 0.0 108.194 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 28.3 mt -85.41 135.88 23.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 m -142.98 162.96 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.733 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -151.68 147.81 27.17 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.03 151.48 35.43 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.2 -0.937 . . . . 0.0 108.675 178.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 6.1 t70 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 120.878 -1.139 . . . . 0.0 109.226 179.411 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.506 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.9 mm 53.02 92.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.253 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.464 ' O ' ' CG ' ' A' ' 3' ' ' PHE . 24.3 p90 -151.25 115.94 5.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.204 -0.935 . . . . 0.0 109.455 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -118.44 -48.67 2.5 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.548 -0.72 . . . . 0.0 109.221 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 7' ' ' PHE . 1.3 p-10 -106.11 -88.9 0.44 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.427 -0.796 . . . . 0.0 109.536 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 50' ' ' MET . 29.7 mtpt 59.52 -67.93 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.225 0.535 . . . . 0.0 110.271 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.585 ' N ' ' O ' ' A' ' 5' ' ' ASP . 73.2 t80 -90.19 120.73 31.6 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.512 -0.743 . . . . 0.0 109.162 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.8 mt -134.1 131.69 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.341 -0.849 . . . . 0.0 110.205 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 9' ' ' ILE . 19.5 tt -129.37 125.22 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.08 -1.012 . . . . 0.0 108.762 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.8 t -122.88 139.04 54.46 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.332 -0.855 . . . . 0.0 110.302 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.526 ' OG1' ' OG1' ' B' ' 69' ' ' THR . 3.1 m -91.12 98.6 11.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.012 -1.055 . . . . 0.0 108.928 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.56 91.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.23 -0.919 . . . . 0.0 110.319 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -162.93 -128.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -173.68 -17.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.271 -0.893 . . . . 0.0 109.6 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.1 mt 49.69 69.0 2.93 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.581 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.76 156.85 50.93 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.975 1.783 . . . . 0.0 110.035 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.18 -9.42 74.88 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.824 -1.179 . . . . 0.0 110.495 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 18' ' ' LEU . 32.5 mt -122.54 139.31 54.04 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.137 -1.214 . . . . 0.0 110.071 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -87.56 116.46 25.69 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.7 mt -107.12 134.62 49.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.348 -0.845 . . . . 0.0 109.339 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.532 ' CE1' ' O ' ' A' ' 22' ' ' SER . 2.1 t80 -121.11 129.71 53.42 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.532 ' O ' ' CE1' ' A' ' 21' ' ' TYR . 20.8 t -84.24 129.07 34.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.407 -0.808 . . . . 0.0 110.522 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.923 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -119.29 15.44 13.07 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.03 170.8 11.94 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.352 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -109.13 144.5 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.78 144.75 42.99 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.552 -0.718 . . . . 0.0 109.4 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -152.39 139.92 19.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.91 -1.119 . . . . 0.0 108.258 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 t -150.26 136.55 18.78 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.902 -1.124 . . . . 0.0 109.548 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.0 mt -101.38 126.91 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.144 -0.973 . . . . 0.0 109.171 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.7 p -175.36 175.98 2.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.338 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 16.0 p-10 -115.75 161.16 19.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.542 -0.723 . . . . 0.0 109.117 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 11.2 m-20 77.14 120.26 0.05 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.6 t -66.26 -33.13 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.444 -0.785 . . . . 0.0 109.697 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -56.97 -39.65 75.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.911 . . . . 0.0 110.145 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -76.57 -36.51 57.54 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.179 -0.95 . . . . 0.0 109.372 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.7 mt -64.36 -51.9 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.932 -1.105 . . . . 0.0 109.399 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.74 -50.18 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.048 -1.033 . . . . 0.0 109.257 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -60.16 -41.38 92.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.295 -0.878 . . . . 0.0 109.758 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -62.93 -46.16 89.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.136 -0.977 . . . . 0.0 110.009 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.5 mt -69.38 -46.47 66.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.001 -1.062 . . . . 0.0 108.767 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -48.03 -55.05 11.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.789 -1.194 . . . . 0.0 108.87 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.45 -35.23 67.65 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.939 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -75.13 -35.88 61.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.37 -0.831 . . . . 0.0 109.81 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.8 t -73.82 -50.91 26.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.146 -0.971 . . . . 0.0 109.439 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -68.71 -31.7 70.97 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.566 -1.334 . . . . 0.0 109.174 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.84 -31.63 72.68 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -90.38 5.63 46.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -0.877 . . . . 0.0 109.023 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.72 27.04 73.03 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.664 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.92 -167.58 23.8 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.457 ' O ' ' O ' ' A' ' 6' ' ' LYS . 34.7 ttp -110.73 -41.3 4.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.616 -0.932 . . . . 0.0 109.478 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.91 -153.01 11.35 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 tp -133.2 135.46 45.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.357 -1.084 . . . . 0.0 109.788 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.575 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 1.1 pt -111.0 146.38 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.497 -0.752 . . . . 0.0 110.276 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 75.01 87.79 0.09 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.357 -0.839 . . . . 0.0 109.14 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -115.05 50.51 0.97 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.591 ' O ' ' O ' ' A' ' 57' ' ' ILE . 30.4 ttm180 -65.87 -56.81 9.89 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.536 -0.727 . . . . 0.0 109.602 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.591 ' O ' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER 42.22 108.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-O 122.202 1.001 . . . . 0.0 109.436 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.1 t -72.38 171.79 11.58 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 120.052 -1.655 . . . . 0.0 109.426 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 24.7 p -68.58 168.19 13.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.181 -0.95 . . . . 0.0 109.331 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.14 158.93 24.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.1 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -160.83 -31.5 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.924 . . . . 0.0 109.395 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.99 -29.93 0.12 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -167.25 70.17 0.1 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.151 -1.205 . . . . 0.0 109.569 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -94.55 -167.03 1.58 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.209 -0.932 . . . . 0.0 109.67 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.418 HD12 ' H ' ' A' ' 66' ' ' GLY . 41.2 tp -167.33 139.06 3.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.185 -0.947 . . . . 0.0 109.985 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.418 ' H ' HD12 ' A' ' 65' ' ' LEU . . . -105.08 83.36 0.37 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -77.87 152.01 33.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -1.162 . . . . 0.0 109.904 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.98 159.57 29.72 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.4 m -107.03 140.13 40.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.149 -1.207 . . . . 0.0 109.37 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.4 mt -87.34 135.74 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 m -138.96 162.14 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 109.673 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -154.46 143.11 20.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.887 . . . . 0.0 109.042 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.84 150.37 35.62 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.915 -1.116 . . . . 0.0 108.015 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -165.2 163.07 20.31 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.919 -1.113 . . . . 0.0 109.097 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.62 137.34 55.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.397 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.78 174.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.335 -0.853 . . . . 0.0 109.769 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -91.2 -153.51 0.32 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.259 -0.901 . . . . 0.0 109.455 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.44 ' O ' ' CD2' ' A' ' 78' ' ' PHE . 18.2 p90 -79.91 117.08 20.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.892 . . . . 0.0 109.61 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 80' ' ' MET . 0.1 OUTLIER -85.6 -81.62 0.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.242 -0.911 . . . . 0.0 109.319 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.46 ' H ' HG23 ' A' ' 79' ' ' THR . 55.8 mtt 51.96 21.51 1.52 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 109.602 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.495 179.91 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.7 mmt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.622 HD13 ' H ' ' B' ' 2' ' ' ILE . 0.1 OUTLIER -100.5 4.05 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.407 -0.808 . . . . 0.0 109.097 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.585 ' O ' ' N ' ' B' ' 5' ' ' ASP . 63.5 m-85 -61.14 -37.35 82.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.459 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 53.6 -80.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.681 -0.637 . . . . 0.0 109.607 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' B' ' 3' ' ' PHE . 1.6 m-20 -54.64 136.45 45.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 109.813 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' B' ' 50' ' ' MET . 46.1 mtmt -134.95 -63.91 0.68 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.42 -0.8 . . . . 0.0 109.333 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -89.91 120.91 31.54 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.266 -0.897 . . . . 0.0 109.172 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 11.9 mt -136.09 138.27 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.284 -0.885 . . . . 0.0 109.962 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.443 ' O ' ' CG2' ' B' ' 9' ' ' ILE . 3.8 tt -118.99 121.84 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.267 -0.895 . . . . 0.0 108.588 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 7.3 t -123.76 135.56 53.89 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.395 -0.815 . . . . 0.0 110.296 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.401 ' OG1' HD11 ' C' ' 25' ' ' ILE . 21.6 m -113.68 112.42 23.45 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 52.52 55.55 8.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.394 -0.816 . . . . 0.0 110.205 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -160.4 111.73 1.91 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.538 -0.727 . . . . 0.0 109.082 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -64.38 169.91 4.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 109.62 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 22.5 mt -135.48 71.69 65.61 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.519 -0.738 . . . . 0.0 109.064 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.8 157.6 37.18 Favored 'Trans proline' 0 C--N 1.319 -0.979 0 C-N-CA 121.873 1.715 . . . . 0.0 110.054 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.73 -8.4 73.99 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.367 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' B' ' 18' ' ' LEU . 20.4 mt -123.38 139.55 53.92 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.221 -1.164 . . . . 0.0 110.097 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -88.48 109.01 19.69 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt -97.85 141.34 30.95 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.266 -0.896 . . . . 0.0 110.773 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' TYR . . . . . 0.463 ' H ' ' H ' ' B' ' 72' ' ' LYS . 4.2 t80 -121.35 129.27 52.97 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 28.9 t -72.94 130.61 40.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.674 -1.266 . . . . 0.0 111.317 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.572 HD11 ' CB ' ' B' ' 72' ' ' LYS . 18.5 mt -118.68 9.35 12.13 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.3 -161.81 19.71 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.22 144.99 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 122.234 -0.568 . . . . 0.0 109.484 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.69 158.12 20.44 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 86.0 p -150.25 140.82 22.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 108.917 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 20.6 p -140.24 135.34 32.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.326 -0.859 . . . . 0.0 109.409 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.459 ' O ' ' CB ' ' B' ' 30' ' ' SER . 96.5 mt -126.79 125.48 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' B' ' 29' ' ' ILE . 1.9 p 163.3 -164.11 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 16.0 p-10 -122.19 173.13 7.78 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 18.3 m-80 76.91 112.46 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.3 -35.36 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.435 -0.791 . . . . 0.0 109.642 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -56.99 -37.27 71.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 110.057 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -76.46 -36.61 57.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.219 -0.926 . . . . 0.0 109.324 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 82.0 mt -66.22 -53.62 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.898 -1.126 . . . . 0.0 109.425 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 40.2 t -59.35 -51.87 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.004 -1.06 . . . . 0.0 109.513 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -56.13 -36.22 68.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 109.622 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -66.68 -40.33 88.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.043 -1.036 . . . . 0.0 109.852 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 70.4 mt -74.5 -50.84 16.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.95 -1.094 . . . . 0.0 108.988 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -48.85 -53.01 21.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.808 -1.182 . . . . 0.0 108.861 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' B' ' 46' ' ' ALA . 31.6 ttpt -59.0 -36.79 75.49 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.438 -0.788 . . . . 0.0 110.026 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -75.25 -35.85 61.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.232 -0.918 . . . . 0.0 109.945 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 4.9 t -74.2 -51.42 23.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 109.448 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 33.7 tptt -70.75 -29.75 66.07 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.234 -1.386 . . . . 0.0 109.548 -175.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' B' ' 42' ' ' LYS . . . -62.12 -31.25 71.7 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -92.75 2.19 56.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 109.226 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.22 29.3 64.62 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.336 -1.411 . . . . 0.0 110.016 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.77 -170.54 25.73 Favored Glycine 0 N--CA 1.492 2.383 0 O-C-N 121.209 -1.171 . . . . 0.0 110.585 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' MET . . . . . 0.501 ' O ' ' O ' ' B' ' 6' ' ' LYS . 0.3 OUTLIER -107.95 -48.8 3.32 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.725 -0.868 . . . . 0.0 109.291 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -167.7 -160.94 16.14 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.4 tp -136.82 138.51 40.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.299 -1.118 . . . . 0.0 109.99 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.655 ' O ' ' HB3' ' B' ' 54' ' ' ALA . 0.4 OUTLIER -107.0 147.62 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.411 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 90.38 -146.59 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.64 ' CB ' ' O ' ' B' ' 54' ' ' ALA . 67.4 t80 120.71 -101.52 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 120.529 1.513 . . . . 0.0 107.077 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' B' ' 55' ' ' PHE . 25.8 mtm180 55.52 161.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.38 -0.825 . . . . 0.0 109.79 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.465 HG22 ' N ' ' B' ' 58' ' ' THR . 79.3 mt -138.93 160.08 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.249 -0.907 . . . . 0.0 108.941 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' THR . . . . . 0.488 HG23 ' CD2' ' C' ' 64' ' ' PHE . 2.7 m -167.61 157.64 10.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.256 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 42.8 t 50.5 75.8 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.46 -0.775 . . . . 0.0 109.824 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.51 176.08 9.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 109.354 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t70 53.22 14.58 0.53 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 109.649 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -154.99 -171.89 22.15 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.66 152.82 18.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.238 -1.154 . . . . 0.0 110.368 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.469 ' CD2' ' N ' ' B' ' 65' ' ' LEU . 61.8 t80 -146.01 -111.02 0.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.466 -0.771 . . . . 0.0 108.943 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.469 ' N ' ' CD2' ' B' ' 64' ' ' PHE . 6.4 tp -175.57 108.44 0.09 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.53 115.43 4.72 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' B' ' 67' ' ' TYR . 7.3 p90 -137.24 -175.96 4.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -1.115 . . . . 0.0 110.319 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.48 167.63 29.4 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' THR . . . . . 0.526 ' OG1' ' OG1' ' A' ' 11' ' ' THR . 87.5 m -95.01 138.48 32.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.029 -1.277 . . . . 0.0 109.076 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.418 HG22 HD12 ' B' ' 23' ' ' LEU . 70.6 mt -87.5 125.36 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 3.0 m -122.78 162.51 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.306 -0.871 . . . . 0.0 110.558 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.572 ' CB ' HD11 ' B' ' 23' ' ' LEU . 11.6 tttp -154.92 135.15 13.17 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.02 114.82 29.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.556 -1.34 . . . . 0.0 111.598 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ASP . . . . . 0.427 ' CG ' ' NZ ' ' B' ' 72' ' ' LYS . 6.8 p-10 -168.95 4.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.241 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' B' ' 75' ' ' GLU . 1.8 pm0 -71.25 -5.69 34.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.93 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.17 -175.57 0.05 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.911 . . . . 0.0 109.506 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' B' ' 77' ' ' GLN . 20.3 mp0 -95.36 -139.12 0.24 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.263 -0.898 . . . . 0.0 109.547 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -155.83 151.55 27.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.255 -0.903 . . . . 0.0 109.395 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 44.8 p -70.22 138.78 51.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 109.574 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -71.85 85.95 0.96 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.923 . . . . 0.0 109.52 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.509 179.949 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 14.4 mmt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 77.1 mt -78.31 119.75 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.0 109.432 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -86.79 -172.3 3.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.3 -0.875 . . . . 0.0 109.406 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.82 153.8 41.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 109.344 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' ASP . . . . . 0.46 ' CG ' ' H ' ' C' ' 6' ' ' LYS . 2.0 p-10 -102.63 -96.42 0.29 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.385 -0.822 . . . . 0.0 109.287 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 6' ' ' LYS . . . . . 0.501 ' HG2' ' N ' ' C' ' 7' ' ' PHE . 53.6 tttp -133.35 -95.63 0.31 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 7' ' ' PHE . . . . . 0.501 ' N ' ' HG2' ' C' ' 6' ' ' LYS . 70.1 t80 -101.42 119.88 39.43 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.042 -1.036 . . . . 0.0 109.268 -178.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 8' ' ' ILE . . . . . 0.444 ' O ' ' HA3' ' C' ' 51' ' ' GLY . 60.8 mt -115.46 143.21 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.543 -0.723 . . . . 0.0 110.067 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 9' ' ' ILE . . . . . 0.551 ' O ' HG23 ' C' ' 9' ' ' ILE . 12.9 tt -138.54 114.56 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.742 -1.224 . . . . 0.0 108.853 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -123.95 161.78 24.73 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.395 -0.816 . . . . 0.0 108.958 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 1.2 p -114.6 79.0 1.21 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' ALA . . . . . 0.463 ' O ' ' CG ' ' C' ' 13' ' ' ASP . . . -179.04 -10.21 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.486 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 13' ' ' ASP . . . . . 0.463 ' CG ' ' O ' ' C' ' 12' ' ' ALA . 3.2 p30 43.73 83.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.348 0.594 . . . . 0.0 110.272 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -154.72 -87.86 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.402 -0.811 . . . . 0.0 109.545 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 7.3 mt 48.99 66.23 6.01 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.226 -0.921 . . . . 0.0 109.247 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.53 157.71 49.55 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 C-N-CA 122.085 1.856 . . . . 0.0 109.885 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.99 -7.0 73.22 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.676 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 18' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' C' ' 18' ' ' LEU . 58.2 mt -124.46 140.55 52.84 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.997 -1.296 . . . . 0.0 110.246 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 19' ' ' GLN . . . . . 0.419 ' N ' ' CD ' ' C' ' 19' ' ' GLN . 2.9 mp0 -85.64 108.38 17.98 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -92.2 134.25 35.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.077 -1.014 . . . . 0.0 110.092 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 21' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -117.35 130.31 56.43 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.82 131.64 43.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.68 -1.262 . . . . 0.0 111.134 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.803 HD11 ' HB2' ' C' ' 72' ' ' LYS . 25.0 mt -114.64 10.54 16.75 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.14 -154.57 16.41 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' ILE . . . . . 0.401 HD11 ' OG1' ' B' ' 11' ' ' THR . 0.3 OUTLIER -134.69 143.56 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.82 -0.812 . . . . 0.0 109.492 -179.411 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.98 149.24 40.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.832 -0.542 . . . . 0.0 109.714 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 60.7 p -151.56 138.18 18.75 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -149.34 147.77 28.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.98 -1.075 . . . . 0.0 108.973 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 tt -127.59 133.37 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.2 -0.937 . . . . 0.0 109.049 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 5.3 t -169.54 170.56 8.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.291 -0.88 . . . . 0.0 109.474 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -104.31 37.56 2.07 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.835 0.826 . . . . 0.0 110.296 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -152.5 125.08 8.3 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.457 ' H ' HG13 ' C' ' 33' ' ' VAL . 0.7 OUTLIER -72.69 -45.51 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.106 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 34' ' ' ASP . . . . . 0.43 ' N ' ' CG2' ' C' ' 33' ' ' VAL . 5.7 p-10 -62.08 -34.77 76.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.426 -0.796 . . . . 0.0 109.99 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -74.01 -38.51 64.07 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.584 -0.846 . . . . 0.0 108.808 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 68.1 mt -63.02 -51.33 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.96 . . . . 0.0 108.646 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.55 -49.8 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.991 . . . . 0.0 108.691 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -61.68 -45.5 93.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.348 -0.845 . . . . 0.0 109.955 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -59.39 -46.63 88.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.329 -0.857 . . . . 0.0 109.557 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' C' ' 40' ' ' LEU . 41.1 mt -66.93 -44.24 81.19 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.123 -0.986 . . . . 0.0 108.384 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -46.76 -56.21 6.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.818 -1.176 . . . . 0.0 108.636 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -53.46 -32.16 48.78 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.34 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -74.42 -40.77 61.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.444 -0.785 . . . . 0.0 109.259 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 10.1 t -77.85 -53.53 14.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 120.774 -1.204 . . . . 0.0 108.921 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -50.58 -31.66 16.46 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.769 1.271 . . . . 0.0 109.795 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.38 -25.81 46.38 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.482 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -98.15 -0.92 43.38 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.9 26.46 73.91 Favored Glycine 0 N--CA 1.487 2.087 0 C-N-CA 118.335 -1.888 . . . . 0.0 109.637 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.79 -167.87 15.55 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 5.0 ttp -110.18 -43.79 3.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.586 -0.949 . . . . 0.0 110.462 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' C' ' 8' ' ' ILE . . . 177.55 -172.22 44.95 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.556 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.52 132.07 53.64 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.374 -1.074 . . . . 0.0 110.62 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 pt -109.61 139.14 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.44 61.96 2.65 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.888 -1.133 . . . . 0.0 108.665 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -96.57 109.32 21.94 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' ARG . . . . . 0.713 ' HG3' HH11 ' C' ' 56' ' ' ARG . 9.7 mmm-85 -125.02 154.62 40.98 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.419 -0.8 . . . . 0.0 109.306 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 57' ' ' ILE . . . . . 0.421 ' C ' HG22 ' C' ' 58' ' ' THR . 0.3 OUTLIER -141.18 147.45 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.014 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 58' ' ' THR . . . . . 0.421 HG22 ' C ' ' C' ' 57' ' ' ILE . 0.0 OUTLIER 175.57 90.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.455 -0.778 . . . . 0.0 109.198 178.559 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 59' ' ' CYS . . . . . 0.491 ' SG ' ' N ' ' C' ' 63' ' ' LYS . 4.3 t -164.97 149.53 9.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.072 -1.017 . . . . 0.0 109.499 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.4 -73.79 0.65 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.606 -0.684 . . . . 0.0 109.161 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.08 -71.46 0.36 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.92 . . . . 0.0 108.925 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.91 41.43 0.35 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' LYS . . . . . 0.491 ' N ' ' SG ' ' C' ' 59' ' ' CYS . 7.8 mtmp? -80.46 -115.15 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.109 -1.23 . . . . 0.0 110.031 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 64' ' ' PHE . . . . . 0.488 ' CD2' HG23 ' B' ' 58' ' ' THR . 4.9 m-85 -61.92 -174.82 0.06 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.543 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.487 ' N ' HD23 ' C' ' 65' ' ' LEU . 1.9 pt? -163.66 -174.0 3.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.098 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.5 147.84 19.69 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -159.04 161.16 36.52 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.188 -1.183 . . . . 0.0 109.711 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.48 166.42 34.17 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.406 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 34.4 m -101.92 140.21 36.5 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.307 -1.113 . . . . 0.0 108.424 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 70' ' ' ILE . . . . . 0.539 HG22 HD12 ' C' ' 23' ' ' LEU . 56.2 mt -85.53 148.5 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 6.8 m -142.96 156.18 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.158 -0.964 . . . . 0.0 109.765 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 72' ' ' LYS . . . . . 0.803 ' HB2' HD11 ' C' ' 23' ' ' LEU . 21.6 ttpt -146.04 156.17 43.29 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.216 -0.927 . . . . 0.0 108.731 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' C' ' 74' ' ' ASP . . . -119.88 153.38 35.92 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' C' ' 73' ' ' ALA . 16.2 m-20 92.66 -171.91 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.37 0.605 . . . . 0.0 109.736 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 75' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -67.98 150.46 48.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.828 . . . . 0.0 109.553 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.01 14.25 12.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.306 -0.871 . . . . 0.0 109.537 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 77' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 53.52 17.8 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.232 -0.918 . . . . 0.0 109.512 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -144.54 119.62 10.07 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.271 -0.893 . . . . 0.0 108.824 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 23.1 m -131.32 -55.45 1.03 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.541 -0.724 . . . . 0.0 109.364 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 9.4 mmt -137.66 -61.07 0.64 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.377 -0.827 . . . . 0.0 109.144 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.541 -179.909 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.432 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.7 mpt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 tp -164.74 -33.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.327 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -87.81 143.29 27.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.283 -0.886 . . . . 0.0 109.642 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 56.46 54.78 7.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 109.61 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 5' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -154.69 -0.01 0.18 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.235 -0.916 . . . . 0.0 109.509 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -92.81 96.47 10.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.202 -0.936 . . . . 0.0 109.429 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -101.44 123.8 46.08 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.274 -0.891 . . . . 0.0 109.515 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 87.4 mt -119.12 146.29 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.636 -0.665 . . . . 0.0 109.489 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 9' ' ' ILE . . . . . 0.59 HG23 ' O ' ' D' ' 9' ' ' ILE . 13.2 tt -138.35 116.38 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.419 -0.8 . . . . 0.0 109.001 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t -121.95 160.75 24.18 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 11' ' ' THR . . . . . 0.512 ' OG1' ' OG1' ' E' ' 69' ' ' THR . 1.3 m -130.45 123.79 30.57 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 12' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' D' ' 11' ' ' THR . . . 59.85 49.81 7.56 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 122.117 0.96 . . . . 0.0 109.307 178.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -138.6 -171.02 2.96 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 55.0 mp0 -147.09 -18.03 0.4 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.035 -1.041 . . . . 0.0 109.622 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 27.8 mt 49.36 66.74 5.26 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.237 -0.914 . . . . 0.0 109.148 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.04 157.59 38.39 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 121.962 1.774 . . . . 0.0 110.076 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.97 -8.09 73.27 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.508 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 25.5 mt -122.52 138.44 54.56 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.147 -1.207 . . . . 0.0 110.187 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -90.31 116.74 28.51 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 11.9 mt -100.61 140.43 34.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.576 -0.702 . . . . 0.0 110.725 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 21' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -118.63 129.79 55.5 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 6.2 t -68.46 130.2 42.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.712 -1.243 . . . . 0.0 112.022 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.587 HD11 ' CB ' ' D' ' 72' ' ' LYS . 40.4 mt -116.54 13.64 15.37 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.68 -170.13 13.21 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.51 142.3 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.843 -0.798 . . . . 0.0 109.419 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.81 144.17 44.37 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.57 -0.706 . . . . 0.0 109.46 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 51.8 m -152.09 138.19 18.25 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.955 -1.091 . . . . 0.0 108.479 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 28' ' ' THR . . . . . 0.433 ' O ' HG23 ' D' ' 28' ' ' THR . 11.6 t -150.07 132.16 15.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.914 -1.116 . . . . 0.0 109.327 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 tt -100.01 130.04 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.108 -0.995 . . . . 0.0 109.379 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 6.3 p -178.21 179.47 0.81 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.439 -0.788 . . . . 0.0 109.238 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 31' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' D' ' 32' ' ' ASN . 3.3 p30 -112.18 157.17 21.18 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.515 -0.741 . . . . 0.0 109.166 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 5.7 t-20 79.23 117.1 0.06 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.556 -0.715 . . . . 0.0 109.129 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 91.6 t -62.75 -31.03 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.542 -0.724 . . . . 0.0 109.534 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -59.4 -41.01 88.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.933 . . . . 0.0 110.029 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -74.09 -39.65 63.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.261 -0.899 . . . . 0.0 109.087 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 71.4 mt -65.36 -53.97 33.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.953 -1.092 . . . . 0.0 108.908 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 25.3 t -61.43 -50.23 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.124 -0.985 . . . . 0.0 109.224 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -56.42 -36.43 68.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.2 -0.937 . . . . 0.0 109.828 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -71.73 -38.01 70.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.032 -1.042 . . . . 0.0 109.406 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.702 HD13 ' CD2' ' D' ' 52' ' ' LEU . 26.7 mt -69.56 -48.92 58.7 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.962 -1.086 . . . . 0.0 108.152 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 41' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' D' ' 40' ' ' LEU . 99.2 mtt180 -46.24 -57.76 4.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.308 -1.495 . . . . 0.0 108.993 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -50.17 -28.93 8.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.037 -1.039 . . . . 0.0 110.448 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -68.61 -56.66 7.5 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.732 -1.23 . . . . 0.0 110.011 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 44' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' D' ' 48' ' ' GLY . 1.8 m -64.91 -48.82 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.672 0 O-C-N 120.275 -1.515 . . . . 0.0 107.825 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -49.94 -46.15 51.92 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.72 1.248 . . . . 0.0 110.809 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.89 -30.15 56.06 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.642 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 47' ' ' LYS . . . . . 0.464 ' NZ ' ' O ' ' D' ' 23' ' ' LEU . 5.8 ttmt -92.47 -3.87 54.52 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.239 -0.913 . . . . 0.0 108.794 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 48' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' D' ' 44' ' ' VAL . . . 81.1 20.24 65.39 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.313 -1.422 . . . . 0.0 109.598 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.8 -166.57 13.27 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.68 -25.49 5.48 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.581 -0.952 . . . . 0.0 111.822 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 51' ' ' GLY . . . . . 0.501 ' O ' HD12 ' D' ' 52' ' ' LEU . . . 159.34 -163.21 33.31 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 52' ' ' LEU . . . . . 0.702 ' CD2' HD13 ' D' ' 40' ' ' LEU . 5.6 mp -123.93 139.43 53.96 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.443 -1.033 . . . . 0.0 109.833 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 53' ' ' ILE . . . . . . . . . . . . . 1.3 pt -106.75 143.42 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.593 -0.692 . . . . 0.0 109.412 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 57.03 60.01 3.19 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.824 -1.172 . . . . 0.0 108.554 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.412 ' CD2' HD11 ' D' ' 9' ' ' ILE . 46.9 t80 -84.35 71.34 10.68 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 56' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -91.8 120.54 32.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.493 -0.754 . . . . 0.0 109.846 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 57' ' ' ILE . . . . . 0.51 ' O ' ' C ' ' D' ' 58' ' ' THR . 39.6 mt -89.8 -51.89 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 108.737 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 58' ' ' THR . . . . . 0.51 ' C ' ' O ' ' D' ' 57' ' ' ILE . 0.0 OUTLIER 28.57 87.77 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.159 0.504 . . . . 0.0 110.728 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 59' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' D' ' 60' ' ' ALA . 42.7 t -80.74 167.05 20.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 109.509 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 60' ' ' ALA . . . . . 0.434 ' N ' ' SG ' ' D' ' 59' ' ' CYS . . . -131.45 -48.8 0.98 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.541 -0.725 . . . . 0.0 109.246 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -165.61 78.36 0.28 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.39 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.91 -11.93 51.47 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -85.35 101.87 12.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.206 -1.173 . . . . 0.0 109.256 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -114.61 48.22 1.15 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.588 -0.695 . . . . 0.0 109.221 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' D' ' 67' ' ' TYR . 2.4 mp -84.15 92.47 7.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.175 -0.953 . . . . 0.0 109.753 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.89 76.11 0.02 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 67' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' D' ' 65' ' ' LEU . 0.4 OUTLIER -57.73 130.71 47.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.282 -1.128 . . . . 0.0 110.365 -179.106 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.31 152.52 23.68 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 76.7 m -107.3 137.71 44.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.034 -1.274 . . . . 0.0 108.298 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 mt -87.78 137.0 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 108.272 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.1 m -126.65 162.58 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 CA-C-O 121.617 0.722 . . . . 0.0 109.92 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 72' ' ' LYS . . . . . 0.587 ' CB ' HD11 ' D' ' 23' ' ' LEU . 2.0 ttmt -147.19 145.14 29.4 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.05 151.84 23.48 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.1 -1.0 . . . . 0.0 108.322 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.59 -174.81 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.81 -1.181 . . . . 0.0 109.683 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 54.37 65.89 1.38 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.403 -0.811 . . . . 0.0 108.944 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 76' ' ' ALA . . . . . 0.459 ' C ' ' H ' ' D' ' 78' ' ' PHE . . . -81.35 -28.6 34.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.623 -0.673 . . . . 0.0 109.579 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 59.09 3.08 0.31 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.274 -0.891 . . . . 0.0 109.247 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 78' ' ' PHE . . . . . 0.459 ' H ' ' C ' ' D' ' 76' ' ' ALA . 88.3 t80 -95.43 -37.1 11.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.118 -0.989 . . . . 0.0 109.574 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 92.6 m -158.17 119.44 3.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.214 -0.929 . . . . 0.0 109.378 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 19.3 mmt -57.88 -34.11 69.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.549 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.625 179.998 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ptp . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 24.2 mt -80.63 99.45 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 0.0 109.429 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 3' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -68.07 -162.08 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.916 . . . . 0.0 109.412 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -161.75 128.07 3.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.862 . . . . 0.0 108.703 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 5' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' E' ' 7' ' ' PHE . 0.5 OUTLIER 168.12 -55.92 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 6' ' ' LYS . . . . . 0.406 ' N ' ' OD1' ' E' ' 5' ' ' ASP . 25.5 tptp 51.84 -87.77 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.589 -1.319 . . . . 0.0 109.867 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 7' ' ' PHE . . . . . 0.563 ' N ' ' O ' ' E' ' 5' ' ' ASP . 73.2 t80 -107.29 119.74 40.21 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.368 -0.833 . . . . 0.0 109.492 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 54.2 mt -107.59 130.89 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.533 -0.73 . . . . 0.0 109.203 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 9' ' ' ILE . . . . . 0.471 HD11 ' CG ' ' E' ' 55' ' ' PHE . 8.3 tt -120.92 115.09 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.13 155.6 39.65 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.833 -1.167 . . . . 0.0 108.659 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 11' ' ' THR . . . . . . . . . . . . . 2.3 p -118.9 95.96 5.05 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -165.88 -113.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.141 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -135.64 -42.32 0.68 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.833 . . . . 0.0 109.576 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -173.29 174.16 3.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.225 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 72.9 mt -112.57 95.68 33.3 Favored Pre-proline 0 N--CA 1.498 1.953 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.47 155.9 59.7 Favored 'Trans proline' 0 C--N 1.325 -0.671 0 C-N-CA 121.726 1.618 . . . . 0.0 110.83 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.48 -7.86 77.46 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 18' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' E' ' 18' ' ' LEU . 56.3 mt -129.3 141.55 51.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -1.118 . . . . 0.0 109.836 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 19' ' ' GLN . . . . . 0.46 ' N ' ' CD ' ' E' ' 19' ' ' GLN . 3.5 mp0 -85.37 108.59 17.91 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 13.9 mt -96.78 135.0 39.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.247 -0.908 . . . . 0.0 110.036 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 21' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -123.46 129.48 51.3 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -86.53 132.53 33.89 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.205 -0.935 . . . . 0.0 111.292 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.948 ' N ' HD23 ' E' ' 23' ' ' LEU . 0.4 OUTLIER -121.7 21.23 10.87 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.42 172.79 13.41 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.406 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 43.8 mm -108.69 143.52 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.39 145.03 41.79 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.315 -0.866 . . . . 0.0 108.886 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 84.8 p -152.08 136.66 16.93 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 13.5 t -150.06 149.65 30.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.936 -1.103 . . . . 0.0 109.192 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 2.2 tp -125.41 132.47 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 1.3 p 175.71 -173.82 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.008 -1.058 . . . . 0.0 109.251 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 31' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' E' ' 32' ' ' ASN . 29.1 m-20 -123.81 168.4 12.79 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.61 -0.681 . . . . 0.0 109.369 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 32' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 9.1 t-20 75.64 123.89 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.02 -34.36 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.341 -0.85 . . . . 0.0 109.467 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -59.16 -46.26 88.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 110.172 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -75.55 -39.4 58.26 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.086 -1.009 . . . . 0.0 109.564 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.62 -48.97 85.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.843 -1.16 . . . . 0.0 109.104 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 48.7 t -63.17 -48.91 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.014 -1.054 . . . . 0.0 109.478 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -59.42 -40.22 86.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.938 . . . . 0.0 109.618 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -58.48 -45.13 89.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.529 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 49.1 mt -72.37 -48.03 44.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.114 -0.992 . . . . 0.0 109.164 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -50.74 -42.96 58.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.716 -1.24 . . . . 0.0 109.354 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -69.25 -38.89 78.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.557 -0.715 . . . . 0.0 109.694 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -76.08 -34.69 59.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.918 . . . . 0.0 109.742 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 t -69.25 -52.6 31.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.197 -0.94 . . . . 0.0 109.668 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -72.3 -34.4 68.1 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.323 -1.351 . . . . 0.0 109.14 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.96 -32.27 61.36 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.14 -5.27 55.28 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.236 -0.915 . . . . 0.0 110.11 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.95 6.17 37.51 Favored Glycine 0 N--CA 1.504 3.21 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.36 159.58 48.73 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -124.37 -9.48 7.49 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.289 -1.124 . . . . 0.0 110.786 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.3 163.17 35.91 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.05 -1.548 . . . . 0.0 109.898 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 4.9 tp -120.79 143.09 49.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.653 -0.91 . . . . 0.0 110.093 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 53' ' ' ILE . . . . . 0.416 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 14.0 mt -113.12 138.87 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.568 -0.708 . . . . 0.0 110.411 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 64.73 78.69 0.28 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.436 -0.79 . . . . 0.0 110.593 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 55' ' ' PHE . . . . . 0.471 ' CG ' HD11 ' E' ' 9' ' ' ILE . 84.0 t80 -90.49 98.94 12.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.514 -0.742 . . . . 0.0 109.931 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 56' ' ' ARG . . . . . 0.494 ' NH1' ' NH1' ' A' ' 56' ' ' ARG . 7.6 tpp180 -97.66 166.77 11.34 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.288 -0.883 . . . . 0.0 109.068 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 47.8 mt -133.88 -64.69 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.361 -0.837 . . . . 0.0 109.172 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 58' ' ' THR . . . . . . . . . . . . . 2.5 p -143.12 145.59 32.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.339 -0.851 . . . . 0.0 109.352 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 59' ' ' CYS . . . . . . . . . . . . . 34.2 m -141.41 -50.1 0.41 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.473 -0.767 . . . . 0.0 109.142 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.98 11.61 1.39 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -0.857 . . . . 0.0 109.427 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 55.01 46.62 23.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.72 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.77 -123.25 0.87 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -69.32 124.27 23.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -1.162 . . . . 0.0 109.417 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 64' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -167.81 121.54 0.94 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.278 -0.889 . . . . 0.0 109.252 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.748 HD12 ' N ' ' E' ' 65' ' ' LEU . 4.3 mp -89.8 143.47 26.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 108.67 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 66' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' E' ' 67' ' ' TYR . . . -55.85 -41.88 84.7 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 67' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' E' ' 66' ' ' GLY . 4.0 t80 59.74 127.81 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.543 -0.974 . . . . 0.0 110.407 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.58 140.18 6.38 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 69' ' ' THR . . . . . 0.512 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 20.4 m -93.11 138.7 31.3 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.93 -1.335 . . . . 0.0 108.623 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 70' ' ' ILE . . . . . 0.45 HG22 HD21 ' E' ' 23' ' ' LEU . 72.4 mt -85.48 139.19 17.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.44 161.46 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.175 -0.953 . . . . 0.0 110.189 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -155.92 147.25 22.59 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -110.95 150.65 28.94 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.123 -0.986 . . . . 0.0 108.595 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -69.65 151.6 45.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.056 -1.027 . . . . 0.0 109.563 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -84.91 -57.75 2.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.424 -0.798 . . . . 0.0 109.645 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.69 -14.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.928 . . . . 0.0 109.501 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 77' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -68.72 129.24 39.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.435 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -76.39 143.75 40.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 109.485 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 26.6 p -75.38 -8.79 57.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.863 . . . . 0.0 109.37 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 20.8 mmt -64.52 -41.75 96.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 109.47 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.397 -179.988 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 tpt . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.3 mm -70.79 96.36 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 109.463 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -96.49 8.32 44.36 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.241 -0.912 . . . . 0.0 109.456 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -79.7 25.2 0.35 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 109.514 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -172.54 96.9 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.382 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -166.1 70.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 109.322 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -102.62 123.14 45.79 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.422 -0.799 . . . . 0.0 110.141 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.4 mt -112.07 139.11 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.513 -0.742 . . . . 0.0 109.823 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 9' ' ' ILE . 6.3 tt -130.56 118.51 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -124.02 148.97 46.6 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.604 ' OG1' HD11 ' B' ' 25' ' ' ILE . 1.7 m -123.92 73.27 1.2 Allowed 'General case' 0 N--CA 1.511 2.622 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.727 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.2 -86.67 0.03 OUTLIER 'General case' 0 C--O 1.214 -0.791 0 O-C-N 119.585 -1.947 . . . . 0.0 107.576 -176.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.45 -78.56 0.6 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.274 -0.891 . . . . 0.0 109.68 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -162.4 -159.29 0.57 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.134 -0.979 . . . . 0.0 109.317 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.4 mt -120.78 91.76 47.62 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.495 -0.753 . . . . 0.0 109.235 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.51 155.73 51.17 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.784 1.656 . . . . 0.0 110.23 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.63 -14.08 64.97 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 18' ' ' LEU . 50.1 mt -121.86 139.48 53.57 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.427 -1.043 . . . . 0.0 109.503 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.27 108.43 15.72 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.1 mt -99.33 133.55 43.47 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.304 -0.873 . . . . 0.0 110.038 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.527 ' CE1' ' O ' ' A' ' 22' ' ' SER . 0.4 OUTLIER -120.86 129.97 53.74 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.527 ' O ' ' CE1' ' A' ' 21' ' ' TYR . 47.0 t -51.85 127.87 22.27 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.127 -0.983 . . . . 0.0 111.067 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' A' ' 23' ' ' LEU . 5.8 mt -114.44 5.9 15.77 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.17 -177.24 16.36 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.88 144.81 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 122.002 -0.705 . . . . 0.0 109.485 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.48 155.93 23.43 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.6 p -151.62 144.5 24.45 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.826 -1.171 . . . . 0.0 108.469 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.478 ' O ' HD12 ' A' ' 65' ' ' LEU . 12.2 p -148.47 132.4 17.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.246 -0.909 . . . . 0.0 109.305 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.62 126.99 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.3 p 173.11 -125.87 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.301 0.572 . . . . 0.0 109.609 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -162.59 168.53 21.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.159 -0.963 . . . . 0.0 108.589 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.2 m120 72.06 115.1 0.05 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.443 -0.786 . . . . 0.0 109.279 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.7 -31.99 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.607 -0.683 . . . . 0.0 109.314 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -58.99 -42.26 89.61 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.259 -0.9 . . . . 0.0 109.568 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.433 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 96.3 mt-10 -75.38 -41.02 57.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.988 -1.07 . . . . 0.0 109.869 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.33 -53.01 51.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 120.896 -1.127 . . . . 0.0 109.535 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.9 t -57.17 -48.81 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.134 -0.978 . . . . 0.0 109.028 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -59.31 -38.94 81.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.958 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 35' ' ' GLU . 4.5 m-80 -68.13 -39.98 82.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.058 -1.026 . . . . 0.0 109.768 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 40' ' ' LEU . 67.9 mt -64.93 -44.07 90.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.972 -1.08 . . . . 0.0 109.002 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -48.63 -54.48 14.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.801 -1.187 . . . . 0.0 109.471 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -57.82 -35.86 71.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.378 -0.826 . . . . 0.0 110.105 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -75.06 -36.18 61.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.219 -0.925 . . . . 0.0 109.806 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 t -71.16 -51.15 36.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.247 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -72.65 -33.28 66.49 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 117.81 -1.556 . . . . 0.0 109.598 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.69 76.18 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.869 . . . . 0.0 109.826 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -85.28 -4.11 59.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.539 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.75 0.49 55.26 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.66 155.55 53.4 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.34 -10.54 8.9 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.235 -1.156 . . . . 0.0 110.057 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.84 143.39 8.27 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.17 -1.491 . . . . 0.0 109.51 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.7 tp -101.32 142.64 32.44 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.743 -0.857 . . . . 0.0 110.12 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.831 ' O ' HD12 ' A' ' 53' ' ' ILE . 1.3 pp -120.27 150.29 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.476 -0.765 . . . . 0.0 110.559 -176.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.65 61.89 2.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.262 -1.524 . . . . 0.0 109.429 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.493 ' CD2' HD11 ' A' ' 9' ' ' ILE . 39.8 t80 -100.22 73.96 1.73 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.712 HH11 ' HG2' ' A' ' 56' ' ' ARG . 7.0 mtt-85 -72.37 143.76 48.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.587 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.543 HG22 HG23 ' A' ' 58' ' ' THR . 36.0 mm -84.9 -81.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 109.213 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.543 HG23 HG22 ' A' ' 57' ' ' ILE . 16.8 p -123.03 85.98 2.51 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.463 -0.773 . . . . 0.0 109.622 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 16.0 p -82.66 -127.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.368 -0.832 . . . . 0.0 109.179 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.67 -83.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.97 . . . . 0.0 109.497 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 3.1 m-20 -74.73 7.31 3.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.386 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.83 48.1 2.61 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 64' ' ' PHE . 0.7 OUTLIER -53.6 -53.59 49.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.916 -1.344 . . . . 0.0 109.146 -179.66 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.449 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 54.2 m-85 -158.0 60.53 0.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.392 -0.818 . . . . 0.0 109.085 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 28' ' ' THR . 7.2 tp -149.25 123.17 9.35 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.15 132.21 11.02 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 26.0 p90 -141.98 -176.04 4.64 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.255 -1.144 . . . . 0.0 109.549 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.01 165.66 26.78 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.47 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.9 m -97.93 134.73 40.65 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.6 mt -88.02 146.53 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.64 160.51 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.177 -0.952 . . . . 0.0 110.462 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.503 ' HZ2' ' CB ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -144.64 160.42 41.21 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.158 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 74' ' ' ASP . . . -118.34 152.14 36.39 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 73' ' ' ALA . 20.8 t0 79.07 -158.47 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.293 0.568 . . . . 0.0 109.608 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.427 ' H ' ' CG ' ' A' ' 74' ' ' ASP . 11.2 pt-20 -95.24 -173.06 2.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.221 -0.925 . . . . 0.0 109.416 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.0 -111.78 0.16 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.427 -0.796 . . . . 0.0 108.971 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -132.31 -4.3 3.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.45 -0.781 . . . . 0.0 109.266 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -63.88 -73.39 0.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 0.0 109.407 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 84.7 m -65.79 144.18 57.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 109.432 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.533 ' N ' ' SD ' ' A' ' 80' ' ' MET . 3.9 mpp? -67.93 118.05 10.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 109.399 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.48 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ptp . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 83.2 mt -129.71 -66.99 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.425 -0.797 . . . . 0.0 109.308 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.432 ' O ' ' CG ' ' B' ' 3' ' ' PHE . 6.6 p90 -146.19 34.53 0.99 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.102 -0.999 . . . . 0.0 109.56 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -150.69 -41.38 0.13 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.962 -1.086 . . . . 0.0 108.917 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.48 36.67 2.09 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.566 -0.709 . . . . 0.0 109.721 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -99.17 112.22 24.42 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.296 -0.877 . . . . 0.0 108.859 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -105.23 118.33 36.27 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 39.6 mt -103.9 134.78 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.322 -0.861 . . . . 0.0 110.123 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 39.0 mt -125.56 117.38 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 7.7 t -126.18 151.96 46.63 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.909 0.861 . . . . 0.0 108.749 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.456 ' CB ' ' HG1' ' C' ' 69' ' ' THR . 4.4 p -119.66 96.56 5.24 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -178.45 -87.74 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.528 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -155.55 -160.72 1.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.399 -0.813 . . . . 0.0 109.597 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -65.36 121.94 15.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.313 -0.867 . . . . 0.0 109.601 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 77.5 mt -52.58 110.27 1.86 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.56 -0.713 . . . . 0.0 109.386 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.46 153.75 72.76 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.293 1.329 . . . . 0.0 110.396 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.65 -16.09 58.86 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' B' ' 18' ' ' LEU . 71.8 mt -121.88 140.16 52.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.403 -1.057 . . . . 0.0 109.34 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -85.1 108.42 17.66 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 12.7 mt -96.89 138.35 34.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.211 -0.931 . . . . 0.0 110.233 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' TYR . . . . . 0.504 ' CE1' ' O ' ' B' ' 22' ' ' SER . 2.1 t80 -121.01 130.09 53.66 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.504 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 41.0 t -72.01 131.84 43.46 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 120.892 -1.13 . . . . 0.0 110.532 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.48 HD11 ' CB ' ' B' ' 72' ' ' LYS . 1.2 mp -118.92 12.79 12.95 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.67 -174.39 16.29 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ILE . . . . . 0.604 HD11 ' OG1' ' A' ' 11' ' ' THR . 0.3 OUTLIER -116.66 145.2 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.252 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.83 143.9 43.9 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 46.2 m -152.52 141.79 21.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.581 -1.325 . . . . 0.0 108.305 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 12.9 t -149.48 151.84 34.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.036 -1.04 . . . . 0.0 108.646 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' B' ' 30' ' ' SER . 49.1 mt -112.4 158.02 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.117 -0.989 . . . . 0.0 108.674 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.672 ' O ' ' CG ' ' B' ' 31' ' ' ASP . 16.9 m 51.34 108.35 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.741 0 O-C-N 121.039 -1.038 . . . . 0.0 110.683 177.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.672 ' CG ' ' O ' ' B' ' 30' ' ' SER . 37.3 m-20 171.15 129.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ASN . . . . . 0.488 ' O ' HG12 ' B' ' 36' ' ' ILE . 23.0 t-20 -84.27 173.04 11.31 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 120.917 -1.114 . . . . 0.0 108.384 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.532 ' HA ' HD11 ' B' ' 36' ' ' ILE . 15.5 t -44.8 -42.77 2.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 O-C-N 120.943 -1.098 . . . . 0.0 110.297 -174.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -64.19 -44.23 92.66 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.63 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -74.73 -45.83 41.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.327 -1.483 . . . . 0.0 111.546 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.532 HD11 ' HA ' ' B' ' 33' ' ' VAL . 0.6 OUTLIER -58.75 -48.98 84.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 O-C-N 120.017 -1.677 . . . . 0.0 109.413 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.79 -45.19 99.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 118.846 -1.142 . . . . 0.0 108.711 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -67.55 -50.34 59.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.347 -0.845 . . . . 0.0 109.424 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.451 ' ND2' ' OD2' ' B' ' 31' ' ' ASP . 4.5 m-20 -54.9 -47.39 74.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.108 -0.995 . . . . 0.0 108.966 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.75 -43.46 79.81 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.411 -0.806 . . . . 0.0 108.943 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -50.85 -45.33 59.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.626 -1.296 . . . . 0.0 109.419 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' B' ' 46' ' ' ALA . 64.0 mttm -66.41 -39.37 88.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.461 -0.774 . . . . 0.0 110.055 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -76.82 -34.99 57.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.689 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.473 HG21 HD13 ' B' ' 52' ' ' LEU . 15.3 t -71.86 -51.9 28.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.209 -0.932 . . . . 0.0 109.025 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -70.22 -30.18 67.2 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.14 -1.424 . . . . 0.0 109.558 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' B' ' 42' ' ' LYS . . . -61.55 -30.01 70.38 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -93.62 -5.31 49.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.381 -0.824 . . . . 0.0 109.821 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.87 15.49 28.62 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.02 159.84 29.24 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.1 -1.02 4.63 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.173 -1.193 . . . . 0.0 110.816 -176.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.82 173.62 43.4 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.422 -1.37 . . . . 0.0 109.773 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.473 HD13 HG21 ' B' ' 44' ' ' VAL . 5.5 tp -130.53 133.81 46.53 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.67 -0.9 . . . . 0.0 109.43 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.57 139.66 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.672 -0.643 . . . . 0.0 110.243 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 50.83 61.12 3.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.949 -1.094 . . . . 0.0 110.633 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -100.39 114.3 27.74 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.323 0.583 . . . . 0.0 110.654 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -102.46 119.12 38.28 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 pt -75.01 175.42 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.128 -0.982 . . . . 0.0 109.858 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 76.6 p -78.21 -151.67 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.811 . . . . 0.0 109.897 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 8.7 p -168.3 177.5 5.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.755 -1.215 . . . . 0.0 109.2 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.48 83.94 6.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 109.428 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -156.81 46.87 0.43 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.262 -0.898 . . . . 0.0 109.303 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.3 -160.01 45.52 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -75.43 82.94 2.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -1.129 . . . . 0.0 109.831 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -69.72 -148.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.157 -0.965 . . . . 0.0 108.917 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.1 mt -159.59 114.98 2.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.427 -0.796 . . . . 0.0 109.671 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.26 149.66 20.39 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' B' ' 67' ' ' TYR . 4.8 p90 -150.03 152.97 35.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.158 -1.201 . . . . 0.0 110.202 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.73 156.53 28.07 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 52.6 m -101.21 136.12 41.56 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.061 -1.258 . . . . 0.0 107.92 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 53.5 mt -86.04 146.62 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.9 m -138.51 156.71 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.308 -0.87 . . . . 0.0 110.21 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.48 ' CB ' HD11 ' B' ' 23' ' ' LEU . 23.4 ttpp -150.55 132.44 15.11 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.54 129.34 50.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.856 -1.152 . . . . 0.0 108.3 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -172.62 -142.03 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.844 -1.16 . . . . 0.0 108.681 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -166.19 -47.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.152 -0.968 . . . . 0.0 109.171 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.515 ' O ' ' O ' ' B' ' 77' ' ' GLN . . . -79.38 1.67 24.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.262 -0.899 . . . . 0.0 109.67 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' GLN . . . . . 0.515 ' O ' ' O ' ' B' ' 76' ' ' ALA . 25.4 mm100 54.92 160.21 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 118.701 -1.2 . . . . 0.0 108.883 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -168.38 20.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.355 -0.841 . . . . 0.0 109.58 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 44.6 p -130.01 67.39 1.47 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.412 -0.805 . . . . 0.0 109.419 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' MET . . . . . . . . . . . . . 11.7 mmt 49.58 83.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.382 -0.823 . . . . 0.0 109.563 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.511 179.939 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.0 mtt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' ILE . . . . . 0.749 ' N ' HD12 ' C' ' 2' ' ' ILE . 3.5 mp -88.04 86.13 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.232 -0.918 . . . . 0.0 109.35 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -75.17 135.71 41.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 109.274 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 4' ' ' GLU . . . . . 0.45 ' N ' ' OE1' ' C' ' 4' ' ' GLU . 56.9 mp0 -103.4 -21.58 13.79 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.404 -0.81 . . . . 0.0 109.178 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 5' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' C' ' 4' ' ' GLU . 5.1 m-20 52.18 99.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.061 -1.025 . . . . 0.0 109.745 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -155.12 53.09 0.62 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.569 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -95.23 122.59 38.09 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.518 -0.738 . . . . 0.0 110.026 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 86.2 mt -111.06 128.89 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.485 -0.76 . . . . 0.0 109.866 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 9' ' ' ILE . . . . . 0.615 HG23 HD13 ' D' ' 25' ' ' ILE . 7.7 tt -124.19 116.92 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 7.9 t -113.36 135.99 53.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.661 -1.274 . . . . 0.0 109.039 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' C' ' 12' ' ' ALA . 0.3 OUTLIER -56.99 -85.75 0.01 OUTLIER 'General case' 0 C--N 1.279 -2.471 0 O-C-N 121.873 -0.517 . . . . 0.0 111.178 178.673 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 12' ' ' ALA . . . . . 0.492 ' N ' ' OG1' ' C' ' 11' ' ' THR . . . -133.43 92.68 3.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.639 -1.288 . . . . 0.0 108.131 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -147.57 -134.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.294 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -165.86 -9.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.07 -1.019 . . . . 0.0 109.474 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 27.8 mt 55.64 68.74 2.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.39 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.89 156.22 50.18 Favored 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 121.931 1.754 . . . . 0.0 109.984 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.12 -14.96 63.15 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 18' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' C' ' 18' ' ' LEU . 19.1 mt -119.34 137.47 53.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.434 -1.039 . . . . 0.0 109.153 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.77 107.92 19.22 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.474 HD13 HD11 ' C' ' 53' ' ' ILE . 11.6 mt -97.88 140.66 31.9 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.199 -0.938 . . . . 0.0 110.246 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 21' ' ' TYR . . . . . 0.62 ' CE1' ' O ' ' C' ' 22' ' ' SER . 0.6 OUTLIER -123.17 129.94 52.1 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.63 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 22' ' ' SER . . . . . 0.62 ' O ' ' CE1' ' C' ' 21' ' ' TYR . 24.9 t -66.37 135.71 54.73 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.273 1.035 . . . . 0.0 112.45 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 mt -123.86 13.86 9.23 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.512 -0.742 . . . . 0.0 109.357 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.29 179.74 15.99 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.5 145.8 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 122.21 -0.583 . . . . 0.0 109.56 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.89 159.71 18.78 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.93 147.09 26.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.752 -1.217 . . . . 0.0 108.474 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.427 HG23 HD21 ' C' ' 40' ' ' LEU . 51.7 p -146.0 142.1 28.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.509 -0.744 . . . . 0.0 109.872 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' C' ' 30' ' ' SER . 55.8 mt -127.18 124.86 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 29' ' ' ILE . 3.6 p 157.77 -159.59 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -132.62 -174.7 3.53 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 73.97 114.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.481 HG22 HD12 ' C' ' 57' ' ' ILE . 22.2 t -68.39 -34.34 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.445 -0.784 . . . . 0.0 109.482 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.4 -38.87 78.25 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.236 -0.915 . . . . 0.0 109.269 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -75.14 -39.81 60.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.932 -1.105 . . . . 0.0 109.586 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.45 -52.38 56.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.602 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 5.7 t -58.24 -48.31 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.009 -1.057 . . . . 0.0 108.782 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.77 -44.97 91.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 109.955 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -57.21 -49.9 74.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.104 -0.997 . . . . 0.0 109.496 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' LEU . . . . . 0.427 HD21 HG23 ' C' ' 28' ' ' THR . 82.7 mt -64.44 -43.71 93.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.076 -1.015 . . . . 0.0 108.673 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 41' ' ' ARG . . . . . 0.789 HH11 ' HG2' ' C' ' 41' ' ' ARG . 2.7 ttt-85 -49.78 -47.28 51.18 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.774 -1.204 . . . . 0.0 109.579 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -67.04 -38.41 85.82 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.488 -0.758 . . . . 0.0 110.253 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -76.65 -35.5 57.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.897 . . . . 0.0 109.795 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 t -67.58 -50.88 57.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.176 -0.953 . . . . 0.0 108.949 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -71.76 -35.47 70.1 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.155 -1.418 . . . . 0.0 109.208 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.26 -33.34 67.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.486 -0.759 . . . . 0.0 108.97 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.61 -4.97 59.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.509 -0.744 . . . . 0.0 109.521 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.47 5.18 59.16 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.3 161.65 48.89 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -128.46 -0.2 5.61 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.293 -1.122 . . . . 0.0 110.014 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.42 151.09 17.48 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 16.0 tp -112.96 140.47 47.74 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.565 -0.962 . . . . 0.0 109.949 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.654 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 27.9 mt -112.34 140.66 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.59 -0.694 . . . . 0.0 109.488 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 92.01 -41.36 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 118.342 0.519 . . . . 0.0 110.093 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 55' ' ' PHE . . . . . 0.511 ' C ' ' O ' ' C' ' 54' ' ' ALA . 18.0 t80 27.97 89.77 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 120.804 0.335 . . . . 0.0 110.177 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 56' ' ' ARG . . . . . 0.652 ' CG ' HH11 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -93.82 143.79 26.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.013 -1.054 . . . . 0.0 109.65 -178.745 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 57' ' ' ILE . . . . . 0.513 ' O ' ' C ' ' C' ' 58' ' ' THR . 0.1 OUTLIER -150.97 -11.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 58' ' ' THR . . . . . 0.513 ' C ' ' O ' ' C' ' 57' ' ' ILE . 3.1 m -33.76 140.69 0.05 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.545 -0.722 . . . . 0.0 110.171 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 59' ' ' CYS . . . . . . . . . . . . . 52.7 t -140.95 150.79 43.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.309 -0.87 . . . . 0.0 109.445 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.19 117.9 1.43 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 58.06 19.9 6.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.512 -0.742 . . . . 0.0 109.6 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.36 121.41 2.65 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 63' ' ' LYS . . . . . 0.686 ' HZ1' ' N ' ' C' ' 66' ' ' GLY . 22.8 tptp -47.67 145.3 2.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.427 -1.043 . . . . 0.0 109.553 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -102.24 -66.75 0.91 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.514 -0.741 . . . . 0.0 109.432 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -174.32 122.77 0.29 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.204 -0.935 . . . . 0.0 109.722 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 66' ' ' GLY . . . . . 0.686 ' N ' ' HZ1' ' C' ' 63' ' ' LYS . . . -95.38 147.6 18.68 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.611 -1.795 . . . . 0.0 108.611 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -149.42 173.6 13.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.103 -1.233 . . . . 0.0 109.987 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.44 161.76 31.76 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 69' ' ' THR . . . . . 0.456 ' HG1' ' CB ' ' B' ' 11' ' ' THR . 69.1 m -93.83 137.02 33.5 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.276 -1.132 . . . . 0.0 108.406 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 60.9 mt -86.11 141.32 14.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 71' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' C' ' 21' ' ' TYR . 6.9 m -144.92 163.21 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.788 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -152.06 162.32 41.27 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' C' ' 74' ' ' ASP . . . -104.03 151.43 23.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 108.985 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' C' ' 73' ' ' ALA . 2.9 t0 -55.59 -165.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 109.85 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 75' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 54.53 52.14 12.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.147 -0.971 . . . . 0.0 109.096 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.8 -136.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 77' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 54.7 -179.41 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.31 -0.869 . . . . 0.0 109.647 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -157.67 -18.49 0.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.926 . . . . 0.0 109.437 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 56.0 p -67.36 -157.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 109.379 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 51.2 ttp -161.77 103.14 1.18 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.372 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.524 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.55 ' C ' HD12 ' D' ' 2' ' ' ILE . 16.4 mmt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 2' ' ' ILE . . . . . 0.55 HD12 ' C ' ' D' ' 1' ' ' MET . 4.9 mp 55.27 165.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.479 -0.763 . . . . 0.0 109.473 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 3' ' ' PHE . . . . . 0.528 ' N ' HG22 ' D' ' 2' ' ' ILE . 27.9 m-85 51.7 21.04 1.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.353 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -74.43 62.42 0.99 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.205 -0.934 . . . . 0.0 109.306 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 5' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -160.22 117.43 2.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.407 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.61 166.37 13.22 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.44 -0.787 . . . . 0.0 109.332 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -94.12 124.29 38.04 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.668 -0.645 . . . . 0.0 109.849 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 71.8 mt -116.94 143.17 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.618 -0.676 . . . . 0.0 109.91 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 9' ' ' ILE . . . . . 0.607 HG23 ' O ' ' D' ' 9' ' ' ILE . 7.7 tt -136.03 114.65 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.8 t -122.18 161.72 22.68 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.333 -0.855 . . . . 0.0 108.826 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.16 73.27 1.29 Allowed 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.17 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.69 -116.64 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.766 0 O-C-N 119.43 -2.044 . . . . 0.0 107.363 -176.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 24.7 p30 -93.68 -137.97 0.2 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.971 -1.08 . . . . 0.0 109.428 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -109.86 -159.75 0.69 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.379 -0.826 . . . . 0.0 109.151 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 56.6 mt -125.48 85.27 58.88 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.579 -0.701 . . . . 0.0 109.203 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -60.11 157.26 35.38 Favored 'Trans proline' 0 N--CA 1.48 0.725 0 C-N-CA 121.91 1.74 . . . . 0.0 110.093 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.95 -4.46 75.0 Favored Glycine 0 N--CA 1.498 2.779 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.056 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 59.6 mt -130.64 141.38 50.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.191 . . . . 0.0 109.706 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -85.42 108.5 17.89 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 14.1 mt -94.95 133.11 39.07 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.117 -0.989 . . . . 0.0 109.635 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 21' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' D' ' 22' ' ' SER . 1.6 t80 -114.02 129.67 56.59 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 22' ' ' SER . . . . . 0.433 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 0.0 OUTLIER -70.63 131.69 44.31 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 120.618 -1.301 . . . . 0.0 110.942 -179.415 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 mt -117.29 11.34 14.0 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.91 -179.68 18.4 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 25' ' ' ILE . . . . . 0.615 HD13 HG23 ' C' ' 9' ' ' ILE . 1.5 mp -108.87 141.87 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.853 -0.792 . . . . 0.0 108.933 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.59 142.94 44.58 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 43.8 p -152.2 130.82 12.29 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 28' ' ' THR . . . . . 0.626 ' H ' ' HA3' ' D' ' 66' ' ' GLY . 10.6 t -143.35 130.23 20.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.758 -1.213 . . . . 0.0 108.716 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.493 HD11 ' N ' ' D' ' 61' ' ' ASP . 19.4 tt -97.72 130.29 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.879 -1.138 . . . . 0.0 108.961 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.531 ' O ' ' O ' ' D' ' 31' ' ' ASP . 72.1 m -168.73 2.36 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.739 -1.226 . . . . 0.0 109.968 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 31' ' ' ASP . . . . . 0.531 ' O ' ' O ' ' D' ' 30' ' ' SER . 26.5 t70 51.27 161.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.48 -0.763 . . . . 0.0 110.447 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 4.6 t-20 71.86 128.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.63 -1.293 . . . . 0.0 108.67 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 20.2 t -69.94 -36.73 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 121.224 -0.923 . . . . 0.0 110.15 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 34' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' D' ' 35' ' ' GLU . 25.4 p-10 -58.51 -47.03 85.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.161 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 35' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' D' ' 34' ' ' ASP . 49.9 mt-10 -76.26 -38.64 55.96 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.957 -1.089 . . . . 0.0 109.86 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 60.9 mt -63.79 -53.69 41.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 120.882 -1.136 . . . . 0.0 109.493 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 43.4 t -63.5 -49.65 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.167 -0.958 . . . . 0.0 109.658 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -58.13 -39.44 78.75 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.159 -0.963 . . . . 0.0 109.637 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -65.98 -42.31 90.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.649 HD13 HD21 ' D' ' 52' ' ' LEU . 29.1 mt -67.77 -46.29 72.44 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.956 -1.09 . . . . 0.0 108.749 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -46.77 -53.4 11.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.884 -1.135 . . . . 0.0 109.056 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -55.65 -31.0 61.96 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.32 -0.862 . . . . 0.0 109.154 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -73.11 -36.27 66.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.16 -0.963 . . . . 0.0 109.609 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.66 -50.71 25.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 120.886 -1.134 . . . . 0.0 109.281 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -49.92 -33.81 18.61 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 122.988 1.375 . . . . 0.0 109.873 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.97 -29.06 49.57 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.824 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -97.75 6.27 48.12 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.36 29.14 59.99 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 117.952 -2.071 . . . . 0.0 109.687 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.75 -170.27 5.07 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 11.3 ttp -109.51 -41.57 4.55 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.494 -1.004 . . . . 0.0 110.063 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 171.25 175.69 39.87 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 52' ' ' LEU . . . . . 0.649 HD21 HD13 ' D' ' 40' ' ' LEU . 1.0 OUTLIER -108.24 139.42 42.96 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.479 -1.012 . . . . 0.0 109.993 -179.509 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 53' ' ' ILE . . . . . 0.5 ' O ' ' HB3' ' D' ' 54' ' ' ALA . 1.2 pt -112.28 142.47 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.748 -0.595 . . . . 0.0 110.238 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 68.93 -61.54 0.42 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.42 -0.8 . . . . 0.0 110.516 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.437 ' N ' ' O ' ' D' ' 53' ' ' ILE . 13.1 t80 42.7 83.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 56' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -84.28 140.37 31.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.05 -1.031 . . . . 0.0 109.493 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 57' ' ' ILE . . . . . . . . . . . . . 60.2 mt -99.19 157.44 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.391 -0.818 . . . . 0.0 108.968 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 58' ' ' THR . . . . . 0.723 HG23 HD11 ' D' ' 65' ' ' LEU . 0.2 OUTLIER -160.01 179.02 9.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.365 -0.835 . . . . 0.0 109.113 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 59' ' ' CYS . . . . . 0.493 ' N ' ' OG1' ' D' ' 58' ' ' THR . 49.2 t -63.67 -119.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.65 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 60' ' ' ALA . . . . . 0.437 ' N ' ' SG ' ' D' ' 59' ' ' CYS . . . -176.48 119.1 0.13 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.187 -0.945 . . . . 0.0 109.32 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 61' ' ' ASP . . . . . 0.493 ' N ' HD11 ' D' ' 29' ' ' ILE . 12.1 t70 -163.75 118.92 1.6 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 109.377 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.2 135.43 4.48 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 63' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' D' ' 64' ' ' PHE . 68.7 mttm -50.12 150.72 2.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.761 -0.846 . . . . 0.0 109.743 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 64' ' ' PHE . . . . . 0.449 ' O ' ' O ' ' D' ' 63' ' ' LYS . 34.2 m-85 57.95 113.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.565 -0.709 . . . . 0.0 109.576 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 1.008 ' O ' ' O ' ' D' ' 66' ' ' GLY . 1.4 tm? -156.57 -33.41 0.08 Allowed 'General case' 0 C--O 1.185 -2.329 0 O-C-N 121.149 -0.969 . . . . 0.0 109.321 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 66' ' ' GLY . . . . . 1.008 ' O ' ' O ' ' D' ' 65' ' ' LEU . . . -23.84 -147.94 0.0 OUTLIER Glycine 1 N--CA 1.516 4.033 0 CA-C-O 122.271 0.928 . . . . 0.0 112.134 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -177.38 99.23 0.05 OUTLIER 'General case' 0 C--N 1.287 -2.15 0 O-C-N 118.88 -2.541 . . . . 0.0 110.112 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.0 137.43 3.18 Favored Glycine 0 C--N 1.288 -2.101 0 C-N-CA 119.015 -1.564 . . . . 0.0 110.856 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 6.9 m -101.08 144.29 30.17 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.74 -0.859 . . . . 0.0 108.951 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 26.7 mt -89.07 142.19 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 m -135.13 166.65 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.371 0.605 . . . . 0.0 109.48 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 72' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' D' ' 21' ' ' TYR . 7.7 tttt -146.47 145.39 30.18 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' D' ' 74' ' ' ASP . . . -125.42 153.98 42.63 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 74' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' D' ' 73' ' ' ALA . 25.2 t0 71.81 77.93 0.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 119.018 0.826 . . . . 0.0 110.15 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -117.25 45.46 1.89 Allowed 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.21 -141.78 0.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.293 -0.879 . . . . 0.0 108.956 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -123.3 174.24 7.44 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.309 -0.869 . . . . 0.0 109.379 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 78' ' ' PHE . . . . . 0.512 ' CD2' ' N ' ' D' ' 79' ' ' THR . 9.4 p90 -79.9 -55.79 4.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 109.511 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 79' ' ' THR . . . . . 0.512 ' N ' ' CD2' ' D' ' 78' ' ' PHE . 50.4 p 46.29 83.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.333 -0.854 . . . . 0.0 109.733 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 56.4 mtp -73.09 -18.01 61.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.504 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.461 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ptt? . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 13.6 pt -75.94 53.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.902 . . . . 0.0 109.364 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 3' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -62.55 -50.3 71.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.541 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -161.62 90.49 0.79 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 0.0 109.611 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 5' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -159.03 157.04 30.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.9 . . . . 0.0 108.909 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 6' ' ' LYS . . . . . 0.442 ' HZ2' ' HG3' ' E' ' 6' ' ' LYS . 6.8 ptmm? -130.83 121.55 25.51 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.415 -0.803 . . . . 0.0 109.435 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -94.93 119.08 32.88 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.388 -0.82 . . . . 0.0 109.788 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 33.8 mt -113.35 134.21 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.568 -0.708 . . . . 0.0 109.407 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 9' ' ' ILE . . . . . 0.624 ' O ' HG23 ' E' ' 9' ' ' ILE . 15.7 tt -130.67 114.42 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 6.5 t -122.46 157.9 30.95 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.891 0.853 . . . . 0.0 109.103 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 11' ' ' THR . . . . . 0.601 ' O ' ' HB2' ' E' ' 12' ' ' ALA . 4.1 p -100.25 77.69 1.99 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 177.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 12' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' E' ' 11' ' ' THR . . . 157.55 -90.97 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.778 0.799 . . . . 0.0 109.714 177.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -165.16 -71.32 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 51.14 -153.26 0.18 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 110.245 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 15' ' ' ILE . . . . . 0.667 ' N ' ' HD3' ' E' ' 16' ' ' PRO . 2.8 mt 60.54 48.16 1.6 Allowed Pre-proline 0 N--CA 1.483 1.223 0 O-C-N 121.849 -0.532 . . . . 0.0 109.632 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 16' ' ' PRO . . . . . 0.667 ' HD3' ' N ' ' E' ' 15' ' ' ILE . 1.6 Cg_endo -66.77 154.48 74.36 Favored 'Trans proline' 0 C--N 1.326 -0.629 0 C-N-CA 121.532 1.488 . . . . 0.0 109.81 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.99 -9.96 74.71 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.927 -1.606 . . . . 0.0 110.943 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 18' ' ' LEU . . . . . 0.487 HD12 ' CG2' ' E' ' 15' ' ' ILE . 75.5 mt -118.73 137.72 53.15 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.138 1.469 . . . . 0.0 109.387 -178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -86.12 112.88 21.71 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 12.5 mt -89.16 135.22 33.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -0.912 . . . . 0.0 110.62 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 21' ' ' TYR . . . . . 0.554 ' CE1' ' O ' ' E' ' 22' ' ' SER . 1.2 t80 -119.66 130.79 55.23 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 22' ' ' SER . . . . . 0.554 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 0.0 OUTLIER -71.68 131.46 43.2 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.977 -1.077 . . . . 0.0 111.071 -179.403 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.502 HD11 ' CB ' ' E' ' 72' ' ' LYS . 1.1 mp -118.41 12.92 13.46 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.03 179.49 15.97 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 tp -114.47 144.81 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.977 -0.719 . . . . 0.0 109.303 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.6 144.98 41.18 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 90.3 p -152.43 139.95 19.68 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.705 -1.247 . . . . 0.0 107.93 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 8.7 t -150.49 144.14 25.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.889 -1.132 . . . . 0.0 109.025 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 4.7 mm -106.42 128.46 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.251 -0.906 . . . . 0.0 108.879 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 29.0 t -175.06 177.9 1.86 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -0.802 . . . . 0.0 109.007 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 31' ' ' ASP . . . . . 0.403 ' O ' ' CB ' ' E' ' 32' ' ' ASN . 46.6 t0 -116.43 161.14 19.54 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.486 -0.759 . . . . 0.0 109.235 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 32' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 7.0 m-20 75.96 123.56 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 52.6 t -67.5 -33.33 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.396 -0.815 . . . . 0.0 109.415 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -58.55 -43.05 89.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 110.153 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -75.6 -37.93 59.45 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.112 -0.993 . . . . 0.0 109.466 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.71 -49.42 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 109.451 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 44.7 t -63.83 -49.64 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.031 -1.043 . . . . 0.0 109.653 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.79 -37.37 73.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.832 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -65.56 -41.49 92.89 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -0.958 . . . . 0.0 109.792 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 40' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' E' ' 40' ' ' LEU . 30.9 mt -68.2 -45.96 71.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.085 -1.01 . . . . 0.0 109.106 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -48.62 -50.71 31.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.786 -1.196 . . . . 0.0 109.363 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 42' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' E' ' 46' ' ' ALA . 31.7 ttpt -61.04 -36.47 79.64 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.464 -0.773 . . . . 0.0 110.209 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -76.57 -35.08 58.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.952 . . . . 0.0 109.77 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 9.1 t -70.44 -51.82 34.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.07 -1.019 . . . . 0.0 108.846 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 -30.72 67.33 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.046 -1.462 . . . . 0.0 109.275 -175.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' E' ' 42' ' ' LYS . . . -61.48 -34.9 76.26 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.449 -0.782 . . . . 0.0 109.713 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.42 -5.45 58.84 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.064 -1.023 . . . . 0.0 109.889 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 106.49 -1.19 36.99 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.04 156.95 52.69 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 6.4 ptm -120.53 -2.46 9.97 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.392 -1.063 . . . . 0.0 110.29 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.65 156.01 19.88 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.06 -1.543 . . . . 0.0 109.686 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 5.3 tp -106.26 136.28 46.25 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.722 -0.869 . . . . 0.0 109.28 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 53' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 1.2 pt -108.83 144.38 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.45 -0.781 . . . . 0.0 110.012 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.493 ' HA ' HH12 ' E' ' 56' ' ' ARG . . . 64.12 82.55 0.18 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.114 -0.991 . . . . 0.0 110.794 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 55' ' ' PHE . . . . . 0.486 ' O ' ' CG ' ' E' ' 55' ' ' PHE . 72.6 t80 -113.75 19.04 17.03 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.192 0.52 . . . . 0.0 109.683 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 56' ' ' ARG . . . . . 0.755 HH11 ' HG3' ' E' ' 56' ' ' ARG . 15.8 mtm-85 -59.68 111.86 1.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.16 -0.962 . . . . 0.0 109.645 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 64.6 mt -78.16 94.84 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.284 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.08 91.51 0.15 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.288 -0.882 . . . . 0.0 109.493 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 59' ' ' CYS . . . . . 0.4 ' H ' ' CG ' ' A' ' 61' ' ' ASP . 67.9 m -152.49 -95.34 0.05 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.012 -1.055 . . . . 0.0 109.491 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.14 121.0 17.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.647 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -64.35 155.17 33.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 109.283 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.4 132.05 0.05 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp 55.54 98.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.327 -1.102 . . . . 0.0 109.418 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 64' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -57.35 178.35 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 109.69 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.55 168.8 23.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.284 -0.885 . . . . 0.0 109.15 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 66' ' ' GLY . . . . . . . . . . . . . . . -146.21 110.54 0.54 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -142.9 -176.66 4.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.426 -1.044 . . . . 0.0 109.395 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.3 172.33 25.3 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.327 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 54.8 m -99.17 134.62 41.75 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.348 -1.089 . . . . 0.0 108.196 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 66.9 mt -78.31 146.07 8.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.8 m -130.34 152.11 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.96 -1.088 . . . . 0.0 109.905 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 72' ' ' LYS . . . . . 0.502 ' CB ' HD11 ' E' ' 23' ' ' LEU . 24.4 ttpp -144.9 141.16 28.83 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.76 138.86 36.25 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -76.06 137.66 40.33 Favored 'General case' 0 C--N 1.312 -1.063 0 O-C-N 120.451 -1.406 . . . . 0.0 108.969 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -57.09 153.09 12.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.617 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.83 -34.24 72.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.374 -0.829 . . . . 0.0 109.685 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -108.79 98.16 7.7 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.48 -0.763 . . . . 0.0 109.292 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -164.78 148.13 8.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.326 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 40.2 p -82.11 -144.44 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.933 . . . . 0.0 109.392 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -140.95 -162.95 1.44 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.34 -0.85 . . . . 0.0 109.351 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.408 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.4 ttt . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.9 mm -83.2 151.08 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.187 -0.946 . . . . 0.0 109.329 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -158.95 6.72 0.11 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 109.278 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -87.56 52.93 2.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.92 . . . . 0.0 109.441 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -168.91 14.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.092 -1.005 . . . . 0.0 109.44 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 50' ' ' MET . 0.2 OUTLIER -86.47 147.85 25.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.271 -0.893 . . . . 0.0 109.267 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -115.26 122.18 45.19 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.0 mt -132.9 124.76 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.284 -0.885 . . . . 0.0 109.723 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.465 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 7.4 tt -119.3 118.99 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 t -117.35 133.39 56.04 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.388 -0.82 . . . . 0.0 108.868 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.456 ' OG1' ' OG1' ' B' ' 69' ' ' THR . 3.2 m -107.96 70.03 0.75 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.426 -0.796 . . . . 0.0 111.863 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.414 ' H ' ' H ' ' A' ' 13' ' ' ASP . . . -162.98 -9.92 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 O-C-N 120.197 -1.564 . . . . 0.0 108.328 -175.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.6 OUTLIER 64.25 57.54 1.21 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.711 -0.618 . . . . 0.0 110.331 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -178.85 137.81 0.15 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.576 -0.703 . . . . 0.0 109.889 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.768 HG23 ' O ' ' A' ' 15' ' ' ILE . 9.5 tt -163.78 58.65 0.71 Allowed Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.217 -0.927 . . . . 0.0 108.857 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HD3' ' N ' ' A' ' 15' ' ' ILE . 3.2 Cg_exo -59.21 158.24 26.96 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 121.971 1.781 . . . . 0.0 110.562 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.33 -3.91 66.67 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.671 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.737 ' HB3' HD21 ' A' ' 20' ' ' LEU . 25.2 mt -128.33 136.95 51.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.817 -1.402 . . . . 0.0 109.344 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -87.84 108.62 19.24 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.737 HD21 ' HB3' ' A' ' 18' ' ' LEU . 1.9 mt -120.8 129.98 53.8 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.105 0.478 . . . . 0.0 110.544 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -104.88 141.9 35.71 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.634 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 24' ' ' GLY . 28.8 t -78.74 88.06 4.62 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.03 11.01 0.61 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.591 -0.693 . . . . 0.0 110.499 -177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 22' ' ' SER . . . 125.17 -175.89 17.24 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.421 HD11 HG23 ' E' ' 9' ' ' ILE . 47.0 mm -110.05 141.67 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.364 0.602 . . . . 0.0 109.381 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -109.88 151.89 26.48 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 122.025 0.917 . . . . 0.0 109.628 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.3 m -139.97 143.65 36.63 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.69 147.49 43.76 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.999 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.437 ' O ' ' OG ' ' A' ' 30' ' ' SER . 4.2 tp -127.5 132.98 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 120.935 1.698 . . . . 0.0 106.66 176.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 29' ' ' ILE . 2.0 m 173.29 -161.5 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.907 -1.121 . . . . 0.0 108.991 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -117.67 -75.31 0.58 Allowed 'General case' 0 N--CA 1.512 2.641 0 O-C-N 121.301 -0.874 . . . . 0.0 112.449 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -65.57 149.18 50.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.772 -1.205 . . . . 0.0 108.128 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.46 ' H ' HG13 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -70.45 -40.3 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -52.39 -28.49 19.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.349 -0.845 . . . . 0.0 109.791 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -79.51 -33.13 42.35 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.187 -0.945 . . . . 0.0 109.368 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 33' ' ' VAL . 41.6 mt -60.66 -53.01 54.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.311 -0.868 . . . . 0.0 109.234 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.5 t -54.9 -50.37 62.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.084 -1.01 . . . . 0.0 109.105 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -60.18 -40.07 88.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 110.149 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -65.4 -41.91 93.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.073 -1.017 . . . . 0.0 109.514 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 40' ' ' LEU . 13.3 mt -62.43 -41.38 98.66 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.054 -1.029 . . . . 0.0 109.146 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.542 ' CG ' HH11 ' A' ' 41' ' ' ARG . 0.0 OUTLIER -49.91 -51.3 41.83 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.504 -1.373 . . . . 0.0 109.296 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -61.67 -37.48 84.23 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.774 -1.204 . . . . 0.0 110.68 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -77.1 -36.02 55.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.306 -0.871 . . . . 0.0 110.089 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 t -70.81 -50.56 42.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.425 -0.797 . . . . 0.0 108.965 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -67.74 -29.04 68.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.393 -1.442 . . . . 0.0 109.271 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.71 -31.21 71.0 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.524 0.678 . . . . 0.0 109.385 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -89.27 -5.62 57.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.443 -0.785 . . . . 0.0 109.466 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.09 7.67 63.85 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.77 157.62 41.93 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -129.35 -1.58 5.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.243 -1.151 . . . . 0.0 110.349 -177.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.61 153.02 23.04 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.318 -1.42 . . . . 0.0 109.72 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.7 tp -116.99 139.75 50.29 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.656 -0.908 . . . . 0.0 109.793 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.482 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 22.4 mt -113.13 139.23 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.742 -0.599 . . . . 0.0 110.053 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 67.75 84.38 0.15 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.292 -0.88 . . . . 0.0 110.884 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -122.11 69.94 0.96 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.249 0.547 . . . . 0.0 110.431 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.425 HH22 ' NE ' ' E' ' 56' ' ' ARG . 14.6 ptt180 -98.13 122.68 41.57 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.269 -0.894 . . . . 0.0 109.178 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.5 mt -79.82 129.16 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.341 -0.849 . . . . 0.0 109.449 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.6 p -95.12 156.16 16.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.265 -0.897 . . . . 0.0 109.156 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.1 t -59.02 -52.26 66.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 109.383 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 44.09 79.7 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.541 -0.725 . . . . 0.0 109.576 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.6 67.93 1.15 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.27 -0.894 . . . . 0.0 109.894 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.417 ' O ' ' CD2' ' A' ' 64' ' ' PHE . . . 147.3 -101.13 0.23 Allowed Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -64.84 101.97 0.54 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.336 -1.096 . . . . 0.0 110.184 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.417 ' CD2' ' O ' ' A' ' 62' ' ' GLY . 98.0 m-85 -88.09 140.27 29.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.276 -0.89 . . . . 0.0 109.15 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 tp -165.36 92.9 0.57 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.094 -1.004 . . . . 0.0 111.453 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.53 170.03 10.34 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -158.45 160.19 36.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.99 -1.3 . . . . 0.0 110.045 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.18 -178.02 48.02 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.4 m -118.89 137.69 53.27 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.5 mt -89.31 130.59 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.676 ' HB ' ' HB3' ' A' ' 20' ' ' LEU . 14.0 m -144.27 151.62 15.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 119.352 -0.939 . . . . 0.0 109.189 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.7 pttt -145.48 151.13 37.7 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.1 -1.0 . . . . 0.0 109.167 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.02 150.58 39.71 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.493 ' N ' ' OH ' ' A' ' 21' ' ' TYR . 14.2 p-10 -136.84 -158.17 0.84 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.094 -1.004 . . . . 0.0 108.622 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -99.88 -84.85 0.41 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.312 -0.868 . . . . 0.0 109.47 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.9 157.04 18.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.346 -0.847 . . . . 0.0 109.21 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.419 ' O ' ' O ' ' A' ' 78' ' ' PHE . 13.5 mm100 -135.26 -80.53 0.43 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.38 -0.825 . . . . 0.0 108.927 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.419 ' O ' ' O ' ' A' ' 77' ' ' GLN . 5.3 t80 62.23 125.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.517 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.7 m -163.12 -26.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.907 . . . . 0.0 109.394 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 19.8 mmt -67.4 -101.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.494 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.441 -179.953 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ttt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.699 ' N ' HD13 ' B' ' 2' ' ' ILE . 0.5 OUTLIER -69.98 129.64 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 20.9 t80 70.23 -33.85 0.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.728 -0.608 . . . . 0.0 109.857 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.503 ' H ' ' C ' ' B' ' 2' ' ' ILE . 24.3 tt0 50.62 -131.15 2.04 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.321 -0.862 . . . . 0.0 110.09 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 50.25 40.95 23.47 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.027 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -114.2 121.91 45.17 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.325 -0.859 . . . . 0.0 109.281 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -94.09 117.83 30.66 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.227 -0.921 . . . . 0.0 108.868 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 64.5 mt -112.5 128.02 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.591 -0.693 . . . . 0.0 110.079 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.624 ' O ' HG23 ' B' ' 9' ' ' ILE . 5.7 tt -124.74 113.34 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.3 t -123.52 161.13 25.51 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.907 0.861 . . . . 0.0 109.181 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.572 ' O ' ' C ' ' B' ' 12' ' ' ALA . 12.3 p -99.89 -109.88 0.2 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.173 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.572 ' C ' ' O ' ' B' ' 11' ' ' THR . . . 16.6 -115.03 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 118.486 0.584 . . . . 0.0 111.715 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -111.38 -140.1 0.38 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.623 -0.673 . . . . 0.0 109.312 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -93.93 -157.3 0.54 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.279 -0.888 . . . . 0.0 109.973 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 mt -113.54 98.47 46.98 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.486 -0.759 . . . . 0.0 109.356 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.74 156.83 40.69 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 C-N-CA 121.694 1.596 . . . . 0.0 110.144 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.84 -4.5 75.44 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' B' ' 18' ' ' LEU . 34.3 mt -131.45 141.35 49.79 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.175 -1.191 . . . . 0.0 109.996 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -85.05 107.65 17.26 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 12.9 mt -103.16 137.27 41.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.612 -0.68 . . . . 0.0 109.831 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' TYR . . . . . 0.53 ' CE1' ' O ' ' B' ' 22' ' ' SER . 1.3 t80 -118.62 130.31 55.8 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.53 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 32.6 t -66.27 134.07 51.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 0.0 111.341 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 8.0 mt -121.07 10.31 10.72 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.6 175.0 15.78 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ILE . . . . . 0.451 HD11 ' OG1' ' A' ' 11' ' ' THR . 0.1 OUTLIER -113.32 146.6 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.47 159.72 21.64 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 48.8 m -153.04 147.43 25.88 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.712 ' OG1' HG23 ' B' ' 36' ' ' ILE . 5.2 p -149.64 148.27 29.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 109.533 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.465 ' O ' ' OG ' ' B' ' 30' ' ' SER . 1.3 tp -126.5 127.51 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' B' ' 29' ' ' ILE . 2.8 m -168.27 171.29 9.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.168 -0.958 . . . . 0.0 109.751 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -80.41 -61.05 2.09 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.422 -0.799 . . . . 0.0 112.124 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -74.57 128.26 35.12 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.555 -1.341 . . . . 0.0 108.501 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.404 ' H ' HG13 ' B' ' 33' ' ' VAL . 2.1 m -69.33 -33.65 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.613 -0.68 . . . . 0.0 109.182 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -59.57 -29.71 68.14 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.475 -0.765 . . . . 0.0 110.103 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -70.88 -35.93 72.57 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.507 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.712 HG23 ' OG1' ' B' ' 28' ' ' THR . 77.3 mt -61.45 -47.28 94.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.114 -0.991 . . . . 0.0 109.397 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 68.9 t -54.98 -50.6 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.919 -1.113 . . . . 0.0 109.285 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -59.91 -40.63 89.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.393 -0.817 . . . . 0.0 109.585 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -64.65 -41.9 95.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.164 -0.96 . . . . 0.0 109.369 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 73.0 mt -65.75 -44.07 87.02 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 109.027 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -48.79 -46.66 41.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.49 -1.381 . . . . 0.0 109.383 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -65.27 -37.38 87.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.627 -0.671 . . . . 0.0 110.207 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -77.04 -35.03 57.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 109.912 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.64 -51.57 44.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.286 -0.884 . . . . 0.0 108.834 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.07 -30.54 66.71 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 118.108 -1.437 . . . . 0.0 109.216 -175.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.0 -32.14 72.58 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -91.61 -5.49 53.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.728 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.61 3.63 46.58 Favored Glycine 0 N--CA 1.502 3.094 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.78 159.41 47.78 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -126.71 -2.06 6.68 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.352 -1.087 . . . . 0.0 110.471 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -165.42 158.09 30.81 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.324 -1.417 . . . . 0.0 109.612 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 6.1 tp -114.99 137.24 52.23 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.668 -0.901 . . . . 0.0 109.744 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.514 ' O ' ' HB3' ' B' ' 54' ' ' ALA . 68.1 mt -114.35 145.63 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.674 -0.641 . . . . 0.0 110.239 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 69.61 88.9 0.11 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.045 -1.034 . . . . 0.0 111.199 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -142.56 69.48 1.31 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.23 0.538 . . . . 0.0 110.171 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -108.35 146.16 33.41 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mm -109.62 37.26 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -71.03 -131.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 109.48 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' CYS . . . . . 0.457 ' SG ' ' CE1' ' B' ' 64' ' ' PHE . 84.4 m 56.55 -174.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.513 -0.742 . . . . 0.0 109.569 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -151.87 110.57 3.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.276 -0.89 . . . . 0.0 109.628 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -172.94 177.92 2.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.458 -0.776 . . . . 0.0 109.254 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -51.79 -51.42 39.38 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -137.44 -165.6 1.79 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.393 -1.063 . . . . 0.0 109.258 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.457 ' CE1' ' SG ' ' B' ' 59' ' ' CYS . 16.7 t80 -157.0 146.05 20.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 109.761 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.798 HD22 ' N ' ' B' ' 65' ' ' LEU . 2.0 mm? -89.38 148.45 23.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.446 -0.784 . . . . 0.0 109.165 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.12 71.12 0.54 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' TYR . . . . . 0.45 ' O ' ' CD2' ' B' ' 67' ' ' TYR . 49.6 p90 -73.38 126.12 29.42 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.267 -1.137 . . . . 0.0 109.494 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.95 156.44 26.68 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' THR . . . . . 0.456 ' OG1' ' OG1' ' A' ' 11' ' ' THR . 48.4 m -103.04 134.89 45.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.861 -1.376 . . . . 0.0 108.523 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 66.1 mt -89.98 134.59 28.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.8 m -141.66 163.12 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 110.48 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -153.78 148.98 26.96 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.36 150.75 30.64 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.129 -0.982 . . . . 0.0 108.494 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' B' ' 74' ' ' ASP . 26.7 p-10 -163.43 58.0 0.18 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.93 -1.106 . . . . 0.0 108.914 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -145.35 102.31 3.7 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.321 -0.862 . . . . 0.0 109.27 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.51 -46.96 2.75 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.57 -0.706 . . . . 0.0 109.371 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -61.79 140.55 58.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 109.415 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -163.08 102.93 0.98 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 109.354 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.36 170.49 8.19 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.524 -0.735 . . . . 0.0 109.363 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' MET . . . . . 0.556 ' N ' ' SD ' ' B' ' 80' ' ' MET . 0.0 OUTLIER -73.81 -80.39 0.07 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.857 . . . . 0.0 109.53 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.529 -179.942 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 41.5 mtt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 tt -161.3 -48.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.335 -0.853 . . . . 0.0 108.934 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -168.93 -78.91 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.306 -0.871 . . . . 0.0 109.149 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 47.76 -133.4 1.26 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 109.495 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 5' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' C' ' 6' ' ' LYS . 24.0 t0 -67.08 -147.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.152 -0.968 . . . . 0.0 109.119 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 6' ' ' LYS . . . . . 0.547 ' O ' ' O ' ' C' ' 50' ' ' MET . 44.8 mtmt -150.61 84.38 1.36 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 109.214 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -104.85 121.53 43.87 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 76.1 mt -134.57 126.66 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.284 -0.885 . . . . 0.0 109.607 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 9' ' ' ILE . . . . . 0.58 ' O ' HG23 ' C' ' 9' ' ' ILE . 14.8 tt -122.06 115.5 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.76 156.88 42.84 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 122.139 0.971 . . . . 0.0 108.849 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -116.24 94.04 4.48 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.53 -108.73 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.799 177.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -148.26 -50.93 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 109.592 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 14' ' ' GLU . . . . . 0.411 ' HG3' ' H ' ' C' ' 15' ' ' ILE . 3.3 tp10 -154.78 176.8 12.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.168 -0.958 . . . . 0.0 109.294 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 15' ' ' ILE . . . . . 0.411 ' H ' ' HG3' ' C' ' 14' ' ' GLU . 29.3 mt -124.04 87.74 53.04 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -60.63 156.0 44.89 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.876 1.717 . . . . 0.0 110.238 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.28 -8.81 77.19 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 31.7 mt -132.23 142.79 49.54 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.373 -1.075 . . . . 0.0 109.496 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -86.19 108.66 18.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 14.8 mt -96.71 137.33 35.96 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 109.964 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 21' ' ' TYR . . . . . 0.404 ' N ' ' O ' ' C' ' 72' ' ' LYS . 18.1 t80 -123.5 129.04 50.64 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.1 t -87.56 131.79 34.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.342 -0.849 . . . . 0.0 109.608 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.942 ' N ' HD23 ' C' ' 23' ' ' LEU . 0.2 OUTLIER -123.28 11.53 9.39 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.61 168.49 11.85 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.266 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -106.7 146.18 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.99 144.83 42.45 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 75.2 m -152.68 138.66 18.14 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 12.1 t -149.77 141.06 23.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.843 -1.161 . . . . 0.0 108.644 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.491 HG23 ' O ' ' C' ' 29' ' ' ILE . 15.3 tt -115.31 129.82 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' C' ' 29' ' ' ILE . 6.4 m -169.72 -141.36 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.043 -1.036 . . . . 0.0 109.796 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -157.55 161.73 38.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.248 -0.908 . . . . 0.0 108.972 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 73.81 127.34 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -67.57 -33.68 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.51 -0.744 . . . . 0.0 109.363 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -59.01 -46.69 87.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.358 -0.839 . . . . 0.0 110.176 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -76.03 -40.27 53.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.203 -0.936 . . . . 0.0 109.78 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 71.5 mt -60.29 -39.42 80.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.881 -1.137 . . . . 0.0 109.297 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -69.3 -47.03 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.776 -1.202 . . . . 0.0 109.534 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -60.24 -41.42 93.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.935 . . . . 0.0 109.843 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -58.81 -48.32 81.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 109.941 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 28.4 mt -70.32 -47.59 60.41 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.047 -1.033 . . . . 0.0 109.111 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 41' ' ' ARG . . . . . 0.425 HH21 ' NZ ' ' C' ' 45' ' ' LYS . 39.9 mtp180 -49.44 -48.0 47.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.535 -1.353 . . . . 0.0 109.016 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 42' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' C' ' 46' ' ' ALA . 46.1 mtpt -63.8 -37.65 88.17 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 109.831 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 43' ' ' GLN . . . . . 0.426 ' O ' ' NE2' ' C' ' 43' ' ' GLN . 0.0 OUTLIER -75.98 -35.66 59.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 109.912 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 20.2 t -76.63 -51.75 18.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 109.067 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 45' ' ' LYS . . . . . 0.425 ' NZ ' HH21 ' C' ' 41' ' ' ARG . 18.2 mtmt -69.43 -29.94 67.76 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.858 -1.537 . . . . 0.0 109.461 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' C' ' 42' ' ' LYS . . . -64.07 -33.38 75.63 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 47' ' ' LYS . . . . . 0.543 ' HD2' HD12 ' C' ' 23' ' ' LEU . 0.0 OUTLIER -90.63 2.69 55.64 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.245 -0.91 . . . . 0.0 108.699 179.325 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.42 29.65 65.75 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.053 -1.546 . . . . 0.0 109.962 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.37 -168.74 24.33 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.057 -1.261 . . . . 0.0 110.053 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 50' ' ' MET . . . . . 0.547 ' O ' ' O ' ' C' ' 6' ' ' LYS . 14.6 ttt -108.42 -41.75 4.76 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.567 -0.961 . . . . 0.0 109.692 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 173.96 -153.9 18.19 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 tp -136.01 137.45 41.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.413 -1.051 . . . . 0.0 109.985 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.446 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 49.0 mt -110.52 141.12 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.571 -0.706 . . . . 0.0 109.741 -178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 64.65 75.18 0.38 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.204 -0.935 . . . . 0.0 108.66 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -93.99 140.31 29.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 109.075 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 56' ' ' ARG . . . . . 0.73 HH11 ' HG2' ' C' ' 56' ' ' ARG . 0.0 OUTLIER -134.57 174.66 10.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.584 -0.698 . . . . 0.0 109.284 179.688 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 39.8 mt -136.92 154.12 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 58' ' ' THR . . . . . . . . . . . . . 4.7 m -78.85 138.01 37.95 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' CYS . . . . . 0.55 ' SG ' ' N ' ' C' ' 60' ' ' ALA . 15.1 p -65.22 -145.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.145 -0.972 . . . . 0.0 109.514 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.55 ' N ' ' SG ' ' C' ' 59' ' ' CYS . . . -73.15 52.12 0.33 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.362 -0.837 . . . . 0.0 109.409 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 61' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' C' ' 60' ' ' ALA . 21.5 t70 60.15 116.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.468 -0.77 . . . . 0.0 109.634 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.03 -10.54 4.8 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' LYS . . . . . 0.415 ' O ' ' CD2' ' C' ' 64' ' ' PHE . 88.2 tttt -83.78 -93.9 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -1.152 . . . . 0.0 109.507 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 64' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' C' ' 63' ' ' LYS . 4.1 m-85 -156.69 -99.28 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 109.043 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.589 ' N ' HD23 ' C' ' 65' ' ' LEU . 1.4 pt? -167.31 -177.79 3.79 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.248 -0.907 . . . . 0.0 110.109 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 66' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' C' ' 67' ' ' TYR . . . -64.42 -75.46 0.37 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 67' ' ' TYR . . . . . 0.456 ' CB ' ' O ' ' C' ' 66' ' ' GLY . 3.7 t80 76.55 144.21 0.08 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.428 -1.043 . . . . 0.0 109.958 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 174.35 157.6 16.3 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 21.1 m -98.37 144.26 27.94 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.357 -1.084 . . . . 0.0 109.59 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 56.1 mt -91.19 132.06 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.09 163.14 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.44 0.638 . . . . 0.0 109.854 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 72' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' C' ' 21' ' ' TYR . 16.2 ttmm -153.65 141.05 19.7 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.0 150.0 36.52 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.737 -1.227 . . . . 0.0 108.152 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.83 -177.23 4.8 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.982 -1.074 . . . . 0.0 109.029 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 75' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -141.25 53.77 1.55 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.346 -0.846 . . . . 0.0 109.342 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.51 -13.42 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.358 -0.839 . . . . 0.0 109.4 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 77' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 57.68 -130.3 1.5 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.892 . . . . 0.0 109.517 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -59.07 119.49 7.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.954 . . . . 0.0 109.568 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.447 ' H ' HG22 ' C' ' 79' ' ' THR . 0.0 OUTLIER -71.69 124.37 24.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.283 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 9.8 tpt -60.54 -47.85 84.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.922 . . . . 0.0 109.433 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.474 -179.994 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 2' ' ' ILE . . . . . . . . . . . . . 11.0 pt -62.62 129.62 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.275 -0.891 . . . . 0.0 109.259 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -88.97 106.38 18.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.008 -1.057 . . . . 0.0 109.368 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 4' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' D' ' 6' ' ' LYS . 27.2 tt0 -160.86 5.82 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 109.677 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 5' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' D' ' 6' ' ' LYS . 4.7 m-20 63.61 -65.21 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 6' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' D' ' 4' ' ' GLU . 72.1 tttt 73.15 104.41 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.614 0.721 . . . . 0.0 109.543 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -94.59 124.52 38.67 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.717 -0.615 . . . . 0.0 109.462 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 20.0 mt -115.94 137.71 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.556 -0.715 . . . . 0.0 109.963 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 9' ' ' ILE . . . . . 0.431 ' O ' ' CG2' ' D' ' 9' ' ' ILE . 9.4 tt -119.49 124.28 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.99 130.81 56.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.511 -0.743 . . . . 0.0 109.556 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 11' ' ' THR . . . . . 0.403 ' O ' ' HB3' ' D' ' 12' ' ' ALA . 3.1 m -129.79 120.86 25.72 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 12' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' D' ' 11' ' ' THR . . . 60.05 12.04 2.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.248 -0.907 . . . . 0.0 109.697 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -126.23 108.38 11.24 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.482 0.658 . . . . 0.0 109.36 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 14' ' ' GLU . . . . . 0.446 ' HG3' ' H ' ' D' ' 15' ' ' ILE . 8.2 tp10 -62.33 169.42 2.88 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.269 -0.895 . . . . 0.0 108.655 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 15' ' ' ILE . . . . . 0.746 ' O ' HG23 ' D' ' 15' ' ' ILE . 13.1 tt -134.55 60.91 45.73 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.271 -0.893 . . . . 0.0 109.509 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' D' ' 15' ' ' ILE . 2.0 Cg_endo -61.14 157.58 38.93 Favored 'Trans proline' 0 C--N 1.323 -0.787 0 C-N-CA 122.242 1.961 . . . . 0.0 110.171 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.68 -2.77 67.44 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.671 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 18' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' D' ' 18' ' ' LEU . 19.1 mt -128.43 138.47 52.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.813 -1.404 . . . . 0.0 109.803 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -85.12 108.69 17.8 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt -97.95 139.36 33.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.356 -0.84 . . . . 0.0 110.516 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 21' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -119.85 129.13 54.26 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 10.3 t -71.62 131.25 42.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.48 -1.388 . . . . 0.0 111.105 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' D' ' 72' ' ' LYS . 32.1 mt -115.94 5.86 14.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.38 -176.18 16.01 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.54 143.05 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.9 -0.765 . . . . 0.0 109.158 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.19 162.6 16.83 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.861 0.838 . . . . 0.0 110.34 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -152.21 149.57 28.88 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -151.41 153.24 34.31 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.143 0.973 . . . . 0.0 109.475 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 tt -123.08 145.83 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.029 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 2.1 m 169.92 155.07 0.05 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.392 -0.817 . . . . 0.0 109.547 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 31' ' ' ASP . . . . . 0.496 ' O ' ' ND2' ' D' ' 32' ' ' ASN . 1.8 p30 -100.09 63.78 1.18 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.303 -0.873 . . . . 0.0 109.627 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' D' ' 31' ' ' ASP . 0.2 OUTLIER 176.84 132.76 0.05 Allowed 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 33' ' ' VAL . . . . . 0.429 ' H ' HG13 ' D' ' 33' ' ' VAL . 2.0 m -69.81 -40.89 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -63.31 -32.67 74.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.488 -0.757 . . . . 0.0 109.915 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -74.1 -39.34 63.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.246 -0.909 . . . . 0.0 109.109 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 mt -60.34 -48.99 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.35 -0.844 . . . . 0.0 108.963 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 63.0 t -57.48 -45.41 85.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.717 0 O-C-N 121.13 -0.981 . . . . 0.0 108.518 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -63.84 -43.1 97.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.186 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -57.95 -47.74 82.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.132 -0.98 . . . . 0.0 109.548 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 26.6 mt -63.95 -41.58 97.56 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 109.259 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -51.51 -39.84 58.44 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.443 -1.41 . . . . 0.0 109.815 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -72.95 -40.62 65.21 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.388 -0.82 . . . . 0.0 110.238 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -76.32 -36.15 58.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.389 -0.82 . . . . 0.0 109.704 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.97 -49.82 64.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.453 -0.78 . . . . 0.0 108.927 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -70.47 -31.22 68.27 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.087 -1.445 . . . . 0.0 108.989 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.06 -33.71 76.37 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -87.17 0.62 55.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.472 -0.768 . . . . 0.0 109.393 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.0 2.49 74.68 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.3 158.58 49.4 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.95 -1.3 5.92 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.261 -1.141 . . . . 0.0 110.196 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.04 168.29 40.69 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 52' ' ' LEU . . . . . 0.413 HD21 ' HA3' ' D' ' 68' ' ' GLY . 2.7 tp -131.7 137.98 48.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.601 -0.941 . . . . 0.0 109.291 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 53' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' D' ' 54' ' ' ALA . 1.9 pt -106.72 144.24 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.515 -0.74 . . . . 0.0 109.538 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 65.77 76.36 0.32 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 0.0 109.815 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.539 ' CG ' ' O ' ' D' ' 55' ' ' PHE . 62.6 t80 -106.36 34.44 3.38 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 56' ' ' ARG . . . . . 0.573 ' NH1' HH22 ' E' ' 56' ' ' ARG . 25.5 mtm180 -54.89 126.39 24.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.989 -1.069 . . . . 0.0 109.42 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 57' ' ' ILE . . . . . . . . . . . . . 48.1 mm -62.66 153.97 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.295 -0.878 . . . . 0.0 109.38 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 58' ' ' THR . . . . . 0.465 HG23 ' H ' ' D' ' 59' ' ' CYS . 0.1 OUTLIER -79.3 -87.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.418 -0.802 . . . . 0.0 109.443 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 59' ' ' CYS . . . . . 0.465 ' H ' HG23 ' D' ' 58' ' ' THR . 49.4 t -165.42 161.82 19.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.943 . . . . 0.0 109.482 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . 49.57 78.25 0.1 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 109.648 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 45.1 t0 48.56 -99.29 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 109.614 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 62' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' D' ' 64' ' ' PHE . . . -162.76 26.35 0.23 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -77.47 18.97 0.38 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -1.148 . . . . 0.0 109.781 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 64' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' D' ' 62' ' ' GLY . 12.9 m-85 -112.6 -89.92 0.51 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.451 -0.781 . . . . 0.0 109.091 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 65' ' ' LEU . . . . . . . . . . . . . 10.2 tp -161.84 -114.29 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.551 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . 152.79 143.59 3.72 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 67' ' ' TYR . . . . . 0.488 ' O ' ' CD2' ' D' ' 67' ' ' TYR . 16.4 p90 -134.16 106.91 7.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.781 -0.835 . . . . 0.0 109.47 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 68' ' ' GLY . . . . . 0.413 ' HA3' HD21 ' D' ' 52' ' ' LEU . . . -127.35 166.51 20.06 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 54.7 m -110.71 138.08 47.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.109 -1.23 . . . . 0.0 108.482 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 70' ' ' ILE . . . . . 0.491 HG22 HD12 ' D' ' 23' ' ' LEU . 41.0 mt -84.32 150.3 4.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.24 158.96 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.138 -0.976 . . . . 0.0 109.993 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 72' ' ' LYS . . . . . 0.674 ' HB2' HD11 ' D' ' 23' ' ' LEU . 5.2 ttpt -144.44 154.32 42.83 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.68 151.86 42.66 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -137.97 178.87 6.79 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.019 -1.051 . . . . 0.0 108.527 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -158.44 146.33 18.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 109.174 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.23 62.77 1.11 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.352 -0.842 . . . . 0.0 109.502 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -141.92 -140.97 0.13 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.314 -0.866 . . . . 0.0 109.293 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 78' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -78.17 101.3 6.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.545 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 5.7 m -63.98 -42.95 97.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.197 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 11.8 tpp -150.07 -137.11 0.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.282 -0.886 . . . . 0.0 109.465 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.494 -179.911 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 8.1 ptp . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.234 0.54 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 2' ' ' ILE . . . . . 0.484 ' O ' ' C ' ' E' ' 3' ' ' PHE . 14.4 mt 48.37 48.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.349 -0.844 . . . . 0.0 109.549 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 3' ' ' PHE . . . . . 0.484 ' C ' ' O ' ' E' ' 2' ' ' ILE . 9.3 p90 34.08 47.25 0.18 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.553 -0.717 . . . . 0.0 110.268 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.75 107.0 1.89 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.327 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 5' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -69.33 -143.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.464 -0.772 . . . . 0.0 108.958 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -94.27 77.67 3.96 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.081 -1.012 . . . . 0.0 109.838 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -93.99 118.71 31.88 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.056 -1.027 . . . . 0.0 109.328 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 71.7 mt -111.65 129.18 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.588 -0.695 . . . . 0.0 110.113 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 9' ' ' ILE . . . . . 0.623 ' O ' HG23 ' E' ' 9' ' ' ILE . 17.4 tt -130.08 113.36 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 3.7 t -122.88 161.68 23.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.264 -0.897 . . . . 0.0 108.784 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 11' ' ' THR . . . . . . . . . . . . . 3.1 p -113.07 85.71 2.23 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.68 -124.12 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.351 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 13' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' E' ' 14' ' ' GLU . 1.0 OUTLIER -162.34 92.68 0.83 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.431 -0.793 . . . . 0.0 109.031 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 14' ' ' GLU . . . . . 0.541 ' H ' HG21 ' E' ' 53' ' ' ILE . 12.1 tt0 75.46 150.35 0.11 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.875 -0.515 . . . . 0.0 110.069 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.38 97.13 50.43 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -60.09 154.9 48.22 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.608 1.539 . . . . 0.0 110.507 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.33 -5.78 77.97 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 18' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' E' ' 18' ' ' LEU . 17.1 mt -130.99 140.88 50.19 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.267 -1.137 . . . . 0.0 110.058 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 19' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' E' ' 73' ' ' ALA . 3.2 mp0 -83.64 109.48 17.48 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 18.0 mt -97.92 135.84 39.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.077 -1.014 . . . . 0.0 110.464 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 21' ' ' TYR . . . . . 0.434 ' H ' ' H ' ' E' ' 72' ' ' LYS . 1.2 t80 -119.85 129.41 54.39 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 22' ' ' SER . . . . . 0.425 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 16.4 t -61.65 127.41 31.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.628 -1.295 . . . . 0.0 111.587 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' E' ' 23' ' ' LEU . 7.5 mt -114.61 9.36 16.54 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.74 -177.62 16.86 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 50.3 mm -113.13 140.93 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.659 -0.907 . . . . 0.0 109.325 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.92 146.02 43.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.663 -0.648 . . . . 0.0 109.395 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 68.1 m -152.2 140.19 20.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.9 -1.125 . . . . 0.0 108.137 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.23 150.96 33.44 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.079 -1.013 . . . . 0.0 108.747 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 mm -120.03 135.05 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.4 -0.813 . . . . 0.0 109.487 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.87 159.93 18.85 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.517 -0.739 . . . . 0.0 109.896 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 31' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -83.18 -60.63 2.09 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.521 -0.737 . . . . 0.0 112.707 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -79.7 147.87 31.78 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.662 -1.274 . . . . 0.0 108.306 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 94.7 t -68.31 -34.59 66.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.696 -0.627 . . . . 0.0 109.626 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.11 -35.21 59.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.306 -0.871 . . . . 0.0 110.073 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -78.57 -33.63 47.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.057 -1.027 . . . . 0.0 109.188 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.08 -52.9 53.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 120.866 -1.146 . . . . 0.0 109.603 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.88 -50.52 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.084 -1.01 . . . . 0.0 110.145 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -57.21 -37.52 72.35 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.24 -0.913 . . . . 0.0 109.102 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -69.16 -40.48 78.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.937 -1.102 . . . . 0.0 110.137 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 39.3 mt -72.05 -49.62 35.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.882 -1.137 . . . . 0.0 109.196 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -48.1 -48.88 33.48 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.664 -1.272 . . . . 0.0 109.169 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -57.93 -32.9 68.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.317 -0.864 . . . . 0.0 109.32 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -73.38 -35.25 65.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.166 -0.959 . . . . 0.0 109.435 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.11 -51.34 20.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 120.56 -1.337 . . . . 0.0 109.083 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.35 -30.96 8.43 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.48 1.133 . . . . 0.0 109.699 -176.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.6 -25.11 49.62 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.59 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -95.65 13.53 26.01 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.07 29.87 29.43 Favored Glycine 0 N--CA 1.486 1.971 0 C-N-CA 118.032 -2.032 . . . . 0.0 109.877 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.37 -164.42 6.13 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -114.59 -35.68 4.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.59 -0.947 . . . . 0.0 110.011 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 172.33 -169.97 43.05 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 tp -118.54 140.86 49.22 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.404 -1.057 . . . . 0.0 110.173 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 53' ' ' ILE . . . . . 0.541 HG21 ' H ' ' E' ' 14' ' ' GLU . 64.5 mt -113.13 143.02 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.587 -0.696 . . . . 0.0 110.803 -178.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . 62.39 75.7 0.39 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 110.176 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -97.53 85.62 3.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.497 -0.752 . . . . 0.0 109.287 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 56' ' ' ARG . . . . . 0.573 HH22 ' NH1' ' D' ' 56' ' ' ARG . 28.6 ttm180 -84.44 160.44 20.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.405 -0.809 . . . . 0.0 109.621 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 76.6 mt -137.19 97.6 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.415 -0.803 . . . . 0.0 108.905 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 58' ' ' THR . . . . . . . . . . . . . 23.3 p -67.29 152.32 45.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.141 -0.974 . . . . 0.0 109.254 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 59' ' ' CYS . . . . . . . . . . . . . 69.3 m -149.08 125.33 10.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.206 -0.934 . . . . 0.0 109.479 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -175.97 -74.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.859 . . . . 0.0 109.353 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -164.45 87.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.889 . . . . 0.0 109.459 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.27 -11.4 6.64 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -71.94 0.89 8.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -1.155 . . . . 0.0 109.616 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 64' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -50.96 124.11 10.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.266 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 27.0 tp -152.54 125.76 8.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.306 -0.871 . . . . 0.0 108.886 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 66' ' ' GLY . . . . . . . . . . . . . . . -122.59 127.07 6.59 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -148.36 -170.16 3.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -1.138 . . . . 0.0 109.663 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . 162.04 170.18 26.44 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 1.9 m -98.34 136.26 38.75 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 49.9 mt -81.69 143.31 12.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 71' ' ' VAL . . . . . 0.461 HG21 HD11 ' E' ' 53' ' ' ILE . 2.7 m -129.33 158.45 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.361 -0.837 . . . . 0.0 109.654 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 72' ' ' LYS . . . . . 0.434 ' H ' ' H ' ' E' ' 21' ' ' TYR . 16.1 tttm -139.47 156.66 46.8 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 73' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' E' ' 19' ' ' GLN . . . -117.31 113.88 22.78 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.016 0.912 . . . . 0.0 111.765 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -169.99 101.81 0.3 Allowed 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.132 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -154.09 -33.58 0.11 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.926 -1.109 . . . . 0.0 109.381 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.86 -171.55 3.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.94 . . . . 0.0 109.512 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 77' ' ' GLN . . . . . 0.519 ' N ' ' CD ' ' E' ' 77' ' ' GLN . 0.0 OUTLIER -163.81 26.36 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 109.495 -179.533 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -159.68 109.38 1.86 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 0.0 109.457 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 1.6 t -172.74 43.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.384 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 80' ' ' MET . . . . . 0.529 ' SD ' ' N ' ' E' ' 80' ' ' MET . 1.9 mpt? 47.42 -118.09 0.88 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 109.545 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.377 179.851 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 mmt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 74.6 mt -80.54 -33.95 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.336 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 24.5 t80 58.04 97.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 109.397 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -54.9 158.62 2.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.246 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -103.44 99.54 9.38 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.284 -0.885 . . . . 0.0 109.252 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -87.67 156.19 19.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.243 -0.911 . . . . 0.0 109.16 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -94.49 124.28 38.42 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.168 -0.957 . . . . 0.0 109.86 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.6 mt -114.64 138.15 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.548 -0.72 . . . . 0.0 109.62 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.611 ' O ' HG23 ' A' ' 9' ' ' ILE . 12.8 tt -134.97 115.16 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.518 -0.738 . . . . 0.0 109.326 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.8 t -122.16 157.96 30.4 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.28 113.33 22.83 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.47 80.3 0.19 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 122.119 0.961 . . . . 0.0 109.819 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 14' ' ' GLU . 19.2 t0 -152.98 -140.95 0.1 Allowed 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.718 -0.614 . . . . 0.0 109.413 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 4.0 tm-20 -167.7 -22.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.496 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.419 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 11.6 mt 52.88 64.51 7.12 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.338 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 15' ' ' ILE . 2.4 Cg_endo -62.14 154.81 60.15 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 122.018 1.812 . . . . 0.0 110.12 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.56 -10.07 75.6 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.454 ' HA ' HD23 ' A' ' 18' ' ' LEU . 35.5 mt -123.13 136.14 54.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.299 -1.118 . . . . 0.0 109.214 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -97.99 112.92 24.68 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.08 137.05 54.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.615 -0.678 . . . . 0.0 109.244 -178.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -108.22 153.22 23.51 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.433 ' HA ' HG12 ' A' ' 71' ' ' VAL . 32.1 t -74.33 132.77 42.35 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.753 0.787 . . . . 0.0 110.769 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 mt -119.85 17.62 12.61 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.654 0.74 . . . . 0.0 109.119 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.8 176.84 16.6 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.408 HD13 HG23 ' E' ' 9' ' ' ILE . 1.0 OUTLIER -114.62 144.48 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.397 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.78 144.71 45.08 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.88 141.55 21.81 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.87 -1.144 . . . . 0.0 107.926 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -150.21 151.66 33.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.963 -1.085 . . . . 0.0 109.072 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.7 mt -114.02 128.08 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.45 -0.781 . . . . 0.0 109.101 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.7 p -177.74 178.67 0.97 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.85 . . . . 0.0 108.93 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -118.46 168.1 10.97 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.519 -0.738 . . . . 0.0 109.03 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.1 m120 75.09 119.46 0.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.6 t -68.06 -34.59 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.439 -0.788 . . . . 0.0 109.159 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -59.26 -40.41 85.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.883 . . . . 0.0 110.231 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -75.89 -38.59 57.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.226 -0.921 . . . . 0.0 109.628 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.2 mt -62.2 -46.66 95.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.036 -1.04 . . . . 0.0 109.365 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.2 t -56.95 -48.73 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.947 -1.096 . . . . 0.0 108.913 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.22 -42.58 99.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.364 -0.835 . . . . 0.0 110.366 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -57.09 -49.02 77.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 109.497 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 40' ' ' LEU . 43.0 mt -68.64 -45.07 72.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.098 -1.001 . . . . 0.0 108.714 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -51.45 -48.31 62.8 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.888 -1.133 . . . . 0.0 109.88 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -63.69 -37.29 86.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.44 -0.787 . . . . 0.0 110.23 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -76.56 -35.54 58.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.388 -0.82 . . . . 0.0 109.835 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.3 t -68.09 -51.04 52.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.996 -1.065 . . . . 0.0 108.857 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -65.99 -32.75 74.41 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.15 -1.42 . . . . 0.0 109.555 -175.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.45 -28.47 69.7 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.9 -4.71 57.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.522 -0.736 . . . . 0.0 109.864 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.09 10.45 59.71 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.5 156.53 39.09 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.435 ' SD ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -123.08 -11.54 8.03 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.389 -1.066 . . . . 0.0 109.327 -178.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.435 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -154.55 162.29 30.63 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.3 tp -128.91 139.99 51.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.677 -0.896 . . . . 0.0 109.489 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.498 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 59.9 mt -113.3 144.41 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.568 -0.707 . . . . 0.0 109.684 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 67.48 72.85 0.33 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.263 -0.898 . . . . 0.0 110.081 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.508 ' CG ' ' O ' ' A' ' 55' ' ' PHE . 65.8 t80 -95.31 45.59 1.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 108.965 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.2 tpp180 -44.2 128.99 6.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.418 -0.801 . . . . 0.0 109.94 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 58' ' ' THR . 5.6 mm -69.63 161.81 4.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.367 -0.833 . . . . 0.0 109.318 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.461 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.9 OUTLIER -144.55 65.22 1.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.453 -0.78 . . . . 0.0 109.281 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.1 p -49.01 -37.23 19.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.55 -174.71 0.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 109.344 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -156.87 -5.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.216 -0.927 . . . . 0.0 109.497 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.62 -128.8 0.02 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -71.87 -0.88 12.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.193 -1.181 . . . . 0.0 109.722 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -97.16 156.57 16.34 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.411 -0.805 . . . . 0.0 108.956 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.632 ' N ' HD23 ' A' ' 65' ' ' LEU . 1.4 pt? -169.16 179.02 4.15 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.468 -0.77 . . . . 0.0 109.852 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.56 164.63 20.0 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.415 ' CD2' HD12 ' E' ' 57' ' ' ILE . 0.2 OUTLIER -166.09 -177.87 4.37 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.358 -1.084 . . . . 0.0 109.695 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 178.57 171.32 41.72 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.631 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.704 ' OG1' ' OG1' ' E' ' 11' ' ' THR . 86.8 m -103.15 135.9 43.94 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.206 -1.173 . . . . 0.0 108.776 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.6 mt -85.06 121.67 37.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 22' ' ' SER . 16.7 m -139.23 157.44 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 O-C-N 121.302 -0.874 . . . . 0.0 109.817 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -149.51 153.61 37.47 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.096 -1.002 . . . . 0.0 109.449 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.57 150.99 30.58 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.174 -0.954 . . . . 0.0 108.931 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.585 ' N ' ' OH ' ' A' ' 21' ' ' TYR . 1.9 p-10 -78.22 -2.38 37.47 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.151 -0.968 . . . . 0.0 109.291 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 61.62 40.74 13.06 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.788 -0.57 . . . . 0.0 109.788 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 48.43 -166.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.227 -0.921 . . . . 0.0 109.446 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 44.04 71.41 0.25 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.411 -0.806 . . . . 0.0 109.627 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -157.5 -62.89 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.931 . . . . 0.0 109.518 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.7 p -68.79 86.78 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 19.5 mtt 48.1 78.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.915 . . . . 0.0 109.608 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.434 -179.96 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 53.2 mtp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 15.9 pt -88.61 16.75 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.225 -0.922 . . . . 0.0 109.475 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -59.36 148.61 31.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.446 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.429 ' H ' ' H ' ' B' ' 5' ' ' ASP . 18.0 pt-20 -165.96 -4.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 0.0 109.495 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.429 ' H ' ' H ' ' B' ' 4' ' ' GLU . 37.2 p-10 -155.63 156.67 35.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.404 -0.81 . . . . 0.0 109.218 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -109.73 -69.64 0.85 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.589 -0.695 . . . . 0.0 109.915 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -114.4 151.31 33.32 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 90.8 mt -122.3 129.7 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.24 -0.913 . . . . 0.0 109.833 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.536 ' O ' HG23 ' B' ' 9' ' ' ILE . 16.6 tt -134.27 118.66 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t -125.54 152.91 44.41 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.097 -1.002 . . . . 0.0 108.557 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.624 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 1.0 OUTLIER -96.89 79.99 2.97 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.451 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' B' ' 11' ' ' THR . . . 148.76 -98.41 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 35.8 t70 178.1 56.02 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -96.27 81.84 3.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.075 -1.016 . . . . 0.0 109.994 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.621 ' N ' ' HD3' ' B' ' 16' ' ' PRO . 5.7 mt -144.08 52.78 2.01 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.455 -0.778 . . . . 0.0 109.213 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.621 ' HD3' ' N ' ' B' ' 15' ' ' ILE . 2.1 Cg_endo -62.73 151.98 80.82 Favored 'Trans proline' 0 C--N 1.322 -0.865 0 C-N-CA 121.883 1.722 . . . . 0.0 109.945 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.43 -9.08 78.17 Favored Glycine 0 N--CA 1.484 1.874 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.23 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' LEU . . . . . 0.426 HD12 ' CG2' ' B' ' 15' ' ' ILE . 71.2 mt -126.63 139.59 53.06 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 119.038 1.419 . . . . 0.0 108.879 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' B' ' 73' ' ' ALA . 23.0 mp0 -84.33 115.45 22.5 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.5 mt -89.67 138.69 31.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.802 -1.186 . . . . 0.0 110.174 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' TYR . . . . . 0.461 ' H ' ' H ' ' B' ' 72' ' ' LYS . 31.1 t80 -120.02 128.91 53.97 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.54 -0.725 . . . . 0.0 109.644 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 30.2 t -77.69 132.97 38.43 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 120.59 -1.319 . . . . 0.0 109.858 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.444 HD11 ' CB ' ' B' ' 72' ' ' LYS . 37.5 mt -116.99 9.54 13.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.576 -0.703 . . . . 0.0 109.112 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.49 -170.67 17.39 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 33.9 mm -112.4 141.58 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.984 -0.715 . . . . 0.0 109.263 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.43 144.02 42.59 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.52 -0.738 . . . . 0.0 109.591 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 70.0 m -152.24 138.99 18.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 108.786 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 11.9 t -149.65 141.21 23.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.993 -1.067 . . . . 0.0 109.333 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.63 HD12 ' N ' ' B' ' 29' ' ' ILE . 4.4 mp -111.74 125.57 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.164 -0.96 . . . . 0.0 109.244 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 45.5 p -173.74 -145.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.685 -0.634 . . . . 0.0 109.723 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 11.3 m-20 -157.68 164.89 36.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.289 -0.882 . . . . 0.0 109.137 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 21.4 t30 75.75 132.0 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 108.823 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 44.8 t -65.06 -32.1 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.66 -0.65 . . . . 0.0 109.493 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -58.72 -46.61 86.97 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.281 -0.887 . . . . 0.0 110.126 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.46 -41.11 61.35 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.352 -0.842 . . . . 0.0 109.756 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.64 -44.76 99.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 120.887 -1.133 . . . . 0.0 109.333 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 33.1 t -68.8 -47.11 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.856 -1.152 . . . . 0.0 109.574 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.99 -43.17 99.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.132 -0.98 . . . . 0.0 110.009 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -58.33 -48.71 79.68 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.32 -0.862 . . . . 0.0 109.67 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 52.4 mt -70.13 -47.88 59.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.083 -1.011 . . . . 0.0 108.662 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -49.79 -52.62 30.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.882 -1.136 . . . . 0.0 109.523 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -59.35 -35.69 74.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.315 -0.866 . . . . 0.0 110.084 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -75.53 -35.85 60.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.743 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 24.2 t -71.39 -50.93 37.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.11 -0.994 . . . . 0.0 109.104 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -70.35 -36.79 74.42 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.104 -1.438 . . . . 0.0 109.401 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.7 -34.19 69.19 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -85.09 3.72 37.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.25 -0.906 . . . . 0.0 109.053 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.95 7.94 84.84 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.86 -158.48 1.09 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' MET . . . . . 0.442 ' SD ' ' C ' ' B' ' 50' ' ' MET . 0.0 OUTLIER -170.47 -26.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.177 -1.19 . . . . 0.0 110.164 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -136.77 159.14 24.45 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 5.4 tp -138.39 143.08 39.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.414 -1.05 . . . . 0.0 109.39 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.561 ' O ' ' HB3' ' B' ' 54' ' ' ALA . 0.6 OUTLIER -106.79 150.24 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.493 -0.754 . . . . 0.0 108.979 -179.175 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 75.82 177.5 0.2 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.62 ' CG ' ' O ' ' B' ' 55' ' ' PHE . 36.5 t80 170.98 11.79 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 121.646 2.021 . . . . 0.0 106.143 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.696 ' CG ' HH11 ' B' ' 56' ' ' ARG . 0.0 OUTLIER -44.08 122.46 2.91 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.392 -1.442 . . . . 0.0 109.854 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 pt -104.4 172.75 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.561 -0.712 . . . . 0.0 109.421 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 47.3 p -150.99 129.72 12.34 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.354 -0.841 . . . . 0.0 109.301 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 83.0 m -70.19 -174.71 0.85 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.39 133.95 48.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.214 -0.929 . . . . 0.0 109.371 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -149.0 -66.92 0.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.227 -0.92 . . . . 0.0 109.366 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -171.4 -48.69 0.04 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -144.48 -14.14 0.58 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.073 -1.251 . . . . 0.0 109.321 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -49.82 152.89 1.4 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.174 -0.954 . . . . 0.0 109.211 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.557 HD23 ' N ' ' B' ' 65' ' ' LEU . 1.5 pt? -161.15 176.59 11.13 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 122.543 1.164 . . . . 0.0 110.053 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.98 158.82 18.3 Favored Glycine 0 N--CA 1.505 3.294 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -161.14 174.87 13.04 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.16 -1.2 . . . . 0.0 109.691 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.72 -165.25 32.44 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 55.1 m -126.47 137.77 53.43 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 61.2 mt -85.27 133.31 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 4.4 m -126.42 154.98 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.52 -0.737 . . . . 0.0 109.21 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.461 ' H ' ' H ' ' B' ' 21' ' ' TYR . 5.5 tttt -146.46 137.99 24.58 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' B' ' 19' ' ' GLN . . . -109.41 151.46 26.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.156 -0.965 . . . . 0.0 109.228 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' B' ' 74' ' ' ASP . 35.6 p-10 -130.67 -167.53 1.85 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -167.0 168.79 13.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 109.263 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.64 57.09 0.75 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.533 -0.73 . . . . 0.0 109.345 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 55.75 -147.34 0.53 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.578 -0.701 . . . . 0.0 109.549 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -64.78 160.12 20.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.192 -0.943 . . . . 0.0 109.48 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.438 ' OG1' ' N ' ' B' ' 80' ' ' MET . 2.0 t -73.48 -176.35 2.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.641 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' MET . . . . . 0.438 ' N ' ' OG1' ' B' ' 79' ' ' THR . 13.5 mmt -72.0 114.57 10.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.869 . . . . 0.0 109.41 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.507 -179.982 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 33.4 tpp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 20.5 tt -164.57 142.97 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.887 . . . . 0.0 109.435 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -80.71 -47.49 13.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 109.461 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -163.81 156.41 17.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 109.526 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -68.99 -158.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -120.79 95.66 4.8 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.454 -0.779 . . . . 0.0 110.052 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -93.29 124.98 37.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.309 -0.869 . . . . 0.0 109.214 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 13.2 mt -121.13 147.9 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.461 -0.775 . . . . 0.0 110.655 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 9' ' ' ILE . . . . . 0.633 ' O ' HG23 ' C' ' 9' ' ' ILE . 11.1 tt -137.08 114.42 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.093 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 9.9 t -122.24 158.71 28.88 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.004 0.907 . . . . 0.0 108.848 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 11' ' ' THR . . . . . 0.429 HG23 ' OG1' ' D' ' 69' ' ' THR . 1.4 p -85.21 -115.44 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.11 101.36 10.92 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.099 -1.0 . . . . 0.0 109.019 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -167.06 -18.55 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.524 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 59.5 163.2 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.599 -0.688 . . . . 0.0 109.22 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 66.5 mt -125.73 85.09 59.59 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.525 -0.735 . . . . 0.0 109.223 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.44 156.83 39.17 Favored 'Trans proline' 0 C--N 1.324 -0.736 0 C-N-CA 122.024 1.816 . . . . 0.0 110.168 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.05 -6.69 76.36 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 61.6 mt -128.7 137.82 51.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -1.209 . . . . 0.0 108.786 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -87.37 108.35 18.95 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 10.5 mt -93.91 138.45 32.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.4 -0.812 . . . . 0.0 109.652 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 21' ' ' TYR . . . . . 0.416 ' CZ ' ' O ' ' C' ' 22' ' ' SER . 3.0 t80 -123.2 131.82 53.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.502 -0.749 . . . . 0.0 109.252 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 22' ' ' SER . . . . . 0.416 ' O ' ' CZ ' ' C' ' 21' ' ' TYR . 0.0 OUTLIER -53.85 128.74 31.15 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.114 -0.991 . . . . 0.0 111.169 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mt -120.14 11.73 11.7 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.899 0.856 . . . . 0.0 109.308 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.5 -169.05 13.23 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 25' ' ' ILE . . . . . 0.427 HD11 HG23 ' B' ' 9' ' ' ILE . 40.5 mm -122.73 139.09 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.683 0.754 . . . . 0.0 109.777 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -110.26 149.96 29.4 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' SER . . . . . 0.525 ' HB3' HD21 ' C' ' 65' ' ' LEU . 29.6 m -143.47 138.83 29.53 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.566 -0.709 . . . . 0.0 109.827 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.428 ' O ' ' CD1' ' C' ' 65' ' ' LEU . 15.1 t -150.01 153.69 36.94 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.186 -0.946 . . . . 0.0 109.154 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' C' ' 30' ' ' SER . 5.5 tp -88.43 144.23 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.491 -1.381 . . . . 0.0 109.958 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.456 ' O ' ' O ' ' C' ' 29' ' ' ILE . 48.0 t -51.59 -106.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.567 -0.708 . . . . 0.0 110.276 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 31' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' C' ' 32' ' ' ASN . 34.9 t0 59.78 63.05 1.56 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 32' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' C' ' 31' ' ' ASP . 5.4 t-20 89.16 115.67 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.4 -38.92 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.121 -0.987 . . . . 0.0 109.754 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.14 -30.27 48.44 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.31 -0.869 . . . . 0.0 108.709 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.69 -35.57 70.29 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 70.3 mt -65.23 -52.31 54.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 C-N-CA 118.429 -1.308 . . . . 0.0 110.43 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 85.4 t -71.04 -46.02 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.881 -1.137 . . . . 0.0 109.752 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.06 -43.85 97.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 0.0 109.397 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -64.13 -39.88 94.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.988 -1.07 . . . . 0.0 109.58 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 65.7 mt -68.97 -44.59 72.6 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 108.809 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 41' ' ' ARG . . . . . 0.788 HH11 ' HG3' ' C' ' 41' ' ' ARG . 0.1 OUTLIER -51.25 -53.68 33.09 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.752 -1.217 . . . . 0.0 109.913 -179.109 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 42' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' C' ' 46' ' ' ALA . 54.4 mttt -59.48 -37.66 78.8 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.777 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -75.9 -35.02 59.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.133 -0.979 . . . . 0.0 110.091 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 44' ' ' VAL . . . . . 0.421 ' O ' ' HG3' ' C' ' 47' ' ' LYS . 5.2 t -73.97 -51.88 22.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.12 -0.988 . . . . 0.0 108.934 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -72.61 -29.9 63.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 119.972 -1.705 . . . . 0.0 109.488 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' C' ' 42' ' ' LYS . . . -61.11 -29.73 69.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.522 -0.736 . . . . 0.0 109.491 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 47' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' C' ' 44' ' ' VAL . 0.0 OUTLIER -103.66 -4.84 23.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.45 -0.782 . . . . 0.0 109.773 -179.157 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.38 31.58 6.41 Favored Glycine 0 N--CA 1.498 2.825 0 C-N-CA 119.509 -1.329 . . . . 0.0 111.892 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.69 -178.73 52.49 Favored Glycine 0 N--CA 1.487 2.069 0 O-C-N 120.075 -1.838 . . . . 0.0 111.2 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 21.2 ttt -108.31 -40.86 5.04 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.459 -1.024 . . . . 0.0 110.712 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 175.07 -175.81 47.13 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 6.1 tp -110.62 132.07 54.5 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.511 -0.993 . . . . 0.0 109.694 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.434 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 1.2 pt -107.84 143.95 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.573 -0.704 . . . . 0.0 109.562 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 64.55 81.72 0.2 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.973 . . . . 0.0 110.113 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.54 -59.15 5.09 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.764 -0.775 . . . . 0.0 108.931 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 56' ' ' ARG . . . . . 0.589 ' HE ' ' HA ' ' C' ' 56' ' ' ARG . 0.0 OUTLIER 60.07 82.99 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.426 -0.796 . . . . 0.0 109.5 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.0 136.53 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 58' ' ' THR . . . . . . . . . . . . . 14.9 m -162.09 133.58 5.32 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.377 -0.827 . . . . 0.0 109.407 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 59' ' ' CYS . . . . . . . . . . . . . 41.1 t -98.58 135.74 39.67 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.312 -0.868 . . . . 0.0 109.13 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.66 65.65 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 0.0 109.518 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 t70 46.91 44.27 14.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.612 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . 174.41 64.4 0.05 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -55.5 101.32 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -1.164 . . . . 0.0 109.465 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -82.76 -177.09 6.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 109.379 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.525 HD21 ' HB3' ' C' ' 27' ' ' SER . 14.8 tp -88.17 127.74 35.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -0.944 . . . . 0.0 109.466 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 66' ' ' GLY . . . . . 0.444 ' N ' HD12 ' C' ' 65' ' ' LEU . . . -64.68 166.64 30.89 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 67' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' C' ' 67' ' ' TYR . 11.1 p90 -151.66 119.99 6.38 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.913 -1.345 . . . . 0.0 108.923 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -131.82 155.69 21.55 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 81.2 m -104.86 136.36 44.5 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.879 -1.365 . . . . 0.0 107.811 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 33.9 mt -90.45 139.0 18.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 108.746 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -145.08 164.13 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.356 -0.84 . . . . 0.0 110.216 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -150.6 147.74 27.79 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' C' ' 74' ' ' ASP . . . -124.09 150.73 44.68 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.19 -0.944 . . . . 0.0 108.939 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' C' ' 73' ' ' ALA . 3.9 m-20 40.27 100.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.388 -0.82 . . . . 0.0 111.262 178.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 75' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' C' ' 76' ' ' ALA . 25.0 tt0 -115.5 -30.27 6.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.306 -0.871 . . . . 0.0 109.348 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 76' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' C' ' 75' ' ' GLU . . . 42.66 -145.85 0.06 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 77' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -132.29 -135.73 0.19 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.408 -0.807 . . . . 0.0 109.176 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 47.54 29.35 1.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.489 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 70.0 p -53.66 -22.03 8.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.4 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 80' ' ' MET . . . . . 0.405 ' HG2' ' H ' ' C' ' 80' ' ' MET . 11.8 ptt? -78.17 37.86 0.27 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.385 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.44 -179.914 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.431 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.3 0.572 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 2' ' ' ILE . . . . . . . . . . . . . 2.9 tp -165.66 -28.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.909 . . . . 0.0 108.974 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -148.54 -150.26 0.34 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.096 -1.002 . . . . 0.0 109.313 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 54.5 179.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.657 -0.652 . . . . 0.0 109.396 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 5' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -148.25 -39.82 0.17 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.145 -0.972 . . . . 0.0 109.414 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -168.88 -111.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.654 -0.654 . . . . 0.0 109.744 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -116.32 120.06 37.68 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.388 -0.82 . . . . 0.0 109.419 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 76.5 mt -99.75 133.78 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.287 -0.883 . . . . 0.0 109.286 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 9' ' ' ILE . . . . . 0.517 HG23 ' O ' ' D' ' 9' ' ' ILE . 20.3 tt -125.1 124.63 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.492 -0.755 . . . . 0.0 109.555 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.512 ' OG1' ' CG ' ' D' ' 13' ' ' ASP . 11.3 t -119.17 131.9 55.91 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m -112.59 114.84 27.68 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.3 -0.875 . . . . 0.0 110.896 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . 51.67 77.39 0.14 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.231 -0.918 . . . . 0.0 109.816 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 13' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' D' ' 13' ' ' ASP . 4.5 p-10 178.07 -138.6 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -173.28 171.55 4.01 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.848 -1.157 . . . . 0.0 108.759 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 11.5 mt -129.62 78.45 75.42 Favored Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.76 156.13 44.83 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 122.054 1.836 . . . . 0.0 110.035 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.86 -9.79 74.93 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 18' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' D' ' 18' ' ' LEU . 59.1 mt -127.4 136.04 51.3 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 119.032 1.416 . . . . 0.0 108.501 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -86.56 108.05 18.4 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' D' ' 71' ' ' VAL . 6.0 mt -102.81 128.29 49.63 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.506 -0.746 . . . . 0.0 109.853 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 21' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' D' ' 71' ' ' VAL . 0.5 OUTLIER -119.17 145.98 45.55 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.338 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.3 t -86.87 131.63 34.05 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.455 0.645 . . . . 0.0 110.426 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.943 HD23 ' N ' ' D' ' 23' ' ' LEU . 0.3 OUTLIER -119.56 5.94 11.07 Favored 'General case' 0 N--CA 1.512 2.637 0 CA-C-O 122.948 1.356 . . . . 0.0 108.381 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.46 174.0 21.16 Favored Glycine 0 N--CA 1.497 2.73 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.685 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.12 144.81 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.86 144.19 42.83 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 74.0 m -151.48 139.73 20.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 15.1 t -149.62 147.83 28.59 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.964 -1.085 . . . . 0.0 109.036 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 80.3 mt -117.08 128.17 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.306 -0.871 . . . . 0.0 108.847 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' D' ' 31' ' ' ASP . 12.8 t -177.67 179.62 0.89 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.445 -0.785 . . . . 0.0 108.962 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 31' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' D' ' 32' ' ' ASN . 19.4 p-10 -116.06 163.7 15.55 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.558 -0.714 . . . . 0.0 109.555 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 5.8 t-20 75.68 126.3 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.142 -0.974 . . . . 0.0 108.68 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 89.1 t -68.98 -33.73 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.595 -0.691 . . . . 0.0 109.738 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 34' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' D' ' 35' ' ' GLU . 1.3 p30 -59.57 -41.52 90.39 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.125 -0.984 . . . . 0.0 109.58 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 35' ' ' GLU . . . . . 0.527 ' N ' ' OD1' ' D' ' 34' ' ' ASP . 16.8 tp10 -75.3 -41.22 57.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.124 -0.985 . . . . 0.0 109.284 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 90.9 mt -64.26 -42.57 95.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 O-C-N 120.962 -1.086 . . . . 0.0 109.232 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 t -64.14 -49.79 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.769 -1.207 . . . . 0.0 109.223 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.09 -38.66 83.59 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.861 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -60.55 -44.06 96.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 109.602 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 35.1 mt -70.37 -46.23 64.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.206 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -51.37 -45.37 62.39 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.767 -1.208 . . . . 0.0 109.601 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -67.3 -39.29 85.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.432 -0.793 . . . . 0.0 110.062 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -75.91 -36.09 59.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.411 -0.806 . . . . 0.0 109.727 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 15.4 t -69.7 -50.77 47.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 108.787 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -64.6 -34.07 77.41 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 118.243 -1.383 . . . . 0.0 109.322 -175.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.93 -30.94 71.94 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.736 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -85.02 -3.97 58.98 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.16 5.09 68.05 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.15 159.97 52.17 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.36 -7.67 7.56 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.424 -1.045 . . . . 0.0 109.379 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.69 166.37 37.95 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 52' ' ' LEU . . . . . 0.452 HD21 ' HA3' ' D' ' 68' ' ' GLY . 8.0 tp -129.73 142.79 50.64 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.661 -0.905 . . . . 0.0 109.794 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 53' ' ' ILE . . . . . 0.477 ' O ' ' HB3' ' D' ' 54' ' ' ALA . 0.7 OUTLIER -107.41 140.65 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.734 -0.604 . . . . 0.0 110.577 -179.017 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 67.64 86.47 0.13 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.515 -0.741 . . . . 0.0 110.47 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.472 ' CD2' HD11 ' D' ' 9' ' ' ILE . 4.9 t80 -100.63 37.67 1.66 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.694 0.759 . . . . 0.0 109.743 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 56' ' ' ARG . . . . . 0.791 ' HG3' HH11 ' D' ' 56' ' ' ARG . 0.1 OUTLIER -66.18 130.56 43.64 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.481 -1.387 . . . . 0.0 109.135 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 57' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.2 -177.29 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.386 -0.821 . . . . 0.0 109.162 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 58' ' ' THR . . . . . 0.61 ' O ' ' CG ' ' D' ' 64' ' ' PHE . 53.6 m -160.45 76.31 0.59 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 59' ' ' CYS . . . . . . . . . . . . . 43.4 t -146.37 140.32 26.28 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.044 -1.035 . . . . 0.0 109.723 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -179.83 11.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.411 -0.806 . . . . 0.0 109.462 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -162.65 3.57 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.132 -0.98 . . . . 0.0 109.584 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.88 -154.28 16.87 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -98.26 147.44 24.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.344 -1.092 . . . . 0.0 109.394 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 64' ' ' PHE . . . . . 0.61 ' CG ' ' O ' ' D' ' 58' ' ' THR . 56.6 m-85 -140.83 -105.57 0.15 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.316 -0.865 . . . . 0.0 109.413 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 65' ' ' LEU . . . . . . . . . . . . . 14.1 tp -176.78 122.49 0.14 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.25 -0.906 . . . . 0.0 110.403 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.75 123.98 5.88 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -137.47 -167.03 2.04 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.557 1.17 . . . . 0.0 110.359 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 68' ' ' GLY . . . . . 0.452 ' HA3' HD21 ' D' ' 52' ' ' LEU . . . 169.66 -176.79 43.44 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 69' ' ' THR . . . . . 0.429 ' OG1' HG23 ' C' ' 11' ' ' THR . 70.9 m -111.64 137.61 49.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.275 -1.132 . . . . 0.0 108.864 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 62.5 mt -84.54 136.71 22.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 71' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' D' ' 20' ' ' LEU . 13.5 m -146.75 151.56 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.543 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.07 164.59 29.38 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.973 -1.08 . . . . 0.0 109.029 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.7 150.83 36.17 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -165.24 95.73 0.67 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.979 -1.076 . . . . 0.0 108.569 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -164.51 -70.18 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.3 -0.875 . . . . 0.0 109.014 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.23 64.34 1.73 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.45 -0.781 . . . . 0.0 109.552 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -166.15 93.86 0.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.448 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 78' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -155.7 147.05 22.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.87 . . . . 0.0 109.355 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 74.0 m 51.43 86.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.881 . . . . 0.0 109.409 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 3.6 mmt -57.53 131.58 50.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.527 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.45 -179.952 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ptt? . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.454 0.645 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 19.9 pt -62.01 -179.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.039 -1.038 . . . . 0.0 109.486 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 3' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' E' ' 3' ' ' PHE . 6.3 p90 -151.52 -34.51 0.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 109.453 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 4' ' ' GLU . . . . . 0.504 ' CD ' HH21 ' E' ' 41' ' ' ARG . 15.7 tp10 177.34 103.79 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 175.52 72.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.606 -0.684 . . . . 0.0 109.214 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -168.14 59.32 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -0.859 . . . . 0.0 108.923 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -105.36 123.73 48.36 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.655 -0.653 . . . . 0.0 109.762 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 89.7 mt -98.0 123.64 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.072 -1.017 . . . . 0.0 110.672 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 9' ' ' ILE . . . . . 0.572 ' O ' HG23 ' E' ' 9' ' ' ILE . 19.5 tt -137.21 116.66 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 10' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' E' ' 13' ' ' ASP . 15.2 t -124.66 157.29 35.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.0 -1.063 . . . . 0.0 108.934 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 11' ' ' THR . . . . . 0.704 ' OG1' ' OG1' ' A' ' 69' ' ' THR . 0.0 OUTLIER -135.26 128.24 31.49 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.346 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.4 35.37 24.87 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.898 0.856 . . . . 0.0 109.612 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 13' ' ' ASP . . . . . 0.484 ' HB3' ' OG1' ' E' ' 10' ' ' THR . 23.5 t0 -152.48 86.26 1.27 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.617 -0.677 . . . . 0.0 109.355 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -57.81 170.01 0.66 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 108.957 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 40.0 mt -122.32 80.19 45.22 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.358 -0.839 . . . . 0.0 109.116 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.53 156.99 38.75 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.109 1.873 . . . . 0.0 110.083 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.52 -5.48 73.99 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 18' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' E' ' 18' ' ' LEU . 50.0 mt -128.21 136.62 51.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.938 -1.331 . . . . 0.0 108.776 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -86.04 108.61 18.33 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 10.7 mt -95.42 136.58 35.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.329 -0.857 . . . . 0.0 109.703 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 21' ' ' TYR . . . . . 0.427 ' CZ ' ' O ' ' E' ' 22' ' ' SER . 2.4 t80 -121.04 132.3 54.8 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.575 -0.703 . . . . 0.0 109.174 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 22' ' ' SER . . . . . 0.427 ' O ' ' CZ ' ' E' ' 21' ' ' TYR . 0.0 OUTLIER -58.72 130.77 48.49 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.04 -1.037 . . . . 0.0 111.162 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 mt -116.87 12.53 14.76 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.14 -174.08 15.07 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 25' ' ' ILE . . . . . 0.442 HD11 ' CG2' ' D' ' 9' ' ' ILE . 31.0 mm -112.44 140.87 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.609 -0.936 . . . . 0.0 109.416 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.32 143.98 45.38 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.706 -0.621 . . . . 0.0 109.657 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 4.0 p -152.38 141.61 21.43 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.817 -1.177 . . . . 0.0 108.512 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 28' ' ' THR . . . . . 0.416 ' O ' HG23 ' E' ' 28' ' ' THR . 14.2 t -149.64 134.01 17.41 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.107 -0.996 . . . . 0.0 109.152 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 59.9 mt -108.41 127.5 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.333 -0.855 . . . . 0.0 108.909 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 94.5 p -172.55 -140.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.42 -0.8 . . . . 0.0 109.535 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 31' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' E' ' 32' ' ' ASN . 24.7 t70 -155.97 158.67 38.29 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.207 -0.933 . . . . 0.0 109.578 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 32' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 15.1 t30 73.83 126.72 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.19 -0.943 . . . . 0.0 108.867 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.27 -32.16 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.479 -0.763 . . . . 0.0 109.527 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -57.45 -45.59 84.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.876 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -76.05 -38.91 56.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.164 -0.96 . . . . 0.0 109.756 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 79.6 mt -61.78 -49.57 83.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.891 -1.131 . . . . 0.0 109.3 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -62.48 -48.6 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.973 -1.079 . . . . 0.0 109.287 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.67 -39.84 81.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.221 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 -64.51 -44.89 89.5 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.24 -0.913 . . . . 0.0 109.688 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 40' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' E' ' 40' ' ' LEU . 27.8 mt -68.63 -45.7 71.17 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.014 -1.054 . . . . 0.0 108.543 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 41' ' ' ARG . . . . . 0.878 HH11 ' HG2' ' E' ' 41' ' ' ARG . 5.3 ttt-85 -47.84 -53.67 14.87 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.79 -1.193 . . . . 0.0 109.054 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -60.01 -35.87 75.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.408 -0.808 . . . . 0.0 110.012 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -77.16 -35.03 56.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.503 -0.748 . . . . 0.0 109.93 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 t -70.45 -51.92 33.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 121.053 -1.029 . . . . 0.0 108.677 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -68.42 -31.8 71.38 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.326 -1.35 . . . . 0.0 109.275 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.75 -29.44 69.95 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.22 -5.62 58.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.589 -0.694 . . . . 0.0 109.686 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.49 3.94 58.38 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.74 163.2 45.75 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -125.15 -10.45 7.06 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.394 -1.062 . . . . 0.0 109.771 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.68 157.92 30.0 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.106 -1.521 . . . . 0.0 109.648 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.43 139.93 46.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.709 -0.877 . . . . 0.0 109.32 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 53' ' ' ILE . . . . . 0.417 HG21 HD13 ' E' ' 53' ' ' ILE . 1.2 pt -106.66 140.06 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.418 -0.801 . . . . 0.0 109.597 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.79 82.2 0.16 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 122.259 1.028 . . . . 0.0 111.73 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 55' ' ' PHE . . . . . 0.48 ' CD1' HD11 ' E' ' 9' ' ' ILE . 45.9 t80 -60.11 -102.84 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.142 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 56' ' ' ARG . . . . . 0.559 ' HE ' ' HA2' ' E' ' 66' ' ' GLY . 6.4 ttm180 -173.84 -125.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.962 -1.086 . . . . 0.0 108.989 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 57' ' ' ILE . . . . . 0.491 ' H ' ' HD2' ' E' ' 56' ' ' ARG . 0.0 OUTLIER 39.34 96.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 121.726 -0.609 . . . . 0.0 109.771 179.03 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 58' ' ' THR . . . . . 0.41 HG22 ' H ' ' E' ' 59' ' ' CYS . 2.0 m -122.7 -134.92 0.29 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 59' ' ' CYS . . . . . 0.41 ' H ' HG22 ' E' ' 58' ' ' THR . 27.1 t -171.5 157.79 4.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.879 . . . . 0.0 109.531 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . 51.53 57.11 6.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 109.877 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -173.85 -12.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.362 -0.836 . . . . 0.0 109.546 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.65 132.79 0.09 OUTLIER Glycine 0 N--CA 1.495 2.58 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 pptp? -163.31 153.15 15.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -1.128 . . . . 0.0 109.619 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 64' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -168.19 35.02 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -0.925 . . . . 0.0 109.471 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.401 ' O ' ' NE ' ' E' ' 56' ' ' ARG . 0.0 OUTLIER -163.57 150.57 12.31 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.3 -0.875 . . . . 0.0 109.213 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 66' ' ' GLY . . . . . 0.559 ' HA2' ' HE ' ' E' ' 56' ' ' ARG . . . -85.69 146.46 21.5 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 176.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -153.9 110.05 3.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.269 -1.136 . . . . 0.0 109.493 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.16 165.93 28.11 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 61.3 m -107.79 137.77 45.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.407 -1.054 . . . . 0.0 108.183 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 28.9 mt -85.37 144.33 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 m -144.77 163.33 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.287 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -153.79 155.43 35.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 0.0 108.749 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.48 150.94 35.69 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.123 -0.986 . . . . 0.0 108.739 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -168.66 53.84 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.964 -1.085 . . . . 0.0 108.666 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -124.44 105.4 9.38 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.496 -0.753 . . . . 0.0 109.341 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . -167.01 -60.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.291 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 77' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -87.16 -177.64 6.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.285 -0.884 . . . . 0.0 109.333 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -88.5 120.29 29.74 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.259 -0.9 . . . . 0.0 109.423 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 25.6 m -160.26 -77.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.42 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 36.6 mtp -81.05 155.06 26.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.294 -0.879 . . . . 0.0 109.563 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.492 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.7 ttp . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.0 pt -144.77 -174.02 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.344 -0.848 . . . . 0.0 109.195 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 3' ' ' PHE . 9.2 p90 -145.34 49.77 1.24 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.194 -0.942 . . . . 0.0 109.338 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 60.08 8.29 1.44 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -0.834 . . . . 0.0 109.554 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 50.71 -151.92 0.2 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.889 . . . . 0.0 109.446 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.476 ' HG2' ' N ' ' A' ' 7' ' ' PHE . 29.0 ttmt -152.18 173.51 14.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.387 -0.821 . . . . 0.0 109.786 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.476 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 56.7 t80 -91.68 120.01 32.05 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.33 -0.856 . . . . 0.0 109.437 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.6 mt -115.21 143.51 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.63 -0.669 . . . . 0.0 109.477 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.45 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 11.4 tt -124.69 119.71 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.425 ' OG1' ' OD2' ' A' ' 13' ' ' ASP . 5.5 t -112.32 132.48 54.96 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.372 -0.83 . . . . 0.0 109.351 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.533 ' OG1' ' HB ' ' B' ' 69' ' ' THR . 0.2 OUTLIER -64.05 -135.77 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.387 -0.821 . . . . 0.0 109.919 -179.671 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.19 80.27 6.29 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.714 0.768 . . . . 0.0 109.843 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.425 ' OD2' ' OG1' ' A' ' 10' ' ' THR . 8.1 p-10 -154.99 -126.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -171.49 171.58 5.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.987 -1.07 . . . . 0.0 109.3 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.1 mt -130.65 75.12 79.35 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.389 -0.82 . . . . 0.0 108.884 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.77 157.65 36.83 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 122.09 1.86 . . . . 0.0 110.177 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.01 -7.49 73.16 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 18' ' ' LEU . 73.3 mt -125.41 137.81 54.01 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.077 -1.249 . . . . 0.0 109.482 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -86.55 108.4 18.56 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 3.7 mt -110.56 128.81 55.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.495 -0.753 . . . . 0.0 109.999 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.596 ' OH ' ' N ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -107.75 149.81 27.73 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.038 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.25 126.01 30.21 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.68 14.28 21.19 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.6 178.37 18.48 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.03 143.96 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.958 -0.731 . . . . 0.0 109.174 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.52 154.87 25.25 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.668 -0.645 . . . . 0.0 109.779 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.2 m -128.7 156.46 43.45 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.48 145.98 49.22 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.246 -0.909 . . . . 0.0 109.324 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.418 ' O ' ' CB ' ' A' ' 30' ' ' SER . 2.2 mm -129.13 128.48 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 120.953 1.706 . . . . 0.0 106.797 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 1.2 m 171.86 -165.54 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.919 -1.113 . . . . 0.0 109.303 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -120.84 -70.86 0.76 Allowed 'General case' 0 N--CA 1.513 2.704 0 O-C-N 121.619 -0.675 . . . . 0.0 112.453 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -62.61 149.76 42.48 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.526 -1.359 . . . . 0.0 108.453 176.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.474 ' H ' HG13 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -70.17 -39.98 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.83 -29.44 40.99 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.421 -0.799 . . . . 0.0 109.762 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.402 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 12.8 mm-40 -78.46 -33.91 48.08 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.38 -0.825 . . . . 0.0 109.371 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.6 mt -62.56 -47.64 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.911 . . . . 0.0 109.258 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.25 -53.17 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.738 -1.226 . . . . 0.0 110.267 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -57.2 -36.9 71.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.203 -0.936 . . . . 0.0 109.95 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 35' ' ' GLU . 76.8 m-20 -64.71 -43.44 93.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.201 -0.937 . . . . 0.0 110.132 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 40' ' ' LEU . 21.1 mt -69.89 -45.86 66.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.935 -1.103 . . . . 0.0 109.53 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -48.97 -45.88 42.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.8 -1.188 . . . . 0.0 109.223 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -64.52 -36.62 84.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.479 -0.763 . . . . 0.0 110.182 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -75.53 -36.16 60.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.365 -0.835 . . . . 0.0 109.824 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.8 t -69.24 -50.13 55.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.126 -0.984 . . . . 0.0 109.487 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -64.76 -29.7 70.68 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.013 -175.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.2 -32.09 69.85 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.498 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.88 3.29 34.5 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.479 -0.763 . . . . 0.0 109.099 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.84 4.33 88.21 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.88 -157.22 0.4 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -166.11 -23.46 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.203 -1.174 . . . . 0.0 110.023 178.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.548 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -151.18 143.9 11.09 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.6 tp -106.84 138.98 41.98 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.962 . . . . 0.0 109.357 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.8 OUTLIER -109.48 139.67 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.604 -0.685 . . . . 0.0 110.628 -178.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 73.09 85.24 0.11 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.679 -0.638 . . . . 0.0 110.586 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -111.47 121.2 44.57 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -140.39 105.87 5.08 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -0.853 . . . . 0.0 109.422 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.7 mt -63.95 139.5 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.363 -0.836 . . . . 0.0 109.248 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.7 m -77.27 -94.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 109.448 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.9 p -156.79 174.13 15.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.07 -1.018 . . . . 0.0 109.405 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.37 136.65 32.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.268 -0.895 . . . . 0.0 109.544 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 50.03 85.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 109.768 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 64' ' ' PHE . . . 150.79 136.32 2.5 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 1.5 mptp? 65.44 -45.28 0.37 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.456 ' N ' ' O ' ' A' ' 62' ' ' GLY . 46.7 m-85 47.44 47.96 16.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.24 -0.913 . . . . 0.0 109.706 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.491 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.3 OUTLIER 177.96 141.41 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.32 -0.863 . . . . 0.0 109.25 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -122.61 -125.86 3.12 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -172.2 137.35 0.89 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.793 -1.416 . . . . 0.0 110.185 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.27 148.04 17.47 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 79.5 m -105.12 143.0 33.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.015 -1.286 . . . . 0.0 109.384 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.8 mt -91.66 143.72 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.41 -0.806 . . . . 0.0 109.102 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 20' ' ' LEU . 10.6 m -142.27 151.97 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 109.101 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -141.09 143.82 34.55 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.16 -0.962 . . . . 0.0 108.933 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.591 ' O ' ' CB ' ' A' ' 74' ' ' ASP . . . -124.44 152.58 43.12 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.596 ' N ' ' OH ' ' A' ' 21' ' ' TYR . 25.6 t0 97.57 85.5 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 CA-C-O 121.221 0.534 . . . . 0.0 110.213 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -139.8 -48.73 0.47 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.32 -0.862 . . . . 0.0 109.168 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.502 ' O ' ' C ' ' A' ' 77' ' ' GLN . . . -168.31 44.08 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 109.182 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 79' ' ' THR . 1.1 tm0? -30.58 -52.69 0.17 Allowed 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.345 0.593 . . . . 0.0 110.453 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -64.27 72.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.395 -0.816 . . . . 0.0 109.476 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.4 m -166.48 144.14 5.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.897 . . . . 0.0 109.215 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.51 18.07 4.14 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.282 -0.886 . . . . 0.0 109.217 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.519 179.846 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.531 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 9.8 mm -75.52 -27.02 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.204 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -71.73 -159.93 0.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.248 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.432 ' N ' ' CD ' ' B' ' 4' ' ' GLU . 15.5 mp0 -122.97 77.48 1.46 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.517 -0.739 . . . . 0.0 109.293 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' B' ' 6' ' ' LYS . 22.5 t70 -136.08 -148.87 0.31 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.537 -0.727 . . . . 0.0 109.15 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.516 ' H ' ' CG ' ' B' ' 5' ' ' ASP . 32.3 tttm 63.91 121.61 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.867 . . . . 0.0 109.536 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -106.46 118.89 37.83 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.368 -0.833 . . . . 0.0 109.526 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.5 mt -112.08 132.73 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.625 ' O ' HG23 ' B' ' 9' ' ' ILE . 10.1 tt -125.78 114.39 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.78 158.93 32.13 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.412 -0.805 . . . . 0.0 108.945 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 12.6 p -110.64 86.52 2.33 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.38 -110.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.685 -0.635 . . . . 0.0 109.914 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -147.02 -161.35 1.31 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.227 -0.92 . . . . 0.0 109.576 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLU . . . . . 0.418 ' O ' ' HD3' ' B' ' 16' ' ' PRO . 0.7 OUTLIER -58.84 131.45 51.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.421 -0.799 . . . . 0.0 109.583 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.03 110.2 3.01 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' B' ' 14' ' ' GLU . 1.9 Cg_endo -63.68 154.11 71.17 Favored 'Trans proline' 0 N--CA 1.481 0.746 0 C-N-CA 121.286 1.324 . . . . 0.0 110.26 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.44 -6.68 82.23 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.32 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 73.2 mt -129.94 142.43 50.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -1.139 . . . . 0.0 109.976 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -87.7 108.25 19.02 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -93.29 140.52 29.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.156 -0.965 . . . . 0.0 110.484 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' TYR . . . . . 0.454 ' H ' ' H ' ' B' ' 72' ' ' LYS . 1.3 t80 -123.2 131.3 53.63 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.405 ' N ' ' CD1' ' B' ' 21' ' ' TYR . 11.8 t -59.5 129.75 43.5 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.085 -1.009 . . . . 0.0 110.607 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.453 ' HA ' HD23 ' B' ' 23' ' ' LEU . 7.1 mt -117.07 9.24 13.56 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.78 173.77 16.38 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 49.3 mm -111.19 143.5 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.868 -0.783 . . . . 0.0 109.101 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.28 144.65 43.42 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.377 -0.827 . . . . 0.0 109.199 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 9.4 p -152.53 143.74 23.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.986 -1.071 . . . . 0.0 108.71 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 7.7 t -150.35 152.82 35.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.137 -0.977 . . . . 0.0 109.426 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 1.8 mm -122.92 128.1 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 53.8 p -173.49 -153.17 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.519 -0.738 . . . . 0.0 109.709 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 3.7 p-10 -135.31 157.14 47.67 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.461 -0.774 . . . . 0.0 109.495 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 4.1 t-20 82.57 115.16 0.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.485 ' H ' HG13 ' B' ' 33' ' ' VAL . 0.8 OUTLIER -70.1 -39.94 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.26 -35.44 77.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.374 -0.829 . . . . 0.0 110.129 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -73.33 -37.17 66.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.317 -0.865 . . . . 0.0 108.929 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 14.3 mt -62.23 -42.88 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 108.928 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 63.6 t -55.44 -48.82 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.988 -1.07 . . . . 0.0 108.627 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.74 -40.45 92.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.4 -0.812 . . . . 0.0 110.008 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -59.16 -46.57 88.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.13 -0.981 . . . . 0.0 109.72 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.97 -46.39 65.32 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.799 -1.188 . . . . 0.0 108.678 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ARG . . . . . 0.804 HH11 ' HG2' ' B' ' 41' ' ' ARG . 6.4 ttt-85 -49.63 -49.61 46.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.822 -1.174 . . . . 0.0 108.878 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 6.3 pttm -61.42 -35.24 76.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 0.0 108.909 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -71.67 -36.5 70.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.517 -0.74 . . . . 0.0 109.225 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 52.2 t -75.35 -49.75 26.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.981 -1.074 . . . . 0.0 109.21 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.519 ' HZ2' ' NH1' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -48.96 -31.99 8.35 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.531 1.158 . . . . 0.0 110.276 -178.287 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.53 -27.04 51.56 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.71 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -93.84 13.12 23.53 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.14 31.11 32.94 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 118.656 -1.735 . . . . 0.0 109.814 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.3 153.75 28.03 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 68.1 mmm -63.1 -45.35 92.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.349 -1.089 . . . . 0.0 110.673 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.27 -169.49 39.82 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.1 tp -102.43 141.82 34.64 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.507 -0.996 . . . . 0.0 110.034 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.789 HD12 ' O ' ' B' ' 53' ' ' ILE . 1.1 pp -119.64 147.77 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.794 0.807 . . . . 0.0 112.075 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 52.94 52.73 13.29 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 119.692 -1.88 . . . . 0.0 109.403 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.525 ' CD2' HD11 ' B' ' 9' ' ' ILE . 46.2 t80 -83.76 96.35 8.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.018 -1.051 . . . . 0.0 109.327 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.851 HH21 HH22 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -97.56 138.04 35.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.351 -0.843 . . . . 0.0 109.189 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 97.7 mt -109.07 118.14 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 35.7 p -128.43 26.53 5.66 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 45.7 t -69.24 112.17 5.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.313 -0.867 . . . . 0.0 109.25 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.89 -117.52 0.08 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.267 -0.896 . . . . 0.0 109.206 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.58 -8.62 14.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.097 -1.002 . . . . 0.0 109.392 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.66 139.16 6.32 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.519 ' HD3' ' H ' ' B' ' 63' ' ' LYS . 0.8 OUTLIER -81.95 120.14 24.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.428 -1.042 . . . . 0.0 109.772 -179.453 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.443 ' O ' ' O ' ' B' ' 65' ' ' LEU . 92.0 m-85 -98.51 13.5 31.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.373 -0.83 . . . . 0.0 109.416 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' B' ' 64' ' ' PHE . 5.3 mp 58.89 144.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.601 0.715 . . . . 0.0 110.255 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' B' ' 67' ' ' TYR . . . -81.71 60.64 4.73 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' B' ' 66' ' ' GLY . 3.0 p90 -44.02 121.57 2.51 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.512 -0.993 . . . . 0.0 109.334 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.22 135.28 5.58 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' THR . . . . . 0.533 ' HB ' ' OG1' ' A' ' 11' ' ' THR . 23.6 m -95.79 138.22 33.75 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.104 -1.233 . . . . 0.0 108.348 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 47.6 mt -84.94 141.78 14.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.52 163.97 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.774 0.797 . . . . 0.0 109.811 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.454 ' H ' ' H ' ' B' ' 21' ' ' TYR . 15.6 tttt -151.01 151.32 31.9 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.97 149.88 45.46 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -73.39 150.78 41.51 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.026 -1.046 . . . . 0.0 109.366 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' B' ' 75' ' ' GLU . 3.3 mp0 -82.57 25.81 0.61 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.932 . . . . 0.0 109.514 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -162.32 168.5 22.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' GLN . . . . . 0.495 ' CD ' ' N ' ' B' ' 77' ' ' GLN . 3.8 pm0 -151.77 -8.19 0.22 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.226 -0.921 . . . . 0.0 109.445 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -81.71 61.23 5.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.351 -0.843 . . . . 0.0 109.467 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 60.9 p -142.24 130.32 22.0 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.326 -0.859 . . . . 0.0 109.287 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' MET . . . . . 0.511 ' N ' ' SD ' ' B' ' 80' ' ' MET . 1.1 mpt? -67.38 -101.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.361 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.536 -179.94 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 10.1 ptt? . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' ILE . . . . . 0.401 HG22 ' H ' ' C' ' 2' ' ' ILE . 1.1 tp -93.63 105.2 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.293 -0.88 . . . . 0.0 109.133 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 3' ' ' PHE . . . . . 0.476 ' O ' ' N ' ' C' ' 5' ' ' ASP . 18.4 m-85 -91.79 64.44 4.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.783 -1.198 . . . . 0.0 108.86 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 4' ' ' GLU . . . . . 0.482 ' O ' ' C ' ' C' ' 5' ' ' ASP . 12.3 pt-20 34.56 33.99 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.826 -0.546 . . . . 0.0 110.684 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 5' ' ' ASP . . . . . 0.482 ' C ' ' O ' ' C' ' 4' ' ' GLU . 3.4 p-10 33.95 79.85 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.246 0.546 . . . . 0.0 109.909 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -72.96 126.53 30.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.885 . . . . 0.0 109.858 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -92.03 120.76 32.97 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 80.5 mt -116.82 145.75 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.535 -0.728 . . . . 0.0 109.817 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 9' ' ' ILE . . . . . 0.647 ' O ' HG23 ' C' ' 9' ' ' ILE . 11.5 tt -130.5 114.63 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 11.7 t -123.09 159.36 28.66 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.962 0.887 . . . . 0.0 108.823 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 11' ' ' THR . . . . . 0.568 ' HG1' ' CB ' ' D' ' 69' ' ' THR . 1.7 p -88.5 -113.5 0.06 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.49 99.0 8.62 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.258 -0.902 . . . . 0.0 109.239 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -169.01 -13.44 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.72 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 57.24 173.02 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.312 -0.867 . . . . 0.0 109.57 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 66.4 mt -134.37 83.35 44.07 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.47 -0.769 . . . . 0.0 109.142 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.64 157.14 43.59 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 121.936 1.758 . . . . 0.0 110.139 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.38 -7.85 75.15 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 37.0 mt -127.86 140.37 52.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.142 -1.211 . . . . 0.0 109.716 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -86.44 110.39 19.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -95.67 136.29 36.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.112 -0.993 . . . . 0.0 110.182 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 21' ' ' TYR . . . . . 0.449 ' H ' ' H ' ' C' ' 72' ' ' LYS . 1.9 t80 -118.51 130.16 55.77 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 4.9 t -65.26 128.38 35.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.935 -1.103 . . . . 0.0 110.746 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' C' ' 23' ' ' LEU . 12.4 mt -115.04 8.5 15.76 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.74 178.72 18.86 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.08 144.22 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.801 -0.823 . . . . 0.0 109.066 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.62 144.21 44.23 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.645 -0.66 . . . . 0.0 109.609 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 86.9 p -152.41 136.08 16.16 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 10.7 t -149.88 153.34 36.53 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.942 -1.099 . . . . 0.0 109.339 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.578 ' N ' HD12 ' C' ' 29' ' ' ILE . 4.9 mp -125.28 132.03 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.18 -0.95 . . . . 0.0 108.726 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.425 ' O ' ' O ' ' C' ' 31' ' ' ASP . 0.2 OUTLIER -169.98 7.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.568 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 31' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' C' ' 32' ' ' ASN . 21.5 t0 58.88 153.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.314 -0.866 . . . . 0.0 109.808 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 32' ' ' ASN . . . . . 0.469 ' N ' ' OD1' ' C' ' 31' ' ' ASP . 10.7 m-20 81.26 115.17 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.48 ' H ' HG13 ' C' ' 33' ' ' VAL . 0.9 OUTLIER -70.11 -40.81 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -58.81 -33.71 70.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.364 -0.835 . . . . 0.0 109.914 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -76.44 -36.36 58.0 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.289 -0.882 . . . . 0.0 109.188 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 55.5 mt -62.95 -52.7 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 0.0 109.086 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -51.71 -49.45 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 108.574 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -61.42 -41.84 97.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.394 -0.816 . . . . 0.0 109.631 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -64.63 -46.15 83.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 0.0 109.871 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.32 -46.86 72.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.025 -1.047 . . . . 0.0 108.547 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 41' ' ' ARG . . . . . 0.632 ' CG ' HH11 ' C' ' 41' ' ' ARG . 0.0 OUTLIER -47.75 -53.71 14.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.0 -1.062 . . . . 0.0 109.087 178.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -57.56 -35.11 69.93 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.306 -0.871 . . . . 0.0 110.214 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -75.9 -35.69 59.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.508 -0.745 . . . . 0.0 109.706 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 4.7 t -73.55 -51.64 24.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.139 -0.975 . . . . 0.0 108.99 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -63.45 -29.13 70.46 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.205 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.77 -29.57 69.56 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -91.39 6.47 45.27 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.411 -0.805 . . . . 0.0 109.146 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.11 28.97 74.09 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.0 -1.571 . . . . 0.0 109.479 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.57 -164.11 14.18 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 5.6 tmm? -117.39 -37.55 3.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.947 . . . . 0.0 110.573 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 176.75 169.27 37.87 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 7.5 tp -95.64 132.78 40.44 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.348 -1.089 . . . . 0.0 109.836 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.531 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 1.1 pt -109.85 144.86 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.507 -0.746 . . . . 0.0 109.936 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 69.37 82.81 0.16 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 55' ' ' PHE . . . . . 0.43 ' H ' ' HA ' ' C' ' 11' ' ' THR . 90.1 t80 -114.73 85.55 2.27 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 56' ' ' ARG . . . . . 0.851 HH22 HH21 ' B' ' 56' ' ' ARG . 89.3 mtt180 -112.1 161.54 16.39 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.543 -0.723 . . . . 0.0 109.262 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 67.8 mt -139.21 80.37 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.443 -0.786 . . . . 0.0 108.934 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 58' ' ' THR . . . . . . . . . . . . . 70.9 p -74.46 -55.54 5.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 109.136 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 59' ' ' CYS . . . . . . . . . . . . . 73.3 m 49.7 -97.03 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.345 -0.847 . . . . 0.0 109.827 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . 57.13 34.03 24.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -160.22 -73.95 0.07 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.121 -0.987 . . . . 0.0 110.013 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 62' ' ' GLY . . . . . 0.465 ' O ' ' CE1' ' C' ' 64' ' ' PHE . . . -168.36 -77.53 0.04 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -55.13 143.53 26.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.846 -0.797 . . . . 0.0 109.997 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 64' ' ' PHE . . . . . 0.465 ' CE1' ' O ' ' C' ' 62' ' ' GLY . 32.7 m-85 -110.09 117.06 32.71 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 11.1 mt -118.59 109.22 15.9 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.87 0.843 . . . . 0.0 110.986 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.32 57.2 2.76 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -49.46 133.16 20.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.15 -1.206 . . . . 0.0 110.103 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.35 149.09 20.82 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 49.8 m -96.8 136.8 36.84 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.975 -1.309 . . . . 0.0 108.271 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 37.4 mt -83.83 139.72 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.8 m -126.31 165.04 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.306 -0.871 . . . . 0.0 109.913 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 72' ' ' LYS . . . . . 0.449 ' H ' ' H ' ' C' ' 21' ' ' TYR . 9.5 tttm -155.28 140.02 17.1 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.448 ' O ' ' CG ' ' C' ' 74' ' ' ASP . . . -116.58 115.06 25.03 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.895 -1.128 . . . . 0.0 110.674 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' C' ' 73' ' ' ALA . 3.0 m-20 -178.49 12.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.597 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 75' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -80.99 38.1 0.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 109.639 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.93 3.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.537 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 77' ' ' GLN . . . . . 0.409 ' O ' ' CG ' ' C' ' 78' ' ' PHE . 7.9 tp-100 -82.03 39.95 0.59 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.0 109.432 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 78' ' ' PHE . . . . . 0.409 ' CG ' ' O ' ' C' ' 77' ' ' GLN . 75.2 m-85 -155.49 53.63 0.61 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 109.304 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 28.7 p 47.87 83.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.27 -0.894 . . . . 0.0 109.526 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 23.8 mtt 55.2 -123.7 2.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.402 -0.811 . . . . 0.0 109.499 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.409 -179.937 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ptp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 2' ' ' ILE . . . . . . . . . . . . . 33.1 pt -83.59 -151.1 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.33 -0.856 . . . . 0.0 109.331 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -161.14 25.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.286 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 50.82 -146.13 0.46 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.317 -0.865 . . . . 0.0 109.553 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 5' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' D' ' 5' ' ' ASP . 3.7 m-20 60.33 3.9 0.61 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.445 -0.784 . . . . 0.0 109.97 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -88.7 72.74 8.63 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.074 -1.016 . . . . 0.0 109.192 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -94.3 124.95 38.63 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.362 -0.836 . . . . 0.0 109.807 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 75.5 mt -114.54 127.41 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.554 -0.716 . . . . 0.0 109.219 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 9' ' ' ILE . . . . . 0.709 HD11 ' CG ' ' D' ' 55' ' ' PHE . 17.0 tt -121.26 114.94 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.7 t -122.52 151.88 40.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.39 72.45 0.95 Allowed 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.555 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.31 -101.59 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.159 -1.588 . . . . 0.0 108.417 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -119.87 -154.6 0.58 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.414 -0.804 . . . . 0.0 109.614 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -78.68 -172.0 2.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.237 -0.914 . . . . 0.0 109.564 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 84.5 mt -120.35 93.68 48.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -61.58 155.62 52.17 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.716 1.611 . . . . 0.0 110.607 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.44 -9.63 75.64 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 71.7 mt -129.37 141.41 51.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.266 -1.137 . . . . 0.0 109.487 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -84.96 108.86 17.79 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 13.8 mt -91.4 133.82 35.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.896 -1.128 . . . . 0.0 110.145 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 21' ' ' TYR . . . . . 0.541 ' CE1' ' O ' ' D' ' 22' ' ' SER . 0.9 OUTLIER -120.82 130.67 54.06 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 22' ' ' SER . . . . . 0.541 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 0.0 OUTLIER -66.37 130.64 43.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.156 -0.965 . . . . 0.0 111.494 -179.018 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 14.0 mt -119.94 14.16 12.35 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.04 -174.46 15.21 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 46.7 mm -112.75 138.87 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 122.014 -0.698 . . . . 0.0 109.187 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.28 144.39 43.81 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.336 -0.853 . . . . 0.0 110.212 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 22.4 p -153.17 135.33 14.85 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 7.3 t -150.17 141.21 22.98 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.821 -1.175 . . . . 0.0 109.85 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.532 HD13 ' O ' ' D' ' 64' ' ' PHE . 1.4 tp -126.47 131.84 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.491 ' O ' ' O ' ' D' ' 31' ' ' ASP . 56.8 p -168.51 8.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.625 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 31' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' D' ' 30' ' ' SER . 36.9 t0 54.2 156.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.528 -0.733 . . . . 0.0 110.177 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 2.3 t-20 74.37 129.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.959 -1.088 . . . . 0.0 108.504 -178.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 33' ' ' VAL . . . . . 0.41 HG22 ' CD1' ' D' ' 57' ' ' ILE . 4.0 t -67.61 -35.55 73.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.424 -0.797 . . . . 0.0 109.587 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -59.06 -44.31 91.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.355 -0.841 . . . . 0.0 110.559 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -75.5 -37.47 60.14 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.958 -1.089 . . . . 0.0 109.517 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 83.5 mt -66.48 -42.09 89.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.914 -1.116 . . . . 0.0 109.513 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -65.46 -53.73 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.639 -1.288 . . . . 0.0 110.135 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -55.42 -35.52 65.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.293 -0.88 . . . . 0.0 109.433 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -66.55 -41.14 89.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.843 . . . . 0.0 109.813 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 17.4 mt -75.42 -51.07 13.94 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.883 -1.136 . . . . 0.0 108.815 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -48.85 -52.6 23.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.835 -1.165 . . . . 0.0 108.974 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 42' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' D' ' 46' ' ' ALA . 27.7 ttmt -59.81 -36.75 77.4 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.472 -0.768 . . . . 0.0 110.225 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -75.27 -35.77 61.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.122 -0.987 . . . . 0.0 110.003 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -74.38 -51.7 22.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.135 -0.978 . . . . 0.0 109.487 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -71.74 -34.57 69.64 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.451 -1.406 . . . . 0.0 109.812 -176.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' D' ' 42' ' ' LYS . . . -56.69 -30.81 63.82 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -92.63 -5.06 52.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.34 -0.85 . . . . 0.0 109.748 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.35 8.23 56.49 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.63 -173.6 4.52 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 50' ' ' MET . . . . . 0.435 ' SD ' ' C ' ' D' ' 50' ' ' MET . 0.0 OUTLIER -161.19 -23.37 0.05 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.091 -1.241 . . . . 0.0 110.885 176.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -137.32 146.8 18.75 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 52' ' ' LEU . . . . . 0.522 HD12 ' O ' ' D' ' 69' ' ' THR . 34.9 tp -137.12 146.17 44.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.678 -0.895 . . . . 0.0 109.289 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 53' ' ' ILE . . . . . 0.838 HD12 ' H ' ' D' ' 53' ' ' ILE . 0.1 OUTLIER -109.69 162.63 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.47 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.622 ' O ' ' CB ' ' D' ' 55' ' ' PHE . . . 65.81 -163.45 0.25 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.709 ' CG ' HD11 ' D' ' 9' ' ' ILE . 67.2 t80 134.19 -5.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 56' ' ' ARG . . . . . 0.704 ' NH1' HH22 ' E' ' 56' ' ' ARG . 16.6 ptm180 -51.21 145.81 7.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.3 -0.875 . . . . 0.0 109.805 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 57' ' ' ILE . . . . . 0.41 ' CD1' HG22 ' D' ' 33' ' ' VAL . 0.9 OUTLIER -126.52 140.11 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.479 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.59 95.86 1.95 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.905 . . . . 0.0 109.398 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 59' ' ' CYS . . . . . . . . . . . . . 25.7 p -102.01 135.57 43.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.406 -0.809 . . . . 0.0 108.974 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -146.72 125.27 12.44 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.203 -0.936 . . . . 0.0 109.701 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 49.65 -97.5 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.379 -0.826 . . . . 0.0 109.721 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.16 -172.7 0.73 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -77.98 -159.5 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.411 -1.052 . . . . 0.0 110.172 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 64' ' ' PHE . . . . . 0.667 ' CG ' ' N ' ' D' ' 65' ' ' LEU . 61.9 t80 -165.61 -179.2 5.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.352 -0.842 . . . . 0.0 109.328 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.667 ' N ' ' CG ' ' D' ' 64' ' ' PHE . 12.2 tp -164.0 105.24 0.9 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.069 -1.02 . . . . 0.0 111.006 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.09 179.73 1.09 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -154.11 138.89 17.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.05 -1.264 . . . . 0.0 109.401 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.21 166.03 35.61 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 69' ' ' THR . . . . . 0.568 ' CB ' ' HG1' ' C' ' 11' ' ' THR . 98.7 m -115.14 137.95 51.45 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.568 -0.96 . . . . 0.0 108.417 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 46.0 mt -87.16 126.42 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.94 -1.1 . . . . 0.0 108.326 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 71' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' D' ' 21' ' ' TYR . 3.5 m -137.97 162.97 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.337 -0.852 . . . . 0.0 110.22 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -153.52 154.11 33.69 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.468 ' O ' ' CB ' ' D' ' 74' ' ' ASP . . . -121.15 115.41 23.02 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.548 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 74' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' D' ' 73' ' ' ALA . 2.0 m-20 159.79 -102.02 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -173.03 138.23 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.68 157.74 34.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.105 -0.997 . . . . 0.0 108.663 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -64.83 -2.86 2.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.521 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 78' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -76.61 88.24 3.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.94 . . . . 0.0 109.323 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 79' ' ' THR . . . . . 0.456 HG23 ' N ' ' D' ' 80' ' ' MET . 9.5 t -163.44 -39.59 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.902 . . . . 0.0 109.516 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 80' ' ' MET . . . . . 0.456 ' N ' HG23 ' D' ' 79' ' ' THR . 21.7 ttt -162.77 -30.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 109.503 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 117.887 -1.054 . . . . 0.0 109.71 -179.968 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 2.2 tpt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 2' ' ' ILE . . . . . 0.439 ' O ' ' CG ' ' E' ' 3' ' ' PHE . 3.2 tt -166.47 117.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.297 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 3' ' ' PHE . . . . . 0.439 ' CG ' ' O ' ' E' ' 2' ' ' ILE . 85.1 m-85 -154.46 17.73 0.47 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.011 -1.055 . . . . 0.0 109.182 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 4' ' ' GLU . . . . . 0.422 ' CD ' ' N ' ' E' ' 4' ' ' GLU . 10.9 mp0 -67.72 -13.38 62.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.873 . . . . 0.0 109.27 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 5' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -72.25 111.62 7.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.304 -0.873 . . . . 0.0 109.37 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -103.03 -79.1 0.54 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.351 -0.843 . . . . 0.0 109.286 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -112.17 119.71 39.31 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.363 -0.836 . . . . 0.0 109.595 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 69.8 mt -100.85 128.18 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.396 -0.815 . . . . 0.0 109.77 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 9' ' ' ILE . . . . . 0.676 HD11 ' CG ' ' E' ' 55' ' ' PHE . 11.3 tt -128.42 115.03 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 1.7 t -125.41 157.47 36.76 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.902 0.858 . . . . 0.0 109.11 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.97 92.58 3.79 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.99 -150.87 0.06 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.194 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 13' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' E' ' 14' ' ' GLU . 1.7 p-10 -76.63 -72.52 0.33 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.214 -0.929 . . . . 0.0 109.551 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 14' ' ' GLU . . . . . 0.454 ' H ' ' CG ' ' E' ' 13' ' ' ASP . 13.8 pt-20 -153.44 -166.95 2.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.168 -0.958 . . . . 0.0 109.291 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 52.9 mt -121.45 88.34 46.1 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.14 156.18 51.78 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 121.791 1.66 . . . . 0.0 110.641 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.97 -5.92 76.2 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 18' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' E' ' 18' ' ' LEU . 37.9 mt -129.34 139.86 51.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.286 -1.126 . . . . 0.0 109.971 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -84.23 108.53 17.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 14.2 mt -101.91 136.54 41.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.344 -0.848 . . . . 0.0 110.304 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 21' ' ' TYR . . . . . 0.55 ' CE1' ' O ' ' E' ' 22' ' ' SER . 0.4 OUTLIER -120.57 129.91 53.98 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 22' ' ' SER . . . . . 0.55 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 13.4 t -56.74 130.16 44.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 111.668 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 11.9 mt -119.22 5.62 11.23 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.39 -179.19 16.68 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.09 145.33 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 122.033 -0.687 . . . . 0.0 109.263 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.25 159.68 22.28 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.645 -0.659 . . . . 0.0 109.348 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 89.3 p -153.11 143.6 22.59 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 28' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' E' ' 65' ' ' LEU . 11.2 p -142.93 134.47 26.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.183 -0.948 . . . . 0.0 111.02 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.513 ' O ' ' CB ' ' E' ' 30' ' ' SER . 2.1 mm -125.63 126.39 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' E' ' 29' ' ' ILE . 3.3 m 157.09 16.12 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 31' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' E' ' 32' ' ' ASN . 1.0 OUTLIER 51.5 -174.08 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.006 -1.059 . . . . 0.0 108.892 -179.082 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 32' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 9.2 t-20 73.48 94.3 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 33' ' ' VAL . . . . . 0.49 ' H ' HG13 ' E' ' 33' ' ' VAL . 0.7 OUTLIER -70.78 -42.98 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.309 -0.869 . . . . 0.0 108.993 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 34' ' ' ASP . . . . . 0.408 ' N ' ' CG2' ' E' ' 33' ' ' VAL . 43.1 t0 -58.39 -44.19 88.83 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.388 -0.82 . . . . 0.0 110.771 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 35' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' E' ' 39' ' ' ASN . 62.1 mm-40 -70.03 -37.05 75.48 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.95 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 37.8 mt -61.64 -41.36 90.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.149 -0.97 . . . . 0.0 108.886 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 48.4 t -55.16 -51.58 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.941 -1.099 . . . . 0.0 108.778 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -59.1 -39.2 81.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.347 -0.846 . . . . 0.0 109.541 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 39' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' E' ' 35' ' ' GLU . 34.0 m120 -63.42 -42.11 98.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 109.508 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 40' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' E' ' 40' ' ' LEU . 74.5 mt -73.36 -50.03 24.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.132 -0.98 . . . . 0.0 108.962 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -48.93 -48.31 42.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.756 -1.215 . . . . 0.0 108.993 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -63.36 -37.4 87.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.582 -0.699 . . . . 0.0 109.935 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -75.6 -35.55 60.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.267 -0.896 . . . . 0.0 109.66 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 13.2 t -70.74 -51.44 36.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.308 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -71.21 -35.34 71.49 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.294 -176.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.63 -30.61 67.42 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -92.14 -5.44 52.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.364 -0.835 . . . . 0.0 109.871 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.63 11.82 46.18 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.61 159.28 33.16 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.26 -6.19 5.4 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.27 -1.135 . . . . 0.0 110.521 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -152.24 164.21 30.45 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 6.9 tp -136.95 143.45 42.87 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.405 -1.056 . . . . 0.0 109.516 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 53' ' ' ILE . . . . . 0.655 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 4.8 mt -113.6 151.66 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 88.7 -144.58 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 55' ' ' PHE . . . . . 0.676 ' CG ' HD11 ' E' ' 9' ' ' ILE . 62.9 t80 104.87 11.96 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 120.726 1.603 . . . . 0.0 107.607 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 56' ' ' ARG . . . . . 0.704 HH22 ' NH1' ' D' ' 56' ' ' ARG . 73.8 mtm180 -69.16 124.73 24.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.354 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 57' ' ' ILE . . . . . 0.577 HG22 ' N ' ' E' ' 58' ' ' THR . 88.3 mt -124.92 166.03 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.516 -0.74 . . . . 0.0 109.292 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 58' ' ' THR . . . . . 0.577 ' N ' HG22 ' E' ' 57' ' ' ILE . 3.2 m -144.79 3.38 1.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.282 -0.886 . . . . 0.0 109.063 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 59' ' ' CYS . . . . . 0.517 ' H ' HG22 ' E' ' 57' ' ' ILE . 92.2 m 51.87 25.88 3.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.575 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.46 -121.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.337 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -170.16 29.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.228 -0.92 . . . . 0.0 109.395 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.36 -20.64 0.09 OUTLIER Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.012 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -76.62 -110.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.072 -1.252 . . . . 0.0 108.536 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 64' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -56.23 174.54 0.13 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.972 . . . . 0.0 108.929 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.775 ' N ' HD23 ' E' ' 65' ' ' LEU . 1.6 pt? -161.65 -35.3 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.129 -0.982 . . . . 0.0 110.257 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 66' ' ' GLY . . . . . . . . . . . . . . . 130.19 65.87 0.1 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 107.692 -2.163 . . . . 0.0 107.692 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 67' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' E' ' 67' ' ' TYR . 18.4 p90 -118.08 176.98 4.96 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.141 -1.211 . . . . 0.0 110.292 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.66 157.97 14.71 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 93.6 m -90.52 134.6 34.25 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.038 -1.272 . . . . 0.0 107.691 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 58.6 mt -90.23 137.91 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 71' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' E' ' 21' ' ' TYR . 3.2 m -144.17 163.92 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.26 -0.9 . . . . 0.0 110.766 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -148.01 152.61 37.74 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.18 152.55 33.5 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.327 -0.858 . . . . 0.0 108.727 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 57.37 -99.43 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 110.094 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -138.12 161.44 36.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.351 -0.843 . . . . 0.0 109.48 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 76' ' ' ALA . . . . . 0.454 ' C ' ' H ' ' E' ' 78' ' ' PHE . . . -57.09 -164.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.511 -0.743 . . . . 0.0 109.202 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 77' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -74.94 36.5 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.285 -0.884 . . . . 0.0 109.174 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 78' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' E' ' 76' ' ' ALA . 94.7 m-85 51.69 16.14 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.335 -0.853 . . . . 0.0 109.813 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 66.9 p 44.29 -119.78 0.7 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.465 -0.772 . . . . 0.0 109.733 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 45.8 mtt -81.96 147.98 28.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 0.0 109.207 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.462 -179.941 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.429 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.354 0.597 . . . . 0.0 109.399 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.9 tt -71.63 -31.75 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.243 -0.911 . . . . 0.0 109.409 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -160.52 0.17 0.07 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.176 -0.953 . . . . 0.0 109.474 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 64.48 55.0 1.41 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -127.15 -153.82 0.59 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.301 -0.874 . . . . 0.0 109.113 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -161.24 76.99 0.55 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.329 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -99.37 122.26 42.25 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.478 -0.764 . . . . 0.0 109.358 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 70.0 mt -112.17 140.02 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.518 -0.739 . . . . 0.0 110.009 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 9' ' ' ILE . 5.8 tt -137.61 115.88 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.446 -0.784 . . . . 0.0 108.923 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -123.49 158.38 31.4 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.27 121.02 32.84 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.75 47.34 20.62 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.994 0.902 . . . . 0.0 109.624 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -167.4 94.77 0.45 Allowed 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.404 0.621 . . . . 0.0 109.445 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -61.24 -178.2 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.263 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.7 mt -123.67 87.9 52.22 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.51 -0.744 . . . . 0.0 109.085 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -61.1 156.02 47.29 Favored 'Trans proline' 0 C--N 1.321 -0.888 0 C-N-CA 121.905 1.736 . . . . 0.0 110.222 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.64 -11.76 71.37 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.2 mt -126.79 137.64 53.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.143 -1.21 . . . . 0.0 108.734 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.728 ' NE2' ' H ' ' A' ' 74' ' ' ASP . 1.2 pp0? -87.62 118.47 27.12 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.4 mt -101.46 128.35 47.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.131 -0.98 . . . . 0.0 109.587 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' A' ' 22' ' ' SER . 2.3 t80 -115.21 129.95 56.78 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.531 ' O ' ' CE1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -85.57 130.26 34.62 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.408 -0.808 . . . . 0.0 110.353 -179.719 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.942 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -118.94 19.44 13.03 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 137.33 172.42 12.53 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.98 145.14 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.11 147.45 37.29 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.623 -0.673 . . . . 0.0 109.315 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.5 p -151.48 135.55 16.63 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.63 150.56 34.64 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.044 -1.035 . . . . 0.0 108.766 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.21 129.45 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 83.8 p -169.37 175.95 5.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 109.126 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.429 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 3.2 m-20 -101.94 146.91 27.2 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.297 -0.877 . . . . 0.0 110.152 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 13.2 m-20 77.63 128.95 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.566 -0.708 . . . . 0.0 109.259 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.98 -31.09 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.593 -0.692 . . . . 0.0 109.36 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -56.22 -40.24 73.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.299 -0.876 . . . . 0.0 109.712 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.402 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 1.1 mp0 -76.23 -40.28 52.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.324 -0.86 . . . . 0.0 109.277 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.3 mt -62.22 -50.53 79.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.896 -1.127 . . . . 0.0 108.847 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.0 t -66.63 -49.45 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.11 -0.994 . . . . 0.0 109.473 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.53 -40.71 88.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.0 109.601 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 35' ' ' GLU . 15.9 m120 -64.13 -41.33 97.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 109.321 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 40' ' ' LEU . 29.4 mt -68.23 -44.24 76.18 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.15 -0.969 . . . . 0.0 109.128 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -48.92 -42.77 38.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.572 -1.33 . . . . 0.0 109.436 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -69.94 -38.02 76.05 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.493 0.663 . . . . 0.0 110.102 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -77.32 -35.04 55.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.492 -0.755 . . . . 0.0 110.057 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.83 -52.07 31.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.027 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -66.59 -29.53 69.6 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.215 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.49 -28.6 68.69 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.626 0.727 . . . . 0.0 109.048 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -90.22 -5.65 56.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.564 -0.71 . . . . 0.0 109.558 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.5 4.37 58.24 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.84 161.93 48.24 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -129.58 -2.35 4.85 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.303 -1.116 . . . . 0.0 110.303 -177.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.8 166.48 39.68 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.308 -1.425 . . . . 0.0 109.685 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 tp -125.16 143.63 50.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.665 -0.903 . . . . 0.0 109.655 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.801 HD13 ' O ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -117.73 148.71 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.625 -0.672 . . . . 0.0 110.072 -178.228 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.22 68.78 0.74 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.897 -1.127 . . . . 0.0 110.125 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -107.29 54.56 0.67 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.671 ' NH1' HH22 ' E' ' 56' ' ' ARG . 1.7 ttt-85 -80.18 152.96 28.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.302 -0.874 . . . . 0.0 109.634 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.4 mt -131.21 152.93 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 m -138.45 66.05 1.44 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.375 -0.828 . . . . 0.0 109.155 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.8 p -169.64 -172.5 1.43 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 0.0 109.468 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.54 -131.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.306 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.13 -44.55 83.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.937 . . . . 0.0 109.452 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.64 -129.74 1.4 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm 54.09 51.17 15.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 109.254 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -143.18 -82.09 0.18 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.279 -0.888 . . . . 0.0 109.354 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.5 tp -176.11 120.61 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 109.524 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.9 74.61 0.21 Allowed Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -74.08 153.9 39.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.176 -1.191 . . . . 0.0 110.083 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.58 153.23 17.07 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.427 ' OG1' ' OG1' ' E' ' 11' ' ' THR . 96.8 m -105.71 138.26 42.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.304 -1.115 . . . . 0.0 108.964 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 50.4 mt -83.01 137.32 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.4 m -140.66 159.05 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.247 -0.908 . . . . 0.0 109.701 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -153.69 159.09 41.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.296 -0.878 . . . . 0.0 109.052 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.519 ' O ' ' CG ' ' A' ' 74' ' ' ASP . . . -114.83 114.17 25.18 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.227 -0.921 . . . . 0.0 110.756 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.728 ' H ' ' NE2' ' A' ' 19' ' ' GLN . 20.5 m-20 -170.69 -129.3 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.424 ' H ' ' HB3' ' A' ' 74' ' ' ASP . 15.7 tt0 67.42 -49.21 0.5 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.203 -0.936 . . . . 0.0 109.855 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 74' ' ' ASP . . . -54.39 173.28 0.08 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.229 -0.919 . . . . 0.0 109.572 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -148.53 -159.29 1.01 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.363 -0.836 . . . . 0.0 109.374 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -159.71 130.25 5.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 109.373 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.8 m -162.27 87.55 0.63 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.911 . . . . 0.0 109.441 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 10.0 ttt -95.21 25.52 4.26 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.244 -0.91 . . . . 0.0 109.226 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.382 180.0 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.564 ' C ' HD12 ' B' ' 2' ' ' ILE . 2.6 pp -118.66 -178.04 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -147.01 -83.16 0.12 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.306 -0.871 . . . . 0.0 108.931 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -58.59 134.33 56.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.93 . . . . 0.0 109.517 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.56 -51.53 3.18 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.557 -0.715 . . . . 0.0 109.435 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' B' ' 50' ' ' MET . 25.2 ttmt -158.42 87.67 0.91 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 109.416 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -109.91 122.34 47.31 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 93.8 mt -132.87 129.96 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.386 -0.821 . . . . 0.0 109.754 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.602 ' O ' HG23 ' B' ' 9' ' ' ILE . 10.9 tt -133.01 116.36 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.2 t -123.9 152.78 42.01 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 0.8 OUTLIER -103.01 74.76 1.33 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' B' ' 11' ' ' THR . . . 176.97 -116.18 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 176.98 54.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -129.38 104.44 7.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.39 -0.819 . . . . 0.0 109.605 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.752 HG22 ' O ' ' B' ' 15' ' ' ILE . 6.2 mm -140.61 53.04 3.62 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.346 -0.847 . . . . 0.0 108.915 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.628 ' HD3' ' N ' ' B' ' 15' ' ' ILE . 1.8 Cg_endo -64.07 155.49 64.41 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.531 1.487 . . . . 0.0 110.196 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.12 -11.71 71.43 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 79.8 mt -128.24 139.5 52.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.01 -1.288 . . . . 0.0 109.035 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -85.51 108.86 18.12 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.427 HD11 ' HB ' ' B' ' 15' ' ' ILE . 13.4 mt -89.84 132.63 35.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 110.348 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' TYR . . . . . 0.54 ' CE1' ' O ' ' B' ' 22' ' ' SER . 0.4 OUTLIER -112.38 129.29 56.36 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.54 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 36.2 t -71.73 118.25 14.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.793 -1.192 . . . . 0.0 109.336 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' B' ' 72' ' ' LYS . 5.8 mt -94.69 -4.57 47.29 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.42 -163.4 24.03 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -122.39 141.76 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.407 ' HB2' HD11 ' B' ' 70' ' ' ILE . . . -113.54 144.81 42.23 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.567 -0.708 . . . . 0.0 109.275 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 3.0 t -151.77 137.88 18.28 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -148.92 141.76 24.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.013 -1.054 . . . . 0.0 109.247 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 tp -104.8 127.93 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.287 -0.883 . . . . 0.0 109.213 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 15.5 t -171.19 169.79 6.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.918 . . . . 0.0 109.053 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 2.7 p-10 -110.16 158.78 17.98 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.507 -0.746 . . . . 0.0 109.215 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 2.2 m120 75.97 129.55 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.97 -32.86 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.488 -0.757 . . . . 0.0 109.306 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.96 -42.15 89.2 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.282 -0.886 . . . . 0.0 109.773 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -75.73 -41.4 53.54 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.225 -0.922 . . . . 0.0 109.516 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.79 -43.05 98.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 120.858 -1.151 . . . . 0.0 108.923 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.21 -50.78 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.768 -1.208 . . . . 0.0 109.497 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -59.01 -39.51 82.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.339 -0.851 . . . . 0.0 109.513 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -61.65 -46.12 91.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.639 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' B' ' 40' ' ' LEU . 28.6 mt -70.74 -46.83 62.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.105 -0.997 . . . . 0.0 108.986 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -48.57 -44.54 36.84 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.695 -1.253 . . . . 0.0 109.405 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -67.97 -38.4 82.69 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.559 0.695 . . . . 0.0 110.242 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -77.54 -34.11 54.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.395 -0.816 . . . . 0.0 110.183 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.796 ' O ' ' N ' ' B' ' 48' ' ' GLY . 2.3 t -70.03 -51.67 37.54 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.946 0 O-C-N 121.148 -0.97 . . . . 0.0 109.812 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -60.11 -31.39 69.99 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 119.666 -1.896 . . . . 0.0 110.328 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.7 -37.22 56.49 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.009 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.4 -12.92 11.01 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.549 -0.719 . . . . 0.0 109.923 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' GLY . . . . . 0.796 ' N ' ' O ' ' B' ' 44' ' ' VAL . . . -105.8 -45.75 1.26 Allowed Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.96 -35.23 0.29 Allowed Glycine 0 C--N 1.289 -2.066 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.156 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' MET . . . . . 0.456 ' H ' ' C ' ' B' ' 48' ' ' GLY . 0.0 OUTLIER -96.44 -75.08 0.54 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 119.253 1.527 . . . . 0.0 109.886 -179.313 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.37 -153.58 10.77 Favored Glycine 0 C--N 1.288 -2.104 0 C-N-CA 118.288 -1.91 . . . . 0.0 109.425 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.2 tp -133.11 139.13 46.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.696 -0.885 . . . . 0.0 109.682 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.466 ' O ' ' HB3' ' B' ' 54' ' ' ALA . 1.7 pt -111.82 145.53 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.658 -0.651 . . . . 0.0 109.913 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 63.92 72.45 0.46 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.121 -0.987 . . . . 0.0 109.337 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.558 ' CG ' ' O ' ' B' ' 55' ' ' PHE . 60.4 t80 -101.51 33.65 2.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.37 -0.831 . . . . 0.0 108.917 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.795 ' HG3' HH11 ' B' ' 56' ' ' ARG . 0.0 OUTLIER -59.51 122.98 15.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.982 -1.074 . . . . 0.0 109.34 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 91.2 mt -75.59 150.12 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 80.8 p -73.97 -119.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.318 -0.863 . . . . 0.0 109.413 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' B' ' 60' ' ' ALA . 47.0 t -67.26 -116.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.925 . . . . 0.0 109.638 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.424 ' N ' ' SG ' ' B' ' 59' ' ' CYS . . . -64.81 -156.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.164 -0.96 . . . . 0.0 109.608 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -51.98 -18.05 1.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.216 -0.928 . . . . 0.0 109.244 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' GLY . . . . . 0.446 ' C ' ' N ' ' B' ' 64' ' ' PHE . . . 171.34 -96.97 0.11 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 mttm 50.1 12.88 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.477 -1.013 . . . . 0.0 109.692 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.446 ' N ' ' C ' ' B' ' 62' ' ' GLY . 7.2 m-85 -139.33 -76.07 0.35 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.357 -0.839 . . . . 0.0 108.872 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' B' ' 64' ' ' PHE . 20.7 tp 172.78 120.3 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.694 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.78 165.05 33.12 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -167.13 179.83 4.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.04 -1.271 . . . . 0.0 110.209 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.09 169.63 35.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 50.4 m -100.66 132.94 45.79 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.123 -1.222 . . . . 0.0 108.037 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.498 HG22 ' HA2' ' B' ' 48' ' ' GLY . 3.0 mt -87.82 145.44 7.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 5.9 m -146.29 166.06 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.886 -1.134 . . . . 0.0 111.01 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.537 ' HB2' HD11 ' B' ' 23' ' ' LEU . 0.4 OUTLIER -146.55 156.25 43.1 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.728 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.45 ' O ' ' OD1' ' B' ' 74' ' ' ASP . . . -116.57 116.02 26.83 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.72 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' B' ' 73' ' ' ALA . 0.1 OUTLIER 175.41 168.79 0.34 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -178.286 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 75' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -60.26 92.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.413 -0.804 . . . . 0.0 109.17 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' B' ' 78' ' ' PHE . . . -81.76 -167.82 1.66 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.278 -0.889 . . . . 0.0 108.905 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 53.96 -82.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.592 -0.692 . . . . 0.0 109.692 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' PHE . . . . . 0.558 ' N ' ' O ' ' B' ' 76' ' ' ALA . 19.5 m-85 -72.98 55.16 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 0.0 109.479 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 29.1 m -73.66 128.62 36.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 109.506 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' MET . . . . . . . . . . . . . 21.0 mmt 49.58 80.98 0.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 109.606 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.568 -179.952 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 1' ' ' MET . . . . . 0.461 ' N ' ' SD ' ' C' ' 1' ' ' MET . 2.3 mpt? . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 18.1 tt -161.65 6.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.909 . . . . 0.0 109.227 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 59.49 176.81 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.103 -0.998 . . . . 0.0 109.262 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -142.55 8.04 1.74 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.283 -0.885 . . . . 0.0 109.283 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -99.79 9.27 43.32 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.312 -0.867 . . . . 0.0 109.42 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? -73.93 84.56 1.73 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.304 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -105.78 120.66 42.26 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.099 -1.001 . . . . 0.0 109.126 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 17.7 mt -116.39 143.01 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 9' ' ' ILE . . . . . 0.456 ' O ' HG23 ' C' ' 9' ' ' ILE . 7.2 tt -112.96 124.62 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.93 131.28 55.16 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.44 -0.787 . . . . 0.0 109.369 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 11' ' ' THR . . . . . 0.487 ' HG1' HD11 ' D' ' 25' ' ' ILE . 1.6 m -121.3 114.37 21.25 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.42 34.56 24.45 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.301 -0.875 . . . . 0.0 109.653 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -153.36 95.49 1.93 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.708 -0.62 . . . . 0.0 109.505 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -67.31 176.82 2.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.086 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 51.4 mt -127.04 81.68 69.47 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.485 -0.759 . . . . 0.0 109.095 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.31 156.78 38.78 Favored 'Trans proline' 0 C--N 1.322 -0.83 0 C-N-CA 121.964 1.776 . . . . 0.0 110.119 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.17 -4.54 74.37 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.307 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 18' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' C' ' 18' ' ' LEU . 25.7 mt -126.78 137.48 53.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.105 -1.232 . . . . 0.0 109.17 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -86.77 108.28 18.64 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 12.8 mt -92.36 132.97 36.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 109.462 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 21' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' C' ' 71' ' ' VAL . 1.2 t80 -114.73 129.37 56.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.363 -0.835 . . . . 0.0 108.755 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 22' ' ' SER . . . . . 0.436 ' O ' ' CE1' ' C' ' 21' ' ' TYR . 8.2 t -61.97 127.68 32.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.899 -1.126 . . . . 0.0 111.624 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' C' ' 23' ' ' LEU . 14.2 mt -113.47 9.13 18.03 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.71 -174.52 15.34 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 177.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.57 139.76 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.651 -0.911 . . . . 0.0 109.584 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.47 146.84 44.19 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.693 -0.63 . . . . 0.0 109.92 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 4.7 t -151.91 139.23 19.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.154 -0.966 . . . . 0.0 108.688 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.77 140.28 22.46 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.962 -1.086 . . . . 0.0 109.641 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 7.1 tp -95.66 147.9 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.999 -1.063 . . . . 0.0 108.602 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.501 ' OG ' ' N ' ' C' ' 31' ' ' ASP . 27.1 t -169.3 -168.24 0.8 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.112 -0.992 . . . . 0.0 109.12 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 31' ' ' ASP . . . . . 0.501 ' N ' ' OG ' ' C' ' 30' ' ' SER . 19.4 t0 -109.72 -80.64 0.58 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.352 -0.843 . . . . 0.0 111.667 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -75.98 159.66 30.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.909 -1.12 . . . . 0.0 109.434 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.33 -31.44 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 CA-C-O 121.241 0.543 . . . . 0.0 109.591 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.5 -37.85 65.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.65 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 35' ' ' GLU . . . . . 0.492 ' O ' ' ND2' ' C' ' 39' ' ' ASN . 12.2 mm-40 -76.38 -36.22 58.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.35 -0.844 . . . . 0.0 109.019 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 82.9 mt -61.78 -51.98 66.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 120.984 -1.073 . . . . 0.0 109.539 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 51.4 t -57.65 -48.11 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.086 -1.009 . . . . 0.0 108.985 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -63.49 -43.89 95.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.652 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' C' ' 35' ' ' GLU . 2.5 m-80 -58.27 -48.63 79.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.13 -0.981 . . . . 0.0 109.47 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 55.5 mt -68.98 -44.22 73.33 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.736 -1.227 . . . . 0.0 108.76 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -50.97 -46.18 61.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.773 -1.205 . . . . 0.0 109.445 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -61.87 -34.66 76.4 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.516 -0.874 . . . . 0.0 108.967 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -70.76 -36.09 72.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.447 -0.783 . . . . 0.0 108.971 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 51.5 t -72.89 -49.29 40.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.89 -1.131 . . . . 0.0 109.155 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -49.36 -34.23 15.53 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.448 1.118 . . . . 0.0 110.505 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.84 -28.55 50.2 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.573 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -94.62 9.53 38.36 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.89 30.73 30.21 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 118.355 -1.879 . . . . 0.0 109.534 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.35 -162.44 8.81 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -115.07 -35.66 4.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.44 -1.036 . . . . 0.0 110.424 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.19 179.73 40.32 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 tp -101.36 138.33 38.52 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.427 -1.043 . . . . 0.0 109.786 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.45 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 1.3 pt -113.97 144.38 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.528 -0.732 . . . . 0.0 110.149 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 62.72 62.45 1.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -0.88 . . . . 0.0 109.236 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -92.99 66.0 4.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.958 -1.089 . . . . 0.0 108.448 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 56' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -72.68 149.66 43.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.5 -0.75 . . . . 0.0 110.032 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 59.0 mt -125.52 -43.84 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 58' ' ' THR . . . . . 0.812 HG21 ' HE ' ' D' ' 56' ' ' ARG . 88.8 m -73.99 176.51 6.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.878 . . . . 0.0 109.047 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 59' ' ' CYS . . . . . 0.676 ' N ' HG22 ' C' ' 58' ' ' THR . 41.6 t 49.61 -85.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.421 -0.799 . . . . 0.0 109.0 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.609 ' N ' ' O ' ' C' ' 58' ' ' THR . . . -78.62 146.31 34.2 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 61' ' ' ASP . . . . . 0.477 ' CG ' ' O ' ' C' ' 61' ' ' ASP . 6.7 t0 53.36 51.86 14.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.16 -0.963 . . . . 0.0 109.252 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.27 75.16 0.19 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' C' ' 61' ' ' ASP . 34.2 ttpt 53.59 69.38 0.71 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.64 -0.918 . . . . 0.0 109.473 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -160.93 -26.84 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.391 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 17.3 tp -178.4 117.09 0.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.449 -0.782 . . . . 0.0 109.326 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.69 152.59 24.17 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -158.15 -175.07 5.14 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.214 -1.168 . . . . 0.0 109.885 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.92 -173.25 44.03 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 29.3 m -119.46 134.05 55.4 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 45.2 mt -82.56 146.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 71' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' C' ' 21' ' ' TYR . 4.6 m -139.83 164.06 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.392 -0.817 . . . . 0.0 110.225 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -142.34 154.61 44.81 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.36 116.21 29.32 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.843 0.83 . . . . 0.0 111.239 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -167.58 -114.46 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 75' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 52.56 87.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.235 -0.916 . . . . 0.0 109.323 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -165.44 168.11 16.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 0.0 109.13 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 77' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -124.23 156.84 36.13 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.497 -0.752 . . . . 0.0 109.351 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -58.94 147.97 32.19 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.341 -0.85 . . . . 0.0 109.562 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 76.4 p -71.08 166.42 21.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 109.421 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -17.44 64.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.496 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.518 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 2' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' D' ' 3' ' ' PHE . 1.1 pt -145.56 -87.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.264 -0.898 . . . . 0.0 109.025 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 3' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' D' ' 2' ' ' ILE . 0.2 OUTLIER 62.37 148.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.56 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 4' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' D' ' 3' ' ' PHE . 61.0 mt-10 40.85 -147.29 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.133 -0.98 . . . . 0.0 110.184 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 5' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -125.99 159.85 31.6 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.536 -0.728 . . . . 0.0 109.107 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -71.03 85.35 0.71 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 109.55 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -96.43 128.85 43.73 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.212 -0.93 . . . . 0.0 109.611 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 62.8 mt -128.14 141.99 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.543 -0.723 . . . . 0.0 109.095 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 9' ' ' ILE . . . . . 0.405 ' O ' HG23 ' D' ' 9' ' ' ILE . 10.1 tt -114.97 117.36 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.16 131.83 54.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.934 -1.104 . . . . 0.0 108.971 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 11' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' D' ' 12' ' ' ALA . 3.4 m -104.02 98.0 7.89 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 12' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' D' ' 11' ' ' THR . . . 61.89 65.12 0.94 Allowed 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.948 0.88 . . . . 0.0 110.068 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -132.97 -141.44 0.2 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -169.44 -31.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 109.389 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 28.7 mt 50.21 67.14 4.67 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.185 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.85 156.41 48.88 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 C-N-CA 122.122 1.881 . . . . 0.0 110.126 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.5 -4.01 72.54 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.612 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 29.0 mt -125.16 135.83 53.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.872 -1.369 . . . . 0.0 108.967 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -86.38 112.49 21.5 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 11.9 mt -95.59 133.68 39.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.044 -1.035 . . . . 0.0 109.807 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 21' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' D' ' 22' ' ' SER . 4.4 t80 -122.45 129.97 52.59 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 22' ' ' SER . . . . . 0.433 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 48.2 t -85.84 129.63 34.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.573 -0.704 . . . . 0.0 110.97 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.919 HD23 ' N ' ' D' ' 23' ' ' LEU . 0.3 OUTLIER -119.4 13.31 12.66 Favored 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 122.235 1.017 . . . . 0.0 108.483 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 143.26 170.29 12.98 Favored Glycine 0 N--CA 1.49 2.298 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.026 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 25' ' ' ILE . . . . . 0.487 HD11 ' HG1' ' C' ' 11' ' ' THR . 0.7 OUTLIER -109.39 142.69 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.389 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 26' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' D' ' 67' ' ' TYR . . . -114.22 148.21 37.73 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 89.4 p -152.09 141.55 21.63 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 14.9 t -149.67 140.84 23.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.157 -0.965 . . . . 0.0 109.044 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 tt -115.7 129.81 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 90.1 p -177.26 -131.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.545 -0.722 . . . . 0.0 109.257 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 31' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' D' ' 32' ' ' ASN . 15.1 p-10 -166.51 169.69 13.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.211 -0.931 . . . . 0.0 109.471 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 6.8 t-20 73.65 127.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 0.0 108.666 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 22.9 t -68.88 -35.09 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.379 -0.826 . . . . 0.0 109.656 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 34' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' D' ' 35' ' ' GLU . 0.9 OUTLIER -59.21 -45.11 91.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.85 -179.509 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 35' ' ' GLU . . . . . 0.463 ' N ' ' OD1' ' D' ' 34' ' ' ASP . 55.2 mm-40 -75.25 -40.11 59.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.185 -0.947 . . . . 0.0 109.413 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.79 -53.17 50.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.962 -1.087 . . . . 0.0 109.482 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 44.3 t -61.49 -47.81 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.056 -1.027 . . . . 0.0 109.211 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -61.45 -41.98 98.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.691 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -58.54 -46.66 86.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 109.474 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' D' ' 40' ' ' LEU . 47.7 mt -71.4 -46.89 59.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.175 -0.953 . . . . 0.0 109.007 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -49.9 -44.99 50.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.816 -1.177 . . . . 0.0 109.172 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -63.31 -34.61 78.07 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.057 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -73.92 -36.9 64.75 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.324 -0.86 . . . . 0.0 109.328 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 t -73.4 -51.21 26.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.792 -1.193 . . . . 0.0 108.887 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.92 -33.42 37.08 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.73 1.253 . . . . 0.0 110.098 -177.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.82 -30.33 51.08 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.837 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -92.2 4.2 53.73 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.77 26.44 62.74 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 118.492 -1.813 . . . . 0.0 109.359 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.38 -167.67 13.37 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 9.9 ttp -107.38 -43.47 4.55 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.499 -1.0 . . . . 0.0 109.706 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 173.55 -152.79 16.13 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 tp -131.81 142.34 49.7 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.446 -1.032 . . . . 0.0 109.716 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 53' ' ' ILE . . . . . 1.035 HD12 ' H ' ' D' ' 53' ' ' ILE . 0.0 OUTLIER -113.98 147.4 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.598 -0.689 . . . . 0.0 110.181 -178.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 84.08 -54.63 0.13 Allowed 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 118.683 0.674 . . . . 0.0 111.607 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.601 ' O ' ' O ' ' D' ' 54' ' ' ALA . 50.4 t80 43.03 -179.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 56' ' ' ARG . . . . . 0.812 ' HE ' HG21 ' C' ' 58' ' ' THR . 1.6 mmm180 174.22 144.57 0.05 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.461 -1.4 . . . . 0.0 109.139 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 57' ' ' ILE . . . . . 0.436 HG21 HD13 ' E' ' 65' ' ' LEU . 15.4 mm -83.24 145.82 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 109.045 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 58' ' ' THR . . . . . . . . . . . . . 82.6 p -79.57 -124.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.406 -0.809 . . . . 0.0 109.257 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 59' ' ' CYS . . . . . . . . . . . . . 26.0 p -165.94 -163.63 0.64 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 109.392 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.66 -65.61 0.66 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -80.13 -117.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.556 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . -150.56 54.07 0.49 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.94 -34.01 21.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.334 -1.098 . . . . 0.0 109.616 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -115.29 138.86 50.5 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.555 -0.716 . . . . 0.0 109.357 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.406 ' N ' HD12 ' D' ' 65' ' ' LEU . 6.2 mp -106.69 162.32 13.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.504 -0.747 . . . . 0.0 109.054 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.58 41.14 2.3 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 67' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' D' ' 26' ' ' ALA . 4.3 p90 -64.76 -167.86 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.441 -1.035 . . . . 0.0 110.125 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.18 175.15 40.09 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 69' ' ' THR . . . . . 0.468 ' OG1' HD11 ' D' ' 25' ' ' ILE . 4.9 m -97.9 134.91 40.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.99 -1.3 . . . . 0.0 108.176 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 70' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' D' ' 22' ' ' SER . 50.3 mt -79.45 134.71 27.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.9 163.04 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.466 -0.771 . . . . 0.0 109.737 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 72' ' ' LYS . . . . . 0.428 ' H ' ' H ' ' D' ' 21' ' ' TYR . 14.9 ttpp -154.19 140.35 18.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.446 -0.784 . . . . 0.0 108.998 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.74 150.78 25.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.829 -1.169 . . . . 0.0 108.868 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 74' ' ' ASP . . . . . 0.407 ' CG ' ' H ' ' D' ' 75' ' ' GLU . 7.6 t70 -73.58 -151.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.087 -1.008 . . . . 0.0 109.317 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 75' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' D' ' 76' ' ' ALA . 2.5 tm-20 -164.13 81.4 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 109.489 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 76' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' D' ' 78' ' ' PHE . . . 176.63 -13.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.358 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 62.96 -70.46 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.511 -0.743 . . . . 0.0 109.161 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 78' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' D' ' 76' ' ' ALA . 68.7 m-85 -83.45 104.28 13.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.921 . . . . 0.0 109.231 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 23.6 m -55.8 95.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.649 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 24.2 mmt 49.71 -114.66 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.898 . . . . 0.0 109.529 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.385 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 2' ' ' ILE . . . . . 0.886 ' H ' HD13 ' E' ' 2' ' ' ILE . 0.1 OUTLIER -136.26 -5.84 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.5 -0.75 . . . . 0.0 109.519 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 3' ' ' PHE . . . . . 0.407 ' CZ ' HD11 ' E' ' 2' ' ' ILE . 49.0 m-85 -78.25 37.89 0.27 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.904 . . . . 0.0 109.4 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -69.28 -51.76 34.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.884 . . . . 0.0 109.551 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.44 117.19 9.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 6' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' E' ' 50' ' ' MET . 54.8 tttt -138.33 -68.65 0.45 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.187 -0.945 . . . . 0.0 109.082 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -105.08 122.51 46.03 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 14.3 mt -134.3 131.56 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.362 -0.836 . . . . 0.0 109.736 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 9' ' ' ILE . . . . . 0.585 ' O ' HG23 ' E' ' 9' ' ' ILE . 19.2 tt -121.82 117.25 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.53 133.63 55.79 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.459 -0.776 . . . . 0.0 108.988 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 11' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' E' ' 12' ' ' ALA . 25.3 m -86.88 61.63 6.92 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.048 -1.032 . . . . 0.0 111.085 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 12' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' E' ' 11' ' ' THR . . . 174.99 -110.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -176.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 167.88 113.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 14' ' ' GLU . . . . . 0.425 ' CG ' ' H ' ' E' ' 15' ' ' ILE . 0.8 OUTLIER -173.73 -96.79 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.057 -1.027 . . . . 0.0 109.635 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 15' ' ' ILE . . . . . 0.51 ' N ' ' HD3' ' E' ' 16' ' ' PRO . 8.6 mt 59.0 60.1 5.12 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 109.61 -179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 16' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' E' ' 15' ' ' ILE . 1.6 Cg_endo -64.9 153.15 79.51 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 122.018 1.812 . . . . 0.0 109.734 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.52 -8.77 78.48 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.356 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 18' ' ' LEU . . . . . 0.482 HD12 ' CG2' ' E' ' 15' ' ' ILE . 61.3 mt -124.55 137.56 54.39 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.077 -1.249 . . . . 0.0 109.188 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -86.99 108.73 18.97 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 12.8 mt -89.4 136.32 33.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 110.001 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 21' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' E' ' 71' ' ' VAL . 4.3 t80 -117.81 129.69 55.82 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.0 127.38 30.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.811 -1.181 . . . . 0.0 110.941 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' E' ' 23' ' ' LEU . 23.4 mt -113.58 8.49 17.7 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.55 -163.15 13.13 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -128.18 143.67 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.867 -0.784 . . . . 0.0 109.216 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.24 147.81 39.9 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.4 0.619 . . . . 0.0 109.439 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 60.0 p -151.71 135.01 15.98 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.84 148.79 30.31 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.98 -1.075 . . . . 0.0 108.835 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 tp -127.1 133.51 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 4.5 m -151.21 -152.7 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 109.067 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 31' ' ' ASP . . . . . 0.423 ' CG ' ' H ' ' E' ' 32' ' ' ASN . 0.9 OUTLIER -106.22 -82.72 0.53 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.36 -0.837 . . . . 0.0 111.114 -178.51 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 32' ' ' ASN . . . . . 0.423 ' H ' ' CG ' ' E' ' 31' ' ' ASP . 87.7 m-20 -81.01 165.11 22.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.03 . . . . 0.0 109.428 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 64.6 t -68.15 -31.9 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.789 -0.569 . . . . 0.0 109.731 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.37 -40.91 68.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 109.859 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -76.66 -35.48 57.92 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.19 -0.944 . . . . 0.0 109.082 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 69.2 mt -63.97 -52.89 50.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 120.929 -1.107 . . . . 0.0 109.425 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.54 -49.1 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.067 -1.021 . . . . 0.0 109.396 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -58.61 -39.11 79.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.892 . . . . 0.0 109.381 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -69.47 -39.94 77.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 0.0 109.782 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 40' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' E' ' 40' ' ' LEU . 21.7 mt -68.2 -45.59 72.95 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.917 -1.115 . . . . 0.0 108.711 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -47.43 -56.61 6.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.859 -1.151 . . . . 0.0 108.944 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -55.06 -32.94 62.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.861 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -75.53 -40.82 56.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.9 . . . . 0.0 110.087 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 38.4 t -76.88 -52.51 16.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.935 -1.103 . . . . 0.0 108.879 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -56.57 -28.6 60.56 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.381 1.086 . . . . 0.0 110.21 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.73 -28.46 58.54 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.507 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -87.22 10.91 15.49 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.64 29.17 53.6 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.081 -1.533 . . . . 0.0 109.417 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.97 -168.81 30.04 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 50' ' ' MET . . . . . 0.473 ' O ' ' O ' ' E' ' 6' ' ' LYS . 65.5 mtp -103.96 -37.42 7.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.514 -0.992 . . . . 0.0 109.288 177.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 174.5 -153.27 15.91 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 12.0 tp -126.94 135.72 51.28 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.525 -0.985 . . . . 0.0 109.744 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 53' ' ' ILE . . . . . 0.476 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 1.2 pt -110.36 146.19 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.528 -0.732 . . . . 0.0 109.958 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 67.66 87.41 0.12 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 109.711 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -138.4 82.16 1.89 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 56' ' ' ARG . . . . . 0.671 HH22 ' NH1' ' A' ' 56' ' ' ARG . 12.8 ptm180 -120.48 8.74 10.78 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.636 -0.665 . . . . 0.0 109.338 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 57' ' ' ILE . . . . . 0.541 HG22 ' O ' ' E' ' 57' ' ' ILE . 72.4 mt 57.63 -0.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.539 -0.726 . . . . 0.0 109.693 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 58' ' ' THR . . . . . 0.534 ' H ' ' C ' ' E' ' 56' ' ' ARG . 63.0 m 54.59 -87.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.69 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 59' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' E' ' 57' ' ' ILE . 73.1 m -76.09 -120.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 109.609 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.6 79.57 1.33 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.113 -0.992 . . . . 0.0 109.513 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 61' ' ' ASP . . . . . 0.456 ' H ' HG21 ' E' ' 57' ' ' ILE . 43.9 t0 51.06 19.6 0.71 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.342 -0.849 . . . . 0.0 109.656 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.88 -141.4 1.26 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -91.0 61.62 4.67 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.226 -1.161 . . . . 0.0 109.433 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 64' ' ' PHE . . . . . 0.508 ' C ' HD12 ' E' ' 65' ' ' LEU . 55.0 m-85 -137.38 -173.35 3.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.39 -0.819 . . . . 0.0 109.201 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.611 HD12 ' N ' ' E' ' 65' ' ' LEU . 3.7 mp -137.2 146.11 44.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.404 -0.81 . . . . 0.0 109.877 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.4 60.71 4.52 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -55.82 169.28 0.36 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.327 -1.102 . . . . 0.0 110.039 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.01 162.07 32.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 52.8 m -102.96 134.34 46.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.103 -1.233 . . . . 0.0 108.09 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 37.2 mt -86.07 136.45 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 71' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' E' ' 21' ' ' TYR . 6.5 m -132.22 165.86 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.4 -0.813 . . . . 0.0 110.2 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 72' ' ' LYS . . . . . 0.449 ' CB ' HD11 ' E' ' 23' ' ' LEU . 1.5 ttpp -153.95 140.74 19.09 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.97 151.1 22.86 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.791 -1.193 . . . . 0.0 108.85 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -72.54 -1.93 17.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.063 -1.023 . . . . 0.0 109.576 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 75' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' E' ' 77' ' ' GLN . 13.2 tt0 65.97 18.06 10.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.376 -0.828 . . . . 0.0 109.634 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 76' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' E' ' 75' ' ' GLU . . . 62.03 1.21 0.63 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.325 -0.859 . . . . 0.0 109.717 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 77' ' ' GLN . . . . . 0.439 ' H ' ' C ' ' E' ' 75' ' ' GLU . 21.5 mm-40 51.39 -153.91 0.17 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.211 -0.93 . . . . 0.0 109.578 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -59.04 159.6 7.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.616 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 79' ' ' THR . . . . . 0.55 HG22 ' N ' ' E' ' 80' ' ' MET . 88.4 m -79.49 165.88 22.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 109.177 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 80' ' ' MET . . . . . 0.55 ' N ' HG22 ' E' ' 79' ' ' THR . 4.7 ptt? -138.25 86.75 2.19 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.382 -0.823 . . . . 0.0 109.278 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.415 179.857 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mtm . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.9 tp -93.52 151.12 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.266 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 3' ' ' PHE . 0.6 OUTLIER -90.03 67.43 7.04 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.164 -0.96 . . . . 0.0 109.089 179.604 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 56.19 -89.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.439 -0.788 . . . . 0.0 110.194 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 3' ' ' PHE . 57.5 t0 56.9 100.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.401 -0.812 . . . . 0.0 109.47 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -82.44 105.44 13.5 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.26 -0.9 . . . . 0.0 109.296 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -103.44 122.98 46.0 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.607 -0.683 . . . . 0.0 109.328 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 76.6 mt -109.91 130.86 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.376 -0.828 . . . . 0.0 109.936 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.61 ' O ' HG23 ' A' ' 9' ' ' ILE . 6.7 tt -135.05 114.61 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.6 t -123.16 160.05 27.32 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.958 0.885 . . . . 0.0 109.223 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 12' ' ' ALA . 11.0 p -96.34 -110.1 0.15 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.746 -0.596 . . . . 0.0 109.733 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 11' ' ' THR . . . 37.7 -104.44 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.1 -1.0 . . . . 0.0 111.073 177.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 15.0 p-10 -142.85 -64.68 0.4 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.446 -0.784 . . . . 0.0 109.793 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.467 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 11.5 pt-20 -152.16 -166.75 2.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.108 -0.995 . . . . 0.0 109.56 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.8 mt -116.59 97.72 50.59 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.603 -0.686 . . . . 0.0 109.303 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.18 156.31 46.02 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.82 1.68 . . . . 0.0 110.273 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.11 -7.59 78.46 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 18' ' ' LEU . 62.4 mt -129.88 141.37 50.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.31 -1.112 . . . . 0.0 109.467 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.6 117.05 25.12 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.6 mt -101.34 136.66 40.82 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.132 -0.98 . . . . 0.0 109.154 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.424 ' H ' ' H ' ' A' ' 72' ' ' LYS . 12.3 t80 -113.62 129.26 56.6 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.385 -0.822 . . . . 0.0 109.083 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.1 t -73.37 124.57 26.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.488 -1.383 . . . . 0.0 109.377 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.7 mt -111.07 8.45 21.82 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.37 -167.04 21.47 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.3 mm -122.26 142.23 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.8 153.44 29.09 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.5 m -152.2 145.08 24.4 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.07 -1.019 . . . . 0.0 109.084 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.7 p -143.84 131.07 20.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.469 -0.769 . . . . 0.0 108.983 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.628 ' O ' ' CB ' ' A' ' 30' ' ' SER . 91.8 mt -105.87 153.34 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.628 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 88.9 p 120.89 -147.53 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 32' ' ' ASN . 22.0 t70 -145.64 -160.73 1.18 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.457 ' H ' ' CG ' ' A' ' 31' ' ' ASP . 14.0 m-20 70.66 101.61 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.4 t -62.56 -35.97 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.123 -0.986 . . . . 0.0 109.325 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.69 -41.7 86.87 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.248 -0.908 . . . . 0.0 109.692 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -75.81 -41.17 53.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.316 -0.865 . . . . 0.0 109.486 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.5 mt -63.41 -53.79 40.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.945 -1.097 . . . . 0.0 108.959 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.9 t -55.96 -49.87 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 108.999 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.91 -40.12 87.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 109.94 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -62.11 -44.02 97.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.176 -0.953 . . . . 0.0 109.499 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.3 mt -71.12 -49.08 48.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.105 -0.997 . . . . 0.0 108.7 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -48.8 -49.35 39.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.805 -1.184 . . . . 0.0 109.277 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -63.21 -36.39 83.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.513 -0.742 . . . . 0.0 110.217 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.67 -35.53 57.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.833 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 t -68.3 -51.2 50.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 109.196 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -67.13 -37.94 84.7 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.773 -1.205 . . . . 0.0 109.161 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.1 -32.64 66.5 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -85.45 -4.53 59.19 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.46 -0.775 . . . . 0.0 109.341 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.66 9.13 61.63 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.84 -157.22 3.76 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.4 ptm -165.1 -20.15 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.09 -1.241 . . . . 0.0 110.385 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -152.56 160.11 28.8 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 tp -118.06 138.87 51.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.652 -0.91 . . . . 0.0 109.115 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.551 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 1.1 pt -114.51 147.08 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.483 -0.761 . . . . 0.0 109.969 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 70.75 85.08 0.13 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.456 -0.778 . . . . 0.0 110.932 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.4 ' CG ' HD11 ' A' ' 9' ' ' ILE . 52.8 t80 -123.62 102.59 7.93 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -123.13 138.09 54.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.517 -0.739 . . . . 0.0 109.813 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.405 ' O ' ' CG1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -142.64 110.99 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.661 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 59' ' ' CYS . 37.3 p -81.09 114.18 19.77 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.829 -1.169 . . . . 0.0 109.288 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.445 ' C ' ' O ' ' A' ' 58' ' ' THR . 12.5 m 38.18 -137.58 0.06 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.628 -0.67 . . . . 0.0 110.16 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -153.03 45.12 0.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -0.91 . . . . 0.0 109.199 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.2 p30 -136.9 -16.81 1.45 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.483 -0.76 . . . . 0.0 109.408 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 64' ' ' PHE . . . -134.14 -179.21 16.2 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.4 tttt 65.25 -70.97 0.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -1.111 . . . . 0.0 109.507 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 62' ' ' GLY . 1.8 m-85 49.57 53.19 13.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.242 -0.911 . . . . 0.0 109.13 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.8 tp -164.75 103.11 0.8 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.828 -1.17 . . . . 0.0 109.922 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.54 61.21 4.19 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -46.62 144.18 2.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.317 -1.108 . . . . 0.0 110.02 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.7 149.21 18.75 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.492 ' OG1' HG23 ' E' ' 11' ' ' THR . 21.2 m -106.56 140.65 39.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -1.131 . . . . 0.0 108.821 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.2 mt -84.5 134.04 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.68 155.47 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.235 -0.916 . . . . 0.0 109.104 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.424 ' H ' ' H ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -148.26 134.24 19.17 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.16 148.41 28.88 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.139 -0.976 . . . . 0.0 108.542 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 25.2 p-10 -176.35 55.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.129 -0.982 . . . . 0.0 109.031 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -101.72 -115.54 0.19 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.297 -0.877 . . . . 0.0 109.471 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.39 -178.86 0.55 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 109.258 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -126.35 -120.44 0.26 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.495 -0.753 . . . . 0.0 109.041 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 47.58 76.76 0.1 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.208 -0.932 . . . . 0.0 109.497 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.4 p 50.07 -163.59 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.381 -0.824 . . . . 0.0 109.584 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 15.9 mmt -64.65 134.77 54.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 109.434 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.387 -179.916 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.281 0.562 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.582 ' C ' HD12 ' B' ' 2' ' ' ILE . 2.8 pp -69.33 178.1 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.345 -0.847 . . . . 0.0 109.417 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -150.63 120.44 7.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.327 -0.858 . . . . 0.0 109.204 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -75.8 108.41 8.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.989 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 t0 68.94 112.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.555 -178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -167.86 99.65 0.47 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -0.968 . . . . 0.0 109.074 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -98.18 132.54 43.61 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.504 -0.747 . . . . 0.0 109.137 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 71.1 mt -124.44 141.47 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.476 -0.765 . . . . 0.0 109.433 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.462 ' O ' ' CG2' ' B' ' 9' ' ' ILE . 6.8 tt -136.87 119.76 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 7.6 t -124.6 156.58 37.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.196 -0.94 . . . . 0.0 108.622 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.477 ' HB ' ' H ' ' B' ' 12' ' ' ALA . 0.0 OUTLIER -68.33 -132.34 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.477 ' H ' ' HB ' ' B' ' 11' ' ' THR . . . -94.09 110.21 21.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.138 -0.976 . . . . 0.0 110.014 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -162.75 -134.22 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLU . . . . . 0.634 ' O ' ' C ' ' B' ' 15' ' ' ILE . 6.4 pt-20 -172.99 46.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.064 -1.022 . . . . 0.0 109.49 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.634 ' C ' ' O ' ' B' ' 14' ' ' GLU . 11.3 mt -1.81 77.58 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.505 0 O-C-N 122.357 -0.214 . . . . 0.0 110.586 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.498 ' N ' ' O ' ' B' ' 14' ' ' GLU . 2.3 Cg_endo -62.12 155.49 55.8 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.831 1.687 . . . . 0.0 110.183 -177.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.44 -11.59 71.74 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 34.7 mt -124.37 137.52 54.46 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.08 -1.247 . . . . 0.0 109.228 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.17 116.1 24.15 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.45 138.73 35.24 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.242 -0.911 . . . . 0.0 109.687 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -118.29 129.79 55.66 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.82 129.18 39.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.732 -1.23 . . . . 0.0 110.673 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.404 HD11 ' CB ' ' B' ' 72' ' ' LYS . 74.2 mt -115.62 7.1 14.71 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.96 -156.06 16.18 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.63 142.94 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.885 -0.773 . . . . 0.0 109.389 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.2 144.6 44.6 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.774 -0.579 . . . . 0.0 109.954 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 30.7 p -152.45 141.83 21.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.191 -0.943 . . . . 0.0 108.743 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.59 152.76 36.02 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.077 -1.015 . . . . 0.0 109.72 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.428 HD12 ' N ' ' B' ' 29' ' ' ILE . 3.4 mp -98.52 152.27 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.245 -0.909 . . . . 0.0 108.949 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 173.05 143.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.445 -0.784 . . . . 0.0 109.242 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.411 ' O ' ' CG ' ' B' ' 32' ' ' ASN . 15.2 p-10 -93.08 30.1 1.71 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.235 -0.916 . . . . 0.0 110.325 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ASN . . . . . 0.411 ' CG ' ' O ' ' B' ' 31' ' ' ASP . 27.1 m120 -162.23 141.17 9.28 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.548 0.689 . . . . 0.0 109.902 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.23 -37.27 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.396 -0.815 . . . . 0.0 109.57 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.71 -38.77 72.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 0.0 109.536 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -75.28 -36.93 61.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.235 -0.916 . . . . 0.0 108.696 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 82.4 mt -65.29 -53.5 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.917 -1.114 . . . . 0.0 109.25 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -54.54 -51.34 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.109 -0.994 . . . . 0.0 109.134 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.83 -43.02 98.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.35 -0.844 . . . . 0.0 109.758 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -60.65 -45.24 94.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.29 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' B' ' 40' ' ' LEU . 61.1 mt -67.09 -46.08 75.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.155 -0.966 . . . . 0.0 108.911 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -50.1 -43.7 51.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.764 -1.21 . . . . 0.0 109.459 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -67.87 -38.6 83.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.614 -0.679 . . . . 0.0 110.272 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -76.48 -35.62 58.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.453 -0.779 . . . . 0.0 109.858 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 t -66.12 -50.12 71.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 109.21 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -62.96 -31.03 72.04 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.238 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.68 -31.74 71.05 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.763 0.792 . . . . 0.0 109.394 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -84.91 -5.38 59.34 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.75 8.96 75.64 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.69 164.61 45.18 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.98 1.85 2.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.03 -1.277 . . . . 0.0 110.325 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.7 165.75 38.61 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.921 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 tp -136.52 137.9 40.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.585 -0.95 . . . . 0.0 109.163 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.906 HD13 ' O ' ' B' ' 53' ' ' ILE . 0.0 OUTLIER -109.4 151.68 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.47 -0.769 . . . . 0.0 109.872 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 78.83 -64.02 0.27 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.327 -0.858 . . . . 0.0 112.678 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.495 ' CG ' ' O ' ' B' ' 55' ' ' PHE . 61.2 t80 34.74 36.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.394 0.616 . . . . 0.0 109.788 177.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.793 ' HG3' HH11 ' B' ' 56' ' ' ARG . 14.3 mtm-85 -64.39 154.71 34.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.868 -1.145 . . . . 0.0 109.73 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.429 HG22 ' N ' ' B' ' 58' ' ' THR . 84.6 mt -132.43 157.61 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' THR . . . . . 0.429 ' N ' HG22 ' B' ' 57' ' ' ILE . 2.3 m -124.36 -131.27 0.26 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 43.6 t -160.02 151.95 20.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 109.369 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -168.72 -178.23 3.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 109.486 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -72.47 -64.42 0.96 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.319 -0.863 . . . . 0.0 109.376 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.02 -32.35 0.27 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -49.59 -54.3 19.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.479 -1.013 . . . . 0.0 110.1 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.445 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 1.5 t80 58.66 -127.68 1.39 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.219 -0.926 . . . . 0.0 109.173 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' B' ' 64' ' ' PHE . 4.4 tt 61.45 137.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.612 -0.68 . . . . 0.0 109.605 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -127.79 -114.89 1.86 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' TYR . . . . . 0.436 ' CD1' ' O ' ' B' ' 67' ' ' TYR . 32.4 p90 -172.87 130.97 0.51 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -1.172 . . . . 0.0 109.142 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.54 148.11 19.75 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 79.0 m -102.18 136.29 42.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.907 -1.349 . . . . 0.0 108.761 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 49.1 mt -83.03 142.88 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 m -135.45 157.71 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.151 -0.968 . . . . 0.0 109.767 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.404 ' CB ' HD11 ' B' ' 23' ' ' LEU . 0.0 OUTLIER -147.17 151.35 36.63 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.31 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.4 150.22 34.99 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -84.77 169.73 13.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.028 -1.045 . . . . 0.0 109.242 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' GLU . . . . . 0.45 ' HG3' ' H ' ' B' ' 77' ' ' GLN . 6.8 tp10 -90.28 123.99 34.51 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.292 -0.88 . . . . 0.0 109.345 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.16 11.16 17.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.173 -0.954 . . . . 0.0 109.538 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' GLN . . . . . 0.45 ' H ' ' HG3' ' B' ' 75' ' ' GLU . 93.5 mm-40 -84.82 124.27 31.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.213 -0.929 . . . . 0.0 109.398 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -78.6 14.36 1.32 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 109.496 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 6.7 t -163.84 26.02 0.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 109.485 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' MET . . . . . . . . . . . . . 6.8 mmt 50.89 -157.13 0.11 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -0.936 . . . . 0.0 109.5 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.448 179.992 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 70.0 mt -71.94 -23.91 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.449 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -160.49 -30.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 109.416 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 4' ' ' GLU . . . . . 0.423 ' N ' ' CD ' ' C' ' 4' ' ' GLU . 13.8 mp0 -69.7 2.06 3.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.326 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 5' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' C' ' 6' ' ' LYS . 19.2 t70 -77.44 -146.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 109.291 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 6' ' ' LYS . . . . . 0.44 ' H ' ' CG ' ' C' ' 5' ' ' ASP . 41.6 mtpt -138.69 74.99 1.5 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.274 -0.891 . . . . 0.0 109.269 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -102.46 144.31 31.07 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 14.1 mt -132.98 135.97 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.464 -0.772 . . . . 0.0 109.577 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 9' ' ' ILE . . . . . 0.61 ' O ' HG23 ' C' ' 9' ' ' ILE . 16.4 tt -137.77 115.0 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -123.05 158.68 30.06 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 7.6 p -114.82 85.09 2.18 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.35 -133.08 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.72 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -107.6 -55.98 2.28 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.55 -0.719 . . . . 0.0 109.39 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 14' ' ' GLU . . . . . 0.522 ' HG2' ' H ' ' C' ' 15' ' ' ILE . 22.7 tt0 -164.89 -179.32 5.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.933 . . . . 0.0 108.886 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 15' ' ' ILE . . . . . 0.522 ' H ' ' HG2' ' C' ' 14' ' ' GLU . 63.6 mt -112.12 92.04 17.44 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.95 156.7 42.53 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 122.0 1.8 . . . . 0.0 110.456 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.74 -6.08 76.92 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 77.6 mt -130.63 140.44 50.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -1.179 . . . . 0.0 109.494 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -86.01 107.56 17.83 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.545 ' HB3' ' HB ' ' C' ' 71' ' ' VAL . 6.7 mt -111.0 128.17 55.76 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.485 -0.759 . . . . 0.0 110.451 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 21' ' ' TYR . . . . . 0.641 ' CD1' ' N ' ' C' ' 21' ' ' TYR . 0.0 OUTLIER -112.42 142.75 44.58 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.7 136.42 45.58 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.627 0.727 . . . . 0.0 110.106 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.451 HD21 ' HD3' ' C' ' 72' ' ' LYS . 2.1 mt -120.43 12.93 11.74 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.5 -175.46 16.72 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' ILE . . . . . 0.438 HD11 HG23 ' B' ' 9' ' ' ILE . 49.4 mm -114.58 139.23 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.13 143.95 42.32 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.35 -0.843 . . . . 0.0 109.217 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 19.2 m -152.83 146.87 25.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.094 -1.004 . . . . 0.0 109.211 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 9.6 t -149.9 137.18 19.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.351 -0.843 . . . . 0.0 109.171 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.404 HG22 ' N ' ' C' ' 30' ' ' SER . 89.2 mt -108.23 157.97 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.698 ' O ' ' CG ' ' C' ' 31' ' ' ASP . 15.4 m 62.74 85.09 0.13 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.526 -0.734 . . . . 0.0 109.774 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 31' ' ' ASP . . . . . 0.698 ' CG ' ' O ' ' C' ' 30' ' ' SER . 27.2 m-20 173.04 132.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -83.73 175.17 9.87 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 1.9 m -46.16 -42.62 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.636 0 O-C-N 120.56 -1.337 . . . . 0.0 107.673 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -63.0 -48.7 77.66 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.297 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -73.14 -36.73 66.74 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.955 -1.091 . . . . 0.0 108.896 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 89.5 mt -61.96 -52.53 59.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.824 -1.172 . . . . 0.0 109.396 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.97 -48.58 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -0.965 . . . . 0.0 109.399 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 38' ' ' GLU . . . . . 0.442 ' HA ' ' HE ' ' C' ' 41' ' ' ARG . 24.3 mm-40 -56.0 -36.23 67.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 109.007 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 39' ' ' ASN . . . . . 0.48 ' ND2' ' OD2' ' C' ' 31' ' ' ASP . 79.8 m-20 -76.07 -37.79 57.82 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.728 -1.232 . . . . 0.0 110.565 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 40' ' ' LEU . . . . . 0.58 ' O ' HG13 ' C' ' 44' ' ' VAL . 78.7 mt -74.27 -53.28 10.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.741 -1.225 . . . . 0.0 110.024 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 41' ' ' ARG . . . . . 0.453 ' NH1' ' HE2' ' C' ' 45' ' ' LYS . 2.2 ppt_? -47.19 -45.23 22.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.075 -1.016 . . . . 0.0 109.279 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -60.12 -32.46 71.02 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.051 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 43' ' ' GLN . . . . . 0.524 ' O ' ' HB2' ' C' ' 47' ' ' LYS . 69.8 mm-40 -75.31 -36.61 61.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -0.971 . . . . 0.0 110.756 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 44' ' ' VAL . . . . . 0.617 ' O ' ' N ' ' C' ' 49' ' ' GLY . 0.8 OUTLIER -76.8 -52.1 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.712 -1.243 . . . . 0.0 109.83 -179.189 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 45' ' ' LYS . . . . . 0.475 ' N ' ' CG2' ' C' ' 44' ' ' VAL . 0.3 OUTLIER -61.53 -33.0 73.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.28 -1.512 . . . . 0.0 109.38 -175.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.7 -32.89 62.31 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.85 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 47' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' C' ' 43' ' ' GLN . 3.9 mtpp -93.31 -7.61 44.41 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 48' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' C' ' 44' ' ' VAL . . . 105.39 -1.25 40.05 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 49' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' C' ' 44' ' ' VAL . . . -65.18 -173.68 4.08 Favored Glycine 0 N--CA 1.483 1.798 0 O-C-N 119.913 -1.934 . . . . 0.0 109.597 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.08 9.87 0.44 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.094 -1.239 . . . . 0.0 110.003 176.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.07 164.73 18.81 Favored Glycine 0 N--CA 1.483 1.8 0 C-N-CA 118.974 -1.584 . . . . 0.0 109.813 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 52' ' ' LEU . . . . . 0.427 HD22 HD13 ' C' ' 40' ' ' LEU . 0.4 OUTLIER -115.76 149.6 38.23 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.87 -0.783 . . . . 0.0 109.88 179.033 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.63 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 1.1 pt -113.15 143.67 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.678 -0.639 . . . . 0.0 110.104 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 77.78 -50.66 0.51 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.68 -0.637 . . . . 0.0 110.679 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 55' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' C' ' 54' ' ' ALA . 50.0 t80 42.24 68.98 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 56' ' ' ARG . . . . . 0.67 ' CG ' HH11 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -77.02 137.98 39.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.129 -178.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.59 132.63 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 58' ' ' THR . . . . . 0.489 ' OG1' ' N ' ' C' ' 59' ' ' CYS . 2.1 t -135.81 -167.47 2.04 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 59' ' ' CYS . . . . . 0.489 ' N ' ' OG1' ' C' ' 58' ' ' THR . 48.7 t -138.8 143.14 38.78 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.313 -0.867 . . . . 0.0 109.274 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' C' ' 62' ' ' GLY . . . -165.02 133.37 3.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.175 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 5.6 t70 70.15 -33.09 0.25 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.59 -0.694 . . . . 0.0 109.805 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 62' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' C' ' 60' ' ' ALA . . . 152.34 -66.28 0.34 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -66.13 -164.45 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.629 -0.924 . . . . 0.0 109.656 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 64' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' C' ' 64' ' ' PHE . 0.6 OUTLIER -141.65 179.06 7.05 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.337 -0.852 . . . . 0.0 109.247 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 23.7 tp -145.48 106.42 4.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.358 -0.839 . . . . 0.0 108.945 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.88 147.09 18.09 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -162.21 -176.49 5.16 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.323 -1.104 . . . . 0.0 109.51 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 166.49 -162.0 35.68 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 21.8 m -123.92 136.65 54.47 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.13 142.85 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 71' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' C' ' 20' ' ' LEU . 5.2 m -137.18 150.19 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.661 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 72' ' ' LYS . . . . . 0.451 ' HD3' HD21 ' C' ' 23' ' ' LEU . 12.9 mtpp -119.17 146.01 45.53 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.45 149.43 26.17 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' C' ' 74' ' ' ASP . 25.9 p-10 -83.64 142.33 30.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.772 -1.205 . . . . 0.0 109.376 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 75' ' ' GLU . . . . . 0.586 ' O ' ' HB3' ' C' ' 76' ' ' ALA . 68.8 tt0 -91.12 -39.14 12.32 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.19 -0.944 . . . . 0.0 109.673 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 76' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' C' ' 75' ' ' GLU . . . 73.16 -48.01 0.68 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.695 -0.628 . . . . 0.0 109.879 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 77' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -77.79 78.47 4.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.219 -0.926 . . . . 0.0 109.709 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 45.93 -153.78 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.361 -0.837 . . . . 0.0 109.697 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 66.8 p -144.32 -123.8 0.08 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.2 -0.938 . . . . 0.0 109.059 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 36.3 mtm -93.77 -56.36 2.92 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.164 -0.96 . . . . 0.0 109.53 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.558 -179.989 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ptt? . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 2' ' ' ILE . . . . . . . . . . . . . 4.6 pt -75.71 -40.01 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 109.427 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -114.03 44.93 1.57 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.416 -0.802 . . . . 0.0 109.083 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.65 154.06 22.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.216 -0.927 . . . . 0.0 109.38 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 5' ' ' ASP . . . . . . . . . . . . . 42.3 p-10 -75.17 -172.9 1.83 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 109.317 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -80.26 108.73 14.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.219 -0.926 . . . . 0.0 109.69 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -92.49 120.01 32.54 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.102 -0.999 . . . . 0.0 108.743 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 50.7 mt -126.14 129.87 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.461 -0.774 . . . . 0.0 110.093 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 9' ' ' ILE . . . . . 0.601 HG23 ' O ' ' D' ' 9' ' ' ILE . 17.1 tt -113.64 114.43 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t -123.55 160.68 26.49 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.147 -0.971 . . . . 0.0 109.082 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.5 p -91.84 -113.2 0.09 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.5 -120.15 0.87 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.106 . . . . 0.0 110.426 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -152.7 -27.16 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.728 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -168.56 177.1 5.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 0.0 109.53 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 96.1 mt -116.55 97.61 50.37 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.13 155.96 47.82 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.772 1.648 . . . . 0.0 110.415 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.18 -7.54 78.34 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 64.8 mt -129.28 140.46 51.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -1.103 . . . . 0.0 109.513 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -84.52 108.49 17.32 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 15.1 mt -97.26 135.26 39.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.825 . . . . 0.0 110.025 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 21' ' ' TYR . . . . . 0.5 ' CE1' ' O ' ' D' ' 22' ' ' SER . 1.5 t80 -117.74 130.04 56.07 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 22' ' ' SER . . . . . 0.5 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 28.3 t -75.0 129.68 38.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.911 -1.118 . . . . 0.0 110.917 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mt -117.3 12.17 14.24 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.79 177.84 15.2 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.65 145.02 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.892 -0.769 . . . . 0.0 108.943 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.69 144.12 42.74 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.6 -0.688 . . . . 0.0 109.348 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 92.4 p -152.2 138.42 18.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.083 -1.011 . . . . 0.0 108.611 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 13.5 t -149.51 146.33 27.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.052 -1.03 . . . . 0.0 109.134 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 47.5 mm -116.94 131.54 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.274 -0.891 . . . . 0.0 109.199 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 11.9 m -153.46 -158.04 0.84 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.207 -0.933 . . . . 0.0 109.408 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 31' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -106.88 -80.03 0.57 Allowed 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.406 -0.809 . . . . 0.0 111.153 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 32' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -65.39 144.78 56.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.896 -1.127 . . . . 0.0 109.153 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 33' ' ' VAL . . . . . 0.413 ' H ' HG13 ' D' ' 33' ' ' VAL . 1.9 m -69.42 -36.15 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -58.25 -29.47 65.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.522 -0.736 . . . . 0.0 109.606 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -75.03 -36.02 61.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.364 -0.835 . . . . 0.0 108.888 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 54.8 mt -60.97 -49.62 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.308 -0.87 . . . . 0.0 108.96 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 54.1 t -55.45 -49.44 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.998 . . . . 0.0 109.019 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.82 -41.07 90.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 109.593 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -62.48 -42.76 99.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 0.0 109.337 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 60.5 mt -67.55 -45.38 75.85 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.086 -1.009 . . . . 0.0 108.59 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -50.14 -55.3 15.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.858 -1.152 . . . . 0.0 109.198 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -58.76 -37.63 76.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.252 -0.905 . . . . 0.0 110.453 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -75.68 -35.61 60.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 109.764 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 9.6 t -69.0 -50.49 53.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.25 -0.907 . . . . 0.0 109.234 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -64.21 -29.92 71.01 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.483 -1.287 . . . . 0.0 109.002 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.71 -29.03 67.37 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.33 -5.29 56.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.503 -0.748 . . . . 0.0 109.921 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.0 9.42 58.32 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.2 158.74 40.46 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 3.0 ptm -126.9 -5.04 6.3 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.295 -1.121 . . . . 0.0 110.07 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.27 164.18 36.5 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 8.2 tp -125.42 134.05 52.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.7 -0.882 . . . . 0.0 109.186 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 53' ' ' ILE . . . . . 0.808 HD13 ' O ' ' D' ' 53' ' ' ILE . 0.0 OUTLIER -107.68 147.3 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.525 -0.735 . . . . 0.0 110.58 -178.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 51.73 63.44 2.24 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.369 -1.457 . . . . 0.0 109.668 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.572 ' O ' ' O ' ' D' ' 56' ' ' ARG . 2.7 t80 -46.27 -60.15 2.49 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.282 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 56' ' ' ARG . . . . . 0.572 ' O ' ' O ' ' D' ' 55' ' ' PHE . 26.2 mmt180 53.44 125.17 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.649 0.737 . . . . 0.0 110.201 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 57' ' ' ILE . . . . . 0.483 HD11 HD21 ' E' ' 65' ' ' LEU . 1.6 pt -136.87 -34.8 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.85 -1.156 . . . . 0.0 108.39 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 46.36 -163.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.597 0.713 . . . . 0.0 109.753 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 59' ' ' CYS . . . . . . . . . . . . . 19.0 p -167.4 -41.94 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.006 -1.059 . . . . 0.0 109.074 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . 47.46 -149.97 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.827 . . . . 0.0 109.606 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -58.17 104.98 0.23 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.218 -0.926 . . . . 0.0 109.18 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.32 -146.71 18.13 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 63' ' ' LYS . . . . . 0.407 ' NZ ' HD11 ' E' ' 29' ' ' ILE . 84.8 tttt -168.72 91.6 0.27 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.346 -1.091 . . . . 0.0 109.34 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.63 72.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 109.514 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 65' ' ' LEU . . . . . . . . . . . . . 31.0 tp -152.64 128.43 10.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.743 -1.223 . . . . 0.0 110.228 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.95 121.17 1.59 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -137.71 132.68 33.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.519 -0.989 . . . . 0.0 109.576 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -149.13 169.46 29.51 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 88.9 m -113.03 138.04 50.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.254 -1.145 . . . . 0.0 108.67 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 27.5 mt -87.36 135.65 24.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.6 155.72 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.799 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -151.55 158.0 42.98 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -120.19 150.16 41.1 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.27 154.53 38.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.123 -0.985 . . . . 0.0 109.306 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -89.55 135.86 33.36 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.309 -0.869 . . . . 0.0 109.503 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.1 -155.73 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.364 -0.835 . . . . 0.0 109.701 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -156.73 -145.01 0.14 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.203 -0.935 . . . . 0.0 109.308 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 78' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -78.72 -105.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.872 . . . . 0.0 109.361 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 74.4 p -92.64 -67.29 0.87 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.287 -0.883 . . . . 0.0 109.557 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 43.9 mtm -57.73 104.78 0.2 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.425 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.388 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ptt? . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.313 0.578 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 75.3 mt -64.76 143.81 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 109.299 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 3' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -81.04 -64.68 1.14 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 0.0 109.496 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -157.55 -8.63 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.925 . . . . 0.0 109.606 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 5' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -45.94 112.72 0.51 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.305 -0.872 . . . . 0.0 109.246 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 6' ' ' LYS . . . . . 0.431 ' H ' ' HG2' ' E' ' 6' ' ' LYS . 10.5 ptpt -95.7 106.23 18.32 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.442 -0.786 . . . . 0.0 110.095 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -94.21 118.82 32.12 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 76.2 mt -107.03 125.5 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.375 -0.828 . . . . 0.0 110.242 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 9' ' ' ILE . . . . . 0.617 ' O ' HG23 ' E' ' 9' ' ' ILE . 20.8 tt -133.42 113.79 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -123.78 161.57 24.95 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.294 -0.879 . . . . 0.0 109.528 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 11' ' ' THR . . . . . 0.492 HG23 ' OG1' ' A' ' 69' ' ' THR . 0.8 OUTLIER -87.87 -113.75 0.05 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 12' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' E' ' 11' ' ' THR . . . 41.64 -122.92 0.56 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 109.486 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 p30 175.53 26.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.549 -0.72 . . . . 0.0 109.647 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -173.44 151.69 2.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.206 -0.934 . . . . 0.0 109.638 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 15' ' ' ILE . . . . . 0.722 ' O ' HG23 ' E' ' 15' ' ' ILE . 18.0 tt -138.4 77.53 34.8 Favored Pre-proline 0 N--CA 1.498 1.971 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.86 156.85 36.06 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 122.116 1.878 . . . . 0.0 110.935 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.4 -6.73 71.63 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 18' ' ' LEU . . . . . 0.463 ' HA ' HD23 ' E' ' 18' ' ' LEU . 28.9 mt -128.69 137.43 51.61 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.896 -1.356 . . . . 0.0 109.544 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -84.22 108.79 17.31 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 20' ' ' LEU . . . . . 0.613 HD11 ' CG2' ' E' ' 15' ' ' ILE . 10.9 mt -104.95 146.05 29.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 111.009 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 21' ' ' TYR . . . . . 0.423 ' CZ ' ' O ' ' E' ' 22' ' ' SER . 1.6 t80 -129.76 130.66 45.68 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 22' ' ' SER . . . . . 0.423 ' O ' ' CZ ' ' E' ' 21' ' ' TYR . 13.7 t -53.02 130.61 34.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 111.104 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' E' ' 23' ' ' LEU . 5.3 mt -120.41 9.22 10.9 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.75 177.77 18.42 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 47.2 mm -112.42 143.23 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.784 -0.833 . . . . 0.0 109.358 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.06 154.53 28.7 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 5.2 p -149.67 147.32 27.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.054 -1.029 . . . . 0.0 109.043 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 28' ' ' THR . . . . . 0.556 ' OG1' HG23 ' E' ' 36' ' ' ILE . 17.2 p -148.71 132.09 16.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.44 -0.788 . . . . 0.0 109.354 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.453 ' O ' ' CB ' ' E' ' 30' ' ' SER . 86.3 mt -126.66 127.5 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' E' ' 29' ' ' ILE . 2.6 t 164.37 14.07 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 31' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' E' ' 32' ' ' ASN . 30.8 t0 51.91 -179.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.171 -0.956 . . . . 0.0 109.32 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 32' ' ' ASN . . . . . 0.462 ' H ' ' CG ' ' E' ' 31' ' ' ASP . 5.6 m-20 68.59 105.8 0.05 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.582 -0.698 . . . . 0.0 109.246 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 50.3 t -67.0 -34.52 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.259 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -58.73 -46.88 86.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 110.127 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 35' ' ' GLU . . . . . 0.481 ' O ' ' ND2' ' E' ' 39' ' ' ASN . 30.9 tt0 -75.46 -37.44 60.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.107 -0.995 . . . . 0.0 109.187 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 36' ' ' ILE . . . . . 0.556 HG23 ' OG1' ' E' ' 28' ' ' THR . 70.2 mt -64.84 -50.82 73.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.945 -1.097 . . . . 0.0 109.579 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 19.2 t -58.91 -51.12 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.05 -1.032 . . . . 0.0 109.195 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -38.44 73.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 109.116 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 39' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' E' ' 35' ' ' GLU . 2.3 m-80 -65.05 -39.02 92.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.163 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 54.4 mt -71.13 -48.13 53.92 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.147 -0.971 . . . . 0.0 109.084 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 41' ' ' ARG . . . . . 0.845 HH11 ' HG3' ' E' ' 41' ' ' ARG . 0.2 OUTLIER -50.67 -46.17 58.5 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.929 -1.107 . . . . 0.0 109.638 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -62.67 -34.53 77.29 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.176 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -70.63 -36.59 73.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.195 -0.941 . . . . 0.0 108.767 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 20.9 t -77.2 -51.36 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.754 -1.217 . . . . 0.0 109.222 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -49.03 -33.01 10.4 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.444 1.116 . . . . 0.0 110.254 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.31 -26.99 52.74 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.437 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -94.26 10.91 32.18 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.99 31.17 55.6 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 118.342 -1.885 . . . . 0.0 109.797 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -86.14 159.57 32.69 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 34.9 mmm -67.41 -41.69 84.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.144 -1.209 . . . . 0.0 110.5 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.74 -142.64 7.74 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 6.7 tp -130.71 132.55 45.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.531 -0.982 . . . . 0.0 109.284 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 53' ' ' ILE . . . . . 0.574 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 1.3 pt -107.53 145.52 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.568 -0.708 . . . . 0.0 110.192 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' E' ' 56' ' ' ARG . . . 71.37 -50.52 0.69 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.264 -0.897 . . . . 0.0 109.821 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 5.9 t80 50.93 -79.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 56' ' ' ARG . . . . . 0.748 HH11 ' HG2' ' E' ' 56' ' ' ARG . 0.0 OUTLIER 64.04 145.48 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.429 -0.794 . . . . 0.0 109.774 178.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 75.9 mt -128.1 112.08 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 58' ' ' THR . . . . . . . . . . . . . 11.3 m -84.9 70.28 10.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 109.442 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 59' ' ' CYS . . . . . . . . . . . . . 7.9 p -95.26 41.12 1.1 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.198 -0.939 . . . . 0.0 109.218 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -46.96 -78.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.27 -0.894 . . . . 0.0 109.882 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -152.0 100.67 2.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.195 -0.94 . . . . 0.0 109.44 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.14 164.64 17.63 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt 49.66 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.346 -1.09 . . . . 0.0 110.567 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 64' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -91.13 159.42 16.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.452 -0.78 . . . . 0.0 109.206 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.483 HD21 HD11 ' D' ' 57' ' ' ILE . 28.0 tp -169.66 109.81 0.43 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.013 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.44 74.2 0.66 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -65.5 138.59 58.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.116 -1.226 . . . . 0.0 109.721 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.42 154.15 25.31 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 70.6 m -99.97 134.9 42.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.144 -1.21 . . . . 0.0 108.082 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 12.6 mt -89.2 141.21 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 m -144.72 163.41 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.387 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -149.04 154.62 39.56 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.94 151.57 37.91 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 t70 66.91 -123.65 0.24 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.67 -0.644 . . . . 0.0 109.634 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -119.39 177.85 4.76 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.349 -0.844 . . . . 0.0 109.473 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.74 -179.34 4.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.416 -0.803 . . . . 0.0 109.143 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 77' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -82.05 73.71 9.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 109.316 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -158.29 125.63 5.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 109.434 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 46.9 p -76.1 152.27 36.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 45.0 ttm -150.48 77.95 1.31 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.212 -0.93 . . . . 0.0 109.283 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.39 -179.947 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 mtp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.45 ' H ' HD12 ' A' ' 2' ' ' ILE . 3.8 mp -100.58 150.25 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.335 -0.853 . . . . 0.0 109.35 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.0 t80 60.97 29.74 19.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 109.467 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.24 -35.23 63.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 109.489 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -70.06 121.42 17.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.527 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -62.93 95.95 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.3 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -104.01 123.02 46.44 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.653 -0.654 . . . . 0.0 109.77 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.0 mt -114.66 140.88 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.541 -0.724 . . . . 0.0 109.218 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 9' ' ' ILE . 14.4 tt -125.02 125.02 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.85 130.25 56.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.481 -0.762 . . . . 0.0 109.004 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.445 ' OG1' ' OG1' ' B' ' 69' ' ' THR . 45.7 m -105.21 105.15 15.06 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 52.88 58.11 5.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.311 -0.868 . . . . 0.0 109.892 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 39.9 t0 -143.59 -140.03 0.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.568 -0.708 . . . . 0.0 109.376 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.455 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 5.9 pt-20 -173.66 166.44 4.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.194 -0.942 . . . . 0.0 109.187 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.5 mt -136.13 71.21 62.03 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.378 -0.826 . . . . 0.0 109.158 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.26 156.55 45.02 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 C-N-CA 122.211 1.941 . . . . 0.0 110.225 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.27 -1.08 69.36 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.284 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 18' ' ' LEU . 37.1 mt -130.77 138.86 50.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.961 -1.317 . . . . 0.0 109.433 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.409 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 22.3 mm100 -84.6 108.77 17.52 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.6 mt -93.84 136.42 34.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.145 -0.972 . . . . 0.0 110.241 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 72' ' ' LYS . 47.4 t80 -116.02 129.13 56.23 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.23 124.52 24.32 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 120.305 -1.497 . . . . 0.0 110.316 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 72' ' ' LYS . 35.7 mt -110.1 3.86 20.64 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.04 -178.37 16.46 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.28 144.74 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.802 -0.822 . . . . 0.0 109.187 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.49 143.95 44.95 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.246 0.546 . . . . 0.0 110.078 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.3 m -152.29 134.69 15.21 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.0 t -150.1 153.65 36.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.822 -1.174 . . . . 0.0 109.328 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.2 mp -105.33 154.38 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 173.81 158.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 109.231 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -100.65 139.29 36.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.337 -0.852 . . . . 0.0 110.053 -178.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 3.9 t-20 81.04 141.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.81 -32.76 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.847 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.403 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 1.2 p30 -57.92 -43.5 86.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.927 . . . . 0.0 110.16 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.403 ' N ' ' CG ' ' A' ' 34' ' ' ASP . 63.9 mt-10 -75.18 -38.65 60.74 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.408 -0.808 . . . . 0.0 109.377 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.7 mt -63.52 -44.86 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.992 . . . . 0.0 109.478 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.77 -49.8 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.966 -1.084 . . . . 0.0 109.799 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -58.43 -38.94 78.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 109.678 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -63.12 -44.74 94.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.713 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.493 ' HA ' HD23 ' A' ' 40' ' ' LEU . 15.1 mt -69.44 -46.51 66.59 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.091 -1.006 . . . . 0.0 109.102 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.8 ' HG3' HH11 ' A' ' 41' ' ' ARG . 0.1 OUTLIER -49.43 -49.87 43.24 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 120.797 -1.19 . . . . 0.0 109.892 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -61.39 -36.97 81.74 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.521 -0.737 . . . . 0.0 110.29 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -77.07 -35.49 56.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.511 -0.743 . . . . 0.0 109.899 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.8 t -66.71 -50.88 62.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.035 -1.041 . . . . 0.0 109.103 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.72 -35.65 80.63 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.392 -1.323 . . . . 0.0 109.015 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.26 -28.86 69.47 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -5.63 56.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.517 -0.74 . . . . 0.0 109.881 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.81 11.82 57.42 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.08 161.55 36.12 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -125.27 -3.4 7.46 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.27 -1.135 . . . . 0.0 109.918 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.31 154.99 24.22 Favored Glycine 0 N--CA 1.487 2.087 0 C-N-CA 119.35 -1.405 . . . . 0.0 109.699 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.06 146.46 36.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.663 -0.904 . . . . 0.0 109.815 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.513 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -119.38 145.6 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.5 -0.75 . . . . 0.0 110.071 -177.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 70.2 79.24 0.19 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.581 -0.699 . . . . 0.0 110.451 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -103.07 136.61 42.56 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.51 ' HE ' HG21 ' A' ' 58' ' ' THR . 58.0 ttt180 -151.84 156.47 40.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.73 -1.231 . . . . 0.0 109.764 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.1 mt -140.62 -63.84 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.51 HG21 ' HE ' ' A' ' 56' ' ' ARG . 66.6 p 47.26 -167.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.378 -0.827 . . . . 0.0 109.717 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.417 ' HG ' ' CB ' ' E' ' 59' ' ' CYS . 13.2 m 54.89 170.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.506 -0.746 . . . . 0.0 109.684 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.14 -60.14 1.64 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.344 -0.847 . . . . 0.0 109.539 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -54.87 124.09 15.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.429 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -93.91 41.92 2.57 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.34 30.53 3.55 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.287 -1.125 . . . . 0.0 109.672 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -83.55 -98.31 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.134 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -173.04 100.34 0.13 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.475 -0.766 . . . . 0.0 110.282 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.42 -175.88 0.61 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -161.47 141.6 10.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.143 -1.21 . . . . 0.0 110.073 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.23 153.23 22.62 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.324 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.433 ' OG1' HG23 ' E' ' 11' ' ' THR . 19.2 m -105.22 137.47 42.95 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.225 -1.162 . . . . 0.0 108.703 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 52.4 mt -80.66 141.86 14.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -131.59 153.7 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.379 -0.826 . . . . 0.0 109.466 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.574 ' NZ ' ' O ' ' A' ' 74' ' ' ASP . 15.9 ttpp -142.03 133.53 26.7 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 19' ' ' GLN . . . -123.45 151.82 42.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.001 -1.062 . . . . 0.0 108.568 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.574 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 13.4 m-20 55.45 -143.8 0.71 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.882 -1.136 . . . . 0.0 110.234 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.417 ' CD ' ' H ' ' A' ' 75' ' ' GLU . 18.2 mp0 -62.79 -85.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 109.305 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -169.94 -46.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 109.464 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -93.4 -67.37 0.86 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.227 -0.92 . . . . 0.0 109.444 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 79' ' ' THR . 88.7 t80 -164.87 127.55 2.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.405 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.435 ' O ' ' CD2' ' A' ' 78' ' ' PHE . 0.9 OUTLIER -55.47 160.49 2.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 109.557 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.525 ' N ' ' SD ' ' A' ' 80' ' ' MET . 0.3 OUTLIER -61.91 -56.25 21.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 109.483 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.451 -179.913 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 55.2 mtt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 4.8 tt -167.06 148.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.88 . . . . 0.0 109.155 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' B' ' 3' ' ' PHE . 15.6 p90 -142.59 54.23 1.41 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.343 -0.848 . . . . 0.0 109.387 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -60.49 -25.56 66.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.278 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.81 132.61 35.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 109.521 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -138.54 -108.3 0.17 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -0.923 . . . . 0.0 108.671 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -92.81 120.44 33.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.139 -0.975 . . . . 0.0 109.22 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 68.4 mt -115.94 146.28 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.612 -0.68 . . . . 0.0 109.6 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.617 ' O ' HG23 ' B' ' 9' ' ' ILE . 9.5 tt -131.82 115.22 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -123.49 158.36 31.46 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.463 ' OG1' ' OG1' ' C' ' 69' ' ' THR . 1.5 m -112.67 103.18 11.21 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.33 88.45 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.468 -0.77 . . . . 0.0 109.853 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -162.08 -20.78 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.428 -0.795 . . . . 0.0 109.514 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 60.37 160.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.627 -0.671 . . . . 0.0 109.417 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 mt -130.4 82.94 64.03 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.561 -0.712 . . . . 0.0 109.084 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.58 156.37 42.52 Favored 'Trans proline' 0 C--N 1.323 -0.815 0 C-N-CA 122.068 1.845 . . . . 0.0 110.252 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.71 -6.34 77.12 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' B' ' 18' ' ' LEU . 66.9 mt -130.96 139.64 50.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.049 -1.265 . . . . 0.0 109.06 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.18 116.43 23.53 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.79 140.42 33.01 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.18 -0.95 . . . . 0.0 110.032 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' B' ' 71' ' ' VAL . 2.1 t80 -123.31 129.51 51.43 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 42.0 t -67.44 130.61 43.59 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.826 -1.171 . . . . 0.0 111.138 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.521 HD11 ' CB ' ' B' ' 72' ' ' LYS . 72.3 mt -116.71 8.24 13.69 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.42 -171.13 14.9 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 40.6 mm -119.05 141.9 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.908 -0.76 . . . . 0.0 109.367 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.15 144.82 42.01 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.616 -0.678 . . . . 0.0 109.425 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 85.3 p -152.22 137.8 17.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.097 -1.002 . . . . 0.0 108.599 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 8.8 t -149.74 149.6 30.81 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.937 -1.102 . . . . 0.0 109.265 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 66.1 mt -116.13 126.33 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.307 -0.87 . . . . 0.0 109.047 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 32.5 t -174.87 -146.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.148 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -158.91 172.01 18.99 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.211 -0.931 . . . . 0.0 108.814 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 2.1 m120 73.46 130.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 t -68.88 -35.12 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.551 -0.718 . . . . 0.0 109.49 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -58.96 -45.22 91.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.268 -0.895 . . . . 0.0 109.944 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -75.58 -42.1 52.93 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 0.0 109.872 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 77.8 mt -63.46 -53.77 41.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.917 -1.115 . . . . 0.0 109.322 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 t -56.9 -48.54 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.012 -1.055 . . . . 0.0 108.765 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -61.65 -41.18 97.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 110.064 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -58.68 -48.01 82.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.551 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 57.6 mt -74.26 -50.49 18.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 108.934 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -48.81 -47.85 41.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.776 -1.202 . . . . 0.0 108.892 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -61.32 -34.91 76.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 109.449 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -74.42 -36.03 63.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.524 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.29 -51.66 20.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.926 -1.109 . . . . 0.0 108.898 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -51.32 -29.25 14.45 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 122.613 1.196 . . . . 0.0 109.788 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.3 -26.76 52.59 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.439 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -94.26 8.41 41.88 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.07 31.13 68.14 Favored Glycine 0 N--CA 1.476 1.353 0 C-N-CA 118.157 -1.973 . . . . 0.0 109.911 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.48 -169.34 32.44 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 25.0 mmm -106.86 -37.2 6.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.397 -1.061 . . . . 0.0 109.554 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 176.16 -149.49 9.91 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 tp -137.65 143.72 41.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.357 -1.084 . . . . 0.0 109.823 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.65 ' O ' ' HB3' ' B' ' 54' ' ' ALA . 1.2 pt -114.36 146.63 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.5 -0.75 . . . . 0.0 109.376 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 82.88 -48.42 0.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 118.769 0.713 . . . . 0.0 109.893 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.524 ' C ' ' O ' ' B' ' 54' ' ' ALA . 78.5 t80 25.1 92.54 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 120.965 0.412 . . . . 0.0 110.593 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.833 ' HG3' HH11 ' B' ' 56' ' ' ARG . 11.2 ttm-85 -98.77 153.46 18.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.214 -0.929 . . . . 0.0 109.821 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -162.73 151.16 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' THR . . . . . 0.401 ' OG1' ' CD2' ' B' ' 64' ' ' PHE . 63.5 p -137.46 -136.05 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' CYS . . . . . 0.461 ' O ' ' HB3' ' B' ' 60' ' ' ALA . 0.8 OUTLIER 179.83 -173.29 0.21 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -0.963 . . . . 0.0 109.02 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' B' ' 59' ' ' CYS . . . 64.67 -176.9 0.17 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.651 -0.656 . . . . 0.0 109.644 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -72.31 148.4 45.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.334 -0.854 . . . . 0.0 109.214 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' B' ' 64' ' ' PHE . . . 136.76 2.57 2.47 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' B' ' 64' ' ' PHE . 52.7 mttp 60.06 -71.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.999 -0.706 . . . . 0.0 110.192 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.544 ' N ' ' O ' ' B' ' 62' ' ' GLY . 59.5 m-85 58.68 157.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mp -140.73 136.45 32.57 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.755 0.788 . . . . 0.0 110.763 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.14 53.49 0.94 Allowed Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -59.3 178.44 0.14 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.685 1.231 . . . . 0.0 110.228 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.63 160.41 26.25 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' THR . . . . . 0.445 ' OG1' ' OG1' ' A' ' 11' ' ' THR . 21.7 m -95.87 135.04 38.13 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 120.494 -1.591 . . . . 0.0 107.786 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 58.9 mt -83.64 146.39 6.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 4.3 m -136.31 162.33 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.551 -0.718 . . . . 0.0 109.989 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.521 ' CB ' HD11 ' B' ' 23' ' ' LEU . 5.9 tttt -152.28 141.76 21.67 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.37 151.36 29.87 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.953 -1.092 . . . . 0.0 108.694 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -154.35 64.6 0.69 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.957 -1.089 . . . . 0.0 108.689 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' GLU . . . . . 0.432 ' O ' ' HB3' ' B' ' 76' ' ' ALA . 30.9 mm-40 -75.47 -56.59 4.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 109.562 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' B' ' 75' ' ' GLU . . . 63.34 47.64 3.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.56 -0.713 . . . . 0.0 109.65 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -129.46 107.49 9.53 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.484 -0.76 . . . . 0.0 109.409 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -164.4 109.91 1.0 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.83 . . . . 0.0 109.343 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' B' ' 80' ' ' MET . 1.4 t -160.21 -177.56 6.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.451 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' MET . . . . . 0.445 ' N ' ' OG1' ' B' ' 79' ' ' THR . 26.5 mmt -61.85 -32.99 73.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 109.53 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.418 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' MET . . . . . 0.54 ' O ' ' N ' ' C' ' 3' ' ' PHE . 1.8 mpt? . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 59.5 mt 58.51 -79.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.679 -0.638 . . . . 0.0 109.522 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' C' ' 1' ' ' MET . 0.1 OUTLIER 54.67 -156.59 0.22 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 109.068 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -125.55 -31.11 3.02 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.573 -0.704 . . . . 0.0 109.396 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 5' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -51.99 -47.17 65.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.076 -1.015 . . . . 0.0 109.104 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? 70.33 104.95 0.06 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.505 -0.747 . . . . 0.0 109.987 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -97.8 121.82 40.16 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.479 -0.763 . . . . 0.0 109.053 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.94 135.98 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.479 -0.763 . . . . 0.0 110.591 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 9' ' ' ILE . . . . . 0.633 ' O ' HG23 ' C' ' 9' ' ' ILE . 13.9 tt -132.12 113.33 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 4.9 t -124.45 160.65 27.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.346 -0.846 . . . . 0.0 109.284 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 4.3 p -110.26 83.45 1.76 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.75 -28.45 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.647 -0.658 . . . . 0.0 110.14 177.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 13' ' ' ASP . . . . . 0.604 ' N ' ' OD1' ' C' ' 13' ' ' ASP . 0.0 OUTLIER 68.51 43.33 1.41 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.479 -0.763 . . . . 0.0 109.49 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -178.67 129.3 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.105 -0.997 . . . . 0.0 109.521 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 16.6 mt -134.28 79.14 56.21 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.98 155.14 51.83 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 122.02 1.814 . . . . 0.0 110.503 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.15 -6.17 78.61 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 18' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' C' ' 18' ' ' LEU . 53.9 mt -131.6 139.58 49.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -1.198 . . . . 0.0 109.518 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 19' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' C' ' 73' ' ' ALA . 85.6 mt-30 -84.91 114.24 21.98 Favored 'General case' 0 C--O 1.192 -1.929 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 16.1 mt -94.64 138.56 32.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.783 -1.198 . . . . 0.0 110.752 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 21' ' ' TYR . . . . . 0.688 ' H ' ' H ' ' C' ' 72' ' ' LYS . 29.3 t80 -116.99 128.29 55.04 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.606 -0.684 . . . . 0.0 109.733 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.04 123.34 21.87 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 120.022 -1.674 . . . . 0.0 110.308 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.474 HD11 ' CB ' ' C' ' 72' ' ' LYS . 78.6 mt -114.69 7.68 16.0 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.96 -174.74 15.89 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.17 144.17 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 122.037 -0.684 . . . . 0.0 109.244 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.3 144.6 45.71 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.95 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 42.1 m -152.61 142.39 22.0 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.96 -1.087 . . . . 0.0 108.421 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 9.2 t -149.52 146.69 27.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.101 -0.999 . . . . 0.0 109.359 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 71.7 mt -113.52 137.37 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.399 -0.813 . . . . 0.0 110.253 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.554 ' OG ' ' N ' ' C' ' 31' ' ' ASP . 0.1 OUTLIER -158.97 -172.81 3.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.48 -0.763 . . . . 0.0 109.78 -179.1 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 31' ' ' ASP . . . . . 0.554 ' N ' ' OG ' ' C' ' 30' ' ' SER . 4.8 m-20 -97.14 -76.14 0.52 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.322 -0.861 . . . . 0.0 111.91 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -76.88 156.07 32.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.927 -1.108 . . . . 0.0 109.104 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.52 -32.89 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.315 0.579 . . . . 0.0 109.803 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.54 -38.0 63.38 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.329 -0.857 . . . . 0.0 109.474 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -76.86 -35.36 57.53 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.017 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 81.5 mt -63.56 -53.28 47.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.047 -1.033 . . . . 0.0 108.991 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.11 -50.59 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.05 -1.031 . . . . 0.0 109.152 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -57.92 -38.94 76.81 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.304 -0.873 . . . . 0.0 108.964 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -65.79 -42.12 91.14 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.93 . . . . 0.0 109.522 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 40' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' C' ' 40' ' ' LEU . 24.8 mt -69.41 -47.65 63.46 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.012 -1.055 . . . . 0.0 108.753 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -49.41 -54.15 18.98 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.885 -1.134 . . . . 0.0 109.261 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -56.66 -34.16 67.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.899 . . . . 0.0 109.208 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -74.8 -43.74 53.14 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.33 -0.856 . . . . 0.0 109.321 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 10.5 t -71.64 -52.29 26.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 O-C-N 120.846 -1.159 . . . . 0.0 108.647 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -51.73 -31.5 26.66 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.823 1.296 . . . . 0.0 110.075 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.3 -28.09 47.43 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.705 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.13 4.32 53.4 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.72 26.49 69.95 Favored Glycine 0 N--CA 1.48 1.605 0 C-N-CA 118.631 -1.747 . . . . 0.0 109.804 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.85 162.98 50.76 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 16.2 ttp -79.91 -42.04 24.9 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.836 -1.39 . . . . 0.0 109.946 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 172.5 -170.3 43.37 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 tp -113.2 141.97 46.34 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.561 -0.964 . . . . 0.0 110.403 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 2.2 pt -119.82 145.71 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.44 -0.787 . . . . 0.0 110.406 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 70.99 -56.01 0.63 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.209 -0.932 . . . . 0.0 110.823 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 1.1 t80 61.37 -123.4 0.84 Allowed 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' ARG . . . . . 0.838 HH11 ' HG2' ' C' ' 56' ' ' ARG . 0.0 OUTLIER -170.36 -138.65 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.239 -0.913 . . . . 0.0 109.928 -179.432 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 57' ' ' ILE . . . . . 0.484 ' H ' ' CG ' ' C' ' 56' ' ' ARG . 0.6 OUTLIER 49.95 84.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.185 -0.947 . . . . 0.0 109.637 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 58' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' C' ' 59' ' ' CYS . 2.2 t -167.55 -172.82 2.02 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.114 -0.991 . . . . 0.0 109.5 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 59' ' ' CYS . . . . . 0.45 ' N ' ' OG1' ' C' ' 58' ' ' THR . 40.9 t 52.5 -96.09 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.361 -0.837 . . . . 0.0 109.607 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.94 41.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.226 -0.922 . . . . 0.0 109.411 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -162.33 108.13 1.24 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.336 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.79 72.78 0.2 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -119.22 -52.29 2.29 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.504 -0.998 . . . . 0.0 109.315 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -74.12 -145.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 109.715 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.537 ' O ' HD12 ' C' ' 65' ' ' LEU . 0.4 OUTLIER -82.48 -176.39 6.21 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.123 -0.985 . . . . 0.0 109.416 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 66' ' ' GLY . . . . . 0.51 ' C ' ' CD2' ' C' ' 67' ' ' TYR . . . -126.05 -140.26 5.27 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 106.144 -2.782 . . . . 0.0 106.144 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 67' ' ' TYR . . . . . 0.51 ' CD2' ' C ' ' C' ' 66' ' ' GLY . 0.1 OUTLIER -165.67 102.23 0.69 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.869 -1.371 . . . . 0.0 108.127 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.39 173.41 15.37 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 69' ' ' THR . . . . . 0.463 ' OG1' ' OG1' ' B' ' 11' ' ' THR . 53.0 m -122.75 132.82 54.4 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 119.036 1.418 . . . . 0.0 107.582 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 57.7 mt -79.13 129.73 37.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.17 161.88 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.445 -0.784 . . . . 0.0 109.87 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 72' ' ' LYS . . . . . 0.688 ' H ' ' H ' ' C' ' 21' ' ' TYR . 6.5 tttt -154.21 142.62 20.61 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' C' ' 19' ' ' GLN . . . -102.64 128.8 49.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.08 -1.013 . . . . 0.0 109.374 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.1 165.53 18.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.0 109.065 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 75' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -99.18 147.5 25.05 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.443 -0.786 . . . . 0.0 109.473 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -163.42 -22.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 0.0 109.306 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 77' ' ' GLN . . . . . 0.449 ' H ' ' HG2' ' C' ' 77' ' ' GLN . 18.4 pt20 -74.51 140.34 44.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.388 -0.82 . . . . 0.0 109.471 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 78' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' C' ' 78' ' ' PHE . 4.4 p90 -82.75 -29.1 29.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.286 -0.884 . . . . 0.0 109.58 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 1.8 p -139.55 152.65 47.06 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.295 -0.878 . . . . 0.0 109.277 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 15.3 tpt -164.18 149.68 10.58 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.399 -0.813 . . . . 0.0 109.385 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.314 -179.896 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' D' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 2' ' ' ILE . . . . . . . . . . . . . 5.3 tt -69.25 156.82 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.069 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -122.85 94.31 4.23 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -81.35 -74.4 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.865 . . . . 0.0 109.343 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 5' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.34 137.57 18.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.261 -0.899 . . . . 0.0 109.425 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -144.28 -65.21 0.36 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.997 0.903 . . . . 0.0 109.828 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -102.15 121.57 42.48 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 58.3 mt -133.65 128.42 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.434 -0.791 . . . . 0.0 109.351 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 9' ' ' ILE . . . . . 0.625 HG23 ' O ' ' D' ' 9' ' ' ILE . 9.1 tt -128.23 115.12 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.7 t -125.64 157.36 37.45 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 3.5 m -102.55 81.9 2.09 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.3 -112.15 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.452 -0.78 . . . . 0.0 110.203 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -152.49 -135.67 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.552 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -63.22 158.96 18.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -0.876 . . . . 0.0 109.371 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 38.9 mt -112.23 98.95 44.91 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.18 155.84 43.37 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.896 1.731 . . . . 0.0 110.392 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.68 -8.11 78.89 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 80.6 mt -131.44 142.27 49.98 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.42 -1.047 . . . . 0.0 109.309 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -87.77 108.45 19.13 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 20' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' D' ' 71' ' ' VAL . 4.3 mt -114.9 131.6 56.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.687 -0.633 . . . . 0.0 109.599 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 21' ' ' TYR . . . . . 0.595 ' OH ' ' N ' ' D' ' 74' ' ' ASP . 0.0 OUTLIER -113.73 143.42 44.64 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.576 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 16.6 t -75.06 128.33 35.29 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' D' ' 72' ' ' LYS . 0.7 OUTLIER -111.93 12.38 20.77 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.575 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.5 -179.09 16.35 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.9 144.01 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 122.174 -0.604 . . . . 0.0 109.606 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.25 144.28 40.67 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.405 0.621 . . . . 0.0 109.377 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 27' ' ' SER . . . . . 0.611 ' HB2' HD21 ' D' ' 65' ' ' LEU . 0.9 OUTLIER -152.47 138.4 18.1 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.265 -0.897 . . . . 0.0 109.356 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 12.7 t -149.73 144.5 26.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.044 -1.035 . . . . 0.0 109.189 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.43 ' O ' HG23 ' D' ' 29' ' ' ILE . 12.9 tt -117.95 127.91 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.271 -0.893 . . . . 0.0 108.93 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 30.1 t -173.65 174.28 3.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 109.056 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 31' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' D' ' 32' ' ' ASN . 29.5 t70 -107.49 157.29 18.14 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.332 -0.855 . . . . 0.0 109.565 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 3.7 t-20 85.97 123.81 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 -177.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 33' ' ' VAL . . . . . 0.454 ' H ' HG13 ' D' ' 33' ' ' VAL . 1.0 OUTLIER -69.86 -38.95 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -63.12 -31.0 72.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.539 -0.726 . . . . 0.0 109.878 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -75.0 -41.08 60.19 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.223 -0.923 . . . . 0.0 109.717 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 92.6 mt -62.2 -46.31 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.999 -1.063 . . . . 0.0 108.7 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 17.0 t -55.75 -48.07 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.909 -1.119 . . . . 0.0 108.288 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -62.76 -42.23 99.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.024 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -59.67 -45.56 91.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.333 -0.855 . . . . 0.0 109.415 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' D' ' 40' ' ' LEU . 49.4 mt -71.36 -48.0 52.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 108.899 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -49.07 -50.92 34.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.79 -1.194 . . . . 0.0 109.113 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -59.96 -36.21 76.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.398 -0.814 . . . . 0.0 109.952 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -75.8 -35.85 59.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.465 -0.772 . . . . 0.0 109.598 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 13.1 t -71.07 -50.79 39.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.066 -1.022 . . . . 0.0 108.799 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -64.74 -30.13 71.13 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 118.29 -1.364 . . . . 0.0 109.255 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.66 -30.41 69.95 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 47' ' ' LYS . . . . . 0.514 ' NZ ' ' HB3' ' D' ' 47' ' ' LYS . 0.1 OUTLIER -90.36 2.07 55.93 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.79 23.83 74.13 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.08 -165.65 7.92 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 7.8 ttt -110.2 -41.26 4.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.418 -1.048 . . . . 0.0 109.702 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 173.58 -158.66 28.06 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 3.4 tp -125.07 139.86 53.42 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.595 -0.944 . . . . 0.0 110.36 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 53' ' ' ILE . . . . . 0.656 ' O ' ' HB3' ' D' ' 54' ' ' ALA . 1.0 OUTLIER -118.06 148.53 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.672 -0.643 . . . . 0.0 110.501 -177.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 82.73 -38.22 0.09 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 118.832 0.742 . . . . 0.0 109.131 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.498 ' O ' ' O ' ' D' ' 56' ' ' ARG . 31.3 t80 49.18 -110.41 0.4 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.624 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 56' ' ' ARG . . . . . 0.753 ' HG2' HH11 ' D' ' 56' ' ' ARG . 6.4 mtt-85 57.59 123.54 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.418 0.628 . . . . 0.0 109.868 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 57' ' ' ILE . . . . . 0.401 HG13 ' N ' ' D' ' 58' ' ' THR . 1.9 pt -136.21 -168.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.246 -0.909 . . . . 0.0 109.198 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 58' ' ' THR . . . . . 0.401 ' N ' HG13 ' D' ' 57' ' ' ILE . 39.7 p -144.93 118.68 9.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.534 -0.729 . . . . 0.0 109.107 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 59' ' ' CYS . . . . . . . . . . . . . 15.3 p -163.87 68.42 0.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.413 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.28 -8.84 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.359 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -162.04 -17.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.33 -0.856 . . . . 0.0 109.31 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . 174.38 106.95 0.2 Allowed Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.632 -1.27 . . . . 0.0 109.959 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 63' ' ' LYS . . . . . 0.731 ' HD3' ' H ' ' D' ' 63' ' ' LYS . 0.0 OUTLIER -61.68 -93.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.895 -1.356 . . . . 0.0 109.293 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 64' ' ' PHE . . . . . 0.495 ' HB3' ' O ' ' D' ' 63' ' ' LYS . 63.9 t80 74.38 60.42 0.08 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.183 0.516 . . . . 0.0 110.518 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.611 HD21 ' HB2' ' D' ' 27' ' ' SER . 3.2 tp 68.05 159.7 0.16 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.341 -0.849 . . . . 0.0 109.182 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 66' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' D' ' 67' ' ' TYR . . . -118.0 -30.44 1.78 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 178.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 67' ' ' TYR . . . . . 0.502 ' CB ' ' O ' ' D' ' 66' ' ' GLY . 1.7 t80 81.03 123.79 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.277 1.037 . . . . 0.0 111.665 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.1 139.68 5.81 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 46.9 m -109.55 148.32 31.45 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.065 -1.256 . . . . 0.0 109.536 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 24.1 mt -97.78 148.04 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.54 0.686 . . . . 0.0 109.577 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 71' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' D' ' 20' ' ' LEU . 12.2 m -143.34 154.18 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.491 -0.755 . . . . 0.0 109.357 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 72' ' ' LYS . . . . . 0.431 ' HB2' HD11 ' D' ' 23' ' ' LEU . 26.3 ttpp -139.98 142.5 36.33 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.049 -1.032 . . . . 0.0 108.667 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' D' ' 74' ' ' ASP . . . -124.11 141.36 52.12 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 74' ' ' ASP . . . . . 0.595 ' N ' ' OH ' ' D' ' 21' ' ' TYR . 3.5 p30 172.37 30.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -78.17 122.38 25.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.039 -1.038 . . . . 0.0 109.696 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -175.93 -101.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.983 . . . . 0.0 111.011 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 171.95 146.15 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 78' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -123.5 -44.79 2.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.442 -0.786 . . . . 0.0 109.437 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 3.8 t -166.76 31.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 17.6 mmt 49.73 -159.33 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.281 -0.887 . . . . 0.0 109.477 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.449 -179.938 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 33.1 mtt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 6.2 pt -88.17 166.45 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.249 -0.907 . . . . 0.0 109.179 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 3' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -137.64 1.35 2.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.425 -0.797 . . . . 0.0 109.222 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -76.25 63.75 1.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 109.635 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 5' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -54.1 173.12 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.297 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 6' ' ' LYS . . . . . 0.512 ' CG ' ' H ' ' E' ' 7' ' ' PHE . 14.7 tttt -154.57 -154.51 0.51 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.912 -1.118 . . . . 0.0 109.793 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 7' ' ' PHE . . . . . 0.512 ' H ' ' CG ' ' E' ' 6' ' ' LYS . 18.8 t80 -109.85 120.73 43.39 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.562 -0.711 . . . . 0.0 109.672 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 83.7 mt -96.86 128.57 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.323 -0.86 . . . . 0.0 110.988 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 9' ' ' ILE . . . . . 0.554 ' O ' HG23 ' E' ' 9' ' ' ILE . 17.1 tt -134.48 121.01 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 1.3 t -113.34 133.25 55.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.322 -0.861 . . . . 0.0 109.336 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 11' ' ' THR . . . . . 0.433 HG23 ' OG1' ' A' ' 69' ' ' THR . 0.0 OUTLIER -53.63 -90.74 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.397 -0.814 . . . . 0.0 110.984 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.09 72.72 1.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.123 -0.986 . . . . 0.0 108.366 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -160.26 141.53 12.32 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.415 0.626 . . . . 0.0 109.512 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -79.56 178.68 7.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.398 -0.814 . . . . 0.0 109.127 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 57.5 mt -123.6 88.17 51.96 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.474 -0.766 . . . . 0.0 109.184 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.55 155.49 52.76 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 121.962 1.775 . . . . 0.0 110.158 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.02 -12.34 69.78 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 18' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' E' ' 18' ' ' LEU . 15.9 mt -125.2 136.83 53.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -1.185 . . . . 0.0 108.982 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.14 112.84 21.68 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt -99.08 142.62 30.34 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.187 -0.946 . . . . 0.0 109.83 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 21' ' ' TYR . . . . . 0.479 ' H ' ' H ' ' E' ' 72' ' ' LYS . 1.5 t80 -123.29 130.07 52.23 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 22' ' ' SER . . . . . 0.403 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 4.3 t -61.39 129.97 43.8 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.83 -1.169 . . . . 0.0 110.953 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' E' ' 23' ' ' LEU . 6.8 mt -117.65 9.26 13.03 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.67 -173.6 14.86 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.77 143.92 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 122.033 -0.687 . . . . 0.0 109.433 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.61 144.04 47.34 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.943 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 19.4 m -152.18 136.34 16.57 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 10.9 t -149.92 151.49 33.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.972 -1.08 . . . . 0.0 109.222 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 56.6 mt -127.0 133.44 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.111 -0.993 . . . . 0.0 108.702 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.574 ' O ' ' N ' ' E' ' 32' ' ' ASN . 78.1 p -156.29 31.77 0.33 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.134 -0.979 . . . . 0.0 110.769 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 31' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' E' ' 31' ' ' ASP . 0.7 OUTLIER 54.28 -70.59 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 32' ' ' ASN . . . . . 0.574 ' N ' ' O ' ' E' ' 30' ' ' SER . 7.3 m120 -66.1 135.41 54.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.732 -1.23 . . . . 0.0 107.93 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 33' ' ' VAL . . . . . 0.482 ' H ' HG13 ' E' ' 33' ' ' VAL . 1.0 OUTLIER -70.88 -42.21 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 34' ' ' ASP . . . . . 0.421 ' N ' ' CG2' ' E' ' 33' ' ' VAL . 29.8 t70 -52.53 -28.02 18.98 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.512 -0.742 . . . . 0.0 109.825 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -78.11 -33.39 50.6 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.422 -0.799 . . . . 0.0 109.202 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.16 -52.77 57.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.031 -1.043 . . . . 0.0 108.776 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.89 -49.24 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.085 -1.01 . . . . 0.0 108.967 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -60.71 -41.86 96.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.414 -0.804 . . . . 0.0 108.978 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -64.46 -45.2 88.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.471 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 40' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' E' ' 40' ' ' LEU . 70.4 mt -64.57 -44.03 92.01 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.098 -1.001 . . . . 0.0 108.329 178.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 41' ' ' ARG . . . . . 0.796 HH11 ' HG2' ' E' ' 41' ' ' ARG . 0.0 OUTLIER -48.84 -55.5 11.48 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.845 -1.159 . . . . 0.0 109.352 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -55.96 -33.56 64.89 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.088 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -74.44 -40.07 62.17 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.462 -0.773 . . . . 0.0 109.494 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 12.8 t -73.87 -52.01 22.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 120.879 -1.138 . . . . 0.0 108.82 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -50.59 -29.6 11.22 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.692 1.234 . . . . 0.0 109.741 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.63 -25.84 50.04 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.383 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -95.71 4.38 53.04 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.67 30.73 78.73 Favored Glycine 0 N--CA 1.479 1.555 0 C-N-CA 118.009 -2.043 . . . . 0.0 110.181 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.32 153.92 23.84 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 10.8 mtm -66.46 -29.61 69.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -1.111 . . . . 0.0 110.474 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.74 -137.51 4.61 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 tp -133.64 137.93 45.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.421 -1.046 . . . . 0.0 110.086 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 53' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 1.1 pt -115.12 144.9 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.609 -0.682 . . . . 0.0 110.163 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 64.91 74.84 0.38 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.166 -0.959 . . . . 0.0 110.216 178.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 55' ' ' PHE . . . . . 0.4 ' CE2' HG21 ' E' ' 57' ' ' ILE . 17.9 t80 -98.56 107.47 19.93 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 56' ' ' ARG . . . . . 0.685 ' CG ' HH11 ' E' ' 56' ' ' ARG . 0.4 OUTLIER -97.3 135.63 38.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.582 -0.699 . . . . 0.0 110.529 -178.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 57' ' ' ILE . . . . . 0.4 HG21 ' CE2' ' E' ' 55' ' ' PHE . 1.2 tt 179.04 104.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 58' ' ' THR . . . . . . . . . . . . . 63.0 m -149.51 -95.48 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.04 -1.038 . . . . 0.0 109.408 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 59' ' ' CYS . . . . . 0.417 ' CB ' ' HG ' ' A' ' 59' ' ' CYS . 78.4 m -67.24 104.93 1.59 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.195 -0.941 . . . . 0.0 109.768 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.02 48.18 0.7 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.255 -0.903 . . . . 0.0 109.258 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -54.22 -22.03 10.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.865 . . . . 0.0 109.502 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 163.14 -6.05 0.08 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -92.08 150.21 21.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.16 -1.2 . . . . 0.0 109.523 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 64' ' ' PHE . . . . . 0.527 ' H ' HD12 ' E' ' 65' ' ' LEU . 96.7 m-85 -153.55 31.44 0.46 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.253 -0.904 . . . . 0.0 109.286 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.527 HD12 ' H ' ' E' ' 64' ' ' PHE . 3.3 mp -99.53 118.15 35.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.399 -0.813 . . . . 0.0 110.306 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 66' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' E' ' 67' ' ' TYR . . . -71.11 59.56 1.05 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 67' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' E' ' 66' ' ' GLY . 78.3 m-85 -39.55 114.2 0.4 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.63 -0.924 . . . . 0.0 110.032 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.61 149.72 21.11 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 8.6 m -112.81 137.5 51.05 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 32.0 mt -82.78 148.68 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 m -130.44 164.8 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.662 -0.649 . . . . 0.0 109.907 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 72' ' ' LYS . . . . . 0.479 ' H ' ' H ' ' E' ' 21' ' ' TYR . 14.6 tttm -147.95 145.43 28.57 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.89 137.96 49.15 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -145.3 120.53 10.18 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.728 -1.233 . . . . 0.0 108.13 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -160.95 54.6 0.3 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -0.936 . . . . 0.0 109.326 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.19 -46.18 11.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.908 . . . . 0.0 109.491 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 77' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -165.31 -143.55 0.06 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.301 -0.874 . . . . 0.0 109.412 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -95.25 115.5 27.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.094 -1.004 . . . . 0.0 109.363 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 36.7 p -69.08 102.58 1.67 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.341 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 11.1 mmt -57.31 154.75 10.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.497 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.44 -179.967 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.289 0.566 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.3 mm -78.05 -64.16 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 109.357 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -85.98 116.98 24.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -0.912 . . . . 0.0 109.443 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.03 164.56 23.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 109.529 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -84.79 134.71 34.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 109.46 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -89.93 132.75 35.16 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.327 -0.858 . . . . 0.0 108.884 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -101.7 121.98 43.06 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.5 mt -134.49 138.15 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.29 -0.881 . . . . 0.0 109.978 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.478 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 6.9 tt -127.8 118.21 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.788 -1.195 . . . . 0.0 108.088 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.4 t -127.24 154.93 44.24 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.059 -1.026 . . . . 0.0 109.563 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.424 HG21 ' HG3' ' A' ' 56' ' ' ARG . 1.4 m -135.54 115.95 13.63 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.52 66.23 1.23 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.344 -0.848 . . . . 0.0 109.655 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -164.13 -24.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.54 -0.725 . . . . 0.0 109.504 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 57.15 171.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.519 -0.738 . . . . 0.0 109.438 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mt -139.01 74.7 36.53 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.371 -0.831 . . . . 0.0 109.099 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.44 156.47 41.22 Favored 'Trans proline' 0 C--N 1.32 -0.952 0 C-N-CA 122.132 1.888 . . . . 0.0 110.197 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.08 -3.71 73.55 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.261 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 18' ' ' LEU . 42.6 mt -129.9 137.87 50.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.279 . . . . 0.0 108.871 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.454 ' H ' ' HG2' ' A' ' 19' ' ' GLN . 12.0 pt20 -85.91 113.82 22.33 Favored 'General case' 0 C--O 1.2 -1.518 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -95.0 138.81 32.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.892 -1.13 . . . . 0.0 109.603 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.712 ' O ' HG12 ' A' ' 71' ' ' VAL . 42.4 t80 -109.97 155.07 22.26 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.45 126.56 38.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 119.857 -1.777 . . . . 0.0 108.07 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.7 mt -117.08 5.91 12.83 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.69 -164.36 13.51 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.35 145.24 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 122.027 -0.69 . . . . 0.0 109.653 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.99 154.37 25.41 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 87.0 p -147.11 150.18 34.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.126 -0.984 . . . . 0.0 109.087 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.7 p -148.86 134.71 18.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.539 -0.726 . . . . 0.0 109.468 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.653 ' O ' ' OG ' ' A' ' 30' ' ' SER . 10.6 mm -127.12 126.0 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.653 ' OG ' ' O ' ' A' ' 29' ' ' ILE . 23.4 m 171.81 -129.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.175 0.512 . . . . 0.0 109.679 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.464 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 3.1 p30 -153.38 165.15 36.68 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.045 -1.034 . . . . 0.0 109.227 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 7.8 t-20 77.55 109.52 0.07 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -177.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.494 ' H ' HG13 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -69.36 -38.06 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.359 -0.838 . . . . 0.0 108.868 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 35' ' ' GLU . 1.9 p30 -61.17 -32.4 72.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.845 . . . . 0.0 110.095 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.46 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 31.1 tt0 -75.69 -37.45 59.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 0.0 109.139 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.1 mt -62.51 -42.61 96.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.12 -0.988 . . . . 0.0 108.836 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.28 -50.19 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.007 -1.058 . . . . 0.0 108.81 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -59.37 -38.94 81.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 109.663 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -61.76 -43.34 99.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.387 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 76.8 mt -68.07 -46.05 72.15 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.169 -0.957 . . . . 0.0 108.527 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -50.65 -53.3 32.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.899 -1.126 . . . . 0.0 109.199 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -57.81 -33.53 68.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.426 -0.796 . . . . 0.0 109.093 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -72.98 -41.88 63.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.331 -0.855 . . . . 0.0 109.34 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.568 HG21 HD21 ' A' ' 52' ' ' LEU . 21.1 t -77.01 -50.93 19.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 120.682 -1.261 . . . . 0.0 109.359 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -49.73 -32.97 14.79 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 122.681 1.229 . . . . 0.0 109.954 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.25 -29.26 48.0 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.824 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -93.54 5.8 50.39 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.25 29.43 68.71 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 118.265 -1.922 . . . . 0.0 109.629 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.2 -168.53 11.06 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -104.85 -53.9 2.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -1.059 . . . . 0.0 109.955 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.415 ' C ' HD22 ' A' ' 52' ' ' LEU . . . -176.74 178.21 48.02 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.568 HD21 HG21 ' A' ' 44' ' ' VAL . 3.9 mm? -98.88 135.05 40.87 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.377 -1.073 . . . . 0.0 110.261 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 54' ' ' ALA . 1.4 pt -112.11 139.01 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.664 -0.647 . . . . 0.0 109.392 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 53' ' ' ILE . . . 43.52 45.79 5.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.157 -0.964 . . . . 0.0 109.501 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.12 -27.17 28.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 0.0 109.209 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.643 HH22 ' CB ' ' B' ' 27' ' ' SER . 8.4 mmt180 -42.33 160.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.665 0.745 . . . . 0.0 109.891 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.669 ' H ' ' CD1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -51.12 -21.76 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.478 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 59' ' ' CYS . 0.2 OUTLIER 69.61 -176.99 0.21 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 0.0 109.48 -179.387 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.483 ' H ' HG22 ' A' ' 58' ' ' THR . 41.9 t -65.71 80.98 0.07 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.215 -0.928 . . . . 0.0 109.565 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -151.5 -38.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.911 . . . . 0.0 109.265 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.5 t70 53.75 18.73 1.62 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.366 -0.833 . . . . 0.0 109.341 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.58 -25.12 73.97 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.9 tttt 54.44 39.09 30.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.365 -1.08 . . . . 0.0 109.28 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.467 ' CE1' ' O ' ' A' ' 30' ' ' SER . 1.4 t80 -168.56 42.38 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.23 -0.919 . . . . 0.0 109.37 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.5 tp -165.89 129.9 2.22 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.252 -0.905 . . . . 0.0 109.804 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.07 133.13 6.3 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -150.17 174.54 12.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.389 -1.065 . . . . 0.0 109.83 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.31 156.98 13.09 Favored Glycine 0 N--CA 1.487 2.091 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.284 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.8 m -98.29 135.39 39.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.193 -1.18 . . . . 0.0 108.617 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.4 mt -89.63 131.28 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 21' ' ' TYR . 5.4 m -138.5 167.7 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.664 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -150.94 150.86 31.33 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 19' ' ' GLN . . . -105.98 115.65 30.59 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.181 -0.949 . . . . 0.0 110.938 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 173.63 165.73 0.18 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.384 0.612 . . . . 0.0 109.596 -178.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -58.89 -29.13 66.79 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.457 -0.777 . . . . 0.0 109.251 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.55 -172.14 0.06 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.337 -0.852 . . . . 0.0 109.086 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 61.04 158.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.475 -0.765 . . . . 0.0 109.604 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -61.45 145.31 52.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.31 -0.868 . . . . 0.0 109.41 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.76 171.14 14.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.887 . . . . 0.0 109.309 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 50.6 mtm -57.89 -58.74 7.05 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.436 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 16.2 pt -58.07 -20.43 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.918 . . . . 0.0 109.457 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 23.4 t80 54.18 -126.84 2.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.306 -0.872 . . . . 0.0 109.483 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -64.63 123.66 19.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 0.0 109.41 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -75.18 -71.63 0.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.28 -0.888 . . . . 0.0 109.362 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -168.0 98.13 0.45 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.098 -1.001 . . . . 0.0 109.71 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -92.95 120.08 32.9 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.172 -0.955 . . . . 0.0 108.728 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 14.9 mt -115.57 135.68 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.454 -0.779 . . . . 0.0 110.383 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.677 HD11 ' CD1' ' B' ' 55' ' ' PHE . 19.0 tt -134.46 114.09 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.9 t -123.01 159.59 28.06 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.377 -0.827 . . . . 0.0 108.926 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.0 p -101.68 72.72 1.39 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -177.01 -137.3 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.156 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 179.68 90.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.473 -0.767 . . . . 0.0 109.577 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLU . . . . . 0.401 ' HB3' ' HD3' ' B' ' 16' ' ' PRO . 32.5 mt-10 -156.85 -81.56 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.349 -0.844 . . . . 0.0 109.447 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.506 ' N ' ' HD3' ' B' ' 16' ' ' PRO . 8.2 mt 47.18 62.35 12.02 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.118 -0.989 . . . . 0.0 108.952 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' B' ' 15' ' ' ILE . 1.4 Cg_endo -65.97 155.63 68.53 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.997 1.798 . . . . 0.0 109.909 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.07 -10.65 74.42 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.308 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' LEU . . . . . 0.408 HD12 ' CG2' ' B' ' 15' ' ' ILE . 76.1 mt -124.89 137.28 54.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.08 -1.247 . . . . 0.0 108.638 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -101.45 116.41 32.72 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' B' ' 72' ' ' LYS . 0.2 OUTLIER -111.99 134.57 53.46 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.556 -0.715 . . . . 0.0 110.688 -177.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 21' ' ' TYR . . . . . 0.658 ' CD1' ' N ' ' B' ' 21' ' ' TYR . 0.0 OUTLIER -105.17 152.75 22.44 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.02 128.83 34.8 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.504 -0.747 . . . . 0.0 109.6 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 mt -113.17 7.06 17.77 Favored 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.03 -157.08 22.49 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 176.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -135.02 143.68 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.963 -0.728 . . . . 0.0 109.359 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.94 145.59 45.65 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.128 0.49 . . . . 0.0 109.738 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.643 ' CB ' HH22 ' A' ' 56' ' ' ARG . 0.0 OUTLIER -152.05 141.36 21.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.005 -1.059 . . . . 0.0 108.459 179.783 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 14.1 t -149.63 152.85 36.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.199 -0.938 . . . . 0.0 109.083 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 68.6 mt -126.8 133.1 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.2 -0.937 . . . . 0.0 109.375 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 34.2 t -165.59 166.06 18.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.438 -0.789 . . . . 0.0 109.338 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -96.63 70.95 2.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.238 -0.914 . . . . 0.0 109.645 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 169.31 129.04 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.44 ' CG2' ' N ' ' B' ' 34' ' ' ASP . 1.3 m -71.16 -43.62 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.44 ' N ' ' CG2' ' B' ' 33' ' ' VAL . 33.9 m-20 -63.76 -45.16 91.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.348 -0.845 . . . . 0.0 109.681 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -60.37 -39.18 86.31 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.678 -0.809 . . . . 0.0 108.872 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 48.5 mt -64.07 -51.89 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.92 . . . . 0.0 108.877 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -53.64 -48.31 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.977 . . . . 0.0 108.508 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -60.8 -40.26 91.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.335 -0.853 . . . . 0.0 110.102 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -64.36 -44.38 91.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 109.478 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' B' ' 40' ' ' LEU . 40.9 mt -68.45 -48.76 63.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.131 -0.981 . . . . 0.0 108.527 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -49.0 -48.58 43.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.846 -1.159 . . . . 0.0 108.945 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -62.19 -36.31 81.5 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.51 -0.744 . . . . 0.0 109.965 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -75.5 -35.96 60.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.385 -0.822 . . . . 0.0 109.668 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.75 -51.6 26.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.062 -1.024 . . . . 0.0 108.902 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -56.0 -28.73 58.47 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.669 1.223 . . . . 0.0 109.147 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.26 -28.33 59.78 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.385 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -96.42 -5.22 40.25 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.11 24.72 70.7 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 118.466 -1.825 . . . . 0.0 109.175 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.25 -171.11 9.25 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -112.36 -40.12 4.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.502 -0.999 . . . . 0.0 109.896 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 171.52 175.53 39.94 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.495 ' CD2' ' N ' ' B' ' 52' ' ' LEU . 2.3 mm? -96.99 133.85 41.13 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.378 -1.072 . . . . 0.0 109.942 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 49.7 mt -110.25 137.05 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.727 -0.608 . . . . 0.0 109.973 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 57.95 71.42 0.58 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.816 . . . . 0.0 109.815 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.677 ' CD1' HD11 ' B' ' 9' ' ' ILE . 2.0 t80 -58.38 -73.25 0.08 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.36 -0.837 . . . . 0.0 108.923 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' B' ' 55' ' ' PHE . 7.1 tpt180 58.01 113.61 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.411 -0.806 . . . . 0.0 110.157 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.78 133.49 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 17.0 p -143.9 142.2 30.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.31 -0.869 . . . . 0.0 109.367 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 7.6 t -179.82 151.11 0.42 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -165.76 43.4 0.07 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.893 . . . . 0.0 109.328 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -164.38 -9.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 109.519 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.02 -138.45 2.43 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -77.65 165.0 24.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -1.141 . . . . 0.0 109.605 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -79.22 -165.0 0.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 0.0 109.565 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 46.7 tp -157.49 113.43 2.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.393 -0.817 . . . . 0.0 109.078 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -123.12 152.4 16.93 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -167.81 -175.48 2.76 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.473 -1.016 . . . . 0.0 109.399 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.0 -162.4 35.29 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 97.6 m -123.84 137.79 54.6 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 31.1 mt -83.81 125.49 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 6.5 m -136.94 164.18 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.824 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' B' ' 20' ' ' LEU . 3.0 mttt -136.1 146.67 47.26 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.33 -0.856 . . . . 0.0 108.879 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' B' ' 74' ' ' ASP . . . -114.88 116.75 29.05 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.81 -0.556 . . . . 0.0 110.235 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' ASP . . . . . 0.566 ' O ' ' OH ' ' B' ' 21' ' ' TYR . 5.5 t70 156.25 131.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.774 0.797 . . . . 0.0 109.655 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -173.41 158.24 3.46 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.724 -1.235 . . . . 0.0 109.462 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.31 167.67 20.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.866 . . . . 0.0 109.197 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -99.55 -60.14 1.59 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.34 -0.85 . . . . 0.0 109.489 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -67.45 143.63 56.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.209 -0.932 . . . . 0.0 110.002 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 10.0 m -50.16 159.66 0.43 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.475 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' MET . . . . . . . . . . . . . 7.3 tpt -112.61 61.15 0.63 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.546 -0.721 . . . . 0.0 109.297 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.379 179.902 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 11.2 mm -62.65 -84.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -83.35 170.85 14.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.893 . . . . 0.0 109.161 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -139.03 172.86 12.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.362 -0.836 . . . . 0.0 109.215 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 5' ' ' ASP . . . . . 0.439 ' OD1' ' NH2' ' C' ' 41' ' ' ARG . 26.3 t70 -162.44 48.69 0.17 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.234 -0.916 . . . . 0.0 110.362 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -73.23 45.87 0.17 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.722 -1.236 . . . . 0.0 110.147 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -92.77 120.31 33.02 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.135 -0.978 . . . . 0.0 108.728 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 44.8 mt -119.45 128.57 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.513 -0.742 . . . . 0.0 109.788 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 9' ' ' ILE . . . . . 0.61 ' O ' HG23 ' C' ' 9' ' ' ILE . 13.4 tt -119.96 114.14 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -122.94 159.97 27.17 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 11' ' ' THR . . . . . 0.432 HG22 ' H ' ' C' ' 55' ' ' PHE . 7.7 p -125.55 77.57 1.66 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.642 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.35 -117.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.398 -1.439 . . . . 0.0 108.371 -176.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -84.41 -134.27 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.136 -0.977 . . . . 0.0 109.796 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.75 28.93 5.54 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.529 -0.732 . . . . 0.0 109.862 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 33.2 mt 57.06 81.63 0.25 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.393 -0.817 . . . . 0.0 109.58 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.93 156.84 41.61 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 122.21 1.94 . . . . 0.0 110.37 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.18 -0.95 69.44 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.378 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 60.8 mt -131.52 138.99 49.17 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.111 -1.229 . . . . 0.0 109.155 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -97.54 109.55 22.29 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' LEU . . . . . 0.604 HD23 ' HB2' ' C' ' 73' ' ' ALA . 0.0 OUTLIER -120.2 143.97 47.97 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.748 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 21' ' ' TYR . . . . . 0.666 ' CD1' ' N ' ' C' ' 21' ' ' TYR . 0.0 OUTLIER -113.65 146.85 39.14 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.509 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -72.85 136.91 45.41 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.642 0.734 . . . . 0.0 109.999 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.437 HD12 HG22 ' C' ' 70' ' ' ILE . 5.8 mt -118.47 15.37 13.8 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.02 179.76 16.18 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 47.1 mm -112.3 142.26 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.795 -0.827 . . . . 0.0 108.826 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.38 144.17 43.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.528 -0.733 . . . . 0.0 109.899 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 35.4 t -152.31 137.66 17.57 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 15.2 t -149.62 152.3 35.22 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.055 -1.028 . . . . 0.0 109.369 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -102.15 155.02 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 30' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' C' ' 31' ' ' ASP . 12.1 t -176.19 -178.06 0.95 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.975 . . . . 0.0 109.225 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 31' ' ' ASP . . . . . 0.448 ' N ' ' OG ' ' C' ' 30' ' ' SER . 20.0 t70 -102.2 -80.78 0.5 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.411 -0.806 . . . . 0.0 110.971 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -65.08 144.12 57.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.996 -1.065 . . . . 0.0 108.731 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 33' ' ' VAL . . . . . 0.417 ' H ' HG13 ' C' ' 33' ' ' VAL . 1.4 m -69.47 -38.44 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -54.59 -28.16 44.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.459 -0.776 . . . . 0.0 109.848 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -76.23 -34.74 59.22 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.309 -0.869 . . . . 0.0 109.479 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 84.2 mt -58.76 -46.9 90.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.171 -0.955 . . . . 0.0 108.913 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 55.6 t -56.86 -49.57 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.952 -1.092 . . . . 0.0 108.637 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -61.8 -42.78 99.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.437 -0.789 . . . . 0.0 109.402 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -60.26 -48.67 80.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.535 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 67.2 mt -64.68 -42.9 95.03 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 41' ' ' ARG . . . . . 0.778 HH11 ' HG2' ' C' ' 41' ' ' ARG . 0.8 OUTLIER -48.2 -47.7 35.28 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.861 -1.15 . . . . 0.0 109.275 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -63.13 -31.83 73.06 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -73.8 -41.74 61.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.832 . . . . 0.0 109.518 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 38.1 t -68.29 -51.24 49.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.705 -1.247 . . . . 0.0 109.292 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -51.0 -33.44 24.84 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.642 1.211 . . . . 0.0 110.223 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.76 -28.83 50.72 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.678 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.55 7.31 43.8 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.48 29.77 64.11 Favored Glycine 0 N--CA 1.487 2.08 0 C-N-CA 118.672 -1.727 . . . . 0.0 109.759 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.26 148.9 27.14 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -65.23 -33.63 76.45 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.174 -1.192 . . . . 0.0 110.826 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 171.56 -159.04 30.47 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 11.4 tp -121.18 135.57 55.12 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.588 -0.948 . . . . 0.0 109.622 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 60.7 mt -110.87 144.03 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.492 -0.755 . . . . 0.0 110.022 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.12 82.64 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.232 -0.918 . . . . 0.0 110.713 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 55' ' ' PHE . . . . . 0.439 ' O ' ' CD2' ' C' ' 55' ' ' PHE . 82.5 t80 -126.9 65.79 1.28 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.332 0.587 . . . . 0.0 110.143 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 56' ' ' ARG . . . . . 0.744 HH11 ' HG2' ' C' ' 56' ' ' ARG . 7.7 mtt-85 -80.02 148.43 31.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 109.495 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 44.5 mm -77.81 154.13 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.828 . . . . 0.0 109.292 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 58' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' C' ' 59' ' ' CYS . 1.1 t -59.99 -179.04 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.33 -0.856 . . . . 0.0 109.517 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 59' ' ' CYS . . . . . 0.447 ' N ' ' OG1' ' C' ' 58' ' ' THR . 12.4 p -161.39 -10.42 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 109.445 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.421 ' H ' ' H ' ' C' ' 59' ' ' CYS . . . -165.36 -127.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 109.467 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -69.96 71.58 0.39 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.191 -0.943 . . . . 0.0 108.854 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -168.57 9.01 0.05 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.84 174.87 10.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.473 -1.016 . . . . 0.0 109.739 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 49.35 49.76 19.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.354 -0.841 . . . . 0.0 109.194 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 8.1 tp -176.43 89.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.536 -0.727 . . . . 0.0 109.895 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.91 155.09 50.57 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 67' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' C' ' 67' ' ' TYR . 21.7 p90 -147.53 120.83 8.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.105 -1.232 . . . . 0.0 109.767 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.38 165.34 32.85 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 95.1 m -117.05 141.46 48.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.294 -1.121 . . . . 0.0 108.925 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 70' ' ' ILE . . . . . 0.437 HG22 HD12 ' C' ' 23' ' ' LEU . 41.9 mt -95.09 133.48 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.443 -0.785 . . . . 0.0 109.019 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 10.6 m -144.26 156.15 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.41 -0.806 . . . . 0.0 109.608 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 72' ' ' LYS . . . . . 0.463 ' HG3' ' CE2' ' C' ' 21' ' ' TYR . 18.4 ptpt -142.33 140.06 32.0 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.26 -0.9 . . . . 0.0 108.691 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.604 ' HB2' HD23 ' C' ' 20' ' ' LEU . . . -126.67 152.96 46.03 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.761 -1.212 . . . . 0.0 108.503 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.576 ' O ' ' CB ' ' C' ' 75' ' ' GLU . 27.1 t70 82.47 -130.99 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 75' ' ' GLU . . . . . 0.576 ' CB ' ' O ' ' C' ' 74' ' ' ASP . 35.6 tt0 93.78 -54.93 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 76' ' ' ALA . . . . . 0.523 ' C ' ' O ' ' C' ' 75' ' ' GLU . . . 27.51 51.52 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.66 0 O-C-N 122.012 -0.43 . . . . 0.0 110.028 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 77' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' C' ' 76' ' ' ALA . 16.7 tp60 35.84 -120.65 0.13 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.986 -0.446 . . . . 0.0 109.854 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -130.36 -79.23 0.54 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.312 -0.868 . . . . 0.0 109.085 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 7.3 m -160.82 -116.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 109.35 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 37.3 mtt -64.97 -60.81 2.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.082 -1.011 . . . . 0.0 109.452 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.49 -179.878 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.494 ' SD ' ' N ' ' D' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 2' ' ' ILE . . . . . . . . . . . . . 11.6 pt -147.33 56.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.278 -0.888 . . . . 0.0 109.254 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -62.94 -44.77 95.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.433 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.8 152.09 46.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.336 -0.852 . . . . 0.0 108.837 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -121.28 103.99 9.38 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.631 -0.668 . . . . 0.0 109.45 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 mtpt -151.73 80.95 1.28 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 109.412 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -114.77 121.96 44.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.493 -0.754 . . . . 0.0 109.555 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 51.6 mt -101.65 131.39 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.445 -0.784 . . . . 0.0 109.477 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 9' ' ' ILE . . . . . 0.664 HD11 ' CD2' ' D' ' 55' ' ' PHE . 18.7 tt -124.42 119.89 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 6.0 t -116.35 132.19 56.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.341 -0.85 . . . . 0.0 109.228 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 11' ' ' THR . . . . . 0.729 ' OG1' ' OG1' ' E' ' 69' ' ' THR . 8.6 m -67.74 -117.83 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 12' ' ' ALA . . . . . 0.659 ' C ' ' O ' ' D' ' 11' ' ' THR . . . -2.39 -98.83 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.504 0 CA-C-N 118.318 0.508 . . . . 0.0 110.357 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 13' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' D' ' 12' ' ' ALA . 3.5 p30 161.91 91.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? 176.65 128.99 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.503 -0.748 . . . . 0.0 109.864 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 35.5 mt -143.46 69.34 17.44 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.26 155.49 56.53 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.928 1.752 . . . . 0.0 110.284 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.63 -4.73 76.41 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 18' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' D' ' 18' ' ' LEU . 15.7 mt -129.88 138.64 51.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -1.193 . . . . 0.0 109.967 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -83.74 108.39 16.76 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 mt -103.3 138.88 39.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.463 -0.773 . . . . 0.0 110.425 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 21' ' ' TYR . . . . . 0.473 ' CE1' ' O ' ' D' ' 22' ' ' SER . 1.4 t80 -121.39 129.94 53.32 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 22' ' ' SER . . . . . 0.473 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 21.5 t -67.37 133.1 48.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.987 -1.07 . . . . 0.0 111.478 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 mt -123.74 12.42 9.18 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.34 176.03 19.33 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -109.78 144.33 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.905 -0.762 . . . . 0.0 109.567 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.56 154.1 30.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.663 -0.648 . . . . 0.0 109.556 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 6.6 p -152.51 137.29 17.04 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 12.5 t -149.44 151.36 33.87 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.077 -1.014 . . . . 0.0 109.63 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 6.4 mt -102.99 155.26 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 120.924 -1.11 . . . . 0.0 108.658 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.516 ' O ' ' N ' ' D' ' 32' ' ' ASN . 0.6 OUTLIER 176.13 -20.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.04 -1.037 . . . . 0.0 110.403 179.622 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 62.8 -41.39 0.18 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.777 -0.577 . . . . 0.0 111.465 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.541 ' O ' HG13 ' D' ' 36' ' ' ILE . 7.8 t-20 -85.86 141.22 29.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.972 -1.08 . . . . 0.0 109.28 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 33' ' ' VAL . . . . . 0.4 ' H ' HG23 ' D' ' 33' ' ' VAL . 3.0 t -68.41 -41.6 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.874 -1.141 . . . . 0.0 110.612 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -54.53 -43.97 72.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.39 -0.819 . . . . 0.0 110.238 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -76.8 -36.64 56.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.426 -0.797 . . . . 0.0 109.678 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 36' ' ' ILE . . . . . 0.645 HG22 ' CE1' ' D' ' 55' ' ' PHE . 96.8 mt -61.69 -41.52 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.961 -1.087 . . . . 0.0 108.623 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.416 HG23 ' CZ ' ' D' ' 55' ' ' PHE . 13.6 t -69.39 -46.37 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.665 -1.272 . . . . 0.0 108.954 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -66.98 -44.34 80.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.397 -0.814 . . . . 0.0 110.793 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -55.04 -48.5 73.36 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.041 -1.037 . . . . 0.0 109.659 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 38.8 mt -64.85 -37.79 88.81 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.297 -0.877 . . . . 0.0 109.287 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -54.53 -43.8 72.25 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.614 -1.304 . . . . 0.0 109.73 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm -67.62 -40.07 84.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.3 -0.875 . . . . 0.0 110.373 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -75.79 -36.14 59.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.86 . . . . 0.0 109.755 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.83 -50.07 73.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.049 -1.032 . . . . 0.0 109.333 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -65.25 -30.71 71.61 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 118.411 -1.316 . . . . 0.0 108.743 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.33 -28.46 66.26 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.554 0.692 . . . . 0.0 109.267 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -93.09 -6.55 47.82 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.469 -0.769 . . . . 0.0 109.514 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.16 30.06 15.45 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.145 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.77 155.55 18.29 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.39 -9.1 9.53 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.466 -1.02 . . . . 0.0 109.282 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.94 162.74 30.62 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 4.1 tp -130.47 140.32 50.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.632 -0.923 . . . . 0.0 109.769 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 53' ' ' ILE . . . . . 0.458 ' O ' ' HB3' ' D' ' 54' ' ' ALA . 13.9 mt -108.48 138.39 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 65.63 76.71 0.32 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.314 -0.867 . . . . 0.0 109.779 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.664 ' CD2' HD11 ' D' ' 9' ' ' ILE . 84.1 t80 -99.06 138.89 35.52 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.49 -0.756 . . . . 0.0 110.313 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 56' ' ' ARG . . . . . 0.661 ' O ' ' CE2' ' D' ' 55' ' ' PHE . 26.7 ttp180 -95.72 163.17 13.3 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 57' ' ' ILE . . . . . 0.976 ' N ' HD13 ' D' ' 57' ' ' ILE . 0.1 OUTLIER -134.15 -129.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.321 -0.862 . . . . 0.0 109.676 -177.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 58' ' ' THR . . . . . . . . . . . . . 75.1 p -55.54 -77.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.077 -1.015 . . . . 0.0 110.094 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 59' ' ' CYS . . . . . . . . . . . . . 5.9 t 68.49 105.57 0.05 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 60' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' D' ' 62' ' ' GLY . . . -46.39 145.92 1.59 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.283 -0.886 . . . . 0.0 109.708 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 50.88 -90.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.3 -0.875 . . . . 0.0 109.412 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 62' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' D' ' 60' ' ' ALA . . . 80.56 48.58 6.2 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -52.24 -23.87 6.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -1.117 . . . . 0.0 109.271 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -85.1 -125.89 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.392 -0.818 . . . . 0.0 109.381 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 65' ' ' LEU . . . . . 0.686 HD23 ' N ' ' D' ' 65' ' ' LEU . 1.2 pt? -168.66 170.29 9.56 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.361 -0.837 . . . . 0.0 109.978 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.01 171.89 11.52 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -160.89 153.61 20.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.953 -1.321 . . . . 0.0 109.535 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.24 152.32 11.01 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.544 -1.312 . . . . 0.0 110.327 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 48.9 m -94.04 134.5 36.38 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.009 -1.289 . . . . 0.0 108.458 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 44.5 mt -84.81 127.58 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 71' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' D' ' 21' ' ' TYR . 4.3 m -135.38 159.31 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 110.218 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 10.6 pttp -152.25 148.6 27.76 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.76 150.72 26.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.23 -0.919 . . . . 0.0 108.852 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -73.88 154.25 39.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.023 -1.048 . . . . 0.0 109.393 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -88.88 -127.28 0.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.237 -0.914 . . . . 0.0 109.477 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -163.33 -171.71 2.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.924 . . . . 0.0 109.188 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -141.35 135.07 30.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.308 -0.87 . . . . 0.0 109.454 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 78' ' ' PHE . . . . . . . . . . . . . 76.2 t80 48.67 84.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.37 -0.831 . . . . 0.0 109.554 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 6.3 t -125.0 166.74 15.8 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.453 -0.779 . . . . 0.0 109.478 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 34.8 ttm 53.19 86.65 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.368 -0.833 . . . . 0.0 109.52 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.468 -179.967 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mmt . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.43 0.633 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 2' ' ' ILE . . . . . 0.441 HG13 ' H ' ' E' ' 2' ' ' ILE . 0.8 OUTLIER -70.55 161.23 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.418 -0.801 . . . . 0.0 109.196 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 3' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -70.54 -50.97 32.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.453 -0.779 . . . . 0.0 109.564 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -136.3 -179.78 5.88 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.377 -0.827 . . . . 0.0 109.419 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 5' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' E' ' 6' ' ' LYS . 1.7 p-10 -59.66 -78.03 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.867 . . . . 0.0 109.347 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 6' ' ' LYS . . . . . 0.494 ' H ' ' CG ' ' E' ' 5' ' ' ASP . 0.0 OUTLIER -175.36 85.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.333 -0.854 . . . . 0.0 108.961 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -97.92 123.08 41.74 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.355 -0.841 . . . . 0.0 109.416 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 34.0 mt -111.67 135.33 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.459 -0.776 . . . . 0.0 109.591 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 9' ' ' ILE . . . . . 0.6 ' O ' HG23 ' E' ' 9' ' ' ILE . 10.5 tt -132.43 115.76 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 4.1 t -124.0 155.87 37.46 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 11' ' ' THR . . . . . . . . . . . . . 2.0 p -115.95 89.45 3.11 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.74 -95.57 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.987 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -160.14 -35.9 0.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.4 -0.813 . . . . 0.0 109.426 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 14' ' ' GLU . . . . . 0.411 ' CG ' ' N ' ' E' ' 15' ' ' ILE . 29.7 tt0 -166.71 167.32 15.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 109.302 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 15' ' ' ILE . . . . . 0.411 ' N ' ' CG ' ' E' ' 14' ' ' GLU . 87.0 mt -115.73 92.75 35.03 Favored Pre-proline 0 N--CA 1.496 1.843 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.12 155.28 51.75 Favored 'Trans proline' 0 C--N 1.322 -0.85 0 C-N-CA 121.912 1.741 . . . . 0.0 110.318 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.9 -10.19 75.05 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 18' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' E' ' 18' ' ' LEU . 20.4 mt -127.59 138.95 53.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -1.1 . . . . 0.0 109.52 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -84.45 108.68 17.38 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 14.1 mt -96.99 142.97 28.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.389 -0.82 . . . . 0.0 110.752 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 21' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -126.36 130.15 50.21 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.77 129.37 39.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.733 -1.23 . . . . 0.0 110.793 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.899 HD11 ' HB2' ' E' ' 72' ' ' LYS . 97.6 mt -114.41 3.9 15.14 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.3 -172.9 19.68 Favored Glycine 0 N--CA 1.499 2.9 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 25' ' ' ILE . . . . . 0.471 HD11 HG23 ' D' ' 9' ' ' ILE . 39.6 mm -110.39 140.87 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.798 -0.825 . . . . 0.0 109.32 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.3 146.93 44.86 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.646 -0.659 . . . . 0.0 109.313 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 40.5 m -152.59 148.41 27.31 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.907 -1.121 . . . . 0.0 108.916 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 28' ' ' THR . . . . . 0.459 ' OG1' HG23 ' E' ' 36' ' ' ILE . 25.2 p -148.88 134.15 18.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.45 -0.781 . . . . 0.0 109.337 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' E' ' 30' ' ' SER . 87.5 mt -126.53 127.83 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' E' ' 29' ' ' ILE . 3.6 t 162.51 14.43 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 31' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' E' ' 31' ' ' ASP . 1.4 m-20 51.55 -174.23 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.125 -0.984 . . . . 0.0 109.02 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 32' ' ' ASN . . . . . . . . . . . . . 8.0 m120 68.1 100.18 0.05 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 45.0 t -69.16 -37.27 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.211 -0.931 . . . . 0.0 109.5 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -57.52 -42.14 82.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 110.029 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.79 -38.18 58.48 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.287 -0.883 . . . . 0.0 109.42 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 36' ' ' ILE . . . . . 0.459 HG23 ' OG1' ' E' ' 28' ' ' THR . 55.9 mt -63.51 -51.71 67.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.03 -1.044 . . . . 0.0 109.534 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 57.6 t -51.8 -51.14 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.082 -1.011 . . . . 0.0 109.125 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.07 -38.06 78.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -0.869 . . . . 0.0 109.409 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -63.66 -40.81 97.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.122 -0.986 . . . . 0.0 109.511 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 40' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' E' ' 40' ' ' LEU . 41.6 mt -68.49 -44.45 74.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.148 -0.97 . . . . 0.0 109.338 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -51.43 -37.71 49.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.653 -1.28 . . . . 0.0 109.596 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -73.71 -39.46 64.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.59 -0.694 . . . . 0.0 109.831 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -75.98 -35.79 59.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.371 -0.831 . . . . 0.0 109.67 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 11.5 t -67.32 -50.92 58.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 109.055 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -70.4 -36.88 74.33 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.315 -1.354 . . . . 0.0 109.035 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.45 -31.26 69.14 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -87.89 -5.25 58.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.412 -0.805 . . . . 0.0 109.809 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.21 5.54 58.11 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.03 161.23 48.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.99 -3.2 5.15 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.086 -1.243 . . . . 0.0 109.893 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.82 149.45 12.54 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 4.6 tp -108.64 139.96 42.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.675 -0.897 . . . . 0.0 109.595 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 53' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 1.0 OUTLIER -111.67 142.85 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.567 -0.708 . . . . 0.0 110.255 -178.67 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 62.24 75.87 0.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 110.131 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 55' ' ' PHE . . . . . 0.482 ' O ' ' CG ' ' E' ' 55' ' ' PHE . 58.7 t80 -104.65 23.95 12.54 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 56' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -54.82 149.16 11.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.84 . . . . 0.0 109.242 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 65.0 mt -119.96 97.87 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 58' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' E' ' 59' ' ' CYS . 1.0 OUTLIER -140.74 -168.49 2.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.442 -0.786 . . . . 0.0 109.212 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 59' ' ' CYS . . . . . 0.539 ' N ' ' OG1' ' E' ' 58' ' ' THR . 4.8 t 63.08 51.4 2.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.881 . . . . 0.0 109.498 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.71 78.72 0.11 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 109.402 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -77.59 -28.53 51.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -0.87 . . . . 0.0 109.494 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 62' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' E' ' 64' ' ' PHE . . . -176.8 -101.68 0.15 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -76.83 34.9 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.397 -1.06 . . . . 0.0 109.561 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 64' ' ' PHE . . . . . 0.43 ' H ' ' C ' ' E' ' 62' ' ' GLY . 75.4 m-85 51.46 -174.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.571 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 tp -174.86 127.83 0.3 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.87 79.21 0.62 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -80.01 134.14 36.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -1.173 . . . . 0.0 109.45 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.46 165.12 35.4 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 69' ' ' THR . . . . . 0.729 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 30.5 m -113.7 139.67 48.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.639 -0.918 . . . . 0.0 108.757 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 70' ' ' ILE . . . . . 0.546 HG22 HD12 ' E' ' 23' ' ' LEU . 43.3 mt -84.93 146.44 6.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 m -139.42 154.4 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.206 -0.934 . . . . 0.0 109.942 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 72' ' ' LYS . . . . . 0.899 ' HB2' HD11 ' E' ' 23' ' ' LEU . 33.0 ttpt -143.47 151.81 40.76 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.13 150.53 35.86 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.419 -0.801 . . . . 0.0 108.957 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -79.02 -168.17 1.38 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.102 -0.999 . . . . 0.0 109.132 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 75' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' E' ' 76' ' ' ALA . 0.7 OUTLIER -115.84 -86.65 0.61 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.513 -0.742 . . . . 0.0 109.546 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 76' ' ' ALA . . . . . 0.407 ' H ' ' HB3' ' E' ' 75' ' ' GLU . . . -169.12 174.92 5.97 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.033 -1.042 . . . . 0.0 109.041 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 77' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -90.84 -64.46 1.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.199 -0.938 . . . . 0.0 109.33 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -75.26 144.85 42.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -0.959 . . . . 0.0 109.43 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -167.95 -23.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.865 . . . . 0.0 109.453 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 16.6 tpp -163.68 32.24 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.226 -0.921 . . . . 0.0 109.42 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.666 -179.959 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.337 0.589 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.571 ' N ' HD13 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -62.49 174.99 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.348 -0.845 . . . . 0.0 109.541 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -160.46 -162.44 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.063 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -131.48 45.86 2.74 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.343 -0.848 . . . . 0.0 109.344 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -63.81 131.34 47.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 109.228 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -138.07 -65.23 0.52 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.39 -0.819 . . . . 0.0 110.541 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -89.69 121.07 31.52 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.147 -0.971 . . . . 0.0 109.247 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 57.0 mt -136.82 139.18 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.383 -0.823 . . . . 0.0 109.461 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.537 ' O ' HG23 ' A' ' 9' ' ' ILE . 13.9 tt -121.38 115.6 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.2 t -127.01 147.02 50.15 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.109 -0.994 . . . . 0.0 108.509 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.574 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -66.84 -110.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 177.111 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.519 ' N ' ' OG1' ' A' ' 11' ' ' THR . . . -33.0 -88.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.724 -0.61 . . . . 0.0 110.186 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 1.3 p-10 -170.33 -92.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.951 -1.093 . . . . 0.0 109.086 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.463 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 30.0 mt-10 74.71 -135.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.699 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 2.6 mt 65.01 46.41 0.54 Allowed Pre-proline 0 N--CA 1.486 1.351 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -176.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.699 ' HD3' ' N ' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -66.08 151.77 82.96 Favored 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 121.431 1.421 . . . . 0.0 110.003 179.184 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.16 -5.38 78.34 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.118 -1.515 . . . . 0.0 111.122 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 18' ' ' LEU . 59.7 mt -124.77 137.07 54.34 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.792 -1.416 . . . . 0.0 108.503 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -90.14 113.41 25.16 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.46 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 3.3 mt -107.22 128.18 54.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.701 -0.624 . . . . 0.0 110.106 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.581 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -109.86 157.88 18.75 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.3 t -81.56 126.45 31.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.478 -0.764 . . . . 0.0 109.618 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.712 HD11 ' CB ' ' A' ' 72' ' ' LYS . 16.4 mt -108.95 2.5 21.41 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.94 177.65 14.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.46 141.5 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.82 144.77 42.99 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.1 t -152.57 138.07 17.69 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.9 t -149.8 150.4 31.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.028 -1.045 . . . . 0.0 108.997 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.93 131.88 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 31' ' ' ASP . 14.3 p -172.5 13.47 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.324 -0.86 . . . . 0.0 109.576 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 30' ' ' SER . 37.1 t70 57.35 154.44 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.63 -0.669 . . . . 0.0 110.196 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 3.5 t-20 73.84 111.2 0.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.082 -1.011 . . . . 0.0 108.567 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.88 -33.54 62.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.358 -0.839 . . . . 0.0 109.354 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -52.52 -35.98 54.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 85.4 mt-10 -78.44 -33.88 48.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 108.809 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.0 mt -65.07 -53.82 36.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 120.961 -1.087 . . . . 0.0 108.937 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 t -58.06 -50.32 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.085 -1.009 . . . . 0.0 108.348 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -61.26 -41.27 96.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.565 -0.709 . . . . 0.0 109.761 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 35' ' ' GLU . 17.9 m120 -66.64 -42.52 86.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 0.0 109.329 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 40' ' ' LEU . 70.2 mt -62.49 -42.67 99.65 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.107 -0.995 . . . . 0.0 108.448 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -48.06 -56.4 7.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.625 -1.297 . . . . 0.0 109.389 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 93.8 mttt -57.34 -35.41 69.87 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.288 -0.882 . . . . 0.0 110.249 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -76.27 -35.53 58.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.791 . . . . 0.0 109.903 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.5 t -72.19 -51.29 30.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.187 -0.946 . . . . 0.0 108.834 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -69.6 -31.47 69.62 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 117.942 -1.503 . . . . 0.0 108.962 -175.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 42' ' ' LYS . . . -62.22 -31.12 71.62 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.7 mtpt -95.64 -3.83 45.51 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.36 27.6 47.61 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 118.864 -1.636 . . . . 0.0 109.751 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.18 -166.67 34.41 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -109.78 -46.65 3.46 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.53 -0.982 . . . . 0.0 109.851 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 174.98 -152.08 13.2 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -129.07 140.27 51.66 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.677 -0.896 . . . . 0.0 109.886 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.781 HD13 ' O ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -121.81 150.15 25.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.941 -0.474 . . . . 0.0 109.854 -178.167 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 11' ' ' THR . . . 73.5 108.5 0.07 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.996 -1.065 . . . . 0.0 111.301 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -127.07 148.38 50.14 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.504 0.669 . . . . 0.0 109.86 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.708 ' HE ' ' NH1' ' B' ' 56' ' ' ARG . 19.3 ttt180 -131.72 -31.57 1.54 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.457 0.646 . . . . 0.0 109.446 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -103.29 -173.46 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.473 ' HB ' ' OG ' ' B' ' 27' ' ' SER . 0.0 OUTLIER -168.96 -13.53 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.161 -0.962 . . . . 0.0 109.898 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.417 ' H ' ' H ' ' A' ' 58' ' ' THR . 49.7 t -166.67 -79.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.133 -0.979 . . . . 0.0 109.281 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.31 149.18 34.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.172 -0.955 . . . . 0.0 109.325 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -145.33 -66.98 0.31 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.364 -0.835 . . . . 0.0 109.41 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.56 84.51 0.03 OUTLIER Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 mttp 53.31 75.46 0.25 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.334 -1.097 . . . . 0.0 109.326 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -134.94 -33.39 0.93 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.434 -0.791 . . . . 0.0 109.683 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.1 tp 54.14 96.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.788 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.97 170.63 5.16 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -156.46 137.79 13.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.209 -1.171 . . . . 0.0 109.735 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.58 161.23 32.07 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.602 ' CB ' ' HG1' ' E' ' 11' ' ' THR . 80.8 m -107.8 140.0 41.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.265 -1.138 . . . . 0.0 108.862 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.515 HG22 HD12 ' A' ' 23' ' ' LEU . 54.8 mt -88.55 129.77 39.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 20' ' ' LEU . 15.7 m -132.75 155.04 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.498 -0.751 . . . . 0.0 109.602 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.712 ' CB ' HD11 ' A' ' 23' ' ' LEU . 10.4 tttp -142.61 147.91 36.6 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.176 -0.953 . . . . 0.0 109.245 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.87 151.04 39.49 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.339 -0.851 . . . . 0.0 108.807 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -146.3 86.21 1.68 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.102 -0.999 . . . . 0.0 108.702 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -68.24 -153.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.297 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.86 9.76 0.33 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.277 -0.889 . . . . 0.0 109.356 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -72.31 -149.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.337 -0.852 . . . . 0.0 109.394 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.7 t80 51.73 55.39 9.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 109.488 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t -59.51 161.48 5.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.505 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 26.4 ttt -153.95 110.68 3.36 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.314 -0.866 . . . . 0.0 109.361 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.369 -179.922 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 40.2 mtt . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 4.1 tt -152.14 127.61 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.384 -0.823 . . . . 0.0 109.139 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -151.77 -130.93 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 109.29 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -171.22 33.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.14 -0.975 . . . . 0.0 109.174 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -82.55 81.89 8.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.873 . . . . 0.0 108.955 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -107.85 -89.33 0.46 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -103.63 121.22 42.49 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.211 -0.93 . . . . 0.0 109.549 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 68.0 mt -112.89 128.37 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.507 -0.746 . . . . 0.0 109.985 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' B' ' 52' ' ' LEU . 2.9 tt -131.67 114.67 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.478 HG22 HG22 ' B' ' 53' ' ' ILE . 4.5 t -122.46 158.59 29.42 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.308 1.051 . . . . 0.0 109.272 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.475 HG23 ' OG1' ' C' ' 69' ' ' THR . 9.3 p -90.64 -105.84 0.1 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 42.72 -112.72 0.21 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.121 -0.987 . . . . 0.0 110.901 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -165.82 -20.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.271 -0.893 . . . . 0.0 109.909 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLU . . . . . 0.465 ' CG ' ' N ' ' B' ' 15' ' ' ILE . 67.3 tt0 -167.33 166.63 14.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.117 -0.99 . . . . 0.0 109.25 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.465 ' N ' ' CG ' ' B' ' 14' ' ' GLU . 61.5 mt -114.58 93.0 30.96 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -61.61 155.01 55.92 Favored 'Trans proline' 0 C--N 1.323 -0.803 0 C-N-CA 121.787 1.658 . . . . 0.0 110.485 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.88 -6.38 79.38 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 43.1 mt -132.17 141.43 49.1 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.474 -1.015 . . . . 0.0 109.699 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' GLN . . . . . 0.448 ' CG ' ' O ' ' B' ' 19' ' ' GLN . 19.5 pt20 -84.91 109.62 18.27 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 mt -102.57 136.71 41.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.953 -1.092 . . . . 0.0 109.437 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' B' ' 22' ' ' SER . 0.8 OUTLIER -121.39 130.46 53.61 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.559 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.56 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 40.2 t -60.2 129.3 41.01 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.035 0.921 . . . . 0.0 111.691 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 11.2 mt -114.08 12.09 17.82 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.33 -166.2 13.22 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 mm -120.13 134.74 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.06 149.41 38.95 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.487 -0.758 . . . . 0.0 109.917 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.473 ' OG ' ' HB ' ' A' ' 58' ' ' THR . 7.7 t -152.6 140.85 20.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.2 -0.937 . . . . 0.0 109.384 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 4.3 t -149.62 146.46 27.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.296 -0.877 . . . . 0.0 109.167 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 31.3 mt -127.7 131.75 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 53.8 m -155.91 14.77 0.34 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.993 -1.067 . . . . 0.0 110.306 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 72.36 -70.03 0.17 Allowed 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -76.81 140.42 40.68 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.993 -1.067 . . . . 0.0 108.153 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.471 HG11 ' OH ' ' C' ' 67' ' ' TYR . 96.7 t -69.05 -37.46 77.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.523 -0.736 . . . . 0.0 109.806 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.22 -36.27 51.7 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.356 -0.84 . . . . 0.0 110.516 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.08 -32.85 39.21 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.278 -0.889 . . . . 0.0 109.618 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 35.0 mt -62.27 -53.58 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.275 -0.89 . . . . 0.0 109.045 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 23.4 t -56.99 -49.8 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.229 -0.919 . . . . 0.0 108.59 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -60.95 -39.71 90.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.407 -0.808 . . . . 0.0 110.108 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -64.05 -43.43 95.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.164 -0.96 . . . . 0.0 109.594 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' B' ' 40' ' ' LEU . 18.8 mt -64.81 -43.05 94.42 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.115 -0.99 . . . . 0.0 109.185 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -49.94 -40.99 45.37 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.584 -1.323 . . . . 0.0 109.923 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -70.31 -37.11 74.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.605 -0.685 . . . . 0.0 110.051 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -76.5 -35.35 58.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.46 -0.775 . . . . 0.0 109.677 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 3.0 t -66.5 -50.3 68.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.134 -0.979 . . . . 0.0 108.913 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -65.45 -30.1 70.85 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.044 -1.462 . . . . 0.0 109.142 -175.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.93 -29.83 68.17 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.488 0.661 . . . . 0.0 109.312 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 mmmt -86.56 -5.47 59.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.627 -0.67 . . . . 0.0 109.517 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.01 5.38 62.54 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.66 164.32 50.5 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -128.65 -3.62 5.33 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.093 -1.24 . . . . 0.0 110.075 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.31 143.57 8.67 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' B' ' 9' ' ' ILE . 8.8 tp -108.23 141.87 39.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.582 -0.952 . . . . 0.0 109.659 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.478 HG22 HG22 ' B' ' 10' ' ' THR . 11.6 pt -142.66 172.07 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.789 -1.194 . . . . 0.0 108.876 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.35 33.01 22.75 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.518 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.6 120.41 30.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.788 -1.195 . . . . 0.0 108.612 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.708 ' NH1' ' HE ' ' A' ' 56' ' ' ARG . 39.4 ttp180 -105.13 166.8 10.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.419 -0.801 . . . . 0.0 109.626 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.805 HD11 ' CE1' ' C' ' 67' ' ' TYR . 16.5 mm -86.22 175.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.396 -0.815 . . . . 0.0 109.407 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' THR . . . . . 0.699 ' N ' HG22 ' B' ' 57' ' ' ILE . 0.5 OUTLIER -145.54 168.01 21.64 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.435 -0.79 . . . . 0.0 109.274 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 10.7 t -71.55 -178.73 2.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.347 -0.846 . . . . 0.0 109.458 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.67 -52.97 11.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.471 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' B' ' 62' ' ' GLY . 29.2 t70 -69.4 -175.13 0.76 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.453 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' B' ' 64' ' ' PHE . . . -63.23 -111.45 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 54.6 mttp 52.06 -92.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -1.116 . . . . 0.0 109.43 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.477 ' N ' ' O ' ' B' ' 62' ' ' GLY . 26.8 m-85 -79.52 169.19 18.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.216 -0.927 . . . . 0.0 109.146 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.628 HD23 ' N ' ' B' ' 65' ' ' LEU . 1.5 pt? -163.79 179.24 7.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.391 -0.818 . . . . 0.0 109.179 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.62 126.18 8.15 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' TYR . . . . . 0.482 ' CG ' ' O ' ' B' ' 67' ' ' TYR . 7.7 p90 -122.75 129.03 51.28 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.579 -0.954 . . . . 0.0 109.053 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.87 151.55 23.26 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m -104.48 143.76 32.59 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.303 -1.116 . . . . 0.0 108.79 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 49.2 mt -90.01 143.26 11.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.61 164.91 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.931 . . . . 0.0 110.02 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -154.08 157.31 38.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.538 -0.726 . . . . 0.0 109.236 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.33 150.7 38.38 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.165 -0.96 . . . . 0.0 108.605 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -69.24 139.56 54.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.95 -1.094 . . . . 0.0 109.453 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' GLU . . . . . 0.608 ' CD ' ' H ' ' B' ' 75' ' ' GLU . 1.4 pm0 -69.55 -169.54 0.23 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.273 -0.892 . . . . 0.0 109.402 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -157.21 156.52 32.73 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.311 -0.868 . . . . 0.0 109.126 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -80.66 156.54 26.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.093 -1.004 . . . . 0.0 109.259 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 35.1 t80 57.24 58.6 3.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.386 -0.821 . . . . 0.0 109.545 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.451 HG22 ' H ' ' B' ' 79' ' ' THR . 0.0 OUTLIER -76.3 115.77 16.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.433 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 80' ' ' MET . . . . . . . . . . . . . 9.2 ptt? -79.14 38.37 0.35 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.307 -0.87 . . . . 0.0 109.433 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.52 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 51.5 mtp . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 59.0 mt -68.13 131.1 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.299 -0.876 . . . . 0.0 109.271 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 17.3 t80 55.46 92.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.389 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -59.6 157.06 12.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.275 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -136.65 -20.56 1.33 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.399 -0.813 . . . . 0.0 109.602 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 6' ' ' LYS . . . . . 0.458 ' CG ' ' H ' ' C' ' 7' ' ' PHE . 42.1 tttm 56.69 176.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.475 0.655 . . . . 0.0 109.658 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 7' ' ' PHE . . . . . 0.458 ' H ' ' CG ' ' C' ' 6' ' ' LYS . 67.6 t80 -92.75 124.33 36.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.423 -0.798 . . . . 0.0 109.778 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 64.3 mt -115.24 143.26 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.481 -0.762 . . . . 0.0 110.045 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 9' ' ' ILE . . . . . 0.59 ' O ' HG23 ' C' ' 9' ' ' ILE . 11.2 tt -137.49 117.62 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.511 -0.743 . . . . 0.0 109.483 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.528 HG22 HG22 ' C' ' 53' ' ' ILE . 1.0 OUTLIER -120.91 147.04 45.97 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.643 1.211 . . . . 0.0 107.938 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 11' ' ' THR . . . . . 0.433 ' O ' HG23 ' C' ' 11' ' ' THR . 4.4 t -86.87 55.58 3.63 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.169 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -177.83 -124.77 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 119.955 -1.716 . . . . 0.0 108.321 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.82 108.4 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.229 -0.92 . . . . 0.0 109.002 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -163.49 -100.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.155 -0.965 . . . . 0.0 109.751 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' ILE . . . . . 0.491 ' N ' ' HD3' ' C' ' 16' ' ' PRO . 5.3 mt 57.23 61.23 6.53 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.825 . . . . 0.0 109.285 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 16' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' C' ' 15' ' ' ILE . 2.2 Cg_endo -63.67 155.37 63.64 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 122.195 1.93 . . . . 0.0 109.618 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.29 -17.11 57.11 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 18' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' C' ' 18' ' ' LEU . 51.5 mt -117.04 135.74 53.49 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.098 -1.236 . . . . 0.0 108.807 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -86.41 108.6 18.56 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 11.3 mt -93.2 136.66 33.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.305 -0.872 . . . . 0.0 109.724 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 21' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -118.52 130.27 55.83 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 9.3 t -58.06 131.41 50.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.779 -1.2 . . . . 0.0 111.102 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 mt -120.36 11.59 11.5 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.74 -179.95 19.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' ILE . . . . . 0.481 ' N ' HD13 ' C' ' 25' ' ' ILE . 0.0 OUTLIER -113.43 141.06 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 122.007 -0.701 . . . . 0.0 109.465 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.48 146.46 38.4 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 6.5 p -151.9 139.77 19.97 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.991 -1.068 . . . . 0.0 108.53 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 15.0 t -149.92 138.63 20.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.012 -1.055 . . . . 0.0 108.813 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.413 HG23 ' O ' ' C' ' 29' ' ' ILE . 11.6 tt -105.18 130.44 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.925 . . . . 0.0 109.068 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 91.8 p -168.97 -145.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.039 -1.038 . . . . 0.0 109.668 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' ASP . . . . . 0.465 ' O ' ' CB ' ' C' ' 32' ' ' ASN . 21.3 t0 -150.73 153.96 36.5 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.204 -0.935 . . . . 0.0 109.523 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 32' ' ' ASN . . . . . 0.506 ' H ' ' NZ ' ' C' ' 63' ' ' LYS . 3.7 t-20 77.15 129.26 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 108.748 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 45.2 t -66.58 -31.94 55.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.56 -0.712 . . . . 0.0 109.466 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -56.75 -42.6 79.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.821 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -75.97 -38.37 57.57 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.206 -0.933 . . . . 0.0 109.301 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 79.2 mt -59.81 -42.1 87.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 120.819 -1.175 . . . . 0.0 109.336 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.1 -43.91 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.718 -1.238 . . . . 0.0 109.092 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -66.33 -46.88 75.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.381 -0.824 . . . . 0.0 110.189 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -56.08 -49.67 73.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.071 -1.018 . . . . 0.0 109.682 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 84.2 mt -67.85 -44.71 76.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.128 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -50.73 -43.09 57.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.714 -1.241 . . . . 0.0 109.797 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -65.97 -36.26 82.83 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.797 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -76.39 -35.36 58.67 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.798 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 t -68.52 -50.85 52.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.952 -1.093 . . . . 0.0 109.079 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -59.55 -29.73 68.12 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.567 -1.253 . . . . 0.0 109.882 -175.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.3 -29.24 61.54 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.791 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -85.5 8.53 18.84 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.37 3.04 81.66 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.33 162.32 54.53 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 50' ' ' MET . . . . . 0.419 ' C ' ' SD ' ' C' ' 50' ' ' MET . 0.0 OUTLIER -131.17 -3.09 3.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.128 -1.219 . . . . 0.0 110.222 -177.189 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.5 127.85 1.81 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.245 -1.455 . . . . 0.0 110.01 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 53.5 tp -96.45 139.19 32.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.553 -0.969 . . . . 0.0 108.844 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.543 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 26.7 pt -144.01 173.26 5.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.788 -1.195 . . . . 0.0 108.313 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 70.99 77.22 0.18 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.936 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 55' ' ' PHE . . . . . 0.439 ' CE2' ' OH ' ' D' ' 67' ' ' TYR . 0.2 OUTLIER -80.08 154.4 28.13 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.122 -0.986 . . . . 0.0 109.333 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 56' ' ' ARG . . . . . 0.622 ' CG ' HH11 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -136.78 46.36 2.22 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.56 -0.712 . . . . 0.0 109.957 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.62 -18.36 6.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 58' ' ' THR . . . . . . . . . . . . . 37.5 p -67.74 -61.27 1.96 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.045 -1.034 . . . . 0.0 109.722 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 59' ' ' CYS . . . . . 0.432 ' O ' ' HB3' ' C' ' 60' ' ' ALA . 24.0 p -68.35 -178.51 1.1 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.29 -0.881 . . . . 0.0 109.448 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' C' ' 59' ' ' CYS . . . 63.3 150.97 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.496 -0.753 . . . . 0.0 109.702 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -56.73 119.11 5.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.282 -0.887 . . . . 0.0 109.213 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.25 -98.95 0.12 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' LYS . . . . . 0.506 ' NZ ' ' H ' ' C' ' 32' ' ' ASN . 17.4 pttt -135.94 -48.66 0.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 2.9 t80 65.38 -69.25 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.947 . . . . 0.0 109.816 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' C' ' 63' ' ' LYS . 1.0 OUTLIER -143.58 128.21 18.13 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.286 -0.884 . . . . 0.0 109.192 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.35 141.33 20.48 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.136 -1.986 . . . . 0.0 108.136 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 67' ' ' TYR . . . . . 0.805 ' CE1' HD11 ' B' ' 57' ' ' ILE . 0.3 OUTLIER -134.2 150.78 51.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.507 -0.996 . . . . 0.0 109.866 -179.404 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.02 140.99 6.61 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 69' ' ' THR . . . . . 0.475 ' OG1' HG23 ' B' ' 11' ' ' THR . 3.4 m -90.12 135.53 33.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.868 -1.372 . . . . 0.0 107.775 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 47.3 mt -86.1 145.15 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 m -144.73 162.9 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.966 . . . . 0.0 110.229 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -152.37 147.03 25.82 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.96 140.58 39.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.923 -1.111 . . . . 0.0 108.012 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' C' ' 75' ' ' GLU . 42.2 t0 -131.3 39.67 3.51 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 75' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' C' ' 74' ' ' ASP . 30.4 tt0 -39.48 129.62 1.84 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.587 -0.696 . . . . 0.0 109.942 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -157.98 -32.56 0.07 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.312 -0.868 . . . . 0.0 109.249 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 77' ' ' GLN . . . . . 0.429 ' CD ' ' H ' ' C' ' 77' ' ' GLN . 1.7 pm0 -103.94 141.56 35.95 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.541 -0.725 . . . . 0.0 109.132 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -67.81 148.24 51.48 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.256 -0.902 . . . . 0.0 109.469 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 52.5 m -161.13 139.53 9.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.87 . . . . 0.0 109.309 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 3.9 ptp -80.11 87.09 5.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.856 . . . . 0.0 109.26 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.423 179.867 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 29.9 mtm . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 2' ' ' ILE . . . . . 0.862 HD13 ' H ' ' D' ' 2' ' ' ILE . 0.2 OUTLIER -140.67 -22.71 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.458 -0.776 . . . . 0.0 109.426 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 55.7 -165.14 0.12 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.489 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -158.22 62.83 0.45 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.356 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 5' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' D' ' 7' ' ' PHE . 22.0 p-10 -169.54 45.89 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.214 -0.929 . . . . 0.0 110.048 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -63.9 81.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.045 -1.034 . . . . 0.0 110.23 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 7' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' D' ' 5' ' ' ASP . 67.0 t80 -108.54 121.93 46.02 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 28.2 mt -133.82 129.73 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.365 -0.834 . . . . 0.0 109.928 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 9' ' ' ILE . . . . . 0.633 HG23 ' O ' ' D' ' 9' ' ' ILE . 13.4 tt -137.15 114.19 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.56 160.75 27.67 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 11' ' ' THR . . . . . 0.547 ' OG1' ' OG1' ' E' ' 69' ' ' THR . 1.2 p -121.43 83.53 2.1 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.34 -134.26 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.331 -0.855 . . . . 0.0 109.099 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -99.79 -56.27 2.43 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.374 -0.829 . . . . 0.0 109.774 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -161.85 -171.05 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.124 -0.985 . . . . 0.0 109.444 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 68.4 mt -123.53 87.81 51.97 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.542 -0.724 . . . . 0.0 109.113 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.67 155.19 55.2 Favored 'Trans proline' 0 C--N 1.323 -0.781 0 C-N-CA 121.927 1.751 . . . . 0.0 110.305 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.14 -9.76 75.74 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 18' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' D' ' 18' ' ' LEU . 43.9 mt -128.0 139.01 52.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.118 -1.225 . . . . 0.0 109.27 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -85.2 108.05 17.54 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 12.2 mt -99.45 134.92 41.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.448 -0.783 . . . . 0.0 109.502 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 21' ' ' TYR . . . . . 0.497 ' CE1' ' O ' ' D' ' 22' ' ' SER . 0.8 OUTLIER -116.68 129.99 56.46 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 22' ' ' SER . . . . . 0.497 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 0.0 OUTLIER -61.87 128.34 35.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.771 -1.206 . . . . 0.0 110.517 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' D' ' 23' ' ' LEU . 8.3 mt -114.6 7.6 16.1 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.2 -179.54 17.06 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 49.6 mm -111.95 142.33 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.733 -0.863 . . . . 0.0 108.927 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.12 143.99 44.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.69 -0.631 . . . . 0.0 109.679 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 98.8 p -152.71 136.04 15.84 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 14.6 t -149.81 150.88 32.65 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.916 -1.115 . . . . 0.0 109.327 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 47.3 mm -113.39 139.86 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.322 -0.861 . . . . 0.0 109.555 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 30' ' ' SER . . . . . 0.557 ' OG ' ' N ' ' D' ' 31' ' ' ASP . 1.4 t -175.72 -171.66 0.48 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.384 -0.822 . . . . 0.0 108.938 -178.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 31' ' ' ASP . . . . . 0.557 ' N ' ' OG ' ' D' ' 30' ' ' SER . 1.3 p30 -124.86 145.08 49.97 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.495 -0.753 . . . . 0.0 109.415 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 32' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' D' ' 31' ' ' ASP . 1.5 m-20 78.21 133.18 0.06 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.604 0.716 . . . . 0.0 109.333 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.29 -31.27 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.547 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -56.95 -42.5 80.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 110.112 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -76.2 -38.89 55.91 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.338 -0.851 . . . . 0.0 109.486 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.04 -46.88 92.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.847 -1.158 . . . . 0.0 109.416 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.37 -51.53 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.97 -1.081 . . . . 0.0 110.01 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -55.99 -36.18 67.59 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 109.643 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -67.25 -42.4 84.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.105 -0.997 . . . . 0.0 110.091 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' D' ' 40' ' ' LEU . 44.8 mt -69.05 -46.51 67.69 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.981 -1.074 . . . . 0.0 108.724 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -47.16 -55.91 7.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.72 -1.237 . . . . 0.0 109.456 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -54.98 -33.44 62.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.215 -0.928 . . . . 0.0 110.408 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -77.35 -35.02 54.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.365 -0.834 . . . . 0.0 109.975 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 t -68.6 -51.4 46.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.038 -1.038 . . . . 0.0 108.904 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -67.78 -33.85 75.63 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 117.988 -1.485 . . . . 0.0 109.415 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.38 -32.83 72.76 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 mmtm -87.76 -4.94 58.86 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.41 -0.806 . . . . 0.0 109.125 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.56 9.39 64.72 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.16 175.92 54.35 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.14 2.45 0.77 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.897 -1.355 . . . . 0.0 110.143 -175.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.18 160.12 33.05 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.575 -1.297 . . . . 0.0 109.958 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 7.0 tp -130.06 139.12 51.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.724 -0.868 . . . . 0.0 109.339 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 53' ' ' ILE . . . . . . . . . . . . . 23.9 mt -114.04 141.15 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.644 -0.66 . . . . 0.0 110.242 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 63.1 79.55 0.26 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.341 -0.85 . . . . 0.0 111.904 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.536 ' CG ' ' O ' ' D' ' 55' ' ' PHE . 56.0 t80 -107.22 35.91 2.88 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.51 0.671 . . . . 0.0 110.279 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 56' ' ' ARG . . . . . 0.877 ' HG3' HH11 ' D' ' 56' ' ' ARG . 0.6 OUTLIER -67.47 158.4 31.93 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.961 -1.087 . . . . 0.0 109.911 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 57' ' ' ILE . . . . . . . . . . . . . 97.3 mt -135.99 148.51 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 58' ' ' THR . . . . . . . . . . . . . 68.9 p -66.3 -155.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.445 -0.784 . . . . 0.0 109.243 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 59' ' ' CYS . . . . . . . . . . . . . 18.7 p -65.22 -128.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.921 . . . . 0.0 109.322 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.66 177.67 2.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.971 . . . . 0.0 109.161 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 59.04 103.52 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.526 -0.734 . . . . 0.0 109.926 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.89 9.02 85.19 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -162.48 118.17 1.9 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.113 -1.228 . . . . 0.0 109.477 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -139.58 145.93 39.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.467 -0.771 . . . . 0.0 109.138 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 65' ' ' LEU . . . . . . . . . . . . . 58.4 tp -165.75 118.16 1.11 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.838 . . . . 0.0 109.315 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.44 128.46 9.32 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 67' ' ' TYR . . . . . 0.439 ' OH ' ' CE2' ' C' ' 55' ' ' PHE . 62.8 t80 -133.23 144.27 49.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.441 -1.035 . . . . 0.0 110.008 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.58 155.67 21.54 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 54.3 m -106.52 140.12 39.91 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.443 -1.034 . . . . 0.0 108.806 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 70' ' ' ILE . . . . . 0.404 HD13 HG21 ' D' ' 70' ' ' ILE . 33.3 mt -90.25 137.68 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 m -144.39 166.28 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.82 . . . . 0.0 109.501 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.78 150.36 27.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.95 151.65 37.02 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.174 -0.954 . . . . 0.0 108.6 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -71.9 -3.54 23.09 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.907 -1.121 . . . . 0.0 109.59 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 57.68 174.02 0.05 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.458 -0.776 . . . . 0.0 109.692 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -172.45 -22.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -62.61 -22.86 66.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.574 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -64.44 -47.31 79.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 109.498 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 3.9 m -160.46 153.59 21.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.341 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 23.3 ttt -158.67 -60.49 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.421 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.489 179.985 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 12.2 ttt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 82.3 mt -122.52 149.89 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.499 -0.751 . . . . 0.0 109.326 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 3' ' ' PHE . . . . . 0.43 ' CZ ' ' CD2' ' A' ' 21' ' ' TYR . 37.2 m-85 -88.57 -134.33 0.09 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -52.27 168.14 0.11 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.799 -1.188 . . . . 0.0 109.639 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 5' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' E' ' 6' ' ' LYS . 37.5 t0 -147.87 -157.17 0.79 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.345 -0.847 . . . . 0.0 109.545 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 6' ' ' LYS . . . . . 0.521 ' H ' ' CG ' ' E' ' 5' ' ' ASP . 43.0 mtmt 61.17 -82.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.421 0.629 . . . . 0.0 110.646 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -115.17 150.55 35.88 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 42.5 mt -129.25 137.61 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.506 -0.746 . . . . 0.0 109.147 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 9' ' ' ILE . . . . . 0.594 ' O ' HG23 ' E' ' 9' ' ' ILE . 17.5 tt -123.91 117.12 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 13.2 t -126.05 148.94 49.2 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 11' ' ' THR . . . . . 0.602 ' HG1' ' CB ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -76.19 -119.21 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.639 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 12' ' ' ALA . . . . . 0.406 ' H ' ' HB ' ' E' ' 11' ' ' THR . . . -111.35 98.5 7.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.312 -0.868 . . . . 0.0 109.68 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 13' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' E' ' 13' ' ' ASP . 20.3 p-10 -163.22 -7.09 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.694 -0.629 . . . . 0.0 109.475 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 59.8 163.59 0.05 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.599 -0.688 . . . . 0.0 109.468 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 18.4 mt -124.98 84.01 59.47 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.85 156.25 44.63 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 122.002 1.801 . . . . 0.0 110.095 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.63 -9.92 74.94 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 18' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' E' ' 18' ' ' LEU . 65.7 mt -126.96 137.86 53.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.075 -1.25 . . . . 0.0 108.821 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 19' ' ' GLN . . . . . 0.443 ' H ' ' HG2' ' E' ' 19' ' ' GLN . 7.8 pt20 -86.86 110.61 20.09 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 11.7 mt -92.1 135.2 34.16 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.969 -1.082 . . . . 0.0 109.592 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 21' ' ' TYR . . . . . 0.467 ' CE1' ' O ' ' E' ' 22' ' ' SER . 1.0 OUTLIER -117.83 129.82 55.89 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 22' ' ' SER . . . . . 0.467 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 0.0 OUTLIER -63.97 129.95 42.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.779 -1.201 . . . . 0.0 111.259 -179.252 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' E' ' 23' ' ' LEU . 13.1 mt -120.09 12.52 11.92 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.68 -155.41 16.22 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 25' ' ' ILE . . . . . 0.418 HG21 HD13 ' E' ' 25' ' ' ILE . 0.7 OUTLIER -135.34 144.12 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.979 -0.718 . . . . 0.0 109.596 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.03 144.11 44.13 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 38.5 t -152.14 138.95 18.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.053 -1.029 . . . . 0.0 108.455 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.54 153.43 37.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.082 -1.011 . . . . 0.0 109.033 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 71.0 mt -124.9 130.98 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.193 -0.942 . . . . 0.0 109.276 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 31.2 t -163.09 167.85 21.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.393 -0.817 . . . . 0.0 109.664 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 31' ' ' ASP . . . . . 0.553 ' N ' ' OD1' ' E' ' 31' ' ' ASP . 16.4 p-10 -81.38 -65.55 1.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.404 -0.81 . . . . 0.0 112.628 -177.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 32' ' ' ASN . . . . . 0.459 ' H ' ' CG ' ' E' ' 31' ' ' ASP . 6.3 t-20 -78.28 147.62 34.24 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.711 -1.243 . . . . 0.0 109.05 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 73.3 t -68.88 -31.18 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.564 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -54.09 -34.09 59.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 109.734 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 35' ' ' GLU . . . . . 0.419 ' O ' ' ND2' ' E' ' 39' ' ' ASN . 41.5 mm-40 -77.23 -35.02 55.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.312 -0.867 . . . . 0.0 108.803 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 66.3 mt -64.74 -53.6 40.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.042 -1.036 . . . . 0.0 109.154 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 60.9 t -55.79 -52.87 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.105 -0.997 . . . . 0.0 109.564 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.01 -36.49 70.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.419 -0.8 . . . . 0.0 109.633 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 39' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' E' ' 35' ' ' GLU . 74.1 m-20 -66.74 -41.11 88.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.043 -1.036 . . . . 0.0 109.831 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 40.2 mt -72.4 -50.34 27.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.99 -1.068 . . . . 0.0 109.041 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -49.04 -52.16 26.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.697 -1.252 . . . . 0.0 109.371 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -59.36 -37.3 77.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.261 -0.9 . . . . 0.0 110.824 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -77.91 -34.84 51.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 110.032 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 12.8 t -74.05 -52.8 19.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.148 -0.97 . . . . 0.0 108.864 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 9.9 mtpp -59.26 -27.88 66.21 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.704 -1.248 . . . . 0.0 110.058 -176.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.03 -28.19 62.2 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.819 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -87.84 0.1 56.25 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.82 6.89 84.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.19 -174.88 5.88 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 3.3 ptm -155.71 -1.21 0.14 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.211 -1.17 . . . . 0.0 110.83 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.82 150.55 18.72 Favored Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.296 -1.43 . . . . 0.0 109.738 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 15.2 tp -122.37 134.22 54.63 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 53' ' ' ILE . . . . . 0.882 HD13 ' O ' ' E' ' 53' ' ' ILE . 0.0 OUTLIER -106.93 147.4 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.521 -0.737 . . . . 0.0 109.659 -178.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 54' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 78.56 -63.43 0.3 Allowed 'General case' 0 N--CA 1.508 2.443 0 O-C-N 121.156 -0.965 . . . . 0.0 112.794 177.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 55' ' ' PHE . . . . . 0.552 ' O ' ' CG ' ' E' ' 55' ' ' PHE . 52.5 t80 31.64 39.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.595 0.712 . . . . 0.0 109.866 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 56' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' E' ' 54' ' ' ALA . 97.5 mtt180 -62.65 127.53 31.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.879 -1.138 . . . . 0.0 109.612 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 78.3 mt -92.16 -34.78 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.255 -0.903 . . . . 0.0 109.161 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 58' ' ' THR . . . . . . . . . . . . . 69.7 p -76.63 146.49 38.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.67 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 59' ' ' CYS . . . . . . . . . . . . . 6.3 p -173.87 141.13 0.78 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.0 109.349 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . 51.03 -131.38 2.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.89 . . . . 0.0 109.55 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -165.39 115.87 1.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 0.0 109.263 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.32 -60.74 0.54 Allowed Glycine 0 N--CA 1.501 2.978 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -95.89 -176.43 3.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.286 -1.126 . . . . 0.0 109.36 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -135.57 159.47 41.52 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.49 -0.757 . . . . 0.0 109.185 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 53.1 tp -165.23 126.93 2.05 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.476 -0.765 . . . . 0.0 109.401 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.36 -67.15 1.77 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 66.12 121.65 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.221 -1.164 . . . . 0.0 109.656 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.11 156.73 28.4 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 69' ' ' THR . . . . . 0.547 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 98.1 m -104.39 137.1 42.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.415 -1.05 . . . . 0.0 108.194 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 28.3 mt -85.41 135.88 23.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 m -142.98 162.96 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.733 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -151.68 147.81 27.17 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.03 151.48 35.43 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.2 -0.937 . . . . 0.0 108.675 178.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -76.75 -5.88 49.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.878 -1.139 . . . . 0.0 109.226 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 54.58 -100.99 0.11 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.293 -0.88 . . . . 0.0 109.605 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . -166.64 70.22 0.11 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.908 -1.12 . . . . 0.0 109.735 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 77' ' ' GLN . . . . . 0.575 ' O ' ' N ' ' E' ' 79' ' ' THR . 98.0 mt-30 -46.11 -87.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.255 -0.903 . . . . 0.0 109.883 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 41.8 t80 56.09 -79.09 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.491 -0.755 . . . . 0.0 109.696 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 79' ' ' THR . . . . . 0.575 ' N ' ' O ' ' E' ' 77' ' ' GLN . 0.1 OUTLIER -56.71 -28.63 61.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.422 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 21.0 ttt 50.76 85.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 109.555 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.453 -179.94 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.2 t80 . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.8 mt -134.1 131.69 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.341 -0.849 . . . . 0.0 110.205 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 9' ' ' ILE . 19.5 tt -129.37 125.22 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.08 -1.012 . . . . 0.0 108.762 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.8 t -122.88 139.04 54.46 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.332 -0.855 . . . . 0.0 110.302 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.526 ' OG1' ' OG1' ' B' ' 69' ' ' THR . 3.1 m -91.12 98.6 11.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.012 -1.055 . . . . 0.0 108.928 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.56 91.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.23 -0.919 . . . . 0.0 110.319 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -162.93 -128.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -173.68 -17.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.271 -0.893 . . . . 0.0 109.6 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.1 mt 49.69 69.0 2.93 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.581 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.76 156.85 50.93 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.975 1.783 . . . . 0.0 110.035 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.18 -9.42 74.88 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.824 -1.179 . . . . 0.0 110.495 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 18' ' ' LEU . 32.5 mt -122.54 139.31 54.04 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.137 -1.214 . . . . 0.0 110.071 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -87.56 116.46 25.69 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.7 mt -107.12 134.62 49.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.348 -0.845 . . . . 0.0 109.339 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.532 ' CE1' ' O ' ' A' ' 22' ' ' SER . 2.1 t80 -121.11 129.71 53.42 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.532 ' O ' ' CE1' ' A' ' 21' ' ' TYR . 20.8 t -84.24 129.07 34.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.407 -0.808 . . . . 0.0 110.522 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.923 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -119.29 15.44 13.07 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.03 170.8 11.94 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.352 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -109.13 144.5 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.78 144.75 42.99 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.552 -0.718 . . . . 0.0 109.4 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -152.39 139.92 19.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.91 -1.119 . . . . 0.0 108.258 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 t -150.26 136.55 18.78 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.902 -1.124 . . . . 0.0 109.548 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.0 mt -101.38 126.91 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.144 -0.973 . . . . 0.0 109.171 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.7 p -175.36 175.98 2.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.338 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 16.0 p-10 -115.75 161.16 19.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.542 -0.723 . . . . 0.0 109.117 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 11.2 m-20 77.14 120.26 0.05 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.6 t -66.26 -33.13 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.444 -0.785 . . . . 0.0 109.697 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -56.97 -39.65 75.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.911 . . . . 0.0 110.145 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -76.57 -36.51 57.54 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.179 -0.95 . . . . 0.0 109.372 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.7 mt -64.36 -51.9 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.932 -1.105 . . . . 0.0 109.399 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.74 -50.18 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.048 -1.033 . . . . 0.0 109.257 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -60.16 -41.38 92.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.295 -0.878 . . . . 0.0 109.758 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -62.93 -46.16 89.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.136 -0.977 . . . . 0.0 110.009 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.5 mt -69.38 -46.47 66.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.001 -1.062 . . . . 0.0 108.767 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -48.03 -55.05 11.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.789 -1.194 . . . . 0.0 108.87 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.45 -35.23 67.65 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.939 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -75.13 -35.88 61.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.37 -0.831 . . . . 0.0 109.81 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.8 t -73.82 -50.91 26.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.146 -0.971 . . . . 0.0 109.439 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -68.71 -31.7 70.97 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.566 -1.334 . . . . 0.0 109.174 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.84 -31.63 72.68 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -90.38 5.63 46.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -0.877 . . . . 0.0 109.023 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.72 27.04 73.03 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.664 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.92 -167.58 23.8 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 34.7 ttp -110.73 -41.3 4.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.616 -0.932 . . . . 0.0 109.478 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.91 -153.01 11.35 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 tp -133.2 135.46 45.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.357 -1.084 . . . . 0.0 109.788 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.575 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 1.1 pt -111.0 146.38 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.497 -0.752 . . . . 0.0 110.276 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 75.01 87.79 0.09 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.357 -0.839 . . . . 0.0 109.14 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -115.05 50.51 0.97 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.591 ' O ' ' O ' ' A' ' 57' ' ' ILE . 30.4 ttm180 -65.87 -56.81 9.89 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.536 -0.727 . . . . 0.0 109.602 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.591 ' O ' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.065 0 CA-C-O 122.202 1.001 . . . . 0.0 109.436 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.7 p90 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.665 0.745 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.98 159.57 29.72 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.4 m -107.03 140.13 40.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.149 -1.207 . . . . 0.0 109.37 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.4 mt -87.34 135.74 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 m -138.96 162.14 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 109.673 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -154.46 143.11 20.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.887 . . . . 0.0 109.042 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.84 150.37 35.62 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.915 -1.116 . . . . 0.0 108.015 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.9 t70 . . . . . 0 C--N 1.3 -1.547 0 O-C-N 120.919 -1.113 . . . . 0.0 109.097 179.645 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 82.1 t80 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 11.9 mt -136.09 138.27 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.284 -0.885 . . . . 0.0 109.962 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.443 ' CG2' ' O ' ' B' ' 9' ' ' ILE . 3.8 tt -118.99 121.84 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.267 -0.895 . . . . 0.0 108.588 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 7.3 t -123.76 135.56 53.89 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.395 -0.815 . . . . 0.0 110.296 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.401 ' OG1' HD11 ' C' ' 25' ' ' ILE . 21.6 m -113.68 112.42 23.45 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 52.52 55.55 8.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.394 -0.816 . . . . 0.0 110.205 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -160.4 111.73 1.91 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.538 -0.727 . . . . 0.0 109.082 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -64.38 169.91 4.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 109.62 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 22.5 mt -135.48 71.69 65.61 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.519 -0.738 . . . . 0.0 109.064 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.8 157.6 37.18 Favored 'Trans proline' 0 C--N 1.319 -0.979 0 C-N-CA 121.873 1.715 . . . . 0.0 110.054 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.73 -8.4 73.99 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.367 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' B' ' 18' ' ' LEU . 20.4 mt -123.38 139.55 53.92 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.221 -1.164 . . . . 0.0 110.097 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -88.48 109.01 19.69 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt -97.85 141.34 30.95 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.266 -0.896 . . . . 0.0 110.773 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . 0.463 ' H ' ' H ' ' B' ' 72' ' ' LYS . 4.2 t80 -121.35 129.27 52.97 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 28.9 t -72.94 130.61 40.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.674 -1.266 . . . . 0.0 111.317 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.572 HD11 ' CB ' ' B' ' 72' ' ' LYS . 18.5 mt -118.68 9.35 12.13 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.3 -161.81 19.71 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.22 144.99 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 122.234 -0.568 . . . . 0.0 109.484 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.69 158.12 20.44 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 86.0 p -150.25 140.82 22.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 108.917 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 20.6 p -140.24 135.34 32.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.326 -0.859 . . . . 0.0 109.409 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.459 ' O ' ' CB ' ' B' ' 30' ' ' SER . 96.5 mt -126.79 125.48 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' B' ' 29' ' ' ILE . 1.9 p 163.3 -164.11 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 16.0 p-10 -122.19 173.13 7.78 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 18.3 m-80 76.91 112.46 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.3 -35.36 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.435 -0.791 . . . . 0.0 109.642 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -56.99 -37.27 71.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 110.057 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -76.46 -36.61 57.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.219 -0.926 . . . . 0.0 109.324 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 82.0 mt -66.22 -53.62 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.898 -1.126 . . . . 0.0 109.425 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 40.2 t -59.35 -51.87 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.004 -1.06 . . . . 0.0 109.513 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -56.13 -36.22 68.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 109.622 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -66.68 -40.33 88.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.043 -1.036 . . . . 0.0 109.852 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 70.4 mt -74.5 -50.84 16.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.95 -1.094 . . . . 0.0 108.988 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -48.85 -53.01 21.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.808 -1.182 . . . . 0.0 108.861 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' B' ' 46' ' ' ALA . 31.6 ttpt -59.0 -36.79 75.49 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.438 -0.788 . . . . 0.0 110.026 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -75.25 -35.85 61.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.232 -0.918 . . . . 0.0 109.945 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 4.9 t -74.2 -51.42 23.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 109.448 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 33.7 tptt -70.75 -29.75 66.07 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.234 -1.386 . . . . 0.0 109.548 -175.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' B' ' 42' ' ' LYS . . . -62.12 -31.25 71.7 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -92.75 2.19 56.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 109.226 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.22 29.3 64.62 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.336 -1.411 . . . . 0.0 110.016 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.77 -170.54 25.73 Favored Glycine 0 N--CA 1.492 2.383 0 O-C-N 121.209 -1.171 . . . . 0.0 110.585 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -107.95 -48.8 3.32 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.725 -0.868 . . . . 0.0 109.291 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -167.7 -160.94 16.14 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.4 tp -136.82 138.51 40.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.299 -1.118 . . . . 0.0 109.99 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.655 ' O ' ' HB3' ' B' ' 54' ' ' ALA . 0.4 OUTLIER -107.0 147.62 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 90.38 -146.59 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.64 ' CB ' ' O ' ' B' ' 54' ' ' ALA . 67.4 t80 120.71 -101.52 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 120.529 1.513 . . . . 0.0 107.077 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' B' ' 55' ' ' PHE . 25.8 mtm180 55.52 161.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.38 -0.825 . . . . 0.0 109.79 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 79.3 mt . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.249 -0.907 . . . . 0.0 108.941 -179.594 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 tp . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.53 115.43 4.72 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' B' ' 67' ' ' TYR . 7.3 p90 -137.24 -175.96 4.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -1.115 . . . . 0.0 110.319 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.48 167.63 29.4 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . 0.526 ' OG1' ' OG1' ' A' ' 11' ' ' THR . 87.5 m -95.01 138.48 32.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.029 -1.277 . . . . 0.0 109.076 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.418 HG22 HD12 ' B' ' 23' ' ' LEU . 70.6 mt -87.5 125.36 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 3.0 m -122.78 162.51 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.306 -0.871 . . . . 0.0 110.558 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.572 ' CB ' HD11 ' B' ' 23' ' ' LEU . 11.6 tttp -154.92 135.15 13.17 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.02 114.82 29.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.556 -1.34 . . . . 0.0 111.598 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . 0.427 ' CG ' ' NZ ' ' B' ' 72' ' ' LYS . 6.8 p-10 . . . . . 0 N--CA 1.491 1.603 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.241 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . 0.501 ' HG2' ' N ' ' C' ' 7' ' ' PHE . 53.6 tttp . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' PHE . . . . . 0.501 ' N ' ' HG2' ' C' ' 6' ' ' LYS . 70.1 t80 -101.42 119.88 39.43 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.042 -1.036 . . . . 0.0 109.268 -178.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 8' ' ' ILE . . . . . 0.444 ' O ' ' HA3' ' C' ' 51' ' ' GLY . 60.8 mt -115.46 143.21 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.543 -0.723 . . . . 0.0 110.067 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' ILE . . . . . 0.551 HG23 ' O ' ' C' ' 9' ' ' ILE . 12.9 tt -138.54 114.56 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.742 -1.224 . . . . 0.0 108.853 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -123.95 161.78 24.73 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.395 -0.816 . . . . 0.0 108.958 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 1.2 p -114.6 79.0 1.21 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . 0.463 ' O ' ' CG ' ' C' ' 13' ' ' ASP . . . -179.04 -10.21 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.486 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . 0.463 ' CG ' ' O ' ' C' ' 12' ' ' ALA . 3.2 p30 43.73 83.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.348 0.594 . . . . 0.0 110.272 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -154.72 -87.86 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.402 -0.811 . . . . 0.0 109.545 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 7.3 mt 48.99 66.23 6.01 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.226 -0.921 . . . . 0.0 109.247 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.53 157.71 49.55 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 C-N-CA 122.085 1.856 . . . . 0.0 109.885 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.99 -7.0 73.22 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.676 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' C' ' 18' ' ' LEU . 58.2 mt -124.46 140.55 52.84 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.997 -1.296 . . . . 0.0 110.246 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . 0.419 ' N ' ' CD ' ' C' ' 19' ' ' GLN . 2.9 mp0 -85.64 108.38 17.98 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -92.2 134.25 35.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.077 -1.014 . . . . 0.0 110.092 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -117.35 130.31 56.43 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.82 131.64 43.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.68 -1.262 . . . . 0.0 111.134 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.803 HD11 ' HB2' ' C' ' 72' ' ' LYS . 25.0 mt -114.64 10.54 16.75 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.14 -154.57 16.41 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' ILE . . . . . 0.401 HD11 ' OG1' ' B' ' 11' ' ' THR . 0.3 OUTLIER -134.69 143.56 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.82 -0.812 . . . . 0.0 109.492 -179.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.98 149.24 40.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.832 -0.542 . . . . 0.0 109.714 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 60.7 p -151.56 138.18 18.75 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -149.34 147.77 28.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.98 -1.075 . . . . 0.0 108.973 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 tt -127.59 133.37 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.2 -0.937 . . . . 0.0 109.049 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 5.3 t -169.54 170.56 8.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.291 -0.88 . . . . 0.0 109.474 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -104.31 37.56 2.07 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.835 0.826 . . . . 0.0 110.296 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -152.5 125.08 8.3 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.457 ' H ' HG13 ' C' ' 33' ' ' VAL . 0.7 OUTLIER -72.69 -45.51 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . 0.43 ' N ' ' CG2' ' C' ' 33' ' ' VAL . 5.7 p-10 -62.08 -34.77 76.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.426 -0.796 . . . . 0.0 109.99 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -74.01 -38.51 64.07 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.584 -0.846 . . . . 0.0 108.808 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 68.1 mt -63.02 -51.33 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.96 . . . . 0.0 108.646 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.55 -49.8 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.991 . . . . 0.0 108.691 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -61.68 -45.5 93.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.348 -0.845 . . . . 0.0 109.955 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -59.39 -46.63 88.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.329 -0.857 . . . . 0.0 109.557 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' C' ' 40' ' ' LEU . 41.1 mt -66.93 -44.24 81.19 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.123 -0.986 . . . . 0.0 108.384 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -46.76 -56.21 6.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.818 -1.176 . . . . 0.0 108.636 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -53.46 -32.16 48.78 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.34 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -74.42 -40.77 61.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.444 -0.785 . . . . 0.0 109.259 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 10.1 t -77.85 -53.53 14.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 120.774 -1.204 . . . . 0.0 108.921 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -50.58 -31.66 16.46 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.769 1.271 . . . . 0.0 109.795 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.38 -25.81 46.38 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.482 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -98.15 -0.92 43.38 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.9 26.46 73.91 Favored Glycine 0 N--CA 1.487 2.087 0 C-N-CA 118.335 -1.888 . . . . 0.0 109.637 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.79 -167.87 15.55 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 5.0 ttp -110.18 -43.79 3.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.586 -0.949 . . . . 0.0 110.462 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' C' ' 8' ' ' ILE . . . 177.55 -172.22 44.95 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.556 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.52 132.07 53.64 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.374 -1.074 . . . . 0.0 110.62 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 pt -109.61 139.14 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.44 61.96 2.65 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.888 -1.133 . . . . 0.0 108.665 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -96.57 109.32 21.94 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' ARG . . . . . 0.713 HH11 ' HG3' ' C' ' 56' ' ' ARG . 9.7 mmm-85 -125.02 154.62 40.98 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.419 -0.8 . . . . 0.0 109.306 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 44.6 p90 . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 121.694 0.759 . . . . 0.0 109.711 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.48 166.42 34.17 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.406 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 34.4 m -101.92 140.21 36.5 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.307 -1.113 . . . . 0.0 108.424 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' ILE . . . . . 0.539 HG22 HD12 ' C' ' 23' ' ' LEU . 56.2 mt -85.53 148.5 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 6.8 m -142.96 156.18 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.158 -0.964 . . . . 0.0 109.765 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' LYS . . . . . 0.803 ' HB2' HD11 ' C' ' 23' ' ' LEU . 21.6 ttpt -146.04 156.17 43.29 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.216 -0.927 . . . . 0.0 108.731 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' C' ' 74' ' ' ASP . . . -119.88 153.38 35.92 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' C' ' 73' ' ' ALA . 16.2 m-20 . . . . . 0 N--CA 1.505 2.288 0 CA-C-O 121.37 0.605 . . . . 0.0 109.736 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -101.44 123.8 46.08 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.274 -0.891 . . . . 0.0 109.515 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 87.4 mt -119.12 146.29 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.636 -0.665 . . . . 0.0 109.489 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 9' ' ' ILE . . . . . 0.59 HG23 ' O ' ' D' ' 9' ' ' ILE . 13.2 tt -138.35 116.38 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.419 -0.8 . . . . 0.0 109.001 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t -121.95 160.75 24.18 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . 0.512 ' OG1' ' OG1' ' E' ' 69' ' ' THR . 1.3 m -130.45 123.79 30.57 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 12' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' D' ' 11' ' ' THR . . . 59.85 49.81 7.56 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 122.117 0.96 . . . . 0.0 109.307 178.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -138.6 -171.02 2.96 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 55.0 mp0 -147.09 -18.03 0.4 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.035 -1.041 . . . . 0.0 109.622 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 27.8 mt 49.36 66.74 5.26 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.237 -0.914 . . . . 0.0 109.148 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.04 157.59 38.39 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 121.962 1.774 . . . . 0.0 110.076 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.97 -8.09 73.27 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.508 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 25.5 mt -122.52 138.44 54.56 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.147 -1.207 . . . . 0.0 110.187 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -90.31 116.74 28.51 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 11.9 mt -100.61 140.43 34.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.576 -0.702 . . . . 0.0 110.725 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -118.63 129.79 55.5 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 6.2 t -68.46 130.2 42.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.712 -1.243 . . . . 0.0 112.022 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.587 HD11 ' CB ' ' D' ' 72' ' ' LYS . 40.4 mt -116.54 13.64 15.37 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.68 -170.13 13.21 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.51 142.3 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.843 -0.798 . . . . 0.0 109.419 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.81 144.17 44.37 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.57 -0.706 . . . . 0.0 109.46 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 51.8 m -152.09 138.19 18.25 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.955 -1.091 . . . . 0.0 108.479 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' THR . . . . . 0.433 ' O ' HG23 ' D' ' 28' ' ' THR . 11.6 t -150.07 132.16 15.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.914 -1.116 . . . . 0.0 109.327 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 tt -100.01 130.04 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.108 -0.995 . . . . 0.0 109.379 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 6.3 p -178.21 179.47 0.81 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.439 -0.788 . . . . 0.0 109.238 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' D' ' 32' ' ' ASN . 3.3 p30 -112.18 157.17 21.18 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.515 -0.741 . . . . 0.0 109.166 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.672 HD22 ' H ' ' D' ' 34' ' ' ASP . 0.1 OUTLIER 79.23 117.1 0.06 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.556 -0.715 . . . . 0.0 109.129 -178.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 91.6 t -62.75 -31.03 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.542 -0.724 . . . . 0.0 109.534 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' ASP . . . . . 0.672 ' H ' HD22 ' D' ' 32' ' ' ASN . 62.5 m-20 -59.4 -41.01 88.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.933 . . . . 0.0 110.029 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -74.09 -39.65 63.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.261 -0.899 . . . . 0.0 109.087 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 71.4 mt -65.36 -53.97 33.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.953 -1.092 . . . . 0.0 108.908 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 25.3 t -61.43 -50.23 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.124 -0.985 . . . . 0.0 109.224 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -56.42 -36.43 68.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.2 -0.937 . . . . 0.0 109.828 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' ASN . . . . . 0.496 ' N ' HD22 ' D' ' 39' ' ' ASN . 0.9 OUTLIER -71.73 -38.01 70.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.032 -1.042 . . . . 0.0 109.406 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . 0.702 HD13 ' CD2' ' D' ' 52' ' ' LEU . 26.7 mt -69.56 -48.92 58.7 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.962 -1.086 . . . . 0.0 108.152 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' D' ' 40' ' ' LEU . 99.2 mtt180 -46.24 -57.76 4.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.308 -1.495 . . . . 0.0 108.993 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -50.17 -28.93 8.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.037 -1.039 . . . . 0.0 110.448 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -68.61 -56.66 7.5 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.732 -1.23 . . . . 0.0 110.011 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' D' ' 48' ' ' GLY . 1.8 m -64.91 -48.82 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.672 0 O-C-N 120.275 -1.515 . . . . 0.0 107.825 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -49.94 -46.15 51.92 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.72 1.248 . . . . 0.0 110.809 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.89 -30.15 56.06 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.642 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . 0.464 ' NZ ' ' O ' ' D' ' 23' ' ' LEU . 5.8 ttmt -92.47 -3.87 54.52 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.239 -0.913 . . . . 0.0 108.794 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' D' ' 44' ' ' VAL . . . 81.1 20.24 65.39 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.313 -1.422 . . . . 0.0 109.598 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.8 -166.57 13.27 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.68 -25.49 5.48 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.581 -0.952 . . . . 0.0 111.822 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . 0.501 ' O ' HD12 ' D' ' 52' ' ' LEU . . . 159.34 -163.21 33.31 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . 0.702 ' CD2' HD13 ' D' ' 40' ' ' LEU . 5.6 mp -123.93 139.43 53.96 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.443 -1.033 . . . . 0.0 109.833 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 53' ' ' ILE . . . . . . . . . . . . . 1.3 pt -106.75 143.42 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.593 -0.692 . . . . 0.0 109.412 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 57.03 60.01 3.19 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.824 -1.172 . . . . 0.0 108.554 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . 0.412 ' CD2' HD11 ' D' ' 9' ' ' ILE . 46.9 t80 -84.35 71.34 10.68 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.493 -0.754 . . . . 0.0 109.846 -179.213 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 121.762 0.791 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.31 152.52 23.68 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 76.7 m -107.3 137.71 44.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.034 -1.274 . . . . 0.0 108.298 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 mt -87.78 137.0 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 108.272 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.1 m -126.65 162.58 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 CA-C-O 121.617 0.722 . . . . 0.0 109.92 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 72' ' ' LYS . . . . . 0.587 ' CB ' HD11 ' D' ' 23' ' ' LEU . 2.0 ttmt -147.19 145.14 29.4 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.05 151.84 23.48 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.1 -1.0 . . . . 0.0 108.322 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 O-C-N 120.81 -1.181 . . . . 0.0 109.683 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 tptp . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 120.992 0.425 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -107.29 119.74 40.21 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.368 -0.833 . . . . 0.0 109.492 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 54.2 mt -107.59 130.89 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.533 -0.73 . . . . 0.0 109.203 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 9' ' ' ILE . . . . . 0.471 HD11 ' CG ' ' E' ' 55' ' ' PHE . 8.3 tt -120.92 115.09 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.13 155.6 39.65 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.833 -1.167 . . . . 0.0 108.659 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 11' ' ' THR . . . . . . . . . . . . . 2.3 p -118.9 95.96 5.05 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -165.88 -113.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.141 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -135.64 -42.32 0.68 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.833 . . . . 0.0 109.576 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -173.29 174.16 3.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.225 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 72.9 mt -112.57 95.68 33.3 Favored Pre-proline 0 N--CA 1.498 1.953 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.47 155.9 59.7 Favored 'Trans proline' 0 C--N 1.325 -0.671 0 C-N-CA 121.726 1.618 . . . . 0.0 110.83 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.48 -7.86 77.46 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 18' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' E' ' 18' ' ' LEU . 56.3 mt -129.3 141.55 51.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -1.118 . . . . 0.0 109.836 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 19' ' ' GLN . . . . . 0.46 ' CD ' ' N ' ' E' ' 19' ' ' GLN . 3.5 mp0 -85.37 108.59 17.91 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 13.9 mt -96.78 135.0 39.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.247 -0.908 . . . . 0.0 110.036 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 21' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -123.46 129.48 51.3 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -86.53 132.53 33.89 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.205 -0.935 . . . . 0.0 111.292 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.948 HD23 ' N ' ' E' ' 23' ' ' LEU . 0.4 OUTLIER -121.7 21.23 10.87 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.42 172.79 13.41 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.406 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 43.8 mm -108.69 143.52 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.39 145.03 41.79 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.315 -0.866 . . . . 0.0 108.886 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 84.8 p -152.08 136.66 16.93 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 13.5 t -150.06 149.65 30.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.936 -1.103 . . . . 0.0 109.192 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 2.2 tp -125.41 132.47 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 1.3 p 175.71 -173.82 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.008 -1.058 . . . . 0.0 109.251 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 31' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' E' ' 32' ' ' ASN . 29.1 m-20 -123.81 168.4 12.79 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.61 -0.681 . . . . 0.0 109.369 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 32' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 9.1 t-20 75.64 123.89 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.02 -34.36 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.341 -0.85 . . . . 0.0 109.467 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -59.16 -46.26 88.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 110.172 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -75.55 -39.4 58.26 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.086 -1.009 . . . . 0.0 109.564 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.62 -48.97 85.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.843 -1.16 . . . . 0.0 109.104 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 48.7 t -63.17 -48.91 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.014 -1.054 . . . . 0.0 109.478 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -59.42 -40.22 86.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.938 . . . . 0.0 109.618 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -58.48 -45.13 89.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.529 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 49.1 mt -72.37 -48.03 44.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.114 -0.992 . . . . 0.0 109.164 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -50.74 -42.96 58.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.716 -1.24 . . . . 0.0 109.354 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -69.25 -38.89 78.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.557 -0.715 . . . . 0.0 109.694 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.08 -34.69 59.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.918 . . . . 0.0 109.742 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 t -69.25 -52.6 31.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.197 -0.94 . . . . 0.0 109.668 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -72.3 -34.4 68.1 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.323 -1.351 . . . . 0.0 109.14 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.96 -32.27 61.36 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.14 -5.27 55.28 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.236 -0.915 . . . . 0.0 110.11 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.95 6.17 37.51 Favored Glycine 0 N--CA 1.504 3.21 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.36 159.58 48.73 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -124.37 -9.48 7.49 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.289 -1.124 . . . . 0.0 110.786 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.3 163.17 35.91 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.05 -1.548 . . . . 0.0 109.898 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 4.9 tp -120.79 143.09 49.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.653 -0.91 . . . . 0.0 110.093 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 53' ' ' ILE . . . . . 0.416 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 14.0 mt -113.12 138.87 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.568 -0.708 . . . . 0.0 110.411 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 64.73 78.69 0.28 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.436 -0.79 . . . . 0.0 110.593 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 55' ' ' PHE . . . . . 0.471 ' CG ' HD11 ' E' ' 9' ' ' ILE . 84.0 t80 -90.49 98.94 12.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.514 -0.742 . . . . 0.0 109.931 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 56' ' ' ARG . . . . . 0.494 ' NH1' ' NH1' ' A' ' 56' ' ' ARG . 7.6 tpp180 -97.66 166.77 11.34 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.288 -0.883 . . . . 0.0 109.068 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 47.8 mt . . . . . 0 N--CA 1.497 1.915 0 O-C-N 121.361 -0.837 . . . . 0.0 109.172 179.947 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 67' ' ' TYR . . . . . 0.401 ' OH ' ' CE2' ' D' ' 55' ' ' PHE . 4.0 t80 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 121.717 0.77 . . . . 0.0 110.407 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.58 140.18 6.38 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 69' ' ' THR . . . . . 0.512 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 20.4 m -93.11 138.7 31.3 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.93 -1.335 . . . . 0.0 108.623 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 70' ' ' ILE . . . . . 0.45 HG22 HD21 ' E' ' 23' ' ' LEU . 72.4 mt -85.48 139.19 17.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.44 161.46 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.175 -0.953 . . . . 0.0 110.189 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -155.92 147.25 22.59 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -110.95 150.65 28.94 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.123 -0.986 . . . . 0.0 108.595 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.056 -1.027 . . . . 0.0 109.563 179.879 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.7 t80 . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 121.009 0.433 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.4 mt -112.07 139.11 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.513 -0.742 . . . . 0.0 109.823 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 9' ' ' ILE . 6.3 tt -130.56 118.51 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -124.02 148.97 46.6 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.604 ' OG1' HD11 ' B' ' 25' ' ' ILE . 1.7 m -123.92 73.27 1.2 Allowed 'General case' 0 N--CA 1.511 2.622 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.727 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.2 -86.67 0.03 OUTLIER 'General case' 0 C--O 1.214 -0.791 0 O-C-N 119.585 -1.947 . . . . 0.0 107.576 -176.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.45 -78.56 0.6 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.274 -0.891 . . . . 0.0 109.68 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -162.4 -159.29 0.57 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.134 -0.979 . . . . 0.0 109.317 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.4 mt -120.78 91.76 47.62 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.495 -0.753 . . . . 0.0 109.235 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.51 155.73 51.17 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.784 1.656 . . . . 0.0 110.23 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.63 -14.08 64.97 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 18' ' ' LEU . 50.1 mt -121.86 139.48 53.57 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.427 -1.043 . . . . 0.0 109.503 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.27 108.43 15.72 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.1 mt -99.33 133.55 43.47 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.304 -0.873 . . . . 0.0 110.038 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.527 ' CE1' ' O ' ' A' ' 22' ' ' SER . 0.4 OUTLIER -120.86 129.97 53.74 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.527 ' O ' ' CE1' ' A' ' 21' ' ' TYR . 47.0 t -51.85 127.87 22.27 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.127 -0.983 . . . . 0.0 111.067 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' A' ' 23' ' ' LEU . 5.8 mt -114.44 5.9 15.77 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.17 -177.24 16.36 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.88 144.81 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 122.002 -0.705 . . . . 0.0 109.485 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.48 155.93 23.43 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.6 p -151.62 144.5 24.45 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.826 -1.171 . . . . 0.0 108.469 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.2 p -148.47 132.4 17.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.246 -0.909 . . . . 0.0 109.305 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.62 126.99 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.3 p 173.11 -125.87 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.301 0.572 . . . . 0.0 109.609 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -162.59 168.53 21.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.159 -0.963 . . . . 0.0 108.589 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.2 m120 72.06 115.1 0.05 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.443 -0.786 . . . . 0.0 109.279 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.7 -31.99 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.607 -0.683 . . . . 0.0 109.314 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -58.99 -42.26 89.61 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.259 -0.9 . . . . 0.0 109.568 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -75.38 -41.02 57.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.988 -1.07 . . . . 0.0 109.869 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.33 -53.01 51.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 120.896 -1.127 . . . . 0.0 109.535 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.9 t -57.17 -48.81 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.134 -0.978 . . . . 0.0 109.028 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -59.31 -38.94 81.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.958 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -68.13 -39.98 82.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.058 -1.026 . . . . 0.0 109.768 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 40' ' ' LEU . 67.9 mt -64.93 -44.07 90.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.972 -1.08 . . . . 0.0 109.002 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -48.63 -54.48 14.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.801 -1.187 . . . . 0.0 109.471 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -57.82 -35.86 71.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.378 -0.826 . . . . 0.0 110.105 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -75.06 -36.18 61.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.219 -0.925 . . . . 0.0 109.806 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 t -71.16 -51.15 36.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.247 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -72.65 -33.28 66.49 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 117.81 -1.556 . . . . 0.0 109.598 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.69 76.18 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.869 . . . . 0.0 109.826 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -85.28 -4.11 59.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.539 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.75 0.49 55.26 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.66 155.55 53.4 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.34 -10.54 8.9 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.235 -1.156 . . . . 0.0 110.057 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.84 143.39 8.27 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.17 -1.491 . . . . 0.0 109.51 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.7 tp -101.32 142.64 32.44 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.743 -0.857 . . . . 0.0 110.12 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.831 ' O ' HD12 ' A' ' 53' ' ' ILE . 1.3 pp -120.27 150.29 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.476 -0.765 . . . . 0.0 110.559 -176.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.65 61.89 2.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.262 -1.524 . . . . 0.0 109.429 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.493 ' CD2' HD11 ' A' ' 9' ' ' ILE . 39.8 t80 -100.22 73.96 1.73 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.712 ' HG2' HH11 ' A' ' 56' ' ' ARG . 7.0 mtt-85 -72.37 143.76 48.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.587 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.0 mm . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 109.213 179.846 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 26.0 p90 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.874 0.845 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.01 165.66 26.78 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.47 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.9 m -97.93 134.73 40.65 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.6 mt -88.02 146.53 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.64 160.51 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.177 -0.952 . . . . 0.0 110.462 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.503 ' CB ' ' HZ2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -144.64 160.42 41.21 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 74' ' ' ASP . . . -118.34 152.14 36.39 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 73' ' ' ALA . 20.8 t0 . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 121.293 0.568 . . . . 0.0 109.608 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 39.2 t80 . . . . . 0 N--CA 1.503 2.185 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 39.6 mt -103.9 134.78 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.322 -0.861 . . . . 0.0 110.123 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 39.0 mt -125.56 117.38 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 7.7 t -126.18 151.96 46.63 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.909 0.861 . . . . 0.0 108.749 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.456 ' CB ' ' HG1' ' C' ' 69' ' ' THR . 4.4 p -119.66 96.56 5.24 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -178.45 -87.74 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.528 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -155.55 -160.72 1.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.399 -0.813 . . . . 0.0 109.597 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -65.36 121.94 15.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.313 -0.867 . . . . 0.0 109.601 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 77.5 mt -52.58 110.27 1.86 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.56 -0.713 . . . . 0.0 109.386 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.46 153.75 72.76 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.293 1.329 . . . . 0.0 110.396 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.65 -16.09 58.86 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' B' ' 18' ' ' LEU . 71.8 mt -121.88 140.16 52.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.403 -1.057 . . . . 0.0 109.34 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -85.1 108.42 17.66 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 12.7 mt -96.89 138.35 34.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.211 -0.931 . . . . 0.0 110.233 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . 0.504 ' CE1' ' O ' ' B' ' 22' ' ' SER . 2.1 t80 -121.01 130.09 53.66 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.504 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 41.0 t -72.01 131.84 43.46 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 120.892 -1.13 . . . . 0.0 110.532 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.48 HD11 ' CB ' ' B' ' 72' ' ' LYS . 1.2 mp -118.92 12.79 12.95 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.67 -174.39 16.29 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . 0.604 HD11 ' OG1' ' A' ' 11' ' ' THR . 0.3 OUTLIER -116.66 145.2 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.252 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.83 143.9 43.9 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 46.2 m -152.52 141.79 21.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.581 -1.325 . . . . 0.0 108.305 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 12.9 t -149.48 151.84 34.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.036 -1.04 . . . . 0.0 108.646 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' B' ' 30' ' ' SER . 49.1 mt -112.4 158.02 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.117 -0.989 . . . . 0.0 108.674 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.672 ' O ' ' CG ' ' B' ' 31' ' ' ASP . 16.9 m 51.34 108.35 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.741 0 O-C-N 121.039 -1.038 . . . . 0.0 110.683 177.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.672 ' CG ' ' O ' ' B' ' 30' ' ' SER . 37.3 m-20 171.15 129.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . 0.488 ' O ' HG12 ' B' ' 36' ' ' ILE . 23.0 t-20 -84.27 173.04 11.31 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 120.917 -1.114 . . . . 0.0 108.384 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.532 ' HA ' HD11 ' B' ' 36' ' ' ILE . 15.5 t -44.8 -42.77 2.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 O-C-N 120.943 -1.098 . . . . 0.0 110.297 -174.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -64.19 -44.23 92.66 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.63 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -74.73 -45.83 41.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.327 -1.483 . . . . 0.0 111.546 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.532 HD11 ' HA ' ' B' ' 33' ' ' VAL . 0.6 OUTLIER -58.75 -48.98 84.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 O-C-N 120.017 -1.677 . . . . 0.0 109.413 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.79 -45.19 99.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 118.846 -1.142 . . . . 0.0 108.711 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -67.55 -50.34 59.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.347 -0.845 . . . . 0.0 109.424 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.577 ' N ' HD22 ' B' ' 39' ' ' ASN . 0.8 OUTLIER -54.9 -47.39 74.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.108 -0.995 . . . . 0.0 108.966 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.75 -43.46 79.81 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.411 -0.806 . . . . 0.0 108.943 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -50.85 -45.33 59.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.626 -1.296 . . . . 0.0 109.419 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' B' ' 46' ' ' ALA . 64.0 mttm -66.41 -39.37 88.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.461 -0.774 . . . . 0.0 110.055 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -76.82 -34.99 57.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.689 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.473 HG21 HD13 ' B' ' 52' ' ' LEU . 15.3 t -71.86 -51.9 28.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.209 -0.932 . . . . 0.0 109.025 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -70.22 -30.18 67.2 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.14 -1.424 . . . . 0.0 109.558 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' B' ' 42' ' ' LYS . . . -61.55 -30.01 70.38 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -93.62 -5.31 49.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.381 -0.824 . . . . 0.0 109.821 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.87 15.49 28.62 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.02 159.84 29.24 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.1 -1.02 4.63 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.173 -1.193 . . . . 0.0 110.816 -176.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.82 173.62 43.4 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.422 -1.37 . . . . 0.0 109.773 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.473 HD13 HG21 ' B' ' 44' ' ' VAL . 5.5 tp -130.53 133.81 46.53 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.67 -0.9 . . . . 0.0 109.43 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.57 139.66 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.672 -0.643 . . . . 0.0 110.243 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 50.83 61.12 3.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.949 -1.094 . . . . 0.0 110.633 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -100.39 114.3 27.74 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.323 0.583 . . . . 0.0 110.654 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -102.46 119.12 38.28 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 pt . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.128 -0.982 . . . . 0.0 109.858 -179.547 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.26 149.66 20.39 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' B' ' 67' ' ' TYR . 4.8 p90 -150.03 152.97 35.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.158 -1.201 . . . . 0.0 110.202 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.73 156.53 28.07 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 52.6 m -101.21 136.12 41.56 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.061 -1.258 . . . . 0.0 107.92 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 53.5 mt -86.04 146.62 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.9 m -138.51 156.71 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.308 -0.87 . . . . 0.0 110.21 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.48 ' CB ' HD11 ' B' ' 23' ' ' LEU . 23.4 ttpp -150.55 132.44 15.11 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.54 129.34 50.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.856 -1.152 . . . . 0.0 108.3 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 t70 . . . . . 0 N--CA 1.488 1.445 0 O-C-N 120.844 -1.16 . . . . 0.0 108.681 177.785 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.375 0.607 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -95.23 122.59 38.09 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.518 -0.738 . . . . 0.0 110.026 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 86.2 mt -111.06 128.89 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.485 -0.76 . . . . 0.0 109.866 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' ILE . . . . . 0.615 HG23 HD13 ' D' ' 25' ' ' ILE . 7.7 tt -124.19 116.92 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 7.9 t -113.36 135.99 53.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.661 -1.274 . . . . 0.0 109.039 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' C' ' 12' ' ' ALA . 0.3 OUTLIER -56.99 -85.75 0.01 OUTLIER 'General case' 0 C--N 1.279 -2.471 0 O-C-N 121.873 -0.517 . . . . 0.0 111.178 178.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . 0.492 ' N ' ' OG1' ' C' ' 11' ' ' THR . . . -133.43 92.68 3.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.639 -1.288 . . . . 0.0 108.131 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -147.57 -134.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.294 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -165.86 -9.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.07 -1.019 . . . . 0.0 109.474 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 27.8 mt 55.64 68.74 2.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.39 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.89 156.22 50.18 Favored 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 121.931 1.754 . . . . 0.0 109.984 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.12 -14.96 63.15 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' C' ' 18' ' ' LEU . 19.1 mt -119.34 137.47 53.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.434 -1.039 . . . . 0.0 109.153 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.77 107.92 19.22 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.474 HD13 HD11 ' C' ' 53' ' ' ILE . 11.6 mt -97.88 140.66 31.9 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.199 -0.938 . . . . 0.0 110.246 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' TYR . . . . . 0.62 ' CE1' ' O ' ' C' ' 22' ' ' SER . 0.6 OUTLIER -123.17 129.94 52.1 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . 0.62 ' O ' ' CE1' ' C' ' 21' ' ' TYR . 24.9 t -66.37 135.71 54.73 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.273 1.035 . . . . 0.0 112.45 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 mt -123.86 13.86 9.23 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.512 -0.742 . . . . 0.0 109.357 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.29 179.74 15.99 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.5 145.8 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 122.21 -0.583 . . . . 0.0 109.56 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.89 159.71 18.78 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.93 147.09 26.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.752 -1.217 . . . . 0.0 108.474 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . 0.427 HG23 HD21 ' C' ' 40' ' ' LEU . 51.7 p -146.0 142.1 28.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.509 -0.744 . . . . 0.0 109.872 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' C' ' 30' ' ' SER . 55.8 mt -127.18 124.86 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 29' ' ' ILE . 3.6 p 157.77 -159.59 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -132.62 -174.7 3.53 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 1.8 m120 73.97 114.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.481 HG22 HD12 ' C' ' 57' ' ' ILE . 22.2 t -68.39 -34.34 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.445 -0.784 . . . . 0.0 109.482 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.4 -38.87 78.25 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.236 -0.915 . . . . 0.0 109.269 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -75.14 -39.81 60.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.932 -1.105 . . . . 0.0 109.586 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.45 -52.38 56.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.602 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 5.7 t -58.24 -48.31 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.009 -1.057 . . . . 0.0 108.782 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.77 -44.97 91.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 109.955 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -57.21 -49.9 74.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.104 -0.997 . . . . 0.0 109.496 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . 0.427 HD21 HG23 ' C' ' 28' ' ' THR . 82.7 mt -64.44 -43.71 93.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.076 -1.015 . . . . 0.0 108.673 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' ARG . . . . . 0.789 ' HG2' HH11 ' C' ' 41' ' ' ARG . 2.7 ttt-85 -49.78 -47.28 51.18 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.774 -1.204 . . . . 0.0 109.579 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -67.04 -38.41 85.82 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.488 -0.758 . . . . 0.0 110.253 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -76.65 -35.5 57.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.897 . . . . 0.0 109.795 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 t -67.58 -50.88 57.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.176 -0.953 . . . . 0.0 108.949 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -71.76 -35.47 70.1 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.155 -1.418 . . . . 0.0 109.208 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.26 -33.34 67.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.486 -0.759 . . . . 0.0 108.97 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.61 -4.97 59.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.509 -0.744 . . . . 0.0 109.521 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.47 5.18 59.16 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.3 161.65 48.89 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -128.46 -0.2 5.61 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.293 -1.122 . . . . 0.0 110.014 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.42 151.09 17.48 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 16.0 tp -112.96 140.47 47.74 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.565 -0.962 . . . . 0.0 109.949 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' ILE . . . . . 0.654 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 27.9 mt -112.34 140.66 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.59 -0.694 . . . . 0.0 109.488 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 92.01 -41.36 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 118.342 0.519 . . . . 0.0 110.093 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . 0.511 ' C ' ' O ' ' C' ' 54' ' ' ALA . 18.0 t80 27.97 89.77 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 120.804 0.335 . . . . 0.0 110.177 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' ARG . . . . . 0.652 ' CG ' HH11 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -93.82 143.79 26.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.013 -1.054 . . . . 0.0 109.65 -178.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' ILE . . . . . 0.481 HD12 HG22 ' C' ' 33' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 26.2 p90 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 122.252 1.025 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.44 161.76 31.76 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' THR . . . . . 0.456 ' HG1' ' CB ' ' B' ' 11' ' ' THR . 69.1 m -93.83 137.02 33.5 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.276 -1.132 . . . . 0.0 108.406 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 60.9 mt -86.11 141.32 14.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' C' ' 21' ' ' TYR . 6.9 m -144.92 163.21 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.788 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -152.06 162.32 41.27 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' C' ' 74' ' ' ASP . . . -104.03 151.43 23.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 108.985 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' C' ' 73' ' ' ALA . 2.9 t0 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 109.85 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 121.587 0.708 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -94.12 124.29 38.04 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.668 -0.645 . . . . 0.0 109.849 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 71.8 mt -116.94 143.17 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.618 -0.676 . . . . 0.0 109.91 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 9' ' ' ILE . . . . . 0.607 HG23 ' O ' ' D' ' 9' ' ' ILE . 7.7 tt -136.03 114.65 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.8 t -122.18 161.72 22.68 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.333 -0.855 . . . . 0.0 108.826 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.16 73.27 1.29 Allowed 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.17 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.69 -116.64 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.766 0 O-C-N 119.43 -2.044 . . . . 0.0 107.363 -176.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 24.7 p30 -93.68 -137.97 0.2 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.971 -1.08 . . . . 0.0 109.428 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -109.86 -159.75 0.69 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.379 -0.826 . . . . 0.0 109.151 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 56.6 mt -125.48 85.27 58.88 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.579 -0.701 . . . . 0.0 109.203 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -60.11 157.26 35.38 Favored 'Trans proline' 0 N--CA 1.48 0.725 0 C-N-CA 121.91 1.74 . . . . 0.0 110.093 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.95 -4.46 75.0 Favored Glycine 0 N--CA 1.498 2.779 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.056 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 59.6 mt -130.64 141.38 50.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.191 . . . . 0.0 109.706 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -85.42 108.5 17.89 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 14.1 mt -94.95 133.11 39.07 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.117 -0.989 . . . . 0.0 109.635 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' D' ' 22' ' ' SER . 1.6 t80 -114.02 129.67 56.59 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . 0.433 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 0.0 OUTLIER -70.63 131.69 44.31 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 120.618 -1.301 . . . . 0.0 110.942 -179.415 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 mt -117.29 11.34 14.0 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.91 -179.68 18.4 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' ILE . . . . . 0.615 HD13 HG23 ' C' ' 9' ' ' ILE . 1.5 mp -108.87 141.87 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.853 -0.792 . . . . 0.0 108.933 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.59 142.94 44.58 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 43.8 p -152.2 130.82 12.29 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' THR . . . . . 0.427 ' O ' HG23 ' D' ' 28' ' ' THR . 10.6 t -143.35 130.23 20.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.758 -1.213 . . . . 0.0 108.716 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . 0.484 HG23 ' O ' ' D' ' 29' ' ' ILE . 19.4 tt -97.72 130.29 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.879 -1.138 . . . . 0.0 108.961 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.531 ' O ' ' O ' ' D' ' 31' ' ' ASP . 72.1 m -168.73 2.36 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.739 -1.226 . . . . 0.0 109.968 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' ASP . . . . . 0.531 ' O ' ' O ' ' D' ' 30' ' ' SER . 26.5 t70 51.27 161.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.48 -0.763 . . . . 0.0 110.447 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 0.1 OUTLIER 71.86 128.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.63 -1.293 . . . . 0.0 108.67 -178.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 20.2 t -69.94 -36.73 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 121.224 -0.923 . . . . 0.0 110.15 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' D' ' 35' ' ' GLU . 25.4 p-10 -58.51 -47.03 85.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.161 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' D' ' 34' ' ' ASP . 49.9 mt-10 -76.26 -38.64 55.96 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.957 -1.089 . . . . 0.0 109.86 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 60.9 mt -63.79 -53.69 41.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 120.882 -1.136 . . . . 0.0 109.493 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 43.4 t -63.5 -49.65 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.167 -0.958 . . . . 0.0 109.658 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -58.13 -39.44 78.75 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.159 -0.963 . . . . 0.0 109.637 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -65.98 -42.31 90.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . 0.649 HD13 HD21 ' D' ' 52' ' ' LEU . 29.1 mt -67.77 -46.29 72.44 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.956 -1.09 . . . . 0.0 108.749 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -46.77 -53.4 11.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.884 -1.135 . . . . 0.0 109.056 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -55.65 -31.0 61.96 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.32 -0.862 . . . . 0.0 109.154 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -73.11 -36.27 66.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.16 -0.963 . . . . 0.0 109.609 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.66 -50.71 25.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 120.886 -1.134 . . . . 0.0 109.281 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -49.92 -33.81 18.61 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 122.988 1.375 . . . . 0.0 109.873 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.97 -29.06 49.57 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.824 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -97.75 6.27 48.12 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.36 29.14 59.99 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 117.952 -2.071 . . . . 0.0 109.687 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.75 -170.27 5.07 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 11.3 ttp -109.51 -41.57 4.55 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.494 -1.004 . . . . 0.0 110.063 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 171.25 175.69 39.87 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . 0.649 HD21 HD13 ' D' ' 40' ' ' LEU . 1.0 OUTLIER -108.24 139.42 42.96 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.479 -1.012 . . . . 0.0 109.993 -179.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 53' ' ' ILE . . . . . 0.5 ' O ' ' HB3' ' D' ' 54' ' ' ALA . 1.2 pt -112.28 142.47 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.748 -0.595 . . . . 0.0 110.238 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 68.93 -61.54 0.42 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.42 -0.8 . . . . 0.0 110.516 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . 0.437 ' N ' ' O ' ' D' ' 53' ' ' ILE . 13.1 t80 42.7 83.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.05 -1.031 . . . . 0.0 109.493 -179.776 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 121.48 0.657 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.0 137.43 3.18 Favored Glycine 0 C--N 1.288 -2.101 0 C-N-CA 119.015 -1.564 . . . . 0.0 110.856 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 6.9 m -101.08 144.29 30.17 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.74 -0.859 . . . . 0.0 108.951 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 26.7 mt -89.07 142.19 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 m -135.13 166.65 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.371 0.605 . . . . 0.0 109.48 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 72' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' D' ' 21' ' ' TYR . 7.7 tttt -146.47 145.39 30.18 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' D' ' 74' ' ' ASP . . . -125.42 153.98 42.63 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' D' ' 73' ' ' ALA . 25.2 t0 . . . . . 0 N--CA 1.492 1.642 0 CA-C-N 119.018 0.826 . . . . 0.0 110.15 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 6' ' ' LYS . . . . . 0.442 ' HG3' ' HZ2' ' E' ' 6' ' ' LYS . 6.8 ptmm? . . . . . 0 N--CA 1.498 1.954 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -94.93 119.08 32.88 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.388 -0.82 . . . . 0.0 109.788 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 33.8 mt -113.35 134.21 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.568 -0.708 . . . . 0.0 109.407 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 9' ' ' ILE . . . . . 0.624 HG23 ' O ' ' E' ' 9' ' ' ILE . 15.7 tt -130.67 114.42 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 6.5 t -122.46 157.9 30.95 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.891 0.853 . . . . 0.0 109.103 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 11' ' ' THR . . . . . 0.601 ' O ' ' HB2' ' E' ' 12' ' ' ALA . 4.1 p -100.25 77.69 1.99 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 177.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' E' ' 11' ' ' THR . . . 157.55 -90.97 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.778 0.799 . . . . 0.0 109.714 177.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -165.16 -71.32 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 51.14 -153.26 0.18 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 110.245 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 15' ' ' ILE . . . . . 0.667 ' N ' ' HD3' ' E' ' 16' ' ' PRO . 2.8 mt 60.54 48.16 1.6 Allowed Pre-proline 0 N--CA 1.483 1.223 0 O-C-N 121.849 -0.532 . . . . 0.0 109.632 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . 0.667 ' HD3' ' N ' ' E' ' 15' ' ' ILE . 1.6 Cg_endo -66.77 154.48 74.36 Favored 'Trans proline' 0 C--N 1.326 -0.629 0 C-N-CA 121.532 1.488 . . . . 0.0 109.81 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.99 -9.96 74.71 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.927 -1.606 . . . . 0.0 110.943 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 18' ' ' LEU . . . . . 0.487 HD12 ' CG2' ' E' ' 15' ' ' ILE . 75.5 mt -118.73 137.72 53.15 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.138 1.469 . . . . 0.0 109.387 -178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -86.12 112.88 21.71 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 12.5 mt -89.16 135.22 33.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -0.912 . . . . 0.0 110.62 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 21' ' ' TYR . . . . . 0.554 ' CE1' ' O ' ' E' ' 22' ' ' SER . 1.2 t80 -119.66 130.79 55.23 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 22' ' ' SER . . . . . 0.554 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 0.0 OUTLIER -71.68 131.46 43.2 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.977 -1.077 . . . . 0.0 111.071 -179.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.502 HD11 ' CB ' ' E' ' 72' ' ' LYS . 1.1 mp -118.41 12.92 13.46 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.03 179.49 15.97 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 tp -114.47 144.81 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.977 -0.719 . . . . 0.0 109.303 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.6 144.98 41.18 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 90.3 p -152.43 139.95 19.68 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.705 -1.247 . . . . 0.0 107.93 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 8.7 t -150.49 144.14 25.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.889 -1.132 . . . . 0.0 109.025 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 4.7 mm -106.42 128.46 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.251 -0.906 . . . . 0.0 108.879 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 29.0 t -175.06 177.9 1.86 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -0.802 . . . . 0.0 109.007 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 31' ' ' ASP . . . . . 0.403 ' O ' ' CB ' ' E' ' 32' ' ' ASN . 46.6 t0 -116.43 161.14 19.54 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.486 -0.759 . . . . 0.0 109.235 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 32' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 2.4 m120 75.96 123.56 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 52.6 t -67.5 -33.33 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.396 -0.815 . . . . 0.0 109.415 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -58.55 -43.05 89.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 110.153 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -75.6 -37.93 59.45 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.112 -0.993 . . . . 0.0 109.466 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.71 -49.42 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 109.451 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 44.7 t -63.83 -49.64 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.031 -1.043 . . . . 0.0 109.653 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.79 -37.37 73.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.832 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -65.56 -41.49 92.89 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -0.958 . . . . 0.0 109.792 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 40' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' E' ' 40' ' ' LEU . 30.9 mt -68.2 -45.96 71.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.085 -1.01 . . . . 0.0 109.106 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -48.62 -50.71 31.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.786 -1.196 . . . . 0.0 109.363 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 42' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' E' ' 46' ' ' ALA . 31.7 ttpt -61.04 -36.47 79.64 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.464 -0.773 . . . . 0.0 110.209 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -76.57 -35.08 58.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.952 . . . . 0.0 109.77 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 9.1 t -70.44 -51.82 34.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.07 -1.019 . . . . 0.0 108.846 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 -30.72 67.33 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.046 -1.462 . . . . 0.0 109.275 -175.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' E' ' 42' ' ' LYS . . . -61.48 -34.9 76.26 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.449 -0.782 . . . . 0.0 109.713 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.42 -5.45 58.84 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.064 -1.023 . . . . 0.0 109.889 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 106.49 -1.19 36.99 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.04 156.95 52.69 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 6.4 ptm -120.53 -2.46 9.97 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.392 -1.063 . . . . 0.0 110.29 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.65 156.01 19.88 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.06 -1.543 . . . . 0.0 109.686 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 5.3 tp -106.26 136.28 46.25 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.722 -0.869 . . . . 0.0 109.28 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 53' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 1.2 pt -108.83 144.38 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.45 -0.781 . . . . 0.0 110.012 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.493 ' HA ' HH12 ' E' ' 56' ' ' ARG . . . 64.12 82.55 0.18 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.114 -0.991 . . . . 0.0 110.794 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 55' ' ' PHE . . . . . 0.486 ' O ' ' CG ' ' E' ' 55' ' ' PHE . 72.6 t80 -113.75 19.04 17.03 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.192 0.52 . . . . 0.0 109.683 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 56' ' ' ARG . . . . . 0.755 ' HG3' HH11 ' E' ' 56' ' ' ARG . 15.8 mtm-85 -59.68 111.86 1.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.16 -0.962 . . . . 0.0 109.645 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 64.6 mt . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.284 179.874 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 38.1 p90 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.567 0.699 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.3 172.33 25.3 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.327 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 54.8 m -99.17 134.62 41.75 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.348 -1.089 . . . . 0.0 108.196 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 66.9 mt -78.31 146.07 8.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.8 m -130.34 152.11 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.96 -1.088 . . . . 0.0 109.905 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 72' ' ' LYS . . . . . 0.502 ' CB ' HD11 ' E' ' 23' ' ' LEU . 24.4 ttpp -144.9 141.16 28.83 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.76 138.86 36.25 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--N 1.312 -1.063 0 O-C-N 120.451 -1.406 . . . . 0.0 108.969 178.087 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.2 t80 . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.0 mt -132.9 124.76 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.284 -0.885 . . . . 0.0 109.723 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.465 ' CG2' ' O ' ' A' ' 9' ' ' ILE . 7.4 tt -119.3 118.99 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 t -117.35 133.39 56.04 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.388 -0.82 . . . . 0.0 108.868 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.456 ' OG1' ' OG1' ' B' ' 69' ' ' THR . 3.2 m -107.96 70.03 0.75 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.426 -0.796 . . . . 0.0 111.863 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.414 ' H ' ' H ' ' A' ' 13' ' ' ASP . . . -162.98 -9.92 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 O-C-N 120.197 -1.564 . . . . 0.0 108.328 -175.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.6 OUTLIER 64.25 57.54 1.21 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.711 -0.618 . . . . 0.0 110.331 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -178.85 137.81 0.15 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.576 -0.703 . . . . 0.0 109.889 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.768 HG23 ' O ' ' A' ' 15' ' ' ILE . 9.5 tt -163.78 58.65 0.71 Allowed Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.217 -0.927 . . . . 0.0 108.857 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HD3' ' N ' ' A' ' 15' ' ' ILE . 3.2 Cg_exo -59.21 158.24 26.96 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 121.971 1.781 . . . . 0.0 110.562 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.33 -3.91 66.67 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.671 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.737 ' HB3' HD21 ' A' ' 20' ' ' LEU . 25.2 mt -128.33 136.95 51.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.817 -1.402 . . . . 0.0 109.344 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -87.84 108.62 19.24 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.737 HD21 ' HB3' ' A' ' 18' ' ' LEU . 1.9 mt -120.8 129.98 53.8 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.105 0.478 . . . . 0.0 110.544 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.626 ' N ' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -104.88 141.9 35.71 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 24' ' ' GLY . 28.8 t -78.74 88.06 4.62 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.03 11.01 0.61 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.591 -0.693 . . . . 0.0 110.499 -177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 22' ' ' SER . . . 125.17 -175.89 17.24 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.421 HD11 HG23 ' E' ' 9' ' ' ILE . 47.0 mm -110.05 141.67 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.364 0.602 . . . . 0.0 109.381 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -109.88 151.89 26.48 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 122.025 0.917 . . . . 0.0 109.628 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.3 m -139.97 143.65 36.63 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.69 147.49 43.76 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.999 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.437 ' O ' ' OG ' ' A' ' 30' ' ' SER . 4.2 tp -127.5 132.98 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 120.935 1.698 . . . . 0.0 106.66 176.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 29' ' ' ILE . 2.0 m 173.29 -161.5 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.907 -1.121 . . . . 0.0 108.991 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -117.67 -75.31 0.58 Allowed 'General case' 0 N--CA 1.512 2.641 0 O-C-N 121.301 -0.874 . . . . 0.0 112.449 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -65.57 149.18 50.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.772 -1.205 . . . . 0.0 108.128 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.46 ' H ' HG13 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -70.45 -40.3 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -52.39 -28.49 19.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.349 -0.845 . . . . 0.0 109.791 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -79.51 -33.13 42.35 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.187 -0.945 . . . . 0.0 109.368 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 33' ' ' VAL . 41.6 mt -60.66 -53.01 54.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.311 -0.868 . . . . 0.0 109.234 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.5 t -54.9 -50.37 62.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.084 -1.01 . . . . 0.0 109.105 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -60.18 -40.07 88.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 110.149 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -65.4 -41.91 93.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.073 -1.017 . . . . 0.0 109.514 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 40' ' ' LEU . 13.3 mt -62.43 -41.38 98.66 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.054 -1.029 . . . . 0.0 109.146 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.542 ' CG ' HH11 ' A' ' 41' ' ' ARG . 0.0 OUTLIER -49.91 -51.3 41.83 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.504 -1.373 . . . . 0.0 109.296 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -61.67 -37.48 84.23 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.774 -1.204 . . . . 0.0 110.68 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -77.1 -36.02 55.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.306 -0.871 . . . . 0.0 110.089 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 t -70.81 -50.56 42.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.425 -0.797 . . . . 0.0 108.965 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -67.74 -29.04 68.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.393 -1.442 . . . . 0.0 109.271 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.71 -31.21 71.0 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.524 0.678 . . . . 0.0 109.385 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -89.27 -5.62 57.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.443 -0.785 . . . . 0.0 109.466 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.09 7.67 63.85 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.77 157.62 41.93 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.35 -1.58 5.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.243 -1.151 . . . . 0.0 110.349 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.61 153.02 23.04 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.318 -1.42 . . . . 0.0 109.72 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.7 tp -116.99 139.75 50.29 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.656 -0.908 . . . . 0.0 109.793 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.482 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 22.4 mt -113.13 139.23 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.742 -0.599 . . . . 0.0 110.053 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 67.75 84.38 0.15 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.292 -0.88 . . . . 0.0 110.884 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -122.11 69.94 0.96 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.249 0.547 . . . . 0.0 110.431 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.425 HH22 ' NE ' ' E' ' 56' ' ' ARG . 14.6 ptt180 -98.13 122.68 41.57 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.269 -0.894 . . . . 0.0 109.178 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.5 mt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.341 -0.849 . . . . 0.0 109.449 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.5 p90 . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.982 0.896 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.18 -178.02 48.02 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.4 m -118.89 137.69 53.27 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.5 mt -89.31 130.59 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.676 ' HB ' ' HB3' ' A' ' 20' ' ' LEU . 14.0 m -144.27 151.62 15.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 119.352 -0.939 . . . . 0.0 109.189 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.7 pttt -145.48 151.13 37.7 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.1 -1.0 . . . . 0.0 109.167 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.02 150.58 39.71 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.493 ' N ' ' OH ' ' A' ' 21' ' ' TYR . 14.2 p-10 . . . . . 0 N--CA 1.498 1.946 0 O-C-N 121.094 -1.004 . . . . 0.0 108.622 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 86.3 t80 . . . . . 0 N--CA 1.499 2.003 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 64.5 mt -112.5 128.02 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.591 -0.693 . . . . 0.0 110.079 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.624 HG23 ' O ' ' B' ' 9' ' ' ILE . 5.7 tt -124.74 113.34 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.3 t -123.52 161.13 25.51 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.907 0.861 . . . . 0.0 109.181 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.572 ' O ' ' C ' ' B' ' 12' ' ' ALA . 12.3 p -99.89 -109.88 0.2 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.173 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.572 ' C ' ' O ' ' B' ' 11' ' ' THR . . . 16.6 -115.03 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 118.486 0.584 . . . . 0.0 111.715 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -111.38 -140.1 0.38 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.623 -0.673 . . . . 0.0 109.312 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -93.93 -157.3 0.54 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.279 -0.888 . . . . 0.0 109.973 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 mt -113.54 98.47 46.98 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.486 -0.759 . . . . 0.0 109.356 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.74 156.83 40.69 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 C-N-CA 121.694 1.596 . . . . 0.0 110.144 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.84 -4.5 75.44 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' B' ' 18' ' ' LEU . 34.3 mt -131.45 141.35 49.79 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.175 -1.191 . . . . 0.0 109.996 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -85.05 107.65 17.26 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 12.9 mt -103.16 137.27 41.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.612 -0.68 . . . . 0.0 109.831 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . 0.53 ' CE1' ' O ' ' B' ' 22' ' ' SER . 1.3 t80 -118.62 130.31 55.8 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.53 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 32.6 t -66.27 134.07 51.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 0.0 111.341 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 8.0 mt -121.07 10.31 10.72 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.6 175.0 15.78 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . 0.451 HD11 ' OG1' ' A' ' 11' ' ' THR . 0.1 OUTLIER -113.32 146.6 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.47 159.72 21.64 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 48.8 m -153.04 147.43 25.88 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.712 ' OG1' HG23 ' B' ' 36' ' ' ILE . 5.2 p -149.64 148.27 29.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 109.533 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.465 ' O ' ' OG ' ' B' ' 30' ' ' SER . 1.3 tp -126.5 127.51 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' B' ' 29' ' ' ILE . 2.8 m -168.27 171.29 9.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.168 -0.958 . . . . 0.0 109.751 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -80.41 -61.05 2.09 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.422 -0.799 . . . . 0.0 112.124 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -74.57 128.26 35.12 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.555 -1.341 . . . . 0.0 108.501 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.404 ' H ' HG13 ' B' ' 33' ' ' VAL . 2.1 m -69.33 -33.65 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.613 -0.68 . . . . 0.0 109.182 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -59.57 -29.71 68.14 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.475 -0.765 . . . . 0.0 110.103 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -70.88 -35.93 72.57 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.507 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.712 HG23 ' OG1' ' B' ' 28' ' ' THR . 77.3 mt -61.45 -47.28 94.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.114 -0.991 . . . . 0.0 109.397 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 68.9 t -54.98 -50.6 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.919 -1.113 . . . . 0.0 109.285 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -59.91 -40.63 89.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.393 -0.817 . . . . 0.0 109.585 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -64.65 -41.9 95.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.164 -0.96 . . . . 0.0 109.369 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 73.0 mt -65.75 -44.07 87.02 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 109.027 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -48.79 -46.66 41.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.49 -1.381 . . . . 0.0 109.383 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -65.27 -37.38 87.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.627 -0.671 . . . . 0.0 110.207 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -77.04 -35.03 57.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 109.912 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.64 -51.57 44.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.286 -0.884 . . . . 0.0 108.834 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.07 -30.54 66.71 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 118.108 -1.437 . . . . 0.0 109.216 -175.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.0 -32.14 72.58 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -91.61 -5.49 53.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.728 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.61 3.63 46.58 Favored Glycine 0 N--CA 1.502 3.094 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.78 159.41 47.78 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -126.71 -2.06 6.68 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.352 -1.087 . . . . 0.0 110.471 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -165.42 158.09 30.81 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.324 -1.417 . . . . 0.0 109.612 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 6.1 tp -114.99 137.24 52.23 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.668 -0.901 . . . . 0.0 109.744 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.514 ' O ' ' HB3' ' B' ' 54' ' ' ALA . 68.1 mt -114.35 145.63 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.674 -0.641 . . . . 0.0 110.239 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 69.61 88.9 0.11 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.045 -1.034 . . . . 0.0 111.199 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -142.56 69.48 1.31 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.23 0.538 . . . . 0.0 110.171 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -108.35 146.16 33.41 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mm . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.585 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.798 HD22 ' N ' ' B' ' 65' ' ' LEU . 2.0 mm? . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.12 71.12 0.54 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' TYR . . . . . 0.45 ' CD2' ' O ' ' B' ' 67' ' ' TYR . 49.6 p90 -73.38 126.12 29.42 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.267 -1.137 . . . . 0.0 109.494 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.95 156.44 26.68 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . 0.456 ' OG1' ' OG1' ' A' ' 11' ' ' THR . 48.4 m -103.04 134.89 45.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.861 -1.376 . . . . 0.0 108.523 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 66.1 mt -89.98 134.59 28.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.8 m -141.66 163.12 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 110.48 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -153.78 148.98 26.96 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.36 150.75 30.64 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.129 -0.982 . . . . 0.0 108.494 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' B' ' 74' ' ' ASP . 26.7 p-10 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 120.93 -1.106 . . . . 0.0 108.914 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . 0.547 ' O ' ' O ' ' C' ' 50' ' ' MET . 44.8 mtmt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -104.85 121.53 43.87 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 76.1 mt -134.57 126.66 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.284 -0.885 . . . . 0.0 109.607 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' ILE . . . . . 0.58 HG23 ' O ' ' C' ' 9' ' ' ILE . 14.8 tt -122.06 115.5 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.76 156.88 42.84 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 122.139 0.971 . . . . 0.0 108.849 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -116.24 94.04 4.48 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.53 -108.73 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.799 177.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -148.26 -50.93 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 109.592 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . 0.411 ' HG3' ' H ' ' C' ' 15' ' ' ILE . 3.3 tp10 -154.78 176.8 12.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.168 -0.958 . . . . 0.0 109.294 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . 0.411 ' H ' ' HG3' ' C' ' 14' ' ' GLU . 29.3 mt -124.04 87.74 53.04 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -60.63 156.0 44.89 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.876 1.717 . . . . 0.0 110.238 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.28 -8.81 77.19 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 31.7 mt -132.23 142.79 49.54 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.373 -1.075 . . . . 0.0 109.496 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -86.19 108.66 18.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 14.8 mt -96.71 137.33 35.96 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 109.964 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' TYR . . . . . 0.404 ' N ' ' O ' ' C' ' 72' ' ' LYS . 18.1 t80 -123.5 129.04 50.64 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.1 t -87.56 131.79 34.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.342 -0.849 . . . . 0.0 109.608 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.942 HD23 ' N ' ' C' ' 23' ' ' LEU . 0.2 OUTLIER -123.28 11.53 9.39 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.61 168.49 11.85 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.266 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -106.7 146.18 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.99 144.83 42.45 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 75.2 m -152.68 138.66 18.14 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 12.1 t -149.77 141.06 23.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.843 -1.161 . . . . 0.0 108.644 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.491 HG23 ' O ' ' C' ' 29' ' ' ILE . 15.3 tt -115.31 129.82 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' C' ' 29' ' ' ILE . 6.4 m -169.72 -141.36 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.043 -1.036 . . . . 0.0 109.796 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -157.55 161.73 38.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.248 -0.908 . . . . 0.0 108.972 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 73.81 127.34 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -67.57 -33.68 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.51 -0.744 . . . . 0.0 109.363 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -59.01 -46.69 87.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.358 -0.839 . . . . 0.0 110.176 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -76.03 -40.27 53.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.203 -0.936 . . . . 0.0 109.78 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 71.5 mt -60.29 -39.42 80.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.881 -1.137 . . . . 0.0 109.297 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -69.3 -47.03 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.776 -1.202 . . . . 0.0 109.534 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -60.24 -41.42 93.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.935 . . . . 0.0 109.843 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -58.81 -48.32 81.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 109.941 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 28.4 mt -70.32 -47.59 60.41 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.047 -1.033 . . . . 0.0 109.111 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' ARG . . . . . 0.425 HH21 ' NZ ' ' C' ' 45' ' ' LYS . 39.9 mtp180 -49.44 -48.0 47.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.535 -1.353 . . . . 0.0 109.016 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' C' ' 46' ' ' ALA . 46.1 mtpt -63.8 -37.65 88.17 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 109.831 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' GLN . . . . . 0.574 HE22 ' HZ1' ' C' ' 47' ' ' LYS . 0.0 OUTLIER -75.98 -35.66 59.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 109.912 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 20.2 t -76.63 -51.75 18.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 109.067 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' LYS . . . . . 0.425 ' NZ ' HH21 ' C' ' 41' ' ' ARG . 18.2 mtmt -69.43 -29.94 67.76 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.858 -1.537 . . . . 0.0 109.461 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' C' ' 42' ' ' LYS . . . -64.07 -33.38 75.63 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . 0.574 ' HZ1' HE22 ' C' ' 43' ' ' GLN . 0.0 OUTLIER -90.63 2.69 55.64 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.245 -0.91 . . . . 0.0 108.699 179.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.42 29.65 65.75 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.053 -1.546 . . . . 0.0 109.962 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.37 -168.74 24.33 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.057 -1.261 . . . . 0.0 110.053 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . 0.547 ' O ' ' O ' ' C' ' 6' ' ' LYS . 14.6 ttt -108.42 -41.75 4.76 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.567 -0.961 . . . . 0.0 109.692 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 173.96 -153.9 18.19 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 tp -136.01 137.45 41.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.413 -1.051 . . . . 0.0 109.985 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' ILE . . . . . 0.446 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 49.0 mt -110.52 141.12 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.571 -0.706 . . . . 0.0 109.741 -178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 64.65 75.18 0.38 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.204 -0.935 . . . . 0.0 108.66 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -93.99 140.31 29.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 109.075 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' ARG . . . . . 0.73 ' HG2' HH11 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -134.57 174.66 10.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.584 -0.698 . . . . 0.0 109.284 179.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 39.8 mt . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 3.7 t80 . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.879 0.847 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 174.35 157.6 16.3 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 21.1 m -98.37 144.26 27.94 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.357 -1.084 . . . . 0.0 109.59 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 56.1 mt -91.19 132.06 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.09 163.14 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.44 0.638 . . . . 0.0 109.854 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' C' ' 21' ' ' TYR . 16.2 ttmm -153.65 141.05 19.7 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.0 150.0 36.52 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.737 -1.227 . . . . 0.0 108.152 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--N 1.301 -1.501 0 O-C-N 120.982 -1.074 . . . . 0.0 109.029 179.754 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 72.1 tttt . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.614 0.721 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -94.59 124.52 38.67 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.717 -0.615 . . . . 0.0 109.462 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 20.0 mt -115.94 137.71 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.556 -0.715 . . . . 0.0 109.963 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 9' ' ' ILE . . . . . 0.431 ' O ' ' CG2' ' D' ' 9' ' ' ILE . 9.4 tt -119.49 124.28 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.99 130.81 56.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.511 -0.743 . . . . 0.0 109.556 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . 0.403 ' O ' ' HB3' ' D' ' 12' ' ' ALA . 3.1 m -129.79 120.86 25.72 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 12' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' D' ' 11' ' ' THR . . . 60.05 12.04 2.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.248 -0.907 . . . . 0.0 109.697 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -126.23 108.38 11.24 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.482 0.658 . . . . 0.0 109.36 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . 0.446 ' HG3' ' H ' ' D' ' 15' ' ' ILE . 8.2 tp10 -62.33 169.42 2.88 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.269 -0.895 . . . . 0.0 108.655 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' ILE . . . . . 0.746 HG23 ' O ' ' D' ' 15' ' ' ILE . 13.1 tt -134.55 60.91 45.73 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.271 -0.893 . . . . 0.0 109.509 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' D' ' 15' ' ' ILE . 2.0 Cg_endo -61.14 157.58 38.93 Favored 'Trans proline' 0 C--N 1.323 -0.787 0 C-N-CA 122.242 1.961 . . . . 0.0 110.171 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.68 -2.77 67.44 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.671 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' D' ' 18' ' ' LEU . 19.1 mt -128.43 138.47 52.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.813 -1.404 . . . . 0.0 109.803 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -85.12 108.69 17.8 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt -97.95 139.36 33.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.356 -0.84 . . . . 0.0 110.516 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -119.85 129.13 54.26 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 10.3 t -71.62 131.25 42.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.48 -1.388 . . . . 0.0 111.105 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' D' ' 72' ' ' LYS . 32.1 mt -115.94 5.86 14.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.38 -176.18 16.01 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.54 143.05 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.9 -0.765 . . . . 0.0 109.158 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.19 162.6 16.83 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.861 0.838 . . . . 0.0 110.34 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -152.21 149.57 28.88 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -151.41 153.24 34.31 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.143 0.973 . . . . 0.0 109.475 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 tt -123.08 145.83 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.029 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 2.1 m 169.92 155.07 0.05 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.392 -0.817 . . . . 0.0 109.547 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' ASP . . . . . 0.496 ' O ' ' ND2' ' D' ' 32' ' ' ASN . 1.8 p30 -100.09 63.78 1.18 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.303 -0.873 . . . . 0.0 109.627 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' D' ' 31' ' ' ASP . 0.2 OUTLIER 176.84 132.76 0.05 Allowed 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . 0.429 ' H ' HG13 ' D' ' 33' ' ' VAL . 2.0 m -69.81 -40.89 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -63.31 -32.67 74.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.488 -0.757 . . . . 0.0 109.915 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -74.1 -39.34 63.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.246 -0.909 . . . . 0.0 109.109 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 mt -60.34 -48.99 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.35 -0.844 . . . . 0.0 108.963 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 63.0 t -57.48 -45.41 85.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.717 0 O-C-N 121.13 -0.981 . . . . 0.0 108.518 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -63.84 -43.1 97.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.186 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' ASN . . . . . 0.449 ' N ' HD22 ' D' ' 39' ' ' ASN . 1.5 m120 -57.95 -47.74 82.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.132 -0.98 . . . . 0.0 109.548 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 26.6 mt -63.95 -41.58 97.56 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 109.259 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -51.51 -39.84 58.44 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.443 -1.41 . . . . 0.0 109.815 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -72.95 -40.62 65.21 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.388 -0.82 . . . . 0.0 110.238 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -76.32 -36.15 58.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.389 -0.82 . . . . 0.0 109.704 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.97 -49.82 64.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.453 -0.78 . . . . 0.0 108.927 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -70.47 -31.22 68.27 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.087 -1.445 . . . . 0.0 108.989 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.06 -33.71 76.37 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -87.17 0.62 55.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.472 -0.768 . . . . 0.0 109.393 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.0 2.49 74.68 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.3 158.58 49.4 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.95 -1.3 5.92 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.261 -1.141 . . . . 0.0 110.196 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.04 168.29 40.69 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . 0.413 HD21 ' HA3' ' D' ' 68' ' ' GLY . 2.7 tp -131.7 137.98 48.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.601 -0.941 . . . . 0.0 109.291 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 53' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' D' ' 54' ' ' ALA . 1.9 pt -106.72 144.24 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.515 -0.74 . . . . 0.0 109.538 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 65.77 76.36 0.32 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 0.0 109.815 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . 0.539 ' O ' ' CG ' ' D' ' 55' ' ' PHE . 62.6 t80 -106.36 34.44 3.38 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' ARG . . . . . 0.573 ' NH1' HH22 ' E' ' 56' ' ' ARG . 25.5 mtm180 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 120.989 -1.069 . . . . 0.0 109.42 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 67' ' ' TYR . . . . . 0.488 ' O ' ' CD2' ' D' ' 67' ' ' TYR . 16.4 p90 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.348 0.594 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 68' ' ' GLY . . . . . 0.413 ' HA3' HD21 ' D' ' 52' ' ' LEU . . . -127.35 166.51 20.06 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 54.7 m -110.71 138.08 47.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.109 -1.23 . . . . 0.0 108.482 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 70' ' ' ILE . . . . . 0.491 HG22 HD12 ' D' ' 23' ' ' LEU . 41.0 mt -84.32 150.3 4.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.24 158.96 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.138 -0.976 . . . . 0.0 109.993 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 72' ' ' LYS . . . . . 0.674 ' HB2' HD11 ' D' ' 23' ' ' LEU . 5.2 ttpt -144.44 154.32 42.83 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.68 151.86 42.66 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.019 -1.051 . . . . 0.0 108.527 179.388 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -93.99 118.71 31.88 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.056 -1.027 . . . . 0.0 109.328 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 71.7 mt -111.65 129.18 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.588 -0.695 . . . . 0.0 110.113 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 9' ' ' ILE . . . . . 0.623 HG23 ' O ' ' E' ' 9' ' ' ILE . 17.4 tt -130.08 113.36 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 3.7 t -122.88 161.68 23.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.264 -0.897 . . . . 0.0 108.784 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 11' ' ' THR . . . . . . . . . . . . . 3.1 p -113.07 85.71 2.23 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.68 -124.12 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.351 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 13' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' E' ' 14' ' ' GLU . 1.0 OUTLIER -162.34 92.68 0.83 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.431 -0.793 . . . . 0.0 109.031 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . 0.541 ' H ' HG21 ' E' ' 53' ' ' ILE . 12.1 tt0 75.46 150.35 0.11 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.875 -0.515 . . . . 0.0 110.069 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.38 97.13 50.43 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -60.09 154.9 48.22 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.608 1.539 . . . . 0.0 110.507 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.33 -5.78 77.97 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 18' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' E' ' 18' ' ' LEU . 17.1 mt -130.99 140.88 50.19 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.267 -1.137 . . . . 0.0 110.058 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 19' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' E' ' 73' ' ' ALA . 3.2 mp0 -83.64 109.48 17.48 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 18.0 mt -97.92 135.84 39.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.077 -1.014 . . . . 0.0 110.464 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 21' ' ' TYR . . . . . 0.434 ' H ' ' H ' ' E' ' 72' ' ' LYS . 1.2 t80 -119.85 129.41 54.39 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 22' ' ' SER . . . . . 0.425 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 16.4 t -61.65 127.41 31.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.628 -1.295 . . . . 0.0 111.587 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' E' ' 23' ' ' LEU . 7.5 mt -114.61 9.36 16.54 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.74 -177.62 16.86 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 50.3 mm -113.13 140.93 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.659 -0.907 . . . . 0.0 109.325 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.92 146.02 43.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.663 -0.648 . . . . 0.0 109.395 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 68.1 m -152.2 140.19 20.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.9 -1.125 . . . . 0.0 108.137 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.23 150.96 33.44 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.079 -1.013 . . . . 0.0 108.747 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 mm -120.03 135.05 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.4 -0.813 . . . . 0.0 109.487 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.87 159.93 18.85 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.517 -0.739 . . . . 0.0 109.896 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 31' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -83.18 -60.63 2.09 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.521 -0.737 . . . . 0.0 112.707 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -79.7 147.87 31.78 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.662 -1.274 . . . . 0.0 108.306 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 94.7 t -68.31 -34.59 66.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.696 -0.627 . . . . 0.0 109.626 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.11 -35.21 59.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.306 -0.871 . . . . 0.0 110.073 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -78.57 -33.63 47.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.057 -1.027 . . . . 0.0 109.188 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.08 -52.9 53.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 120.866 -1.146 . . . . 0.0 109.603 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.88 -50.52 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.084 -1.01 . . . . 0.0 110.145 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -57.21 -37.52 72.35 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.24 -0.913 . . . . 0.0 109.102 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -69.16 -40.48 78.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.937 -1.102 . . . . 0.0 110.137 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 39.3 mt -72.05 -49.62 35.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.882 -1.137 . . . . 0.0 109.196 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -48.1 -48.88 33.48 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.664 -1.272 . . . . 0.0 109.169 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -57.93 -32.9 68.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.317 -0.864 . . . . 0.0 109.32 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -73.38 -35.25 65.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.166 -0.959 . . . . 0.0 109.435 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.11 -51.34 20.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 120.56 -1.337 . . . . 0.0 109.083 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.35 -30.96 8.43 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.48 1.133 . . . . 0.0 109.699 -176.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.6 -25.11 49.62 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.59 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -95.65 13.53 26.01 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.07 29.87 29.43 Favored Glycine 0 N--CA 1.486 1.971 0 C-N-CA 118.032 -2.032 . . . . 0.0 109.877 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.37 -164.42 6.13 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -114.59 -35.68 4.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.59 -0.947 . . . . 0.0 110.011 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 172.33 -169.97 43.05 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 tp -118.54 140.86 49.22 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.404 -1.057 . . . . 0.0 110.173 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 53' ' ' ILE . . . . . 0.541 HG21 ' H ' ' E' ' 14' ' ' GLU . 64.5 mt -113.13 143.02 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.587 -0.696 . . . . 0.0 110.803 -178.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . 62.39 75.7 0.39 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 110.176 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -97.53 85.62 3.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.497 -0.752 . . . . 0.0 109.287 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 56' ' ' ARG . . . . . 0.573 HH22 ' NH1' ' D' ' 56' ' ' ARG . 28.6 ttm180 -84.44 160.44 20.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.405 -0.809 . . . . 0.0 109.621 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 76.6 mt . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.415 -0.803 . . . . 0.0 108.905 179.645 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 33.2 p90 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.66 0.743 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . 162.04 170.18 26.44 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 1.9 m -98.34 136.26 38.75 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 49.9 mt -81.69 143.31 12.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 71' ' ' VAL . . . . . 0.461 HG21 HD11 ' E' ' 53' ' ' ILE . 2.7 m -129.33 158.45 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.361 -0.837 . . . . 0.0 109.654 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 72' ' ' LYS . . . . . 0.434 ' H ' ' H ' ' E' ' 21' ' ' TYR . 16.1 tttm -139.47 156.66 46.8 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' E' ' 19' ' ' GLN . . . -117.31 113.88 22.78 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.016 0.912 . . . . 0.0 111.765 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 . . . . . 0 C--N 1.299 -1.609 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.132 -178.498 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.1 t80 . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.6 mt -114.64 138.15 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.548 -0.72 . . . . 0.0 109.62 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.611 ' O ' HG23 ' A' ' 9' ' ' ILE . 12.8 tt -134.97 115.16 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.518 -0.738 . . . . 0.0 109.326 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.8 t -122.16 157.96 30.4 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.28 113.33 22.83 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.47 80.3 0.19 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 122.119 0.961 . . . . 0.0 109.819 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 14' ' ' GLU . 19.2 t0 -152.98 -140.95 0.1 Allowed 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.718 -0.614 . . . . 0.0 109.413 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 4.0 tm-20 -167.7 -22.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.496 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.419 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 11.6 mt 52.88 64.51 7.12 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.338 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 15' ' ' ILE . 2.4 Cg_endo -62.14 154.81 60.15 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 122.018 1.812 . . . . 0.0 110.12 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.56 -10.07 75.6 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.454 ' HA ' HD23 ' A' ' 18' ' ' LEU . 35.5 mt -123.13 136.14 54.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.299 -1.118 . . . . 0.0 109.214 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -97.99 112.92 24.68 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.08 137.05 54.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.615 -0.678 . . . . 0.0 109.244 -178.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.62 ' N ' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -108.22 153.22 23.51 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.433 ' HA ' HG12 ' A' ' 71' ' ' VAL . 32.1 t -74.33 132.77 42.35 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.753 0.787 . . . . 0.0 110.769 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 mt -119.85 17.62 12.61 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.654 0.74 . . . . 0.0 109.119 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.8 176.84 16.6 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.408 HD13 HG23 ' E' ' 9' ' ' ILE . 1.0 OUTLIER -114.62 144.48 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.397 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.78 144.71 45.08 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.88 141.55 21.81 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.87 -1.144 . . . . 0.0 107.926 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -150.21 151.66 33.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.963 -1.085 . . . . 0.0 109.072 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.7 mt -114.02 128.08 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.45 -0.781 . . . . 0.0 109.101 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.7 p -177.74 178.67 0.97 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.85 . . . . 0.0 108.93 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -118.46 168.1 10.97 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.519 -0.738 . . . . 0.0 109.03 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 75.09 119.46 0.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.6 t -68.06 -34.59 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.439 -0.788 . . . . 0.0 109.159 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -59.26 -40.41 85.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.883 . . . . 0.0 110.231 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -75.89 -38.59 57.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.226 -0.921 . . . . 0.0 109.628 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.2 mt -62.2 -46.66 95.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.036 -1.04 . . . . 0.0 109.365 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.2 t -56.95 -48.73 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.947 -1.096 . . . . 0.0 108.913 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.22 -42.58 99.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.364 -0.835 . . . . 0.0 110.366 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -57.09 -49.02 77.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 109.497 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 40' ' ' LEU . 43.0 mt -68.64 -45.07 72.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.098 -1.001 . . . . 0.0 108.714 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -51.45 -48.31 62.8 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.888 -1.133 . . . . 0.0 109.88 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -63.69 -37.29 86.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.44 -0.787 . . . . 0.0 110.23 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -76.56 -35.54 58.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.388 -0.82 . . . . 0.0 109.835 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.3 t -68.09 -51.04 52.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.996 -1.065 . . . . 0.0 108.857 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -65.99 -32.75 74.41 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.15 -1.42 . . . . 0.0 109.555 -175.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.45 -28.47 69.7 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.9 -4.71 57.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.522 -0.736 . . . . 0.0 109.864 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.09 10.45 59.71 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.5 156.53 39.09 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.435 ' SD ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -123.08 -11.54 8.03 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.389 -1.066 . . . . 0.0 109.327 -178.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.435 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -154.55 162.29 30.63 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.3 tp -128.91 139.99 51.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.677 -0.896 . . . . 0.0 109.489 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.498 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 59.9 mt -113.3 144.41 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.568 -0.707 . . . . 0.0 109.684 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 67.48 72.85 0.33 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.263 -0.898 . . . . 0.0 110.081 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.508 ' CG ' ' O ' ' A' ' 55' ' ' PHE . 65.8 t80 -95.31 45.59 1.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 108.965 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.2 tpp180 -44.2 128.99 6.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.418 -0.801 . . . . 0.0 109.94 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mm . . . . . 0 C--N 1.303 -1.448 0 O-C-N 121.367 -0.833 . . . . 0.0 109.318 -179.89 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.415 ' CD2' HD12 ' E' ' 57' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 122.239 1.019 . . . . 0.0 109.695 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 178.57 171.32 41.72 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.631 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.704 ' OG1' ' OG1' ' E' ' 11' ' ' THR . 86.8 m -103.15 135.9 43.94 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.206 -1.173 . . . . 0.0 108.776 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.6 mt -85.06 121.67 37.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 22' ' ' SER . 16.7 m -139.23 157.44 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 O-C-N 121.302 -0.874 . . . . 0.0 109.817 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -149.51 153.61 37.47 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.096 -1.002 . . . . 0.0 109.449 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.57 150.99 30.58 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.174 -0.954 . . . . 0.0 108.931 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.585 ' N ' ' OH ' ' A' ' 21' ' ' TYR . 1.9 p-10 . . . . . 0 C--N 1.302 -1.489 0 O-C-N 121.151 -0.968 . . . . 0.0 109.291 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 t80 . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 90.8 mt -122.3 129.7 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.24 -0.913 . . . . 0.0 109.833 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.536 HG23 ' O ' ' B' ' 9' ' ' ILE . 16.6 tt -134.27 118.66 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t -125.54 152.91 44.41 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.097 -1.002 . . . . 0.0 108.557 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.624 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 1.0 OUTLIER -96.89 79.99 2.97 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.451 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' B' ' 11' ' ' THR . . . 148.76 -98.41 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 35.8 t70 178.1 56.02 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -96.27 81.84 3.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.075 -1.016 . . . . 0.0 109.994 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.621 ' N ' ' HD3' ' B' ' 16' ' ' PRO . 5.7 mt -144.08 52.78 2.01 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.455 -0.778 . . . . 0.0 109.213 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.621 ' HD3' ' N ' ' B' ' 15' ' ' ILE . 2.1 Cg_endo -62.73 151.98 80.82 Favored 'Trans proline' 0 C--N 1.322 -0.865 0 C-N-CA 121.883 1.722 . . . . 0.0 109.945 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.43 -9.08 78.17 Favored Glycine 0 N--CA 1.484 1.874 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.23 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' LEU . . . . . 0.426 HD12 ' CG2' ' B' ' 15' ' ' ILE . 71.2 mt -126.63 139.59 53.06 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 119.038 1.419 . . . . 0.0 108.879 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' B' ' 73' ' ' ALA . 23.0 mp0 -84.33 115.45 22.5 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.5 mt -89.67 138.69 31.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.802 -1.186 . . . . 0.0 110.174 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . 0.461 ' H ' ' H ' ' B' ' 72' ' ' LYS . 31.1 t80 -120.02 128.91 53.97 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.54 -0.725 . . . . 0.0 109.644 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 30.2 t -77.69 132.97 38.43 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 120.59 -1.319 . . . . 0.0 109.858 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.444 HD11 ' CB ' ' B' ' 72' ' ' LYS . 37.5 mt -116.99 9.54 13.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.576 -0.703 . . . . 0.0 109.112 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.49 -170.67 17.39 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 33.9 mm -112.4 141.58 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.984 -0.715 . . . . 0.0 109.263 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.43 144.02 42.59 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.52 -0.738 . . . . 0.0 109.591 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 70.0 m -152.24 138.99 18.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 108.786 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 11.9 t -149.65 141.21 23.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.993 -1.067 . . . . 0.0 109.333 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.63 ' N ' HD12 ' B' ' 29' ' ' ILE . 4.4 mp -111.74 125.57 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.164 -0.96 . . . . 0.0 109.244 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 45.5 p -173.74 -145.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.685 -0.634 . . . . 0.0 109.723 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 11.3 m-20 -157.68 164.89 36.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.289 -0.882 . . . . 0.0 109.137 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 21.4 t30 75.75 132.0 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 108.823 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 44.8 t -65.06 -32.1 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.66 -0.65 . . . . 0.0 109.493 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -58.72 -46.61 86.97 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.281 -0.887 . . . . 0.0 110.126 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.46 -41.11 61.35 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.352 -0.842 . . . . 0.0 109.756 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.64 -44.76 99.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 120.887 -1.133 . . . . 0.0 109.333 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 33.1 t -68.8 -47.11 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.856 -1.152 . . . . 0.0 109.574 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.99 -43.17 99.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.132 -0.98 . . . . 0.0 110.009 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -58.33 -48.71 79.68 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.32 -0.862 . . . . 0.0 109.67 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 52.4 mt -70.13 -47.88 59.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.083 -1.011 . . . . 0.0 108.662 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -49.79 -52.62 30.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.882 -1.136 . . . . 0.0 109.523 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -59.35 -35.69 74.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.315 -0.866 . . . . 0.0 110.084 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -75.53 -35.85 60.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.743 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 24.2 t -71.39 -50.93 37.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.11 -0.994 . . . . 0.0 109.104 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -70.35 -36.79 74.42 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.104 -1.438 . . . . 0.0 109.401 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.7 -34.19 69.19 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -85.09 3.72 37.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.25 -0.906 . . . . 0.0 109.053 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.95 7.94 84.84 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.86 -158.48 1.09 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' B' ' 50' ' ' MET . 0.0 OUTLIER -170.47 -26.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.177 -1.19 . . . . 0.0 110.164 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -136.77 159.14 24.45 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 5.4 tp -138.39 143.08 39.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.414 -1.05 . . . . 0.0 109.39 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.561 ' O ' ' HB3' ' B' ' 54' ' ' ALA . 0.6 OUTLIER -106.79 150.24 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.493 -0.754 . . . . 0.0 108.979 -179.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 75.82 177.5 0.2 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.62 ' O ' ' CG ' ' B' ' 55' ' ' PHE . 36.5 t80 170.98 11.79 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 121.646 2.021 . . . . 0.0 106.143 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . 0.696 ' CG ' HH11 ' B' ' 56' ' ' ARG . 0.0 OUTLIER -44.08 122.46 2.91 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.392 -1.442 . . . . 0.0 109.854 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 pt . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.561 -0.712 . . . . 0.0 109.421 -179.869 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.557 ' N ' HD23 ' B' ' 65' ' ' LEU . 1.5 pt? . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 122.543 1.164 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.98 158.82 18.3 Favored Glycine 0 N--CA 1.505 3.294 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -161.14 174.87 13.04 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.16 -1.2 . . . . 0.0 109.691 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.72 -165.25 32.44 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 55.1 m -126.47 137.77 53.43 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 61.2 mt -85.27 133.31 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 4.4 m -126.42 154.98 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.52 -0.737 . . . . 0.0 109.21 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.461 ' H ' ' H ' ' B' ' 21' ' ' TYR . 5.5 tttt -146.46 137.99 24.58 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' B' ' 19' ' ' GLN . . . -109.41 151.46 26.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.156 -0.965 . . . . 0.0 109.228 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' B' ' 74' ' ' ASP . 35.6 p-10 . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 60.7 mttm . . . . . 0 N--CA 1.5 2.036 0 CA-C-O 121.303 0.573 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -93.29 124.98 37.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.309 -0.869 . . . . 0.0 109.214 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 13.2 mt -121.13 147.9 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.461 -0.775 . . . . 0.0 110.655 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' ILE . . . . . 0.633 HG23 ' O ' ' C' ' 9' ' ' ILE . 11.1 tt -137.08 114.42 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.093 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 9.9 t -122.24 158.71 28.88 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.004 0.907 . . . . 0.0 108.848 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . 0.429 HG23 ' OG1' ' D' ' 69' ' ' THR . 1.4 p -85.21 -115.44 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.11 101.36 10.92 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.099 -1.0 . . . . 0.0 109.019 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -167.06 -18.55 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.524 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 59.5 163.2 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.599 -0.688 . . . . 0.0 109.22 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 66.5 mt -125.73 85.09 59.59 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.525 -0.735 . . . . 0.0 109.223 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.44 156.83 39.17 Favored 'Trans proline' 0 C--N 1.324 -0.736 0 C-N-CA 122.024 1.816 . . . . 0.0 110.168 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.05 -6.69 76.36 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 61.6 mt -128.7 137.82 51.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -1.209 . . . . 0.0 108.786 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -87.37 108.35 18.95 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 10.5 mt -93.91 138.45 32.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.4 -0.812 . . . . 0.0 109.652 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' TYR . . . . . 0.416 ' CZ ' ' O ' ' C' ' 22' ' ' SER . 3.0 t80 -123.2 131.82 53.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.502 -0.749 . . . . 0.0 109.252 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . 0.416 ' O ' ' CZ ' ' C' ' 21' ' ' TYR . 0.0 OUTLIER -53.85 128.74 31.15 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.114 -0.991 . . . . 0.0 111.169 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mt -120.14 11.73 11.7 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.899 0.856 . . . . 0.0 109.308 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.5 -169.05 13.23 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' ILE . . . . . 0.427 HD11 HG23 ' B' ' 9' ' ' ILE . 40.5 mm -122.73 139.09 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.683 0.754 . . . . 0.0 109.777 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -110.26 149.96 29.4 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 29.6 m -143.47 138.83 29.53 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.566 -0.709 . . . . 0.0 109.827 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 15.1 t -150.01 153.69 36.94 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.186 -0.946 . . . . 0.0 109.154 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' C' ' 30' ' ' SER . 5.5 tp -88.43 144.23 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.491 -1.381 . . . . 0.0 109.958 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.456 ' O ' ' O ' ' C' ' 29' ' ' ILE . 48.0 t -51.59 -106.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.567 -0.708 . . . . 0.0 110.276 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' C' ' 32' ' ' ASN . 34.9 t0 59.78 63.05 1.56 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' C' ' 31' ' ' ASP . 0.5 OUTLIER 89.16 115.67 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -176.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.4 -38.92 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.121 -0.987 . . . . 0.0 109.754 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . 0.485 ' H ' HD22 ' C' ' 32' ' ' ASN . 0.8 OUTLIER -54.14 -30.27 48.44 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.31 -0.869 . . . . 0.0 108.709 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.69 -35.57 70.29 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 70.3 mt -65.23 -52.31 54.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 C-N-CA 118.429 -1.308 . . . . 0.0 110.43 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 85.4 t -71.04 -46.02 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.881 -1.137 . . . . 0.0 109.752 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.06 -43.85 97.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 0.0 109.397 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -64.13 -39.88 94.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.988 -1.07 . . . . 0.0 109.58 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 65.7 mt -68.97 -44.59 72.6 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 108.809 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' ARG . . . . . 0.788 ' HG3' HH11 ' C' ' 41' ' ' ARG . 0.1 OUTLIER -51.25 -53.68 33.09 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.752 -1.217 . . . . 0.0 109.913 -179.109 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' C' ' 46' ' ' ALA . 54.4 mttt -59.48 -37.66 78.8 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.777 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -75.9 -35.02 59.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.133 -0.979 . . . . 0.0 110.091 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' VAL . . . . . 0.421 ' O ' ' HG3' ' C' ' 47' ' ' LYS . 5.2 t -73.97 -51.88 22.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.12 -0.988 . . . . 0.0 108.934 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -72.61 -29.9 63.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 119.972 -1.705 . . . . 0.0 109.488 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' C' ' 42' ' ' LYS . . . -61.11 -29.73 69.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.522 -0.736 . . . . 0.0 109.491 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' C' ' 44' ' ' VAL . 0.0 OUTLIER -103.66 -4.84 23.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.45 -0.782 . . . . 0.0 109.773 -179.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.38 31.58 6.41 Favored Glycine 0 N--CA 1.498 2.825 0 C-N-CA 119.509 -1.329 . . . . 0.0 111.892 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.69 -178.73 52.49 Favored Glycine 0 N--CA 1.487 2.069 0 O-C-N 120.075 -1.838 . . . . 0.0 111.2 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 21.2 ttt -108.31 -40.86 5.04 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.459 -1.024 . . . . 0.0 110.712 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 175.07 -175.81 47.13 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 6.1 tp -110.62 132.07 54.5 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.511 -0.993 . . . . 0.0 109.694 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' ILE . . . . . 0.434 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 1.2 pt -107.84 143.95 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.573 -0.704 . . . . 0.0 109.562 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 64.55 81.72 0.2 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.973 . . . . 0.0 110.113 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.54 -59.15 5.09 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.764 -0.775 . . . . 0.0 108.931 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' ARG . . . . . 0.589 ' HA ' ' HE ' ' C' ' 56' ' ' ARG . 0.0 OUTLIER 60.07 82.99 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.426 -0.796 . . . . 0.0 109.5 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' C' ' 67' ' ' TYR . 11.1 p90 . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -131.82 155.69 21.55 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 81.2 m -104.86 136.36 44.5 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.879 -1.365 . . . . 0.0 107.811 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 33.9 mt -90.45 139.0 18.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 108.746 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -145.08 164.13 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.356 -0.84 . . . . 0.0 110.216 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -150.6 147.74 27.79 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' C' ' 74' ' ' ASP . . . -124.09 150.73 44.68 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.19 -0.944 . . . . 0.0 108.939 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' C' ' 73' ' ' ALA . 3.9 m-20 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.388 -0.82 . . . . 0.0 111.262 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -116.32 120.06 37.68 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.388 -0.82 . . . . 0.0 109.419 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 76.5 mt -99.75 133.78 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.287 -0.883 . . . . 0.0 109.286 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 9' ' ' ILE . . . . . 0.517 HG23 ' O ' ' D' ' 9' ' ' ILE . 20.3 tt -125.1 124.63 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.492 -0.755 . . . . 0.0 109.555 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.512 ' OG1' ' CG ' ' D' ' 13' ' ' ASP . 11.3 t -119.17 131.9 55.91 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m -112.59 114.84 27.68 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.3 -0.875 . . . . 0.0 110.896 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . 51.67 77.39 0.14 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.231 -0.918 . . . . 0.0 109.816 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . 0.563 ' N ' ' OD1' ' D' ' 13' ' ' ASP . 4.5 p-10 178.07 -138.6 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -173.28 171.55 4.01 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.848 -1.157 . . . . 0.0 108.759 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 11.5 mt -129.62 78.45 75.42 Favored Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.76 156.13 44.83 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 122.054 1.836 . . . . 0.0 110.035 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.86 -9.79 74.93 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' D' ' 18' ' ' LEU . 59.1 mt -127.4 136.04 51.3 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 119.032 1.416 . . . . 0.0 108.501 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -86.56 108.05 18.4 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' D' ' 71' ' ' VAL . 6.0 mt -102.81 128.29 49.63 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.506 -0.746 . . . . 0.0 109.853 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' D' ' 71' ' ' VAL . 0.5 OUTLIER -119.17 145.98 45.55 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.338 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.3 t -86.87 131.63 34.05 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.455 0.645 . . . . 0.0 110.426 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.943 HD23 ' N ' ' D' ' 23' ' ' LEU . 0.3 OUTLIER -119.56 5.94 11.07 Favored 'General case' 0 N--CA 1.512 2.637 0 CA-C-O 122.948 1.356 . . . . 0.0 108.381 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.46 174.0 21.16 Favored Glycine 0 N--CA 1.497 2.73 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.685 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.12 144.81 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.86 144.19 42.83 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 74.0 m -151.48 139.73 20.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 15.1 t -149.62 147.83 28.59 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.964 -1.085 . . . . 0.0 109.036 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 80.3 mt -117.08 128.17 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.306 -0.871 . . . . 0.0 108.847 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' D' ' 31' ' ' ASP . 12.8 t -177.67 179.62 0.89 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.445 -0.785 . . . . 0.0 108.962 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' D' ' 32' ' ' ASN . 19.4 p-10 -116.06 163.7 15.55 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.558 -0.714 . . . . 0.0 109.555 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 5.8 t-20 75.68 126.3 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.142 -0.974 . . . . 0.0 108.68 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 89.1 t -68.98 -33.73 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.595 -0.691 . . . . 0.0 109.738 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' D' ' 35' ' ' GLU . 1.3 p30 -59.57 -41.52 90.39 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.125 -0.984 . . . . 0.0 109.58 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' GLU . . . . . 0.527 ' N ' ' OD1' ' D' ' 34' ' ' ASP . 16.8 tp10 -75.3 -41.22 57.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.124 -0.985 . . . . 0.0 109.284 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 90.9 mt -64.26 -42.57 95.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 O-C-N 120.962 -1.086 . . . . 0.0 109.232 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 t -64.14 -49.79 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.769 -1.207 . . . . 0.0 109.223 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.09 -38.66 83.59 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.861 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -60.55 -44.06 96.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 109.602 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 35.1 mt -70.37 -46.23 64.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.206 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -51.37 -45.37 62.39 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.767 -1.208 . . . . 0.0 109.601 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -67.3 -39.29 85.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.432 -0.793 . . . . 0.0 110.062 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -75.91 -36.09 59.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.411 -0.806 . . . . 0.0 109.727 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 15.4 t -69.7 -50.77 47.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 108.787 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -64.6 -34.07 77.41 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 118.243 -1.383 . . . . 0.0 109.322 -175.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.93 -30.94 71.94 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.736 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -85.02 -3.97 58.98 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.16 5.09 68.05 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.15 159.97 52.17 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.36 -7.67 7.56 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.424 -1.045 . . . . 0.0 109.379 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.69 166.37 37.95 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . 0.452 HD21 ' HA3' ' D' ' 68' ' ' GLY . 8.0 tp -129.73 142.79 50.64 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.661 -0.905 . . . . 0.0 109.794 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 53' ' ' ILE . . . . . 0.477 ' O ' ' HB3' ' D' ' 54' ' ' ALA . 0.7 OUTLIER -107.41 140.65 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.734 -0.604 . . . . 0.0 110.577 -179.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 67.64 86.47 0.13 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.515 -0.741 . . . . 0.0 110.47 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . 0.472 ' CD2' HD11 ' D' ' 9' ' ' ILE . 4.9 t80 -100.63 37.67 1.66 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.694 0.759 . . . . 0.0 109.743 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' ARG . . . . . 0.791 HH11 ' HG3' ' D' ' 56' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.769 0 O-C-N 120.481 -1.387 . . . . 0.0 109.135 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 18.6 p90 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 122.557 1.17 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 68' ' ' GLY . . . . . 0.452 ' HA3' HD21 ' D' ' 52' ' ' LEU . . . 169.66 -176.79 43.44 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 69' ' ' THR . . . . . 0.429 ' OG1' HG23 ' C' ' 11' ' ' THR . 70.9 m -111.64 137.61 49.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.275 -1.132 . . . . 0.0 108.864 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 62.5 mt -84.54 136.71 22.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 71' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' D' ' 20' ' ' LEU . 13.5 m -146.75 151.56 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.543 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.07 164.59 29.38 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.973 -1.08 . . . . 0.0 109.029 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.7 150.83 36.17 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 16.9 t0 . . . . . 0 N--CA 1.487 1.381 0 O-C-N 120.979 -1.076 . . . . 0.0 108.569 179.179 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 pttp . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.786 0.803 . . . . 0.0 108.923 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -105.36 123.73 48.36 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.655 -0.653 . . . . 0.0 109.762 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 89.7 mt -98.0 123.64 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.072 -1.017 . . . . 0.0 110.672 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 9' ' ' ILE . . . . . 0.572 HG23 ' O ' ' E' ' 9' ' ' ILE . 19.5 tt -137.21 116.66 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 10' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' E' ' 13' ' ' ASP . 15.2 t -124.66 157.29 35.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.0 -1.063 . . . . 0.0 108.934 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 11' ' ' THR . . . . . 0.704 ' OG1' ' OG1' ' A' ' 69' ' ' THR . 0.0 OUTLIER -135.26 128.24 31.49 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.346 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.4 35.37 24.87 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.898 0.856 . . . . 0.0 109.612 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 13' ' ' ASP . . . . . 0.484 ' HB3' ' OG1' ' E' ' 10' ' ' THR . 23.5 t0 -152.48 86.26 1.27 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.617 -0.677 . . . . 0.0 109.355 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -57.81 170.01 0.66 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 108.957 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 40.0 mt -122.32 80.19 45.22 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.358 -0.839 . . . . 0.0 109.116 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.53 156.99 38.75 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.109 1.873 . . . . 0.0 110.083 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.52 -5.48 73.99 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 18' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' E' ' 18' ' ' LEU . 50.0 mt -128.21 136.62 51.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.938 -1.331 . . . . 0.0 108.776 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -86.04 108.61 18.33 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 10.7 mt -95.42 136.58 35.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.329 -0.857 . . . . 0.0 109.703 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 21' ' ' TYR . . . . . 0.427 ' CZ ' ' O ' ' E' ' 22' ' ' SER . 2.4 t80 -121.04 132.3 54.8 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.575 -0.703 . . . . 0.0 109.174 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 22' ' ' SER . . . . . 0.427 ' O ' ' CZ ' ' E' ' 21' ' ' TYR . 0.0 OUTLIER -58.72 130.77 48.49 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.04 -1.037 . . . . 0.0 111.162 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 mt -116.87 12.53 14.76 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.14 -174.08 15.07 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . 0.442 HD11 ' CG2' ' D' ' 9' ' ' ILE . 31.0 mm -112.44 140.87 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.609 -0.936 . . . . 0.0 109.416 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.32 143.98 45.38 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.706 -0.621 . . . . 0.0 109.657 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 4.0 p -152.38 141.61 21.43 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.817 -1.177 . . . . 0.0 108.512 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . 0.416 HG23 ' O ' ' E' ' 28' ' ' THR . 14.2 t -149.64 134.01 17.41 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.107 -0.996 . . . . 0.0 109.152 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 59.9 mt -108.41 127.5 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.333 -0.855 . . . . 0.0 108.909 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 94.5 p -172.55 -140.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.42 -0.8 . . . . 0.0 109.535 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 31' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' E' ' 32' ' ' ASN . 24.7 t70 -155.97 158.67 38.29 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.207 -0.933 . . . . 0.0 109.578 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 32' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 15.1 t30 73.83 126.72 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.19 -0.943 . . . . 0.0 108.867 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.27 -32.16 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.479 -0.763 . . . . 0.0 109.527 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -57.45 -45.59 84.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.876 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -76.05 -38.91 56.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.164 -0.96 . . . . 0.0 109.756 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 79.6 mt -61.78 -49.57 83.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.891 -1.131 . . . . 0.0 109.3 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -62.48 -48.6 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.973 -1.079 . . . . 0.0 109.287 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.67 -39.84 81.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.221 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 39' ' ' ASN . . . . . 0.464 HD22 ' N ' ' E' ' 39' ' ' ASN . 2.0 m120 -64.51 -44.89 89.5 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.24 -0.913 . . . . 0.0 109.688 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 40' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' E' ' 40' ' ' LEU . 27.8 mt -68.63 -45.7 71.17 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.014 -1.054 . . . . 0.0 108.543 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 41' ' ' ARG . . . . . 0.878 ' HG2' HH11 ' E' ' 41' ' ' ARG . 5.3 ttt-85 -47.84 -53.67 14.87 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.79 -1.193 . . . . 0.0 109.054 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -60.01 -35.87 75.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.408 -0.808 . . . . 0.0 110.012 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -77.16 -35.03 56.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.503 -0.748 . . . . 0.0 109.93 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 t -70.45 -51.92 33.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 121.053 -1.029 . . . . 0.0 108.677 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -68.42 -31.8 71.38 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.326 -1.35 . . . . 0.0 109.275 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.75 -29.44 69.95 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.22 -5.62 58.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.589 -0.694 . . . . 0.0 109.686 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.49 3.94 58.38 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.74 163.2 45.75 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -125.15 -10.45 7.06 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.394 -1.062 . . . . 0.0 109.771 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.68 157.92 30.0 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.106 -1.521 . . . . 0.0 109.648 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.43 139.93 46.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.709 -0.877 . . . . 0.0 109.32 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 53' ' ' ILE . . . . . 0.417 HG21 HD13 ' E' ' 53' ' ' ILE . 1.2 pt -106.66 140.06 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.418 -0.801 . . . . 0.0 109.597 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.79 82.2 0.16 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 122.259 1.028 . . . . 0.0 111.73 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 55' ' ' PHE . . . . . 0.48 ' CD1' HD11 ' E' ' 9' ' ' ILE . 45.9 t80 -60.11 -102.84 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.142 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 56' ' ' ARG . . . . . 0.491 ' HD2' ' H ' ' E' ' 57' ' ' ILE . 6.4 ttm180 -173.84 -125.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.962 -1.086 . . . . 0.0 108.989 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 57' ' ' ILE . . . . . 0.491 ' H ' ' HD2' ' E' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.246 0 O-C-N 121.726 -0.609 . . . . 0.0 109.771 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 33.6 t80 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.615 0.721 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.16 165.93 28.11 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 61.3 m -107.79 137.77 45.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.407 -1.054 . . . . 0.0 108.183 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 28.9 mt -85.37 144.33 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 m -144.77 163.33 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.287 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -153.79 155.43 35.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 0.0 108.749 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.48 150.94 35.69 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.123 -0.986 . . . . 0.0 108.739 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.4 t0 . . . . . 0 N--CA 1.486 1.336 0 O-C-N 120.964 -1.085 . . . . 0.0 108.666 179.31 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 56.7 t80 . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.6 mt -115.21 143.51 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.63 -0.669 . . . . 0.0 109.477 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.45 ' CG2' ' O ' ' A' ' 9' ' ' ILE . 11.4 tt -124.69 119.71 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.425 ' OG1' ' OD2' ' A' ' 13' ' ' ASP . 5.5 t -112.32 132.48 54.96 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.372 -0.83 . . . . 0.0 109.351 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.533 ' OG1' ' HB ' ' B' ' 69' ' ' THR . 0.2 OUTLIER -64.05 -135.77 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.387 -0.821 . . . . 0.0 109.919 -179.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.19 80.27 6.29 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.714 0.768 . . . . 0.0 109.843 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.425 ' OD2' ' OG1' ' A' ' 10' ' ' THR . 8.1 p-10 -154.99 -126.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -171.49 171.58 5.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.987 -1.07 . . . . 0.0 109.3 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.1 mt -130.65 75.12 79.35 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.389 -0.82 . . . . 0.0 108.884 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.77 157.65 36.83 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 122.09 1.86 . . . . 0.0 110.177 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.01 -7.49 73.16 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 18' ' ' LEU . 73.3 mt -125.41 137.81 54.01 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.077 -1.249 . . . . 0.0 109.482 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -86.55 108.4 18.56 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 3.7 mt -110.56 128.81 55.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.495 -0.753 . . . . 0.0 109.999 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.596 ' OH ' ' N ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -107.75 149.81 27.73 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.25 126.01 30.21 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.68 14.28 21.19 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.6 178.37 18.48 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.03 143.96 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.958 -0.731 . . . . 0.0 109.174 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.52 154.87 25.25 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.668 -0.645 . . . . 0.0 109.779 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.2 m -128.7 156.46 43.45 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.48 145.98 49.22 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.246 -0.909 . . . . 0.0 109.324 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.418 ' O ' ' CB ' ' A' ' 30' ' ' SER . 2.2 mm -129.13 128.48 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 120.953 1.706 . . . . 0.0 106.797 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 1.2 m 171.86 -165.54 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.919 -1.113 . . . . 0.0 109.303 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -120.84 -70.86 0.76 Allowed 'General case' 0 N--CA 1.513 2.704 0 O-C-N 121.619 -0.675 . . . . 0.0 112.453 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -62.61 149.76 42.48 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.526 -1.359 . . . . 0.0 108.453 176.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.474 ' H ' HG13 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -70.17 -39.98 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.83 -29.44 40.99 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.421 -0.799 . . . . 0.0 109.762 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.402 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 12.8 mm-40 -78.46 -33.91 48.08 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.38 -0.825 . . . . 0.0 109.371 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.6 mt -62.56 -47.64 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.911 . . . . 0.0 109.258 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.25 -53.17 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.738 -1.226 . . . . 0.0 110.267 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -57.2 -36.9 71.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.203 -0.936 . . . . 0.0 109.95 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 35' ' ' GLU . 76.8 m-20 -64.71 -43.44 93.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.201 -0.937 . . . . 0.0 110.132 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 40' ' ' LEU . 21.1 mt -69.89 -45.86 66.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.935 -1.103 . . . . 0.0 109.53 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -48.97 -45.88 42.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.8 -1.188 . . . . 0.0 109.223 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -64.52 -36.62 84.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.479 -0.763 . . . . 0.0 110.182 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -75.53 -36.16 60.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.365 -0.835 . . . . 0.0 109.824 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.8 t -69.24 -50.13 55.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.126 -0.984 . . . . 0.0 109.487 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -64.76 -29.7 70.68 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.013 -175.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.2 -32.09 69.85 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.498 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.88 3.29 34.5 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.479 -0.763 . . . . 0.0 109.099 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.84 4.33 88.21 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.88 -157.22 0.4 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -166.11 -23.46 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.203 -1.174 . . . . 0.0 110.023 178.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.548 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -151.18 143.9 11.09 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.6 tp -106.84 138.98 41.98 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.962 . . . . 0.0 109.357 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.8 OUTLIER -109.48 139.67 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.604 -0.685 . . . . 0.0 110.628 -178.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 73.09 85.24 0.11 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.679 -0.638 . . . . 0.0 110.586 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -111.47 121.2 44.57 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -140.39 105.87 5.08 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -0.853 . . . . 0.0 109.422 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.7 mt . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.363 -0.836 . . . . 0.0 109.248 179.829 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.8 p90 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.602 0.715 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.27 148.04 17.47 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 79.5 m -105.12 143.0 33.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.015 -1.286 . . . . 0.0 109.384 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.8 mt -91.66 143.72 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.41 -0.806 . . . . 0.0 109.102 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 20' ' ' LEU . 10.6 m -142.27 151.97 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 109.101 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -141.09 143.82 34.55 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.16 -0.962 . . . . 0.0 108.933 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.591 ' O ' ' CB ' ' A' ' 74' ' ' ASP . . . -124.44 152.58 43.12 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.596 ' N ' ' OH ' ' A' ' 21' ' ' TYR . 25.6 t0 . . . . . 0 N--CA 1.507 2.389 0 CA-C-O 121.221 0.534 . . . . 0.0 110.213 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 71.7 t80 . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 121.274 0.559 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.5 mt -112.08 132.73 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.625 HG23 ' O ' ' B' ' 9' ' ' ILE . 10.1 tt -125.78 114.39 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.78 158.93 32.13 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.412 -0.805 . . . . 0.0 108.945 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 12.6 p -110.64 86.52 2.33 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.38 -110.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.685 -0.635 . . . . 0.0 109.914 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -147.02 -161.35 1.31 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.227 -0.92 . . . . 0.0 109.576 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . 0.418 ' O ' ' HD3' ' B' ' 16' ' ' PRO . 0.7 OUTLIER -58.84 131.45 51.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.421 -0.799 . . . . 0.0 109.583 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.03 110.2 3.01 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' B' ' 14' ' ' GLU . 1.9 Cg_endo -63.68 154.11 71.17 Favored 'Trans proline' 0 N--CA 1.481 0.746 0 C-N-CA 121.286 1.324 . . . . 0.0 110.26 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.44 -6.68 82.23 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.32 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 73.2 mt -129.94 142.43 50.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -1.139 . . . . 0.0 109.976 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -87.7 108.25 19.02 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -93.29 140.52 29.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.156 -0.965 . . . . 0.0 110.484 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . 0.454 ' H ' ' H ' ' B' ' 72' ' ' LYS . 1.3 t80 -123.2 131.3 53.63 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.405 ' N ' ' CD1' ' B' ' 21' ' ' TYR . 11.8 t -59.5 129.75 43.5 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.085 -1.009 . . . . 0.0 110.607 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' B' ' 23' ' ' LEU . 7.1 mt -117.07 9.24 13.56 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.78 173.77 16.38 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 49.3 mm -111.19 143.5 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.868 -0.783 . . . . 0.0 109.101 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.28 144.65 43.42 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.377 -0.827 . . . . 0.0 109.199 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 9.4 p -152.53 143.74 23.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.986 -1.071 . . . . 0.0 108.71 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 7.7 t -150.35 152.82 35.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.137 -0.977 . . . . 0.0 109.426 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 1.8 mm -122.92 128.1 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 53.8 p -173.49 -153.17 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.519 -0.738 . . . . 0.0 109.709 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 3.7 p-10 -135.31 157.14 47.67 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.461 -0.774 . . . . 0.0 109.495 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 4.1 t-20 82.57 115.16 0.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.485 ' H ' HG13 ' B' ' 33' ' ' VAL . 0.8 OUTLIER -70.1 -39.94 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.26 -35.44 77.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.374 -0.829 . . . . 0.0 110.129 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -73.33 -37.17 66.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.317 -0.865 . . . . 0.0 108.929 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 14.3 mt -62.23 -42.88 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 108.928 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 63.6 t -55.44 -48.82 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.988 -1.07 . . . . 0.0 108.627 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.74 -40.45 92.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.4 -0.812 . . . . 0.0 110.008 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -59.16 -46.57 88.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.13 -0.981 . . . . 0.0 109.72 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.97 -46.39 65.32 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.799 -1.188 . . . . 0.0 108.678 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . 0.804 ' HG2' HH11 ' B' ' 41' ' ' ARG . 6.4 ttt-85 -49.63 -49.61 46.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.822 -1.174 . . . . 0.0 108.878 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 6.3 pttm -61.42 -35.24 76.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 0.0 108.909 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -71.67 -36.5 70.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.517 -0.74 . . . . 0.0 109.225 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 52.2 t -75.35 -49.75 26.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.981 -1.074 . . . . 0.0 109.21 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.519 ' HZ2' ' NH1' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -48.96 -31.99 8.35 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.531 1.158 . . . . 0.0 110.276 -178.287 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.53 -27.04 51.56 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.71 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -93.84 13.12 23.53 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.14 31.11 32.94 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 118.656 -1.735 . . . . 0.0 109.814 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.3 153.75 28.03 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 68.1 mmm -63.1 -45.35 92.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.349 -1.089 . . . . 0.0 110.673 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.27 -169.49 39.82 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.1 tp -102.43 141.82 34.64 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.507 -0.996 . . . . 0.0 110.034 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.789 HD12 ' O ' ' B' ' 53' ' ' ILE . 1.1 pp -119.64 147.77 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.794 0.807 . . . . 0.0 112.075 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 52.94 52.73 13.29 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 119.692 -1.88 . . . . 0.0 109.403 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.525 ' CD2' HD11 ' B' ' 9' ' ' ILE . 46.2 t80 -83.76 96.35 8.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.018 -1.051 . . . . 0.0 109.327 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . 0.851 HH21 HH22 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -97.56 138.04 35.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.351 -0.843 . . . . 0.0 109.189 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 97.7 mt . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.344 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.442 ' N ' HD12 ' B' ' 65' ' ' LEU . 5.3 mp . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.601 0.715 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' B' ' 67' ' ' TYR . . . -81.71 60.64 4.73 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' B' ' 66' ' ' GLY . 3.0 p90 -44.02 121.57 2.51 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.512 -0.993 . . . . 0.0 109.334 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.22 135.28 5.58 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . 0.533 ' HB ' ' OG1' ' A' ' 11' ' ' THR . 23.6 m -95.79 138.22 33.75 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.104 -1.233 . . . . 0.0 108.348 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 47.6 mt -84.94 141.78 14.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.52 163.97 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.774 0.797 . . . . 0.0 109.811 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.454 ' H ' ' H ' ' B' ' 21' ' ' TYR . 15.6 tttt -151.01 151.32 31.9 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.97 149.88 45.46 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 7.7 t70 . . . . . 0 C--N 1.302 -1.478 0 O-C-N 121.026 -1.046 . . . . 0.0 109.366 179.693 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 56.7 mttm . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.058 0.456 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -92.03 120.76 32.97 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 80.5 mt -116.82 145.75 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.535 -0.728 . . . . 0.0 109.817 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' ILE . . . . . 0.647 HG23 ' O ' ' C' ' 9' ' ' ILE . 11.5 tt -130.5 114.63 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 11.7 t -123.09 159.36 28.66 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.962 0.887 . . . . 0.0 108.823 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . 0.568 ' HG1' ' CB ' ' D' ' 69' ' ' THR . 1.7 p -88.5 -113.5 0.06 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.49 99.0 8.62 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.258 -0.902 . . . . 0.0 109.239 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -169.01 -13.44 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.72 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 57.24 173.02 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.312 -0.867 . . . . 0.0 109.57 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 66.4 mt -134.37 83.35 44.07 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.47 -0.769 . . . . 0.0 109.142 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.64 157.14 43.59 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 121.936 1.758 . . . . 0.0 110.139 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.38 -7.85 75.15 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 37.0 mt -127.86 140.37 52.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.142 -1.211 . . . . 0.0 109.716 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -86.44 110.39 19.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -95.67 136.29 36.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.112 -0.993 . . . . 0.0 110.182 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' TYR . . . . . 0.449 ' H ' ' H ' ' C' ' 72' ' ' LYS . 1.9 t80 -118.51 130.16 55.77 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 4.9 t -65.26 128.38 35.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.935 -1.103 . . . . 0.0 110.746 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' C' ' 23' ' ' LEU . 12.4 mt -115.04 8.5 15.76 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.74 178.72 18.86 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.08 144.22 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.801 -0.823 . . . . 0.0 109.066 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.62 144.21 44.23 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.645 -0.66 . . . . 0.0 109.609 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 86.9 p -152.41 136.08 16.16 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 10.7 t -149.88 153.34 36.53 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.942 -1.099 . . . . 0.0 109.339 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.578 ' N ' HD12 ' C' ' 29' ' ' ILE . 4.9 mp -125.28 132.03 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.18 -0.95 . . . . 0.0 108.726 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.425 ' O ' ' O ' ' C' ' 31' ' ' ASP . 0.2 OUTLIER -169.98 7.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.568 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' C' ' 32' ' ' ASN . 21.5 t0 58.88 153.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.314 -0.866 . . . . 0.0 109.808 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . 0.469 ' N ' ' OD1' ' C' ' 31' ' ' ASP . 3.6 m120 81.26 115.17 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.48 ' H ' HG13 ' C' ' 33' ' ' VAL . 0.9 OUTLIER -70.11 -40.81 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -58.81 -33.71 70.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.364 -0.835 . . . . 0.0 109.914 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -76.44 -36.36 58.0 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.289 -0.882 . . . . 0.0 109.188 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 55.5 mt -62.95 -52.7 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 0.0 109.086 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -51.71 -49.45 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 108.574 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -61.42 -41.84 97.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.394 -0.816 . . . . 0.0 109.631 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -64.63 -46.15 83.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 0.0 109.871 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.32 -46.86 72.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.025 -1.047 . . . . 0.0 108.547 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' ARG . . . . . 0.632 ' CG ' HH11 ' C' ' 41' ' ' ARG . 0.0 OUTLIER -47.75 -53.71 14.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.0 -1.062 . . . . 0.0 109.087 178.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -57.56 -35.11 69.93 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.306 -0.871 . . . . 0.0 110.214 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -75.9 -35.69 59.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.508 -0.745 . . . . 0.0 109.706 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 4.7 t -73.55 -51.64 24.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.139 -0.975 . . . . 0.0 108.99 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -63.45 -29.13 70.46 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.205 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.77 -29.57 69.56 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -91.39 6.47 45.27 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.411 -0.805 . . . . 0.0 109.146 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.11 28.97 74.09 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.0 -1.571 . . . . 0.0 109.479 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.57 -164.11 14.18 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 5.6 tmm? -117.39 -37.55 3.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.947 . . . . 0.0 110.573 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 176.75 169.27 37.87 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 7.5 tp -95.64 132.78 40.44 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.348 -1.089 . . . . 0.0 109.836 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' ILE . . . . . 0.531 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 1.1 pt -109.85 144.86 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.507 -0.746 . . . . 0.0 109.936 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 69.37 82.81 0.16 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . 0.43 ' H ' ' HA ' ' C' ' 11' ' ' THR . 90.1 t80 -114.73 85.55 2.27 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' ARG . . . . . 0.851 HH22 HH21 ' B' ' 56' ' ' ARG . 89.3 mtt180 -112.1 161.54 16.39 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.543 -0.723 . . . . 0.0 109.262 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 67.8 mt . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.443 -0.786 . . . . 0.0 108.934 -179.922 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 36.7 p90 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.631 0.729 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.35 149.09 20.82 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 49.8 m -96.8 136.8 36.84 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.975 -1.309 . . . . 0.0 108.271 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 37.4 mt -83.83 139.72 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.8 m -126.31 165.04 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.306 -0.871 . . . . 0.0 109.913 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' LYS . . . . . 0.449 ' H ' ' H ' ' C' ' 21' ' ' TYR . 9.5 tttm -155.28 140.02 17.1 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.448 ' O ' ' CG ' ' C' ' 74' ' ' ASP . . . -116.58 115.06 25.03 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.895 -1.128 . . . . 0.0 110.674 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' C' ' 73' ' ' ALA . 3.0 m-20 . . . . . 0 N--CA 1.494 1.742 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.597 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 94.9 mttt . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -94.3 124.95 38.63 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.362 -0.836 . . . . 0.0 109.807 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 75.5 mt -114.54 127.41 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.554 -0.716 . . . . 0.0 109.219 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 9' ' ' ILE . . . . . 0.709 HD11 ' CG ' ' D' ' 55' ' ' PHE . 17.0 tt -121.26 114.94 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.7 t -122.52 151.88 40.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.39 72.45 0.95 Allowed 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.555 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.31 -101.59 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.159 -1.588 . . . . 0.0 108.417 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -119.87 -154.6 0.58 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.414 -0.804 . . . . 0.0 109.614 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -78.68 -172.0 2.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.237 -0.914 . . . . 0.0 109.564 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 84.5 mt -120.35 93.68 48.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -61.58 155.62 52.17 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.716 1.611 . . . . 0.0 110.607 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.44 -9.63 75.64 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 71.7 mt -129.37 141.41 51.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.266 -1.137 . . . . 0.0 109.487 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -84.96 108.86 17.79 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 13.8 mt -91.4 133.82 35.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.896 -1.128 . . . . 0.0 110.145 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' TYR . . . . . 0.541 ' CE1' ' O ' ' D' ' 22' ' ' SER . 0.9 OUTLIER -120.82 130.67 54.06 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . 0.541 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 0.0 OUTLIER -66.37 130.64 43.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.156 -0.965 . . . . 0.0 111.494 -179.018 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 14.0 mt -119.94 14.16 12.35 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.04 -174.46 15.21 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 46.7 mm -112.75 138.87 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 122.014 -0.698 . . . . 0.0 109.187 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.28 144.39 43.81 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.336 -0.853 . . . . 0.0 110.212 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 22.4 p -153.17 135.33 14.85 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 7.3 t -150.17 141.21 22.98 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.821 -1.175 . . . . 0.0 109.85 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 tp -126.47 131.84 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.491 ' O ' ' O ' ' D' ' 31' ' ' ASP . 56.8 p -168.51 8.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.625 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' D' ' 30' ' ' SER . 36.9 t0 54.2 156.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.528 -0.733 . . . . 0.0 110.177 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 2.3 t-20 74.37 129.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.959 -1.088 . . . . 0.0 108.504 -178.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 t -67.61 -35.55 73.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.424 -0.797 . . . . 0.0 109.587 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -59.06 -44.31 91.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.355 -0.841 . . . . 0.0 110.559 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -75.5 -37.47 60.14 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.958 -1.089 . . . . 0.0 109.517 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 83.5 mt -66.48 -42.09 89.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.914 -1.116 . . . . 0.0 109.513 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -65.46 -53.73 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.639 -1.288 . . . . 0.0 110.135 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -55.42 -35.52 65.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.293 -0.88 . . . . 0.0 109.433 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' ASN . . . . . 0.493 ' N ' HD22 ' D' ' 39' ' ' ASN . 1.0 OUTLIER -66.55 -41.14 89.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.843 . . . . 0.0 109.813 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 17.4 mt -75.42 -51.07 13.94 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.883 -1.136 . . . . 0.0 108.815 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -48.85 -52.6 23.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.835 -1.165 . . . . 0.0 108.974 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' D' ' 46' ' ' ALA . 27.7 ttmt -59.81 -36.75 77.4 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.472 -0.768 . . . . 0.0 110.225 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -75.27 -35.77 61.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.122 -0.987 . . . . 0.0 110.003 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -74.38 -51.7 22.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.135 -0.978 . . . . 0.0 109.487 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -71.74 -34.57 69.64 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.451 -1.406 . . . . 0.0 109.812 -176.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' D' ' 42' ' ' LYS . . . -56.69 -30.81 63.82 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -92.63 -5.06 52.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.34 -0.85 . . . . 0.0 109.748 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.35 8.23 56.49 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.63 -173.6 4.52 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 50' ' ' MET . . . . . 0.435 ' C ' ' SD ' ' D' ' 50' ' ' MET . 0.0 OUTLIER -161.19 -23.37 0.05 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.091 -1.241 . . . . 0.0 110.885 176.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -137.32 146.8 18.75 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . 0.522 HD12 ' O ' ' D' ' 69' ' ' THR . 34.9 tp -137.12 146.17 44.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.678 -0.895 . . . . 0.0 109.289 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 53' ' ' ILE . . . . . 0.838 ' H ' HD12 ' D' ' 53' ' ' ILE . 0.1 OUTLIER -109.69 162.63 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.47 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.622 ' O ' ' CB ' ' D' ' 55' ' ' PHE . . . 65.81 -163.45 0.25 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . 0.709 ' CG ' HD11 ' D' ' 9' ' ' ILE . 67.2 t80 134.19 -5.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' ARG . . . . . 0.704 ' NH1' HH22 ' E' ' 56' ' ' ARG . 16.6 ptm180 . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.3 -0.875 . . . . 0.0 109.805 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 3.5 p90 . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 121.502 0.668 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.21 166.03 35.61 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 69' ' ' THR . . . . . 0.568 ' CB ' ' HG1' ' C' ' 11' ' ' THR . 98.7 m -115.14 137.95 51.45 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.568 -0.96 . . . . 0.0 108.417 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 46.0 mt -87.16 126.42 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.94 -1.1 . . . . 0.0 108.326 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 71' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' D' ' 21' ' ' TYR . 3.5 m -137.97 162.97 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.337 -0.852 . . . . 0.0 110.22 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -153.52 154.11 33.69 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.468 ' O ' ' CB ' ' D' ' 74' ' ' ASP . . . -121.15 115.41 23.02 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.548 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' D' ' 73' ' ' ALA . 2.0 m-20 . . . . . 0 N--CA 1.503 2.212 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 60.1 mttp . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -112.17 119.71 39.31 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.363 -0.836 . . . . 0.0 109.595 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 69.8 mt -100.85 128.18 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.396 -0.815 . . . . 0.0 109.77 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 9' ' ' ILE . . . . . 0.676 HD11 ' CG ' ' E' ' 55' ' ' PHE . 11.3 tt -128.42 115.03 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 1.7 t -125.41 157.47 36.76 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.902 0.858 . . . . 0.0 109.11 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.97 92.58 3.79 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.99 -150.87 0.06 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.194 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 13' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' E' ' 14' ' ' GLU . 1.7 p-10 -76.63 -72.52 0.33 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.214 -0.929 . . . . 0.0 109.551 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . 0.454 ' H ' ' CG ' ' E' ' 13' ' ' ASP . 13.8 pt-20 -153.44 -166.95 2.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.168 -0.958 . . . . 0.0 109.291 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 52.9 mt -121.45 88.34 46.1 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.14 156.18 51.78 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 121.791 1.66 . . . . 0.0 110.641 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.97 -5.92 76.2 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 18' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' E' ' 18' ' ' LEU . 37.9 mt -129.34 139.86 51.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.286 -1.126 . . . . 0.0 109.971 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -84.23 108.53 17.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 14.2 mt -101.91 136.54 41.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.344 -0.848 . . . . 0.0 110.304 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 21' ' ' TYR . . . . . 0.55 ' CE1' ' O ' ' E' ' 22' ' ' SER . 0.4 OUTLIER -120.57 129.91 53.98 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 22' ' ' SER . . . . . 0.55 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 13.4 t -56.74 130.16 44.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 111.668 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 11.9 mt -119.22 5.62 11.23 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.39 -179.19 16.68 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.09 145.33 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 122.033 -0.687 . . . . 0.0 109.263 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.25 159.68 22.28 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.645 -0.659 . . . . 0.0 109.348 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 89.3 p -153.11 143.6 22.59 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . 0.404 HG23 HD21 ' E' ' 40' ' ' LEU . 11.2 p -142.93 134.47 26.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.183 -0.948 . . . . 0.0 111.02 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.513 ' O ' ' CB ' ' E' ' 30' ' ' SER . 2.1 mm -125.63 126.39 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' E' ' 29' ' ' ILE . 3.3 m 157.09 16.12 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 31' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' E' ' 32' ' ' ASN . 1.0 OUTLIER 51.5 -174.08 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.006 -1.059 . . . . 0.0 108.892 -179.082 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 32' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 9.2 t-20 73.48 94.3 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 33' ' ' VAL . . . . . 0.49 ' H ' HG13 ' E' ' 33' ' ' VAL . 0.7 OUTLIER -70.78 -42.98 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.309 -0.869 . . . . 0.0 108.993 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 34' ' ' ASP . . . . . 0.408 ' N ' ' CG2' ' E' ' 33' ' ' VAL . 43.1 t0 -58.39 -44.19 88.83 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.388 -0.82 . . . . 0.0 110.771 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 35' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' E' ' 39' ' ' ASN . 62.1 mm-40 -70.03 -37.05 75.48 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.95 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 37.8 mt -61.64 -41.36 90.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.149 -0.97 . . . . 0.0 108.886 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 48.4 t -55.16 -51.58 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.941 -1.099 . . . . 0.0 108.778 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -59.1 -39.2 81.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.347 -0.846 . . . . 0.0 109.541 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 39' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' E' ' 35' ' ' GLU . 34.0 m120 -63.42 -42.11 98.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 109.508 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 40' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' E' ' 40' ' ' LEU . 74.5 mt -73.36 -50.03 24.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.132 -0.98 . . . . 0.0 108.962 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -48.93 -48.31 42.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.756 -1.215 . . . . 0.0 108.993 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -63.36 -37.4 87.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.582 -0.699 . . . . 0.0 109.935 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -75.6 -35.55 60.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.267 -0.896 . . . . 0.0 109.66 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 13.2 t -70.74 -51.44 36.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.308 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -71.21 -35.34 71.49 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.294 -176.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.63 -30.61 67.42 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -92.14 -5.44 52.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.364 -0.835 . . . . 0.0 109.871 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.63 11.82 46.18 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.61 159.28 33.16 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.26 -6.19 5.4 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.27 -1.135 . . . . 0.0 110.521 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -152.24 164.21 30.45 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 6.9 tp -136.95 143.45 42.87 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.405 -1.056 . . . . 0.0 109.516 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 53' ' ' ILE . . . . . 0.655 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 4.8 mt -113.6 151.66 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 88.7 -144.58 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 55' ' ' PHE . . . . . 0.676 ' CG ' HD11 ' E' ' 9' ' ' ILE . 62.9 t80 104.87 11.96 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 120.726 1.603 . . . . 0.0 107.607 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 56' ' ' ARG . . . . . 0.704 HH22 ' NH1' ' D' ' 56' ' ' ARG . 73.8 mtm180 -69.16 124.73 24.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.354 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 88.3 mt . . . . . 0 N--CA 1.498 1.967 0 O-C-N 121.516 -0.74 . . . . 0.0 109.292 -179.784 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 67' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' E' ' 67' ' ' TYR . 18.4 p90 . . . . . 0 N--CA 1.5 2.055 0 CA-C-O 122.286 1.041 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.66 157.97 14.71 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 93.6 m -90.52 134.6 34.25 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.038 -1.272 . . . . 0.0 107.691 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 58.6 mt -90.23 137.91 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 71' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' E' ' 21' ' ' TYR . 3.2 m -144.17 163.92 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.26 -0.9 . . . . 0.0 110.766 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -148.01 152.61 37.74 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.18 152.55 33.5 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.327 -0.858 . . . . 0.0 108.727 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 110.094 179.422 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 57.5 t80 . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 70.0 mt -112.17 140.02 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.518 -0.739 . . . . 0.0 110.009 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 9' ' ' ILE . 5.8 tt -137.61 115.88 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.446 -0.784 . . . . 0.0 108.923 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -123.49 158.38 31.4 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.27 121.02 32.84 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.75 47.34 20.62 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.994 0.902 . . . . 0.0 109.624 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -167.4 94.77 0.45 Allowed 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.404 0.621 . . . . 0.0 109.445 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -61.24 -178.2 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.263 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.7 mt -123.67 87.9 52.22 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.51 -0.744 . . . . 0.0 109.085 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -61.1 156.02 47.29 Favored 'Trans proline' 0 C--N 1.321 -0.888 0 C-N-CA 121.905 1.736 . . . . 0.0 110.222 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.64 -11.76 71.37 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.2 mt -126.79 137.64 53.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.143 -1.21 . . . . 0.0 108.734 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.728 ' NE2' ' H ' ' A' ' 74' ' ' ASP . 1.2 pp0? -87.62 118.47 27.12 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.4 mt -101.46 128.35 47.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.131 -0.98 . . . . 0.0 109.587 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' A' ' 22' ' ' SER . 2.3 t80 -115.21 129.95 56.78 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.531 ' O ' ' CE1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -85.57 130.26 34.62 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.408 -0.808 . . . . 0.0 110.353 -179.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.942 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -118.94 19.44 13.03 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 137.33 172.42 12.53 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.98 145.14 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.11 147.45 37.29 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.623 -0.673 . . . . 0.0 109.315 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.5 p -151.48 135.55 16.63 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.63 150.56 34.64 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.044 -1.035 . . . . 0.0 108.766 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.21 129.45 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 83.8 p -169.37 175.95 5.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 109.126 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.429 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 3.2 m-20 -101.94 146.91 27.2 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.297 -0.877 . . . . 0.0 110.152 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 13.2 m-20 77.63 128.95 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.566 -0.708 . . . . 0.0 109.259 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.98 -31.09 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.593 -0.692 . . . . 0.0 109.36 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -56.22 -40.24 73.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.299 -0.876 . . . . 0.0 109.712 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.402 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 1.1 mp0 -76.23 -40.28 52.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.324 -0.86 . . . . 0.0 109.277 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.3 mt -62.22 -50.53 79.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.896 -1.127 . . . . 0.0 108.847 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.0 t -66.63 -49.45 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.11 -0.994 . . . . 0.0 109.473 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.53 -40.71 88.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.0 109.601 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 35' ' ' GLU . 15.9 m120 -64.13 -41.33 97.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 109.321 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 40' ' ' LEU . 29.4 mt -68.23 -44.24 76.18 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.15 -0.969 . . . . 0.0 109.128 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -48.92 -42.77 38.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.572 -1.33 . . . . 0.0 109.436 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -69.94 -38.02 76.05 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.493 0.663 . . . . 0.0 110.102 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -77.32 -35.04 55.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.492 -0.755 . . . . 0.0 110.057 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.83 -52.07 31.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.027 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -66.59 -29.53 69.6 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.215 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.49 -28.6 68.69 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.626 0.727 . . . . 0.0 109.048 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -90.22 -5.65 56.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.564 -0.71 . . . . 0.0 109.558 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.5 4.37 58.24 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.84 161.93 48.24 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -129.58 -2.35 4.85 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.303 -1.116 . . . . 0.0 110.303 -177.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.8 166.48 39.68 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.308 -1.425 . . . . 0.0 109.685 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 tp -125.16 143.63 50.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.665 -0.903 . . . . 0.0 109.655 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.801 ' O ' HD13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -117.73 148.71 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.625 -0.672 . . . . 0.0 110.072 -178.228 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.22 68.78 0.74 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.897 -1.127 . . . . 0.0 110.125 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -107.29 54.56 0.67 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.671 ' NH1' HH22 ' E' ' 56' ' ' ARG . 1.7 ttt-85 -80.18 152.96 28.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.302 -0.874 . . . . 0.0 109.634 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.4 mt . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.947 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.1 p90 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.815 0.816 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.58 153.23 17.07 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.427 ' OG1' ' OG1' ' E' ' 11' ' ' THR . 96.8 m -105.71 138.26 42.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.304 -1.115 . . . . 0.0 108.964 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 50.4 mt -83.01 137.32 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.4 m -140.66 159.05 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.247 -0.908 . . . . 0.0 109.701 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -153.69 159.09 41.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.296 -0.878 . . . . 0.0 109.052 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.519 ' O ' ' CG ' ' A' ' 74' ' ' ASP . . . -114.83 114.17 25.18 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.227 -0.921 . . . . 0.0 110.756 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.728 ' H ' ' NE2' ' A' ' 19' ' ' GLN . 20.5 m-20 . . . . . 0 N--CA 1.496 1.856 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 68.6 t80 . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 93.8 mt -132.87 129.96 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.386 -0.821 . . . . 0.0 109.754 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.602 HG23 ' O ' ' B' ' 9' ' ' ILE . 10.9 tt -133.01 116.36 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.2 t -123.9 152.78 42.01 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 0.8 OUTLIER -103.01 74.76 1.33 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' B' ' 11' ' ' THR . . . 176.97 -116.18 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 176.98 54.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -129.38 104.44 7.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.39 -0.819 . . . . 0.0 109.605 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.752 HG22 ' O ' ' B' ' 15' ' ' ILE . 6.2 mm -140.61 53.04 3.62 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.346 -0.847 . . . . 0.0 108.915 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.628 ' HD3' ' N ' ' B' ' 15' ' ' ILE . 1.8 Cg_endo -64.07 155.49 64.41 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.531 1.487 . . . . 0.0 110.196 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.12 -11.71 71.43 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 79.8 mt -128.24 139.5 52.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.01 -1.288 . . . . 0.0 109.035 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -85.51 108.86 18.12 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.427 HD11 ' HB ' ' B' ' 15' ' ' ILE . 13.4 mt -89.84 132.63 35.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 110.348 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . 0.54 ' CE1' ' O ' ' B' ' 22' ' ' SER . 0.4 OUTLIER -112.38 129.29 56.36 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.54 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 36.2 t -71.73 118.25 14.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.793 -1.192 . . . . 0.0 109.336 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' B' ' 72' ' ' LYS . 5.8 mt -94.69 -4.57 47.29 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.42 -163.4 24.03 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -122.39 141.76 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.407 ' HB2' HD11 ' B' ' 70' ' ' ILE . . . -113.54 144.81 42.23 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.567 -0.708 . . . . 0.0 109.275 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 3.0 t -151.77 137.88 18.28 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -148.92 141.76 24.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.013 -1.054 . . . . 0.0 109.247 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 tp -104.8 127.93 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.287 -0.883 . . . . 0.0 109.213 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 15.5 t -171.19 169.79 6.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.918 . . . . 0.0 109.053 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 2.7 p-10 -110.16 158.78 17.98 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.507 -0.746 . . . . 0.0 109.215 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 2.2 m120 75.97 129.55 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.97 -32.86 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.488 -0.757 . . . . 0.0 109.306 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.96 -42.15 89.2 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.282 -0.886 . . . . 0.0 109.773 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -75.73 -41.4 53.54 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.225 -0.922 . . . . 0.0 109.516 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.79 -43.05 98.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 120.858 -1.151 . . . . 0.0 108.923 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.21 -50.78 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.768 -1.208 . . . . 0.0 109.497 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -59.01 -39.51 82.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.339 -0.851 . . . . 0.0 109.513 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -61.65 -46.12 91.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.639 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' B' ' 40' ' ' LEU . 28.6 mt -70.74 -46.83 62.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.105 -0.997 . . . . 0.0 108.986 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -48.57 -44.54 36.84 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.695 -1.253 . . . . 0.0 109.405 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -67.97 -38.4 82.69 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.559 0.695 . . . . 0.0 110.242 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -77.54 -34.11 54.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.395 -0.816 . . . . 0.0 110.183 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.796 ' O ' ' N ' ' B' ' 48' ' ' GLY . 2.3 t -70.03 -51.67 37.54 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.946 0 O-C-N 121.148 -0.97 . . . . 0.0 109.812 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -60.11 -31.39 69.99 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 119.666 -1.896 . . . . 0.0 110.328 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.7 -37.22 56.49 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.009 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.4 -12.92 11.01 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.549 -0.719 . . . . 0.0 109.923 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . 0.796 ' N ' ' O ' ' B' ' 44' ' ' VAL . . . -105.8 -45.75 1.26 Allowed Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.96 -35.23 0.29 Allowed Glycine 0 C--N 1.289 -2.066 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.156 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . 0.456 ' H ' ' C ' ' B' ' 48' ' ' GLY . 0.0 OUTLIER -96.44 -75.08 0.54 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 119.253 1.527 . . . . 0.0 109.886 -179.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.37 -153.58 10.77 Favored Glycine 0 C--N 1.288 -2.104 0 C-N-CA 118.288 -1.91 . . . . 0.0 109.425 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.2 tp -133.11 139.13 46.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.696 -0.885 . . . . 0.0 109.682 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.466 ' O ' ' HB3' ' B' ' 54' ' ' ALA . 1.7 pt -111.82 145.53 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.658 -0.651 . . . . 0.0 109.913 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 63.92 72.45 0.46 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.121 -0.987 . . . . 0.0 109.337 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.558 ' O ' ' CG ' ' B' ' 55' ' ' PHE . 60.4 t80 -101.51 33.65 2.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.37 -0.831 . . . . 0.0 108.917 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . 0.795 HH11 ' HG3' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -59.51 122.98 15.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.982 -1.074 . . . . 0.0 109.34 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 91.2 mt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 179.999 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 20.7 tp . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.192 0.52 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.78 165.05 33.12 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -167.13 179.83 4.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.04 -1.271 . . . . 0.0 110.209 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.09 169.63 35.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 50.4 m -100.66 132.94 45.79 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.123 -1.222 . . . . 0.0 108.037 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.498 HG22 ' HA2' ' B' ' 48' ' ' GLY . 3.0 mt -87.82 145.44 7.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 5.9 m -146.29 166.06 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.886 -1.134 . . . . 0.0 111.01 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.537 ' HB2' HD11 ' B' ' 23' ' ' LEU . 0.4 OUTLIER -146.55 156.25 43.1 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.45 ' O ' ' OD1' ' B' ' 74' ' ' ASP . . . -116.57 116.02 26.83 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.72 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' B' ' 73' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -105.78 120.66 42.26 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.099 -1.001 . . . . 0.0 109.126 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 17.7 mt -116.39 143.01 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' ILE . . . . . 0.456 ' O ' HG23 ' C' ' 9' ' ' ILE . 7.2 tt -112.96 124.62 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.93 131.28 55.16 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.44 -0.787 . . . . 0.0 109.369 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . 0.487 ' HG1' HD11 ' D' ' 25' ' ' ILE . 1.6 m -121.3 114.37 21.25 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.42 34.56 24.45 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.301 -0.875 . . . . 0.0 109.653 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -153.36 95.49 1.93 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.708 -0.62 . . . . 0.0 109.505 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -67.31 176.82 2.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.086 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 51.4 mt -127.04 81.68 69.47 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.485 -0.759 . . . . 0.0 109.095 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.31 156.78 38.78 Favored 'Trans proline' 0 C--N 1.322 -0.83 0 C-N-CA 121.964 1.776 . . . . 0.0 110.119 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.17 -4.54 74.37 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.307 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' C' ' 18' ' ' LEU . 25.7 mt -126.78 137.48 53.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.105 -1.232 . . . . 0.0 109.17 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -86.77 108.28 18.64 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 12.8 mt -92.36 132.97 36.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 109.462 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' C' ' 71' ' ' VAL . 1.2 t80 -114.73 129.37 56.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.363 -0.835 . . . . 0.0 108.755 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . 0.436 ' O ' ' CE1' ' C' ' 21' ' ' TYR . 8.2 t -61.97 127.68 32.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.899 -1.126 . . . . 0.0 111.624 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' C' ' 23' ' ' LEU . 14.2 mt -113.47 9.13 18.03 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.71 -174.52 15.34 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 177.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.57 139.76 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.651 -0.911 . . . . 0.0 109.584 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.47 146.84 44.19 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.693 -0.63 . . . . 0.0 109.92 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 4.7 t -151.91 139.23 19.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.154 -0.966 . . . . 0.0 108.688 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.77 140.28 22.46 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.962 -1.086 . . . . 0.0 109.641 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 7.1 tp -95.66 147.9 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.999 -1.063 . . . . 0.0 108.602 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.501 ' OG ' ' N ' ' C' ' 31' ' ' ASP . 27.1 t -169.3 -168.24 0.8 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.112 -0.992 . . . . 0.0 109.12 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' ASP . . . . . 0.501 ' N ' ' OG ' ' C' ' 30' ' ' SER . 19.4 t0 -109.72 -80.64 0.58 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.352 -0.843 . . . . 0.0 111.667 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -75.98 159.66 30.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.909 -1.12 . . . . 0.0 109.434 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.33 -31.44 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 CA-C-O 121.241 0.543 . . . . 0.0 109.591 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.5 -37.85 65.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.65 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -76.38 -36.22 58.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.35 -0.844 . . . . 0.0 109.019 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 82.9 mt -61.78 -51.98 66.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 120.984 -1.073 . . . . 0.0 109.539 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 51.4 t -57.65 -48.11 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.086 -1.009 . . . . 0.0 108.985 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -63.49 -43.89 95.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.652 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -58.27 -48.63 79.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.13 -0.981 . . . . 0.0 109.47 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 55.5 mt -68.98 -44.22 73.33 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.736 -1.227 . . . . 0.0 108.76 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -50.97 -46.18 61.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.773 -1.205 . . . . 0.0 109.445 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -61.87 -34.66 76.4 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.516 -0.874 . . . . 0.0 108.967 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -70.76 -36.09 72.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.447 -0.783 . . . . 0.0 108.971 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 51.5 t -72.89 -49.29 40.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.89 -1.131 . . . . 0.0 109.155 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -49.36 -34.23 15.53 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.448 1.118 . . . . 0.0 110.505 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.84 -28.55 50.2 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.573 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -94.62 9.53 38.36 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.89 30.73 30.21 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 118.355 -1.879 . . . . 0.0 109.534 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.35 -162.44 8.81 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -115.07 -35.66 4.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.44 -1.036 . . . . 0.0 110.424 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.19 179.73 40.32 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 tp -101.36 138.33 38.52 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.427 -1.043 . . . . 0.0 109.786 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' ILE . . . . . 0.45 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 1.3 pt -113.97 144.38 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.528 -0.732 . . . . 0.0 110.149 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 62.72 62.45 1.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -0.88 . . . . 0.0 109.236 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -92.99 66.0 4.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.958 -1.089 . . . . 0.0 108.448 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -72.68 149.66 43.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.5 -0.75 . . . . 0.0 110.032 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 59.0 mt . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.08 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 37.1 p90 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.871 0.843 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.92 -173.25 44.03 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 29.3 m -119.46 134.05 55.4 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 45.2 mt -82.56 146.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' C' ' 21' ' ' TYR . 4.6 m -139.83 164.06 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.392 -0.817 . . . . 0.0 110.225 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -142.34 154.61 44.81 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.36 116.21 29.32 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.843 0.83 . . . . 0.0 111.239 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 25.9 t70 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.391 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 63.4 mttp . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -96.43 128.85 43.73 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.212 -0.93 . . . . 0.0 109.611 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 62.8 mt -128.14 141.99 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.543 -0.723 . . . . 0.0 109.095 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 9' ' ' ILE . . . . . 0.405 ' O ' HG23 ' D' ' 9' ' ' ILE . 10.1 tt -114.97 117.36 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.16 131.83 54.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.934 -1.104 . . . . 0.0 108.971 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' D' ' 12' ' ' ALA . 3.4 m -104.02 98.0 7.89 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 12' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' D' ' 11' ' ' THR . . . 61.89 65.12 0.94 Allowed 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.948 0.88 . . . . 0.0 110.068 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -132.97 -141.44 0.2 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -169.44 -31.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 109.389 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 28.7 mt 50.21 67.14 4.67 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.185 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.85 156.41 48.88 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 C-N-CA 122.122 1.881 . . . . 0.0 110.126 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.5 -4.01 72.54 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.612 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 29.0 mt -125.16 135.83 53.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.872 -1.369 . . . . 0.0 108.967 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -86.38 112.49 21.5 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 11.9 mt -95.59 133.68 39.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.044 -1.035 . . . . 0.0 109.807 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' D' ' 22' ' ' SER . 4.4 t80 -122.45 129.97 52.59 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . 0.433 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 48.2 t -85.84 129.63 34.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.573 -0.704 . . . . 0.0 110.97 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.919 HD23 ' N ' ' D' ' 23' ' ' LEU . 0.3 OUTLIER -119.4 13.31 12.66 Favored 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 122.235 1.017 . . . . 0.0 108.483 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 143.26 170.29 12.98 Favored Glycine 0 N--CA 1.49 2.298 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.026 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' ILE . . . . . 0.487 HD11 ' HG1' ' C' ' 11' ' ' THR . 0.7 OUTLIER -109.39 142.69 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.389 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' D' ' 67' ' ' TYR . . . -114.22 148.21 37.73 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 89.4 p -152.09 141.55 21.63 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 14.9 t -149.67 140.84 23.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.157 -0.965 . . . . 0.0 109.044 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 tt -115.7 129.81 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 90.1 p -177.26 -131.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.545 -0.722 . . . . 0.0 109.257 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' D' ' 32' ' ' ASN . 15.1 p-10 -166.51 169.69 13.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.211 -0.931 . . . . 0.0 109.471 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 6.8 t-20 73.65 127.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 0.0 108.666 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 22.9 t -68.88 -35.09 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.379 -0.826 . . . . 0.0 109.656 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' D' ' 35' ' ' GLU . 0.9 OUTLIER -59.21 -45.11 91.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.85 -179.509 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' GLU . . . . . 0.463 ' N ' ' OD1' ' D' ' 34' ' ' ASP . 55.2 mm-40 -75.25 -40.11 59.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.185 -0.947 . . . . 0.0 109.413 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.79 -53.17 50.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.962 -1.087 . . . . 0.0 109.482 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 44.3 t -61.49 -47.81 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.056 -1.027 . . . . 0.0 109.211 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -61.45 -41.98 98.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.691 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -58.54 -46.66 86.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 109.474 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' D' ' 40' ' ' LEU . 47.7 mt -71.4 -46.89 59.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.175 -0.953 . . . . 0.0 109.007 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -49.9 -44.99 50.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.816 -1.177 . . . . 0.0 109.172 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -63.31 -34.61 78.07 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.057 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -73.92 -36.9 64.75 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.324 -0.86 . . . . 0.0 109.328 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 t -73.4 -51.21 26.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.792 -1.193 . . . . 0.0 108.887 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.92 -33.42 37.08 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.73 1.253 . . . . 0.0 110.098 -177.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.82 -30.33 51.08 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.837 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -92.2 4.2 53.73 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.77 26.44 62.74 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 118.492 -1.813 . . . . 0.0 109.359 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.38 -167.67 13.37 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 9.9 ttp -107.38 -43.47 4.55 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.499 -1.0 . . . . 0.0 109.706 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 173.55 -152.79 16.13 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 tp -131.81 142.34 49.7 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.446 -1.032 . . . . 0.0 109.716 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 53' ' ' ILE . . . . . 1.035 ' H ' HD12 ' D' ' 53' ' ' ILE . 0.0 OUTLIER -113.98 147.4 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.598 -0.689 . . . . 0.0 110.181 -178.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 84.08 -54.63 0.13 Allowed 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 118.683 0.674 . . . . 0.0 111.607 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . 0.601 ' O ' ' O ' ' D' ' 54' ' ' ALA . 50.4 t80 43.03 -179.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' ARG . . . . . 0.451 ' N ' ' CD2' ' D' ' 55' ' ' PHE . 1.6 mmm180 . . . . . 0 N--CA 1.499 2.007 0 O-C-N 120.461 -1.4 . . . . 0.0 109.139 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 67' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' D' ' 26' ' ' ALA . 4.3 p90 . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 121.968 0.89 . . . . 0.0 110.125 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.18 175.15 40.09 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 69' ' ' THR . . . . . 0.468 ' OG1' HD11 ' D' ' 25' ' ' ILE . 4.9 m -97.9 134.91 40.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.99 -1.3 . . . . 0.0 108.176 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 70' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' D' ' 22' ' ' SER . 50.3 mt -79.45 134.71 27.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.9 163.04 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.466 -0.771 . . . . 0.0 109.737 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 72' ' ' LYS . . . . . 0.428 ' H ' ' H ' ' D' ' 21' ' ' TYR . 14.9 ttpp -154.19 140.35 18.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.446 -0.784 . . . . 0.0 108.998 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.74 150.78 25.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.829 -1.169 . . . . 0.0 108.868 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 7.6 t70 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.087 -1.008 . . . . 0.0 109.317 179.494 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 6' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' E' ' 50' ' ' MET . 54.8 tttt . . . . . 0 N--CA 1.499 1.99 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -105.08 122.51 46.03 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 14.3 mt -134.3 131.56 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.362 -0.836 . . . . 0.0 109.736 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 9' ' ' ILE . . . . . 0.585 HG23 ' O ' ' E' ' 9' ' ' ILE . 19.2 tt -121.82 117.25 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.53 133.63 55.79 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.459 -0.776 . . . . 0.0 108.988 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 11' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' E' ' 12' ' ' ALA . 25.3 m -86.88 61.63 6.92 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.048 -1.032 . . . . 0.0 111.085 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' E' ' 11' ' ' THR . . . 174.99 -110.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -176.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 167.88 113.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . 0.425 ' CG ' ' H ' ' E' ' 15' ' ' ILE . 0.8 OUTLIER -173.73 -96.79 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.057 -1.027 . . . . 0.0 109.635 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 15' ' ' ILE . . . . . 0.51 ' N ' ' HD3' ' E' ' 16' ' ' PRO . 8.6 mt 59.0 60.1 5.12 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 109.61 -179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' E' ' 15' ' ' ILE . 1.6 Cg_endo -64.9 153.15 79.51 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 122.018 1.812 . . . . 0.0 109.734 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.52 -8.77 78.48 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.356 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 18' ' ' LEU . . . . . 0.482 HD12 ' CG2' ' E' ' 15' ' ' ILE . 61.3 mt -124.55 137.56 54.39 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.077 -1.249 . . . . 0.0 109.188 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -86.99 108.73 18.97 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 12.8 mt -89.4 136.32 33.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 110.001 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 21' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' E' ' 71' ' ' VAL . 4.3 t80 -117.81 129.69 55.82 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.0 127.38 30.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.811 -1.181 . . . . 0.0 110.941 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' E' ' 23' ' ' LEU . 23.4 mt -113.58 8.49 17.7 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.55 -163.15 13.13 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -128.18 143.67 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.867 -0.784 . . . . 0.0 109.216 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.24 147.81 39.9 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.4 0.619 . . . . 0.0 109.439 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 60.0 p -151.71 135.01 15.98 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.84 148.79 30.31 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.98 -1.075 . . . . 0.0 108.835 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 tp -127.1 133.51 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 4.5 m -151.21 -152.7 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 109.067 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 31' ' ' ASP . . . . . 0.423 ' CG ' ' H ' ' E' ' 32' ' ' ASN . 0.9 OUTLIER -106.22 -82.72 0.53 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.36 -0.837 . . . . 0.0 111.114 -178.51 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 32' ' ' ASN . . . . . 0.423 ' H ' ' CG ' ' E' ' 31' ' ' ASP . 87.7 m-20 -81.01 165.11 22.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.03 . . . . 0.0 109.428 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 64.6 t -68.15 -31.9 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.789 -0.569 . . . . 0.0 109.731 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.37 -40.91 68.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 109.859 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -76.66 -35.48 57.92 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.19 -0.944 . . . . 0.0 109.082 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 69.2 mt -63.97 -52.89 50.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 120.929 -1.107 . . . . 0.0 109.425 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.54 -49.1 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.067 -1.021 . . . . 0.0 109.396 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -58.61 -39.11 79.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.892 . . . . 0.0 109.381 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -69.47 -39.94 77.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 0.0 109.782 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 40' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' E' ' 40' ' ' LEU . 21.7 mt -68.2 -45.59 72.95 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.917 -1.115 . . . . 0.0 108.711 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -47.43 -56.61 6.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.859 -1.151 . . . . 0.0 108.944 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -55.06 -32.94 62.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.861 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -75.53 -40.82 56.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.9 . . . . 0.0 110.087 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 38.4 t -76.88 -52.51 16.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.935 -1.103 . . . . 0.0 108.879 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -56.57 -28.6 60.56 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.381 1.086 . . . . 0.0 110.21 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.73 -28.46 58.54 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.507 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -87.22 10.91 15.49 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.64 29.17 53.6 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.081 -1.533 . . . . 0.0 109.417 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.97 -168.81 30.04 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 50' ' ' MET . . . . . 0.473 ' O ' ' O ' ' E' ' 6' ' ' LYS . 65.5 mtp -103.96 -37.42 7.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.514 -0.992 . . . . 0.0 109.288 177.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 174.5 -153.27 15.91 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 12.0 tp -126.94 135.72 51.28 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.525 -0.985 . . . . 0.0 109.744 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 53' ' ' ILE . . . . . 0.476 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 1.2 pt -110.36 146.19 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.528 -0.732 . . . . 0.0 109.958 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 67.66 87.41 0.12 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 109.711 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -138.4 82.16 1.89 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 56' ' ' ARG . . . . . 0.671 HH22 ' NH1' ' A' ' 56' ' ' ARG . 12.8 ptm180 -120.48 8.74 10.78 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.636 -0.665 . . . . 0.0 109.338 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 57' ' ' ILE . . . . . 0.541 HG22 ' O ' ' E' ' 57' ' ' ILE . 72.4 mt . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.539 -0.726 . . . . 0.0 109.693 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 19.0 p90 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 122.048 0.928 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.01 162.07 32.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 52.8 m -102.96 134.34 46.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.103 -1.233 . . . . 0.0 108.09 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 37.2 mt -86.07 136.45 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 71' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' E' ' 21' ' ' TYR . 6.5 m -132.22 165.86 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.4 -0.813 . . . . 0.0 110.2 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 72' ' ' LYS . . . . . 0.449 ' CB ' HD11 ' E' ' 23' ' ' LEU . 1.5 ttpp -153.95 140.74 19.09 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.97 151.1 22.86 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.791 -1.193 . . . . 0.0 108.85 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.063 -1.023 . . . . 0.0 109.576 179.49 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.4 t80 . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 76.6 mt -109.91 130.86 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.376 -0.828 . . . . 0.0 109.936 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.61 ' O ' HG23 ' A' ' 9' ' ' ILE . 6.7 tt -135.05 114.61 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.6 t -123.16 160.05 27.32 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.958 0.885 . . . . 0.0 109.223 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 12' ' ' ALA . 11.0 p -96.34 -110.1 0.15 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.746 -0.596 . . . . 0.0 109.733 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 11' ' ' THR . . . 37.7 -104.44 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.1 -1.0 . . . . 0.0 111.073 177.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 15.0 p-10 -142.85 -64.68 0.4 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.446 -0.784 . . . . 0.0 109.793 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.467 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 11.5 pt-20 -152.16 -166.75 2.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.108 -0.995 . . . . 0.0 109.56 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.8 mt -116.59 97.72 50.59 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.603 -0.686 . . . . 0.0 109.303 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.18 156.31 46.02 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.82 1.68 . . . . 0.0 110.273 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.11 -7.59 78.46 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 18' ' ' LEU . 62.4 mt -129.88 141.37 50.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.31 -1.112 . . . . 0.0 109.467 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.6 117.05 25.12 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.6 mt -101.34 136.66 40.82 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.132 -0.98 . . . . 0.0 109.154 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.424 ' H ' ' H ' ' A' ' 72' ' ' LYS . 12.3 t80 -113.62 129.26 56.6 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.385 -0.822 . . . . 0.0 109.083 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.1 t -73.37 124.57 26.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.488 -1.383 . . . . 0.0 109.377 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.7 mt -111.07 8.45 21.82 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.37 -167.04 21.47 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.3 mm -122.26 142.23 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.8 153.44 29.09 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.5 m -152.2 145.08 24.4 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.07 -1.019 . . . . 0.0 109.084 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.7 p -143.84 131.07 20.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.469 -0.769 . . . . 0.0 108.983 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.628 ' O ' ' CB ' ' A' ' 30' ' ' SER . 91.8 mt -105.87 153.34 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.628 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 88.9 p 120.89 -147.53 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 32' ' ' ASN . 22.0 t70 -145.64 -160.73 1.18 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.457 ' H ' ' CG ' ' A' ' 31' ' ' ASP . 14.0 m-20 70.66 101.61 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.4 t -62.56 -35.97 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.123 -0.986 . . . . 0.0 109.325 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.69 -41.7 86.87 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.248 -0.908 . . . . 0.0 109.692 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -75.81 -41.17 53.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.316 -0.865 . . . . 0.0 109.486 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.5 mt -63.41 -53.79 40.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.945 -1.097 . . . . 0.0 108.959 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.9 t -55.96 -49.87 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 108.999 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.91 -40.12 87.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 109.94 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.448 HD22 ' N ' ' A' ' 39' ' ' ASN . 1.5 m120 -62.11 -44.02 97.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.176 -0.953 . . . . 0.0 109.499 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.3 mt -71.12 -49.08 48.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.105 -0.997 . . . . 0.0 108.7 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -48.8 -49.35 39.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.805 -1.184 . . . . 0.0 109.277 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -63.21 -36.39 83.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.513 -0.742 . . . . 0.0 110.217 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.67 -35.53 57.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.833 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 t -68.3 -51.2 50.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 109.196 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -67.13 -37.94 84.7 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.773 -1.205 . . . . 0.0 109.161 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.1 -32.64 66.5 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -85.45 -4.53 59.19 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.46 -0.775 . . . . 0.0 109.341 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.66 9.13 61.63 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.84 -157.22 3.76 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.4 ptm -165.1 -20.15 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.09 -1.241 . . . . 0.0 110.385 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -152.56 160.11 28.8 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 tp -118.06 138.87 51.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.652 -0.91 . . . . 0.0 109.115 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.551 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 1.1 pt -114.51 147.08 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.483 -0.761 . . . . 0.0 109.969 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 70.75 85.08 0.13 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.456 -0.778 . . . . 0.0 110.932 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.4 ' CG ' HD11 ' A' ' 9' ' ' ILE . 52.8 t80 -123.62 102.59 7.93 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -123.13 138.09 54.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.517 -0.739 . . . . 0.0 109.813 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.405 ' O ' ' CG1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.7 p90 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.414 0.626 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.7 149.21 18.75 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.492 ' OG1' HG23 ' E' ' 11' ' ' THR . 21.2 m -106.56 140.65 39.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -1.131 . . . . 0.0 108.821 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.2 mt -84.5 134.04 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.68 155.47 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.235 -0.916 . . . . 0.0 109.104 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.424 ' H ' ' H ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -148.26 134.24 19.17 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.16 148.41 28.88 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.139 -0.976 . . . . 0.0 108.542 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 25.2 p-10 . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.129 -0.982 . . . . 0.0 109.031 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 74.5 t80 . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 71.1 mt -124.44 141.47 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.476 -0.765 . . . . 0.0 109.433 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.462 ' CG2' ' O ' ' B' ' 9' ' ' ILE . 6.8 tt -136.87 119.76 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 7.6 t -124.6 156.58 37.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.196 -0.94 . . . . 0.0 108.622 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.477 ' HB ' ' H ' ' B' ' 12' ' ' ALA . 0.0 OUTLIER -68.33 -132.34 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.477 ' H ' ' HB ' ' B' ' 11' ' ' THR . . . -94.09 110.21 21.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.138 -0.976 . . . . 0.0 110.014 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -162.75 -134.22 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . 0.634 ' O ' ' C ' ' B' ' 15' ' ' ILE . 6.4 pt-20 -172.99 46.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.064 -1.022 . . . . 0.0 109.49 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.634 ' C ' ' O ' ' B' ' 14' ' ' GLU . 11.3 mt -1.81 77.58 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.505 0 O-C-N 122.357 -0.214 . . . . 0.0 110.586 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.498 ' N ' ' O ' ' B' ' 14' ' ' GLU . 2.3 Cg_endo -62.12 155.49 55.8 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.831 1.687 . . . . 0.0 110.183 -177.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.44 -11.59 71.74 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 34.7 mt -124.37 137.52 54.46 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.08 -1.247 . . . . 0.0 109.228 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.17 116.1 24.15 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.45 138.73 35.24 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.242 -0.911 . . . . 0.0 109.687 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -118.29 129.79 55.66 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.82 129.18 39.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.732 -1.23 . . . . 0.0 110.673 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.404 HD11 ' CB ' ' B' ' 72' ' ' LYS . 74.2 mt -115.62 7.1 14.71 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.96 -156.06 16.18 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.63 142.94 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.885 -0.773 . . . . 0.0 109.389 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.2 144.6 44.6 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.774 -0.579 . . . . 0.0 109.954 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 30.7 p -152.45 141.83 21.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.191 -0.943 . . . . 0.0 108.743 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.59 152.76 36.02 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.077 -1.015 . . . . 0.0 109.72 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.428 ' N ' HD12 ' B' ' 29' ' ' ILE . 3.4 mp -98.52 152.27 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.245 -0.909 . . . . 0.0 108.949 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 173.05 143.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.445 -0.784 . . . . 0.0 109.242 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.411 ' O ' ' CG ' ' B' ' 32' ' ' ASN . 15.2 p-10 -93.08 30.1 1.71 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.235 -0.916 . . . . 0.0 110.325 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . 0.411 ' CG ' ' O ' ' B' ' 31' ' ' ASP . 27.1 m120 -162.23 141.17 9.28 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.548 0.689 . . . . 0.0 109.902 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.23 -37.27 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.396 -0.815 . . . . 0.0 109.57 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.71 -38.77 72.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 0.0 109.536 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -75.28 -36.93 61.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.235 -0.916 . . . . 0.0 108.696 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 82.4 mt -65.29 -53.5 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.917 -1.114 . . . . 0.0 109.25 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -54.54 -51.34 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.109 -0.994 . . . . 0.0 109.134 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.83 -43.02 98.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.35 -0.844 . . . . 0.0 109.758 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -60.65 -45.24 94.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.29 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' B' ' 40' ' ' LEU . 61.1 mt -67.09 -46.08 75.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.155 -0.966 . . . . 0.0 108.911 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -50.1 -43.7 51.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.764 -1.21 . . . . 0.0 109.459 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -67.87 -38.6 83.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.614 -0.679 . . . . 0.0 110.272 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -76.48 -35.62 58.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.453 -0.779 . . . . 0.0 109.858 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 t -66.12 -50.12 71.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 109.21 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -62.96 -31.03 72.04 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.238 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.68 -31.74 71.05 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.763 0.792 . . . . 0.0 109.394 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -84.91 -5.38 59.34 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.75 8.96 75.64 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.69 164.61 45.18 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.98 1.85 2.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.03 -1.277 . . . . 0.0 110.325 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.7 165.75 38.61 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.921 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 tp -136.52 137.9 40.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.585 -0.95 . . . . 0.0 109.163 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.906 ' O ' HD13 ' B' ' 53' ' ' ILE . 0.0 OUTLIER -109.4 151.68 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.47 -0.769 . . . . 0.0 109.872 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 78.83 -64.02 0.27 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.327 -0.858 . . . . 0.0 112.678 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.495 ' O ' ' CG ' ' B' ' 55' ' ' PHE . 61.2 t80 34.74 36.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.394 0.616 . . . . 0.0 109.788 177.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . 0.793 HH11 ' HG3' ' B' ' 56' ' ' ARG . 14.3 mtm-85 -64.39 154.71 34.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.868 -1.145 . . . . 0.0 109.73 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 84.6 mt . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.788 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -127.79 -114.89 1.86 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' TYR . . . . . 0.436 ' CD1' ' O ' ' B' ' 67' ' ' TYR . 32.4 p90 -172.87 130.97 0.51 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -1.172 . . . . 0.0 109.142 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.54 148.11 19.75 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 79.0 m -102.18 136.29 42.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.907 -1.349 . . . . 0.0 108.761 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 49.1 mt -83.03 142.88 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 m -135.45 157.71 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.151 -0.968 . . . . 0.0 109.767 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.404 ' CB ' HD11 ' B' ' 23' ' ' LEU . 0.0 OUTLIER -147.17 151.35 36.63 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.31 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.4 150.22 34.99 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.028 -1.045 . . . . 0.0 109.242 179.435 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -102.46 144.31 31.07 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 14.1 mt -132.98 135.97 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.464 -0.772 . . . . 0.0 109.577 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' ILE . . . . . 0.61 HG23 ' O ' ' C' ' 9' ' ' ILE . 16.4 tt -137.77 115.0 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -123.05 158.68 30.06 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 7.6 p -114.82 85.09 2.18 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.35 -133.08 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.72 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -107.6 -55.98 2.28 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.55 -0.719 . . . . 0.0 109.39 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . 0.522 ' HG2' ' H ' ' C' ' 15' ' ' ILE . 22.7 tt0 -164.89 -179.32 5.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.933 . . . . 0.0 108.886 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . 0.522 ' H ' ' HG2' ' C' ' 14' ' ' GLU . 63.6 mt -112.12 92.04 17.44 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.95 156.7 42.53 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 122.0 1.8 . . . . 0.0 110.456 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.74 -6.08 76.92 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 77.6 mt -130.63 140.44 50.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -1.179 . . . . 0.0 109.494 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -86.01 107.56 17.83 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.545 ' HB3' ' HB ' ' C' ' 71' ' ' VAL . 6.7 mt -111.0 128.17 55.76 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.485 -0.759 . . . . 0.0 110.451 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' TYR . . . . . 0.641 ' N ' ' CD1' ' C' ' 21' ' ' TYR . 0.0 OUTLIER -112.42 142.75 44.58 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.7 136.42 45.58 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.627 0.727 . . . . 0.0 110.106 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.451 HD21 ' HD3' ' C' ' 72' ' ' LYS . 2.1 mt -120.43 12.93 11.74 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.5 -175.46 16.72 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' ILE . . . . . 0.438 HD11 HG23 ' B' ' 9' ' ' ILE . 49.4 mm -114.58 139.23 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.13 143.95 42.32 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.35 -0.843 . . . . 0.0 109.217 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 19.2 m -152.83 146.87 25.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.094 -1.004 . . . . 0.0 109.211 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 9.6 t -149.9 137.18 19.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.351 -0.843 . . . . 0.0 109.171 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.404 HG22 ' N ' ' C' ' 30' ' ' SER . 89.2 mt -108.23 157.97 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.698 ' O ' ' CG ' ' C' ' 31' ' ' ASP . 15.4 m 62.74 85.09 0.13 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.526 -0.734 . . . . 0.0 109.774 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' ASP . . . . . 0.698 ' CG ' ' O ' ' C' ' 30' ' ' SER . 27.2 m-20 173.04 132.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -83.73 175.17 9.87 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 1.9 m -46.16 -42.62 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.636 0 O-C-N 120.56 -1.337 . . . . 0.0 107.673 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -63.0 -48.7 77.66 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.297 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -73.14 -36.73 66.74 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.955 -1.091 . . . . 0.0 108.896 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 89.5 mt -61.96 -52.53 59.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.824 -1.172 . . . . 0.0 109.396 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.97 -48.58 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -0.965 . . . . 0.0 109.399 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' GLU . . . . . 0.442 ' HA ' ' HE ' ' C' ' 41' ' ' ARG . 24.3 mm-40 -56.0 -36.23 67.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 109.007 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' ASN . . . . . 0.48 ' ND2' ' OD2' ' C' ' 31' ' ' ASP . 79.8 m-20 -76.07 -37.79 57.82 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.728 -1.232 . . . . 0.0 110.565 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . 0.58 ' O ' HG13 ' C' ' 44' ' ' VAL . 78.7 mt -74.27 -53.28 10.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.741 -1.225 . . . . 0.0 110.024 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' ARG . . . . . 0.453 ' NH1' ' HE2' ' C' ' 45' ' ' LYS . 2.2 ppt_? -47.19 -45.23 22.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.075 -1.016 . . . . 0.0 109.279 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -60.12 -32.46 71.02 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.051 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' GLN . . . . . 0.524 ' O ' ' HB2' ' C' ' 47' ' ' LYS . 69.8 mm-40 -75.31 -36.61 61.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -0.971 . . . . 0.0 110.756 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' VAL . . . . . 0.617 ' O ' ' N ' ' C' ' 49' ' ' GLY . 0.8 OUTLIER -76.8 -52.1 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.712 -1.243 . . . . 0.0 109.83 -179.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' LYS . . . . . 0.475 ' N ' ' CG2' ' C' ' 44' ' ' VAL . 0.3 OUTLIER -61.53 -33.0 73.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.28 -1.512 . . . . 0.0 109.38 -175.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.7 -32.89 62.31 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.85 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' C' ' 43' ' ' GLN . 3.9 mtpp -93.31 -7.61 44.41 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' C' ' 44' ' ' VAL . . . 105.39 -1.25 40.05 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' C' ' 44' ' ' VAL . . . -65.18 -173.68 4.08 Favored Glycine 0 N--CA 1.483 1.798 0 O-C-N 119.913 -1.934 . . . . 0.0 109.597 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.08 9.87 0.44 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.094 -1.239 . . . . 0.0 110.003 176.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.07 164.73 18.81 Favored Glycine 0 N--CA 1.483 1.8 0 C-N-CA 118.974 -1.584 . . . . 0.0 109.813 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . 0.427 HD22 HD13 ' C' ' 40' ' ' LEU . 0.4 OUTLIER -115.76 149.6 38.23 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.87 -0.783 . . . . 0.0 109.88 179.033 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' ILE . . . . . 0.63 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 1.1 pt -113.15 143.67 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.678 -0.639 . . . . 0.0 110.104 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 77.78 -50.66 0.51 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.68 -0.637 . . . . 0.0 110.679 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' C' ' 54' ' ' ALA . 50.0 t80 42.24 68.98 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' ARG . . . . . 0.67 ' CG ' HH11 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -77.02 137.98 39.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.129 -178.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 42.7 p90 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.578 0.704 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 166.49 -162.0 35.68 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 21.8 m -123.92 136.65 54.47 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.13 142.85 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' C' ' 20' ' ' LEU . 5.2 m -137.18 150.19 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.661 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' LYS . . . . . 0.451 ' HD3' HD21 ' C' ' 23' ' ' LEU . 12.9 mtpp -119.17 146.01 45.53 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.45 149.43 26.17 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' C' ' 74' ' ' ASP . 25.9 p-10 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 120.772 -1.205 . . . . 0.0 109.376 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 N--CA 1.494 1.742 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -92.49 120.01 32.54 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.102 -0.999 . . . . 0.0 108.743 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 50.7 mt -126.14 129.87 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.461 -0.774 . . . . 0.0 110.093 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 9' ' ' ILE . . . . . 0.601 HG23 ' O ' ' D' ' 9' ' ' ILE . 17.1 tt -113.64 114.43 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t -123.55 160.68 26.49 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.147 -0.971 . . . . 0.0 109.082 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.5 p -91.84 -113.2 0.09 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.5 -120.15 0.87 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.106 . . . . 0.0 110.426 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -152.7 -27.16 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.728 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -168.56 177.1 5.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 0.0 109.53 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 96.1 mt -116.55 97.61 50.37 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.13 155.96 47.82 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.772 1.648 . . . . 0.0 110.415 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.18 -7.54 78.34 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 64.8 mt -129.28 140.46 51.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -1.103 . . . . 0.0 109.513 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -84.52 108.49 17.32 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 15.1 mt -97.26 135.26 39.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.825 . . . . 0.0 110.025 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' TYR . . . . . 0.5 ' CE1' ' O ' ' D' ' 22' ' ' SER . 1.5 t80 -117.74 130.04 56.07 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . 0.5 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 28.3 t -75.0 129.68 38.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.911 -1.118 . . . . 0.0 110.917 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mt -117.3 12.17 14.24 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.79 177.84 15.2 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.65 145.02 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.892 -0.769 . . . . 0.0 108.943 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.69 144.12 42.74 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.6 -0.688 . . . . 0.0 109.348 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 92.4 p -152.2 138.42 18.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.083 -1.011 . . . . 0.0 108.611 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 13.5 t -149.51 146.33 27.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.052 -1.03 . . . . 0.0 109.134 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 47.5 mm -116.94 131.54 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.274 -0.891 . . . . 0.0 109.199 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 11.9 m -153.46 -158.04 0.84 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.207 -0.933 . . . . 0.0 109.408 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -106.88 -80.03 0.57 Allowed 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.406 -0.809 . . . . 0.0 111.153 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.499 ' ND2' ' H ' ' D' ' 32' ' ' ASN . 3.4 m-80 -65.39 144.78 56.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.896 -1.127 . . . . 0.0 109.153 177.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . 0.413 ' H ' HG13 ' D' ' 33' ' ' VAL . 1.9 m -69.42 -36.15 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -58.25 -29.47 65.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.522 -0.736 . . . . 0.0 109.606 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -75.03 -36.02 61.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.364 -0.835 . . . . 0.0 108.888 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 54.8 mt -60.97 -49.62 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.308 -0.87 . . . . 0.0 108.96 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 54.1 t -55.45 -49.44 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.998 . . . . 0.0 109.019 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.82 -41.07 90.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 109.593 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -62.48 -42.76 99.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 0.0 109.337 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 60.5 mt -67.55 -45.38 75.85 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.086 -1.009 . . . . 0.0 108.59 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -50.14 -55.3 15.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.858 -1.152 . . . . 0.0 109.198 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -58.76 -37.63 76.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.252 -0.905 . . . . 0.0 110.453 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -75.68 -35.61 60.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 109.764 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 9.6 t -69.0 -50.49 53.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.25 -0.907 . . . . 0.0 109.234 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -64.21 -29.92 71.01 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.483 -1.287 . . . . 0.0 109.002 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.71 -29.03 67.37 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.33 -5.29 56.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.503 -0.748 . . . . 0.0 109.921 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.0 9.42 58.32 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.2 158.74 40.46 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 3.0 ptm -126.9 -5.04 6.3 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.295 -1.121 . . . . 0.0 110.07 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.27 164.18 36.5 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 8.2 tp -125.42 134.05 52.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.7 -0.882 . . . . 0.0 109.186 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 53' ' ' ILE . . . . . 0.808 ' O ' HD13 ' D' ' 53' ' ' ILE . 0.0 OUTLIER -107.68 147.3 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.525 -0.735 . . . . 0.0 110.58 -178.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 51.73 63.44 2.24 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.369 -1.457 . . . . 0.0 109.668 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . 0.572 ' O ' ' O ' ' D' ' 56' ' ' ARG . 2.7 t80 -46.27 -60.15 2.49 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.282 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' ARG . . . . . 0.572 ' O ' ' O ' ' D' ' 55' ' ' PHE . 26.2 mmt180 . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 121.649 0.737 . . . . 0.0 110.201 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 34.7 p90 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.573 0.702 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -149.13 169.46 29.51 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 88.9 m -113.03 138.04 50.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.254 -1.145 . . . . 0.0 108.67 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 27.5 mt -87.36 135.65 24.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.6 155.72 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.799 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -151.55 158.0 42.98 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -120.19 150.16 41.1 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.123 -0.985 . . . . 0.0 109.306 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 121.562 0.696 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -94.21 118.82 32.12 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 76.2 mt -107.03 125.5 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.375 -0.828 . . . . 0.0 110.242 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 9' ' ' ILE . . . . . 0.617 HG23 ' O ' ' E' ' 9' ' ' ILE . 20.8 tt -133.42 113.79 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -123.78 161.57 24.95 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.294 -0.879 . . . . 0.0 109.528 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 11' ' ' THR . . . . . 0.492 HG23 ' OG1' ' A' ' 69' ' ' THR . 0.8 OUTLIER -87.87 -113.75 0.05 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' E' ' 11' ' ' THR . . . 41.64 -122.92 0.56 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 109.486 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 p30 175.53 26.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.549 -0.72 . . . . 0.0 109.647 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -173.44 151.69 2.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.206 -0.934 . . . . 0.0 109.638 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 15' ' ' ILE . . . . . 0.722 HG23 ' O ' ' E' ' 15' ' ' ILE . 18.0 tt -138.4 77.53 34.8 Favored Pre-proline 0 N--CA 1.498 1.971 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.86 156.85 36.06 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 122.116 1.878 . . . . 0.0 110.935 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.4 -6.73 71.63 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 18' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' E' ' 18' ' ' LEU . 28.9 mt -128.69 137.43 51.61 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.896 -1.356 . . . . 0.0 109.544 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -84.22 108.79 17.31 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 20' ' ' LEU . . . . . 0.613 HD11 ' CG2' ' E' ' 15' ' ' ILE . 10.9 mt -104.95 146.05 29.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 111.009 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 21' ' ' TYR . . . . . 0.423 ' CZ ' ' O ' ' E' ' 22' ' ' SER . 1.6 t80 -129.76 130.66 45.68 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 22' ' ' SER . . . . . 0.423 ' O ' ' CZ ' ' E' ' 21' ' ' TYR . 13.7 t -53.02 130.61 34.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 111.104 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' E' ' 23' ' ' LEU . 5.3 mt -120.41 9.22 10.9 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.75 177.77 18.42 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 47.2 mm -112.42 143.23 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.784 -0.833 . . . . 0.0 109.358 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.06 154.53 28.7 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 5.2 p -149.67 147.32 27.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.054 -1.029 . . . . 0.0 109.043 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . 0.556 ' OG1' HG23 ' E' ' 36' ' ' ILE . 17.2 p -148.71 132.09 16.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.44 -0.788 . . . . 0.0 109.354 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.453 ' O ' ' CB ' ' E' ' 30' ' ' SER . 86.3 mt -126.66 127.5 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' E' ' 29' ' ' ILE . 2.6 t 164.37 14.07 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 31' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' E' ' 32' ' ' ASN . 30.8 t0 51.91 -179.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.171 -0.956 . . . . 0.0 109.32 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 32' ' ' ASN . . . . . 0.462 ' H ' ' CG ' ' E' ' 31' ' ' ASP . 5.6 m-20 68.59 105.8 0.05 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.582 -0.698 . . . . 0.0 109.246 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 50.3 t -67.0 -34.52 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.259 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -58.73 -46.88 86.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 110.127 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -75.46 -37.44 60.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.107 -0.995 . . . . 0.0 109.187 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 36' ' ' ILE . . . . . 0.556 HG23 ' OG1' ' E' ' 28' ' ' THR . 70.2 mt -64.84 -50.82 73.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.945 -1.097 . . . . 0.0 109.579 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 19.2 t -58.91 -51.12 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.05 -1.032 . . . . 0.0 109.195 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -38.44 73.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 109.116 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -65.05 -39.02 92.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.163 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 54.4 mt -71.13 -48.13 53.92 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.147 -0.971 . . . . 0.0 109.084 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 41' ' ' ARG . . . . . 0.845 HH11 ' HG3' ' E' ' 41' ' ' ARG . 0.2 OUTLIER -50.67 -46.17 58.5 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.929 -1.107 . . . . 0.0 109.638 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -62.67 -34.53 77.29 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.176 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -70.63 -36.59 73.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.195 -0.941 . . . . 0.0 108.767 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 20.9 t -77.2 -51.36 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.754 -1.217 . . . . 0.0 109.222 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -49.03 -33.01 10.4 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.444 1.116 . . . . 0.0 110.254 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.31 -26.99 52.74 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.437 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -94.26 10.91 32.18 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.99 31.17 55.6 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 118.342 -1.885 . . . . 0.0 109.797 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -86.14 159.57 32.69 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 34.9 mmm -67.41 -41.69 84.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.144 -1.209 . . . . 0.0 110.5 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.74 -142.64 7.74 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 6.7 tp -130.71 132.55 45.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.531 -0.982 . . . . 0.0 109.284 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 53' ' ' ILE . . . . . 0.574 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 1.3 pt -107.53 145.52 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.568 -0.708 . . . . 0.0 110.192 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' E' ' 56' ' ' ARG . . . 71.37 -50.52 0.69 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.264 -0.897 . . . . 0.0 109.821 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 5.9 t80 50.93 -79.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 56' ' ' ARG . . . . . 0.748 ' HG2' HH11 ' E' ' 56' ' ' ARG . 0.0 OUTLIER 64.04 145.48 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.429 -0.794 . . . . 0.0 109.774 178.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 75.9 mt . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.777 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 13.4 p90 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.372 0.606 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.42 154.15 25.31 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 70.6 m -99.97 134.9 42.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.144 -1.21 . . . . 0.0 108.082 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 12.6 mt -89.2 141.21 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 m -144.72 163.41 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.387 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -149.04 154.62 39.56 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.94 151.57 37.91 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 t70 . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.67 -0.644 . . . . 0.0 109.634 179.817 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.4 t80 . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.0 mt -114.66 140.88 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.541 -0.724 . . . . 0.0 109.218 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 9' ' ' ILE . 14.4 tt -125.02 125.02 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.85 130.25 56.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.481 -0.762 . . . . 0.0 109.004 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.445 ' OG1' ' OG1' ' B' ' 69' ' ' THR . 45.7 m -105.21 105.15 15.06 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 52.88 58.11 5.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.311 -0.868 . . . . 0.0 109.892 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 39.9 t0 -143.59 -140.03 0.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.568 -0.708 . . . . 0.0 109.376 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.455 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 5.9 pt-20 -173.66 166.44 4.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.194 -0.942 . . . . 0.0 109.187 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.5 mt -136.13 71.21 62.03 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.378 -0.826 . . . . 0.0 109.158 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.26 156.55 45.02 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 C-N-CA 122.211 1.941 . . . . 0.0 110.225 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.27 -1.08 69.36 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.284 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 18' ' ' LEU . 37.1 mt -130.77 138.86 50.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.961 -1.317 . . . . 0.0 109.433 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.409 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 22.3 mm100 -84.6 108.77 17.52 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.6 mt -93.84 136.42 34.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.145 -0.972 . . . . 0.0 110.241 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 72' ' ' LYS . 47.4 t80 -116.02 129.13 56.23 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.23 124.52 24.32 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 120.305 -1.497 . . . . 0.0 110.316 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 72' ' ' LYS . 35.7 mt -110.1 3.86 20.64 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.04 -178.37 16.46 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.28 144.74 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.802 -0.822 . . . . 0.0 109.187 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.49 143.95 44.95 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.246 0.546 . . . . 0.0 110.078 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.3 m -152.29 134.69 15.21 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.0 t -150.1 153.65 36.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.822 -1.174 . . . . 0.0 109.328 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.2 mp -105.33 154.38 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 173.81 158.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 109.231 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -100.65 139.29 36.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.337 -0.852 . . . . 0.0 110.053 -178.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 3.9 t-20 81.04 141.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.81 -32.76 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.847 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.403 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 1.2 p30 -57.92 -43.5 86.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.927 . . . . 0.0 110.16 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.403 ' N ' ' CG ' ' A' ' 34' ' ' ASP . 63.9 mt-10 -75.18 -38.65 60.74 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.408 -0.808 . . . . 0.0 109.377 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.7 mt -63.52 -44.86 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.992 . . . . 0.0 109.478 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.77 -49.8 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.966 -1.084 . . . . 0.0 109.799 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -58.43 -38.94 78.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 109.678 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.518 HD22 ' N ' ' A' ' 39' ' ' ASN . 1.0 OUTLIER -63.12 -44.74 94.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.713 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.493 ' HA ' HD23 ' A' ' 40' ' ' LEU . 15.1 mt -69.44 -46.51 66.59 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.091 -1.006 . . . . 0.0 109.102 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.8 HH11 ' HG3' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -49.43 -49.87 43.24 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 120.797 -1.19 . . . . 0.0 109.892 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -61.39 -36.97 81.74 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.521 -0.737 . . . . 0.0 110.29 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -77.07 -35.49 56.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.511 -0.743 . . . . 0.0 109.899 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.8 t -66.71 -50.88 62.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.035 -1.041 . . . . 0.0 109.103 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.72 -35.65 80.63 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.392 -1.323 . . . . 0.0 109.015 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.26 -28.86 69.47 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -5.63 56.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.517 -0.74 . . . . 0.0 109.881 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.81 11.82 57.42 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.08 161.55 36.12 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -125.27 -3.4 7.46 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.27 -1.135 . . . . 0.0 109.918 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.31 154.99 24.22 Favored Glycine 0 N--CA 1.487 2.087 0 C-N-CA 119.35 -1.405 . . . . 0.0 109.699 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.06 146.46 36.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.663 -0.904 . . . . 0.0 109.815 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.513 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -119.38 145.6 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.5 -0.75 . . . . 0.0 110.071 -177.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 70.2 79.24 0.19 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.581 -0.699 . . . . 0.0 110.451 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -103.07 136.61 42.56 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.488 ' NH1' ' NH2' ' E' ' 56' ' ' ARG . 58.0 ttt180 -151.84 156.47 40.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.73 -1.231 . . . . 0.0 109.764 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.1 mt . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.8 t80 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.804 0.811 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.23 153.23 22.62 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.324 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.433 ' OG1' HG23 ' E' ' 11' ' ' THR . 19.2 m -105.22 137.47 42.95 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.225 -1.162 . . . . 0.0 108.703 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 52.4 mt -80.66 141.86 14.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -131.59 153.7 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.379 -0.826 . . . . 0.0 109.466 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.574 ' NZ ' ' O ' ' A' ' 74' ' ' ASP . 15.9 ttpp -142.03 133.53 26.7 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 19' ' ' GLN . . . -123.45 151.82 42.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.001 -1.062 . . . . 0.0 108.568 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.574 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 13.4 m-20 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 120.882 -1.136 . . . . 0.0 110.234 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 86.7 t80 . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 68.4 mt -115.94 146.28 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.612 -0.68 . . . . 0.0 109.6 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.617 HG23 ' O ' ' B' ' 9' ' ' ILE . 9.5 tt -131.82 115.22 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -123.49 158.36 31.46 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.463 ' OG1' ' OG1' ' C' ' 69' ' ' THR . 1.5 m -112.67 103.18 11.21 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.33 88.45 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.468 -0.77 . . . . 0.0 109.853 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -162.08 -20.78 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.428 -0.795 . . . . 0.0 109.514 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 60.37 160.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.627 -0.671 . . . . 0.0 109.417 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 mt -130.4 82.94 64.03 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.561 -0.712 . . . . 0.0 109.084 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.58 156.37 42.52 Favored 'Trans proline' 0 C--N 1.323 -0.815 0 C-N-CA 122.068 1.845 . . . . 0.0 110.252 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.71 -6.34 77.12 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' B' ' 18' ' ' LEU . 66.9 mt -130.96 139.64 50.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.049 -1.265 . . . . 0.0 109.06 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.18 116.43 23.53 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.79 140.42 33.01 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.18 -0.95 . . . . 0.0 110.032 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' B' ' 71' ' ' VAL . 2.1 t80 -123.31 129.51 51.43 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 42.0 t -67.44 130.61 43.59 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.826 -1.171 . . . . 0.0 111.138 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.521 HD11 ' CB ' ' B' ' 72' ' ' LYS . 72.3 mt -116.71 8.24 13.69 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.42 -171.13 14.9 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 40.6 mm -119.05 141.9 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.908 -0.76 . . . . 0.0 109.367 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.15 144.82 42.01 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.616 -0.678 . . . . 0.0 109.425 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 85.3 p -152.22 137.8 17.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.097 -1.002 . . . . 0.0 108.599 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 8.8 t -149.74 149.6 30.81 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.937 -1.102 . . . . 0.0 109.265 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 66.1 mt -116.13 126.33 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.307 -0.87 . . . . 0.0 109.047 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 32.5 t -174.87 -146.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.148 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -158.91 172.01 18.99 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.211 -0.931 . . . . 0.0 108.814 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 2.1 m120 73.46 130.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 t -68.88 -35.12 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.551 -0.718 . . . . 0.0 109.49 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -58.96 -45.22 91.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.268 -0.895 . . . . 0.0 109.944 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -75.58 -42.1 52.93 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 0.0 109.872 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 77.8 mt -63.46 -53.77 41.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.917 -1.115 . . . . 0.0 109.322 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 t -56.9 -48.54 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.012 -1.055 . . . . 0.0 108.765 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -61.65 -41.18 97.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 110.064 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -58.68 -48.01 82.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.551 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 57.6 mt -74.26 -50.49 18.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 108.934 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -48.81 -47.85 41.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.776 -1.202 . . . . 0.0 108.892 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -61.32 -34.91 76.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 109.449 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -74.42 -36.03 63.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.524 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.29 -51.66 20.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.926 -1.109 . . . . 0.0 108.898 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -51.32 -29.25 14.45 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 122.613 1.196 . . . . 0.0 109.788 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.3 -26.76 52.59 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.439 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -94.26 8.41 41.88 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.07 31.13 68.14 Favored Glycine 0 N--CA 1.476 1.353 0 C-N-CA 118.157 -1.973 . . . . 0.0 109.911 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.48 -169.34 32.44 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 25.0 mmm -106.86 -37.2 6.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.397 -1.061 . . . . 0.0 109.554 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 176.16 -149.49 9.91 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 tp -137.65 143.72 41.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.357 -1.084 . . . . 0.0 109.823 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.65 ' O ' ' HB3' ' B' ' 54' ' ' ALA . 1.2 pt -114.36 146.63 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.5 -0.75 . . . . 0.0 109.376 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 82.88 -48.42 0.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 118.769 0.713 . . . . 0.0 109.893 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.524 ' C ' ' O ' ' B' ' 54' ' ' ALA . 78.5 t80 25.1 92.54 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 120.965 0.412 . . . . 0.0 110.593 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . 0.833 HH11 ' HG3' ' B' ' 56' ' ' ARG . 11.2 ttm-85 -98.77 153.46 18.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.214 -0.929 . . . . 0.0 109.821 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mp . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.755 0.788 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.14 53.49 0.94 Allowed Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -59.3 178.44 0.14 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.685 1.231 . . . . 0.0 110.228 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.63 160.41 26.25 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . 0.445 ' OG1' ' OG1' ' A' ' 11' ' ' THR . 21.7 m -95.87 135.04 38.13 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 120.494 -1.591 . . . . 0.0 107.786 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 58.9 mt -83.64 146.39 6.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 4.3 m -136.31 162.33 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.551 -0.718 . . . . 0.0 109.989 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.521 ' CB ' HD11 ' B' ' 23' ' ' LEU . 5.9 tttt -152.28 141.76 21.67 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.37 151.36 29.87 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.953 -1.092 . . . . 0.0 108.694 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 56.4 t0 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 120.957 -1.089 . . . . 0.0 108.689 179.264 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 120.963 0.411 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -97.8 121.82 40.16 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.479 -0.763 . . . . 0.0 109.053 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.94 135.98 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.479 -0.763 . . . . 0.0 110.591 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' ILE . . . . . 0.633 HG23 ' O ' ' C' ' 9' ' ' ILE . 13.9 tt -132.12 113.33 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 4.9 t -124.45 160.65 27.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.346 -0.846 . . . . 0.0 109.284 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 4.3 p -110.26 83.45 1.76 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.75 -28.45 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.647 -0.658 . . . . 0.0 110.14 177.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . 0.604 ' OD1' ' N ' ' C' ' 13' ' ' ASP . 0.0 OUTLIER 68.51 43.33 1.41 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.479 -0.763 . . . . 0.0 109.49 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -178.67 129.3 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.105 -0.997 . . . . 0.0 109.521 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 16.6 mt -134.28 79.14 56.21 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.98 155.14 51.83 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 122.02 1.814 . . . . 0.0 110.503 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.15 -6.17 78.61 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' C' ' 18' ' ' LEU . 53.9 mt -131.6 139.58 49.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -1.198 . . . . 0.0 109.518 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' C' ' 73' ' ' ALA . 25.9 mt-30 -84.91 114.24 21.98 Favored 'General case' 0 C--O 1.192 -1.929 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 16.1 mt -94.64 138.56 32.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.783 -1.198 . . . . 0.0 110.752 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' TYR . . . . . 0.688 ' H ' ' H ' ' C' ' 72' ' ' LYS . 29.3 t80 -116.99 128.29 55.04 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.606 -0.684 . . . . 0.0 109.733 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.04 123.34 21.87 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 120.022 -1.674 . . . . 0.0 110.308 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.474 HD11 ' CB ' ' C' ' 72' ' ' LYS . 78.6 mt -114.69 7.68 16.0 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.96 -174.74 15.89 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.17 144.17 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 122.037 -0.684 . . . . 0.0 109.244 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.3 144.6 45.71 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.95 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 42.1 m -152.61 142.39 22.0 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.96 -1.087 . . . . 0.0 108.421 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 9.2 t -149.52 146.69 27.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.101 -0.999 . . . . 0.0 109.359 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 71.7 mt -113.52 137.37 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.399 -0.813 . . . . 0.0 110.253 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.554 ' OG ' ' N ' ' C' ' 31' ' ' ASP . 0.1 OUTLIER -158.97 -172.81 3.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.48 -0.763 . . . . 0.0 109.78 -179.1 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' ASP . . . . . 0.554 ' N ' ' OG ' ' C' ' 30' ' ' SER . 4.8 m-20 -97.14 -76.14 0.52 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.322 -0.861 . . . . 0.0 111.91 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -76.88 156.07 32.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.927 -1.108 . . . . 0.0 109.104 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.52 -32.89 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.315 0.579 . . . . 0.0 109.803 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.54 -38.0 63.38 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.329 -0.857 . . . . 0.0 109.474 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -76.86 -35.36 57.53 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.017 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 81.5 mt -63.56 -53.28 47.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.047 -1.033 . . . . 0.0 108.991 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.11 -50.59 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.05 -1.031 . . . . 0.0 109.152 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -57.92 -38.94 76.81 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.304 -0.873 . . . . 0.0 108.964 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -65.79 -42.12 91.14 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.93 . . . . 0.0 109.522 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' C' ' 40' ' ' LEU . 24.8 mt -69.41 -47.65 63.46 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.012 -1.055 . . . . 0.0 108.753 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -49.41 -54.15 18.98 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.885 -1.134 . . . . 0.0 109.261 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -56.66 -34.16 67.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.899 . . . . 0.0 109.208 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -74.8 -43.74 53.14 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.33 -0.856 . . . . 0.0 109.321 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 10.5 t -71.64 -52.29 26.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 O-C-N 120.846 -1.159 . . . . 0.0 108.647 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -51.73 -31.5 26.66 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.823 1.296 . . . . 0.0 110.075 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.3 -28.09 47.43 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.705 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.13 4.32 53.4 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.72 26.49 69.95 Favored Glycine 0 N--CA 1.48 1.605 0 C-N-CA 118.631 -1.747 . . . . 0.0 109.804 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.85 162.98 50.76 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 16.2 ttp -79.91 -42.04 24.9 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.836 -1.39 . . . . 0.0 109.946 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 172.5 -170.3 43.37 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 tp -113.2 141.97 46.34 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.561 -0.964 . . . . 0.0 110.403 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 2.2 pt -119.82 145.71 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.44 -0.787 . . . . 0.0 110.406 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 70.99 -56.01 0.63 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.209 -0.932 . . . . 0.0 110.823 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 1.1 t80 61.37 -123.4 0.84 Allowed 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' ARG . . . . . 0.838 ' HG2' HH11 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -170.36 -138.65 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.239 -0.913 . . . . 0.0 109.928 -179.432 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' ILE . . . . . 0.484 ' H ' ' CG ' ' C' ' 56' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.185 -0.947 . . . . 0.0 109.637 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' TYR . . . . . 0.438 ' OH ' ' CZ ' ' C' ' 56' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.39 173.41 15.37 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' THR . . . . . 0.463 ' OG1' ' OG1' ' B' ' 11' ' ' THR . 53.0 m -122.75 132.82 54.4 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 119.036 1.418 . . . . 0.0 107.582 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 57.7 mt -79.13 129.73 37.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.17 161.88 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.445 -0.784 . . . . 0.0 109.87 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' LYS . . . . . 0.688 ' H ' ' H ' ' C' ' 21' ' ' TYR . 6.5 tttt -154.21 142.62 20.61 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' C' ' 19' ' ' GLN . . . -102.64 128.8 49.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.08 -1.013 . . . . 0.0 109.374 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.0 109.065 178.853 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt . . . . . 0 N--CA 1.498 1.933 0 CA-C-O 121.997 0.903 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -102.15 121.57 42.48 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 58.3 mt -133.65 128.42 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.434 -0.791 . . . . 0.0 109.351 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 9' ' ' ILE . . . . . 0.625 HG23 ' O ' ' D' ' 9' ' ' ILE . 9.1 tt -128.23 115.12 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.7 t -125.64 157.36 37.45 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 3.5 m -102.55 81.9 2.09 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.3 -112.15 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.452 -0.78 . . . . 0.0 110.203 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -152.49 -135.67 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.552 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -63.22 158.96 18.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -0.876 . . . . 0.0 109.371 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 38.9 mt -112.23 98.95 44.91 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.18 155.84 43.37 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.896 1.731 . . . . 0.0 110.392 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.68 -8.11 78.89 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 80.6 mt -131.44 142.27 49.98 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.42 -1.047 . . . . 0.0 109.309 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -87.77 108.45 19.13 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' D' ' 71' ' ' VAL . 4.3 mt -114.9 131.6 56.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.687 -0.633 . . . . 0.0 109.599 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' TYR . . . . . 0.595 ' OH ' ' N ' ' D' ' 74' ' ' ASP . 0.0 OUTLIER -113.73 143.42 44.64 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 16.6 t -75.06 128.33 35.29 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' D' ' 72' ' ' LYS . 0.7 OUTLIER -111.93 12.38 20.77 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.5 -179.09 16.35 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.9 144.01 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 122.174 -0.604 . . . . 0.0 109.606 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.25 144.28 40.67 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.405 0.621 . . . . 0.0 109.377 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.47 138.4 18.1 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.265 -0.897 . . . . 0.0 109.356 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 12.7 t -149.73 144.5 26.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.044 -1.035 . . . . 0.0 109.189 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . 0.43 HG23 ' O ' ' D' ' 29' ' ' ILE . 12.9 tt -117.95 127.91 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.271 -0.893 . . . . 0.0 108.93 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 30.1 t -173.65 174.28 3.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 109.056 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' D' ' 32' ' ' ASN . 29.5 t70 -107.49 157.29 18.14 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.332 -0.855 . . . . 0.0 109.565 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 8.6 t30 85.97 123.81 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 -177.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . 0.454 HG13 ' H ' ' D' ' 33' ' ' VAL . 1.0 OUTLIER -69.86 -38.95 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -63.12 -31.0 72.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.539 -0.726 . . . . 0.0 109.878 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -75.0 -41.08 60.19 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.223 -0.923 . . . . 0.0 109.717 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 92.6 mt -62.2 -46.31 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.999 -1.063 . . . . 0.0 108.7 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 17.0 t -55.75 -48.07 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.909 -1.119 . . . . 0.0 108.288 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -62.76 -42.23 99.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.024 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -59.67 -45.56 91.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.333 -0.855 . . . . 0.0 109.415 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' D' ' 40' ' ' LEU . 49.4 mt -71.36 -48.0 52.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 108.899 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -49.07 -50.92 34.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.79 -1.194 . . . . 0.0 109.113 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -59.96 -36.21 76.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.398 -0.814 . . . . 0.0 109.952 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -75.8 -35.85 59.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.465 -0.772 . . . . 0.0 109.598 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 13.1 t -71.07 -50.79 39.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.066 -1.022 . . . . 0.0 108.799 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -64.74 -30.13 71.13 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 118.29 -1.364 . . . . 0.0 109.255 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.66 -30.41 69.95 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . 0.514 ' HB3' ' NZ ' ' D' ' 47' ' ' LYS . 0.1 OUTLIER -90.36 2.07 55.93 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.79 23.83 74.13 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.08 -165.65 7.92 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 7.8 ttt -110.2 -41.26 4.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.418 -1.048 . . . . 0.0 109.702 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 173.58 -158.66 28.06 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 3.4 tp -125.07 139.86 53.42 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.595 -0.944 . . . . 0.0 110.36 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 53' ' ' ILE . . . . . 0.656 ' O ' ' HB3' ' D' ' 54' ' ' ALA . 1.0 OUTLIER -118.06 148.53 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.672 -0.643 . . . . 0.0 110.501 -177.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 82.73 -38.22 0.09 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 118.832 0.742 . . . . 0.0 109.131 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . 0.498 ' O ' ' O ' ' D' ' 56' ' ' ARG . 31.3 t80 49.18 -110.41 0.4 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.624 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' ARG . . . . . 0.753 ' HG2' HH11 ' D' ' 56' ' ' ARG . 6.4 mtt-85 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.418 0.628 . . . . 0.0 109.868 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 t80 . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 122.277 1.037 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.1 139.68 5.81 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 46.9 m -109.55 148.32 31.45 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.065 -1.256 . . . . 0.0 109.536 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 24.1 mt -97.78 148.04 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.54 0.686 . . . . 0.0 109.577 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 71' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' D' ' 20' ' ' LEU . 12.2 m -143.34 154.18 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.491 -0.755 . . . . 0.0 109.357 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 72' ' ' LYS . . . . . 0.431 ' HB2' HD11 ' D' ' 23' ' ' LEU . 26.3 ttpp -139.98 142.5 36.33 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.049 -1.032 . . . . 0.0 108.667 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' D' ' 74' ' ' ASP . . . -124.11 141.36 52.12 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . 0.595 ' N ' ' OH ' ' D' ' 21' ' ' TYR . 3.5 p30 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 6' ' ' LYS . . . . . 0.512 ' CG ' ' H ' ' E' ' 7' ' ' PHE . 14.7 tttt . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 121.215 0.531 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 7' ' ' PHE . . . . . 0.512 ' H ' ' CG ' ' E' ' 6' ' ' LYS . 18.8 t80 -109.85 120.73 43.39 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.562 -0.711 . . . . 0.0 109.672 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 83.7 mt -96.86 128.57 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.323 -0.86 . . . . 0.0 110.988 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 9' ' ' ILE . . . . . 0.554 HG23 ' O ' ' E' ' 9' ' ' ILE . 17.1 tt -134.48 121.01 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 1.3 t -113.34 133.25 55.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.322 -0.861 . . . . 0.0 109.336 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 11' ' ' THR . . . . . 0.433 HG23 ' OG1' ' A' ' 69' ' ' THR . 0.0 OUTLIER -53.63 -90.74 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.397 -0.814 . . . . 0.0 110.984 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.09 72.72 1.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.123 -0.986 . . . . 0.0 108.366 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -160.26 141.53 12.32 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.415 0.626 . . . . 0.0 109.512 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -79.56 178.68 7.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.398 -0.814 . . . . 0.0 109.127 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 57.5 mt -123.6 88.17 51.96 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.474 -0.766 . . . . 0.0 109.184 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.55 155.49 52.76 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 121.962 1.775 . . . . 0.0 110.158 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.02 -12.34 69.78 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 18' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' E' ' 18' ' ' LEU . 15.9 mt -125.2 136.83 53.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -1.185 . . . . 0.0 108.982 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.14 112.84 21.68 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt -99.08 142.62 30.34 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.187 -0.946 . . . . 0.0 109.83 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 21' ' ' TYR . . . . . 0.479 ' H ' ' H ' ' E' ' 72' ' ' LYS . 1.5 t80 -123.29 130.07 52.23 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 22' ' ' SER . . . . . 0.403 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 4.3 t -61.39 129.97 43.8 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.83 -1.169 . . . . 0.0 110.953 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' E' ' 23' ' ' LEU . 6.8 mt -117.65 9.26 13.03 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.67 -173.6 14.86 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.77 143.92 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 122.033 -0.687 . . . . 0.0 109.433 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.61 144.04 47.34 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.943 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 19.4 m -152.18 136.34 16.57 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 10.9 t -149.92 151.49 33.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.972 -1.08 . . . . 0.0 109.222 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 56.6 mt -127.0 133.44 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.111 -0.993 . . . . 0.0 108.702 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.574 ' O ' ' N ' ' E' ' 32' ' ' ASN . 78.1 p -156.29 31.77 0.33 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.134 -0.979 . . . . 0.0 110.769 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 31' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' E' ' 31' ' ' ASP . 0.7 OUTLIER 54.28 -70.59 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 32' ' ' ASN . . . . . 0.574 ' N ' ' O ' ' E' ' 30' ' ' SER . 7.3 m120 -66.1 135.41 54.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.732 -1.23 . . . . 0.0 107.93 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 33' ' ' VAL . . . . . 0.482 ' H ' HG13 ' E' ' 33' ' ' VAL . 1.0 OUTLIER -70.88 -42.21 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 34' ' ' ASP . . . . . 0.421 ' N ' ' CG2' ' E' ' 33' ' ' VAL . 29.8 t70 -52.53 -28.02 18.98 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.512 -0.742 . . . . 0.0 109.825 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -78.11 -33.39 50.6 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.422 -0.799 . . . . 0.0 109.202 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.16 -52.77 57.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.031 -1.043 . . . . 0.0 108.776 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.89 -49.24 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.085 -1.01 . . . . 0.0 108.967 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -60.71 -41.86 96.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.414 -0.804 . . . . 0.0 108.978 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -64.46 -45.2 88.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.471 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 40' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' E' ' 40' ' ' LEU . 70.4 mt -64.57 -44.03 92.01 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.098 -1.001 . . . . 0.0 108.329 178.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 41' ' ' ARG . . . . . 0.796 ' HG2' HH11 ' E' ' 41' ' ' ARG . 0.0 OUTLIER -48.84 -55.5 11.48 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.845 -1.159 . . . . 0.0 109.352 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -55.96 -33.56 64.89 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.088 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -74.44 -40.07 62.17 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.462 -0.773 . . . . 0.0 109.494 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 12.8 t -73.87 -52.01 22.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 120.879 -1.138 . . . . 0.0 108.82 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -50.59 -29.6 11.22 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.692 1.234 . . . . 0.0 109.741 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.63 -25.84 50.04 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.383 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -95.71 4.38 53.04 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.67 30.73 78.73 Favored Glycine 0 N--CA 1.479 1.555 0 C-N-CA 118.009 -2.043 . . . . 0.0 110.181 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.32 153.92 23.84 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 10.8 mtm -66.46 -29.61 69.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -1.111 . . . . 0.0 110.474 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.74 -137.51 4.61 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 tp -133.64 137.93 45.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.421 -1.046 . . . . 0.0 110.086 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 53' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 1.1 pt -115.12 144.9 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.609 -0.682 . . . . 0.0 110.163 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 64.91 74.84 0.38 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.166 -0.959 . . . . 0.0 110.216 178.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 55' ' ' PHE . . . . . 0.4 ' CE2' HG21 ' E' ' 57' ' ' ILE . 17.9 t80 -98.56 107.47 19.93 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 56' ' ' ARG . . . . . 0.685 ' CG ' HH11 ' E' ' 56' ' ' ARG . 0.4 OUTLIER -97.3 135.63 38.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.582 -0.699 . . . . 0.0 110.529 -178.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 57' ' ' ILE . . . . . 0.4 HG21 ' CE2' ' E' ' 55' ' ' PHE . 1.2 tt . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 . . . . . 0 N--CA 1.498 1.929 0 CA-C-O 121.358 0.599 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.61 149.72 21.11 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 8.6 m -112.81 137.5 51.05 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 32.0 mt -82.78 148.68 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 m -130.44 164.8 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.662 -0.649 . . . . 0.0 109.907 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 72' ' ' LYS . . . . . 0.479 ' H ' ' H ' ' E' ' 21' ' ' TYR . 14.6 tttm -147.95 145.43 28.57 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.89 137.96 49.15 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t70 . . . . . 0 N--CA 1.488 1.47 0 O-C-N 120.728 -1.233 . . . . 0.0 108.13 178.118 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.7 t80 . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.5 mt -134.49 138.15 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.29 -0.881 . . . . 0.0 109.978 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.478 ' CG2' ' O ' ' A' ' 9' ' ' ILE . 6.9 tt -127.8 118.21 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.788 -1.195 . . . . 0.0 108.088 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.4 t -127.24 154.93 44.24 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.059 -1.026 . . . . 0.0 109.563 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.424 HG21 ' HG3' ' A' ' 56' ' ' ARG . 1.4 m -135.54 115.95 13.63 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.52 66.23 1.23 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.344 -0.848 . . . . 0.0 109.655 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -164.13 -24.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.54 -0.725 . . . . 0.0 109.504 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 57.15 171.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.519 -0.738 . . . . 0.0 109.438 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mt -139.01 74.7 36.53 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.371 -0.831 . . . . 0.0 109.099 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.44 156.47 41.22 Favored 'Trans proline' 0 C--N 1.32 -0.952 0 C-N-CA 122.132 1.888 . . . . 0.0 110.197 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.08 -3.71 73.55 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.261 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 18' ' ' LEU . 42.6 mt -129.9 137.87 50.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.279 . . . . 0.0 108.871 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.454 ' H ' ' HG2' ' A' ' 19' ' ' GLN . 12.0 pt20 -85.91 113.82 22.33 Favored 'General case' 0 C--O 1.2 -1.518 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -95.0 138.81 32.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.892 -1.13 . . . . 0.0 109.603 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.712 ' O ' HG12 ' A' ' 71' ' ' VAL . 42.4 t80 -109.97 155.07 22.26 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.45 126.56 38.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 119.857 -1.777 . . . . 0.0 108.07 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.7 mt -117.08 5.91 12.83 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.69 -164.36 13.51 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.35 145.24 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 122.027 -0.69 . . . . 0.0 109.653 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.99 154.37 25.41 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 87.0 p -147.11 150.18 34.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.126 -0.984 . . . . 0.0 109.087 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.7 p -148.86 134.71 18.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.539 -0.726 . . . . 0.0 109.468 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.653 ' O ' ' OG ' ' A' ' 30' ' ' SER . 10.6 mm -127.12 126.0 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.653 ' OG ' ' O ' ' A' ' 29' ' ' ILE . 23.4 m 171.81 -129.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.175 0.512 . . . . 0.0 109.679 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.464 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 3.1 p30 -153.38 165.15 36.68 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.045 -1.034 . . . . 0.0 109.227 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 7.8 t-20 77.55 109.52 0.07 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -177.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.494 ' H ' HG13 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -69.36 -38.06 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.359 -0.838 . . . . 0.0 108.868 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 35' ' ' GLU . 1.9 p30 -61.17 -32.4 72.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.845 . . . . 0.0 110.095 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.46 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 31.1 tt0 -75.69 -37.45 59.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 0.0 109.139 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.1 mt -62.51 -42.61 96.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.12 -0.988 . . . . 0.0 108.836 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.28 -50.19 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.007 -1.058 . . . . 0.0 108.81 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -59.37 -38.94 81.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 109.663 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -61.76 -43.34 99.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.387 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 76.8 mt -68.07 -46.05 72.15 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.169 -0.957 . . . . 0.0 108.527 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -50.65 -53.3 32.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.899 -1.126 . . . . 0.0 109.199 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -57.81 -33.53 68.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.426 -0.796 . . . . 0.0 109.093 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -72.98 -41.88 63.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.331 -0.855 . . . . 0.0 109.34 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.568 HG21 HD21 ' A' ' 52' ' ' LEU . 21.1 t -77.01 -50.93 19.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 120.682 -1.261 . . . . 0.0 109.359 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -49.73 -32.97 14.79 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 122.681 1.229 . . . . 0.0 109.954 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.25 -29.26 48.0 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.824 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -93.54 5.8 50.39 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.25 29.43 68.71 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 118.265 -1.922 . . . . 0.0 109.629 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.2 -168.53 11.06 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -104.85 -53.9 2.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -1.059 . . . . 0.0 109.955 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.415 ' C ' HD22 ' A' ' 52' ' ' LEU . . . -176.74 178.21 48.02 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.568 HD21 HG21 ' A' ' 44' ' ' VAL . 3.9 mm? -98.88 135.05 40.87 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.377 -1.073 . . . . 0.0 110.261 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 54' ' ' ALA . 1.4 pt -112.11 139.01 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.664 -0.647 . . . . 0.0 109.392 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 53' ' ' ILE . . . 43.52 45.79 5.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.157 -0.964 . . . . 0.0 109.501 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.12 -27.17 28.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 0.0 109.209 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.643 HH22 ' CB ' ' B' ' 27' ' ' SER . 8.4 mmt180 -42.33 160.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.665 0.745 . . . . 0.0 109.891 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.669 ' H ' ' CD1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.769 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.6 p90 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.984 0.897 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.31 156.98 13.09 Favored Glycine 0 N--CA 1.487 2.091 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.284 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.8 m -98.29 135.39 39.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.193 -1.18 . . . . 0.0 108.617 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.4 mt -89.63 131.28 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 21' ' ' TYR . 5.4 m -138.5 167.7 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.664 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -150.94 150.86 31.33 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 19' ' ' GLN . . . -105.98 115.65 30.59 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.181 -0.949 . . . . 0.0 110.938 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.384 0.612 . . . . 0.0 109.596 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 88.9 t80 . . . . . 0 N--CA 1.501 2.092 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 14.9 mt -115.57 135.68 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.454 -0.779 . . . . 0.0 110.383 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.677 HD11 ' CD1' ' B' ' 55' ' ' PHE . 19.0 tt -134.46 114.09 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.9 t -123.01 159.59 28.06 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.377 -0.827 . . . . 0.0 108.926 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.0 p -101.68 72.72 1.39 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -177.01 -137.3 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.156 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 179.68 90.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.473 -0.767 . . . . 0.0 109.577 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . 0.401 ' HB3' ' HD3' ' B' ' 16' ' ' PRO . 32.5 mt-10 -156.85 -81.56 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.349 -0.844 . . . . 0.0 109.447 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.506 ' N ' ' HD3' ' B' ' 16' ' ' PRO . 8.2 mt 47.18 62.35 12.02 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.118 -0.989 . . . . 0.0 108.952 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' B' ' 15' ' ' ILE . 1.4 Cg_endo -65.97 155.63 68.53 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.997 1.798 . . . . 0.0 109.909 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.07 -10.65 74.42 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.308 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' LEU . . . . . 0.408 HD12 ' CG2' ' B' ' 15' ' ' ILE . 76.1 mt -124.89 137.28 54.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.08 -1.247 . . . . 0.0 108.638 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -101.45 116.41 32.72 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' B' ' 72' ' ' LYS . 0.2 OUTLIER -111.99 134.57 53.46 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.556 -0.715 . . . . 0.0 110.688 -177.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . 0.658 ' CD1' ' N ' ' B' ' 21' ' ' TYR . 0.0 OUTLIER -105.17 152.75 22.44 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.02 128.83 34.8 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.504 -0.747 . . . . 0.0 109.6 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 mt -113.17 7.06 17.77 Favored 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.03 -157.08 22.49 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 176.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -135.02 143.68 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.963 -0.728 . . . . 0.0 109.359 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.94 145.59 45.65 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.128 0.49 . . . . 0.0 109.738 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.643 ' CB ' HH22 ' A' ' 56' ' ' ARG . 0.0 OUTLIER -152.05 141.36 21.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.005 -1.059 . . . . 0.0 108.459 179.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 14.1 t -149.63 152.85 36.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.199 -0.938 . . . . 0.0 109.083 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 68.6 mt -126.8 133.1 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.2 -0.937 . . . . 0.0 109.375 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 34.2 t -165.59 166.06 18.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.438 -0.789 . . . . 0.0 109.338 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -96.63 70.95 2.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.238 -0.914 . . . . 0.0 109.645 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 169.31 129.04 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.44 ' CG2' ' N ' ' B' ' 34' ' ' ASP . 1.3 m -71.16 -43.62 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.44 ' N ' ' CG2' ' B' ' 33' ' ' VAL . 33.9 m-20 -63.76 -45.16 91.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.348 -0.845 . . . . 0.0 109.681 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -60.37 -39.18 86.31 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.678 -0.809 . . . . 0.0 108.872 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 48.5 mt -64.07 -51.89 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.92 . . . . 0.0 108.877 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -53.64 -48.31 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.977 . . . . 0.0 108.508 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -60.8 -40.26 91.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.335 -0.853 . . . . 0.0 110.102 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -64.36 -44.38 91.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 109.478 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' B' ' 40' ' ' LEU . 40.9 mt -68.45 -48.76 63.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.131 -0.981 . . . . 0.0 108.527 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -49.0 -48.58 43.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.846 -1.159 . . . . 0.0 108.945 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -62.19 -36.31 81.5 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.51 -0.744 . . . . 0.0 109.965 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -75.5 -35.96 60.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.385 -0.822 . . . . 0.0 109.668 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.75 -51.6 26.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.062 -1.024 . . . . 0.0 108.902 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -56.0 -28.73 58.47 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.669 1.223 . . . . 0.0 109.147 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.26 -28.33 59.78 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.385 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -96.42 -5.22 40.25 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.11 24.72 70.7 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 118.466 -1.825 . . . . 0.0 109.175 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.25 -171.11 9.25 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -112.36 -40.12 4.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.502 -0.999 . . . . 0.0 109.896 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 171.52 175.53 39.94 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.495 ' N ' ' CD2' ' B' ' 52' ' ' LEU . 2.3 mm? -96.99 133.85 41.13 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.378 -1.072 . . . . 0.0 109.942 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 49.7 mt -110.25 137.05 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.727 -0.608 . . . . 0.0 109.973 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 57.95 71.42 0.58 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.816 . . . . 0.0 109.815 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.677 ' CD1' HD11 ' B' ' 9' ' ' ILE . 2.0 t80 -58.38 -73.25 0.08 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.36 -0.837 . . . . 0.0 108.923 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' B' ' 55' ' ' PHE . 7.1 tpt180 58.01 113.61 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.411 -0.806 . . . . 0.0 110.157 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 46.7 tp . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -123.12 152.4 16.93 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -167.81 -175.48 2.76 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.473 -1.016 . . . . 0.0 109.399 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.0 -162.4 35.29 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 97.6 m -123.84 137.79 54.6 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 31.1 mt -83.81 125.49 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 6.5 m -136.94 164.18 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.824 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' B' ' 20' ' ' LEU . 3.0 mttt -136.1 146.67 47.26 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.33 -0.856 . . . . 0.0 108.879 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' B' ' 74' ' ' ASP . . . -114.88 116.75 29.05 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.81 -0.556 . . . . 0.0 110.235 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . 0.566 ' O ' ' OH ' ' B' ' 21' ' ' TYR . 5.5 t70 . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 121.774 0.797 . . . . 0.0 109.655 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 53.8 mttm . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -92.77 120.31 33.02 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.135 -0.978 . . . . 0.0 108.728 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 44.8 mt -119.45 128.57 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.513 -0.742 . . . . 0.0 109.788 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' ILE . . . . . 0.61 HG23 ' O ' ' C' ' 9' ' ' ILE . 13.4 tt -119.96 114.14 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -122.94 159.97 27.17 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . 0.432 HG22 ' H ' ' C' ' 55' ' ' PHE . 7.7 p -125.55 77.57 1.66 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.642 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.35 -117.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.398 -1.439 . . . . 0.0 108.371 -176.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -84.41 -134.27 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.136 -0.977 . . . . 0.0 109.796 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.75 28.93 5.54 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.529 -0.732 . . . . 0.0 109.862 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 33.2 mt 57.06 81.63 0.25 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.393 -0.817 . . . . 0.0 109.58 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.93 156.84 41.61 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 122.21 1.94 . . . . 0.0 110.37 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.18 -0.95 69.44 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.378 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 60.8 mt -131.52 138.99 49.17 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.111 -1.229 . . . . 0.0 109.155 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -97.54 109.55 22.29 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . 0.604 HD23 ' HB2' ' C' ' 73' ' ' ALA . 0.0 OUTLIER -120.2 143.97 47.97 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' TYR . . . . . 0.666 ' N ' ' CD1' ' C' ' 21' ' ' TYR . 0.0 OUTLIER -113.65 146.85 39.14 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.509 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -72.85 136.91 45.41 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.642 0.734 . . . . 0.0 109.999 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.437 HD12 HG22 ' C' ' 70' ' ' ILE . 5.8 mt -118.47 15.37 13.8 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.02 179.76 16.18 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 47.1 mm -112.3 142.26 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.795 -0.827 . . . . 0.0 108.826 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.38 144.17 43.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.528 -0.733 . . . . 0.0 109.899 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 35.4 t -152.31 137.66 17.57 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 15.2 t -149.62 152.3 35.22 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.055 -1.028 . . . . 0.0 109.369 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -102.15 155.02 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' C' ' 31' ' ' ASP . 12.1 t -176.19 -178.06 0.95 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.975 . . . . 0.0 109.225 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' ASP . . . . . 0.448 ' N ' ' OG ' ' C' ' 30' ' ' SER . 20.0 t70 -102.2 -80.78 0.5 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.411 -0.806 . . . . 0.0 110.971 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -65.08 144.12 57.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.996 -1.065 . . . . 0.0 108.731 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . 0.417 ' H ' HG13 ' C' ' 33' ' ' VAL . 1.4 m -69.47 -38.44 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -54.59 -28.16 44.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.459 -0.776 . . . . 0.0 109.848 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -76.23 -34.74 59.22 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.309 -0.869 . . . . 0.0 109.479 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 84.2 mt -58.76 -46.9 90.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.171 -0.955 . . . . 0.0 108.913 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 55.6 t -56.86 -49.57 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.952 -1.092 . . . . 0.0 108.637 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -61.8 -42.78 99.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.437 -0.789 . . . . 0.0 109.402 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -60.26 -48.67 80.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.535 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 67.2 mt -64.68 -42.9 95.03 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' ARG . . . . . 0.778 ' HG2' HH11 ' C' ' 41' ' ' ARG . 0.8 OUTLIER -48.2 -47.7 35.28 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.861 -1.15 . . . . 0.0 109.275 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -63.13 -31.83 73.06 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -73.8 -41.74 61.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.832 . . . . 0.0 109.518 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 38.1 t -68.29 -51.24 49.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.705 -1.247 . . . . 0.0 109.292 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -51.0 -33.44 24.84 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.642 1.211 . . . . 0.0 110.223 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.76 -28.83 50.72 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.678 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.55 7.31 43.8 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.48 29.77 64.11 Favored Glycine 0 N--CA 1.487 2.08 0 C-N-CA 118.672 -1.727 . . . . 0.0 109.759 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.26 148.9 27.14 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -65.23 -33.63 76.45 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.174 -1.192 . . . . 0.0 110.826 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 171.56 -159.04 30.47 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 11.4 tp -121.18 135.57 55.12 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.588 -0.948 . . . . 0.0 109.622 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 60.7 mt -110.87 144.03 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.492 -0.755 . . . . 0.0 110.022 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.12 82.64 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.232 -0.918 . . . . 0.0 110.713 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . 0.439 ' O ' ' CD2' ' C' ' 55' ' ' PHE . 82.5 t80 -126.9 65.79 1.28 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.332 0.587 . . . . 0.0 110.143 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' ARG . . . . . 0.744 ' HG2' HH11 ' C' ' 56' ' ' ARG . 7.7 mtt-85 -80.02 148.43 31.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 109.495 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 44.5 mm . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.828 . . . . 0.0 109.292 179.905 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' C' ' 67' ' ' TYR . 21.7 p90 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.571 0.701 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.38 165.34 32.85 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 95.1 m -117.05 141.46 48.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.294 -1.121 . . . . 0.0 108.925 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' ILE . . . . . 0.437 HG22 HD12 ' C' ' 23' ' ' LEU . 41.9 mt -95.09 133.48 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.443 -0.785 . . . . 0.0 109.019 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 10.6 m -144.26 156.15 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.41 -0.806 . . . . 0.0 109.608 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' LYS . . . . . 0.463 ' HG3' ' CE2' ' C' ' 21' ' ' TYR . 18.4 ptpt -142.33 140.06 32.0 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.26 -0.9 . . . . 0.0 108.691 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.604 ' HB2' HD23 ' C' ' 20' ' ' LEU . . . -126.67 152.96 46.03 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.761 -1.212 . . . . 0.0 108.503 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' C' ' 73' ' ' ALA . 27.1 t70 . . . . . 0 N--CA 1.499 1.989 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 mtpt . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -114.77 121.96 44.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.493 -0.754 . . . . 0.0 109.555 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 51.6 mt -101.65 131.39 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.445 -0.784 . . . . 0.0 109.477 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 9' ' ' ILE . . . . . 0.664 HD11 ' CD2' ' D' ' 55' ' ' PHE . 18.7 tt -124.42 119.89 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 6.0 t -116.35 132.19 56.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.341 -0.85 . . . . 0.0 109.228 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . 0.729 ' OG1' ' OG1' ' E' ' 69' ' ' THR . 8.6 m -67.74 -117.83 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 12' ' ' ALA . . . . . 0.659 ' C ' ' O ' ' D' ' 11' ' ' THR . . . -2.39 -98.83 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.504 0 CA-C-N 118.318 0.508 . . . . 0.0 110.357 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' D' ' 12' ' ' ALA . 3.5 p30 161.91 91.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? 176.65 128.99 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.503 -0.748 . . . . 0.0 109.864 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 35.5 mt -143.46 69.34 17.44 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.26 155.49 56.53 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.928 1.752 . . . . 0.0 110.284 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.63 -4.73 76.41 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' D' ' 18' ' ' LEU . 15.7 mt -129.88 138.64 51.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -1.193 . . . . 0.0 109.967 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -83.74 108.39 16.76 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 mt -103.3 138.88 39.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.463 -0.773 . . . . 0.0 110.425 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' TYR . . . . . 0.473 ' CE1' ' O ' ' D' ' 22' ' ' SER . 1.4 t80 -121.39 129.94 53.32 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . 0.473 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 21.5 t -67.37 133.1 48.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.987 -1.07 . . . . 0.0 111.478 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 mt -123.74 12.42 9.18 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.34 176.03 19.33 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -109.78 144.33 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.905 -0.762 . . . . 0.0 109.567 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.56 154.1 30.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.663 -0.648 . . . . 0.0 109.556 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 6.6 p -152.51 137.29 17.04 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 12.5 t -149.44 151.36 33.87 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.077 -1.014 . . . . 0.0 109.63 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 6.4 mt -102.99 155.26 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 120.924 -1.11 . . . . 0.0 108.658 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.516 ' O ' ' N ' ' D' ' 32' ' ' ASN . 0.6 OUTLIER 176.13 -20.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.04 -1.037 . . . . 0.0 110.403 179.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 62.8 -41.39 0.18 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.777 -0.577 . . . . 0.0 111.465 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.541 ' O ' HG13 ' D' ' 36' ' ' ILE . 7.8 t-20 -85.86 141.22 29.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.972 -1.08 . . . . 0.0 109.28 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . 0.4 ' H ' HG23 ' D' ' 33' ' ' VAL . 3.0 t -68.41 -41.6 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.874 -1.141 . . . . 0.0 110.612 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -54.53 -43.97 72.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.39 -0.819 . . . . 0.0 110.238 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -76.8 -36.64 56.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.426 -0.797 . . . . 0.0 109.678 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . 0.645 HG22 ' CE1' ' D' ' 55' ' ' PHE . 96.8 mt -61.69 -41.52 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.961 -1.087 . . . . 0.0 108.623 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.416 HG23 ' CZ ' ' D' ' 55' ' ' PHE . 13.6 t -69.39 -46.37 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.665 -1.272 . . . . 0.0 108.954 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -66.98 -44.34 80.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.397 -0.814 . . . . 0.0 110.793 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -55.04 -48.5 73.36 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.041 -1.037 . . . . 0.0 109.659 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 38.8 mt -64.85 -37.79 88.81 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.297 -0.877 . . . . 0.0 109.287 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -54.53 -43.8 72.25 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.614 -1.304 . . . . 0.0 109.73 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm -67.62 -40.07 84.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.3 -0.875 . . . . 0.0 110.373 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -75.79 -36.14 59.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.86 . . . . 0.0 109.755 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.83 -50.07 73.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.049 -1.032 . . . . 0.0 109.333 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -65.25 -30.71 71.61 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 118.411 -1.316 . . . . 0.0 108.743 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.33 -28.46 66.26 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.554 0.692 . . . . 0.0 109.267 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -93.09 -6.55 47.82 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.469 -0.769 . . . . 0.0 109.514 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.16 30.06 15.45 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.145 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.77 155.55 18.29 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.39 -9.1 9.53 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.466 -1.02 . . . . 0.0 109.282 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.94 162.74 30.62 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 4.1 tp -130.47 140.32 50.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.632 -0.923 . . . . 0.0 109.769 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 53' ' ' ILE . . . . . 0.458 ' O ' ' HB3' ' D' ' 54' ' ' ALA . 13.9 mt -108.48 138.39 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 65.63 76.71 0.32 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.314 -0.867 . . . . 0.0 109.779 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . 0.664 ' CD2' HD11 ' D' ' 9' ' ' ILE . 84.1 t80 -99.06 138.89 35.52 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.49 -0.756 . . . . 0.0 110.313 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' ARG . . . . . 0.661 ' O ' ' CE2' ' D' ' 55' ' ' PHE . 26.7 ttp180 . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 30.4 p90 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.625 0.726 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.24 152.32 11.01 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.544 -1.312 . . . . 0.0 110.327 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 48.9 m -94.04 134.5 36.38 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.009 -1.289 . . . . 0.0 108.458 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 44.5 mt -84.81 127.58 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 71' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' D' ' 21' ' ' TYR . 4.3 m -135.38 159.31 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 110.218 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 10.6 pttp -152.25 148.6 27.76 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.76 150.72 26.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.23 -0.919 . . . . 0.0 108.852 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 p30 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.023 -1.048 . . . . 0.0 109.393 179.41 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -97.92 123.08 41.74 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.355 -0.841 . . . . 0.0 109.416 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 34.0 mt -111.67 135.33 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.459 -0.776 . . . . 0.0 109.591 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 9' ' ' ILE . . . . . 0.6 HG23 ' O ' ' E' ' 9' ' ' ILE . 10.5 tt -132.43 115.76 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 4.1 t -124.0 155.87 37.46 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 11' ' ' THR . . . . . . . . . . . . . 2.0 p -115.95 89.45 3.11 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.74 -95.57 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.987 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -160.14 -35.9 0.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.4 -0.813 . . . . 0.0 109.426 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . 0.411 ' CG ' ' N ' ' E' ' 15' ' ' ILE . 29.7 tt0 -166.71 167.32 15.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 109.302 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 15' ' ' ILE . . . . . 0.411 ' N ' ' CG ' ' E' ' 14' ' ' GLU . 87.0 mt -115.73 92.75 35.03 Favored Pre-proline 0 N--CA 1.496 1.843 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.12 155.28 51.75 Favored 'Trans proline' 0 C--N 1.322 -0.85 0 C-N-CA 121.912 1.741 . . . . 0.0 110.318 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.9 -10.19 75.05 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 18' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' E' ' 18' ' ' LEU . 20.4 mt -127.59 138.95 53.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -1.1 . . . . 0.0 109.52 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -84.45 108.68 17.38 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 14.1 mt -96.99 142.97 28.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.389 -0.82 . . . . 0.0 110.752 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 21' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -126.36 130.15 50.21 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.77 129.37 39.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.733 -1.23 . . . . 0.0 110.793 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.899 HD11 ' HB2' ' E' ' 72' ' ' LYS . 97.6 mt -114.41 3.9 15.14 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.3 -172.9 19.68 Favored Glycine 0 N--CA 1.499 2.9 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . 0.471 HD11 HG23 ' D' ' 9' ' ' ILE . 39.6 mm -110.39 140.87 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.798 -0.825 . . . . 0.0 109.32 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.3 146.93 44.86 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.646 -0.659 . . . . 0.0 109.313 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 40.5 m -152.59 148.41 27.31 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.907 -1.121 . . . . 0.0 108.916 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . 0.459 ' OG1' HG23 ' E' ' 36' ' ' ILE . 25.2 p -148.88 134.15 18.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.45 -0.781 . . . . 0.0 109.337 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' E' ' 30' ' ' SER . 87.5 mt -126.53 127.83 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' E' ' 29' ' ' ILE . 3.6 t 162.51 14.43 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 31' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' E' ' 31' ' ' ASP . 1.4 m-20 51.55 -174.23 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.125 -0.984 . . . . 0.0 109.02 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 32' ' ' ASN . . . . . . . . . . . . . 8.0 m120 68.1 100.18 0.05 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 45.0 t -69.16 -37.27 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.211 -0.931 . . . . 0.0 109.5 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -57.52 -42.14 82.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 110.029 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.79 -38.18 58.48 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.287 -0.883 . . . . 0.0 109.42 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 36' ' ' ILE . . . . . 0.459 HG23 ' OG1' ' E' ' 28' ' ' THR . 55.9 mt -63.51 -51.71 67.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.03 -1.044 . . . . 0.0 109.534 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 57.6 t -51.8 -51.14 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.082 -1.011 . . . . 0.0 109.125 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.07 -38.06 78.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -0.869 . . . . 0.0 109.409 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -63.66 -40.81 97.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.122 -0.986 . . . . 0.0 109.511 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 40' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' E' ' 40' ' ' LEU . 41.6 mt -68.49 -44.45 74.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.148 -0.97 . . . . 0.0 109.338 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -51.43 -37.71 49.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.653 -1.28 . . . . 0.0 109.596 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -73.71 -39.46 64.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.59 -0.694 . . . . 0.0 109.831 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -75.98 -35.79 59.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.371 -0.831 . . . . 0.0 109.67 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 11.5 t -67.32 -50.92 58.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 109.055 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -70.4 -36.88 74.33 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.315 -1.354 . . . . 0.0 109.035 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.45 -31.26 69.14 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -87.89 -5.25 58.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.412 -0.805 . . . . 0.0 109.809 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.21 5.54 58.11 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.03 161.23 48.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.99 -3.2 5.15 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.086 -1.243 . . . . 0.0 109.893 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.82 149.45 12.54 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 4.6 tp -108.64 139.96 42.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.675 -0.897 . . . . 0.0 109.595 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 53' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 1.0 OUTLIER -111.67 142.85 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.567 -0.708 . . . . 0.0 110.255 -178.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 62.24 75.87 0.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 110.131 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 55' ' ' PHE . . . . . 0.482 ' O ' ' CG ' ' E' ' 55' ' ' PHE . 58.7 t80 -104.65 23.95 12.54 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 56' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -54.82 149.16 11.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.84 . . . . 0.0 109.242 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 65.0 mt . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.932 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 37.2 p90 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.394 0.616 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.46 165.12 35.4 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 69' ' ' THR . . . . . 0.729 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 30.5 m -113.7 139.67 48.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.639 -0.918 . . . . 0.0 108.757 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 70' ' ' ILE . . . . . 0.546 HG22 HD12 ' E' ' 23' ' ' LEU . 43.3 mt -84.93 146.44 6.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 m -139.42 154.4 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.206 -0.934 . . . . 0.0 109.942 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 72' ' ' LYS . . . . . 0.899 ' HB2' HD11 ' E' ' 23' ' ' LEU . 33.0 ttpt -143.47 151.81 40.76 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.13 150.53 35.86 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.419 -0.801 . . . . 0.0 108.957 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.102 -0.999 . . . . 0.0 109.132 179.254 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.9 t80 . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 57.0 mt -136.82 139.18 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.383 -0.823 . . . . 0.0 109.461 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.537 ' O ' HG23 ' A' ' 9' ' ' ILE . 13.9 tt -121.38 115.6 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.2 t -127.01 147.02 50.15 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.109 -0.994 . . . . 0.0 108.509 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.574 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -66.84 -110.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 177.111 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.519 ' N ' ' OG1' ' A' ' 11' ' ' THR . . . -33.0 -88.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.724 -0.61 . . . . 0.0 110.186 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 1.3 p-10 -170.33 -92.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.951 -1.093 . . . . 0.0 109.086 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.463 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 30.0 mt-10 74.71 -135.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.699 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 2.6 mt 65.01 46.41 0.54 Allowed Pre-proline 0 N--CA 1.486 1.351 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -176.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.699 ' HD3' ' N ' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -66.08 151.77 82.96 Favored 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 121.431 1.421 . . . . 0.0 110.003 179.184 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.16 -5.38 78.34 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.118 -1.515 . . . . 0.0 111.122 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 18' ' ' LEU . 59.7 mt -124.77 137.07 54.34 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.792 -1.416 . . . . 0.0 108.503 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.716 ' NE2' ' H ' ' A' ' 19' ' ' GLN . 0.7 OUTLIER -90.14 113.41 25.16 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.46 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 3.3 mt -107.22 128.18 54.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.701 -0.624 . . . . 0.0 110.106 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.581 ' N ' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -109.86 157.88 18.75 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.3 t -81.56 126.45 31.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.478 -0.764 . . . . 0.0 109.618 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.712 HD11 ' CB ' ' A' ' 72' ' ' LYS . 16.4 mt -108.95 2.5 21.41 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.94 177.65 14.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.46 141.5 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.82 144.77 42.99 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.1 t -152.57 138.07 17.69 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.9 t -149.8 150.4 31.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.028 -1.045 . . . . 0.0 108.997 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.93 131.88 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 31' ' ' ASP . 14.3 p -172.5 13.47 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.324 -0.86 . . . . 0.0 109.576 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 30' ' ' SER . 37.1 t70 57.35 154.44 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.63 -0.669 . . . . 0.0 110.196 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER 73.84 111.2 0.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.082 -1.011 . . . . 0.0 108.567 -178.298 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.88 -33.54 62.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.358 -0.839 . . . . 0.0 109.354 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -52.52 -35.98 54.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 85.4 mt-10 -78.44 -33.88 48.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 108.809 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.0 mt -65.07 -53.82 36.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 120.961 -1.087 . . . . 0.0 108.937 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 t -58.06 -50.32 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.085 -1.009 . . . . 0.0 108.348 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -61.26 -41.27 96.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.565 -0.709 . . . . 0.0 109.761 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 35' ' ' GLU . 17.9 m120 -66.64 -42.52 86.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 0.0 109.329 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 40' ' ' LEU . 70.2 mt -62.49 -42.67 99.65 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.107 -0.995 . . . . 0.0 108.448 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -48.06 -56.4 7.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.625 -1.297 . . . . 0.0 109.389 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 93.8 mttt -57.34 -35.41 69.87 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.288 -0.882 . . . . 0.0 110.249 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.27 -35.53 58.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.791 . . . . 0.0 109.903 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.5 t -72.19 -51.29 30.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.187 -0.946 . . . . 0.0 108.834 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -69.6 -31.47 69.62 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 117.942 -1.503 . . . . 0.0 108.962 -175.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 42' ' ' LYS . . . -62.22 -31.12 71.62 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.7 mtpt -95.64 -3.83 45.51 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.36 27.6 47.61 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 118.864 -1.636 . . . . 0.0 109.751 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.18 -166.67 34.41 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -109.78 -46.65 3.46 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.53 -0.982 . . . . 0.0 109.851 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 174.98 -152.08 13.2 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -129.07 140.27 51.66 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.677 -0.896 . . . . 0.0 109.886 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.781 ' O ' HD13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -121.81 150.15 25.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.941 -0.474 . . . . 0.0 109.854 -178.167 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 11' ' ' THR . . . 73.5 108.5 0.07 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.996 -1.065 . . . . 0.0 111.301 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -127.07 148.38 50.14 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.504 0.669 . . . . 0.0 109.86 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.708 ' HE ' ' NH1' ' B' ' 56' ' ' ARG . 19.3 ttt180 -131.72 -31.57 1.54 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.457 0.646 . . . . 0.0 109.446 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.297 -1.689 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 33.7 p90 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.559 0.695 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.58 161.23 32.07 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.602 ' CB ' ' HG1' ' E' ' 11' ' ' THR . 80.8 m -107.8 140.0 41.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.265 -1.138 . . . . 0.0 108.862 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.515 HG22 HD12 ' A' ' 23' ' ' LEU . 54.8 mt -88.55 129.77 39.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 20' ' ' LEU . 15.7 m -132.75 155.04 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.498 -0.751 . . . . 0.0 109.602 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.712 ' CB ' HD11 ' A' ' 23' ' ' LEU . 10.4 tttp -142.61 147.91 36.6 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.176 -0.953 . . . . 0.0 109.245 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.87 151.04 39.49 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.339 -0.851 . . . . 0.0 108.807 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.102 -0.999 . . . . 0.0 108.702 179.269 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 66.7 t80 . . . . . 0 N--CA 1.505 2.323 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 68.0 mt -112.89 128.37 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.507 -0.746 . . . . 0.0 109.985 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' B' ' 52' ' ' LEU . 2.9 tt -131.67 114.67 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.478 HG22 HG22 ' B' ' 53' ' ' ILE . 4.5 t -122.46 158.59 29.42 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.308 1.051 . . . . 0.0 109.272 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.475 HG23 ' OG1' ' C' ' 69' ' ' THR . 9.3 p -90.64 -105.84 0.1 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 42.72 -112.72 0.21 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.121 -0.987 . . . . 0.0 110.901 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -165.82 -20.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.271 -0.893 . . . . 0.0 109.909 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . 0.465 ' CG ' ' N ' ' B' ' 15' ' ' ILE . 67.3 tt0 -167.33 166.63 14.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.117 -0.99 . . . . 0.0 109.25 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.465 ' N ' ' CG ' ' B' ' 14' ' ' GLU . 61.5 mt -114.58 93.0 30.96 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -61.61 155.01 55.92 Favored 'Trans proline' 0 C--N 1.323 -0.803 0 C-N-CA 121.787 1.658 . . . . 0.0 110.485 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.88 -6.38 79.38 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 43.1 mt -132.17 141.43 49.1 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.474 -1.015 . . . . 0.0 109.699 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . 0.448 ' CG ' ' O ' ' B' ' 19' ' ' GLN . 2.5 pt20 -84.91 109.62 18.27 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 mt -102.57 136.71 41.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.953 -1.092 . . . . 0.0 109.437 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' B' ' 22' ' ' SER . 0.8 OUTLIER -121.39 130.46 53.61 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.56 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 40.2 t -60.2 129.3 41.01 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.035 0.921 . . . . 0.0 111.691 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 11.2 mt -114.08 12.09 17.82 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.33 -166.2 13.22 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 mm -120.13 134.74 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.06 149.41 38.95 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.487 -0.758 . . . . 0.0 109.917 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 7.7 t -152.6 140.85 20.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.2 -0.937 . . . . 0.0 109.384 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 4.3 t -149.62 146.46 27.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.296 -0.877 . . . . 0.0 109.167 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 31.3 mt -127.7 131.75 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 53.8 m -155.91 14.77 0.34 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.993 -1.067 . . . . 0.0 110.306 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 72.36 -70.03 0.17 Allowed 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -76.81 140.42 40.68 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.993 -1.067 . . . . 0.0 108.153 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.471 HG11 ' OH ' ' C' ' 67' ' ' TYR . 96.7 t -69.05 -37.46 77.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.523 -0.736 . . . . 0.0 109.806 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.22 -36.27 51.7 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.356 -0.84 . . . . 0.0 110.516 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.08 -32.85 39.21 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.278 -0.889 . . . . 0.0 109.618 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 35.0 mt -62.27 -53.58 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.275 -0.89 . . . . 0.0 109.045 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 23.4 t -56.99 -49.8 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.229 -0.919 . . . . 0.0 108.59 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -60.95 -39.71 90.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.407 -0.808 . . . . 0.0 110.108 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -64.05 -43.43 95.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.164 -0.96 . . . . 0.0 109.594 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' B' ' 40' ' ' LEU . 18.8 mt -64.81 -43.05 94.42 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.115 -0.99 . . . . 0.0 109.185 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -49.94 -40.99 45.37 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.584 -1.323 . . . . 0.0 109.923 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -70.31 -37.11 74.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.605 -0.685 . . . . 0.0 110.051 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -76.5 -35.35 58.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.46 -0.775 . . . . 0.0 109.677 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 3.0 t -66.5 -50.3 68.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.134 -0.979 . . . . 0.0 108.913 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -65.45 -30.1 70.85 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.044 -1.462 . . . . 0.0 109.142 -175.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.93 -29.83 68.17 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.488 0.661 . . . . 0.0 109.312 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 mmmt -86.56 -5.47 59.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.627 -0.67 . . . . 0.0 109.517 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.01 5.38 62.54 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.66 164.32 50.5 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -128.65 -3.62 5.33 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.093 -1.24 . . . . 0.0 110.075 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.31 143.57 8.67 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' B' ' 9' ' ' ILE . 8.8 tp -108.23 141.87 39.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.582 -0.952 . . . . 0.0 109.659 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.478 HG22 HG22 ' B' ' 10' ' ' THR . 11.6 pt -142.66 172.07 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.789 -1.194 . . . . 0.0 108.876 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.35 33.01 22.75 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.518 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.6 120.41 30.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.788 -1.195 . . . . 0.0 108.612 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' ARG . . . . . 0.708 ' NH1' ' HE ' ' A' ' 56' ' ' ARG . 39.4 ttp180 -105.13 166.8 10.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.419 -0.801 . . . . 0.0 109.626 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.805 HD11 ' CE1' ' C' ' 67' ' ' TYR . 16.5 mm . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.396 -0.815 . . . . 0.0 109.407 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.628 ' N ' HD23 ' B' ' 65' ' ' LEU . 1.5 pt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.62 126.18 8.15 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' TYR . . . . . 0.482 ' O ' ' CG ' ' B' ' 67' ' ' TYR . 7.7 p90 -122.75 129.03 51.28 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.579 -0.954 . . . . 0.0 109.053 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.87 151.55 23.26 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m -104.48 143.76 32.59 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.303 -1.116 . . . . 0.0 108.79 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 49.2 mt -90.01 143.26 11.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.61 164.91 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.931 . . . . 0.0 110.02 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -154.08 157.31 38.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.538 -0.726 . . . . 0.0 109.236 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.33 150.7 38.38 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.165 -0.96 . . . . 0.0 108.605 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 8.5 t70 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.95 -1.094 . . . . 0.0 109.453 179.658 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . 0.458 ' CG ' ' H ' ' C' ' 7' ' ' PHE . 42.1 tttm . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.475 0.655 . . . . 0.0 109.658 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' PHE . . . . . 0.458 ' H ' ' CG ' ' C' ' 6' ' ' LYS . 67.6 t80 -92.75 124.33 36.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.423 -0.798 . . . . 0.0 109.778 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 64.3 mt -115.24 143.26 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.481 -0.762 . . . . 0.0 110.045 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' ILE . . . . . 0.59 HG23 ' O ' ' C' ' 9' ' ' ILE . 11.2 tt -137.49 117.62 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.511 -0.743 . . . . 0.0 109.483 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.528 HG22 HG22 ' C' ' 53' ' ' ILE . 1.0 OUTLIER -120.91 147.04 45.97 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.643 1.211 . . . . 0.0 107.938 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' THR . . . . . 0.433 HG23 ' O ' ' C' ' 11' ' ' THR . 4.4 t -86.87 55.58 3.63 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.169 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -177.83 -124.77 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 119.955 -1.716 . . . . 0.0 108.321 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.82 108.4 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.229 -0.92 . . . . 0.0 109.002 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -163.49 -100.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.155 -0.965 . . . . 0.0 109.751 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' ILE . . . . . 0.491 ' N ' ' HD3' ' C' ' 16' ' ' PRO . 5.3 mt 57.23 61.23 6.53 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.825 . . . . 0.0 109.285 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' C' ' 15' ' ' ILE . 2.2 Cg_endo -63.67 155.37 63.64 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 122.195 1.93 . . . . 0.0 109.618 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.29 -17.11 57.11 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' C' ' 18' ' ' LEU . 51.5 mt -117.04 135.74 53.49 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.098 -1.236 . . . . 0.0 108.807 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -86.41 108.6 18.56 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 11.3 mt -93.2 136.66 33.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.305 -0.872 . . . . 0.0 109.724 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -118.52 130.27 55.83 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 9.3 t -58.06 131.41 50.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.779 -1.2 . . . . 0.0 111.102 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 mt -120.36 11.59 11.5 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.74 -179.95 19.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' ILE . . . . . 0.481 HD13 ' N ' ' C' ' 25' ' ' ILE . 0.0 OUTLIER -113.43 141.06 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 122.007 -0.701 . . . . 0.0 109.465 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.48 146.46 38.4 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 6.5 p -151.9 139.77 19.97 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.991 -1.068 . . . . 0.0 108.53 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 15.0 t -149.92 138.63 20.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.012 -1.055 . . . . 0.0 108.813 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.413 HG23 ' O ' ' C' ' 29' ' ' ILE . 11.6 tt -105.18 130.44 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.925 . . . . 0.0 109.068 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 91.8 p -168.97 -145.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.039 -1.038 . . . . 0.0 109.668 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' ASP . . . . . 0.465 ' O ' ' CB ' ' C' ' 32' ' ' ASN . 21.3 t0 -150.73 153.96 36.5 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.204 -0.935 . . . . 0.0 109.523 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' C' ' 31' ' ' ASP . 3.7 t-20 77.15 129.26 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 108.748 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 45.2 t -66.58 -31.94 55.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.56 -0.712 . . . . 0.0 109.466 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -56.75 -42.6 79.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.821 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -75.97 -38.37 57.57 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.206 -0.933 . . . . 0.0 109.301 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 79.2 mt -59.81 -42.1 87.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 120.819 -1.175 . . . . 0.0 109.336 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.1 -43.91 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.718 -1.238 . . . . 0.0 109.092 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -66.33 -46.88 75.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.381 -0.824 . . . . 0.0 110.189 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -56.08 -49.67 73.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.071 -1.018 . . . . 0.0 109.682 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 84.2 mt -67.85 -44.71 76.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.128 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -50.73 -43.09 57.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.714 -1.241 . . . . 0.0 109.797 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -65.97 -36.26 82.83 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.797 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -76.39 -35.36 58.67 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.798 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 t -68.52 -50.85 52.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.952 -1.093 . . . . 0.0 109.079 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -59.55 -29.73 68.12 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.567 -1.253 . . . . 0.0 109.882 -175.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.3 -29.24 61.54 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.791 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -85.5 8.53 18.84 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.37 3.04 81.66 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.33 162.32 54.53 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . 0.419 ' C ' ' SD ' ' C' ' 50' ' ' MET . 0.0 OUTLIER -131.17 -3.09 3.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.128 -1.219 . . . . 0.0 110.222 -177.189 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.5 127.85 1.81 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.245 -1.455 . . . . 0.0 110.01 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 53.5 tp -96.45 139.19 32.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.553 -0.969 . . . . 0.0 108.844 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' ILE . . . . . 0.543 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 26.7 pt -144.01 173.26 5.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.788 -1.195 . . . . 0.0 108.313 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 70.99 77.22 0.18 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.936 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . 0.439 ' CE2' ' OH ' ' D' ' 67' ' ' TYR . 0.2 OUTLIER -80.08 154.4 28.13 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.122 -0.986 . . . . 0.0 109.333 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' ARG . . . . . 0.622 ' CG ' HH11 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -136.78 46.36 2.22 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.56 -0.712 . . . . 0.0 109.957 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.299 -1.619 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' TYR . . . . . 0.805 ' CE1' HD11 ' B' ' 57' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 122.082 0.944 . . . . 0.0 109.866 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.02 140.99 6.61 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' THR . . . . . 0.475 ' OG1' HG23 ' B' ' 11' ' ' THR . 3.4 m -90.12 135.53 33.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.868 -1.372 . . . . 0.0 107.775 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 47.3 mt -86.1 145.15 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 m -144.73 162.9 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.966 . . . . 0.0 110.229 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -152.37 147.03 25.82 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.96 140.58 39.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.923 -1.111 . . . . 0.0 108.012 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 42.2 t0 . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.245 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.676 0.75 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -108.54 121.93 46.02 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 28.2 mt -133.82 129.73 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.365 -0.834 . . . . 0.0 109.928 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 9' ' ' ILE . . . . . 0.633 HG23 ' O ' ' D' ' 9' ' ' ILE . 13.4 tt -137.15 114.19 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.56 160.75 27.67 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 11' ' ' THR . . . . . 0.547 ' OG1' ' OG1' ' E' ' 69' ' ' THR . 1.2 p -121.43 83.53 2.1 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.34 -134.26 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.331 -0.855 . . . . 0.0 109.099 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -99.79 -56.27 2.43 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.374 -0.829 . . . . 0.0 109.774 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -161.85 -171.05 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.124 -0.985 . . . . 0.0 109.444 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 68.4 mt -123.53 87.81 51.97 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.542 -0.724 . . . . 0.0 109.113 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.67 155.19 55.2 Favored 'Trans proline' 0 C--N 1.323 -0.781 0 C-N-CA 121.927 1.751 . . . . 0.0 110.305 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.14 -9.76 75.74 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' D' ' 18' ' ' LEU . 43.9 mt -128.0 139.01 52.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.118 -1.225 . . . . 0.0 109.27 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -85.2 108.05 17.54 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 12.2 mt -99.45 134.92 41.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.448 -0.783 . . . . 0.0 109.502 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' TYR . . . . . 0.497 ' CE1' ' O ' ' D' ' 22' ' ' SER . 0.8 OUTLIER -116.68 129.99 56.46 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . 0.497 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 0.0 OUTLIER -61.87 128.34 35.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.771 -1.206 . . . . 0.0 110.517 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' D' ' 23' ' ' LEU . 8.3 mt -114.6 7.6 16.1 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.2 -179.54 17.06 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 49.6 mm -111.95 142.33 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.733 -0.863 . . . . 0.0 108.927 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.12 143.99 44.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.69 -0.631 . . . . 0.0 109.679 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 98.8 p -152.71 136.04 15.84 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 14.6 t -149.81 150.88 32.65 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.916 -1.115 . . . . 0.0 109.327 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 47.3 mm -113.39 139.86 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.322 -0.861 . . . . 0.0 109.555 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' SER . . . . . 0.557 ' OG ' ' N ' ' D' ' 31' ' ' ASP . 1.4 t -175.72 -171.66 0.48 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.384 -0.822 . . . . 0.0 108.938 -178.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' ASP . . . . . 0.557 ' N ' ' OG ' ' D' ' 30' ' ' SER . 1.3 p30 -124.86 145.08 49.97 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.495 -0.753 . . . . 0.0 109.415 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' D' ' 31' ' ' ASP . 1.5 m-20 78.21 133.18 0.06 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.604 0.716 . . . . 0.0 109.333 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.29 -31.27 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.547 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -56.95 -42.5 80.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 110.112 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -76.2 -38.89 55.91 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.338 -0.851 . . . . 0.0 109.486 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.04 -46.88 92.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.847 -1.158 . . . . 0.0 109.416 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.37 -51.53 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.97 -1.081 . . . . 0.0 110.01 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -55.99 -36.18 67.59 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 109.643 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -67.25 -42.4 84.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.105 -0.997 . . . . 0.0 110.091 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' D' ' 40' ' ' LEU . 44.8 mt -69.05 -46.51 67.69 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.981 -1.074 . . . . 0.0 108.724 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -47.16 -55.91 7.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.72 -1.237 . . . . 0.0 109.456 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -54.98 -33.44 62.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.215 -0.928 . . . . 0.0 110.408 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -77.35 -35.02 54.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.365 -0.834 . . . . 0.0 109.975 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 t -68.6 -51.4 46.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.038 -1.038 . . . . 0.0 108.904 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -67.78 -33.85 75.63 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 117.988 -1.485 . . . . 0.0 109.415 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.38 -32.83 72.76 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 mmtm -87.76 -4.94 58.86 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.41 -0.806 . . . . 0.0 109.125 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.56 9.39 64.72 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.16 175.92 54.35 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.14 2.45 0.77 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.897 -1.355 . . . . 0.0 110.143 -175.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.18 160.12 33.05 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.575 -1.297 . . . . 0.0 109.958 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 7.0 tp -130.06 139.12 51.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.724 -0.868 . . . . 0.0 109.339 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 53' ' ' ILE . . . . . . . . . . . . . 23.9 mt -114.04 141.15 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.644 -0.66 . . . . 0.0 110.242 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 63.1 79.55 0.26 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.341 -0.85 . . . . 0.0 111.904 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . 0.536 ' O ' ' CG ' ' D' ' 55' ' ' PHE . 56.0 t80 -107.22 35.91 2.88 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.51 0.671 . . . . 0.0 110.279 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' ARG . . . . . 0.877 HH11 ' HG3' ' D' ' 56' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.301 -1.54 0 O-C-N 120.961 -1.087 . . . . 0.0 109.911 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 67' ' ' TYR . . . . . 0.439 ' OH ' ' CE2' ' C' ' 55' ' ' PHE . 62.8 t80 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.827 0.823 . . . . 0.0 110.008 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.58 155.67 21.54 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 54.3 m -106.52 140.12 39.91 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.443 -1.034 . . . . 0.0 108.806 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 70' ' ' ILE . . . . . 0.404 HD13 HG21 ' D' ' 70' ' ' ILE . 33.3 mt -90.25 137.68 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 m -144.39 166.28 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.82 . . . . 0.0 109.501 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.78 150.36 27.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.95 151.65 37.02 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.174 -0.954 . . . . 0.0 108.6 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 120.907 -1.121 . . . . 0.0 109.59 179.654 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 121.421 0.629 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -115.17 150.55 35.88 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 42.5 mt -129.25 137.61 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.506 -0.746 . . . . 0.0 109.147 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 9' ' ' ILE . . . . . 0.594 HG23 ' O ' ' E' ' 9' ' ' ILE . 17.5 tt -123.91 117.12 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 13.2 t -126.05 148.94 49.2 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 11' ' ' THR . . . . . 0.602 ' HG1' ' CB ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -76.19 -119.21 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 12' ' ' ALA . . . . . 0.406 ' H ' ' HB ' ' E' ' 11' ' ' THR . . . -111.35 98.5 7.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.312 -0.868 . . . . 0.0 109.68 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 13' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' E' ' 13' ' ' ASP . 20.3 p-10 -163.22 -7.09 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.694 -0.629 . . . . 0.0 109.475 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 59.8 163.59 0.05 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.599 -0.688 . . . . 0.0 109.468 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 18.4 mt -124.98 84.01 59.47 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.85 156.25 44.63 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 122.002 1.801 . . . . 0.0 110.095 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.63 -9.92 74.94 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 18' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' E' ' 18' ' ' LEU . 65.7 mt -126.96 137.86 53.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.075 -1.25 . . . . 0.0 108.821 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 19' ' ' GLN . . . . . 0.443 ' H ' ' HG2' ' E' ' 19' ' ' GLN . 7.8 pt20 -86.86 110.61 20.09 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 11.7 mt -92.1 135.2 34.16 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.969 -1.082 . . . . 0.0 109.592 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 21' ' ' TYR . . . . . 0.467 ' CE1' ' O ' ' E' ' 22' ' ' SER . 1.0 OUTLIER -117.83 129.82 55.89 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 22' ' ' SER . . . . . 0.467 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 0.0 OUTLIER -63.97 129.95 42.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.779 -1.201 . . . . 0.0 111.259 -179.252 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' E' ' 23' ' ' LEU . 13.1 mt -120.09 12.52 11.92 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.68 -155.41 16.22 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 25' ' ' ILE . . . . . 0.418 HG21 HD13 ' E' ' 25' ' ' ILE . 0.7 OUTLIER -135.34 144.12 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.979 -0.718 . . . . 0.0 109.596 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.03 144.11 44.13 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 38.5 t -152.14 138.95 18.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.053 -1.029 . . . . 0.0 108.455 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.54 153.43 37.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.082 -1.011 . . . . 0.0 109.033 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 71.0 mt -124.9 130.98 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.193 -0.942 . . . . 0.0 109.276 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 31.2 t -163.09 167.85 21.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.393 -0.817 . . . . 0.0 109.664 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 31' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' E' ' 31' ' ' ASP . 16.4 p-10 -81.38 -65.55 1.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.404 -0.81 . . . . 0.0 112.628 -177.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 32' ' ' ASN . . . . . 0.459 ' H ' ' CG ' ' E' ' 31' ' ' ASP . 6.3 t-20 -78.28 147.62 34.24 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.711 -1.243 . . . . 0.0 109.05 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 73.3 t -68.88 -31.18 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.564 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -54.09 -34.09 59.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 109.734 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 35' ' ' GLU . . . . . 0.419 ' O ' ' ND2' ' E' ' 39' ' ' ASN . 41.5 mm-40 -77.23 -35.02 55.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.312 -0.867 . . . . 0.0 108.803 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 66.3 mt -64.74 -53.6 40.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.042 -1.036 . . . . 0.0 109.154 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 60.9 t -55.79 -52.87 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.105 -0.997 . . . . 0.0 109.564 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.01 -36.49 70.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.419 -0.8 . . . . 0.0 109.633 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 39' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' E' ' 35' ' ' GLU . 74.1 m-20 -66.74 -41.11 88.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.043 -1.036 . . . . 0.0 109.831 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 40.2 mt -72.4 -50.34 27.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.99 -1.068 . . . . 0.0 109.041 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -49.04 -52.16 26.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.697 -1.252 . . . . 0.0 109.371 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -59.36 -37.3 77.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.261 -0.9 . . . . 0.0 110.824 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -77.91 -34.84 51.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 110.032 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 12.8 t -74.05 -52.8 19.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.148 -0.97 . . . . 0.0 108.864 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 9.9 mtpp -59.26 -27.88 66.21 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.704 -1.248 . . . . 0.0 110.058 -176.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.03 -28.19 62.2 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.819 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -87.84 0.1 56.25 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.82 6.89 84.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.19 -174.88 5.88 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 3.3 ptm -155.71 -1.21 0.14 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.211 -1.17 . . . . 0.0 110.83 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.82 150.55 18.72 Favored Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.296 -1.43 . . . . 0.0 109.738 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 15.2 tp -122.37 134.22 54.63 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 53' ' ' ILE . . . . . 0.882 HD13 ' O ' ' E' ' 53' ' ' ILE . 0.0 OUTLIER -106.93 147.4 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.521 -0.737 . . . . 0.0 109.659 -178.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 54' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 78.56 -63.43 0.3 Allowed 'General case' 0 N--CA 1.508 2.443 0 O-C-N 121.156 -0.965 . . . . 0.0 112.794 177.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 55' ' ' PHE . . . . . 0.552 ' O ' ' CG ' ' E' ' 55' ' ' PHE . 52.5 t80 31.64 39.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.595 0.712 . . . . 0.0 109.866 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 56' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' E' ' 54' ' ' ALA . 97.5 mtt180 -62.65 127.53 31.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.879 -1.138 . . . . 0.0 109.612 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 78.3 mt . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.255 -0.903 . . . . 0.0 109.161 179.912 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 121.465 0.65 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.11 156.73 28.4 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 69' ' ' THR . . . . . 0.547 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 98.1 m -104.39 137.1 42.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.415 -1.05 . . . . 0.0 108.194 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 28.3 mt -85.41 135.88 23.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 m -142.98 162.96 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.733 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -151.68 147.81 27.17 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.03 151.48 35.43 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.2 -0.937 . . . . 0.0 108.675 178.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 6.1 t70 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 120.878 -1.139 . . . . 0.0 109.226 179.411 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.506 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.9 mm 53.02 92.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.253 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.464 ' O ' ' CG ' ' A' ' 3' ' ' PHE . 24.3 p90 -151.25 115.94 5.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.204 -0.935 . . . . 0.0 109.455 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -118.44 -48.67 2.5 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.548 -0.72 . . . . 0.0 109.221 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 7' ' ' PHE . 1.3 p-10 -106.11 -88.9 0.44 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.427 -0.796 . . . . 0.0 109.536 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 50' ' ' MET . 29.7 mtpt 59.52 -67.93 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.225 0.535 . . . . 0.0 110.271 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.585 ' N ' ' O ' ' A' ' 5' ' ' ASP . 73.2 t80 -90.19 120.73 31.6 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.512 -0.743 . . . . 0.0 109.162 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.8 mt -134.1 131.69 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.341 -0.849 . . . . 0.0 110.205 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 9' ' ' ILE . 19.5 tt -129.37 125.22 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.08 -1.012 . . . . 0.0 108.762 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.8 t -122.88 139.04 54.46 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.332 -0.855 . . . . 0.0 110.302 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.526 ' OG1' ' OG1' ' B' ' 69' ' ' THR . 3.1 m -91.12 98.6 11.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.012 -1.055 . . . . 0.0 108.928 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.56 91.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.23 -0.919 . . . . 0.0 110.319 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -162.93 -128.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -173.68 -17.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.271 -0.893 . . . . 0.0 109.6 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.1 mt 49.69 69.0 2.93 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.581 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.76 156.85 50.93 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.975 1.783 . . . . 0.0 110.035 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.18 -9.42 74.88 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.824 -1.179 . . . . 0.0 110.495 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 18' ' ' LEU . 32.5 mt -122.54 139.31 54.04 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.137 -1.214 . . . . 0.0 110.071 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -87.56 116.46 25.69 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.7 mt -107.12 134.62 49.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.348 -0.845 . . . . 0.0 109.339 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.532 ' CE1' ' O ' ' A' ' 22' ' ' SER . 2.1 t80 -121.11 129.71 53.42 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.532 ' O ' ' CE1' ' A' ' 21' ' ' TYR . 20.8 t -84.24 129.07 34.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.407 -0.808 . . . . 0.0 110.522 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.923 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -119.29 15.44 13.07 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.03 170.8 11.94 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.352 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -109.13 144.5 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.78 144.75 42.99 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.552 -0.718 . . . . 0.0 109.4 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -152.39 139.92 19.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.91 -1.119 . . . . 0.0 108.258 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 t -150.26 136.55 18.78 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.902 -1.124 . . . . 0.0 109.548 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.0 mt -101.38 126.91 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.144 -0.973 . . . . 0.0 109.171 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.7 p -175.36 175.98 2.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.338 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 16.0 p-10 -115.75 161.16 19.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.542 -0.723 . . . . 0.0 109.117 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 11.2 m-20 77.14 120.26 0.05 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.6 t -66.26 -33.13 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.444 -0.785 . . . . 0.0 109.697 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -56.97 -39.65 75.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.911 . . . . 0.0 110.145 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -76.57 -36.51 57.54 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.179 -0.95 . . . . 0.0 109.372 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.7 mt -64.36 -51.9 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.932 -1.105 . . . . 0.0 109.399 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.74 -50.18 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.048 -1.033 . . . . 0.0 109.257 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -60.16 -41.38 92.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.295 -0.878 . . . . 0.0 109.758 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -62.93 -46.16 89.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.136 -0.977 . . . . 0.0 110.009 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.5 mt -69.38 -46.47 66.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.001 -1.062 . . . . 0.0 108.767 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -48.03 -55.05 11.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.789 -1.194 . . . . 0.0 108.87 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.45 -35.23 67.65 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.939 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -75.13 -35.88 61.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.37 -0.831 . . . . 0.0 109.81 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.8 t -73.82 -50.91 26.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.146 -0.971 . . . . 0.0 109.439 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -68.71 -31.7 70.97 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.566 -1.334 . . . . 0.0 109.174 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.84 -31.63 72.68 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -90.38 5.63 46.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -0.877 . . . . 0.0 109.023 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.72 27.04 73.03 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.664 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.92 -167.58 23.8 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.457 ' O ' ' O ' ' A' ' 6' ' ' LYS . 34.7 ttp -110.73 -41.3 4.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.616 -0.932 . . . . 0.0 109.478 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.91 -153.01 11.35 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 tp -133.2 135.46 45.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.357 -1.084 . . . . 0.0 109.788 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.575 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 1.1 pt -111.0 146.38 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.497 -0.752 . . . . 0.0 110.276 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 75.01 87.79 0.09 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.357 -0.839 . . . . 0.0 109.14 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -115.05 50.51 0.97 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.591 ' O ' ' O ' ' A' ' 57' ' ' ILE . 30.4 ttm180 -65.87 -56.81 9.89 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.536 -0.727 . . . . 0.0 109.602 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.591 ' O ' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER 42.22 108.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-O 122.202 1.001 . . . . 0.0 109.436 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.1 t -72.38 171.79 11.58 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 120.052 -1.655 . . . . 0.0 109.426 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 24.7 p -68.58 168.19 13.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.181 -0.95 . . . . 0.0 109.331 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.14 158.93 24.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.1 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -160.83 -31.5 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.924 . . . . 0.0 109.395 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.99 -29.93 0.12 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -167.25 70.17 0.1 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.151 -1.205 . . . . 0.0 109.569 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -94.55 -167.03 1.58 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.209 -0.932 . . . . 0.0 109.67 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.418 HD12 ' H ' ' A' ' 66' ' ' GLY . 41.2 tp -167.33 139.06 3.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.185 -0.947 . . . . 0.0 109.985 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.418 ' H ' HD12 ' A' ' 65' ' ' LEU . . . -105.08 83.36 0.37 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -77.87 152.01 33.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -1.162 . . . . 0.0 109.904 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.98 159.57 29.72 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.4 m -107.03 140.13 40.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.149 -1.207 . . . . 0.0 109.37 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.4 mt -87.34 135.74 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 m -138.96 162.14 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 109.673 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -154.46 143.11 20.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.887 . . . . 0.0 109.042 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.84 150.37 35.62 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.915 -1.116 . . . . 0.0 108.015 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -165.2 163.07 20.31 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.919 -1.113 . . . . 0.0 109.097 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.62 137.34 55.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.397 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.78 174.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.335 -0.853 . . . . 0.0 109.769 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -91.2 -153.51 0.32 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.259 -0.901 . . . . 0.0 109.455 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.44 ' O ' ' CD2' ' A' ' 78' ' ' PHE . 18.2 p90 -79.91 117.08 20.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.892 . . . . 0.0 109.61 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 80' ' ' MET . 0.1 OUTLIER -85.6 -81.62 0.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.242 -0.911 . . . . 0.0 109.319 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.46 ' H ' HG23 ' A' ' 79' ' ' THR . 55.8 mtt 51.96 21.51 1.52 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 109.602 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.495 179.91 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.7 mmt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.622 HD13 ' H ' ' B' ' 2' ' ' ILE . 0.1 OUTLIER -100.5 4.05 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.407 -0.808 . . . . 0.0 109.097 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.585 ' O ' ' N ' ' B' ' 5' ' ' ASP . 63.5 m-85 -61.14 -37.35 82.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.459 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 53.6 -80.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.681 -0.637 . . . . 0.0 109.607 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' B' ' 3' ' ' PHE . 1.6 m-20 -54.64 136.45 45.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 109.813 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' B' ' 50' ' ' MET . 46.1 mtmt -134.95 -63.91 0.68 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.42 -0.8 . . . . 0.0 109.333 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -89.91 120.91 31.54 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.266 -0.897 . . . . 0.0 109.172 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 11.9 mt -136.09 138.27 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.284 -0.885 . . . . 0.0 109.962 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.443 ' CG2' ' O ' ' B' ' 9' ' ' ILE . 3.8 tt -118.99 121.84 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.267 -0.895 . . . . 0.0 108.588 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 7.3 t -123.76 135.56 53.89 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.395 -0.815 . . . . 0.0 110.296 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.401 ' OG1' HD11 ' C' ' 25' ' ' ILE . 21.6 m -113.68 112.42 23.45 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 52.52 55.55 8.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.394 -0.816 . . . . 0.0 110.205 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -160.4 111.73 1.91 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.538 -0.727 . . . . 0.0 109.082 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -64.38 169.91 4.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 109.62 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 22.5 mt -135.48 71.69 65.61 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.519 -0.738 . . . . 0.0 109.064 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.8 157.6 37.18 Favored 'Trans proline' 0 C--N 1.319 -0.979 0 C-N-CA 121.873 1.715 . . . . 0.0 110.054 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.73 -8.4 73.99 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.367 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' B' ' 18' ' ' LEU . 20.4 mt -123.38 139.55 53.92 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.221 -1.164 . . . . 0.0 110.097 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -88.48 109.01 19.69 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt -97.85 141.34 30.95 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.266 -0.896 . . . . 0.0 110.773 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . 0.463 ' H ' ' H ' ' B' ' 72' ' ' LYS . 4.2 t80 -121.35 129.27 52.97 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 28.9 t -72.94 130.61 40.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.674 -1.266 . . . . 0.0 111.317 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.572 HD11 ' CB ' ' B' ' 72' ' ' LYS . 18.5 mt -118.68 9.35 12.13 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.3 -161.81 19.71 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.22 144.99 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 122.234 -0.568 . . . . 0.0 109.484 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.69 158.12 20.44 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 86.0 p -150.25 140.82 22.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 108.917 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 20.6 p -140.24 135.34 32.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.326 -0.859 . . . . 0.0 109.409 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.459 ' O ' ' CB ' ' B' ' 30' ' ' SER . 96.5 mt -126.79 125.48 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' B' ' 29' ' ' ILE . 1.9 p 163.3 -164.11 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 16.0 p-10 -122.19 173.13 7.78 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 18.3 m-80 76.91 112.46 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.3 -35.36 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.435 -0.791 . . . . 0.0 109.642 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -56.99 -37.27 71.41 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 110.057 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -76.46 -36.61 57.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.219 -0.926 . . . . 0.0 109.324 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 82.0 mt -66.22 -53.62 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.898 -1.126 . . . . 0.0 109.425 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 40.2 t -59.35 -51.87 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.004 -1.06 . . . . 0.0 109.513 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -56.13 -36.22 68.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 109.622 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -66.68 -40.33 88.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.043 -1.036 . . . . 0.0 109.852 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 70.4 mt -74.5 -50.84 16.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.95 -1.094 . . . . 0.0 108.988 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -48.85 -53.01 21.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.808 -1.182 . . . . 0.0 108.861 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' B' ' 46' ' ' ALA . 31.6 ttpt -59.0 -36.79 75.49 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.438 -0.788 . . . . 0.0 110.026 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -75.25 -35.85 61.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.232 -0.918 . . . . 0.0 109.945 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 4.9 t -74.2 -51.42 23.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 109.448 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 33.7 tptt -70.75 -29.75 66.07 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.234 -1.386 . . . . 0.0 109.548 -175.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' B' ' 42' ' ' LYS . . . -62.12 -31.25 71.7 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -92.75 2.19 56.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 109.226 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.22 29.3 64.62 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.336 -1.411 . . . . 0.0 110.016 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.77 -170.54 25.73 Favored Glycine 0 N--CA 1.492 2.383 0 O-C-N 121.209 -1.171 . . . . 0.0 110.585 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . 0.501 ' O ' ' O ' ' B' ' 6' ' ' LYS . 0.3 OUTLIER -107.95 -48.8 3.32 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.725 -0.868 . . . . 0.0 109.291 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -167.7 -160.94 16.14 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.4 tp -136.82 138.51 40.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.299 -1.118 . . . . 0.0 109.99 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.655 ' O ' ' HB3' ' B' ' 54' ' ' ALA . 0.4 OUTLIER -107.0 147.62 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 90.38 -146.59 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.64 ' CB ' ' O ' ' B' ' 54' ' ' ALA . 67.4 t80 120.71 -101.52 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 CA-C-N 120.529 1.513 . . . . 0.0 107.077 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' B' ' 55' ' ' PHE . 25.8 mtm180 55.52 161.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.38 -0.825 . . . . 0.0 109.79 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.465 HG22 ' N ' ' B' ' 58' ' ' THR . 79.3 mt -138.93 160.08 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.249 -0.907 . . . . 0.0 108.941 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . 0.488 HG23 ' CD2' ' C' ' 64' ' ' PHE . 2.7 m -167.61 157.64 10.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.256 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 42.8 t 50.5 75.8 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.46 -0.775 . . . . 0.0 109.824 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.51 176.08 9.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 109.354 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t70 53.22 14.58 0.53 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 109.649 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -154.99 -171.89 22.15 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.66 152.82 18.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.238 -1.154 . . . . 0.0 110.368 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.469 ' CD2' ' N ' ' B' ' 65' ' ' LEU . 61.8 t80 -146.01 -111.02 0.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.466 -0.771 . . . . 0.0 108.943 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.469 ' N ' ' CD2' ' B' ' 64' ' ' PHE . 6.4 tp -175.57 108.44 0.09 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.53 115.43 4.72 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' B' ' 67' ' ' TYR . 7.3 p90 -137.24 -175.96 4.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -1.115 . . . . 0.0 110.319 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.48 167.63 29.4 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . 0.526 ' OG1' ' OG1' ' A' ' 11' ' ' THR . 87.5 m -95.01 138.48 32.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.029 -1.277 . . . . 0.0 109.076 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.418 HG22 HD12 ' B' ' 23' ' ' LEU . 70.6 mt -87.5 125.36 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 3.0 m -122.78 162.51 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.306 -0.871 . . . . 0.0 110.558 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.572 ' CB ' HD11 ' B' ' 23' ' ' LEU . 11.6 tttp -154.92 135.15 13.17 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.02 114.82 29.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.556 -1.34 . . . . 0.0 111.598 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . 0.427 ' CG ' ' NZ ' ' B' ' 72' ' ' LYS . 6.8 p-10 -168.95 4.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.241 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' B' ' 75' ' ' GLU . 1.8 pm0 -71.25 -5.69 34.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.93 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.17 -175.57 0.05 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.911 . . . . 0.0 109.506 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . 0.472 ' N ' ' CD ' ' B' ' 77' ' ' GLN . 20.3 mp0 -95.36 -139.12 0.24 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.263 -0.898 . . . . 0.0 109.547 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -155.83 151.55 27.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.255 -0.903 . . . . 0.0 109.395 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 44.8 p -70.22 138.78 51.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 109.574 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -71.85 85.95 0.96 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.923 . . . . 0.0 109.52 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.509 179.949 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 14.4 mmt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 77.1 mt -78.31 119.75 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.0 109.432 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -86.79 -172.3 3.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.3 -0.875 . . . . 0.0 109.406 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.82 153.8 41.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 109.344 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' ASP . . . . . 0.46 ' CG ' ' H ' ' C' ' 6' ' ' LYS . 2.0 p-10 -102.63 -96.42 0.29 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.385 -0.822 . . . . 0.0 109.287 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . 0.501 ' HG2' ' N ' ' C' ' 7' ' ' PHE . 53.6 tttp -133.35 -95.63 0.31 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' PHE . . . . . 0.501 ' N ' ' HG2' ' C' ' 6' ' ' LYS . 70.1 t80 -101.42 119.88 39.43 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.042 -1.036 . . . . 0.0 109.268 -178.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' ILE . . . . . 0.444 ' O ' ' HA3' ' C' ' 51' ' ' GLY . 60.8 mt -115.46 143.21 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.543 -0.723 . . . . 0.0 110.067 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' ILE . . . . . 0.551 HG23 ' O ' ' C' ' 9' ' ' ILE . 12.9 tt -138.54 114.56 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.742 -1.224 . . . . 0.0 108.853 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -123.95 161.78 24.73 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.395 -0.816 . . . . 0.0 108.958 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 1.2 p -114.6 79.0 1.21 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . 0.463 ' O ' ' CG ' ' C' ' 13' ' ' ASP . . . -179.04 -10.21 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.486 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . 0.463 ' CG ' ' O ' ' C' ' 12' ' ' ALA . 3.2 p30 43.73 83.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.348 0.594 . . . . 0.0 110.272 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -154.72 -87.86 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.402 -0.811 . . . . 0.0 109.545 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 7.3 mt 48.99 66.23 6.01 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.226 -0.921 . . . . 0.0 109.247 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.53 157.71 49.55 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 C-N-CA 122.085 1.856 . . . . 0.0 109.885 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.99 -7.0 73.22 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.676 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' C' ' 18' ' ' LEU . 58.2 mt -124.46 140.55 52.84 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.997 -1.296 . . . . 0.0 110.246 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . 0.419 ' N ' ' CD ' ' C' ' 19' ' ' GLN . 2.9 mp0 -85.64 108.38 17.98 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -92.2 134.25 35.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.077 -1.014 . . . . 0.0 110.092 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -117.35 130.31 56.43 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.82 131.64 43.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.68 -1.262 . . . . 0.0 111.134 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.803 HD11 ' HB2' ' C' ' 72' ' ' LYS . 25.0 mt -114.64 10.54 16.75 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.14 -154.57 16.41 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' ILE . . . . . 0.401 HD11 ' OG1' ' B' ' 11' ' ' THR . 0.3 OUTLIER -134.69 143.56 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.82 -0.812 . . . . 0.0 109.492 -179.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.98 149.24 40.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.832 -0.542 . . . . 0.0 109.714 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 60.7 p -151.56 138.18 18.75 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -149.34 147.77 28.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.98 -1.075 . . . . 0.0 108.973 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 tt -127.59 133.37 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.2 -0.937 . . . . 0.0 109.049 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 5.3 t -169.54 170.56 8.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.291 -0.88 . . . . 0.0 109.474 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -104.31 37.56 2.07 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.835 0.826 . . . . 0.0 110.296 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -152.5 125.08 8.3 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.457 ' H ' HG13 ' C' ' 33' ' ' VAL . 0.7 OUTLIER -72.69 -45.51 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . 0.43 ' N ' ' CG2' ' C' ' 33' ' ' VAL . 5.7 p-10 -62.08 -34.77 76.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.426 -0.796 . . . . 0.0 109.99 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -74.01 -38.51 64.07 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.584 -0.846 . . . . 0.0 108.808 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 68.1 mt -63.02 -51.33 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.165 -0.96 . . . . 0.0 108.646 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.55 -49.8 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.115 -0.991 . . . . 0.0 108.691 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -61.68 -45.5 93.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.348 -0.845 . . . . 0.0 109.955 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -59.39 -46.63 88.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.329 -0.857 . . . . 0.0 109.557 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' C' ' 40' ' ' LEU . 41.1 mt -66.93 -44.24 81.19 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.123 -0.986 . . . . 0.0 108.384 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -46.76 -56.21 6.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.818 -1.176 . . . . 0.0 108.636 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -53.46 -32.16 48.78 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.34 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -74.42 -40.77 61.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.444 -0.785 . . . . 0.0 109.259 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 10.1 t -77.85 -53.53 14.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 120.774 -1.204 . . . . 0.0 108.921 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -50.58 -31.66 16.46 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.769 1.271 . . . . 0.0 109.795 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.38 -25.81 46.38 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.482 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -98.15 -0.92 43.38 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.9 26.46 73.91 Favored Glycine 0 N--CA 1.487 2.087 0 C-N-CA 118.335 -1.888 . . . . 0.0 109.637 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.79 -167.87 15.55 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 5.0 ttp -110.18 -43.79 3.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.586 -0.949 . . . . 0.0 110.462 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' C' ' 8' ' ' ILE . . . 177.55 -172.22 44.95 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.384 -1.388 . . . . 0.0 110.556 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.52 132.07 53.64 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.374 -1.074 . . . . 0.0 110.62 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 pt -109.61 139.14 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.44 61.96 2.65 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.888 -1.133 . . . . 0.0 108.665 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -96.57 109.32 21.94 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' ARG . . . . . 0.713 HH11 ' HG3' ' C' ' 56' ' ' ARG . 9.7 mmm-85 -125.02 154.62 40.98 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.419 -0.8 . . . . 0.0 109.306 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' ILE . . . . . 0.421 ' C ' HG22 ' C' ' 58' ' ' THR . 0.3 OUTLIER -141.18 147.45 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.014 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' THR . . . . . 0.421 HG22 ' C ' ' C' ' 57' ' ' ILE . 0.0 OUTLIER 175.57 90.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.455 -0.778 . . . . 0.0 109.198 178.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' CYS . . . . . 0.491 ' SG ' ' N ' ' C' ' 63' ' ' LYS . 4.3 t -164.97 149.53 9.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.072 -1.017 . . . . 0.0 109.499 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.4 -73.79 0.65 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.606 -0.684 . . . . 0.0 109.161 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.08 -71.46 0.36 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.92 . . . . 0.0 108.925 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.91 41.43 0.35 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . 0.491 ' N ' ' SG ' ' C' ' 59' ' ' CYS . 7.8 mtmp? -80.46 -115.15 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.109 -1.23 . . . . 0.0 110.031 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . 0.488 ' CD2' HG23 ' B' ' 58' ' ' THR . 4.9 m-85 -61.92 -174.82 0.06 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.543 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.487 HD23 ' N ' ' C' ' 65' ' ' LEU . 1.9 pt? -163.66 -174.0 3.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 109.098 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.5 147.84 19.69 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -159.04 161.16 36.52 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.188 -1.183 . . . . 0.0 109.711 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.48 166.42 34.17 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.406 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 34.4 m -101.92 140.21 36.5 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.307 -1.113 . . . . 0.0 108.424 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' ILE . . . . . 0.539 HG22 HD12 ' C' ' 23' ' ' LEU . 56.2 mt -85.53 148.5 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 6.8 m -142.96 156.18 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.158 -0.964 . . . . 0.0 109.765 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' LYS . . . . . 0.803 ' HB2' HD11 ' C' ' 23' ' ' LEU . 21.6 ttpt -146.04 156.17 43.29 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.216 -0.927 . . . . 0.0 108.731 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' C' ' 74' ' ' ASP . . . -119.88 153.38 35.92 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' C' ' 73' ' ' ALA . 16.2 m-20 92.66 -171.91 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.37 0.605 . . . . 0.0 109.736 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -67.98 150.46 48.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.828 . . . . 0.0 109.553 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.01 14.25 12.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.306 -0.871 . . . . 0.0 109.537 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 53.52 17.8 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.232 -0.918 . . . . 0.0 109.512 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -144.54 119.62 10.07 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.271 -0.893 . . . . 0.0 108.824 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 23.1 m -131.32 -55.45 1.03 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.541 -0.724 . . . . 0.0 109.364 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 9.4 mmt -137.66 -61.07 0.64 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.377 -0.827 . . . . 0.0 109.144 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.541 -179.909 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.432 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.7 mpt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 tp -164.74 -33.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.327 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -87.81 143.29 27.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.283 -0.886 . . . . 0.0 109.642 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 56.46 54.78 7.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 109.61 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -154.69 -0.01 0.18 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.235 -0.916 . . . . 0.0 109.509 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -92.81 96.47 10.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.202 -0.936 . . . . 0.0 109.429 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -101.44 123.8 46.08 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.274 -0.891 . . . . 0.0 109.515 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 87.4 mt -119.12 146.29 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.636 -0.665 . . . . 0.0 109.489 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' ILE . . . . . 0.59 HG23 ' O ' ' D' ' 9' ' ' ILE . 13.2 tt -138.35 116.38 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.419 -0.8 . . . . 0.0 109.001 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t -121.95 160.75 24.18 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . 0.512 ' OG1' ' OG1' ' E' ' 69' ' ' THR . 1.3 m -130.45 123.79 30.57 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' D' ' 11' ' ' THR . . . 59.85 49.81 7.56 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 122.117 0.96 . . . . 0.0 109.307 178.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -138.6 -171.02 2.96 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 55.0 mp0 -147.09 -18.03 0.4 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.035 -1.041 . . . . 0.0 109.622 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 27.8 mt 49.36 66.74 5.26 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.237 -0.914 . . . . 0.0 109.148 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.04 157.59 38.39 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 121.962 1.774 . . . . 0.0 110.076 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.97 -8.09 73.27 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.508 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 25.5 mt -122.52 138.44 54.56 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.147 -1.207 . . . . 0.0 110.187 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -90.31 116.74 28.51 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 11.9 mt -100.61 140.43 34.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.576 -0.702 . . . . 0.0 110.725 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -118.63 129.79 55.5 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 6.2 t -68.46 130.2 42.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.712 -1.243 . . . . 0.0 112.022 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.587 HD11 ' CB ' ' D' ' 72' ' ' LYS . 40.4 mt -116.54 13.64 15.37 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.68 -170.13 13.21 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.51 142.3 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.843 -0.798 . . . . 0.0 109.419 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.81 144.17 44.37 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.57 -0.706 . . . . 0.0 109.46 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 51.8 m -152.09 138.19 18.25 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.955 -1.091 . . . . 0.0 108.479 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' THR . . . . . 0.433 ' O ' HG23 ' D' ' 28' ' ' THR . 11.6 t -150.07 132.16 15.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.914 -1.116 . . . . 0.0 109.327 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 tt -100.01 130.04 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.108 -0.995 . . . . 0.0 109.379 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 6.3 p -178.21 179.47 0.81 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.439 -0.788 . . . . 0.0 109.238 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' D' ' 32' ' ' ASN . 3.3 p30 -112.18 157.17 21.18 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.515 -0.741 . . . . 0.0 109.166 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.672 HD22 ' H ' ' D' ' 34' ' ' ASP . 0.1 OUTLIER 79.23 117.1 0.06 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.556 -0.715 . . . . 0.0 109.129 -178.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 91.6 t -62.75 -31.03 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.542 -0.724 . . . . 0.0 109.534 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' ASP . . . . . 0.672 ' H ' HD22 ' D' ' 32' ' ' ASN . 62.5 m-20 -59.4 -41.01 88.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.933 . . . . 0.0 110.029 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -74.09 -39.65 63.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.261 -0.899 . . . . 0.0 109.087 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 71.4 mt -65.36 -53.97 33.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.953 -1.092 . . . . 0.0 108.908 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 25.3 t -61.43 -50.23 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.124 -0.985 . . . . 0.0 109.224 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -56.42 -36.43 68.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.2 -0.937 . . . . 0.0 109.828 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' ASN . . . . . 0.496 ' N ' HD22 ' D' ' 39' ' ' ASN . 0.9 OUTLIER -71.73 -38.01 70.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.032 -1.042 . . . . 0.0 109.406 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.702 HD13 ' CD2' ' D' ' 52' ' ' LEU . 26.7 mt -69.56 -48.92 58.7 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.962 -1.086 . . . . 0.0 108.152 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' D' ' 40' ' ' LEU . 99.2 mtt180 -46.24 -57.76 4.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.308 -1.495 . . . . 0.0 108.993 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -50.17 -28.93 8.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.037 -1.039 . . . . 0.0 110.448 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -68.61 -56.66 7.5 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.732 -1.23 . . . . 0.0 110.011 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' D' ' 48' ' ' GLY . 1.8 m -64.91 -48.82 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.672 0 O-C-N 120.275 -1.515 . . . . 0.0 107.825 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -49.94 -46.15 51.92 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.72 1.248 . . . . 0.0 110.809 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.89 -30.15 56.06 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.642 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . 0.464 ' NZ ' ' O ' ' D' ' 23' ' ' LEU . 5.8 ttmt -92.47 -3.87 54.52 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.239 -0.913 . . . . 0.0 108.794 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' D' ' 44' ' ' VAL . . . 81.1 20.24 65.39 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.313 -1.422 . . . . 0.0 109.598 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.8 -166.57 13.27 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.68 -25.49 5.48 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.581 -0.952 . . . . 0.0 111.822 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . 0.501 ' O ' HD12 ' D' ' 52' ' ' LEU . . . 159.34 -163.21 33.31 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . 0.702 ' CD2' HD13 ' D' ' 40' ' ' LEU . 5.6 mp -123.93 139.43 53.96 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.443 -1.033 . . . . 0.0 109.833 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' ILE . . . . . . . . . . . . . 1.3 pt -106.75 143.42 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.593 -0.692 . . . . 0.0 109.412 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 57.03 60.01 3.19 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.824 -1.172 . . . . 0.0 108.554 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.412 ' CD2' HD11 ' D' ' 9' ' ' ILE . 46.9 t80 -84.35 71.34 10.68 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -91.8 120.54 32.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.493 -0.754 . . . . 0.0 109.846 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' ILE . . . . . 0.51 ' O ' ' C ' ' D' ' 58' ' ' THR . 39.6 mt -89.8 -51.89 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 108.737 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' THR . . . . . 0.51 ' C ' ' O ' ' D' ' 57' ' ' ILE . 0.0 OUTLIER 28.57 87.77 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.159 0.504 . . . . 0.0 110.728 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' D' ' 60' ' ' ALA . 42.7 t -80.74 167.05 20.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 109.509 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' ALA . . . . . 0.434 ' N ' ' SG ' ' D' ' 59' ' ' CYS . . . -131.45 -48.8 0.98 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.541 -0.725 . . . . 0.0 109.246 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -165.61 78.36 0.28 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.39 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.91 -11.93 51.47 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -85.35 101.87 12.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.206 -1.173 . . . . 0.0 109.256 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -114.61 48.22 1.15 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.588 -0.695 . . . . 0.0 109.221 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' D' ' 67' ' ' TYR . 2.4 mp -84.15 92.47 7.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.175 -0.953 . . . . 0.0 109.753 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.89 76.11 0.02 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' D' ' 65' ' ' LEU . 0.4 OUTLIER -57.73 130.71 47.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.282 -1.128 . . . . 0.0 110.365 -179.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.31 152.52 23.68 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 76.7 m -107.3 137.71 44.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.034 -1.274 . . . . 0.0 108.298 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 mt -87.78 137.0 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 108.272 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.1 m -126.65 162.58 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 CA-C-O 121.617 0.722 . . . . 0.0 109.92 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' LYS . . . . . 0.587 ' CB ' HD11 ' D' ' 23' ' ' LEU . 2.0 ttmt -147.19 145.14 29.4 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.05 151.84 23.48 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.1 -1.0 . . . . 0.0 108.322 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.59 -174.81 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.81 -1.181 . . . . 0.0 109.683 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 54.37 65.89 1.38 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.403 -0.811 . . . . 0.0 108.944 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . 0.459 ' C ' ' H ' ' D' ' 78' ' ' PHE . . . -81.35 -28.6 34.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.623 -0.673 . . . . 0.0 109.579 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 59.09 3.08 0.31 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.274 -0.891 . . . . 0.0 109.247 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 78' ' ' PHE . . . . . 0.459 ' H ' ' C ' ' D' ' 76' ' ' ALA . 88.3 t80 -95.43 -37.1 11.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.118 -0.989 . . . . 0.0 109.574 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 92.6 m -158.17 119.44 3.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.214 -0.929 . . . . 0.0 109.378 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 19.3 mmt -57.88 -34.11 69.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.549 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.625 179.998 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ptp . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 24.2 mt -80.63 99.45 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 0.0 109.429 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 3' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -68.07 -162.08 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.916 . . . . 0.0 109.412 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -161.75 128.07 3.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.862 . . . . 0.0 108.703 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 5' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' E' ' 7' ' ' PHE . 0.5 OUTLIER 168.12 -55.92 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 6' ' ' LYS . . . . . 0.406 ' N ' ' OD1' ' E' ' 5' ' ' ASP . 25.5 tptp 51.84 -87.77 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.589 -1.319 . . . . 0.0 109.867 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 7' ' ' PHE . . . . . 0.563 ' N ' ' O ' ' E' ' 5' ' ' ASP . 73.2 t80 -107.29 119.74 40.21 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.368 -0.833 . . . . 0.0 109.492 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 54.2 mt -107.59 130.89 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.533 -0.73 . . . . 0.0 109.203 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 9' ' ' ILE . . . . . 0.471 HD11 ' CG ' ' E' ' 55' ' ' PHE . 8.3 tt -120.92 115.09 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.13 155.6 39.65 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.833 -1.167 . . . . 0.0 108.659 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 11' ' ' THR . . . . . . . . . . . . . 2.3 p -118.9 95.96 5.05 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -165.88 -113.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.141 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -135.64 -42.32 0.68 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.833 . . . . 0.0 109.576 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -173.29 174.16 3.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.225 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 72.9 mt -112.57 95.68 33.3 Favored Pre-proline 0 N--CA 1.498 1.953 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.47 155.9 59.7 Favored 'Trans proline' 0 C--N 1.325 -0.671 0 C-N-CA 121.726 1.618 . . . . 0.0 110.83 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.48 -7.86 77.46 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 18' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' E' ' 18' ' ' LEU . 56.3 mt -129.3 141.55 51.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -1.118 . . . . 0.0 109.836 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 19' ' ' GLN . . . . . 0.46 ' CD ' ' N ' ' E' ' 19' ' ' GLN . 3.5 mp0 -85.37 108.59 17.91 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 13.9 mt -96.78 135.0 39.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.247 -0.908 . . . . 0.0 110.036 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 21' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -123.46 129.48 51.3 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -86.53 132.53 33.89 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.205 -0.935 . . . . 0.0 111.292 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.948 HD23 ' N ' ' E' ' 23' ' ' LEU . 0.4 OUTLIER -121.7 21.23 10.87 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.42 172.79 13.41 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.406 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 43.8 mm -108.69 143.52 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.39 145.03 41.79 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.315 -0.866 . . . . 0.0 108.886 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 84.8 p -152.08 136.66 16.93 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 13.5 t -150.06 149.65 30.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.936 -1.103 . . . . 0.0 109.192 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 2.2 tp -125.41 132.47 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 1.3 p 175.71 -173.82 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.008 -1.058 . . . . 0.0 109.251 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 31' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' E' ' 32' ' ' ASN . 29.1 m-20 -123.81 168.4 12.79 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.61 -0.681 . . . . 0.0 109.369 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 32' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 9.1 t-20 75.64 123.89 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.02 -34.36 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.341 -0.85 . . . . 0.0 109.467 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -59.16 -46.26 88.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 110.172 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -75.55 -39.4 58.26 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.086 -1.009 . . . . 0.0 109.564 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.62 -48.97 85.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.843 -1.16 . . . . 0.0 109.104 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 48.7 t -63.17 -48.91 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.014 -1.054 . . . . 0.0 109.478 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -59.42 -40.22 86.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.938 . . . . 0.0 109.618 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -58.48 -45.13 89.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.529 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 49.1 mt -72.37 -48.03 44.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.114 -0.992 . . . . 0.0 109.164 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -50.74 -42.96 58.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.716 -1.24 . . . . 0.0 109.354 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -69.25 -38.89 78.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.557 -0.715 . . . . 0.0 109.694 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.08 -34.69 59.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.918 . . . . 0.0 109.742 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 t -69.25 -52.6 31.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.197 -0.94 . . . . 0.0 109.668 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -72.3 -34.4 68.1 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.323 -1.351 . . . . 0.0 109.14 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.96 -32.27 61.36 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.14 -5.27 55.28 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.236 -0.915 . . . . 0.0 110.11 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.95 6.17 37.51 Favored Glycine 0 N--CA 1.504 3.21 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.36 159.58 48.73 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -124.37 -9.48 7.49 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.289 -1.124 . . . . 0.0 110.786 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.3 163.17 35.91 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.05 -1.548 . . . . 0.0 109.898 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 4.9 tp -120.79 143.09 49.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.653 -0.91 . . . . 0.0 110.093 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 53' ' ' ILE . . . . . 0.416 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 14.0 mt -113.12 138.87 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.568 -0.708 . . . . 0.0 110.411 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 64.73 78.69 0.28 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.436 -0.79 . . . . 0.0 110.593 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 55' ' ' PHE . . . . . 0.471 ' CG ' HD11 ' E' ' 9' ' ' ILE . 84.0 t80 -90.49 98.94 12.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.514 -0.742 . . . . 0.0 109.931 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 56' ' ' ARG . . . . . 0.494 ' NH1' ' NH1' ' A' ' 56' ' ' ARG . 7.6 tpp180 -97.66 166.77 11.34 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.288 -0.883 . . . . 0.0 109.068 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 47.8 mt -133.88 -64.69 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.361 -0.837 . . . . 0.0 109.172 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 58' ' ' THR . . . . . . . . . . . . . 2.5 p -143.12 145.59 32.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.339 -0.851 . . . . 0.0 109.352 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 59' ' ' CYS . . . . . . . . . . . . . 34.2 m -141.41 -50.1 0.41 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.473 -0.767 . . . . 0.0 109.142 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.98 11.61 1.39 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -0.857 . . . . 0.0 109.427 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 55.01 46.62 23.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.72 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.77 -123.25 0.87 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -69.32 124.27 23.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -1.162 . . . . 0.0 109.417 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 64' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -167.81 121.54 0.94 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.278 -0.889 . . . . 0.0 109.252 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.748 ' N ' HD12 ' E' ' 65' ' ' LEU . 4.3 mp -89.8 143.47 26.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 108.67 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 66' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' E' ' 67' ' ' TYR . . . -55.85 -41.88 84.7 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 67' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' E' ' 66' ' ' GLY . 4.0 t80 59.74 127.81 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.543 -0.974 . . . . 0.0 110.407 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.58 140.18 6.38 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 69' ' ' THR . . . . . 0.512 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 20.4 m -93.11 138.7 31.3 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.93 -1.335 . . . . 0.0 108.623 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 70' ' ' ILE . . . . . 0.45 HG22 HD21 ' E' ' 23' ' ' LEU . 72.4 mt -85.48 139.19 17.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.44 161.46 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.175 -0.953 . . . . 0.0 110.189 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -155.92 147.25 22.59 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -110.95 150.65 28.94 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.123 -0.986 . . . . 0.0 108.595 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -69.65 151.6 45.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.056 -1.027 . . . . 0.0 109.563 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -84.91 -57.75 2.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.424 -0.798 . . . . 0.0 109.645 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.69 -14.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.928 . . . . 0.0 109.501 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 77' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -68.72 129.24 39.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.435 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -76.39 143.75 40.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 109.485 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 26.6 p -75.38 -8.79 57.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.863 . . . . 0.0 109.37 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 20.8 mmt -64.52 -41.75 96.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 109.47 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.397 -179.988 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 tpt . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.3 mm -70.79 96.36 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 109.463 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -96.49 8.32 44.36 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.241 -0.912 . . . . 0.0 109.456 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -79.7 25.2 0.35 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 109.514 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -172.54 96.9 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.382 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -166.1 70.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 109.322 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -102.62 123.14 45.79 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.422 -0.799 . . . . 0.0 110.141 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.4 mt -112.07 139.11 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.513 -0.742 . . . . 0.0 109.823 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 9' ' ' ILE . 6.3 tt -130.56 118.51 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -124.02 148.97 46.6 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.604 ' OG1' HD11 ' B' ' 25' ' ' ILE . 1.7 m -123.92 73.27 1.2 Allowed 'General case' 0 N--CA 1.511 2.622 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.727 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.2 -86.67 0.03 OUTLIER 'General case' 0 C--O 1.214 -0.791 0 O-C-N 119.585 -1.947 . . . . 0.0 107.576 -176.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.45 -78.56 0.6 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.274 -0.891 . . . . 0.0 109.68 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -162.4 -159.29 0.57 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.134 -0.979 . . . . 0.0 109.317 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.4 mt -120.78 91.76 47.62 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.495 -0.753 . . . . 0.0 109.235 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.51 155.73 51.17 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.784 1.656 . . . . 0.0 110.23 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.63 -14.08 64.97 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 18' ' ' LEU . 50.1 mt -121.86 139.48 53.57 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.427 -1.043 . . . . 0.0 109.503 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.27 108.43 15.72 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.1 mt -99.33 133.55 43.47 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.304 -0.873 . . . . 0.0 110.038 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.527 ' CE1' ' O ' ' A' ' 22' ' ' SER . 0.4 OUTLIER -120.86 129.97 53.74 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.527 ' O ' ' CE1' ' A' ' 21' ' ' TYR . 47.0 t -51.85 127.87 22.27 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.127 -0.983 . . . . 0.0 111.067 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' A' ' 23' ' ' LEU . 5.8 mt -114.44 5.9 15.77 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.17 -177.24 16.36 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.88 144.81 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 122.002 -0.705 . . . . 0.0 109.485 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.48 155.93 23.43 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.6 p -151.62 144.5 24.45 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.826 -1.171 . . . . 0.0 108.469 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.478 ' O ' HD12 ' A' ' 65' ' ' LEU . 12.2 p -148.47 132.4 17.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.246 -0.909 . . . . 0.0 109.305 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.62 126.99 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.3 p 173.11 -125.87 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.301 0.572 . . . . 0.0 109.609 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -162.59 168.53 21.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.159 -0.963 . . . . 0.0 108.589 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.2 m120 72.06 115.1 0.05 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.443 -0.786 . . . . 0.0 109.279 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.7 -31.99 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.607 -0.683 . . . . 0.0 109.314 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -58.99 -42.26 89.61 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.259 -0.9 . . . . 0.0 109.568 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -75.38 -41.02 57.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.988 -1.07 . . . . 0.0 109.869 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.33 -53.01 51.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 120.896 -1.127 . . . . 0.0 109.535 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.9 t -57.17 -48.81 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.134 -0.978 . . . . 0.0 109.028 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -59.31 -38.94 81.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.958 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -68.13 -39.98 82.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.058 -1.026 . . . . 0.0 109.768 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 40' ' ' LEU . 67.9 mt -64.93 -44.07 90.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.972 -1.08 . . . . 0.0 109.002 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -48.63 -54.48 14.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.801 -1.187 . . . . 0.0 109.471 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -57.82 -35.86 71.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.378 -0.826 . . . . 0.0 110.105 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -75.06 -36.18 61.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.219 -0.925 . . . . 0.0 109.806 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 t -71.16 -51.15 36.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.247 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -72.65 -33.28 66.49 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 117.81 -1.556 . . . . 0.0 109.598 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.69 76.18 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.869 . . . . 0.0 109.826 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -85.28 -4.11 59.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.539 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.75 0.49 55.26 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.66 155.55 53.4 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.34 -10.54 8.9 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.235 -1.156 . . . . 0.0 110.057 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.84 143.39 8.27 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.17 -1.491 . . . . 0.0 109.51 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.7 tp -101.32 142.64 32.44 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.743 -0.857 . . . . 0.0 110.12 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.831 ' O ' HD12 ' A' ' 53' ' ' ILE . 1.3 pp -120.27 150.29 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.476 -0.765 . . . . 0.0 110.559 -176.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.65 61.89 2.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.262 -1.524 . . . . 0.0 109.429 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.493 ' CD2' HD11 ' A' ' 9' ' ' ILE . 39.8 t80 -100.22 73.96 1.73 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.712 ' HG2' HH11 ' A' ' 56' ' ' ARG . 7.0 mtt-85 -72.37 143.76 48.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.587 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.543 HG22 HG23 ' A' ' 58' ' ' THR . 36.0 mm -84.9 -81.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 109.213 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.543 HG23 HG22 ' A' ' 57' ' ' ILE . 16.8 p -123.03 85.98 2.51 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.463 -0.773 . . . . 0.0 109.622 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 16.0 p -82.66 -127.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.368 -0.832 . . . . 0.0 109.179 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.67 -83.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.97 . . . . 0.0 109.497 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 3.1 m-20 -74.73 7.31 3.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.386 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.83 48.1 2.61 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 64' ' ' PHE . 0.7 OUTLIER -53.6 -53.59 49.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.916 -1.344 . . . . 0.0 109.146 -179.66 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.449 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 54.2 m-85 -158.0 60.53 0.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.392 -0.818 . . . . 0.0 109.085 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 28' ' ' THR . 7.2 tp -149.25 123.17 9.35 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.15 132.21 11.02 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 26.0 p90 -141.98 -176.04 4.64 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.255 -1.144 . . . . 0.0 109.549 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.01 165.66 26.78 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.47 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.9 m -97.93 134.73 40.65 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.6 mt -88.02 146.53 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.64 160.51 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.177 -0.952 . . . . 0.0 110.462 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.503 ' CB ' ' HZ2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -144.64 160.42 41.21 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 74' ' ' ASP . . . -118.34 152.14 36.39 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 73' ' ' ALA . 20.8 t0 79.07 -158.47 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.293 0.568 . . . . 0.0 109.608 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.427 ' H ' ' CG ' ' A' ' 74' ' ' ASP . 11.2 pt-20 -95.24 -173.06 2.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.221 -0.925 . . . . 0.0 109.416 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.0 -111.78 0.16 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.427 -0.796 . . . . 0.0 108.971 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -132.31 -4.3 3.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.45 -0.781 . . . . 0.0 109.266 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -63.88 -73.39 0.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 0.0 109.407 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 84.7 m -65.79 144.18 57.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 109.432 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.533 ' N ' ' SD ' ' A' ' 80' ' ' MET . 3.9 mpp? -67.93 118.05 10.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 109.399 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.48 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ptp . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 83.2 mt -129.71 -66.99 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.425 -0.797 . . . . 0.0 109.308 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.432 ' O ' ' CG ' ' B' ' 3' ' ' PHE . 6.6 p90 -146.19 34.53 0.99 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.102 -0.999 . . . . 0.0 109.56 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -150.69 -41.38 0.13 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.962 -1.086 . . . . 0.0 108.917 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.48 36.67 2.09 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.566 -0.709 . . . . 0.0 109.721 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -99.17 112.22 24.42 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.296 -0.877 . . . . 0.0 108.859 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -105.23 118.33 36.27 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 39.6 mt -103.9 134.78 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.322 -0.861 . . . . 0.0 110.123 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 39.0 mt -125.56 117.38 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 7.7 t -126.18 151.96 46.63 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.909 0.861 . . . . 0.0 108.749 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.456 ' CB ' ' HG1' ' C' ' 69' ' ' THR . 4.4 p -119.66 96.56 5.24 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -178.45 -87.74 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.528 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -155.55 -160.72 1.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.399 -0.813 . . . . 0.0 109.597 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -65.36 121.94 15.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.313 -0.867 . . . . 0.0 109.601 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 77.5 mt -52.58 110.27 1.86 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.56 -0.713 . . . . 0.0 109.386 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.46 153.75 72.76 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.293 1.329 . . . . 0.0 110.396 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.65 -16.09 58.86 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' B' ' 18' ' ' LEU . 71.8 mt -121.88 140.16 52.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.403 -1.057 . . . . 0.0 109.34 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -85.1 108.42 17.66 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 12.7 mt -96.89 138.35 34.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.211 -0.931 . . . . 0.0 110.233 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . 0.504 ' CE1' ' O ' ' B' ' 22' ' ' SER . 2.1 t80 -121.01 130.09 53.66 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.504 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 41.0 t -72.01 131.84 43.46 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 120.892 -1.13 . . . . 0.0 110.532 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.48 HD11 ' CB ' ' B' ' 72' ' ' LYS . 1.2 mp -118.92 12.79 12.95 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.67 -174.39 16.29 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . 0.604 HD11 ' OG1' ' A' ' 11' ' ' THR . 0.3 OUTLIER -116.66 145.2 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.252 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.83 143.9 43.9 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 46.2 m -152.52 141.79 21.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.581 -1.325 . . . . 0.0 108.305 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 12.9 t -149.48 151.84 34.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.036 -1.04 . . . . 0.0 108.646 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' B' ' 30' ' ' SER . 49.1 mt -112.4 158.02 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.117 -0.989 . . . . 0.0 108.674 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.672 ' O ' ' CG ' ' B' ' 31' ' ' ASP . 16.9 m 51.34 108.35 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.741 0 O-C-N 121.039 -1.038 . . . . 0.0 110.683 177.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.672 ' CG ' ' O ' ' B' ' 30' ' ' SER . 37.3 m-20 171.15 129.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . 0.488 ' O ' HG12 ' B' ' 36' ' ' ILE . 23.0 t-20 -84.27 173.04 11.31 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 120.917 -1.114 . . . . 0.0 108.384 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.532 ' HA ' HD11 ' B' ' 36' ' ' ILE . 15.5 t -44.8 -42.77 2.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 O-C-N 120.943 -1.098 . . . . 0.0 110.297 -174.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -64.19 -44.23 92.66 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.63 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -74.73 -45.83 41.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.327 -1.483 . . . . 0.0 111.546 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.532 HD11 ' HA ' ' B' ' 33' ' ' VAL . 0.6 OUTLIER -58.75 -48.98 84.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 O-C-N 120.017 -1.677 . . . . 0.0 109.413 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.79 -45.19 99.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 118.846 -1.142 . . . . 0.0 108.711 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -67.55 -50.34 59.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.347 -0.845 . . . . 0.0 109.424 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.577 ' N ' HD22 ' B' ' 39' ' ' ASN . 0.8 OUTLIER -54.9 -47.39 74.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.108 -0.995 . . . . 0.0 108.966 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.75 -43.46 79.81 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.411 -0.806 . . . . 0.0 108.943 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -50.85 -45.33 59.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.626 -1.296 . . . . 0.0 109.419 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' B' ' 46' ' ' ALA . 64.0 mttm -66.41 -39.37 88.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.461 -0.774 . . . . 0.0 110.055 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -76.82 -34.99 57.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.689 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.473 HG21 HD13 ' B' ' 52' ' ' LEU . 15.3 t -71.86 -51.9 28.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.209 -0.932 . . . . 0.0 109.025 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -70.22 -30.18 67.2 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.14 -1.424 . . . . 0.0 109.558 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' B' ' 42' ' ' LYS . . . -61.55 -30.01 70.38 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -93.62 -5.31 49.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.381 -0.824 . . . . 0.0 109.821 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.87 15.49 28.62 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.02 159.84 29.24 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.1 -1.02 4.63 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.173 -1.193 . . . . 0.0 110.816 -176.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.82 173.62 43.4 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.422 -1.37 . . . . 0.0 109.773 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.473 HD13 HG21 ' B' ' 44' ' ' VAL . 5.5 tp -130.53 133.81 46.53 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.67 -0.9 . . . . 0.0 109.43 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.57 139.66 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.672 -0.643 . . . . 0.0 110.243 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 50.83 61.12 3.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.949 -1.094 . . . . 0.0 110.633 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -100.39 114.3 27.74 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.323 0.583 . . . . 0.0 110.654 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -102.46 119.12 38.28 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 pt -75.01 175.42 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.128 -0.982 . . . . 0.0 109.858 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 76.6 p -78.21 -151.67 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.811 . . . . 0.0 109.897 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 8.7 p -168.3 177.5 5.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.755 -1.215 . . . . 0.0 109.2 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.48 83.94 6.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 109.428 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -156.81 46.87 0.43 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.262 -0.898 . . . . 0.0 109.303 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.3 -160.01 45.52 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -75.43 82.94 2.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -1.129 . . . . 0.0 109.831 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -69.72 -148.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.157 -0.965 . . . . 0.0 108.917 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.1 mt -159.59 114.98 2.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.427 -0.796 . . . . 0.0 109.671 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.26 149.66 20.39 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' B' ' 67' ' ' TYR . 4.8 p90 -150.03 152.97 35.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.158 -1.201 . . . . 0.0 110.202 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.73 156.53 28.07 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 52.6 m -101.21 136.12 41.56 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.061 -1.258 . . . . 0.0 107.92 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 53.5 mt -86.04 146.62 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.9 m -138.51 156.71 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.308 -0.87 . . . . 0.0 110.21 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.48 ' CB ' HD11 ' B' ' 23' ' ' LEU . 23.4 ttpp -150.55 132.44 15.11 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.54 129.34 50.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.856 -1.152 . . . . 0.0 108.3 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -172.62 -142.03 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.844 -1.16 . . . . 0.0 108.681 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -166.19 -47.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.152 -0.968 . . . . 0.0 109.171 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.515 ' O ' ' O ' ' B' ' 77' ' ' GLN . . . -79.38 1.67 24.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.262 -0.899 . . . . 0.0 109.67 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . 0.515 ' O ' ' O ' ' B' ' 76' ' ' ALA . 25.4 mm100 54.92 160.21 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 118.701 -1.2 . . . . 0.0 108.883 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -168.38 20.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.355 -0.841 . . . . 0.0 109.58 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 44.6 p -130.01 67.39 1.47 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.412 -0.805 . . . . 0.0 109.419 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' MET . . . . . . . . . . . . . 11.7 mmt 49.58 83.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.382 -0.823 . . . . 0.0 109.563 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.511 179.939 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.0 mtt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . 0.749 ' N ' HD12 ' C' ' 2' ' ' ILE . 3.5 mp -88.04 86.13 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.232 -0.918 . . . . 0.0 109.35 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -75.17 135.71 41.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 109.274 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . 0.45 ' OE1' ' N ' ' C' ' 4' ' ' GLU . 56.9 mp0 -103.4 -21.58 13.79 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.404 -0.81 . . . . 0.0 109.178 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' C' ' 4' ' ' GLU . 5.1 m-20 52.18 99.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.061 -1.025 . . . . 0.0 109.745 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -155.12 53.09 0.62 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.569 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -95.23 122.59 38.09 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.518 -0.738 . . . . 0.0 110.026 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 86.2 mt -111.06 128.89 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.485 -0.76 . . . . 0.0 109.866 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' ILE . . . . . 0.615 HG23 HD13 ' D' ' 25' ' ' ILE . 7.7 tt -124.19 116.92 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 7.9 t -113.36 135.99 53.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.661 -1.274 . . . . 0.0 109.039 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' C' ' 12' ' ' ALA . 0.3 OUTLIER -56.99 -85.75 0.01 OUTLIER 'General case' 0 C--N 1.279 -2.471 0 O-C-N 121.873 -0.517 . . . . 0.0 111.178 178.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . 0.492 ' N ' ' OG1' ' C' ' 11' ' ' THR . . . -133.43 92.68 3.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.639 -1.288 . . . . 0.0 108.131 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -147.57 -134.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.294 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -165.86 -9.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.07 -1.019 . . . . 0.0 109.474 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 27.8 mt 55.64 68.74 2.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.39 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.89 156.22 50.18 Favored 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 121.931 1.754 . . . . 0.0 109.984 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.12 -14.96 63.15 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' C' ' 18' ' ' LEU . 19.1 mt -119.34 137.47 53.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.434 -1.039 . . . . 0.0 109.153 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.77 107.92 19.22 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.474 HD13 HD11 ' C' ' 53' ' ' ILE . 11.6 mt -97.88 140.66 31.9 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.199 -0.938 . . . . 0.0 110.246 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' TYR . . . . . 0.62 ' CE1' ' O ' ' C' ' 22' ' ' SER . 0.6 OUTLIER -123.17 129.94 52.1 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . 0.62 ' O ' ' CE1' ' C' ' 21' ' ' TYR . 24.9 t -66.37 135.71 54.73 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.273 1.035 . . . . 0.0 112.45 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 mt -123.86 13.86 9.23 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.512 -0.742 . . . . 0.0 109.357 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.29 179.74 15.99 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.5 145.8 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 122.21 -0.583 . . . . 0.0 109.56 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.89 159.71 18.78 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.93 147.09 26.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.752 -1.217 . . . . 0.0 108.474 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.427 HG23 HD21 ' C' ' 40' ' ' LEU . 51.7 p -146.0 142.1 28.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.509 -0.744 . . . . 0.0 109.872 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' C' ' 30' ' ' SER . 55.8 mt -127.18 124.86 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 29' ' ' ILE . 3.6 p 157.77 -159.59 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -132.62 -174.7 3.53 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 1.8 m120 73.97 114.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.481 HG22 HD12 ' C' ' 57' ' ' ILE . 22.2 t -68.39 -34.34 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.445 -0.784 . . . . 0.0 109.482 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.4 -38.87 78.25 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.236 -0.915 . . . . 0.0 109.269 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -75.14 -39.81 60.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.932 -1.105 . . . . 0.0 109.586 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.45 -52.38 56.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.602 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 5.7 t -58.24 -48.31 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.009 -1.057 . . . . 0.0 108.782 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.77 -44.97 91.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 109.955 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -57.21 -49.9 74.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.104 -0.997 . . . . 0.0 109.496 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . 0.427 HD21 HG23 ' C' ' 28' ' ' THR . 82.7 mt -64.44 -43.71 93.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.076 -1.015 . . . . 0.0 108.673 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' ARG . . . . . 0.789 ' HG2' HH11 ' C' ' 41' ' ' ARG . 2.7 ttt-85 -49.78 -47.28 51.18 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.774 -1.204 . . . . 0.0 109.579 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -67.04 -38.41 85.82 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.488 -0.758 . . . . 0.0 110.253 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -76.65 -35.5 57.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.897 . . . . 0.0 109.795 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 t -67.58 -50.88 57.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.176 -0.953 . . . . 0.0 108.949 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -71.76 -35.47 70.1 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.155 -1.418 . . . . 0.0 109.208 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.26 -33.34 67.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.486 -0.759 . . . . 0.0 108.97 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.61 -4.97 59.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.509 -0.744 . . . . 0.0 109.521 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.47 5.18 59.16 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.3 161.65 48.89 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -128.46 -0.2 5.61 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.293 -1.122 . . . . 0.0 110.014 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.42 151.09 17.48 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 16.0 tp -112.96 140.47 47.74 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.565 -0.962 . . . . 0.0 109.949 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.654 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 27.9 mt -112.34 140.66 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.59 -0.694 . . . . 0.0 109.488 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 92.01 -41.36 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 118.342 0.519 . . . . 0.0 110.093 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . 0.511 ' C ' ' O ' ' C' ' 54' ' ' ALA . 18.0 t80 27.97 89.77 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 120.804 0.335 . . . . 0.0 110.177 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' ARG . . . . . 0.652 ' CG ' HH11 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -93.82 143.79 26.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.013 -1.054 . . . . 0.0 109.65 -178.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' ILE . . . . . 0.513 ' O ' ' C ' ' C' ' 58' ' ' THR . 0.1 OUTLIER -150.97 -11.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' THR . . . . . 0.513 ' C ' ' O ' ' C' ' 57' ' ' ILE . 3.1 m -33.76 140.69 0.05 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.545 -0.722 . . . . 0.0 110.171 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' CYS . . . . . . . . . . . . . 52.7 t -140.95 150.79 43.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.309 -0.87 . . . . 0.0 109.445 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.19 117.9 1.43 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 58.06 19.9 6.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.512 -0.742 . . . . 0.0 109.6 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.36 121.41 2.65 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . 0.686 ' HZ1' ' N ' ' C' ' 66' ' ' GLY . 22.8 tptp -47.67 145.3 2.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.427 -1.043 . . . . 0.0 109.553 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -102.24 -66.75 0.91 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.514 -0.741 . . . . 0.0 109.432 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -174.32 122.77 0.29 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.204 -0.935 . . . . 0.0 109.722 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . 0.686 ' N ' ' HZ1' ' C' ' 63' ' ' LYS . . . -95.38 147.6 18.68 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.611 -1.795 . . . . 0.0 108.611 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -149.42 173.6 13.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.103 -1.233 . . . . 0.0 109.987 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.44 161.76 31.76 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' THR . . . . . 0.456 ' HG1' ' CB ' ' B' ' 11' ' ' THR . 69.1 m -93.83 137.02 33.5 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.276 -1.132 . . . . 0.0 108.406 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 60.9 mt -86.11 141.32 14.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' C' ' 21' ' ' TYR . 6.9 m -144.92 163.21 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.788 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -152.06 162.32 41.27 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' C' ' 74' ' ' ASP . . . -104.03 151.43 23.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 108.985 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' C' ' 73' ' ' ALA . 2.9 t0 -55.59 -165.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 109.85 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 54.53 52.14 12.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.147 -0.971 . . . . 0.0 109.096 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.8 -136.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 54.7 -179.41 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.31 -0.869 . . . . 0.0 109.647 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -157.67 -18.49 0.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.926 . . . . 0.0 109.437 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 56.0 p -67.36 -157.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 109.379 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 51.2 ttp -161.77 103.14 1.18 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.372 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.524 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.55 ' C ' HD12 ' D' ' 2' ' ' ILE . 16.4 mmt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' ILE . . . . . 0.55 HD12 ' C ' ' D' ' 1' ' ' MET . 4.9 mp 55.27 165.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.479 -0.763 . . . . 0.0 109.473 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' PHE . . . . . 0.528 ' N ' HG22 ' D' ' 2' ' ' ILE . 27.9 m-85 51.7 21.04 1.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.353 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -74.43 62.42 0.99 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.205 -0.934 . . . . 0.0 109.306 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -160.22 117.43 2.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.407 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.61 166.37 13.22 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.44 -0.787 . . . . 0.0 109.332 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -94.12 124.29 38.04 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.668 -0.645 . . . . 0.0 109.849 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 71.8 mt -116.94 143.17 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.618 -0.676 . . . . 0.0 109.91 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' ILE . . . . . 0.607 HG23 ' O ' ' D' ' 9' ' ' ILE . 7.7 tt -136.03 114.65 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.8 t -122.18 161.72 22.68 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.333 -0.855 . . . . 0.0 108.826 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.16 73.27 1.29 Allowed 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.17 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.69 -116.64 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.766 0 O-C-N 119.43 -2.044 . . . . 0.0 107.363 -176.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 24.7 p30 -93.68 -137.97 0.2 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.971 -1.08 . . . . 0.0 109.428 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -109.86 -159.75 0.69 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.379 -0.826 . . . . 0.0 109.151 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 56.6 mt -125.48 85.27 58.88 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.579 -0.701 . . . . 0.0 109.203 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -60.11 157.26 35.38 Favored 'Trans proline' 0 N--CA 1.48 0.725 0 C-N-CA 121.91 1.74 . . . . 0.0 110.093 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.95 -4.46 75.0 Favored Glycine 0 N--CA 1.498 2.779 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.056 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 59.6 mt -130.64 141.38 50.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.191 . . . . 0.0 109.706 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -85.42 108.5 17.89 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 14.1 mt -94.95 133.11 39.07 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.117 -0.989 . . . . 0.0 109.635 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' D' ' 22' ' ' SER . 1.6 t80 -114.02 129.67 56.59 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . 0.433 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 0.0 OUTLIER -70.63 131.69 44.31 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 120.618 -1.301 . . . . 0.0 110.942 -179.415 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 mt -117.29 11.34 14.0 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.91 -179.68 18.4 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' ILE . . . . . 0.615 HD13 HG23 ' C' ' 9' ' ' ILE . 1.5 mp -108.87 141.87 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.853 -0.792 . . . . 0.0 108.933 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.59 142.94 44.58 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 43.8 p -152.2 130.82 12.29 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' THR . . . . . 0.626 ' H ' ' HA3' ' D' ' 66' ' ' GLY . 10.6 t -143.35 130.23 20.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.758 -1.213 . . . . 0.0 108.716 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.493 HD11 ' N ' ' D' ' 61' ' ' ASP . 19.4 tt -97.72 130.29 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.879 -1.138 . . . . 0.0 108.961 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.531 ' O ' ' O ' ' D' ' 31' ' ' ASP . 72.1 m -168.73 2.36 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.739 -1.226 . . . . 0.0 109.968 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' ASP . . . . . 0.531 ' O ' ' O ' ' D' ' 30' ' ' SER . 26.5 t70 51.27 161.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.48 -0.763 . . . . 0.0 110.447 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 0.1 OUTLIER 71.86 128.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.63 -1.293 . . . . 0.0 108.67 -178.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 20.2 t -69.94 -36.73 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 121.224 -0.923 . . . . 0.0 110.15 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' D' ' 35' ' ' GLU . 25.4 p-10 -58.51 -47.03 85.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.161 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' D' ' 34' ' ' ASP . 49.9 mt-10 -76.26 -38.64 55.96 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.957 -1.089 . . . . 0.0 109.86 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 60.9 mt -63.79 -53.69 41.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 120.882 -1.136 . . . . 0.0 109.493 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 43.4 t -63.5 -49.65 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.167 -0.958 . . . . 0.0 109.658 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -58.13 -39.44 78.75 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.159 -0.963 . . . . 0.0 109.637 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -65.98 -42.31 90.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.649 HD13 HD21 ' D' ' 52' ' ' LEU . 29.1 mt -67.77 -46.29 72.44 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.956 -1.09 . . . . 0.0 108.749 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -46.77 -53.4 11.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.884 -1.135 . . . . 0.0 109.056 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -55.65 -31.0 61.96 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.32 -0.862 . . . . 0.0 109.154 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -73.11 -36.27 66.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.16 -0.963 . . . . 0.0 109.609 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.66 -50.71 25.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 120.886 -1.134 . . . . 0.0 109.281 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -49.92 -33.81 18.61 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 122.988 1.375 . . . . 0.0 109.873 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.97 -29.06 49.57 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.824 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -97.75 6.27 48.12 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.36 29.14 59.99 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 117.952 -2.071 . . . . 0.0 109.687 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.75 -170.27 5.07 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 11.3 ttp -109.51 -41.57 4.55 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.494 -1.004 . . . . 0.0 110.063 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 171.25 175.69 39.87 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . 0.649 HD21 HD13 ' D' ' 40' ' ' LEU . 1.0 OUTLIER -108.24 139.42 42.96 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.479 -1.012 . . . . 0.0 109.993 -179.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' ILE . . . . . 0.5 ' O ' ' HB3' ' D' ' 54' ' ' ALA . 1.2 pt -112.28 142.47 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.748 -0.595 . . . . 0.0 110.238 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 68.93 -61.54 0.42 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.42 -0.8 . . . . 0.0 110.516 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.437 ' N ' ' O ' ' D' ' 53' ' ' ILE . 13.1 t80 42.7 83.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -84.28 140.37 31.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.05 -1.031 . . . . 0.0 109.493 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' ILE . . . . . . . . . . . . . 60.2 mt -99.19 157.44 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.391 -0.818 . . . . 0.0 108.968 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' THR . . . . . 0.723 HG23 HD11 ' D' ' 65' ' ' LEU . 0.2 OUTLIER -160.01 179.02 9.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.365 -0.835 . . . . 0.0 109.113 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' CYS . . . . . 0.493 ' N ' ' OG1' ' D' ' 58' ' ' THR . 49.2 t -63.67 -119.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.65 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' ALA . . . . . 0.437 ' N ' ' SG ' ' D' ' 59' ' ' CYS . . . -176.48 119.1 0.13 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.187 -0.945 . . . . 0.0 109.32 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 61' ' ' ASP . . . . . 0.493 ' N ' HD11 ' D' ' 29' ' ' ILE . 12.1 t70 -163.75 118.92 1.6 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 109.377 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.2 135.43 4.48 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' D' ' 64' ' ' PHE . 68.7 mttm -50.12 150.72 2.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.761 -0.846 . . . . 0.0 109.743 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . 0.449 ' O ' ' O ' ' D' ' 63' ' ' LYS . 34.2 m-85 57.95 113.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.565 -0.709 . . . . 0.0 109.576 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 1.008 ' O ' ' O ' ' D' ' 66' ' ' GLY . 1.4 tm? -156.57 -33.41 0.08 Allowed 'General case' 0 C--O 1.185 -2.329 0 O-C-N 121.149 -0.969 . . . . 0.0 109.321 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 66' ' ' GLY . . . . . 1.008 ' O ' ' O ' ' D' ' 65' ' ' LEU . . . -23.84 -147.94 0.0 OUTLIER Glycine 1 N--CA 1.516 4.033 0 CA-C-O 122.271 0.928 . . . . 0.0 112.134 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -177.38 99.23 0.05 OUTLIER 'General case' 0 C--N 1.287 -2.15 0 O-C-N 118.88 -2.541 . . . . 0.0 110.112 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.0 137.43 3.18 Favored Glycine 0 C--N 1.288 -2.101 0 C-N-CA 119.015 -1.564 . . . . 0.0 110.856 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 6.9 m -101.08 144.29 30.17 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.74 -0.859 . . . . 0.0 108.951 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 26.7 mt -89.07 142.19 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 m -135.13 166.65 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.371 0.605 . . . . 0.0 109.48 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 72' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' D' ' 21' ' ' TYR . 7.7 tttt -146.47 145.39 30.18 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' D' ' 74' ' ' ASP . . . -125.42 153.98 42.63 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' D' ' 73' ' ' ALA . 25.2 t0 71.81 77.93 0.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 119.018 0.826 . . . . 0.0 110.15 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -117.25 45.46 1.89 Allowed 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.21 -141.78 0.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.293 -0.879 . . . . 0.0 108.956 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -123.3 174.24 7.44 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.309 -0.869 . . . . 0.0 109.379 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 78' ' ' PHE . . . . . 0.512 ' CD2' ' N ' ' D' ' 79' ' ' THR . 9.4 p90 -79.9 -55.79 4.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 109.511 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . 0.512 ' N ' ' CD2' ' D' ' 78' ' ' PHE . 50.4 p 46.29 83.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.333 -0.854 . . . . 0.0 109.733 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 56.4 mtp -73.09 -18.01 61.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.504 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.461 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ptt? . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 13.6 pt -75.94 53.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.902 . . . . 0.0 109.364 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 3' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -62.55 -50.3 71.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.541 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -161.62 90.49 0.79 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 0.0 109.611 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 5' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -159.03 157.04 30.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.9 . . . . 0.0 108.909 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 6' ' ' LYS . . . . . 0.442 ' HG3' ' HZ2' ' E' ' 6' ' ' LYS . 6.8 ptmm? -130.83 121.55 25.51 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.415 -0.803 . . . . 0.0 109.435 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -94.93 119.08 32.88 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.388 -0.82 . . . . 0.0 109.788 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 33.8 mt -113.35 134.21 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.568 -0.708 . . . . 0.0 109.407 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 9' ' ' ILE . . . . . 0.624 HG23 ' O ' ' E' ' 9' ' ' ILE . 15.7 tt -130.67 114.42 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 6.5 t -122.46 157.9 30.95 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.891 0.853 . . . . 0.0 109.103 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 11' ' ' THR . . . . . 0.601 ' O ' ' HB2' ' E' ' 12' ' ' ALA . 4.1 p -100.25 77.69 1.99 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 177.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' E' ' 11' ' ' THR . . . 157.55 -90.97 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.778 0.799 . . . . 0.0 109.714 177.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -165.16 -71.32 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 51.14 -153.26 0.18 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 110.245 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 15' ' ' ILE . . . . . 0.667 ' N ' ' HD3' ' E' ' 16' ' ' PRO . 2.8 mt 60.54 48.16 1.6 Allowed Pre-proline 0 N--CA 1.483 1.223 0 O-C-N 121.849 -0.532 . . . . 0.0 109.632 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . 0.667 ' HD3' ' N ' ' E' ' 15' ' ' ILE . 1.6 Cg_endo -66.77 154.48 74.36 Favored 'Trans proline' 0 C--N 1.326 -0.629 0 C-N-CA 121.532 1.488 . . . . 0.0 109.81 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.99 -9.96 74.71 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.927 -1.606 . . . . 0.0 110.943 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 18' ' ' LEU . . . . . 0.487 HD12 ' CG2' ' E' ' 15' ' ' ILE . 75.5 mt -118.73 137.72 53.15 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 119.138 1.469 . . . . 0.0 109.387 -178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -86.12 112.88 21.71 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 12.5 mt -89.16 135.22 33.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -0.912 . . . . 0.0 110.62 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 21' ' ' TYR . . . . . 0.554 ' CE1' ' O ' ' E' ' 22' ' ' SER . 1.2 t80 -119.66 130.79 55.23 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 22' ' ' SER . . . . . 0.554 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 0.0 OUTLIER -71.68 131.46 43.2 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.977 -1.077 . . . . 0.0 111.071 -179.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.502 HD11 ' CB ' ' E' ' 72' ' ' LYS . 1.1 mp -118.41 12.92 13.46 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.03 179.49 15.97 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 tp -114.47 144.81 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.977 -0.719 . . . . 0.0 109.303 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.6 144.98 41.18 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 90.3 p -152.43 139.95 19.68 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.705 -1.247 . . . . 0.0 107.93 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 8.7 t -150.49 144.14 25.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.889 -1.132 . . . . 0.0 109.025 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 4.7 mm -106.42 128.46 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.251 -0.906 . . . . 0.0 108.879 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 29.0 t -175.06 177.9 1.86 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -0.802 . . . . 0.0 109.007 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 31' ' ' ASP . . . . . 0.403 ' O ' ' CB ' ' E' ' 32' ' ' ASN . 46.6 t0 -116.43 161.14 19.54 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.486 -0.759 . . . . 0.0 109.235 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 32' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 2.4 m120 75.96 123.56 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 52.6 t -67.5 -33.33 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.396 -0.815 . . . . 0.0 109.415 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -58.55 -43.05 89.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 110.153 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -75.6 -37.93 59.45 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.112 -0.993 . . . . 0.0 109.466 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.71 -49.42 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 109.451 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 44.7 t -63.83 -49.64 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.031 -1.043 . . . . 0.0 109.653 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.79 -37.37 73.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.832 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -65.56 -41.49 92.89 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -0.958 . . . . 0.0 109.792 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 40' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' E' ' 40' ' ' LEU . 30.9 mt -68.2 -45.96 71.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.085 -1.01 . . . . 0.0 109.106 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -48.62 -50.71 31.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.786 -1.196 . . . . 0.0 109.363 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 42' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' E' ' 46' ' ' ALA . 31.7 ttpt -61.04 -36.47 79.64 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.464 -0.773 . . . . 0.0 110.209 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -76.57 -35.08 58.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.952 . . . . 0.0 109.77 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 9.1 t -70.44 -51.82 34.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.07 -1.019 . . . . 0.0 108.846 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 -30.72 67.33 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.046 -1.462 . . . . 0.0 109.275 -175.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' E' ' 42' ' ' LYS . . . -61.48 -34.9 76.26 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.449 -0.782 . . . . 0.0 109.713 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.42 -5.45 58.84 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.064 -1.023 . . . . 0.0 109.889 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 106.49 -1.19 36.99 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.04 156.95 52.69 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 6.4 ptm -120.53 -2.46 9.97 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.392 -1.063 . . . . 0.0 110.29 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.65 156.01 19.88 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.06 -1.543 . . . . 0.0 109.686 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 5.3 tp -106.26 136.28 46.25 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.722 -0.869 . . . . 0.0 109.28 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 53' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 1.2 pt -108.83 144.38 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.45 -0.781 . . . . 0.0 110.012 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.493 ' HA ' HH12 ' E' ' 56' ' ' ARG . . . 64.12 82.55 0.18 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.114 -0.991 . . . . 0.0 110.794 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 55' ' ' PHE . . . . . 0.486 ' O ' ' CG ' ' E' ' 55' ' ' PHE . 72.6 t80 -113.75 19.04 17.03 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.192 0.52 . . . . 0.0 109.683 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 56' ' ' ARG . . . . . 0.755 ' HG3' HH11 ' E' ' 56' ' ' ARG . 15.8 mtm-85 -59.68 111.86 1.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.16 -0.962 . . . . 0.0 109.645 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 64.6 mt -78.16 94.84 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.284 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.08 91.51 0.15 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.288 -0.882 . . . . 0.0 109.493 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 59' ' ' CYS . . . . . 0.4 ' H ' ' CG ' ' A' ' 61' ' ' ASP . 67.9 m -152.49 -95.34 0.05 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.012 -1.055 . . . . 0.0 109.491 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.14 121.0 17.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.647 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -64.35 155.17 33.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 109.283 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.4 132.05 0.05 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp 55.54 98.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.327 -1.102 . . . . 0.0 109.418 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 64' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -57.35 178.35 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 109.69 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.55 168.8 23.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.284 -0.885 . . . . 0.0 109.15 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 66' ' ' GLY . . . . . . . . . . . . . . . -146.21 110.54 0.54 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -142.9 -176.66 4.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.426 -1.044 . . . . 0.0 109.395 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.3 172.33 25.3 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.327 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 54.8 m -99.17 134.62 41.75 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.348 -1.089 . . . . 0.0 108.196 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 66.9 mt -78.31 146.07 8.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.8 m -130.34 152.11 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.96 -1.088 . . . . 0.0 109.905 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 72' ' ' LYS . . . . . 0.502 ' CB ' HD11 ' E' ' 23' ' ' LEU . 24.4 ttpp -144.9 141.16 28.83 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.76 138.86 36.25 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -76.06 137.66 40.33 Favored 'General case' 0 C--N 1.312 -1.063 0 O-C-N 120.451 -1.406 . . . . 0.0 108.969 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -57.09 153.09 12.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.617 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.83 -34.24 72.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.374 -0.829 . . . . 0.0 109.685 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -108.79 98.16 7.7 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.48 -0.763 . . . . 0.0 109.292 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -164.78 148.13 8.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.326 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 40.2 p -82.11 -144.44 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.933 . . . . 0.0 109.392 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -140.95 -162.95 1.44 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.34 -0.85 . . . . 0.0 109.351 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.408 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.4 ttt . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.9 mm -83.2 151.08 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.187 -0.946 . . . . 0.0 109.329 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -158.95 6.72 0.11 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 109.278 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -87.56 52.93 2.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.92 . . . . 0.0 109.441 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -168.91 14.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.092 -1.005 . . . . 0.0 109.44 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 50' ' ' MET . 0.2 OUTLIER -86.47 147.85 25.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.271 -0.893 . . . . 0.0 109.267 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -115.26 122.18 45.19 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.0 mt -132.9 124.76 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.284 -0.885 . . . . 0.0 109.723 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.465 ' CG2' ' O ' ' A' ' 9' ' ' ILE . 7.4 tt -119.3 118.99 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 t -117.35 133.39 56.04 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.388 -0.82 . . . . 0.0 108.868 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.456 ' OG1' ' OG1' ' B' ' 69' ' ' THR . 3.2 m -107.96 70.03 0.75 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.426 -0.796 . . . . 0.0 111.863 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.414 ' H ' ' H ' ' A' ' 13' ' ' ASP . . . -162.98 -9.92 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 O-C-N 120.197 -1.564 . . . . 0.0 108.328 -175.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.6 OUTLIER 64.25 57.54 1.21 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.711 -0.618 . . . . 0.0 110.331 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -178.85 137.81 0.15 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.576 -0.703 . . . . 0.0 109.889 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.768 HG23 ' O ' ' A' ' 15' ' ' ILE . 9.5 tt -163.78 58.65 0.71 Allowed Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.217 -0.927 . . . . 0.0 108.857 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HD3' ' N ' ' A' ' 15' ' ' ILE . 3.2 Cg_exo -59.21 158.24 26.96 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 121.971 1.781 . . . . 0.0 110.562 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.33 -3.91 66.67 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.671 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.737 ' HB3' HD21 ' A' ' 20' ' ' LEU . 25.2 mt -128.33 136.95 51.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.817 -1.402 . . . . 0.0 109.344 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -87.84 108.62 19.24 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.737 HD21 ' HB3' ' A' ' 18' ' ' LEU . 1.9 mt -120.8 129.98 53.8 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.105 0.478 . . . . 0.0 110.544 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.626 ' N ' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -104.88 141.9 35.71 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 24' ' ' GLY . 28.8 t -78.74 88.06 4.62 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.03 11.01 0.61 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.591 -0.693 . . . . 0.0 110.499 -177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 22' ' ' SER . . . 125.17 -175.89 17.24 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.421 HD11 HG23 ' E' ' 9' ' ' ILE . 47.0 mm -110.05 141.67 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.364 0.602 . . . . 0.0 109.381 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -109.88 151.89 26.48 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 122.025 0.917 . . . . 0.0 109.628 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.3 m -139.97 143.65 36.63 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.69 147.49 43.76 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.999 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.437 ' O ' ' OG ' ' A' ' 30' ' ' SER . 4.2 tp -127.5 132.98 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 120.935 1.698 . . . . 0.0 106.66 176.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 29' ' ' ILE . 2.0 m 173.29 -161.5 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.907 -1.121 . . . . 0.0 108.991 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -117.67 -75.31 0.58 Allowed 'General case' 0 N--CA 1.512 2.641 0 O-C-N 121.301 -0.874 . . . . 0.0 112.449 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -65.57 149.18 50.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.772 -1.205 . . . . 0.0 108.128 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.46 ' H ' HG13 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -70.45 -40.3 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -52.39 -28.49 19.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.349 -0.845 . . . . 0.0 109.791 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -79.51 -33.13 42.35 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.187 -0.945 . . . . 0.0 109.368 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 33' ' ' VAL . 41.6 mt -60.66 -53.01 54.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.311 -0.868 . . . . 0.0 109.234 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.5 t -54.9 -50.37 62.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.084 -1.01 . . . . 0.0 109.105 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -60.18 -40.07 88.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 110.149 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -65.4 -41.91 93.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.073 -1.017 . . . . 0.0 109.514 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 40' ' ' LEU . 13.3 mt -62.43 -41.38 98.66 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.054 -1.029 . . . . 0.0 109.146 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.542 ' CG ' HH11 ' A' ' 41' ' ' ARG . 0.0 OUTLIER -49.91 -51.3 41.83 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.504 -1.373 . . . . 0.0 109.296 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -61.67 -37.48 84.23 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.774 -1.204 . . . . 0.0 110.68 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -77.1 -36.02 55.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.306 -0.871 . . . . 0.0 110.089 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 t -70.81 -50.56 42.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.425 -0.797 . . . . 0.0 108.965 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -67.74 -29.04 68.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.393 -1.442 . . . . 0.0 109.271 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.71 -31.21 71.0 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.524 0.678 . . . . 0.0 109.385 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -89.27 -5.62 57.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.443 -0.785 . . . . 0.0 109.466 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.09 7.67 63.85 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.77 157.62 41.93 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -129.35 -1.58 5.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.243 -1.151 . . . . 0.0 110.349 -177.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.61 153.02 23.04 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.318 -1.42 . . . . 0.0 109.72 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.7 tp -116.99 139.75 50.29 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.656 -0.908 . . . . 0.0 109.793 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.482 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 22.4 mt -113.13 139.23 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.742 -0.599 . . . . 0.0 110.053 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 67.75 84.38 0.15 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.292 -0.88 . . . . 0.0 110.884 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -122.11 69.94 0.96 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.249 0.547 . . . . 0.0 110.431 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.425 HH22 ' NE ' ' E' ' 56' ' ' ARG . 14.6 ptt180 -98.13 122.68 41.57 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.269 -0.894 . . . . 0.0 109.178 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.5 mt -79.82 129.16 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.341 -0.849 . . . . 0.0 109.449 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.6 p -95.12 156.16 16.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.265 -0.897 . . . . 0.0 109.156 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.1 t -59.02 -52.26 66.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 109.383 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 44.09 79.7 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.541 -0.725 . . . . 0.0 109.576 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.6 67.93 1.15 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.27 -0.894 . . . . 0.0 109.894 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.417 ' O ' ' CD2' ' A' ' 64' ' ' PHE . . . 147.3 -101.13 0.23 Allowed Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -64.84 101.97 0.54 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.336 -1.096 . . . . 0.0 110.184 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.417 ' CD2' ' O ' ' A' ' 62' ' ' GLY . 98.0 m-85 -88.09 140.27 29.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.276 -0.89 . . . . 0.0 109.15 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 tp -165.36 92.9 0.57 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.094 -1.004 . . . . 0.0 111.453 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.53 170.03 10.34 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -158.45 160.19 36.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.99 -1.3 . . . . 0.0 110.045 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.18 -178.02 48.02 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.4 m -118.89 137.69 53.27 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.5 mt -89.31 130.59 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.676 ' HB ' ' HB3' ' A' ' 20' ' ' LEU . 14.0 m -144.27 151.62 15.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 119.352 -0.939 . . . . 0.0 109.189 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.7 pttt -145.48 151.13 37.7 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.1 -1.0 . . . . 0.0 109.167 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.02 150.58 39.71 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.493 ' N ' ' OH ' ' A' ' 21' ' ' TYR . 14.2 p-10 -136.84 -158.17 0.84 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.094 -1.004 . . . . 0.0 108.622 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -99.88 -84.85 0.41 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.312 -0.868 . . . . 0.0 109.47 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.9 157.04 18.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.346 -0.847 . . . . 0.0 109.21 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.419 ' O ' ' O ' ' A' ' 78' ' ' PHE . 13.5 mm100 -135.26 -80.53 0.43 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.38 -0.825 . . . . 0.0 108.927 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.419 ' O ' ' O ' ' A' ' 77' ' ' GLN . 5.3 t80 62.23 125.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.517 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.7 m -163.12 -26.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.907 . . . . 0.0 109.394 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 19.8 mmt -67.4 -101.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.494 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.441 -179.953 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ttt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.699 HD13 ' N ' ' B' ' 2' ' ' ILE . 0.5 OUTLIER -69.98 129.64 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 20.9 t80 70.23 -33.85 0.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.728 -0.608 . . . . 0.0 109.857 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.503 ' H ' ' C ' ' B' ' 2' ' ' ILE . 24.3 tt0 50.62 -131.15 2.04 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.321 -0.862 . . . . 0.0 110.09 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 50.25 40.95 23.47 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.027 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -114.2 121.91 45.17 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.325 -0.859 . . . . 0.0 109.281 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -94.09 117.83 30.66 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.227 -0.921 . . . . 0.0 108.868 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 64.5 mt -112.5 128.02 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.591 -0.693 . . . . 0.0 110.079 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.624 HG23 ' O ' ' B' ' 9' ' ' ILE . 5.7 tt -124.74 113.34 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.3 t -123.52 161.13 25.51 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.907 0.861 . . . . 0.0 109.181 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.572 ' O ' ' C ' ' B' ' 12' ' ' ALA . 12.3 p -99.89 -109.88 0.2 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.173 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.572 ' C ' ' O ' ' B' ' 11' ' ' THR . . . 16.6 -115.03 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 118.486 0.584 . . . . 0.0 111.715 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -111.38 -140.1 0.38 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.623 -0.673 . . . . 0.0 109.312 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -93.93 -157.3 0.54 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.279 -0.888 . . . . 0.0 109.973 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 mt -113.54 98.47 46.98 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.486 -0.759 . . . . 0.0 109.356 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.74 156.83 40.69 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 C-N-CA 121.694 1.596 . . . . 0.0 110.144 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.84 -4.5 75.44 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' B' ' 18' ' ' LEU . 34.3 mt -131.45 141.35 49.79 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.175 -1.191 . . . . 0.0 109.996 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -85.05 107.65 17.26 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 12.9 mt -103.16 137.27 41.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.612 -0.68 . . . . 0.0 109.831 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . 0.53 ' CE1' ' O ' ' B' ' 22' ' ' SER . 1.3 t80 -118.62 130.31 55.8 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.53 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 32.6 t -66.27 134.07 51.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 0.0 111.341 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 8.0 mt -121.07 10.31 10.72 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.6 175.0 15.78 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . 0.451 HD11 ' OG1' ' A' ' 11' ' ' THR . 0.1 OUTLIER -113.32 146.6 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.47 159.72 21.64 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 48.8 m -153.04 147.43 25.88 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.712 ' OG1' HG23 ' B' ' 36' ' ' ILE . 5.2 p -149.64 148.27 29.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 109.533 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.465 ' O ' ' OG ' ' B' ' 30' ' ' SER . 1.3 tp -126.5 127.51 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' B' ' 29' ' ' ILE . 2.8 m -168.27 171.29 9.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.168 -0.958 . . . . 0.0 109.751 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -80.41 -61.05 2.09 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.422 -0.799 . . . . 0.0 112.124 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -74.57 128.26 35.12 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 120.555 -1.341 . . . . 0.0 108.501 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.404 ' H ' HG13 ' B' ' 33' ' ' VAL . 2.1 m -69.33 -33.65 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.613 -0.68 . . . . 0.0 109.182 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -59.57 -29.71 68.14 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.475 -0.765 . . . . 0.0 110.103 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -70.88 -35.93 72.57 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.507 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.712 HG23 ' OG1' ' B' ' 28' ' ' THR . 77.3 mt -61.45 -47.28 94.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.114 -0.991 . . . . 0.0 109.397 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 68.9 t -54.98 -50.6 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.919 -1.113 . . . . 0.0 109.285 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -59.91 -40.63 89.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.393 -0.817 . . . . 0.0 109.585 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -64.65 -41.9 95.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.164 -0.96 . . . . 0.0 109.369 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 73.0 mt -65.75 -44.07 87.02 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 109.027 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -48.79 -46.66 41.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.49 -1.381 . . . . 0.0 109.383 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -65.27 -37.38 87.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.627 -0.671 . . . . 0.0 110.207 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -77.04 -35.03 57.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 109.912 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.64 -51.57 44.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.286 -0.884 . . . . 0.0 108.834 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.07 -30.54 66.71 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 118.108 -1.437 . . . . 0.0 109.216 -175.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.0 -32.14 72.58 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -91.61 -5.49 53.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.728 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.61 3.63 46.58 Favored Glycine 0 N--CA 1.502 3.094 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.78 159.41 47.78 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -126.71 -2.06 6.68 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.352 -1.087 . . . . 0.0 110.471 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -165.42 158.09 30.81 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.324 -1.417 . . . . 0.0 109.612 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 6.1 tp -114.99 137.24 52.23 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.668 -0.901 . . . . 0.0 109.744 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.514 ' O ' ' HB3' ' B' ' 54' ' ' ALA . 68.1 mt -114.35 145.63 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.674 -0.641 . . . . 0.0 110.239 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 69.61 88.9 0.11 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.045 -1.034 . . . . 0.0 111.199 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -142.56 69.48 1.31 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.23 0.538 . . . . 0.0 110.171 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -108.35 146.16 33.41 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mm -109.62 37.26 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -71.03 -131.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 109.48 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . 0.457 ' SG ' ' CE1' ' B' ' 64' ' ' PHE . 84.4 m 56.55 -174.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.513 -0.742 . . . . 0.0 109.569 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -151.87 110.57 3.81 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.276 -0.89 . . . . 0.0 109.628 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -172.94 177.92 2.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.458 -0.776 . . . . 0.0 109.254 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -51.79 -51.42 39.38 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -137.44 -165.6 1.79 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.393 -1.063 . . . . 0.0 109.258 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.457 ' CE1' ' SG ' ' B' ' 59' ' ' CYS . 16.7 t80 -157.0 146.05 20.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 109.761 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.798 HD22 ' N ' ' B' ' 65' ' ' LEU . 2.0 mm? -89.38 148.45 23.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.446 -0.784 . . . . 0.0 109.165 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.12 71.12 0.54 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' TYR . . . . . 0.45 ' CD2' ' O ' ' B' ' 67' ' ' TYR . 49.6 p90 -73.38 126.12 29.42 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.267 -1.137 . . . . 0.0 109.494 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.95 156.44 26.68 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . 0.456 ' OG1' ' OG1' ' A' ' 11' ' ' THR . 48.4 m -103.04 134.89 45.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.861 -1.376 . . . . 0.0 108.523 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 66.1 mt -89.98 134.59 28.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.8 m -141.66 163.12 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 110.48 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -153.78 148.98 26.96 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.36 150.75 30.64 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.129 -0.982 . . . . 0.0 108.494 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' B' ' 74' ' ' ASP . 26.7 p-10 -163.43 58.0 0.18 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.93 -1.106 . . . . 0.0 108.914 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -145.35 102.31 3.7 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.321 -0.862 . . . . 0.0 109.27 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.51 -46.96 2.75 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.57 -0.706 . . . . 0.0 109.371 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -61.79 140.55 58.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 109.415 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -163.08 102.93 0.98 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 109.354 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.36 170.49 8.19 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.524 -0.735 . . . . 0.0 109.363 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' MET . . . . . 0.556 ' N ' ' SD ' ' B' ' 80' ' ' MET . 0.0 OUTLIER -73.81 -80.39 0.07 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.857 . . . . 0.0 109.53 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.529 -179.942 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 41.5 mtt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 tt -161.3 -48.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.335 -0.853 . . . . 0.0 108.934 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -168.93 -78.91 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.306 -0.871 . . . . 0.0 109.149 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 47.76 -133.4 1.26 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 109.495 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' C' ' 6' ' ' LYS . 24.0 t0 -67.08 -147.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.152 -0.968 . . . . 0.0 109.119 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . 0.547 ' O ' ' O ' ' C' ' 50' ' ' MET . 44.8 mtmt -150.61 84.38 1.36 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 109.214 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -104.85 121.53 43.87 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 76.1 mt -134.57 126.66 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.284 -0.885 . . . . 0.0 109.607 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' ILE . . . . . 0.58 HG23 ' O ' ' C' ' 9' ' ' ILE . 14.8 tt -122.06 115.5 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.76 156.88 42.84 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 122.139 0.971 . . . . 0.0 108.849 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -116.24 94.04 4.48 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.53 -108.73 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.799 177.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -148.26 -50.93 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 109.592 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . 0.411 ' HG3' ' H ' ' C' ' 15' ' ' ILE . 3.3 tp10 -154.78 176.8 12.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.168 -0.958 . . . . 0.0 109.294 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . 0.411 ' H ' ' HG3' ' C' ' 14' ' ' GLU . 29.3 mt -124.04 87.74 53.04 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -60.63 156.0 44.89 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.876 1.717 . . . . 0.0 110.238 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.28 -8.81 77.19 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 31.7 mt -132.23 142.79 49.54 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.373 -1.075 . . . . 0.0 109.496 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -86.19 108.66 18.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 14.8 mt -96.71 137.33 35.96 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 109.964 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' TYR . . . . . 0.404 ' N ' ' O ' ' C' ' 72' ' ' LYS . 18.1 t80 -123.5 129.04 50.64 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.1 t -87.56 131.79 34.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.342 -0.849 . . . . 0.0 109.608 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.942 HD23 ' N ' ' C' ' 23' ' ' LEU . 0.2 OUTLIER -123.28 11.53 9.39 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.61 168.49 11.85 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.266 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -106.7 146.18 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.99 144.83 42.45 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 75.2 m -152.68 138.66 18.14 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 12.1 t -149.77 141.06 23.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.843 -1.161 . . . . 0.0 108.644 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.491 HG23 ' O ' ' C' ' 29' ' ' ILE . 15.3 tt -115.31 129.82 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' C' ' 29' ' ' ILE . 6.4 m -169.72 -141.36 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.043 -1.036 . . . . 0.0 109.796 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -157.55 161.73 38.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.248 -0.908 . . . . 0.0 108.972 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 73.81 127.34 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -67.57 -33.68 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.51 -0.744 . . . . 0.0 109.363 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -59.01 -46.69 87.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.358 -0.839 . . . . 0.0 110.176 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -76.03 -40.27 53.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.203 -0.936 . . . . 0.0 109.78 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 71.5 mt -60.29 -39.42 80.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.881 -1.137 . . . . 0.0 109.297 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -69.3 -47.03 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.776 -1.202 . . . . 0.0 109.534 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -60.24 -41.42 93.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.935 . . . . 0.0 109.843 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -58.81 -48.32 81.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 109.941 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 28.4 mt -70.32 -47.59 60.41 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.047 -1.033 . . . . 0.0 109.111 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' ARG . . . . . 0.425 HH21 ' NZ ' ' C' ' 45' ' ' LYS . 39.9 mtp180 -49.44 -48.0 47.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.535 -1.353 . . . . 0.0 109.016 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' C' ' 46' ' ' ALA . 46.1 mtpt -63.8 -37.65 88.17 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 109.831 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' GLN . . . . . 0.574 HE22 ' HZ1' ' C' ' 47' ' ' LYS . 0.0 OUTLIER -75.98 -35.66 59.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 109.912 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 20.2 t -76.63 -51.75 18.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 109.067 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' LYS . . . . . 0.425 ' NZ ' HH21 ' C' ' 41' ' ' ARG . 18.2 mtmt -69.43 -29.94 67.76 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 117.858 -1.537 . . . . 0.0 109.461 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' C' ' 42' ' ' LYS . . . -64.07 -33.38 75.63 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . 0.574 ' HZ1' HE22 ' C' ' 43' ' ' GLN . 0.0 OUTLIER -90.63 2.69 55.64 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.245 -0.91 . . . . 0.0 108.699 179.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.42 29.65 65.75 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.053 -1.546 . . . . 0.0 109.962 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.37 -168.74 24.33 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.057 -1.261 . . . . 0.0 110.053 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . 0.547 ' O ' ' O ' ' C' ' 6' ' ' LYS . 14.6 ttt -108.42 -41.75 4.76 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.567 -0.961 . . . . 0.0 109.692 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 173.96 -153.9 18.19 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 tp -136.01 137.45 41.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.413 -1.051 . . . . 0.0 109.985 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.446 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 49.0 mt -110.52 141.12 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.571 -0.706 . . . . 0.0 109.741 -178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 64.65 75.18 0.38 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.204 -0.935 . . . . 0.0 108.66 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -93.99 140.31 29.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.369 -0.832 . . . . 0.0 109.075 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' ARG . . . . . 0.73 ' HG2' HH11 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -134.57 174.66 10.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.584 -0.698 . . . . 0.0 109.284 179.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 39.8 mt -136.92 154.12 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' THR . . . . . . . . . . . . . 4.7 m -78.85 138.01 37.95 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' CYS . . . . . 0.55 ' SG ' ' N ' ' C' ' 60' ' ' ALA . 15.1 p -65.22 -145.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.145 -0.972 . . . . 0.0 109.514 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.55 ' N ' ' SG ' ' C' ' 59' ' ' CYS . . . -73.15 52.12 0.33 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.362 -0.837 . . . . 0.0 109.409 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' C' ' 60' ' ' ALA . 21.5 t70 60.15 116.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.468 -0.77 . . . . 0.0 109.634 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.03 -10.54 4.8 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . 0.415 ' O ' ' CD2' ' C' ' 64' ' ' PHE . 88.2 tttt -83.78 -93.9 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -1.152 . . . . 0.0 109.507 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' C' ' 63' ' ' LYS . 4.1 m-85 -156.69 -99.28 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 109.043 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.589 HD23 ' N ' ' C' ' 65' ' ' LEU . 1.4 pt? -167.31 -177.79 3.79 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.248 -0.907 . . . . 0.0 110.109 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' C' ' 67' ' ' TYR . . . -64.42 -75.46 0.37 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' TYR . . . . . 0.456 ' CB ' ' O ' ' C' ' 66' ' ' GLY . 3.7 t80 76.55 144.21 0.08 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.428 -1.043 . . . . 0.0 109.958 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 174.35 157.6 16.3 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 21.1 m -98.37 144.26 27.94 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.357 -1.084 . . . . 0.0 109.59 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 56.1 mt -91.19 132.06 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.09 163.14 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.44 0.638 . . . . 0.0 109.854 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' C' ' 21' ' ' TYR . 16.2 ttmm -153.65 141.05 19.7 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.0 150.0 36.52 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.737 -1.227 . . . . 0.0 108.152 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.83 -177.23 4.8 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.982 -1.074 . . . . 0.0 109.029 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -141.25 53.77 1.55 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.346 -0.846 . . . . 0.0 109.342 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.51 -13.42 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.358 -0.839 . . . . 0.0 109.4 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 57.68 -130.3 1.5 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.892 . . . . 0.0 109.517 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -59.07 119.49 7.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.954 . . . . 0.0 109.568 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.447 ' H ' HG22 ' C' ' 79' ' ' THR . 0.0 OUTLIER -71.69 124.37 24.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.283 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 9.8 tpt -60.54 -47.85 84.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.922 . . . . 0.0 109.433 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.474 -179.994 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' ILE . . . . . . . . . . . . . 11.0 pt -62.62 129.62 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.275 -0.891 . . . . 0.0 109.259 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -88.97 106.38 18.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.008 -1.057 . . . . 0.0 109.368 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' D' ' 6' ' ' LYS . 27.2 tt0 -160.86 5.82 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 109.677 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' D' ' 6' ' ' LYS . 4.7 m-20 63.61 -65.21 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' D' ' 4' ' ' GLU . 72.1 tttt 73.15 104.41 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.614 0.721 . . . . 0.0 109.543 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -94.59 124.52 38.67 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.717 -0.615 . . . . 0.0 109.462 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 20.0 mt -115.94 137.71 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.556 -0.715 . . . . 0.0 109.963 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' ILE . . . . . 0.431 ' O ' ' CG2' ' D' ' 9' ' ' ILE . 9.4 tt -119.49 124.28 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.99 130.81 56.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.511 -0.743 . . . . 0.0 109.556 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . 0.403 ' O ' ' HB3' ' D' ' 12' ' ' ALA . 3.1 m -129.79 120.86 25.72 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' D' ' 11' ' ' THR . . . 60.05 12.04 2.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.248 -0.907 . . . . 0.0 109.697 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -126.23 108.38 11.24 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.482 0.658 . . . . 0.0 109.36 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . 0.446 ' HG3' ' H ' ' D' ' 15' ' ' ILE . 8.2 tp10 -62.33 169.42 2.88 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.269 -0.895 . . . . 0.0 108.655 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' ILE . . . . . 0.746 HG23 ' O ' ' D' ' 15' ' ' ILE . 13.1 tt -134.55 60.91 45.73 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.271 -0.893 . . . . 0.0 109.509 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' D' ' 15' ' ' ILE . 2.0 Cg_endo -61.14 157.58 38.93 Favored 'Trans proline' 0 C--N 1.323 -0.787 0 C-N-CA 122.242 1.961 . . . . 0.0 110.171 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.68 -2.77 67.44 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.671 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' D' ' 18' ' ' LEU . 19.1 mt -128.43 138.47 52.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.813 -1.404 . . . . 0.0 109.803 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -85.12 108.69 17.8 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt -97.95 139.36 33.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.356 -0.84 . . . . 0.0 110.516 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -119.85 129.13 54.26 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 10.3 t -71.62 131.25 42.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.48 -1.388 . . . . 0.0 111.105 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' D' ' 72' ' ' LYS . 32.1 mt -115.94 5.86 14.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.38 -176.18 16.01 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.54 143.05 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.9 -0.765 . . . . 0.0 109.158 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.19 162.6 16.83 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.861 0.838 . . . . 0.0 110.34 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 3.4 m -152.21 149.57 28.88 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -151.41 153.24 34.31 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.143 0.973 . . . . 0.0 109.475 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 tt -123.08 145.83 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.029 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 2.1 m 169.92 155.07 0.05 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.392 -0.817 . . . . 0.0 109.547 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' ASP . . . . . 0.496 ' O ' ' ND2' ' D' ' 32' ' ' ASN . 1.8 p30 -100.09 63.78 1.18 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.303 -0.873 . . . . 0.0 109.627 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' D' ' 31' ' ' ASP . 0.2 OUTLIER 176.84 132.76 0.05 Allowed 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . 0.429 ' H ' HG13 ' D' ' 33' ' ' VAL . 2.0 m -69.81 -40.89 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -63.31 -32.67 74.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.488 -0.757 . . . . 0.0 109.915 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -74.1 -39.34 63.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.246 -0.909 . . . . 0.0 109.109 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 mt -60.34 -48.99 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.35 -0.844 . . . . 0.0 108.963 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 63.0 t -57.48 -45.41 85.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.717 0 O-C-N 121.13 -0.981 . . . . 0.0 108.518 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -63.84 -43.1 97.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.186 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' ASN . . . . . 0.449 ' N ' HD22 ' D' ' 39' ' ' ASN . 1.5 m120 -57.95 -47.74 82.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.132 -0.98 . . . . 0.0 109.548 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 26.6 mt -63.95 -41.58 97.56 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 109.259 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -51.51 -39.84 58.44 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.443 -1.41 . . . . 0.0 109.815 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -72.95 -40.62 65.21 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.388 -0.82 . . . . 0.0 110.238 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -76.32 -36.15 58.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.389 -0.82 . . . . 0.0 109.704 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.97 -49.82 64.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.453 -0.78 . . . . 0.0 108.927 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -70.47 -31.22 68.27 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 118.087 -1.445 . . . . 0.0 108.989 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.06 -33.71 76.37 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -87.17 0.62 55.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.472 -0.768 . . . . 0.0 109.393 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.0 2.49 74.68 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.3 158.58 49.4 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.95 -1.3 5.92 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.261 -1.141 . . . . 0.0 110.196 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.04 168.29 40.69 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . 0.413 HD21 ' HA3' ' D' ' 68' ' ' GLY . 2.7 tp -131.7 137.98 48.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.601 -0.941 . . . . 0.0 109.291 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' D' ' 54' ' ' ALA . 1.9 pt -106.72 144.24 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.515 -0.74 . . . . 0.0 109.538 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 65.77 76.36 0.32 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 0.0 109.815 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.539 ' O ' ' CG ' ' D' ' 55' ' ' PHE . 62.6 t80 -106.36 34.44 3.38 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' ARG . . . . . 0.573 ' NH1' HH22 ' E' ' 56' ' ' ARG . 25.5 mtm180 -54.89 126.39 24.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.989 -1.069 . . . . 0.0 109.42 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' ILE . . . . . . . . . . . . . 48.1 mm -62.66 153.97 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.295 -0.878 . . . . 0.0 109.38 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' THR . . . . . 0.465 HG23 ' H ' ' D' ' 59' ' ' CYS . 0.1 OUTLIER -79.3 -87.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.418 -0.802 . . . . 0.0 109.443 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' CYS . . . . . 0.465 ' H ' HG23 ' D' ' 58' ' ' THR . 49.4 t -165.42 161.82 19.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.943 . . . . 0.0 109.482 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . 49.57 78.25 0.1 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 109.648 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 45.1 t0 48.56 -99.29 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 109.614 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 62' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' D' ' 64' ' ' PHE . . . -162.76 26.35 0.23 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -77.47 18.97 0.38 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -1.148 . . . . 0.0 109.781 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' D' ' 62' ' ' GLY . 12.9 m-85 -112.6 -89.92 0.51 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.451 -0.781 . . . . 0.0 109.091 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . . . . . . . . . 10.2 tp -161.84 -114.29 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.551 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . 152.79 143.59 3.72 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 67' ' ' TYR . . . . . 0.488 ' O ' ' CD2' ' D' ' 67' ' ' TYR . 16.4 p90 -134.16 106.91 7.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.781 -0.835 . . . . 0.0 109.47 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 68' ' ' GLY . . . . . 0.413 ' HA3' HD21 ' D' ' 52' ' ' LEU . . . -127.35 166.51 20.06 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 54.7 m -110.71 138.08 47.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.109 -1.23 . . . . 0.0 108.482 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 70' ' ' ILE . . . . . 0.491 HG22 HD12 ' D' ' 23' ' ' LEU . 41.0 mt -84.32 150.3 4.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -142.24 158.96 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.138 -0.976 . . . . 0.0 109.993 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 72' ' ' LYS . . . . . 0.674 ' HB2' HD11 ' D' ' 23' ' ' LEU . 5.2 ttpt -144.44 154.32 42.83 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.68 151.86 42.66 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -137.97 178.87 6.79 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.019 -1.051 . . . . 0.0 108.527 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -158.44 146.33 18.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 109.174 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.23 62.77 1.11 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.352 -0.842 . . . . 0.0 109.502 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -141.92 -140.97 0.13 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.314 -0.866 . . . . 0.0 109.293 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 78' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -78.17 101.3 6.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.545 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 5.7 m -63.98 -42.95 97.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.197 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 11.8 tpp -150.07 -137.11 0.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.282 -0.886 . . . . 0.0 109.465 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.494 -179.911 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 8.1 ptp . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.234 0.54 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . 0.484 ' O ' ' C ' ' E' ' 3' ' ' PHE . 14.4 mt 48.37 48.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.349 -0.844 . . . . 0.0 109.549 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 3' ' ' PHE . . . . . 0.484 ' C ' ' O ' ' E' ' 2' ' ' ILE . 9.3 p90 34.08 47.25 0.18 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.553 -0.717 . . . . 0.0 110.268 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.75 107.0 1.89 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.327 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 5' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -69.33 -143.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.464 -0.772 . . . . 0.0 108.958 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -94.27 77.67 3.96 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.081 -1.012 . . . . 0.0 109.838 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -93.99 118.71 31.88 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.056 -1.027 . . . . 0.0 109.328 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 71.7 mt -111.65 129.18 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.588 -0.695 . . . . 0.0 110.113 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 9' ' ' ILE . . . . . 0.623 HG23 ' O ' ' E' ' 9' ' ' ILE . 17.4 tt -130.08 113.36 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 3.7 t -122.88 161.68 23.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.264 -0.897 . . . . 0.0 108.784 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 11' ' ' THR . . . . . . . . . . . . . 3.1 p -113.07 85.71 2.23 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.68 -124.12 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.351 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 13' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' E' ' 14' ' ' GLU . 1.0 OUTLIER -162.34 92.68 0.83 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.431 -0.793 . . . . 0.0 109.031 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . 0.541 ' H ' HG21 ' E' ' 53' ' ' ILE . 12.1 tt0 75.46 150.35 0.11 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.875 -0.515 . . . . 0.0 110.069 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.38 97.13 50.43 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -60.09 154.9 48.22 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.608 1.539 . . . . 0.0 110.507 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.33 -5.78 77.97 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 18' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' E' ' 18' ' ' LEU . 17.1 mt -130.99 140.88 50.19 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.267 -1.137 . . . . 0.0 110.058 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 19' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' E' ' 73' ' ' ALA . 3.2 mp0 -83.64 109.48 17.48 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 18.0 mt -97.92 135.84 39.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.077 -1.014 . . . . 0.0 110.464 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 21' ' ' TYR . . . . . 0.434 ' H ' ' H ' ' E' ' 72' ' ' LYS . 1.2 t80 -119.85 129.41 54.39 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 22' ' ' SER . . . . . 0.425 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 16.4 t -61.65 127.41 31.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.628 -1.295 . . . . 0.0 111.587 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' E' ' 23' ' ' LEU . 7.5 mt -114.61 9.36 16.54 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.74 -177.62 16.86 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 50.3 mm -113.13 140.93 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.659 -0.907 . . . . 0.0 109.325 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.92 146.02 43.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.663 -0.648 . . . . 0.0 109.395 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 68.1 m -152.2 140.19 20.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.9 -1.125 . . . . 0.0 108.137 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.23 150.96 33.44 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.079 -1.013 . . . . 0.0 108.747 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 mm -120.03 135.05 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.4 -0.813 . . . . 0.0 109.487 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.87 159.93 18.85 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.517 -0.739 . . . . 0.0 109.896 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 31' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -83.18 -60.63 2.09 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.521 -0.737 . . . . 0.0 112.707 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -79.7 147.87 31.78 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.662 -1.274 . . . . 0.0 108.306 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 94.7 t -68.31 -34.59 66.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.696 -0.627 . . . . 0.0 109.626 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.11 -35.21 59.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.306 -0.871 . . . . 0.0 110.073 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -78.57 -33.63 47.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.057 -1.027 . . . . 0.0 109.188 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.08 -52.9 53.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 120.866 -1.146 . . . . 0.0 109.603 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.88 -50.52 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.084 -1.01 . . . . 0.0 110.145 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -57.21 -37.52 72.35 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.24 -0.913 . . . . 0.0 109.102 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -69.16 -40.48 78.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.937 -1.102 . . . . 0.0 110.137 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 39.3 mt -72.05 -49.62 35.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.882 -1.137 . . . . 0.0 109.196 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -48.1 -48.88 33.48 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.664 -1.272 . . . . 0.0 109.169 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -57.93 -32.9 68.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.317 -0.864 . . . . 0.0 109.32 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -73.38 -35.25 65.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.166 -0.959 . . . . 0.0 109.435 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.11 -51.34 20.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 120.56 -1.337 . . . . 0.0 109.083 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.35 -30.96 8.43 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.48 1.133 . . . . 0.0 109.699 -176.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.6 -25.11 49.62 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.59 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -95.65 13.53 26.01 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.07 29.87 29.43 Favored Glycine 0 N--CA 1.486 1.971 0 C-N-CA 118.032 -2.032 . . . . 0.0 109.877 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.37 -164.42 6.13 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -114.59 -35.68 4.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.59 -0.947 . . . . 0.0 110.011 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 172.33 -169.97 43.05 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 tp -118.54 140.86 49.22 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.404 -1.057 . . . . 0.0 110.173 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 53' ' ' ILE . . . . . 0.541 HG21 ' H ' ' E' ' 14' ' ' GLU . 64.5 mt -113.13 143.02 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.587 -0.696 . . . . 0.0 110.803 -178.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . 62.39 75.7 0.39 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 110.176 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -97.53 85.62 3.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.497 -0.752 . . . . 0.0 109.287 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 56' ' ' ARG . . . . . 0.573 HH22 ' NH1' ' D' ' 56' ' ' ARG . 28.6 ttm180 -84.44 160.44 20.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.405 -0.809 . . . . 0.0 109.621 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 76.6 mt -137.19 97.6 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.415 -0.803 . . . . 0.0 108.905 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 58' ' ' THR . . . . . . . . . . . . . 23.3 p -67.29 152.32 45.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.141 -0.974 . . . . 0.0 109.254 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 59' ' ' CYS . . . . . . . . . . . . . 69.3 m -149.08 125.33 10.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.206 -0.934 . . . . 0.0 109.479 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -175.97 -74.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.859 . . . . 0.0 109.353 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -164.45 87.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.889 . . . . 0.0 109.459 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.27 -11.4 6.64 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -71.94 0.89 8.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -1.155 . . . . 0.0 109.616 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 64' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -50.96 124.11 10.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.266 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 27.0 tp -152.54 125.76 8.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.306 -0.871 . . . . 0.0 108.886 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 66' ' ' GLY . . . . . . . . . . . . . . . -122.59 127.07 6.59 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -148.36 -170.16 3.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -1.138 . . . . 0.0 109.663 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . 162.04 170.18 26.44 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 1.9 m -98.34 136.26 38.75 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 49.9 mt -81.69 143.31 12.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 71' ' ' VAL . . . . . 0.461 HG21 HD11 ' E' ' 53' ' ' ILE . 2.7 m -129.33 158.45 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.361 -0.837 . . . . 0.0 109.654 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 72' ' ' LYS . . . . . 0.434 ' H ' ' H ' ' E' ' 21' ' ' TYR . 16.1 tttm -139.47 156.66 46.8 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' E' ' 19' ' ' GLN . . . -117.31 113.88 22.78 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.016 0.912 . . . . 0.0 111.765 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -169.99 101.81 0.3 Allowed 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.132 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -154.09 -33.58 0.11 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.926 -1.109 . . . . 0.0 109.381 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.86 -171.55 3.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.94 . . . . 0.0 109.512 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 77' ' ' GLN . . . . . 0.519 ' N ' ' CD ' ' E' ' 77' ' ' GLN . 2.1 pm0 -163.81 26.36 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 109.495 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -159.68 109.38 1.86 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 0.0 109.457 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 1.6 t -172.74 43.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.384 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 80' ' ' MET . . . . . 0.529 ' N ' ' SD ' ' E' ' 80' ' ' MET . 1.9 mpt? 47.42 -118.09 0.88 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 109.545 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.377 179.851 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 mmt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 74.6 mt -80.54 -33.95 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.336 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 24.5 t80 58.04 97.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 109.397 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -54.9 158.62 2.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.246 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -103.44 99.54 9.38 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.284 -0.885 . . . . 0.0 109.252 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -87.67 156.19 19.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.243 -0.911 . . . . 0.0 109.16 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -94.49 124.28 38.42 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.168 -0.957 . . . . 0.0 109.86 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.6 mt -114.64 138.15 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.548 -0.72 . . . . 0.0 109.62 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.611 ' O ' HG23 ' A' ' 9' ' ' ILE . 12.8 tt -134.97 115.16 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.518 -0.738 . . . . 0.0 109.326 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.8 t -122.16 157.96 30.4 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.28 113.33 22.83 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.47 80.3 0.19 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 122.119 0.961 . . . . 0.0 109.819 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 14' ' ' GLU . 19.2 t0 -152.98 -140.95 0.1 Allowed 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.718 -0.614 . . . . 0.0 109.413 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 4.0 tm-20 -167.7 -22.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.496 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.419 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 11.6 mt 52.88 64.51 7.12 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.338 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 15' ' ' ILE . 2.4 Cg_endo -62.14 154.81 60.15 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 122.018 1.812 . . . . 0.0 110.12 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.56 -10.07 75.6 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.454 ' HA ' HD23 ' A' ' 18' ' ' LEU . 35.5 mt -123.13 136.14 54.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.299 -1.118 . . . . 0.0 109.214 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -97.99 112.92 24.68 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.08 137.05 54.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.615 -0.678 . . . . 0.0 109.244 -178.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.62 ' N ' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -108.22 153.22 23.51 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.433 ' HA ' HG12 ' A' ' 71' ' ' VAL . 32.1 t -74.33 132.77 42.35 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.753 0.787 . . . . 0.0 110.769 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 mt -119.85 17.62 12.61 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.654 0.74 . . . . 0.0 109.119 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.8 176.84 16.6 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.408 HD13 HG23 ' E' ' 9' ' ' ILE . 1.0 OUTLIER -114.62 144.48 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.397 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.78 144.71 45.08 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.88 141.55 21.81 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.87 -1.144 . . . . 0.0 107.926 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -150.21 151.66 33.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.963 -1.085 . . . . 0.0 109.072 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.7 mt -114.02 128.08 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.45 -0.781 . . . . 0.0 109.101 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.7 p -177.74 178.67 0.97 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.85 . . . . 0.0 108.93 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -118.46 168.1 10.97 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.519 -0.738 . . . . 0.0 109.03 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 75.09 119.46 0.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.6 t -68.06 -34.59 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.439 -0.788 . . . . 0.0 109.159 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -59.26 -40.41 85.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.883 . . . . 0.0 110.231 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -75.89 -38.59 57.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.226 -0.921 . . . . 0.0 109.628 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.2 mt -62.2 -46.66 95.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.036 -1.04 . . . . 0.0 109.365 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.2 t -56.95 -48.73 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.947 -1.096 . . . . 0.0 108.913 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.22 -42.58 99.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.364 -0.835 . . . . 0.0 110.366 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -57.09 -49.02 77.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 109.497 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 40' ' ' LEU . 43.0 mt -68.64 -45.07 72.79 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.098 -1.001 . . . . 0.0 108.714 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -51.45 -48.31 62.8 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.888 -1.133 . . . . 0.0 109.88 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -63.69 -37.29 86.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.44 -0.787 . . . . 0.0 110.23 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -76.56 -35.54 58.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.388 -0.82 . . . . 0.0 109.835 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.3 t -68.09 -51.04 52.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.996 -1.065 . . . . 0.0 108.857 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -65.99 -32.75 74.41 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.15 -1.42 . . . . 0.0 109.555 -175.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.45 -28.47 69.7 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.9 -4.71 57.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.522 -0.736 . . . . 0.0 109.864 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.09 10.45 59.71 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.5 156.53 39.09 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.435 ' SD ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -123.08 -11.54 8.03 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.389 -1.066 . . . . 0.0 109.327 -178.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.435 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -154.55 162.29 30.63 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.3 tp -128.91 139.99 51.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.677 -0.896 . . . . 0.0 109.489 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.498 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 59.9 mt -113.3 144.41 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.568 -0.707 . . . . 0.0 109.684 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 67.48 72.85 0.33 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.263 -0.898 . . . . 0.0 110.081 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.508 ' CG ' ' O ' ' A' ' 55' ' ' PHE . 65.8 t80 -95.31 45.59 1.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 108.965 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.2 tpp180 -44.2 128.99 6.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.418 -0.801 . . . . 0.0 109.94 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 58' ' ' THR . 5.6 mm -69.63 161.81 4.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.367 -0.833 . . . . 0.0 109.318 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.461 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.9 OUTLIER -144.55 65.22 1.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.453 -0.78 . . . . 0.0 109.281 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.1 p -49.01 -37.23 19.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.55 -174.71 0.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 109.344 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -156.87 -5.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.216 -0.927 . . . . 0.0 109.497 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.62 -128.8 0.02 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -71.87 -0.88 12.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.193 -1.181 . . . . 0.0 109.722 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -97.16 156.57 16.34 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.411 -0.805 . . . . 0.0 108.956 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 65' ' ' LEU . 1.4 pt? -169.16 179.02 4.15 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.468 -0.77 . . . . 0.0 109.852 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.56 164.63 20.0 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.415 ' CD2' HD12 ' E' ' 57' ' ' ILE . 0.2 OUTLIER -166.09 -177.87 4.37 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.358 -1.084 . . . . 0.0 109.695 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 178.57 171.32 41.72 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.631 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.704 ' OG1' ' OG1' ' E' ' 11' ' ' THR . 86.8 m -103.15 135.9 43.94 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.206 -1.173 . . . . 0.0 108.776 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.6 mt -85.06 121.67 37.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 22' ' ' SER . 16.7 m -139.23 157.44 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 O-C-N 121.302 -0.874 . . . . 0.0 109.817 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -149.51 153.61 37.47 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.096 -1.002 . . . . 0.0 109.449 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.57 150.99 30.58 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.174 -0.954 . . . . 0.0 108.931 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.585 ' N ' ' OH ' ' A' ' 21' ' ' TYR . 1.9 p-10 -78.22 -2.38 37.47 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.151 -0.968 . . . . 0.0 109.291 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 61.62 40.74 13.06 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.788 -0.57 . . . . 0.0 109.788 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 48.43 -166.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.227 -0.921 . . . . 0.0 109.446 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 44.04 71.41 0.25 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.411 -0.806 . . . . 0.0 109.627 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -157.5 -62.89 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.931 . . . . 0.0 109.518 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.7 p -68.79 86.78 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 19.5 mtt 48.1 78.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.915 . . . . 0.0 109.608 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.434 -179.96 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 53.2 mtp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 15.9 pt -88.61 16.75 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.225 -0.922 . . . . 0.0 109.475 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -59.36 148.61 31.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.446 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.429 ' H ' ' H ' ' B' ' 5' ' ' ASP . 18.0 pt-20 -165.96 -4.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 0.0 109.495 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.429 ' H ' ' H ' ' B' ' 4' ' ' GLU . 37.2 p-10 -155.63 156.67 35.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.404 -0.81 . . . . 0.0 109.218 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -109.73 -69.64 0.85 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.589 -0.695 . . . . 0.0 109.915 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -114.4 151.31 33.32 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 90.8 mt -122.3 129.7 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.24 -0.913 . . . . 0.0 109.833 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.536 HG23 ' O ' ' B' ' 9' ' ' ILE . 16.6 tt -134.27 118.66 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t -125.54 152.91 44.41 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.097 -1.002 . . . . 0.0 108.557 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.624 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 1.0 OUTLIER -96.89 79.99 2.97 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.451 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' B' ' 11' ' ' THR . . . 148.76 -98.41 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 35.8 t70 178.1 56.02 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -96.27 81.84 3.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.075 -1.016 . . . . 0.0 109.994 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.621 ' N ' ' HD3' ' B' ' 16' ' ' PRO . 5.7 mt -144.08 52.78 2.01 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.455 -0.778 . . . . 0.0 109.213 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.621 ' HD3' ' N ' ' B' ' 15' ' ' ILE . 2.1 Cg_endo -62.73 151.98 80.82 Favored 'Trans proline' 0 C--N 1.322 -0.865 0 C-N-CA 121.883 1.722 . . . . 0.0 109.945 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.43 -9.08 78.17 Favored Glycine 0 N--CA 1.484 1.874 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.23 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' LEU . . . . . 0.426 HD12 ' CG2' ' B' ' 15' ' ' ILE . 71.2 mt -126.63 139.59 53.06 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 119.038 1.419 . . . . 0.0 108.879 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' B' ' 73' ' ' ALA . 23.0 mp0 -84.33 115.45 22.5 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.5 mt -89.67 138.69 31.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.802 -1.186 . . . . 0.0 110.174 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . 0.461 ' H ' ' H ' ' B' ' 72' ' ' LYS . 31.1 t80 -120.02 128.91 53.97 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.54 -0.725 . . . . 0.0 109.644 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 30.2 t -77.69 132.97 38.43 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 120.59 -1.319 . . . . 0.0 109.858 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.444 HD11 ' CB ' ' B' ' 72' ' ' LYS . 37.5 mt -116.99 9.54 13.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.576 -0.703 . . . . 0.0 109.112 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.49 -170.67 17.39 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 33.9 mm -112.4 141.58 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.984 -0.715 . . . . 0.0 109.263 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.43 144.02 42.59 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.52 -0.738 . . . . 0.0 109.591 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 70.0 m -152.24 138.99 18.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 108.786 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 11.9 t -149.65 141.21 23.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.993 -1.067 . . . . 0.0 109.333 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.63 ' N ' HD12 ' B' ' 29' ' ' ILE . 4.4 mp -111.74 125.57 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.164 -0.96 . . . . 0.0 109.244 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 45.5 p -173.74 -145.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.685 -0.634 . . . . 0.0 109.723 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 11.3 m-20 -157.68 164.89 36.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.289 -0.882 . . . . 0.0 109.137 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 21.4 t30 75.75 132.0 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 108.823 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 44.8 t -65.06 -32.1 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.66 -0.65 . . . . 0.0 109.493 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -58.72 -46.61 86.97 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.281 -0.887 . . . . 0.0 110.126 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.46 -41.11 61.35 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.352 -0.842 . . . . 0.0 109.756 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.64 -44.76 99.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 120.887 -1.133 . . . . 0.0 109.333 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 33.1 t -68.8 -47.11 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.856 -1.152 . . . . 0.0 109.574 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.99 -43.17 99.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.132 -0.98 . . . . 0.0 110.009 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -58.33 -48.71 79.68 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.32 -0.862 . . . . 0.0 109.67 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 52.4 mt -70.13 -47.88 59.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.083 -1.011 . . . . 0.0 108.662 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -49.79 -52.62 30.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.882 -1.136 . . . . 0.0 109.523 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -59.35 -35.69 74.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.315 -0.866 . . . . 0.0 110.084 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -75.53 -35.85 60.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.743 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 24.2 t -71.39 -50.93 37.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.11 -0.994 . . . . 0.0 109.104 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -70.35 -36.79 74.42 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.104 -1.438 . . . . 0.0 109.401 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.7 -34.19 69.19 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -85.09 3.72 37.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.25 -0.906 . . . . 0.0 109.053 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.95 7.94 84.84 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.86 -158.48 1.09 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' B' ' 50' ' ' MET . 0.0 OUTLIER -170.47 -26.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.177 -1.19 . . . . 0.0 110.164 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -136.77 159.14 24.45 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 5.4 tp -138.39 143.08 39.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.414 -1.05 . . . . 0.0 109.39 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.561 ' O ' ' HB3' ' B' ' 54' ' ' ALA . 0.6 OUTLIER -106.79 150.24 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.493 -0.754 . . . . 0.0 108.979 -179.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 75.82 177.5 0.2 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.62 ' O ' ' CG ' ' B' ' 55' ' ' PHE . 36.5 t80 170.98 11.79 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 121.646 2.021 . . . . 0.0 106.143 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.696 ' CG ' HH11 ' B' ' 56' ' ' ARG . 0.0 OUTLIER -44.08 122.46 2.91 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.392 -1.442 . . . . 0.0 109.854 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 pt -104.4 172.75 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.561 -0.712 . . . . 0.0 109.421 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 47.3 p -150.99 129.72 12.34 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.354 -0.841 . . . . 0.0 109.301 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 83.0 m -70.19 -174.71 0.85 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.39 133.95 48.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.214 -0.929 . . . . 0.0 109.371 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -149.0 -66.92 0.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.227 -0.92 . . . . 0.0 109.366 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -171.4 -48.69 0.04 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -144.48 -14.14 0.58 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.073 -1.251 . . . . 0.0 109.321 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -49.82 152.89 1.4 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.174 -0.954 . . . . 0.0 109.211 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.557 ' N ' HD23 ' B' ' 65' ' ' LEU . 1.5 pt? -161.15 176.59 11.13 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 122.543 1.164 . . . . 0.0 110.053 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.98 158.82 18.3 Favored Glycine 0 N--CA 1.505 3.294 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -161.14 174.87 13.04 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.16 -1.2 . . . . 0.0 109.691 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.72 -165.25 32.44 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 55.1 m -126.47 137.77 53.43 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 61.2 mt -85.27 133.31 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 4.4 m -126.42 154.98 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.52 -0.737 . . . . 0.0 109.21 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.461 ' H ' ' H ' ' B' ' 21' ' ' TYR . 5.5 tttt -146.46 137.99 24.58 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' B' ' 19' ' ' GLN . . . -109.41 151.46 26.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.156 -0.965 . . . . 0.0 109.228 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' B' ' 74' ' ' ASP . 35.6 p-10 -130.67 -167.53 1.85 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -167.0 168.79 13.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 109.263 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.64 57.09 0.75 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.533 -0.73 . . . . 0.0 109.345 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 55.75 -147.34 0.53 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.578 -0.701 . . . . 0.0 109.549 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -64.78 160.12 20.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.192 -0.943 . . . . 0.0 109.48 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.438 ' OG1' ' N ' ' B' ' 80' ' ' MET . 2.0 t -73.48 -176.35 2.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.641 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' MET . . . . . 0.438 ' N ' ' OG1' ' B' ' 79' ' ' THR . 13.5 mmt -72.0 114.57 10.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.869 . . . . 0.0 109.41 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.507 -179.982 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 33.4 tpp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 20.5 tt -164.57 142.97 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.887 . . . . 0.0 109.435 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -80.71 -47.49 13.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 109.461 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -163.81 156.41 17.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 109.526 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -68.99 -158.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -120.79 95.66 4.8 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.454 -0.779 . . . . 0.0 110.052 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -93.29 124.98 37.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.309 -0.869 . . . . 0.0 109.214 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 13.2 mt -121.13 147.9 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.461 -0.775 . . . . 0.0 110.655 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' ILE . . . . . 0.633 HG23 ' O ' ' C' ' 9' ' ' ILE . 11.1 tt -137.08 114.42 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.093 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 9.9 t -122.24 158.71 28.88 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.004 0.907 . . . . 0.0 108.848 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . 0.429 HG23 ' OG1' ' D' ' 69' ' ' THR . 1.4 p -85.21 -115.44 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.11 101.36 10.92 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.099 -1.0 . . . . 0.0 109.019 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -167.06 -18.55 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.524 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 59.5 163.2 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.599 -0.688 . . . . 0.0 109.22 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 66.5 mt -125.73 85.09 59.59 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.525 -0.735 . . . . 0.0 109.223 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.44 156.83 39.17 Favored 'Trans proline' 0 C--N 1.324 -0.736 0 C-N-CA 122.024 1.816 . . . . 0.0 110.168 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.05 -6.69 76.36 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 61.6 mt -128.7 137.82 51.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -1.209 . . . . 0.0 108.786 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -87.37 108.35 18.95 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 10.5 mt -93.91 138.45 32.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.4 -0.812 . . . . 0.0 109.652 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' TYR . . . . . 0.416 ' CZ ' ' O ' ' C' ' 22' ' ' SER . 3.0 t80 -123.2 131.82 53.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.502 -0.749 . . . . 0.0 109.252 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . 0.416 ' O ' ' CZ ' ' C' ' 21' ' ' TYR . 0.0 OUTLIER -53.85 128.74 31.15 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.114 -0.991 . . . . 0.0 111.169 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mt -120.14 11.73 11.7 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.899 0.856 . . . . 0.0 109.308 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.5 -169.05 13.23 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' ILE . . . . . 0.427 HD11 HG23 ' B' ' 9' ' ' ILE . 40.5 mm -122.73 139.09 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.683 0.754 . . . . 0.0 109.777 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -110.26 149.96 29.4 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' SER . . . . . 0.525 ' HB3' HD21 ' C' ' 65' ' ' LEU . 29.6 m -143.47 138.83 29.53 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.566 -0.709 . . . . 0.0 109.827 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.428 ' O ' ' CD1' ' C' ' 65' ' ' LEU . 15.1 t -150.01 153.69 36.94 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.186 -0.946 . . . . 0.0 109.154 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' C' ' 30' ' ' SER . 5.5 tp -88.43 144.23 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.491 -1.381 . . . . 0.0 109.958 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.456 ' O ' ' O ' ' C' ' 29' ' ' ILE . 48.0 t -51.59 -106.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.567 -0.708 . . . . 0.0 110.276 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' C' ' 32' ' ' ASN . 34.9 t0 59.78 63.05 1.56 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' C' ' 31' ' ' ASP . 0.5 OUTLIER 89.16 115.67 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -176.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.4 -38.92 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.121 -0.987 . . . . 0.0 109.754 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . 0.485 ' H ' HD22 ' C' ' 32' ' ' ASN . 0.8 OUTLIER -54.14 -30.27 48.44 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.31 -0.869 . . . . 0.0 108.709 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.69 -35.57 70.29 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 70.3 mt -65.23 -52.31 54.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 C-N-CA 118.429 -1.308 . . . . 0.0 110.43 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 85.4 t -71.04 -46.02 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.881 -1.137 . . . . 0.0 109.752 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.06 -43.85 97.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 0.0 109.397 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -64.13 -39.88 94.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.988 -1.07 . . . . 0.0 109.58 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 65.7 mt -68.97 -44.59 72.6 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 108.809 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' ARG . . . . . 0.788 ' HG3' HH11 ' C' ' 41' ' ' ARG . 0.1 OUTLIER -51.25 -53.68 33.09 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.752 -1.217 . . . . 0.0 109.913 -179.109 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' C' ' 46' ' ' ALA . 54.4 mttt -59.48 -37.66 78.8 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.777 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -75.9 -35.02 59.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.133 -0.979 . . . . 0.0 110.091 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' VAL . . . . . 0.421 ' O ' ' HG3' ' C' ' 47' ' ' LYS . 5.2 t -73.97 -51.88 22.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.12 -0.988 . . . . 0.0 108.934 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -72.61 -29.9 63.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 119.972 -1.705 . . . . 0.0 109.488 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' C' ' 42' ' ' LYS . . . -61.11 -29.73 69.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.522 -0.736 . . . . 0.0 109.491 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' C' ' 44' ' ' VAL . 0.0 OUTLIER -103.66 -4.84 23.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.45 -0.782 . . . . 0.0 109.773 -179.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.38 31.58 6.41 Favored Glycine 0 N--CA 1.498 2.825 0 C-N-CA 119.509 -1.329 . . . . 0.0 111.892 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.69 -178.73 52.49 Favored Glycine 0 N--CA 1.487 2.069 0 O-C-N 120.075 -1.838 . . . . 0.0 111.2 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 21.2 ttt -108.31 -40.86 5.04 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.459 -1.024 . . . . 0.0 110.712 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 175.07 -175.81 47.13 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 6.1 tp -110.62 132.07 54.5 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.511 -0.993 . . . . 0.0 109.694 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.434 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 1.2 pt -107.84 143.95 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.573 -0.704 . . . . 0.0 109.562 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 64.55 81.72 0.2 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.973 . . . . 0.0 110.113 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.54 -59.15 5.09 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.764 -0.775 . . . . 0.0 108.931 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' ARG . . . . . 0.589 ' HA ' ' HE ' ' C' ' 56' ' ' ARG . 0.0 OUTLIER 60.07 82.99 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.426 -0.796 . . . . 0.0 109.5 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.0 136.53 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' THR . . . . . . . . . . . . . 14.9 m -162.09 133.58 5.32 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.377 -0.827 . . . . 0.0 109.407 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' CYS . . . . . . . . . . . . . 41.1 t -98.58 135.74 39.67 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.312 -0.868 . . . . 0.0 109.13 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.66 65.65 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 0.0 109.518 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 t70 46.91 44.27 14.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.612 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . 174.41 64.4 0.05 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -55.5 101.32 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -1.164 . . . . 0.0 109.465 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -82.76 -177.09 6.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 109.379 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.525 HD21 ' HB3' ' C' ' 27' ' ' SER . 14.8 tp -88.17 127.74 35.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -0.944 . . . . 0.0 109.466 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . 0.444 ' N ' HD12 ' C' ' 65' ' ' LEU . . . -64.68 166.64 30.89 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' C' ' 67' ' ' TYR . 11.1 p90 -151.66 119.99 6.38 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.913 -1.345 . . . . 0.0 108.923 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -131.82 155.69 21.55 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 81.2 m -104.86 136.36 44.5 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.879 -1.365 . . . . 0.0 107.811 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 33.9 mt -90.45 139.0 18.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 108.746 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -145.08 164.13 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.356 -0.84 . . . . 0.0 110.216 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -150.6 147.74 27.79 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' C' ' 74' ' ' ASP . . . -124.09 150.73 44.68 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.19 -0.944 . . . . 0.0 108.939 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' C' ' 73' ' ' ALA . 3.9 m-20 40.27 100.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.388 -0.82 . . . . 0.0 111.262 178.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' C' ' 76' ' ' ALA . 25.0 tt0 -115.5 -30.27 6.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.306 -0.871 . . . . 0.0 109.348 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' C' ' 75' ' ' GLU . . . 42.66 -145.85 0.06 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -132.29 -135.73 0.19 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.408 -0.807 . . . . 0.0 109.176 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 47.54 29.35 1.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.489 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 70.0 p -53.66 -22.03 8.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.4 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' MET . . . . . 0.405 ' HG2' ' H ' ' C' ' 80' ' ' MET . 11.8 ptt? -78.17 37.86 0.27 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.385 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.44 -179.914 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.431 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.3 0.572 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' ILE . . . . . . . . . . . . . 2.9 tp -165.66 -28.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.909 . . . . 0.0 108.974 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -148.54 -150.26 0.34 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.096 -1.002 . . . . 0.0 109.313 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 54.5 179.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.657 -0.652 . . . . 0.0 109.396 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -148.25 -39.82 0.17 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.145 -0.972 . . . . 0.0 109.414 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -168.88 -111.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.654 -0.654 . . . . 0.0 109.744 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -116.32 120.06 37.68 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.388 -0.82 . . . . 0.0 109.419 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 76.5 mt -99.75 133.78 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.287 -0.883 . . . . 0.0 109.286 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' ILE . . . . . 0.517 HG23 ' O ' ' D' ' 9' ' ' ILE . 20.3 tt -125.1 124.63 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.492 -0.755 . . . . 0.0 109.555 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.512 ' OG1' ' CG ' ' D' ' 13' ' ' ASP . 11.3 t -119.17 131.9 55.91 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m -112.59 114.84 27.68 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.3 -0.875 . . . . 0.0 110.896 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . 51.67 77.39 0.14 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.231 -0.918 . . . . 0.0 109.816 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . 0.563 ' N ' ' OD1' ' D' ' 13' ' ' ASP . 4.5 p-10 178.07 -138.6 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -173.28 171.55 4.01 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.848 -1.157 . . . . 0.0 108.759 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 11.5 mt -129.62 78.45 75.42 Favored Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.76 156.13 44.83 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 122.054 1.836 . . . . 0.0 110.035 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.86 -9.79 74.93 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' D' ' 18' ' ' LEU . 59.1 mt -127.4 136.04 51.3 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 119.032 1.416 . . . . 0.0 108.501 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -86.56 108.05 18.4 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' D' ' 71' ' ' VAL . 6.0 mt -102.81 128.29 49.63 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.506 -0.746 . . . . 0.0 109.853 -178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' D' ' 71' ' ' VAL . 0.5 OUTLIER -119.17 145.98 45.55 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.338 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.3 t -86.87 131.63 34.05 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.455 0.645 . . . . 0.0 110.426 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.943 HD23 ' N ' ' D' ' 23' ' ' LEU . 0.3 OUTLIER -119.56 5.94 11.07 Favored 'General case' 0 N--CA 1.512 2.637 0 CA-C-O 122.948 1.356 . . . . 0.0 108.381 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.46 174.0 21.16 Favored Glycine 0 N--CA 1.497 2.73 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.685 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.12 144.81 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.86 144.19 42.83 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 74.0 m -151.48 139.73 20.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 15.1 t -149.62 147.83 28.59 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.964 -1.085 . . . . 0.0 109.036 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 80.3 mt -117.08 128.17 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.306 -0.871 . . . . 0.0 108.847 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' D' ' 31' ' ' ASP . 12.8 t -177.67 179.62 0.89 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.445 -0.785 . . . . 0.0 108.962 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' D' ' 32' ' ' ASN . 19.4 p-10 -116.06 163.7 15.55 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.558 -0.714 . . . . 0.0 109.555 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 5.8 t-20 75.68 126.3 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.142 -0.974 . . . . 0.0 108.68 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 89.1 t -68.98 -33.73 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.595 -0.691 . . . . 0.0 109.738 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' D' ' 35' ' ' GLU . 1.3 p30 -59.57 -41.52 90.39 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.125 -0.984 . . . . 0.0 109.58 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' GLU . . . . . 0.527 ' N ' ' OD1' ' D' ' 34' ' ' ASP . 16.8 tp10 -75.3 -41.22 57.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.124 -0.985 . . . . 0.0 109.284 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 90.9 mt -64.26 -42.57 95.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 O-C-N 120.962 -1.086 . . . . 0.0 109.232 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 t -64.14 -49.79 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.769 -1.207 . . . . 0.0 109.223 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.09 -38.66 83.59 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.861 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -60.55 -44.06 96.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 109.602 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 35.1 mt -70.37 -46.23 64.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.206 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -51.37 -45.37 62.39 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.767 -1.208 . . . . 0.0 109.601 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -67.3 -39.29 85.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.432 -0.793 . . . . 0.0 110.062 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -75.91 -36.09 59.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.411 -0.806 . . . . 0.0 109.727 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 15.4 t -69.7 -50.77 47.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 108.787 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -64.6 -34.07 77.41 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 118.243 -1.383 . . . . 0.0 109.322 -175.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.93 -30.94 71.94 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.736 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -85.02 -3.97 58.98 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.16 5.09 68.05 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.15 159.97 52.17 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.36 -7.67 7.56 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.424 -1.045 . . . . 0.0 109.379 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.69 166.37 37.95 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . 0.452 HD21 ' HA3' ' D' ' 68' ' ' GLY . 8.0 tp -129.73 142.79 50.64 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.661 -0.905 . . . . 0.0 109.794 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' ILE . . . . . 0.477 ' O ' ' HB3' ' D' ' 54' ' ' ALA . 0.7 OUTLIER -107.41 140.65 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.734 -0.604 . . . . 0.0 110.577 -179.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 67.64 86.47 0.13 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.515 -0.741 . . . . 0.0 110.47 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.472 ' CD2' HD11 ' D' ' 9' ' ' ILE . 4.9 t80 -100.63 37.67 1.66 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.694 0.759 . . . . 0.0 109.743 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' ARG . . . . . 0.791 HH11 ' HG3' ' D' ' 56' ' ' ARG . 0.1 OUTLIER -66.18 130.56 43.64 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.481 -1.387 . . . . 0.0 109.135 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.2 -177.29 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.386 -0.821 . . . . 0.0 109.162 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' THR . . . . . 0.61 ' O ' ' CG ' ' D' ' 64' ' ' PHE . 53.6 m -160.45 76.31 0.59 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' CYS . . . . . . . . . . . . . 43.4 t -146.37 140.32 26.28 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.044 -1.035 . . . . 0.0 109.723 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -179.83 11.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.411 -0.806 . . . . 0.0 109.462 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -162.65 3.57 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.132 -0.98 . . . . 0.0 109.584 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.88 -154.28 16.87 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -98.26 147.44 24.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.344 -1.092 . . . . 0.0 109.394 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . 0.61 ' CG ' ' O ' ' D' ' 58' ' ' THR . 56.6 m-85 -140.83 -105.57 0.15 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.316 -0.865 . . . . 0.0 109.413 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . . . . . . . . . 14.1 tp -176.78 122.49 0.14 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.25 -0.906 . . . . 0.0 110.403 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.75 123.98 5.88 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -137.47 -167.03 2.04 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.557 1.17 . . . . 0.0 110.359 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 68' ' ' GLY . . . . . 0.452 ' HA3' HD21 ' D' ' 52' ' ' LEU . . . 169.66 -176.79 43.44 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 69' ' ' THR . . . . . 0.429 ' OG1' HG23 ' C' ' 11' ' ' THR . 70.9 m -111.64 137.61 49.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.275 -1.132 . . . . 0.0 108.864 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 62.5 mt -84.54 136.71 22.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 71' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' D' ' 20' ' ' LEU . 13.5 m -146.75 151.56 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.543 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.07 164.59 29.38 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.973 -1.08 . . . . 0.0 109.029 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.7 150.83 36.17 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -165.24 95.73 0.67 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.979 -1.076 . . . . 0.0 108.569 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -164.51 -70.18 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.3 -0.875 . . . . 0.0 109.014 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.23 64.34 1.73 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.45 -0.781 . . . . 0.0 109.552 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -166.15 93.86 0.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.448 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 78' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -155.7 147.05 22.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.87 . . . . 0.0 109.355 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 74.0 m 51.43 86.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.881 . . . . 0.0 109.409 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 3.6 mmt -57.53 131.58 50.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.527 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.45 -179.952 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ptt? . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.454 0.645 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 19.9 pt -62.01 -179.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.039 -1.038 . . . . 0.0 109.486 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 3' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' E' ' 3' ' ' PHE . 6.3 p90 -151.52 -34.51 0.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 109.453 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . 0.504 ' CD ' HH21 ' E' ' 41' ' ' ARG . 15.7 tp10 177.34 103.79 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 175.52 72.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.606 -0.684 . . . . 0.0 109.214 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -168.14 59.32 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -0.859 . . . . 0.0 108.923 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -105.36 123.73 48.36 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.655 -0.653 . . . . 0.0 109.762 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 89.7 mt -98.0 123.64 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.072 -1.017 . . . . 0.0 110.672 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 9' ' ' ILE . . . . . 0.572 HG23 ' O ' ' E' ' 9' ' ' ILE . 19.5 tt -137.21 116.66 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 10' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' E' ' 13' ' ' ASP . 15.2 t -124.66 157.29 35.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.0 -1.063 . . . . 0.0 108.934 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 11' ' ' THR . . . . . 0.704 ' OG1' ' OG1' ' A' ' 69' ' ' THR . 0.0 OUTLIER -135.26 128.24 31.49 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.346 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.4 35.37 24.87 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.898 0.856 . . . . 0.0 109.612 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 13' ' ' ASP . . . . . 0.484 ' HB3' ' OG1' ' E' ' 10' ' ' THR . 23.5 t0 -152.48 86.26 1.27 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.617 -0.677 . . . . 0.0 109.355 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -57.81 170.01 0.66 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 108.957 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 40.0 mt -122.32 80.19 45.22 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.358 -0.839 . . . . 0.0 109.116 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.53 156.99 38.75 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.109 1.873 . . . . 0.0 110.083 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.52 -5.48 73.99 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 18' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' E' ' 18' ' ' LEU . 50.0 mt -128.21 136.62 51.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.938 -1.331 . . . . 0.0 108.776 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -86.04 108.61 18.33 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 10.7 mt -95.42 136.58 35.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.329 -0.857 . . . . 0.0 109.703 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 21' ' ' TYR . . . . . 0.427 ' CZ ' ' O ' ' E' ' 22' ' ' SER . 2.4 t80 -121.04 132.3 54.8 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.575 -0.703 . . . . 0.0 109.174 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 22' ' ' SER . . . . . 0.427 ' O ' ' CZ ' ' E' ' 21' ' ' TYR . 0.0 OUTLIER -58.72 130.77 48.49 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.04 -1.037 . . . . 0.0 111.162 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 mt -116.87 12.53 14.76 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.14 -174.08 15.07 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . 0.442 HD11 ' CG2' ' D' ' 9' ' ' ILE . 31.0 mm -112.44 140.87 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.609 -0.936 . . . . 0.0 109.416 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.32 143.98 45.38 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.706 -0.621 . . . . 0.0 109.657 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 4.0 p -152.38 141.61 21.43 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.817 -1.177 . . . . 0.0 108.512 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . 0.416 HG23 ' O ' ' E' ' 28' ' ' THR . 14.2 t -149.64 134.01 17.41 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.107 -0.996 . . . . 0.0 109.152 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 59.9 mt -108.41 127.5 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.333 -0.855 . . . . 0.0 108.909 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 94.5 p -172.55 -140.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.42 -0.8 . . . . 0.0 109.535 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 31' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' E' ' 32' ' ' ASN . 24.7 t70 -155.97 158.67 38.29 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.207 -0.933 . . . . 0.0 109.578 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 32' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 15.1 t30 73.83 126.72 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.19 -0.943 . . . . 0.0 108.867 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.27 -32.16 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.479 -0.763 . . . . 0.0 109.527 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -57.45 -45.59 84.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.876 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -76.05 -38.91 56.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.164 -0.96 . . . . 0.0 109.756 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 79.6 mt -61.78 -49.57 83.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.891 -1.131 . . . . 0.0 109.3 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -62.48 -48.6 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.973 -1.079 . . . . 0.0 109.287 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.67 -39.84 81.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.221 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 39' ' ' ASN . . . . . 0.464 HD22 ' N ' ' E' ' 39' ' ' ASN . 2.0 m120 -64.51 -44.89 89.5 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.24 -0.913 . . . . 0.0 109.688 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 40' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' E' ' 40' ' ' LEU . 27.8 mt -68.63 -45.7 71.17 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.014 -1.054 . . . . 0.0 108.543 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 41' ' ' ARG . . . . . 0.878 ' HG2' HH11 ' E' ' 41' ' ' ARG . 5.3 ttt-85 -47.84 -53.67 14.87 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.79 -1.193 . . . . 0.0 109.054 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -60.01 -35.87 75.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.408 -0.808 . . . . 0.0 110.012 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -77.16 -35.03 56.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.503 -0.748 . . . . 0.0 109.93 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 t -70.45 -51.92 33.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 121.053 -1.029 . . . . 0.0 108.677 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -68.42 -31.8 71.38 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.326 -1.35 . . . . 0.0 109.275 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.75 -29.44 69.95 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.22 -5.62 58.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.589 -0.694 . . . . 0.0 109.686 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.49 3.94 58.38 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.74 163.2 45.75 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -125.15 -10.45 7.06 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.394 -1.062 . . . . 0.0 109.771 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.68 157.92 30.0 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.106 -1.521 . . . . 0.0 109.648 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.43 139.93 46.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.709 -0.877 . . . . 0.0 109.32 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 53' ' ' ILE . . . . . 0.417 HG21 HD13 ' E' ' 53' ' ' ILE . 1.2 pt -106.66 140.06 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.418 -0.801 . . . . 0.0 109.597 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.79 82.2 0.16 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 122.259 1.028 . . . . 0.0 111.73 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 55' ' ' PHE . . . . . 0.48 ' CD1' HD11 ' E' ' 9' ' ' ILE . 45.9 t80 -60.11 -102.84 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.142 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 56' ' ' ARG . . . . . 0.559 ' HE ' ' HA2' ' E' ' 66' ' ' GLY . 6.4 ttm180 -173.84 -125.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.962 -1.086 . . . . 0.0 108.989 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 57' ' ' ILE . . . . . 0.491 ' H ' ' HD2' ' E' ' 56' ' ' ARG . 0.0 OUTLIER 39.34 96.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 121.726 -0.609 . . . . 0.0 109.771 179.03 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 58' ' ' THR . . . . . 0.41 HG22 ' H ' ' E' ' 59' ' ' CYS . 2.0 m -122.7 -134.92 0.29 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 59' ' ' CYS . . . . . 0.41 ' H ' HG22 ' E' ' 58' ' ' THR . 27.1 t -171.5 157.79 4.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.879 . . . . 0.0 109.531 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . 51.53 57.11 6.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 109.877 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -173.85 -12.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.362 -0.836 . . . . 0.0 109.546 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.65 132.79 0.09 OUTLIER Glycine 0 N--CA 1.495 2.58 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 pptp? -163.31 153.15 15.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -1.128 . . . . 0.0 109.619 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 64' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -168.19 35.02 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -0.925 . . . . 0.0 109.471 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.401 ' O ' ' NE ' ' E' ' 56' ' ' ARG . 0.0 OUTLIER -163.57 150.57 12.31 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.3 -0.875 . . . . 0.0 109.213 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 66' ' ' GLY . . . . . 0.559 ' HA2' ' HE ' ' E' ' 56' ' ' ARG . . . -85.69 146.46 21.5 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 176.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -153.9 110.05 3.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.269 -1.136 . . . . 0.0 109.493 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.16 165.93 28.11 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 61.3 m -107.79 137.77 45.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.407 -1.054 . . . . 0.0 108.183 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 28.9 mt -85.37 144.33 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 m -144.77 163.33 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.287 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -153.79 155.43 35.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 0.0 108.749 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.48 150.94 35.69 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.123 -0.986 . . . . 0.0 108.739 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -168.66 53.84 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.964 -1.085 . . . . 0.0 108.666 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -124.44 105.4 9.38 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.496 -0.753 . . . . 0.0 109.341 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . -167.01 -60.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.291 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 77' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -87.16 -177.64 6.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.285 -0.884 . . . . 0.0 109.333 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -88.5 120.29 29.74 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.259 -0.9 . . . . 0.0 109.423 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 25.6 m -160.26 -77.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.42 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 36.6 mtp -81.05 155.06 26.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.294 -0.879 . . . . 0.0 109.563 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.492 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.7 ttp . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.0 pt -144.77 -174.02 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.344 -0.848 . . . . 0.0 109.195 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.468 ' N ' ' CD1' ' A' ' 3' ' ' PHE . 9.2 p90 -145.34 49.77 1.24 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.194 -0.942 . . . . 0.0 109.338 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 60.08 8.29 1.44 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -0.834 . . . . 0.0 109.554 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 50.71 -151.92 0.2 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.889 . . . . 0.0 109.446 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.476 ' HG2' ' N ' ' A' ' 7' ' ' PHE . 29.0 ttmt -152.18 173.51 14.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.387 -0.821 . . . . 0.0 109.786 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.476 ' N ' ' HG2' ' A' ' 6' ' ' LYS . 56.7 t80 -91.68 120.01 32.05 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.33 -0.856 . . . . 0.0 109.437 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.6 mt -115.21 143.51 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.63 -0.669 . . . . 0.0 109.477 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.45 ' CG2' ' O ' ' A' ' 9' ' ' ILE . 11.4 tt -124.69 119.71 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.425 ' OG1' ' OD2' ' A' ' 13' ' ' ASP . 5.5 t -112.32 132.48 54.96 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.372 -0.83 . . . . 0.0 109.351 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.533 ' OG1' ' HB ' ' B' ' 69' ' ' THR . 0.2 OUTLIER -64.05 -135.77 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.387 -0.821 . . . . 0.0 109.919 -179.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.19 80.27 6.29 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.714 0.768 . . . . 0.0 109.843 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.425 ' OD2' ' OG1' ' A' ' 10' ' ' THR . 8.1 p-10 -154.99 -126.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -171.49 171.58 5.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.987 -1.07 . . . . 0.0 109.3 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.1 mt -130.65 75.12 79.35 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.389 -0.82 . . . . 0.0 108.884 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.77 157.65 36.83 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 122.09 1.86 . . . . 0.0 110.177 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.01 -7.49 73.16 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 18' ' ' LEU . 73.3 mt -125.41 137.81 54.01 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.077 -1.249 . . . . 0.0 109.482 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -86.55 108.4 18.56 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 3.7 mt -110.56 128.81 55.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.495 -0.753 . . . . 0.0 109.999 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.596 ' OH ' ' N ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -107.75 149.81 27.73 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.25 126.01 30.21 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.68 14.28 21.19 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.6 178.37 18.48 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.03 143.96 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.958 -0.731 . . . . 0.0 109.174 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.52 154.87 25.25 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.668 -0.645 . . . . 0.0 109.779 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.2 m -128.7 156.46 43.45 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.48 145.98 49.22 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.246 -0.909 . . . . 0.0 109.324 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.418 ' O ' ' CB ' ' A' ' 30' ' ' SER . 2.2 mm -129.13 128.48 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 120.953 1.706 . . . . 0.0 106.797 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 1.2 m 171.86 -165.54 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.919 -1.113 . . . . 0.0 109.303 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -120.84 -70.86 0.76 Allowed 'General case' 0 N--CA 1.513 2.704 0 O-C-N 121.619 -0.675 . . . . 0.0 112.453 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -62.61 149.76 42.48 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.526 -1.359 . . . . 0.0 108.453 176.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.474 ' H ' HG13 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -70.17 -39.98 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.83 -29.44 40.99 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.421 -0.799 . . . . 0.0 109.762 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.402 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 12.8 mm-40 -78.46 -33.91 48.08 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.38 -0.825 . . . . 0.0 109.371 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.6 mt -62.56 -47.64 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.911 . . . . 0.0 109.258 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.25 -53.17 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.738 -1.226 . . . . 0.0 110.267 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -57.2 -36.9 71.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.203 -0.936 . . . . 0.0 109.95 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 35' ' ' GLU . 76.8 m-20 -64.71 -43.44 93.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.201 -0.937 . . . . 0.0 110.132 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 40' ' ' LEU . 21.1 mt -69.89 -45.86 66.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.935 -1.103 . . . . 0.0 109.53 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -48.97 -45.88 42.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.8 -1.188 . . . . 0.0 109.223 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -64.52 -36.62 84.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.479 -0.763 . . . . 0.0 110.182 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -75.53 -36.16 60.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.365 -0.835 . . . . 0.0 109.824 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.8 t -69.24 -50.13 55.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.126 -0.984 . . . . 0.0 109.487 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -64.76 -29.7 70.68 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.013 -175.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.2 -32.09 69.85 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.498 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.88 3.29 34.5 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.479 -0.763 . . . . 0.0 109.099 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.84 4.33 88.21 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.88 -157.22 0.4 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -166.11 -23.46 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.203 -1.174 . . . . 0.0 110.023 178.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.548 ' N ' ' SD ' ' A' ' 50' ' ' MET . . . -151.18 143.9 11.09 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.6 tp -106.84 138.98 41.98 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.962 . . . . 0.0 109.357 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.8 OUTLIER -109.48 139.67 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.604 -0.685 . . . . 0.0 110.628 -178.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 73.09 85.24 0.11 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.679 -0.638 . . . . 0.0 110.586 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -111.47 121.2 44.57 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -140.39 105.87 5.08 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -0.853 . . . . 0.0 109.422 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.7 mt -63.95 139.5 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.363 -0.836 . . . . 0.0 109.248 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.7 m -77.27 -94.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 109.448 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.9 p -156.79 174.13 15.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.07 -1.018 . . . . 0.0 109.405 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.37 136.65 32.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.268 -0.895 . . . . 0.0 109.544 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 50.03 85.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 109.768 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 64' ' ' PHE . . . 150.79 136.32 2.5 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 1.5 mptp? 65.44 -45.28 0.37 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.456 ' N ' ' O ' ' A' ' 62' ' ' GLY . 46.7 m-85 47.44 47.96 16.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.24 -0.913 . . . . 0.0 109.706 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.491 HD23 ' O ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER 177.96 141.41 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.32 -0.863 . . . . 0.0 109.25 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -122.61 -125.86 3.12 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -172.2 137.35 0.89 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.793 -1.416 . . . . 0.0 110.185 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.27 148.04 17.47 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 79.5 m -105.12 143.0 33.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.015 -1.286 . . . . 0.0 109.384 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.8 mt -91.66 143.72 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.41 -0.806 . . . . 0.0 109.102 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 20' ' ' LEU . 10.6 m -142.27 151.97 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 109.101 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -141.09 143.82 34.55 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.16 -0.962 . . . . 0.0 108.933 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.591 ' O ' ' CB ' ' A' ' 74' ' ' ASP . . . -124.44 152.58 43.12 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.596 ' N ' ' OH ' ' A' ' 21' ' ' TYR . 25.6 t0 97.57 85.5 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 CA-C-O 121.221 0.534 . . . . 0.0 110.213 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -139.8 -48.73 0.47 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.32 -0.862 . . . . 0.0 109.168 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.502 ' O ' ' C ' ' A' ' 77' ' ' GLN . . . -168.31 44.08 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 109.182 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 79' ' ' THR . 1.1 tm0? -30.58 -52.69 0.17 Allowed 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.345 0.593 . . . . 0.0 110.453 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -64.27 72.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.395 -0.816 . . . . 0.0 109.476 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.4 m -166.48 144.14 5.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.897 . . . . 0.0 109.215 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.51 18.07 4.14 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.282 -0.886 . . . . 0.0 109.217 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.519 179.846 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.531 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 9.8 mm -75.52 -27.02 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.204 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -71.73 -159.93 0.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.248 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.432 ' N ' ' CD ' ' B' ' 4' ' ' GLU . 15.5 mp0 -122.97 77.48 1.46 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.517 -0.739 . . . . 0.0 109.293 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' B' ' 6' ' ' LYS . 22.5 t70 -136.08 -148.87 0.31 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.537 -0.727 . . . . 0.0 109.15 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.516 ' H ' ' CG ' ' B' ' 5' ' ' ASP . 32.3 tttm 63.91 121.61 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.867 . . . . 0.0 109.536 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -106.46 118.89 37.83 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.368 -0.833 . . . . 0.0 109.526 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.5 mt -112.08 132.73 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.625 HG23 ' O ' ' B' ' 9' ' ' ILE . 10.1 tt -125.78 114.39 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.78 158.93 32.13 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.412 -0.805 . . . . 0.0 108.945 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 12.6 p -110.64 86.52 2.33 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.38 -110.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.685 -0.635 . . . . 0.0 109.914 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -147.02 -161.35 1.31 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.227 -0.92 . . . . 0.0 109.576 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . 0.418 ' O ' ' HD3' ' B' ' 16' ' ' PRO . 0.7 OUTLIER -58.84 131.45 51.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.421 -0.799 . . . . 0.0 109.583 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.03 110.2 3.01 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' B' ' 14' ' ' GLU . 1.9 Cg_endo -63.68 154.11 71.17 Favored 'Trans proline' 0 N--CA 1.481 0.746 0 C-N-CA 121.286 1.324 . . . . 0.0 110.26 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.44 -6.68 82.23 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.32 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 73.2 mt -129.94 142.43 50.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -1.139 . . . . 0.0 109.976 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -87.7 108.25 19.02 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -93.29 140.52 29.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.156 -0.965 . . . . 0.0 110.484 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . 0.454 ' H ' ' H ' ' B' ' 72' ' ' LYS . 1.3 t80 -123.2 131.3 53.63 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.405 ' N ' ' CD1' ' B' ' 21' ' ' TYR . 11.8 t -59.5 129.75 43.5 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.085 -1.009 . . . . 0.0 110.607 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' B' ' 23' ' ' LEU . 7.1 mt -117.07 9.24 13.56 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.78 173.77 16.38 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 49.3 mm -111.19 143.5 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.868 -0.783 . . . . 0.0 109.101 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.28 144.65 43.42 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.377 -0.827 . . . . 0.0 109.199 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 9.4 p -152.53 143.74 23.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.986 -1.071 . . . . 0.0 108.71 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 7.7 t -150.35 152.82 35.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.137 -0.977 . . . . 0.0 109.426 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 1.8 mm -122.92 128.1 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 53.8 p -173.49 -153.17 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.519 -0.738 . . . . 0.0 109.709 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 3.7 p-10 -135.31 157.14 47.67 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.461 -0.774 . . . . 0.0 109.495 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 4.1 t-20 82.57 115.16 0.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.485 ' H ' HG13 ' B' ' 33' ' ' VAL . 0.8 OUTLIER -70.1 -39.94 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.26 -35.44 77.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.374 -0.829 . . . . 0.0 110.129 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -73.33 -37.17 66.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.317 -0.865 . . . . 0.0 108.929 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 14.3 mt -62.23 -42.88 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 108.928 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 63.6 t -55.44 -48.82 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.988 -1.07 . . . . 0.0 108.627 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.74 -40.45 92.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.4 -0.812 . . . . 0.0 110.008 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -59.16 -46.57 88.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.13 -0.981 . . . . 0.0 109.72 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.97 -46.39 65.32 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.799 -1.188 . . . . 0.0 108.678 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . 0.804 ' HG2' HH11 ' B' ' 41' ' ' ARG . 6.4 ttt-85 -49.63 -49.61 46.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.822 -1.174 . . . . 0.0 108.878 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 6.3 pttm -61.42 -35.24 76.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 0.0 108.909 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -71.67 -36.5 70.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.517 -0.74 . . . . 0.0 109.225 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 52.2 t -75.35 -49.75 26.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.981 -1.074 . . . . 0.0 109.21 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.519 ' HZ2' ' NH1' ' B' ' 41' ' ' ARG . 0.0 OUTLIER -48.96 -31.99 8.35 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.531 1.158 . . . . 0.0 110.276 -178.287 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.53 -27.04 51.56 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.71 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -93.84 13.12 23.53 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.14 31.11 32.94 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 118.656 -1.735 . . . . 0.0 109.814 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.3 153.75 28.03 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 68.1 mmm -63.1 -45.35 92.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.349 -1.089 . . . . 0.0 110.673 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.27 -169.49 39.82 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.1 tp -102.43 141.82 34.64 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.507 -0.996 . . . . 0.0 110.034 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.789 HD12 ' O ' ' B' ' 53' ' ' ILE . 1.1 pp -119.64 147.77 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.794 0.807 . . . . 0.0 112.075 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 52.94 52.73 13.29 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 119.692 -1.88 . . . . 0.0 109.403 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.525 ' CD2' HD11 ' B' ' 9' ' ' ILE . 46.2 t80 -83.76 96.35 8.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.018 -1.051 . . . . 0.0 109.327 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.851 HH21 HH22 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -97.56 138.04 35.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.351 -0.843 . . . . 0.0 109.189 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 97.7 mt -109.07 118.14 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 35.7 p -128.43 26.53 5.66 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 45.7 t -69.24 112.17 5.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.313 -0.867 . . . . 0.0 109.25 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.89 -117.52 0.08 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.267 -0.896 . . . . 0.0 109.206 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.58 -8.62 14.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.097 -1.002 . . . . 0.0 109.392 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.66 139.16 6.32 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.519 ' HD3' ' H ' ' B' ' 63' ' ' LYS . 0.8 OUTLIER -81.95 120.14 24.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.428 -1.042 . . . . 0.0 109.772 -179.453 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.443 ' O ' ' O ' ' B' ' 65' ' ' LEU . 92.0 m-85 -98.51 13.5 31.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.373 -0.83 . . . . 0.0 109.416 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' B' ' 64' ' ' PHE . 5.3 mp 58.89 144.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.601 0.715 . . . . 0.0 110.255 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' B' ' 67' ' ' TYR . . . -81.71 60.64 4.73 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' B' ' 66' ' ' GLY . 3.0 p90 -44.02 121.57 2.51 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.512 -0.993 . . . . 0.0 109.334 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.22 135.28 5.58 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . 0.533 ' HB ' ' OG1' ' A' ' 11' ' ' THR . 23.6 m -95.79 138.22 33.75 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.104 -1.233 . . . . 0.0 108.348 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 47.6 mt -84.94 141.78 14.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.52 163.97 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.774 0.797 . . . . 0.0 109.811 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.454 ' H ' ' H ' ' B' ' 21' ' ' TYR . 15.6 tttt -151.01 151.32 31.9 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.97 149.88 45.46 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -73.39 150.78 41.51 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.026 -1.046 . . . . 0.0 109.366 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' B' ' 75' ' ' GLU . 3.3 mp0 -82.57 25.81 0.61 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.932 . . . . 0.0 109.514 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -162.32 168.5 22.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . 0.495 ' N ' ' CD ' ' B' ' 77' ' ' GLN . 3.8 pm0 -151.77 -8.19 0.22 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.226 -0.921 . . . . 0.0 109.445 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -81.71 61.23 5.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.351 -0.843 . . . . 0.0 109.467 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 60.9 p -142.24 130.32 22.0 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.326 -0.859 . . . . 0.0 109.287 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' MET . . . . . 0.511 ' N ' ' SD ' ' B' ' 80' ' ' MET . 1.1 mpt? -67.38 -101.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.361 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.536 -179.94 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 10.1 ptt? . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . 0.401 HG22 ' H ' ' C' ' 2' ' ' ILE . 1.1 tp -93.63 105.2 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.293 -0.88 . . . . 0.0 109.133 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' PHE . . . . . 0.476 ' O ' ' N ' ' C' ' 5' ' ' ASP . 18.4 m-85 -91.79 64.44 4.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.783 -1.198 . . . . 0.0 108.86 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . 0.482 ' O ' ' C ' ' C' ' 5' ' ' ASP . 12.3 pt-20 34.56 33.99 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.826 -0.546 . . . . 0.0 110.684 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' ASP . . . . . 0.482 ' C ' ' O ' ' C' ' 4' ' ' GLU . 3.4 p-10 33.95 79.85 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.246 0.546 . . . . 0.0 109.909 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -72.96 126.53 30.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.885 . . . . 0.0 109.858 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -92.03 120.76 32.97 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 80.5 mt -116.82 145.75 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.535 -0.728 . . . . 0.0 109.817 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' ILE . . . . . 0.647 HG23 ' O ' ' C' ' 9' ' ' ILE . 11.5 tt -130.5 114.63 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 11.7 t -123.09 159.36 28.66 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.962 0.887 . . . . 0.0 108.823 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . 0.568 ' HG1' ' CB ' ' D' ' 69' ' ' THR . 1.7 p -88.5 -113.5 0.06 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.49 99.0 8.62 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.258 -0.902 . . . . 0.0 109.239 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -169.01 -13.44 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.72 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 57.24 173.02 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.312 -0.867 . . . . 0.0 109.57 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 66.4 mt -134.37 83.35 44.07 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.47 -0.769 . . . . 0.0 109.142 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.64 157.14 43.59 Favored 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 121.936 1.758 . . . . 0.0 110.139 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.38 -7.85 75.15 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 37.0 mt -127.86 140.37 52.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.142 -1.211 . . . . 0.0 109.716 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -86.44 110.39 19.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -95.67 136.29 36.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.112 -0.993 . . . . 0.0 110.182 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' TYR . . . . . 0.449 ' H ' ' H ' ' C' ' 72' ' ' LYS . 1.9 t80 -118.51 130.16 55.77 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 4.9 t -65.26 128.38 35.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.935 -1.103 . . . . 0.0 110.746 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' C' ' 23' ' ' LEU . 12.4 mt -115.04 8.5 15.76 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.74 178.72 18.86 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.08 144.22 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.801 -0.823 . . . . 0.0 109.066 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.62 144.21 44.23 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.645 -0.66 . . . . 0.0 109.609 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 86.9 p -152.41 136.08 16.16 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 10.7 t -149.88 153.34 36.53 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.942 -1.099 . . . . 0.0 109.339 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.578 ' N ' HD12 ' C' ' 29' ' ' ILE . 4.9 mp -125.28 132.03 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.18 -0.95 . . . . 0.0 108.726 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.425 ' O ' ' O ' ' C' ' 31' ' ' ASP . 0.2 OUTLIER -169.98 7.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.568 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' C' ' 32' ' ' ASN . 21.5 t0 58.88 153.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.314 -0.866 . . . . 0.0 109.808 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . 0.469 ' N ' ' OD1' ' C' ' 31' ' ' ASP . 3.6 m120 81.26 115.17 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.48 ' H ' HG13 ' C' ' 33' ' ' VAL . 0.9 OUTLIER -70.11 -40.81 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -58.81 -33.71 70.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.364 -0.835 . . . . 0.0 109.914 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -76.44 -36.36 58.0 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.289 -0.882 . . . . 0.0 109.188 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 55.5 mt -62.95 -52.7 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 0.0 109.086 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -51.71 -49.45 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 108.574 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -61.42 -41.84 97.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.394 -0.816 . . . . 0.0 109.631 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -64.63 -46.15 83.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 0.0 109.871 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.32 -46.86 72.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.025 -1.047 . . . . 0.0 108.547 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' ARG . . . . . 0.632 ' CG ' HH11 ' C' ' 41' ' ' ARG . 0.0 OUTLIER -47.75 -53.71 14.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.0 -1.062 . . . . 0.0 109.087 178.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -57.56 -35.11 69.93 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.306 -0.871 . . . . 0.0 110.214 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -75.9 -35.69 59.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.508 -0.745 . . . . 0.0 109.706 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 4.7 t -73.55 -51.64 24.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.139 -0.975 . . . . 0.0 108.99 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -63.45 -29.13 70.46 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.205 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.77 -29.57 69.56 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -91.39 6.47 45.27 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.411 -0.805 . . . . 0.0 109.146 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.11 28.97 74.09 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.0 -1.571 . . . . 0.0 109.479 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.57 -164.11 14.18 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 5.6 tmm? -117.39 -37.55 3.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.947 . . . . 0.0 110.573 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 176.75 169.27 37.87 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 7.5 tp -95.64 132.78 40.44 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.348 -1.089 . . . . 0.0 109.836 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.531 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 1.1 pt -109.85 144.86 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.507 -0.746 . . . . 0.0 109.936 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 69.37 82.81 0.16 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . 0.43 ' H ' ' HA ' ' C' ' 11' ' ' THR . 90.1 t80 -114.73 85.55 2.27 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' ARG . . . . . 0.851 HH22 HH21 ' B' ' 56' ' ' ARG . 89.3 mtt180 -112.1 161.54 16.39 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.543 -0.723 . . . . 0.0 109.262 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 67.8 mt -139.21 80.37 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.443 -0.786 . . . . 0.0 108.934 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' THR . . . . . . . . . . . . . 70.9 p -74.46 -55.54 5.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 109.136 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' CYS . . . . . . . . . . . . . 73.3 m 49.7 -97.03 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.345 -0.847 . . . . 0.0 109.827 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . 57.13 34.03 24.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -160.22 -73.95 0.07 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.121 -0.987 . . . . 0.0 110.013 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . 0.465 ' O ' ' CE1' ' C' ' 64' ' ' PHE . . . -168.36 -77.53 0.04 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -55.13 143.53 26.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.846 -0.797 . . . . 0.0 109.997 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . 0.465 ' CE1' ' O ' ' C' ' 62' ' ' GLY . 32.7 m-85 -110.09 117.06 32.71 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 11.1 mt -118.59 109.22 15.9 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.87 0.843 . . . . 0.0 110.986 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.32 57.2 2.76 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -49.46 133.16 20.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.15 -1.206 . . . . 0.0 110.103 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.35 149.09 20.82 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 49.8 m -96.8 136.8 36.84 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.975 -1.309 . . . . 0.0 108.271 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 37.4 mt -83.83 139.72 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.8 m -126.31 165.04 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.306 -0.871 . . . . 0.0 109.913 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' LYS . . . . . 0.449 ' H ' ' H ' ' C' ' 21' ' ' TYR . 9.5 tttm -155.28 140.02 17.1 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.448 ' O ' ' CG ' ' C' ' 74' ' ' ASP . . . -116.58 115.06 25.03 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.895 -1.128 . . . . 0.0 110.674 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' C' ' 73' ' ' ALA . 3.0 m-20 -178.49 12.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.597 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -80.99 38.1 0.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 109.639 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.93 3.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.537 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' GLN . . . . . 0.409 ' O ' ' CG ' ' C' ' 78' ' ' PHE . 7.9 tp-100 -82.03 39.95 0.59 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.0 109.432 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . 0.409 ' CG ' ' O ' ' C' ' 77' ' ' GLN . 75.2 m-85 -155.49 53.63 0.61 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 109.304 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 28.7 p 47.87 83.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.27 -0.894 . . . . 0.0 109.526 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 23.8 mtt 55.2 -123.7 2.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.402 -0.811 . . . . 0.0 109.499 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.409 -179.937 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ptp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' ILE . . . . . . . . . . . . . 33.1 pt -83.59 -151.1 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.33 -0.856 . . . . 0.0 109.331 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -161.14 25.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.286 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 50.82 -146.13 0.46 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.317 -0.865 . . . . 0.0 109.553 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' D' ' 5' ' ' ASP . 3.7 m-20 60.33 3.9 0.61 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.445 -0.784 . . . . 0.0 109.97 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -88.7 72.74 8.63 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.074 -1.016 . . . . 0.0 109.192 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -94.3 124.95 38.63 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.362 -0.836 . . . . 0.0 109.807 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 75.5 mt -114.54 127.41 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.554 -0.716 . . . . 0.0 109.219 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' ILE . . . . . 0.709 HD11 ' CG ' ' D' ' 55' ' ' PHE . 17.0 tt -121.26 114.94 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.7 t -122.52 151.88 40.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.39 72.45 0.95 Allowed 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.555 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.31 -101.59 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.159 -1.588 . . . . 0.0 108.417 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -119.87 -154.6 0.58 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.414 -0.804 . . . . 0.0 109.614 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -78.68 -172.0 2.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.237 -0.914 . . . . 0.0 109.564 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 84.5 mt -120.35 93.68 48.33 Favored Pre-proline 0 N--CA 1.494 1.766 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -61.58 155.62 52.17 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.716 1.611 . . . . 0.0 110.607 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.44 -9.63 75.64 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 71.7 mt -129.37 141.41 51.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.266 -1.137 . . . . 0.0 109.487 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -84.96 108.86 17.79 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 13.8 mt -91.4 133.82 35.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.896 -1.128 . . . . 0.0 110.145 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' TYR . . . . . 0.541 ' CE1' ' O ' ' D' ' 22' ' ' SER . 0.9 OUTLIER -120.82 130.67 54.06 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . 0.541 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 0.0 OUTLIER -66.37 130.64 43.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.156 -0.965 . . . . 0.0 111.494 -179.018 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 14.0 mt -119.94 14.16 12.35 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.04 -174.46 15.21 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 46.7 mm -112.75 138.87 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 122.014 -0.698 . . . . 0.0 109.187 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.28 144.39 43.81 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.336 -0.853 . . . . 0.0 110.212 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 22.4 p -153.17 135.33 14.85 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 7.3 t -150.17 141.21 22.98 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.821 -1.175 . . . . 0.0 109.85 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.532 HD13 ' O ' ' D' ' 64' ' ' PHE . 1.4 tp -126.47 131.84 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.491 ' O ' ' O ' ' D' ' 31' ' ' ASP . 56.8 p -168.51 8.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.625 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' D' ' 30' ' ' SER . 36.9 t0 54.2 156.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.528 -0.733 . . . . 0.0 110.177 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 2.3 t-20 74.37 129.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.959 -1.088 . . . . 0.0 108.504 -178.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . 0.41 HG22 ' CD1' ' D' ' 57' ' ' ILE . 4.0 t -67.61 -35.55 73.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.424 -0.797 . . . . 0.0 109.587 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -59.06 -44.31 91.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.355 -0.841 . . . . 0.0 110.559 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -75.5 -37.47 60.14 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.958 -1.089 . . . . 0.0 109.517 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 83.5 mt -66.48 -42.09 89.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.914 -1.116 . . . . 0.0 109.513 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -65.46 -53.73 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.639 -1.288 . . . . 0.0 110.135 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -55.42 -35.52 65.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.293 -0.88 . . . . 0.0 109.433 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' ASN . . . . . 0.493 ' N ' HD22 ' D' ' 39' ' ' ASN . 1.0 OUTLIER -66.55 -41.14 89.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.843 . . . . 0.0 109.813 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 17.4 mt -75.42 -51.07 13.94 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.883 -1.136 . . . . 0.0 108.815 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -48.85 -52.6 23.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.835 -1.165 . . . . 0.0 108.974 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' D' ' 46' ' ' ALA . 27.7 ttmt -59.81 -36.75 77.4 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.472 -0.768 . . . . 0.0 110.225 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -75.27 -35.77 61.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.122 -0.987 . . . . 0.0 110.003 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -74.38 -51.7 22.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.135 -0.978 . . . . 0.0 109.487 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -71.74 -34.57 69.64 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.451 -1.406 . . . . 0.0 109.812 -176.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' D' ' 42' ' ' LYS . . . -56.69 -30.81 63.82 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -92.63 -5.06 52.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.34 -0.85 . . . . 0.0 109.748 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.35 8.23 56.49 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.63 -173.6 4.52 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' MET . . . . . 0.435 ' C ' ' SD ' ' D' ' 50' ' ' MET . 0.0 OUTLIER -161.19 -23.37 0.05 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.091 -1.241 . . . . 0.0 110.885 176.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -137.32 146.8 18.75 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . 0.522 HD12 ' O ' ' D' ' 69' ' ' THR . 34.9 tp -137.12 146.17 44.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.678 -0.895 . . . . 0.0 109.289 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' ILE . . . . . 0.838 ' H ' HD12 ' D' ' 53' ' ' ILE . 0.1 OUTLIER -109.69 162.63 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.47 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.622 ' O ' ' CB ' ' D' ' 55' ' ' PHE . . . 65.81 -163.45 0.25 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.709 ' CG ' HD11 ' D' ' 9' ' ' ILE . 67.2 t80 134.19 -5.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' ARG . . . . . 0.704 ' NH1' HH22 ' E' ' 56' ' ' ARG . 16.6 ptm180 -51.21 145.81 7.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.3 -0.875 . . . . 0.0 109.805 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' ILE . . . . . 0.41 ' CD1' HG22 ' D' ' 33' ' ' VAL . 0.9 OUTLIER -126.52 140.11 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.59 95.86 1.95 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.905 . . . . 0.0 109.398 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' CYS . . . . . . . . . . . . . 25.7 p -102.01 135.57 43.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.406 -0.809 . . . . 0.0 108.974 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -146.72 125.27 12.44 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.203 -0.936 . . . . 0.0 109.701 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 49.65 -97.5 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.379 -0.826 . . . . 0.0 109.721 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.16 -172.7 0.73 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -77.98 -159.5 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.411 -1.052 . . . . 0.0 110.172 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . 0.667 ' CG ' ' N ' ' D' ' 65' ' ' LEU . 61.9 t80 -165.61 -179.2 5.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.352 -0.842 . . . . 0.0 109.328 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.667 ' N ' ' CG ' ' D' ' 64' ' ' PHE . 12.2 tp -164.0 105.24 0.9 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.069 -1.02 . . . . 0.0 111.006 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.09 179.73 1.09 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -154.11 138.89 17.07 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.05 -1.264 . . . . 0.0 109.401 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.21 166.03 35.61 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 69' ' ' THR . . . . . 0.568 ' CB ' ' HG1' ' C' ' 11' ' ' THR . 98.7 m -115.14 137.95 51.45 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.568 -0.96 . . . . 0.0 108.417 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 46.0 mt -87.16 126.42 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.94 -1.1 . . . . 0.0 108.326 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 71' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' D' ' 21' ' ' TYR . 3.5 m -137.97 162.97 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.337 -0.852 . . . . 0.0 110.22 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -153.52 154.11 33.69 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.468 ' O ' ' CB ' ' D' ' 74' ' ' ASP . . . -121.15 115.41 23.02 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.548 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' D' ' 73' ' ' ALA . 2.0 m-20 159.79 -102.02 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -173.03 138.23 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.68 157.74 34.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.105 -0.997 . . . . 0.0 108.663 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -64.83 -2.86 2.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.521 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 78' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -76.61 88.24 3.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.94 . . . . 0.0 109.323 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . 0.456 HG23 ' N ' ' D' ' 80' ' ' MET . 9.5 t -163.44 -39.59 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.902 . . . . 0.0 109.516 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 80' ' ' MET . . . . . 0.456 ' N ' HG23 ' D' ' 79' ' ' THR . 21.7 ttt -162.77 -30.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 109.503 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 117.887 -1.054 . . . . 0.0 109.71 -179.968 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 2.2 tpt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . 0.439 ' O ' ' CG ' ' E' ' 3' ' ' PHE . 3.2 tt -166.47 117.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.297 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 3' ' ' PHE . . . . . 0.439 ' CG ' ' O ' ' E' ' 2' ' ' ILE . 85.1 m-85 -154.46 17.73 0.47 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.011 -1.055 . . . . 0.0 109.182 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . 0.422 ' N ' ' CD ' ' E' ' 4' ' ' GLU . 10.9 mp0 -67.72 -13.38 62.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.873 . . . . 0.0 109.27 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 5' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -72.25 111.62 7.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.304 -0.873 . . . . 0.0 109.37 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 6' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -103.03 -79.1 0.54 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.351 -0.843 . . . . 0.0 109.286 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -112.17 119.71 39.31 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.363 -0.836 . . . . 0.0 109.595 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 69.8 mt -100.85 128.18 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.396 -0.815 . . . . 0.0 109.77 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 9' ' ' ILE . . . . . 0.676 HD11 ' CG ' ' E' ' 55' ' ' PHE . 11.3 tt -128.42 115.03 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 1.7 t -125.41 157.47 36.76 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.902 0.858 . . . . 0.0 109.11 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.97 92.58 3.79 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.99 -150.87 0.06 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.194 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 13' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' E' ' 14' ' ' GLU . 1.7 p-10 -76.63 -72.52 0.33 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.214 -0.929 . . . . 0.0 109.551 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . 0.454 ' H ' ' CG ' ' E' ' 13' ' ' ASP . 13.8 pt-20 -153.44 -166.95 2.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.168 -0.958 . . . . 0.0 109.291 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 52.9 mt -121.45 88.34 46.1 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.14 156.18 51.78 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 121.791 1.66 . . . . 0.0 110.641 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.97 -5.92 76.2 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 18' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' E' ' 18' ' ' LEU . 37.9 mt -129.34 139.86 51.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.286 -1.126 . . . . 0.0 109.971 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -84.23 108.53 17.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 14.2 mt -101.91 136.54 41.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.344 -0.848 . . . . 0.0 110.304 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 21' ' ' TYR . . . . . 0.55 ' CE1' ' O ' ' E' ' 22' ' ' SER . 0.4 OUTLIER -120.57 129.91 53.98 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 22' ' ' SER . . . . . 0.55 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 13.4 t -56.74 130.16 44.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 111.668 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 11.9 mt -119.22 5.62 11.23 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.39 -179.19 16.68 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.09 145.33 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 122.033 -0.687 . . . . 0.0 109.263 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.25 159.68 22.28 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.645 -0.659 . . . . 0.0 109.348 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 89.3 p -153.11 143.6 22.59 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' E' ' 65' ' ' LEU . 11.2 p -142.93 134.47 26.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.183 -0.948 . . . . 0.0 111.02 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.513 ' O ' ' CB ' ' E' ' 30' ' ' SER . 2.1 mm -125.63 126.39 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' E' ' 29' ' ' ILE . 3.3 m 157.09 16.12 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 31' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' E' ' 32' ' ' ASN . 1.0 OUTLIER 51.5 -174.08 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.006 -1.059 . . . . 0.0 108.892 -179.082 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 32' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' E' ' 31' ' ' ASP . 9.2 t-20 73.48 94.3 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 33' ' ' VAL . . . . . 0.49 ' H ' HG13 ' E' ' 33' ' ' VAL . 0.7 OUTLIER -70.78 -42.98 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.309 -0.869 . . . . 0.0 108.993 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 34' ' ' ASP . . . . . 0.408 ' N ' ' CG2' ' E' ' 33' ' ' VAL . 43.1 t0 -58.39 -44.19 88.83 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.388 -0.82 . . . . 0.0 110.771 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 35' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' E' ' 39' ' ' ASN . 62.1 mm-40 -70.03 -37.05 75.48 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.95 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 37.8 mt -61.64 -41.36 90.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.149 -0.97 . . . . 0.0 108.886 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 48.4 t -55.16 -51.58 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.941 -1.099 . . . . 0.0 108.778 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -59.1 -39.2 81.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.347 -0.846 . . . . 0.0 109.541 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 39' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' E' ' 35' ' ' GLU . 34.0 m120 -63.42 -42.11 98.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 109.508 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 40' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' E' ' 40' ' ' LEU . 74.5 mt -73.36 -50.03 24.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.132 -0.98 . . . . 0.0 108.962 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -48.93 -48.31 42.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.756 -1.215 . . . . 0.0 108.993 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -63.36 -37.4 87.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.582 -0.699 . . . . 0.0 109.935 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -75.6 -35.55 60.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.267 -0.896 . . . . 0.0 109.66 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 13.2 t -70.74 -51.44 36.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.308 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -71.21 -35.34 71.49 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.294 -176.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.63 -30.61 67.42 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -92.14 -5.44 52.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.364 -0.835 . . . . 0.0 109.871 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.63 11.82 46.18 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.61 159.28 33.16 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.26 -6.19 5.4 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.27 -1.135 . . . . 0.0 110.521 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -152.24 164.21 30.45 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 6.9 tp -136.95 143.45 42.87 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.405 -1.056 . . . . 0.0 109.516 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 53' ' ' ILE . . . . . 0.655 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 4.8 mt -113.6 151.66 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 88.7 -144.58 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 55' ' ' PHE . . . . . 0.676 ' CG ' HD11 ' E' ' 9' ' ' ILE . 62.9 t80 104.87 11.96 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 120.726 1.603 . . . . 0.0 107.607 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 56' ' ' ARG . . . . . 0.704 HH22 ' NH1' ' D' ' 56' ' ' ARG . 73.8 mtm180 -69.16 124.73 24.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.354 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 57' ' ' ILE . . . . . 0.577 HG22 ' N ' ' E' ' 58' ' ' THR . 88.3 mt -124.92 166.03 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.516 -0.74 . . . . 0.0 109.292 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 58' ' ' THR . . . . . 0.577 ' N ' HG22 ' E' ' 57' ' ' ILE . 3.2 m -144.79 3.38 1.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.282 -0.886 . . . . 0.0 109.063 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 59' ' ' CYS . . . . . 0.517 ' H ' HG22 ' E' ' 57' ' ' ILE . 92.2 m 51.87 25.88 3.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.575 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.46 -121.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.337 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -170.16 29.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.228 -0.92 . . . . 0.0 109.395 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.36 -20.64 0.09 OUTLIER Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.012 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -76.62 -110.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.072 -1.252 . . . . 0.0 108.536 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 64' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -56.23 174.54 0.13 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.972 . . . . 0.0 108.929 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.775 HD23 ' N ' ' E' ' 65' ' ' LEU . 1.6 pt? -161.65 -35.3 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.129 -0.982 . . . . 0.0 110.257 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 66' ' ' GLY . . . . . . . . . . . . . . . 130.19 65.87 0.1 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 107.692 -2.163 . . . . 0.0 107.692 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 67' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' E' ' 67' ' ' TYR . 18.4 p90 -118.08 176.98 4.96 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.141 -1.211 . . . . 0.0 110.292 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.66 157.97 14.71 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 93.6 m -90.52 134.6 34.25 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.038 -1.272 . . . . 0.0 107.691 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 58.6 mt -90.23 137.91 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 71' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' E' ' 21' ' ' TYR . 3.2 m -144.17 163.92 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.26 -0.9 . . . . 0.0 110.766 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -148.01 152.61 37.74 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.18 152.55 33.5 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.327 -0.858 . . . . 0.0 108.727 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 57.37 -99.43 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 110.094 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -138.12 161.44 36.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.351 -0.843 . . . . 0.0 109.48 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 76' ' ' ALA . . . . . 0.454 ' C ' ' H ' ' E' ' 78' ' ' PHE . . . -57.09 -164.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.511 -0.743 . . . . 0.0 109.202 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 77' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -74.94 36.5 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.285 -0.884 . . . . 0.0 109.174 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 78' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' E' ' 76' ' ' ALA . 94.7 m-85 51.69 16.14 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.335 -0.853 . . . . 0.0 109.813 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 66.9 p 44.29 -119.78 0.7 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.465 -0.772 . . . . 0.0 109.733 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 45.8 mtt -81.96 147.98 28.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 0.0 109.207 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.462 -179.941 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.429 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.354 0.597 . . . . 0.0 109.399 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.9 tt -71.63 -31.75 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.243 -0.911 . . . . 0.0 109.409 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -160.52 0.17 0.07 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.176 -0.953 . . . . 0.0 109.474 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 64.48 55.0 1.41 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -127.15 -153.82 0.59 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.301 -0.874 . . . . 0.0 109.113 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -161.24 76.99 0.55 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.329 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -99.37 122.26 42.25 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.478 -0.764 . . . . 0.0 109.358 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 70.0 mt -112.17 140.02 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.518 -0.739 . . . . 0.0 110.009 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 9' ' ' ILE . 5.8 tt -137.61 115.88 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.446 -0.784 . . . . 0.0 108.923 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -123.49 158.38 31.4 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.27 121.02 32.84 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.75 47.34 20.62 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.994 0.902 . . . . 0.0 109.624 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -167.4 94.77 0.45 Allowed 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.404 0.621 . . . . 0.0 109.445 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -61.24 -178.2 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.263 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.7 mt -123.67 87.9 52.22 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.51 -0.744 . . . . 0.0 109.085 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -61.1 156.02 47.29 Favored 'Trans proline' 0 C--N 1.321 -0.888 0 C-N-CA 121.905 1.736 . . . . 0.0 110.222 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.64 -11.76 71.37 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.2 mt -126.79 137.64 53.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.143 -1.21 . . . . 0.0 108.734 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.728 ' NE2' ' H ' ' A' ' 74' ' ' ASP . 1.2 pp0? -87.62 118.47 27.12 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.4 mt -101.46 128.35 47.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.131 -0.98 . . . . 0.0 109.587 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' A' ' 22' ' ' SER . 2.3 t80 -115.21 129.95 56.78 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.531 ' O ' ' CE1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -85.57 130.26 34.62 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.408 -0.808 . . . . 0.0 110.353 -179.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.942 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -118.94 19.44 13.03 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 137.33 172.42 12.53 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.98 145.14 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.11 147.45 37.29 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.623 -0.673 . . . . 0.0 109.315 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.5 p -151.48 135.55 16.63 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.63 150.56 34.64 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.044 -1.035 . . . . 0.0 108.766 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.21 129.45 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 83.8 p -169.37 175.95 5.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 109.126 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.429 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 3.2 m-20 -101.94 146.91 27.2 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.297 -0.877 . . . . 0.0 110.152 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 13.2 m-20 77.63 128.95 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.566 -0.708 . . . . 0.0 109.259 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.98 -31.09 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.593 -0.692 . . . . 0.0 109.36 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -56.22 -40.24 73.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.299 -0.876 . . . . 0.0 109.712 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.402 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 1.1 mp0 -76.23 -40.28 52.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.324 -0.86 . . . . 0.0 109.277 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.3 mt -62.22 -50.53 79.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.896 -1.127 . . . . 0.0 108.847 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.0 t -66.63 -49.45 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.11 -0.994 . . . . 0.0 109.473 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.53 -40.71 88.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.0 109.601 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 35' ' ' GLU . 15.9 m120 -64.13 -41.33 97.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 109.321 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 40' ' ' LEU . 29.4 mt -68.23 -44.24 76.18 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.15 -0.969 . . . . 0.0 109.128 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -48.92 -42.77 38.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.572 -1.33 . . . . 0.0 109.436 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -69.94 -38.02 76.05 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.493 0.663 . . . . 0.0 110.102 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -77.32 -35.04 55.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.492 -0.755 . . . . 0.0 110.057 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.83 -52.07 31.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.027 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -66.59 -29.53 69.6 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.215 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.49 -28.6 68.69 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.626 0.727 . . . . 0.0 109.048 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -90.22 -5.65 56.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.564 -0.71 . . . . 0.0 109.558 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.5 4.37 58.24 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.84 161.93 48.24 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -129.58 -2.35 4.85 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.303 -1.116 . . . . 0.0 110.303 -177.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.8 166.48 39.68 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.308 -1.425 . . . . 0.0 109.685 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 tp -125.16 143.63 50.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.665 -0.903 . . . . 0.0 109.655 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.801 ' O ' HD13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -117.73 148.71 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.625 -0.672 . . . . 0.0 110.072 -178.228 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.22 68.78 0.74 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.897 -1.127 . . . . 0.0 110.125 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -107.29 54.56 0.67 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.671 ' NH1' HH22 ' E' ' 56' ' ' ARG . 1.7 ttt-85 -80.18 152.96 28.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.302 -0.874 . . . . 0.0 109.634 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.4 mt -131.21 152.93 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 m -138.45 66.05 1.44 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.375 -0.828 . . . . 0.0 109.155 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.8 p -169.64 -172.5 1.43 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 0.0 109.468 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.54 -131.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.306 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.13 -44.55 83.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.937 . . . . 0.0 109.452 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.64 -129.74 1.4 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm 54.09 51.17 15.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 109.254 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -143.18 -82.09 0.18 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.279 -0.888 . . . . 0.0 109.354 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.5 tp -176.11 120.61 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 109.524 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.9 74.61 0.21 Allowed Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -74.08 153.9 39.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.176 -1.191 . . . . 0.0 110.083 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.58 153.23 17.07 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.427 ' OG1' ' OG1' ' E' ' 11' ' ' THR . 96.8 m -105.71 138.26 42.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.304 -1.115 . . . . 0.0 108.964 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 50.4 mt -83.01 137.32 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.4 m -140.66 159.05 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.247 -0.908 . . . . 0.0 109.701 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -153.69 159.09 41.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.296 -0.878 . . . . 0.0 109.052 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.519 ' O ' ' CG ' ' A' ' 74' ' ' ASP . . . -114.83 114.17 25.18 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.227 -0.921 . . . . 0.0 110.756 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.728 ' H ' ' NE2' ' A' ' 19' ' ' GLN . 20.5 m-20 -170.69 -129.3 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.424 ' H ' ' HB3' ' A' ' 74' ' ' ASP . 15.7 tt0 67.42 -49.21 0.5 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.203 -0.936 . . . . 0.0 109.855 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 74' ' ' ASP . . . -54.39 173.28 0.08 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.229 -0.919 . . . . 0.0 109.572 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -148.53 -159.29 1.01 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.363 -0.836 . . . . 0.0 109.374 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -159.71 130.25 5.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 109.373 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.8 m -162.27 87.55 0.63 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.911 . . . . 0.0 109.441 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 10.0 ttt -95.21 25.52 4.26 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.244 -0.91 . . . . 0.0 109.226 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.382 180.0 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.564 ' C ' HD12 ' B' ' 2' ' ' ILE . 2.6 pp -118.66 -178.04 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -147.01 -83.16 0.12 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.306 -0.871 . . . . 0.0 108.931 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -58.59 134.33 56.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.93 . . . . 0.0 109.517 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.56 -51.53 3.18 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.557 -0.715 . . . . 0.0 109.435 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' B' ' 50' ' ' MET . 25.2 ttmt -158.42 87.67 0.91 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 109.416 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -109.91 122.34 47.31 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 93.8 mt -132.87 129.96 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.386 -0.821 . . . . 0.0 109.754 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.602 HG23 ' O ' ' B' ' 9' ' ' ILE . 10.9 tt -133.01 116.36 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.2 t -123.9 152.78 42.01 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' B' ' 12' ' ' ALA . 0.8 OUTLIER -103.01 74.76 1.33 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' B' ' 11' ' ' THR . . . 176.97 -116.18 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 176.98 54.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -129.38 104.44 7.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.39 -0.819 . . . . 0.0 109.605 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.752 HG22 ' O ' ' B' ' 15' ' ' ILE . 6.2 mm -140.61 53.04 3.62 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.346 -0.847 . . . . 0.0 108.915 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.628 ' HD3' ' N ' ' B' ' 15' ' ' ILE . 1.8 Cg_endo -64.07 155.49 64.41 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.531 1.487 . . . . 0.0 110.196 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.12 -11.71 71.43 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 79.8 mt -128.24 139.5 52.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.01 -1.288 . . . . 0.0 109.035 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -85.51 108.86 18.12 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.427 HD11 ' HB ' ' B' ' 15' ' ' ILE . 13.4 mt -89.84 132.63 35.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 110.348 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . 0.54 ' CE1' ' O ' ' B' ' 22' ' ' SER . 0.4 OUTLIER -112.38 129.29 56.36 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.54 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 36.2 t -71.73 118.25 14.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.793 -1.192 . . . . 0.0 109.336 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' B' ' 72' ' ' LYS . 5.8 mt -94.69 -4.57 47.29 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.42 -163.4 24.03 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -122.39 141.76 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.407 ' HB2' HD11 ' B' ' 70' ' ' ILE . . . -113.54 144.81 42.23 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.567 -0.708 . . . . 0.0 109.275 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 3.0 t -151.77 137.88 18.28 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -148.92 141.76 24.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.013 -1.054 . . . . 0.0 109.247 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 tp -104.8 127.93 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.287 -0.883 . . . . 0.0 109.213 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 15.5 t -171.19 169.79 6.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.918 . . . . 0.0 109.053 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' B' ' 32' ' ' ASN . 2.7 p-10 -110.16 158.78 17.98 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.507 -0.746 . . . . 0.0 109.215 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' B' ' 31' ' ' ASP . 2.2 m120 75.97 129.55 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.97 -32.86 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.488 -0.757 . . . . 0.0 109.306 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.96 -42.15 89.2 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.282 -0.886 . . . . 0.0 109.773 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -75.73 -41.4 53.54 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.225 -0.922 . . . . 0.0 109.516 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.79 -43.05 98.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 120.858 -1.151 . . . . 0.0 108.923 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 38.2 t -66.21 -50.78 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.768 -1.208 . . . . 0.0 109.497 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -59.01 -39.51 82.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.339 -0.851 . . . . 0.0 109.513 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -61.65 -46.12 91.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.639 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' B' ' 40' ' ' LEU . 28.6 mt -70.74 -46.83 62.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.105 -0.997 . . . . 0.0 108.986 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -48.57 -44.54 36.84 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.695 -1.253 . . . . 0.0 109.405 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -67.97 -38.4 82.69 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.559 0.695 . . . . 0.0 110.242 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -77.54 -34.11 54.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.395 -0.816 . . . . 0.0 110.183 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.796 ' O ' ' N ' ' B' ' 48' ' ' GLY . 2.3 t -70.03 -51.67 37.54 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.946 0 O-C-N 121.148 -0.97 . . . . 0.0 109.812 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -60.11 -31.39 69.99 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 119.666 -1.896 . . . . 0.0 110.328 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.7 -37.22 56.49 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.009 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.4 -12.92 11.01 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.549 -0.719 . . . . 0.0 109.923 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . 0.796 ' N ' ' O ' ' B' ' 44' ' ' VAL . . . -105.8 -45.75 1.26 Allowed Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.96 -35.23 0.29 Allowed Glycine 0 C--N 1.289 -2.066 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.156 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . 0.456 ' H ' ' C ' ' B' ' 48' ' ' GLY . 0.0 OUTLIER -96.44 -75.08 0.54 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 119.253 1.527 . . . . 0.0 109.886 -179.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.37 -153.58 10.77 Favored Glycine 0 C--N 1.288 -2.104 0 C-N-CA 118.288 -1.91 . . . . 0.0 109.425 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.2 tp -133.11 139.13 46.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.696 -0.885 . . . . 0.0 109.682 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.466 ' O ' ' HB3' ' B' ' 54' ' ' ALA . 1.7 pt -111.82 145.53 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.658 -0.651 . . . . 0.0 109.913 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 63.92 72.45 0.46 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.121 -0.987 . . . . 0.0 109.337 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.558 ' O ' ' CG ' ' B' ' 55' ' ' PHE . 60.4 t80 -101.51 33.65 2.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.37 -0.831 . . . . 0.0 108.917 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.795 HH11 ' HG3' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -59.51 122.98 15.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.982 -1.074 . . . . 0.0 109.34 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 91.2 mt -75.59 150.12 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 80.8 p -73.97 -119.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.318 -0.863 . . . . 0.0 109.413 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' B' ' 60' ' ' ALA . 47.0 t -67.26 -116.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.925 . . . . 0.0 109.638 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.424 ' N ' ' SG ' ' B' ' 59' ' ' CYS . . . -64.81 -156.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.164 -0.96 . . . . 0.0 109.608 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -51.98 -18.05 1.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.216 -0.928 . . . . 0.0 109.244 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . 0.446 ' C ' ' N ' ' B' ' 64' ' ' PHE . . . 171.34 -96.97 0.11 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 mttm 50.1 12.88 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.477 -1.013 . . . . 0.0 109.692 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.446 ' N ' ' C ' ' B' ' 62' ' ' GLY . 7.2 m-85 -139.33 -76.07 0.35 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.357 -0.839 . . . . 0.0 108.872 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' B' ' 64' ' ' PHE . 20.7 tp 172.78 120.3 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.694 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.78 165.05 33.12 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -167.13 179.83 4.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.04 -1.271 . . . . 0.0 110.209 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.09 169.63 35.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 50.4 m -100.66 132.94 45.79 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.123 -1.222 . . . . 0.0 108.037 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.498 HG22 ' HA2' ' B' ' 48' ' ' GLY . 3.0 mt -87.82 145.44 7.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 5.9 m -146.29 166.06 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.886 -1.134 . . . . 0.0 111.01 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.537 ' HB2' HD11 ' B' ' 23' ' ' LEU . 0.4 OUTLIER -146.55 156.25 43.1 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.45 ' O ' ' OD1' ' B' ' 74' ' ' ASP . . . -116.57 116.02 26.83 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.72 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' B' ' 73' ' ' ALA . 0.1 OUTLIER 175.41 168.79 0.34 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -178.286 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -60.26 92.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.413 -0.804 . . . . 0.0 109.17 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' B' ' 78' ' ' PHE . . . -81.76 -167.82 1.66 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.278 -0.889 . . . . 0.0 108.905 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 53.96 -82.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.592 -0.692 . . . . 0.0 109.692 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . 0.558 ' N ' ' O ' ' B' ' 76' ' ' ALA . 19.5 m-85 -72.98 55.16 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 0.0 109.479 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 29.1 m -73.66 128.62 36.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 109.506 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' MET . . . . . . . . . . . . . 21.0 mmt 49.58 80.98 0.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 109.606 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.568 -179.952 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . 0.461 ' N ' ' SD ' ' C' ' 1' ' ' MET . 2.3 mpt? . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 18.1 tt -161.65 6.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.909 . . . . 0.0 109.227 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 59.49 176.81 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.103 -0.998 . . . . 0.0 109.262 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -142.55 8.04 1.74 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.283 -0.885 . . . . 0.0 109.283 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -99.79 9.27 43.32 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.312 -0.867 . . . . 0.0 109.42 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? -73.93 84.56 1.73 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.304 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -105.78 120.66 42.26 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.099 -1.001 . . . . 0.0 109.126 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 17.7 mt -116.39 143.01 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' ILE . . . . . 0.456 ' O ' HG23 ' C' ' 9' ' ' ILE . 7.2 tt -112.96 124.62 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.93 131.28 55.16 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.44 -0.787 . . . . 0.0 109.369 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . 0.487 ' HG1' HD11 ' D' ' 25' ' ' ILE . 1.6 m -121.3 114.37 21.25 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.42 34.56 24.45 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.301 -0.875 . . . . 0.0 109.653 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -153.36 95.49 1.93 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.708 -0.62 . . . . 0.0 109.505 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -67.31 176.82 2.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.086 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 51.4 mt -127.04 81.68 69.47 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.485 -0.759 . . . . 0.0 109.095 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.31 156.78 38.78 Favored 'Trans proline' 0 C--N 1.322 -0.83 0 C-N-CA 121.964 1.776 . . . . 0.0 110.119 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.17 -4.54 74.37 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.307 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' C' ' 18' ' ' LEU . 25.7 mt -126.78 137.48 53.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.105 -1.232 . . . . 0.0 109.17 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -86.77 108.28 18.64 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 12.8 mt -92.36 132.97 36.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 109.462 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' C' ' 71' ' ' VAL . 1.2 t80 -114.73 129.37 56.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.363 -0.835 . . . . 0.0 108.755 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . 0.436 ' O ' ' CE1' ' C' ' 21' ' ' TYR . 8.2 t -61.97 127.68 32.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.899 -1.126 . . . . 0.0 111.624 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' C' ' 23' ' ' LEU . 14.2 mt -113.47 9.13 18.03 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.71 -174.52 15.34 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 177.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.57 139.76 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.651 -0.911 . . . . 0.0 109.584 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.47 146.84 44.19 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.693 -0.63 . . . . 0.0 109.92 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 4.7 t -151.91 139.23 19.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.154 -0.966 . . . . 0.0 108.688 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.77 140.28 22.46 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.962 -1.086 . . . . 0.0 109.641 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 7.1 tp -95.66 147.9 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.999 -1.063 . . . . 0.0 108.602 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.501 ' OG ' ' N ' ' C' ' 31' ' ' ASP . 27.1 t -169.3 -168.24 0.8 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.112 -0.992 . . . . 0.0 109.12 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' ASP . . . . . 0.501 ' N ' ' OG ' ' C' ' 30' ' ' SER . 19.4 t0 -109.72 -80.64 0.58 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.352 -0.843 . . . . 0.0 111.667 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -75.98 159.66 30.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.909 -1.12 . . . . 0.0 109.434 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.33 -31.44 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 CA-C-O 121.241 0.543 . . . . 0.0 109.591 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.5 -37.85 65.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.65 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -76.38 -36.22 58.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.35 -0.844 . . . . 0.0 109.019 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 82.9 mt -61.78 -51.98 66.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 120.984 -1.073 . . . . 0.0 109.539 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 51.4 t -57.65 -48.11 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.086 -1.009 . . . . 0.0 108.985 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -63.49 -43.89 95.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.652 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -58.27 -48.63 79.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.13 -0.981 . . . . 0.0 109.47 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 55.5 mt -68.98 -44.22 73.33 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.736 -1.227 . . . . 0.0 108.76 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -50.97 -46.18 61.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.773 -1.205 . . . . 0.0 109.445 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -61.87 -34.66 76.4 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.516 -0.874 . . . . 0.0 108.967 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -70.76 -36.09 72.93 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.447 -0.783 . . . . 0.0 108.971 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 51.5 t -72.89 -49.29 40.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.89 -1.131 . . . . 0.0 109.155 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -49.36 -34.23 15.53 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.448 1.118 . . . . 0.0 110.505 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.84 -28.55 50.2 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.573 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -94.62 9.53 38.36 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.89 30.73 30.21 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 118.355 -1.879 . . . . 0.0 109.534 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.35 -162.44 8.81 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -115.07 -35.66 4.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.44 -1.036 . . . . 0.0 110.424 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.19 179.73 40.32 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 tp -101.36 138.33 38.52 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.427 -1.043 . . . . 0.0 109.786 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.45 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 1.3 pt -113.97 144.38 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.528 -0.732 . . . . 0.0 110.149 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 62.72 62.45 1.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -0.88 . . . . 0.0 109.236 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -92.99 66.0 4.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.958 -1.089 . . . . 0.0 108.448 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -72.68 149.66 43.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.5 -0.75 . . . . 0.0 110.032 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 59.0 mt -125.52 -43.84 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' THR . . . . . 0.812 HG21 ' HE ' ' D' ' 56' ' ' ARG . 88.8 m -73.99 176.51 6.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.878 . . . . 0.0 109.047 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' CYS . . . . . 0.676 ' N ' HG22 ' C' ' 58' ' ' THR . 41.6 t 49.61 -85.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.421 -0.799 . . . . 0.0 109.0 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.609 ' N ' ' O ' ' C' ' 58' ' ' THR . . . -78.62 146.31 34.2 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' ASP . . . . . 0.477 ' O ' ' CG ' ' C' ' 61' ' ' ASP . 6.7 t0 53.36 51.86 14.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.16 -0.963 . . . . 0.0 109.252 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.27 75.16 0.19 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' C' ' 61' ' ' ASP . 34.2 ttpt 53.59 69.38 0.71 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.64 -0.918 . . . . 0.0 109.473 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -160.93 -26.84 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.391 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 17.3 tp -178.4 117.09 0.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.449 -0.782 . . . . 0.0 109.326 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.69 152.59 24.17 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -158.15 -175.07 5.14 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.214 -1.168 . . . . 0.0 109.885 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.92 -173.25 44.03 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 29.3 m -119.46 134.05 55.4 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 45.2 mt -82.56 146.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' C' ' 21' ' ' TYR . 4.6 m -139.83 164.06 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.392 -0.817 . . . . 0.0 110.225 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -142.34 154.61 44.81 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.36 116.21 29.32 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.843 0.83 . . . . 0.0 111.239 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -167.58 -114.46 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 52.56 87.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.235 -0.916 . . . . 0.0 109.323 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -165.44 168.11 16.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 0.0 109.13 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -124.23 156.84 36.13 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.497 -0.752 . . . . 0.0 109.351 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -58.94 147.97 32.19 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.341 -0.85 . . . . 0.0 109.562 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 76.4 p -71.08 166.42 21.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 109.421 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -17.44 64.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.496 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.518 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' D' ' 3' ' ' PHE . 1.1 pt -145.56 -87.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.264 -0.898 . . . . 0.0 109.025 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' D' ' 2' ' ' ILE . 0.2 OUTLIER 62.37 148.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' D' ' 3' ' ' PHE . 61.0 mt-10 40.85 -147.29 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.133 -0.98 . . . . 0.0 110.184 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -125.99 159.85 31.6 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.536 -0.728 . . . . 0.0 109.107 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -71.03 85.35 0.71 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 109.55 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -96.43 128.85 43.73 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.212 -0.93 . . . . 0.0 109.611 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 62.8 mt -128.14 141.99 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.543 -0.723 . . . . 0.0 109.095 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' ILE . . . . . 0.405 ' O ' HG23 ' D' ' 9' ' ' ILE . 10.1 tt -114.97 117.36 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.16 131.83 54.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.934 -1.104 . . . . 0.0 108.971 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' D' ' 12' ' ' ALA . 3.4 m -104.02 98.0 7.89 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' D' ' 11' ' ' THR . . . 61.89 65.12 0.94 Allowed 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.948 0.88 . . . . 0.0 110.068 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -132.97 -141.44 0.2 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -169.44 -31.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 109.389 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 28.7 mt 50.21 67.14 4.67 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.185 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.85 156.41 48.88 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 C-N-CA 122.122 1.881 . . . . 0.0 110.126 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.5 -4.01 72.54 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.612 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 29.0 mt -125.16 135.83 53.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.872 -1.369 . . . . 0.0 108.967 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -86.38 112.49 21.5 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 11.9 mt -95.59 133.68 39.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.044 -1.035 . . . . 0.0 109.807 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' D' ' 22' ' ' SER . 4.4 t80 -122.45 129.97 52.59 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . 0.433 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 48.2 t -85.84 129.63 34.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.573 -0.704 . . . . 0.0 110.97 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.919 HD23 ' N ' ' D' ' 23' ' ' LEU . 0.3 OUTLIER -119.4 13.31 12.66 Favored 'General case' 0 N--CA 1.507 2.395 0 CA-C-O 122.235 1.017 . . . . 0.0 108.483 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 143.26 170.29 12.98 Favored Glycine 0 N--CA 1.49 2.298 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.026 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' ILE . . . . . 0.487 HD11 ' HG1' ' C' ' 11' ' ' THR . 0.7 OUTLIER -109.39 142.69 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.389 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' D' ' 67' ' ' TYR . . . -114.22 148.21 37.73 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 89.4 p -152.09 141.55 21.63 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 14.9 t -149.67 140.84 23.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.157 -0.965 . . . . 0.0 109.044 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 tt -115.7 129.81 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 90.1 p -177.26 -131.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.545 -0.722 . . . . 0.0 109.257 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' D' ' 32' ' ' ASN . 15.1 p-10 -166.51 169.69 13.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.211 -0.931 . . . . 0.0 109.471 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 6.8 t-20 73.65 127.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 0.0 108.666 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 22.9 t -68.88 -35.09 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.379 -0.826 . . . . 0.0 109.656 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' D' ' 35' ' ' GLU . 0.9 OUTLIER -59.21 -45.11 91.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.85 -179.509 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' GLU . . . . . 0.463 ' N ' ' OD1' ' D' ' 34' ' ' ASP . 55.2 mm-40 -75.25 -40.11 59.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.185 -0.947 . . . . 0.0 109.413 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.79 -53.17 50.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.962 -1.087 . . . . 0.0 109.482 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 44.3 t -61.49 -47.81 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.056 -1.027 . . . . 0.0 109.211 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -61.45 -41.98 98.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.691 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -58.54 -46.66 86.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 109.474 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' D' ' 40' ' ' LEU . 47.7 mt -71.4 -46.89 59.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.175 -0.953 . . . . 0.0 109.007 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -49.9 -44.99 50.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.816 -1.177 . . . . 0.0 109.172 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -63.31 -34.61 78.07 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.057 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -73.92 -36.9 64.75 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.324 -0.86 . . . . 0.0 109.328 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 t -73.4 -51.21 26.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.792 -1.193 . . . . 0.0 108.887 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.92 -33.42 37.08 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.73 1.253 . . . . 0.0 110.098 -177.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.82 -30.33 51.08 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.837 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -92.2 4.2 53.73 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.77 26.44 62.74 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 118.492 -1.813 . . . . 0.0 109.359 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.38 -167.67 13.37 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 9.9 ttp -107.38 -43.47 4.55 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.499 -1.0 . . . . 0.0 109.706 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 173.55 -152.79 16.13 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 tp -131.81 142.34 49.7 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.446 -1.032 . . . . 0.0 109.716 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' ILE . . . . . 1.035 ' H ' HD12 ' D' ' 53' ' ' ILE . 0.0 OUTLIER -113.98 147.4 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.598 -0.689 . . . . 0.0 110.181 -178.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 84.08 -54.63 0.13 Allowed 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 118.683 0.674 . . . . 0.0 111.607 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.601 ' O ' ' O ' ' D' ' 54' ' ' ALA . 50.4 t80 43.03 -179.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' ARG . . . . . 0.812 ' HE ' HG21 ' C' ' 58' ' ' THR . 1.6 mmm180 174.22 144.57 0.05 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.461 -1.4 . . . . 0.0 109.139 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' ILE . . . . . 0.436 HG21 HD13 ' E' ' 65' ' ' LEU . 15.4 mm -83.24 145.82 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 109.045 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' THR . . . . . . . . . . . . . 82.6 p -79.57 -124.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.406 -0.809 . . . . 0.0 109.257 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' CYS . . . . . . . . . . . . . 26.0 p -165.94 -163.63 0.64 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 109.392 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.66 -65.61 0.66 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -80.13 -117.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.556 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . -150.56 54.07 0.49 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.94 -34.01 21.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.334 -1.098 . . . . 0.0 109.616 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -115.29 138.86 50.5 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.555 -0.716 . . . . 0.0 109.357 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.406 ' N ' HD12 ' D' ' 65' ' ' LEU . 6.2 mp -106.69 162.32 13.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.504 -0.747 . . . . 0.0 109.054 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.58 41.14 2.3 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 67' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' D' ' 26' ' ' ALA . 4.3 p90 -64.76 -167.86 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.441 -1.035 . . . . 0.0 110.125 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.18 175.15 40.09 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 69' ' ' THR . . . . . 0.468 ' OG1' HD11 ' D' ' 25' ' ' ILE . 4.9 m -97.9 134.91 40.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.99 -1.3 . . . . 0.0 108.176 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 70' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' D' ' 22' ' ' SER . 50.3 mt -79.45 134.71 27.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.9 163.04 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.466 -0.771 . . . . 0.0 109.737 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 72' ' ' LYS . . . . . 0.428 ' H ' ' H ' ' D' ' 21' ' ' TYR . 14.9 ttpp -154.19 140.35 18.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.446 -0.784 . . . . 0.0 108.998 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.74 150.78 25.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.829 -1.169 . . . . 0.0 108.868 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . 0.407 ' CG ' ' H ' ' D' ' 75' ' ' GLU . 7.6 t70 -73.58 -151.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.087 -1.008 . . . . 0.0 109.317 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 75' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' D' ' 76' ' ' ALA . 2.5 tm-20 -164.13 81.4 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 109.489 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' D' ' 78' ' ' PHE . . . 176.63 -13.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.358 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 62.96 -70.46 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.511 -0.743 . . . . 0.0 109.161 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 78' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' D' ' 76' ' ' ALA . 68.7 m-85 -83.45 104.28 13.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.921 . . . . 0.0 109.231 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 23.6 m -55.8 95.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.649 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 24.2 mmt 49.71 -114.66 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.898 . . . . 0.0 109.529 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.385 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . 0.886 HD13 ' H ' ' E' ' 2' ' ' ILE . 0.1 OUTLIER -136.26 -5.84 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.5 -0.75 . . . . 0.0 109.519 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 3' ' ' PHE . . . . . 0.407 ' CZ ' HD11 ' E' ' 2' ' ' ILE . 49.0 m-85 -78.25 37.89 0.27 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.904 . . . . 0.0 109.4 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -69.28 -51.76 34.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.884 . . . . 0.0 109.551 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.44 117.19 9.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 6' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' E' ' 50' ' ' MET . 54.8 tttt -138.33 -68.65 0.45 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.187 -0.945 . . . . 0.0 109.082 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -105.08 122.51 46.03 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 14.3 mt -134.3 131.56 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.362 -0.836 . . . . 0.0 109.736 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 9' ' ' ILE . . . . . 0.585 HG23 ' O ' ' E' ' 9' ' ' ILE . 19.2 tt -121.82 117.25 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.53 133.63 55.79 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.459 -0.776 . . . . 0.0 108.988 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 11' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' E' ' 12' ' ' ALA . 25.3 m -86.88 61.63 6.92 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.048 -1.032 . . . . 0.0 111.085 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' E' ' 11' ' ' THR . . . 174.99 -110.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -176.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 167.88 113.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . 0.425 ' CG ' ' H ' ' E' ' 15' ' ' ILE . 0.8 OUTLIER -173.73 -96.79 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.057 -1.027 . . . . 0.0 109.635 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 15' ' ' ILE . . . . . 0.51 ' N ' ' HD3' ' E' ' 16' ' ' PRO . 8.6 mt 59.0 60.1 5.12 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 109.61 -179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' E' ' 15' ' ' ILE . 1.6 Cg_endo -64.9 153.15 79.51 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 122.018 1.812 . . . . 0.0 109.734 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.52 -8.77 78.48 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.356 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 18' ' ' LEU . . . . . 0.482 HD12 ' CG2' ' E' ' 15' ' ' ILE . 61.3 mt -124.55 137.56 54.39 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.077 -1.249 . . . . 0.0 109.188 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -86.99 108.73 18.97 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 12.8 mt -89.4 136.32 33.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 110.001 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 21' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' E' ' 71' ' ' VAL . 4.3 t80 -117.81 129.69 55.82 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.0 127.38 30.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.811 -1.181 . . . . 0.0 110.941 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' E' ' 23' ' ' LEU . 23.4 mt -113.58 8.49 17.7 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.55 -163.15 13.13 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -128.18 143.67 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.867 -0.784 . . . . 0.0 109.216 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.24 147.81 39.9 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.4 0.619 . . . . 0.0 109.439 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 60.0 p -151.71 135.01 15.98 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.84 148.79 30.31 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.98 -1.075 . . . . 0.0 108.835 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 tp -127.1 133.51 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 4.5 m -151.21 -152.7 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 109.067 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 31' ' ' ASP . . . . . 0.423 ' CG ' ' H ' ' E' ' 32' ' ' ASN . 0.9 OUTLIER -106.22 -82.72 0.53 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.36 -0.837 . . . . 0.0 111.114 -178.51 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 32' ' ' ASN . . . . . 0.423 ' H ' ' CG ' ' E' ' 31' ' ' ASP . 87.7 m-20 -81.01 165.11 22.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.03 . . . . 0.0 109.428 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 64.6 t -68.15 -31.9 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.789 -0.569 . . . . 0.0 109.731 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.37 -40.91 68.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 109.859 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -76.66 -35.48 57.92 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.19 -0.944 . . . . 0.0 109.082 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 69.2 mt -63.97 -52.89 50.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 120.929 -1.107 . . . . 0.0 109.425 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.54 -49.1 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.067 -1.021 . . . . 0.0 109.396 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -58.61 -39.11 79.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.892 . . . . 0.0 109.381 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -69.47 -39.94 77.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.022 -1.049 . . . . 0.0 109.782 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 40' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' E' ' 40' ' ' LEU . 21.7 mt -68.2 -45.59 72.95 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.917 -1.115 . . . . 0.0 108.711 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -47.43 -56.61 6.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.859 -1.151 . . . . 0.0 108.944 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -55.06 -32.94 62.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.861 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -75.53 -40.82 56.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.9 . . . . 0.0 110.087 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 38.4 t -76.88 -52.51 16.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.935 -1.103 . . . . 0.0 108.879 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -56.57 -28.6 60.56 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.381 1.086 . . . . 0.0 110.21 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.73 -28.46 58.54 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.507 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -87.22 10.91 15.49 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.64 29.17 53.6 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.081 -1.533 . . . . 0.0 109.417 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.97 -168.81 30.04 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 50' ' ' MET . . . . . 0.473 ' O ' ' O ' ' E' ' 6' ' ' LYS . 65.5 mtp -103.96 -37.42 7.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.514 -0.992 . . . . 0.0 109.288 177.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 174.5 -153.27 15.91 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 12.0 tp -126.94 135.72 51.28 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.525 -0.985 . . . . 0.0 109.744 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 53' ' ' ILE . . . . . 0.476 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 1.2 pt -110.36 146.19 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.528 -0.732 . . . . 0.0 109.958 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 67.66 87.41 0.12 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 109.711 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -138.4 82.16 1.89 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 56' ' ' ARG . . . . . 0.671 HH22 ' NH1' ' A' ' 56' ' ' ARG . 12.8 ptm180 -120.48 8.74 10.78 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.636 -0.665 . . . . 0.0 109.338 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 57' ' ' ILE . . . . . 0.541 HG22 ' O ' ' E' ' 57' ' ' ILE . 72.4 mt 57.63 -0.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.539 -0.726 . . . . 0.0 109.693 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 58' ' ' THR . . . . . 0.534 ' H ' ' C ' ' E' ' 56' ' ' ARG . 63.0 m 54.59 -87.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.69 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 59' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' E' ' 57' ' ' ILE . 73.1 m -76.09 -120.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 109.609 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.6 79.57 1.33 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.113 -0.992 . . . . 0.0 109.513 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 61' ' ' ASP . . . . . 0.456 ' H ' HG21 ' E' ' 57' ' ' ILE . 43.9 t0 51.06 19.6 0.71 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.342 -0.849 . . . . 0.0 109.656 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.88 -141.4 1.26 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -91.0 61.62 4.67 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.226 -1.161 . . . . 0.0 109.433 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 64' ' ' PHE . . . . . 0.508 ' C ' HD12 ' E' ' 65' ' ' LEU . 55.0 m-85 -137.38 -173.35 3.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.39 -0.819 . . . . 0.0 109.201 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.611 ' N ' HD12 ' E' ' 65' ' ' LEU . 3.7 mp -137.2 146.11 44.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.404 -0.81 . . . . 0.0 109.877 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.4 60.71 4.52 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -55.82 169.28 0.36 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.327 -1.102 . . . . 0.0 110.039 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.01 162.07 32.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 52.8 m -102.96 134.34 46.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.103 -1.233 . . . . 0.0 108.09 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 37.2 mt -86.07 136.45 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 71' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' E' ' 21' ' ' TYR . 6.5 m -132.22 165.86 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.4 -0.813 . . . . 0.0 110.2 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 72' ' ' LYS . . . . . 0.449 ' CB ' HD11 ' E' ' 23' ' ' LEU . 1.5 ttpp -153.95 140.74 19.09 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.97 151.1 22.86 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.791 -1.193 . . . . 0.0 108.85 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -72.54 -1.93 17.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.063 -1.023 . . . . 0.0 109.576 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 75' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' E' ' 77' ' ' GLN . 13.2 tt0 65.97 18.06 10.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.376 -0.828 . . . . 0.0 109.634 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 76' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' E' ' 75' ' ' GLU . . . 62.03 1.21 0.63 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.325 -0.859 . . . . 0.0 109.717 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 77' ' ' GLN . . . . . 0.439 ' H ' ' C ' ' E' ' 75' ' ' GLU . 21.5 mm-40 51.39 -153.91 0.17 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.211 -0.93 . . . . 0.0 109.578 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -59.04 159.6 7.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.616 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . 0.55 HG22 ' N ' ' E' ' 80' ' ' MET . 88.4 m -79.49 165.88 22.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 109.177 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 80' ' ' MET . . . . . 0.55 ' N ' HG22 ' E' ' 79' ' ' THR . 4.7 ptt? -138.25 86.75 2.19 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.382 -0.823 . . . . 0.0 109.278 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.415 179.857 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mtm . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.9 tp -93.52 151.12 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.266 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 3' ' ' PHE . 0.6 OUTLIER -90.03 67.43 7.04 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.164 -0.96 . . . . 0.0 109.089 179.604 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 56.19 -89.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.439 -0.788 . . . . 0.0 110.194 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 3' ' ' PHE . 57.5 t0 56.9 100.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.401 -0.812 . . . . 0.0 109.47 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -82.44 105.44 13.5 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.26 -0.9 . . . . 0.0 109.296 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -103.44 122.98 46.0 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.607 -0.683 . . . . 0.0 109.328 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 76.6 mt -109.91 130.86 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.376 -0.828 . . . . 0.0 109.936 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.61 ' O ' HG23 ' A' ' 9' ' ' ILE . 6.7 tt -135.05 114.61 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.6 t -123.16 160.05 27.32 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.958 0.885 . . . . 0.0 109.223 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 12' ' ' ALA . 11.0 p -96.34 -110.1 0.15 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.746 -0.596 . . . . 0.0 109.733 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 11' ' ' THR . . . 37.7 -104.44 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.1 -1.0 . . . . 0.0 111.073 177.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 15.0 p-10 -142.85 -64.68 0.4 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.446 -0.784 . . . . 0.0 109.793 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.467 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 11.5 pt-20 -152.16 -166.75 2.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.108 -0.995 . . . . 0.0 109.56 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.8 mt -116.59 97.72 50.59 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.603 -0.686 . . . . 0.0 109.303 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.18 156.31 46.02 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.82 1.68 . . . . 0.0 110.273 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.11 -7.59 78.46 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 18' ' ' LEU . 62.4 mt -129.88 141.37 50.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.31 -1.112 . . . . 0.0 109.467 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.6 117.05 25.12 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.6 mt -101.34 136.66 40.82 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.132 -0.98 . . . . 0.0 109.154 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.424 ' H ' ' H ' ' A' ' 72' ' ' LYS . 12.3 t80 -113.62 129.26 56.6 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.385 -0.822 . . . . 0.0 109.083 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.1 t -73.37 124.57 26.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.488 -1.383 . . . . 0.0 109.377 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.7 mt -111.07 8.45 21.82 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.37 -167.04 21.47 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.3 mm -122.26 142.23 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.8 153.44 29.09 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.5 m -152.2 145.08 24.4 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.07 -1.019 . . . . 0.0 109.084 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.7 p -143.84 131.07 20.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.469 -0.769 . . . . 0.0 108.983 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.628 ' O ' ' CB ' ' A' ' 30' ' ' SER . 91.8 mt -105.87 153.34 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.628 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 88.9 p 120.89 -147.53 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 32' ' ' ASN . 22.0 t70 -145.64 -160.73 1.18 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.457 ' H ' ' CG ' ' A' ' 31' ' ' ASP . 14.0 m-20 70.66 101.61 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.4 t -62.56 -35.97 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.123 -0.986 . . . . 0.0 109.325 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.69 -41.7 86.87 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.248 -0.908 . . . . 0.0 109.692 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -75.81 -41.17 53.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.316 -0.865 . . . . 0.0 109.486 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.5 mt -63.41 -53.79 40.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.945 -1.097 . . . . 0.0 108.959 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.9 t -55.96 -49.87 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 108.999 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.91 -40.12 87.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 109.94 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.448 HD22 ' N ' ' A' ' 39' ' ' ASN . 1.5 m120 -62.11 -44.02 97.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.176 -0.953 . . . . 0.0 109.499 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.3 mt -71.12 -49.08 48.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.105 -0.997 . . . . 0.0 108.7 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -48.8 -49.35 39.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.805 -1.184 . . . . 0.0 109.277 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -63.21 -36.39 83.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.513 -0.742 . . . . 0.0 110.217 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.67 -35.53 57.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.833 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 t -68.3 -51.2 50.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 109.196 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -67.13 -37.94 84.7 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.773 -1.205 . . . . 0.0 109.161 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.1 -32.64 66.5 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -85.45 -4.53 59.19 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.46 -0.775 . . . . 0.0 109.341 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.66 9.13 61.63 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.84 -157.22 3.76 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.4 ptm -165.1 -20.15 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.09 -1.241 . . . . 0.0 110.385 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -152.56 160.11 28.8 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 tp -118.06 138.87 51.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.652 -0.91 . . . . 0.0 109.115 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.551 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 1.1 pt -114.51 147.08 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.483 -0.761 . . . . 0.0 109.969 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 70.75 85.08 0.13 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.456 -0.778 . . . . 0.0 110.932 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.4 ' CG ' HD11 ' A' ' 9' ' ' ILE . 52.8 t80 -123.62 102.59 7.93 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -123.13 138.09 54.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.517 -0.739 . . . . 0.0 109.813 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.405 ' O ' ' CG1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -142.64 110.99 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.661 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 59' ' ' CYS . 37.3 p -81.09 114.18 19.77 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.829 -1.169 . . . . 0.0 109.288 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.445 ' C ' ' O ' ' A' ' 58' ' ' THR . 12.5 m 38.18 -137.58 0.06 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.628 -0.67 . . . . 0.0 110.16 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -153.03 45.12 0.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -0.91 . . . . 0.0 109.199 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.2 p30 -136.9 -16.81 1.45 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.483 -0.76 . . . . 0.0 109.408 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 64' ' ' PHE . . . -134.14 -179.21 16.2 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.4 tttt 65.25 -70.97 0.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -1.111 . . . . 0.0 109.507 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 62' ' ' GLY . 1.8 m-85 49.57 53.19 13.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.242 -0.911 . . . . 0.0 109.13 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.8 tp -164.75 103.11 0.8 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.828 -1.17 . . . . 0.0 109.922 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.54 61.21 4.19 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -46.62 144.18 2.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.317 -1.108 . . . . 0.0 110.02 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.7 149.21 18.75 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.492 ' OG1' HG23 ' E' ' 11' ' ' THR . 21.2 m -106.56 140.65 39.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -1.131 . . . . 0.0 108.821 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.2 mt -84.5 134.04 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.68 155.47 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.235 -0.916 . . . . 0.0 109.104 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.424 ' H ' ' H ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -148.26 134.24 19.17 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.16 148.41 28.88 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.139 -0.976 . . . . 0.0 108.542 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 25.2 p-10 -176.35 55.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.129 -0.982 . . . . 0.0 109.031 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -101.72 -115.54 0.19 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.297 -0.877 . . . . 0.0 109.471 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.39 -178.86 0.55 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 109.258 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -126.35 -120.44 0.26 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.495 -0.753 . . . . 0.0 109.041 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 47.58 76.76 0.1 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.208 -0.932 . . . . 0.0 109.497 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.4 p 50.07 -163.59 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.381 -0.824 . . . . 0.0 109.584 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 15.9 mmt -64.65 134.77 54.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 109.434 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.387 -179.916 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.281 0.562 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.582 ' C ' HD12 ' B' ' 2' ' ' ILE . 2.8 pp -69.33 178.1 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.345 -0.847 . . . . 0.0 109.417 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -150.63 120.44 7.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.327 -0.858 . . . . 0.0 109.204 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -75.8 108.41 8.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.989 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 t0 68.94 112.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.555 -178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -167.86 99.65 0.47 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -0.968 . . . . 0.0 109.074 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -98.18 132.54 43.61 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.504 -0.747 . . . . 0.0 109.137 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 71.1 mt -124.44 141.47 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.476 -0.765 . . . . 0.0 109.433 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.462 ' CG2' ' O ' ' B' ' 9' ' ' ILE . 6.8 tt -136.87 119.76 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 7.6 t -124.6 156.58 37.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.196 -0.94 . . . . 0.0 108.622 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.477 ' HB ' ' H ' ' B' ' 12' ' ' ALA . 0.0 OUTLIER -68.33 -132.34 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.477 ' H ' ' HB ' ' B' ' 11' ' ' THR . . . -94.09 110.21 21.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.138 -0.976 . . . . 0.0 110.014 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -162.75 -134.22 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . 0.634 ' O ' ' C ' ' B' ' 15' ' ' ILE . 6.4 pt-20 -172.99 46.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.064 -1.022 . . . . 0.0 109.49 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.634 ' C ' ' O ' ' B' ' 14' ' ' GLU . 11.3 mt -1.81 77.58 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.505 0 O-C-N 122.357 -0.214 . . . . 0.0 110.586 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.498 ' N ' ' O ' ' B' ' 14' ' ' GLU . 2.3 Cg_endo -62.12 155.49 55.8 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.831 1.687 . . . . 0.0 110.183 -177.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.44 -11.59 71.74 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 34.7 mt -124.37 137.52 54.46 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.08 -1.247 . . . . 0.0 109.228 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.17 116.1 24.15 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.45 138.73 35.24 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.242 -0.911 . . . . 0.0 109.687 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -118.29 129.79 55.66 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.82 129.18 39.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.732 -1.23 . . . . 0.0 110.673 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.404 HD11 ' CB ' ' B' ' 72' ' ' LYS . 74.2 mt -115.62 7.1 14.71 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.96 -156.06 16.18 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.63 142.94 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.885 -0.773 . . . . 0.0 109.389 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -117.2 144.6 44.6 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.774 -0.579 . . . . 0.0 109.954 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 30.7 p -152.45 141.83 21.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.191 -0.943 . . . . 0.0 108.743 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.59 152.76 36.02 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.077 -1.015 . . . . 0.0 109.72 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.428 ' N ' HD12 ' B' ' 29' ' ' ILE . 3.4 mp -98.52 152.27 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.245 -0.909 . . . . 0.0 108.949 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 173.05 143.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.445 -0.784 . . . . 0.0 109.242 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.411 ' O ' ' CG ' ' B' ' 32' ' ' ASN . 15.2 p-10 -93.08 30.1 1.71 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.235 -0.916 . . . . 0.0 110.325 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . 0.411 ' CG ' ' O ' ' B' ' 31' ' ' ASP . 27.1 m120 -162.23 141.17 9.28 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.548 0.689 . . . . 0.0 109.902 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.23 -37.27 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.396 -0.815 . . . . 0.0 109.57 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.71 -38.77 72.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 0.0 109.536 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -75.28 -36.93 61.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.235 -0.916 . . . . 0.0 108.696 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 82.4 mt -65.29 -53.5 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.917 -1.114 . . . . 0.0 109.25 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -54.54 -51.34 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.109 -0.994 . . . . 0.0 109.134 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.83 -43.02 98.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.35 -0.844 . . . . 0.0 109.758 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -60.65 -45.24 94.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.29 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' B' ' 40' ' ' LEU . 61.1 mt -67.09 -46.08 75.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.155 -0.966 . . . . 0.0 108.911 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -50.1 -43.7 51.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.764 -1.21 . . . . 0.0 109.459 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -67.87 -38.6 83.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.614 -0.679 . . . . 0.0 110.272 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -76.48 -35.62 58.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.453 -0.779 . . . . 0.0 109.858 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 t -66.12 -50.12 71.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 109.21 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -62.96 -31.03 72.04 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.238 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.68 -31.74 71.05 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.763 0.792 . . . . 0.0 109.394 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -84.91 -5.38 59.34 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.75 8.96 75.64 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.69 164.61 45.18 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.98 1.85 2.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.03 -1.277 . . . . 0.0 110.325 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.7 165.75 38.61 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.921 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 tp -136.52 137.9 40.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.585 -0.95 . . . . 0.0 109.163 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.906 ' O ' HD13 ' B' ' 53' ' ' ILE . 0.0 OUTLIER -109.4 151.68 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.47 -0.769 . . . . 0.0 109.872 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 78.83 -64.02 0.27 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.327 -0.858 . . . . 0.0 112.678 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.495 ' O ' ' CG ' ' B' ' 55' ' ' PHE . 61.2 t80 34.74 36.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.394 0.616 . . . . 0.0 109.788 177.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.793 HH11 ' HG3' ' B' ' 56' ' ' ARG . 14.3 mtm-85 -64.39 154.71 34.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.868 -1.145 . . . . 0.0 109.73 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.429 HG22 ' N ' ' B' ' 58' ' ' THR . 84.6 mt -132.43 157.61 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . 0.429 ' N ' HG22 ' B' ' 57' ' ' ILE . 2.3 m -124.36 -131.27 0.26 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 43.6 t -160.02 151.95 20.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 109.369 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -168.72 -178.23 3.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 109.486 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -72.47 -64.42 0.96 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.319 -0.863 . . . . 0.0 109.376 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.02 -32.35 0.27 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -49.59 -54.3 19.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.479 -1.013 . . . . 0.0 110.1 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.445 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 1.5 t80 58.66 -127.68 1.39 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.219 -0.926 . . . . 0.0 109.173 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' B' ' 64' ' ' PHE . 4.4 tt 61.45 137.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.612 -0.68 . . . . 0.0 109.605 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -127.79 -114.89 1.86 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' TYR . . . . . 0.436 ' CD1' ' O ' ' B' ' 67' ' ' TYR . 32.4 p90 -172.87 130.97 0.51 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -1.172 . . . . 0.0 109.142 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.54 148.11 19.75 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 79.0 m -102.18 136.29 42.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.907 -1.349 . . . . 0.0 108.761 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 49.1 mt -83.03 142.88 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 m -135.45 157.71 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.151 -0.968 . . . . 0.0 109.767 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.404 ' CB ' HD11 ' B' ' 23' ' ' LEU . 0.0 OUTLIER -147.17 151.35 36.63 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.31 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.4 150.22 34.99 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -84.77 169.73 13.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.028 -1.045 . . . . 0.0 109.242 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' GLU . . . . . 0.45 ' HG3' ' H ' ' B' ' 77' ' ' GLN . 6.8 tp10 -90.28 123.99 34.51 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.292 -0.88 . . . . 0.0 109.345 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.16 11.16 17.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.173 -0.954 . . . . 0.0 109.538 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . 0.45 ' H ' ' HG3' ' B' ' 75' ' ' GLU . 93.5 mm-40 -84.82 124.27 31.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.213 -0.929 . . . . 0.0 109.398 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -78.6 14.36 1.32 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 109.496 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 6.7 t -163.84 26.02 0.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 109.485 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' MET . . . . . . . . . . . . . 6.8 mmt 50.89 -157.13 0.11 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -0.936 . . . . 0.0 109.5 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.448 179.992 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 70.0 mt -71.94 -23.91 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.449 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -160.49 -30.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 109.416 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . 0.423 ' CD ' ' N ' ' C' ' 4' ' ' GLU . 13.8 mp0 -69.7 2.06 3.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.326 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' C' ' 6' ' ' LYS . 19.2 t70 -77.44 -146.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 109.291 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . 0.44 ' H ' ' CG ' ' C' ' 5' ' ' ASP . 41.6 mtpt -138.69 74.99 1.5 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.274 -0.891 . . . . 0.0 109.269 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -102.46 144.31 31.07 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 14.1 mt -132.98 135.97 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.464 -0.772 . . . . 0.0 109.577 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' ILE . . . . . 0.61 HG23 ' O ' ' C' ' 9' ' ' ILE . 16.4 tt -137.77 115.0 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -123.05 158.68 30.06 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 7.6 p -114.82 85.09 2.18 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.35 -133.08 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.72 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -107.6 -55.98 2.28 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.55 -0.719 . . . . 0.0 109.39 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . 0.522 ' HG2' ' H ' ' C' ' 15' ' ' ILE . 22.7 tt0 -164.89 -179.32 5.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.933 . . . . 0.0 108.886 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . 0.522 ' H ' ' HG2' ' C' ' 14' ' ' GLU . 63.6 mt -112.12 92.04 17.44 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.95 156.7 42.53 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 122.0 1.8 . . . . 0.0 110.456 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.74 -6.08 76.92 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 77.6 mt -130.63 140.44 50.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -1.179 . . . . 0.0 109.494 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -86.01 107.56 17.83 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.545 ' HB3' ' HB ' ' C' ' 71' ' ' VAL . 6.7 mt -111.0 128.17 55.76 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.485 -0.759 . . . . 0.0 110.451 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' TYR . . . . . 0.641 ' N ' ' CD1' ' C' ' 21' ' ' TYR . 0.0 OUTLIER -112.42 142.75 44.58 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.7 136.42 45.58 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.627 0.727 . . . . 0.0 110.106 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.451 HD21 ' HD3' ' C' ' 72' ' ' LYS . 2.1 mt -120.43 12.93 11.74 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.5 -175.46 16.72 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' ILE . . . . . 0.438 HD11 HG23 ' B' ' 9' ' ' ILE . 49.4 mm -114.58 139.23 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.13 143.95 42.32 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.35 -0.843 . . . . 0.0 109.217 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 19.2 m -152.83 146.87 25.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.094 -1.004 . . . . 0.0 109.211 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 9.6 t -149.9 137.18 19.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.351 -0.843 . . . . 0.0 109.171 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.404 HG22 ' N ' ' C' ' 30' ' ' SER . 89.2 mt -108.23 157.97 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.698 ' O ' ' CG ' ' C' ' 31' ' ' ASP . 15.4 m 62.74 85.09 0.13 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.526 -0.734 . . . . 0.0 109.774 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' ASP . . . . . 0.698 ' CG ' ' O ' ' C' ' 30' ' ' SER . 27.2 m-20 173.04 132.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -83.73 175.17 9.87 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 1.9 m -46.16 -42.62 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.636 0 O-C-N 120.56 -1.337 . . . . 0.0 107.673 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -63.0 -48.7 77.66 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.297 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -73.14 -36.73 66.74 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.955 -1.091 . . . . 0.0 108.896 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 89.5 mt -61.96 -52.53 59.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.824 -1.172 . . . . 0.0 109.396 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.97 -48.58 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -0.965 . . . . 0.0 109.399 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' GLU . . . . . 0.442 ' HA ' ' HE ' ' C' ' 41' ' ' ARG . 24.3 mm-40 -56.0 -36.23 67.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 109.007 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' ASN . . . . . 0.48 ' ND2' ' OD2' ' C' ' 31' ' ' ASP . 79.8 m-20 -76.07 -37.79 57.82 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.728 -1.232 . . . . 0.0 110.565 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . 0.58 ' O ' HG13 ' C' ' 44' ' ' VAL . 78.7 mt -74.27 -53.28 10.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.741 -1.225 . . . . 0.0 110.024 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' ARG . . . . . 0.453 ' NH1' ' HE2' ' C' ' 45' ' ' LYS . 2.2 ppt_? -47.19 -45.23 22.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.075 -1.016 . . . . 0.0 109.279 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -60.12 -32.46 71.02 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.051 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' GLN . . . . . 0.524 ' O ' ' HB2' ' C' ' 47' ' ' LYS . 69.8 mm-40 -75.31 -36.61 61.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -0.971 . . . . 0.0 110.756 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' VAL . . . . . 0.617 ' O ' ' N ' ' C' ' 49' ' ' GLY . 0.8 OUTLIER -76.8 -52.1 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.712 -1.243 . . . . 0.0 109.83 -179.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' LYS . . . . . 0.475 ' N ' ' CG2' ' C' ' 44' ' ' VAL . 0.3 OUTLIER -61.53 -33.0 73.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.28 -1.512 . . . . 0.0 109.38 -175.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.7 -32.89 62.31 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.85 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' C' ' 43' ' ' GLN . 3.9 mtpp -93.31 -7.61 44.41 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' C' ' 44' ' ' VAL . . . 105.39 -1.25 40.05 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' C' ' 44' ' ' VAL . . . -65.18 -173.68 4.08 Favored Glycine 0 N--CA 1.483 1.798 0 O-C-N 119.913 -1.934 . . . . 0.0 109.597 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.08 9.87 0.44 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.094 -1.239 . . . . 0.0 110.003 176.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.07 164.73 18.81 Favored Glycine 0 N--CA 1.483 1.8 0 C-N-CA 118.974 -1.584 . . . . 0.0 109.813 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . 0.427 HD22 HD13 ' C' ' 40' ' ' LEU . 0.4 OUTLIER -115.76 149.6 38.23 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.87 -0.783 . . . . 0.0 109.88 179.033 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.63 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 1.1 pt -113.15 143.67 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.678 -0.639 . . . . 0.0 110.104 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 77.78 -50.66 0.51 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.68 -0.637 . . . . 0.0 110.679 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' C' ' 54' ' ' ALA . 50.0 t80 42.24 68.98 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' ARG . . . . . 0.67 ' CG ' HH11 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -77.02 137.98 39.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.129 -178.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.59 132.63 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' THR . . . . . 0.489 ' OG1' ' N ' ' C' ' 59' ' ' CYS . 2.1 t -135.81 -167.47 2.04 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' CYS . . . . . 0.489 ' N ' ' OG1' ' C' ' 58' ' ' THR . 48.7 t -138.8 143.14 38.78 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.313 -0.867 . . . . 0.0 109.274 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' C' ' 62' ' ' GLY . . . -165.02 133.37 3.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.175 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 5.6 t70 70.15 -33.09 0.25 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.59 -0.694 . . . . 0.0 109.805 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' C' ' 60' ' ' ALA . . . 152.34 -66.28 0.34 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -66.13 -164.45 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.629 -0.924 . . . . 0.0 109.656 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' C' ' 64' ' ' PHE . 0.6 OUTLIER -141.65 179.06 7.05 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.337 -0.852 . . . . 0.0 109.247 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 23.7 tp -145.48 106.42 4.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.358 -0.839 . . . . 0.0 108.945 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.88 147.09 18.09 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -162.21 -176.49 5.16 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.323 -1.104 . . . . 0.0 109.51 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . 166.49 -162.0 35.68 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 21.8 m -123.92 136.65 54.47 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.13 142.85 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' C' ' 20' ' ' LEU . 5.2 m -137.18 150.19 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.661 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' LYS . . . . . 0.451 ' HD3' HD21 ' C' ' 23' ' ' LEU . 12.9 mtpp -119.17 146.01 45.53 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.45 149.43 26.17 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' C' ' 74' ' ' ASP . 25.9 p-10 -83.64 142.33 30.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.772 -1.205 . . . . 0.0 109.376 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' GLU . . . . . 0.586 ' O ' ' HB3' ' C' ' 76' ' ' ALA . 68.8 tt0 -91.12 -39.14 12.32 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.19 -0.944 . . . . 0.0 109.673 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' C' ' 75' ' ' GLU . . . 73.16 -48.01 0.68 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.695 -0.628 . . . . 0.0 109.879 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -77.79 78.47 4.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.219 -0.926 . . . . 0.0 109.709 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 45.93 -153.78 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.361 -0.837 . . . . 0.0 109.697 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 66.8 p -144.32 -123.8 0.08 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.2 -0.938 . . . . 0.0 109.059 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 36.3 mtm -93.77 -56.36 2.92 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.164 -0.96 . . . . 0.0 109.53 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.558 -179.989 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ptt? . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' ILE . . . . . . . . . . . . . 4.6 pt -75.71 -40.01 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 109.427 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -114.03 44.93 1.57 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.416 -0.802 . . . . 0.0 109.083 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.65 154.06 22.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.216 -0.927 . . . . 0.0 109.38 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' ASP . . . . . . . . . . . . . 42.3 p-10 -75.17 -172.9 1.83 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 109.317 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -80.26 108.73 14.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.219 -0.926 . . . . 0.0 109.69 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -92.49 120.01 32.54 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.102 -0.999 . . . . 0.0 108.743 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 50.7 mt -126.14 129.87 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.461 -0.774 . . . . 0.0 110.093 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' ILE . . . . . 0.601 HG23 ' O ' ' D' ' 9' ' ' ILE . 17.1 tt -113.64 114.43 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t -123.55 160.68 26.49 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.147 -0.971 . . . . 0.0 109.082 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 11.5 p -91.84 -113.2 0.09 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.5 -120.15 0.87 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.106 . . . . 0.0 110.426 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -152.7 -27.16 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.728 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -168.56 177.1 5.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 0.0 109.53 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 96.1 mt -116.55 97.61 50.37 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.13 155.96 47.82 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.772 1.648 . . . . 0.0 110.415 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.18 -7.54 78.34 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 64.8 mt -129.28 140.46 51.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -1.103 . . . . 0.0 109.513 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -84.52 108.49 17.32 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 15.1 mt -97.26 135.26 39.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.825 . . . . 0.0 110.025 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' TYR . . . . . 0.5 ' CE1' ' O ' ' D' ' 22' ' ' SER . 1.5 t80 -117.74 130.04 56.07 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . 0.5 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 28.3 t -75.0 129.68 38.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.911 -1.118 . . . . 0.0 110.917 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mt -117.3 12.17 14.24 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.79 177.84 15.2 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.65 145.02 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.892 -0.769 . . . . 0.0 108.943 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.69 144.12 42.74 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.6 -0.688 . . . . 0.0 109.348 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 92.4 p -152.2 138.42 18.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.083 -1.011 . . . . 0.0 108.611 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 13.5 t -149.51 146.33 27.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.052 -1.03 . . . . 0.0 109.134 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 47.5 mm -116.94 131.54 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.274 -0.891 . . . . 0.0 109.199 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 11.9 m -153.46 -158.04 0.84 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.207 -0.933 . . . . 0.0 109.408 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -106.88 -80.03 0.57 Allowed 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.406 -0.809 . . . . 0.0 111.153 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.499 ' ND2' ' H ' ' D' ' 32' ' ' ASN . 3.4 m-80 -65.39 144.78 56.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.896 -1.127 . . . . 0.0 109.153 177.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . 0.413 ' H ' HG13 ' D' ' 33' ' ' VAL . 1.9 m -69.42 -36.15 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -58.25 -29.47 65.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.522 -0.736 . . . . 0.0 109.606 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -75.03 -36.02 61.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.364 -0.835 . . . . 0.0 108.888 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 54.8 mt -60.97 -49.62 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.308 -0.87 . . . . 0.0 108.96 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 54.1 t -55.45 -49.44 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.998 . . . . 0.0 109.019 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.82 -41.07 90.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 109.593 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -62.48 -42.76 99.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 0.0 109.337 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 60.5 mt -67.55 -45.38 75.85 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.086 -1.009 . . . . 0.0 108.59 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -50.14 -55.3 15.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.858 -1.152 . . . . 0.0 109.198 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -58.76 -37.63 76.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.252 -0.905 . . . . 0.0 110.453 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -75.68 -35.61 60.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 109.764 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 9.6 t -69.0 -50.49 53.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.25 -0.907 . . . . 0.0 109.234 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -64.21 -29.92 71.01 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.483 -1.287 . . . . 0.0 109.002 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.71 -29.03 67.37 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.33 -5.29 56.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.503 -0.748 . . . . 0.0 109.921 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.0 9.42 58.32 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.2 158.74 40.46 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 3.0 ptm -126.9 -5.04 6.3 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.295 -1.121 . . . . 0.0 110.07 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.27 164.18 36.5 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 8.2 tp -125.42 134.05 52.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.7 -0.882 . . . . 0.0 109.186 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' ILE . . . . . 0.808 ' O ' HD13 ' D' ' 53' ' ' ILE . 0.0 OUTLIER -107.68 147.3 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.525 -0.735 . . . . 0.0 110.58 -178.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 51.73 63.44 2.24 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.369 -1.457 . . . . 0.0 109.668 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.572 ' O ' ' O ' ' D' ' 56' ' ' ARG . 2.7 t80 -46.27 -60.15 2.49 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.282 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' ARG . . . . . 0.572 ' O ' ' O ' ' D' ' 55' ' ' PHE . 26.2 mmt180 53.44 125.17 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.649 0.737 . . . . 0.0 110.201 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' ILE . . . . . 0.483 HD11 HD21 ' E' ' 65' ' ' LEU . 1.6 pt -136.87 -34.8 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.85 -1.156 . . . . 0.0 108.39 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 46.36 -163.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.597 0.713 . . . . 0.0 109.753 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' CYS . . . . . . . . . . . . . 19.0 p -167.4 -41.94 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.006 -1.059 . . . . 0.0 109.074 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . 47.46 -149.97 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.827 . . . . 0.0 109.606 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -58.17 104.98 0.23 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.218 -0.926 . . . . 0.0 109.18 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.32 -146.71 18.13 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . 0.407 ' NZ ' HD11 ' E' ' 29' ' ' ILE . 84.8 tttt -168.72 91.6 0.27 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.346 -1.091 . . . . 0.0 109.34 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.63 72.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 109.514 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . . . . . . . . . 31.0 tp -152.64 128.43 10.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.743 -1.223 . . . . 0.0 110.228 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.95 121.17 1.59 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -137.71 132.68 33.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.519 -0.989 . . . . 0.0 109.576 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -149.13 169.46 29.51 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 88.9 m -113.03 138.04 50.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.254 -1.145 . . . . 0.0 108.67 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 27.5 mt -87.36 135.65 24.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.6 155.72 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.799 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -151.55 158.0 42.98 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -120.19 150.16 41.1 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.27 154.53 38.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.123 -0.985 . . . . 0.0 109.306 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -89.55 135.86 33.36 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.309 -0.869 . . . . 0.0 109.503 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.1 -155.73 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.364 -0.835 . . . . 0.0 109.701 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -156.73 -145.01 0.14 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.203 -0.935 . . . . 0.0 109.308 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 78' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -78.72 -105.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.872 . . . . 0.0 109.361 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 74.4 p -92.64 -67.29 0.87 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.287 -0.883 . . . . 0.0 109.557 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 43.9 mtm -57.73 104.78 0.2 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.425 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.388 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ptt? . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.313 0.578 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 75.3 mt -64.76 143.81 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 109.299 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 3' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -81.04 -64.68 1.14 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 0.0 109.496 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -157.55 -8.63 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.925 . . . . 0.0 109.606 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 5' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -45.94 112.72 0.51 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.305 -0.872 . . . . 0.0 109.246 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 6' ' ' LYS . . . . . 0.431 ' H ' ' HG2' ' E' ' 6' ' ' LYS . 10.5 ptpt -95.7 106.23 18.32 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.442 -0.786 . . . . 0.0 110.095 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -94.21 118.82 32.12 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 76.2 mt -107.03 125.5 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.375 -0.828 . . . . 0.0 110.242 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 9' ' ' ILE . . . . . 0.617 HG23 ' O ' ' E' ' 9' ' ' ILE . 20.8 tt -133.42 113.79 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -123.78 161.57 24.95 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.294 -0.879 . . . . 0.0 109.528 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 11' ' ' THR . . . . . 0.492 HG23 ' OG1' ' A' ' 69' ' ' THR . 0.8 OUTLIER -87.87 -113.75 0.05 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' E' ' 11' ' ' THR . . . 41.64 -122.92 0.56 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 109.486 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 p30 175.53 26.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.549 -0.72 . . . . 0.0 109.647 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -173.44 151.69 2.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.206 -0.934 . . . . 0.0 109.638 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 15' ' ' ILE . . . . . 0.722 HG23 ' O ' ' E' ' 15' ' ' ILE . 18.0 tt -138.4 77.53 34.8 Favored Pre-proline 0 N--CA 1.498 1.971 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.86 156.85 36.06 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 122.116 1.878 . . . . 0.0 110.935 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.4 -6.73 71.63 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 18' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' E' ' 18' ' ' LEU . 28.9 mt -128.69 137.43 51.61 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.896 -1.356 . . . . 0.0 109.544 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -84.22 108.79 17.31 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 20' ' ' LEU . . . . . 0.613 HD11 ' CG2' ' E' ' 15' ' ' ILE . 10.9 mt -104.95 146.05 29.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 111.009 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 21' ' ' TYR . . . . . 0.423 ' CZ ' ' O ' ' E' ' 22' ' ' SER . 1.6 t80 -129.76 130.66 45.68 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 22' ' ' SER . . . . . 0.423 ' O ' ' CZ ' ' E' ' 21' ' ' TYR . 13.7 t -53.02 130.61 34.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 111.104 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' E' ' 23' ' ' LEU . 5.3 mt -120.41 9.22 10.9 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.75 177.77 18.42 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 47.2 mm -112.42 143.23 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.784 -0.833 . . . . 0.0 109.358 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.06 154.53 28.7 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 5.2 p -149.67 147.32 27.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.054 -1.029 . . . . 0.0 109.043 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . 0.556 ' OG1' HG23 ' E' ' 36' ' ' ILE . 17.2 p -148.71 132.09 16.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.44 -0.788 . . . . 0.0 109.354 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.453 ' O ' ' CB ' ' E' ' 30' ' ' SER . 86.3 mt -126.66 127.5 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' E' ' 29' ' ' ILE . 2.6 t 164.37 14.07 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 31' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' E' ' 32' ' ' ASN . 30.8 t0 51.91 -179.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.171 -0.956 . . . . 0.0 109.32 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 32' ' ' ASN . . . . . 0.462 ' H ' ' CG ' ' E' ' 31' ' ' ASP . 5.6 m-20 68.59 105.8 0.05 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.582 -0.698 . . . . 0.0 109.246 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 50.3 t -67.0 -34.52 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.259 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -58.73 -46.88 86.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 110.127 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -75.46 -37.44 60.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.107 -0.995 . . . . 0.0 109.187 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 36' ' ' ILE . . . . . 0.556 HG23 ' OG1' ' E' ' 28' ' ' THR . 70.2 mt -64.84 -50.82 73.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.945 -1.097 . . . . 0.0 109.579 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 19.2 t -58.91 -51.12 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.05 -1.032 . . . . 0.0 109.195 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -38.44 73.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 109.116 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -65.05 -39.02 92.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.163 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 54.4 mt -71.13 -48.13 53.92 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.147 -0.971 . . . . 0.0 109.084 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 41' ' ' ARG . . . . . 0.845 HH11 ' HG3' ' E' ' 41' ' ' ARG . 0.2 OUTLIER -50.67 -46.17 58.5 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.929 -1.107 . . . . 0.0 109.638 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -62.67 -34.53 77.29 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.176 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -70.63 -36.59 73.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.195 -0.941 . . . . 0.0 108.767 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 20.9 t -77.2 -51.36 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.754 -1.217 . . . . 0.0 109.222 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -49.03 -33.01 10.4 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.444 1.116 . . . . 0.0 110.254 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.31 -26.99 52.74 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.437 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -94.26 10.91 32.18 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.99 31.17 55.6 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 118.342 -1.885 . . . . 0.0 109.797 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -86.14 159.57 32.69 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 34.9 mmm -67.41 -41.69 84.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.144 -1.209 . . . . 0.0 110.5 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.74 -142.64 7.74 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 6.7 tp -130.71 132.55 45.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.531 -0.982 . . . . 0.0 109.284 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 53' ' ' ILE . . . . . 0.574 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 1.3 pt -107.53 145.52 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.568 -0.708 . . . . 0.0 110.192 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' E' ' 56' ' ' ARG . . . 71.37 -50.52 0.69 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.264 -0.897 . . . . 0.0 109.821 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 55' ' ' PHE . . . . . . . . . . . . . 5.9 t80 50.93 -79.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 56' ' ' ARG . . . . . 0.748 ' HG2' HH11 ' E' ' 56' ' ' ARG . 0.0 OUTLIER 64.04 145.48 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.429 -0.794 . . . . 0.0 109.774 178.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 75.9 mt -128.1 112.08 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 58' ' ' THR . . . . . . . . . . . . . 11.3 m -84.9 70.28 10.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 109.442 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 59' ' ' CYS . . . . . . . . . . . . . 7.9 p -95.26 41.12 1.1 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.198 -0.939 . . . . 0.0 109.218 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -46.96 -78.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.27 -0.894 . . . . 0.0 109.882 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -152.0 100.67 2.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.195 -0.94 . . . . 0.0 109.44 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.14 164.64 17.63 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt 49.66 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.346 -1.09 . . . . 0.0 110.567 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 64' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -91.13 159.42 16.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.452 -0.78 . . . . 0.0 109.206 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.483 HD21 HD11 ' D' ' 57' ' ' ILE . 28.0 tp -169.66 109.81 0.43 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.013 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.44 74.2 0.66 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -65.5 138.59 58.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.116 -1.226 . . . . 0.0 109.721 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.42 154.15 25.31 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 70.6 m -99.97 134.9 42.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.144 -1.21 . . . . 0.0 108.082 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 12.6 mt -89.2 141.21 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 m -144.72 163.41 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.387 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -149.04 154.62 39.56 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.94 151.57 37.91 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 t70 66.91 -123.65 0.24 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.67 -0.644 . . . . 0.0 109.634 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -119.39 177.85 4.76 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.349 -0.844 . . . . 0.0 109.473 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.74 -179.34 4.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.416 -0.803 . . . . 0.0 109.143 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 77' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -82.05 73.71 9.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 109.316 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -158.29 125.63 5.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 109.434 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 46.9 p -76.1 152.27 36.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 45.0 ttm -150.48 77.95 1.31 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.212 -0.93 . . . . 0.0 109.283 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.39 -179.947 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 mtp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.45 ' H ' HD12 ' A' ' 2' ' ' ILE . 3.8 mp -100.58 150.25 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.335 -0.853 . . . . 0.0 109.35 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.0 t80 60.97 29.74 19.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 109.467 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.24 -35.23 63.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 109.489 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -70.06 121.42 17.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.527 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -62.93 95.95 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.3 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -104.01 123.02 46.44 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.653 -0.654 . . . . 0.0 109.77 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.0 mt -114.66 140.88 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.541 -0.724 . . . . 0.0 109.218 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 9' ' ' ILE . 14.4 tt -125.02 125.02 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.85 130.25 56.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.481 -0.762 . . . . 0.0 109.004 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.445 ' OG1' ' OG1' ' B' ' 69' ' ' THR . 45.7 m -105.21 105.15 15.06 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 52.88 58.11 5.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.311 -0.868 . . . . 0.0 109.892 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 39.9 t0 -143.59 -140.03 0.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.568 -0.708 . . . . 0.0 109.376 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.455 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 5.9 pt-20 -173.66 166.44 4.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.194 -0.942 . . . . 0.0 109.187 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.5 mt -136.13 71.21 62.03 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.378 -0.826 . . . . 0.0 109.158 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.26 156.55 45.02 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 C-N-CA 122.211 1.941 . . . . 0.0 110.225 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.27 -1.08 69.36 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.284 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 18' ' ' LEU . 37.1 mt -130.77 138.86 50.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.961 -1.317 . . . . 0.0 109.433 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.409 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 22.3 mm100 -84.6 108.77 17.52 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.6 mt -93.84 136.42 34.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.145 -0.972 . . . . 0.0 110.241 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 72' ' ' LYS . 47.4 t80 -116.02 129.13 56.23 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.23 124.52 24.32 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 120.305 -1.497 . . . . 0.0 110.316 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 72' ' ' LYS . 35.7 mt -110.1 3.86 20.64 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.04 -178.37 16.46 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.28 144.74 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.802 -0.822 . . . . 0.0 109.187 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.49 143.95 44.95 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.246 0.546 . . . . 0.0 110.078 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.3 m -152.29 134.69 15.21 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.0 t -150.1 153.65 36.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.822 -1.174 . . . . 0.0 109.328 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.2 mp -105.33 154.38 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 173.81 158.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 109.231 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -100.65 139.29 36.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.337 -0.852 . . . . 0.0 110.053 -178.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 3.9 t-20 81.04 141.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.81 -32.76 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.847 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.403 ' CG ' ' N ' ' A' ' 35' ' ' GLU . 1.2 p30 -57.92 -43.5 86.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.927 . . . . 0.0 110.16 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.403 ' N ' ' CG ' ' A' ' 34' ' ' ASP . 63.9 mt-10 -75.18 -38.65 60.74 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.408 -0.808 . . . . 0.0 109.377 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.7 mt -63.52 -44.86 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.992 . . . . 0.0 109.478 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.4 t -65.77 -49.8 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.966 -1.084 . . . . 0.0 109.799 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -58.43 -38.94 78.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 0.0 109.678 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.518 HD22 ' N ' ' A' ' 39' ' ' ASN . 1.0 OUTLIER -63.12 -44.74 94.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.713 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.493 ' HA ' HD23 ' A' ' 40' ' ' LEU . 15.1 mt -69.44 -46.51 66.59 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.091 -1.006 . . . . 0.0 109.102 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.8 HH11 ' HG3' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -49.43 -49.87 43.24 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 120.797 -1.19 . . . . 0.0 109.892 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -61.39 -36.97 81.74 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.521 -0.737 . . . . 0.0 110.29 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -77.07 -35.49 56.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.511 -0.743 . . . . 0.0 109.899 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.8 t -66.71 -50.88 62.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.035 -1.041 . . . . 0.0 109.103 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.72 -35.65 80.63 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.392 -1.323 . . . . 0.0 109.015 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.26 -28.86 69.47 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -5.63 56.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.517 -0.74 . . . . 0.0 109.881 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.81 11.82 57.42 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.08 161.55 36.12 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -125.27 -3.4 7.46 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.27 -1.135 . . . . 0.0 109.918 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.31 154.99 24.22 Favored Glycine 0 N--CA 1.487 2.087 0 C-N-CA 119.35 -1.405 . . . . 0.0 109.699 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.06 146.46 36.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.663 -0.904 . . . . 0.0 109.815 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.513 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -119.38 145.6 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.5 -0.75 . . . . 0.0 110.071 -177.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 53' ' ' ILE . . . 70.2 79.24 0.19 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.581 -0.699 . . . . 0.0 110.451 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -103.07 136.61 42.56 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.51 ' HE ' HG21 ' A' ' 58' ' ' THR . 58.0 ttt180 -151.84 156.47 40.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.73 -1.231 . . . . 0.0 109.764 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 98.1 mt -140.62 -63.84 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.51 HG21 ' HE ' ' A' ' 56' ' ' ARG . 66.6 p 47.26 -167.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.378 -0.827 . . . . 0.0 109.717 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.417 ' HG ' ' CB ' ' E' ' 59' ' ' CYS . 13.2 m 54.89 170.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.506 -0.746 . . . . 0.0 109.684 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.14 -60.14 1.64 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.344 -0.847 . . . . 0.0 109.539 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -54.87 124.09 15.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.429 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -93.91 41.92 2.57 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.34 30.53 3.55 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.287 -1.125 . . . . 0.0 109.672 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -83.55 -98.31 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.134 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -173.04 100.34 0.13 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.475 -0.766 . . . . 0.0 110.282 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.42 -175.88 0.61 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -161.47 141.6 10.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.143 -1.21 . . . . 0.0 110.073 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.23 153.23 22.62 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.324 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.433 ' OG1' HG23 ' E' ' 11' ' ' THR . 19.2 m -105.22 137.47 42.95 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.225 -1.162 . . . . 0.0 108.703 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 52.4 mt -80.66 141.86 14.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -131.59 153.7 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.379 -0.826 . . . . 0.0 109.466 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.574 ' NZ ' ' O ' ' A' ' 74' ' ' ASP . 15.9 ttpp -142.03 133.53 26.7 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 19' ' ' GLN . . . -123.45 151.82 42.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.001 -1.062 . . . . 0.0 108.568 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.574 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 13.4 m-20 55.45 -143.8 0.71 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.882 -1.136 . . . . 0.0 110.234 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 75' ' ' GLU . 18.2 mp0 -62.79 -85.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.171 -0.956 . . . . 0.0 109.305 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -169.94 -46.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 109.464 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -93.4 -67.37 0.86 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.227 -0.92 . . . . 0.0 109.444 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 79' ' ' THR . 88.7 t80 -164.87 127.55 2.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.405 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.435 ' O ' ' CD2' ' A' ' 78' ' ' PHE . 0.9 OUTLIER -55.47 160.49 2.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 109.557 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.525 ' N ' ' SD ' ' A' ' 80' ' ' MET . 0.3 OUTLIER -61.91 -56.25 21.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 109.483 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.451 -179.913 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 55.2 mtt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 4.8 tt -167.06 148.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.88 . . . . 0.0 109.155 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' B' ' 3' ' ' PHE . 15.6 p90 -142.59 54.23 1.41 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.343 -0.848 . . . . 0.0 109.387 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -60.49 -25.56 66.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.278 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.81 132.61 35.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 109.521 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -138.54 -108.3 0.17 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -0.923 . . . . 0.0 108.671 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -92.81 120.44 33.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.139 -0.975 . . . . 0.0 109.22 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 68.4 mt -115.94 146.28 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.612 -0.68 . . . . 0.0 109.6 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.617 HG23 ' O ' ' B' ' 9' ' ' ILE . 9.5 tt -131.82 115.22 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -123.49 158.36 31.46 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.463 ' OG1' ' OG1' ' C' ' 69' ' ' THR . 1.5 m -112.67 103.18 11.21 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.33 88.45 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.468 -0.77 . . . . 0.0 109.853 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -162.08 -20.78 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.428 -0.795 . . . . 0.0 109.514 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 60.37 160.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.627 -0.671 . . . . 0.0 109.417 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . . . . . . . . . 13.0 mt -130.4 82.94 64.03 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.561 -0.712 . . . . 0.0 109.084 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.58 156.37 42.52 Favored 'Trans proline' 0 C--N 1.323 -0.815 0 C-N-CA 122.068 1.845 . . . . 0.0 110.252 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.71 -6.34 77.12 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' B' ' 18' ' ' LEU . 66.9 mt -130.96 139.64 50.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.049 -1.265 . . . . 0.0 109.06 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.18 116.43 23.53 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.79 140.42 33.01 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.18 -0.95 . . . . 0.0 110.032 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' B' ' 71' ' ' VAL . 2.1 t80 -123.31 129.51 51.43 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 42.0 t -67.44 130.61 43.59 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.826 -1.171 . . . . 0.0 111.138 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.521 HD11 ' CB ' ' B' ' 72' ' ' LYS . 72.3 mt -116.71 8.24 13.69 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.42 -171.13 14.9 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 40.6 mm -119.05 141.9 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.908 -0.76 . . . . 0.0 109.367 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.15 144.82 42.01 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.616 -0.678 . . . . 0.0 109.425 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 85.3 p -152.22 137.8 17.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.097 -1.002 . . . . 0.0 108.599 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 8.8 t -149.74 149.6 30.81 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.937 -1.102 . . . . 0.0 109.265 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 66.1 mt -116.13 126.33 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.307 -0.87 . . . . 0.0 109.047 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 32.5 t -174.87 -146.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.148 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -158.91 172.01 18.99 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.211 -0.931 . . . . 0.0 108.814 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 2.1 m120 73.46 130.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 t -68.88 -35.12 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.551 -0.718 . . . . 0.0 109.49 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -58.96 -45.22 91.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.268 -0.895 . . . . 0.0 109.944 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -75.58 -42.1 52.93 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 0.0 109.872 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 77.8 mt -63.46 -53.77 41.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.917 -1.115 . . . . 0.0 109.322 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 t -56.9 -48.54 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.012 -1.055 . . . . 0.0 108.765 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -61.65 -41.18 97.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 110.064 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -58.68 -48.01 82.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.551 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 57.6 mt -74.26 -50.49 18.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 108.934 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -48.81 -47.85 41.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.776 -1.202 . . . . 0.0 108.892 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -61.32 -34.91 76.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 109.449 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -74.42 -36.03 63.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.524 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.29 -51.66 20.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.926 -1.109 . . . . 0.0 108.898 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -51.32 -29.25 14.45 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 122.613 1.196 . . . . 0.0 109.788 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.3 -26.76 52.59 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.439 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -94.26 8.41 41.88 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.07 31.13 68.14 Favored Glycine 0 N--CA 1.476 1.353 0 C-N-CA 118.157 -1.973 . . . . 0.0 109.911 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.48 -169.34 32.44 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 25.0 mmm -106.86 -37.2 6.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.397 -1.061 . . . . 0.0 109.554 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 176.16 -149.49 9.91 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 2.3 tp -137.65 143.72 41.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.357 -1.084 . . . . 0.0 109.823 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.65 ' O ' ' HB3' ' B' ' 54' ' ' ALA . 1.2 pt -114.36 146.63 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.5 -0.75 . . . . 0.0 109.376 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' B' ' 53' ' ' ILE . . . 82.88 -48.42 0.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 118.769 0.713 . . . . 0.0 109.893 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.524 ' C ' ' O ' ' B' ' 54' ' ' ALA . 78.5 t80 25.1 92.54 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 120.965 0.412 . . . . 0.0 110.593 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.833 HH11 ' HG3' ' B' ' 56' ' ' ARG . 11.2 ttm-85 -98.77 153.46 18.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.214 -0.929 . . . . 0.0 109.821 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -162.73 151.16 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . 0.401 ' OG1' ' CD2' ' B' ' 64' ' ' PHE . 63.5 p -137.46 -136.05 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . 0.461 ' O ' ' HB3' ' B' ' 60' ' ' ALA . 0.8 OUTLIER 179.83 -173.29 0.21 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -0.963 . . . . 0.0 109.02 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' B' ' 59' ' ' CYS . . . 64.67 -176.9 0.17 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.651 -0.656 . . . . 0.0 109.644 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -72.31 148.4 45.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.334 -0.854 . . . . 0.0 109.214 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' B' ' 64' ' ' PHE . . . 136.76 2.57 2.47 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' B' ' 64' ' ' PHE . 52.7 mttp 60.06 -71.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.999 -0.706 . . . . 0.0 110.192 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.544 ' N ' ' O ' ' B' ' 62' ' ' GLY . 59.5 m-85 58.68 157.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mp -140.73 136.45 32.57 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.755 0.788 . . . . 0.0 110.763 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.14 53.49 0.94 Allowed Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -59.3 178.44 0.14 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.685 1.231 . . . . 0.0 110.228 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.63 160.41 26.25 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . 0.445 ' OG1' ' OG1' ' A' ' 11' ' ' THR . 21.7 m -95.87 135.04 38.13 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 120.494 -1.591 . . . . 0.0 107.786 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 58.9 mt -83.64 146.39 6.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 4.3 m -136.31 162.33 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.551 -0.718 . . . . 0.0 109.989 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.521 ' CB ' HD11 ' B' ' 23' ' ' LEU . 5.9 tttt -152.28 141.76 21.67 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.37 151.36 29.87 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.953 -1.092 . . . . 0.0 108.694 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -154.35 64.6 0.69 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.957 -1.089 . . . . 0.0 108.689 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' GLU . . . . . 0.432 ' O ' ' HB3' ' B' ' 76' ' ' ALA . 30.9 mm-40 -75.47 -56.59 4.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 109.562 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' B' ' 75' ' ' GLU . . . 63.34 47.64 3.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.56 -0.713 . . . . 0.0 109.65 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -129.46 107.49 9.53 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.484 -0.76 . . . . 0.0 109.409 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -164.4 109.91 1.0 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.83 . . . . 0.0 109.343 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' B' ' 80' ' ' MET . 1.4 t -160.21 -177.56 6.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.451 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' MET . . . . . 0.445 ' N ' ' OG1' ' B' ' 79' ' ' THR . 26.5 mmt -61.85 -32.99 73.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 109.53 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.418 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . 0.54 ' O ' ' N ' ' C' ' 3' ' ' PHE . 1.8 mpt? . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 59.5 mt 58.51 -79.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.679 -0.638 . . . . 0.0 109.522 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' C' ' 1' ' ' MET . 0.1 OUTLIER 54.67 -156.59 0.22 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 109.068 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -125.55 -31.11 3.02 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.573 -0.704 . . . . 0.0 109.396 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -51.99 -47.17 65.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.076 -1.015 . . . . 0.0 109.104 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? 70.33 104.95 0.06 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.505 -0.747 . . . . 0.0 109.987 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -97.8 121.82 40.16 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.479 -0.763 . . . . 0.0 109.053 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.94 135.98 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.479 -0.763 . . . . 0.0 110.591 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' ILE . . . . . 0.633 HG23 ' O ' ' C' ' 9' ' ' ILE . 13.9 tt -132.12 113.33 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 4.9 t -124.45 160.65 27.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.346 -0.846 . . . . 0.0 109.284 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . . . . . . . . . 4.3 p -110.26 83.45 1.76 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.75 -28.45 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.647 -0.658 . . . . 0.0 110.14 177.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . 0.604 ' OD1' ' N ' ' C' ' 13' ' ' ASP . 0.0 OUTLIER 68.51 43.33 1.41 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.479 -0.763 . . . . 0.0 109.49 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -178.67 129.3 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.105 -0.997 . . . . 0.0 109.521 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 16.6 mt -134.28 79.14 56.21 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.98 155.14 51.83 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 122.02 1.814 . . . . 0.0 110.503 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.15 -6.17 78.61 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' C' ' 18' ' ' LEU . 53.9 mt -131.6 139.58 49.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -1.198 . . . . 0.0 109.518 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' C' ' 73' ' ' ALA . 25.9 mt-30 -84.91 114.24 21.98 Favored 'General case' 0 C--O 1.192 -1.929 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 16.1 mt -94.64 138.56 32.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.783 -1.198 . . . . 0.0 110.752 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' TYR . . . . . 0.688 ' H ' ' H ' ' C' ' 72' ' ' LYS . 29.3 t80 -116.99 128.29 55.04 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.606 -0.684 . . . . 0.0 109.733 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.04 123.34 21.87 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 120.022 -1.674 . . . . 0.0 110.308 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.474 HD11 ' CB ' ' C' ' 72' ' ' LYS . 78.6 mt -114.69 7.68 16.0 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.96 -174.74 15.89 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.17 144.17 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 122.037 -0.684 . . . . 0.0 109.244 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.3 144.6 45.71 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.95 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 42.1 m -152.61 142.39 22.0 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.96 -1.087 . . . . 0.0 108.421 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 9.2 t -149.52 146.69 27.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.101 -0.999 . . . . 0.0 109.359 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 71.7 mt -113.52 137.37 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.399 -0.813 . . . . 0.0 110.253 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.554 ' OG ' ' N ' ' C' ' 31' ' ' ASP . 0.1 OUTLIER -158.97 -172.81 3.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.48 -0.763 . . . . 0.0 109.78 -179.1 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' ASP . . . . . 0.554 ' N ' ' OG ' ' C' ' 30' ' ' SER . 4.8 m-20 -97.14 -76.14 0.52 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.322 -0.861 . . . . 0.0 111.91 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -76.88 156.07 32.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.927 -1.108 . . . . 0.0 109.104 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.52 -32.89 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.315 0.579 . . . . 0.0 109.803 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.54 -38.0 63.38 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.329 -0.857 . . . . 0.0 109.474 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -76.86 -35.36 57.53 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.017 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 81.5 mt -63.56 -53.28 47.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.047 -1.033 . . . . 0.0 108.991 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.11 -50.59 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.05 -1.031 . . . . 0.0 109.152 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -57.92 -38.94 76.81 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.304 -0.873 . . . . 0.0 108.964 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -65.79 -42.12 91.14 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.93 . . . . 0.0 109.522 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' C' ' 40' ' ' LEU . 24.8 mt -69.41 -47.65 63.46 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.012 -1.055 . . . . 0.0 108.753 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -49.41 -54.15 18.98 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.885 -1.134 . . . . 0.0 109.261 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -56.66 -34.16 67.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.899 . . . . 0.0 109.208 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -74.8 -43.74 53.14 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.33 -0.856 . . . . 0.0 109.321 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 10.5 t -71.64 -52.29 26.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 O-C-N 120.846 -1.159 . . . . 0.0 108.647 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -51.73 -31.5 26.66 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.823 1.296 . . . . 0.0 110.075 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.3 -28.09 47.43 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.705 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.13 4.32 53.4 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.72 26.49 69.95 Favored Glycine 0 N--CA 1.48 1.605 0 C-N-CA 118.631 -1.747 . . . . 0.0 109.804 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.85 162.98 50.76 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 16.2 ttp -79.91 -42.04 24.9 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.836 -1.39 . . . . 0.0 109.946 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 172.5 -170.3 43.37 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 tp -113.2 141.97 46.34 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.561 -0.964 . . . . 0.0 110.403 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 2.2 pt -119.82 145.71 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.44 -0.787 . . . . 0.0 110.406 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 70.99 -56.01 0.63 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.209 -0.932 . . . . 0.0 110.823 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 1.1 t80 61.37 -123.4 0.84 Allowed 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' ARG . . . . . 0.838 ' HG2' HH11 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -170.36 -138.65 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.239 -0.913 . . . . 0.0 109.928 -179.432 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' ILE . . . . . 0.484 ' H ' ' CG ' ' C' ' 56' ' ' ARG . 0.6 OUTLIER 49.95 84.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.185 -0.947 . . . . 0.0 109.637 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' C' ' 59' ' ' CYS . 2.2 t -167.55 -172.82 2.02 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.114 -0.991 . . . . 0.0 109.5 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' CYS . . . . . 0.45 ' N ' ' OG1' ' C' ' 58' ' ' THR . 40.9 t 52.5 -96.09 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.361 -0.837 . . . . 0.0 109.607 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.94 41.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.226 -0.922 . . . . 0.0 109.411 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -162.33 108.13 1.24 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.336 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.79 72.78 0.2 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -119.22 -52.29 2.29 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.504 -0.998 . . . . 0.0 109.315 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -74.12 -145.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 109.715 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.537 HD12 ' O ' ' C' ' 65' ' ' LEU . 0.4 OUTLIER -82.48 -176.39 6.21 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.123 -0.985 . . . . 0.0 109.416 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . 0.51 ' C ' ' CD2' ' C' ' 67' ' ' TYR . . . -126.05 -140.26 5.27 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 106.144 -2.782 . . . . 0.0 106.144 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' TYR . . . . . 0.51 ' CD2' ' C ' ' C' ' 66' ' ' GLY . 0.1 OUTLIER -165.67 102.23 0.69 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.869 -1.371 . . . . 0.0 108.127 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.39 173.41 15.37 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' THR . . . . . 0.463 ' OG1' ' OG1' ' B' ' 11' ' ' THR . 53.0 m -122.75 132.82 54.4 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 119.036 1.418 . . . . 0.0 107.582 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 57.7 mt -79.13 129.73 37.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.17 161.88 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.445 -0.784 . . . . 0.0 109.87 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' LYS . . . . . 0.688 ' H ' ' H ' ' C' ' 21' ' ' TYR . 6.5 tttt -154.21 142.62 20.61 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' C' ' 19' ' ' GLN . . . -102.64 128.8 49.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.08 -1.013 . . . . 0.0 109.374 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.1 165.53 18.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.0 109.065 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -99.18 147.5 25.05 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.443 -0.786 . . . . 0.0 109.473 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -163.42 -22.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 0.0 109.306 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' GLN . . . . . 0.449 ' H ' ' HG2' ' C' ' 77' ' ' GLN . 18.4 pt20 -74.51 140.34 44.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.388 -0.82 . . . . 0.0 109.471 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' C' ' 78' ' ' PHE . 4.4 p90 -82.75 -29.1 29.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.286 -0.884 . . . . 0.0 109.58 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 1.8 p -139.55 152.65 47.06 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.295 -0.878 . . . . 0.0 109.277 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 15.3 tpt -164.18 149.68 10.58 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.399 -0.813 . . . . 0.0 109.385 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.314 -179.896 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' D' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' ILE . . . . . . . . . . . . . 5.3 tt -69.25 156.82 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.069 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -122.85 94.31 4.23 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -81.35 -74.4 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.865 . . . . 0.0 109.343 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.34 137.57 18.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.261 -0.899 . . . . 0.0 109.425 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -144.28 -65.21 0.36 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.997 0.903 . . . . 0.0 109.828 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -102.15 121.57 42.48 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 58.3 mt -133.65 128.42 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.434 -0.791 . . . . 0.0 109.351 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' ILE . . . . . 0.625 HG23 ' O ' ' D' ' 9' ' ' ILE . 9.1 tt -128.23 115.12 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.7 t -125.64 157.36 37.45 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . . . . . . . . . 3.5 m -102.55 81.9 2.09 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.3 -112.15 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.452 -0.78 . . . . 0.0 110.203 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -152.49 -135.67 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.552 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -63.22 158.96 18.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -0.876 . . . . 0.0 109.371 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 38.9 mt -112.23 98.95 44.91 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.18 155.84 43.37 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.896 1.731 . . . . 0.0 110.392 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.68 -8.11 78.89 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' LEU . . . . . . . . . . . . . 80.6 mt -131.44 142.27 49.98 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.42 -1.047 . . . . 0.0 109.309 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -87.77 108.45 19.13 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' D' ' 71' ' ' VAL . 4.3 mt -114.9 131.6 56.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.687 -0.633 . . . . 0.0 109.599 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' TYR . . . . . 0.595 ' OH ' ' N ' ' D' ' 74' ' ' ASP . 0.0 OUTLIER -113.73 143.42 44.64 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 16.6 t -75.06 128.33 35.29 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' D' ' 72' ' ' LYS . 0.7 OUTLIER -111.93 12.38 20.77 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.5 -179.09 16.35 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.9 144.01 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 122.174 -0.604 . . . . 0.0 109.606 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.25 144.28 40.67 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.405 0.621 . . . . 0.0 109.377 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' SER . . . . . 0.611 ' HB2' HD21 ' D' ' 65' ' ' LEU . 0.9 OUTLIER -152.47 138.4 18.1 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.265 -0.897 . . . . 0.0 109.356 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 12.7 t -149.73 144.5 26.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.044 -1.035 . . . . 0.0 109.189 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.43 HG23 ' O ' ' D' ' 29' ' ' ILE . 12.9 tt -117.95 127.91 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.271 -0.893 . . . . 0.0 108.93 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . . . . . . . . . 30.1 t -173.65 174.28 3.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 109.056 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' D' ' 32' ' ' ASN . 29.5 t70 -107.49 157.29 18.14 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.332 -0.855 . . . . 0.0 109.565 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' D' ' 31' ' ' ASP . 8.6 t30 85.97 123.81 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 -177.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . 0.454 HG13 ' H ' ' D' ' 33' ' ' VAL . 1.0 OUTLIER -69.86 -38.95 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -63.12 -31.0 72.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.539 -0.726 . . . . 0.0 109.878 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -75.0 -41.08 60.19 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.223 -0.923 . . . . 0.0 109.717 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 92.6 mt -62.2 -46.31 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.999 -1.063 . . . . 0.0 108.7 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 17.0 t -55.75 -48.07 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.909 -1.119 . . . . 0.0 108.288 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -62.76 -42.23 99.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.024 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -59.67 -45.56 91.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.333 -0.855 . . . . 0.0 109.415 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' D' ' 40' ' ' LEU . 49.4 mt -71.36 -48.0 52.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 108.899 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -49.07 -50.92 34.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.79 -1.194 . . . . 0.0 109.113 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -59.96 -36.21 76.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.398 -0.814 . . . . 0.0 109.952 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -75.8 -35.85 59.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.465 -0.772 . . . . 0.0 109.598 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 13.1 t -71.07 -50.79 39.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.066 -1.022 . . . . 0.0 108.799 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -64.74 -30.13 71.13 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 118.29 -1.364 . . . . 0.0 109.255 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.66 -30.41 69.95 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . 0.514 ' HB3' ' NZ ' ' D' ' 47' ' ' LYS . 0.1 OUTLIER -90.36 2.07 55.93 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.79 23.83 74.13 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.08 -165.65 7.92 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 7.8 ttt -110.2 -41.26 4.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.418 -1.048 . . . . 0.0 109.702 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 173.58 -158.66 28.06 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 3.4 tp -125.07 139.86 53.42 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.595 -0.944 . . . . 0.0 110.36 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' ILE . . . . . 0.656 ' O ' ' HB3' ' D' ' 54' ' ' ALA . 1.0 OUTLIER -118.06 148.53 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.672 -0.643 . . . . 0.0 110.501 -177.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 82.73 -38.22 0.09 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 118.832 0.742 . . . . 0.0 109.131 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.498 ' O ' ' O ' ' D' ' 56' ' ' ARG . 31.3 t80 49.18 -110.41 0.4 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.624 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' ARG . . . . . 0.753 ' HG2' HH11 ' D' ' 56' ' ' ARG . 6.4 mtt-85 57.59 123.54 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.418 0.628 . . . . 0.0 109.868 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' ILE . . . . . 0.401 HG13 ' N ' ' D' ' 58' ' ' THR . 1.9 pt -136.21 -168.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.246 -0.909 . . . . 0.0 109.198 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' THR . . . . . 0.401 ' N ' HG13 ' D' ' 57' ' ' ILE . 39.7 p -144.93 118.68 9.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.534 -0.729 . . . . 0.0 109.107 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' CYS . . . . . . . . . . . . . 15.3 p -163.87 68.42 0.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.413 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.28 -8.84 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.359 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -162.04 -17.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.33 -0.856 . . . . 0.0 109.31 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . 174.38 106.95 0.2 Allowed Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.632 -1.27 . . . . 0.0 109.959 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . 0.731 ' HD3' ' H ' ' D' ' 63' ' ' LYS . 0.0 OUTLIER -61.68 -93.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.895 -1.356 . . . . 0.0 109.293 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . 0.495 ' HB3' ' O ' ' D' ' 63' ' ' LYS . 63.9 t80 74.38 60.42 0.08 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.183 0.516 . . . . 0.0 110.518 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.611 HD21 ' HB2' ' D' ' 27' ' ' SER . 3.2 tp 68.05 159.7 0.16 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.341 -0.849 . . . . 0.0 109.182 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 66' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' D' ' 67' ' ' TYR . . . -118.0 -30.44 1.78 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 178.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 67' ' ' TYR . . . . . 0.502 ' CB ' ' O ' ' D' ' 66' ' ' GLY . 1.7 t80 81.03 123.79 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.277 1.037 . . . . 0.0 111.665 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.1 139.68 5.81 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 46.9 m -109.55 148.32 31.45 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.065 -1.256 . . . . 0.0 109.536 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 24.1 mt -97.78 148.04 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.54 0.686 . . . . 0.0 109.577 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 71' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' D' ' 20' ' ' LEU . 12.2 m -143.34 154.18 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.491 -0.755 . . . . 0.0 109.357 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 72' ' ' LYS . . . . . 0.431 ' HB2' HD11 ' D' ' 23' ' ' LEU . 26.3 ttpp -139.98 142.5 36.33 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.049 -1.032 . . . . 0.0 108.667 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' D' ' 74' ' ' ASP . . . -124.11 141.36 52.12 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . 0.595 ' N ' ' OH ' ' D' ' 21' ' ' TYR . 3.5 p30 172.37 30.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -78.17 122.38 25.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.039 -1.038 . . . . 0.0 109.696 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -175.93 -101.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.983 . . . . 0.0 111.011 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 171.95 146.15 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 78' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -123.5 -44.79 2.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.442 -0.786 . . . . 0.0 109.437 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 3.8 t -166.76 31.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 17.6 mmt 49.73 -159.33 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.281 -0.887 . . . . 0.0 109.477 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.449 -179.938 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 33.1 mtt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 6.2 pt -88.17 166.45 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.249 -0.907 . . . . 0.0 109.179 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 3' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -137.64 1.35 2.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.425 -0.797 . . . . 0.0 109.222 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -76.25 63.75 1.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 109.635 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 5' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -54.1 173.12 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.297 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 6' ' ' LYS . . . . . 0.512 ' CG ' ' H ' ' E' ' 7' ' ' PHE . 14.7 tttt -154.57 -154.51 0.51 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.912 -1.118 . . . . 0.0 109.793 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 7' ' ' PHE . . . . . 0.512 ' H ' ' CG ' ' E' ' 6' ' ' LYS . 18.8 t80 -109.85 120.73 43.39 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.562 -0.711 . . . . 0.0 109.672 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 83.7 mt -96.86 128.57 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.323 -0.86 . . . . 0.0 110.988 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 9' ' ' ILE . . . . . 0.554 HG23 ' O ' ' E' ' 9' ' ' ILE . 17.1 tt -134.48 121.01 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 1.3 t -113.34 133.25 55.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.322 -0.861 . . . . 0.0 109.336 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 11' ' ' THR . . . . . 0.433 HG23 ' OG1' ' A' ' 69' ' ' THR . 0.0 OUTLIER -53.63 -90.74 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.397 -0.814 . . . . 0.0 110.984 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.09 72.72 1.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.123 -0.986 . . . . 0.0 108.366 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -160.26 141.53 12.32 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.415 0.626 . . . . 0.0 109.512 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -79.56 178.68 7.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.398 -0.814 . . . . 0.0 109.127 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 57.5 mt -123.6 88.17 51.96 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.474 -0.766 . . . . 0.0 109.184 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.55 155.49 52.76 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 121.962 1.775 . . . . 0.0 110.158 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.02 -12.34 69.78 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 18' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' E' ' 18' ' ' LEU . 15.9 mt -125.2 136.83 53.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -1.185 . . . . 0.0 108.982 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.14 112.84 21.68 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt -99.08 142.62 30.34 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.187 -0.946 . . . . 0.0 109.83 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 21' ' ' TYR . . . . . 0.479 ' H ' ' H ' ' E' ' 72' ' ' LYS . 1.5 t80 -123.29 130.07 52.23 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 22' ' ' SER . . . . . 0.403 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 4.3 t -61.39 129.97 43.8 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.83 -1.169 . . . . 0.0 110.953 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' E' ' 23' ' ' LEU . 6.8 mt -117.65 9.26 13.03 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.67 -173.6 14.86 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.77 143.92 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 122.033 -0.687 . . . . 0.0 109.433 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.61 144.04 47.34 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.943 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 19.4 m -152.18 136.34 16.57 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 10.9 t -149.92 151.49 33.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.972 -1.08 . . . . 0.0 109.222 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 56.6 mt -127.0 133.44 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.111 -0.993 . . . . 0.0 108.702 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.574 ' O ' ' N ' ' E' ' 32' ' ' ASN . 78.1 p -156.29 31.77 0.33 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.134 -0.979 . . . . 0.0 110.769 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 31' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' E' ' 31' ' ' ASP . 0.7 OUTLIER 54.28 -70.59 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 32' ' ' ASN . . . . . 0.574 ' N ' ' O ' ' E' ' 30' ' ' SER . 7.3 m120 -66.1 135.41 54.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.732 -1.23 . . . . 0.0 107.93 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 33' ' ' VAL . . . . . 0.482 ' H ' HG13 ' E' ' 33' ' ' VAL . 1.0 OUTLIER -70.88 -42.21 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 34' ' ' ASP . . . . . 0.421 ' N ' ' CG2' ' E' ' 33' ' ' VAL . 29.8 t70 -52.53 -28.02 18.98 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.512 -0.742 . . . . 0.0 109.825 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -78.11 -33.39 50.6 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.422 -0.799 . . . . 0.0 109.202 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.16 -52.77 57.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.031 -1.043 . . . . 0.0 108.776 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.89 -49.24 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.085 -1.01 . . . . 0.0 108.967 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -60.71 -41.86 96.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.414 -0.804 . . . . 0.0 108.978 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -64.46 -45.2 88.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.471 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 40' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' E' ' 40' ' ' LEU . 70.4 mt -64.57 -44.03 92.01 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.098 -1.001 . . . . 0.0 108.329 178.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 41' ' ' ARG . . . . . 0.796 ' HG2' HH11 ' E' ' 41' ' ' ARG . 0.0 OUTLIER -48.84 -55.5 11.48 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.845 -1.159 . . . . 0.0 109.352 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -55.96 -33.56 64.89 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.088 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -74.44 -40.07 62.17 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.462 -0.773 . . . . 0.0 109.494 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 12.8 t -73.87 -52.01 22.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 120.879 -1.138 . . . . 0.0 108.82 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -50.59 -29.6 11.22 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.692 1.234 . . . . 0.0 109.741 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.63 -25.84 50.04 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.383 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -95.71 4.38 53.04 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.67 30.73 78.73 Favored Glycine 0 N--CA 1.479 1.555 0 C-N-CA 118.009 -2.043 . . . . 0.0 110.181 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.32 153.92 23.84 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 10.8 mtm -66.46 -29.61 69.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -1.111 . . . . 0.0 110.474 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.74 -137.51 4.61 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 tp -133.64 137.93 45.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.421 -1.046 . . . . 0.0 110.086 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 53' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 1.1 pt -115.12 144.9 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.609 -0.682 . . . . 0.0 110.163 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 64.91 74.84 0.38 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.166 -0.959 . . . . 0.0 110.216 178.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 55' ' ' PHE . . . . . 0.4 ' CE2' HG21 ' E' ' 57' ' ' ILE . 17.9 t80 -98.56 107.47 19.93 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 56' ' ' ARG . . . . . 0.685 ' CG ' HH11 ' E' ' 56' ' ' ARG . 0.4 OUTLIER -97.3 135.63 38.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.582 -0.699 . . . . 0.0 110.529 -178.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 57' ' ' ILE . . . . . 0.4 HG21 ' CE2' ' E' ' 55' ' ' PHE . 1.2 tt 179.04 104.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 58' ' ' THR . . . . . . . . . . . . . 63.0 m -149.51 -95.48 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.04 -1.038 . . . . 0.0 109.408 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 59' ' ' CYS . . . . . 0.417 ' CB ' ' HG ' ' A' ' 59' ' ' CYS . 78.4 m -67.24 104.93 1.59 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.195 -0.941 . . . . 0.0 109.768 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.02 48.18 0.7 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.255 -0.903 . . . . 0.0 109.258 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -54.22 -22.03 10.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.865 . . . . 0.0 109.502 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 163.14 -6.05 0.08 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -92.08 150.21 21.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.16 -1.2 . . . . 0.0 109.523 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 64' ' ' PHE . . . . . 0.527 ' H ' HD12 ' E' ' 65' ' ' LEU . 96.7 m-85 -153.55 31.44 0.46 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.253 -0.904 . . . . 0.0 109.286 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.527 HD12 ' H ' ' E' ' 64' ' ' PHE . 3.3 mp -99.53 118.15 35.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.399 -0.813 . . . . 0.0 110.306 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 66' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' E' ' 67' ' ' TYR . . . -71.11 59.56 1.05 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 67' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' E' ' 66' ' ' GLY . 78.3 m-85 -39.55 114.2 0.4 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.63 -0.924 . . . . 0.0 110.032 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.61 149.72 21.11 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 69' ' ' THR . . . . . . . . . . . . . 8.6 m -112.81 137.5 51.05 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 32.0 mt -82.78 148.68 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 m -130.44 164.8 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.662 -0.649 . . . . 0.0 109.907 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 72' ' ' LYS . . . . . 0.479 ' H ' ' H ' ' E' ' 21' ' ' TYR . 14.6 tttm -147.95 145.43 28.57 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.89 137.96 49.15 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -145.3 120.53 10.18 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.728 -1.233 . . . . 0.0 108.13 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -160.95 54.6 0.3 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -0.936 . . . . 0.0 109.326 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.19 -46.18 11.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.908 . . . . 0.0 109.491 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 77' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -165.31 -143.55 0.06 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.301 -0.874 . . . . 0.0 109.412 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -95.25 115.5 27.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.094 -1.004 . . . . 0.0 109.363 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 36.7 p -69.08 102.58 1.67 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.341 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 11.1 mmt -57.31 154.75 10.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.497 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.44 -179.967 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.289 0.566 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.3 mm -78.05 -64.16 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 109.357 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -85.98 116.98 24.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -0.912 . . . . 0.0 109.443 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.03 164.56 23.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 109.529 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -84.79 134.71 34.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 109.46 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -89.93 132.75 35.16 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.327 -0.858 . . . . 0.0 108.884 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -101.7 121.98 43.06 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.5 mt -134.49 138.15 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.29 -0.881 . . . . 0.0 109.978 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.478 ' CG2' ' O ' ' A' ' 9' ' ' ILE . 6.9 tt -127.8 118.21 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.788 -1.195 . . . . 0.0 108.088 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.4 t -127.24 154.93 44.24 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.059 -1.026 . . . . 0.0 109.563 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.424 HG21 ' HG3' ' A' ' 56' ' ' ARG . 1.4 m -135.54 115.95 13.63 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.52 66.23 1.23 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.344 -0.848 . . . . 0.0 109.655 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -164.13 -24.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.54 -0.725 . . . . 0.0 109.504 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 57.15 171.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.519 -0.738 . . . . 0.0 109.438 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mt -139.01 74.7 36.53 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.371 -0.831 . . . . 0.0 109.099 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.44 156.47 41.22 Favored 'Trans proline' 0 C--N 1.32 -0.952 0 C-N-CA 122.132 1.888 . . . . 0.0 110.197 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.08 -3.71 73.55 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.261 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 18' ' ' LEU . 42.6 mt -129.9 137.87 50.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.279 . . . . 0.0 108.871 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.454 ' H ' ' HG2' ' A' ' 19' ' ' GLN . 12.0 pt20 -85.91 113.82 22.33 Favored 'General case' 0 C--O 1.2 -1.518 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.6 mt -95.0 138.81 32.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.892 -1.13 . . . . 0.0 109.603 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.712 ' O ' HG12 ' A' ' 71' ' ' VAL . 42.4 t80 -109.97 155.07 22.26 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.45 126.56 38.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 119.857 -1.777 . . . . 0.0 108.07 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.7 mt -117.08 5.91 12.83 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.69 -164.36 13.51 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.35 145.24 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 122.027 -0.69 . . . . 0.0 109.653 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.99 154.37 25.41 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 87.0 p -147.11 150.18 34.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.126 -0.984 . . . . 0.0 109.087 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.7 p -148.86 134.71 18.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.539 -0.726 . . . . 0.0 109.468 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.653 ' O ' ' OG ' ' A' ' 30' ' ' SER . 10.6 mm -127.12 126.0 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.653 ' OG ' ' O ' ' A' ' 29' ' ' ILE . 23.4 m 171.81 -129.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.175 0.512 . . . . 0.0 109.679 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.464 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 3.1 p30 -153.38 165.15 36.68 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.045 -1.034 . . . . 0.0 109.227 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 7.8 t-20 77.55 109.52 0.07 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -177.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.494 ' H ' HG13 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -69.36 -38.06 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.359 -0.838 . . . . 0.0 108.868 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 35' ' ' GLU . 1.9 p30 -61.17 -32.4 72.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.845 . . . . 0.0 110.095 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.46 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 31.1 tt0 -75.69 -37.45 59.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 0.0 109.139 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.1 mt -62.51 -42.61 96.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.12 -0.988 . . . . 0.0 108.836 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.28 -50.19 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.007 -1.058 . . . . 0.0 108.81 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -59.37 -38.94 81.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 109.663 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -61.76 -43.34 99.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.387 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 76.8 mt -68.07 -46.05 72.15 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.169 -0.957 . . . . 0.0 108.527 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -50.65 -53.3 32.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.899 -1.126 . . . . 0.0 109.199 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -57.81 -33.53 68.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.426 -0.796 . . . . 0.0 109.093 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -72.98 -41.88 63.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.331 -0.855 . . . . 0.0 109.34 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.568 HG21 HD21 ' A' ' 52' ' ' LEU . 21.1 t -77.01 -50.93 19.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 120.682 -1.261 . . . . 0.0 109.359 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -49.73 -32.97 14.79 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 122.681 1.229 . . . . 0.0 109.954 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.25 -29.26 48.0 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.824 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -93.54 5.8 50.39 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.25 29.43 68.71 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 118.265 -1.922 . . . . 0.0 109.629 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.2 -168.53 11.06 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -104.85 -53.9 2.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -1.059 . . . . 0.0 109.955 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.415 ' C ' HD22 ' A' ' 52' ' ' LEU . . . -176.74 178.21 48.02 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.568 HD21 HG21 ' A' ' 44' ' ' VAL . 3.9 mm? -98.88 135.05 40.87 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.377 -1.073 . . . . 0.0 110.261 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 54' ' ' ALA . 1.4 pt -112.11 139.01 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.664 -0.647 . . . . 0.0 109.392 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 53' ' ' ILE . . . 43.52 45.79 5.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.157 -0.964 . . . . 0.0 109.501 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.12 -27.17 28.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 0.0 109.209 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.643 HH22 ' CB ' ' B' ' 27' ' ' SER . 8.4 mmt180 -42.33 160.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.665 0.745 . . . . 0.0 109.891 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.669 ' H ' ' CD1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -51.12 -21.76 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 59' ' ' CYS . 0.2 OUTLIER 69.61 -176.99 0.21 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 0.0 109.48 -179.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.483 ' H ' HG22 ' A' ' 58' ' ' THR . 41.9 t -65.71 80.98 0.07 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.215 -0.928 . . . . 0.0 109.565 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -151.5 -38.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.911 . . . . 0.0 109.265 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.5 t70 53.75 18.73 1.62 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.366 -0.833 . . . . 0.0 109.341 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.58 -25.12 73.97 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.9 tttt 54.44 39.09 30.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.365 -1.08 . . . . 0.0 109.28 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.467 ' CE1' ' O ' ' A' ' 30' ' ' SER . 1.4 t80 -168.56 42.38 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.23 -0.919 . . . . 0.0 109.37 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.5 tp -165.89 129.9 2.22 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.252 -0.905 . . . . 0.0 109.804 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.07 133.13 6.3 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -150.17 174.54 12.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.389 -1.065 . . . . 0.0 109.83 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.31 156.98 13.09 Favored Glycine 0 N--CA 1.487 2.091 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.284 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.8 m -98.29 135.39 39.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.193 -1.18 . . . . 0.0 108.617 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.4 mt -89.63 131.28 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 21' ' ' TYR . 5.4 m -138.5 167.7 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.664 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -150.94 150.86 31.33 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 19' ' ' GLN . . . -105.98 115.65 30.59 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.181 -0.949 . . . . 0.0 110.938 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 173.63 165.73 0.18 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.384 0.612 . . . . 0.0 109.596 -178.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -58.89 -29.13 66.79 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.457 -0.777 . . . . 0.0 109.251 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.55 -172.14 0.06 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.337 -0.852 . . . . 0.0 109.086 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 61.04 158.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.475 -0.765 . . . . 0.0 109.604 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -61.45 145.31 52.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.31 -0.868 . . . . 0.0 109.41 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.76 171.14 14.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.887 . . . . 0.0 109.309 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 50.6 mtm -57.89 -58.74 7.05 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.436 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 16.2 pt -58.07 -20.43 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.918 . . . . 0.0 109.457 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 23.4 t80 54.18 -126.84 2.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.306 -0.872 . . . . 0.0 109.483 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -64.63 123.66 19.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 0.0 109.41 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -75.18 -71.63 0.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.28 -0.888 . . . . 0.0 109.362 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -168.0 98.13 0.45 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.098 -1.001 . . . . 0.0 109.71 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -92.95 120.08 32.9 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.172 -0.955 . . . . 0.0 108.728 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 14.9 mt -115.57 135.68 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.454 -0.779 . . . . 0.0 110.383 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.677 HD11 ' CD1' ' B' ' 55' ' ' PHE . 19.0 tt -134.46 114.09 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.9 t -123.01 159.59 28.06 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.377 -0.827 . . . . 0.0 108.926 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.0 p -101.68 72.72 1.39 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -177.01 -137.3 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.156 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 179.68 90.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.473 -0.767 . . . . 0.0 109.577 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . 0.401 ' HB3' ' HD3' ' B' ' 16' ' ' PRO . 32.5 mt-10 -156.85 -81.56 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.349 -0.844 . . . . 0.0 109.447 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.506 ' N ' ' HD3' ' B' ' 16' ' ' PRO . 8.2 mt 47.18 62.35 12.02 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.118 -0.989 . . . . 0.0 108.952 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' B' ' 15' ' ' ILE . 1.4 Cg_endo -65.97 155.63 68.53 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.997 1.798 . . . . 0.0 109.909 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.07 -10.65 74.42 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.308 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' LEU . . . . . 0.408 HD12 ' CG2' ' B' ' 15' ' ' ILE . 76.1 mt -124.89 137.28 54.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.08 -1.247 . . . . 0.0 108.638 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -101.45 116.41 32.72 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' B' ' 72' ' ' LYS . 0.2 OUTLIER -111.99 134.57 53.46 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.556 -0.715 . . . . 0.0 110.688 -177.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . 0.658 ' CD1' ' N ' ' B' ' 21' ' ' TYR . 0.0 OUTLIER -105.17 152.75 22.44 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.02 128.83 34.8 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.504 -0.747 . . . . 0.0 109.6 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 mt -113.17 7.06 17.77 Favored 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.03 -157.08 22.49 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 176.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -135.02 143.68 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.963 -0.728 . . . . 0.0 109.359 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.94 145.59 45.65 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.128 0.49 . . . . 0.0 109.738 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.643 ' CB ' HH22 ' A' ' 56' ' ' ARG . 0.0 OUTLIER -152.05 141.36 21.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.005 -1.059 . . . . 0.0 108.459 179.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 14.1 t -149.63 152.85 36.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.199 -0.938 . . . . 0.0 109.083 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 68.6 mt -126.8 133.1 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.2 -0.937 . . . . 0.0 109.375 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 34.2 t -165.59 166.06 18.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.438 -0.789 . . . . 0.0 109.338 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -96.63 70.95 2.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.238 -0.914 . . . . 0.0 109.645 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 169.31 129.04 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.44 ' CG2' ' N ' ' B' ' 34' ' ' ASP . 1.3 m -71.16 -43.62 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.44 ' N ' ' CG2' ' B' ' 33' ' ' VAL . 33.9 m-20 -63.76 -45.16 91.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.348 -0.845 . . . . 0.0 109.681 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -60.37 -39.18 86.31 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.678 -0.809 . . . . 0.0 108.872 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 48.5 mt -64.07 -51.89 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.92 . . . . 0.0 108.877 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -53.64 -48.31 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.977 . . . . 0.0 108.508 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -60.8 -40.26 91.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.335 -0.853 . . . . 0.0 110.102 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -64.36 -44.38 91.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 109.478 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' B' ' 40' ' ' LEU . 40.9 mt -68.45 -48.76 63.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.131 -0.981 . . . . 0.0 108.527 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -49.0 -48.58 43.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.846 -1.159 . . . . 0.0 108.945 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -62.19 -36.31 81.5 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.51 -0.744 . . . . 0.0 109.965 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -75.5 -35.96 60.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.385 -0.822 . . . . 0.0 109.668 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.75 -51.6 26.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.062 -1.024 . . . . 0.0 108.902 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -56.0 -28.73 58.47 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.669 1.223 . . . . 0.0 109.147 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.26 -28.33 59.78 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.385 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -96.42 -5.22 40.25 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.11 24.72 70.7 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 118.466 -1.825 . . . . 0.0 109.175 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.25 -171.11 9.25 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -112.36 -40.12 4.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.502 -0.999 . . . . 0.0 109.896 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 171.52 175.53 39.94 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.495 ' N ' ' CD2' ' B' ' 52' ' ' LEU . 2.3 mm? -96.99 133.85 41.13 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.378 -1.072 . . . . 0.0 109.942 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 49.7 mt -110.25 137.05 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.727 -0.608 . . . . 0.0 109.973 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 57.95 71.42 0.58 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.816 . . . . 0.0 109.815 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.677 ' CD1' HD11 ' B' ' 9' ' ' ILE . 2.0 t80 -58.38 -73.25 0.08 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.36 -0.837 . . . . 0.0 108.923 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' B' ' 55' ' ' PHE . 7.1 tpt180 58.01 113.61 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.411 -0.806 . . . . 0.0 110.157 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.78 133.49 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 17.0 p -143.9 142.2 30.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.31 -0.869 . . . . 0.0 109.367 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 7.6 t -179.82 151.11 0.42 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -165.76 43.4 0.07 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.893 . . . . 0.0 109.328 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -164.38 -9.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 109.519 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.02 -138.45 2.43 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -77.65 165.0 24.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -1.141 . . . . 0.0 109.605 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -79.22 -165.0 0.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 0.0 109.565 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 46.7 tp -157.49 113.43 2.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.393 -0.817 . . . . 0.0 109.078 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -123.12 152.4 16.93 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -167.81 -175.48 2.76 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.473 -1.016 . . . . 0.0 109.399 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.0 -162.4 35.29 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 97.6 m -123.84 137.79 54.6 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 31.1 mt -83.81 125.49 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' B' ' 21' ' ' TYR . 6.5 m -136.94 164.18 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.824 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' B' ' 20' ' ' LEU . 3.0 mttt -136.1 146.67 47.26 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.33 -0.856 . . . . 0.0 108.879 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' B' ' 74' ' ' ASP . . . -114.88 116.75 29.05 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.81 -0.556 . . . . 0.0 110.235 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . 0.566 ' O ' ' OH ' ' B' ' 21' ' ' TYR . 5.5 t70 156.25 131.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.774 0.797 . . . . 0.0 109.655 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -173.41 158.24 3.46 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.724 -1.235 . . . . 0.0 109.462 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.31 167.67 20.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.866 . . . . 0.0 109.197 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -99.55 -60.14 1.59 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.34 -0.85 . . . . 0.0 109.489 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -67.45 143.63 56.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.209 -0.932 . . . . 0.0 110.002 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 10.0 m -50.16 159.66 0.43 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.475 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' MET . . . . . . . . . . . . . 7.3 tpt -112.61 61.15 0.63 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.546 -0.721 . . . . 0.0 109.297 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.379 179.902 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 11.2 mm -62.65 -84.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -83.35 170.85 14.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.893 . . . . 0.0 109.161 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -139.03 172.86 12.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.362 -0.836 . . . . 0.0 109.215 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' ASP . . . . . 0.439 ' OD1' ' NH2' ' C' ' 41' ' ' ARG . 26.3 t70 -162.44 48.69 0.17 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.234 -0.916 . . . . 0.0 110.362 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -73.23 45.87 0.17 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.722 -1.236 . . . . 0.0 110.147 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -92.77 120.31 33.02 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.135 -0.978 . . . . 0.0 108.728 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 44.8 mt -119.45 128.57 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.513 -0.742 . . . . 0.0 109.788 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' ILE . . . . . 0.61 HG23 ' O ' ' C' ' 9' ' ' ILE . 13.4 tt -119.96 114.14 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -122.94 159.97 27.17 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . 0.432 HG22 ' H ' ' C' ' 55' ' ' PHE . 7.7 p -125.55 77.57 1.66 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.642 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.35 -117.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.398 -1.439 . . . . 0.0 108.371 -176.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -84.41 -134.27 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.136 -0.977 . . . . 0.0 109.796 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.75 28.93 5.54 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.529 -0.732 . . . . 0.0 109.862 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . . . . . . . . . 33.2 mt 57.06 81.63 0.25 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.393 -0.817 . . . . 0.0 109.58 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.93 156.84 41.61 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 122.21 1.94 . . . . 0.0 110.37 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.18 -0.95 69.44 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.378 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' LEU . . . . . . . . . . . . . 60.8 mt -131.52 138.99 49.17 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.111 -1.229 . . . . 0.0 109.155 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -97.54 109.55 22.29 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . 0.604 HD23 ' HB2' ' C' ' 73' ' ' ALA . 0.0 OUTLIER -120.2 143.97 47.97 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' TYR . . . . . 0.666 ' N ' ' CD1' ' C' ' 21' ' ' TYR . 0.0 OUTLIER -113.65 146.85 39.14 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.509 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -72.85 136.91 45.41 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.642 0.734 . . . . 0.0 109.999 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.437 HD12 HG22 ' C' ' 70' ' ' ILE . 5.8 mt -118.47 15.37 13.8 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.02 179.76 16.18 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' ILE . . . . . . . . . . . . . 47.1 mm -112.3 142.26 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.795 -0.827 . . . . 0.0 108.826 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.38 144.17 43.23 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.528 -0.733 . . . . 0.0 109.899 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 35.4 t -152.31 137.66 17.57 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 15.2 t -149.62 152.3 35.22 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.055 -1.028 . . . . 0.0 109.369 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -102.15 155.02 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' C' ' 31' ' ' ASP . 12.1 t -176.19 -178.06 0.95 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.975 . . . . 0.0 109.225 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' ASP . . . . . 0.448 ' N ' ' OG ' ' C' ' 30' ' ' SER . 20.0 t70 -102.2 -80.78 0.5 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.411 -0.806 . . . . 0.0 110.971 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -65.08 144.12 57.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.996 -1.065 . . . . 0.0 108.731 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . 0.417 ' H ' HG13 ' C' ' 33' ' ' VAL . 1.4 m -69.47 -38.44 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -54.59 -28.16 44.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.459 -0.776 . . . . 0.0 109.848 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -76.23 -34.74 59.22 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.309 -0.869 . . . . 0.0 109.479 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 84.2 mt -58.76 -46.9 90.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.171 -0.955 . . . . 0.0 108.913 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 55.6 t -56.86 -49.57 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.952 -1.092 . . . . 0.0 108.637 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -61.8 -42.78 99.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.437 -0.789 . . . . 0.0 109.402 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -60.26 -48.67 80.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.535 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 67.2 mt -64.68 -42.9 95.03 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' ARG . . . . . 0.778 ' HG2' HH11 ' C' ' 41' ' ' ARG . 0.8 OUTLIER -48.2 -47.7 35.28 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.861 -1.15 . . . . 0.0 109.275 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -63.13 -31.83 73.06 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -73.8 -41.74 61.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.832 . . . . 0.0 109.518 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 38.1 t -68.29 -51.24 49.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.705 -1.247 . . . . 0.0 109.292 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -51.0 -33.44 24.84 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.642 1.211 . . . . 0.0 110.223 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.76 -28.83 50.72 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.678 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.55 7.31 43.8 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.48 29.77 64.11 Favored Glycine 0 N--CA 1.487 2.08 0 C-N-CA 118.672 -1.727 . . . . 0.0 109.759 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.26 148.9 27.14 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -65.23 -33.63 76.45 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.174 -1.192 . . . . 0.0 110.826 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 171.56 -159.04 30.47 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 11.4 tp -121.18 135.57 55.12 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.588 -0.948 . . . . 0.0 109.622 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 60.7 mt -110.87 144.03 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.492 -0.755 . . . . 0.0 110.022 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.12 82.64 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.232 -0.918 . . . . 0.0 110.713 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . 0.439 ' O ' ' CD2' ' C' ' 55' ' ' PHE . 82.5 t80 -126.9 65.79 1.28 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.332 0.587 . . . . 0.0 110.143 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' ARG . . . . . 0.744 ' HG2' HH11 ' C' ' 56' ' ' ARG . 7.7 mtt-85 -80.02 148.43 31.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 109.495 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 44.5 mm -77.81 154.13 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.828 . . . . 0.0 109.292 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' C' ' 59' ' ' CYS . 1.1 t -59.99 -179.04 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.33 -0.856 . . . . 0.0 109.517 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' CYS . . . . . 0.447 ' N ' ' OG1' ' C' ' 58' ' ' THR . 12.4 p -161.39 -10.42 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 109.445 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.421 ' H ' ' H ' ' C' ' 59' ' ' CYS . . . -165.36 -127.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 109.467 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -69.96 71.58 0.39 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.191 -0.943 . . . . 0.0 108.854 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . -168.57 9.01 0.05 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.84 174.87 10.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.473 -1.016 . . . . 0.0 109.739 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 49.35 49.76 19.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.354 -0.841 . . . . 0.0 109.194 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 8.1 tp -176.43 89.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.536 -0.727 . . . . 0.0 109.895 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.91 155.09 50.57 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' C' ' 67' ' ' TYR . 21.7 p90 -147.53 120.83 8.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.105 -1.232 . . . . 0.0 109.767 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.38 165.34 32.85 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' THR . . . . . . . . . . . . . 95.1 m -117.05 141.46 48.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.294 -1.121 . . . . 0.0 108.925 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' ILE . . . . . 0.437 HG22 HD12 ' C' ' 23' ' ' LEU . 41.9 mt -95.09 133.48 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.443 -0.785 . . . . 0.0 109.019 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 10.6 m -144.26 156.15 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.41 -0.806 . . . . 0.0 109.608 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' LYS . . . . . 0.463 ' HG3' ' CE2' ' C' ' 21' ' ' TYR . 18.4 ptpt -142.33 140.06 32.0 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.26 -0.9 . . . . 0.0 108.691 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.604 ' HB2' HD23 ' C' ' 20' ' ' LEU . . . -126.67 152.96 46.03 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.761 -1.212 . . . . 0.0 108.503 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.576 ' O ' ' CB ' ' C' ' 75' ' ' GLU . 27.1 t70 82.47 -130.99 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' GLU . . . . . 0.576 ' CB ' ' O ' ' C' ' 74' ' ' ASP . 35.6 tt0 93.78 -54.93 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' ALA . . . . . 0.523 ' C ' ' O ' ' C' ' 75' ' ' GLU . . . 27.51 51.52 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.66 0 O-C-N 122.012 -0.43 . . . . 0.0 110.028 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' C' ' 76' ' ' ALA . 16.7 tp60 35.84 -120.65 0.13 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.986 -0.446 . . . . 0.0 109.854 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -130.36 -79.23 0.54 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.312 -0.868 . . . . 0.0 109.085 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 7.3 m -160.82 -116.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 109.35 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 37.3 mtt -64.97 -60.81 2.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.082 -1.011 . . . . 0.0 109.452 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.49 -179.878 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.494 ' SD ' ' N ' ' D' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' ILE . . . . . . . . . . . . . 11.6 pt -147.33 56.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.278 -0.888 . . . . 0.0 109.254 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -62.94 -44.77 95.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.433 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.8 152.09 46.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.336 -0.852 . . . . 0.0 108.837 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -121.28 103.99 9.38 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.631 -0.668 . . . . 0.0 109.45 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 mtpt -151.73 80.95 1.28 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 109.412 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -114.77 121.96 44.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.493 -0.754 . . . . 0.0 109.555 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 51.6 mt -101.65 131.39 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.445 -0.784 . . . . 0.0 109.477 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' ILE . . . . . 0.664 HD11 ' CD2' ' D' ' 55' ' ' PHE . 18.7 tt -124.42 119.89 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 6.0 t -116.35 132.19 56.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.341 -0.85 . . . . 0.0 109.228 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . 0.729 ' OG1' ' OG1' ' E' ' 69' ' ' THR . 8.6 m -67.74 -117.83 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' ALA . . . . . 0.659 ' C ' ' O ' ' D' ' 11' ' ' THR . . . -2.39 -98.83 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.504 0 CA-C-N 118.318 0.508 . . . . 0.0 110.357 -178.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' D' ' 12' ' ' ALA . 3.5 p30 161.91 91.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? 176.65 128.99 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.503 -0.748 . . . . 0.0 109.864 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 35.5 mt -143.46 69.34 17.44 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.26 155.49 56.53 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.928 1.752 . . . . 0.0 110.284 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.63 -4.73 76.41 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' D' ' 18' ' ' LEU . 15.7 mt -129.88 138.64 51.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -1.193 . . . . 0.0 109.967 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -83.74 108.39 16.76 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 mt -103.3 138.88 39.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.463 -0.773 . . . . 0.0 110.425 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' TYR . . . . . 0.473 ' CE1' ' O ' ' D' ' 22' ' ' SER . 1.4 t80 -121.39 129.94 53.32 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . 0.473 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 21.5 t -67.37 133.1 48.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.987 -1.07 . . . . 0.0 111.478 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 mt -123.74 12.42 9.18 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.34 176.03 19.33 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -109.78 144.33 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.905 -0.762 . . . . 0.0 109.567 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.56 154.1 30.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.663 -0.648 . . . . 0.0 109.556 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 6.6 p -152.51 137.29 17.04 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 12.5 t -149.44 151.36 33.87 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.077 -1.014 . . . . 0.0 109.63 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 6.4 mt -102.99 155.26 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 120.924 -1.11 . . . . 0.0 108.658 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.516 ' O ' ' N ' ' D' ' 32' ' ' ASN . 0.6 OUTLIER 176.13 -20.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.04 -1.037 . . . . 0.0 110.403 179.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 62.8 -41.39 0.18 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.777 -0.577 . . . . 0.0 111.465 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.541 ' O ' HG13 ' D' ' 36' ' ' ILE . 7.8 t-20 -85.86 141.22 29.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.972 -1.08 . . . . 0.0 109.28 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . 0.4 ' H ' HG23 ' D' ' 33' ' ' VAL . 3.0 t -68.41 -41.6 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.874 -1.141 . . . . 0.0 110.612 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -54.53 -43.97 72.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.39 -0.819 . . . . 0.0 110.238 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -76.8 -36.64 56.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.426 -0.797 . . . . 0.0 109.678 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . 0.645 HG22 ' CE1' ' D' ' 55' ' ' PHE . 96.8 mt -61.69 -41.52 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.961 -1.087 . . . . 0.0 108.623 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.416 HG23 ' CZ ' ' D' ' 55' ' ' PHE . 13.6 t -69.39 -46.37 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.665 -1.272 . . . . 0.0 108.954 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -66.98 -44.34 80.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.397 -0.814 . . . . 0.0 110.793 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -55.04 -48.5 73.36 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.041 -1.037 . . . . 0.0 109.659 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 38.8 mt -64.85 -37.79 88.81 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.297 -0.877 . . . . 0.0 109.287 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -54.53 -43.8 72.25 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.614 -1.304 . . . . 0.0 109.73 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm -67.62 -40.07 84.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.3 -0.875 . . . . 0.0 110.373 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -75.79 -36.14 59.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.86 . . . . 0.0 109.755 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.83 -50.07 73.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.049 -1.032 . . . . 0.0 109.333 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -65.25 -30.71 71.61 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 118.411 -1.316 . . . . 0.0 108.743 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.33 -28.46 66.26 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.554 0.692 . . . . 0.0 109.267 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -93.09 -6.55 47.82 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.469 -0.769 . . . . 0.0 109.514 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.16 30.06 15.45 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.145 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.77 155.55 18.29 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.39 -9.1 9.53 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.466 -1.02 . . . . 0.0 109.282 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.94 162.74 30.62 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 4.1 tp -130.47 140.32 50.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.632 -0.923 . . . . 0.0 109.769 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' ILE . . . . . 0.458 ' O ' ' HB3' ' D' ' 54' ' ' ALA . 13.9 mt -108.48 138.39 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' D' ' 53' ' ' ILE . . . 65.63 76.71 0.32 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.314 -0.867 . . . . 0.0 109.779 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.664 ' CD2' HD11 ' D' ' 9' ' ' ILE . 84.1 t80 -99.06 138.89 35.52 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.49 -0.756 . . . . 0.0 110.313 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' ARG . . . . . 0.661 ' O ' ' CE2' ' D' ' 55' ' ' PHE . 26.7 ttp180 -95.72 163.17 13.3 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' ILE . . . . . 0.976 HD13 ' N ' ' D' ' 57' ' ' ILE . 0.1 OUTLIER -134.15 -129.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.321 -0.862 . . . . 0.0 109.676 -177.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' THR . . . . . . . . . . . . . 75.1 p -55.54 -77.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.077 -1.015 . . . . 0.0 110.094 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' CYS . . . . . . . . . . . . . 5.9 t 68.49 105.57 0.05 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' D' ' 62' ' ' GLY . . . -46.39 145.92 1.59 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.283 -0.886 . . . . 0.0 109.708 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 50.88 -90.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.3 -0.875 . . . . 0.0 109.412 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 62' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' D' ' 60' ' ' ALA . . . 80.56 48.58 6.2 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -52.24 -23.87 6.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -1.117 . . . . 0.0 109.271 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -85.1 -125.89 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.392 -0.818 . . . . 0.0 109.381 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . 0.686 HD23 ' N ' ' D' ' 65' ' ' LEU . 1.2 pt? -168.66 170.29 9.56 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.361 -0.837 . . . . 0.0 109.978 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.01 171.89 11.52 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -160.89 153.61 20.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.953 -1.321 . . . . 0.0 109.535 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.24 152.32 11.01 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.544 -1.312 . . . . 0.0 110.327 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 48.9 m -94.04 134.5 36.38 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.009 -1.289 . . . . 0.0 108.458 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 70' ' ' ILE . . . . . . . . . . . . . 44.5 mt -84.81 127.58 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 71' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' D' ' 21' ' ' TYR . 4.3 m -135.38 159.31 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 110.218 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 10.6 pttp -152.25 148.6 27.76 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.76 150.72 26.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.23 -0.919 . . . . 0.0 108.852 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -73.88 154.25 39.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.023 -1.048 . . . . 0.0 109.393 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -88.88 -127.28 0.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.237 -0.914 . . . . 0.0 109.477 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -163.33 -171.71 2.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.924 . . . . 0.0 109.188 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -141.35 135.07 30.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.308 -0.87 . . . . 0.0 109.454 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 78' ' ' PHE . . . . . . . . . . . . . 76.2 t80 48.67 84.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.37 -0.831 . . . . 0.0 109.554 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 6.3 t -125.0 166.74 15.8 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.453 -0.779 . . . . 0.0 109.478 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 34.8 ttm 53.19 86.65 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.368 -0.833 . . . . 0.0 109.52 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.468 -179.967 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mmt . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.43 0.633 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . 0.441 HG13 ' H ' ' E' ' 2' ' ' ILE . 0.8 OUTLIER -70.55 161.23 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.418 -0.801 . . . . 0.0 109.196 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 3' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -70.54 -50.97 32.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.453 -0.779 . . . . 0.0 109.564 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -136.3 -179.78 5.88 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.377 -0.827 . . . . 0.0 109.419 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 5' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' E' ' 6' ' ' LYS . 1.7 p-10 -59.66 -78.03 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.867 . . . . 0.0 109.347 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 6' ' ' LYS . . . . . 0.494 ' H ' ' CG ' ' E' ' 5' ' ' ASP . 0.0 OUTLIER -175.36 85.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.333 -0.854 . . . . 0.0 108.961 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -97.92 123.08 41.74 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.355 -0.841 . . . . 0.0 109.416 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 34.0 mt -111.67 135.33 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.459 -0.776 . . . . 0.0 109.591 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 9' ' ' ILE . . . . . 0.6 HG23 ' O ' ' E' ' 9' ' ' ILE . 10.5 tt -132.43 115.76 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 4.1 t -124.0 155.87 37.46 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 11' ' ' THR . . . . . . . . . . . . . 2.0 p -115.95 89.45 3.11 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.74 -95.57 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.987 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 13' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -160.14 -35.9 0.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.4 -0.813 . . . . 0.0 109.426 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . 0.411 ' CG ' ' N ' ' E' ' 15' ' ' ILE . 29.7 tt0 -166.71 167.32 15.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 109.302 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 15' ' ' ILE . . . . . 0.411 ' N ' ' CG ' ' E' ' 14' ' ' GLU . 87.0 mt -115.73 92.75 35.03 Favored Pre-proline 0 N--CA 1.496 1.843 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.12 155.28 51.75 Favored 'Trans proline' 0 C--N 1.322 -0.85 0 C-N-CA 121.912 1.741 . . . . 0.0 110.318 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.9 -10.19 75.05 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 18' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' E' ' 18' ' ' LEU . 20.4 mt -127.59 138.95 53.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -1.1 . . . . 0.0 109.52 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 19' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -84.45 108.68 17.38 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 14.1 mt -96.99 142.97 28.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.389 -0.82 . . . . 0.0 110.752 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 21' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -126.36 130.15 50.21 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.77 129.37 39.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.733 -1.23 . . . . 0.0 110.793 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.899 HD11 ' HB2' ' E' ' 72' ' ' LYS . 97.6 mt -114.41 3.9 15.14 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.3 -172.9 19.68 Favored Glycine 0 N--CA 1.499 2.9 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . 0.471 HD11 HG23 ' D' ' 9' ' ' ILE . 39.6 mm -110.39 140.87 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.798 -0.825 . . . . 0.0 109.32 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.3 146.93 44.86 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.646 -0.659 . . . . 0.0 109.313 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 40.5 m -152.59 148.41 27.31 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.907 -1.121 . . . . 0.0 108.916 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . 0.459 ' OG1' HG23 ' E' ' 36' ' ' ILE . 25.2 p -148.88 134.15 18.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.45 -0.781 . . . . 0.0 109.337 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' E' ' 30' ' ' SER . 87.5 mt -126.53 127.83 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' E' ' 29' ' ' ILE . 3.6 t 162.51 14.43 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 31' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' E' ' 31' ' ' ASP . 1.4 m-20 51.55 -174.23 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.125 -0.984 . . . . 0.0 109.02 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 32' ' ' ASN . . . . . . . . . . . . . 8.0 m120 68.1 100.18 0.05 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 45.0 t -69.16 -37.27 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.211 -0.931 . . . . 0.0 109.5 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -57.52 -42.14 82.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 110.029 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.79 -38.18 58.48 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.287 -0.883 . . . . 0.0 109.42 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 36' ' ' ILE . . . . . 0.459 HG23 ' OG1' ' E' ' 28' ' ' THR . 55.9 mt -63.51 -51.71 67.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.03 -1.044 . . . . 0.0 109.534 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 57.6 t -51.8 -51.14 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.082 -1.011 . . . . 0.0 109.125 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.07 -38.06 78.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -0.869 . . . . 0.0 109.409 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 39' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -63.66 -40.81 97.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.122 -0.986 . . . . 0.0 109.511 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 40' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' E' ' 40' ' ' LEU . 41.6 mt -68.49 -44.45 74.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.148 -0.97 . . . . 0.0 109.338 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -51.43 -37.71 49.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.653 -1.28 . . . . 0.0 109.596 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -73.71 -39.46 64.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.59 -0.694 . . . . 0.0 109.831 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -75.98 -35.79 59.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.371 -0.831 . . . . 0.0 109.67 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 11.5 t -67.32 -50.92 58.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 109.055 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -70.4 -36.88 74.33 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.315 -1.354 . . . . 0.0 109.035 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.45 -31.26 69.14 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -87.89 -5.25 58.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.412 -0.805 . . . . 0.0 109.809 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.21 5.54 58.11 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.03 161.23 48.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.99 -3.2 5.15 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.086 -1.243 . . . . 0.0 109.893 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.82 149.45 12.54 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 4.6 tp -108.64 139.96 42.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.675 -0.897 . . . . 0.0 109.595 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 53' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' E' ' 54' ' ' ALA . 1.0 OUTLIER -111.67 142.85 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.567 -0.708 . . . . 0.0 110.255 -178.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 62.24 75.87 0.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 110.131 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 55' ' ' PHE . . . . . 0.482 ' O ' ' CG ' ' E' ' 55' ' ' PHE . 58.7 t80 -104.65 23.95 12.54 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 56' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -54.82 149.16 11.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.84 . . . . 0.0 109.242 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 65.0 mt -119.96 97.87 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 58' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' E' ' 59' ' ' CYS . 1.0 OUTLIER -140.74 -168.49 2.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.442 -0.786 . . . . 0.0 109.212 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 59' ' ' CYS . . . . . 0.539 ' N ' ' OG1' ' E' ' 58' ' ' THR . 4.8 t 63.08 51.4 2.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.881 . . . . 0.0 109.498 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.71 78.72 0.11 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 109.402 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -77.59 -28.53 51.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -0.87 . . . . 0.0 109.494 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 62' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' E' ' 64' ' ' PHE . . . -176.8 -101.68 0.15 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -76.83 34.9 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.397 -1.06 . . . . 0.0 109.561 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 64' ' ' PHE . . . . . 0.43 ' H ' ' C ' ' E' ' 62' ' ' GLY . 75.4 m-85 51.46 -174.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.571 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 tp -174.86 127.83 0.3 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.87 79.21 0.62 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -80.01 134.14 36.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -1.173 . . . . 0.0 109.45 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.46 165.12 35.4 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 69' ' ' THR . . . . . 0.729 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 30.5 m -113.7 139.67 48.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.639 -0.918 . . . . 0.0 108.757 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 70' ' ' ILE . . . . . 0.546 HG22 HD12 ' E' ' 23' ' ' LEU . 43.3 mt -84.93 146.44 6.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 m -139.42 154.4 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.206 -0.934 . . . . 0.0 109.942 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 72' ' ' LYS . . . . . 0.899 ' HB2' HD11 ' E' ' 23' ' ' LEU . 33.0 ttpt -143.47 151.81 40.76 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.13 150.53 35.86 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.419 -0.801 . . . . 0.0 108.957 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -79.02 -168.17 1.38 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.102 -0.999 . . . . 0.0 109.132 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 75' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' E' ' 76' ' ' ALA . 0.7 OUTLIER -115.84 -86.65 0.61 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.513 -0.742 . . . . 0.0 109.546 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 76' ' ' ALA . . . . . 0.407 ' H ' ' HB3' ' E' ' 75' ' ' GLU . . . -169.12 174.92 5.97 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.033 -1.042 . . . . 0.0 109.041 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 77' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -90.84 -64.46 1.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.199 -0.938 . . . . 0.0 109.33 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -75.26 144.85 42.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -0.959 . . . . 0.0 109.43 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -167.95 -23.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.865 . . . . 0.0 109.453 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 16.6 tpp -163.68 32.24 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.226 -0.921 . . . . 0.0 109.42 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.666 -179.959 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.337 0.589 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.571 ' N ' HD13 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -62.49 174.99 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.348 -0.845 . . . . 0.0 109.541 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -160.46 -162.44 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.063 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -131.48 45.86 2.74 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.343 -0.848 . . . . 0.0 109.344 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -63.81 131.34 47.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 109.228 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -138.07 -65.23 0.52 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.39 -0.819 . . . . 0.0 110.541 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -89.69 121.07 31.52 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.147 -0.971 . . . . 0.0 109.247 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 57.0 mt -136.82 139.18 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.383 -0.823 . . . . 0.0 109.461 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.537 ' O ' HG23 ' A' ' 9' ' ' ILE . 13.9 tt -121.38 115.6 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.2 t -127.01 147.02 50.15 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.109 -0.994 . . . . 0.0 108.509 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.574 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -66.84 -110.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 177.111 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.519 ' N ' ' OG1' ' A' ' 11' ' ' THR . . . -33.0 -88.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.724 -0.61 . . . . 0.0 110.186 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 1.3 p-10 -170.33 -92.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.951 -1.093 . . . . 0.0 109.086 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.463 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 30.0 mt-10 74.71 -135.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.699 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 2.6 mt 65.01 46.41 0.54 Allowed Pre-proline 0 N--CA 1.486 1.351 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -176.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.699 ' HD3' ' N ' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -66.08 151.77 82.96 Favored 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 121.431 1.421 . . . . 0.0 110.003 179.184 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.16 -5.38 78.34 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.118 -1.515 . . . . 0.0 111.122 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 18' ' ' LEU . 59.7 mt -124.77 137.07 54.34 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.792 -1.416 . . . . 0.0 108.503 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.716 ' NE2' ' H ' ' A' ' 19' ' ' GLN . 0.7 OUTLIER -90.14 113.41 25.16 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.46 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 3.3 mt -107.22 128.18 54.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.701 -0.624 . . . . 0.0 110.106 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.581 ' N ' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -109.86 157.88 18.75 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.3 t -81.56 126.45 31.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.478 -0.764 . . . . 0.0 109.618 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.712 HD11 ' CB ' ' A' ' 72' ' ' LYS . 16.4 mt -108.95 2.5 21.41 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.94 177.65 14.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.46 141.5 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.82 144.77 42.99 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.1 t -152.57 138.07 17.69 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.9 t -149.8 150.4 31.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.028 -1.045 . . . . 0.0 108.997 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.93 131.88 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 31' ' ' ASP . 14.3 p -172.5 13.47 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.324 -0.86 . . . . 0.0 109.576 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 30' ' ' SER . 37.1 t70 57.35 154.44 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.63 -0.669 . . . . 0.0 110.196 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER 73.84 111.2 0.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.082 -1.011 . . . . 0.0 108.567 -178.298 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.88 -33.54 62.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.358 -0.839 . . . . 0.0 109.354 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -52.52 -35.98 54.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 85.4 mt-10 -78.44 -33.88 48.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 108.809 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.0 mt -65.07 -53.82 36.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 120.961 -1.087 . . . . 0.0 108.937 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 t -58.06 -50.32 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.085 -1.009 . . . . 0.0 108.348 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -61.26 -41.27 96.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.565 -0.709 . . . . 0.0 109.761 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 35' ' ' GLU . 17.9 m120 -66.64 -42.52 86.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 0.0 109.329 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 40' ' ' LEU . 70.2 mt -62.49 -42.67 99.65 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.107 -0.995 . . . . 0.0 108.448 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -48.06 -56.4 7.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.625 -1.297 . . . . 0.0 109.389 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 93.8 mttt -57.34 -35.41 69.87 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.288 -0.882 . . . . 0.0 110.249 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.27 -35.53 58.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.791 . . . . 0.0 109.903 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.5 t -72.19 -51.29 30.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.187 -0.946 . . . . 0.0 108.834 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -69.6 -31.47 69.62 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 117.942 -1.503 . . . . 0.0 108.962 -175.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 42' ' ' LYS . . . -62.22 -31.12 71.62 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.7 mtpt -95.64 -3.83 45.51 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.36 27.6 47.61 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 118.864 -1.636 . . . . 0.0 109.751 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.18 -166.67 34.41 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -109.78 -46.65 3.46 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.53 -0.982 . . . . 0.0 109.851 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 174.98 -152.08 13.2 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -129.07 140.27 51.66 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.677 -0.896 . . . . 0.0 109.886 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.781 ' O ' HD13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -121.81 150.15 25.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.941 -0.474 . . . . 0.0 109.854 -178.167 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 11' ' ' THR . . . 73.5 108.5 0.07 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.996 -1.065 . . . . 0.0 111.301 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -127.07 148.38 50.14 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.504 0.669 . . . . 0.0 109.86 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.708 ' HE ' ' NH1' ' B' ' 56' ' ' ARG . 19.3 ttt180 -131.72 -31.57 1.54 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.457 0.646 . . . . 0.0 109.446 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -103.29 -173.46 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.473 ' HB ' ' OG ' ' B' ' 27' ' ' SER . 0.0 OUTLIER -168.96 -13.53 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.161 -0.962 . . . . 0.0 109.898 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.417 ' H ' ' H ' ' A' ' 58' ' ' THR . 49.7 t -166.67 -79.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.133 -0.979 . . . . 0.0 109.281 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.31 149.18 34.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.172 -0.955 . . . . 0.0 109.325 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -145.33 -66.98 0.31 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.364 -0.835 . . . . 0.0 109.41 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.56 84.51 0.03 OUTLIER Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 mttp 53.31 75.46 0.25 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.334 -1.097 . . . . 0.0 109.326 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -134.94 -33.39 0.93 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.434 -0.791 . . . . 0.0 109.683 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.1 tp 54.14 96.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.788 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.97 170.63 5.16 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -156.46 137.79 13.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.209 -1.171 . . . . 0.0 109.735 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.58 161.23 32.07 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.602 ' CB ' ' HG1' ' E' ' 11' ' ' THR . 80.8 m -107.8 140.0 41.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.265 -1.138 . . . . 0.0 108.862 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.515 HG22 HD12 ' A' ' 23' ' ' LEU . 54.8 mt -88.55 129.77 39.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 20' ' ' LEU . 15.7 m -132.75 155.04 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.498 -0.751 . . . . 0.0 109.602 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.712 ' CB ' HD11 ' A' ' 23' ' ' LEU . 10.4 tttp -142.61 147.91 36.6 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.176 -0.953 . . . . 0.0 109.245 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.87 151.04 39.49 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.339 -0.851 . . . . 0.0 108.807 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -146.3 86.21 1.68 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.102 -0.999 . . . . 0.0 108.702 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -68.24 -153.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.297 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.86 9.76 0.33 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.277 -0.889 . . . . 0.0 109.356 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -72.31 -149.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.337 -0.852 . . . . 0.0 109.394 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.7 t80 51.73 55.39 9.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 109.488 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t -59.51 161.48 5.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.505 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 26.4 ttt -153.95 110.68 3.36 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.314 -0.866 . . . . 0.0 109.361 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.369 -179.922 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 40.2 mtt . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 4.1 tt -152.14 127.61 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.384 -0.823 . . . . 0.0 109.139 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -151.77 -130.93 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 109.29 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -171.22 33.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.14 -0.975 . . . . 0.0 109.174 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -82.55 81.89 8.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.873 . . . . 0.0 108.955 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -107.85 -89.33 0.46 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -103.63 121.22 42.49 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.211 -0.93 . . . . 0.0 109.549 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 68.0 mt -112.89 128.37 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.507 -0.746 . . . . 0.0 109.985 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' B' ' 52' ' ' LEU . 2.9 tt -131.67 114.67 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.478 HG22 HG22 ' B' ' 53' ' ' ILE . 4.5 t -122.46 158.59 29.42 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.308 1.051 . . . . 0.0 109.272 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.475 HG23 ' OG1' ' C' ' 69' ' ' THR . 9.3 p -90.64 -105.84 0.1 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 42.72 -112.72 0.21 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.121 -0.987 . . . . 0.0 110.901 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -165.82 -20.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.271 -0.893 . . . . 0.0 109.909 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . 0.465 ' CG ' ' N ' ' B' ' 15' ' ' ILE . 67.3 tt0 -167.33 166.63 14.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.117 -0.99 . . . . 0.0 109.25 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.465 ' N ' ' CG ' ' B' ' 14' ' ' GLU . 61.5 mt -114.58 93.0 30.96 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -61.61 155.01 55.92 Favored 'Trans proline' 0 C--N 1.323 -0.803 0 C-N-CA 121.787 1.658 . . . . 0.0 110.485 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.88 -6.38 79.38 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 43.1 mt -132.17 141.43 49.1 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.474 -1.015 . . . . 0.0 109.699 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . 0.448 ' CG ' ' O ' ' B' ' 19' ' ' GLN . 2.5 pt20 -84.91 109.62 18.27 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 mt -102.57 136.71 41.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.953 -1.092 . . . . 0.0 109.437 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' B' ' 22' ' ' SER . 0.8 OUTLIER -121.39 130.46 53.61 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.56 ' O ' ' CE1' ' B' ' 21' ' ' TYR . 40.2 t -60.2 129.3 41.01 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.035 0.921 . . . . 0.0 111.691 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 11.2 mt -114.08 12.09 17.82 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.33 -166.2 13.22 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 mm -120.13 134.74 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.06 149.41 38.95 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.487 -0.758 . . . . 0.0 109.917 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.473 ' OG ' ' HB ' ' A' ' 58' ' ' THR . 7.7 t -152.6 140.85 20.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.2 -0.937 . . . . 0.0 109.384 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 4.3 t -149.62 146.46 27.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.296 -0.877 . . . . 0.0 109.167 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 31.3 mt -127.7 131.75 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 53.8 m -155.91 14.77 0.34 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.993 -1.067 . . . . 0.0 110.306 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 72.36 -70.03 0.17 Allowed 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -76.81 140.42 40.68 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.993 -1.067 . . . . 0.0 108.153 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.471 HG11 ' OH ' ' C' ' 67' ' ' TYR . 96.7 t -69.05 -37.46 77.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.523 -0.736 . . . . 0.0 109.806 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.22 -36.27 51.7 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.356 -0.84 . . . . 0.0 110.516 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.08 -32.85 39.21 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.278 -0.889 . . . . 0.0 109.618 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 35.0 mt -62.27 -53.58 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.275 -0.89 . . . . 0.0 109.045 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 23.4 t -56.99 -49.8 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.229 -0.919 . . . . 0.0 108.59 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -60.95 -39.71 90.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.407 -0.808 . . . . 0.0 110.108 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -64.05 -43.43 95.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.164 -0.96 . . . . 0.0 109.594 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' B' ' 40' ' ' LEU . 18.8 mt -64.81 -43.05 94.42 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.115 -0.99 . . . . 0.0 109.185 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -49.94 -40.99 45.37 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.584 -1.323 . . . . 0.0 109.923 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -70.31 -37.11 74.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.605 -0.685 . . . . 0.0 110.051 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -76.5 -35.35 58.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.46 -0.775 . . . . 0.0 109.677 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 3.0 t -66.5 -50.3 68.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.134 -0.979 . . . . 0.0 108.913 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -65.45 -30.1 70.85 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.044 -1.462 . . . . 0.0 109.142 -175.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.93 -29.83 68.17 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.488 0.661 . . . . 0.0 109.312 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 mmmt -86.56 -5.47 59.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.627 -0.67 . . . . 0.0 109.517 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.01 5.38 62.54 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.66 164.32 50.5 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -128.65 -3.62 5.33 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.093 -1.24 . . . . 0.0 110.075 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.31 143.57 8.67 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' B' ' 9' ' ' ILE . 8.8 tp -108.23 141.87 39.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.582 -0.952 . . . . 0.0 109.659 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.478 HG22 HG22 ' B' ' 10' ' ' THR . 11.6 pt -142.66 172.07 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.789 -1.194 . . . . 0.0 108.876 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.35 33.01 22.75 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.518 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.6 120.41 30.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.788 -1.195 . . . . 0.0 108.612 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.708 ' NH1' ' HE ' ' A' ' 56' ' ' ARG . 39.4 ttp180 -105.13 166.8 10.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.419 -0.801 . . . . 0.0 109.626 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.805 HD11 ' CE1' ' C' ' 67' ' ' TYR . 16.5 mm -86.22 175.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.396 -0.815 . . . . 0.0 109.407 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . 0.699 ' N ' HG22 ' B' ' 57' ' ' ILE . 0.5 OUTLIER -145.54 168.01 21.64 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.435 -0.79 . . . . 0.0 109.274 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 10.7 t -71.55 -178.73 2.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.347 -0.846 . . . . 0.0 109.458 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.67 -52.97 11.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.471 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' B' ' 62' ' ' GLY . 29.2 t70 -69.4 -175.13 0.76 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.453 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' B' ' 64' ' ' PHE . . . -63.23 -111.45 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 54.6 mttp 52.06 -92.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -1.116 . . . . 0.0 109.43 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.477 ' N ' ' O ' ' B' ' 62' ' ' GLY . 26.8 m-85 -79.52 169.19 18.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.216 -0.927 . . . . 0.0 109.146 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.628 ' N ' HD23 ' B' ' 65' ' ' LEU . 1.5 pt? -163.79 179.24 7.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.391 -0.818 . . . . 0.0 109.179 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.62 126.18 8.15 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' TYR . . . . . 0.482 ' O ' ' CG ' ' B' ' 67' ' ' TYR . 7.7 p90 -122.75 129.03 51.28 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.579 -0.954 . . . . 0.0 109.053 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.87 151.55 23.26 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m -104.48 143.76 32.59 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.303 -1.116 . . . . 0.0 108.79 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 49.2 mt -90.01 143.26 11.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.61 164.91 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.931 . . . . 0.0 110.02 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -154.08 157.31 38.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.538 -0.726 . . . . 0.0 109.236 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.33 150.7 38.38 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.165 -0.96 . . . . 0.0 108.605 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -69.24 139.56 54.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.95 -1.094 . . . . 0.0 109.453 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' GLU . . . . . 0.608 ' H ' ' CD ' ' B' ' 75' ' ' GLU . 1.4 pm0 -69.55 -169.54 0.23 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.273 -0.892 . . . . 0.0 109.402 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -157.21 156.52 32.73 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.311 -0.868 . . . . 0.0 109.126 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -80.66 156.54 26.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.093 -1.004 . . . . 0.0 109.259 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' PHE . . . . . . . . . . . . . 35.1 t80 57.24 58.6 3.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.386 -0.821 . . . . 0.0 109.545 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.451 HG22 ' H ' ' B' ' 79' ' ' THR . 0.0 OUTLIER -76.3 115.77 16.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.433 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' MET . . . . . . . . . . . . . 9.2 ptt? -79.14 38.37 0.35 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.307 -0.87 . . . . 0.0 109.433 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.52 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 51.5 mtp . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 59.0 mt -68.13 131.1 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.299 -0.876 . . . . 0.0 109.271 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' PHE . . . . . . . . . . . . . 17.3 t80 55.46 92.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.389 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -59.6 157.06 12.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.275 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -136.65 -20.56 1.33 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.399 -0.813 . . . . 0.0 109.602 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . 0.458 ' CG ' ' H ' ' C' ' 7' ' ' PHE . 42.1 tttm 56.69 176.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.475 0.655 . . . . 0.0 109.658 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' PHE . . . . . 0.458 ' H ' ' CG ' ' C' ' 6' ' ' LYS . 67.6 t80 -92.75 124.33 36.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.423 -0.798 . . . . 0.0 109.778 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' ILE . . . . . . . . . . . . . 64.3 mt -115.24 143.26 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.481 -0.762 . . . . 0.0 110.045 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' ILE . . . . . 0.59 HG23 ' O ' ' C' ' 9' ' ' ILE . 11.2 tt -137.49 117.62 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.511 -0.743 . . . . 0.0 109.483 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.528 HG22 HG22 ' C' ' 53' ' ' ILE . 1.0 OUTLIER -120.91 147.04 45.97 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.643 1.211 . . . . 0.0 107.938 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' THR . . . . . 0.433 HG23 ' O ' ' C' ' 11' ' ' THR . 4.4 t -86.87 55.58 3.63 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.169 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -177.83 -124.77 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 119.955 -1.716 . . . . 0.0 108.321 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.82 108.4 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.229 -0.92 . . . . 0.0 109.002 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -163.49 -100.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.155 -0.965 . . . . 0.0 109.751 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' ILE . . . . . 0.491 ' N ' ' HD3' ' C' ' 16' ' ' PRO . 5.3 mt 57.23 61.23 6.53 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.825 . . . . 0.0 109.285 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' C' ' 15' ' ' ILE . 2.2 Cg_endo -63.67 155.37 63.64 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 122.195 1.93 . . . . 0.0 109.618 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.29 -17.11 57.11 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' C' ' 18' ' ' LEU . 51.5 mt -117.04 135.74 53.49 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.098 -1.236 . . . . 0.0 108.807 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -86.41 108.6 18.56 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 11.3 mt -93.2 136.66 33.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.305 -0.872 . . . . 0.0 109.724 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -118.52 130.27 55.83 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 9.3 t -58.06 131.41 50.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.779 -1.2 . . . . 0.0 111.102 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 mt -120.36 11.59 11.5 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.74 -179.95 19.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' ILE . . . . . 0.481 HD13 ' N ' ' C' ' 25' ' ' ILE . 0.0 OUTLIER -113.43 141.06 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 122.007 -0.701 . . . . 0.0 109.465 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.48 146.46 38.4 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 6.5 p -151.9 139.77 19.97 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.991 -1.068 . . . . 0.0 108.53 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 15.0 t -149.92 138.63 20.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.012 -1.055 . . . . 0.0 108.813 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.413 HG23 ' O ' ' C' ' 29' ' ' ILE . 11.6 tt -105.18 130.44 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.925 . . . . 0.0 109.068 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' SER . . . . . . . . . . . . . 91.8 p -168.97 -145.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.039 -1.038 . . . . 0.0 109.668 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' ASP . . . . . 0.465 ' O ' ' CB ' ' C' ' 32' ' ' ASN . 21.3 t0 -150.73 153.96 36.5 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.204 -0.935 . . . . 0.0 109.523 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' ASN . . . . . 0.506 ' H ' ' NZ ' ' C' ' 63' ' ' LYS . 3.7 t-20 77.15 129.26 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 108.748 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 45.2 t -66.58 -31.94 55.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.56 -0.712 . . . . 0.0 109.466 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -56.75 -42.6 79.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.821 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -75.97 -38.37 57.57 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.206 -0.933 . . . . 0.0 109.301 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 79.2 mt -59.81 -42.1 87.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 120.819 -1.175 . . . . 0.0 109.336 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.1 -43.91 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.718 -1.238 . . . . 0.0 109.092 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -66.33 -46.88 75.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.381 -0.824 . . . . 0.0 110.189 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -56.08 -49.67 73.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.071 -1.018 . . . . 0.0 109.682 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 84.2 mt -67.85 -44.71 76.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.128 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -50.73 -43.09 57.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.714 -1.241 . . . . 0.0 109.797 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -65.97 -36.26 82.83 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.797 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -76.39 -35.36 58.67 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.798 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 t -68.52 -50.85 52.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.952 -1.093 . . . . 0.0 109.079 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -59.55 -29.73 68.12 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.567 -1.253 . . . . 0.0 109.882 -175.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.3 -29.24 61.54 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.791 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -85.5 8.53 18.84 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.37 3.04 81.66 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.33 162.32 54.53 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . 0.419 ' C ' ' SD ' ' C' ' 50' ' ' MET . 0.0 OUTLIER -131.17 -3.09 3.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.128 -1.219 . . . . 0.0 110.222 -177.189 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.5 127.85 1.81 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.245 -1.455 . . . . 0.0 110.01 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 53.5 tp -96.45 139.19 32.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.553 -0.969 . . . . 0.0 108.844 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.543 ' O ' ' HB3' ' C' ' 54' ' ' ALA . 26.7 pt -144.01 173.26 5.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.788 -1.195 . . . . 0.0 108.313 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' C' ' 53' ' ' ILE . . . 70.99 77.22 0.18 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.936 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . 0.439 ' CE2' ' OH ' ' D' ' 67' ' ' TYR . 0.2 OUTLIER -80.08 154.4 28.13 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.122 -0.986 . . . . 0.0 109.333 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' ARG . . . . . 0.622 ' CG ' HH11 ' C' ' 56' ' ' ARG . 0.0 OUTLIER -136.78 46.36 2.22 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.56 -0.712 . . . . 0.0 109.957 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.62 -18.36 6.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' THR . . . . . . . . . . . . . 37.5 p -67.74 -61.27 1.96 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.045 -1.034 . . . . 0.0 109.722 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' CYS . . . . . 0.432 ' O ' ' HB3' ' C' ' 60' ' ' ALA . 24.0 p -68.35 -178.51 1.1 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.29 -0.881 . . . . 0.0 109.448 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' C' ' 59' ' ' CYS . . . 63.3 150.97 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.496 -0.753 . . . . 0.0 109.702 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -56.73 119.11 5.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.282 -0.887 . . . . 0.0 109.213 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.25 -98.95 0.12 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . 0.506 ' NZ ' ' H ' ' C' ' 32' ' ' ASN . 17.4 pttt -135.94 -48.66 0.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' PHE . . . . . . . . . . . . . 2.9 t80 65.38 -69.25 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.947 . . . . 0.0 109.816 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' C' ' 63' ' ' LYS . 1.0 OUTLIER -143.58 128.21 18.13 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.286 -0.884 . . . . 0.0 109.192 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.35 141.33 20.48 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.136 -1.986 . . . . 0.0 108.136 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' TYR . . . . . 0.805 ' CE1' HD11 ' B' ' 57' ' ' ILE . 0.3 OUTLIER -134.2 150.78 51.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.507 -0.996 . . . . 0.0 109.866 -179.404 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.02 140.99 6.61 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' THR . . . . . 0.475 ' OG1' HG23 ' B' ' 11' ' ' THR . 3.4 m -90.12 135.53 33.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.868 -1.372 . . . . 0.0 107.775 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' ILE . . . . . . . . . . . . . 47.3 mt -86.1 145.15 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 m -144.73 162.9 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.966 . . . . 0.0 110.229 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -152.37 147.03 25.82 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.96 140.58 39.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.923 -1.111 . . . . 0.0 108.012 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' C' ' 75' ' ' GLU . 42.2 t0 -131.3 39.67 3.51 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' C' ' 74' ' ' ASP . 30.4 tt0 -39.48 129.62 1.84 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.587 -0.696 . . . . 0.0 109.942 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -157.98 -32.56 0.07 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.312 -0.868 . . . . 0.0 109.249 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' GLN . . . . . 0.429 ' H ' ' CD ' ' C' ' 77' ' ' GLN . 1.7 pm0 -103.94 141.56 35.95 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.541 -0.725 . . . . 0.0 109.132 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -67.81 148.24 51.48 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.256 -0.902 . . . . 0.0 109.469 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 52.5 m -161.13 139.53 9.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.87 . . . . 0.0 109.309 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' MET . . . . . . . . . . . . . 3.9 ptp -80.11 87.09 5.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.856 . . . . 0.0 109.26 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.423 179.867 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 29.9 mtm . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' ILE . . . . . 0.862 ' H ' HD13 ' D' ' 2' ' ' ILE . 0.2 OUTLIER -140.67 -22.71 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.458 -0.776 . . . . 0.0 109.426 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 55.7 -165.14 0.12 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.489 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -158.22 62.83 0.45 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.356 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' D' ' 7' ' ' PHE . 22.0 p-10 -169.54 45.89 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.214 -0.929 . . . . 0.0 110.048 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -63.9 81.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.045 -1.034 . . . . 0.0 110.23 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' D' ' 5' ' ' ASP . 67.0 t80 -108.54 121.93 46.02 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' ILE . . . . . . . . . . . . . 28.2 mt -133.82 129.73 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.365 -0.834 . . . . 0.0 109.928 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' ILE . . . . . 0.633 HG23 ' O ' ' D' ' 9' ' ' ILE . 13.4 tt -137.15 114.19 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.56 160.75 27.67 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' THR . . . . . 0.547 ' OG1' ' OG1' ' E' ' 69' ' ' THR . 1.2 p -121.43 83.53 2.1 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.34 -134.26 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.331 -0.855 . . . . 0.0 109.099 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -99.79 -56.27 2.43 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.374 -0.829 . . . . 0.0 109.774 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -161.85 -171.05 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.124 -0.985 . . . . 0.0 109.444 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' ILE . . . . . . . . . . . . . 68.4 mt -123.53 87.81 51.97 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.542 -0.724 . . . . 0.0 109.113 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.67 155.19 55.2 Favored 'Trans proline' 0 C--N 1.323 -0.781 0 C-N-CA 121.927 1.751 . . . . 0.0 110.305 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.14 -9.76 75.74 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' D' ' 18' ' ' LEU . 43.9 mt -128.0 139.01 52.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.118 -1.225 . . . . 0.0 109.27 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -85.2 108.05 17.54 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' LEU . . . . . . . . . . . . . 12.2 mt -99.45 134.92 41.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.448 -0.783 . . . . 0.0 109.502 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' TYR . . . . . 0.497 ' CE1' ' O ' ' D' ' 22' ' ' SER . 0.8 OUTLIER -116.68 129.99 56.46 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . 0.497 ' O ' ' CE1' ' D' ' 21' ' ' TYR . 0.0 OUTLIER -61.87 128.34 35.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.771 -1.206 . . . . 0.0 110.517 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' D' ' 23' ' ' LEU . 8.3 mt -114.6 7.6 16.1 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.2 -179.54 17.06 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' ILE . . . . . . . . . . . . . 49.6 mm -111.95 142.33 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.733 -0.863 . . . . 0.0 108.927 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.12 143.99 44.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.69 -0.631 . . . . 0.0 109.679 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 98.8 p -152.71 136.04 15.84 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' THR . . . . . . . . . . . . . 14.6 t -149.81 150.88 32.65 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.916 -1.115 . . . . 0.0 109.327 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 47.3 mm -113.39 139.86 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.322 -0.861 . . . . 0.0 109.555 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' SER . . . . . 0.557 ' OG ' ' N ' ' D' ' 31' ' ' ASP . 1.4 t -175.72 -171.66 0.48 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.384 -0.822 . . . . 0.0 108.938 -178.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' ASP . . . . . 0.557 ' N ' ' OG ' ' D' ' 30' ' ' SER . 1.3 p30 -124.86 145.08 49.97 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.495 -0.753 . . . . 0.0 109.415 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' D' ' 31' ' ' ASP . 1.5 m-20 78.21 133.18 0.06 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.604 0.716 . . . . 0.0 109.333 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.29 -31.27 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.547 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -56.95 -42.5 80.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 110.112 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -76.2 -38.89 55.91 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.338 -0.851 . . . . 0.0 109.486 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.04 -46.88 92.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.847 -1.158 . . . . 0.0 109.416 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.37 -51.53 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.97 -1.081 . . . . 0.0 110.01 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -55.99 -36.18 67.59 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 109.643 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -67.25 -42.4 84.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.105 -0.997 . . . . 0.0 110.091 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' D' ' 40' ' ' LEU . 44.8 mt -69.05 -46.51 67.69 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.981 -1.074 . . . . 0.0 108.724 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -47.16 -55.91 7.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.72 -1.237 . . . . 0.0 109.456 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -54.98 -33.44 62.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.215 -0.928 . . . . 0.0 110.408 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -77.35 -35.02 54.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.365 -0.834 . . . . 0.0 109.975 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 t -68.6 -51.4 46.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.038 -1.038 . . . . 0.0 108.904 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -67.78 -33.85 75.63 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 117.988 -1.485 . . . . 0.0 109.415 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.38 -32.83 72.76 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 mmtm -87.76 -4.94 58.86 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.41 -0.806 . . . . 0.0 109.125 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.56 9.39 64.72 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.16 175.92 54.35 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.14 2.45 0.77 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.897 -1.355 . . . . 0.0 110.143 -175.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.18 160.12 33.05 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.575 -1.297 . . . . 0.0 109.958 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 7.0 tp -130.06 139.12 51.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.724 -0.868 . . . . 0.0 109.339 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' ILE . . . . . . . . . . . . . 23.9 mt -114.04 141.15 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.644 -0.66 . . . . 0.0 110.242 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 63.1 79.55 0.26 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.341 -0.85 . . . . 0.0 111.904 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.536 ' O ' ' CG ' ' D' ' 55' ' ' PHE . 56.0 t80 -107.22 35.91 2.88 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.51 0.671 . . . . 0.0 110.279 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' ARG . . . . . 0.877 HH11 ' HG3' ' D' ' 56' ' ' ARG . 0.6 OUTLIER -67.47 158.4 31.93 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.961 -1.087 . . . . 0.0 109.911 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' ILE . . . . . . . . . . . . . 97.3 mt -135.99 148.51 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' THR . . . . . . . . . . . . . 68.9 p -66.3 -155.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.445 -0.784 . . . . 0.0 109.243 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' CYS . . . . . . . . . . . . . 18.7 p -65.22 -128.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.226 -0.921 . . . . 0.0 109.322 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.66 177.67 2.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.971 . . . . 0.0 109.161 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 59.04 103.52 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.526 -0.734 . . . . 0.0 109.926 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.89 9.02 85.19 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -162.48 118.17 1.9 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.113 -1.228 . . . . 0.0 109.477 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 64' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -139.58 145.93 39.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.467 -0.771 . . . . 0.0 109.138 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 65' ' ' LEU . . . . . . . . . . . . . 58.4 tp -165.75 118.16 1.11 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.838 . . . . 0.0 109.315 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.44 128.46 9.32 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 67' ' ' TYR . . . . . 0.439 ' OH ' ' CE2' ' C' ' 55' ' ' PHE . 62.8 t80 -133.23 144.27 49.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.441 -1.035 . . . . 0.0 110.008 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.58 155.67 21.54 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 69' ' ' THR . . . . . . . . . . . . . 54.3 m -106.52 140.12 39.91 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.443 -1.034 . . . . 0.0 108.806 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 70' ' ' ILE . . . . . 0.404 HD13 HG21 ' D' ' 70' ' ' ILE . 33.3 mt -90.25 137.68 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 m -144.39 166.28 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.82 . . . . 0.0 109.501 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.78 150.36 27.46 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.95 151.65 37.02 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.174 -0.954 . . . . 0.0 108.6 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -71.9 -3.54 23.09 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.907 -1.121 . . . . 0.0 109.59 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 75' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 57.68 174.02 0.05 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.458 -0.776 . . . . 0.0 109.692 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -172.45 -22.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 77' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -62.61 -22.86 66.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.574 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 78' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -64.44 -47.31 79.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 109.498 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 79' ' ' THR . . . . . . . . . . . . . 3.9 m -160.46 153.59 21.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.341 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 80' ' ' MET . . . . . . . . . . . . . 23.3 ttt -158.67 -60.49 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.421 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.489 179.985 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 12.2 ttt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 82.3 mt -122.52 149.89 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.499 -0.751 . . . . 0.0 109.326 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 3' ' ' PHE . . . . . 0.43 ' CZ ' ' CD2' ' A' ' 21' ' ' TYR . 37.2 m-85 -88.57 -134.33 0.09 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -52.27 168.14 0.11 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.799 -1.188 . . . . 0.0 109.639 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 5' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' E' ' 6' ' ' LYS . 37.5 t0 -147.87 -157.17 0.79 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.345 -0.847 . . . . 0.0 109.545 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 6' ' ' LYS . . . . . 0.521 ' H ' ' CG ' ' E' ' 5' ' ' ASP . 43.0 mtmt 61.17 -82.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.421 0.629 . . . . 0.0 110.646 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 7' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -115.17 150.55 35.88 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 8' ' ' ILE . . . . . . . . . . . . . 42.5 mt -129.25 137.61 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.506 -0.746 . . . . 0.0 109.147 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 9' ' ' ILE . . . . . 0.594 HG23 ' O ' ' E' ' 9' ' ' ILE . 17.5 tt -123.91 117.12 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 10' ' ' THR . . . . . . . . . . . . . 13.2 t -126.05 148.94 49.2 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 11' ' ' THR . . . . . 0.602 ' HG1' ' CB ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -76.19 -119.21 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . 0.406 ' H ' ' HB ' ' E' ' 11' ' ' THR . . . -111.35 98.5 7.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.312 -0.868 . . . . 0.0 109.68 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 13' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' E' ' 13' ' ' ASP . 20.3 p-10 -163.22 -7.09 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.694 -0.629 . . . . 0.0 109.475 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 59.8 163.59 0.05 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.599 -0.688 . . . . 0.0 109.468 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 15' ' ' ILE . . . . . . . . . . . . . 18.4 mt -124.98 84.01 59.47 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.85 156.25 44.63 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 122.002 1.801 . . . . 0.0 110.095 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.63 -9.92 74.94 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 18' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' E' ' 18' ' ' LEU . 65.7 mt -126.96 137.86 53.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.075 -1.25 . . . . 0.0 108.821 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 19' ' ' GLN . . . . . 0.443 ' H ' ' HG2' ' E' ' 19' ' ' GLN . 7.8 pt20 -86.86 110.61 20.09 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 20' ' ' LEU . . . . . . . . . . . . . 11.7 mt -92.1 135.2 34.16 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.969 -1.082 . . . . 0.0 109.592 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 21' ' ' TYR . . . . . 0.467 ' CE1' ' O ' ' E' ' 22' ' ' SER . 1.0 OUTLIER -117.83 129.82 55.89 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 22' ' ' SER . . . . . 0.467 ' O ' ' CE1' ' E' ' 21' ' ' TYR . 0.0 OUTLIER -63.97 129.95 42.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.779 -1.201 . . . . 0.0 111.259 -179.252 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' E' ' 23' ' ' LEU . 13.1 mt -120.09 12.52 11.92 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.68 -155.41 16.22 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 25' ' ' ILE . . . . . 0.418 HG21 HD13 ' E' ' 25' ' ' ILE . 0.7 OUTLIER -135.34 144.12 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.979 -0.718 . . . . 0.0 109.596 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.03 144.11 44.13 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 38.5 t -152.14 138.95 18.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.053 -1.029 . . . . 0.0 108.455 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.54 153.43 37.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.082 -1.011 . . . . 0.0 109.033 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 71.0 mt -124.9 130.98 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.193 -0.942 . . . . 0.0 109.276 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 31.2 t -163.09 167.85 21.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.393 -0.817 . . . . 0.0 109.664 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 31' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' E' ' 31' ' ' ASP . 16.4 p-10 -81.38 -65.55 1.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.404 -0.81 . . . . 0.0 112.628 -177.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 32' ' ' ASN . . . . . 0.459 ' H ' ' CG ' ' E' ' 31' ' ' ASP . 6.3 t-20 -78.28 147.62 34.24 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.711 -1.243 . . . . 0.0 109.05 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 73.3 t -68.88 -31.18 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.564 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -54.09 -34.09 59.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 109.734 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 35' ' ' GLU . . . . . 0.419 ' O ' ' ND2' ' E' ' 39' ' ' ASN . 41.5 mm-40 -77.23 -35.02 55.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.312 -0.867 . . . . 0.0 108.803 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 36' ' ' ILE . . . . . . . . . . . . . 66.3 mt -64.74 -53.6 40.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.042 -1.036 . . . . 0.0 109.154 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 60.9 t -55.79 -52.87 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.105 -0.997 . . . . 0.0 109.564 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 38' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.01 -36.49 70.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.419 -0.8 . . . . 0.0 109.633 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 39' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' E' ' 35' ' ' GLU . 74.1 m-20 -66.74 -41.11 88.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.043 -1.036 . . . . 0.0 109.831 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 40' ' ' LEU . . . . . . . . . . . . . 40.2 mt -72.4 -50.34 27.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.99 -1.068 . . . . 0.0 109.041 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -49.04 -52.16 26.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.697 -1.252 . . . . 0.0 109.371 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 42' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -59.36 -37.3 77.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.261 -0.9 . . . . 0.0 110.824 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 43' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -77.91 -34.84 51.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 110.032 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 12.8 t -74.05 -52.8 19.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.148 -0.97 . . . . 0.0 108.864 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 9.9 mtpp -59.26 -27.88 66.21 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.704 -1.248 . . . . 0.0 110.058 -176.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.03 -28.19 62.2 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.819 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -87.84 0.1 56.25 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.82 6.89 84.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.19 -174.88 5.88 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 50' ' ' MET . . . . . . . . . . . . . 3.3 ptm -155.71 -1.21 0.14 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.211 -1.17 . . . . 0.0 110.83 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . -164.82 150.55 18.72 Favored Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.296 -1.43 . . . . 0.0 109.738 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 15.2 tp -122.37 134.22 54.63 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 53' ' ' ILE . . . . . 0.882 HD13 ' O ' ' E' ' 53' ' ' ILE . 0.0 OUTLIER -106.93 147.4 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.521 -0.737 . . . . 0.0 109.659 -178.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' E' ' 53' ' ' ILE . . . 78.56 -63.43 0.3 Allowed 'General case' 0 N--CA 1.508 2.443 0 O-C-N 121.156 -0.965 . . . . 0.0 112.794 177.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 55' ' ' PHE . . . . . 0.552 ' O ' ' CG ' ' E' ' 55' ' ' PHE . 52.5 t80 31.64 39.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.595 0.712 . . . . 0.0 109.866 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 56' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' E' ' 54' ' ' ALA . 97.5 mtt180 -62.65 127.53 31.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.879 -1.138 . . . . 0.0 109.612 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 57' ' ' ILE . . . . . . . . . . . . . 78.3 mt -92.16 -34.78 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.255 -0.903 . . . . 0.0 109.161 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 58' ' ' THR . . . . . . . . . . . . . 69.7 p -76.63 146.49 38.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.67 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 59' ' ' CYS . . . . . . . . . . . . . 6.3 p -173.87 141.13 0.78 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.0 109.349 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . 51.03 -131.38 2.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.89 . . . . 0.0 109.55 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -165.39 115.87 1.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 0.0 109.263 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.32 -60.74 0.54 Allowed Glycine 0 N--CA 1.501 2.978 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -95.89 -176.43 3.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.286 -1.126 . . . . 0.0 109.36 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -135.57 159.47 41.52 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.49 -0.757 . . . . 0.0 109.185 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 53.1 tp -165.23 126.93 2.05 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.476 -0.765 . . . . 0.0 109.401 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.36 -67.15 1.77 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 66.12 121.65 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.221 -1.164 . . . . 0.0 109.656 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.11 156.73 28.4 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 69' ' ' THR . . . . . 0.547 ' OG1' ' OG1' ' D' ' 11' ' ' THR . 98.1 m -104.39 137.1 42.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.415 -1.05 . . . . 0.0 108.194 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 70' ' ' ILE . . . . . . . . . . . . . 28.3 mt -85.41 135.88 23.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 m -142.98 162.96 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.733 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 72' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -151.68 147.81 27.17 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.03 151.48 35.43 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.2 -0.937 . . . . 0.0 108.675 178.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -76.75 -5.88 49.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.878 -1.139 . . . . 0.0 109.226 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 75' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 54.58 -100.99 0.11 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.293 -0.88 . . . . 0.0 109.605 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 76' ' ' ALA . . . . . . . . . . . . . . . -166.64 70.22 0.11 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.908 -1.12 . . . . 0.0 109.735 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 77' ' ' GLN . . . . . 0.575 ' O ' ' N ' ' E' ' 79' ' ' THR . 98.0 mt-30 -46.11 -87.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.255 -0.903 . . . . 0.0 109.883 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 78' ' ' PHE . . . . . . . . . . . . . 41.8 t80 56.09 -79.09 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.491 -0.755 . . . . 0.0 109.696 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 79' ' ' THR . . . . . 0.575 ' N ' ' O ' ' E' ' 77' ' ' GLN . 0.1 OUTLIER -56.71 -28.63 61.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.422 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 80' ' ' MET . . . . . . . . . . . . . 21.0 ttt 50.76 85.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 109.555 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.453 -179.94 . . . . . . . . 0 0 . 1 stop_ save_